Citrus Sinensis ID: 021181

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310------
Protein Sequence
MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPTH
Secondary Structure (PSIPRED)
cccccccEEEEEccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccHHHHcccccHHHHHHHHHccccccccccccccccccHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccc
Secondary Structure Prediction (SSPRO)
cEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEccccEEEccccccccccEEEEEEcccEEHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEcccccEEEccccccEccccccccccccccHHHccHHHcccEcccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHcccccHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAikdiirppqretfndVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYvhsanvlhrdlkpsnlllnancdlkigdfglarttsetdfMTEYVVTRwyrapelllncseyTAAIDIWSVGCILgeimtrqplfpgkdyvHQLRLITEligspdetslgflrsdnARRYVRmlpqfpkqnfsarfpnkspgaVDLLEKMlvfdpnrritvdealchpylaplhdineepvcprpfsfdfehpsfteENIKELIYREsvkfnpdpth
Flexible Loop (DISEMBL)
MNSETREEVAIKkignafdnridaKRTLREIKLLRHMDHENiiaikdiirppqreTFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFglarttsetdFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEligspdetslgFLRSDNARRYVRMLPqfpkqnfsarfpNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKeliyresvkfnpdpth
Low Complexity Region (SEG)
MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPTH
Disordered region (IsUnstruct)
**********IKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF**************GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYR***********
Disordered Region (DISOPRED)
***ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP*****NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRES**FN*****
Disordered Region (DISEMBL)
********VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPTH
Disordered Region (DISPRO)
****TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPTH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	316	2.2.26 [Sep-21-2011]
Q39024	376	Mitogen-activated protein	yes	no	0.984	0.827	0.906	1e-170
Q40353	371	Mitogen-activated protein	N/A	no	0.993	0.846	0.888	1e-169
Q5J4W4	394	Mitogen-activated protein	yes	no	1.0	0.802	0.841	1e-162
Q9LMM5	369	Mitogen-activated protein	no	no	0.984	0.842	0.884	1e-162
Q336X9	376	Mitogen-activated protein	no	no	1.0	0.840	0.851	1e-160
Q8GYQ5	372	Mitogen-activated protein	no	no	0.990	0.841	0.817	1e-153
Q39025	376	Mitogen-activated protein	no	no	0.996	0.837	0.780	1e-149
Q40531	371	Mitogen-activated protein	N/A	no	0.987	0.840	0.778	1e-145
Q40532	393	Mitogen-activated protein	N/A	no	0.996	0.801	0.740	1e-141
Q84UI5	398	Mitogen-activated protein	no	no	0.987	0.783	0.747	1e-141

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  597 bits (1539), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 282/311 (90%), Positives = 299/311 (96%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           NSET EEVAIKKIGNAFDN IDAKRTLREIKLL+HMDHEN+IA+KDII+PPQRE FNDVY
Sbjct: 62  NSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVY 121

Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           IVYELMDTDLHQIIRS+Q LTDDHCR+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct: 122 IVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 181

Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           DLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE MTR+
Sbjct: 182 DLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTRE 241

Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           PLFPGKDYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S G
Sbjct: 242 PLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAG 301

Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
           AVDLLEKMLVFDP+RRITVDEALCHPYLAPLHDINEEPVC RPF+FDFE P+ TEENIKE
Sbjct: 302 AVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKE 361

Query: 302 LIYRESVKFNP 312
           LIYRE+VKFNP
Sbjct: 362 LIYRETVKFNP 372

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  595 bits (1535), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 279/314 (88%), Positives = 303/314 (96%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N+ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+++IKDIIRPPQ+E FN V
Sbjct: 55  VNAETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVMSIKDIIRPPQKENFNHV 114

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIV ELMDTDLHQIIRS+Q +TDDHCRYF+YQLLRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 115 YIVSELMDTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 174

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS+YTAAIDIWSVGCILGEI+TR
Sbjct: 175 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTR 234

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPG+DYVHQLRL+TELIGSPD+ SLGFLRS+NARRYVR LPQ+PKQNFSARFPN SP
Sbjct: 235 QPLFPGRDYVHQLRLVTELIGSPDDASLGFLRSENARRYVRQLPQYPKQNFSARFPNMSP 294

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GAVDLLEKML+FDP++RI VDEALCHPY+APLHDINEEPVC RPFSFDFE P FTEE+IK
Sbjct: 295 GAVDLLEKMLIFDPSKRIKVDEALCHPYMAPLHDINEEPVCARPFSFDFEEPMFTEEDIK 354

Query: 301 ELIYRESVKFNPDP 314
           ELI++ESV+FNPDP
Sbjct: 355 ELIWKESVRFNPDP 368

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q5J4W4|MPK2_ORYSJ Mitogen-activated protein kinase 2 OS=Oryza sativa subsp. japonica GN=MPK2 PE=2 SV=1

 Score =  571 bits (1471), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 266/316 (84%), Positives = 299/316 (94%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N++TR+EVAIKKIGNAFDN+IDAKRTLREIKLLRHMDH+N+I+IKDIIRPP+RE FNDV
Sbjct: 79  VNAQTRQEVAIKKIGNAFDNQIDAKRTLREIKLLRHMDHDNVISIKDIIRPPRRENFNDV 138

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLH ++RS+Q LTDDHC+YFLYQ+LRGLKYVHSANVLHRDL+PSNLLLNA 
Sbjct: 139 YIVYELMDTDLHHLLRSNQPLTDDHCQYFLYQVLRGLKYVHSANVLHRDLRPSNLLLNAK 198

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTT+ETDFM EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI+TR
Sbjct: 199 CDLKIGDFGLARTTNETDFMMEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIVTR 258

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPGKDYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+PKQ F ARFP  S 
Sbjct: 259 EPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRSLPQYPKQQFRARFPTMSS 318

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GA+DLLE+MLVFDP++RITVDEALCHPYLA LH+I +EPVCP PFSFDFE PS TEE+IK
Sbjct: 319 GAMDLLERMLVFDPSKRITVDEALCHPYLASLHEIYDEPVCPAPFSFDFEQPSLTEEDIK 378

Query: 301 ELIYRESVKFNPDPTH 316
           E+I+RE++KFNP+P H
Sbjct: 379 EIIWREALKFNPEPIH 394

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1

 Score =  570 bits (1469), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 275/311 (88%), Positives = 291/311 (93%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           NSET EEVAIKKIGNAF N IDAKRTLREIKLL+HMDH+N+IAI DIIRPPQ + FNDV+
Sbjct: 59  NSETGEEVAIKKIGNAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVH 118

Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           IVYELMDTDLH IIRS+Q LTDDH R+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct: 119 IVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 178

Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           DLKIGDFGLART SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR+
Sbjct: 179 DLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRE 238

Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           PLFPG+DYV QLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S  
Sbjct: 239 PLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVN 298

Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
           AVDLL+KMLVFDPNRRITVDEALCHPYLAPLH+ NEEPVC RPF FDFE PS TEENIKE
Sbjct: 299 AVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKE 358

Query: 302 LIYRESVKFNP 312
           LIYRESVKFNP
Sbjct: 359 LIYRESVKFNP 369

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q336X9|MPK6_ORYSJ Mitogen-activated protein kinase 6 OS=Oryza sativa subsp. japonica GN=MPK6 PE=2 SV=1

 Score =  565 bits (1455), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 269/316 (85%), Positives = 293/316 (92%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +NSE  EEVAIKKIGNAFDN IDAKRTLREIKLLRHMDHENIIAIKDIIRPP+R+ FNDV
Sbjct: 61  VNSENGEEVAIKKIGNAFDNHIDAKRTLREIKLLRHMDHENIIAIKDIIRPPRRDNFNDV 120

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIV ELMDTDLHQIIRS+Q LTDDHC+YFLYQLLRGLKYVHSANVLHRDLKPSNL LNAN
Sbjct: 121 YIVSELMDTDLHQIIRSNQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNAN 180

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKI DFGLARTT+ETD MTEYVVTRWYRAPELLLNCS+YTAAID+WSVGCILGEI+TR
Sbjct: 181 CDLKIADFGLARTTTETDLMTEYVVTRWYRAPELLLNCSQYTAAIDVWSVGCILGEIVTR 240

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPG+DY+ QL+LITELIGSPD++SLGFLRSDNARRY++ LPQ+P+Q+F  RF N S 
Sbjct: 241 QPLFPGRDYIQQLKLITELIGSPDDSSLGFLRSDNARRYMKQLPQYPRQDFRLRFRNMSA 300

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GAVDLLEKMLVFDP+RRITVDEAL HPYLA LHDINEEP CP PFSFDFE PSFTEE+IK
Sbjct: 301 GAVDLLEKMLVFDPSRRITVDEALHHPYLASLHDINEEPTCPAPFSFDFEQPSFTEEHIK 360

Query: 301 ELIYRESVKFNPDPTH 316
           ELI+RES+ FNPDP +
Sbjct: 361 ELIWRESLAFNPDPPY 376

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q8GYQ5|MPK12_ARATH Mitogen-activated protein kinase 12 OS=Arabidopsis thaliana GN=MPK12 PE=1 SV=1

 Score =  540 bits (1392), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 256/313 (81%), Positives = 285/313 (91%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +NS T E+VAIKKIGNAFDN IDAKRTLREIKLLRHMDHEN+I IKDI+RPPQR+ FNDV
Sbjct: 59  VNSVTGEKVAIKKIGNAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDV 118

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDL +I+RS+Q LT D CR+ +YQLLRGLKYVHSAN+LHRDL+PSN+LLN+ 
Sbjct: 119 YIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSK 178

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKIGDFGLARTTS+TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 
Sbjct: 179 NELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTG 238

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPGKDYVHQLRLITEL+GSPD +SLGFLRSDNARRYVR LP++PKQ F+ARFP    
Sbjct: 239 QPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPT 298

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DLLE+MLVFDPNRRI+VDEAL H YL+P HD+ +EPVC  PFSFDFEHPS TEE+IK
Sbjct: 299 TAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCTEEHIK 358

Query: 301 ELIYRESVKFNPD 313
           ELIY+ESVKFNPD
Sbjct: 359 ELIYKESVKFNPD 371

Negative regulator of the auxin transduction signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2

 Score =  528 bits (1361), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 246/315 (78%), Positives = 285/315 (90%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++SET EE+AIKKIG AFDN++DAKRTLREIKLLRH++HEN++ IKDIIRPP++E F DV
Sbjct: 61  VDSETHEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDV 120

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIV+ELMDTDLHQIIRS+Q L DDHC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN+N
Sbjct: 121 YIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSN 180

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKI DFGLARTTSET++MTEYVVTRWYRAPELLLN SEYT+AID+WSVGCI  EIMTR
Sbjct: 181 CDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTR 240

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPGKDYVHQL+LITELIGSPD  SL FLRS NAR+YV+ LP+FP+QNFSARFP+ + 
Sbjct: 241 EPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNS 300

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DLLEKMLVFDP +RITV+EALC+PYL+ LHD+N+EPVC   FSF FE PS TEE IK
Sbjct: 301 TAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIK 360

Query: 301 ELIYRESVKFNPDPT 315
           EL++ ESVKFNP P+
Sbjct: 361 ELVWLESVKFNPLPS 375

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  513 bits (1322), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 243/312 (77%), Positives = 278/312 (89%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           NSET+EEVAIKKIGNAF+NRIDAKRTLREIKLL HMDHENII IKDI+RPP RE FNDVY
Sbjct: 57  NSETKEEVAIKKIGNAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVY 116

Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           IVYELMDTDLHQIIRS Q LTDDHC+YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct: 117 IVYELMDTDLHQIIRSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 176

Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           DLKI DFGLARTTSE DFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCIL E++ R+
Sbjct: 177 DLKICDFGLARTTSEADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKRE 236

Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           PLFPG+DY  QL LI  L+GSP+++ LGFLRSDNAR+YV+ LP+ P+  FS +FP+ SP 
Sbjct: 237 PLFPGRDYAQQLGLIIALLGSPEDSDLGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPL 296

Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
           A+DL E+MLVFDP +RITV++AL HP+L  LH+INEEPVC  PF+FDFE  S +E++IKE
Sbjct: 297 ALDLAERMLVFDPAKRITVEDALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKE 356

Query: 302 LIYRESVKFNPD 313
           LI+ E++KF+P+
Sbjct: 357 LIWNEALKFDPN 368

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  500 bits (1288), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 234/316 (74%), Positives = 275/316 (87%), Gaps = 1/316 (0%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +NSET E VAIKKI NAFDN+IDAKRTLREIKLLRHMDHENI+AI+DII PPQRE FNDV
Sbjct: 78  LNSETNEHVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPQREAFNDV 137

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YI YELMDTDLHQIIRS+Q L+++HC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLNAN
Sbjct: 138 YIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 197

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKI DFGLAR TSETDFMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E+M R
Sbjct: 198 CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 257

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPG+D+VHQLRL+ ELIG+P E  + FL ++NA+RY+R LP + +Q+F  +FP+ +P
Sbjct: 258 KPLFPGRDHVHQLRLLMELIGTPSEAEMEFL-NENAKRYIRQLPLYRRQSFVEKFPHVNP 316

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DL+EKML FDP RRITV++AL HPYL  LHDI++EPVC  PF+FDFE  + TEE +K
Sbjct: 317 AAIDLVEKMLTFDPRRRITVEDALAHPYLTSLHDISDEPVCMTPFNFDFEQHALTEEQMK 376

Query: 301 ELIYRESVKFNPDPTH 316
           ELIYRE + FNP+  H
Sbjct: 377 ELIYREGLAFNPEYQH 392

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  499 bits (1286), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 234/313 (74%), Positives = 276/313 (88%), Gaps = 1/313 (0%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +NSET E+VAIKKI NAFDN+IDAKRTLREIKLLRHMDHENI+AI+DII PPQR +FNDV
Sbjct: 85  LNSETGEQVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPQRNSFNDV 144

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YI YELMDTDLHQIIRS+Q L+++HC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLNAN
Sbjct: 145 YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 204

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKI DFGLARTTSETDFMTEYVVTRWYRAPELLLN SEYTAAID+WSVGCI  E+M R
Sbjct: 205 CDLKICDFGLARTTSETDFMTEYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIFMELMDR 264

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPG+D+VHQLRL+ ELIG+P+E  L F+ ++NARRY+R LP+  +Q+F  +FP+  P
Sbjct: 265 KPLFPGRDHVHQLRLLMELIGTPNEADLDFV-NENARRYIRQLPRHARQSFPEKFPHVHP 323

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DL+EKML FDP +RITV+ AL HPYLA LHDI++EPVC  PFSFDFE  + +EE +K
Sbjct: 324 LAIDLVEKMLTFDPRQRITVEGALAHPYLASLHDISDEPVCSSPFSFDFEQHALSEEQMK 383

Query: 301 ELIYRESVKFNPD 313
           +LIY+E + FNPD
Sbjct: 384 DLIYQEGLAFNPD 396

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	316
315258227	373	mitogen-activated protein kinase 4 [Nico	1.0	0.847	0.920	1e-176
78096654	373	mitogen-activated protein kinase [Nicoti	1.0	0.847	0.911	1e-174
350528643	373	mitogen-activated protein kinase 1 [Prun	1.0	0.847	0.927	1e-174
25052804	374	mitogen-activated protein kinase 4 [Petr	0.993	0.839	0.929	1e-173
359489658	375	PREDICTED: mitogen-activated protein kin	0.993	0.837	0.920	1e-171
255541680	370	big map kinase/bmk, putative [Ricinus co	0.990	0.845	0.916	1e-170
224067920	372	predicted protein [Populus trichocarpa]	0.993	0.844	0.914	1e-170
225426166	375	PREDICTED: mitogen-activated protein kin	1.0	0.842	0.905	1e-170
224130362	372	predicted protein [Populus trichocarpa]	0.990	0.841	0.920	1e-169
363808060	373	uncharacterized protein LOC100815697 [Gl	0.993	0.841	0.910	1e-169

>gi|315258227|gb|ADT91692.1| mitogen-activated protein kinase 4 [Nicotiana attenuata]

 Score =  622 bits (1604), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 291/316 (92%), Positives = 308/316 (97%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH+N+IAIKDIIRPPQ E FNDV
Sbjct: 58  MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHDNVIAIKDIIRPPQTENFNDV 117

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q LTDDHCRYFLYQ+LRGLKY+HSANVLHRDLKPSNLLLNAN
Sbjct: 118 YIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 177

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLK+GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE+MTR
Sbjct: 178 CDLKVGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEMMTR 237

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPGKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+P+Q F+ARFPN SP
Sbjct: 238 QPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQYPRQQFAARFPNSSP 297

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GAVDLLEKMLVFDP+RR+TVD+ALCHPYLAPLHDINEEP+CP+PFSFDFE PSFTEENIK
Sbjct: 298 GAVDLLEKMLVFDPSRRVTVDQALCHPYLAPLHDINEEPICPKPFSFDFEQPSFTEENIK 357

Query: 301 ELIYRESVKFNPDPTH 316
           ELI+RESVKFNPDPTH
Sbjct: 358 ELIWRESVKFNPDPTH 373

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|78096654|dbj|BAE46985.1| mitogen-activated protein kinase [Nicotiana tabacum]

 Score =  617 bits (1592), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 288/316 (91%), Positives = 306/316 (96%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH+N+IA KDIIRPPQ E FNDV
Sbjct: 58  MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHDNVIATKDIIRPPQTENFNDV 117

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q LTDDHCRYFLYQ+LRGLKY+HSANVLHRDLKPSNL LNAN
Sbjct: 118 YIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQILRGLKYIHSANVLHRDLKPSNLFLNAN 177

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLK+GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE+MTR
Sbjct: 178 CDLKVGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEMMTR 237

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPGKDYVHQL+LITELIGSPD+ SLGFLRSDNARRYVR LPQ+P+Q F+ARFPN SP
Sbjct: 238 QPLFPGKDYVHQLKLITELIGSPDDASLGFLRSDNARRYVRQLPQYPRQQFAARFPNSSP 297

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GAVDLLEKMLVFDP+RR+TVD+ALCHPYLAPLHDINEEP+CP+PFSFDFE PSFTEENIK
Sbjct: 298 GAVDLLEKMLVFDPSRRVTVDQALCHPYLAPLHDINEEPICPKPFSFDFEQPSFTEENIK 357

Query: 301 ELIYRESVKFNPDPTH 316
           ELI+RESVKFNPDPTH
Sbjct: 358 ELIWRESVKFNPDPTH 373

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350528643|gb|AEQ28763.1| mitogen-activated protein kinase 1 [Prunus salicina]

 Score =  617 bits (1590), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 293/316 (92%), Positives = 307/316 (97%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N+ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+IAIKDIIRPPQ+E FNDV
Sbjct: 58  VNAETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPQKENFNDV 117

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q L DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL+NAN
Sbjct: 118 YIVYELMDTDLHQIIRSNQPLNDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLMNAN 177

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR
Sbjct: 178 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 237

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPGKDYVHQLRLITEL+GSPD++SLGFLRSDNARRYVR LPQ+PKQ+FSA FPN SP
Sbjct: 238 RPLFPGKDYVHQLRLITELLGSPDDSSLGFLRSDNARRYVRQLPQYPKQSFSAGFPNMSP 297

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP PF+FDFE PSFTEENIK
Sbjct: 298 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPMPFNFDFEQPSFTEENIK 357

Query: 301 ELIYRESVKFNPDPTH 316
           ELI+RESVKFNPDP H
Sbjct: 358 ELIWRESVKFNPDPIH 373

Source: Prunus salicina

Species: Prunus salicina

Genus: Prunus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|25052804|gb|AAN65180.1| mitogen-activated protein kinase 4 [Petroselinum crispum]

 Score =  613 bits (1581), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 292/314 (92%), Positives = 305/314 (97%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           MNS+TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM+HEN+IAIKDIIRPPQ E+FNDV
Sbjct: 59  MNSDTREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMNHENVIAIKDIIRPPQIESFNDV 118

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 119 YIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 178

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE+MTR
Sbjct: 179 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEVMTR 238

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPGKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+PKQ FSARF NKSP
Sbjct: 239 QPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQYPKQQFSARFLNKSP 298

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GA+DLLEKML+FDPNRRITVDEALCHPYLA LHDINEEPVCPRPFSFDFE P+ TEENIK
Sbjct: 299 GALDLLEKMLIFDPNRRITVDEALCHPYLAALHDINEEPVCPRPFSFDFEQPTCTEENIK 358

Query: 301 ELIYRESVKFNPDP 314
           ELI++ESVKFNPDP
Sbjct: 359 ELIWKESVKFNPDP 372

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359489658|ref|XP_003633959.1| PREDICTED: mitogen-activated protein kinase homolog MMK2-like [Vitis vinifera] gi|147786894|emb|CAN75543.1| hypothetical protein VITISV_000466 [Vitis vinifera] gi|297745345|emb|CBI40425.3| unnamed protein product [Vitis vinifera]

 Score =  608 bits (1568), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 289/314 (92%), Positives = 302/314 (96%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+I +KDIIRPP+RE FNDV
Sbjct: 59  MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIVLKDIIRPPKRENFNDV 118

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q L DDHCRYFLYQ+LRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 119 YIVYELMDTDLHQIIRSNQPLNDDHCRYFLYQVLRGLKYVHSANVLHRDLKPSNLLLNAN 178

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR
Sbjct: 179 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 238

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPG+DYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+Q F ARFPN SP
Sbjct: 239 QPLFPGRDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQQFQARFPNMSP 298

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GA+DLLEKMLVFDPNRRITV+ AL HPYLAPLHDINEEPVCPRPF FDFE PSFTEENIK
Sbjct: 299 GAIDLLEKMLVFDPNRRITVEGALSHPYLAPLHDINEEPVCPRPFVFDFEQPSFTEENIK 358

Query: 301 ELIYRESVKFNPDP 314
           ELI+RESVKFNPDP
Sbjct: 359 ELIWRESVKFNPDP 372

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255541680|ref|XP_002511904.1| big map kinase/bmk, putative [Ricinus communis] gi|223549084|gb|EEF50573.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  604 bits (1557), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 287/313 (91%), Positives = 302/313 (96%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N+ET+EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI+AIKDIIRPPQ+E FNDVY
Sbjct: 58  NAETQEEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIVAIKDIIRPPQKENFNDVY 117

Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           IV ELMDTDLH IIRS+Q LTDDHCRYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNANC
Sbjct: 118 IVSELMDTDLHHIIRSNQSLTDDHCRYFLYQLLRGLKYVHSAHVLHRDLKPSNLLLNANC 177

Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           DLKI DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ
Sbjct: 178 DLKIADFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 237

Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           PLFPGKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+P++NF+ RFPN S G
Sbjct: 238 PLFPGKDYVHQLRLITELIGSPDDNSLGFLRSDNARRYVRQLPQYPRKNFATRFPNMSSG 297

Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
           A+DLLE+MLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF+FDFE PSFTEENIKE
Sbjct: 298 AIDLLERMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFNFDFEQPSFTEENIKE 357

Query: 302 LIYRESVKFNPDP 314
           LI+RESVKFNPDP
Sbjct: 358 LIWRESVKFNPDP 370

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224067920|ref|XP_002302599.1| predicted protein [Populus trichocarpa] gi|222844325|gb|EEE81872.1| predicted protein [Populus trichocarpa]

 Score =  603 bits (1556), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 287/314 (91%), Positives = 300/314 (95%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N+ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+IAIKDIIRPPQ E FNDV
Sbjct: 59  VNAETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPQTENFNDV 118

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL LNAN
Sbjct: 119 YIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNAN 178

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI+TR
Sbjct: 179 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEILTR 238

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPGKDYVHQLRL+TELIGSPD++ LGFLRS+NARRYVR LPQ+P+QNF+ARFPN S 
Sbjct: 239 QPLFPGKDYVHQLRLVTELIGSPDDSCLGFLRSENARRYVRQLPQYPRQNFAARFPNISA 298

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GA DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF FDFE PSFTEENIK
Sbjct: 299 GAADLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFLFDFEQPSFTEENIK 358

Query: 301 ELIYRESVKFNPDP 314
           ELI+ ESV FNP P
Sbjct: 359 ELIWMESVNFNPGP 372

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426166|ref|XP_002278860.1| PREDICTED: mitogen-activated protein kinase homolog MMK2 [Vitis vinifera] gi|297742231|emb|CBI34380.3| unnamed protein product [Vitis vinifera]

 Score =  602 bits (1551), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 286/316 (90%), Positives = 301/316 (95%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +NSET EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+IAIKDIIRPP++ETFNDV
Sbjct: 60  VNSETHEEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPKKETFNDV 119

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQII S+Q LTDDHC+YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 120 YIVYELMDTDLHQIICSNQSLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR
Sbjct: 180 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPGKDYVHQLRLITEL+GSPD+ SLGFLRS+NARRYVR LPQ+PKQ  SARFPN SP
Sbjct: 240 EPLFPGKDYVHQLRLITELLGSPDDASLGFLRSNNARRYVRQLPQYPKQQISARFPNMSP 299

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLVFDP +RITVDEALCHPYL+ LHDIN+EPVCP PFSFDFE  S TEENIK
Sbjct: 300 SAVDLLEKMLVFDPTKRITVDEALCHPYLSSLHDINDEPVCPSPFSFDFEQSSITEENIK 359

Query: 301 ELIYRESVKFNPDPTH 316
           ELI+RESVKFNPDPTH
Sbjct: 360 ELIWRESVKFNPDPTH 375

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224130362|ref|XP_002320818.1| predicted protein [Populus trichocarpa] gi|222861591|gb|EEE99133.1| predicted protein [Populus trichocarpa]

 Score =  601 bits (1550), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 288/313 (92%), Positives = 299/313 (95%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+IAIKDIIRPPQ E FNDV
Sbjct: 59  VNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPQTENFNDV 118

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL LNAN
Sbjct: 119 YIVYELMDTDLHQIIRSNQLLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNAN 178

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 
Sbjct: 179 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTG 238

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPGKDYVHQLRLITELIGSPD+ SLGFLRS+NARRYVR LPQ+P+Q F+ARFPN S 
Sbjct: 239 QPLFPGKDYVHQLRLITELIGSPDDFSLGFLRSENARRYVRQLPQYPRQKFAARFPNMSA 298

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GAV+LLEKMLVFDPNRRITVDEALCHPYL PLH INEEPVCP+PFSFDFE PSFTEENIK
Sbjct: 299 GAVELLEKMLVFDPNRRITVDEALCHPYLEPLHGINEEPVCPKPFSFDFEQPSFTEENIK 358

Query: 301 ELIYRESVKFNPD 313
           ELI+RESV FNPD
Sbjct: 359 ELIWRESVNFNPD 371

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363808060|ref|NP_001242213.1| uncharacterized protein LOC100815697 [Glycine max] gi|255640002|gb|ACU20292.1| unknown [Glycine max]

 Score =  600 bits (1548), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 286/314 (91%), Positives = 301/314 (95%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N+ETREEVAIKK+GNAFDNRIDAKRTLREIKLLRHMDHEN+IA+KDIIRPPQR+ FNDV
Sbjct: 57  VNAETREEVAIKKVGNAFDNRIDAKRTLREIKLLRHMDHENVIALKDIIRPPQRDNFNDV 116

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS+Q LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 117 YIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 176

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           CDLKI DFGLAR TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI+TR
Sbjct: 177 CDLKIADFGLARATSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIITR 236

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           QPLFPGKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+P+Q F+ RFP+ SP
Sbjct: 237 QPLFPGKDYVHQLRLITELIGSPDDHSLGFLRSDNARRYVRQLPQYPRQQFATRFPSMSP 296

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
           GAVDLLEKMLVFDPNRRITV EALCHPYLAPLHDINEEPVC RPFSFDFE PSFTEE+IK
Sbjct: 297 GAVDLLEKMLVFDPNRRITVKEALCHPYLAPLHDINEEPVCVRPFSFDFEQPSFTEEDIK 356

Query: 301 ELIYRESVKFNPDP 314
           ELI+RESV FNPDP
Sbjct: 357 ELIWRESVLFNPDP 370

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	316
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.984	0.827	0.906	2.1e-155
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.984	0.842	0.884	3e-149
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.990	0.841	0.817	2.4e-140
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.996	0.837	0.780	9.5e-137
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.977	0.851	0.763	1.1e-128
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.987	0.789	0.734	6.8e-127
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.987	0.843	0.692	1.9e-122
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.993	0.798	0.662	1.2e-113
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.981	0.586	0.600	1e-100
TAIR|locus:2012808	370	MPK1 "mitogen-activated protei	0.984	0.840	0.578	1.7e-98

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1515 (538.4 bits), Expect = 2.1e-155, P = 2.1e-155
 Identities = 282/311 (90%), Positives = 299/311 (96%)

Query:     2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
             NSET EEVAIKKIGNAFDN IDAKRTLREIKLL+HMDHEN+IA+KDII+PPQRE FNDVY
Sbjct:    62 NSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVY 121

Query:    62 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
             IVYELMDTDLHQIIRS+Q LTDDHCR+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct:   122 IVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 181

Query:   122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
             DLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE MTR+
Sbjct:   182 DLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTRE 241

Query:   182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
             PLFPGKDYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S G
Sbjct:   242 PLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAG 301

Query:   242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
             AVDLLEKMLVFDP+RRITVDEALCHPYLAPLHDINEEPVC RPF+FDFE P+ TEENIKE
Sbjct:   302 AVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKE 361

Query:   302 LIYRESVKFNP 312
             LIYRE+VKFNP
Sbjct:   362 LIYRETVKFNP 372

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1457 (517.9 bits), Expect = 3.0e-149, P = 3.0e-149
 Identities = 275/311 (88%), Positives = 291/311 (93%)

Query:     2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
             NSET EEVAIKKIGNAF N IDAKRTLREIKLL+HMDH+N+IAI DIIRPPQ + FNDV+
Sbjct:    59 NSETGEEVAIKKIGNAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVH 118

Query:    62 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
             IVYELMDTDLH IIRS+Q LTDDH R+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct:   119 IVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 178

Query:   122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
             DLKIGDFGLART SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR+
Sbjct:   179 DLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRE 238

Query:   182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
             PLFPG+DYV QLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S  
Sbjct:   239 PLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVN 298

Query:   242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
             AVDLL+KMLVFDPNRRITVDEALCHPYLAPLH+ NEEPVC RPF FDFE PS TEENIKE
Sbjct:   299 AVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKE 358

Query:   302 LIYRESVKFNP 312
             LIYRESVKFNP
Sbjct:   359 LIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
 Identities = 256/313 (81%), Positives = 285/313 (91%)

Query:     1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             +NS T E+VAIKKIGNAFDN IDAKRTLREIKLLRHMDHEN+I IKDI+RPPQR+ FNDV
Sbjct:    59 VNSVTGEKVAIKKIGNAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDV 118

Query:    61 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
             YIVYELMDTDL +I+RS+Q LT D CR+ +YQLLRGLKYVHSAN+LHRDL+PSN+LLN+ 
Sbjct:   119 YIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSK 178

Query:   121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
              +LKIGDFGLARTTS+TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 
Sbjct:   179 NELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTG 238

Query:   181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
             QPLFPGKDYVHQLRLITEL+GSPD +SLGFLRSDNARRYVR LP++PKQ F+ARFP    
Sbjct:   239 QPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPT 298

Query:   241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
              A+DLLE+MLVFDPNRRI+VDEAL H YL+P HD+ +EPVC  PFSFDFEHPS TEE+IK
Sbjct:   299 TAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCTEEHIK 358

Query:   301 ELIYRESVKFNPD 313
             ELIY+ESVKFNPD
Sbjct:   359 ELIYKESVKFNPD 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1339 (476.4 bits), Expect = 9.5e-137, P = 9.5e-137
 Identities = 246/315 (78%), Positives = 285/315 (90%)

Query:     1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             ++SET EE+AIKKIG AFDN++DAKRTLREIKLLRH++HEN++ IKDIIRPP++E F DV
Sbjct:    61 VDSETHEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDV 120

Query:    61 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
             YIV+ELMDTDLHQIIRS+Q L DDHC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN+N
Sbjct:   121 YIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSN 180

Query:   121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             CDLKI DFGLARTTSET++MTEYVVTRWYRAPELLLN SEYT+AID+WSVGCI  EIMTR
Sbjct:   181 CDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTR 240

Query:   181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
             +PLFPGKDYVHQL+LITELIGSPD  SL FLRS NAR+YV+ LP+FP+QNFSARFP+ + 
Sbjct:   241 EPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNS 300

Query:   241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
              A+DLLEKMLVFDP +RITV+EALC+PYL+ LHD+N+EPVC   FSF FE PS TEE IK
Sbjct:   301 TAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIK 360

Query:   301 ELIYRESVKFNPDPT 315
             EL++ ESVKFNP P+
Sbjct:   361 ELVWLESVKFNPLPS 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1263 (449.7 bits), Expect = 1.1e-128, P = 1.1e-128
 Identities = 236/309 (76%), Positives = 268/309 (86%)

Query:     2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
             NSET EEVAIKKI NAFDNR+DAKRTLREIKLL HMDH+N+I IKDII  P++E F DVY
Sbjct:    52 NSETNEEVAIKKIANAFDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVY 111

Query:    62 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
             IVYELMDTDLHQIIRS Q LTDDHC+YFLYQ+LRGLKY+HSANVLHRDLKPSNL+LN NC
Sbjct:   112 IVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNC 171

Query:   122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
             DLKI DFGLART++ET+ MTEYVVTRWYRAPELLLN SEYT AIDIWSVGCI  EI+ R+
Sbjct:   172 DLKICDFGLARTSNETEIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRE 231

Query:   182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
              LFPGKDYV QL+LITEL+GSPD++ L FLRSDNAR+YV+ LP   KQ+F  +FPN SP 
Sbjct:   232 TLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPM 291

Query:   242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
             A+DL EKMLVFDP++RITVDEAL  PYLA LH+INEEP CP PFSFDFE  +  E++IKE
Sbjct:   292 ALDLAEKMLVFDPSKRITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALDEQDIKE 351

Query:   302 LIYRESVKF 310
             L++RES+ F
Sbjct:   352 LVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1246 (443.7 bits), Expect = 6.8e-127, P = 6.8e-127
 Identities = 230/313 (73%), Positives = 271/313 (86%)

Query:     1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             MNSET E VAIKKI NAFDN+IDAKRTLREIKLLRHMDHENI+AI+DII PP R  FNDV
Sbjct:    81 MNSETNESVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPLRNAFNDV 140

Query:    61 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
             YI YELMDTDLHQIIRS+Q L+++HC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLNAN
Sbjct:   141 YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 200

Query:   121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             CDLKI DFGLAR TSE+DFMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E+M R
Sbjct:   201 CDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 260

Query:   181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
             +PLFPG+D+VHQLRL+ ELIG+P E  L FL ++NA+RY+R LP +P+Q+ + +FP   P
Sbjct:   261 KPLFPGRDHVHQLRLLMELIGTPSEEELEFL-NENAKRYIRQLPPYPRQSITDKFPTVHP 319

Query:   241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
              A+DL+EKML FDP RRITV +AL HPYL  LHDI++EP C  PF+FDFE+ + +EE +K
Sbjct:   320 LAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISDEPECTIPFNFDFENHALSEEQMK 379

Query:   301 ELIYRESVKFNPD 313
             ELIYRE++ FNP+
Sbjct:   380 ELIYREALAFNPE 392

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
 Identities = 216/312 (69%), Positives = 267/312 (85%)

Query:     1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             +++ET E VA+KKI NAFDN +DAKRTLREIKLLRH+DHENIIAI+D++ PP R  F+DV
Sbjct:    56 LDTETNELVAMKKIANAFDNHMDAKRTLREIKLLRHLDHENIIAIRDVVPPPLRRQFSDV 115

Query:    61 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
             YI  ELMDTDLHQIIRS+Q L+++HC+YFLYQLLRGLKY+HSAN++HRDLKPSNLLLNAN
Sbjct:   116 YISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNAN 175

Query:   121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             CDLKI DFGLAR TSE DFMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E+M R
Sbjct:   176 CDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 235

Query:   181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
             +PLFPGKD+VHQ+RL+TEL+G+P E+ LGF  +++A+RY+R LP FP+Q  +  F + +P
Sbjct:   236 KPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNP 295

Query:   241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
              A+DL+++ML FDPNRRITV++AL H YLA LHD N+EP+C +PFSF+FE     EE IK
Sbjct:   296 MAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPICQKPFSFEFEQQPLDEEQIK 355

Query:   301 ELIYRESVKFNP 312
             E+IY+E++  NP
Sbjct:   356 EMIYQEAIALNP 367

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1121 (399.7 bits), Expect = 1.2e-113, P = 1.2e-113
 Identities = 210/317 (66%), Positives = 258/317 (81%)

Query:     1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             ++SET E+VAIKKI   FDN I+AKRTLREIKLLRH DHENI+AI+D+I PPQR++F DV
Sbjct:    78 VDSETNEKVAIKKITQVFDNTIEAKRTLREIKLLRHFDHENIVAIRDVILPPQRDSFEDV 137

Query:    61 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
             YIV ELM+ DL++ ++S Q+LT DH  YF+YQ+LRGLKY+HSANVLHRDLKPSNLLL+  
Sbjct:   138 YIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNLLLSTQ 197

Query:   121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             CDLKI DFGLAR T E++ MTEYVVTRWYRAPELLL  S+YTAAID+WSVGCI  EIM R
Sbjct:   198 CDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLGSSDYTAAIDVWSVGCIFMEIMNR 257

Query:   181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
             +PLFPGKD V+QLRL+ ELIG+P E  LG L S+ A+RY+R LP  P+Q+F+ +FPN  P
Sbjct:   258 EPLFPGKDQVNQLRLLLELIGTPSEEELGSL-SEYAKRYIRQLPTLPRQSFTEKFPNVPP 316

Query:   241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDF-EHPSFTEENI 299
              A+DL+EKML FDP +RI+V EAL HPYL+  HDI +EP C  PF+FD  EHP F+EE  
Sbjct:   317 LAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDEPECSEPFNFDLDEHP-FSEEQF 375

Query:   300 KELIYRESVKFNPDPTH 316
             +ELIY E++ FNP+ ++
Sbjct:   376 RELIYCEALAFNPETSN 392

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 999 (356.7 bits), Expect = 1.0e-100, P = 1.0e-100
 Identities = 188/313 (60%), Positives = 237/313 (75%)

Query:     5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
             T E+VAIKKI  AFDN  D KRTLREI LLRH  HEN+I+IKDI++P  +E F DVYIV 
Sbjct:   171 TGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHENLISIKDILKPNSKEQFEDVYIVS 230

Query:    65 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
             ELMDTDLHQII S Q L+DDHC+YF+YQ+LRGLK++HSANVLHRDLKPSNLL+N +C LK
Sbjct:   231 ELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIHSANVLHRDLKPSNLLINEDCLLK 290

Query:   125 IGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
             I D GLAR    T   FMTEYV TRWYRAPE++L+ ++YT AIDIWSVGCI  E++ R+P
Sbjct:   291 ICDLGLARVEDATHQGFMTEYVATRWYRAPEVILSWNKYTKAIDIWSVGCIFAELLGRKP 350

Query:   183 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGA 242
             LF GKDY+HQ+ LI E IGSP E  +  + ++ AR+++R +   PK NF+  FP  +P A
Sbjct:   351 LFQGKDYIHQITLIIETIGSPSEEDICNIANEQARQFIRNMGNQPKVNFANMFPKANPDA 410

Query:   243 VDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKEL 302
             +DLLE+ML FDP++R+TV+EAL HPY   LHD ++EP+C   FS +FE      + +KEL
Sbjct:   411 IDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPSDEPICLHKFSLNFEAWDLNRDLLKEL 470

Query:   303 IYRESVKFNP-DP 314
             IY E + ++P DP
Sbjct:   471 IYNEMLAYHPEDP 483

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2012808 MPK1 "mitogen-activated protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
 Identities = 181/313 (57%), Positives = 239/313 (76%)

Query:     1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             +NS+T E+VAIKKI N ++NRIDA RTLRE+KLLRH+ HEN+IA+KD++ P  + +F DV
Sbjct:    50 VNSDTNEKVAIKKIHNVYENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHKMSFKDV 109

Query:    61 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
             Y+VYELMDTDLHQII+S Q L++DHC+YFL+QLLRGLKY+HSAN+LHRDLKP NLL+NAN
Sbjct:   110 YLVYELMDTDLHQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNAN 169

Query:   121 CDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             CDLKI DFGLAR ++ +  FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  E++ 
Sbjct:   170 CDLKICDFGLARASNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG 229

Query:   180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             R+P+F G + ++QL+LI  ++GS  E  L F+ +  A+RY+R LP  P  + S  +P   
Sbjct:   230 RKPIFQGTECLNQLKLIVNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAH 289

Query:   240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
               A+DLL+KMLVFDP++RI+V EAL HPY+APL+D N  P    P   D +     EE I
Sbjct:   290 VLAIDLLQKMLVFDPSKRISVSEALQHPYMAPLYDPNANPPAQVPIDLDVDE-DLREEMI 348

Query:   300 KELIYRESVKFNP 312
             +E+++ E + ++P
Sbjct:   349 REMMWNEMLHYHP 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006635 "fatty acid beta-oxidation" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0008219 "cell death" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009755 "hormone-mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0016558 "protein import into peroxisome matrix" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0009734 "auxin mediated signaling pathway" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q336X9	MPK6_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8512	1.0	0.8404	no	no
Q8GYQ5	MPK12_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8178	0.9905	0.8413	no	no
Q40884	MAPK_PETHY	2, ., 7, ., 1, 1, ., 2, 4	0.5955	0.9873	0.8125	N/A	no
Q9LMM5	MPK11_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8842	0.9841	0.8428	no	no
Q9LQQ9	MPK13_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7637	0.9778	0.8512	no	no
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.7403	0.9841	0.7893	N/A	no
Q5J4W4	MPK2_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8417	1.0	0.8020	yes	no
P0CP67	CPK1_CRYNB	2, ., 7, ., 1, 1, ., 2, 4	0.5420	0.9620	0.8306	N/A	no
O42781	MAPK2_PNECA	2, ., 7, ., 1, 1, ., 2, 4	0.5492	0.9651	0.8689	N/A	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7788	0.9873	0.8409	N/A	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7405	0.9968	0.8015	N/A	no
P0CP66	CPK1_CRYNJ	2, ., 7, ., 1, 1, ., 2, 4	0.5420	0.9620	0.8306	yes	no
Q40517	NTF3_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5923	0.9873	0.8387	N/A	no
Q00859	MAPK_FUSSO	2, ., 7, ., 1, 1, ., 2, 4	0.5627	0.9525	0.8478	N/A	no
P26696	MK01_XENLA	2, ., 7, ., 1, 1, ., 2, 4	0.5422	0.9556	0.8365	N/A	no
Q39025	MPK5_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7809	0.9968	0.8377	no	no
Q39024	MPK4_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.9067	0.9841	0.8271	yes	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.6741	0.9905	0.8482	N/A	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5480	0.9240	0.7849	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.7435	0.9841	0.8036	N/A	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.8885	0.9936	0.8463	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.979
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00026919001	SubName- Full=Putative uncharacterized protein (Chromosome chr15 scaffold_40, whole genome shotgun sequence); (375 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00015318001	SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (563 aa)			•			•		•	0.817
	GSVIVG00016514001	SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa)			•			•		•	0.814
	GSVIVG00016645001	SubName- Full=Putative uncharacterized protein (Chromosome chr11 scaffold_13, whole genome shot [...] (354 aa)			•			•		•	0.812
	GSVIVG00023994001	SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (533 aa)						•			0.800
	GSVIVG00005840001	SubName- Full=Chromosome chr12 scaffold_159, whole genome shotgun sequence; (552 aa)						•		•	0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	316
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.0
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-164
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-156
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-146
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-142
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-133
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-123
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-115
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-114
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-111
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-111
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-108
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-106
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-104
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-102
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-97
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-95
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-88
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-88
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-86
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-82
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-81
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-80
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-78
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-78
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-77
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-76
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-74
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-74
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-73
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-72
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-72
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-71
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-70
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-69
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-67
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-66
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-65
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-64
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-64
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-63
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-61
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-61
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-59
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-59
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-58
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-57
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-56
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-54
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-54
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-49
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-48
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-48
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-45
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-44
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-43
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-37
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-36
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-33
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-29
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-23
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-20
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-20
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  635 bits (1641), Expect = 0.0
 Identities = 243/313 (77%), Positives = 276/313 (88%), Gaps = 1/313 (0%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            NSET E+VAIKKI NAFDNRIDAKRTLREIKLLRH+DHEN+IAIKDI+ PP RE FNDV
Sbjct: 25  KNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIVYELMDTDLHQIIRS Q L+DDHC+YFLYQLLRGLKY+HSANVLHRDLKPSNLLLNAN
Sbjct: 85  YIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN 144

Query: 121 CDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           CDLKI DFGLARTTSE  DFMTEYVVTRWYRAPELLLNCSEYT AID+WSVGCI  E++ 
Sbjct: 145 CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
           R+PLFPGKDYVHQL+LITEL+GSP E  LGF+R++ ARRY+R LP  P+Q+F+  FP+ +
Sbjct: 205 RKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHAN 264

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P A+DLLEKMLVFDP++RITV+EAL HPYLA LHD ++EPVC  PFSFDFE  + TEE+I
Sbjct: 265 PLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDI 324

Query: 300 KELIYRESVKFNP 312
           KELIY E + ++P
Sbjct: 325 KELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  534 bits (1377), Expect = 0.0
 Identities = 203/311 (65%), Positives = 241/311 (77%), Gaps = 5/311 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++  T  +VAIKKI N FD+ IDAKR LREIKLLRH+ HENII + DI+RPP  E FNDV
Sbjct: 20  VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIV ELM+TDLH++I+S Q LTDDH +YFLYQ+LRGLKY+HSANV+HRDLKPSN+L+N+N
Sbjct: 80  YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139

Query: 121 CDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           CDLKI DFGLAR       E  F+TEYVVTRWYRAPELLL+ S YT AIDIWSVGCI  E
Sbjct: 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++TR+PLFPG+DY+ QL LI E++G+P E  L F+ S+ AR Y++ LP+ PK+  S  FP
Sbjct: 200 LLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP 259

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS-FT 295
             SP A+DLLEKMLVFDP +RIT DEAL HPYLA LHD  +EPV   PF FDF      T
Sbjct: 260 GASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELT 319

Query: 296 EENIKELIYRE 306
           EE +KELIY E
Sbjct: 320 EEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  459 bits (1184), Expect = e-164
 Identities = 184/310 (59%), Positives = 233/310 (75%), Gaps = 7/310 (2%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T  +VAIKKI + F+++   +RTLREIK+LR   HENII I DIIRPP  E+FNDVYIV 
Sbjct: 29  TGVKVAIKKI-SPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           ELM+TDL+++I++ Q L++DH +YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN NCDLK
Sbjct: 88  ELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLK 146

Query: 125 IGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           I DFGLAR        T F+TEYV TRWYRAPE++LN   YT AIDIWSVGCIL E+++ 
Sbjct: 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPGKDY+HQL LI  ++G+P +  L  + S  AR Y++ LP  PK  ++  FPN  P
Sbjct: 207 RPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADP 266

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFE-HPSFTEENI 299
            A+DLL+KML F+P++RITV+EAL HPYL   HD ++EPV   PF FDFE      +E +
Sbjct: 267 KALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKL 326

Query: 300 KELIYRESVK 309
           KELI+ E ++
Sbjct: 327 KELIFEEIMR 336

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  440 bits (1135), Expect = e-156
 Identities = 183/311 (58%), Positives = 237/311 (76%), Gaps = 6/311 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++ + ++VAIKKI +AFD    AKRTLRE+K+LRH  H+NIIAI+DI+RPP  + F DV
Sbjct: 25  IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD-FKDV 83

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V +LM++DLH II S Q LT++H RYFLYQLLRGLKY+HSANV+HRDLKPSNLL+N +
Sbjct: 84  YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED 143

Query: 121 CDLKIGDFGLAR--TTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           C+L+IGDFG+AR  ++S T+   FMTEYV TRWYRAPELLL+  EYT AID+WSVGCI  
Sbjct: 144 CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFA 203

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E++ R+ LFPGK+YVHQL+LI  ++GSP E  L  + SD  R+Y++ LP+     +S  F
Sbjct: 204 EMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF 263

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFT 295
           P  SP A+DLL +ML FDP  RITV++AL HP+LA  HD ++EP CP PF FDFE    +
Sbjct: 264 PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELS 323

Query: 296 EENIKELIYRE 306
            E +KE I +E
Sbjct: 324 REQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  415 bits (1069), Expect = e-146
 Identities = 162/312 (51%), Positives = 220/312 (70%), Gaps = 5/312 (1%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDV 60
           +++T  +VAIKK+   F + I AKRT RE++LL+HMDHEN+I + D+  P    E F DV
Sbjct: 36  DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q L+DDH ++ +YQ+LRGLKY+HSA ++HRDLKPSN+ +N +
Sbjct: 96  YLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 154

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 155 CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+ I  L+G+PDE  L  + S++AR Y++ LPQ PK++F   F   +P
Sbjct: 213 KTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANP 272

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DLLEKMLV DP++RIT  EAL HPYLA  HD  +EPV P P+   FE    T +  K
Sbjct: 273 LAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP-PYDQSFESRDLTVDEWK 331

Query: 301 ELIYRESVKFNP 312
           EL+Y+E + F P
Sbjct: 332 ELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  403 bits (1037), Expect = e-142
 Identities = 180/315 (57%), Positives = 228/315 (72%), Gaps = 14/315 (4%)

Query: 2   NSETREE--VAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI--KDIIRPPQRET 56
           N+ET EE  VAIKKI N F  +I AKR LRE+KLLRH   H+NI  +   DI+ P     
Sbjct: 21  NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN--- 77

Query: 57  FNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           FN++Y+  ELM+ DLHQIIRS Q LTD H + F+YQ+L GLKY+HSANVLHRDLKP NLL
Sbjct: 78  FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL 137

Query: 117 LNANCDLKIGDFGLARTTSE-----TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           +NA+C+LKI DFGLAR  SE       FMTEYV TRWYRAPE++L+   YT AID+WSVG
Sbjct: 138 VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG 197

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           CIL E++ R+P+F GKDYV QL  I +++G+PDE +L  + S  A+ Y+R LP  PK+ F
Sbjct: 198 CILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF 257

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEH 291
            + FPN +P A+DLLEK+L FDP +RI+V+EAL HPYLA  HD ++EPVC +PF F FE 
Sbjct: 258 ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES 317

Query: 292 PSFTEENIKELIYRE 306
               EE ++++I  E
Sbjct: 318 EDSMEE-LRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  380 bits (978), Expect = e-133
 Identities = 165/322 (51%), Positives = 225/322 (69%), Gaps = 13/322 (4%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++ T E+VAIKKI + F++  DA R LREIKLLR + H +I+ IK I+ PP R  F D+
Sbjct: 20  IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V+ELM++DLHQ+I+++ DLT +H ++FLYQLLR LKY+H+ANV HRDLKP N+L NA+
Sbjct: 80  YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139

Query: 121 CDLKIGDFGLART----TSETDFMTEYVVTRWYRAPELLLNC----SEYTAAIDIWSVGC 172
           C LKI DFGLAR     T    F T+YV TRWYRAPEL   C    S+YT AIDIWS+GC
Sbjct: 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGC 196

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           I  E++T +PLFPGK+ VHQL LIT+L+G+P   ++  +R++ ARRY+  + +     FS
Sbjct: 197 IFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFS 256

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC-PRP-FSFDFE 290
            +FPN  P A+ LLE++L FDP  R T +EAL  PY   L  +  EP   P     F+FE
Sbjct: 257 QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFE 316

Query: 291 HPSFTEENIKELIYRESVKFNP 312
               T+E+++ELIYRE ++++P
Sbjct: 317 RRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  357 bits (918), Expect = e-123
 Identities = 143/314 (45%), Positives = 207/314 (65%), Gaps = 12/314 (3%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
           ++  T+E VA+KKI +AF N  DA+RT REI  L+ + DH NI+ + ++I+    E   D
Sbjct: 27  IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDKD 83

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V+E M+TDLH +IR    L D H RY +YQLL+ LKY+HS NV+HRDLKPSN+LLN+
Sbjct: 84  IYLVFEYMETDLHAVIR-ANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS 142

Query: 120 NCDLKIGDFGLARTTSETD------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +C +K+ DFGLAR+ SE +       +T+YV TRWYRAPE+LL  + YT  +D+WSVGCI
Sbjct: 143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           LGE++  +PLFPG   ++QL  I E+IG P    +  ++S  A   +  LP  P++    
Sbjct: 203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE 262

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDF-EHP 292
             P  S  A+DLL+K+LVF+PN+R+T +EAL HPY+A  H+ ++EPV P P +    ++ 
Sbjct: 263 LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNV 322

Query: 293 SFTEENIKELIYRE 306
             +    +  +Y E
Sbjct: 323 KLSVAEYRNKLYEE 336

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  334 bits (858), Expect = e-115
 Identities = 154/302 (50%), Positives = 202/302 (66%), Gaps = 7/302 (2%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T + VAIKKI   F   + AKRT RE+KLL+H+ HENII++ DI   P      D+Y V 
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LEDIYFVT 89

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           EL+ TDLH+++ S + L     +YFLYQ+LRGLKYVHSA V+HRDLKPSN+L+N NCDLK
Sbjct: 90  ELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148

Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           I DFGLAR       MT YV TR+YRAPE++L   +Y   +DIWS GCI  E++  +PLF
Sbjct: 149 ICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206

Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGKD+V+Q  +IT+L+G+P +  +  + S+N  R+V+ LP+     FS +F N  P A+D
Sbjct: 207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAID 266

Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LLEKMLVFDP +RI+  EAL HPYLAP HD  +EPV    F + F       +  K ++Y
Sbjct: 267 LLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMY 326

Query: 305 RE 306
            E
Sbjct: 327 SE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  330 bits (848), Expect = e-114
 Identities = 128/270 (47%), Positives = 169/270 (62%), Gaps = 8/270 (2%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +  T E VAIKKI   F++    K  LREIKLL+ ++H NII + D+ R        D+Y
Sbjct: 20  DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-----DLY 74

Query: 62  IVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E MDTDL+++I+  Q  L +   + +LYQLL+GL + HS  +LHRDLKP NLL+N  
Sbjct: 75  LVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE 134

Query: 121 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             LK+ DFGLAR+  S     T YVVTRWYRAPELLL    Y+  +DIWSVGCI  E+++
Sbjct: 135 GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
           R+PLFPGK  + QL  I   +G+PD        S  AR Y    P+         FPN S
Sbjct: 195 RRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSFPKKAGMPLPKLFPNAS 253

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           P A+DLL +ML +DP++RIT ++AL HPY 
Sbjct: 254 PQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  326 bits (837), Expect = e-111
 Identities = 156/312 (50%), Positives = 212/312 (67%), Gaps = 5/312 (1%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 38  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 98  YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 156

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 157 CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 215 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 274

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 275 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWK 333

Query: 301 ELIYRESVKFNP 312
            L Y E + F P
Sbjct: 334 SLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  324 bits (832), Expect = e-111
 Identities = 148/312 (47%), Positives = 209/312 (66%), Gaps = 5/312 (1%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           ++  R++VA+KK+   F + I A+RT RE++LL+HM HEN+I + D+  P    E FN+V
Sbjct: 36  DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q L+D+H ++ +YQLLRGLKY+HSA ++HRDLKPSN+ +N +
Sbjct: 96  YLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 154

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+L+I DFGLAR     D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++  
Sbjct: 155 CELRILDFGLARQAD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG DY+ QL+ I E++G+P    L  + S++AR+Y++ LP  P+Q+    F   +P
Sbjct: 213 KALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANP 272

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DLLEKMLV D ++RI+  EAL HPY +  HD  +EP    P+    E+   T E  K
Sbjct: 273 LAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAE-PYDESPENKERTIEEWK 331

Query: 301 ELIYRESVKFNP 312
           EL Y E   F P
Sbjct: 332 ELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  318 bits (816), Expect = e-108
 Identities = 142/313 (45%), Positives = 198/313 (63%), Gaps = 6/313 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP-PQRETFND 59
           ++  T E+VAIKK+   F + I AKR  RE+ LL+HM HEN+I + D+       + F D
Sbjct: 35  IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            Y+V   M TDL +I+     L++D  +Y +YQ+L GLKY+HSA ++HRDLKP NL +N 
Sbjct: 95  FYLVMPYMQTDLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR       MT YVVTRWYRAPE++LN   Y   +DIWSVGCI+ E++T
Sbjct: 153 DCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LP++P+++FS  FP  S
Sbjct: 211 GKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKAS 270

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P AVDLLEKML  D ++R+T  EAL HPY     D +EE    +P+    E+   + +  
Sbjct: 271 PQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE-QQPYDDSLENEKLSVDEW 329

Query: 300 KELIYRESVKFNP 312
           K+ IY+E   F+P
Sbjct: 330 KKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  315 bits (808), Expect = e-106
 Identities = 134/322 (41%), Positives = 196/322 (60%), Gaps = 27/322 (8%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VA+KK+ N F N +  KR  RE+K+L    H+N+++  DI++PP  + F ++Y+V ELM 
Sbjct: 28  VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ 87

Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           +DLH+II S Q L+ DH + FLYQ+LRGLKY+HSA +LHRD+KP NLL+N+NC LKI DF
Sbjct: 88  SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDF 147

Query: 129 GLARTTS--ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 186
           GLAR     E+  MT+ VVT++YRAPE+L+    YT+A+DIWSVGCI  E++ R+ LF  
Sbjct: 148 GLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207

Query: 187 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG---AV 243
           +  + QL LIT+L+G+P   ++       AR ++   P  P  +    +   S     AV
Sbjct: 208 QSPIQQLDLITDLLGTPSLEAMRSACE-GARAHILRGPHKPP-SLPVLYTLSSQATHEAV 265

Query: 244 DLLEKMLVFDPNRRITVDEALCHPYL--------------------APLHDINEEPVCPR 283
            LL +MLVFDP++RI+  +AL HPYL                      ++  + EP    
Sbjct: 266 HLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANP 325

Query: 284 PFSFDFEHPSFTEENIKELIYR 305
           PF  ++E    +   +KE +++
Sbjct: 326 PFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  306 bits (786), Expect = e-104
 Identities = 142/313 (45%), Positives = 208/313 (66%), Gaps = 5/313 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
           ++  T  +VAIKK+   F + + AKR  RE++LL+HM HEN+I + D+  P    + F+D
Sbjct: 35  LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            Y+V   M TDL ++++ H+ L++D  ++ +YQ+L+GLKY+H+A ++HRDLKP NL +N 
Sbjct: 95  FYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR T     MT YVVTRWYRAPE++LN   YT  +DIWSVGCI+ E++T
Sbjct: 154 DCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +PLF G D++ QL  I ++ G+P +  +  L+S++A+ YV+ LP+F K++F +  PN +
Sbjct: 212 GKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNAN 271

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P AV++LEKMLV D   RIT  EAL HPY    HD  +E   P P+   F+    + E  
Sbjct: 272 PLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP-PYDDSFDEVDQSLEEW 330

Query: 300 KELIYRESVKFNP 312
           K L + E + F P
Sbjct: 331 KRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  300 bits (770), Expect = e-102
 Identities = 114/278 (41%), Positives = 159/278 (57%), Gaps = 23/278 (8%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQR 54
            + +T E VA+KKI      R+D +        LREI LL+ + H NI+ + D+I     
Sbjct: 19  RDKKTGEIVALKKI------RLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH---- 68

Query: 55  ETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
            T   +Y+V+E  D DL + +      L+ +  +  +YQLLRGL Y HS  +LHRDLKP 
Sbjct: 69  -TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQ 127

Query: 114 NLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+L+N +  LK+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+DIWSVGC
Sbjct: 128 NILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGC 187

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS-LGFLRSDNARRYVRMLPQFPKQNF 231
           I  E++T +PLFPG   + QL  I +++G+P E S  G  +  +   Y    P+FP ++ 
Sbjct: 188 IFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD---YKPTFPKFPPKDL 244

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               P   P  +DLL KML ++P +RI+  EAL HPY 
Sbjct: 245 EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  290 bits (745), Expect = 3e-97
 Identities = 138/317 (43%), Positives = 193/317 (60%), Gaps = 19/317 (5%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIV 63
           T + VAIKK+   F N   AKR  RE+ L++ ++H+NII + ++  P +  E F DVY+V
Sbjct: 40  TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99

Query: 64  YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            ELMD +L Q+I    DL  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C L
Sbjct: 100 MELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157

Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    L
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVL 216

Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP------- 236
           FPG D++ Q   I E +G+P +  +  L+    R YV   P++   +F   FP       
Sbjct: 217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-TVRNYVENRPKYAGYSFEELFPDVLFPPD 275

Query: 237 ------NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDF 289
                  K+  A DLL KMLV DP +RI+VD+AL HPY+   +D +E E   P P+    
Sbjct: 276 SESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSI 335

Query: 290 EHPSFTEENIKELIYRE 306
           +    T E  KELIY+E
Sbjct: 336 DEREHTVEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  283 bits (727), Expect = 2e-95
 Identities = 110/286 (38%), Positives = 160/286 (55%), Gaps = 36/286 (12%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQR 54
            N +T E VA+KKI      R++ ++       +REIKLL+ + H NI+ +K+I+    +
Sbjct: 19  RNKKTGELVALKKI------RMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK 72

Query: 55  ETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
                +Y+V+E MD DL  ++ S +   T+   + ++ QLL GL+Y+HS  +LHRD+K S
Sbjct: 73  ---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGS 129

Query: 114 NLLLNANCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           N+L+N +  LK+ DFGLAR  +   +   T  V+T WYR PELLL  + Y   +D+WSVG
Sbjct: 130 NILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVG 189

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF----P 227
           CIL E+   +P+F G   + QL  I EL GSP          D     V  LP F    P
Sbjct: 190 CILAELFLGKPIFQGSTELEQLEKIFELCGSPT---------DENWPGVSKLPWFENLKP 240

Query: 228 KQNFSARFPNK-----SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
           K+ +  R          P A+DLL+K+L  DP +RI+ D+AL H Y
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  268 bits (686), Expect = 1e-88
 Identities = 126/321 (39%), Positives = 187/321 (58%), Gaps = 19/321 (5%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE----- 55
           ++S+  + VA+KKI     +    K  LREIK++R +DH+NI+ + +++ P   +     
Sbjct: 25  VDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82

Query: 56  ----TFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
                 N VYIV E M+TDL  ++     L+++H R F+YQLLRGLKY+HSANVLHRDLK
Sbjct: 83  GSLTELNSVYIVQEYMETDLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLK 141

Query: 112 PSNLLLNA-NCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCSEYTAAID 166
           P+N+ +N  +  LKIGDFGLAR      S   +++E +VT+WYR+P LLL+ + YT AID
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +W+ GCI  E++T +PLF G   + Q++LI E +    E     L +     +VR     
Sbjct: 202 MWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIP-SFVRNDGGE 260

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFS 286
           P++      P  +P A+D LE++L F+P  R+T +EAL HPY++      +EPV   PF 
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFH 320

Query: 287 FDFEHPSFTE-ENIKELIYRE 306
            + E         I  +IY  
Sbjct: 321 IEDELDDILLMTEIHSIIYNW 341

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  264 bits (677), Expect = 3e-88
 Identities = 98/269 (36%), Positives = 148/269 (55%), Gaps = 35/269 (13%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + +T + VAIK I      + D +R LREIK+L+ + H NI+ + D+      E  + +Y
Sbjct: 20  DKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRLYDVF-----EDEDKLY 73

Query: 62  IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V E  +  DL  +++    L++D  R++L Q+L  L+Y+HS  ++HRDLKP N+LL+ +
Sbjct: 74  LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDED 133

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             +K+ DFGLAR     + +T +V T  Y APE+LL    Y  A+DIWS+G IL E++T 
Sbjct: 134 GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GKGYGKAVDIWSLGVILYELLTG 192

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +P FPG D   QL  + + IG P                           F     + SP
Sbjct: 193 KPPFPGDD---QLLELFKKIGKPKPP------------------------FPPPEWDISP 225

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            A DL+ K+LV DP +R+T +EAL HP+ 
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  261 bits (670), Expect = 1e-86
 Identities = 117/272 (43%), Positives = 157/272 (57%), Gaps = 17/272 (6%)

Query: 4   ETREEVAIKKIGNAFDNRIDAK----RT-LREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
           ET   VAIKKI      R +AK     T LREIKLL+ + H NII + D+          
Sbjct: 23  ETGRIVAIKKIKL--GERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN---- 76

Query: 59  DVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            + +V+E M+TDL ++I+     LT    + ++   LRGL+Y+HS  +LHRDLKP+NLL+
Sbjct: 77  -INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI 135

Query: 118 NANCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
            ++  LK+ DFGLAR+  S    MT  VVTRWYRAPELL     Y   +D+WSVGCI  E
Sbjct: 136 ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++ R P  PG   + QL  I E +G+P E +   + S     YV   P FP       FP
Sbjct: 196 LLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP--DYVEFKP-FPPTPLKQIFP 252

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
             S  A+DLL+++L  +PN+RIT  +AL HPY
Sbjct: 253 AASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  249 bits (637), Expect = 7e-82
 Identities = 102/277 (36%), Positives = 157/277 (56%), Gaps = 25/277 (9%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ET E VA+KK+           + LREIK L+   H  ++ + D+             +V
Sbjct: 23  ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG-----FVLV 77

Query: 64  YELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E M +DL +++R  +  L +   + ++  LL+G+ Y+H+  ++HRDLKP+NLL++A+  
Sbjct: 78  MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV 137

Query: 123 LKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           LKI DFGLAR  SE +    +  V TRWYRAPELL    +Y   +D+W+VGCI  E++  
Sbjct: 138 LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR------ 234
            PLFPG++ + QL ++   +G+P+E +   L S         LP + K  F         
Sbjct: 198 SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS---------LPDYNKITFPESKPIPLE 248

Query: 235 --FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             FP+ SP A+DLL+ +LV+DP++R++  EAL HPY 
Sbjct: 249 EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  251 bits (641), Expect = 1e-81
 Identities = 136/312 (43%), Positives = 192/312 (61%), Gaps = 18/312 (5%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VA+KK+   F N+  AKR  RE+ LL+ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I  H +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 109 DANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 166

Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART      MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    +F G 
Sbjct: 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGT 225

Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   PQ+P  +F   FP+          
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERD 284

Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP++RI+VDEAL HPY+   +D  E E   P+ +    E    
Sbjct: 285 KLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREH 344

Query: 295 TEENIKELIYRE 306
             E  KELIY+E
Sbjct: 345 AIEEWKELIYKE 356

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  245 bits (628), Expect = 2e-80
 Identities = 107/281 (38%), Positives = 162/281 (57%), Gaps = 30/281 (10%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDV 60
           N ET E VAIKK+   F +  +    LRE+K LR + +H NI+ +K++ R       +++
Sbjct: 20  NKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVKLKEVFR-----ENDEL 73

Query: 61  YIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           Y V+E M+ +L+Q+++  +    ++   R  +YQ+L+GL ++H     HRDLKP NLL++
Sbjct: 74  YFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               +KI DFGLAR        T+YV TRWYRAPE+LL  + Y++ +DIW++GCI+ E+ 
Sbjct: 134 GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY 193

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDE----------TSLGFLRSDNARRYVRMLPQFPK 228
           T +PLFPG   + QL  I  ++G+P +          + LGF             PQF  
Sbjct: 194 TLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF-----------RFPQFAP 242

Query: 229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            +     PN SP A+DL++ ML +DP +R T  +AL HPY 
Sbjct: 243 TSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  243 bits (620), Expect = 2e-78
 Identities = 136/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104

Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 105 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 162

Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 221

Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280

Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VDEAL HPY+   +D  E E   P+ +    +    
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 340

Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 341 TIEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  238 bits (609), Expect = 5e-78
 Identities = 90/271 (33%), Positives = 144/271 (53%), Gaps = 31/271 (11%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            +  T + VA+K +    +     +   REI++LR + H NI+ + D       E  + +
Sbjct: 19  KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAF-----EDKDHL 73

Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V E  +  DL   +     L++D  +    Q+LRGL+Y+HS  ++HRDLKP N+LL+ 
Sbjct: 74  YLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDE 133

Query: 120 NCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           N  +KI DFGLA+   ++   +T +V T WY APE+LL  + Y   +D+WS+G IL E++
Sbjct: 134 NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELL 193

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           T +P F G++ + QL+LI   I  P                     +F +  +S    + 
Sbjct: 194 TGKPPFSGENILDQLQLI-RRILGPP-------------------LEFDEPKWS----SG 229

Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           S  A DL++K L  DP++R T +E L HP+ 
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  241 bits (615), Expect = 1e-77
 Identities = 135/312 (43%), Positives = 192/312 (61%), Gaps = 18/312 (5%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169

Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228

Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287

Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347

Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  235 bits (603), Expect = 1e-76
 Identities = 107/282 (37%), Positives = 160/282 (56%), Gaps = 28/282 (9%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQR 54
            + +T E VA+KK+      +++ ++      +LREI +L  + H NI+ +K+++     
Sbjct: 25  RDKKTGEIVALKKL------KMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV---VG 75

Query: 55  ETFNDVYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
              + +Y+V E ++ DL  ++    Q       +  + QLL G+ ++H   +LHRDLK S
Sbjct: 76  SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS 135

Query: 114 NLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           NLLLN    LKI DFGLAR         T+ VVT WYRAPELLL   EY+ AID+WSVGC
Sbjct: 136 NLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGC 195

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNF 231
           I  E++T++PLFPGK  + QL  I +L+G+P E    GF     A++       F K  +
Sbjct: 196 IFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK-----TFTKYPY 250

Query: 232 S---ARFPNKSPG--AVDLLEKMLVFDPNRRITVDEALCHPY 268
           +    +FP  S      DLL ++L +DP +RI+ ++AL HPY
Sbjct: 251 NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  229 bits (586), Expect = 3e-74
 Identities = 102/273 (37%), Positives = 154/273 (56%), Gaps = 9/273 (3%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            N  T E VAIKK   + D+    K  LRE+K+LR + HENI+ +K+  R   R     +
Sbjct: 21  RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR-----L 75

Query: 61  YIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V+E ++  L +++  S   L  D  R +++QLL+ + Y HS N++HRD+KP N+L++ 
Sbjct: 76  YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135

Query: 120 NCDLKIGDFGLARTTSE--TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           +  LK+ DFG AR         +T+YV TRWYRAPELL+  + Y   +D+W++GCI+ E+
Sbjct: 136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +  +PLFPG   + QL LI + +G    +      S+     V        ++   R+P 
Sbjct: 196 LDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG 255

Query: 238 K-SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           K S  A+D L+  L  DP  R+T DE L HPY 
Sbjct: 256 KVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  229 bits (585), Expect = 4e-74
 Identities = 112/284 (39%), Positives = 159/284 (55%), Gaps = 36/284 (12%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQRE 55
           +  T E VA+KKI      R++ +        +REI LL+ ++H NI+ + D++    + 
Sbjct: 20  DKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK- 72

Query: 56  TFNDVYIVYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
               +Y+V+E +D DL + + S     L     + +LYQLL+G+ Y HS  VLHRDLKP 
Sbjct: 73  ----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQ 128

Query: 114 NLLLNANCDLKIGDFGLARTTSETDF------MTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           NLL++    LK+ DFGLAR      F       T  VVT WYRAPE+LL   +Y+  +DI
Sbjct: 129 NLLIDREGALKLADFGLARA-----FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDI 183

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS--DNARRYVRMLPQ 225
           WS+GCI  E++ R+PLFPG   + QL  I   +G+PDE     + S  D    Y    P+
Sbjct: 184 WSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD----YKPTFPK 239

Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           + +Q+ S   PN     +DLL KMLV+DP +RI+   AL HPY 
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  226 bits (579), Expect = 3e-73
 Identities = 98/272 (36%), Positives = 152/272 (55%), Gaps = 19/272 (6%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDII--RPPQRETFNDV 60
           +T +  AIK +   F + ++    LREI+ LR +  H NI+ + +++  R   R      
Sbjct: 22  KTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL--- 77

Query: 61  YIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
             V+ELMD +L+++I+   + L +   + ++YQLL+ L ++H   + HRD+KP N+L+  
Sbjct: 78  --VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  LK+ DFG  R        TEY+ TRWYRAPE LL    Y   +DIW+VGC+  EI++
Sbjct: 136 DI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN---FSARFP 236
             PLFPG + + Q+  I +++G+PD   L        R+   M   FP +         P
Sbjct: 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF-----RKSRHMNYNFPSKKGTGLRKLLP 249

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
           N S   +DLL+K+L +DP+ RIT  +AL HPY
Sbjct: 250 NASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  224 bits (573), Expect = 3e-72
 Identities = 109/277 (39%), Positives = 159/277 (57%), Gaps = 24/277 (8%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHENIIAIKDIIRPPQRET 56
           N  T E VA+K+I       +DA+       +REI L++ + HENI+ + D+I      T
Sbjct: 21  NRTTGEIVALKEI------HLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HT 69

Query: 57  FNDVYIVYELMDTDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
            N + +V+E MD DL + + +H     L  +  + F YQLL+G+ + H   VLHRDLKP 
Sbjct: 70  ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ 129

Query: 114 NLLLNANCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           NLL+N   +LK+ DFGLAR        F  E VVT WYRAP++LL    Y+ +IDIWSVG
Sbjct: 130 NLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLLGSRTYSTSIDIWSVG 188

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           CI+ E++T +PLFPG +   QL  I  ++G+P E++           Y    P++P Q+ 
Sbjct: 189 CIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP--GISQLPEYKPTFPRYPPQDL 246

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              FP+  P  +DLL ++L  +P  RI+  +AL HP+
Sbjct: 247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  224 bits (572), Expect = 4e-72
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 30/276 (10%)

Query: 9   VAIKKIGNAFDNRIDAKR------TLREIKLLRHMD---HENIIAIKDIIRPPQRETFND 59
           VA+KK+      R+          TLREI LL+ ++   H NI+ + D+   P+ +    
Sbjct: 27  VALKKV------RVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80

Query: 60  VYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           + +V+E +D DL   +       L  +  +  + QLLRG+ ++HS  ++HRDLKP N+L+
Sbjct: 81  LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV 140

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
            ++  +KI DFGLAR  S    +T  VVT WYRAPE+LL  S Y   +D+WSVGCI  E+
Sbjct: 141 TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAEL 199

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDET----SLGFLRSDNARRYVRMLPQFPKQNFSA 233
             R+PLF G     QL  I ++IG P E     ++   RS          P +  ++F +
Sbjct: 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS--------FPSYTPRSFKS 251

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             P      +DLL+KML F+P++RI+  EAL HPY 
Sbjct: 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  222 bits (568), Expect = 3e-71
 Identities = 110/276 (39%), Positives = 164/276 (59%), Gaps = 20/276 (7%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQRE 55
           ++ + E VA+KK+      R+D +R      +LREI LL ++ H NI+ +K+++     +
Sbjct: 28  DTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPNIVELKEVV---VGK 78

Query: 56  TFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
             + +++V E  + DL  ++ +     ++   +  + QLLRGL+Y+H   ++HRDLK SN
Sbjct: 79  HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSN 138

Query: 115 LLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           LLL     LKI DFGLART       MT  VVT WYRAPELLL C+ YT AID+W+VGCI
Sbjct: 139 LLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCI 198

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNFS 232
           L E++  +PL PGK  + QL LI +L+G+P+E+   GF       ++   LP+ P  N  
Sbjct: 199 LAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT--LPKQPYNNLK 256

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
            +FP  S   + LL  +L++DP +R T +EAL   Y
Sbjct: 257 HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  221 bits (564), Expect = 1e-70
 Identities = 103/290 (35%), Positives = 150/290 (51%), Gaps = 35/290 (12%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQ-RETFNDV 60
           +T   VA+KKI    +        LREIK+L+ + H N++ + D+   RP + +     V
Sbjct: 31  KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90

Query: 61  YIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V   MD DL  ++ +    LT+   + ++ QLL G+ Y+H  ++LHRD+K +N+L++ 
Sbjct: 91  YMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN 150

Query: 120 NCDLKIGDFGLAR-------------TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAID 166
              LKI DFGLAR                   + T  VVTRWYR PELLL    YT A+D
Sbjct: 151 QGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TNLVVTRWYRPPELLLGERRYTTAVD 209

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           IW +GC+  E+ TR+P+  GK  + QL LI +L G+P E +    RS         LP  
Sbjct: 210 IWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS---------LPGC 260

Query: 227 PKQNFSARFPNK--------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              +    +P           P  +DLL K+L  DP +R+T  +AL HPY
Sbjct: 261 EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  215 bits (550), Expect = 6e-69
 Identities = 112/282 (39%), Positives = 158/282 (56%), Gaps = 34/282 (12%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQRE 55
           N  T E VA+KKI      R+D +        +REI LL+ ++H NI+ + D+I      
Sbjct: 21  NKLTGEVVALKKI------RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----H 69

Query: 56  TFNDVYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP 
Sbjct: 70  TENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 129

Query: 114 NLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GC
Sbjct: 130 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------TSLGFLRSDNARRYVRMLPQF 226
           I  E++TR+ LFPG   + QL  I   +G+PDE      TSL   +           P++
Sbjct: 190 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS--------FPKW 241

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
            +Q+FS   P       DLL +ML +DPN+RI+   AL HP+
Sbjct: 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  211 bits (539), Expect = 4e-67
 Identities = 109/275 (39%), Positives = 158/275 (57%), Gaps = 11/275 (4%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T E +A+KKI    ++       +REI LL+ M H NI+ ++D++   +R     +Y+V+
Sbjct: 26  TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR-----LYLVF 80

Query: 65  ELMDTDLHQIIRSHQDLTDDH--CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           E +D DL + + S  D   +    + +LYQ+LRG+ Y HS  VLHRDLKP NLL++   +
Sbjct: 81  EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140

Query: 123 -LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            LK+ DFGLAR         T  VVT WYRAPE+LL    Y+  +DIWSVGCI  E++ +
Sbjct: 141 ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +PLFPG   + +L  I  ++G+P+E +   + S     Y    P++P ++ +   P   P
Sbjct: 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKSAFPKWPPKDLATVVPTLEP 258

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 275
             VDLL KML  DP++RIT   AL H Y   L D 
Sbjct: 259 AGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  208 bits (532), Expect = 4e-66
 Identities = 105/276 (38%), Positives = 152/276 (55%), Gaps = 24/276 (8%)

Query: 5   TREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           T + VA+K+I      R++ +       +RE  LL+ + H NI+ + DII   +  T   
Sbjct: 29  TGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL-- 80

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDH-CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
              V+E +DTDL Q +         H  R FL+QLLRGL Y H   VLHRDLKP NLL++
Sbjct: 81  ---VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS 137

Query: 119 ANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
              +LK+ DFGLAR  S  +   +  VVT WYR P++LL  +EY+ ++D+W VGCI  E+
Sbjct: 138 ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEM 197

Query: 178 MTRQPLFPG-KDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
            T +PLFPG  D   QL  I  ++G+P +ET  G   +   + Y    P +P +      
Sbjct: 198 ATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY--SFPFYPPRPLINHA 255

Query: 236 P--NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           P  ++ P   +L  K L ++P +RI+  EA+ HPY 
Sbjct: 256 PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  206 bits (526), Expect = 3e-65
 Identities = 104/271 (38%), Positives = 148/271 (54%), Gaps = 12/271 (4%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET E VA+K++    D+       LREI LL+ + H+NI+ + D++   ++ T     
Sbjct: 21  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLT----- 75

Query: 62  IVYELMDTDLHQIIRSHQDLTDDH-CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E  D DL +   S     D    + F++QLL+GL + HS NVLHRDLKP NLL+N N
Sbjct: 76  LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135

Query: 121 CDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            +LK+ DFGLAR        +  E VVT WYR P++L     Y+ +ID+WS GCI  E+ 
Sbjct: 136 GELKLADFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 194

Query: 179 TR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
              +PLFPG D   QL+ I  L+G+P E S   +       Y          +     P 
Sbjct: 195 NAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV--SKLPDYKPYPMYPATTSLVNVVPK 252

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
            +    DLL+ +LV +P +RI+ +EAL HPY
Sbjct: 253 LNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  205 bits (523), Expect = 4e-64
 Identities = 105/295 (35%), Positives = 160/295 (54%), Gaps = 35/295 (11%)

Query: 1   MNSETREEVAIKKIGN-AFDNRIDAKR-----------TLREIKLLRHMDHENIIAIKDI 48
            ++ T + VAIKK+      N +   R           TLRE+K++  + HENI+ + D+
Sbjct: 29  YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88

Query: 49  IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
               + +  N   +V ++M +DL +++     LT+   +  L Q+L GL  +H    +HR
Sbjct: 89  Y--VEGDFIN---LVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHR 143

Query: 109 DLKPSNLLLNANCDLKIGDFGLAR---------------TTSETDFMTEYVVTRWYRAPE 153
           DL P+N+ +N+    KI DFGLAR               T    + MT  VVT WYRAPE
Sbjct: 144 DLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPE 203

Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 213
           LL+   +Y  A+D+WSVGCI  E++T +PLFPG++ + QL  I EL+G+P+E +  + ++
Sbjct: 204 LLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDN--WPQA 261

Query: 214 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
                Y    P+ PK +    FPN S  A+DLL+ +L  +P  RI+  EAL H Y
Sbjct: 262 KKLPLYTEFTPRKPK-DLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315

Length = 335

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  203 bits (518), Expect = 5e-64
 Identities = 103/277 (37%), Positives = 153/277 (55%), Gaps = 13/277 (4%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQRETFND 59
            +  T + VA+KK     D        LREI LL+ +     I+ + D+    ++     
Sbjct: 21  RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80

Query: 60  VYIVYELMDTDLHQIIRSH-----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           +Y+V+E +D+DL + + S+     + L     + F+YQLL+G+ + H   V+HRDLKP N
Sbjct: 81  LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140

Query: 115 LLLNANCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           LL++     LKI D GL R  +      T  +VT WYRAPE+LL  + Y+  +DIWSVGC
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNF 231
           I  E+  +QPLFPG   + QL  I +L+G+P E    G  +  +   +    PQ+  Q+ 
Sbjct: 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF----PQWKPQDL 256

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
           S   P+ SP  +DLL+KML +DP +RI+   AL HPY
Sbjct: 257 SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  202 bits (515), Expect = 2e-63
 Identities = 114/290 (39%), Positives = 161/290 (55%), Gaps = 37/290 (12%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQ-- 53
           + +T E VA+KK+      R+D ++       +REIK+LR ++H NI+ +K+I+   Q  
Sbjct: 28  DKDTGELVALKKV------RLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81

Query: 54  ---RETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
              ++     Y+V+E MD DL  ++ S     ++DH + F+ QLL GL Y H  N LHRD
Sbjct: 82  LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRD 141

Query: 110 LKPSNLLLNANCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           +K SN+LLN    +K+ DFGLAR   + E+   T  V+T WYR PELLL    Y  AID+
Sbjct: 142 IKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDV 201

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF- 226
           WS GCILGE+ T++P+F     + QL LI+ L GSP                V  LP F 
Sbjct: 202 WSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---------VWPDVIKLPYFN 252

Query: 227 ---PKQNFSAR----FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              PK+ +  R    F      A+DLL+ ML  DP++R T +EAL  P+L
Sbjct: 253 TMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  197 bits (503), Expect = 1e-61
 Identities = 101/278 (36%), Positives = 153/278 (55%), Gaps = 23/278 (8%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N +T + VA+KKI    +        +REI LL+ + H NI+ ++D++    R     +Y
Sbjct: 21  NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR-----LY 75

Query: 62  IVYELMDTDLHQI---IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +++E +  DL +    +   Q +  +  + +LYQ+L+G+ + HS  VLHRDLKP NLL++
Sbjct: 76  LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID 135

Query: 119 ANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
               +K+ DFGLAR         T  VVT WYRAPE+LL    Y+  +DIWS+G I  E+
Sbjct: 136 NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDE------TSLGFLRSDNARRYVRMLPQFPKQNF 231
            T++PLF G   + QL  I  ++G+P E      TSL          Y    P++ K + 
Sbjct: 196 ATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL--------PDYKNTFPKWKKGSL 247

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            +   N     +DLLEKML++DP +RI+  +AL HPY 
Sbjct: 248 RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  196 bits (499), Expect = 8e-61
 Identities = 102/289 (35%), Positives = 150/289 (51%), Gaps = 34/289 (11%)

Query: 2   NSETREEVAIKKIGNAFDNR-----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 56
           + +T++ VA+KK+    +N      I A   LREIK+L+ + HEN++ + +I R      
Sbjct: 33  HKKTKQIVALKKV--LMENEKEGFPITA---LREIKILQLLKHENVVNLIEICRTKATPY 87

Query: 57  FN---DVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
                  Y+V+E  + DL  ++ + +   T    +  +  LL GL Y+H   +LHRD+K 
Sbjct: 88  NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA 147

Query: 113 SNLLLNANCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           +N+L+  +  LK+ DFGLAR  S +     +  T  VVT WYR PELLL   +Y   ID+
Sbjct: 148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDM 207

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS------PDETSLGFLRSDNARRYVR 221
           W  GCI+ E+ TR P+  G    HQL LI++L GS      P    L   +         
Sbjct: 208 WGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK-------KM 260

Query: 222 MLPQFPKQNFSARFP--NKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
            LPQ  K+    R     K P A+DL++K+LV DP +RI  D AL H +
Sbjct: 261 ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  192 bits (489), Expect = 1e-59
 Identities = 87/269 (32%), Positives = 155/269 (57%), Gaps = 7/269 (2%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET + VAIKK   + D+ +  K  LREI++L+ + H N++ + ++ R  ++     ++
Sbjct: 22  NRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK-----LH 76

Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E  D T L+++ ++ + + +   +  ++Q L+ + + H  N +HRD+KP N+L+   
Sbjct: 77  LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ 136

Query: 121 CDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG AR  +      T+YV TRWYRAPELL+  ++Y   +D+W++GC+  E++T
Sbjct: 137 GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            QPL+PGK  V QL LI + +G           ++   + + +     ++   ++FPN S
Sbjct: 197 GQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNIS 256

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPY 268
             A+  L+  L  DP  R++ +E L HPY
Sbjct: 257 SPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  192 bits (491), Expect = 1e-59
 Identities = 102/301 (33%), Positives = 158/301 (52%), Gaps = 42/301 (13%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           N +  +E AIKK  G+       ++   REI LLR + HEN++++ ++      ++   V
Sbjct: 23  NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS---V 79

Query: 61  YIVYELMDTDLHQIIRSHQD-----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           Y++++  + DL QII+ H+      +     +  L+Q+L G+ Y+HS  VLHRDLKP+N+
Sbjct: 80  YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANI 139

Query: 116 LLNANCD----LKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 164
           L+         +KIGD GLAR         ++ D     VVT WYRAPELLL    YT A
Sbjct: 140 LVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PVVVTIWYRAPELLLGARHYTKA 196

Query: 165 IDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRLITELIGSPDETSLGFLRSDN 215
           IDIW++GCI  E++T +P+F G++            QL  I E++G+P E     ++   
Sbjct: 197 IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIK--K 254

Query: 216 ARRYVRMLPQFPKQNFSA--------RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
              Y  ++  F  + + +        +         DLL K+L +DP +RIT +EAL HP
Sbjct: 255 MPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314

Query: 268 Y 268
           Y
Sbjct: 315 Y 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  187 bits (477), Expect = 6e-58
 Identities = 98/245 (40%), Positives = 144/245 (58%), Gaps = 10/245 (4%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-C 86
           +RE+ LL+++ H NI+ + DII      T   + +V+E +D+DL Q + +  +L   H  
Sbjct: 51  IREVSLLKNLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNV 105

Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVV 145
           + F++QLLRGL Y H   +LHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VV
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV 165

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 205
           T WYR P++LL  +EY+  ID+W VGCIL E+ T +P+FPG     +L LI  L+G+P E
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225

Query: 206 TSL-GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
            +  G   ++  R Y  + PQ+  Q      P      +DLL  +L+++   RI+ + AL
Sbjct: 226 ETWPGITSNEEFRSY--LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283

Query: 265 CHPYL 269
            H Y 
Sbjct: 284 RHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  186 bits (473), Expect = 3e-57
 Identities = 97/273 (35%), Positives = 166/273 (60%), Gaps = 15/273 (5%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + ET + VAIKK   + D+++  K  +REI++L+ + HEN++ + ++ R  +R     +Y
Sbjct: 22  HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR-----LY 76

Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E +D T L  + +    L +   R +L+Q+LRG+++ HS N++HRD+KP N+L++ +
Sbjct: 77  LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS 136

Query: 121 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG ART  +  +  T+YV TRWYRAPELL+  ++Y  A+DIW+VGC++ E++T
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Query: 180 RQPLFPGKDYVHQLRLITELIG--SPDETSLGFLRSDNARRYVRM-LPQFPK-QNFSARF 235
            +PLFPG   + QL  I + +G   P    + F ++     +  M LP+  + +    RF
Sbjct: 197 GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-FQKN---PLFAGMRLPEVKEIEPLEKRF 252

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
           P  S   +DL ++ L  DP+ R +  + L H +
Sbjct: 253 PKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  182 bits (464), Expect = 9e-56
 Identities = 99/248 (39%), Positives = 142/248 (57%), Gaps = 10/248 (4%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-C 86
           +RE+ LL+ + H NI+ + DII      T   + +V+E +D DL Q +    +  + H  
Sbjct: 52  IREVSLLKDLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNV 106

Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVV 145
           + FL+QLLRGL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VV
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP-D 204
           T WYR P++LL  ++Y+  ID+W VGCI  E+ T +PLFPG     QL  I  ++G+P +
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226

Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           ET  G L ++  + Y    P++         P       +LL K+L F+  +RI+ +EA+
Sbjct: 227 ETWPGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 265 CHPYLAPL 272
            HPY   L
Sbjct: 285 KHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  179 bits (454), Expect = 2e-54
 Identities = 96/246 (39%), Positives = 141/246 (57%), Gaps = 9/246 (3%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHC 86
           +RE  LL+ + H NI+ + DII   +  TF     V+E M TDL Q +  H   L   + 
Sbjct: 51  IREASLLKGLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNV 105

Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVV 145
           R F++QLLRGL Y+H  ++LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VV
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSP- 203
           T WYR P++LL  ++Y++A+DIW  GCI  E++  QP FPG  D   QL  I  ++G P 
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT 225

Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           ++T  G  +  N +    +  +  +     +  ++ P A DL  +ML+  P  RI+  +A
Sbjct: 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285

Query: 264 LCHPYL 269
           L HPY 
Sbjct: 286 LLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  178 bits (453), Expect = 4e-54
 Identities = 99/248 (39%), Positives = 142/248 (57%), Gaps = 10/248 (4%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-C 86
           +RE+ LL+ + H NI+ + DI+      T   + +V+E +D DL Q +    ++   H  
Sbjct: 52  IREVSLLKDLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNV 106

Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVV 145
           + FLYQ+LRGL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VV
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP-D 204
           T WYR P++LL  SEY+  ID+W VGCI  E+ + +PLFPG     +L LI  L+G+P +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226

Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           ET  G   +D  + Y    P++  Q      P      ++LL K L ++  +RI+ +EA+
Sbjct: 227 ETWPGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284

Query: 265 CHPYLAPL 272
            H Y   L
Sbjct: 285 KHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  172 bits (436), Expect = 8e-52
 Identities = 96/270 (35%), Positives = 157/270 (58%), Gaps = 10/270 (3%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + ET+E VAIKK  ++ +N    + TLRE+K+LR +  ENI+ +K+  R   +     +Y
Sbjct: 22  HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK-----LY 76

Query: 62  IVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E ++ ++ +++    + +  +  R ++YQL++ + + H  +++HRD+KP NLL++ N
Sbjct: 77  LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN 136

Query: 121 CDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
             LK+ DFG AR  SE      TEYV TRWYR+PELLL  + Y  A+D+WSVGCILGE+ 
Sbjct: 137 DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELS 195

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
             QPLFPG+  + QL  I +++G      +    S+     +R       Q+   R+   
Sbjct: 196 DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGI 255

Query: 239 SPGA-VDLLEKMLVFDPNRRITVDEALCHP 267
             G  +DL++ +L  +P  R   ++ L HP
Sbjct: 256 LSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (413), Expect = 4e-49
 Identities = 64/181 (35%), Positives = 106/181 (58%), Gaps = 10/181 (5%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            + +T ++VAIK I    D+    +  LREI++L+ ++H NI+ +  +      E  N +
Sbjct: 13  RDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHL 66

Query: 61  YIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           Y+V E  +   L  +++ +   L++D     L Q+L GL+Y+HS  ++HRDLKP N+LL+
Sbjct: 67  YLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD 126

Query: 119 ANCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           ++   +K+ DFGL++  TS+   +   V T  Y APE+LL    Y+   DIWS+G IL E
Sbjct: 127 SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186

Query: 177 I 177
           +
Sbjct: 187 L 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  161 bits (410), Expect = 3e-48
 Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 36/273 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ +T E +A+K +  + D+  + +   REI++L  + H NI+      R  ++ T N  
Sbjct: 20  LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN-- 77

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            I  E +    L  +++    L +   R +  Q+L GL Y+HS  ++HRD+K +N+L+++
Sbjct: 78  -IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS 136

Query: 120 NCDLKIGDFGLART--TSETDFMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           +  +K+ DFG A+     ET   T  V  T ++ APE ++   EY  A DIWS+GC + E
Sbjct: 137 DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCTVIE 195

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           + T +P +               IGS  E                  P+ P+        
Sbjct: 196 MATGKPPWSELGNPMAALY---KIGSSGE-----------------PPEIPE-------- 227

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           + S  A D L K L  DP +R T DE L HP+L
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  162 bits (410), Expect = 6e-48
 Identities = 94/256 (36%), Positives = 135/256 (52%), Gaps = 26/256 (10%)

Query: 27  TLREIKLLR---HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS--HQDL 81
           T+RE+ LL+     DH NI+ + D+    + +    V +V+E +D DL   +       L
Sbjct: 46  TVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL 105

Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T
Sbjct: 106 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT 165

Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
             VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 166 PVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224

Query: 202 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR--------FPNKSPGAVDLLEKMLVFD 253
            P E        D+  R V +    P+  FS R         P        LL +ML F+
Sbjct: 225 LPPE--------DDWPRDVTL----PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFN 272

Query: 254 PNRRITVDEALCHPYL 269
           P++RI+   AL HP+ 
Sbjct: 273 PHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  154 bits (389), Expect = 7e-45
 Identities = 91/251 (36%), Positives = 137/251 (54%), Gaps = 18/251 (7%)

Query: 27  TLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--L 81
           T+RE+ +LRH++   H N++ + D+    + +    + +V+E +D DL   +    +  +
Sbjct: 48  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 107

Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
             +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T
Sbjct: 108 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 167

Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
             VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG
Sbjct: 168 SVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226

Query: 202 SPDE----TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 257
            P E      +   R     +        P + F     +      DLL K L F+P +R
Sbjct: 227 LPGEEDWPRDVALPRQAFHSK-----SAQPIEKF---VTDIDELGKDLLLKCLTFNPAKR 278

Query: 258 ITVDEALCHPY 268
           I+   AL HPY
Sbjct: 279 ISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  154 bits (389), Expect = 1e-44
 Identities = 96/259 (37%), Positives = 140/259 (54%), Gaps = 29/259 (11%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHC 86
           +RE  LL+ + H NI+ + DII    +ET     +V+E + TDL Q +  H   L  ++ 
Sbjct: 51  IREASLLKGLKHANIVLLHDIIH--TKETLT---LVFEYVHTDLCQYMDKHPGGLHPENV 105

Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVV 145
           + FL+QLLRGL Y+H   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VV
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPD 204
           T WYR P++LL  +EY+  +D+W VGCI  E++     FPG KD   QL  I  ++G+P+
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225

Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS-----------PGAVDLLEKMLVFD 253
           E +   + S         LP F  + F+  +  K+             A DL  K+L   
Sbjct: 226 EDTWPGVHS---------LPHFKPERFTL-YSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275

Query: 254 PNRRITVDEALCHPYLAPL 272
           P  R++   AL H Y + L
Sbjct: 276 PKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  148 bits (376), Expect = 4e-43
 Identities = 74/277 (26%), Positives = 129/277 (46%), Gaps = 48/277 (17%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND-- 59
                +   +K+I  +  +  + +  L E+K+L+ ++H NII           E+F +  
Sbjct: 21  RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY--------YESFEEKG 72

Query: 60  -VYIVYELMD-TDLHQIIRSHQD----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
            + IV E  D  DL Q I+  +       ++    +  QL   LKY+HS  +LHRD+KP 
Sbjct: 73  KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+ L +N  +K+GDFG+++  S T  + + VV T +Y +PEL  N   Y    DIWS+GC
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGC 191

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +L E+ T +  F G+   + L L  +++                +     +P      +S
Sbjct: 192 VLYELCTLKHPFEGE---NLLELALKIL----------------KGQYPPIP----SQYS 228

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +          +L+  +L  DP  R ++ + L  P++
Sbjct: 229 SEL-------RNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  151 bits (382), Expect = 2e-42
 Identities = 99/312 (31%), Positives = 163/312 (52%), Gaps = 28/312 (8%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI-----IRPPQRETFN 58
           +T E+VAIKK+        D +   RE+ ++++++H NII +KD       +  ++  F 
Sbjct: 89  DTSEKVAIKKVLQ------DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142

Query: 59  DVYIVYELMDTDLHQII----RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           +V  V E +   +H+ +    R++  L     + + YQL R L Y+HS  + HRDLKP N
Sbjct: 143 NV--VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQN 200

Query: 115 LLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           LL++ N   LK+ DFG A+          Y+ +R+YRAPEL+L  + YT  ID+WS+GCI
Sbjct: 201 LLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           + E++   P+F G+  V QL  I +++G+P E  L  +  + A       P    ++   
Sbjct: 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD---IKFPDVKPKDLKK 317

Query: 234 RFPNKSP-GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDF--E 290
            FP  +P  A++ + + L ++P +R+   EAL  P+   L D    P    P   D   +
Sbjct: 318 VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD----PCIKLPKYIDKLPD 373

Query: 291 HPSFTEENIKEL 302
             +F +  IKE+
Sbjct: 374 LFNFCDAEIKEM 385

Length = 440

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  148 bits (374), Expect = 7e-42
 Identities = 77/304 (25%), Positives = 132/304 (43%), Gaps = 39/304 (12%)

Query: 6   REEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHE-NIIAIKDIIRPPQRETFNDVYIV 63
           R+ VA+K +    +++    +R LREI++L  ++H  NI+ + D       +    +Y+V
Sbjct: 22  RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSLYLV 76

Query: 64  YELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            E +D   L  +++       L++    + L Q+L  L+Y+HS  ++HRD+KP N+LL+ 
Sbjct: 77  MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR 136

Query: 120 N-CDLKIGDFGLARTTSETD-------FMTEYVVTRWYRAPELLL--NCSEYTAAIDIWS 169
           +   +K+ DFGLA+   +           +  V T  Y APE+LL  + +  +++ DIWS
Sbjct: 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G  L E++T  P F G+          ++I                       P     
Sbjct: 197 LGITLYELLTGLPPFEGEKNSSATSQTLKII------------------LELPTPSLASP 238

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDF 289
              +     S  A DLL+K+L  DP  R++    L H  LA L     +           
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298

Query: 290 EHPS 293
               
Sbjct: 299 PLRL 302

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (334), Expect = 6e-37
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 46/274 (16%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFND 59
            +  T +EVAIK I    +++   ++ + EI++L+   H NI+      ++       ++
Sbjct: 20  RHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK------DE 71

Query: 60  VYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           ++IV E      L  +++S  Q LT+    Y   +LL+GL+Y+HS  ++HRD+K +N+LL
Sbjct: 72  LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
            ++ ++K+ DFGL+   S+T      V T ++ APE ++N   Y    DIWS+G    E+
Sbjct: 132 TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAIEL 190

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
              +P  P  +                      L    A   +      P         N
Sbjct: 191 AEGKP--PYSE----------------------LPPMKALFKIATNG-PPG------LRN 219

Query: 238 K---SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
               S    D L+K L  +P +R T ++ L HP+
Sbjct: 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  131 bits (331), Expect = 3e-36
 Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 62/284 (21%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF--- 57
            +  T +EVAIKK+     N+   +  + EI +++   H NI+   D       +++   
Sbjct: 39  TDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIV---DYY-----DSYLVG 87

Query: 58  NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +++++V E MD    TD+  I ++   + +    Y   ++L+GL+Y+HS NV+HRD+K  
Sbjct: 88  DELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145

Query: 114 NLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+ +  +K+ DFG  A+ T E       V T ++ APE++    +Y   +DIWS+G 
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLG- 203

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELI-GSP---DETSLG--FLRSDNARRYVRMLPQF 226
               IM                   E+  G P    E  L   FL +         +P  
Sbjct: 204 ----IMCI-----------------EMAEGEPPYLREPPLRALFLITTKG------IPPL 236

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                       SP   D L K LV DP +R + +E L HP+L 
Sbjct: 237 KNPE------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  129 bits (326), Expect = 3e-35
 Identities = 91/283 (32%), Positives = 140/283 (49%), Gaps = 54/283 (19%)

Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--------- 79
           REI LLR + H N+IA++ +       +   V+++++  + DL  II+ H+         
Sbjct: 47  REIALLRELKHPNVIALQKVF---LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPM 103

Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTS 135
            L     +  LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 136 ET----DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD--- 188
                   +   VVT WYRAPELLL    YT AIDIW++GCI  E++T +P+F  +    
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223

Query: 189 ------YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP--KQNF-SARFPNKS 239
                 +  QL  I  ++G P         +D     +R +P++P  +++F    + N S
Sbjct: 224 KTSNPFHHDQLDRIFSVMGFP---------ADKDWEDIRKMPEYPTLQKDFRRTTYANSS 274

Query: 240 -------------PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                             LL+K+L  DP +RIT ++AL  PY 
Sbjct: 275 LIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (320), Expect = 6e-35
 Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 42/273 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N ET + VAIK+I          K  ++EI LL+++ H NI+     I     ET + +
Sbjct: 20  LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSL 74

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           YI+ E  +   L QII+      +     ++YQ+L+GL Y+H   V+HRD+K +N+L   
Sbjct: 75  YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           +  +K+ DFG+A   ++       VV T ++ APE++   S  + A DIWS+GC + E++
Sbjct: 135 DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELL 193

Query: 179 TRQPLFPGKDYVHQLRLITEL--IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           T  P +      + L  +  L  I   D                   P  P+        
Sbjct: 194 TGNPPY------YDLNPMAALFRIVQDDH------------------PPLPE-------- 221

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             SP   D L +    DPN R T  + L HP++
Sbjct: 222 GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  126 bits (319), Expect = 1e-34
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 23/198 (11%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
                 EVA+K +  +A + +I  +  LRE +++R +DH NI+ +  +    +      +
Sbjct: 24  GDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHPNIVKLLGVCTEEEP-----L 76

Query: 61  YIVYELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            IV E M   DL   +R ++   L+      F  Q+ RG++Y+ S N +HRDL   N L+
Sbjct: 77  MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVG 171
             N  +KI DFGL+R   + D    Y V       RW  APE L    ++T+  D+WS G
Sbjct: 137 GENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM-APESLKE-GKFTSKSDVWSFG 191

Query: 172 CILGEIMTR-QPLFPGKD 188
            +L EI T  +  +PG  
Sbjct: 192 VLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (318), Expect = 1e-34
 Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 22/197 (11%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             + + EVA+K +  +A + +I  +  LRE +++R +DH N++ +  +    +      +
Sbjct: 24  GGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHPNVVKLLGVCTEEEP-----L 76

Query: 61  YIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           YIV E M+  DL   +R ++  L+      F  Q+ RG++Y+ S N +HRDL   N L+ 
Sbjct: 77  YIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG 136

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGC 172
            N  +KI DFGL+R   + D    Y         RW  APE L    ++T+  D+WS G 
Sbjct: 137 ENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM-APESLKE-GKFTSKSDVWSFGV 191

Query: 173 ILGEIMTR-QPLFPGKD 188
           +L EI T  +  +PG  
Sbjct: 192 LLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  125 bits (316), Expect = 2e-34
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 44/276 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL----REIKLLRHMDHENIIAIKDIIRPPQRET 56
           +N +  +  A+K++ +  D+    +  +    +EI LL  + H NI+         +RE 
Sbjct: 20  LNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY----LGTEREE 74

Query: 57  FNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
            N +YI  EL+    L ++++ +    +   R +  Q+L GL+Y+H  N +HRD+K +N+
Sbjct: 75  DN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI 133

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L++ N  +K+ DFG+A+   E  F   +  + ++ APE++     Y  A DIWS+GC + 
Sbjct: 134 LVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVL 193

Query: 176 EIMTRQPLFPGKDYVHQLRLITEL--IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           E+ T +P +       QL  +  +  IG   E                 LP  P      
Sbjct: 194 EMATGKPPW------SQLEGVAAVFKIGRSKE-----------------LPPIPD----- 225

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              + S  A D + K L  DP+ R T  E L HP++
Sbjct: 226 ---HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  124 bits (314), Expect = 6e-34
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 46/273 (16%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII----AIKDIIRPPQRETFNDV 60
           T +  A+KKI +   +    K+ LRE+K LR  +   ++    A     +  +      +
Sbjct: 25  TGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF---YKEGE------I 74

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLN 118
            IV E MD   L  +++    + +    Y   Q+L+GL Y+H+  +++HRD+KPSNLL+N
Sbjct: 75  SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134

Query: 119 ANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE- 176
           +  ++KI DFG+++    T      +V T  Y +PE  +    Y+ A DIWS+G  L E 
Sbjct: 135 SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLLEC 193

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
            + + P  P         L+  +   P                    P  P + FS  F 
Sbjct: 194 ALGKFPFLPPGQPS-FFELMQAICDGP-------------------PPSLPAEEFSPEF- 232

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                  D +   L  DP +R +  E L HP++
Sbjct: 233 ------RDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  124 bits (313), Expect = 8e-34
 Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 42/278 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N +T E +A+K+I    ++    K    E+K+L  + H N++    +     RE    V
Sbjct: 20  VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV--EVHRE---KV 74

Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHC-RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           YI  E      L +++  H  + D+H  R +  QLL GL Y+HS  ++HRD+KP+N+ L+
Sbjct: 75  YIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD 133

Query: 119 ANCDLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVG 171
            N  +K+GDFG A      TT+  + +     T  Y APE++       +  A DIWS+G
Sbjct: 134 HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG 193

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           C++ E+ T +  +   D   Q   I   +G+                     P  P    
Sbjct: 194 CVVLEMATGKRPWSELDNEFQ---IMFHVGA------------------GHKPPIPDSL- 231

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                  SP   D L++ L  DP +R T  E L HP++
Sbjct: 232 -----QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  124 bits (312), Expect = 3e-33
 Identities = 87/276 (31%), Positives = 138/276 (50%), Gaps = 40/276 (14%)

Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--------- 79
           REI LLR + H N+I+++ +           V+++++  + DL  II+ H+         
Sbjct: 47  REIALLRELKHPNVISLQKVF---LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV 103

Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTS 135
            L     +  LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +
Sbjct: 104 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 136 ET----DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD--- 188
                   +   VVT WYRAPELLL    YT AIDIW++GCI  E++T +P+F  +    
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223

Query: 189 -----YVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS----ARFPNK 238
                Y H QL  I  ++G P +     ++      +  ++  F +  ++     ++  K
Sbjct: 224 KTSNPYHHDQLDRIFNVMGFPADKDWEDIK--KMPEHSTLMKDFRRNTYTNCSLIKYMEK 281

Query: 239 -----SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   A  LL+K+L  DP +RIT ++A+  PY 
Sbjct: 282 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 9e-33
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 45/275 (16%)

Query: 1   MNSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
              +T +  A+K +        + + + TL E  +L  ++H  I+ +         +T  
Sbjct: 13  RKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNILSRINHPFIVKLHYAF-----QTEE 66

Query: 59  DVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            +Y+V E     +L   +      +++  R++  +++  L+Y+HS  +++RDLKP N+LL
Sbjct: 67  KLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126

Query: 118 NANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           +A+  +K+ DFGLA+  +SE      +  T  Y APE+LL    Y  A+D WS+G +L E
Sbjct: 127 DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYE 185

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++T +P F  +D       I E I          L+            +FP         
Sbjct: 186 MLTGKPPFYAEDRK----EIYEKI----------LKDP---------LRFP--------E 214

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALC---HPY 268
             SP A DL+  +L  DP +R+    A     HP+
Sbjct: 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  114 bits (287), Expect = 5e-30
 Identities = 60/171 (35%), Positives = 91/171 (53%), Gaps = 15/171 (8%)

Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQII----RSHQDLTDD 84
           E+ +LR + H NI+   D I     +T   +YIV E  +  DL Q+I    +  + + ++
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEE 105

Query: 85  HCRYFLYQLLRGLKYVH-----SANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETD 138
                L QLL  L   H        VLHRDLKP+N+ L+AN ++K+GDFGLA+    ++ 
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165

Query: 139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 189
           F   YV T +Y +PE L +   Y    DIWS+GC++ E+    P F  ++ 
Sbjct: 166 FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQ 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  112 bits (282), Expect = 3e-29
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 23/197 (11%)

Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
             T  +VA+K +        + +  L E  +++ + H NI+ +  +    +      +YI
Sbjct: 25  EGTETKVAVKTLKEGASEE-EREEFLEEASIMKKLSHPNIVRLLGVCTQGEP-----LYI 78

Query: 63  VYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           V E M   DL   +R H + LT         Q+ +G++Y+ S N +HRDL   N L+  N
Sbjct: 79  VTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTEN 138

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
             +KI DFGL+R   E D    Y          +W  APE L +  ++T+  D+WS G +
Sbjct: 139 LVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-APESLKDG-KFTSKSDVWSFGVL 193

Query: 174 LGEIMT--RQPLFPGKD 188
           L EI T   QP +PG  
Sbjct: 194 LWEIFTLGEQP-YPGMS 209

Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  110 bits (276), Expect = 2e-28
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 46/232 (19%)

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            ++Y+V E +   DL  ++ +   L +D  R ++ +++  L+Y+HS  ++HRDLKP N+L
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 117 LNANCDLKIGDFGLARTT---------SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           +++N  LK+ DFGL++            +       V T  Y APE++L    ++  +D 
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDW 184

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           WS+GCIL E +   P F G+              +P+E     L      +      ++P
Sbjct: 185 WSLGCILYEFLVGIPPFHGE--------------TPEEIFQNIL----NGKI-----EWP 221

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLHDIN 276
           +          S  A+DL+ K+LV DP +R+   +++E   HP+      I+
Sbjct: 222 E------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK---GID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 3e-28
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
                  EVA+K +     +  + K  L+E ++++ + H N++ +  +    +      +
Sbjct: 18  GKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP-----L 71

Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHCR---------YFLYQLLRGLKYVHSANVLHRDL 110
           Y+V E M+  DL   +R  + +     +          F  Q+ +G++Y+ S   +HRDL
Sbjct: 72  YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDL 131

Query: 111 KPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTA 163
              N L+  +  +KI DFGL+R   + D+   Y          RW  APE L +   +T+
Sbjct: 132 AARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWM-APESLKD-GIFTS 186

Query: 164 AIDIWSVGCILGEIMTR--QPLFPGKDYVHQLRLITE 198
             D+WS G +L EI T    P +PG      L  + +
Sbjct: 187 KSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  109 bits (275), Expect = 4e-28
 Identities = 84/304 (27%), Positives = 127/304 (41%), Gaps = 87/304 (28%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIK----------LLRHMDHENIIAIKDIIRPPQ 53
           ET +E AIK         +D ++ ++E K          L R   H  II +        
Sbjct: 24  ETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYY------ 69

Query: 54  RETFND---VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
             TF D   +Y V E   + +L Q IR +  L +   R++  ++L  L+Y+HS  ++HRD
Sbjct: 70  --TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRD 127

Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---------------------YVVTRW 148
           LKP N+LL+ +  +KI DFG A+                               +V T  
Sbjct: 128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAE 187

Query: 149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 208
           Y +PELL        + D+W++GCI+ +++T +P F G +     + I +L         
Sbjct: 188 YVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL--------- 237

Query: 209 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEAL 264
                            FP        PN  P A DL+EK+LV DP  R+ V    DE  
Sbjct: 238 --------------EYSFP--------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275

Query: 265 CHPY 268
            HP+
Sbjct: 276 AHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  104 bits (262), Expect = 2e-26
 Identities = 67/191 (35%), Positives = 104/191 (54%), Gaps = 25/191 (13%)

Query: 9   VAIKKIGNAFDNRIDAK---RTLREIKLLRHMDHENIIAIKDIIRPPQRETF---NDVYI 62
           VA+KK+   F+  +DAK     L+EI LL+ +DH N+I            +F   N++ I
Sbjct: 30  VALKKV-QIFE-MMDAKARQDCLKEIDLLKQLDHPNVIKYLA--------SFIENNELNI 79

Query: 63  VYELMDT-DLHQII---RSHQDLTDDHC--RYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           V EL D  DL ++I   +  + L  +    +YF  QL   L+++HS  ++HRD+KP+N+ 
Sbjct: 80  VLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLCSALEHMHSKRIMHRDIKPANVF 138

Query: 117 LNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           + A   +K+GD GL R  +S+T      V T +Y +PE +   + Y    DIWS+GC+L 
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLY 197

Query: 176 EIMTRQPLFPG 186
           E+   Q  F G
Sbjct: 198 EMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  103 bits (259), Expect = 5e-26
 Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 43/281 (15%)

Query: 1   MNSETREEVAIKKI-------GNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPP 52
           +N  T E +A+K++       G     + D  + LR EI+ L+ +DH NI+         
Sbjct: 21  LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF---- 76

Query: 53  QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
              T   + I  E +    +   +R++    +   R+F  Q+L GL Y+HS  +LHRDLK
Sbjct: 77  -ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLK 135

Query: 112 PSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCSE-YTAAIDI 167
             NLL++A+   KI DFG+++ + +    D       + ++ APE++ + S+ Y+A +DI
Sbjct: 136 ADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDI 195

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           WS+GC++ E      +F G+        I  +        LG  RS          P  P
Sbjct: 196 WSLGCVVLE------MFAGRRPWSDEEAIAAMF------KLGNKRS---------APPIP 234

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
                    N SP A+D L      +P+ R T  E L HP+
Sbjct: 235 ----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (256), Expect = 1e-25
 Identities = 75/274 (27%), Positives = 120/274 (43%), Gaps = 54/274 (19%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF---NDVYIV 63
           +  A+K++     ++ + +  + EI++L  ++H NII+ K        E F   N + IV
Sbjct: 26  QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK--------EAFLDGNKLCIV 77

Query: 64  YELMD-TDLHQIIRSHQDL-----TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            E     DL + I   +         +  R F+ QLLRGL+ +H   +LHRDLK +N+LL
Sbjct: 78  MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQALHEQKILHRDLKSANILL 136

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
            AN  +KIGD G+++   +    T+ + T  Y APE+      Y+   DIWS+GC+L E+
Sbjct: 137 VANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEM 194

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK--QNFSARF 235
            T  P F  +        + +L                  RY     ++P     +S   
Sbjct: 195 ATFAPPFEARS-------MQDL------------------RYKVQRGKYPPIPPIYSQDL 229

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            N        +  ML   P  R   D+ L  P +
Sbjct: 230 QN-------FIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 3e-25
 Identities = 68/274 (24%), Positives = 130/274 (47%), Gaps = 45/274 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLR----EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +T  E+A+K++    D+  + K+ +     EI+LL+++ HE I+     +R  +      
Sbjct: 25  DTGRELAVKQVPFDPDSP-ETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET----- 78

Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           + I  E M    +   ++++  LT+   R +  Q+L G++Y+HS  ++HRD+K +N+L +
Sbjct: 79  LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD 138

Query: 119 ANCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +  ++K+GDFG    L    S    M     T ++ +PE +++   Y    D+WSVGC +
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTV 197

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
            E++T +P  P  ++   +  I ++   P                    PQ P       
Sbjct: 198 VEMLTEKP--PWAEF-EAMAAIFKIATQPTN------------------PQLP------- 229

Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
             + SP A + L +  V +  +R + +E L H +
Sbjct: 230 -SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.2 bits (245), Expect = 5e-24
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 51/272 (18%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-------NDVY 61
           +A+K I    +  I  K+ LRE+ +L   +   I+             F        D+ 
Sbjct: 29  MAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIV------------GFYGAFYNNGDIS 75

Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFL-YQLLRGLKYVHSA-NVLHRDLKPSNLLLN 118
           I  E MD   L +I++  Q    +     +   +L+GL Y+H    ++HRD+KPSN+L+N
Sbjct: 76  ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           +   +K+ DFG++     +   T +V T  Y APE  +  ++Y+   DIWS+G  L E+ 
Sbjct: 136 SRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLSLIELA 193

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSARFPN 237
           T +  FP                  ++   G    +  +  V    P+ P   FS  F  
Sbjct: 194 TGR--FP--------------YPPENDPPDGIF--ELLQYIVNEPPPRLPSGKFSPDF-- 233

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 D +   L+ DP  R +  E L HP++
Sbjct: 234 -----QDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 6e-24
 Identities = 79/282 (28%), Positives = 123/282 (43%), Gaps = 61/282 (21%)

Query: 1   MNSETREEVAIKK--IGNAFDNRIDAKRTLREIKLLRHMDHENIIA-----IKDIIRPPQ 53
           ++ ET + VAIK   +       I      +EI +L+  D   I+       K+      
Sbjct: 23  IHKETGQVVAIKVVPVEEDLQEII------KEISILKQCDSPYIVKYYGSYFKN------ 70

Query: 54  RETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
                D++IV E       +D+ +I      LT++     LYQ L+GL+Y+HS   +HRD
Sbjct: 71  ----TDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124

Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCSEYTAAIDIW 168
           +K  N+LLN     K+ DFG++   ++T      V+ T ++ APE++     Y    DIW
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIW 183

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           S+G    E+   +P  P  D +H +R I                         M+P  P 
Sbjct: 184 SLGITAIEMAEGKP--PYSD-IHPMRAIF------------------------MIPNKPP 216

Query: 229 QNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              S   P K SP   D ++K LV DP  R +  + L HP++
Sbjct: 217 PTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 98.0 bits (244), Expect = 7e-24
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 55/286 (19%)

Query: 1   MNSETREEVAIKK-----IGNAFDNRIDAKRTL-----REIKLLRHMDHENIIAIKDIIR 50
           MN+ + E +A+K+     +  +  +R   KR++     REI LL+ + HENI+       
Sbjct: 20  MNASSGELMAVKQVELPSVSASSKDR---KRSMLDALAREIALLKELQHENIVQYLG--- 73

Query: 51  PPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
                   ++++ Y +    +  ++ ++    +   R F+ Q+L+GL Y+H+  ++HRD+
Sbjct: 74  SSLDADHLNIFLEY-VPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDI 132

Query: 111 KPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR-------WYRAPELLLNCSEYTA 163
           K +N+L++    +KI DFG+++        T+    R       ++ APE++   S YT 
Sbjct: 133 KGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTR 191

Query: 164 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 223
             DIWS+GC++ E++T +  FP      QL+ I + IG                      
Sbjct: 192 KADIWSLGCLVVEMLTGKHPFPDCT---QLQAIFK-IGE------------------NAS 229

Query: 224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           P+ P         N S  A+D LEK    D N+R T  E L HP+L
Sbjct: 230 PEIPS--------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 3e-23
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 35/215 (16%)

Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V E ++  D   +I++   L +D  + ++ +++ G++ +H   ++HRD+KP NLL++
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               LK+ DFGL+R   E     ++V T  Y APE +L   +     D WS+GC++ E +
Sbjct: 132 QTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFL 187

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
              P F                 +PD      L              +P++         
Sbjct: 188 FGYPPFHA--------------ETPDAVFDNILSRR---------INWPEEVKEF----C 220

Query: 239 SPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLA 270
           SP AVDL+ ++L  DP +R+      E   HP+  
Sbjct: 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.8 bits (238), Expect = 4e-23
 Identities = 60/173 (34%), Positives = 87/173 (50%), Gaps = 10/173 (5%)

Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD- 80
             + + +E  LL  M H NI+A K+       E    +YIV E  D  DL Q I+  +  
Sbjct: 41  AVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGK 95

Query: 81  -LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETD 138
              +D    +  Q+  G++++H   VLHRD+K  N+ L  N  +K+GDFG AR  TS   
Sbjct: 96  LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155

Query: 139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH 191
           +   YV T +Y  PE+  N   Y    DIWS+GCIL E+ T +  F    + +
Sbjct: 156 YACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.2 bits (237), Expect = 5e-23
 Identities = 67/249 (26%), Positives = 109/249 (43%), Gaps = 46/249 (18%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD---LTD 83
           L EI +L  + H NIIA  +          N + I  E  +   L+  I   Q      +
Sbjct: 47  LNEIVILSLLQHPNIIAYYN-----HFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEE 100

Query: 84  DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 143
           +   ++L+Q++  + Y+H A +LHRD+K  N+ L     +K+GDFG+++       M E 
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160

Query: 144 VV-TRWYRAPELLLNCS--EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
           VV T +Y +PEL   C   +Y    DIW++GC+L E++T +  F   +    L L+ +++
Sbjct: 161 VVGTPYYMSPEL---CQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIV 214

Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
                       +     Y                   S   + L+  +L  DP +R T 
Sbjct: 215 QGN--------YTPVVSVY-------------------SSELISLVHSLLQQDPEKRPTA 247

Query: 261 DEALCHPYL 269
           DE L  P L
Sbjct: 248 DEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 94.2 bits (235), Expect = 1e-22
 Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 16/185 (8%)

Query: 10  AIKKIGNA--FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           A+K +      +     +    E ++L   +H  I+            TF D   +Y LM
Sbjct: 22  ALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVK--------LYRTFKDKKYIYMLM 72

Query: 68  DT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           +     +L  I+R      +   R+++  ++   +Y+H+  +++RDLKP NLLL++N  +
Sbjct: 73  EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132

Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           K+ DFG A+          +  T  Y APE++LN   Y  ++D WS+G +L E++T +P 
Sbjct: 133 KLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPP 191

Query: 184 FPGKD 188
           F   D
Sbjct: 192 FGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.1 bits (234), Expect = 1e-22
 Identities = 57/176 (32%), Positives = 94/176 (53%), Gaps = 14/176 (7%)

Query: 10  AIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT 69
           A+K+I  +  NR + +  + E ++L  +D   II   +      +     + IV E  + 
Sbjct: 29  AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK-----LNIVMEYAEN 83

Query: 70  -DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
            DLH++++    + L +D    F  Q+L GL ++HS  +LHRD+K  NL L+A  ++KIG
Sbjct: 84  GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIG 143

Query: 127 DFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMT 179
           D G+A+  S  T+F    V T +Y +PEL   C +  Y    D+W++G +L E  T
Sbjct: 144 DLGVAKLLSDNTNFANTIVGTPYYLSPEL---CEDKPYNEKSDVWALGVVLYECCT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 89.8 bits (223), Expect = 6e-21
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVY 61
            R  VAIK + +  D+ +  +   +E++ L+ + H+++I++  +     P        VY
Sbjct: 29  NRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP--------VY 78

Query: 62  IVYELMDT-DLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           I+ ELM+   L   +RS   Q L          Q+  G+ Y+   N +HRDL   N+L+ 
Sbjct: 79  IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138

Query: 119 ANCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
            +   K+ DFGLAR   E  +++    +  +W  APE   +   ++   D+WS G +L E
Sbjct: 139 EDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILLYE 196

Query: 177 IMTR-QPLFPGKDYVHQLRLITE 198
           + T  Q  +PG +       IT 
Sbjct: 197 MFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 7e-21
 Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 59/278 (21%)

Query: 4   ETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMDHENII-----AIKDIIRPPQRET 56
            T + VAIK I    A D   D     +EI+ L       I       +K          
Sbjct: 24  RTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCRSPYITKYYGSFLKG--------- 71

Query: 57  FNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
            + ++I+ E        DL +  +    L + +  + L ++L GL+Y+H    +HRD+K 
Sbjct: 72  -SKLWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLGLEYLHEEGKIHRDIKA 126

Query: 113 SNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           +N+LL+   D+K+ DFG++ + TS       +V T ++ APE++   S Y    DIWS+G
Sbjct: 127 ANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLG 185

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
               E+   +P  P  D  H +R++  +  +                     P      F
Sbjct: 186 ITAIELAKGEP--PLSDL-HPMRVLFLIPKNNP-------------------PSLEGNKF 223

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           S  F        D +   L  DP  R +  E L H ++
Sbjct: 224 SKPFK-------DFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.3 bits (222), Expect = 7e-21
 Identities = 58/249 (23%), Positives = 110/249 (44%), Gaps = 45/249 (18%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFND---VYIVYELM-DTDLHQIIRSHQDLTD 83
           L E ++L+ ++H  ++ +          +F D   +Y+V +L+   DL   +      ++
Sbjct: 48  LNERRILQELNHPFLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE 99

Query: 84  DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 143
           +  ++++ +++  L+Y+HS  ++HRD+KP N+LL+    + I DF +A   +     T  
Sbjct: 100 EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159

Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE-IMTRQPLFPGKDYVHQLRLITELIGS 202
             T  Y APE +L    Y+ A+D WS+G    E +  ++P + G       R I + I  
Sbjct: 160 SGTPGYMAPE-VLCRQGYSVAVDWWSLGVTAYECLRGKRP-YRGHS-----RTIRDQI-- 210

Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI--TV 260
                          +       +P           S  A+D + K+L  DP +R+   +
Sbjct: 211 -------------RAKQETADVLYP--------ATWSTEAIDAINKLLERDPQKRLGDNL 249

Query: 261 DEALCHPYL 269
            +   HPY 
Sbjct: 250 KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.5 bits (219), Expect = 1e-20
 Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 12/194 (6%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           E   IK+I        + + + +E+ LL  M H NI+      +   R     ++IV E 
Sbjct: 26  EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR-----LFIVMEY 80

Query: 67  MDT-DLHQIIRSHQDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            D  DL + I   + +  ++D    +  Q+  GLK++H   +LHRD+K  N+ L+ N  +
Sbjct: 81  CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMV 140

Query: 124 -KIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            K+GDFG+AR  +++ +     V T +Y +PE+  N   Y    DIWS+GC+L E+ T +
Sbjct: 141 AKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLK 199

Query: 182 PLFPGKDYVHQLRL 195
             F G +  HQL L
Sbjct: 200 HPFEGNNL-HQLVL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 88.3 bits (219), Expect = 2e-20
 Identities = 54/190 (28%), Positives = 100/190 (52%), Gaps = 16/190 (8%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + E  ++  IK+I  +  +  + + + +E+ +L +M H NI+          +E+F +  
Sbjct: 21  SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY--------QESFEENG 72

Query: 62  IVYELMD----TDLHQIIRSHQDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
            +Y +MD     DL++ I + + +   +D    +  Q+   LK+VH   +LHRD+K  N+
Sbjct: 73  NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 132

Query: 116 LLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
            L  +  +K+GDFG+AR  + T +     + T +Y +PE+  N   Y    DIW++GC+L
Sbjct: 133 FLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVL 191

Query: 175 GEIMTRQPLF 184
            E+ T +  F
Sbjct: 192 YEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.2 bits (218), Expect = 3e-20
 Identities = 73/234 (31%), Positives = 118/234 (50%), Gaps = 47/234 (20%)

Query: 6   REEVAIKKIGNAFDNRIDAKR---TLREIKLLRHMDHENIIAIKDIIRPPQRETF---ND 59
           R+ VA+KK+   F+  +DAK     ++EI LL+ ++H N+I   D        +F   N+
Sbjct: 27  RKPVALKKV-QIFE-MMDAKARQDCVKEIDLLKQLNHPNVIKYLD--------SFIEDNE 76

Query: 60  VYIVYELMDT-DLHQII---RSHQDLTDDHC--RYFLYQLLRGLKYVHSANVLHRDLKPS 113
           + IV EL D  DL Q+I   +  + L  +    +YF+ QL   ++++HS  V+HRD+KP+
Sbjct: 77  LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLCSAVEHMHSRRVMHRDIKPA 135

Query: 114 NLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+ + A   +K+GD GL R  +S+T      V T +Y +PE  ++ + Y    DIWS+GC
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGC 194

Query: 173 ILGEIMTRQ----------------------PLFPGKDYVHQLRLITELIGSPD 204
           +L E+   Q                      P  P + Y  +LR +  +   PD
Sbjct: 195 LLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.4 bits (216), Expect = 5e-20
 Identities = 69/262 (26%), Positives = 129/262 (49%), Gaps = 32/262 (12%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLRE-------IKLLRHMDHENIIAIKDIIRPPQR 54
           +++T  E+A+K++   FD   ++  T +E       I+LL+++ HE I+     +R P  
Sbjct: 23  DADTGRELAVKQV--QFDP--ESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78

Query: 55  ETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
            T +   I  E M    +   ++S+  LT++  R +  Q+L G+ Y+HS  ++HRD+K +
Sbjct: 79  RTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135

Query: 114 NLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
           N+L ++  ++K+GDFG ++           M     T ++ +PE +++   Y    DIWS
Sbjct: 136 NILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VISGEGYGRKADIWS 194

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           VGC + E++T +P  P  ++   +  I ++   P    L    SD+ R +++ +    K 
Sbjct: 195 VGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKL 251

Query: 230 NFSARFPNKSPGAVDLLEKMLV 251
                     P A +LL    V
Sbjct: 252 R---------PSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 5e-20
 Identities = 70/252 (27%), Positives = 118/252 (46%), Gaps = 48/252 (19%)

Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETF---NDVYIVYELMDTD-LHQII-RSHQDLTDD 84
           EI +L    H NI+ +         E +   N ++I+ E  D   L  I+    + LT+ 
Sbjct: 52  EIDILSECKHPNIVGL--------YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEP 103

Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEY 143
             RY   Q+L  L ++HS  V+HRDLK  N+LL  + D+K+ DFG+ A+  S       +
Sbjct: 104 QIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163

Query: 144 VVTRWYRAPELLLNC-----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
           + T ++ APE ++ C     + Y    DIWS+G  L E+   +P  P  + ++ +R++ +
Sbjct: 164 IGTPYWMAPE-VVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLK 219

Query: 199 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
           ++ S   T       D   ++          +F+           D L+  LV DP+ R 
Sbjct: 220 ILKSEPPT------LDQPSKWSS--------SFN-----------DFLKSCLVKDPDDRP 254

Query: 259 TVDEALCHPYLA 270
           T  E L HP+++
Sbjct: 255 TAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.1 bits (216), Expect = 7e-20
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 25/192 (13%)

Query: 2   NSETREEVAIKKIGNAFDN--RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
              T E+VA+K + ++ +   R D +R   EI++LR +DHENI+  K +   P       
Sbjct: 29  GDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENIVKYKGVCEKPGG---RS 82

Query: 60  VYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLL 116
           + ++ E L    L   ++ H+D   +  R  L+  Q+ +G+ Y+ S   +HRDL   N+L
Sbjct: 83  LRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNIL 141

Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIW 168
           + +   +KI DFGLA+   E     +Y   +        WY APE L    ++++A D+W
Sbjct: 142 VESEDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIFWY-APECLRTS-KFSSASDVW 196

Query: 169 SVGCILGEIMTR 180
           S G  L E+ T 
Sbjct: 197 SFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 47/272 (17%)

Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND----VY 61
            ++  IKK+     +R + K   +E +LL  + H NI+A         RE++      +Y
Sbjct: 25  GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--------RESWEGEDGLLY 76

Query: 62  IVYELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           IV    +  DL+  ++  +   L ++    +  Q+   L+Y+H  ++LHRDLK  N+ L 
Sbjct: 77  IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT 136

Query: 119 ANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
               +K+GD G+AR   ++ D  +  + T +Y +PEL  N   Y    D+W++GC + E+
Sbjct: 137 RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEM 195

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
            T +  F  KD    +  I E                        LP  PK        +
Sbjct: 196 ATLKHAFNAKDMNSLVYRIIE----------------------GKLPPMPK--------D 225

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            SP   +L+  ML   P +R +V   L  PY+
Sbjct: 226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.7 bits (212), Expect = 2e-19
 Identities = 69/274 (25%), Positives = 122/274 (44%), Gaps = 51/274 (18%)

Query: 9   VAIKKIGNAFDNRIDAKRTL----REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           +A+K++    +   + +  +    +EI+L+  ++H +II +       +   FN   +  
Sbjct: 28  MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHFN---LFV 82

Query: 65  ELM-----DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           E M        L +     + +  ++      QLLRGL Y+H   ++HRD+K +NLL+++
Sbjct: 83  EWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGLSYLHENQIIHRDVKGANLLIDS 138

Query: 120 NC-DLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
               L+I DFG A     + T   +F  + + T  + APE+L    +Y  + D+WSVGC+
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCV 197

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           + E+ T +P +  + + + L LI + I S                     P  P+     
Sbjct: 198 IIEMATAKPPWNAEKHSNHLALIFK-IASATTA-----------------PSIPE----- 234

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
              + SPG  D+  + L   P  R    E L HP
Sbjct: 235 ---HLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 76/287 (26%), Positives = 131/287 (45%), Gaps = 57/287 (19%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENI-------IAIKDIIRPPQ 53
           + +T + VAIK +    D   + K    E  +LR   +H NI       I         Q
Sbjct: 27  HKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83

Query: 54  RETFNDVYIVYELMD----TDLHQ-IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
                 +++V EL      TDL + + +  + L ++   Y L + LRGL Y+H   V+HR
Sbjct: 84  ------LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR 137

Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSE-----YT 162
           D+K  N+LL  N ++K+ DFG++     T      ++ T ++ APE++  C E     Y 
Sbjct: 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA-CDEQPDASYD 196

Query: 163 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 222
           A  D+WS+G    E+   +P  P  D +H +R + ++  +P  T    L+S         
Sbjct: 197 ARSDVWSLGITAIELADGKP--PLCD-MHPMRALFKIPRNPPPT----LKS--------- 240

Query: 223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 +N+S +F        D + + L+ +  +R  ++E L HP++
Sbjct: 241 -----PENWSKKF-------NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 81/266 (30%)

Query: 31  IKLLRHMDHENIIAIK-----DIIRPPQRE----------------------TFNDVYIV 63
           + L+RH       A+K      I++  Q E                      +F D   +
Sbjct: 17  VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNL 76

Query: 64  YELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y +M+     +L   +R      +   R++  Q++  L+Y+HS ++++RDLKP NLLL++
Sbjct: 77  YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTR-W-------YRAPELLLNCSEYTAAIDIWSVG 171
           +  +KI DFG A+           V  R +       Y APE++L+   Y  A+D W++G
Sbjct: 137 DGYIKITDFGFAK----------RVKGRTYTLCGTPEYLAPEIILS-KGYGKAVDWWALG 185

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            ++ E++   P F    +      I E I        G +R             FP    
Sbjct: 186 ILIYEMLAGYPPF----FDDNPIQIYEKILE------GKVR-------------FPS--- 219

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRR 257
                  SP A DL+  +L  D  +R
Sbjct: 220 -----FFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 54/278 (19%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF---NDVYIV 63
           E+VAIK+I +    +       +E++ +   +H N++            +F   +++++V
Sbjct: 27  EKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVK--------YYTSFVVGDELWLV 77

Query: 64  YELMDT-DLHQIIRS--HQDLTDDHC-RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
              +    L  I++S   +   D+      L ++L+GL+Y+HS   +HRD+K  N+LL  
Sbjct: 78  MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137

Query: 120 NCDLKIGDFGLARTTSETDFMTE-----YVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +  +KI DFG++ + ++    T      +V T  + APE++     Y    DIWS G   
Sbjct: 138 DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP----KQN 230
            E+ T     P   Y             P +  +  L++D         P        + 
Sbjct: 198 IELATGAA--PYSKY------------PPMKVLMLTLQNDP--------PSLETGADYKK 235

Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
           +S  F         ++   L  DP++R T +E L H +
Sbjct: 236 YSKSFR-------KMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.2 bits (211), Expect = 3e-19
 Identities = 51/165 (30%), Positives = 84/165 (50%), Gaps = 19/165 (11%)

Query: 30  EIKLLR-HMDHENIIAIKDIIRPPQRETF--ND-VYIVYELMD-TDLHQIIRS----HQD 80
           E+ +++  + H NI+           +TF  ND +YIV +L++   L +   S     Q 
Sbjct: 58  EVTIIKEQLRHPNIVRY--------YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR 109

Query: 81  LTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 139
            T++       Q++  L+Y+H    ++HRDL P+N++L  +  + I DFGLA+       
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169

Query: 140 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           +T  V T  Y  PE++ N   Y    D+W+ GCIL ++ T QP F
Sbjct: 170 LTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 85.2 bits (211), Expect = 4e-19
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 53/275 (19%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFN---- 58
           T  +VA+KK+    D R   +R L   E+ ++R   H NI+           E ++    
Sbjct: 43  TGRQVAVKKM----DLRKQQRRELLFNEVVIMRDYQHPNIV-----------EMYSSYLV 87

Query: 59  --DVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
             ++++V E ++      I +H  + ++        +L+ L ++H+  V+HRD+K  ++L
Sbjct: 88  GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL 147

Query: 117 LNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L ++  +K+ DFG  A+ + E       V T ++ APE++     Y   +DIWS+G ++ 
Sbjct: 148 LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVI 206

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E++  +P +  +  +  ++ I +                        LP   K       
Sbjct: 207 EMVDGEPPYFNEPPLQAMKRIRD-----------------------NLPPKLKNLHKV-- 241

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
              SP     L++MLV DP +R T  E L HP+LA
Sbjct: 242 ---SPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 84.7 bits (209), Expect = 4e-19
 Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 51/233 (21%)

Query: 9   VAIKKIGNAFDNRIDAKR---TLREIKLLRHMDHENIIA-----IKDIIRPPQRETFNDV 60
           VA+KK+   FD  +DAK     ++EI LL+ ++H N+I      I+D          N++
Sbjct: 30  VALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----------NEL 77

Query: 61  YIVYELMDT-DLHQIIR---SHQDLTDDHC--RYFLYQLLRGLKYVHSANVLHRDLKPSN 114
            IV EL D  DL ++I+     + L  +    +YF+ QL   L+++HS  V+HRD+KP+N
Sbjct: 78  NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-QLCSALEHMHSRRVMHRDIKPAN 136

Query: 115 LLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           + + A   +K+GD GL R  +S+T      V T +Y +PE  ++ + Y    DIWS+GC+
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCL 195

Query: 174 LGEIMTRQ----------------------PLFPGKDYVHQLRLITELIGSPD 204
           L E+   Q                      P  P   Y  +LR +  +  +PD
Sbjct: 196 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 36/226 (15%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLK 111
           ET +D+ +V  LM+  DL   I +  +      R   Y  Q++ GL+++H   +++RDLK
Sbjct: 63  ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+LL+ + +++I D GLA        +     T  Y APE+L     Y  ++D +++G
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALG 181

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           C L E++  +   P +    ++                  + +  RR + M  ++P +  
Sbjct: 182 CTLYEMIAGRS--PFRQRKEKVE-----------------KEELKRRTLEMAVEYPDKF- 221

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL 272
                  SP A DL E +L  DP +R+     + DE   HP    L
Sbjct: 222 -------SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-18
 Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 42/274 (15%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +  T E VAIK I    +   D +   +EI +L+   H NI+A         R   + ++
Sbjct: 24  DIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNIVAY---FGSYLRR--DKLW 76

Query: 62  IVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           IV E        D++Q+ R    L++    Y   + L+GL Y+H    +HRD+K +N+LL
Sbjct: 77  IVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL 134

Query: 118 NANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCIL 174
             + D+K+ DFG+ A+ T+       ++ T ++ APE+     +  Y    DIW++G   
Sbjct: 135 TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITA 194

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
            E+   QP  P  D +H +R +             FL S       +     PK     +
Sbjct: 195 IELAELQP--PMFD-LHPMRAL-------------FLIS-------KSNFPPPKLKDKEK 231

Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
           +   SP   D ++K L  DP +R T  + L HP+
Sbjct: 232 W---SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (204), Expect = 2e-18
 Identities = 61/235 (25%), Positives = 128/235 (54%), Gaps = 25/235 (10%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLRE-------IKLLRHMDHENIIAIKDIIRPPQR 54
           +++T  E+A+K++   FD   D++ T +E       I+LL+++ H+ I+     +R P+ 
Sbjct: 23  DADTGRELAVKQV--PFDP--DSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78

Query: 55  ETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +  +   I  E M    +   ++++  LT++  R +  Q+L+G+ Y+HS  ++HRD+K +
Sbjct: 79  KKLS---IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELLLNCSEYTAAIDIW 168
           N+L ++  ++K+GDFG ++   +T  M+   +     T ++ +PE +++   Y    D+W
Sbjct: 136 NILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVW 193

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 223
           SV C + E++T +P  P  +Y   +  I ++   P +  L    SD  R +++ +
Sbjct: 194 SVACTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTKPMLPDGVSDACRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.5 bits (204), Expect = 4e-18
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 38/224 (16%)

Query: 59  DVYIVYELMDTDLH----QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPS 113
           DV+I  E+MDT L     ++      + +D        +++ L+Y+HS  +V+HRD+KPS
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCSEYTAAIDIWSV 170
           N+L+N N  +K+ DFG++    ++   T     + Y APE +   LN   Y    D+WS+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193

Query: 171 GCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           G  + E+ T R P    K    QL+ + E      E S                PQ P +
Sbjct: 194 GITMIELATGRFPYDSWKTPFQQLKQVVE------EPS----------------PQLPAE 231

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 273
            FS  F        D + K L  +   R    E L HP+     
Sbjct: 232 KFSPEF-------QDFVNKCLKKNYKERPNYPELLQHPFFELHL 268

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.1 bits (200), Expect = 7e-18
 Identities = 70/243 (28%), Positives = 110/243 (45%), Gaps = 37/243 (15%)

Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCR 87
           E +LL  +DH  I+         +R+ F  +    E  D D  L ++  + + L+++   
Sbjct: 52  EAQLLSKLDHPAIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC 109

Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVT 146
            +  QLL G+ Y+H   +LHRDLK  N+ L  N  LKIGDFG++R      D  T +  T
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGT 168

Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
            +Y +PE L +   Y +  DIWS+GCIL E+      F G++++  +  I E        
Sbjct: 169 PYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE----GPTP 223

Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
           SL          Y R L                     +++ ML  DP+ R +  E L +
Sbjct: 224 SL-------PETYSRQLNS-------------------IMQSMLNKDPSLRPSAAEILRN 257

Query: 267 PYL 269
           P++
Sbjct: 258 PFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.9 bits (199), Expect = 1e-17
 Identities = 52/208 (25%), Positives = 108/208 (51%), Gaps = 10/208 (4%)

Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYF 89
           EI+LL+++ HE I+     +R    +T   +++ Y +    +   ++++  LT+   R +
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLT-IFMEY-MPGGSVKDQLKAYGALTESVTRKY 111

Query: 90  LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVV 145
             Q+L G+ Y+HS  ++HRD+K +N+L ++  ++K+GDFG ++           +     
Sbjct: 112 TRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 205
           T ++ +PE +++   Y    D+WS+GC + E++T +P  P  +Y   +  I ++   P  
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTN 227

Query: 206 TSLGFLRSDNARRYVRMLPQFPKQNFSA 233
             L    S++AR ++  +    +   SA
Sbjct: 228 PQLPSHISEHARDFLGCIFVEARHRPSA 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 47/268 (17%)

Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++V E 
Sbjct: 48  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 98

Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++      I +H  + ++        +L+ L  +H+  V+HRD+K  ++LL  +  +K+ 
Sbjct: 99  LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158

Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  +P + 
Sbjct: 159 DFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 217

Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK---SPGA 242
            +  +  +++I                               + N   +  N    SP  
Sbjct: 218 NEPPLKAMKMI-------------------------------RDNLPPKLKNLHKVSPSL 246

Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYLA 270
              L+++LV DP +R T  E L HP+LA
Sbjct: 247 KGFLDRLLVRDPAQRATAAELLKHPFLA 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 68/282 (24%), Positives = 122/282 (43%), Gaps = 56/282 (19%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLR----EIKLLRHMDHENIIA-----IKDIIRPPQRE 55
             + +A+K++     N + A++       E+ LL+ + H NI+      + D        
Sbjct: 23  QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-------- 74

Query: 56  TFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
             N + I  E +    +  I+     L +     +  Q+L G+ Y+H+  V+HRD+K +N
Sbjct: 75  --NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNN 132

Query: 115 LLLNANCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           ++L  N  +K+ DFG AR         + ++ +     T ++ APE ++N S Y    DI
Sbjct: 133 VMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINESGYGRKSDI 191

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           WS+GC + E+ T +P     D +  +  I            G  R         ++P+ P
Sbjct: 192 WSIGCTVFEMATGKPPLASMDRLAAMFYI------------GAHRG--------LMPRLP 231

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             +FSA        A+D +   L  D + R +  + L H +L
Sbjct: 232 -DSFSA-------AAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 24/265 (9%)

Query: 2   NSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           NS T E VA+KK+  +     +  +  ++E+K L+ + H N I  K           +  
Sbjct: 42  NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTA 96

Query: 61  YIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V E        ++  H+  L +       +  L+GL Y+HS N++HRD+K  N+LL  
Sbjct: 97  WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 156

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEI 177
              +K+ DFG A  +S  +    +V T ++ APE++L   E  Y   +D+WS+G    E+
Sbjct: 157 PGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
             R+P     + +  L  I +   SP   S  +  +D+ R +V    Q        + P 
Sbjct: 214 AERKPPLFNMNAMSALYHIAQ-NDSPTLQSNEW--TDSFRGFVDYCLQ--------KIPQ 262

Query: 238 KSPGAVDLLEKMLVF-DPNRRITVD 261
           + P + +LL    V  D   R+ +D
Sbjct: 263 ERPASAELLRHDFVRRDRPARVLID 287

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 71/268 (26%), Positives = 130/268 (48%), Gaps = 41/268 (15%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           T ++VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++
Sbjct: 46  TGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYHHENVVDMYN-----SYLVGDELWV 96

Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           V E ++      I +H  + ++        +LR L Y+H+  V+HRD+K  ++LL ++  
Sbjct: 97  VMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 156

Query: 123 LKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +K+ DFG  A+ + E       V T ++ APE++     Y   +DIWS+G ++ E++  +
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGE 215

Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           P +  +  +  +R I                 DN       LP  P+   S +  +   G
Sbjct: 216 PPYFNEPPLQAMRRI----------------RDN-------LP--PRVKDSHKVSSVLRG 250

Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYL 269
            +DL   MLV +P++R T  E L HP+L
Sbjct: 251 FLDL---MLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 37/206 (17%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDII---RPPQRETFND 59
             +E VA+K +     N  DA++   RE +LL +  HENI+    +     PP       
Sbjct: 33  NDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGDPP------- 83

Query: 60  VYIVYELMDT-DLHQIIRSH--------------QDLTDDHCRYFLYQLLRGLKYVHSAN 104
             +V+E M+  DL++ +RSH               +LT         Q+  G+ Y+ S +
Sbjct: 84  -IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142

Query: 105 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSE 160
            +HRDL   N L+  +  +KIGDFG++R    TD+        +  RW   PE ++   +
Sbjct: 143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM-PPESIMY-RK 200

Query: 161 YTAAIDIWSVGCILGEIMT--RQPLF 184
           +T   D+WS G +L EI T  +QP +
Sbjct: 201 FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 51/281 (18%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------T 56
           +T E VA+K++          K  L ++  +RH+  E     +DI+   + E        
Sbjct: 24  DTGEIVALKRM---------KKSLLFKLNEVRHVLTE-----RDILTTTKSEWLVKLLYA 69

Query: 57  FNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           F D   +Y  M+     D   ++ +   L++DH R+++ ++   +  +H    +HRDLKP
Sbjct: 70  FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKP 129

Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
            N L++A+  +K+ DFGL++      +    V +  Y APE +L    Y   +D WS+GC
Sbjct: 130 ENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGC 186

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +L E +   P F G               +P+ET       +N + +   L Q P   + 
Sbjct: 187 MLYEFLCGFPPFSGS--------------TPNET------WENLKYWKETL-QRP--VYD 223

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 273
               N S  A DL+ K++     R  ++++   HP+   + 
Sbjct: 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 20/168 (11%)

Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT---DLHQIIRSHQDLTDDH 85
           REI++LR ++H N++   D+      +   ++ ++ E MD    +   I      L D  
Sbjct: 121 REIEILRDVNHPNVVKCHDMF-----DHNGEIQVLLEFMDGGSLEGTHIADEQF-LAD-- 172

Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYV 144
                 Q+L G+ Y+H  +++HRD+KPSNLL+N+  ++KI DFG++R  ++T D     V
Sbjct: 173 ---VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229

Query: 145 VTRWYRAPELL---LNCSEYTA-AIDIWSVG-CILGEIMTRQPLFPGK 187
            T  Y +PE +   LN   Y   A DIWS+G  IL   + R P   G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 73/267 (27%), Positives = 120/267 (44%), Gaps = 34/267 (12%)

Query: 27  TLREIKLLRHMDHENIIAIKD-IIRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDD 84
           TL E  LL++++H ++I +KD ++            +V     +DL+  + +  + L  D
Sbjct: 104 TLIEAMLLQNVNHPSVIRMKDTLVSGAI------TCMVLPHYSSDLYTYLTKRSRPLPID 157

Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEY 143
                  Q+L GL+Y+H+  ++HRD+K  N+ +N    + IGD G A+       F+   
Sbjct: 158 QALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-L 216

Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT------RQPLFPGKDYV-----HQ 192
             T    APE+L    +Y +  DIWS G +L E++         P    ++YV     H 
Sbjct: 217 AGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 193 LRLITELIGSPDETSLGFLRSDNAR------RYVRMLPQ-FPKQNFSARFPNKSPGAVDL 245
           L++I+ L   P+E    F R   +R       Y  +  Q + +     R      G   L
Sbjct: 276 LKIISTLKVHPEE----FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEF-L 330

Query: 246 LEKMLVFDPNRRITVDEALCHPYLAPL 272
           + KML FD   R + +E L +P  A L
Sbjct: 331 VHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 78.5 bits (194), Expect = 7e-17
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 40/198 (20%)

Query: 1   MNSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRE 55
           +  +   +VAIK  K G++   R+D    L E  ++   DH NII ++ ++   RP    
Sbjct: 27  LPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPNIIRLEGVVTKSRP---- 79

Query: 56  TFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYVHSANVLH 107
               V I+ E M+   L + +R +        ++ + QL+        G+KY+   N +H
Sbjct: 80  ----VMIITEYMENGSLDKFLRENDG------KFTVGQLVGMLRGIASGMKYLSEMNYVH 129

Query: 108 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEY 161
           RDL   N+L+N+N   K+ DFGL+R   +++    Y         RW  APE  +   ++
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPIRW-TAPE-AIAYRKF 185

Query: 162 TAAIDIWSVGCILGEIMT 179
           T+A D+WS G ++ E+M+
Sbjct: 186 TSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 36/246 (14%)

Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 129
           DL   I+S     +   R++  +++ GL+++H   +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 130 LARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 188
           + +     +     +  T  Y APE+L    +Y  ++D WS G +L E++  Q  F G+D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 189 YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEK 248
                    EL  S        + +D         P FP+          S  A D L K
Sbjct: 201 E-------DELFDS--------ILNDR--------PHFPRW--------ISKEAKDCLSK 229

Query: 249 MLVFDPNRRITVDEAL-CHPYLAPLH-DINEEPVCPRPFSFDFEHPSFTEENIKELIYRE 306
           +   DP +R+ VD  +  HP+   +  +  E+   P PF    + PS    N       E
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDA-SNFDREFTNE 288

Query: 307 SVKFNP 312
            V+ +P
Sbjct: 289 KVRLSP 294

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 56/188 (29%), Positives = 91/188 (48%), Gaps = 13/188 (6%)

Query: 2   NSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T E VAIKK+  +     +  +  ++E++ L+ + H N I  K       RE     
Sbjct: 36  DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY---LREH--TA 90

Query: 61  YIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V E        I+  H+  L +       +  L+GL Y+HS   +HRD+K  N+LL  
Sbjct: 91  WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEI 177
              +K+ DFG A   S  +    +V T ++ APE++L   E  Y   +D+WS+G    E+
Sbjct: 151 PGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Query: 178 MTRQ-PLF 184
             R+ PLF
Sbjct: 208 AERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 75/276 (27%), Positives = 121/276 (43%), Gaps = 45/276 (16%)

Query: 4   ETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           +T+   A+K I  A   +R +   TL E  +L  ++   I+ +K   + P++     +Y+
Sbjct: 16  DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK-----LYL 70

Query: 63  VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           V   ++  +L   ++          R++  +LL  L+ +H  NV++RDLKP N+LL+   
Sbjct: 71  VLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG 130

Query: 122 DLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            + + DFGL +    + D    +  T  Y APELLL    YT A+D W++G +L E++T 
Sbjct: 131 HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTG 189

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP-NKS 239
            P F                             +N     R + Q P      RFP    
Sbjct: 190 LPPF---------------------------YDENVNEMYRKILQEP-----LRFPDGFD 217

Query: 240 PGAVDLLEKMLVFDPNRRITV---DEALCHPYLAPL 272
             A DLL  +L  DP RR+      E   HP+ + L
Sbjct: 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 76/269 (28%), Positives = 126/269 (46%), Gaps = 42/269 (15%)

Query: 5   TREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           T E+VA+K  K  +  ++  D K+   EI++LR++ HENI+  K I      +  N + +
Sbjct: 32  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGIC---TEDGGNGIKL 85

Query: 63  VYELMDT-DLHQII---RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           + E + +  L + +   ++  +L     +Y + Q+ +G+ Y+ S   +HRDL   N+L+ 
Sbjct: 86  IMEFLPSGSLKEYLPRNKNKINLKQQL-KYAV-QICKGMDYLGSRQYVHRDLAARNVLVE 143

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSV 170
           +   +KIGDFGL +   ETD   EY   +        WY APE L+    Y A+ D+WS 
Sbjct: 144 SEHQVKIGDFGLTKAI-ETD--KEYYTVKDDLDSPVFWY-APECLIQSKFYIAS-DVWSF 198

Query: 171 GCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN 230
           G  L E++T    +   +    + L  ++IG P    +   R        + LP      
Sbjct: 199 GVTLYELLT----YCDSES-SPMTLFLKMIG-PTHGQMTVTRLVRVLEEGKRLP------ 246

Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRIT 259
              R PN       L+ K   F P++R T
Sbjct: 247 ---RPPNCPEEVYQLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.9 bits (189), Expect = 3e-16
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 27/184 (14%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VAIK  K G     R D    L E  ++    H NII ++ ++       F    I+ E 
Sbjct: 36  VAIKTLKPGYTEKQRQD---FLSEASIMGQFSHHNIIRLEGVV-----TKFKPAMIITEY 87

Query: 67  MDTD-LHQIIRSHQDLTDDHCRYFLYQLLRG----LKYVHSANVLHRDLKPSNLLLNANC 121
           M+   L + +R H     +   Y L  +LRG    +KY+   N +HRDL   N+L+N+N 
Sbjct: 88  MENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL 144

Query: 122 DLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           + K+ DFGL+R   E D    Y  +      RW  APE  +   ++T+A D+WS G ++ 
Sbjct: 145 ECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMW 201

Query: 176 EIMT 179
           E+M+
Sbjct: 202 EVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 4e-16
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 20/204 (9%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLL---RHMDHENIIA-----IKDIIRPPQ 53
           +  T   VA+K I N      D     RE+ LL   R     NI       +K       
Sbjct: 22  HVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG------ 74

Query: 54  RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
                 ++I+ E  +    + +     + + +    + ++L  LKY+H   V+HRD+K +
Sbjct: 75  ----PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAA 130

Query: 114 NLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+L+    ++K+ DFG+ A     +   + +V T ++ APE++     Y    DIWS+G 
Sbjct: 131 NILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLI 196
            + E+ T  P +   D    + LI
Sbjct: 191 TIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.2 bits (187), Expect = 6e-16
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 41/265 (15%)

Query: 8   EVAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           +VA+K +    D R   +R L   E+ ++R   H+N++ +             +++++ E
Sbjct: 48  QVAVKMM----DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK-----SYLVGEELWVLME 98

Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
            +       I S   L ++        +L+ L Y+HS  V+HRD+K  ++LL  +  +K+
Sbjct: 99  FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKL 158

Query: 126 GDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG  A+ + +       V T ++ APE++   + Y   +DIWS+G ++ E++  +P +
Sbjct: 159 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPY 217

Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
                V                         A + +R  P    +N        SP   D
Sbjct: 218 FSDSPV------------------------QAMKRLRDSPPPKLKNAH----KISPVLRD 249

Query: 245 LLEKMLVFDPNRRITVDEALCHPYL 269
            LE+ML  +P  R T  E L HP+L
Sbjct: 250 FLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.9 bits (184), Expect = 1e-15
 Identities = 69/268 (25%), Positives = 110/268 (41%), Gaps = 46/268 (17%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF---NDVYIV 63
           + V IK+I      + +      E ++L+ + H NII           E F     + IV
Sbjct: 26  KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY--------YENFLEDKALMIV 77

Query: 64  YELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            E      L + I  R +  L +D   +F  Q+L  L +VH+  +LHRDLK  N+LL+ +
Sbjct: 78  MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137

Query: 121 CD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              +KIGDFG+++  S        V T  Y +PE L     Y    DIW++GC+L E+ +
Sbjct: 138 KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELAS 196

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +  F   +    +  I     +P         SD     +R                  
Sbjct: 197 LKRAFEAANLPALVLKIMSGTFAP--------ISDRYSPDLRQ----------------- 231

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHP 267
                L+  ML  DP++R  + + +  P
Sbjct: 232 -----LILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 52/278 (18%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
            VA+K   N        ++ L+E  ++R  DH +I+ +  +I      T N V+IV EL 
Sbjct: 36  AVAVKTCKNCTSPS-VREKFLQEAYIMRQFDHPHIVKLIGVI------TENPVWIVMELA 88

Query: 68  DT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
              +L   ++ ++  L       + YQL   L Y+ S   +HRD+   N+L+++   +K+
Sbjct: 89  PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKL 148

Query: 126 GDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-- 180
           GDFGL+R   +  +          +W  APE  +N   +T+A D+W  G  + EI+    
Sbjct: 149 GDFGLSRYLEDESYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMLGV 206

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +P    K+         ++IG          R +N  R    LP  P        PN  P
Sbjct: 207 KPFQGVKN--------NDVIG----------RIENGER----LPM-P--------PNCPP 235

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 278
               L+ K   +DP++R    E         L DI +E
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQ-----LSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 58/189 (30%), Positives = 85/189 (44%), Gaps = 21/189 (11%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           N  T E VA+K  K      N    K+   EI +L+ + HENI+  K      Q      
Sbjct: 29  NDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHENIVKYKGCCSE-QGGKGLQ 84

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           + + Y  + +    + +   +L       F  Q+  G+ Y+HS + +HRDL   N+LL+ 
Sbjct: 85  LIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN 142

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSVG 171
           +  +KIGDFGLA+   E     EY   R        WY A E L       A+ D+WS G
Sbjct: 143 DRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-AVECLKENKFSYAS-DVWSFG 197

Query: 172 CILGEIMTR 180
             L E++T 
Sbjct: 198 VTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 60/187 (32%), Positives = 99/187 (52%), Gaps = 24/187 (12%)

Query: 5   TREEVAIKKIGNAFDNRI-DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           T E VA+KK+ ++    + D +R   EI++L+ + H+NI+  K +     R    ++ +V
Sbjct: 32  TGEVVAVKKLQHSTAEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGR---RNLRLV 85

Query: 64  YE-LMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            E L    L   ++ H++  D H +  LY  Q+ +G++Y+ S   +HRDL   N+L+ + 
Sbjct: 86  MEYLPYGSLRDYLQKHRERLD-HRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE 144

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSVGC 172
             +KIGDFGL +   +     EY   R        WY APE  L  S+++ A D+WS G 
Sbjct: 145 NRVKIGDFGLTKVLPQD---KEYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGV 199

Query: 173 ILGEIMT 179
           +L E+ T
Sbjct: 200 VLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 26/198 (13%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T +D+Y+V + M   +L   ++     ++D  ++++ +L+  L+++H  ++++RDLKP 
Sbjct: 66  QTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125

Query: 114 NLLLNANCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+A   + + DFGL++   ++      +  T  Y APE+LL+   YT  +D WS+G 
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR------SDNARRYVRMLPQF 226
           ++ E+      F  +D     R I          + G +R      SD  R++V+ L   
Sbjct: 186 LVFEMCCGWSPFYAEDTQQMYRNI----------AFGKVRFPKNVLSDEGRQFVKGLLN- 234

Query: 227 PKQNFSARFPNKSPGAVD 244
                  R P    GA  
Sbjct: 235 -------RNPQHRLGAHR 245

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 31/197 (15%)

Query: 9   VAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           VA+K + +A DN   A++   RE +LL ++ HE+I+    +         + + +V+E M
Sbjct: 38  VAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYM 89

Query: 68  D-TDLHQIIRSH-------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
              DL++ +R+H              +LT     +   Q+  G+ Y+ S + +HRDL   
Sbjct: 90  KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 149

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCSEYTAAIDIWS 169
           N L+  N  +KIGDFG++R    TD+        +  RW   PE ++   ++T   D+WS
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWS 207

Query: 170 VGCILGEIMT--RQPLF 184
           +G +L EI T  +QP +
Sbjct: 208 LGVVLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 16/189 (8%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T+  +AIK+I          +    EI L  ++ H NI+      +    ++ N  + +
Sbjct: 31  STQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIV------QYLGSDSENGFFKI 82

Query: 64  Y--ELMDTDLHQIIRSHQDLTDDH---CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +  ++    L  ++RS      D+     ++  Q+L GLKY+H   ++HRD+K  N+L+N
Sbjct: 83  FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN 142

Query: 119 ANCD-LKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSE-YTAAIDIWSVGCILG 175
                +KI DFG ++  +  +  TE +  T  Y APE++      Y A  DIWS+GC + 
Sbjct: 143 TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202

Query: 176 EIMTRQPLF 184
           E+ T +P F
Sbjct: 203 EMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 12/185 (6%)

Query: 2   NSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T E VAIKK+  +     +  +  ++E+K L+ + H N I  K       RE  +  
Sbjct: 46  DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY---LRE--HTA 100

Query: 61  YIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V E        ++  H+  L +       +  L+GL Y+HS N++HRD+K  N+LL  
Sbjct: 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEI 177
              +K+ DFG A   S  +    +V T ++ APE++L   E  Y   +D+WS+G    E+
Sbjct: 161 PGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Query: 178 MTRQP 182
             R+P
Sbjct: 218 AERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 58/283 (20%)

Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDH 85
           TL E ++L++  H  + A+K   +   R  F     V E  +  +L   +   +  ++D 
Sbjct: 42  TLTESRVLQNTRHPFLTALKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDR 96

Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYV 144
            R++  +++  L Y+HS +V++RDLK  NL+L+ +  +KI DFGL +   S+   M  + 
Sbjct: 97  ARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156

Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGS 202
            T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+   
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--- 212

Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRI--- 258
                                          RFP   SP A  LL  +L  DP +R+   
Sbjct: 213 -------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGG 241

Query: 259 --TVDEALCHPYLAPL--HDINEEPVCPRPFSFDFEHPSFTEE 297
                E + H + A +   D+ ++ + P PF      P  T E
Sbjct: 242 PEDAKEIMEHRFFASINWQDVVQKKLEP-PFK-----PQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.2 bits (179), Expect = 7e-15
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 32/181 (17%)

Query: 90  LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRW 148
           L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 208
           + APE++   S Y +  DIWS+G    E+   +P  P  D +H +R++            
Sbjct: 167 WMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLF----------- 211

Query: 209 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
                        ++P+      +  F   S    + ++  L  DP+ R T  E L H +
Sbjct: 212 -------------LIPKNNPPTLTGEF---SKPFKEFIDACLNKDPSFRPTAKELLKHKF 255

Query: 269 L 269
           +
Sbjct: 256 I 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.2 bits (180), Expect = 7e-15
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 35/183 (19%)

Query: 94  LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 153
           L+GL Y+HS  ++HRD+KPSN+LL     +K+ DFG++     +   T +  T +Y APE
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE 173

Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP--GKDYVHQLRLITELIGSP-----DET 206
            +     Y+   D+WS+G  L E+   +  FP  G+  +  + L++ ++  P     DE 
Sbjct: 174 RIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232

Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
             G   S+  +                          D +++ L  DP RR T  + L H
Sbjct: 233 GNGIKWSEEFK--------------------------DFIKQCLEKDPTRRPTPWDMLEH 266

Query: 267 PYL 269
           P++
Sbjct: 267 PWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 76/309 (24%), Positives = 131/309 (42%), Gaps = 59/309 (19%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKR--TLREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
           ++++T E V IK            +R  T  E  +LR ++H +II +K         T+N
Sbjct: 112 IDNKTCEHVVIKA----------GQRGGTATEAHILRAINHPSIIQLKGTF------TYN 155

Query: 59  DVY-IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
               ++     TDL+  + + +++           +LR ++Y+H   ++HRD+K  N+ +
Sbjct: 156 KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVTRWY--------RAPELLLNCSEYTAAIDIWS 169
           N   D+ +GDFG A       F  +    ++Y         APELL     Y  A+DIWS
Sbjct: 216 NHPGDVCLGDFGAAC------FPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWS 268

Query: 170 VGCILGEIMTRQPLFPGKDYV-------HQLRLITELIGS-PDETSLGFLRSDNARRYVR 221
            G +L E+ T       KD +        Q++LI    G+ P+E  +   +++    Y+ 
Sbjct: 269 AGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID-AQANLDEIYIG 327

Query: 222 MLPQFPKQNFSARFPNKSPGAVDLLE----------KMLVFDPNRRITVDEALCHPYLAP 271
           +  +      S+R P   P   +L E          KML FD + R + +  L       
Sbjct: 328 LAKK------SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381

Query: 272 LHDINEEPV 280
           + D    P+
Sbjct: 382 IPDPYPNPM 390

Length = 391

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 73.3 bits (180), Expect = 8e-15
 Identities = 56/167 (33%), Positives = 85/167 (50%), Gaps = 29/167 (17%)

Query: 28  LREIKLLRHM-DHENIIAIKD--IIRPPQRETFNDVYIVYEL-MDTDLHQIIRSHQD--L 81
           + E+K++ H+ +HENI+ +     I  P       + ++ E     DL   +R  ++  L
Sbjct: 86  MSELKIMSHLGNHENIVNLLGACTIGGP-------ILVITEYCCYGDLLNFLRRKRESFL 138

Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
           T +    F YQ+ +G+ ++ S N +HRDL   N+LL     +KI DFGLAR     D M 
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMN 193

Query: 142 E--YVV-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  YVV        +W  APE + NC  YT   D+WS G +L EI +
Sbjct: 194 DSNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 41/228 (17%)

Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           M T L+Q      + ++D  R++  +++  L+++H   +++RD+K  N+LL++   + + 
Sbjct: 92  MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147

Query: 127 DFGLART--TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           DFGL++   + E +    +  T  Y APE++     +  A+D WS+G ++ E++T    F
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
                         L G  +       +S+ +RR ++  P FP            P A D
Sbjct: 208 -------------TLEGERNT------QSEVSRRILKCDPPFP--------SFIGPEAQD 240

Query: 245 LLEKMLVFDPNRRI-----TVDEALCHPYLAPLH--DINEEPVCPRPF 285
           LL K+L  DP +R+        E   HP+   L    +    V   PF
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV-NPPF 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 66/255 (25%), Positives = 97/255 (38%), Gaps = 29/255 (11%)

Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           REI +L+ + H  II +    R       + V +V      DL   +     L  +    
Sbjct: 135 REIDILKTISHRAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPLPLEQAIT 189

Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---YVV 145
              +LL  L Y+H   ++HRD+K  N+ L+   +  +GDFG A          +   +  
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLF--PGKDYVHQLRLITELIGS 202
           T    +PELL     Y A  DIWS G +L E+      LF    K    QLR I   I  
Sbjct: 250 TLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI---IRC 305

Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD----------LLEKMLVF 252
                L F ++ +      +   F +     R P   P  +           L+ KML F
Sbjct: 306 MQVHPLEFPQNGST----NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTF 361

Query: 253 DPNRRITVDEALCHP 267
           D   R +  + L  P
Sbjct: 362 DQEFRPSAQDILSLP 376

Length = 392

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 31/232 (13%)

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY---VHSANVLHRDLKPS 113
            ++ I  E MD   L Q+++    + ++        +LRGL Y    H   ++HRD+KPS
Sbjct: 72  GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPS 129

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+L+N+  ++K+ DFG++      D M   +V TR Y +PE L   + YT   DIWS+G 
Sbjct: 130 NILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGL 186

Query: 173 ILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS--DNARRYVRML------ 223
            L E+   R P+ P      +      +     + S   +     ++ R + +       
Sbjct: 187 SLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYI 246

Query: 224 -----PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                P+ P   FS  F        D ++K L  +P  R  + E   HP++ 
Sbjct: 247 VNEPPPKLPSGAFSDEF-------QDFVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 76/331 (22%), Positives = 127/331 (38%), Gaps = 98/331 (29%)

Query: 30  EIKLLRHMDHENIIAIK-----DIIRPPQ-------RE---------------TFNDVYI 62
           E+ L+R  D   + A+K     D+I+  Q       R+               +F D   
Sbjct: 16  EVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75

Query: 63  VYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y +M+     DL  ++       ++  R+++ +L+  L  VH    +HRD+KP N+L++
Sbjct: 76  LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135

Query: 119 ANCDLKIGDFGLA------------RTTSETDFMTEYVVTRW------------------ 148
           A+  +K+ DFGL                S      + V+ R                   
Sbjct: 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPD 195

Query: 149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 208
           Y APE+L   + Y    D WS+G IL E++   P F                 +  ET  
Sbjct: 196 YIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD--------------TLQET-- 238

Query: 209 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-VDEALCHP 267
            + +  N +  +R    FP        P  SP A+DL+ + L+ DP  R+   +E   HP
Sbjct: 239 -YNKIINWKESLR----FPPD------PPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHP 286

Query: 268 YLAPL---HDINEEPVCPRPFSFDFEHPSFT 295
           +   +   +    +P    PF  +   P  T
Sbjct: 287 FFKGIDWENLRETKP----PFVPELSSPLDT 313

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 24/223 (10%)

Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           R+EV I K         +   T+ E ++L++  H  + A+K   +   R  F     V E
Sbjct: 29  RKEVIIAKD--------EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF-----VME 75

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
             +  +L   +   +  T++  R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +K
Sbjct: 76  YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 135

Query: 125 IGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           I DFGL +   S+   M  +  T  Y APE+L + ++Y  A+D W +G ++ E+M  +  
Sbjct: 136 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP 194

Query: 184 FPGKDYVHQLRLI-TELIG-----SPDETSL--GFLRSDNARR 218
           F  +D+     LI  E I      SP+  SL  G L+ D  +R
Sbjct: 195 FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 70/257 (27%), Positives = 109/257 (42%), Gaps = 33/257 (12%)

Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-DLTDD---- 84
           EI  L  ++HENI+ I++I+R        + Y++ +  D DL+  +     D  D     
Sbjct: 213 EILALGRLNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY- 143
             R  + QLL  ++Y+H   ++HRD+K  N+ LN +  + +GDFG A    +     +Y 
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327

Query: 144 -VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP----GKDYVHQLRLITE 198
            V T    +PE+L     Y    DIWS G IL ++++     P    G     QL  I +
Sbjct: 328 WVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHD-FCPIGDGGGKPGKQLLKIID 385

Query: 199 LIGSPDE-------TSLGFLRSDNARRYVRMLPQFPKQ-NFSARFPNKSPGAVDLLEKML 250
            +   DE           ++ S         +P   +     A F  + P     L KML
Sbjct: 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADF--EYP-----LVKML 438

Query: 251 VFDPNRRITVDEALCHP 267
            FD + R    E L  P
Sbjct: 439 TFDWHLRPGAAELLALP 455

Length = 501

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 61/279 (21%), Positives = 121/279 (43%), Gaps = 48/279 (17%)

Query: 11  IKKIGNAFDNRIDAKRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-D 68
           ++K+G     ++ A + L++  ++ +    E+    + ++   +R  F  V + Y    D
Sbjct: 19  VRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL-VTLHYAFQTD 77

Query: 69  TDLHQIIR------------SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           T LH I+               +  T+   R ++ +++  L ++H   +++RD+K  N+L
Sbjct: 78  TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137

Query: 117 LNANCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCSE-YTAAIDIWSVGCI 173
           L++   + + DFGL++     E +    +  T  Y APE++   S  +  A+D WS+G +
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
             E++T    F      +                    +S+ +RR ++  P FP      
Sbjct: 198 TFELLTGASPFTVDGEQNS-------------------QSEISRRILKSKPPFP------ 232

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYL 269
                S  A D ++K+L  DP +R+     DE   HP+ 
Sbjct: 233 --KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 12/182 (6%)

Query: 5   TREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
             E VAIKK+  +     +  +  ++E++ L+ + H N I  +       RE  +  ++V
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY---LRE--HTAWLV 93

Query: 64  YELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E        ++  H+  L +       +  L+GL Y+HS N++HRD+K  N+LL+    
Sbjct: 94  MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153

Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMTR 180
           +K+GDFG A   +  +    +V T ++ APE++L   E  Y   +D+WS+G    E+  R
Sbjct: 154 VKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210

Query: 181 QP 182
           +P
Sbjct: 211 KP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 23/189 (12%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           +VA+K  K G      +  +  L+E ++++ + H+ ++ +  +    + E     YIV E
Sbjct: 32  KVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPI---YIVTE 81

Query: 66  LMDT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            M    L   ++S   + L          Q+  G+ Y+ S N +HRDL   N+L+  N  
Sbjct: 82  YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV 141

Query: 123 LKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            KI DFGLAR   E D  T     ++   + APE   N   +T   D+WS G +L EI+T
Sbjct: 142 CKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRFTIKSDVWSFGILLTEIVT 199

Query: 180 --RQPLFPG 186
             R P +PG
Sbjct: 200 YGRVP-YPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 12/159 (7%)

Query: 26  RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTD 83
           + L E ++L+  DH NI+ +  +    QR+    +YIV EL+   D    +R  +D L  
Sbjct: 38  KFLSEARILKQYDHPNIVKLIGVC--TQRQP---IYIVMELVPGGDFLSFLRKKKDELKT 92

Query: 84  DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-- 141
                F      G+ Y+ S N +HRDL   N L+  N  LKI DFG++R   +  + +  
Sbjct: 93  KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152

Query: 142 -EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + +  +W  APE  LN   Y++  D+WS G +L E  +
Sbjct: 153 LKQIPIKW-TAPE-ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 70.7 bits (173), Expect = 4e-14
 Identities = 61/190 (32%), Positives = 90/190 (47%), Gaps = 39/190 (20%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIV 63
           VAIK  K G     R D    L E  ++   DH NII ++ ++   +P        V IV
Sbjct: 35  VAIKTLKAGYTEKQRRD---FLSEASIMGQFDHPNIIHLEGVVTKSKP--------VMIV 83

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQL---LRG----LKYVHSANVLHRDLKPSNL 115
            E M+   L   +R H        ++ + QL   LRG    +KY+     +HRDL   N+
Sbjct: 84  TEYMENGSLDAFLRKHDG------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWS 169
           L+N+N   K+ DFGL+R   E D    Y         RW  APE  +   ++T+A D+WS
Sbjct: 138 LVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TAPE-AIAYRKFTSASDVWS 194

Query: 170 VGCILGEIMT 179
            G ++ E+M+
Sbjct: 195 YGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 69/274 (25%), Positives = 121/274 (44%), Gaps = 45/274 (16%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++  T +EVAIK++      +   +  + EI ++R   H NI+   D          +++
Sbjct: 39  IDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPNIVNYLD-----SYLVGDEL 91

Query: 61  YIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           ++V E +     TD+       +      CR    + L+ L+++HS  V+HRD+K  N+L
Sbjct: 92  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHRDIKSDNIL 147

Query: 117 LNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L  +  +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAI 206

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E++  +P +  ++ +  L LI    G+P+                  L    K       
Sbjct: 207 EMVEGEPPYLNENPLRALYLIAT-NGTPE------------------LQNPEKL------ 241

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              S    D L + L  D  +R +  E L HP+L
Sbjct: 242 ---SAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 43/136 (31%), Positives = 72/136 (52%), Gaps = 4/136 (2%)

Query: 55  ETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           ET + + +V  +M   D   H     +    ++   ++  ++L GL+ +H  N ++RDLK
Sbjct: 70  ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK 129

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+LL+    ++I D GLA    E + +   V T  Y APE+L N   YT + D W +G
Sbjct: 130 PENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLG 188

Query: 172 CILGEIMTRQPLFPGK 187
           C++ E++  Q  F G+
Sbjct: 189 CLIYEMIEGQSPFRGR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 34/208 (16%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T  +++ V E ++  DL   I+S          ++  +++ GL+++HS  +++RDLK  
Sbjct: 66  QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLD 125

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+ +  +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G 
Sbjct: 126 NILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGV 184

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +L E++  Q  F G D               +E     +R DN        P +P     
Sbjct: 185 LLYEMLIGQSPFHGHD---------------EEELFQSIRMDN--------PCYP----- 216

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITV 260
            R+  +   A D+L K+ V +P RR+ V
Sbjct: 217 -RWLTRE--AKDILVKLFVREPERRLGV 241

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 71.3 bits (174), Expect = 4e-14
 Identities = 69/283 (24%), Positives = 127/283 (44%), Gaps = 50/283 (17%)

Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT 82
           +   TL E ++L++  H  + ++K   +   R  F   Y+       +L   +   +  +
Sbjct: 38  EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV----NGGELFFHLSRERVFS 93

Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMT 141
           +D  R++  +++  L Y+HS  +++RDLK  NL+L+ +  +KI DFGL +   ++   M 
Sbjct: 94  EDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153

Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
            +  T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+     LI     
Sbjct: 154 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----- 207

Query: 202 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI--- 258
                    L  D          +FP+          S  A  LL  +L+ DPN+R+   
Sbjct: 208 ---------LMED---------IKFPR--------TLSADAKSLLSGLLIKDPNKRLGGG 241

Query: 259 --TVDEALCHPYLAPLH--DINEEPVCPRPFSFDFEHPSFTEE 297
                E + H +   ++  D+ ++ + P PF      P  T E
Sbjct: 242 PDDAKEIMRHSFFTGVNWQDVYDKKLVP-PFK-----PQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 50/216 (23%)

Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 129
           DL   I+      +   R++  +++ GL+++H   +++RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 130 LARTTSETDFMTEYVVTRW------YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           + +     + +   V T        Y APE+L     Y  A+D W++G +L E++  Q  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G D               ++     +  D   RY R L               S  A 
Sbjct: 196 FEGDD---------------EDELFQSILEDEV-RYPRWL---------------SKEAK 224

Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
            +L+  L  +P +R+      C P      DI   P
Sbjct: 225 SILKSFLTKNPEKRLG-----CLPTGE--QDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.0 bits (174), Expect = 4e-14
 Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 4/137 (2%)

Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
           ++  ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E + +   V T 
Sbjct: 106 FYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTV 165

Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDET 206
            Y APE++ N   YT + D W +GC++ E++  +  F   K+ V +  +   +    +E 
Sbjct: 166 GYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224

Query: 207 SLGFLRSDNARRYVRML 223
           S  F  S+ AR   R L
Sbjct: 225 SEKF--SEAARSICRQL 239

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIVYEL 66
           +VA+K +  A   R + +  L E   ++  DH N++ +  + ++  + E +    ++   
Sbjct: 28  KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87

Query: 67  MD-TDLHQII------RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           M   DLH  +         Q L       F+  +  G++Y+ S + +HRDL   N +LN 
Sbjct: 88  MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGE 176
           N ++ + DFGL++     D+  +  + +    + A E L +   YT   D+WS G  + E
Sbjct: 148 NMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWE 206

Query: 177 IMTR-QPLFPG------KDYVHQ 192
           I TR Q  +PG       DY+ Q
Sbjct: 207 IATRGQTPYPGVENSEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.5 bits (173), Expect = 5e-14
 Identities = 39/105 (37%), Positives = 55/105 (52%), Gaps = 6/105 (5%)

Query: 79  QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 138
           + LT      F YQ+ RG++++ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 139 FMTEYVVTR----WYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  +    R    W  APE L +   YT   D+WS G +L EI T
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDL 81
           D  RT  E  +L  ++H  I+ +         +T   +Y++ + L   DL   +      
Sbjct: 41  DRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLILDFLRGGDLFTRLSKEVMF 95

Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
           T++  +++L +L   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +   
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155

Query: 142 -EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL- 199
             +  T  Y APE ++N   +T + D WS G ++ E++T    F GKD    + +I +  
Sbjct: 156 YSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214

Query: 200 IGSPDETSLGFLRSDNARRYVRML 223
           +G P      FL S  A+  +R L
Sbjct: 215 LGMPQ-----FL-SPEAQSLLRAL 232

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.5 bits (172), Expect = 7e-14
 Identities = 67/270 (24%), Positives = 123/270 (45%), Gaps = 37/270 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++  T +EVAIK++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 39  IDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDEL 91

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L ++HS  V+HRD+K  N+LL  +
Sbjct: 92  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD 151

Query: 121 CDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 152 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVE 210

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +P +  ++ +  L LI    G+P+                    Q P++  SA F    
Sbjct: 211 GEPPYLNENPLRALYLIAT-NGTPEL-------------------QNPER-LSAVFR--- 246

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               D L + L  D +RR +  E L HP+L
Sbjct: 247 ----DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.8 bits (171), Expect = 7e-14
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 35/197 (17%)

Query: 2   NSETREEVAIKKIGNAFDNRI----DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +   +   A+K +     NRI    + ++ L+E  +++   H N++++  I  P   E  
Sbjct: 19  SDGQKIHCAVKSL-----NRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS--EGS 71

Query: 58  NDVYIVYELMDTDLHQIIRSHQ------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
             V + Y +   DL   IRS        DL       F  Q+ +G++Y+ S   +HRDL 
Sbjct: 72  PLVVLPY-MKHGDLRNFIRSETHNPTVKDLIG-----FGLQVAKGMEYLASKKFVHRDLA 125

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL--------LLNCSEYTA 163
             N +L+ +  +K+ DFGLAR   +     EY     +   +L         L   ++T 
Sbjct: 126 ARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVKWMALESLQTQKFTT 181

Query: 164 AIDIWSVGCILGEIMTR 180
             D+WS G +L E+MTR
Sbjct: 182 KSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 8e-14
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 19/188 (10%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M S    EVA+K +          K  LRE  ++  +DH  I+ +  + +         +
Sbjct: 18  MKSGKEVEVAVKTLKQE-HIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP------L 70

Query: 61  YIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            +V EL     L + ++  +++     +   +Q+  G+ Y+ S + +HRDL   N+LL  
Sbjct: 71  MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN 130

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGC 172
               KI DFG++R          Y  T       +WY APE  +N  ++++  D+WS G 
Sbjct: 131 RHQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYGV 186

Query: 173 ILGEIMTR 180
            L E  + 
Sbjct: 187 TLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.0 bits (171), Expect = 9e-14
 Identities = 50/168 (29%), Positives = 92/168 (54%), Gaps = 13/168 (7%)

Query: 63  VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+N+LL+ + 
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134

Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-- 179
            ++I D GLA   S+       V T  Y APE+L   + Y ++ D +S+GC+L +++   
Sbjct: 135 HVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193

Query: 180 ---RQPLFPGKDYVHQLRLITEL----IGSPDETSL--GFLRSDNARR 218
              RQ     K  + ++ L   +      SP+  SL  G L+ D ++R
Sbjct: 194 SPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 46/235 (19%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHC 86
            +E  +L  + H  I+   +++   Q E  N VY + E ++  +L   +R      +D  
Sbjct: 66  AQEKSILMELSHPFIV---NMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVA 120

Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT 146
           +++  +L+   +Y+HS ++++RDLKP NLLL+    +K+ DFG A+   +  F      T
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT--LCGT 178

Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE ++    +  A+D W++G +L E +   P F                   D+T
Sbjct: 179 PEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPF------------------FDDT 219

Query: 207 SLGFLRSDNARRYVRMLP---QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                     R Y ++L    +FP   F  R       A DL++ +L  D  +R+
Sbjct: 220 PF--------RIYEKILAGRLKFPNW-FDGR-------ARDLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 33/107 (30%), Positives = 64/107 (59%), Gaps = 2/107 (1%)

Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 142
           +D   ++L ++   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 143 -YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 188
            +  T  Y APE+L+    +  A+D WS+G ++ +++T  P F  ++
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 41/200 (20%)

Query: 9   VAIKKIG-NAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIR--PPQRETFNDVYIVY 64
           VA+K +  +A DN R D    L+E+K+L  +   NI  +  +    PP       + ++ 
Sbjct: 49  VAVKVLRPDASDNARED---FLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIM 98

Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRY--------FLY---QLLRGLKYVHSANVLHRDLKP 112
           E M+  DL+Q ++ H   T               LY   Q+  G++Y+ S N +HRDL  
Sbjct: 99  EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158

Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCSEYTAAI 165
            N L+  N  +KI DFG++R    +D+   Y V        RW     +LL   ++T   
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLL--GKFTTKS 213

Query: 166 DIWSVGCILGEIMT---RQP 182
           D+W+ G  L EI+T    QP
Sbjct: 214 DVWAFGVTLWEILTLCREQP 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 36/202 (17%)

Query: 8   EVAIKKIGNAFDNRIDAKRT--LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
            VAIK +    +N    +R   L E  +++  +  +++ +  ++   Q        +V E
Sbjct: 38  RVAIKTV---NENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP-----TLVVME 89

Query: 66  LMDT-DLHQIIRSHQDLTDDHC--------RYFLY--QLLRGLKYVHSANVLHRDLKPSN 114
           LM   DL   +RS +   +++         ++     ++  G+ Y+ +   +HRDL   N
Sbjct: 90  LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDI 167
            ++  +  +KIGDFG+ R   ETD+   Y          RW  APE L +   +T   D+
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-APESLKD-GVFTTKSDV 204

Query: 168 WSVGCILGEIMT--RQPLFPGK 187
           WS G +L E+ T   QP + G 
Sbjct: 205 WSFGVVLWEMATLAEQP-YQGL 225

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 31/207 (14%)

Query: 55  ETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           ET + + +V  LM   D   H          +    ++  ++  GL+ +H   +++RDLK
Sbjct: 70  ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK 129

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+LL+ +  ++I D GLA    E   +   V T  Y APE++ N   YT + D W++G
Sbjct: 130 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALG 188

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           C+L E++  Q                    SP +     ++ +   R V+ +     + +
Sbjct: 189 CLLYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVQ----EEY 224

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRI 258
           S +F   SP A  L + +L  DP  R+
Sbjct: 225 SEKF---SPDARSLCKMLLCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.4 bits (169), Expect = 1e-13
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 10/205 (4%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M+  T +EVAI+++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 40  MDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDEL 92

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L+++HS  V+HRD+K  N+LL  +
Sbjct: 93  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152

Query: 121 CDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIE 211

Query: 180 RQPLFPGKDYVHQLRLITELIGSPD 204
            +P +  ++ +  L LI    G+P+
Sbjct: 212 GEPPYLNENPLRALYLIAT-NGTPE 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 27/172 (15%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ------- 79
           L E  +++ + H+ ++ +  ++      T   +YI+ E M    L   ++S +       
Sbjct: 49  LAEANVMKTLQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 102

Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 139
            L D     F  Q+  G+ ++   N +HRDL+ +N+L++A+   KI DFGLAR   + ++
Sbjct: 103 KLID-----FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157

Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 186
                     +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 158 TAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 54/228 (23%)

Query: 60  VYIVYELMDT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSN 114
           VY+  E MD      L+    + + + +D  R   Y +++GLK++    N++HRD+KP+N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 115 LLLNANCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELL--LNCSE---YTAAI 165
           +L+N N  +K+ DFG    L  + ++T+     +  + Y APE +     ++   YT   
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 166 DIWSVG-CILGEIMTRQPLFPGKDYVH---QLRLITELIGSPDETSLGFLRSDNARRYVR 221
           D+WS+G  IL   + R P +P + Y +   QL  I +  G P                  
Sbjct: 189 DVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDP------------------ 227

Query: 222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             P  P           S  A D + K L   PNRR T  + L HP+L
Sbjct: 228 --PTLP--------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 17/165 (10%)

Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQD- 80
             ++ L+E ++L+  DH NI+ +  +    Q++    +YIV EL+    L   +R  ++ 
Sbjct: 35  LKRKFLQEAEILKQYDHPNIVKLIGVC--VQKQP---IYIVMELVPGGSLLTFLRKKKNR 89

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           LT             G++Y+ S N +HRDL   N L+  N  LKI DFG++R   E   +
Sbjct: 90  LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGI 147

Query: 141 ------TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                  + +  +W  APE  LN   YT+  D+WS G +L E  +
Sbjct: 148 YTVSDGLKQIPIKW-TAPE-ALNYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.0 bits (168), Expect = 2e-13
 Identities = 65/265 (24%), Positives = 120/265 (45%), Gaps = 39/265 (14%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           +EVAIK+I      +   +  + EI +++ + + NI+   D          +++++V E 
Sbjct: 45  QEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEY 97

Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           +       + +   + +        + L+ L+++H+  V+HRD+K  N+LL  +  +K+ 
Sbjct: 98  LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLT 157

Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++  +P + 
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVD 244
            ++ +  L LI    G+P+                        QN     P K SP   D
Sbjct: 217 NENPLRALYLIAT-NGTPE-----------------------LQN-----PEKLSPIFRD 247

Query: 245 LLEKMLVFDPNRRITVDEALCHPYL 269
            L + L  D  +R +  E L HP+L
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 18/143 (12%)

Query: 55  ETFNDVYIVYE-LMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           +T + V  V E     DL   I  H D  ++    ++   ++ GL+Y+H   +++RDLK 
Sbjct: 72  QTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKL 129

Query: 113 SNLLLNANCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 165
            NLLL+    +KI DFGL +        TS       +  T  + APE+L   S YT A+
Sbjct: 130 DNLLLDTEGFVKIADFGLCKEGMGFGDRTS------TFCGTPEFLAPEVLTETS-YTRAV 182

Query: 166 DIWSVGCILGEIMTRQPLFPGKD 188
           D W +G ++ E++  +  FPG D
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 22/192 (11%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET    A K I    +  ++    + EI +L   DH NI+ + D          N+++
Sbjct: 26  NKETGVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKLLDAFYYE-----NNLW 78

Query: 62  IVYEL-----MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           I+ E      +D  + ++ R    LT+   R    Q L  L Y+H   ++HRDLK  N+L
Sbjct: 79  ILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNIL 135

Query: 117 LNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSV 170
              + D+K+ DFG+ A+ T        ++ T ++ APE+++ C       Y    D+WS+
Sbjct: 136 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM-CETSKDRPYDYKADVWSL 194

Query: 171 GCILGEIMTRQP 182
           G  L E+   +P
Sbjct: 195 GITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 58/251 (23%), Positives = 111/251 (44%), Gaps = 37/251 (14%)

Query: 25  KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTD 83
           K+ LRE++++       I++          E  N++ +  E MD   L +I +    +  
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAF---LNE--NNICMCMEFMDCGSLDRIYKKGGPIPV 102

Query: 84  DHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFG----LARTTSETD 138
           +        ++ GL Y+++ + ++HRD+KPSN+L+N+   +K+ DFG    L  + ++T 
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT- 161

Query: 139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
               +V T  Y +PE  +   +YT   D+WS+G  + E+   +  FP           + 
Sbjct: 162 ----FVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGK--FPFAF--------SN 206

Query: 199 LIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 257
           +     +  +G L  D  ++ V+   P+ P  +F            D ++  L+ DP  R
Sbjct: 207 IDDDGQDDPMGIL--DLLQQIVQEPPPRLPSSDF-------PEDLRDFVDACLLKDPTER 257

Query: 258 ITVDEALCHPY 268
            T  +    P 
Sbjct: 258 PTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.4 bits (167), Expect = 3e-13
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 32/192 (16%)

Query: 93  LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 152
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+ DFG++     +     YV T  Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAP 162

Query: 153 ELLLNCSEYTAAIDIWSVGCILGEI-MTRQP---LFPGKDYVHQLRLITELIGSPDETSL 208
           E +    +Y    D+WS+G    E+ + R P   +   +  +  L+L+  ++   DE   
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---DEDP- 217

Query: 209 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
                          P  P   FS +F       V  + + +   P  R   +  + HP+
Sbjct: 218 ---------------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255

Query: 269 LAPLHDINEEPV 280
           +   +D N E V
Sbjct: 256 IVQYNDGNAEVV 267

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 17/180 (9%)

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L + +    L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 141 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 199
              +V T ++ APE++   S Y    DIWS+G    E+   +P  P  D +H +R++  L
Sbjct: 158 RNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-L 212

Query: 200 IGSPDETSLGFLRSDNARRYV--------RMLP---QFPKQNFSARFPNKSPGAVDLLEK 248
           I      +L    S   + +V        R  P   +  K  F  R+  K+    +L+++
Sbjct: 213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDR 272

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.0 bits (166), Expect = 3e-13
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 17/200 (8%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETF 57
               + ++VA+K +     +  D +  LRE   ++  DH N+I +  +    R   R   
Sbjct: 22  SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81

Query: 58  NDVYIVYELMDTDLHQIIRSHQ------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
             V + + +   DLH  +   +       L       F+  +  G++Y+ S N +HRDL 
Sbjct: 82  PMVILPF-MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLA 140

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCSEYTAAIDI 167
             N +LN N  + + DFGL++     D+  +   +    +W     L  N   YT   D+
Sbjct: 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDV 198

Query: 168 WSVGCILGEIMTR-QPLFPG 186
           W+ G  + EIMTR Q  + G
Sbjct: 199 WAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.0 bits (166), Expect = 4e-13
 Identities = 52/169 (30%), Positives = 91/169 (53%), Gaps = 15/169 (8%)

Query: 63  VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+N+LL+ + 
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 134

Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L +++   
Sbjct: 135 HVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193

Query: 182 PLFPG---KDYVHQLRLITELI-------GSPDETSL--GFLRSDNARR 218
             F     KD  H++  +T  +        SP+  SL  G L+ D  RR
Sbjct: 194 SPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 63/233 (27%), Positives = 93/233 (39%), Gaps = 52/233 (22%)

Query: 4   ETREEVAIKKIGNAFDNRIDA-------KRTLREIKLLRHMDHENIIAIKDI-IRPPQRE 55
            T  EVAIK +      R DA        R  RE  L   + H NI+A+ D    PP   
Sbjct: 1   MTGHEVAIKLL------RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL- 53

Query: 56  TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
               ++ V+E +    L +++ +   L        + Q+L  L   H+  ++HRDLKP N
Sbjct: 54  ----LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQN 109

Query: 115 LLLNANCD---LKIGDFGL------------ARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           ++++        K+ DFG+            A  T      TE + T  Y APE L    
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRG-E 164

Query: 160 EYTAAIDIWSVGCILGEIMTRQPLFPGKD----YVHQLRLITELIGSPDETSL 208
             T   D+++ G I  E +T Q +  G         QL        SP + SL
Sbjct: 165 PVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL--------SPVDVSL 209

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 54/188 (28%), Positives = 95/188 (50%), Gaps = 28/188 (14%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T ++VA+K I       + A+  L E  ++  + H+N++ +  +I        N +YIV 
Sbjct: 28  TGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI------LHNGLYIVM 77

Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYVHSANVLHRDLKPSNLL 116
           ELM   +L   +R+            + QLL+       G++Y+ S  ++HRDL   N+L
Sbjct: 78  ELMSKGNLVNFLRTRGRALVS-----VIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132

Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           ++ +   K+ DFGLAR  S     ++  V +W  APE L +  ++++  D+WS G +L E
Sbjct: 133 VSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPEALKH-KKFSSKSDVWSYGVLLWE 189

Query: 177 IMT--RQP 182
           + +  R P
Sbjct: 190 VFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 3/146 (2%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + +Y V E ++  DL   I+      + H  ++  ++  GL ++HS  +++RDLK  
Sbjct: 71  QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD 130

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N++L+A   +KI DFG+ +        T  +  T  Y APE++     Y  ++D W+ G 
Sbjct: 131 NVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGV 189

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITE 198
           +L E++  QP F G+D     + I E
Sbjct: 190 LLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 39/123 (31%), Positives = 65/123 (52%), Gaps = 4/123 (3%)

Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++  + Q ++ H    +       YQ++  L  VHS  ++HRDLK +N+ L     +K+G
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211

Query: 127 DFGLARTTSET---DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           DFG ++  S++   D  + +  T +Y APEL      Y+   D+WS+G IL E++T    
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRP 270

Query: 184 FPG 186
           F G
Sbjct: 271 FKG 273

Length = 478

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.1 bits (164), Expect = 7e-13
 Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 37/188 (19%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVY 64
           +VAIK I     +  D    + E K++  + H N++ +  +    RP        ++IV 
Sbjct: 30  DVAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLVQLYGVCTKQRP--------IFIVT 78

Query: 65  ELMDTD-LHQIIRSHQDLTD-----DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           E M    L   +R  +         D C      +   ++Y+ S   +HRDL   N L+ 
Sbjct: 79  EYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEAMEYLESNGFIHRDLAARNCLVG 134

Query: 119 ANCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
            +  +K+ DFGLAR       T+S+    T++ V +W  AP  + + S +++  D+WS G
Sbjct: 135 EDNVVKVSDFGLARYVLDDQYTSSQG---TKFPV-KW--APPEVFDYSRFSSKSDVWSFG 188

Query: 172 CILGEIMT 179
            ++ E+ +
Sbjct: 189 VLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 14/174 (8%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           ++VA+K +    D+   A+  L E  ++  + H N++ +  ++        N +YIV E 
Sbjct: 30  QKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIVTEY 81

Query: 67  MDT-DLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M    L   +RS     +T      F   +  G++Y+   N +HRDL   N+L++ +   
Sbjct: 82  MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA 141

Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           K+ DFGLA+  S+     +  V +W  APE L    +++   D+WS G +L EI
Sbjct: 142 KVSDFGLAKEASQGQDSGKLPV-KW-TAPEALRE-KKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.2 bits (164), Expect = 8e-13
 Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 34/192 (17%)

Query: 9   VAIKKIGNAFDNRIDAKRT-----LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           VA+K +      R DA +      L+EIK++  +   NII +  +       T + + ++
Sbjct: 49  VAVKML------REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMI 97

Query: 64  YELMDT-DLHQIIRSHQ---DLTDDHCRYFLY--------QLLRGLKYVHSANVLHRDLK 111
            E M+  DL+Q +  H+              Y        Q+  G+KY+ S N +HRDL 
Sbjct: 98  TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDI 167
             N L+  N  +KI DFG++R     D+        +  RW     +LL   ++T A D+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDV 215

Query: 168 WSVGCILGEIMT 179
           W+ G  L EI+T
Sbjct: 216 WAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.9 bits (163), Expect = 9e-13
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 39/202 (19%)

Query: 9   VAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVY 64
           VA+K +  A ++ R D +R   E +LL  + H++I+    +    RP        + +V+
Sbjct: 38  VAVKALKEASESARQDFQR---EAELLTVLQHQHIVRFYGVCTEGRP--------LLMVF 86

Query: 65  ELM-DTDLHQIIRSHQ---------------DLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
           E M   DL++ +RSH                 LT         Q+  G+ Y+ S + +HR
Sbjct: 87  EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHR 146

Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAA 164
           DL   N L+     +KIGDFG++R    TD+        +  RW   PE +L   ++T  
Sbjct: 147 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTE 204

Query: 165 IDIWSVGCILGEIMT--RQPLF 184
            DIWS G +L EI T  +QP +
Sbjct: 205 SDIWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.0 bits (163), Expect = 9e-13
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 34/200 (17%)

Query: 9   VAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           VA+K +    D  + A++   RE +LL ++ HE+I+    +         + + +V+E M
Sbjct: 38  VAVKALK---DPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-----DPLIMVFEYM 89

Query: 68  D-TDLHQIIRSHQD----LTDDHCR------------YFLYQLLRGLKYVHSANVLHRDL 110
              DL++ +R+H      L D   R            +   Q+  G+ Y+ S + +HRDL
Sbjct: 90  KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDL 149

Query: 111 KPSNLLLNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCSEYTAAID 166
              N L+ AN  +KIGDFG++R    TD+        +  RW   PE ++   ++T   D
Sbjct: 150 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESD 207

Query: 167 IWSVGCILGEIMT--RQPLF 184
           +WS G IL EI T  +QP F
Sbjct: 208 VWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 35/189 (18%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVYE 65
           VAIK + + +  +   +  L E  ++   DH NII ++ ++   RP        V I+ E
Sbjct: 35  VAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP--------VMIITE 85

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRYFLYQL---LRG----LKYVHSANVLHRDLKPSNLLL 117
            M+   L   +R +        ++ + QL   LRG    +KY+   N +HRDL   N+L+
Sbjct: 86  FMENGALDSFLRQNDG------QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV 139

Query: 118 NANCDLKIGDFGLARTTSE-------TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSV 170
           N+N   K+ DFGL+R   +       T  +   +  RW  APE  +   ++T+A D+WS 
Sbjct: 140 NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPE-AIAYRKFTSASDVWSY 197

Query: 171 GCILGEIMT 179
           G ++ E+M+
Sbjct: 198 GIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 47/190 (24%), Positives = 96/190 (50%), Gaps = 10/190 (5%)

Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP------PQRETFNDVYIVYE 65
           K  G  +  ++  K+ +   K  +H+  E  + +K++  P         +T   +Y V +
Sbjct: 17  KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD 76

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
            ++  +L   ++  +   +   R++  ++   L Y+HS N+++RDLKP N+LL++   + 
Sbjct: 77  FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV 136

Query: 125 IGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           + DFGL +   +++D  T +  T  Y APE++     Y   +D W +G +L E++   P 
Sbjct: 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPP 195

Query: 184 FPGKDYVHQL 193
           F  +D V ++
Sbjct: 196 FYCRD-VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 35/205 (17%)

Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL---TDDH 85
           E+ ++R + H+NI+   D       +    +YI+ E  D  DL + I+    +    ++H
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 86  CRY-FLYQLLRGLKYVHS-------ANVLHRDLKPSNLLL-----------------NAN 120
                  QLL  L Y H+         VLHRDLKP N+ L                 N  
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMT 179
              KIGDFGL++           V T +Y +PELLL+    Y    D+W++GCI+ E+ +
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 180 RQPLFPGKDYVHQLRLITELIGSPD 204
            +  F   +   Q  LI+EL   PD
Sbjct: 239 GKTPFHKANNFSQ--LISELKRGPD 261

Length = 1021

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 34/100 (34%), Positives = 62/100 (62%), Gaps = 4/100 (4%)

Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRW 148
           Q+L  + +VHS +++HRD+K +N+LL +N  +K+GDFG ++  + T   D    +  T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 188
           Y APE+      Y+   D++S+G +L E++T +  F G++
Sbjct: 211 YVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 56/197 (28%), Positives = 85/197 (43%), Gaps = 39/197 (19%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENII---AIKDIIRPPQRETFNDVYI 62
            VA+K  K G       D K  L E ++++ + H  +I   A+  +  P        +YI
Sbjct: 32  PVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP--------IYI 78

Query: 63  VYELMD-----TDLHQIIRSH---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           V ELM        L            L D        Q+  G+ Y+ + N +HRDL   N
Sbjct: 79  VTELMKYGSLLEYLQGGAGRALKLPQLID-----MAAQVASGMAYLEAQNYIHRDLAARN 133

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVG 171
           +L+  N   K+ DFGLAR   E  +       ++   + APE     + ++   D+WS G
Sbjct: 134 VLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPE-AALYNRFSIKSDVWSFG 191

Query: 172 CILGEIMT--RQPLFPG 186
            +L EI+T  R P +PG
Sbjct: 192 ILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 80/324 (24%), Positives = 129/324 (39%), Gaps = 57/324 (17%)

Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           +E  A+K + N      DAK  ++ ++ +R  D  +   +  I R  Q ET   + IV  
Sbjct: 154 KEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET-GHMCIVMP 212

Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNAN---- 120
                L   I  H   +  H    ++Q    L Y H+  +++H DLKP N+L+  +    
Sbjct: 213 KYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVV 272

Query: 121 ------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 168
                       C ++I D G      E    T  V TR YR+PE++L    +  + D+W
Sbjct: 273 DPVTNRALPPDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMW 329

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS-PDE--------------TSLGFLR- 212
           S+GCI+ E+ T + L+   D +  L L+ + +G  P E               S G LR 
Sbjct: 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389

Query: 213 ---SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                +  R  R  P         R   +     DL+  +L +D  +R+   +   HPY+
Sbjct: 390 CTDPKHLARIARARP--------VREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Query: 270 ---------APLHDINEEPVCPRP 284
                     P +  N   + P P
Sbjct: 442 LKYYPECRQHPNYPDNRSMLRPTP 465

Length = 467

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 40/208 (19%)

Query: 56  TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           T +D   +Y LM+     +L   +R+    ++    ++  +++  L+Y+HS  +++RDLK
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+LL+    +K+ DFG A+     D       T  Y APE++ +   +  A+D W++G
Sbjct: 129 PENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALG 185

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ-N 230
            ++ E++   P F   +            G  ++   G L              FP+  +
Sbjct: 186 ILIYEMLVGYPPFFDDN----------PFGIYEKILAGKLE-------------FPRHLD 222

Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRI 258
             A+         DL++K+LV D  RR+
Sbjct: 223 LYAK---------DLIKKLLVVDRTRRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 27/172 (15%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT---------DLHQIIRSH 78
           L+E ++++ + HE ++ +  ++      +   +YIV E M           ++ + +R  
Sbjct: 49  LQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102

Query: 79  QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 138
           Q L D        Q+  G+ YV   N +HRDL+ +N+L+  N   K+ DFGLAR   + +
Sbjct: 103 Q-LVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156

Query: 139 FMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
           +          +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 157 YTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 4/92 (4%)

Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203

Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 204 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.6 bits (160), Expect = 2e-12
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 37/209 (17%)

Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVT 146
           ++  Q++ GL+++H   +++RDLKP N+LL+ + +++I D GLA    +    T+ Y  T
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160

Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGE-IMTRQPLFPGKDYVHQLRLITELIGSPDE 205
             + APELL    EY  ++D +++G  L E I  R P     + V    L   ++     
Sbjct: 161 PGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-- 217

Query: 206 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TV 260
                                    +  +F   SP +    E +L  DP +R+       
Sbjct: 218 -----------------------VTYPDKF---SPASKSFCEALLAKDPEKRLGFRDGNC 251

Query: 261 DEALCHPYLAPLH-DINEEPVCPRPFSFD 288
           D    HP    L+    E  + P PF  D
Sbjct: 252 DGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 73/301 (24%), Positives = 133/301 (44%), Gaps = 55/301 (18%)

Query: 25  KRTLREIKLLRHMDHENIIAIKDIIRP------PQRETFNDVYIVYELMDT-DLHQIIRS 77
           K+ + + K  +H+  E  + +K++  P         +T + +Y V + ++  +L   ++ 
Sbjct: 30  KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR 89

Query: 78  HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 137
            +   +   R++  ++   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E 
Sbjct: 90  ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149

Query: 138 DFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 196
           +  T  +  T  Y APE +L+   Y   +D W +G +L E++   P F  +         
Sbjct: 150 NGTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------- 199

Query: 197 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 256
                            + A  Y  +L + P Q      PN +  A  LLE +L  D  +
Sbjct: 200 -----------------NTAEMYDNILNK-PLQ----LKPNITNSARHLLEGLLQKDRTK 237

Query: 257 RITVD----EALCHPYLAPLH--DINEEPVCPRPFS------FDFEH--PSFTEENIKEL 302
           R+       E   H + +P++  D+  + + P PF+       D  H  P FTEE +   
Sbjct: 238 RLGAKDDFMEIKNHIFFSPINWDDLINKKITP-PFNPNVSGPNDLRHFDPEFTEEPVPNS 296

Query: 303 I 303
           I
Sbjct: 297 I 297

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 52/232 (22%), Positives = 108/232 (46%), Gaps = 52/232 (22%)

Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           T L Q  R      +   + +  +++  L+++H   +++RD+K  N+LL++N  + + DF
Sbjct: 94  THLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149

Query: 129 GLART--TSETDFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFP 185
           GL++     E +    +  T  Y AP+++      +  A+D WS+G ++ E++T      
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG----- 204

Query: 186 GKDYVHQLRLITELIGSP-----DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
                           SP     ++ S    +++ +RR ++  P +P++         S 
Sbjct: 205 ---------------ASPFTVDGEKNS----QAEISRRILKSEPPYPQE--------MSA 237

Query: 241 GAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH--DINEEPVCPRPF 285
            A D+++++L+ DP +R+       DE   HP+   ++  D+  + V P PF
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKV-PAPF 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)

Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200

Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 201 KWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 45/178 (25%), Positives = 92/178 (51%), Gaps = 12/178 (6%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ++ + VA+K + N  ++       LRE  +++ +D+  I+ +  I    + E++  V  +
Sbjct: 20  KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC---EAESWMLVMEL 76

Query: 64  YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            EL    L++ ++ ++ +T+ +    ++Q+  G+KY+   N +HRDL   N+LL      
Sbjct: 77  AEL--GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYA 134

Query: 124 KIGDFGLARTTSETDFMTEYVVT-----RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           KI DFGL++     +   +         +WY APE  +N  ++++  D+WS G ++ E
Sbjct: 135 KISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 20/154 (12%)

Query: 50  RPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           RPP  +   D+        T + +   S +DL    C    YQ+ RG++Y+ S   +HRD
Sbjct: 113 RPPGPDYTFDI--------TKVPEEQLSFKDLVS--C---AYQVARGMEYLESRRCIHRD 159

Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAID 166
           L   N+L+  +  +KI DFGLAR   + D+  +    R    + APE L +   YT   D
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSD 218

Query: 167 IWSVGCILGEIMTR--QPLFPGKDYVHQLRLITE 198
           +WS G ++ EI T    P +PG       +L+ E
Sbjct: 219 VWSFGILMWEIFTLGGSP-YPGIPVEELFKLLRE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 41/109 (37%), Positives = 58/109 (53%), Gaps = 19/109 (17%)

Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVV- 145
           F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 146 ------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 186
                  +W  APE + +C  YT   D+WS G +L EI +  + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 17/207 (8%)

Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL 81
           +   TL E ++L++  H  + A+K   +   R  F     V E  +  +L   +   +  
Sbjct: 38  EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVF 92

Query: 82  TDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDF 139
           ++D  R++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +   
Sbjct: 93  SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152

Query: 140 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLIT 197
           M  +  T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ 
Sbjct: 153 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211

Query: 198 EL----IGSPDETSL--GFLRSDNARR 218
           E+      SP+  SL  G L+ D  +R
Sbjct: 212 EIRFPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.1 bits (158), Expect = 4e-12
 Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 7/108 (6%)

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDF 139
           LT+   +    Q+L  L+Y+HS  ++HRDLK  N+LL  + D+K+ DFG+ A+       
Sbjct: 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166

Query: 140 MTEYVVTRWYRAPELLLNC-----SEYTAAIDIWSVGCILGEIMTRQP 182
              ++ T ++ APE+++ C     + Y    DIWS+G  L E+   +P
Sbjct: 167 RDSFIGTPYWMAPEVVM-CETMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 34/173 (19%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHC 86
           L+E  ++  +DHEN+I +  ++          + +V EL        + S  D L  D  
Sbjct: 44  LKEAAIMHSLDHENLIRLYGVVLTHP------LMMVTELAP------LGSLLDRLRKDAL 91

Query: 87  RYFLY--------QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 138
            +FL         Q+  G++Y+ S   +HRDL   N+LL ++  +KIGDFGL R   + +
Sbjct: 92  GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151

Query: 139 FMTEYVVTRWYR-------APELLLNCSEYTAAIDIWSVGCILGEIMT--RQP 182
              ++ V   +        APE  L    ++ A D+W  G  L E+ T   +P
Sbjct: 152 ---DHYVMEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 42/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)

Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVV 145
           R++  ++   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +   + +  
Sbjct: 99  RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158

Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY-------VHQ-LRLIT 197
           T  Y APE+L     Y   +D W +G +L E++   P F  +D        +++ LRL  
Sbjct: 159 TPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP 217

Query: 198 ELIGSPDETSLGFLRSDNARR 218
            +  S      G L+ D  +R
Sbjct: 218 NISVSARHLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.1 bits (158), Expect = 5e-12
 Identities = 34/94 (36%), Positives = 59/94 (62%), Gaps = 2/94 (2%)

Query: 90  LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTRW 148
           L ++L+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T      +V T +
Sbjct: 107 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           + APE++   S Y +  DIWS+G    E+   +P
Sbjct: 167 WMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.5 bits (157), Expect = 5e-12
 Identities = 51/187 (27%), Positives = 91/187 (48%), Gaps = 20/187 (10%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK +       +  +  L E  L++ + H  ++ +  ++      T   +YI+ E M
Sbjct: 32  KVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIYIITEYM 82

Query: 68  DT-DLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +   L   +++ +   LT +       Q+  G+ ++   N +HRDL+ +N+L++     K
Sbjct: 83  ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCK 142

Query: 125 IGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-- 179
           I DFGLAR   + ++          +W  APE  +N   +T   D+WS G +L EI+T  
Sbjct: 143 IADFGLARLIEDNEYTAREGAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTYG 200

Query: 180 RQPLFPG 186
           R P +PG
Sbjct: 201 RIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 35/184 (19%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF---NDVYIVYE 65
           VA+KKI     ++ D K   +EI   R + H NI+        P   +F   +++Y+V  
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYVTSFIVDSELYVVSP 79

Query: 66  LMDTDLHQIIRSHQDLTDDHC---------RYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           LM         S +DL   H           + L  +L  L Y+HS   +HR +K S++L
Sbjct: 80  LMAYG------SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133

Query: 117 LNANCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPELL-LNCSEYTAAIDI 167
           L+ +  + +     +        R     DF    V    + +PE+L  N   Y    DI
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193

Query: 168 WSVG 171
           +SVG
Sbjct: 194 YSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 7e-12
 Identities = 42/197 (21%), Positives = 80/197 (40%), Gaps = 19/197 (9%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIV 63
           ++ +VA+K +        + +  L E   ++  DH N++ +  +       +      ++
Sbjct: 26  SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVI 85

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLL--------RGLKYVHSANVLHRDLKPSN 114
              M   DLH  +   +            Q L         G++Y+ + N +HRDL   N
Sbjct: 86  LPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN 143

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCSEYTAAIDIWSV 170
            +L  +  + + DFGL++     D+  +  +     +W     L      YT+  D+W+ 
Sbjct: 144 CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAF 201

Query: 171 GCILGEIMTR-QPLFPG 186
           G  + EI TR Q  +PG
Sbjct: 202 GVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 75/322 (23%), Positives = 136/322 (42%), Gaps = 65/322 (20%)

Query: 19  DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-----------NDVYIVYELM 67
           D    A + L++  +L+  +  +I+A ++++    +  F             +Y V + +
Sbjct: 19  DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78

Query: 68  DT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           +  +L   ++  +   +   R++  ++   + Y+HS N+++RDLKP N+LL++   + + 
Sbjct: 79  NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLT 138

Query: 127 DFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFGL +   E +  T  +  T  Y APE+L     Y   +D W +G +L E++   P F 
Sbjct: 139 DFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDL 245
            +D V Q+                    DN       LP             K+  A DL
Sbjct: 198 SRD-VSQM-------------------YDNILHKPLQLP-----------GGKTVAACDL 226

Query: 246 LEKMLVFDPNRRITVD----EALCHPYLAPLH--DINEEPVCPRPFS------FDFEH-- 291
           L  +L  D  RR+       E   H + +P++  D+  + + P P++       D  H  
Sbjct: 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITP-PYNPNVAGPADLRHFD 285

Query: 292 PSFTEENIKELIYRESVKFNPD 313
           P FT+E +       SV   PD
Sbjct: 286 PEFTQEAVS-----SSVGQTPD 302

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 47/140 (33%), Positives = 70/140 (50%), Gaps = 19/140 (13%)

Query: 47  DIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVL 106
           D  R  +  ++ D  +  E+++ D  ++    +DL       F YQ+ +G+ ++ S N +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED--ELALDTEDLLS-----FSYQVAKGMSFLASKNCI 236

Query: 107 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCS 159
           HRDL   N+LL      KI DFGLAR     D  + YVV        +W  APE + NC 
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR-ND--SNYVVKGNARLPVKWM-APESIFNCV 292

Query: 160 EYTAAIDIWSVGCILGEIMT 179
            YT   D+WS G +L EI +
Sbjct: 293 -YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 42/130 (32%), Positives = 75/130 (57%), Gaps = 5/130 (3%)

Query: 59  DVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLL 116
           ++ I  E MD   L Q+++  + + ++        +LRGL Y+   + ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  + Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 177 I-MTRQPLFP 185
           + + R P+ P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 37/220 (16%)

Query: 58  NDVYIVYELM-DTDLHQIIRSHQDLTD-DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +++Y+V E     DL  ++  ++D  D D  +++L +L+  +  VH    +HRD+KP N+
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133

Query: 116 LLNANCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI-----DIW 168
           L++    +K+ DFG A   T ++       V T  Y APE+L   +           D W
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           S+G I  E++  +  F                     ++  +    N +R+++    FP+
Sbjct: 194 SLGVIAYEMIYGRSPF-----------------HEGTSAKTYNNIMNFQRFLK----FPE 232

Query: 229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
                  P  S   +DL++ +L      R+  +   CHP+
Sbjct: 233 D------PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206

Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G +L EI T
Sbjct: 207 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 33/174 (18%)

Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVT 146
           ++  +++ GL+++HS  +++RDLK  N++L+ +  +KI DFG+ +     D   + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE+L    +YT ++D WS G +L E++  Q  F G D         EL  S    
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFES---- 207

Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +R D         P +P      R+  K   + D+LEK+   DP RR+ V
Sbjct: 208 ----IRVDT--------PHYP------RWITKE--SKDILEKLFERDPTRRLGV 241

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 23/200 (11%)

Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
           ++  +L  GL+ +    +++RDLKP N+LL+    ++I D GLA    E + +   V T 
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTV 165

Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ-PLFPGKDYVHQLRLITELIGSPDET 206
            Y APE++ N  +YT + D W +GC++ E++  Q P    K+ V +  +   +    +E 
Sbjct: 166 GYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY 224

Query: 207 SLGFLRSDNARRYVRM-LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN-RRITVDEAL 264
           S  F  S++A+   RM L + PK+    R      GA  + +  +  + N +R+   EA 
Sbjct: 225 SEKF--SEDAKSICRMLLTKNPKERLGCR----GNGAAGVKQHPIFKNINFKRL---EA- 274

Query: 265 CHPYLAPLHDINEEPVCPRP 284
                    ++ E P CP P
Sbjct: 275 ---------NMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 29/191 (15%)

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDF 139
           L++    Y   + L+GL Y+HS   +HRD+K +N+LL  N D+K+ DFG+ A+ T+    
Sbjct: 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162

Query: 140 MTEYVVTRWYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 197
              ++ T ++ APE+  +     Y    DIW+VG    E+   QP  P  D +H +R + 
Sbjct: 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP--PMFD-LHPMRAL- 218

Query: 198 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 257
                       FL S +         Q PK     ++   S    + ++  L  +P +R
Sbjct: 219 ------------FLMSKSNF-------QPPKLKDKTKW---SSTFHNFVKISLTKNPKKR 256

Query: 258 ITVDEALCHPY 268
            T +  L H +
Sbjct: 257 PTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 48/190 (25%), Positives = 90/190 (47%), Gaps = 19/190 (10%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFN- 58
           ++  +   +A+K+I +  D + + KR L ++  ++R  D   I+     +       F  
Sbjct: 24  LHKPSGTIMAVKRIRSTVDEK-EQKRLLMDLDVVMRSSDCPYIVKFYGAL-------FRE 75

Query: 59  -DVYIVYELMDTDL---HQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLK 111
            D +I  ELMD  L   ++ +       + ++         ++ L Y+     ++HRD+K
Sbjct: 76  GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK 135

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWS 169
           PSN+LL+ N ++K+ DFG++    ++   T     R Y APE +   +   Y    D+WS
Sbjct: 136 PSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWS 195

Query: 170 VGCILGEIMT 179
           +G  L E+ T
Sbjct: 196 LGITLYEVAT 205

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 39/136 (28%), Positives = 73/136 (53%), Gaps = 3/136 (2%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + +Y V E ++  DL   I+      + H  ++  ++  GL ++HS  +++RDLK  
Sbjct: 71  QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD 130

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N++L++   +KI DFG+ +        T+ +  T  Y APE ++    Y  ++D W+ G 
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGV 189

Query: 173 ILGEIMTRQPLFPGKD 188
           +L E++  Q  F G+D
Sbjct: 190 LLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 24/171 (14%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ------- 79
           L E  L++ + H+ ++ +  ++   +      +YI+ E M    L   ++S +       
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEE-----PIYIITEYMAKGSLLDFLKSDEGGKVLLP 103

Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 139
            L D     F  Q+  G+ Y+   N +HRDL+ +N+L++ +   KI DFGLAR   + ++
Sbjct: 104 KLID-----FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158

Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                     +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 159 TAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 6/135 (4%)

Query: 49  IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
           I     E+  D Y+      T    +I     L+      F YQ+  G++++ S N +HR
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263

Query: 109 DLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCSEYTAA 164
           DL   N+L+     +KI DFGLAR    +++++++   ++  +W  APE + N + YT  
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTL 321

Query: 165 IDIWSVGCILGEIMT 179
            D+WS G +L EI T
Sbjct: 322 SDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 19/180 (10%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
            VAIK +          K  L E  ++  +DH +++ +  I    Q      V ++ +LM
Sbjct: 38  PVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLSSQ------VQLITQLM 90

Query: 68  DT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
               L   +R+H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI
Sbjct: 91  PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKI 150

Query: 126 GDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            DFGLA+     +   EY         +W  A E +L+   YT   D+WS G  + E+MT
Sbjct: 151 TDFGLAKLLDVDE--KEYHAEGGKVPIKWM-ALESILH-RIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 63/241 (26%), Positives = 112/241 (46%), Gaps = 28/241 (11%)

Query: 19  DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQ 73
           D  I+A     E  +L+ + +H N++    +     +     +++V EL +    T+L +
Sbjct: 62  DEEIEA-----EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK 116

Query: 74  -IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-A 131
            ++   Q L +    Y LY  L GL+++H+  ++HRD+K +N+LL     +K+ DFG+ A
Sbjct: 117 GLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176

Query: 132 RTTSETDFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSVGCILGEIMTRQPLFPG 186
           + TS        V T ++ APE++  C +     Y A  D+WS+G    E+    P  P 
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIA-CEQQYDYSYDARCDVWSLGITAIELGDGDP--PL 233

Query: 187 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 246
            D +H ++ + ++  +P  T L      +  ++ R    F  Q     F    P    LL
Sbjct: 234 FD-MHPVKTLFKIPRNPPPTLL------HPEKWCRSFNHFISQCLIKDF-EARPSVTHLL 285

Query: 247 E 247
           E
Sbjct: 286 E 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 30/102 (29%), Positives = 60/102 (58%), Gaps = 3/102 (2%)

Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
           ++  Q+  G+ ++HS ++++RD+KP N+LL+   + ++ D GLA    +   +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 189
            Y APE+L     Y+  +D +++GC + E++  +   P KD+
Sbjct: 159 GYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRT--PFKDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.2 bits (151), Expect = 3e-11
 Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 25/186 (13%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVY 64
           +VAIK I    +  +     + E K++  + HE ++ +  +    RP        +YIV 
Sbjct: 30  DVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP--------IYIVT 78

Query: 65  ELMDTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           E M    L   +R H               +  G+ Y+ S   +HRDL   N L++    
Sbjct: 79  EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC 138

Query: 123 LKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           +K+ DFGL+R   + ++     +++ V RW   PE+LL   ++++  D+W+ G ++ E+ 
Sbjct: 139 VKVSDFGLSRYVLDDEYTSSVGSKFPV-RW-SPPEVLLYS-KFSSKSDVWAFGVLMWEVY 195

Query: 179 T--RQP 182
           +  + P
Sbjct: 196 SLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 37/164 (22%), Positives = 75/164 (45%), Gaps = 20/164 (12%)

Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR---------SH 78
           RE+ + R + H+N++ +  + R  + E     Y++ E  D  DL Q +R           
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCR--EAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKP 111

Query: 79  QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 138
             L+         Q+  G+ ++ +A  +HRDL   N L+++  ++K+    L++    ++
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171

Query: 139 ---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                   +  RW  APE +    +++   D+WS G ++ E+ T
Sbjct: 172 YYKLRNALIPLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 62.2 bits (151), Expect = 3e-11
 Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 29/194 (14%)

Query: 25  KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND-VYIVYELMDT-DLHQIIRSHQDLT 82
           K  L+E  L+ + +H NI+ +  +         N+  YI+ ELM+  DL   +R  +   
Sbjct: 44  KEFLKEAHLMSNFNHPNIVKLLGVC------LLNEPQYIIMELMEGGDLLSYLRDARVER 97

Query: 83  DDHCRYFLYQLL-------RGLKYVHSANVLHRDLKPSNLLLNA---NCD--LKIGDFGL 130
                  L +LL       +G  Y+   + +HRDL   N L++    + D  +KIGDFGL
Sbjct: 98  FGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157

Query: 131 ARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 184
           AR   ++D+  +     +  RW  APE LL+  ++T   D+WS G ++ EI+T  +QP +
Sbjct: 158 ARDIYKSDYYRKEGEGLLPVRWM-APESLLD-GKFTTQSDVWSFGVLMWEILTLGQQP-Y 214

Query: 185 PGKDYVHQLRLITE 198
           P  +    L+ +T 
Sbjct: 215 PALNNQEVLQHVTA 228

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 68/272 (25%), Positives = 113/272 (41%), Gaps = 39/272 (14%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDV 60
           N  T E  AIK I    +   D     +EI +++   H NI+A     +R       + +
Sbjct: 30  NVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR------DKL 81

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +I  E      L  I      L++    Y   + L+GL Y+HS   +HRD+K +N+LL  
Sbjct: 82  WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141

Query: 120 NCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LLNCSEYTAAIDIWSVGCILGE 176
           N  +K+ DFG+ A+ T+       ++ T ++ APE+  +     Y    DIW+VG    E
Sbjct: 142 NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE 201

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +   QP       +  L L+T+    P +       S++   +V+M              
Sbjct: 202 LAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM-------------- 247

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
                        L  +P +R T ++ L HP+
Sbjct: 248 ------------ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 26/173 (15%)

Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YV 144
           F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGS 202
             +W  A E L +   YT   D+WS G +L EI+T    P +PG   +   RL   L   
Sbjct: 192 PVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNP-YPG---IAPERLFNLL--- 242

Query: 203 PDETSLGFLRSDNARRYV-RMLPQFPKQNFSARFPNKSPGAVDL---LEKMLV 251
             +T     R +N    +  ++    KQ      P+K P   D+   LEKM+V
Sbjct: 243 --KTGYRMERPENCSEEMYNLMLTCWKQE-----PDKRPTFADISKELEKMMV 288

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 39/207 (18%)

Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIG 126
           D DL  +++    L++   +  + QL+  L  +H  N++H D+K  N+L +   D + + 
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 127 DFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           D+GL +   T S  D   +Y       +PE  +    Y  + D W+VG +  E++T +  
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203

Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
            P K+               DE           +R  + LP F K        N S  A 
Sbjct: 204 HPFKE-------------DEDEE---LDLESLLKRQQKKLP-FIK--------NVSKNAN 238

Query: 244 DLLEKMLVFDPNRR-ITVDEALCHPYL 269
           D ++ ML ++ N R    +E + HP+L
Sbjct: 239 DFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 77/330 (23%), Positives = 122/330 (36%), Gaps = 89/330 (26%)

Query: 24  AKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDVYIVYELMD----TDLH 72
           A +TLR+  +L      ++ A +DI+     E       +F D   +Y +MD     D+ 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 73  QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-- 130
            ++   +   +   R+++ +L   ++ VH    +HRD+KP N+L++ +  +K+ DFGL  
Sbjct: 90  SLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149

Query: 131 ----------------------------------------------ARTTSETDFMTEYV 144
                                                         A    +       V
Sbjct: 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209

Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y APE+LL    YT   D WSVG IL E++  QP F              L  +P 
Sbjct: 210 GTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPT 254

Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDE 262
           ET L  +  +N           P Q         SP AVDL+ K+      R  R   D+
Sbjct: 255 ETQLKVINWENTL-------HIPPQ------VKLSPEAVDLITKLCCSAEERLGRNGADD 301

Query: 263 ALCHPYLAPLHDINEEPVCPRPFSFDFEHP 292
              HP+ + +   ++    P P+     HP
Sbjct: 302 IKAHPFFSEVDFSSDIRTQPAPYVPKISHP 331

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.2 bits (151), Expect = 5e-11
 Identities = 37/113 (32%), Positives = 61/113 (53%), Gaps = 3/113 (2%)

Query: 73  QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 132
           QI RS +   +   R++  ++   L ++H   V++RDLK  N+LL+A    K+ DFG+ +
Sbjct: 86  QIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Query: 133 TTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
                   T  +  T  Y APE+L    EY  ++D W++G ++ E+M  QP F
Sbjct: 145 EGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 40/141 (28%), Positives = 74/141 (52%), Gaps = 13/141 (9%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + +Y V E ++  DL   I+      +    ++  ++  GL ++H   +++RDLK  
Sbjct: 71  QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLD 130

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCSEYTAAIDI 167
           N++L++   +KI DFG+ +     + M + V TR       Y APE++     Y  ++D 
Sbjct: 131 NVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDW 184

Query: 168 WSVGCILGEIMTRQPLFPGKD 188
           W+ G +L E++  QP F G+D
Sbjct: 185 WAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 39/205 (19%)

Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           +E +L+  + H NI+ +  +    Q        +++E +   DLH+ +  +   +D    
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQ-----PTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 88  Y-------------FL---YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 131
                         FL    Q+  G++Y+ S + +HRDL   N L+     +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 132 RTTSETDFMTEYVV-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QP 182
           R     D+   Y V        RW   PE +L   ++T   DIWS G +L EI +   QP
Sbjct: 172 RDIYSADY---YRVQSKSLLPVRWM-PPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQP 226

Query: 183 L--FPGKDYVHQLRLITELIGSPDE 205
              F  ++ +  +R   +L+  P++
Sbjct: 227 YYGFSNQEVIEMIR-SRQLLPCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 40/126 (31%), Positives = 69/126 (54%), Gaps = 4/126 (3%)

Query: 60  VYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V E ++  +    +R ++   +D   ++  Q++   +Y+ S N+++RDLKP NLLL+
Sbjct: 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            +  +K+ DFG A+      +      T  Y APE+LLN     AA D W++G  + EI+
Sbjct: 166 KDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLGIFIYEIL 222

Query: 179 TRQPLF 184
              P F
Sbjct: 223 VGCPPF 228

Length = 340

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 45/198 (22%)

Query: 9   VAIKKIGNAFDNRIDAKRT-----LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           VA+K +      R D  +T     L+EIK++  + + NII +  +         + + ++
Sbjct: 47  VAVKML------RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMI 95

Query: 64  YELMDT-DLHQIIR-----------------SHQDLTDDHCRYFLYQLLRGLKYVHSANV 105
            E M+  DL+Q +                  S  +L      Y   Q+  G+KY+ S N 
Sbjct: 96  TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL-----YMAVQIASGMKYLASLNF 150

Query: 106 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEY 161
           +HRDL   N L+  +  +KI DFG++R     D+        +  RW     +LL   ++
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKF 208

Query: 162 TAAIDIWSVGCILGEIMT 179
           T A D+W+ G  L E+ T
Sbjct: 209 TTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 48/182 (26%), Positives = 94/182 (51%), Gaps = 20/182 (10%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + +++V E ++  DL   ++  + L ++H R++  ++   L ++H   +++RDLK  
Sbjct: 66  QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 114 NLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+A+  +K+ D+G+ +      D  + +  T  Y APE+L    EY  ++D W++G 
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGV 184

Query: 173 ILGEIM---------TRQPLFPGKDYVHQLRLITELIGSPDETSL-------GFLRSDNA 216
           ++ E+M         T  P    +DY+ Q+ ++ + I  P   S+       GFL  D  
Sbjct: 185 LMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKGFLNKDPK 243

Query: 217 RR 218
            R
Sbjct: 244 ER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 74/279 (26%)

Query: 16  NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDL 71
                R   KR L E ++L  +DH  +  +       Q ET+     +  +MD     +L
Sbjct: 37  KEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF---QTETY-----LCLVMDYCPGGEL 88

Query: 72  HQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 129
            +++  +  + L+++  R++  ++L  L+Y+H   +++RDLKP N+LL+ +  + + DF 
Sbjct: 89  FRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFD 148

Query: 130 LARTTS-----------------------------ETDFMT-EYVVTRWYRAPELLLNCS 159
           L++ +                              E  F +  +V T  Y APE++    
Sbjct: 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG 208

Query: 160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 219
            + +A+D W++G +L E++     F G               + DET    L+ +     
Sbjct: 209 -HGSAVDWWTLGILLYEMLYGTTPFKGS--------------NRDETFSNILKKE----- 248

Query: 220 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                 FP        P  S  A DL+ K+LV DP++R+
Sbjct: 249 ----VTFPGS------PPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 81/338 (23%), Positives = 129/338 (38%), Gaps = 91/338 (26%)

Query: 20  NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDVYIVYELMD---- 68
             + A +TLR+  +L      ++ A +DI+     E       +F D   +Y +MD    
Sbjct: 26  KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85

Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            D+  ++       +D  R+++ +L   ++ VH    +HRD+KP N+L++ +  +K+ DF
Sbjct: 86  GDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 145

Query: 129 GLA---RTTSET--------------DFMTEY---------------------------- 143
           GL    R T ++              DF  E+                            
Sbjct: 146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA 205

Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
              V T  Y APE+LL  + YT   D WSVG IL E++  QP F              L 
Sbjct: 206 HSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPF--------------LA 250

Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-- 258
            +P ET +  +    +          P Q         SP A DL+ K L   P  R+  
Sbjct: 251 QTPLETQMKVINWQTSL-------HIPPQ------AKLSPEASDLIIK-LCRGPEDRLGK 296

Query: 259 -TVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFT 295
              DE   HP+   +   ++      P+     HP+ T
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDT 334

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 61.3 bits (148), Expect = 9e-11
 Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 51/257 (19%)

Query: 29  REIKLLRHMDHENIIA------IKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSH 78
           +EI +L+   H   IA      IK    PP  +  + +++V E       TDL +  + +
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGN 106

Query: 79  QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET- 137
             L ++   Y   ++LRGL ++H   V+HRD+K  N+LL  N ++K+ DFG++     T 
Sbjct: 107 T-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165

Query: 138 DFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 192
                ++ T ++ APE++  C E     Y    D+WS+G    E+    P  P  D +H 
Sbjct: 166 GRRNTFIGTPYWMAPEVIA-CDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHP 221

Query: 193 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF 252
           +R +  +  +P                    P+   + +S +F +        +E  LV 
Sbjct: 222 MRALFLIPRNP-------------------APRLKSKKWSKKFQS-------FIESCLVK 255

Query: 253 DPNRRITVDEALCHPYL 269
           + ++R T ++ + HP++
Sbjct: 256 NHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 26/180 (14%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VA+K         + AK  L+E ++L+   H NI+ +  +    Q      +YIV EL+ 
Sbjct: 23  VAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELVQ 76

Query: 69  T-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYVHSANVLHRDLKPSNLLLNAN 120
             D    +R+      +  R  + +L++       G++Y+ S + +HRDL   N L+   
Sbjct: 77  GGDFLTFLRT------EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK 130

Query: 121 CDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             LKI DFG++R   +  + +    + +  +W  APE  LN   Y++  D+WS G +L E
Sbjct: 131 NVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPE-ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 32/200 (16%)

Query: 93  LLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 151
           +++GL Y+   + ++HRD+KPSN+L+N+  ++K+ DFG++    ++     +V TR Y +
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMS 170

Query: 152 PELLLNCSEYTAAIDIWSVGCILGEI-MTRQPLFPGKDYVHQLRLITELIGSPDETSL-- 208
           PE  L  + Y+   DIWS+G  L E+ + R P+ P      +L     + G P E+    
Sbjct: 171 PE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229

Query: 209 --------GFLRSDNARRYVRML-----------PQFPKQNFSARFPNKSPGAVDLLEKM 249
                         ++R  + +            P+ P   F A F        D + K 
Sbjct: 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ-------DFVNKC 282

Query: 250 LVFDPNRRITVDEALCHPYL 269
           L+ +P  R  + + + H ++
Sbjct: 283 LIKNPAERADLKQLMVHAFI 302

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 29/173 (16%)

Query: 28  LREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           L E ++++ + H+ ++ +  ++   P       +YIV E M             L D   
Sbjct: 49  LEEAQIMKKLRHDKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDF-----LKDGEG 96

Query: 87  RYF--------LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 138
           R            Q+  G+ Y+   N +HRDL+ +N+L+      KI DFGLAR   + +
Sbjct: 97  RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156

Query: 139 FMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 186
           +          +W  APE  L    +T   D+WS G +L E++T  R P +PG
Sbjct: 157 YTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 36  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 87

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR----------GLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++       L +          G+ Y+++   +HRDL  
Sbjct: 88  MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAA 147

Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 148 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 205

Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 206 SFGVVLWEIATLAEQP-YQGMSNEQVLRFVMEGGLLDKPD 244

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 32/180 (17%)

Query: 28  LREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRS--HQDLT 82
           L+E  +++ + H N++ +  +    PP        YI+ E M   +L   +R    Q++ 
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVN 102

Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 142
                Y   Q+   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R       MT 
Sbjct: 103 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR------LMTG 156

Query: 143 YVVT---------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVH 191
              T         +W  APE L   ++++   D+W+ G +L EI T    P +PG D   
Sbjct: 157 DTYTAHAGAKFPIKW-TAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 37/103 (35%), Positives = 62/103 (60%), Gaps = 7/103 (6%)

Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTE---YV 144
           F YQ+ RG++++ S N +HRDL   N+LL     +KI DFGLAR    +++++++   ++
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG 186
             +W  APE + + + YT   D+WS G +L EI +     +PG
Sbjct: 302 PVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 44/182 (24%), Positives = 89/182 (48%), Gaps = 21/182 (11%)

Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIV 63
           + +VAIK I     +  D      E +++  + H  ++ +  +   R P       + +V
Sbjct: 28  KRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYGVCTERSP-------ICLV 77

Query: 64  YELMDTD-LHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           +E M+   L   +R+ +   + +        +  G+ Y+ S+NV+HRDL   N L+  N 
Sbjct: 78  FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ 137

Query: 122 DLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
            +K+ DFG+ R   +  +     T++ V +W  +PE + + S+Y++  D+WS G ++ E+
Sbjct: 138 VVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SSPE-VFSFSKYSSKSDVWSFGVLMWEV 194

Query: 178 MT 179
            +
Sbjct: 195 FS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 10/154 (6%)

Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDDH 85
           ++ E +LLR + H  ++A+ D+ R     T     +V     +DL+  +    + L    
Sbjct: 207 SVHEARLLRRLSHPAVLALLDV-RVVGGLTC----LVLPKYRSDLYTYLGARLRPLGLAQ 261

Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG---LARTTSETDFMTE 142
                 QLL  + Y+H   ++HRD+K  N+L+N   D+ +GDFG    AR +  T F   
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              T    APE+L     YT ++DIWS G ++ E
Sbjct: 322 IAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 61/271 (22%), Positives = 122/271 (45%), Gaps = 39/271 (14%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + ++ V E ++  DL   ++  + L ++H R++  ++   L Y+H   +++RDLK  
Sbjct: 66  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125

Query: 114 NLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL++   +K+ D+G+ +      D  + +  T  Y APE+L    +Y  ++D W++G 
Sbjct: 126 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGV 184

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARRYVRMLPQFPKQ 229
           ++ E+M  +  F             +++GS   PD+ +  +L      + +R+    P+ 
Sbjct: 185 LMFEMMAGRSPF-------------DIVGSSDNPDQNTEDYLFQVILEKQIRI----PR- 226

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLH-DINEEPVCP 282
                  + S  A  +L+  L  DP  R+         +   HP+   +  D+ E+    
Sbjct: 227 -------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVV 279

Query: 283 RPFSFDFEHPSFTEENIKELIYRESVKFNPD 313
            PF  +     F  +N       E V+  PD
Sbjct: 280 PPFKPNISG-EFGLDNFDAQFTNEPVQLTPD 309

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 67/256 (26%), Positives = 116/256 (45%), Gaps = 51/256 (19%)

Query: 30  EIKLLRHMDHENIIA------IKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQ 79
           EI +L+   H   IA      IK    PP  +  + +++V E       TDL +  + + 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKK--SPPGHD--DQLWLVMEFCGAGSVTDLVKNTKGNA 117

Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 138
            L +D   Y   ++LRGL ++H+  V+HRD+K  N+LL  N ++K+ DFG++     T  
Sbjct: 118 -LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176

Query: 139 FMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL 193
               ++ T ++ APE++  C E     Y    DIWS+G    E+    P  P  D +H +
Sbjct: 177 RRNTFIGTPYWMAPEVIA-CDENPDATYDYRSDIWSLGITAIEMAEGAP--PLCD-MHPM 232

Query: 194 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFD 253
           R +  +  +P                    P+   + +S +F       +D +E  LV +
Sbjct: 233 RALFLIPRNPP-------------------PKLKSKKWSKKF-------IDFIEGCLVKN 266

Query: 254 PNRRITVDEALCHPYL 269
              R + ++ L HP++
Sbjct: 267 YLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 40/243 (16%)

Query: 38  DHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQ-IIRSHQDLTDDHCRYFLYQ 92
           DH N++    +      +  + +++V EL +    TDL +  ++  + + +    Y L++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 93  LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRA 151
            L GL+++H    +HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 152 PELLLNC-----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
           PE++  C     S Y A  D+WS+G    E+    P  P  D +H +R + ++  +P  T
Sbjct: 193 PEVIA-CEQQLDSTYDARCDVWSLGITAIELGDGDP--PLAD-LHPMRALFKIPRNPPPT 248

Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
               L            P+     F+           D + K L  D  +R TV + L H
Sbjct: 249 ----LHQ----------PELWSNEFN-----------DFIRKCLTKDYEKRPTVSDLLQH 283

Query: 267 PYL 269
            ++
Sbjct: 284 VFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 37/197 (18%)

Query: 30  EIKLLRHMDHENIIAIK--------------------DIIRPPQRE-------TFND--- 59
           E++L+RH   + + A+K                    DI+     E        F D   
Sbjct: 58  EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117

Query: 60  VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V E M   DL  ++ S+ D+ +   R++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 119 ANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLN---CSEYTAAIDIWSVGCI 173
            +  LK+ DFG          +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 174 LGEIMTRQPLFPGKDYV 190
           L E++     F     V
Sbjct: 237 LYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 42/133 (31%), Positives = 69/133 (51%), Gaps = 17/133 (12%)

Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 129
           D   ++++   L  D  R +  + +  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFG
Sbjct: 87  DCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFG 146

Query: 130 LAR------TTS------ETD---FMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           L++      TT+      E D   F+ + V  T  Y APE++L    Y   +D W++G I
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGII 205

Query: 174 LGEIMTRQPLFPG 186
           L E +     F G
Sbjct: 206 LYEFLVGCVPFFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 38/219 (17%)

Query: 59  DVYIVYELMDTDLHQI-IRSHQDLTDD---HCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           DV+I  ELM T L ++  R    + +D        + + L  LK  H   V+HRD+KPSN
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSN 145

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCSEYTAAIDIWSVG 171
           +LL+A+ ++K+ DFG++    ++   T       Y APE +       +Y    D+WS+G
Sbjct: 146 ILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQN 230
             L E+ T Q  FP K+   +  ++T+++                       P  P  + 
Sbjct: 206 ISLVELATGQ--FPYKNCKTEFEVLTKILQEE-------------------PPSLPPNEG 244

Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           FS  F          ++  L  D  +R    E L HP++
Sbjct: 245 FSPDF-------CSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.1 bits (143), Expect = 3e-10
 Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVY 64
           +VAIK I     +  D    + E K++  + H  ++ +  +    +P        +YIV 
Sbjct: 30  KVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLVQLYGVCTQQKP--------LYIVT 78

Query: 65  ELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           E M+    L+ + +    L+ D        +  G++Y+   + +HRDL   N L+++   
Sbjct: 79  EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV 138

Query: 123 LKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +K+ DFG+ R   + ++ +        +W   PE + N S+Y++  D+WS G ++ E+ T
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSKYSSKSDVWSFGVLMWEVFT 196

Query: 180 --RQPLFPGKDYVHQLRLITE 198
             + P F  K     + +I+ 
Sbjct: 197 EGKMP-FEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 77/334 (23%), Positives = 126/334 (37%), Gaps = 87/334 (26%)

Query: 20  NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDVYIVYELMD---- 68
           N + A +TLR+  +L      ++ A +DI+     E       +F D   +Y +MD    
Sbjct: 26  NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85

Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            D+  ++       +D  R+++ +L   ++ VH    +HRD+KP N+L++ +  +K+ DF
Sbjct: 86  GDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 145

Query: 129 GLA---RTTSETDFMTE-----------------------------------------YV 144
           GL    R T ++ +  +                                          V
Sbjct: 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205

Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y APE+LL  + YT   D WSVG IL E++  QP F              L  +P 
Sbjct: 206 GTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPF--------------LADTPA 250

Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVD 261
           ET    L+  N    + +  Q             S  A DL+ + L      R+     D
Sbjct: 251 ETQ---LKVINWETTLHIPSQ----------AKLSREASDLILR-LCCGAEDRLGKNGAD 296

Query: 262 EALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFT 295
           E   HP+   +   +       P+     HP+ T
Sbjct: 297 EIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDT 330

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.8 bits (142), Expect = 4e-10
 Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 18/190 (9%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VA+K I     N   A+  L E  ++  + H N++ +  +I     E    +YIV E M
Sbjct: 31  KVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYM 82

Query: 68  -DTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   +RS     L  D    F   +   ++Y+ + N +HRDL   N+L++ +   K
Sbjct: 83  AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAK 142

Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT----R 180
           + DFGL +  S T    +  V +W  APE L    +++   D+WS G +L EI +     
Sbjct: 143 VSDFGLTKEASSTQDTGKLPV-KW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 199

Query: 181 QPLFPGKDYV 190
            P  P KD V
Sbjct: 200 YPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 42/168 (25%), Positives = 82/168 (48%), Gaps = 19/168 (11%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L+E ++++ + H+ ++ +  ++      +   +YIV E M      ++   ++    + +
Sbjct: 49  LQEAQIMKKLRHDKLVPLYAVV------SEEPIYIVTEFMGKG--SLLDFLKEGDGKYLK 100

Query: 88  Y-----FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 142
                    Q+  G+ Y+   N +HRDL+ +N+L+  N   KI DFGLAR   + ++   
Sbjct: 101 LPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160

Query: 143 Y---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                  +W  APE  L    +T   D+WS G +L E++T+  + +PG
Sbjct: 161 QGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 61/260 (23%), Positives = 102/260 (39%), Gaps = 77/260 (29%)

Query: 56  TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           +F D   +Y +M+     D+  ++      T++  R+++ + +  +  +H    +HRD+K
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEY---------------------------- 143
           P NLLL+A   +K+ DFGL  T  +    TE+                            
Sbjct: 129 PDNLLLDAKGHIKLSDFGLC-TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187

Query: 144 ------------VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH 191
                       V T  Y APE+ L  + Y    D WS+G I+ E++   P F   +   
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDN--- 243

Query: 192 QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLV 251
                      P ET    +   N +  +    QFP +         SP A DL+++ L 
Sbjct: 244 -----------PQETYRKII---NWKETL----QFPDE------VPLSPEAKDLIKR-LC 278

Query: 252 FDPNRRI---TVDEALCHPY 268
            +  RR+    V+E   HP+
Sbjct: 279 CEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 69/330 (20%), Positives = 141/330 (42%), Gaps = 51/330 (15%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDV 60
           EVA+ K+ NA  +++ A + L + ++L+  +       +D++     +        F D 
Sbjct: 16  EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE 73

Query: 61  YIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             +Y +MD     DL  ++   +D L +D  R++L +++  +  VH  + +HRD+KP N+
Sbjct: 74  NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSE----YTAAIDIWS 169
           L++ N  +++ DFG      E   +   V   T  Y +PE+L    +    Y    D WS
Sbjct: 134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWS 193

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G  + E++  +  F  +  V                            Y +++    + 
Sbjct: 194 LGVCMYEMLYGETPFYAESLVET--------------------------YGKIMNHKERF 227

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLHDINEEPVCPRPFSF 287
            F A+  + S  A DL+ +++    +R  +  +++   HP+   + D +    C  P+  
Sbjct: 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI-DWDNIRNCEAPYIP 286

Query: 288 DFEHPSFTEE-NIKELIYRESVKFNPDPTH 316
           +   P+ T   ++ +   + S    P P+H
Sbjct: 287 EVSSPTDTSNFDVDDDCLKNSETM-PPPSH 315

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDF 139
           LT +    + +Q+ +G++++ S   +HRDL   N+LL+ N  +KI DFGLAR    + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 236 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 6/95 (6%)

Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFM---TEYV 144
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KI DFGLAR    + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +W  APE + +   YT   D+WS G +L EI +
Sbjct: 239 PLKWM-APESIFD-KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 43/140 (30%), Positives = 73/140 (52%), Gaps = 20/140 (14%)

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           LT +    + +Q+ RG++++ S   +HRDL   N+LL+ N  +KI DFGLAR   +    
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--- 226

Query: 141 TEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG----K 187
            +YV         +W  APE + +   YT   D+WS G +L EI +    P +PG    +
Sbjct: 227 PDYVRKGDARLPLKWM-APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQIDE 283

Query: 188 DYVHQLRLITELIGSPDETS 207
           ++  +L+  T +  +P+  +
Sbjct: 284 EFCRRLKEGTRM-RAPEYAT 302

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 33/115 (28%), Positives = 65/115 (56%), Gaps = 3/115 (2%)

Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 129
           DL   ++  + L ++H R++  ++   L ++H   +++RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 130 LART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQP 182
           + +      D  + +  T  Y APE+L    +Y  ++D W++G ++ E+M  R P
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 12/157 (7%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQ-DLTDDH 85
           L E   L   DH NI+ ++ +I        N + IV E M    L   +R H+  L    
Sbjct: 54  LAEALTLGQFDHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ 108

Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG-LARTTSETDF--MTE 142
               L  L  G+KY+     +H+ L    +L+N++   KI  F  L    SE  +  M+ 
Sbjct: 109 LMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG 168

Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                W  APE  +    +++A D+WS G ++ E+M+
Sbjct: 169 KSPVLW-AAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 35/118 (29%), Positives = 58/118 (49%), Gaps = 12/118 (10%)

Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           L + +  Q + + Q L          Q+  G+ Y+H   V+H+D+   N +++    +KI
Sbjct: 105 LGEANNPQALSTQQ-LVH-----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158

Query: 126 GDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            D  L+R     D+      E    +W  A E L+N  EY++A D+WS G +L E+MT
Sbjct: 159 TDNALSRDLFPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 40/125 (32%), Positives = 67/125 (53%), Gaps = 7/125 (5%)

Query: 60  VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V E M   DL  ++ S+ D+ +   +++  +++  L  +HS  ++HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176

Query: 119 ANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC---SEYTAAIDIWSVGCI 173
            +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 174 LGEIM 178
           L E++
Sbjct: 237 LFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 8/93 (8%)

Query: 96  GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRA 151
           G+ Y+++   +HRDL   N ++  +  +KIGDFG+ R   ETD+  +     +  RW  A
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-A 189

Query: 152 PELLLNCSEYTAAIDIWSVGCILGEIMT--RQP 182
           PE L +   +T + D+WS G +L EI +   QP
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.6 bits (134), Expect = 6e-09
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 8/99 (8%)

Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTR 147
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPLF 184
           W     +  N   YT   D+W+ G +L EI +   QP +
Sbjct: 198 WMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYY 234

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 31/175 (17%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ------- 79
           L+E+K+L  +   NII +  +         + + ++ E M+  DL+Q + SH        
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 80  ---DLTDDHCR---------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
               +   HC          +   Q+  G+KY+ S N +HRDL   N L+  N  +KI D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 128 FGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           FG++R     D+        +  RW  A E +L   ++T A D+W+ G  L EI+
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECIL-MGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 49/177 (27%), Positives = 87/177 (49%), Gaps = 15/177 (8%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 39  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLT------STVQLITQLMP 91

Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 92  FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKIT 151

Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W  A E +L+   YT   D+WS G  + E+MT
Sbjct: 152 DFGLAKLLGADEKEYHAEGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 1e-08
 Identities = 36/138 (26%), Positives = 64/138 (46%), Gaps = 18/138 (13%)

Query: 62  IVYELMDT-DLHQIIRSHQDLTDDHCRYFLY----QLLRGLKYVHSANVLHRDLKPSNLL 116
           +V+E  +  DL   +   Q    +     L     ++  G+ ++H  N LH DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 117 LNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCSEYTAAID 166
           L ++  +K+GD+G+  +  + D++     + V  RW  APEL+      L  +E T   +
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPSN 190

Query: 167 IWSVGCILGEIM--TRQP 182
           +W++G  L E+     QP
Sbjct: 191 VWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 11/145 (7%)

Query: 57  FNDVYIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           F D   +Y +MD     DL  ++   +D L +D  R+++ +++  +  +H  + +HRD+K
Sbjct: 70  FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129

Query: 112 PSNLLLNANCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL----NCSEYTAAI 165
           P N+LL+ N  +++ DFG  L      T   +  V T  Y +PE+L        +Y    
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 166 DIWSVGCILGEIMTRQPLFPGKDYV 190
           D WS+G  + E++  +  F  +  V
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLV 214

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 44/206 (21%)

Query: 9   VAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           VA+KKI  +  +N +  KR LRE K+   + H  I+ +  I         +D   VY  M
Sbjct: 30  VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSI--------CSDGDPVYYTM 81

Query: 68  ----DTDLHQIIRS---HQDLTDDH-----CRYFL---YQLLRGLKYVHSANVLHRDLKP 112
                  L  +++S    + L+ +         FL   +++   ++YVHS  VLHRDLKP
Sbjct: 82  PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141

Query: 113 SNLLLNANCDLKIGDFGLARTT-------------------SETDFMTEYVVTRWYRAPE 153
            N+LL    ++ I D+G A                      S      + V T  Y APE
Sbjct: 142 DNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201

Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMT 179
            LL     + + DI+++G IL +++T
Sbjct: 202 RLLG-VPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 26/192 (13%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK + N  + +      +RE +++  +D+  I+ +   I   + E    + +V E+ 
Sbjct: 24  DVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRM---IGVCEAEA---LMLVMEMA 76

Query: 68  DTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
               L++ +   +D +T  +    ++Q+  G+KY+   N +HRDL   N+LL      KI
Sbjct: 77  SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKI 136

Query: 126 GDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
            DFGL++     D    Y   R        WY APE  +N  ++++  D+WS G  + E 
Sbjct: 137 SDFGLSKALGADD---SYYKARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWEA 191

Query: 178 MTRQPLFPGKDY 189
            +    +  K Y
Sbjct: 192 FS----YGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 31/180 (17%)

Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQ--IIRS-HQDL--- 81
           +E  L+  + H NI+ +  ++   Q      V +++E ++  DLH+  I+RS H D+   
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQ-----PVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 82  ---------TDDHCRYF--LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 130
                    + DH  +     Q+  G++Y+ S   +H+DL   N+L+     +KI D GL
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 131 ARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 184
           +R     D+        +  RW   PE ++   ++++  DIWS G +L EI +   QP +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 3/105 (2%)

Query: 76  RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 135
            +   L+     +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 136 ETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                T   +  RW       LN S YT   D+WS G +L EI++
Sbjct: 176 VYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 5/124 (4%)

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E M       + S+ D+ +   R++  +++  L  +HS   +HRD+KP N+LL+ 
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 177

Query: 120 NCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC---SEYTAAIDIWSVGCIL 174
           +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 178 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 175 GEIM 178
            E++
Sbjct: 238 YEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 11/97 (11%)

Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVT 146
            ++  GL ++H  N +H DL   N LL A+  +KIGD+GL+    + D+       +V  
Sbjct: 107 CEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 147 RWYRAPELL------LNCSEYTAAIDIWSVGCILGEI 177
           RW  APEL+      L   + T   ++WS+G  + E+
Sbjct: 167 RWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.4 bits (125), Expect = 8e-08
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 14/98 (14%)

Query: 92  QLLR-------GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY- 143
           QLL        G+ Y+     +HRDL   N+L+  N   KI DFGL+R   +  ++ +  
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170

Query: 144 --VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +  RW       LN S YT   D+WS G +L EI++
Sbjct: 171 GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 33/126 (26%), Positives = 65/126 (51%), Gaps = 3/126 (2%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + ++ V E ++  DL   I+  +   +   R++  ++   L ++H   +++RDLK  
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+     K+ DFG+ +        T  +  T  Y APE+L     Y  ++D W++G 
Sbjct: 126 NVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGV 184

Query: 173 ILGEIM 178
           +L E++
Sbjct: 185 LLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 39/126 (30%), Positives = 66/126 (52%), Gaps = 8/126 (6%)

Query: 60  VYIVYELMDTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           V +V +LM    L   +R ++D +       +  Q+ +G+ Y+    ++HRDL   N+L+
Sbjct: 83  VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142

Query: 118 NANCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
            +   +KI DFGLAR     ET++  +   V  +W  A E +L+   +T   D+WS G  
Sbjct: 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM-ALESILH-RRFTHQSDVWSYGVT 200

Query: 174 LGEIMT 179
           + E+MT
Sbjct: 201 VWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 7/102 (6%)

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           LT      F   +  G++Y+     +HRDL   N+L+  N   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 141 TEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            +    +  RW       LN S YT   D+WS G +L EI++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 24/171 (14%)

Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQD-LTDDH 85
           + E  ++  MDH +++ +  +   P       + +V +LM    L   +  H+D +    
Sbjct: 57  MDEALIMASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQL 110

Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS--ETDFMTE- 142
              +  Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     E ++  + 
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170

Query: 143 -YVVTRWYRAPELLLNCSEY---TAAIDIWSVGCILGEIMTRQPLFPGKDY 189
             +  +W     + L C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 171 GKMPIKW-----MALECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 11/94 (11%)

Query: 96  GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRA 151
           GL ++H A+ +H DL   N  L A+  +KIGD+GLA      D+        V  RW  A
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-A 170

Query: 152 PELL------LNCSEYTAAIDIWSVGCILGEIMT 179
           PEL+      L   + T   +IWS+G  + E+ T
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 33/216 (15%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLR-HMDHENIIAIKDIIRPPQRETFNDVYI 62
           E  + VAIK + +  +     +   +   ++R  + H NI+ +  ++   Q  +    Y 
Sbjct: 33  EQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90

Query: 63  VYELMDTDLHQ--IIRS-HQDL--TDDHCR-----------YFLYQLLRGLKYVHSANVL 106
            +    +DLH+  ++RS H D+  TDD              + + Q+  G++++ S +V+
Sbjct: 91  SH----SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV 146

Query: 107 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYT 162
           H+DL   N+L+    ++KI D GL R     D+        +  RW  +PE ++   +++
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIMY-GKFS 204

Query: 163 AAIDIWSVGCILGEIMTR--QPL--FPGKDYVHQLR 194
              DIWS G +L E+ +   QP   +  +D +  +R
Sbjct: 205 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 24/81 (29%), Positives = 49/81 (60%), Gaps = 1/81 (1%)

Query: 55  ETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           ++ N+VY+V E L+  D+  ++  +    ++    ++ ++   L Y+H   ++HRDLKP 
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133

Query: 114 NLLLNANCDLKIGDFGLARTT 134
           N+L++    +K+ DFGL++ T
Sbjct: 134 NMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 38/163 (23%), Positives = 75/163 (46%), Gaps = 38/163 (23%)

Query: 59  DVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           ++Y++ E +   D+  ++     LT++  ++++ + +  +  +H    +HRD+KP NLLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134

Query: 118 NANCDLKIGDFGLA-------RT--------TSETDFMTEYVVTR-----WYR------- 150
           ++   +K+ DFGL        RT        +  +DF  + + ++     W R       
Sbjct: 135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAF 194

Query: 151 ---------APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
                    APE+ +  + Y    D WS+G I+ E++   P F
Sbjct: 195 STVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 48/210 (22%)

Query: 22  IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDVYIVYELMD----TD 70
           I A + LR+  +L      +I A +DI+             +F D   +Y +M+     D
Sbjct: 28  IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGD 87

Query: 71  LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 130
           +  ++     L+++  ++++ + +  +  +H    +HRD+KP NLLL+A   +K+ DFGL
Sbjct: 88  MMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Query: 131 A-------RT--------TSETDFMTEYVVTR-----W----------------YRAPEL 154
                   RT           +DF  + + ++     W                Y APE+
Sbjct: 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207

Query: 155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            +  + Y    D WS+G I+ E++   P F
Sbjct: 208 FMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 22/80 (27%), Positives = 46/80 (57%), Gaps = 4/80 (5%)

Query: 56  TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           +F D   +Y +M+     DL  ++  +   ++D  R+++ + +  ++ VH    +HRD+K
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128

Query: 112 PSNLLLNANCDLKIGDFGLA 131
           P N+L++    +K+ DFGL+
Sbjct: 129 PDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 151
           +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D      V   Y A
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCA 150

Query: 152 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           PE+    SE T A D WS+G IL E++T + L
Sbjct: 151 PEVG-GISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 90  LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 131
           + Q+L GL+ +H   ++HRD+KP NLL+  +  +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 14/170 (8%)

Query: 27  TLREIKLLRHMDHENIIAIK----DIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDL 81
           T  EIK LR +D  NI+ I     DI+    R     + ++ E      L +++   +DL
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPR-----LSLILEYCTRGYLREVLDKEKDL 119

Query: 82  TDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           +            +GL  ++   N  +++L   + L+  N  LKI   GL +  S   F 
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF- 178

Query: 141 TEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 189
            + V    Y + ++L +  SEYT   DI+S+G +L EI T +  F     
Sbjct: 179 -KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227

Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 46.1 bits (109), Expect = 9e-06
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 23/181 (12%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHM------DHENIIAIKDIIRPPQRETFNDVYI 62
           VAIK I +        ++T +EI    HM      DH  I+ +  I      +    +  
Sbjct: 39  VAIKTIQDR-----SGRQTFQEIT--DHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSP 91

Query: 63  VYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           +  L+D      +R H+D L       +  Q+ +G+ Y+    ++HR+L   N+LL ++ 
Sbjct: 92  LGSLLDH-----VRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS 146

Query: 122 DLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            ++I DFG+A      D   F +E+     + A E +L    YT   D+WS G  + E+M
Sbjct: 147 IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMM 205

Query: 179 T 179
           +
Sbjct: 206 S 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 20/155 (12%)

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYVHSANVLHRDLKP 112
           +I+ ELM   DL   +R ++   +      +  LL        G KY+   + +HRD+  
Sbjct: 85  FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144

Query: 113 SNLLLNANCD---LKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
            N LL         KI DFG+AR      +  +     +  +W   PE  L+   +T+  
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM-PPEAFLD-GIFTSKT 202

Query: 166 DIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITE 198
           D+WS G +L EI +    P +PG+     +  +T 
Sbjct: 203 DVWSFGVLLWEIFSLGYMP-YPGRTNQEVMEFVTG 236

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 40/133 (30%), Positives = 66/133 (49%), Gaps = 11/133 (8%)

Query: 57  FNDVYIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           F D   +Y +MD     DL  ++   +D L +D  R++L +++  +  VH    +HRD+K
Sbjct: 70  FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129

Query: 112 PSNLLLNANCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLLNCSE----YTAAI 165
           P N+LL+ N  +++ DFG  L      T      V T  Y +PE+L    +    Y    
Sbjct: 130 PDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC 189

Query: 166 DIWSVGCILGEIM 178
           D WS+G  + E++
Sbjct: 190 DWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 30/124 (24%), Positives = 55/124 (44%), Gaps = 17/124 (13%)

Query: 17  AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY---IVYELMD-TDLH 72
             D RI  +RT RE +++     +  + +  +        F D     IV E ++   L 
Sbjct: 36  ELDERIRRERTRREARIM-SRARKAGVNVPAVY-------FVDPENFIIVMEYIEGEPLK 87

Query: 73  QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 132
            +I S+     +  R     + +    +HSA ++H DL  SN++L+    + + DFGLA 
Sbjct: 88  DLINSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAE 142

Query: 133 TTSE 136
            + +
Sbjct: 143 FSKD 146

Length = 211

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 24/120 (20%), Positives = 48/120 (40%), Gaps = 17/120 (14%)

Query: 19  DNRIDAKRTLREIKLLRHMDHENIIA--IKDIIRPPQRETFNDVYIVYELMDTDLHQIIR 76
           D R+  +RT  E +LL       +    I D+      +      ++  +   DL  ++ 
Sbjct: 375 DERLRTERTRAEARLLSEARRAGVPTPVIYDV------DPEEKTIVMEYIGGKDLKDVLE 428

Query: 77  SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 136
                  +  R    ++   +  +H A ++H DL  SN ++  +  L + DFGL + +  
Sbjct: 429 G----NPELVR----KVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 28/121 (23%), Positives = 50/121 (41%), Gaps = 16/121 (13%)

Query: 18  FDNRIDAKRTLREIKLLR--HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII 75
            D RI  +RT  E +LL        N   + D+      +  N   ++  +    L  +I
Sbjct: 35  LDERIRRERTRNEARLLSRARKAGVNTPVVYDV------DPDNKTIVMEYIEGKPLKDVI 88

Query: 76  RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 135
                  D+  R     + +    +H A ++H DL  SN+++  +  L + DFGL + + 
Sbjct: 89  EE---GNDELLREIGRLVGK----LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSD 140

Query: 136 E 136
           E
Sbjct: 141 E 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 29/125 (23%), Positives = 55/125 (44%), Gaps = 26/125 (20%)

Query: 19  DNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIVYELMDTDLHQIIRS 77
           D ++  +RT RE ++L           ++  +  P         IVY++ D D   I+  
Sbjct: 38  DEKLRRERTRREARILAKA--------REAGVPVP---------IVYDV-DPDNGLIVME 79

Query: 78  H------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 131
           +      +D  ++     L ++ R +  +H A ++H DL  SN++L+    +   DFGL 
Sbjct: 80  YIEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLG 138

Query: 132 RTTSE 136
             + E
Sbjct: 139 EFSDE 143

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	316
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
PRK09188	365	serine/threonine protein kinase; Provisional	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.76
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.76
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
smart00090	237	RIO RIO-like kinase.	99.66
KOG1243	690	consensus Protein kinase [General function predict	99.63
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.6
PRK14879	211	serine/threonine protein kinase; Provisional	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.55
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.46
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.43
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.37
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.36
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.32
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.24
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.16
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.11
COG4248	637	Uncharacterized protein with protein kinase and he	99.06
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.01
PRK09902	216	hypothetical protein; Provisional	98.87
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.85
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.7
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.38
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.15
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.12
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.11
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.92
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.92
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.74
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.74
PF01636	239	APH: Phosphotransferase enzyme family This family	97.71
PLN02876	822	acyl-CoA dehydrogenase	97.65
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.41
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.39
KOG2270	520	consensus Serine/threonine protein kinase involved	97.38
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.11
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.06
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.02
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.75
PRK05231	319	homoserine kinase; Provisional	96.73
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.55
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.47
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.44
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.43
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.31
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.13
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.76
PLN02756	418	S-methyl-5-thioribose kinase	95.33
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.04
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.0
PRK06148	1013	hypothetical protein; Provisional	94.86
PTZ00384	383	choline kinase; Provisional	94.77
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.66
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.16
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.01
PRK10271	188	thiK thiamine kinase; Provisional	93.67
PRK10593	297	hypothetical protein; Provisional	93.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.22
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.01
PLN02236	344	choline kinase	92.71
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.66
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	92.13
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.13
KOG2269	531	consensus Serine/threonine protein kinase [Signal	92.04

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-61  Score=406.01  Aligned_cols=312  Identities=70%  Similarity=1.161  Sum_probs=293.5

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      .|+.||+.||||++...+.+...+++..+|+.+++.++|+||+.+++++..+..+.+..+|+|+|+++.+|.+.|+.+..
T Consensus        42 ~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~  121 (359)
T KOG0660|consen   42 KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQD  121 (359)
T ss_pred             EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCcc
Confidence            37899999999999988889999999999999999999999999999998765567788999999999999999999888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC---CCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++...++.+++||+.||.|+|+.|++|||+||.|++++.+..+|+||||+++....   ....+..+.|.||.|||++..
T Consensus       122 L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  122 LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence            99999999999999999999999999999999999999999999999999988764   455677888999999999998


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...|+.+.||||+||++.||++|++.|.+.+..+++..|....|.++........+..+..+....+..+...+...+++
T Consensus       202 ~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~  281 (359)
T KOG0660|consen  202 SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPN  281 (359)
T ss_pred             cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCC
Confidence            89999999999999999999999999999999999999999999999999888888888999999999999999999999


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP  314 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (316)
                      .++.+.+|+.+||..||.+|+|++|.|.||||..+++.+++|.|...+.. ++.. .+.+++++++.++.+.|+|..
T Consensus       282 a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-~~~~-~~~~~~r~~i~~e~~~~~~~~  356 (359)
T KOG0660|consen  282 ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-FEHE-LTEEELRELIYKEILDFHPDV  356 (359)
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc-cccc-ccHHHHHHHHHHHHHhhCccc
Confidence            99999999999999999999999999999999999999999998877765 4444 889999999999999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1e-54  Score=356.95  Aligned_cols=268  Identities=34%  Similarity=0.647  Sum_probs=236.0

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-C
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-Q   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~   79 (316)
                      +|+.||+-||||++-.+..++...+-.++|+.+|++++|+|+|.++++|...     ..+++|+|||+-++.+-++.. .
T Consensus        22 rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rklhLVFE~~dhTvL~eLe~~p~   96 (396)
T KOG0593|consen   22 RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKLHLVFEYCDHTVLHELERYPN   96 (396)
T ss_pred             ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----ceeEEEeeecchHHHHHHHhccC
Confidence            5899999999999988777777778889999999999999999999999766     459999999998887777665 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++...++.+++|++.|+.|+|+++++||||||+|||++.+|.+||||||+++... ..+.++..+.|.||+|||.+.+.
T Consensus        97 G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGD  176 (396)
T KOG0593|consen   97 GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGD  176 (396)
T ss_pred             CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhccc
Confidence            69999999999999999999999999999999999999999999999999999877 66667788999999999999998


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..|+.++|||++||++.||++|.+.|.+.++.+++-.|++.+|...+.........+...-++.....-...+...++.+
T Consensus       177 tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~  256 (396)
T KOG0593|consen  177 TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKI  256 (396)
T ss_pred             CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccc
Confidence            99999999999999999999999999999999999999999998877655444443333333333333345667788899


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +.-+.+|+++||+.||.+|++.++++.|+||.++-
T Consensus       257 s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  257 SNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             hHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            99999999999999999999999999999997654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-54  Score=368.86  Aligned_cols=243  Identities=34%  Similarity=0.554  Sum_probs=205.1

Q ss_pred             CCCCCceEEEEEecccccCh-----hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHh
Q 021181            2 NSETREEVAIKKIGNAFDNR-----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQII   75 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l   75 (316)
                      ++.||+.||||++.+.....     .....+.+|+++|++|+||+||+++++|..+     ...|+||||++ |+|.+.+
T Consensus       193 e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-----ds~YmVlE~v~GGeLfd~v  267 (475)
T KOG0615|consen  193 EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-----DSSYMVLEYVEGGELFDKV  267 (475)
T ss_pred             EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-----CceEEEEEEecCccHHHHH
Confidence            57899999999998754322     1334568999999999999999999999765     45799999996 7999999


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC---CCEEEeeeccccccCCCCccccccccccccCc
Q 021181           76 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        76 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      -.++.+.+...+.+++||+.|+.|||++||+||||||+|||++.+   ..+||+|||+++..+....+.+.|||+.|.||
T Consensus       268 v~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAP  347 (475)
T KOG0615|consen  268 VANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAP  347 (475)
T ss_pred             HhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccCh
Confidence            999999999999999999999999999999999999999999876   67999999999999988889999999999999


Q ss_pred             ccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          153 ELLLNCS--EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       153 E~~~~~~--~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      |++.+.+  .+..++|+|||||++|-+++|.+||.+.-... ..+.|.+..-..-+.                       
T Consensus       348 EVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~-----------------------  404 (475)
T KOG0615|consen  348 EVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL-----------------------  404 (475)
T ss_pred             hheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh-----------------------
Confidence            9997632  34468899999999999999999998765444 444444322221111                       


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                          ....+|++..+||.+||..||++|||++|+|+||||+.+.-.+
T Consensus       405 ----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  405 ----QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             ----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence                1136799999999999999999999999999999999776333

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-53  Score=374.51  Aligned_cols=242  Identities=34%  Similarity=0.543  Sum_probs=215.8

Q ss_pred             CCCCCceEEEEEeccc-ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..||+.||+|++.+. .......+++.+|+++.+.|+|||||+++++|.+.     ..+|||.|+|. ++|..+++..+
T Consensus        39 ~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~nVYivLELC~~~sL~el~Krrk  113 (592)
T KOG0575|consen   39 DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NNVYIVLELCHRGSLMELLKRRK  113 (592)
T ss_pred             EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----CceEEEEEecCCccHHHHHHhcC
Confidence            5689999999999874 34556778999999999999999999999999554     67999999997 89999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.+++||+.||.|||+.+|+|||||..|++++++.++||+|||++...... ....+.|||+.|+|||++.. 
T Consensus       114 ~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-  192 (592)
T KOG0575|consen  114 PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-  192 (592)
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhcc-
Confidence            9999999999999999999999999999999999999999999999999999987754 55678999999999999987 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ...+..+||||+||++|.||.|+|||+..+..++...|...--..|                               ..+
T Consensus       193 ~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P-------------------------------~~l  241 (592)
T KOG0575|consen  193 SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP-------------------------------SHL  241 (592)
T ss_pred             CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-------------------------------ccc
Confidence            7899999999999999999999999999999999988876332222                               267


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV  280 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~  280 (316)
                      |.++++||++||..||.+|||++++|.|+||++-......+.
T Consensus       242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~  283 (592)
T KOG0575|consen  242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPS  283 (592)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence            999999999999999999999999999999966554444444

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=361.97  Aligned_cols=266  Identities=39%  Similarity=0.698  Sum_probs=235.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~   79 (316)
                      .+++|+.||||+++...-.- +.-.-++|+.-|++|+ ||||+++.+++.+++    ..+|+||||++.+|.++++.+ +
T Consensus        31 ~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L~fVfE~Md~NLYqLmK~R~r  105 (538)
T KOG0661|consen   31 SKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RILYFVFEFMDCNLYQLMKDRNR  105 (538)
T ss_pred             ecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceEeeeHHhhhhhHHHHHhhcCC
Confidence            47899999999998765443 3333468999999998 999999999998664    479999999999999999865 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .|++..++.|++||+.||+++|+.|+.|||+||+|||+..+..+||+|||+++.+......+..+.|.||+|||++..+.
T Consensus       106 ~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~  185 (538)
T KOG0661|consen  106 LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSG  185 (538)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhcc
Confidence            59999999999999999999999999999999999999988899999999999999888899999999999999999889


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .|+.+.|+|++||+++|+.+-++.|.+.+..+++-+|+.++|.+....+..- .......--..+......+....+..+
T Consensus       186 ~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-~~La~~mnf~~P~~~~~~l~~L~p~~s  264 (538)
T KOG0661|consen  186 YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-YNLASAMNFRFPQVKPSPLKDLLPNAS  264 (538)
T ss_pred             ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-HHHHHHhccCCCcCCCCChHHhCcccC
Confidence            9999999999999999999999999999999999999999999988776542 222333334455566667777888899


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .++.++|.+||.|||.+||||+++|+||||+.-.
T Consensus       265 ~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  265 SEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            9999999999999999999999999999998765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-52  Score=351.77  Aligned_cols=241  Identities=27%  Similarity=0.443  Sum_probs=205.5

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +|+.|++-+|+|.+... .+....+++.+|+++++.++|||||++||.|..+.    ..++|+||||+ |+|.++++..+
T Consensus        99 ~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~isI~mEYMDgGSLd~~~k~~g  173 (364)
T KOG0581|consen   99 RHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEISICMEYMDGGSLDDILKRVG  173 (364)
T ss_pred             EEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceEEeehhhcCCCCHHHHHhhcC
Confidence            36889999999999544 45667789999999999999999999999997653    15999999997 79999999889


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++++..+..++.+|+.||.||| +.+|+||||||+|+|++..|++||||||.+...... ...++.||..|||||.+.+ 
T Consensus       174 ~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g-  251 (364)
T KOG0581|consen  174 RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG-  251 (364)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcC-
Confidence            9999999999999999999999 599999999999999999999999999999887665 5678999999999999998 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGK--DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ..|+.++||||||++++|+.+|+.||...  ........+......+++..                        +.  .
T Consensus       252 ~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l------------------------P~--~  305 (364)
T KOG0581|consen  252 ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL------------------------PE--G  305 (364)
T ss_pred             CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC------------------------Cc--c
Confidence            78999999999999999999999999774  22233333333333222211                        00  0


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      .+|+++++||..||++||.+|||++||++|||+++...
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            37999999999999999999999999999999998653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.3e-50  Score=324.85  Aligned_cols=269  Identities=41%  Similarity=0.683  Sum_probs=235.9

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-C
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-Q   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~   79 (316)
                      +|.+||+.||||+++.....+......++|+..|+.++|+||+.++++|.+.     ..+.||+||++.+|...|+.. .
T Consensus        22 ~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l~lVfEfm~tdLe~vIkd~~i   96 (318)
T KOG0659|consen   22 RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNLSLVFEFMPTDLEVVIKDKNI   96 (318)
T ss_pred             EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----CceEEEEEeccccHHHHhccccc
Confidence            4789999999999988755555567789999999999999999999999654     559999999999999999865 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  158 (316)
                      .++..+++.|+.+++.||+|||++.|.|||+||.|+|++.+|.+||+|||+++..+.... ....+-|.||+|||.+.++
T Consensus        97 ~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGs  176 (318)
T KOG0659|consen   97 ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGS  176 (318)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccc
Confidence            589999999999999999999999999999999999999999999999999998775543 3334789999999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..|+..+|+||.||++.||+.|.|.|.+.++.+++..|...+|+|.+..|+.+..-++-.-.+   ..+.......++..
T Consensus       177 r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~---~~P~~~~~~lf~aa  253 (318)
T KOG0659|consen  177 RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ---QFPKPPLNNLFPAA  253 (318)
T ss_pred             hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh---cCCCCccccccccc
Confidence            999999999999999999999999999999999999999999999999888766544332222   33444455588899


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      +.++.+|+.+||..||.+|+++.|+|+|+||++....+.
T Consensus       254 s~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~  292 (318)
T KOG0659|consen  254 SSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP  292 (318)
T ss_pred             cHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence            999999999999999999999999999999998665544

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-49  Score=351.88  Aligned_cols=311  Identities=52%  Similarity=0.951  Sum_probs=247.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |+.+|+.||||++............+.+|+.+++.++||||+++++++..........+|+||||++++|.+++.....+
T Consensus        21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~  100 (338)
T cd07859          21 DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL  100 (338)
T ss_pred             ECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccC
Confidence            56789999999997654444556678899999999999999999999875543444578999999999999999888889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----ccccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......    ......++..|+|||++.+
T Consensus       101 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  180 (338)
T cd07859         101 TPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS  180 (338)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc
Confidence            999999999999999999999999999999999999999999999999987543221    1134568899999999864


Q ss_pred             C-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 C-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      . ..++.++|||||||++|+|++|++||.+.+.......+....+.++..............+...........+...++
T Consensus       181 ~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  260 (338)
T cd07859         181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP  260 (338)
T ss_pred             cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcC
Confidence            2 467899999999999999999999999988777777777777776655444433333334444444333344455566


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC--CcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRP--FSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+++.+.++|.+||+.||++|||++|+++||||+++......+.....  ....+....++.+.++..+.++.+..+|
T Consensus       261 ~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         261 NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP  338 (338)
T ss_pred             CCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhcCHHHHHHHHHHHHHhcCC
Confidence            788999999999999999999999999999999988765543332222  2223344458888999999999888776

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-50  Score=347.59  Aligned_cols=266  Identities=39%  Similarity=0.632  Sum_probs=228.4

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-C
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-Q   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~   79 (316)
                      +|.+||+-||+|+++.+...+....-..+||.+|++|+||||+++.++.....   ...+|+|+|||+.+|..++... -
T Consensus       137 r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~siYlVFeYMdhDL~GLl~~p~v  213 (560)
T KOG0600|consen  137 RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGSIYLVFEYMDHDLSGLLSSPGV  213 (560)
T ss_pred             eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---CceEEEEEecccchhhhhhcCCCc
Confidence            57899999999999887555555667789999999999999999999987652   2679999999999999998773 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC--CCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE--TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .|++.+++.++.||+.||.|||++||.|||||.+|||+|.+|.+||+|||++++...  ...++..+-|.||+|||++.+
T Consensus       214 kft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG  293 (560)
T KOG0600|consen  214 KFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG  293 (560)
T ss_pred             ccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcC
Confidence            799999999999999999999999999999999999999999999999999996443  335677888999999999999


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...|+.++|+||.|||+.||+.|++.|++.+..+++..|.++.|++.+..|....-. ........ ..-...+.+.+..
T Consensus       294 ~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP-~~~~~kp~-~~y~r~l~E~~~~  371 (560)
T KOG0600|consen  294 ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP-HATIFKPQ-QPYKRRLRETFKD  371 (560)
T ss_pred             CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC-cccccCCC-CcccchHHHHhcc
Confidence            999999999999999999999999999999999999999999999999887622111 11111111 1113345566778


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ++....+|+..||..||.+|.||.+.|+++||..
T Consensus       372 ~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  372 FPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            9999999999999999999999999999999943

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-50  Score=338.69  Aligned_cols=236  Identities=28%  Similarity=0.480  Sum_probs=209.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      .+.||+-||+|++++... ...+......|..+|..++||+||+++..|++.     +.+|+|+||+. |.|+-.|++.+
T Consensus        46 k~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-----~kLylVld~~~GGeLf~hL~~eg  120 (357)
T KOG0598|consen   46 KKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-----EKLYLVLDYLNGGELFYHLQREG  120 (357)
T ss_pred             EcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-----CeEEEEEeccCCccHHHHHHhcC
Confidence            457999999999988654 334678889999999999999999999999665     56999999995 79999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccccc-CCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.+|+.||.|||++||+||||||+|||+|..|.++|+|||+++.. .......+.+||+.|+|||++.+ 
T Consensus       121 ~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~-  199 (357)
T KOG0598|consen  121 RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG-  199 (357)
T ss_pred             CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhc-
Confidence            9999999999999999999999999999999999999999999999999999864 44455667899999999999998 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|+||||+++|+|++|.+||.+.+...+.+.|.+......+                              ...
T Consensus       200 ~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p------------------------------~~l  249 (357)
T KOG0598|consen  200 KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP------------------------------GYL  249 (357)
T ss_pred             CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC------------------------------ccC
Confidence            78999999999999999999999999999988888887663311111                              137


Q ss_pred             ChHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp----s~~ell~~~~f~~~~  273 (316)
                      +.+++++|+++|..||++|.    ++.++-+||||+.++
T Consensus       250 s~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  250 SEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             CHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            88999999999999999996    688999999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.8e-49  Score=326.19  Aligned_cols=269  Identities=38%  Similarity=0.645  Sum_probs=230.5

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC-
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-   79 (316)
                      +|+.|++-||+|+++.+.....---..++||.+|.+++|||||.+-++..-...   ..+|+|||||+.+|..++..-+ 
T Consensus        96 kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~iy~VMe~~EhDLksl~d~m~q  172 (419)
T KOG0663|consen   96 KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DKIYIVMEYVEHDLKSLMETMKQ  172 (419)
T ss_pred             ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ceeeeeHHHHHhhHHHHHHhccC
Confidence            589999999999998865333333445799999999999999999999875433   5699999999999999998765 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++...+++.++.|++.|++|||+..|+|||||++|+|++..|.+|++|||+++..+.. ..++..+-|.||+|||++.+.
T Consensus       173 ~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~  252 (419)
T KOG0663|consen  173 PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGA  252 (419)
T ss_pred             CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCC
Confidence            8999999999999999999999999999999999999999999999999999987655 446677889999999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC-
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN-  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (316)
                      ..|+.+.|+||+||++.||+++++.|.+....+++..|.+.+|.+...-|+.+..-+..... ..+..+...+...++. 
T Consensus       253 ~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~-~f~~~pyn~lr~kF~~~  331 (419)
T KOG0663|consen  253 KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM-TFSEHPYNNLRKKFGAL  331 (419)
T ss_pred             cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc-ccCCCCchhhhhhcccc
Confidence            99999999999999999999999999999999999999999999999888776655443311 1122223333444444 


Q ss_pred             -CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 -KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 -~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                       +++...+|+..+|..||.+|.||+|.|+|.||.+..
T Consensus       332 ~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  332 SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence             459999999999999999999999999999999854

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-49  Score=345.72  Aligned_cols=236  Identities=30%  Similarity=0.492  Sum_probs=209.6

Q ss_pred             CCCCCCceEEEEEecccccChhHH-HHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~-~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +++.|++.||||++.+...-+... ..+..|-.+|.+| .||+|+++|-.|.+.     ..+|+|+||+. |+|.++|.+
T Consensus        93 ~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-----~sLYFvLe~A~nGdll~~i~K  167 (604)
T KOG0592|consen   93 REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-----ESLYFVLEYAPNGDLLDLIKK  167 (604)
T ss_pred             eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-----cceEEEEEecCCCcHHHHHHH
Confidence            367899999999998765444433 5567899999999 899999999999765     56999999996 899999999


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--------------ccccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--------------FMTEY  143 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--------------~~~~~  143 (316)
                      .+.|++..++.++.||+.||+|||++||+||||||+|||+|++|+++|+|||.++.+....              ....+
T Consensus       168 ~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SF  247 (604)
T KOG0592|consen  168 YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSF  247 (604)
T ss_pred             hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccce
Confidence            9999999999999999999999999999999999999999999999999999987764321              11458


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      +||..|++||++.. +..++++|+|+|||++|+|+.|.+||.+.+.-.+.++|..+.-..+                   
T Consensus       248 VGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp-------------------  307 (604)
T KOG0592|consen  248 VGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP-------------------  307 (604)
T ss_pred             eeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC-------------------
Confidence            99999999999987 7889999999999999999999999999999888888887554433                   


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                  ++.++.+.+||+++|..||.+|+|+++|.+||||.+++
T Consensus       308 ------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  308 ------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             ------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                        36788999999999999999999999999999999987

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-49  Score=334.39  Aligned_cols=303  Identities=35%  Similarity=0.593  Sum_probs=240.7

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc----C
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS----H   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~----~   78 (316)
                      .++++.||||++-.+..      .--+|+++|+.+.|||||++.-+|......+.-...+||||++.+|.+.++.    +
T Consensus        46 ~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~  119 (364)
T KOG0658|consen   46 RETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRAN  119 (364)
T ss_pred             cCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcC
Confidence            46789999999854422      1238999999999999999998887654222346778999999999999984    5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..++...++.+.+||++||+|||+.||+||||||+|+|+|.+ |.+||||||.++.........+...+..|+|||.+.+
T Consensus       120 ~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifg  199 (364)
T KOG0658|consen  120 QRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG  199 (364)
T ss_pred             CCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcC
Confidence            789999999999999999999999999999999999999977 8999999999999888888888899999999999999


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc-cCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA-RFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  236 (316)
                      ...|+.+.||||.||++.||+.|++.|.+.+..+++..|.+.+|.+....+......-.   ....+......+.. ...
T Consensus       200 a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~---~~~~p~ik~~~~~~~~~~  276 (364)
T KOG0658|consen  200 ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT---EFKFPQIKAHPWHKVFFK  276 (364)
T ss_pred             ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc---cccCcccccccceeeccc
Confidence            99999999999999999999999999999999999999999999998766544332211   11111222222223 445


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC----CCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPR----PFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      ..++++.+|+.++|..+|.+|.++.|++.||||..+.+..-.-.+-.    -|.+.-.....+.+-++.++..+...+++
T Consensus       277 ~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~  356 (364)
T KOG0658|consen  277 RLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRAELGISPELVNVLIPEHLREQEK  356 (364)
T ss_pred             CCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHHHhccchHHHHhhccHhhhhhcc
Confidence            78999999999999999999999999999999999886532222111    12211122224445567777777777776


Q ss_pred             CC
Q 021181          313 DP  314 (316)
Q Consensus       313 ~~  314 (316)
                      +.
T Consensus       357 ~~  358 (364)
T KOG0658|consen  357 DK  358 (364)
T ss_pred             cc
Confidence            64

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-49  Score=350.75  Aligned_cols=241  Identities=29%  Similarity=0.452  Sum_probs=218.7

Q ss_pred             CCCCCceEEEEEeccc-ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |.+||+.+|||++.+. ...+.....+.+|+.+|+.+.|||++++|+++..     ..++|+|.||++ |.|++++...+
T Consensus        33 h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-----~~~lylvlEyv~gGELFdylv~kG  107 (786)
T KOG0588|consen   33 HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-----KQHLYLVLEYVPGGELFDYLVRKG  107 (786)
T ss_pred             cccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-----CceEEEEEEecCCchhHHHHHhhC
Confidence            6789999999999876 4455566788999999999999999999999954     467999999995 89999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++++.++.+++.||+.|+.|+|..+|+|||+||+|+|+|.++++||+|||++.....+....+.||++.|.+||++.+..
T Consensus       108 ~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~p  187 (786)
T KOG0588|consen  108 PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRP  187 (786)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCC
Confidence            99999999999999999999999999999999999999999999999999999988888888999999999999999977


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++||||.||++|.||+|..||++.+....+.+++......+                               ..+|
T Consensus       188 YdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP-------------------------------s~Is  236 (786)
T KOG0588|consen  188 YDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP-------------------------------SNIS  236 (786)
T ss_pred             CCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC-------------------------------CcCC
Confidence            778999999999999999999999998888888877776444333                               3689


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE  278 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~  278 (316)
                      .++++||++||..||++|.|.+||++|||++........
T Consensus       237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            999999999999999999999999999999998765554

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-47  Score=323.71  Aligned_cols=274  Identities=39%  Similarity=0.718  Sum_probs=233.4

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC-ccceeeeecCCC-CCCCCeEEEEEecCCCcHHHHhhcC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      +++.||+.||+|+++.....+..-....+|+.+++.++|+| |+.+++++.... .+....+++|+||++.+|..++...
T Consensus        31 r~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~  110 (323)
T KOG0594|consen   31 RSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSL  110 (323)
T ss_pred             EEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhc
Confidence            46789999999999876544333456789999999999999 999999997543 1233479999999999999999876


Q ss_pred             C----CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcc
Q 021181           79 Q----DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        79 ~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE  153 (316)
                      +    .++...++.+++||+.||+|||+.+|+||||||+|++++.+|.+||+|||+++..+. .......+.|.+|+|||
T Consensus       111 ~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPE  190 (323)
T KOG0594|consen  111 PKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPE  190 (323)
T ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHH
Confidence            5    578889999999999999999999999999999999999999999999999988763 34467788999999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC-CCCcc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNFS  232 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  232 (316)
                      ++.++..|+...||||+||+++||+++++.|.+....+++..|-..+|.+....|+..........  ..+.+. ...+.
T Consensus       191 vLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~  268 (323)
T KOG0594|consen  191 VLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLS  268 (323)
T ss_pred             HhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc--cCcCCCCccchH
Confidence            999988999999999999999999999999999999999999999999999998877655444333  333333 34445


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      ...+..+++..+++.+||+.+|.+|.|++.+|.||||.+.....
T Consensus       269 ~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  269 SILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             HhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            55566778999999999999999999999999999999876433

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-47  Score=337.50  Aligned_cols=311  Identities=78%  Similarity=1.291  Sum_probs=262.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |..+|+.||||.+............+..|+.+++.++|+||+++++++.....+.....|+++||++++|.+++...+.+
T Consensus        26 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l  105 (337)
T cd07858          26 NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTL  105 (337)
T ss_pred             ecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCC
Confidence            56789999999997654444455677889999999999999999998875543444568999999999999999888889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      ++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.....
T Consensus       106 ~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  185 (337)
T cd07858         106 SDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE  185 (337)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCC
Confidence            99999999999999999999999999999999999999999999999998765433 22334467888999999875456


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|+|||||++|+|++|.+||.+.+.......+....+.+....+..........+.......+...+....+.+++
T Consensus       186 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (337)
T cd07858         186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANP  265 (337)
T ss_pred             CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCH
Confidence            88999999999999999999999998887777777777777776655544444444445544444444444555678899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+.++|++||+.||++|||++++++||||..+.+....+.++.+++.+++.-+++.+++.+++..+-+.+.|
T Consensus       266 ~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (337)
T cd07858         266 LAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP  337 (337)
T ss_pred             HHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhcCHHHHHHHHHHHHhhcCC
Confidence            999999999999999999999999999999999999999999999999999999999999999998887765

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-48  Score=315.92  Aligned_cols=234  Identities=26%  Similarity=0.448  Sum_probs=208.6

Q ss_pred             CCCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            1 MNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +++.+|..||+|++++... .-...+....|..+|+.+.||+++++++.+.+.     ..+|+||||++ |.|+.++++.
T Consensus        64 r~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~~lymvmeyv~GGElFS~Lrk~  138 (355)
T KOG0616|consen   64 REKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----SNLYMVMEYVPGGELFSYLRKS  138 (355)
T ss_pred             EEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----CeEEEEEeccCCccHHHHHHhc
Confidence            4678999999999976532 233456677899999999999999999999765     56999999996 7999999999


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++++..++.++.||+.||+|||+++|++||+||+|||+|++|.+||+|||.++.....  ..+.|||+.|+|||++.+ 
T Consensus       139 ~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s-  215 (355)
T KOG0616|consen  139 GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-  215 (355)
T ss_pred             CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhc-
Confidence            99999999999999999999999999999999999999999999999999999988765  567899999999999988 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ++++.++|.|+||+++|||+.|.+||...+...+...|....-..|                               +..
T Consensus       216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP-------------------------------~~f  264 (355)
T KOG0616|consen  216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP-------------------------------SYF  264 (355)
T ss_pred             CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC-------------------------------ccc
Confidence            8899999999999999999999999999998888888766433322                               257


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +.++++||+++|+.|-.+|.     ...+|.+||||+++.
T Consensus       265 s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  265 SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence            89999999999999999994     678999999999887

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=338.61  Aligned_cols=234  Identities=35%  Similarity=0.522  Sum_probs=203.6

Q ss_pred             CCCCCceEEEEEecccccC---hhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDN---RIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      +..||..||+|++......   ......+.+|+.++++++ ||||+++++++...     ..+|+|||||. |+|++.+.
T Consensus        38 ~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-----~~~~ivmEy~~gGdL~~~i~  112 (370)
T KOG0583|consen   38 HRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-----TKIYIVMEYCSGGDLFDYIV  112 (370)
T ss_pred             eccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-----CeEEEEEEecCCccHHHHHH
Confidence            5678999999988765222   123466778999999998 99999999999655     45999999996 69999999


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeecccccc-CCCCccccccccccccCccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE~  154 (316)
                      ..+++.+.+++.++.||+.|++|||+.||+||||||+|++++.+ +++||+|||++... .........+|++.|+|||+
T Consensus       113 ~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEv  192 (370)
T KOG0583|consen  113 NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEV  192 (370)
T ss_pred             HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHH
Confidence            99999999999999999999999999999999999999999999 99999999999988 56677788999999999999


Q ss_pred             ccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~-~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.+.. ..+.++||||+|+++|.|++|+.||...+...+...|....-..+                             
T Consensus       193 l~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p-----------------------------  243 (370)
T KOG0583|consen  193 LSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP-----------------------------  243 (370)
T ss_pred             hCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC-----------------------------
Confidence            98855 446999999999999999999999999877777766543221111                             


Q ss_pred             cCCCC-ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          234 RFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       234 ~~~~~-s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                        ..+ |+++..+|++||..||.+|+++.+++.||||+.
T Consensus       244 --~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  244 --SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence              134 899999999999999999999999999999997

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=320.45  Aligned_cols=239  Identities=32%  Similarity=0.492  Sum_probs=209.7

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +++.+|..||||.+.+........+-+..|+.+|+.++|||||.+++++..+     ..+|+|||||+ |+|.++|+..+
T Consensus        30 ~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~i~lVMEyC~gGDLs~yi~~~~  104 (429)
T KOG0595|consen   30 RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DFIYLVMEYCNGGDLSDYIRRRG  104 (429)
T ss_pred             EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----CeEEEEEEeCCCCCHHHHHHHcC
Confidence            3578899999999987766777788889999999999999999999999665     46999999996 89999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC------CCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                      .+++..++.++.||+.||++||+++|+||||||+|||++..      ..+||.|||+++.........+.+|++.|||||
T Consensus       105 ~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPE  184 (429)
T KOG0595|consen  105 RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPE  184 (429)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHH
Confidence            99999999999999999999999999999999999999875      458999999999998887778899999999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      ++.. ..|+.++|+||+|+++|++++|++||......+....+.+.....+...                          
T Consensus       185 V~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~--------------------------  237 (429)
T KOG0595|consen  185 VIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP--------------------------  237 (429)
T ss_pred             HHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh--------------------------
Confidence            9987 7899999999999999999999999999988888776655433222111                          


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                        ...+..+.+++...|+.+|..|-+..+-+.|++...-.
T Consensus       238 --~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  238 --AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             --hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence              13566678999999999999999999999999887644

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-45  Score=328.55  Aligned_cols=307  Identities=48%  Similarity=0.914  Sum_probs=242.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+++.||||++............+.+|+.+++.++||||+++++++..... ......|+++++++++|.+++.. ..
T Consensus        36 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~  114 (343)
T cd07878          36 DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QK  114 (343)
T ss_pred             ECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc-CC
Confidence            56789999999997654444455677899999999999999999998864321 23356899999999999887754 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......  .....++..|+|||++.+...
T Consensus       115 l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~  192 (343)
T cd07878         115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMH  192 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCcc
Confidence            999999999999999999999999999999999999999999999999998765433  234568899999999877567


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|..||.+.+..+.+..+....+.+...............+....+..+...+...+...++
T Consensus       193 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (343)
T cd07878         193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANP  272 (343)
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCH
Confidence            88999999999999999999999999888888888877777665544443333444444444555555555555667788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+.++|.+||+.||.+|||+.|+++||||.++......+.. .+....-.....+..++++....+...|.|
T Consensus       273 ~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07878         273 LAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEA-EPYDESPENKERTIEEWKELTYEEVSSFKP  343 (343)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcccccc-CccccchhhhhccHHHHHHHHHHHHHhcCC
Confidence            89999999999999999999999999999988765543322 223222223346667788888887777766

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.8e-45  Score=329.72  Aligned_cols=308  Identities=43%  Similarity=0.739  Sum_probs=235.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |..+|+.||||++.....+......+.+|+.+++.++|+||+++++++...........|+||||++++|.+.+.....+
T Consensus        21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l  100 (372)
T cd07853          21 DPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL  100 (372)
T ss_pred             ECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCC
Confidence            56789999999997654444556778899999999999999999999976543334478999999999999999888889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+..
T Consensus       101 ~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  180 (372)
T cd07853         101 SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR  180 (372)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCC
Confidence            999999999999999999999999999999999999999999999999987643322  223345688999999988756


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC--CCccccCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK--QNFSARFPN  237 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  237 (316)
                      .++.++||||+||++|+|++|++||.+.+....+..+....+.+.......... ............+.  .........
T Consensus       181 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  259 (372)
T cd07853         181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAHILRGPHKPPSLPVLYTLSSQ  259 (372)
T ss_pred             CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HHHHHHHhCCCCCCchHHhcccCCC
Confidence            688999999999999999999999999998888888888887766533221111 11111111111110  011122345


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC--------------------CCCCCCCCCCCcccCCCCCCCHH
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD--------------------INEEPVCPRPFSFDFEHPSFTEE  297 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~  297 (316)
                      .++++.+||.+||+.||.+|||++|+++||||++..-                    ...++....+++.++..+..+..
T Consensus       260 ~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (372)
T cd07853         260 ATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVR  339 (372)
T ss_pred             CCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCcccCCCCCCCCCcccccccCCHH
Confidence            6889999999999999999999999999999998431                    12233344455556666666767


Q ss_pred             HHHHHHHHHHHhc
Q 021181          298 NIKELIYRESVKF  310 (316)
Q Consensus       298 ~~~~~~~~~~~~~  310 (316)
                      .+++.+......+
T Consensus       340 ~~~~~~~~~~~~~  352 (372)
T cd07853         340 QVKEELHQFILEQ  352 (372)
T ss_pred             HHHHHHHHHHHHh
Confidence            7777776655444

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=332.82  Aligned_cols=233  Identities=29%  Similarity=0.521  Sum_probs=200.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||||++.....  ...+.+..|+.+|+..+|+|||.+++.|...     ..+|+||||++ |+|.+.+.. -.
T Consensus       294 ~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWVVMEym~ggsLTDvVt~-~~  365 (550)
T KOG0578|consen  294 KISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWVVMEYMEGGSLTDVVTK-TR  365 (550)
T ss_pred             eccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEEEEeecCCCchhhhhhc-cc
Confidence            457889999999976543  3456689999999999999999999999865     45999999996 688888765 45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+.... .+...+||++|+|||+... +
T Consensus       366 ~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k  444 (550)
T KOG0578|consen  366 MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-K  444 (550)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh-c
Confidence            9999999999999999999999999999999999999999999999999998876654 5677899999999999987 8


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .|++++||||||++++||+.|++||-..+....+..|..- |.+...                           ....+|
T Consensus       445 ~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk---------------------------~~~klS  496 (550)
T KOG0578|consen  445 PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK---------------------------NPEKLS  496 (550)
T ss_pred             ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC---------------------------CccccC
Confidence            8999999999999999999999999887766666555432 222211                           113689


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +.+++||.+||+.|+.+|+++.|||+||||+.
T Consensus       497 ~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  497 PELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            99999999999999999999999999999954

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.7e-46  Score=329.52  Aligned_cols=302  Identities=60%  Similarity=1.041  Sum_probs=249.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      ++.+|+.||+|++............+.+|+.++++++||||+++++++.... .....+++||||++|+|.+++...+.+
T Consensus        26 ~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~  104 (334)
T cd07855          26 DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDVYVVMDLMESDLHHIIHSDQPL  104 (334)
T ss_pred             EcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceEEEEEehhhhhHHHHhccCCCC
Confidence            5678999999999765444445677788999999999999999999886543 334578999999999999999888889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~  156 (316)
                      ++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........     .....++..|+|||.+.
T Consensus       105 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (334)
T cd07855         105 TEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL  184 (334)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhc
Confidence            9999999999999999999999999999999999999999999999998866433211     12346788999999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +...++.++|||||||++|+|++|++||.+.+....+..+....|.++..........................+....+
T Consensus       185 ~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (334)
T cd07855         185 SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFP  264 (334)
T ss_pred             CCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcc
Confidence            65668899999999999999999999999988888888888888877665544433333333333333333333344456


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHH
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY  304 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (316)
                      ..+.++.++|++||+.||.+||++++++.||||.+.......+.+..+++.++..-+++.|...+.|.
T Consensus       265 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (334)
T cd07855         265 KASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLKEAIV  332 (334)
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhhhhcChhhHHHHhh
Confidence            78999999999999999999999999999999999999999999999999999999899988777664

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=317.75  Aligned_cols=245  Identities=24%  Similarity=0.358  Sum_probs=202.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--C
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--Q   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~   79 (316)
                      .-+++.||||++..+..+.. .+.+++|+..++.++||||++++-.|...     ..+|+||+|+. |++.++++..  .
T Consensus        48 ~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~LWvVmpfMa~GS~ldIik~~~~~  121 (516)
T KOG0582|consen   48 IPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SELWVVMPFMAGGSLLDIIKTYYPD  121 (516)
T ss_pred             cccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec-----ceeEEeehhhcCCcHHHHHHHHccc
Confidence            45789999999988765554 78899999999999999999999999765     56999999996 8999999764  4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----c-ccccccccccCccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----M-TEYVVTRWYRAPEL  154 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~-~~~~~~~~~~aPE~  154 (316)
                      ++++..+..|+++++.||.|||++|.+|||||+.|||++.+|.++|+|||.+..+.....    . ....++++|+|||+
T Consensus       122 Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEv  201 (516)
T KOG0582|consen  122 GLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEV  201 (516)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHH
Confidence            599999999999999999999999999999999999999999999999998766543322    1 45689999999999


Q ss_pred             -ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 -LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 -~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                       ......|+.++||||||++..||.+|..||.......++.  .++.+.++-......+                   .+
T Consensus       202 l~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp~~~t~~~~-------------------~d  260 (516)
T KOG0582|consen  202 LMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQNDPPTLLTSGLD-------------------KD  260 (516)
T ss_pred             hhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcCCCCCcccccCC-------------------hH
Confidence             4445679999999999999999999999998887665543  4444444422111100                   11


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ....++..++++|..||+.||++|||++++|+|+||++...
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            22346778999999999999999999999999999998873

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.7e-45  Score=318.58  Aligned_cols=260  Identities=37%  Similarity=0.704  Sum_probs=209.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-D   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~   80 (316)
                      ++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++...     ...++||||++|+|.+++...+ .
T Consensus        26 ~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~   99 (288)
T cd07871          26 SKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCLTLVFEYLDSDLKQYLDNCGNL   99 (288)
T ss_pred             ECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEEEEEeCCCcCHHHHHHhcCCC
Confidence            467899999999975432 22334577899999999999999999998654     4689999999999999887644 4


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..
T Consensus       100 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (288)
T cd07871         100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST  179 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCc
Confidence            7899999999999999999999999999999999999999999999999987643322 223456788999999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh-CCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (316)
                      .++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....++......  .+... .+...........+.+
T Consensus       180 ~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  257 (288)
T cd07871         180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE--EFRSYLFPQYRAQPLINHAPRL  257 (288)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch--hhhccccCccCCCchHHhCCCC
Confidence            78999999999999999999999999988888888888888877776554432211  11111 1111122223334567


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +.++.++|++||++||.+|||++|+++||||
T Consensus       258 ~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         258 DTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-46  Score=304.68  Aligned_cols=243  Identities=31%  Similarity=0.516  Sum_probs=209.4

Q ss_pred             CCCCCceEEEEEeccccc---C---hhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHH
Q 021181            2 NSETREEVAIKKIGNAFD---N---RIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~---~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~   73 (316)
                      +++||+.+|+|++.....   +   ..-.+...+|+.+|+++ .||+|+++.++|..+     ..+++|+|.|. |.|++
T Consensus        38 ~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~-----sF~FlVFdl~prGELFD  112 (411)
T KOG0599|consen   38 HKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD-----AFVFLVFDLMPRGELFD  112 (411)
T ss_pred             hcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-----chhhhhhhhcccchHHH
Confidence            678999999999965321   1   11235557899999999 699999999999544     56999999997 99999


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                      ++.+.-.+++.+.+++++|+++|+.|||..+|+||||||+|||++++.+++|+|||++............+||++|+|||
T Consensus       113 yLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPE  192 (411)
T KOG0599|consen  113 YLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPE  192 (411)
T ss_pred             HhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChh
Confidence            99998899999999999999999999999999999999999999999999999999999998888888899999999999


Q ss_pred             cccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          154 LLLN-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       154 ~~~~-----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      .+..     ...|+..+|+|+.|++||.|+.|.+||-......++..|....-++....|                    
T Consensus       193 tikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW--------------------  252 (411)
T KOG0599|consen  193 TIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW--------------------  252 (411)
T ss_pred             heeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch--------------------
Confidence            9753     356888999999999999999999999888777777777665444332222                    


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                             .++|...++||++||+.||++|.|++|+|.||||.++-..+
T Consensus       253 -------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  253 -------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             -------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence                   36788999999999999999999999999999997765333

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=300.18  Aligned_cols=239  Identities=30%  Similarity=0.486  Sum_probs=207.9

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++..||+.+|+|++........+.+++.+|+.+-+.|+||||+++.+.+...     +..|+|+|+++ ++|..-|-.+-
T Consensus        31 ~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~~ylvFe~m~G~dl~~eIV~R~  105 (355)
T KOG0033|consen   31 VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVARE  105 (355)
T ss_pred             HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----ceeEEEEecccchHHHHHHHHHH
Confidence            4678999999999987766667889999999999999999999999988554     45899999996 58876665556


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC---CCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      -+++..+-.++.||++||.|+|.+||+|||+||+|+++-+.   .-+||+|||++...+.........|++.|+|||++.
T Consensus       106 ~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr  185 (355)
T KOG0033|consen  106 FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK  185 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh
Confidence            78999999999999999999999999999999999999543   459999999999888555556788999999999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      . .+++..+|||+-|+++|-|+.|.+||.+.+.....+.|.+..-..+...                           .+
T Consensus       186 k-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~---------------------------w~  237 (355)
T KOG0033|consen  186 K-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE---------------------------WD  237 (355)
T ss_pred             c-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc---------------------------cC
Confidence            8 8899999999999999999999999999888888888776444333222                           24


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      .+++++++||++||..||.+|.|+.|.|+|||+.+-
T Consensus       238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  238 TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            789999999999999999999999999999999864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.3e-46  Score=328.38  Aligned_cols=239  Identities=34%  Similarity=0.538  Sum_probs=214.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      -+.|++.||+|.+.+....+.+...+.+|+++++.++||||+.+++.|     ++..++|+|+|||.|+|+.++...+.+
T Consensus        23 rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~vVte~a~g~L~~il~~d~~l   97 (808)
T KOG0597|consen   23 RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLWVVTEYAVGDLFTILEQDGKL   97 (808)
T ss_pred             cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEEEEehhhhhhHHHHHHhccCC
Confidence            467899999999998888888889999999999999999999999999     555789999999999999999999999


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.++.++++++.||.|||+.+|.|+|+||+||+++.+|.+|+||||+++.++.... .....||+.|+|||+..+ ++
T Consensus        98 pEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-~p  176 (808)
T KOG0597|consen   98 PEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-QP  176 (808)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcC-CC
Confidence            9999999999999999999999999999999999999999999999999999877654 346779999999999987 89


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      |+..+|+|||||++||++.|+|||.........+.|.+--..++                               ...|.
T Consensus       177 yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p-------------------------------~~~S~  225 (808)
T KOG0597|consen  177 YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP-------------------------------STASS  225 (808)
T ss_pred             ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc-------------------------------ccccH
Confidence            99999999999999999999999988877777776654222111                               25688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      .+.+|++.+|.+||..|.+-.+++.|||.++--..-+
T Consensus       226 ~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~  262 (808)
T KOG0597|consen  226 SFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAE  262 (808)
T ss_pred             HHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhc
Confidence            8999999999999999999999999999987654333

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.5e-45  Score=320.78  Aligned_cols=237  Identities=25%  Similarity=0.427  Sum_probs=203.4

Q ss_pred             CCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            3 SETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +.||+.||+|+++++. ........++.|-.+|....+|.||++|-.|.+.     ..+||||||++ |++..+|.+.+.
T Consensus       163 k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-----~~LYLiMEylPGGD~mTLL~~~~~  237 (550)
T KOG0605|consen  163 KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-----EYLYLIMEYLPGGDMMTLLMRKDT  237 (550)
T ss_pred             ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----CeeEEEEEecCCccHHHHHHhcCc
Confidence            5799999999998753 3445567788999999999999999999999766     56999999995 799999999999


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC----------------------C-
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE----------------------T-  137 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~----------------------~-  137 (316)
                      +++..++.++.+++.|+..+|+.|++||||||+|+|+|..|.+||+|||++.....                      . 
T Consensus       238 L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (550)
T KOG0605|consen  238 LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSD  317 (550)
T ss_pred             CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcc
Confidence            99999999999999999999999999999999999999999999999999843211                      0 


Q ss_pred             Cc-------------------------cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 021181          138 DF-------------------------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ  192 (316)
Q Consensus       138 ~~-------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~  192 (316)
                      ..                         ....+||+-|+|||++.+ ..|+..+|+||||||+||||.|.+||.+.+..++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T  396 (550)
T KOG0605|consen  318 FPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET  396 (550)
T ss_pred             ccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            00                         012468999999999999 7799999999999999999999999999999999


Q ss_pred             HHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCC
Q 021181          193 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYL  269 (316)
Q Consensus       193 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f  269 (316)
                      ...|........-.                           ....+++++++||.+||+ ||.+|..   ++||.+||||
T Consensus       397 ~rkI~nwr~~l~fP---------------------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF  448 (550)
T KOG0605|consen  397 YRKIVNWRETLKFP---------------------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF  448 (550)
T ss_pred             HHHHHHHhhhccCC---------------------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence            99887643221110                           012567999999999999 9999995   8999999999


Q ss_pred             CCCC
Q 021181          270 APLH  273 (316)
Q Consensus       270 ~~~~  273 (316)
                      +.++
T Consensus       449 ~~v~  452 (550)
T KOG0605|consen  449 KGVD  452 (550)
T ss_pred             ccCC
Confidence            9987

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-44  Score=321.81  Aligned_cols=304  Identities=66%  Similarity=1.128  Sum_probs=256.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      +..+|+.||||++............+.+|+.+++.++|+||+++++++..........+|++|+|++++|.+++.....+
T Consensus        21 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l  100 (330)
T cd07834          21 DKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL  100 (330)
T ss_pred             eCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCC
Confidence            45679999999997654445566788999999999999999999999876643444578999999999999999888899


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----ccccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......    ......++..|+|||.+.+
T Consensus       101 ~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  180 (330)
T cd07834         101 TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS  180 (330)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeec
Confidence            999999999999999999999999999999999999999999999999988765442    2334567888999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|+||||+++|+|++|.+||.+.+.......+....+.+....+..........+...........+....+.
T Consensus       181 ~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (330)
T cd07834         181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG  260 (330)
T ss_pred             ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhccc
Confidence            44789999999999999999999999999998888888888888777666554445555555555555555555666677


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCccc-CCCCCCCHHHHHHHHHH
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFD-FEHPSFTEENIKELIYR  305 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  305 (316)
                      .+..+.++|++||++||.+||+++++++||||+++.....++....++..+ ++.-++++++.++.|..
T Consensus       261 ~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (330)
T cd07834         261 ASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKELIYE  329 (330)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCHHHHhHHhhc
Confidence            899999999999999999999999999999999999998888888888773 45557999998888764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.9e-44  Score=322.49  Aligned_cols=271  Identities=46%  Similarity=0.804  Sum_probs=209.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++............+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+.+..  .
T Consensus        42 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~  119 (359)
T cd07876          42 DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--E  119 (359)
T ss_pred             EcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--c
Confidence            56789999999997665555566778899999999999999999999864421 23346899999999988887754  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.............++..|+|||.+.+ ..
T Consensus       120 ~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~  198 (359)
T cd07876         120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MG  198 (359)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccC-CC
Confidence            88999999999999999999999999999999999999999999999999876544444455677899999999977 67


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc---------
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF---------  231 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  231 (316)
                      ++.++|||||||++|+|++|..||.+.+.......+....+.+.......... ....+....+..+...+         
T Consensus       199 ~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (359)
T cd07876         199 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP-TVRNYVENRPQYPGISFEELFPDWIF  277 (359)
T ss_pred             CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH-HHHHHHhhCCCCCCcchhhhcccccc
Confidence            89999999999999999999999998887777666666655544322111100 01111111111111111         


Q ss_pred             ---cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          232 ---SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       232 ---~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                         .......+..+++||.+||+.||++|||++|+++||||..+.+..
T Consensus       278 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         278 PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence               111223577899999999999999999999999999998766444

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-46  Score=306.41  Aligned_cols=226  Identities=31%  Similarity=0.442  Sum_probs=195.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      +..+|+.||.|.+....-+....+.+..|+.+|++|+|||||++++.-...   +...++||||+|+ |+|.+.|+.   
T Consensus        40 ~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---~~evlnivmE~c~~GDLsqmIk~~K~  116 (375)
T KOG0591|consen   40 CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---DNEVLNIVMELCDAGDLSQMIKHFKK  116 (375)
T ss_pred             eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---cchhhHHHHHhhcccCHHHHHHHHHh
Confidence            457899999999998777777889999999999999999999999943322   2245899999997 899999864   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhc--CC--ceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccC
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHS--AN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRA  151 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~--~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~a  151 (316)
                       .+.+++..+|.++.|++.||..+|+  .+  |.||||||.||+++.+|.+||+|||+++.+..... ..+.+||++|+|
T Consensus       117 qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMS  196 (375)
T KOG0591|consen  117 QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMS  196 (375)
T ss_pred             ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccC
Confidence             3569999999999999999999998  44  99999999999999999999999999999876543 457899999999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          152 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      ||.+.. .+|+.++||||+||++|||+.-++||.+.+.......|.+.--++-+.                         
T Consensus       197 PE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~-------------------------  250 (375)
T KOG0591|consen  197 PERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD-------------------------  250 (375)
T ss_pred             HHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-------------------------
Confidence            999988 889999999999999999999999999998888888887642211100                         


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCH
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITV  260 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~  260 (316)
                          ..+|.++.++|..|+..||+.||+.
T Consensus       251 ----~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 ----EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ----HHhhhHHHHHHHHHccCCcccCCCc
Confidence                2579999999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=315.77  Aligned_cols=239  Identities=31%  Similarity=0.466  Sum_probs=193.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      +.++|...|||.+...  +....+.+.+|+.+|++++||+||+++|......  + ..++|+|||+. |+|.+.+...+ 
T Consensus        38 ~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~i~mEy~~~GsL~~~~~~~g~  112 (313)
T KOG0198|consen   38 NKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYNIFMEYAPGGSLSDLIKRYGG  112 (313)
T ss_pred             ecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeEeeeeccCCCcHHHHHHHcCC
Confidence            4566899999999765  2222777899999999999999999999754332  1 36999999996 79999999877 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCC----CCccccccccccccCccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~~aPE~  154 (316)
                      ++++..++++.+||++||+|||++||+|+||||+|||++. ++.+||+|||++.....    ........||+.|+|||+
T Consensus       113 ~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEv  192 (313)
T KOG0198|consen  113 KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEV  192 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchh
Confidence            7999999999999999999999999999999999999999 79999999999887663    122345789999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +........++|||||||++.||+||.+||... .....+-.+..   ...                          .+.
T Consensus       193 i~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~~~--------------------------~P~  243 (313)
T KOG0198|consen  193 IRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---EDS--------------------------LPE  243 (313)
T ss_pred             hcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---cCC--------------------------CCC
Confidence            986233446999999999999999999999773 32222222211   110                          012


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ....+|+++++||.+|+..||++||||++||+|||.++...
T Consensus       244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            22358999999999999999999999999999999987554

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-44  Score=319.02  Aligned_cols=304  Identities=60%  Similarity=1.002  Sum_probs=239.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      +..+|+.||||+++... .......+.+|+.+++.++|+||+++++++...........++++||++++|.+.+.. ..+
T Consensus        26 ~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l  103 (336)
T cd07849          26 HKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHL  103 (336)
T ss_pred             EcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc-CCC
Confidence            56789999999986432 2334566788999999999999999999887654445567899999999999888754 679


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++........    .....++..|+|||.+.+
T Consensus       104 ~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (336)
T cd07849         104 SNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN  183 (336)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC
Confidence            9999999999999999999999999999999999999999999999998876543221    123457888999998766


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++||||+||++|+|++|++||.+.+.......+....+.+...............+....+......+....+.
T Consensus       184 ~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (336)
T cd07849         184 SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPN  263 (336)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcc
Confidence            56788999999999999999999999998887777777777777655443322222222333333333333333344556


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCC-CCHHHHHHHHHHHH
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS-FTEENIKELIYRES  307 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  307 (316)
                      .+.++.++|++||+.||++|||+.++++||||+.+......+....++..|++... ...++.++.|+.+.
T Consensus       264 ~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (336)
T cd07849         264 ADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEI  334 (336)
T ss_pred             cCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccccccCHHHHHHHHHHHh
Confidence            78999999999999999999999999999999999988888888777777777664 55667788887765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.5e-44  Score=320.40  Aligned_cols=302  Identities=44%  Similarity=0.752  Sum_probs=223.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+++.||||++............+.+|+.+++.++||||+++++++..... +....+|+||||++++|.+.+..  .
T Consensus        45 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~  122 (364)
T cd07875          45 DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--E  122 (364)
T ss_pred             ECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh--c
Confidence            56789999999998765555566778899999999999999999998864321 23356899999999999888764  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.............++..|+|||++.+ ..
T Consensus       123 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~  201 (364)
T cd07875         123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MG  201 (364)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC-CC
Confidence            88999999999999999999999999999999999999999999999999987655544455678999999999977 67


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc---------
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF---------  231 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  231 (316)
                      ++.++|||||||++|+|++|+.||.+.+.......+....+.+........... ...+....+......+         
T Consensus       202 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  280 (364)
T cd07875         202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT-VRTYVENRPKYAGYSFEKLFPDVLF  280 (364)
T ss_pred             CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH-HHHHHhhCCCcCCCChHhhCccccc
Confidence            899999999999999999999999998888777777766665544322211110 1111111111111000         


Q ss_pred             ---cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC-cccCCCCCCCHHHHHHHHHHHH
Q 021181          232 ---SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF-SFDFEHPSFTEENIKELIYRES  307 (316)
Q Consensus       232 ---~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  307 (316)
                         .......+..++++|.+||+.||.+|||++++|+||||..+.+.......+... ..+.+...-+.+.+.+++..+.
T Consensus       281 ~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (364)
T cd07875         281 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEV  360 (364)
T ss_pred             cccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCCCCCCCccchhhhccHHHHHHHHHHHH
Confidence               111123456799999999999999999999999999998876554433222111 1122222344445666555443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=305.77  Aligned_cols=310  Identities=45%  Similarity=0.765  Sum_probs=252.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |.-++.+||+|+......+...+.+..+|..++..++|+||++++.+|..... +.....|+|||+++.+|.+.+.  ..
T Consensus        37 D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~--~e  114 (369)
T KOG0665|consen   37 DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL--ME  114 (369)
T ss_pred             hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH--Hh
Confidence            56789999999999888888888999999999999999999999999974432 3445689999999999999987  47


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +.-..+..+++|++.|+++||+.||+||||||+||++..++.+|++|||++......-..+..+.+..|.|||++.+ ..
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~-~~  193 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG-MG  193 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheec-cC
Confidence            88899999999999999999999999999999999999999999999999988766655667788999999999988 45


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC----
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP----  236 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  236 (316)
                      +.+.+||||+||++.||++|+..|.+.+..++..++...+|.+.+......... ...+.+..++.....+.+.++    
T Consensus       194 ~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~-~r~yv~~~~~y~~~~f~~~fpD~~f  272 (369)
T KOG0665|consen  194 YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT-VRNYVENRPQYQAISFSELFPDSLF  272 (369)
T ss_pred             CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH-HHHHhhcChHhhccchhhhCCcccc
Confidence            999999999999999999999999999999999999999999887655443322 222333333333333333332    


Q ss_pred             --------CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC--CCCCCCCCcccCCCCCCCHHHHHHHHHHH
Q 021181          237 --------NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE--EPVCPRPFSFDFEHPSFTEENIKELIYRE  306 (316)
Q Consensus       237 --------~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (316)
                              .-+..+++++.+||..||++|.|++++|+|||++-+.....  +|... +..-.++.-..|.++|+++|+++
T Consensus       273 ~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe-~~d~~~d~~~~t~~e~ke~If~e  351 (369)
T KOG0665|consen  273 PVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE-IYDKQLDEREHTIEEWKELIFKE  351 (369)
T ss_pred             cccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc-hhhhhcccccCCHHHHHHHHHHH
Confidence                    22455899999999999999999999999999984332222  12222 34344555567899999999999


Q ss_pred             HHhcCCCCCC
Q 021181          307 SVKFNPDPTH  316 (316)
Q Consensus       307 ~~~~~~~~~~  316 (316)
                      ...|+++-.|
T Consensus       352 v~~f~~~~~~  361 (369)
T KOG0665|consen  352 VQRFEEFNKN  361 (369)
T ss_pred             HHhhcccccc
Confidence            9999996543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-44  Score=318.83  Aligned_cols=307  Identities=52%  Similarity=0.966  Sum_probs=252.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++............+.+|+.+++.++|+||+++++++..... ......++|+||++++|.+++.. .+
T Consensus        36 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~  114 (343)
T cd07851          36 DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QK  114 (343)
T ss_pred             ECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-CC
Confidence            45689999999987654444455677889999999999999999998864432 23345899999999999998865 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......  .....++..|+|||.+.+...
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~  192 (343)
T cd07851         115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMH  192 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCC
Confidence            999999999999999999999999999999999999999999999999998765433  233456788999999866456


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|+.||.+.+.......+....+.++..............+...........+...+..+++
T Consensus       193 ~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  272 (343)
T cd07851         193 YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANP  272 (343)
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCH
Confidence            78999999999999999999999998888777777777777666555444444445555566666555566666667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+.++|++||+.||++|||+.+|++||||.++......+. ...+..++..-.+....+..++..+.--|+|
T Consensus       273 ~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         273 LAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-APPYDQSFESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             HHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc-ccccCcchhhhhcCHHHHHHHhHHHHHhccC
Confidence            9999999999999999999999999999999887766554 5666677777789999999999999998887

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=315.18  Aligned_cols=262  Identities=28%  Similarity=0.438  Sum_probs=222.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +--||+.||||++.+...+......+.+|+..++.++|||||++|++.-     +...+|+|+|.-+ |+|+++|.++ .
T Consensus        39 HVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQTKlyLiLELGD~GDl~DyImKHe~  113 (864)
T KOG4717|consen   39 HVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQTKLYLILELGDGGDLFDYIMKHEE  113 (864)
T ss_pred             hhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccceEEEEEEecCCchHHHHHHhhhc
Confidence            4458999999999998888888899999999999999999999999983     3366999999986 6999998765 6


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++++..++.++.||+.|+.|+|+..+|||||||+|+.+.+ -|-+||.|||++..+.........+|+..|.|||++.+.
T Consensus       114 Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGD  193 (864)
T KOG4717|consen  114 GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGD  193 (864)
T ss_pred             cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcC
Confidence            7999999999999999999999999999999999988765 488999999999998888888899999999999999997


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ....+++|||||||++|-|.+|++||+..++.+.+-.|..-.-                               .+..++
T Consensus       194 sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------------------------------tvPshv  242 (864)
T KOG4717|consen  194 SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------------------------------TVPSHV  242 (864)
T ss_pred             ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-------------------------------cCchhh
Confidence            7777999999999999999999999999988888776643111                               111367


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHH
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYR  305 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (316)
                      |.++++||..||..||++|.|++||.+++|++.++.... ..  .|+.   ....+.+|..+-+|.+
T Consensus       243 S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s-T~--iPLv---sr~~L~ee~Ha~IIq~  303 (864)
T KOG4717|consen  243 SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS-TA--IPLV---SRHHLPEEAHATIIQQ  303 (864)
T ss_pred             hHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc-cc--Ccee---ehhhCChHHHHHHHHH
Confidence            999999999999999999999999999999998763222 11  2222   3345667766666654

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.2e-44  Score=311.54  Aligned_cols=261  Identities=35%  Similarity=0.595  Sum_probs=205.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC--
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--   78 (316)
                      .+|+.||||+++.............+|+.+++.+   +||||+++++++..........+++||||++++|.+++...  
T Consensus        25 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  104 (290)
T cd07862          25 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE  104 (290)
T ss_pred             CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCC
Confidence            3578899999976544443344556777777666   69999999999864432334569999999999999988653  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+.............++..|+|||.+.+ 
T Consensus       105 ~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  183 (290)
T cd07862         105 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-  183 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhC-
Confidence            4589999999999999999999999999999999999999999999999999877655444455678999999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.....-.    ...........+....+.+
T Consensus       184 ~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  259 (290)
T cd07862         184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP----RQAFHSKSAQPIEKFVTDI  259 (290)
T ss_pred             CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc----chhccCCCCCCHHHHccCC
Confidence            678999999999999999999999999998888888887776655543332211000    0011112222333444578


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +..+.++|.+||+.||++|||+.|+++||||
T Consensus       260 ~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         260 DELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             CHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            8999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=328.70  Aligned_cols=232  Identities=24%  Similarity=0.443  Sum_probs=203.9

Q ss_pred             CCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            3 SETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +.|++.||||++++.. ..+.+.+..+.|..++... +||+++.++..|...     .++|+||||+. |+ .-.+++.+
T Consensus       390 k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-----~~l~fvmey~~Ggd-m~~~~~~~  463 (694)
T KOG0694|consen  390 KGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-----EHLFFVMEYVAGGD-LMHHIHTD  463 (694)
T ss_pred             cCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-----CeEEEEEEecCCCc-EEEEEecc
Confidence            6789999999999864 3555678888999999888 599999999999554     67999999996 57 33445568


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.+++.|+.||.|||++||+|||||.+|||+|.+|.+||+|||+++... ....+.+++||+.|+|||++.. 
T Consensus       464 ~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e-  542 (694)
T KOG0694|consen  464 VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-  542 (694)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhcc-
Confidence            89999999999999999999999999999999999999999999999999998854 5667788999999999999988 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC-CC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF-PN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  237 (316)
                      ..|+.++|+|||||+|||||.|.+||.+.+.++.-..|...                                ...+ ..
T Consensus       543 ~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--------------------------------~~~yP~~  590 (694)
T KOG0694|consen  543 QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--------------------------------EVRYPRF  590 (694)
T ss_pred             CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------------------------CCCCCCc
Confidence            88999999999999999999999999999988888777541                                1112 26


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~  273 (316)
                      +|.++.++++++|..+|++|..+     ++|..||||++++
T Consensus       591 ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  591 LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            89999999999999999999965     6899999999998

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.9e-45  Score=326.90  Aligned_cols=262  Identities=34%  Similarity=0.599  Sum_probs=212.3

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC------CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHH
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQI   74 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~   74 (316)
                      .|.+||+.||||+++..   .....+...|+.+|..|+      .-|+|+++++|...     +|+|||+|.++.+|.++
T Consensus       206 ~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-----~HlciVfELL~~NLYel  277 (586)
T KOG0667|consen  206 YDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-----NHLCIVFELLSTNLYEL  277 (586)
T ss_pred             EecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-----cceeeeehhhhhhHHHH
Confidence            47899999999999753   445677889999999996      35799999999765     67999999999999999


Q ss_pred             hhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC--CCEEEeeeccccccCCCCcccccccccccc
Q 021181           75 IRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--CDLKIGDFGLARTTSETDFMTEYVVTRWYR  150 (316)
Q Consensus        75 l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (316)
                      ++.+  .+++...++.++.||+.||.+||+.||+|+||||+|||+...  ..+|++|||.+........  ....+..|+
T Consensus       278 lK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYR  355 (586)
T KOG0667|consen  278 LKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYR  355 (586)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce--eeeeccccc
Confidence            9876  469999999999999999999999999999999999999654  3699999999988776654  778899999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccccccccc--------ch------
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD--------NA------  216 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------~~------  216 (316)
                      |||++.+ .+|+.+.|||||||++.||++|.+.|.+.+..++++.|...+|.++..........        ..      
T Consensus       356 APEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~  434 (586)
T KOG0667|consen  356 APEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVE  434 (586)
T ss_pred             cchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeee
Confidence            9999999 88999999999999999999999999999999999999999998887544221110        00      


Q ss_pred             ------------HHHhh---hCCCC--CCCCccccCC-CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          217 ------------RRYVR---MLPQF--PKQNFSARFP-NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       217 ------------~~~~~---~~~~~--~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                  .....   .....  ....+..... .....+.+||++||.+||.+|+|+.+.|+||||....
T Consensus       435 ~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  435 TSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             ecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence                        00000   00000  0111111122 2345589999999999999999999999999999554

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.1e-44  Score=312.38  Aligned_cols=265  Identities=35%  Similarity=0.597  Sum_probs=199.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      ++.+|+.||||+++..... .....+.+|+.+++.++||||+++++++...     ...++||||++++|.+.+... +.
T Consensus        26 ~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   99 (303)
T cd07869          26 SKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLTLVFEYVHTDLCQYMDKHPGG   99 (303)
T ss_pred             ECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----CeEEEEEECCCcCHHHHHHhCCCC
Confidence            4568999999999754322 2334567899999999999999999998654     569999999999998887654 56


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...... .......++..|+|||++.+..
T Consensus       100 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (303)
T cd07869         100 LHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST  179 (303)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCC
Confidence            899999999999999999999999999999999999999999999999988654322 2223456788999999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC--C
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF--P  236 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  236 (316)
                      .++.++|||||||++|+|++|..||.+... ...+..+....+.+....+.......... ...........+....  .
T Consensus       180 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  258 (303)
T cd07869         180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK-PERFTLYSPKNLRQAWNKL  258 (303)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc-cccccccCCccHHHHhhcc
Confidence            788999999999999999999999987643 44555565555555443332211100000 0000000000111111  1


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .++..+.++|++||+.||++|||++|+++||||+++.
T Consensus       259 ~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             CCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            3567899999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-44  Score=304.80  Aligned_cols=236  Identities=26%  Similarity=0.404  Sum_probs=198.6

Q ss_pred             CCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            3 SETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +.++..+|+|++.+... ...-..+++.|.+||+.++||.++.+|+.|...     ...|++||||+ |+|..+.+++  
T Consensus        99 ~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~~~cl~meyCpGGdL~~LrqkQp~  173 (459)
T KOG0610|consen   99 RGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-----KYSCLVMEYCPGGDLHSLRQKQPG  173 (459)
T ss_pred             cCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-----ceeEEEEecCCCccHHHHHhhCCC
Confidence            56779999999987543 344457788999999999999999999999544     66999999995 7999888765  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC----------------------
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE----------------------  136 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~----------------------  136 (316)
                      +.+++..++.++.+++.||+|||-.|||+|||||+||||.++|.+.|+||.++.....                      
T Consensus       174 ~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~  253 (459)
T KOG0610|consen  174 KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSR  253 (459)
T ss_pred             CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccc
Confidence            4599999999999999999999999999999999999999999999999987632100                      


Q ss_pred             -------------C----------------------CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 021181          137 -------------T----------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       137 -------------~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~  181 (316)
                                   .                      .....++||-.|+|||++.+ ...+.++|+|+||+++|||+.|.
T Consensus       254 ~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAVDWWtfGIflYEmLyG~  332 (459)
T KOG0610|consen  254 QPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAVDWWTFGIFLYEMLYGT  332 (459)
T ss_pred             cccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCchhhHHHHHHHHHHHHhCC
Confidence                         0                      01123567888999999998 77999999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC--
Q 021181          182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT--  259 (316)
Q Consensus       182 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps--  259 (316)
                      -||.+.+..+++..|....-..+.                             .+.++..+++||+++|.+||++|..  
T Consensus       333 TPFKG~~~~~Tl~NIv~~~l~Fp~-----------------------------~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  333 TPFKGSNNKETLRNIVGQPLKFPE-----------------------------EPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             CCcCCCCchhhHHHHhcCCCcCCC-----------------------------CCcchhHHHHHHHHHhccChhhhhccc
Confidence            999999988888776542222111                             1256788999999999999999998  


Q ss_pred             --HHHHhcCCCCCCCC
Q 021181          260 --VDEALCHPYLAPLH  273 (316)
Q Consensus       260 --~~ell~~~~f~~~~  273 (316)
                        |.||.+||||++++
T Consensus       384 rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  384 RGAAEIKRHPFFEGVN  399 (459)
T ss_pred             cchHHhhcCccccCCC
Confidence              99999999999998

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-43  Score=309.34  Aligned_cols=263  Identities=34%  Similarity=0.584  Sum_probs=205.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      ++.+|+.||+|.++...........+.+|+.+++.+   +||||+++++++..........++++||+++++|.+++...
T Consensus        21 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~  100 (288)
T cd07863          21 DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKV  100 (288)
T ss_pred             ECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhc
Confidence            567899999999976433333334455677777665   79999999999875433334568999999999999888764


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           79 --QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 --~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                        ..+++.+++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.............++..|+|||.+.
T Consensus       101 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (288)
T cd07863         101 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL  180 (288)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhh
Confidence              348999999999999999999999999999999999999999999999999987765444444556788999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++||||+||++|+|++|.+||.+.........+....+.+....+........    ...............+
T Consensus       181 ~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  255 (288)
T cd07863         181 Q-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR----GAFSPRGPRPVQSVVP  255 (288)
T ss_pred             C-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc----cccCCCCCCchHHhCc
Confidence            7 6789999999999999999999999998887777777777666554433321110000    0011111222334445


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .++..+.++|.+||+.||++|||+.|++.||||
T Consensus       256 ~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         256 EIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            788899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.1e-44  Score=310.23  Aligned_cols=262  Identities=36%  Similarity=0.661  Sum_probs=199.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh-cCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR-SHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~~   80 (316)
                      ++.+|+.||||+++...........+.+|+.+++.++||||+++++++...     ..+++||||+++++.+.+. ....
T Consensus        22 ~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~   96 (287)
T cd07848          22 HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKLYLVFEYVEKNMLELLEEMPNG   96 (287)
T ss_pred             ECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEEEEEEecCCCCHHHHHHhcCCC
Confidence            567899999999976544455567788999999999999999999998544     5699999999865555444 4467


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||++.+ 
T Consensus        97 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  175 (287)
T cd07848          97 VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-  175 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcC-
Confidence            9999999999999999999999999999999999999999999999999987754322  2234567889999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh-hCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR-MLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||||||++|+|++|++||.+.+..+....+....+..+................. .....+..........
T Consensus       176 ~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T cd07848         176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGI  255 (287)
T ss_pred             CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcc
Confidence            668999999999999999999999999887766666666665554432221111000000000 0000000000111234


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +|.++.+||++||+.||++|||++++++||||
T Consensus       256 ~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         256 LSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            78899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5e-44  Score=316.38  Aligned_cols=235  Identities=27%  Similarity=0.422  Sum_probs=197.0

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||+++.... .......+..|+.++++++||||+++++++...     ..+|+||||++ |+|.+.+...+
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   90 (323)
T cd05571          16 EKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRER   90 (323)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcC
Confidence            467899999999976432 333456678999999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.... .........++..|+|||++.+ 
T Consensus        91 ~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-  169 (323)
T cd05571          91 VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-  169 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC-
Confidence            99999999999999999999999999999999999999999999999999886532 2223345678999999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||...+.......+.....                               .....+
T Consensus       170 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------------------------------~~p~~~  218 (323)
T cd05571         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------------------------------RFPRTL  218 (323)
T ss_pred             CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-------------------------------CCCCCC
Confidence            6789999999999999999999999988765555444322100                               001257


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ++++.++|++||+.||++||     ++.++++||||.++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            88999999999999999999     899999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-44  Score=310.21  Aligned_cols=233  Identities=22%  Similarity=0.345  Sum_probs=195.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.     ..+++||||+. |+|.+++...+
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~   96 (291)
T cd05612          22 DRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RFLYMLMEYVPGGELFSYLRNSG   96 (291)
T ss_pred             EcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----CeEEEEEeCCCCCCHHHHHHHcC
Confidence            467899999999965322 223446678999999999999999999988544     56999999996 79999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++......  .....+++.|+|||++.+ .
T Consensus        97 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~  173 (291)
T cd05612          97 RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS-K  173 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcC-C
Confidence            9999999999999999999999999999999999999999999999999998765432  234568899999999877 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|..||.+.+.......+....-                               .....++
T Consensus       174 ~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~~~  222 (291)
T cd05612         174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-------------------------------EFPRHLD  222 (291)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------------------------------CCCccCC
Confidence            789999999999999999999999988776555544432100                               0012457


Q ss_pred             hHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      +.+.++|++||+.||.+|++     ++++++||||+.+.
T Consensus       223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence            88999999999999999995     99999999999866

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=311.51  Aligned_cols=239  Identities=26%  Similarity=0.416  Sum_probs=195.7

Q ss_pred             CCCCCCceEEEEEecccccC------------hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC
Q 021181            1 MNSETREEVAIKKIGNAFDN------------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD   68 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~   68 (316)
                      +|..+|+.||||++.+....            ....+++.+||.++++|.|||||+++++.-++.   ...+|+|+|||.
T Consensus       117 r~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~---s~~~YlVley~s  193 (576)
T KOG0585|consen  117 RDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE---SDKLYLVLEYCS  193 (576)
T ss_pred             eecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc---cCceEEEEEecc
Confidence            46789999999999764211            112358899999999999999999999986654   367999999997


Q ss_pred             -CcHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccccc------CCCCcc
Q 021181           69 -TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT------SETDFM  140 (316)
Q Consensus        69 -g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~------~~~~~~  140 (316)
                       |.+... -..++ +++.+++.+++.++.||.|||.+||+||||||.|+|++.+|.+||+|||.+...      +..+..
T Consensus       194 ~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L  272 (576)
T KOG0585|consen  194 KGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQL  272 (576)
T ss_pred             CCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHH
Confidence             555433 33344 999999999999999999999999999999999999999999999999998765      222334


Q ss_pred             ccccccccccCcccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchH
Q 021181          141 TEYVVTRWYRAPELLLNCS---EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR  217 (316)
Q Consensus       141 ~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (316)
                      ....||+.|+|||.+.+..   ..+.+.||||+||++|.|+.|+.||.+....++..+|....-..+             
T Consensus       273 ~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP-------------  339 (576)
T KOG0585|consen  273 SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFP-------------  339 (576)
T ss_pred             hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCC-------------
Confidence            4578999999999987732   346789999999999999999999988887777777654221111             


Q ss_pred             HHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                                      ..+.+.+.+++||.+||++||+.|.++.+|..|||....
T Consensus       340 ----------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  340 ----------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ----------------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                            113567889999999999999999999999999999865

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.7e-43  Score=314.18  Aligned_cols=270  Identities=46%  Similarity=0.801  Sum_probs=209.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+++.||||++............+.+|+.+++.++||||+++++++..... +.....|++|||++++|.+.+..  .
T Consensus        38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~  115 (355)
T cd07874          38 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--E  115 (355)
T ss_pred             ecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh--c
Confidence            56789999999998765555566788899999999999999999999865421 23356899999999999888764  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.............++..|+|||++.+ ..
T Consensus       116 l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~  194 (355)
T cd07874         116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MG  194 (355)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcC-CC
Confidence            88999999999999999999999999999999999999999999999999987655544455678999999999977 67


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC-----------
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ-----------  229 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  229 (316)
                      ++.++|||||||++|+|++|+.||.+.+.......+....+.+.......... ....+....+.....           
T Consensus       195 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (355)
T cd07874         195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLF  273 (355)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH-HHHHHHhcCCccccccchhhcccccc
Confidence            89999999999999999999999998887777666666555544322211110 011111111110000           


Q ss_pred             -CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          230 -NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       230 -~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                       .........+..+.++|.+||+.||++|||+.|+++||||..+.+.
T Consensus       274 ~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             ccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence             0011112346779999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.7e-43  Score=310.85  Aligned_cols=297  Identities=58%  Similarity=0.994  Sum_probs=236.2

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCCCHH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDD   84 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~   84 (316)
                      |+.||+|+++...........+.+|+.+++++ +||||+++++.+.... .....+++++++++++|.+++.....+++.
T Consensus        27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~  105 (332)
T cd07857          27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFNELYLYEELMEADLHQIIRSGQPLTDA  105 (332)
T ss_pred             CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCCcEEEEEecccCCHHHHHhcCCCCCHH
Confidence            88999999976544444556778999999999 5999999998754321 223568999999999999999888899999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----ccccccccccccCcccccCCC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......     ......++..|+|||.+.+..
T Consensus       106 ~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  185 (332)
T cd07857         106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ  185 (332)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCC
Confidence            999999999999999999999999999999999999999999999987644321     122346788899999886656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+||++|+|++|.+||...+.......+....+.++..............+.......+...+....+..+
T Consensus       186 ~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (332)
T cd07857         186 SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNAN  265 (332)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCC
Confidence            78899999999999999999999999988888888888887776654433332222223333333333344445556678


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHH
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY  304 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (316)
                      ..+.+++.+||+.||++|||+.+++.||||+++++....+.|..++.++|+..+ +-+.++..|.
T Consensus       266 ~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  329 (332)
T cd07857         266 PLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED-SMEELRDMII  329 (332)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccccc-cHHHHHHHHh
Confidence            999999999999999999999999999999999998889999999998866543 3344555444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.7e-43  Score=309.05  Aligned_cols=267  Identities=37%  Similarity=0.675  Sum_probs=211.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      ++.+++.||||.++.... ......+.+|+.++++++||||+++++++...     ...++||||++++|.+.+... ..
T Consensus        27 ~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~  100 (309)
T cd07872          27 SKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLTLVFEYLDKDLKQYMDDCGNI  100 (309)
T ss_pred             ecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEEEEEeCCCCCHHHHHHhcCCC
Confidence            567899999999975432 22334567899999999999999999998654     468999999999998887654 45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  180 (309)
T cd07872         101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS  180 (309)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCC
Confidence            8999999999999999999999999999999999999999999999999987643322 223446688999999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|++||.+.+..+....+....+.+....++......... ....+...........+.++
T Consensus       181 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  259 (309)
T cd07872         181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK-NYNFPKYKPQPLINHAPRLD  259 (309)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh-hhhcCccCCCchhhhccCCC
Confidence            78999999999999999999999999988888888888888777665544322211110 01111111222223445688


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      +++.++|++||+.||.+|||++|+++||||+.....
T Consensus       260 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         260 TEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             HHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence            999999999999999999999999999999987644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=309.03  Aligned_cols=227  Identities=29%  Similarity=0.397  Sum_probs=192.2

Q ss_pred             Cce-EEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--CCCC
Q 021181            6 REE-VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--HQDL   81 (316)
Q Consensus         6 ~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~   81 (316)
                      |+. ||||++.....+......+.+|+.++++++|||||+++|++..+.    ..++|||||++ |+|.+++..  .+.+
T Consensus        64 g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~iVtEy~~~GsL~~~l~~~~~~~l  139 (362)
T KOG0192|consen   64 GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLCIVTEYMPGGSLSVLLHKKRKRKL  139 (362)
T ss_pred             CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceEEEEEeCCCCcHHHHHhhcccCCC
Confidence            556 999999876555555889999999999999999999999997653    25899999996 899999987  6789


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCC-ceeccCCCCcEEEccCC-CEEEeeeccccccCCC-CccccccccccccCcccccC-
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANC-DLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN-  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-  157 (316)
                      +...+..|+.+|+.|+.|||+++ |+||||||+|+|++.++ ++||+|||+++..... .......||..|+|||++.+ 
T Consensus       140 ~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~  219 (362)
T KOG0192|consen  140 PLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE  219 (362)
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC
Confidence            99999999999999999999999 99999999999999998 9999999999886654 34445789999999999985 


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++||||||+++|||++|+.||.+.........+.. .+..+..                            ...
T Consensus       220 ~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~-~~~Rp~~----------------------------p~~  270 (362)
T KOG0192|consen  220 KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV-GGLRPPI----------------------------PKE  270 (362)
T ss_pred             CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-cCCCCCC----------------------------Ccc
Confidence            26899999999999999999999999999987444443332 2221111                            113


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +++.+..++..||+.||..||++.+++.
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            7888999999999999999999998775

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-42  Score=309.63  Aligned_cols=307  Identities=46%  Similarity=0.848  Sum_probs=243.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++............+..|+.+++.++||||+++++++..... .....+++||++++++|.+++.. ..
T Consensus        36 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~  114 (343)
T cd07880          36 DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EK  114 (343)
T ss_pred             ECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-CC
Confidence            46789999999996654444455678899999999999999999999875431 22345799999998899888764 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||++||+.||+|+||+|+||+++.++.++|+|||.+......  .....++..|+|||.+.+...
T Consensus       115 l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~  192 (343)
T cd07880         115 LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMH  192 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCC
Confidence            999999999999999999999999999999999999999999999999998765432  233456788999999876456


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|+|||||++|+|++|.+||.+.+.......+.+..+..+..............+....+......+....+.+++
T Consensus       193 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (343)
T cd07880         193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANP  272 (343)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCCh
Confidence            78999999999999999999999998877666666666555544333222222223333333333333334444567889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+.++|.+||+.||++|||+.+++.||||+........+ -..++..+++.-+.+-++++.+.+-+.+.|.|
T Consensus       273 ~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         273 LAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET-EAPPYDDSFDEVDQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc-CCCCccccHHhhccchHHHHHHHHHHHHhcCC
Confidence            999999999999999999999999999999987665544 33457778888889999999999999999987

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-43  Score=317.20  Aligned_cols=262  Identities=25%  Similarity=0.329  Sum_probs=199.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |..+++.||||....        ..+.+|++++++++||||+++++++...     ...+++||+++++|..++.....+
T Consensus       113 d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~l  179 (391)
T PHA03212        113 DNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKRNI  179 (391)
T ss_pred             ECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeEEEEecCCCCHHHHHHhcCCC
Confidence            678999999997532        2367899999999999999999998654     458999999999999999888889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC--CccccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......  .......+|+.|+|||++.+ .
T Consensus       180 ~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  258 (391)
T PHA03212        180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-D  258 (391)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-C
Confidence            99999999999999999999999999999999999999999999999998653222  12234578999999999977 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHHhhCCCCccccccccccchHHHhhhC---CCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGK-------DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML---PQFPKQ  229 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  229 (316)
                      .++.++|||||||++|+|++|..||...       +....+..+....+..+..............+....   ...+..
T Consensus       259 ~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (391)
T PHA03212        259 PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGS  338 (391)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCC
Confidence            7899999999999999999999876543       234455666666665543322111111111111111   110000


Q ss_pred             C-ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          230 N-FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       230 ~-~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      . .......++.++.++|.+||+.||.+|||++|+|+||||+++.....
T Consensus       339 ~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~  387 (391)
T PHA03212        339 RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP  387 (391)
T ss_pred             CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCC
Confidence            0 01111245778999999999999999999999999999998764433

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=297.12  Aligned_cols=245  Identities=29%  Similarity=0.470  Sum_probs=204.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.||+.+|+|++..       ..+.++|+++.-.. .|||||.++++|...- .+...+.+|||.++ |.|+..++.++
T Consensus        83 ~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVmE~meGGeLfsriq~~g  154 (400)
T KOG0604|consen   83 HKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVMECMEGGELFSRIQDRG  154 (400)
T ss_pred             eccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeeeecccchHHHHHHHHcc
Confidence            578999999998842       34567899987666 6999999999997542 33467899999996 79999998876


Q ss_pred             C--CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---CCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           80 D--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        80 ~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                      .  +++.++..|++||..|+.|||+.+|.||||||+|+|...   +..+||+|||+++.........+.+.|++|.|||+
T Consensus       155 ~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPev  234 (400)
T KOG0604|consen  155 DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEV  234 (400)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHH
Confidence            6  999999999999999999999999999999999999965   45699999999998877777788899999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      +.. ..|+.+.|+||+||+||-|++|.+||.....    ..+-.+|....-.++...                       
T Consensus       235 lg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE-----------------------  290 (400)
T KOG0604|consen  235 LGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE-----------------------  290 (400)
T ss_pred             hCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh-----------------------
Confidence            977 7799999999999999999999999987753    233334433333333222                       


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP  282 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~  282 (316)
                          +..+|++.+++|+++|..+|++|.|++++++|||+.+.....+-+.+.
T Consensus       291 ----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t  338 (400)
T KOG0604|consen  291 ----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST  338 (400)
T ss_pred             ----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence                236799999999999999999999999999999999988766655543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-44  Score=303.05  Aligned_cols=232  Identities=28%  Similarity=0.500  Sum_probs=208.1

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +...|..||||.|+++. .++.+...+.+|+++++.|+||||+.+|++|...     ..+.|||||.. |.|.+++...+
T Consensus        74 e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----dKIvivMEYaS~GeLYDYiSer~  148 (668)
T KOG0611|consen   74 EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----DKIVIVMEYASGGELYDYISERG  148 (668)
T ss_pred             hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----ceEEEEEEecCCccHHHHHHHhc
Confidence            45689999999998865 4566778999999999999999999999999544     56999999995 89999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.+++.+++||..|+.|+|.++++|||||.+|||+|.++++||.|||++..........++||++.|.+||+.-+..
T Consensus       149 ~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~P  228 (668)
T KOG0611|consen  149 SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTP  228 (668)
T ss_pred             cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCC
Confidence            99999999999999999999999999999999999999999999999999999988888889999999999999998855


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .-++.+|.||||+++|.|..|..||.+.+...++..|....-.-                                |.-+
T Consensus       229 Y~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--------------------------------P~~P  276 (668)
T KOG0611|consen  229 YKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--------------------------------PETP  276 (668)
T ss_pred             CCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--------------------------------CCCC
Confidence            55799999999999999999999999999888888775432211                                2345


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      .++.-||+.||-.+|++|.|++++-+|=|+.
T Consensus       277 SdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  277 SDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             chHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            6688999999999999999999999998875

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=319.03  Aligned_cols=264  Identities=33%  Similarity=0.609  Sum_probs=202.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---CCCCeEEEEEecCCCcHHHHhh--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVYIVYELMDTDLHQIIR--   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~--   76 (316)
                      +..+|+.||||++....      ....+|+.+++.++||||+++++++.....   +....+++||||++++|.+++.  
T Consensus        87 ~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~  160 (440)
T PTZ00036         87 CIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY  160 (440)
T ss_pred             ECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHH
Confidence            45689999999985431      123479999999999999999988753221   1223578999999998877764  


Q ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCCccccccccccccCcc
Q 021181           77 --SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        77 --~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                        ....+++..++.++.||+.||+|||+.||+||||||+||+++.++ .+||+|||+++............+++.|+|||
T Consensus       161 ~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE  240 (440)
T PTZ00036        161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE  240 (440)
T ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHH
Confidence              346799999999999999999999999999999999999998665 69999999998765544444567799999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh-hCCCCCCCCcc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR-MLPQFPKQNFS  232 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (316)
                      ++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..........    .+.. ..+......+.
T Consensus       241 ~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~----~~~~~~~~~~~~~~l~  316 (440)
T PTZ00036        241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP----NYADIKFPDVKPKDLK  316 (440)
T ss_pred             HhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch----hhhcccCCccCchhHH
Confidence            987756789999999999999999999999999888888888887777655432211100    0000 00000111111


Q ss_pred             ccCC-CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          233 ARFP-NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       233 ~~~~-~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ..++ ..++++.+||.+||+.||.+|||+.|+++||||..+.+.
T Consensus       317 ~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        317 KVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             HHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            1122 468899999999999999999999999999999987653

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-42  Score=307.18  Aligned_cols=307  Identities=51%  Similarity=0.915  Sum_probs=242.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|++............+.+|+.++++++|+||+++++++..... ......++++++++++|.+++.. ..
T Consensus        38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-~~  116 (345)
T cd07877          38 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QK  116 (345)
T ss_pred             EcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-CC
Confidence            46789999999997654444445678899999999999999999998864321 22345889999998999888765 46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......  .....++..|+|||.+.+...
T Consensus       117 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~  194 (345)
T cd07877         117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMH  194 (345)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccC
Confidence            999999999999999999999999999999999999999999999999988764332  234466888999999876556


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++||||+||++|+|++|.+||...+.......+....+.+...............+.......+...+.......++
T Consensus       195 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (345)
T cd07877         195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  274 (345)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCH
Confidence            88899999999999999999999988887777777777777666655555544444455554455444445554556789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+.++|.+||+.||.+||++.++++||||+++......+... .+...+.-..+..+.+......++.-|-|
T Consensus       275 ~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         275 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             HHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC-CccCcchhcccCHHHHHHHHHHHHHhcCC
Confidence            999999999999999999999999999999988766666543 33333333344457788888888888866

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-43  Score=309.18  Aligned_cols=235  Identities=30%  Similarity=0.480  Sum_probs=196.0

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||+|+++... ........+..|+.++++++||||+++++++...     ...|+||||+. |+|.+++...+
T Consensus        14 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~   88 (312)
T cd05585          14 KRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFINGGELFHHLQREG   88 (312)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCCCCCcHHHHHHhcC
Confidence            46789999999997542 2334456778999999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... .......++..|+|||.+.+ 
T Consensus        89 ~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  167 (312)
T cd05585          89 RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-  167 (312)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC-
Confidence            8999999999999999999999999999999999999999999999999998754322 22344578999999999987 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||.+.+.......+...   ..                            .....+
T Consensus       168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~~----------------------------~~~~~~  216 (312)
T cd05585         168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---PL----------------------------RFPDGF  216 (312)
T ss_pred             CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---CC----------------------------CCCCcC
Confidence            67899999999999999999999999887655554443221   00                            011256


Q ss_pred             ChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp---s~~ell~~~~f~~~~  273 (316)
                      ++.+.++|.+||+.||.+||   ++.++++||||.+..
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            88899999999999999997   579999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-43  Score=311.99  Aligned_cols=233  Identities=25%  Similarity=0.371  Sum_probs=195.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||+++.... .......+.+|+.+++.++||||+++++++...     ..+|+||||+. |+|.+.+...+
T Consensus        39 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  113 (329)
T PTZ00263         39 HKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----NRVYFLLEFVVGGELFTHLRKAG  113 (329)
T ss_pred             ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----CEEEEEEcCCCCChHHHHHHHcC
Confidence            467899999999975422 223446788999999999999999999998654     56999999996 69999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......  ....+++.|+|||++.+ .
T Consensus       114 ~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~  190 (329)
T PTZ00263        114 RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQS-K  190 (329)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcC-C
Confidence            99999999999999999999999999999999999999999999999999987654332  34578899999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|..||.+.+.......+....  .                     .        ....++
T Consensus       191 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~---------------------~--------~p~~~~  239 (329)
T PTZ00263        191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--L---------------------K--------FPNWFD  239 (329)
T ss_pred             CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--c---------------------C--------CCCCCC
Confidence            78999999999999999999999998776555544433210  0                     0        001367


Q ss_pred             hHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      ..+.++|++||+.||.+|++     ++++++||||++..
T Consensus       240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            88999999999999999997     79999999998854

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7e-43  Score=309.05  Aligned_cols=235  Identities=26%  Similarity=0.411  Sum_probs=196.3

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||+|+++.... .......+..|+.+++.++||||+++++++...     ..+|+||||++ |+|..++...+
T Consensus        16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~   90 (323)
T cd05595          16 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRER   90 (323)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEeCCCCCcHHHHHHHcC
Confidence            467899999999976432 333456677899999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+ 
T Consensus        91 ~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  169 (323)
T cd05595          91 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-  169 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccC-
Confidence            899999999999999999999999999999999999999999999999998875322 222334568999999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||...+.......+......                               ....+
T Consensus       170 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~-------------------------------~p~~~  218 (323)
T cd05595         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------------------------------FPRTL  218 (323)
T ss_pred             CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-------------------------------CCCCC
Confidence            67899999999999999999999999887765554443221000                               01256


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ++++.++|.+||+.||.+|+     ++.++++|+||.+..
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            88999999999999999998     899999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=308.88  Aligned_cols=239  Identities=33%  Similarity=0.519  Sum_probs=206.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.||+.||+|++++... .......+.+|+.+|+++. ||||+.++++|.+.     ..+++|||+|. |.|++.+...
T Consensus        56 ~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-----~~~~lvmEL~~GGeLfd~i~~~  130 (382)
T KOG0032|consen   56 EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-----DSVYLVMELCEGGELFDRIVKK  130 (382)
T ss_pred             ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-----CeEEEEEEecCCchHHHHHHHc
Confidence            578899999999987543 3335578899999999998 99999999999654     57999999996 7999998876


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC----CCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN----CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                       .+++..+..++.|++.++.|||+.|++|||+||+|+|+...    +.++++|||++............+||+.|+|||+
T Consensus       131 -~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEv  209 (382)
T KOG0032|consen  131 -HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEV  209 (382)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchh
Confidence             49999999999999999999999999999999999999543    5799999999999887667788999999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      +.. ..++..+||||+|+++|.|++|.+||.+.........+....-...                           .+.
T Consensus       210 l~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~---------------------------~~~  261 (382)
T KOG0032|consen  210 LGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT---------------------------SEP  261 (382)
T ss_pred             hcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC---------------------------CCC
Confidence            986 7899999999999999999999999999886666665544222111                           233


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ++.+|..+.++|++||..||.+|+++.++|+|||+++...
T Consensus       262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence            4578999999999999999999999999999999987643

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.1e-43  Score=310.00  Aligned_cols=235  Identities=25%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||++..... .......+.+|+.+++.++||||+++++.+...     ..+|+||||++ |+|...+...+
T Consensus        16 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~   90 (328)
T cd05593          16 EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVMEYVNGGELFFHLSRER   90 (328)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHhcC
Confidence            567899999999976432 334456778999999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+ 
T Consensus        91 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  169 (328)
T cd05593          91 VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-  169 (328)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcC-
Confidence            899999999999999999999999999999999999999999999999999875332 222344578999999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||...+.......+.....                               .....+
T Consensus       170 ~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------------------~~p~~~  218 (328)
T cd05593         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------------------------------KFPRTL  218 (328)
T ss_pred             CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc-------------------------------cCCCCC
Confidence            6789999999999999999999999987765544443321000                               011257


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ++++.++|++||+.||.+|+     ++.++++||||.+..
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            88999999999999999997     899999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-42  Score=303.33  Aligned_cols=269  Identities=36%  Similarity=0.664  Sum_probs=209.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      ++.+++.||+|.++..... .....+.+|+.+++.++||||+++++++...     ...++||||++++|.+.+... ..
T Consensus        27 ~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~  100 (301)
T cd07873          27 SKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNS  100 (301)
T ss_pred             EcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeEEEEEeccccCHHHHHHhcCCC
Confidence            4678999999999754322 2334567899999999999999999998654     569999999999999888654 56


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  180 (301)
T cd07873         101 INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST  180 (301)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCC
Confidence            8999999999999999999999999999999999999999999999999987644322 223345688899999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|++||...+..+....+....+.+....+....+.... .....+...........+.++
T Consensus       181 ~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  259 (301)
T cd07873         181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF-KSYNYPKYRADCLHNHAPRLD  259 (301)
T ss_pred             CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc-cccccCccccccHHhhcCCCC
Confidence            6889999999999999999999999988877777777777766555443321111000 000011111111223335678


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      +.+.++|.+||+.||.+|||++|+++||||+.+.+..+
T Consensus       260 ~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~  297 (301)
T cd07873         260 SDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH  297 (301)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence            89999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-42  Score=299.78  Aligned_cols=261  Identities=38%  Similarity=0.693  Sum_probs=205.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH---   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---   78 (316)
                      ++.+|+.||||+++...........+.+|+.++++++||||+++++++...     ..+++||||++++|.+++...   
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~   95 (285)
T cd07861          21 NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLPKG   95 (285)
T ss_pred             ECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEEEEEecCCCCHHHHHhcCCCC
Confidence            456899999999976544444456778999999999999999999998654     468999999999998887643   


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (285)
T cd07861          96 QYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG  175 (285)
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcC
Confidence            468999999999999999999999999999999999999999999999999987654322 1223355788999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|+|||||++|+|++|++||.+.........+....+.+....+.....  ...+......+...........
T Consensus       176 ~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T cd07861         176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LPDYKNTFPKWKKGSLRSAVKN  253 (285)
T ss_pred             CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh--hHHHHhhccccCcchhHHhcCC
Confidence            56678999999999999999999999988876666666655555444333322111  1122222222222333334456


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +++++.++|++||+.||.+|||+.++++||||
T Consensus       254 ~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         254 LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            89999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-42  Score=306.17  Aligned_cols=306  Identities=46%  Similarity=0.857  Sum_probs=236.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++............+.+|+.+++.++||||+++++++..... .....+++++||++++|...+.  ..
T Consensus        36 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~  113 (342)
T cd07879          36 DKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--HP  113 (342)
T ss_pred             eCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHHc--CC
Confidence            45789999999997654444445667899999999999999999999865421 1224579999999888877653  46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..+..++.|++.||++||+.|++||||+|+||+++.++.++|+|||++......  .....++..|+|||.+.+...
T Consensus       114 ~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~  191 (342)
T cd07879         114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMH  191 (342)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccc
Confidence            899999999999999999999999999999999999999999999999998765332  233456788999999876456


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|+|||||++|+|++|+.||.+.+.......+....+.+.+.............+....+..+...+...++..+.
T Consensus       192 ~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (342)
T cd07879         192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP  271 (342)
T ss_pred             cCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCH
Confidence            88999999999999999999999998887777777776666554443333333333333334444444444555567889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+.++|.+||+.||++||++++++.||||..+......+ +..++..+....++..+.+..-|.++.--|-|
T Consensus       272 ~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (342)
T cd07879         272 QAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET-EQQPYDDSLENEKLSVDEWKKHIYKEVKSFSP  342 (342)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC-CCCcccchhhhhhCCHHHHHHHhhhhhhccCC
Confidence            999999999999999999999999999999998654433 45556656556567777777777777655544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.3e-42  Score=302.15  Aligned_cols=239  Identities=22%  Similarity=0.358  Sum_probs=193.2

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--   77 (316)
                      +..+|+.||||++...... ......+.+|+.+++.++|++|+++++++...     ..+++||||++ |+|.+.+..  
T Consensus        21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~   95 (285)
T cd05631          21 VRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMG   95 (285)
T ss_pred             EecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEEEEEEecCCCcHHHHHHhhC
Confidence            4578999999999754322 22334577899999999999999999998654     46999999996 689877754  


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.............++..|+|||++.+
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05631          96 NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN  175 (285)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC
Confidence            34689999999999999999999999999999999999999999999999999877654444445678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|+.||...+.......+........                           ......
T Consensus       176 -~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  227 (285)
T cd05631         176 -EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ---------------------------EEYSEK  227 (285)
T ss_pred             -CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc---------------------------ccCCcc
Confidence             6789999999999999999999999987654333222222111100                           011135


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      ++.++.+||++||+.||.+||+     ++++++||||.++.
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            7889999999999999999997     89999999998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-43  Score=309.11  Aligned_cols=238  Identities=29%  Similarity=0.449  Sum_probs=213.5

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +++..++.||+|++......+.......+|+.++++++|||||.+.+.|..++    ..++|+|+||+ |++.+.|...+
T Consensus        24 rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~l~Ivm~Y~eGg~l~~~i~~~k   99 (426)
T KOG0589|consen   24 RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QLLCIVMEYCEGGDLAQLIKEQK   99 (426)
T ss_pred             hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ceEEEEEeecCCCCHHHHHHHHh
Confidence            46778899999999988777777788999999999999999999999997542    34999999996 69999887654


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccccc
Q 021181           80 --DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 --~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  156 (316)
                        .++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.++|+|||+++...... ...+..||+.|++||++.
T Consensus       100 ~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~  179 (426)
T KOG0589|consen  100 GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILS  179 (426)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhC
Confidence              58999999999999999999999999999999999999999999999999999988776 667889999999999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + .+|+.++|||||||++|||++-+++|.+.+....+.+|......+.+                              .
T Consensus       180 d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------------------------~  228 (426)
T KOG0589|consen  180 D-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------------------------S  228 (426)
T ss_pred             C-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------------------------c
Confidence            8 89999999999999999999999999999988888888775533222                              2


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .+|.+++.+|..||..+|+.||++.+||.+|.+..+.
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            6789999999999999999999999999999988655

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.2e-42  Score=306.28  Aligned_cols=299  Identities=44%  Similarity=0.779  Sum_probs=219.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||.+............+.+|+.++++++|+||+++++++..... ++....|+||||++++|.+.+...  
T Consensus        37 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--  114 (353)
T cd07850          37 DTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--  114 (353)
T ss_pred             ECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--
Confidence            56789999999997654455556678899999999999999999999864421 233568999999999999988653  


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+ ..
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  193 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MG  193 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC-CC
Confidence            89999999999999999999999999999999999999999999999999987655444444567888999999977 77


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc------
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR------  234 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  234 (316)
                      ++.++|||||||++|+|++|+.||...+.......+....+.+........... ...+...........+...      
T Consensus       194 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  272 (353)
T cd07850         194 YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT-VRNYVENRPKYAGYSFEELFPDVLF  272 (353)
T ss_pred             CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh-hhHHhhcCCCCCCcchhhhCccccc
Confidence            899999999999999999999999988877777777776666554322211111 0111111111100000000      


Q ss_pred             -------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCC-CCCCCcccCCCCCCCHHHHHHHHH
Q 021181          235 -------FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV-CPRPFSFDFEHPSFTEENIKELIY  304 (316)
Q Consensus       235 -------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  304 (316)
                             ....+..++++|.+||+.||++|||+.|+|.||||+.+....+... .+...+...+....+.+.++..+.
T Consensus       273 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (353)
T cd07850         273 PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIY  350 (353)
T ss_pred             CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCCCCccccccccccccHHHHHHHHH
Confidence                   1234667999999999999999999999999999987664433222 222223222223344455555444

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-45  Score=311.76  Aligned_cols=236  Identities=28%  Similarity=0.399  Sum_probs=203.7

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      .|.+|++.||+|++..+.. +.+...+.+|+.++..++++||.++|+.|..+     ..++++||||+ |++.+.++..+
T Consensus        33 ~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~LwiiMey~~gGsv~~lL~~~~  106 (467)
T KOG0201|consen   33 IDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLWIIMEYCGGGSVLDLLKSGN  106 (467)
T ss_pred             eeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHHHHHHHhcCcchhhhhccCC
Confidence            4789999999999987643 33667899999999999999999999999876     45999999996 79999999988


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+.+.++..++++++.||.|||.++.+|||||+.||++...|.+||+|||.+........ ...+.||+.|||||++.. 
T Consensus       107 ~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-  185 (467)
T KOG0201|consen  107 ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-  185 (467)
T ss_pred             CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcc-
Confidence            889999999999999999999999999999999999999999999999999887665543 378899999999999985 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..|+.++||||||++.+||++|.||+.....+..+-.|                              +...++..-..+
T Consensus       186 ~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------------------------pk~~PP~L~~~~  235 (467)
T KOG0201|consen  186 SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------------------------PKSAPPRLDGDF  235 (467)
T ss_pred             ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------------------------cCCCCCcccccc
Confidence            78999999999999999999999999887653322211                              111122222378


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      |+.+++|+..||+.||+.||||.+||+|+|++...
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            99999999999999999999999999999999854

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-42  Score=306.42  Aligned_cols=235  Identities=23%  Similarity=0.385  Sum_probs=195.6

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++... ........+..|..++..+ +||||+++++++...     ..+|+||||++ |+|.+++...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~Ey~~~g~L~~~i~~~   90 (320)
T cd05590          16 LKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVMEFVNGGDLMFHIQKS   90 (320)
T ss_pred             EcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEEcCCCCchHHHHHHHc
Confidence            56789999999997543 2233456677888888876 799999999998654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.... .........+++.|+|||.+.+
T Consensus        91 ~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (320)
T cd05590          91 RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE  170 (320)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC
Confidence            899999999999999999999999999999999999999999999999999886532 2223345578999999999976


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+......                               ....
T Consensus       171 -~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~~~~  218 (320)
T cd05590         171 -MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-------------------------------YPTW  218 (320)
T ss_pred             -CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-------------------------------CCCC
Confidence             67899999999999999999999999888766665554321100                               0124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~------~ell~~~~f~~~~  273 (316)
                      ++.++.++|++||+.||.+|+++      +++++||||+.+.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence            68889999999999999999998      8999999999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.5e-42  Score=304.72  Aligned_cols=288  Identities=49%  Similarity=0.896  Sum_probs=223.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++............+.+|+.+++++ +||||+++++++...+   ....++||||++++|.+++... .
T Consensus        28 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~~-~  103 (337)
T cd07852          28 DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---DKDIYLVFEYMETDLHAVIRAN-I  103 (337)
T ss_pred             EcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---CceEEEEecccccCHHHHHhcC-C
Confidence            456899999999866544444556677899999999 9999999999886432   1468999999999999998775 7


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC------ccccccccccccCccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD------FMTEYVVTRWYRAPEL  154 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~aPE~  154 (316)
                      +++..++.++.||+.||++||+.||+|+||+|+||+++.++.++|+|||.+.......      ......++..|+|||.
T Consensus       104 ~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  183 (337)
T cd07852         104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI  183 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCcee
Confidence            8999999999999999999999999999999999999999999999999887653322      1223457888999998


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      +.+...++.++|+||||+++|+|++|++||.+.+.......+....+.+...............................
T Consensus       184 ~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (337)
T cd07852         184 LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL  263 (337)
T ss_pred             eeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh
Confidence            87656678999999999999999999999998887777777776666554332222211112222222222223333444


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS  293 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~  293 (316)
                      .+.++.++.++|.+||+.||.+|||+.++++||||+++......+....++..-+..+.
T Consensus       264 ~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (337)
T cd07852         264 LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNV  322 (337)
T ss_pred             ccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCccccc
Confidence            55689999999999999999999999999999999999877776665555554443333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.4e-43  Score=309.20  Aligned_cols=235  Identities=26%  Similarity=0.422  Sum_probs=196.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|+++...........+..|++++++++||||+++++++...     ..+|+||||++ |+|.+.+.....
T Consensus        20 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   94 (318)
T cd05582          20 GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVM   94 (318)
T ss_pred             cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCC
Confidence            356899999999976543444455677899999999999999999998654     56999999996 799999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||+|||++||+||||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+ .
T Consensus        95 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~  173 (318)
T cd05582          95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-R  173 (318)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC-C
Confidence            999999999999999999999999999999999999999999999999998765433 22334578899999999977 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|+.||...+.......+......                               ....++
T Consensus       174 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~-------------------------------~p~~~~  222 (318)
T cd05582         174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-------------------------------MPQFLS  222 (318)
T ss_pred             CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC-------------------------------CCCCCC
Confidence            7889999999999999999999999887765555544321100                               012468


Q ss_pred             hHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      +.+.++|++||+.||++||+     ++++++||||..+.
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            88999999999999999999     77899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=307.66  Aligned_cols=241  Identities=24%  Similarity=0.425  Sum_probs=199.2

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||+++..... ......+..|+.++..++||||+++++++...     ...|+||||++ |+|.+++...+
T Consensus        22 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~   96 (333)
T cd05600          22 KKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EYLYLAMEYVPGGDFRTLLNNLG   96 (333)
T ss_pred             ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcC
Confidence            4568999999999764322 23446678999999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....  ......++..|+|||.+.+ .
T Consensus        97 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~  173 (333)
T cd05600          97 VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG-K  173 (333)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcC-C
Confidence            899999999999999999999999999999999999999999999999999876543  2345578899999999987 5


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|..||...+..+....+..........                       ........++
T Consensus       174 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----------------------~~~~~~~~~s  230 (333)
T cd05600         174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP-----------------------VYDDPRFNLS  230 (333)
T ss_pred             CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCC-----------------------CCCccccccC
Confidence            78999999999999999999999998877666655544321111000                       0001113568


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .++.++|.+||..+|.+||+++++++||||++..
T Consensus       231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence            8999999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-42  Score=308.07  Aligned_cols=229  Identities=25%  Similarity=0.374  Sum_probs=193.2

Q ss_pred             CceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCCH
Q 021181            6 REEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~   83 (316)
                      +..||+|++.... ........+..|+.+++.++||||+++++++...     ..+|+||||+. |+|.+++...+.+++
T Consensus        56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~~~~  130 (340)
T PTZ00426         56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-----SYLYLVLEFVIGGEFFTFLRRNKRFPN  130 (340)
T ss_pred             CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCH
Confidence            4689999996542 2233456778999999999999999999999654     56999999995 799999998889999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA  163 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (316)
                      ..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......  .....+++.|+|||++.+ ..++.
T Consensus       131 ~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~  207 (340)
T PTZ00426        131 DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLN-VGHGK  207 (340)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhC-CCCCc
Confidence            999999999999999999999999999999999999999999999998765432  234578999999999977 67889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHH
Q 021181          164 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV  243 (316)
Q Consensus       164 ~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  243 (316)
                      ++|||||||++|+|++|.+||.+.+.......+......                               ....+++.+.
T Consensus       208 ~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~~~~~~~  256 (340)
T PTZ00426        208 AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-------------------------------FPKFLDNNCK  256 (340)
T ss_pred             cccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-------------------------------CCCCCCHHHH
Confidence            999999999999999999999887765555544321100                               0124678899


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          244 DLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       244 ~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ++|++||+.||++|+     +++++++||||+++.
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            999999999999995     899999999999875

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-42  Score=304.77  Aligned_cols=234  Identities=26%  Similarity=0.444  Sum_probs=194.4

Q ss_pred             CCCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            3 SETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ..+|+.||||+++....  .......+..|+.+++.++||||+++++++...     ..+|+||||++ |+|.+.+...+
T Consensus        21 ~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~   95 (323)
T cd05584          21 ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMHLEREG   95 (323)
T ss_pred             CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeEEEEEeCCCCchHHHHHHHcC
Confidence            46899999999975422  223345677899999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+ 
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  174 (323)
T cd05584          96 IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-  174 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccC-
Confidence            899999999999999999999999999999999999999999999999998865322 222334568999999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||...+.......+.....                               ...+.+
T Consensus       175 ~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-------------------------------~~~~~~  223 (323)
T cd05584         175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-------------------------------NLPPYL  223 (323)
T ss_pred             CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------------------CCCCCC
Confidence            6688999999999999999999999988776555544432110                               011246


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ++.+.++|++||+.||++||     +++++++||||....
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            88899999999999999999     899999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-41  Score=300.87  Aligned_cols=292  Identities=52%  Similarity=0.921  Sum_probs=232.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      +..+|+.||||++............+..|+.+++.++||||+++++++....    ...+++|||++++|.+++.. .++
T Consensus        31 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~-~~~  105 (328)
T cd07856          31 DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----EDIYFVTELLGTDLHRLLTS-RPL  105 (328)
T ss_pred             ECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----CcEEEEeehhccCHHHHHhc-CCC
Confidence            4678999999998765444445677889999999999999999999986432    45899999999899888754 568


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      ++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  .....++..|+|||.+.+...+
T Consensus       106 ~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~  183 (328)
T cd07856         106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKY  183 (328)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCc
Confidence            89999999999999999999999999999999999999999999999988754332  2334567789999987664568


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          162 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      +.++|+|||||++|+|++|.+||...+.......+....+.++..............+................+.++..
T Consensus       184 ~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (328)
T cd07856         184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPS  263 (328)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHH
Confidence            89999999999999999999999988877777777777776654433322222222222222222222233344567899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHH
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK  300 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (316)
                      +.++|++||+.+|++||++++++.||||...+....++.+.+.|.|.+..-.+-...|.
T Consensus       264 ~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (328)
T cd07856         264 AIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWK  322 (328)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhcccCCHHHHH
Confidence            99999999999999999999999999999999998889999999988777766665554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.4e-42  Score=302.19  Aligned_cols=267  Identities=39%  Similarity=0.681  Sum_probs=207.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      +..+|+.||+|+++...........+.+|+.++++++|+||+++++++....   ...+++||||++++|.+++.. ...
T Consensus        28 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~l~~~~~~  104 (309)
T cd07845          28 DTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDSIFLVMEYCEQDLASLLDNMPTP  104 (309)
T ss_pred             ECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCeEEEEEecCCCCHHHHHHhcccC
Confidence            4678999999999754333333344668999999999999999999986432   246899999999999888765 367


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+....... .......+..|+|||.+.+..
T Consensus       105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  184 (309)
T cd07845         105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT  184 (309)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCC
Confidence            8999999999999999999999999999999999999999999999999987755432 222334577899999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|.+||...+..+....+....+.+....++........... .....+...+.......+
T Consensus       185 ~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  263 (309)
T cd07845         185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF-TLPKQPYNNLKHKFPWLS  263 (309)
T ss_pred             CcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc-cccCCCCCchHHhccccC
Confidence            7889999999999999999999999999888888888887776655443322111100000 001111112222334568


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +.+.++|++||++||++|||++++++||||++.
T Consensus       264 ~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         264 EAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-42  Score=299.94  Aligned_cols=260  Identities=38%  Similarity=0.664  Sum_probs=199.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      ++.+|+.||+|+++...........+.+|+.++++++||||+++++++...     ..+++++||++++|.+.+.. .+.
T Consensus        21 ~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   95 (284)
T cd07839          21 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLTLVFEYCDQDLKKYFDSCNGD   95 (284)
T ss_pred             ECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceEEEEecCCCCHHHHHHhcCCC
Confidence            567899999999976433333345677899999999999999999998654     46999999999999888765 567


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..
T Consensus        96 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  175 (284)
T cd07839          96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  175 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCc
Confidence            9999999999999999999999999999999999999999999999999987654332 222345678899999987756


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC-CCCCccccCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF-PKQNFSARFPN  237 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  237 (316)
                      .++.++|||||||++|+|++|..|| .+.+.......+.+..+.+....+.........   ...... ....+....+.
T Consensus       176 ~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  252 (284)
T cd07839         176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY---KPYPMYPATTSLVNVVPK  252 (284)
T ss_pred             ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc---cccCCCCCcchhhhhccc
Confidence            6789999999999999999988774 555555666666665555443222111100000   000000 01112233456


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +++++.++|++||+.||.+|||++++++||||
T Consensus       253 ~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         253 LNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            88999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.1e-42  Score=307.80  Aligned_cols=238  Identities=21%  Similarity=0.337  Sum_probs=192.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||+++.... .......+..|+.++..++|++|+++++.+...     ..+|+||||++ |+|.+++...+
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~   96 (363)
T cd05628          22 KKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LNLYLIMEFLPGGDMMTLLMKKD   96 (363)
T ss_pred             ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CeEEEEEcCCCCCcHHHHHHhcC
Confidence            467899999999975422 233446678899999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---------------------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---------------------  138 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------  138 (316)
                      .+++.+++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......                     
T Consensus        97 ~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (363)
T cd05628          97 TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM  176 (363)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999999999986542210                     


Q ss_pred             ---------------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q 021181          139 ---------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP  203 (316)
Q Consensus       139 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  203 (316)
                                     .....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~  255 (363)
T cd05628         177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL  255 (363)
T ss_pred             ccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcc
Confidence                           0123468999999999987 678999999999999999999999998877666665554321111


Q ss_pred             CccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCC---CCCCHHHHhcCCCCCCCC
Q 021181          204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN---RRITVDEALCHPYLAPLH  273 (316)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~---~Rps~~ell~~~~f~~~~  273 (316)
                      ..                          . ....+++++.++|.+|+. +|.   .||+++||++||||+++.
T Consensus       256 ~~--------------------------p-~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         256 IF--------------------------P-PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             cC--------------------------C-CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            00                          0 012468899999999876 444   468999999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-41  Score=300.92  Aligned_cols=261  Identities=33%  Similarity=0.594  Sum_probs=193.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH---   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---   78 (316)
                      +..+++.||+|.+.....    ...+.+|+.++++++||||+++++++....   ...++++|||++++|.+++...   
T Consensus        24 ~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~   96 (317)
T cd07868          24 DGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFDYAEHDLWHIIKFHRAS   96 (317)
T ss_pred             cCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEeccCCCHHHHHHhcccc
Confidence            345788999999965322    234678999999999999999999986432   2568999999999998887532   


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE----ccCCCEEEeeeccccccCCCC----cccccc
Q 021181           79 ------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETD----FMTEYV  144 (316)
Q Consensus        79 ------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~----~~~~~~  144 (316)
                            ..+++..++.++.||+.||.|||+.||+||||||+||++    +.++.+||+|||++.......    ......
T Consensus        97 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  176 (317)
T cd07868          97 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV  176 (317)
T ss_pred             cccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcc
Confidence                  248999999999999999999999999999999999999    456789999999987654321    223456


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHhhCCCCccccccccccc
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---------VHQLRLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                      ++..|+|||++.+...++.++||||+||++|+|++|.+||.....         ...+..+....+.+....+.......
T Consensus       177 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (317)
T cd07868         177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMP  256 (317)
T ss_pred             ccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhcc
Confidence            789999999987756689999999999999999999999975432         24455666666655554433221110


Q ss_pred             -----hHHHhhhCCC-CCC-CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          216 -----ARRYVRMLPQ-FPK-QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       216 -----~~~~~~~~~~-~~~-~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                           ...+...... ... ..+.......+..+.++|++||++||.+|||++|+|+||||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         257 EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             chhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                 0000000000 000 00111122346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-42  Score=309.92  Aligned_cols=239  Identities=26%  Similarity=0.395  Sum_probs=192.1

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||++.... ........+..|+.+++.++|+||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus        22 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~   96 (381)
T cd05626          22 KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRME   96 (381)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHhcC
Confidence            56789999999997643 2334456788999999999999999999999654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---------------------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---------------------  138 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------  138 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......                     
T Consensus        97 ~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (381)
T cd05626          97 VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL  176 (381)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccc
Confidence            89999999999999999999999999999999999999999999999999865321000                     


Q ss_pred             ---------------------------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 021181          139 ---------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH  191 (316)
Q Consensus       139 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~  191 (316)
                                                 ......||..|+|||.+.+ ..++.++|||||||++|+|++|..||...+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~  255 (381)
T cd05626         177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE  255 (381)
T ss_pred             cccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHH
Confidence                                       0123468999999999977 678999999999999999999999998876555


Q ss_pred             HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhccc--CCCCCCCHHHHhcCCCC
Q 021181          192 QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF--DPNRRITVDEALCHPYL  269 (316)
Q Consensus       192 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~--dP~~Rps~~ell~~~~f  269 (316)
                      ....+........                           ......+++++.++|.+|+..  +|..|++++++++||||
T Consensus       256 ~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f  308 (381)
T cd05626         256 TQLKVINWENTLH---------------------------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF  308 (381)
T ss_pred             HHHHHHccccccC---------------------------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence            4444332111100                           000124789999999996654  44559999999999999


Q ss_pred             CCCC
Q 021181          270 APLH  273 (316)
Q Consensus       270 ~~~~  273 (316)
                      +++.
T Consensus       309 ~~~~  312 (381)
T cd05626         309 SEVD  312 (381)
T ss_pred             CCCC
Confidence            9865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.8e-42  Score=311.25  Aligned_cols=238  Identities=26%  Similarity=0.415  Sum_probs=192.7

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+++.||+|++.... ........+..|+.+++.++|+||+++++.+...     ..+|+||||++ |+|.+++...+
T Consensus        22 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~   96 (382)
T cd05625          22 KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMG   96 (382)
T ss_pred             ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcC
Confidence            56789999999997542 2233456788999999999999999999999654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC----------------------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET----------------------  137 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----------------------  137 (316)
                      .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......                      
T Consensus        97 ~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (382)
T cd05625          97 IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE  176 (382)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccc
Confidence            8999999999999999999999999999999999999999999999999986432100                      


Q ss_pred             --------------------------CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 021181          138 --------------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH  191 (316)
Q Consensus       138 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~  191 (316)
                                                .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~  255 (382)
T cd05625         177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE  255 (382)
T ss_pred             ccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH
Confidence                                      00112468899999999977 678999999999999999999999998877655


Q ss_pred             HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCC
Q 021181          192 QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPY  268 (316)
Q Consensus       192 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~  268 (316)
                      ....+.........                           .....+++++.++|.+|+ .||++|++   ++++++|||
T Consensus       256 ~~~~i~~~~~~~~~---------------------------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  307 (382)
T cd05625         256 TQMKVINWQTSLHI---------------------------PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF  307 (382)
T ss_pred             HHHHHHccCCCcCC---------------------------CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence            55444321111100                           011257889999999986 59999997   999999999


Q ss_pred             CCCCC
Q 021181          269 LAPLH  273 (316)
Q Consensus       269 f~~~~  273 (316)
                      |+.+.
T Consensus       308 f~~~~  312 (382)
T cd05625         308 FKTID  312 (382)
T ss_pred             cCCcC
Confidence            99875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.4e-42  Score=306.00  Aligned_cols=235  Identities=27%  Similarity=0.416  Sum_probs=194.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||+|+++.... .......+..|+++++.++||||+++++++...     ..+|+||||++ |+|...+...+
T Consensus        16 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~   90 (325)
T cd05594          16 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRER   90 (325)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcC
Confidence            467899999999976432 233446677899999999999999999998654     56999999996 69999988888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..++.++.||+.||+|||+ .||+||||||+||+++.++.++|+|||++.... .........++..|+|||++.+
T Consensus        91 ~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05594          91 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED  170 (325)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc
Confidence            89999999999999999999997 799999999999999999999999999886532 2223334568999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+......                               ....
T Consensus       171 -~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~  218 (325)
T cd05594         171 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-------------------------------FPRT  218 (325)
T ss_pred             -CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC-------------------------------CCCC
Confidence             67899999999999999999999999877655544433211000                               0124


Q ss_pred             CChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +++++.++|.+||+.||++|+     ++.++++||||.++.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            688999999999999999997     899999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=309.41  Aligned_cols=238  Identities=27%  Similarity=0.445  Sum_probs=197.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||+++.... .......+..|+.++..++|+||+++++++...     ..+|+||||+. |+|.+++...+
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   96 (350)
T cd05573          22 DKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EHLYLVMEYMPGGDLMNLLIRKD   96 (350)
T ss_pred             ECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----CeEEEEEcCCCCCCHHHHHHHcC
Confidence            456899999999976432 224456788999999999999999999998654     56999999995 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---------------------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---------------------  138 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------  138 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......                     
T Consensus        97 ~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (350)
T cd05573          97 VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR  176 (350)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccc
Confidence            89999999999999999999999999999999999999999999999999987654332                     


Q ss_pred             ---------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccc
Q 021181          139 ---------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG  209 (316)
Q Consensus       139 ---------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  209 (316)
                               ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.........    
T Consensus       177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  251 (350)
T cd05573         177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRF----  251 (350)
T ss_pred             ccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccC----
Confidence                     2234568899999999987 67899999999999999999999999888765555544331111000    


Q ss_pred             cccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCC
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-VDEALCHPYLAPLH  273 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-~~ell~~~~f~~~~  273 (316)
                                             .....+++++.++|.+||. ||.+|++ ++++++||||+++.
T Consensus       252 -----------------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         252 -----------------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence                                   0012368999999999998 9999999 99999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-42  Score=305.26  Aligned_cols=239  Identities=21%  Similarity=0.393  Sum_probs=190.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... .......+..|..++..+ +||||+++++++...     ..+|+||||++ |+|.+++...
T Consensus        16 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~   90 (329)
T cd05588          16 LKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVIEFVSGGDLMFHMQRQ   90 (329)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHc
Confidence            467899999999976532 333456678999999988 799999999998654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccccc-CCCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++... ..........++..|+|||++.+
T Consensus        91 ~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (329)
T cd05588          91 RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG  170 (329)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcC
Confidence            89999999999999999999999999999999999999999999999999988653 22233345678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-----QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                       ..++.++|+|||||++|+|++|+.||.......     ....+.+.                   .....        .
T Consensus       171 -~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~~--------~  222 (329)
T cd05588         171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-------------------ILEKQ--------I  222 (329)
T ss_pred             -CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-------------------HHcCC--------C
Confidence             678999999999999999999999996432110     00000000                   00000        0


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRIT------VDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps------~~ell~~~~f~~~~  273 (316)
                      .....++..+.++|++||+.||.+|++      ++++++||||.++.
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            111257888999999999999999997      78999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-41  Score=295.51  Aligned_cols=261  Identities=41%  Similarity=0.731  Sum_probs=206.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc--CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS--HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~--~~   79 (316)
                      +..+|+.||||+++...........+.+|++++++++||||+++++++...     ...+++|||+.++|..++..  ..
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~   95 (284)
T cd07860          21 NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASPLS   95 (284)
T ss_pred             ECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEEEEeeccccCHHHHHHhCCCC
Confidence            457899999999976544444456788999999999999999999998644     46899999998899888865  35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.
T Consensus        96 ~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  175 (284)
T cd07860          96 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC  175 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecC
Confidence            68999999999999999999999999999999999999999999999999887654322 22233457789999998765


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||...+.......+....+.+....++....  ..........+....+....+.+
T Consensus       176 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  253 (284)
T cd07860         176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--LPDYKPSFPKWARQDFSKVVPPL  253 (284)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH--HHHHHhhcccccccCHHHHcccC
Confidence            5568899999999999999999999998877777777776666554433221111  11112222233333344445568


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++++.++|.+||+.||++||+++++++||||
T Consensus       254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             CHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=309.10  Aligned_cols=238  Identities=25%  Similarity=0.446  Sum_probs=194.1

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++.... ........+.+|+.+++.++||||+++++++...     ..+|+||||+. |+|.+++...+
T Consensus        22 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~   96 (364)
T cd05599          22 KKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NYLYLIMEYLPGGDMMTLLMKKD   96 (364)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CeEEEEECCCCCcHHHHHHHHcC
Confidence            56789999999997542 2233446678899999999999999999999654     56999999996 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---------------------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---------------------  138 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------  138 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......                     
T Consensus        97 ~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (364)
T cd05599          97 TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS  176 (364)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999999999999999999999886532211                     


Q ss_pred             ------------------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhh
Q 021181          139 ------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI  200 (316)
Q Consensus       139 ------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  200 (316)
                                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~  255 (364)
T cd05599         177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWK  255 (364)
T ss_pred             ccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Confidence                              0112358999999999877 678999999999999999999999998877655554443211


Q ss_pred             CCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 021181          201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLH  273 (316)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~  273 (316)
                      ....                     .      .....+++++.++|++||. +|.+|++   ++++++||||+.+.
T Consensus       256 ~~~~---------------------~------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         256 ETLQ---------------------F------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CccC---------------------C------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            1000                     0      0001468899999999997 9999998   99999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.7e-42  Score=302.61  Aligned_cols=235  Identities=26%  Similarity=0.377  Sum_probs=195.3

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... .......+..|.+++..+ +||||+++++++...     ..+|+||||++ |+|...+...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~   90 (321)
T cd05591          16 LKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVMEYVNGGDLMFQIQRS   90 (321)
T ss_pred             ECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEEeCCCCCcHHHHHHHc
Confidence            467899999999976432 333446677888888866 799999999999654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (321)
T cd05591          91 RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE  170 (321)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcC
Confidence            8999999999999999999999999999999999999999999999999998865322 222344568999999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|+.||...+.......+......                               ....
T Consensus       171 -~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~  218 (321)
T cd05591         171 -LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-------------------------------YPVW  218 (321)
T ss_pred             -CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------------------------CCCC
Confidence             67899999999999999999999999888766665554321100                               0023


Q ss_pred             CChHHHHHHHHhcccCCCCCC-------CHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRI-------TVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rp-------s~~ell~~~~f~~~~  273 (316)
                      ++.++.++|.+||+.||++|+       +++++++||||..+.
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            678899999999999999999       899999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-43  Score=279.14  Aligned_cols=233  Identities=25%  Similarity=0.407  Sum_probs=205.9

Q ss_pred             CCCCCceEEEEEecccccCh-hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh--c
Q 021181            2 NSETREEVAIKKIGNAFDNR-IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR--S   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~--~   77 (316)
                      .++++.-||+|++.++-... ....++.+|+++.+.|+||||+++|++|.+.     ..+|+++||.. |+|+..++  .
T Consensus        43 ekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----~riyLilEya~~gel~k~L~~~~  117 (281)
T KOG0580|consen   43 EKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----KRIYLILEYAPRGELYKDLQEGR  117 (281)
T ss_pred             eccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----ceeEEEEEecCCchHHHHHHhcc
Confidence            46889999999997653322 2346778999999999999999999999876     45999999996 89999998  6


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..++++.....+++|++.||.|+|.++++||||||+|+|++..+.+|++|||-+.... ...+...+||..|.+||...+
T Consensus       118 ~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~  196 (281)
T KOG0580|consen  118 MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG  196 (281)
T ss_pred             cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCC
Confidence            6789999999999999999999999999999999999999999999999999887665 445678899999999999988


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ...+..+|+||+|++.||++.|.+||......++.++|.+.--..+                               ..
T Consensus       197 -~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p-------------------------------~~  244 (281)
T KOG0580|consen  197 -RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP-------------------------------ST  244 (281)
T ss_pred             -CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-------------------------------cc
Confidence             7899999999999999999999999999998888888876433322                               26


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ++.+++++|.+||..+|.+|.+..|++.|||+...
T Consensus       245 is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  245 ISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             cChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            78999999999999999999999999999998754

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.1e-42  Score=301.31  Aligned_cols=235  Identities=24%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+++.||||+++.... .......+..|..++..+ +||||+++++++...     ..+|+||||+. |+|...+...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   90 (318)
T cd05570          16 LKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVMEYVNGGDLMFHIQRS   90 (318)
T ss_pred             ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHc
Confidence            467899999999976432 233456677888998888 799999999998654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++.++..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.... .........++..|+|||++.+
T Consensus        91 ~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  170 (318)
T cd05570          91 GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY  170 (318)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcC
Confidence            899999999999999999999999999999999999999999999999999886532 2222334568899999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+|||||++|+|++|..||.+.+.......+.....                               .....
T Consensus       171 -~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~  218 (318)
T cd05570         171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-------------------------------RYPRW  218 (318)
T ss_pred             -CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-------------------------------CCCCc
Confidence             6789999999999999999999999987775555444322100                               00124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~  273 (316)
                      ++..+.++|++||+.||.+||++     .++++||||+++.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            68889999999999999999999     9999999998864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2e-41  Score=294.38  Aligned_cols=263  Identities=33%  Similarity=0.639  Sum_probs=199.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      ++.+|+.||+|++............+.+|+.++++++|+|++++++++...     ..++++|||+++ .|..++.....
T Consensus        22 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~   96 (286)
T cd07847          22 NRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKLHLVFEYCDHTVLNELEKNPRG   96 (286)
T ss_pred             ECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEEEEEEeccCccHHHHHHhCCCC
Confidence            456899999999875433333445678999999999999999999998654     468999999985 55666666667


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..
T Consensus        97 ~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  176 (286)
T cd07847          97 VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT  176 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCC
Confidence            9999999999999999999999999999999999999999999999999987765433 223345678899999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+|+++|+|++|.+||.+.+..+....+....+...............-..................+.++
T Consensus       177 ~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (286)
T cd07847         177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNIS  256 (286)
T ss_pred             CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCC
Confidence            67899999999999999999999999887766666665544433221111100000000000000000111222345678


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..+.++|.+||+.||++||++.|++.||||
T Consensus       257 ~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         257 SPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-41  Score=300.06  Aligned_cols=235  Identities=24%  Similarity=0.384  Sum_probs=192.3

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... ..........|..++... +||+|+++++++...     ..+|+||||+. |+|...+...
T Consensus        16 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~   90 (316)
T cd05620          16 LKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVMEFLNGGDLMFHIQDK   90 (316)
T ss_pred             ECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEECCCCCCcHHHHHHHc
Confidence            467899999999976432 223445567788887654 899999999998654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++.++..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||++.+
T Consensus        91 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05620          91 GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG  170 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC
Confidence            8899999999999999999999999999999999999999999999999998764322 222345668999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+....   +                            .....
T Consensus       171 -~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~---~----------------------------~~~~~  218 (316)
T cd05620         171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT---P----------------------------HYPRW  218 (316)
T ss_pred             -CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---C----------------------------CCCCC
Confidence             678999999999999999999999998777655544432210   0                            00123


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV-DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~-~ell~~~~f~~~~  273 (316)
                      ++.++.++|++||+.||++|+++ +++++||||+.+.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            68889999999999999999998 5899999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.7e-41  Score=292.77  Aligned_cols=263  Identities=38%  Similarity=0.694  Sum_probs=207.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      +..+|+.||+|++............+.+|+.++++++||||+++++++...     ...++||||++++|.+++.. ...
T Consensus        21 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~L~~~~~~~~~~   95 (286)
T cd07832          21 DRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFVLVMEYMPSDLSEVLRDEERP   95 (286)
T ss_pred             ECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeEEEecccCCCHHHHHHhcCCC
Confidence            456899999999976544444567788999999999999999999998654     56899999998899998864 456


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++.+++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+.
T Consensus        96 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  175 (286)
T cd07832          96 LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA  175 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeecc
Confidence            8999999999999999999999999999999999999999999999999987765432  12345678899999998765


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++||||+||++++|++|.+||.+.+.......+....+.+....++.......... -.........+....+..
T Consensus       176 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  254 (286)
T cd07832         176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK-ITFPESKPIPLEEIFPDA  254 (286)
T ss_pred             ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc-ccCCCCCcchHHHhCCCc
Confidence            6678999999999999999999999988877777777776666554433332211111000 000111111233444567


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      +..+.++|++||+.||.+||+++++++||||.
T Consensus       255 ~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         255 SPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            89999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.6e-42  Score=302.14  Aligned_cols=235  Identities=25%  Similarity=0.442  Sum_probs=192.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHH-HHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||++..... .......+..|.. +++.++||||+++++.+...     ..+|+||||+. |+|..++...
T Consensus        16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~   90 (323)
T cd05575          16 HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVLDYVNGGELFFHLQRE   90 (323)
T ss_pred             ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEEcCCCCCCHHHHHHhc
Confidence            567899999999975422 2223344555555 56788999999999998654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (323)
T cd05575          91 RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK  170 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC
Confidence            8999999999999999999999999999999999999999999999999998865322 223344568999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||...+.......+...   .                            ....+.
T Consensus       171 -~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~----------------------------~~~~~~  218 (323)
T cd05575         171 -QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P----------------------------LRLKPN  218 (323)
T ss_pred             -CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C----------------------------CCCCCC
Confidence             67899999999999999999999999887755554443321   0                            011235


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~  273 (316)
                      ++..+.++|++||+.||.+||++    .++++||||.++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            68899999999999999999988    6999999998865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-41  Score=314.94  Aligned_cols=262  Identities=24%  Similarity=0.387  Sum_probs=197.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC------CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHh
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII   75 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l   75 (316)
                      |..+++.||||+++...   ........|+.+++.++      |.+++++++++....    .++|+||++++++|.+++
T Consensus       150 ~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~----~~~~iv~~~~g~~l~~~l  222 (467)
T PTZ00284        150 DRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET----GHMCIVMPKYGPCLLDWI  222 (467)
T ss_pred             EcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC----ceEEEEEeccCCCHHHHH
Confidence            56789999999996421   12234456777776664      445888888886432    579999999999999999


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCC----------------CEEEeeeccccccCCCC
Q 021181           76 RSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANC----------------DLKIGDFGLARTTSETD  138 (316)
Q Consensus        76 ~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~----------------~~~l~df~~~~~~~~~~  138 (316)
                      ...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++                .+||+|||.+.....  
T Consensus       223 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--  300 (467)
T PTZ00284        223 MKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--  300 (467)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--
Confidence            888899999999999999999999997 6999999999999998765                499999998754322  


Q ss_pred             ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHH
Q 021181          139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR  218 (316)
Q Consensus       139 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  218 (316)
                      ......+|..|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+.+..+..+..+...........
T Consensus       301 ~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~  379 (467)
T PTZ00284        301 SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARL  379 (467)
T ss_pred             ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHH
Confidence            2345678999999999987 679999999999999999999999999988888888888888877654332211111111


Q ss_pred             HhhhCCCCCCC----Ccc-------ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          219 YVRMLPQFPKQ----NFS-------ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       219 ~~~~~~~~~~~----~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +..........    .+.       ......++.+.+||++||++||++|||++|+|+||||.++.
T Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~  445 (467)
T PTZ00284        380 LYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY  445 (467)
T ss_pred             HhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence            11111000000    000       00001256688999999999999999999999999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=262.73  Aligned_cols=265  Identities=39%  Similarity=0.667  Sum_probs=225.6

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      +|++|++-||+|.++.+..++..-...++|+.+++.++|.|||+++++....     ..+-+|+|||+.+|..+..+ ++
T Consensus        22 rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kkltlvfe~cdqdlkkyfdslng   96 (292)
T KOG0662|consen   22 RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSLNG   96 (292)
T ss_pred             ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeEEeHHHhhHHHHHHHHhcCC
Confidence            5789999999999998877777778899999999999999999999998544     45899999999999888755 57


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+..+.++.++.|++.||.++|+.++.|||+||+|.+++.+|++|+.|||+++.++... ..+..+-|.+|.+|.++.+.
T Consensus        97 ~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfga  176 (292)
T KOG0662|consen   97 DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA  176 (292)
T ss_pred             cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeee
Confidence            79999999999999999999999999999999999999999999999999999887664 45566779999999999998


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      +-|+.+.|+||.||++.|+.. |++.|.+.+..+++++|.+.+|.+....|+....-+  ++..-..--....+....|.
T Consensus       177 kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp--dyk~yp~ypattswsqivp~  254 (292)
T KOG0662|consen  177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP--DYKPYPIYPATTSWSQIVPK  254 (292)
T ss_pred             ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC--CCcccCCccccchHHHHhhh
Confidence            889999999999999999986 999999999999999999999999887775432211  11111111112334455566


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ++..-+++++++|..+|..|.++++.++||||.+.
T Consensus       255 lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  255 LNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             hcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            77778999999999999999999999999999863

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9e-42  Score=302.65  Aligned_cols=239  Identities=21%  Similarity=0.391  Sum_probs=189.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||+|+++.... .......+..|+.++.++ +||||+++++++...     ..+++||||+. |+|...+...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~~   90 (329)
T cd05618          16 LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQ   90 (329)
T ss_pred             ECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEEeCCCCCCHHHHHHHc
Confidence            467899999999976532 333456678899988777 899999999998654     56999999996 6999998888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.... .........++..|+|||++.+
T Consensus        91 ~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (329)
T cd05618          91 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG  170 (329)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcC
Confidence            899999999999999999999999999999999999999999999999999987532 2223345678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-----HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                       ..++.++|||||||++|+|++|..||......     .....+....                   ....        .
T Consensus       171 -~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-------------------~~~~--------~  222 (329)
T cd05618         171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------------------LEKQ--------I  222 (329)
T ss_pred             -CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-------------------hcCC--------C
Confidence             67899999999999999999999999532110     0000000000                   0000        0


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRIT------VDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps------~~ell~~~~f~~~~  273 (316)
                      .....++..+.++|++||+.||++||+      ++++++||||+++.
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            111356888999999999999999998      47999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.3e-41  Score=297.47  Aligned_cols=235  Identities=26%  Similarity=0.415  Sum_probs=191.8

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+|+.||||+++.... ..........|..++..+ +||||+++++++...     ..+|+||||++ |+|.+++...
T Consensus        16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~gg~L~~~~~~~   90 (316)
T cd05592          16 LKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVMEYLNGGDLMFHIQSS   90 (316)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEEcCCCCCcHHHHHHHc
Confidence            457899999999976432 223344556677777654 899999999998644     56999999995 7999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05592          91 GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG  170 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC
Confidence            8999999999999999999999999999999999999999999999999999875432 223345578999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+....   +                            .....
T Consensus       171 -~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---~----------------------------~~~~~  218 (316)
T cd05592         171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR---P----------------------------HFPRW  218 (316)
T ss_pred             -CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---C----------------------------CCCCC
Confidence             678999999999999999999999998887655554443210   0                            00124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~  273 (316)
                      ++.++.++|.+||+.||.+||++. ++++||||..+.
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence            688899999999999999999875 888999999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.8e-41  Score=293.00  Aligned_cols=267  Identities=42%  Similarity=0.699  Sum_probs=206.7

Q ss_pred             CCCCCceEEEEEecccccC---hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDN---RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      +..+|+.||||+++.....   ......+..|+.+++.++|+||+++++++...     ...++||||++|+|.+++...
T Consensus        21 ~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~i~~~   95 (298)
T cd07841          21 DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----SNINLVFEFMETDLEKVIKDK   95 (298)
T ss_pred             ECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----CEEEEEEcccCCCHHHHHhcc
Confidence            4567999999999765433   33345677899999999999999999999653     569999999988999999876


Q ss_pred             C-CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccccc
Q 021181           79 Q-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  156 (316)
                      . .+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (298)
T cd07841          96 SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF  175 (298)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHh
Confidence            6 79999999999999999999999999999999999999999999999999987654432 222334577899999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +...++.++|+|||||++|+|++|.++|.+.+.......+....+.+....+........  .. .....+.........
T Consensus       176 ~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~  252 (298)
T cd07841         176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD--YV-EFKPFPPTPLKQIFP  252 (298)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc--cc-cccccCCcchhhhcc
Confidence            656778999999999999999999999988776666666655544433322211111000  00 000111112233345


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      ..+..+.++|.+||.+||++|||+.|+++|+||++.....
T Consensus       253 ~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         253 AASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            6788999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.5e-41  Score=297.94  Aligned_cols=262  Identities=21%  Similarity=0.338  Sum_probs=196.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|..||+|.+.... .......+.+|+++++.++||||+++++++...     ..+++||||++ |+|.+++...+.
T Consensus        26 ~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   99 (331)
T cd06649          26 HKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEAKR   99 (331)
T ss_pred             ECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEeecCCCCcHHHHHHHcCC
Confidence            46789999999997643 334457789999999999999999999998654     46999999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+ .
T Consensus       100 ~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~  177 (331)
T cd06649         100 IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-T  177 (331)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC-C
Confidence            99999999999999999999976 6999999999999999999999999998765432 2234568899999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccc-------------------cccccchHHHh
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG-------------------FLRSDNARRYV  220 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------------------~~~~~~~~~~~  220 (316)
                      .++.++|||||||++|+|++|+.||...+..+....+.............                   ...........
T Consensus       178 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T cd06649         178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELL  257 (331)
T ss_pred             CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHH
Confidence            78999999999999999999999998776544433221111000000000                   00000000011


Q ss_pred             hhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          221 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ........  .......+++++++||.+||+.||++|||+++|++||||+...
T Consensus       258 ~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         258 DYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             HHHHhCCC--cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            11100000  0111124788999999999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4e-41  Score=293.85  Aligned_cols=264  Identities=39%  Similarity=0.702  Sum_probs=204.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-D   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~   80 (316)
                      ++.+|+.||+|.++.....+.....+.+|+.++++++||||+++++++....   ....|+||||++++|.+++.... .
T Consensus        26 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~~~~~  102 (293)
T cd07843          26 DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKIYMVMEYVEHDLKSLMETMKQP  102 (293)
T ss_pred             ECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcEEEEehhcCcCHHHHHHhccCC
Confidence            4568999999999765444333445678999999999999999999886542   25699999999999998887644 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+..
T Consensus       103 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  182 (293)
T cd07843         103 FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAK  182 (293)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCc
Confidence            899999999999999999999999999999999999999999999999988776543 2233445678899999987655


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC--
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN--  237 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  237 (316)
                      .++.++|+||+|+++|+|++|.+||...........+....+.+....+.....-....- ..........+...++.  
T Consensus       183 ~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  261 (293)
T cd07843         183 EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK-KTFTKYPYNQLRKKFPALS  261 (293)
T ss_pred             cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc-cccccccchhhhccccccC
Confidence            578999999999999999999999998888877777777666655443322111000000 00001111112233333  


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +++.+.++|++||+.||++|||++|++.||||
T Consensus       262 ~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         262 LSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             CChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.6e-42  Score=308.68  Aligned_cols=238  Identities=26%  Similarity=0.395  Sum_probs=192.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++..... .......+.+|+.+++.++|+||+++++.+...     ..+|+||||++ |+|.+++...+
T Consensus        22 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~   96 (376)
T cd05598          22 KVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRLG   96 (376)
T ss_pred             ECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcC
Confidence            567899999999965322 223446678999999999999999999999654     56999999996 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC----------------------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET----------------------  137 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----------------------  137 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......                      
T Consensus        97 ~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (376)
T cd05598          97 IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE  176 (376)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccc
Confidence            8999999999999999999999999999999999999999999999999986422100                      


Q ss_pred             ----------------------CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 021181          138 ----------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL  195 (316)
Q Consensus       138 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~  195 (316)
                                            .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~  255 (376)
T cd05598         177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK  255 (376)
T ss_pred             ccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHH
Confidence                                  00113468899999999977 6789999999999999999999999988776555444


Q ss_pred             HHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCC
Q 021181          196 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPL  272 (316)
Q Consensus       196 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~~~~f~~~  272 (316)
                      +........                           ......+++++.++|.+|+ .+|.+|+   ++.++++||||+.+
T Consensus       256 i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         256 VINWETTLH---------------------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             HhccCcccc---------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            322111000                           0011257889999999977 5999999   99999999999986


Q ss_pred             C
Q 021181          273 H  273 (316)
Q Consensus       273 ~  273 (316)
                      .
T Consensus       308 ~  308 (376)
T cd05598         308 D  308 (376)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.9e-41  Score=292.09  Aligned_cols=239  Identities=24%  Similarity=0.385  Sum_probs=189.6

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh---
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR---   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~---   76 (316)
                      +..+|+.||+|++..... .......+..|+.+++.++|+||+++++++...     ..+++||||++ |+|...+.   
T Consensus        14 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~   88 (280)
T cd05608          14 MRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIMNGGDLRYHIYNVD   88 (280)
T ss_pred             EccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCCCCCCHHHHHHhcc
Confidence            467899999999975432 222335677899999999999999999988544     56999999996 68887763   


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCccc
Q 021181           77 -SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPEL  154 (316)
Q Consensus        77 -~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~  154 (316)
                       ....+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||.+........ .....++..|+|||.
T Consensus        89 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  168 (280)
T cd05608          89 EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL  168 (280)
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHH
Confidence             335689999999999999999999999999999999999999999999999999876543322 234567889999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      +.+ ..++.++|+|||||++|+|++|+.||...+.......+.......+                           ...
T Consensus       169 ~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~  220 (280)
T cd05608         169 LQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS---------------------------VTY  220 (280)
T ss_pred             hcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---------------------------CCC
Confidence            987 6788999999999999999999999976543222211111100000                           011


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ...+++.+.+++.+||+.||++||     +++++++||||+.+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence            135788999999999999999999     789999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=306.81  Aligned_cols=238  Identities=22%  Similarity=0.362  Sum_probs=191.2

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++.... ........+.+|+++++.++||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~   96 (377)
T cd05629          22 KKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QYLYLIMEFLPGGDLMTMLIKYD   96 (377)
T ss_pred             ECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CeeEEEEeCCCCCcHHHHHHhcC
Confidence            46789999999986532 2233456778899999999999999999999654     56999999995 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-------------c-------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-------------F-------  139 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-------------~-------  139 (316)
                      .+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......             .       
T Consensus        97 ~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (377)
T cd05629          97 TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR  176 (377)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999999999999999999999885321100             0       


Q ss_pred             ----------------------------cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 021181          140 ----------------------------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH  191 (316)
Q Consensus       140 ----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~  191 (316)
                                                  .....|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~  255 (377)
T cd05629         177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHE  255 (377)
T ss_pred             cccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHH
Confidence                                        012458899999999977 678999999999999999999999998877655


Q ss_pred             HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCC---CCHHHHhcCCC
Q 021181          192 QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR---ITVDEALCHPY  268 (316)
Q Consensus       192 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~ell~~~~  268 (316)
                      ....+........                     .      .....++.++.++|.+||. +|.+|   +++.++++|||
T Consensus       256 ~~~~i~~~~~~~~---------------------~------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~  307 (377)
T cd05629         256 TYRKIINWRETLY---------------------F------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF  307 (377)
T ss_pred             HHHHHHccCCccC---------------------C------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence            5544432111100                     0      0012468899999999998 77665   59999999999


Q ss_pred             CCCCC
Q 021181          269 LAPLH  273 (316)
Q Consensus       269 f~~~~  273 (316)
                      |+++.
T Consensus       308 ~~~~~  312 (377)
T cd05629         308 FRGVD  312 (377)
T ss_pred             cCCCC
Confidence            98764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-41  Score=300.23  Aligned_cols=238  Identities=21%  Similarity=0.357  Sum_probs=190.2

Q ss_pred             CCCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            3 SETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ..+|+.||+|++.....  .......+..|+.+++.+ +|++|+++++++...     ..+++||||++ |+|.+++...
T Consensus        25 ~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~   99 (332)
T cd05614          25 HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE-----AKLHLILDYVSGGEMFTHLYQR   99 (332)
T ss_pred             CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC-----CEEEEEEeCCCCCcHHHHHHHc
Confidence            46899999999965322  223346678899999999 599999999998644     56899999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++.+++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......  ......++..|+|||.+.
T Consensus       100 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  179 (332)
T cd05614         100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR  179 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhc
Confidence            889999999999999999999999999999999999999999999999999987643221  223456899999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-hhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE-LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      +...++.++|||||||++|+|++|..||...........+.. .....                            ....
T Consensus       180 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------------------------~~~~  231 (332)
T cd05614         180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD----------------------------PPFP  231 (332)
T ss_pred             CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC----------------------------CCCC
Confidence            645678899999999999999999999965432211111111 00000                            0011


Q ss_pred             CCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ..+++.+.++|.+||+.||++||     +++++++||||++..
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            25788899999999999999999     888999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-41  Score=290.99  Aligned_cols=239  Identities=23%  Similarity=0.379  Sum_probs=192.8

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +..+|+.||||++...... ......+.+|+.+++.++||||+++++.+...     ..+++||||+. |+|.+.+... 
T Consensus        21 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~   95 (285)
T cd05605          21 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYNMG   95 (285)
T ss_pred             EcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeEEEEEeccCCCcHHHHHHhcC
Confidence            4568999999999754322 22335567899999999999999999998654     46999999996 6898877543 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.............++..|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (285)
T cd05605          96 NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN  175 (285)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC
Confidence             4689999999999999999999999999999999999999999999999999877654433344578899999999976


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||+||++|+|++|..||.+.+.......+........                           ......
T Consensus       176 -~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  227 (285)
T cd05605         176 -ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------------------------EEYSEK  227 (285)
T ss_pred             -CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------------------------cccCcc
Confidence             6789999999999999999999999987654433333322111100                           011124


Q ss_pred             CChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ++..+.++|.+||+.||.+||     +++++++||||.+..
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            788899999999999999999     899999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.8e-41  Score=295.02  Aligned_cols=235  Identities=26%  Similarity=0.412  Sum_probs=192.3

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+|+.||||+++.... ..........|..++... +||||+++++++...     ..+++||||++ |+|.+.+...
T Consensus        16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~   90 (316)
T cd05619          16 LKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVMEYLNGGDLMFHIQSC   90 (316)
T ss_pred             ECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHc
Confidence            467899999999976432 222345566777787764 899999999998654     56999999996 7999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... ........++..|+|||++.+
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05619          91 HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG  170 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC
Confidence            8899999999999999999999999999999999999999999999999998865322 222334568899999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||+||++|+|++|..||.+.+.......+......                               ....
T Consensus       171 -~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-------------------------------~~~~  218 (316)
T cd05619         171 -QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC-------------------------------YPRW  218 (316)
T ss_pred             -CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------------------CCcc
Confidence             67899999999999999999999999887765554443221000                               0013


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~  273 (316)
                      ++.++.++|.+||+.||++||++. ++++||||+.+.
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence            678899999999999999999996 899999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.3e-41  Score=297.83  Aligned_cols=235  Identities=25%  Similarity=0.386  Sum_probs=193.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCC-CCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+++.||||+++.... .......+..|+.++..+.| ++|+++++++...     ..+|+||||++ |+|.+.+...
T Consensus        21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~   95 (324)
T cd05587          21 RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQV   95 (324)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHc
Confidence            467889999999976432 33345677889999999965 5688888888554     46999999996 7999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.... .........++..|+|||++.+
T Consensus        96 ~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  175 (324)
T cd05587          96 GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY  175 (324)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC
Confidence            889999999999999999999999999999999999999999999999999886532 2222344568999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||+||++|+|++|+.||.+.+.......+......                               ....
T Consensus       176 -~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-------------------------------~~~~  223 (324)
T cd05587         176 -QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-------------------------------YPKS  223 (324)
T ss_pred             -CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------------------------CCCC
Confidence             67899999999999999999999999887766655554321110                               0124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~  273 (316)
                      ++.++.+++++||+.||.+|+++     +++++||||+.+.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            68889999999999999999986     8999999999865

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=287.34  Aligned_cols=235  Identities=28%  Similarity=0.424  Sum_probs=206.0

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      .+.||+.||+|+++++.. ...+...-+.|-++|+.++||.+..+.-.|...     ..+|+||||+. |.|+-.+.+.+
T Consensus       189 EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----drlCFVMeyanGGeLf~HLsrer  263 (516)
T KOG0690|consen  189 EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----DRLCFVMEYANGGELFFHLSRER  263 (516)
T ss_pred             ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----ceEEEEEEEccCceEeeehhhhh
Confidence            578999999999998753 444556778999999999999999988888544     56999999995 79999998889


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc-cCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++...+.+..+|+.||.|||+++|++||+|.+|.|+|.+|.+||.|||+++. +.....+..++||+.|+|||++.. 
T Consensus       264 ~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-  342 (516)
T KOG0690|consen  264 VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-  342 (516)
T ss_pred             cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhcc-
Confidence            999999999999999999999999999999999999999999999999999987 455566788999999999999988 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..|+.++|.|.+|++||||++|+.||...+.......|..---..+                               ..+
T Consensus       343 nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP-------------------------------r~l  391 (516)
T KOG0690|consen  343 NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP-------------------------------RTL  391 (516)
T ss_pred             ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC-------------------------------ccC
Confidence            8899999999999999999999999999887776665543111111                               257


Q ss_pred             ChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      |++++.|+..+|..||.+|..     +.|+.+|+||..++
T Consensus       392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            999999999999999999994     78999999999987

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-41  Score=297.80  Aligned_cols=234  Identities=24%  Similarity=0.401  Sum_probs=190.2

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHH---hhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLL---RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      ++.+|+.||||+++... ........+..|+.++   +.++||||+++++++...     ..+|+||||++ |+|...+.
T Consensus        20 ~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~   94 (324)
T cd05589          20 YKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----DHVCFVMEYAAGGDLMMHIH   94 (324)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----CEEEEEEcCCCCCcHHHHhh
Confidence            46789999999997543 2223445666776655   466899999999998654     56999999996 68887775


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~  155 (316)
                      . ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..... ........++..|+|||.+
T Consensus        95 ~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  173 (324)
T cd05589          95 T-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL  173 (324)
T ss_pred             c-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHh
Confidence            4 6799999999999999999999999999999999999999999999999998865322 2223456789999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|..||.+.+.......+......                               ..
T Consensus       174 ~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-------------------------------~p  221 (324)
T cd05589         174 TE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-------------------------------YP  221 (324)
T ss_pred             cC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------------------CC
Confidence            77 67899999999999999999999999887766555544331110                               01


Q ss_pred             CCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ..++..+.++|++||+.||.+||     ++.++++||||+++.
T Consensus       222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            24688899999999999999999     689999999999865

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=302.33  Aligned_cols=237  Identities=24%  Similarity=0.390  Sum_probs=191.6

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      ++.+|+.||||++..... ..........|..++..+   .||+|+++++++...     ..+|+||||+. |+|...+.
T Consensus        14 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~   88 (330)
T cd05586          14 KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVTDYMSGGELFWHLQ   88 (330)
T ss_pred             ECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEEcCCCCChHHHHHH
Confidence            567899999999965322 222334455677777655   699999999998654     56999999996 69999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~  155 (316)
                      ..+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+
T Consensus        89 ~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  168 (330)
T cd05586          89 KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL  168 (330)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHH
Confidence            888999999999999999999999999999999999999999999999999999865322 2233456789999999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+...++.++|||||||++|+|++|..||...+.......+.......+                              .
T Consensus       169 ~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------~  218 (330)
T cd05586         169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP------------------------------K  218 (330)
T ss_pred             cCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------C
Confidence            7655689999999999999999999999988776555444422110000                              0


Q ss_pred             CCCChHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRI----TVDEALCHPYLAPLH  273 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rp----s~~ell~~~~f~~~~  273 (316)
                      ..+++++.++|++||+.||.+||    +++++++||||++..
T Consensus       219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            13688899999999999999998    689999999998764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-41  Score=289.94  Aligned_cols=261  Identities=42%  Similarity=0.747  Sum_probs=205.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--   79 (316)
                      ++.+|+.||||++............+.+|+.+++.++|||++++++++...     ...+++|||++++|.+++...+  
T Consensus        20 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~iv~e~~~~~l~~~~~~~~~~   94 (283)
T cd07835          20 DKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSSPLT   94 (283)
T ss_pred             EcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEEEEeccCcCHHHHHhhCCCC
Confidence            456899999999976543343445678899999999999999999998654     5699999999989999987766  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.
T Consensus        95 ~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  174 (283)
T cd07835          95 GLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGS  174 (283)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecC
Confidence            68999999999999999999999999999999999999999999999999987654321 12233457889999988764


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|+||||+++|+|++|.+||...+.......+....+.+....+....  ....+....+...........+.+
T Consensus       175 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd07835         175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT--SLPDYKPTFPKWARQDLSKVVPNL  252 (283)
T ss_pred             cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh--hchhhhhhcccccccchhhhcCCC
Confidence            567889999999999999999999998887766666666555544433221110  111122222233333334445678


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +..+.++|.+||+.||.+||+++|++.||||
T Consensus       253 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         253 DEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            8999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-40  Score=291.31  Aligned_cols=266  Identities=41%  Similarity=0.732  Sum_probs=206.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~-   80 (316)
                      ++.+|+.||+|++............+..|+.++++++||||+++++++...     ...++||||++++|.+.+..... 
T Consensus        23 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   97 (294)
T PLN00009         23 DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRLYLVFEYLDLDLKKHMDSSPDF   97 (294)
T ss_pred             ecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeEEEEEecccccHHHHHHhCCCC
Confidence            457899999999976543333446678999999999999999999998654     56999999999899888865443 


Q ss_pred             -CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           81 -LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 -~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                       +++..++.++.||+.||++||+.|++|+||+|+||+++. ++.++|+|||.+....... ......++..|+|||.+.+
T Consensus        98 ~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  177 (294)
T PLN00009         98 AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG  177 (294)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhC
Confidence             578889999999999999999999999999999999985 4579999999987654322 2233456788999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++||||+||++|+|++|.+||...+..+....+....+.+....+.....-  ..+....+.+.........+.
T Consensus       178 ~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  255 (294)
T PLN00009        178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL--PDYKSAFPKWPPKDLATVVPT  255 (294)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc--hhhhhhcccCCCCCHHHhCcC
Confidence            556789999999999999999999999988777777766666665544433321111  111122222222233333457


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      +++.+.++|.+||+.||++||++.++++||||.++..
T Consensus       256 ~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             CChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            8899999999999999999999999999999998653

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.8e-41  Score=296.21  Aligned_cols=265  Identities=19%  Similarity=0.250  Sum_probs=191.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+|+.||||+++...........+..|+.+++.++||||+++++++...     ...++||||++ |+|.+++...  
T Consensus        21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~   95 (327)
T cd08227          21 YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFM   95 (327)
T ss_pred             ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEEEEeccCCCcHHHHHHhhcc
Confidence            578999999999976654454556778899999999999999999999655     45899999996 6999988653  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--------cccccccccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--------FMTEYVVTRWYR  150 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~  150 (316)
                      ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++++||+.........        ......++..|+
T Consensus        96 ~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  175 (327)
T cd08227          96 DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL  175 (327)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceeccc
Confidence            458999999999999999999999999999999999999999999999998644322111        011234566799


Q ss_pred             CcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccc-cc--------cc-----ccc
Q 021181          151 APELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GF--------LR-----SDN  215 (316)
Q Consensus       151 aPE~~~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~--------~~-----~~~  215 (316)
                      |||.+.+. ..++.++|||||||++|+|++|..||..............  +..+.... ..        ..     ...
T Consensus       176 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T cd08227         176 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSG  253 (327)
T ss_pred             ChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhhcccCCcccCCcCC
Confidence            99998753 3578999999999999999999999987654333222211  11110000 00        00     000


Q ss_pred             h-HH-Hh-hhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          216 A-RR-YV-RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       216 ~-~~-~~-~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      . .. .. .................+++.+.+||++||+.||++|||++++++||||+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             CCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            0 00 00 00000000011112234678899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.4e-41  Score=301.74  Aligned_cols=239  Identities=22%  Similarity=0.363  Sum_probs=195.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      ++.+|+.||||+++.... .......+..|+.+++.++|+||+++++++...     ..+++||||++ |+|.+++... 
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   96 (330)
T cd05601          22 EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DNLYLVMEYQPGGDLLSLLNRYE   96 (330)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeEEEEECCCCCCCHHHHHHHhc
Confidence            467899999999976533 333456678999999999999999999988654     56999999995 7999999776 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.||+.||.+||+.||+||||||+||+++.++.++|+|||++........  .....++..|+|||++.
T Consensus        97 ~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601          97 DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhc
Confidence            6799999999999999999999999999999999999999999999999999876544322  12346789999999986


Q ss_pred             C-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          157 N-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       157 ~-----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      .     ...++.++|||||||++|+|++|..||...+.......+........                           
T Consensus       177 ~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------  229 (330)
T cd05601         177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK---------------------------  229 (330)
T ss_pred             cccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---------------------------
Confidence            3     35678899999999999999999999988776555554432211000                           


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ....+.++.++.++|++||+ ||.+||+++++++||||+++.
T Consensus       230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            00113578899999999998 999999999999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-40  Score=293.51  Aligned_cols=260  Identities=35%  Similarity=0.599  Sum_probs=190.0

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC----
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH----   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~----   78 (316)
                      ..+++.||+|.+....    ....+.+|+.+++.++||||+++++++....   ...++++|||++++|.+++...    
T Consensus        25 ~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~   97 (317)
T cd07867          25 GKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFDYAEHDLWHIIKFHRASK   97 (317)
T ss_pred             CCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEeeeCCcHHHHHHhhhccc
Confidence            4577899999986432    2234678999999999999999999986432   2568999999999998887521    


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE----ccCCCEEEeeeccccccCCCC----ccccccc
Q 021181           79 -----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETD----FMTEYVV  145 (316)
Q Consensus        79 -----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~----~~~~~~~  145 (316)
                           ..+++..++.++.||+.||.|||+.||+||||||+||++    +.++.++|+|||++.......    ......+
T Consensus        98 ~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  177 (317)
T cd07867          98 ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV  177 (317)
T ss_pred             cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCccee
Confidence                 248899999999999999999999999999999999999    566789999999997654332    1234567


Q ss_pred             cccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHhhCCCCccccccccccc-
Q 021181          146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---------VHQLRLITELIGSPDETSLGFLRSDN-  215 (316)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~-  215 (316)
                      +..|+|||.+.+...++.++|||||||++|+|++|.+||.....         ......+....+.+....+....... 
T Consensus       178 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (317)
T cd07867         178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPE  257 (317)
T ss_pred             cccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            88999999987756689999999999999999999999975432         23344455555544443332211100 


Q ss_pred             ----hHHHhhhCCCCC--CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          216 ----ARRYVRMLPQFP--KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       216 ----~~~~~~~~~~~~--~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                          ...+........  ...........+..+.++|.+||+.||.+|||++|+|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         258 YPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             chhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                000000000000  000111122356779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.3e-41  Score=301.67  Aligned_cols=239  Identities=26%  Similarity=0.375  Sum_probs=192.9

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||+|+++... ........+..|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++.. .
T Consensus        64 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~  137 (370)
T cd05596          64 HKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSN-Y  137 (370)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CEEEEEEcCCCCCcHHHHHHh-c
Confidence            46789999999996532 2233445577899999999999999999998654     56999999996 699988765 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+.......  ......+++.|+|||++.+
T Consensus       138 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  217 (370)
T cd05596         138 DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhcc
Confidence            68999999999999999999999999999999999999999999999999987654322  2234578999999999865


Q ss_pred             C---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 C---SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ~---~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .   ..++.++|||||||++|+|++|.+||.+.+.......+........                     .      ..
T Consensus       218 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------------~------~~  270 (370)
T cd05596         218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---------------------F------PD  270 (370)
T ss_pred             CCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---------------------C------CC
Confidence            2   2478899999999999999999999988776555554432111000                     0      01


Q ss_pred             CCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~  273 (316)
                      ...+|.++.++|++||+.+|.+  |++++++++||||++..
T Consensus       271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            1247899999999999999988  99999999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-40  Score=288.74  Aligned_cols=261  Identities=36%  Similarity=0.684  Sum_probs=200.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~   79 (316)
                      +..+|+.||+|+++...... ......+|+.+++++. |+|++++++++.....   ..+++||||++|+|.+.+... .
T Consensus        20 ~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~~~   95 (282)
T cd07831          20 SRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKT---GRLALVFELMDMNLYELIKGRKR   95 (282)
T ss_pred             EcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCC---CcEEEEEecCCccHHHHHHhccC
Confidence            45689999999997653332 2234457888898885 9999999999875421   468999999999998888763 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.+++.++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+.............++..|+|||.+....
T Consensus        96 ~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  174 (282)
T cd07831          96 PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG  174 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCC
Confidence            6899999999999999999999999999999999999999 999999999987765444434456788999999876546


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++||||+||++|+|++|.+||.+.+..+....+....+.+...............+  ..+...........+.++
T Consensus       175 ~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  252 (282)
T cd07831         175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY--NFPSKKGTGLRKLLPNAS  252 (282)
T ss_pred             CCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc--cCcccccccHHHHccccc
Confidence            678899999999999999999999999888887777777766655432111100000000  000000111122234678


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..+.++|.+||+.||++||+++++++||||
T Consensus       253 ~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         253 AEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-40  Score=288.62  Aligned_cols=239  Identities=21%  Similarity=0.330  Sum_probs=188.8

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||+|++...... ......+..|+++++.++||||+++++++...     ..+++||||++ ++|.+.+....
T Consensus        14 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~~~~~~   88 (277)
T cd05607          14 VKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLMNGGDLKYHIYNVG   88 (277)
T ss_pred             EccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhcc
Confidence            4578999999999654322 22334556799999999999999999998544     56999999996 69988875433


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 --DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 --~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                        .+++..+..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++.............++..|+|||.+.+
T Consensus        89 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  168 (277)
T cd05607          89 ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE  168 (277)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc
Confidence              588999999999999999999999999999999999999999999999999877655443344567889999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-hhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE-LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++||||+||++|+|++|..||...........+.. .....                           ......
T Consensus       169 -~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  220 (277)
T cd05607         169 -EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE---------------------------VKFEHQ  220 (277)
T ss_pred             -CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc---------------------------cccccc
Confidence             5689999999999999999999999976542211111111 00000                           000112


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~  273 (316)
                      .++.++.++|++||+.||++||++    +++++||||+.+.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            578899999999999999999999    6788999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.2e-41  Score=297.98  Aligned_cols=235  Identities=26%  Similarity=0.446  Sum_probs=191.6

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHH-HHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||+|++..... .......+..|.. +++.++||||+++++++...     ..+|+||||+. |+|...+...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   90 (325)
T cd05604          16 RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVLDFVNGGELFFHLQRE   90 (325)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHc
Confidence            467899999999975422 2233345555555 46778999999999998654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.... .........++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05604          91 RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK  170 (325)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC
Confidence            899999999999999999999999999999999999999999999999999986532 2223345678999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||...+.......+....                               ....+.
T Consensus       171 -~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-------------------------------~~~~~~  218 (325)
T cd05604         171 -QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-------------------------------LVLRPG  218 (325)
T ss_pred             -CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------------ccCCCC
Confidence             678999999999999999999999998877555544432210                               011235


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~  273 (316)
                      .+..+.++|++||+.||.+||++    .++++||||+...
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            78889999999999999999977    5899999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-40  Score=300.95  Aligned_cols=259  Identities=25%  Similarity=0.322  Sum_probs=196.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      +..+++.||+|.+...       ....+|+.+++.++||||+++++++...     ..+|++||+++++|.+++...+.+
T Consensus       115 ~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~l  182 (392)
T PHA03207        115 GDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPL  182 (392)
T ss_pred             CCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC-----CEEEEEehhcCCCHHHHHHhcCCC
Confidence            3457789999988543       1245899999999999999999998644     569999999999999999877889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........   .....++..|+|||++.. 
T Consensus       183 ~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  261 (392)
T PHA03207        183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-  261 (392)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC-
Confidence            9999999999999999999999999999999999999999999999999876543322   224568999999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC-CCCccc-
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNFSA-  233 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-  233 (316)
                      ..++.++|||||||++|+|++|..||.+...   ...+..+.+..+..+..............+........ ...... 
T Consensus       262 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (392)
T PHA03207        262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPV  341 (392)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccch
Confidence            6789999999999999999999999977543   34455555555443332211111111111111110000 000111 


Q ss_pred             -cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 -RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 -~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                       ....++.++.++|++||..||++|||+.|+|+||||++..
T Consensus       342 ~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        342 IRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence             1124678899999999999999999999999999998743

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=297.19  Aligned_cols=220  Identities=26%  Similarity=0.435  Sum_probs=190.0

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--CCCCCH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--HQDLTD   83 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~~~   83 (316)
                      ..||+|.++..   ......+.+|+++|++|+|++||++++++...     ..+||||||+. |+|.++++.  ++.++.
T Consensus       231 ~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVtE~m~~GsLl~yLr~~~~~~l~~  302 (468)
T KOG0197|consen  231 TKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVTEYMPKGSLLDYLRTREGGLLNL  302 (468)
T ss_pred             CcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEEEecccCcHHHHhhhcCCCccch
Confidence            48999999754   23345677999999999999999999999654     34999999997 999999987  567999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccc--ccccccccCcccccCCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~  161 (316)
                      .+...++.||++|++||+++++|||||...||||+++..+||+|||+++..........  .-.+..|.|||.+.. ..+
T Consensus       303 ~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~F  381 (468)
T KOG0197|consen  303 PQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKF  381 (468)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCc
Confidence            99999999999999999999999999999999999999999999999996665544322  233567999999988 789


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.+|||||||+++|||.| |+.||.+.+..+.+..+.+..+-+.+                              ..+|+
T Consensus       382 S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P------------------------------~~CP~  431 (468)
T KOG0197|consen  382 SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP------------------------------EGCPD  431 (468)
T ss_pred             ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC------------------------------CCCCH
Confidence            999999999999999998 99999999999999888765443322                              36899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.+++..||+.+|++|||++.+..
T Consensus       432 ~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  432 EVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHHH
Confidence            9999999999999999999997653

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-40  Score=295.24  Aligned_cols=235  Identities=23%  Similarity=0.359  Sum_probs=194.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+++.||||+++.... ..........|..++..+ +|++|+++++++...     ..+|+||||++ |+|.+.+...
T Consensus        21 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~   95 (323)
T cd05616          21 RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYQIQQV   95 (323)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHc
Confidence            467889999999976432 223345567788888777 589999999998554     56999999996 7999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ........+++.|+|||++.+
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05616          96 GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC
Confidence            8899999999999999999999999999999999999999999999999999875432 222345678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+.......                               ...
T Consensus       176 -~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~  223 (323)
T cd05616         176 -QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------------------------------PKS  223 (323)
T ss_pred             -CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------------------------CCc
Confidence             778999999999999999999999998887666655544311100                               124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~  273 (316)
                      ++.++.+++.+||+.||.+|+++     .++++||||+.++
T Consensus       224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            68889999999999999999985     8999999999765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.9e-40  Score=288.57  Aligned_cols=266  Identities=39%  Similarity=0.671  Sum_probs=203.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--   78 (316)
                      +..+|+.||||+++...........+.+|+.+++.+. |+||+++++++......+....|++|||++++|.+++...  
T Consensus        22 ~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  101 (295)
T cd07837          22 DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGR  101 (295)
T ss_pred             ECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcc
Confidence            4578999999998765444334467788999999995 6999999999875532233458999999999998887543  


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCC-CccccccccccccCcc
Q 021181           79 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPE  153 (316)
Q Consensus        79 ---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE  153 (316)
                         ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||.+...... .......++..|+|||
T Consensus       102 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE  181 (295)
T cd07837         102 GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE  181 (295)
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChH
Confidence               35799999999999999999999999999999999999998 889999999988754322 1122335677899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.+...++.++|+||||+++|+|++|.+||.+.+.......+....+.+....+..........   ............
T Consensus       182 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  258 (295)
T cd07837         182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH---EFPQWKPQDLSR  258 (295)
T ss_pred             HhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh---hcCcccchhHHH
Confidence            98765667899999999999999999999999887777776666665554433322111100000   011111222233


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      ..+.++..+.++|.+||..||.+||+++|++.||||+
T Consensus       259 ~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         259 AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            3456889999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-41  Score=301.81  Aligned_cols=238  Identities=23%  Similarity=0.396  Sum_probs=193.1

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||+++... ........+..|+.++..++|++|+++++.+...     ..+|+||||++ |+|.+++...+
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~   96 (360)
T cd05627          22 KKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RNLYLIMEFLPGGDMMTLLMKKD   96 (360)
T ss_pred             ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEeCCCCccHHHHHHhcC
Confidence            46789999999997532 2333456778899999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---------------------
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---------------------  138 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------  138 (316)
                      .+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......                     
T Consensus        97 ~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (360)
T cd05627          97 TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM  176 (360)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccc
Confidence            99999999999999999999999999999999999999999999999999876432110                     


Q ss_pred             ---------------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q 021181          139 ---------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP  203 (316)
Q Consensus       139 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  203 (316)
                                     ......||..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~  255 (360)
T cd05627         177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL  255 (360)
T ss_pred             ccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCce
Confidence                           0113468999999999987 778999999999999999999999998877666555443211100


Q ss_pred             CccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 021181          204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLH  273 (316)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~~~~f~~~~  273 (316)
                      .                          +. ....+++++.++|.+|+. ||.+|+   +++++++||||++++
T Consensus       256 ~--------------------------~p-~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         256 V--------------------------FP-PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             e--------------------------cC-CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence            0                          00 012468899999999874 999998   479999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.7e-41  Score=295.50  Aligned_cols=235  Identities=24%  Similarity=0.428  Sum_probs=189.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHH-HHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+|+.||+|++..... .......+..|.. +++.++||||+++++++...     ...|+||||++ |+|...+...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   90 (321)
T cd05603          16 RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVLDYVNGGELFFHLQRE   90 (321)
T ss_pred             ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHc
Confidence            457899999999975422 2223344555554 57889999999999998654     56999999996 6999988888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++.+++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (321)
T cd05603          91 RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK  170 (321)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC
Confidence            8899999999999999999999999999999999999999999999999998875322 222344568999999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||...+.......+...   +.                            ...+.
T Consensus       171 -~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~----------------------------~~~~~  218 (321)
T cd05603         171 -EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---PL----------------------------QLPGG  218 (321)
T ss_pred             -CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---CC----------------------------CCCCC
Confidence             67899999999999999999999999887755544433221   00                            01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~  273 (316)
                      .+..+.++|.+||+.||.+|+++    .++++|+||..+.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            67889999999999999999976    4999999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=288.61  Aligned_cols=263  Identities=38%  Similarity=0.686  Sum_probs=202.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHH-HHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLH-QIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~-~~l~~~~~   80 (316)
                      ++.+|+.||||+++...........+.+|++++++++|+||+++++++...     ...+++|||+++++. .+..+...
T Consensus        22 ~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~   96 (288)
T cd07833          22 NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRLYLVFEYVERTLLELLEASPGG   96 (288)
T ss_pred             eCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEEEEEEecCCCCHHHHHHhcCCC
Confidence            466899999999976555555567889999999999999999999999654     569999999986554 44555567


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++.++..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+.
T Consensus        97 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~  176 (288)
T cd07833          97 LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD  176 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCC
Confidence            9999999999999999999999999999999999999999999999999987755443  33345678889999999874


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC-C
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP-N  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  237 (316)
                      ..++.++|+||||+++|+|++|.+||.+.+..+....+....+.................................++ .
T Consensus       177 ~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (288)
T cd07833         177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGK  256 (288)
T ss_pred             CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCc
Confidence            478899999999999999999999998887777666666666554443222111110000000000000111112223 3


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++.++.++|++||..||++||+++++++||||
T Consensus       257 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         257 VSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-43  Score=286.56  Aligned_cols=237  Identities=24%  Similarity=0.396  Sum_probs=199.6

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-C
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-H   78 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~   78 (316)
                      +++++|+.||||++..    +.+.+.+.+|+.+++++..||+|++||.|...     ..+|||||||+ |++.+.++. +
T Consensus        53 IH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLWIVMEYCGAGSiSDI~R~R~  123 (502)
T KOG0574|consen   53 IHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLWIVMEYCGAGSISDIMRARR  123 (502)
T ss_pred             HHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceEeehhhcCCCcHHHHHHHhc
Confidence            4789999999999954    45678899999999999999999999998755     44999999998 899999874 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++++.++..+++..+.||+|||...-+|||||..|||++.+|..||.|||.+..... ...++...||+.|+|||++..
T Consensus       124 K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E  203 (502)
T KOG0574|consen  124 KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE  203 (502)
T ss_pred             CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHH
Confidence            7799999999999999999999999999999999999999999999999998866533 234567889999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       -.|...+||||||++..||..|++||.+...+..+-.|-   ..++++..                         ....
T Consensus       204 -IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---T~PPPTF~-------------------------KPE~  254 (502)
T KOG0574|consen  204 -IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---TKPPPTFK-------------------------KPEE  254 (502)
T ss_pred             -hccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---CCCCCCCC-------------------------ChHh
Confidence             679999999999999999999999998776555443221   11111110                         0012


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      -|.++-+||++||.+.|+.|.++-+|++|||+++..+.
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~  292 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC  292 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence            47789999999999999999999999999999987643

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-40  Score=295.43  Aligned_cols=235  Identities=24%  Similarity=0.447  Sum_probs=190.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHH-HHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREI-KLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+++.||+|++..... .......+..|. .+++.++||||+++++++...     ..+|+||||+. |+|.+.+...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   90 (325)
T cd05602          16 HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRE   90 (325)
T ss_pred             ECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEEeCCCCCcHHHHHHhc
Confidence            567889999999975422 122233444444 456788999999999998654     46999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... ........++..|+|||++.+
T Consensus        91 ~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05602          91 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK  170 (325)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC
Confidence            8899999999999999999999999999999999999999999999999999865322 223345678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+..+....+...   +                            ....+.
T Consensus       171 -~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~----------------------------~~~~~~  218 (325)
T cd05602         171 -QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P----------------------------LQLKPN  218 (325)
T ss_pred             -CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C----------------------------cCCCCC
Confidence             77899999999999999999999999887765555444321   0                            011135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHH----HHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVD----EALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~----ell~~~~f~~~~  273 (316)
                      ++..+.++|.+||+.||.+|+++.    ++++|+||..+.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence            788999999999999999999876    899999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-40  Score=287.83  Aligned_cols=260  Identities=40%  Similarity=0.755  Sum_probs=203.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH---   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---   78 (316)
                      +..+|+.||||+++.... ......+.+|+.+++.++|+||+++++++...     ...++||||++++|.+++...   
T Consensus        21 ~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   94 (284)
T cd07836          21 NRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLMLVFEYMDKDLKKYMDTHGVR   94 (284)
T ss_pred             ECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEEEEecCCccHHHHHHhcCCC
Confidence            457899999999976532 22345677899999999999999999999654     458999999999999888654   


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  174 (284)
T cd07836          95 GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG  174 (284)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcC
Confidence            358999999999999999999999999999999999999999999999999887654321 1223456788999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|+|||||++|+|++|.+||.+.+..+....+....+.+....+.....  ...+....+...........+.
T Consensus       175 ~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  252 (284)
T cd07836         175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKPTFPRYPPQDLQQLFPH  252 (284)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--CchhcccccCCChHHHHHHhhh
Confidence            56678999999999999999999999999888777777766665554433222110  0111111111111222333456


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++..+.++|.+||+.||.+||+++++++||||
T Consensus       253 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         253 ADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            78899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.8e-40  Score=288.51  Aligned_cols=267  Identities=36%  Similarity=0.601  Sum_probs=201.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---CCCCeEEEEEecCCCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      +..+|+.||||.+............+.+|+.++++++||||+++++++.....   ......++||||++++|.+.+...
T Consensus        33 ~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~  112 (310)
T cd07865          33 HKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK  112 (310)
T ss_pred             ECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhc
Confidence            45689999999987654333334556789999999999999999998865421   123467999999999998887654


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAP  152 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aP  152 (316)
                       ..+++.+++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........     .....++..|+||
T Consensus       113 ~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         113 NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCc
Confidence             3689999999999999999999999999999999999999999999999998876533221     1233467789999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |.+.+...++.++|+||||+++|+|++|.+||.+.+.......+....+..+....+........... ..+........
T Consensus       193 E~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  271 (310)
T cd07865         193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKM-ELPQGQKRKVK  271 (310)
T ss_pred             HHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhc-cCCCccchhhH
Confidence            99876555788999999999999999999999988877777777777766554433322111111100 00010000111


Q ss_pred             ccC--CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          233 ARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       233 ~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ...  ...+..+.++|.+||+.||.+|||++++++||||
T Consensus       272 ~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         272 ERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            111  1246778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-40  Score=295.62  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=187.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      +..+++.||+|+....        ....|+.++++++|+||+++++++...     ...++|||++.++|.+++.. ...
T Consensus        87 ~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~  153 (357)
T PHA03209         87 KPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTKRSRP  153 (357)
T ss_pred             ECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----CeeEEEEEccCCcHHHHHHhccCC
Confidence            4567889999975432        134699999999999999999998654     45899999999999988865 467


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.+++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+.............++..|+|||.+.+ ..
T Consensus       154 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  232 (357)
T PHA03209        154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR-DK  232 (357)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCC-CC
Confidence            99999999999999999999999999999999999999999999999999876544433445678999999999987 67


Q ss_pred             CCCcchHHHHHHHHHHHHhC-CCCCCCCCcH---------HHHHHHHHhhCCCCccccccccccchHHHhhh--CCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMTR-QPLFPGKDYV---------HQLRLITELIGSPDETSLGFLRSDNARRYVRM--LPQFPK  228 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g-~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  228 (316)
                      ++.++|||||||++|+|+++ .++|......         ..+..+....+..+..............+...  ....+.
T Consensus       233 ~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (357)
T PHA03209        233 YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPY  312 (357)
T ss_pred             CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcc
Confidence            89999999999999999985 4445443211         12222223333222211111111111111111  011111


Q ss_pred             CCcc-ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          229 QNFS-ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       229 ~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      .... .....++.++.++|++||+.||.+|||+.|+|+||||+++
T Consensus       313 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        313 TRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             cccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            1100 0112567788999999999999999999999999999864

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=285.59  Aligned_cols=262  Identities=48%  Similarity=0.815  Sum_probs=207.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      ++.+|+.||+|+++...........+..|+.++++++|+||+++++++...     ...+++|||++++|.+.+.. ...
T Consensus        20 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~l~~~~~~   94 (283)
T cd05118          20 DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRG   94 (283)
T ss_pred             cCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEEEEeccCCCHHHHHHhhccc
Confidence            457899999999976554444567788999999999999999999998654     56999999999999888866 357


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..
T Consensus        95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  174 (283)
T cd05118          95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK  174 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCC
Confidence            8999999999999999999999999999999999999999999999999887765443 223345677899999988744


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||||+++|+|++|+.||...+..+....+....+.+....+...... ....................+.++
T Consensus       175 ~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  253 (283)
T cd05118         175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-ARNYKFSFPKKAGMPLPKLFPNAS  253 (283)
T ss_pred             CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-hhhhhhhhccccccCHHHhhhhhC
Confidence            7899999999999999999999999988887777777666665544333222110 000111111111122233345678


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .++.++|++||+.||.+||+++++++||||
T Consensus       254 ~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         254 PQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-40  Score=287.49  Aligned_cols=263  Identities=35%  Similarity=0.655  Sum_probs=198.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      ++.+|+.||+|++............+.+|+++++.++||||+++++++...     ...++||||+++ .|..+......
T Consensus        22 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~   96 (286)
T cd07846          22 HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRLYLVFEFVDHTVLDDLEKYPNG   96 (286)
T ss_pred             ECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeEEEEEecCCccHHHHHHhccCC
Confidence            356799999999876544444456678999999999999999999998544     569999999975 66666666667


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..
T Consensus        97 ~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  176 (286)
T cd07846          97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT  176 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcccc
Confidence            9999999999999999999999999999999999999999999999999987654332 223345788899999987655


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++||||||+++|+|++|++||...+..+....+....+..................................+.++
T Consensus       177 ~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (286)
T cd07846         177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS  256 (286)
T ss_pred             ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcC
Confidence            67889999999999999999999998777666666655544433221111100000000000000000111122345788


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..+.+++++||+.||++||++.++++||||
T Consensus       257 ~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         257 GLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=281.86  Aligned_cols=233  Identities=25%  Similarity=0.445  Sum_probs=190.1

Q ss_pred             CCCCCceEEEEEecccccCh---hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFDNR---IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+|+.||+|.+.......   .....+.+|++++++++||||+++++++...     ...++++||+. ++|.+++..
T Consensus        23 ~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~   97 (263)
T cd06625          23 DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----ETLSIFMEYMPGGSVKDQLKA   97 (263)
T ss_pred             EcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----CeEEEEEEECCCCcHHHHHHH
Confidence            45789999999987543222   2345678899999999999999999999654     46999999996 699999988


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----ccccccccccCcc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPE  153 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE  153 (316)
                      .+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........    ....++..|+|||
T Consensus        98 ~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  177 (263)
T cd06625          98 YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE  177 (263)
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcc
Confidence            888999999999999999999999999999999999999999999999999988654332111    2345678899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.+ ..++.++||||||+++|+|++|+.||...+.......+......                             ..
T Consensus       178 ~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~  227 (263)
T cd06625         178 VISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-----------------------------PQ  227 (263)
T ss_pred             eecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-----------------------------CC
Confidence            9987 66889999999999999999999999776544443332211000                             01


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ....++..+.++|++||..+|.+||++.++++|+||
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            112568889999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-40  Score=293.31  Aligned_cols=236  Identities=21%  Similarity=0.382  Sum_probs=190.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+++.||+|+++.... .......+..|+.++.++ +||+|+++++++...     ..+|+||||+. |+|...+...
T Consensus        16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   90 (327)
T cd05617          16 LKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVIEYVNGGDLMFHMQRQ   90 (327)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHc
Confidence            457889999999976532 334456788999999888 699999999998654     56999999996 6999998888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.... .........++..|+|||.+.+
T Consensus        91 ~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (327)
T cd05617          91 RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG  170 (327)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC
Confidence            889999999999999999999999999999999999999999999999999887532 2233345678999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY------VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                       ..++.++|||||||++|+|++|..||.....      ........  ...+                            
T Consensus       171 -~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~----------------------------  219 (327)
T cd05617         171 -EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKP----------------------------  219 (327)
T ss_pred             -CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCC----------------------------
Confidence             6789999999999999999999999964321      11111110  0000                            


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRIT------VDEALCHPYLAPLH  273 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps------~~ell~~~~f~~~~  273 (316)
                      ......++..+.++|++||+.||.+|++      ++++++||||+.+.
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            0111246888999999999999999998      46999999999876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=286.09  Aligned_cols=261  Identities=42%  Similarity=0.742  Sum_probs=209.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      +..+|+.||+|.+............+..|+.+++.++|++++++++++...     ...++|||+++++|.+++... ..
T Consensus        20 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~i~~~~~~   94 (282)
T cd07829          20 DKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYLVFEYCDMDLKKYLDKRPGP   94 (282)
T ss_pred             ecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEEEecCcCcCHHHHHHhhccC
Confidence            456799999999987644444556778999999999999999999998654     569999999999999999876 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... .......+..|+|||.+.+..
T Consensus        95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  174 (282)
T cd07829          95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK  174 (282)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCc
Confidence            9999999999999999999999999999999999999999999999999887654432 223344567899999987745


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||+++++++|.+||...+.......+....+.+....+.....-.  .+....+...........+..+
T Consensus       175 ~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd07829         175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYKPTFPKFPPKDLEKVLPRLD  252 (282)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--cccccccccCccchHHhccccc
Confidence            78999999999999999999999999988888877777776665543332211111  1111122222223334455668


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..+.++|++||..||++||+++++++||||
T Consensus       253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.9e-40  Score=298.38  Aligned_cols=238  Identities=24%  Similarity=0.342  Sum_probs=191.0

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+++.||+|++.... ........+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++.. .
T Consensus        64 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~  137 (370)
T cd05621          64 HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-----KYLYMVMEYMPGGDLVNLMSN-Y  137 (370)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-c
Confidence            46789999999996532 2233445677899999999999999999998654     56999999996 799998865 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........  .....++..|+|||++.+
T Consensus       138 ~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  217 (370)
T cd05621         138 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhc
Confidence            689999999999999999999999999999999999999999999999999877543322  235578999999999865


Q ss_pred             C---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 C---SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ~---~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .   ..++.++|+|||||++|+|++|.+||.+.+.......+.........                           ..
T Consensus       218 ~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------p~  270 (370)
T cd05621         218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF---------------------------PE  270 (370)
T ss_pred             cCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC---------------------------CC
Confidence            2   23778999999999999999999999888766655554432111100                           00


Q ss_pred             CCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPL  272 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~  272 (316)
                      ...++..++++|.+||..++.+  |++++|+++||||+..
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            1246888999999999866544  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.2e-40  Score=292.99  Aligned_cols=280  Identities=43%  Similarity=0.766  Sum_probs=204.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCC---------CCCeEEEEEecCCCcHH
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE---------TFNDVYIVYELMDTDLH   72 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---------~~~~~~iv~e~~~g~L~   72 (316)
                      ++.+|+.||+|++.....  .....+.+|+++++.++||||+++++.+......         .....|++|||++++|.
T Consensus        26 ~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~  103 (342)
T cd07854          26 DSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLA  103 (342)
T ss_pred             ECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHH
Confidence            567899999999865422  3456688999999999999999999887654311         12358999999999998


Q ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCCC----ccccccccc
Q 021181           73 QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD----FMTEYVVTR  147 (316)
Q Consensus        73 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~----~~~~~~~~~  147 (316)
                      +.+.. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++++|||.+.......    ......++.
T Consensus       104 ~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  182 (342)
T cd07854         104 NVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK  182 (342)
T ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccc
Confidence            88754 57899999999999999999999999999999999999974 4578999999886543221    112235677


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      .|+|||.+.....++.++|||||||++|+|++|+.||...+.......+................. .............
T Consensus       183 ~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  261 (342)
T cd07854         183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN-VIPSFVRNDGGEP  261 (342)
T ss_pred             cccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh-hhhhhhhhccccc
Confidence            899999876556688899999999999999999999988876665555443322211111100000 0001111011112


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF  285 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~  285 (316)
                      ........+.++.++.++|++||+.||++|||++++++||||+.+....+.++...++
T Consensus       262 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~  319 (342)
T cd07854         262 RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPF  319 (342)
T ss_pred             CCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCCCCCc
Confidence            2223334457889999999999999999999999999999999876555555554444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.5e-40  Score=294.05  Aligned_cols=237  Identities=25%  Similarity=0.336  Sum_probs=184.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++.... .......+.+|+++++.++|+||+++++++...     ..+++||||+. |+|.+.    ..
T Consensus        95 ~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~----~~  164 (353)
T PLN00034         95 HRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GEIQVLLEFMDGGSLEGT----HI  164 (353)
T ss_pred             ECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----CeEEEEEecCCCCccccc----cc
Confidence            45689999999996542 334456788999999999999999999998544     56999999997 576543    34


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC--
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~--  157 (316)
                      ..+..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......++..|+|||.+..  
T Consensus       165 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  244 (353)
T PLN00034        165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL  244 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCcccccccc
Confidence            6788889999999999999999999999999999999999999999999987654322 2234578999999998743  


Q ss_pred             --CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          158 --CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       158 --~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                        ....+.++|||||||++|+|++|+.||......+....+.......                           .....
T Consensus       245 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~  297 (353)
T PLN00034        245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---------------------------PPEAP  297 (353)
T ss_pred             ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC---------------------------CCCCC
Confidence              1334568999999999999999999997443222222111110000                           01112


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ..++.++.+||.+||+.||++||++.|+++||||.+-...
T Consensus       298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            3578899999999999999999999999999999986543

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=286.37  Aligned_cols=261  Identities=38%  Similarity=0.689  Sum_probs=195.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      ++.+|+.||||.+....... ....+.+|+++++.++|+||+++++++...     ...++||||++++|.+++... ..
T Consensus        26 ~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~   99 (291)
T cd07844          26 SKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTK-----KTLTLVFEYLDTDLKQYMDDCGGG   99 (291)
T ss_pred             EcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeEEEEEecCCCCHHHHHHhCCCC
Confidence            45688999999997543221 223466899999999999999999998644     569999999999999988654 46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..
T Consensus       100 ~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  179 (291)
T cd07844         100 LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST  179 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCc
Confidence            8999999999999999999999999999999999999999999999999886543221 112234577899999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++||||+|+++|+|++|..||.... ..+....+....+.+....+......... .................+..
T Consensus       180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  258 (291)
T cd07844         180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF-KPYSFPFYPPRPLINHAPRL  258 (291)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc-ccccccccCChhHHHhCcCC
Confidence            68899999999999999999999997765 45555556665555443332211110000 00000011111112222334


Q ss_pred             C--hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          239 S--PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       239 s--~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +  .++.++|.+||+.||++|||++++++||||
T Consensus       259 ~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         259 DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            4  789999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-40  Score=285.56  Aligned_cols=264  Identities=39%  Similarity=0.674  Sum_probs=206.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      +..+|+.||+|++............+.+|+.+++.++|+|++++++++...+   ....++||||++++|.+++... ..
T Consensus        20 ~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~   96 (287)
T cd07840          20 NKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYMVFEYMDHDLTGLLDSPEVK   96 (287)
T ss_pred             ECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEEEeccccccHHHHHhccCCC
Confidence            4567899999999876434444567889999999999999999999986542   2569999999999999888765 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++.+++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+.
T Consensus        97 ~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  176 (287)
T cd07840          97 FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA  176 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEcc
Confidence            9999999999999999999999999999999999999999999999999987765443  12334557789999987765


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC-
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN-  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (316)
                      ..++.++||||||+++|+|++|..||...+.......+....+.+....+.................. ...+...+.. 
T Consensus       177 ~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  255 (287)
T cd07840         177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPY-KRRLREFFKHL  255 (287)
T ss_pred             ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccc-hhHHHHHhccc
Confidence            66889999999999999999999999998888877777777666554443322211111000000000 1111222233 


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++..+.++|++||+.||.+||+++++++||||
T Consensus       256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         256 IDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.4e-40  Score=290.89  Aligned_cols=264  Identities=37%  Similarity=0.622  Sum_probs=207.2

Q ss_pred             CCCCCceEEEEEecccccChhH------------HHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRID------------AKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      |..+|+.||||+++........            ...+.+|+.+++.++|+||+++++++...     ...+++|||++|
T Consensus        30 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~  104 (335)
T PTZ00024         30 DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG-----DFINLVMDIMAS  104 (335)
T ss_pred             ECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC-----CcEEEEEecccc
Confidence            5678999999998654322100            12467899999999999999999998654     468999999999


Q ss_pred             cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC------------
Q 021181           70 DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET------------  137 (316)
Q Consensus        70 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------------  137 (316)
                      +|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......            
T Consensus       105 ~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  184 (335)
T PTZ00024        105 DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM  184 (335)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccc
Confidence            99999988888999999999999999999999999999999999999999999999999988765411            


Q ss_pred             ---CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccccccccc
Q 021181          138 ---DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD  214 (316)
Q Consensus       138 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  214 (316)
                         .......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+....+....+.+....++.....
T Consensus       185 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (335)
T PTZ00024        185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL  264 (335)
T ss_pred             cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhc
Confidence               11122345778999999876556789999999999999999999999998888888888777776655433221100


Q ss_pred             chHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          215 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..  +. .........+....+..+.++.++|++||+.||++|||++|++.||||+...
T Consensus       265 ~~--~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        265 PL--YT-EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             cc--cc-ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            00  00 0001111222333456788999999999999999999999999999998764

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-40  Score=290.76  Aligned_cols=235  Identities=23%  Similarity=0.376  Sum_probs=193.0

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... .......+..|..++..+. |++|+++++++...     ..+|+||||++ |+|.+++...
T Consensus        21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~   95 (323)
T cd05615          21 RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DRLYFVMEYVNGGDLMYHIQQV   95 (323)
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CEEEEEEcCCCCCcHHHHHHHc
Confidence            467899999999976432 2334456778888888885 67788899888554     46999999996 7999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......++..|+|||++.+
T Consensus        96 ~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05615          96 GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC
Confidence            899999999999999999999999999999999999999999999999999887543222 2334568999999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||+||++|+|++|..||.+.+.......+......                               ....
T Consensus       176 -~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~  223 (323)
T cd05615         176 -QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-------------------------------YPKS  223 (323)
T ss_pred             -CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------------------CCcc
Confidence             67899999999999999999999999887765555544331110                               0124


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      ++.++.+++.+||+.||.+|++     .+++++||||+.+.
T Consensus       224 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         224 LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            6788999999999999999997     47899999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.3e-40  Score=290.89  Aligned_cols=262  Identities=21%  Similarity=0.341  Sum_probs=194.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.+.... .......+.+|+++++.++|+||+++++++...     ..+++||||+. |+|.+++...+.
T Consensus        26 ~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   99 (333)
T cd06650          26 HKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGR   99 (333)
T ss_pred             ECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEEEEEEecCCCCcHHHHHHHcCC
Confidence            45689999999987643 334556788999999999999999999999654     56999999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+ .
T Consensus       100 ~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~  177 (333)
T cd06650         100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-T  177 (333)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC-C
Confidence            99999999999999999999974 7999999999999999999999999988654322 2234467889999999977 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh-hCCCCccccccccc---c-------------chHHHhhh
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRS---D-------------NARRYVRM  222 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~---~-------------~~~~~~~~  222 (316)
                      .++.++|+|||||++|+|++|+.||...+.......+... .+............   .             ........
T Consensus       178 ~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (333)
T cd06650         178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDY  257 (333)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHH
Confidence            7889999999999999999999999876543332222110 01110000000000   0             00000000


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .....  ........++.++.+||.+||+.||.+|||++|++.||||+...
T Consensus       258 ~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         258 IVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             HhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            00000  00001123678899999999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.6e-41  Score=285.98  Aligned_cols=239  Identities=34%  Similarity=0.551  Sum_probs=194.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      +..+++.||+|++...............|+.++++++||||+++++++...     ...+++||++++ +|.+++...+.
T Consensus        20 ~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~v~~~~~~~~L~~~l~~~~~   94 (260)
T PF00069_consen   20 NKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYIVMEYCPGGSLQDYLQKNKP   94 (260)
T ss_dssp             ETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEEEEEEETTEBHHHHHHHHSS
T ss_pred             ECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----cccccccccccccccccccccccc
Confidence            567889999999987655554545556799999999999999999999764     568999999986 99999987788


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccccc-CCCCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..+++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+... ..........++..|.|||++....
T Consensus        95 ~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  174 (260)
T PF00069_consen   95 LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGK  174 (260)
T ss_dssp             BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999999999999999999999998763 2333445567788999999987337


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++|+||||+++++|++|..||...........+.+............                        ....+
T Consensus       175 ~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~  230 (260)
T PF00069_consen  175 KYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ------------------------SREKS  230 (260)
T ss_dssp             SBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS------------------------HTTSH
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc------------------------cchhH
Confidence            889999999999999999999999988744444444433222111100000                        00123


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..+.++|.+||+.||++||++.++++||||
T Consensus       231 ~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  231 EELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            779999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.4e-40  Score=285.21  Aligned_cols=239  Identities=25%  Similarity=0.395  Sum_probs=190.2

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +..+|+.||||.+...... ......+..|+.++++++|++|+.+++.+...     ...++||||+. ++|.+.+... 
T Consensus        21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~   95 (285)
T cd05630          21 VRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMG   95 (285)
T ss_pred             EcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEEEEEEEecCCCcHHHHHHHhc
Confidence            4678999999998754322 22335577899999999999999999998654     56999999996 6998887543 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                       ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.............++..|+|||.+.+
T Consensus        96 ~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05630          96 EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN  175 (285)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcC
Confidence             3589999999999999999999999999999999999999999999999999876554443344578899999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||+||++|+|++|..||....................                           ......
T Consensus       176 -~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  227 (285)
T cd05630         176 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------------------------EEYSEK  227 (285)
T ss_pred             -CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------------------------hhcCcc
Confidence             6789999999999999999999999976542211111111000000                           001124


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      +++++.+++++||+.||++|||     ++|+++||||+.+.
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence            6888999999999999999999     89999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.4e-40  Score=287.61  Aligned_cols=267  Identities=38%  Similarity=0.645  Sum_probs=203.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---CCCCeEEEEEecCCCcHHHHhhc-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVYIVYELMDTDLHQIIRS-   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~-   77 (316)
                      ++.+|+.||||++............+.+|+++++.++||||+++++++.....   .....++++|+|++++|...+.. 
T Consensus        29 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~  108 (311)
T cd07866          29 QIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP  108 (311)
T ss_pred             ECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhcc
Confidence            46789999999996643333333456789999999999999999998764431   22346899999999888887765 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc------------cccccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF------------MTEYVV  145 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~  145 (316)
                      ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........            .....+
T Consensus       109 ~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (311)
T cd07866         109 SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV  188 (311)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCccccccccccee
Confidence            35799999999999999999999999999999999999999999999999998875433211            112345


Q ss_pred             cccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCC
Q 021181          146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ  225 (316)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (316)
                      +..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+....+.+....++.+............ .
T Consensus       189 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  267 (311)
T cd07866         189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSF-T  267 (311)
T ss_pred             ccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccC-C
Confidence            778999999876566889999999999999999999999988888877777777666554433322111110000000 0


Q ss_pred             CCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       226 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .........+...+..+.++|++||+.||++|||+.++++||||
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         268 NYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            11112223344567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=282.13  Aligned_cols=263  Identities=38%  Similarity=0.662  Sum_probs=202.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      ++.+|+.||+|+++...........+.+|+.+++++   +|+|++++++++..........++++|||++++|.+++...
T Consensus        20 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~   99 (287)
T cd07838          20 DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC   99 (287)
T ss_pred             ECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHc
Confidence            345799999999976543333345566788777666   59999999999976543333459999999998999888764


Q ss_pred             C--CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           79 Q--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      .  .+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.
T Consensus       100 ~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~  179 (287)
T cd07838         100 PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL  179 (287)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhc
Confidence            3  48999999999999999999999999999999999999999999999999987765544434455788899999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|+||+||++|+|++|.+||......+....+....+.+....++.........+    ............+
T Consensus       180 ~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  254 (287)
T cd07838         180 Q-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSF----PSYTPRSFKSFVP  254 (287)
T ss_pred             c-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhc----ccccccchhhhhh
Confidence            7 6788999999999999999999999998887777777766554433222211110000000    1111112233334


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..++.+.++|++||+.||.+||+++++++||||
T Consensus       255 ~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         255 EICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-39  Score=284.42  Aligned_cols=267  Identities=39%  Similarity=0.656  Sum_probs=204.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC-----CCCCCeEEEEEecCCCcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-----RETFNDVYIVYELMDTDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~~~iv~e~~~g~L~~~l~   76 (316)
                      ++.+|+.||||+++...........+.+|+.++++++||||+++++++....     .++...+++++||+++++...+.
T Consensus        28 ~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~  107 (302)
T cd07864          28 DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE  107 (302)
T ss_pred             ECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHh
Confidence            4568999999999765433444456778999999999999999999986543     11234799999999988888776


Q ss_pred             cC-CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcc
Q 021181           77 SH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPE  153 (316)
Q Consensus        77 ~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE  153 (316)
                      .. ..+++.+++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||
T Consensus       108 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE  187 (302)
T cd07864         108 SGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE  187 (302)
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChH
Confidence            54 468999999999999999999999999999999999999999999999999887654332  112234567899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.+...++.++|||||||++++|++|++||...+....+..+....+.+....++................ .......
T Consensus       188 ~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  266 (302)
T cd07864         188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ-YRRRLRE  266 (302)
T ss_pred             HhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccc-cccchhh
Confidence            887645678999999999999999999999998888888888887777665544332211111000000000 0011112


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ....++..+.++|.+||+.||.+||++++++.||||
T Consensus       267 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         267 EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            233568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3e-39  Score=276.45  Aligned_cols=233  Identities=28%  Similarity=0.465  Sum_probs=190.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+++.||+|++............+.+|+.++++++|+|++++++.+...+    ..++++|||++ ++|.+++...  
T Consensus        21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~l~~~l~~~~~   96 (257)
T cd08223          21 HRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYIVMGFCEGGDLYHKLKEQKG   96 (257)
T ss_pred             EcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEEEEecccCCCcHHHHHHHhcC
Confidence            4667899999999765555556677889999999999999999998874322    45899999996 6999888753  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++.+++.++.+++.||++||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+
T Consensus        97 ~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  176 (257)
T cd08223          97 KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN  176 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcC
Confidence            458999999999999999999999999999999999999999999999999987654322 2234457888999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+||+||++++|++|..||...+.......+...  ..+                            .....
T Consensus       177 -~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--~~~----------------------------~~~~~  225 (257)
T cd08223         177 -KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLP----------------------------PMPKD  225 (257)
T ss_pred             -CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCC----------------------------CCccc
Confidence             67889999999999999999999999876644443332221  100                            01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +++.+.++|.+||+.||++||++.++++||||
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            67889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=289.40  Aligned_cols=241  Identities=23%  Similarity=0.352  Sum_probs=191.5

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-C
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-H   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~   78 (316)
                      +..+|+.||||++.... ........+.+|+.++..++|+||+++++++...     ..+|+||||+. |+|.+++.. .
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~   96 (331)
T cd05597          22 MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFE   96 (331)
T ss_pred             ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----CeEEEEEecCCCCcHHHHHHHhc
Confidence            46789999999996532 2333456678899999999999999999998654     56999999995 799999876 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........  .....++..|+|||++.
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05597          97 DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ  176 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHh
Confidence            6799999999999999999999999999999999999999999999999999866543322  12346899999999986


Q ss_pred             C----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          157 N----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       157 ~----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      .    ...++.++||||+||++|+|++|+.||...+..+....+.......                          .+.
T Consensus       177 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~~  230 (331)
T cd05597         177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF--------------------------QFP  230 (331)
T ss_pred             hccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc--------------------------cCC
Confidence            3    2457789999999999999999999998876655554443211100                          011


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~  273 (316)
                      ...+.+++.++++|++||+.++.+  |++++++++||||.++.
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            112347889999999999765544  78999999999998865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.2e-40  Score=303.51  Aligned_cols=229  Identities=27%  Similarity=0.408  Sum_probs=188.7

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc----CCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS----HQD   80 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~   80 (316)
                      ++.||+|.+...  .......+..|+.+++.++||||+++++++...     ..+|+||||+. |+|.+.+..    ..+
T Consensus        93 ~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~  165 (478)
T PTZ00267         93 KEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLLIMEYGSGGDLNKQIKQRLKEHLP  165 (478)
T ss_pred             CeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEEEEECCCCCCHHHHHHHHHhccCC
Confidence            778999987543  333445678899999999999999999998654     56999999996 799887643    456


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.++..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......   ......|++.|+|||.+.+
T Consensus       166 l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  245 (478)
T PTZ00267        166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER  245 (478)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC
Confidence            8999999999999999999999999999999999999999999999999987654332   1334568999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+..+....+......+                              ....
T Consensus       246 -~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------------------------------~~~~  294 (478)
T PTZ00267        246 -KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP------------------------------FPCP  294 (478)
T ss_pred             -CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------------------------CCcc
Confidence             678999999999999999999999998776655554443211100                              0124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ++.++.++|.+||+.||++||++++++.|+|++.+
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            67889999999999999999999999999998754

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-39  Score=282.82  Aligned_cols=229  Identities=24%  Similarity=0.240  Sum_probs=186.2

Q ss_pred             CCceEEEEEecccccCh-hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGNAFDNR-IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~   82 (316)
                      +|+.||||.++...... .....+.+|+.++++++||||+++++++.+.. +....+++||||++ |+|.+++...+.++
T Consensus        42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~  120 (283)
T PHA02988         42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILEYCTRGYLREVLDKEKDLS  120 (283)
T ss_pred             CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEEeCCCCcHHHHHhhCCCCC
Confidence            68899999997653322 22467789999999999999999999986521 12246899999996 69999998888899


Q ss_pred             HHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC-CC
Q 021181           83 DDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-SE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~  160 (316)
                      +.....++.+++.||.+||+ .+++||||+|+||+++.++.+||+|||++.......  ....++..|+|||.+.+. ..
T Consensus       121 ~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~  198 (283)
T PHA02988        121 FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSE  198 (283)
T ss_pred             hhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhcccc
Confidence            99999999999999999997 599999999999999999999999999987654322  234578889999998642 46


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|..||.+.+..+....+......++                             ....+++
T Consensus       199 ~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------------~~~~~~~  249 (283)
T PHA02988        199 YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK-----------------------------LPLDCPL  249 (283)
T ss_pred             ccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------------------CCCcCcH
Confidence            89999999999999999999999988776555554432111110                             0014688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.+++.+||+.||.+|||++|+++
T Consensus       250 ~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        250 EIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHH
Confidence            8999999999999999999999985

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-39  Score=283.20  Aligned_cols=233  Identities=26%  Similarity=0.449  Sum_probs=195.0

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~   79 (316)
                      +..+++.||+|++..... .......+.+|++++++++||||+++++++...     ..+++||||+ +++|.+++...+
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~   96 (290)
T cd05580          22 HKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SNLYLVMEYVPGGELFSHLRKSG   96 (290)
T ss_pred             EcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CeEEEEEecCCCCCHHHHHHHcC
Confidence            456899999999965422 233456788999999999999999999998654     5699999999 579999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..+..++.||+.||.+||+.|++|+||+|.||+++.++.++|+|||.+......  .....++..|+|||.+.+ .
T Consensus        97 ~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~  173 (290)
T cd05580          97 RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS-K  173 (290)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcC-C
Confidence            9999999999999999999999999999999999999999999999999998776544  234467889999999876 5


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++|+||||+++|+|++|..||...+.......+...  ...                             .....+
T Consensus       174 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-----------------------------~~~~~~  222 (290)
T cd05580         174 GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVR-----------------------------FPSFFS  222 (290)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Ccc-----------------------------CCccCC
Confidence            7889999999999999999999999877644444433211  000                             012357


Q ss_pred             hHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ..++++|++||..||.+|+     +++|+++||||+.+.
T Consensus       223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            8899999999999999999     999999999998876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.2e-40  Score=294.13  Aligned_cols=239  Identities=24%  Similarity=0.320  Sum_probs=190.5

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+++.||+|++.... ........+.+|+.+++.++||||+++++.+...     ..+|+||||++ |+|.+++.. .
T Consensus        64 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~~~~-~  137 (371)
T cd05622          64 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-Y  137 (371)
T ss_pred             ECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-c
Confidence            56789999999996532 2333445677899999999999999999998654     56999999996 699988865 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  ......+|+.|+|||++..
T Consensus       138 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~  217 (371)
T cd05622         138 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS  217 (371)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhc
Confidence            68999999999999999999999999999999999999999999999999987654332  2234578999999999865


Q ss_pred             CC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 CS---EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ~~---~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      ..   .++.++|||||||++|+|++|..||.+.+.......+.........                           ..
T Consensus       218 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~  270 (371)
T cd05622         218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF---------------------------PD  270 (371)
T ss_pred             cCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC---------------------------CC
Confidence            22   3788999999999999999999999887765555544321111000                           01


Q ss_pred             CCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~  273 (316)
                      ...++..+.++|.+||..++.+  |++++++++|+||++..
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            1357899999999999844433  78999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-39  Score=278.32  Aligned_cols=237  Identities=24%  Similarity=0.398  Sum_probs=194.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+++.||+|++..... .......+.+|+.+++.++||||+++++.+...     ..++++|||++ ++|.+++.+..
T Consensus        14 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   88 (262)
T cd05572          14 VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYCLGGELWTILRDRG   88 (262)
T ss_pred             ECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecCCCCcHHHHHhhcC
Confidence            456799999999976433 233457788999999999999999999988644     45899999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.............++..|++||.+.+ .
T Consensus        89 ~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~  167 (262)
T cd05572          89 LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-K  167 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcC-C
Confidence            899999999999999999999999999999999999999999999999999877655433334567888999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKD--YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      .++.++|+||+|+++|+|++|..||...+  .......+.......                             .....
T Consensus       168 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  218 (262)
T cd05572         168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL-----------------------------EFPNY  218 (262)
T ss_pred             CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC-----------------------------CCCcc
Confidence            68899999999999999999999997765  333332222100000                             00113


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      .+.++.++|.+||+.||.+||+     ++|+++||||+++.
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence            4778999999999999999999     99999999999753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-39  Score=297.38  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=185.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      +..+++.||||....        ..+.+|++++++++|+||+++++++...     ...+++|+++.++|.+++... ..
T Consensus       190 ~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~  256 (461)
T PHA03211        190 HPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGARLRP  256 (461)
T ss_pred             ECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEEccCCCHHHHHHhcCCC
Confidence            456789999996422        2356899999999999999999998654     458999999999999888654 46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........   .....+|..|+|||++.+
T Consensus       257 l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  336 (461)
T PHA03211        257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG  336 (461)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC
Confidence            99999999999999999999999999999999999999999999999999876533211   223568999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHhhCCCCccccccccccchHHHhhhC-----CC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-------YVHQLRLITELIGSPDETSLGFLRSDNARRYVRML-----PQ  225 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  225 (316)
                       ..++.++|||||||++|||++|..++....       ....+..+....+.................+....     ..
T Consensus       337 -~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  415 (461)
T PHA03211        337 -DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPA  415 (461)
T ss_pred             -CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCc
Confidence             678999999999999999999876543221       12223333332222111111000011111111110     00


Q ss_pred             CCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       226 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ..... ...+..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       416 ~~~~~-~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        416 YTRPA-WTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cCCcc-hhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            11111 1222356778999999999999999999999999999975

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-40  Score=297.45  Aligned_cols=238  Identities=26%  Similarity=0.405  Sum_probs=210.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +.-||..||||.++++..+.....++.+|+++++.++|||||+++.+....     ..+|+||||+. |.+++++.+.+.
T Consensus        77 ~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~~lylV~eya~~ge~~~yl~~~gr  151 (596)
T KOG0586|consen   77 HILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----ATLYLVMEYASGGELFDYLVKHGR  151 (596)
T ss_pred             ecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----ceeEEEEEeccCchhHHHHHhccc
Confidence            567899999999999888888888899999999999999999999999544     56999999995 799999999999


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      ..+..++.++.|+..|++|||+++|+|||||.+|++++.+.++||+|||++..+.........+|++.|.|||++.+...
T Consensus       152 ~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y  231 (596)
T KOG0586|consen  152 MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKY  231 (596)
T ss_pred             chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCccc
Confidence            99999999999999999999999999999999999999999999999999999888777889999999999999999777


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      .++.+|+||+|+++|.|+.|.+||.+.+....-.......                               ..+.-.++.
T Consensus       232 ~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-------------------------------~rIp~~ms~  280 (596)
T KOG0586|consen  232 DGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-------------------------------YRIPFYMSC  280 (596)
T ss_pred             CCcceehhhhhhhheeeeecccccCCcccccccchheeee-------------------------------ecccceeec
Confidence            7899999999999999999999998876433322211100                               011125688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ++.++|+++|..+|.+|++.+++..|.|.....+.
T Consensus       281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            89999999999999999999999999999887766

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.1e-39  Score=274.31  Aligned_cols=232  Identities=28%  Similarity=0.405  Sum_probs=192.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+|+.|++|.+............+.+|+.+++.++||||+++++++...     ...++||||+. ++|.+++...  
T Consensus        21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   95 (256)
T cd08529          21 RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLNIVMEYAENGDLHKLLKMQRG   95 (256)
T ss_pred             EcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEEEEEEeCCCCcHHHHHHHhcC
Confidence            356899999999976544556677889999999999999999999998654     56999999996 6999998764  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~  157 (316)
                      ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+
T Consensus        96 ~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (256)
T cd08529          96 RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED  175 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcC
Confidence            5689999999999999999999999999999999999999999999999998876544322 233457788999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+|||||++++|++|..||...+.......+....  .+                            .....
T Consensus       176 -~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~----------------------------~~~~~  224 (256)
T cd08529         176 -KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FP----------------------------PVSQM  224 (256)
T ss_pred             -CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC----------------------------CCccc
Confidence             668899999999999999999999998776544444332211  00                            01114


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++..+.++|++||+.+|++||++.++++|||+
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            67889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-39  Score=301.94  Aligned_cols=241  Identities=25%  Similarity=0.371  Sum_probs=196.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---CCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+|+.||||++.....+......+.+|+.++..++|++|+++++.+.....   .....+++||||+. |+|.+.+..
T Consensus        53 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~  132 (496)
T PTZ00283         53 RVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS  132 (496)
T ss_pred             EcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHH
Confidence            46789999999997765556666778899999999999999999988764321   11224789999996 799998864


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---Ccccccccccccc
Q 021181           78 ----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYR  150 (316)
Q Consensus        78 ----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~  150 (316)
                          ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.....   .......+++.|+
T Consensus       133 ~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~  212 (496)
T PTZ00283        133 RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV  212 (496)
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCccee
Confidence                246899999999999999999999999999999999999999999999999998764432   2233467899999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      |||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.....                             
T Consensus       213 aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-----------------------------  262 (496)
T PTZ00283        213 APEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-----------------------------  262 (496)
T ss_pred             CHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----------------------------
Confidence            9999987 6789999999999999999999999987765554443322100                             


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                       ....+.+++++.+++.+||+.||.+||++.++++|||++.+.
T Consensus       263 -~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 -DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence             011135788999999999999999999999999999988754

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=285.56  Aligned_cols=262  Identities=37%  Similarity=0.658  Sum_probs=192.2

Q ss_pred             CCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-----
Q 021181            5 TREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-----   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----   78 (316)
                      +|+.||||.+.... ........+.+|+.+++.++||||+++++++....   ...+++||||++++|.+.+...     
T Consensus        26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~  102 (316)
T cd07842          26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DKSVYLLFDYAEHDLWQIIKFHRQAKR  102 (316)
T ss_pred             CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---CceEEEEEeCCCcCHHHHHHhhccCCC
Confidence            78999999997643 12223456788999999999999999999997552   1569999999998888776432     


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc----CCCEEEeeeccccccCCCCc----ccccccccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA----NCDLKIGDFGLARTTSETDF----MTEYVVTRWYR  150 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~----~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~  150 (316)
                      ..+++..++.++.||+.||+|||+.+++|+||+|+||+++.    ++.++|+|||++........    .....++..|+
T Consensus       103 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  182 (316)
T cd07842         103 VSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR  182 (316)
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcccccccc
Confidence            36899999999999999999999999999999999999999    89999999998876543321    22345678899


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---------HHHHHHHhhCCCCccccccccccc-hHHHh
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH---------QLRLITELIGSPDETSLGFLRSDN-ARRYV  220 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~---------~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~  220 (316)
                      |||.+.+...++.++|||||||++++|++|++||.+.....         .+..+...++.+....+....... .....
T Consensus       183 aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (316)
T cd07842         183 APELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLM  262 (316)
T ss_pred             CHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhh
Confidence            99998775668899999999999999999999998665322         333444444433322221111000 00000


Q ss_pred             hh--CCCCCCCCc---cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          221 RM--LPQFPKQNF---SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       221 ~~--~~~~~~~~~---~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..  ....+....   .+.....+..+.++|.+||+.||++|||+.|+++||||
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         263 KDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00  000000011   11112577889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.4e-39  Score=285.39  Aligned_cols=264  Identities=21%  Similarity=0.263  Sum_probs=192.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+|+.||||+++...........+.+|+.+++.++|+||+++++++...     ...+++|||++ |+|.+++...  
T Consensus        21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~   95 (314)
T cd08216          21 HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSCEDLLKTHFP   95 (314)
T ss_pred             ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCHHHHHHHhcc
Confidence            456899999999977544555667899999999999999999999998654     45899999997 6898888753  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--------cccccccccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--------FMTEYVVTRWYR  150 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~  150 (316)
                      ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++++||+.+.......        ......++..|+
T Consensus        96 ~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  175 (314)
T cd08216          96 EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL  175 (314)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccccccc
Confidence            468999999999999999999999999999999999999999999999999875432211        112334567899


Q ss_pred             CcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh------C
Q 021181          151 APELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM------L  223 (316)
Q Consensus       151 aPE~~~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~------~  223 (316)
                      |||.+... ..++.++|+||+||++|+|++|..||..........  .+..+..+...... ...........      .
T Consensus       176 aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  252 (314)
T cd08216         176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLLDKS-TYPLYEDSMSQSRSSNEH  252 (314)
T ss_pred             CHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccccccC-chhhhcCCcCcccccccc
Confidence            99998653 357889999999999999999999998765443322  22222211110000 00000000000      0


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..............++.++.+++++||+.||++|||++++++||||+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         253 PNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            00000000111124567899999999999999999999999999999775

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.8e-39  Score=279.69  Aligned_cols=239  Identities=25%  Similarity=0.406  Sum_probs=193.0

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +..+|+.||+|++...... ......+.+|+++++.++|++|+.+++.+...     ...+++|||+. ++|.+.+... 
T Consensus        21 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~   95 (285)
T cd05632          21 VRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMG   95 (285)
T ss_pred             ECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEEEEEEEeccCccHHHHHHHhc
Confidence            4568999999999654322 22345577899999999999999999988654     46999999996 6888777543 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                       .++++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~  175 (285)
T cd05632          96 NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN  175 (285)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcC
Confidence             4699999999999999999999999999999999999999999999999998876544333345578899999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+||+||++|+|++|..||...........+.........                           .....
T Consensus       176 -~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~  227 (285)
T cd05632         176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE---------------------------VYSAK  227 (285)
T ss_pred             -CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc---------------------------ccCcc
Confidence             67899999999999999999999999877654443333221111110                           01135


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      ++.++.+|+.+||+.||++||+     +.++++|+||+++.
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            6788999999999999999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.9e-40  Score=272.75  Aligned_cols=263  Identities=37%  Similarity=0.653  Sum_probs=215.4

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-----CCC
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-----QDL   81 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----~~~   81 (316)
                      +.||||+++.+...........+|+.+++.++|||++.+..+|...+    ..+++++||.+.+|.++|+..     +.+
T Consensus        54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d----~~v~l~fdYAEhDL~~II~fHr~~~~~~l  129 (438)
T KOG0666|consen   54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD----KKVWLLFDYAEHDLWHIIKFHRASKAKQL  129 (438)
T ss_pred             hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC----ceEEEEehhhhhhHHHHHHHhccchhccC
Confidence            47999999877555555567789999999999999999999998643    569999999999999999643     458


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC----CCEEEeeeccccccCCCC----ccccccccccccCcc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN----CDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPE  153 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~----~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE  153 (316)
                      +...++.+++||+.|+.|||++=|.||||||.|||+..+    |.+||+|+|+++.....-    .....+-|.||+|||
T Consensus       130 p~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE  209 (438)
T KOG0666|consen  130 PRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE  209 (438)
T ss_pred             CHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence            899999999999999999999999999999999999887    899999999998865432    234556799999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------cHHHHHHHHHhhCCCCccccccccccchH-HHhhhC
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRLITELIGSPDETSLGFLRSDNAR-RYVRML  223 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~  223 (316)
                      .+.+...|+.+.|||++||++.||++.+|.|.+..         ..+++.+|..++|.+.+..|++...-+.. ..+...
T Consensus       210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f  289 (438)
T KOG0666|consen  210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF  289 (438)
T ss_pred             HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence            99998999999999999999999999999997653         35678899999999999999876654433 222222


Q ss_pred             CCCCCC-----CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          224 PQFPKQ-----NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       224 ~~~~~~-----~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +.....     .+......-++...+|+.+||+.||.+|.|+++.++|+||....
T Consensus       290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~  344 (438)
T KOG0666|consen  290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP  344 (438)
T ss_pred             HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence            211111     11222234566699999999999999999999999999998754

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.7e-39  Score=280.80  Aligned_cols=262  Identities=23%  Similarity=0.351  Sum_probs=193.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.+.... .......+.+|++++++++||||+++++++...     ..++++|||++ ++|.+++...+.
T Consensus        22 ~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ey~~~~~L~~~l~~~~~   95 (308)
T cd06615          22 HRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGR   95 (308)
T ss_pred             EcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEEEEeeccCCCcHHHHHHhcCC
Confidence            45688999999987542 333456788999999999999999999999654     56999999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+ .
T Consensus        96 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~  173 (308)
T cd06615          96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-T  173 (308)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcC-C
Confidence            9999999999999999999997 69999999999999999999999999987654322 2234567889999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccc---------ccccccchHHHhhhCCCCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL---------GFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      .++.++|+|||||++|+|++|..||...+.......+............         ...................  .
T Consensus       174 ~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  251 (308)
T cd06615         174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP--P  251 (308)
T ss_pred             CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCC--C
Confidence            6889999999999999999999999766533332222111110000000         0000000000111100000  0


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .......++.++++++.+||..||++||+++++++||||.+..
T Consensus       252 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         252 PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            0011113688899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.3e-39  Score=276.05  Aligned_cols=232  Identities=29%  Similarity=0.488  Sum_probs=187.9

Q ss_pred             CCCCCceEEEEEecccccCh-------hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHH
Q 021181            2 NSETREEVAIKKIGNAFDNR-------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~   73 (316)
                      +..+++.||+|.+.......       .....+.+|+.++++++||||+++++++...     ...+++|||++ ++|.+
T Consensus        21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~   95 (267)
T cd06628          21 NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-----DHLNIFLEYVPGGSVAA   95 (267)
T ss_pred             ecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CccEEEEEecCCCCHHH
Confidence            45678999999886543221       1235678899999999999999999998654     46899999996 59999


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-------cccccccc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-------FMTEYVVT  146 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~  146 (316)
                      ++...+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......       ......++
T Consensus        96 ~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~  175 (267)
T cd06628          96 LLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS  175 (267)
T ss_pred             HHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCC
Confidence            99888889999999999999999999999999999999999999999999999999887654221       11223467


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      ..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+....+..+.....                         
T Consensus       176 ~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------------  229 (267)
T cd06628         176 VFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-------------------------  229 (267)
T ss_pred             cCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC-------------------------
Confidence            78999999876 6688899999999999999999999987654433332221000                         


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                           ......++..+.++|++||+.||.+||++.++++||||
T Consensus       230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         230 -----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                 01112467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.6e-39  Score=278.60  Aligned_cols=239  Identities=26%  Similarity=0.376  Sum_probs=191.7

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||+|.+..... .......+..|++++++++||||+++++++...     ...|+||||++ ++|.+++...+
T Consensus        14 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   88 (277)
T cd05577          14 VKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLMNGGDLKYHIYNVG   88 (277)
T ss_pred             EcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecCCCCcHHHHHHHcC
Confidence            456899999999975432 222345667899999999999999999998544     56899999996 69999987665


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 --DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 --~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                        .+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+
T Consensus        89 ~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~  168 (277)
T cd05577          89 EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG  168 (277)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcC
Confidence              799999999999999999999999999999999999999999999999998876554433344566788999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+|||||++|+|++|+.||...........+......                           ......+.
T Consensus       169 -~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~  220 (277)
T cd05577         169 -EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE---------------------------MAVEYPDK  220 (277)
T ss_pred             -CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc---------------------------ccccCCcc
Confidence             55889999999999999999999999776532222222111000                           00111134


Q ss_pred             CChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +++.+.++|++||+.||.+||     ++.++++||||.++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence            688999999999999999999     888899999998766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=272.74  Aligned_cols=239  Identities=25%  Similarity=0.398  Sum_probs=194.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~   79 (316)
                      +..||+.||||++.+.  ..-...++.+|++++.++ .|+||+.++++|.+.     ..+|+|||-+ +|+|...|++++
T Consensus        99 ~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~FYLVfEKm~GGplLshI~~~~  171 (463)
T KOG0607|consen   99 SIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TRFYLVFEKMRGGPLLSHIQKRK  171 (463)
T ss_pred             eeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ceEEEEEecccCchHHHHHHHhh
Confidence            5679999999999765  445678899999999999 599999999999654     5699999999 579999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccccCCCC--------cccccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETD--------FMTEYVVTRW  148 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~--------~~~~~~~~~~  148 (316)
                      .+++.++.+++..|+.||.|||.+||.|||+||+|||-....   -+|||||.+...+..+.        ...+.+|+..
T Consensus       172 ~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAE  251 (463)
T KOG0607|consen  172 HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAE  251 (463)
T ss_pred             hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchh
Confidence            999999999999999999999999999999999999986544   38999998765432221        1235678889


Q ss_pred             ccCccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHHhhCCCCccccc
Q 021181          149 YRAPELLL----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV---------------HQLRLITELIGSPDETSLG  209 (316)
Q Consensus       149 ~~aPE~~~----~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~  209 (316)
                      |||||+..    ....|+...|.||||+++|-|++|.+||.+....               .....|+...-.++...| 
T Consensus       252 fMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW-  330 (463)
T KOG0607|consen  252 FMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW-  330 (463)
T ss_pred             hcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh-
Confidence            99999852    2256889999999999999999999999876431               122233333333333322 


Q ss_pred             cccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                                                .++|.+.+++|+.+|..|+..|.++.++++|||+.....
T Consensus       331 --------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  331 --------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             --------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence                                      368999999999999999999999999999999997753

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-38  Score=273.99  Aligned_cols=234  Identities=30%  Similarity=0.481  Sum_probs=193.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      +.++|+.||+|.+............+..|+.+++.++|+||+++++.+.....   ...+++|||++ ++|.+++..   
T Consensus        21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~~~e~~~~~~L~~~l~~~~~   97 (265)
T cd08217          21 RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLYIVMEYCEGGDLAQLIQKCKK   97 (265)
T ss_pred             ecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEEEEehhccCCCHHHHHHHHhh
Confidence            56789999999997665556667788899999999999999999998764322   56899999996 699988865   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhh-----cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-ccccccccccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVH-----SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYR  150 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH-----~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~  150 (316)
                       ...+++..++.++.||+.||.+||     +.+++|+||+|+||+++.++.++|+|||.+........ .....++..|+
T Consensus        98 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~  177 (265)
T cd08217          98 ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM  177 (265)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCcc
Confidence             357899999999999999999999     89999999999999999999999999999887655443 33456788999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      |||.+.+ ..++.++|+||||+++++|++|..||...+.......+.....                             
T Consensus       178 ~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------  227 (265)
T cd08217         178 SPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-----------------------------  227 (265)
T ss_pred             ChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-----------------------------
Confidence            9999877 6688999999999999999999999988764444333322100                             


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                       ......++..+.+++.+||+.+|.+||++++|++|||+
T Consensus       228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence             01112567889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-39  Score=277.15  Aligned_cols=235  Identities=25%  Similarity=0.369  Sum_probs=192.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.+.... .......+.+|+.+++.++|+||+++++++...     ...++|+||++ ++|.+++... +
T Consensus        22 ~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~-~   94 (274)
T cd06609          22 DKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLWIIMEYCGGGSCLDLLKPG-K   94 (274)
T ss_pred             ECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEEEEEEeeCCCcHHHHHhhc-C
Confidence            45689999999997543 233456678999999999999999999988644     56999999996 6999998764 8


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+ .
T Consensus        95 ~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~  173 (274)
T cd06609          95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S  173 (274)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhcc-C
Confidence            899999999999999999999999999999999999999999999999998776544 22334567788999999987 5


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||++|+|++|.+||...+.......+.....  +.                         ..  ...++
T Consensus       174 ~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~-------------------------~~--~~~~~  224 (274)
T cd06609         174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--PS-------------------------LE--GNKFS  224 (274)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC--CC-------------------------Cc--ccccC
Confidence            689999999999999999999999977654433332221100  00                         00  01267


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .++.+++.+||..||++||+++++++||||++..
T Consensus       225 ~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            8899999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-40  Score=265.45  Aligned_cols=272  Identities=34%  Similarity=0.569  Sum_probs=223.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---CCCCeEEEEEecCCCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      .+++|+.||+|++-.+--...--...++|+.+|..|+|+|++.++++|....-   .....+|+|+++|+.+|+.++...
T Consensus        38 ~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~  117 (376)
T KOG0669|consen   38 SKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNR  117 (376)
T ss_pred             hcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCc
Confidence            57889999999875432122223456899999999999999999999874321   223569999999999999998765


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----ccccccccccccCc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAP  152 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aP  152 (316)
                       .+++..+++.++.++++||.|+|+..|+|||+|+.|+|++.+|.++|.|||+++.++...     .....+-|.+|++|
T Consensus       118 ~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  118 KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCH
Confidence             579999999999999999999999999999999999999999999999999997654432     13345569999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC--CCCCCCC
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML--PQFPKQN  230 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  230 (316)
                      |.+.+...++++.|||..||++.+|.++.+.+++...-.++..|..+.|+.....|+....-+..+.....  +.-....
T Consensus       198 EllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rk  277 (376)
T KOG0669|consen  198 ELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRK  277 (376)
T ss_pred             HHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhh
Confidence            99999899999999999999999999999999999999999999999999999888877776666555332  2222233


Q ss_pred             ccccCC--CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          231 FSARFP--NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       231 ~~~~~~--~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...+..  .-.++..+++.+||..||.+|+.++++++|.||.+-.
T Consensus       278 v~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  278 VKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             hhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            333322  2356799999999999999999999999999998743

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.1e-39  Score=286.07  Aligned_cols=241  Identities=22%  Similarity=0.373  Sum_probs=191.8

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-C
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-H   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~   78 (316)
                      ++.+++.||+|++.... ........+..|+.++..++|++|+++++.+...     ..+|+||||+. |+|.+++.. .
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~   96 (332)
T cd05623          22 LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFE   96 (332)
T ss_pred             ECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CEEEEEEeccCCCcHHHHHHHhc
Confidence            45688999999996532 2233345578899999999999999999998654     56999999995 799999976 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........  .....++..|+|||++.
T Consensus        97 ~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623          97 DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHh
Confidence            6789999999999999999999999999999999999999999999999998866433222  22356899999999986


Q ss_pred             C----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          157 N----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       157 ~----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      .    ...++.++|||||||++|+|++|+.||...+.......+.......                          .+.
T Consensus       177 ~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~p  230 (332)
T cd05623         177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------------------------QFP  230 (332)
T ss_pred             ccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc--------------------------cCC
Confidence            2    2467889999999999999999999998877666655543211100                          011


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~  273 (316)
                      .....+++++.++|++||..++.+  |++++++++||||.++.
T Consensus       231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            112357899999999999765554  68999999999999865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-39  Score=310.27  Aligned_cols=240  Identities=28%  Similarity=0.417  Sum_probs=193.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      +..+++.||+|.+............+..|+.+++.++||||++++++|....   ...+||||||++ |+|.++|..   
T Consensus        34 dk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~~~lyIVMEY~~gGSL~~lL~k~~~  110 (1021)
T PTZ00266         34 HKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---NQKLYILMEFCDAGDLSRNIQKCYK  110 (1021)
T ss_pred             ECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---CCEEEEEEeCCCCCcHHHHHHHHhh
Confidence            5678899999999876555666778899999999999999999999986432   256899999996 699988865   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcC-------CceeccCCCCcEEEcc-----------------CCCEEEeeecccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSA-------NVLHRDLKPSNLLLNA-----------------NCDLKIGDFGLAR  132 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~-------~i~H~dl~p~nil~~~-----------------~~~~~l~df~~~~  132 (316)
                       ...+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.                 .+.++|+|||++.
T Consensus       111 ~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr  190 (1021)
T PTZ00266        111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK  190 (1021)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccc
Confidence             35799999999999999999999984       4999999999999964                 3348999999998


Q ss_pred             ccCCCCccccccccccccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccc
Q 021181          133 TTSETDFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL  211 (316)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  211 (316)
                      ............+++.|+|||++.+. ..++.++|||||||++|+|++|..||...+....+.....  ..+.       
T Consensus       191 ~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk--~~p~-------  261 (1021)
T PTZ00266        191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK--RGPD-------  261 (1021)
T ss_pred             cccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh--cCCC-------
Confidence            76554444556789999999998642 4578999999999999999999999977654433322211  0000       


Q ss_pred             cccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          212 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                                           .....++.++.+||..||+.+|.+||++.++|.|+|++.+..
T Consensus       262 ---------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        262 ---------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             ---------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence                                 011246788999999999999999999999999999987753

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-38  Score=274.14  Aligned_cols=232  Identities=26%  Similarity=0.398  Sum_probs=188.0

Q ss_pred             CCCceEEEEEecccccC----hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            4 ETREEVAIKKIGNAFDN----RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      .+|+.+|||.+......    ......+.+|+.+++.++|+||+++++++...     ...+++|||+. ++|.+++.+.
T Consensus        22 ~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   96 (265)
T cd06631          22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----NTISIFMEFVPGGSISSILNRF   96 (265)
T ss_pred             cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----CeEEEEEecCCCCcHHHHHHhc
Confidence            47889999998754322    22345678899999999999999999998654     56999999996 6999999887


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-------CccccccccccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-------DFMTEYVVTRWYRA  151 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~a  151 (316)
                      ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......       .......++..|+|
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (265)
T cd06631          97 GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA  176 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccC
Confidence            88999999999999999999999999999999999999999999999999988654221       11223457888999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          152 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      ||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....+..                            
T Consensus       177 pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------  227 (265)
T cd06631         177 PEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----------------------------  227 (265)
T ss_pred             hhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----------------------------
Confidence            999877 668899999999999999999999997765443332222211111                            


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ......++.++.++|++||+.+|.+||++.++++||||
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         228 PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11113578889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-38  Score=272.41  Aligned_cols=232  Identities=28%  Similarity=0.452  Sum_probs=194.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+|+.|++|.+.....+......+.+|++++++++|+||+++++++...     ..++++|||++ ++|.+++...  
T Consensus        21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~~~~~~~   95 (256)
T cd08221          21 RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKG   95 (256)
T ss_pred             EcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEEEEEEecCCCcHHHHHHhccc
Confidence            467899999999976655566667788999999999999999999999654     56999999996 6999998765  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|.|||.+.+
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~  175 (256)
T cd08221          96 QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG  175 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCC
Confidence            468999999999999999999999999999999999999999999999999887654433 2334567889999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+||||+++|+|++|..||...+..+....+...  ...                            .....
T Consensus       176 -~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~----------------------------~~~~~  224 (256)
T cd08221         176 -VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT----------------------------PVVSV  224 (256)
T ss_pred             -CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC----------------------------CCccc
Confidence             55788999999999999999999999877655555544321  110                            01135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++.++.++|.+||+.+|.+||+++++++|+|+
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         225 YSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            68889999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.9e-39  Score=274.92  Aligned_cols=234  Identities=27%  Similarity=0.374  Sum_probs=186.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||+|.++...  ......+.+|+.+++.++||||+++++.+...     ..++++|||++ ++|.+++...+.
T Consensus        30 ~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~  102 (267)
T cd06645          30 NVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWICMEFCGGGSLQDIYHVTGP  102 (267)
T ss_pred             EcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEEEEeccCCCcHHHHHHhcCC
Confidence            45789999999986542  23445678899999999999999999998654     46899999997 699999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccccc--C
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLL--N  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~--~  157 (316)
                      +++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.  .
T Consensus       103 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  182 (267)
T cd06645         103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER  182 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhcccc
Confidence            9999999999999999999999999999999999999999999999999886654322 223456788999999874  2


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|+|||||++|+|++|.+||..................++                         . ......
T Consensus       183 ~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~-~~~~~~  236 (267)
T cd06645         183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP-------------------------K-LKDKMK  236 (267)
T ss_pred             CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC-------------------------c-ccccCC
Confidence            24578899999999999999999999866553333222211000000                         0 000124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPY  268 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~  268 (316)
                      ++..+.++|.+||+.||++||+++++++|||
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            6778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.5e-39  Score=285.12  Aligned_cols=228  Identities=25%  Similarity=0.412  Sum_probs=178.5

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ..+++.||||+++.. ........+.+|+.+++.+ +||||+++++++....    ..++++|||++ |+|.+++...  
T Consensus        34 ~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~  108 (338)
T cd05102          34 KSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN----GPLMVIVEFCKYGNLSNFLRAKRE  108 (338)
T ss_pred             cccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC----CceEEEEecCCCCcHHHHHHhcch
Confidence            356778999999753 2333456788999999999 8999999999886432    45899999996 7999888642  


Q ss_pred             ------------------------------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 021181           79 ------------------------------------------------------------QDLTDDHCRYFLYQLLRGLK   98 (316)
Q Consensus        79 ------------------------------------------------------------~~~~~~~~~~i~~qi~~~l~   98 (316)
                                                                                  ..+++.++..++.||+.||+
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~  188 (338)
T cd05102         109 FFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME  188 (338)
T ss_pred             hcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHH
Confidence                                                                        23778889999999999999


Q ss_pred             HhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCCCCCCCcchHHHHHHHHH
Q 021181           99 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG  175 (316)
Q Consensus        99 ~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~  175 (316)
                      |||+.||+||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|
T Consensus       189 ~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~  267 (338)
T cd05102         189 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLW  267 (338)
T ss_pred             HHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHH
Confidence            99999999999999999999999999999999876533211   122334578999999877 67899999999999999


Q ss_pred             HHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCC
Q 021181          176 EIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDP  254 (316)
Q Consensus       176 ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP  254 (316)
                      +|++ |..||.+............. +..                            ......+++.+.+++.+||+.||
T Consensus       268 el~~~g~~pf~~~~~~~~~~~~~~~-~~~----------------------------~~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         268 EIFSLGASPYPGVQINEEFCQRLKD-GTR----------------------------MRAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             HHHhCCCCCCCCCCccHHHHHHHhc-CCC----------------------------CCCCCCCCHHHHHHHHHHccCCh
Confidence            9997 99999876543322221110 000                            00012567889999999999999


Q ss_pred             CCCCCHHHHhc
Q 021181          255 NRRITVDEALC  265 (316)
Q Consensus       255 ~~Rps~~ell~  265 (316)
                      .+|||+.++++
T Consensus       319 ~~RPs~~el~~  329 (338)
T cd05102         319 KERPTFSALVE  329 (338)
T ss_pred             hhCcCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-38  Score=274.61  Aligned_cols=235  Identities=25%  Similarity=0.442  Sum_probs=186.6

Q ss_pred             CCCCCceEEEEEecccccC---hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFDN---RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+|..||+|++......   ......+.+|+.+++.++||||+++++++....   ...++++|||++ ++|.+++..
T Consensus        23 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~~~l~~e~~~~~~L~~~l~~   99 (266)
T cd06651          23 DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---EKTLTIFMEYMPGGSVKDQLKA   99 (266)
T ss_pred             EcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---CCEEEEEEeCCCCCcHHHHHHH
Confidence            4578999999998654322   223456788999999999999999999886432   256899999996 699999988


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----ccccccccccccCcc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPE  153 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE  153 (316)
                      .+.+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++.......    ......++..|+|||
T Consensus       100 ~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  179 (266)
T cd06651         100 YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE  179 (266)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHH
Confidence            7889999999999999999999999999999999999999999999999999886543211    112244678899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.+ ..++.++|+||+||++|+|++|+.||...+....+..+..   ....                          ..
T Consensus       180 ~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~--------------------------~~  229 (266)
T cd06651         180 VISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN--------------------------PQ  229 (266)
T ss_pred             HhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC--------------------------CC
Confidence            9877 6788999999999999999999999987654443332211   1000                          00


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      ....+++.+.++| +||..+|++||+++|+++||||+
T Consensus       230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            1124577789999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-39  Score=276.91  Aligned_cols=236  Identities=30%  Similarity=0.438  Sum_probs=189.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..+++.||+|.++..  .......+..|+.++++++|+||+++++.+...     ...|+||||++ ++|.+++... .
T Consensus        26 ~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   98 (280)
T cd06611          26 HKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLWILIEFCDGGALDSIMLELER   98 (280)
T ss_pred             EcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEEEEeeccCCCcHHHHHHHhcC
Confidence            3468999999998643  344556788999999999999999999998654     46899999997 5898888664 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccC-
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN-  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-  157 (316)
                      .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.. 
T Consensus        99 ~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  178 (280)
T cd06611          99 GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE  178 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhc
Confidence            6999999999999999999999999999999999999999999999999987654332 22234567888999999752 


Q ss_pred             ---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 ---CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ---~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                         ...++.++|+|||||++|+|++|.+||...+.......+...  ..+.                          ...
T Consensus       179 ~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------------------------~~~  230 (280)
T cd06611         179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPPT--------------------------LDQ  230 (280)
T ss_pred             ccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCCC--------------------------cCC
Confidence               245678999999999999999999999877654443333211  0000                          001


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ...++.++.++|.+||+.||.+||+++++++||||.+.
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            12467889999999999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-39  Score=277.43  Aligned_cols=260  Identities=40%  Similarity=0.732  Sum_probs=202.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--   79 (316)
                      ..+++.||||++...... .......+|+..+++++ |+|++++++++...     ...++||||++|+|.+.+....  
T Consensus        21 ~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   94 (283)
T cd07830          21 KETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYFVFEYMEGNLYQLMKDRKGK   94 (283)
T ss_pred             CCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEEEEecCCCCHHHHHHhcccc
Confidence            457899999998765332 23334567999999998 99999999998653     5699999999999999887764  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.++..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+....
T Consensus        95 ~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  174 (283)
T cd07830          95 PFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST  174 (283)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCc
Confidence            78999999999999999999999999999999999999999999999999987765544444556788899999987656


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||||+++++|++|.+||......+....+....+.+....+.... ......................+..+
T Consensus       175 ~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (283)
T cd07830         175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY-KLASKLGFRFPQFAPTSLHQLIPNAS  253 (283)
T ss_pred             CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh-hhhccccccccccccccHHHHcccCC
Confidence            68899999999999999999999999988888877777776665443221100 00000000011111111222334457


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .++.++|++||+.||.+||+++|++.||||
T Consensus       254 ~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         254 PEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.4e-39  Score=275.18  Aligned_cols=234  Identities=24%  Similarity=0.451  Sum_probs=191.7

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||+|.+..... .......+.+|++++++++||||+++++.+...     ...++|+||+. ++|.+.+....
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   95 (258)
T cd05578          21 KRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENMYLVVDLLLGGDLRYHLSQKV   95 (258)
T ss_pred             EccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeEEEEEeCCCCCCHHHHHHhcC
Confidence            457899999999976432 224567889999999999999999999998544     56999999996 69999998877


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..+..++.||++||.+||++|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+ .
T Consensus        96 ~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~  174 (258)
T cd05578          96 KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-Q  174 (258)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcc-c
Confidence            899999999999999999999999999999999999999999999999998877655433345567888999999877 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||||+++|+|++|..||...+.... ..+........                           .......+
T Consensus       175 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~---------------------------~~~~~~~~  226 (258)
T cd05578         175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETAD---------------------------VLYPATWS  226 (258)
T ss_pred             CCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHHHhcccc---------------------------ccCcccCc
Confidence            689999999999999999999999987764211 11111111000                           00112457


Q ss_pred             hHHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITV--DEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~--~ell~~~~f  269 (316)
                      .++.++|++||+.||.+||++  +|+++||||
T Consensus       227 ~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         227 TEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            889999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=273.39  Aligned_cols=234  Identities=29%  Similarity=0.400  Sum_probs=188.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..+++.||+|.+....  ......+.+|+.++++++||||+++++.+...     ..+|++|||++ ++|.+++... .
T Consensus        24 ~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l~~e~~~~~~l~~~~~~~~~   96 (262)
T cd06613          24 DIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLWIVMEYCGGGSLQDIYQVTRG   96 (262)
T ss_pred             ecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhhcc
Confidence            45678999999997542  22567888999999999999999999998654     56999999997 5898888776 7


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.
T Consensus        97 ~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~  176 (262)
T cd06613          97 PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE  176 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhccc
Confidence            89999999999999999999999999999999999999999999999999887654332 22344677889999998662


Q ss_pred             --CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          159 --SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       159 --~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                        ..++.++|+|||||++|+|++|.+||...+.......+....-.+..                          .....
T Consensus       177 ~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~  230 (262)
T cd06613         177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK--------------------------LKDKE  230 (262)
T ss_pred             ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc--------------------------ccchh
Confidence              26788999999999999999999999877654443332221000000                          00012


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPY  268 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~  268 (316)
                      .++.++.+++++||..||..||++++++.|+|
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            35678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-38  Score=274.49  Aligned_cols=237  Identities=26%  Similarity=0.445  Sum_probs=189.1

Q ss_pred             CCCCCceEEEEEecccccC----hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDN----RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      +..+|+.||+|.++.....    ......+..|+.++++++|+||+++++++...     .++++||||+. ++|.+++.
T Consensus        21 ~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~   95 (268)
T cd06630          21 DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----SHFNLFVEWMAGGSVSHLLS   95 (268)
T ss_pred             EcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----CeEEEEEeccCCCcHHHHHH
Confidence            4678999999999754321    22356788999999999999999999998654     56999999996 69999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCC-----cccccccccccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETD-----FMTEYVVTRWYR  150 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~  150 (316)
                      ..+++++..+..++.||+.||.+||++|++|+||+|+||+++.++ .++|+|||.+.......     ......++..|+
T Consensus        96 ~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (268)
T cd06630          96 KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM  175 (268)
T ss_pred             HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccccee
Confidence            888899999999999999999999999999999999999998876 59999999886654321     112345678899


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      |||.+.+ ..++.++|+||+||++++|++|..||...+.......+........                          
T Consensus       176 ~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------  228 (268)
T cd06630         176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--------------------------  228 (268)
T ss_pred             CHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC--------------------------
Confidence            9999876 6788999999999999999999999975543322222221110000                          


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      .......+++++.+++.+||..||.+||++.++++||||+
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            0011124678899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.8e-39  Score=275.11  Aligned_cols=238  Identities=27%  Similarity=0.445  Sum_probs=191.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      ++.+|+.||+|.+..... ......+.+|+++++.++||||+++++.+...     ..+++++||++ ++|.+++... .
T Consensus        22 ~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   95 (265)
T cd06605          22 HRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDISICMEYMDGGSLDKILKEVQG   95 (265)
T ss_pred             EcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEEEEEecCCCcHHHHHHHccC
Confidence            456899999999976533 34557788999999999999999999998654     56999999997 6999998776 7


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..+..++.|++.||++||+ .|++|+||+|+||+++.++.++|+|||.+......... ...++..|+|||.+.+ 
T Consensus        96 ~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~-  173 (265)
T cd06605          96 RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-  173 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcC-
Confidence            89999999999999999999999 99999999999999999999999999988665332221 2567788999999877 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ..++.++|+||||+++|+|++|..||...+.  ......+...........                        .  ..
T Consensus       174 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~--~~  227 (265)
T cd06605         174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL------------------------P--SG  227 (265)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC------------------------C--hh
Confidence            6789999999999999999999999966531  111112222111111000                        0  01


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .++.++.++|.+||..||++||++.+++.||||+.+.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            2688899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=294.35  Aligned_cols=269  Identities=26%  Similarity=0.418  Sum_probs=217.6

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc--C
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS--H   78 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~--~   78 (316)
                      ++++||+.||||+|.+..........++.|+++|+.+.||+||.+--.|..+     +.+++|||-+.|+..+.|-+  .
T Consensus       584 ~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVMEKl~GDMLEMILSsEk  658 (888)
T KOG4236|consen  584 KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVMEKLHGDMLEMILSSEK  658 (888)
T ss_pred             eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEehhhcchHHHHHHHhhc
Confidence            4689999999999998766665668899999999999999999998888544     56999999999998887754  4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC---CCEEEeeeccccccCCCCccccccccccccCcccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                      +++++...+.++.||+.||.|||.+||+|.||||+|||+...   ..+||||||+++.+++...+...+||+.|+|||++
T Consensus       659 gRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVL  738 (888)
T KOG4236|consen  659 GRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVL  738 (888)
T ss_pred             ccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHH
Confidence            789999999999999999999999999999999999999654   46999999999999999999999999999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      ++ +.|..+-|+||.|+++|.-++|..||....  +.-..|+....--+..                           .+
T Consensus       739 rn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~---------------------------PW  788 (888)
T KOG4236|consen  739 RN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPN---------------------------PW  788 (888)
T ss_pred             hh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCC---------------------------ch
Confidence            98 889999999999999999999999996553  3333343322222211                           22


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHH
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY  304 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (316)
                      ..+|+.+.+||..+|+..-.+|.|++..|.|||++++..-.+.+......+..+...+-.+..+....+
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThesDD~~~~~~~~  857 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHESDDARWEQLAN  857 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcchhhhhhhhcC
Confidence            468999999999999999999999999999999999874444333333333333333333334444333

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-38  Score=271.45  Aligned_cols=232  Identities=28%  Similarity=0.390  Sum_probs=191.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+++.||||.+............+..|+.+++.++||||+++++.+...     ...++||||++ ++|.+++...  
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   95 (256)
T cd08220          21 RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALMIVMEYAPGGTLAEYIQKRCN   95 (256)
T ss_pred             EcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEEEEEecCCCCCHHHHHHHhcc
Confidence            457899999999976554555667889999999999999999999988543     56899999996 6999998764  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.............++..|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (256)
T cd08220          96 SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG  175 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC
Confidence            3489999999999999999999999999999999999998654 579999999887665544445567889999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+||+|+++|+|++|..||...+.......+......                              .....
T Consensus       176 -~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  224 (256)
T cd08220         176 -KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------------------------PISDR  224 (256)
T ss_pred             -CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------------------------CCCCC
Confidence             66889999999999999999999999877655544433221100                              01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++.++.+++.+||+.||.+|||+.|+++||||
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            68889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=283.67  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=205.1

Q ss_pred             CCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            3 SETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      +.||+-||.|++.+.. .........+.|-.++++++.+.||.+--.|.     +...+|+|+..|. |+|.-.|...+ 
T Consensus       207 raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe-----Tkd~LClVLtlMNGGDLkfHiyn~g~  281 (591)
T KOG0986|consen  207 RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE-----TKDALCLVLTLMNGGDLKFHIYNHGN  281 (591)
T ss_pred             ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec-----CCCceEEEEEeecCCceeEEeeccCC
Confidence            4688889999886542 23334456789999999999999999988884     4467999999995 79987776655 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                       .+++..++.++.+|+.||..||+.+||+||+||+|||+|+.|+++|+|+|++..+.........+||.+|+|||++.+ 
T Consensus       282 ~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-  360 (591)
T KOG0986|consen  282 PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-  360 (591)
T ss_pred             CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcC-
Confidence             799999999999999999999999999999999999999999999999999999988888778899999999999998 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..|+.+.|.|||||++|+|+.|+.||.......--..+.+..-..+                           .+.-...
T Consensus       361 e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~---------------------------~ey~~kF  413 (591)
T KOG0986|consen  361 EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP---------------------------EEYSDKF  413 (591)
T ss_pred             CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch---------------------------hhccccc
Confidence            6699999999999999999999999977643222222221111111                           1111357


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC------CCCCCCCCCCCCc
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH------DINEEPVCPRPFS  286 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~------~~~~~~~~~~~~~  286 (316)
                      |++++++.+.+|+.||++|.     +++++-+||||++++      ++-..|.++.|..
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a  472 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA  472 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence            99999999999999999998     467999999999998      5555666665544

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.9e-38  Score=275.64  Aligned_cols=237  Identities=26%  Similarity=0.405  Sum_probs=188.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      +..+|+.||+|.+...  .......+.+|+.+++.++|+||+++++.+...     ..+++||||++ ++|..++.. ..
T Consensus        33 ~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~  105 (292)
T cd06644          33 NKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWIMIEFCPGGAVDAIMLELDR  105 (292)
T ss_pred             ECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEEEEecCCCCcHHHHHHhhcC
Confidence            4568999999998653  344567788999999999999999999998644     46999999997 577776643 45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccC-
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN-  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-  157 (316)
                      .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+ 
T Consensus       106 ~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  185 (292)
T cd06644         106 GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE  185 (292)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccc
Confidence            7899999999999999999999999999999999999999999999999987654322 12234457788999999852 


Q ss_pred             ---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 ---CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ---~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                         ...++.++|+|||||++|+|++|.+||...+.......+..   .....                         ...
T Consensus       186 ~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~-------------------------~~~  237 (292)
T cd06644         186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPT-------------------------LSQ  237 (292)
T ss_pred             cccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCcc-------------------------CCC
Confidence               24467899999999999999999999977664433332211   10000                         011


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...++.++.++|++||+.||++||+++++++||||..+.
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            125678899999999999999999999999999998765

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=293.38  Aligned_cols=219  Identities=26%  Similarity=0.388  Sum_probs=188.4

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCCH
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTD   83 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~   83 (316)
                      .++.||||+++..         -..+|.-|++|+|+||+.+.|+|....     .+|||||||. |.|..+++....+..
T Consensus       146 ~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiMEfCa~GqL~~VLka~~~itp  211 (904)
T KOG4721|consen  146 HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIMEFCAQGQLYEVLKAGRPITP  211 (904)
T ss_pred             cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEeeeccccccHHHHHhccCccCH
Confidence            5678999988432         136788899999999999999998764     4999999997 899999999999999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA  163 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (316)
                      .....|..+|+.|+.|||..+|+|||||.-||||..+..+||+|||.++..........++||..|+|||++++ .+.++
T Consensus       212 ~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsE  290 (904)
T KOG4721|consen  212 SLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN-EPCSE  290 (904)
T ss_pred             HHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc-CCccc
Confidence            99999999999999999999999999999999999999999999999998877777788999999999999998 89999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHH
Q 021181          164 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV  243 (316)
Q Consensus       164 ~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  243 (316)
                      ++|||||||++||||||..||.+-+...++-.    .|.....                         ..+...+++.++
T Consensus       291 KVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----VGsNsL~-------------------------LpvPstcP~Gfk  341 (904)
T KOG4721|consen  291 KVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----VGSNSLH-------------------------LPVPSTCPDGFK  341 (904)
T ss_pred             ccceehhHHHHHHHHhcCCCccccchheeEEe----ccCCccc-------------------------ccCcccCchHHH
Confidence            99999999999999999999987765443321    1111100                         011125788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCC
Q 021181          244 DLLEKMLVFDPNRRITVDEALCHP  267 (316)
Q Consensus       244 ~li~~~L~~dP~~Rps~~ell~~~  267 (316)
                      -||+.||+-.|..|||+.+++.|-
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHH
Confidence            999999999999999999999983

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.5e-38  Score=274.68  Aligned_cols=236  Identities=27%  Similarity=0.404  Sum_probs=188.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      +..++..+|+|.+...  .......+..|+++++.++|+||+++++++...     ...++||||++ ++|...+.. ..
T Consensus        26 ~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~   98 (282)
T cd06643          26 NKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELER   98 (282)
T ss_pred             ECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEEEEecCCCcHHHHHHhcCC
Confidence            4568899999998643  334556788899999999999999999998654     56899999997 588777654 46


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccC-
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN-  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-  157 (316)
                      ++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++...... .......++..|+|||.+.. 
T Consensus        99 ~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  178 (282)
T cd06643          99 PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE  178 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhcccc
Confidence            7999999999999999999999999999999999999999999999999988664332 22234567889999999742 


Q ss_pred             ---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 ---CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ---~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                         ...++.++|+||+||++|+|++|.+||...+.......+.......                            ...
T Consensus       179 ~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~  230 (282)
T cd06643         179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT----------------------------LAQ  230 (282)
T ss_pred             CCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC----------------------------CCC
Confidence               2456789999999999999999999998776544433332211100                            000


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ...++..+.++|.+||+.||.+||+++++++||||+..
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            12467889999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=280.17  Aligned_cols=237  Identities=25%  Similarity=0.428  Sum_probs=191.4

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +..+|+.||||.+...... ......+..|+++++.++|+||+++++.+...     ...|++|||+. ++|.+++... 
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~   96 (316)
T cd05574          22 LKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TYLCLVMDYCPGGELFRLLQRQP   96 (316)
T ss_pred             EcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CEEEEEEEecCCCCHHHHHHhCC
Confidence            3457899999999765333 23557788999999999999999999998544     56999999996 6999998754 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc------------------
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF------------------  139 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~------------------  139 (316)
                       ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........                  
T Consensus        97 ~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (316)
T cd05574          97 GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI  176 (316)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccccccccc
Confidence             5689999999999999999999999999999999999999999999999998765432110                  


Q ss_pred             ------------cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccc
Q 021181          140 ------------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS  207 (316)
Q Consensus       140 ------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  207 (316)
                                  .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+..   ....  
T Consensus       177 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~---~~~~--  250 (316)
T cd05574         177 PSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK---KEVT--  250 (316)
T ss_pred             chhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhc---CCcc--
Confidence                        112356778999999977 6688999999999999999999999987765544433321   0000  


Q ss_pred             cccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCC
Q 021181          208 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT----VDEALCHPYLAPLH  273 (316)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps----~~ell~~~~f~~~~  273 (316)
                                        .      .....++..+.++|.+||+.||++||+    ++++++||||++..
T Consensus       251 ------------------~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         251 ------------------F------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             ------------------C------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence                              0      000126888999999999999999999    99999999998865

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-38  Score=277.31  Aligned_cols=239  Identities=25%  Similarity=0.453  Sum_probs=193.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+|+.||||.+....  ......+.+|+.+++.++||||+++++.+...     ..+++|+||+. ++|..++.. ..
T Consensus        40 ~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~  111 (296)
T cd06655          40 DVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTE-TC  111 (296)
T ss_pred             EcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEEEEEEecCCCcHHHHHHh-cC
Confidence            56789999999996542  22346678999999999999999999998654     56999999996 688888765 46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+ .
T Consensus       112 l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  190 (296)
T cd06655         112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K  190 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC-C
Confidence            89999999999999999999999999999999999999999999999998876543322 233467888999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||++|+|++|..||...+.......+... +.+.                           ......++
T Consensus       191 ~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~  242 (296)
T cd06655         191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------------------LQNPEKLS  242 (296)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------------------------cCCcccCC
Confidence            6889999999999999999999999877654443332211 1000                           00112568


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      +.+.++|++||..||.+||++.+++.||||+.......
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~  280 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSS  280 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccccc
Confidence            88999999999999999999999999999987664444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-38  Score=278.09  Aligned_cols=238  Identities=25%  Similarity=0.454  Sum_probs=191.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||.+...  .......+.+|+.+++.++|+||+++++.+...     ...+++|||++ ++|.+++.. +.
T Consensus        43 ~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~  114 (292)
T cd06658          43 EKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TR  114 (292)
T ss_pred             ECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEEEeCCCCCcHHHHHhc-CC
Confidence            4568999999998643  333456788999999999999999999998654     45899999996 588887754 56


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+ .
T Consensus       115 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  193 (292)
T cd06658         115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-L  193 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc-C
Confidence            8999999999999999999999999999999999999999999999999886543322 2233567889999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+|+++|+|++|..||...+.......+........                            .....++
T Consensus       194 ~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  245 (292)
T cd06658         194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV----------------------------KDSHKVS  245 (292)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------------------------ccccccC
Confidence            788999999999999999999999987665444433322111100                            0012467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      ..+.+++.+||..||.+|||++++++||||......+
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            8899999999999999999999999999998765333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.5e-38  Score=271.81  Aligned_cols=229  Identities=29%  Similarity=0.474  Sum_probs=185.9

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~   80 (316)
                      ..+++.||+|.++...    ....+.+|+.+++.++|+||+++++.+...     ..+|+++||++ ++|.+++.. ...
T Consensus        25 ~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~l~~~~~~   95 (256)
T cd06612          25 KETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMKITNKT   95 (256)
T ss_pred             cCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEEecCCCCcHHHHHHhCccC
Confidence            4568999999986432    267788999999999999999999998654     56999999997 599998865 457


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ .
T Consensus        96 l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~  174 (256)
T cd06612          96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I  174 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhc-C
Confidence            8999999999999999999999999999999999999999999999999987765443 2233456788999999877 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++||||+|+++|+|++|..||...+.......+..   ....                         .......++
T Consensus       175 ~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~  226 (256)
T cd06612         175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPP-------------------------TLSDPEKWS  226 (256)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCC-------------------------CCCchhhcC
Confidence            788999999999999999999999976644332221110   0000                         000112467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..+.++|.+||+.||++|||+++++.||||
T Consensus       227 ~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         227 PEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-38  Score=275.23  Aligned_cols=260  Identities=37%  Similarity=0.627  Sum_probs=190.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      +..+|+.||+|.++.... ......+.+|+.+++.++|+||+++++++...     ...|+||||++++|.+.+.. ...
T Consensus        26 ~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   99 (291)
T cd07870          26 SRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLTFVFEYMHTDLAQYMIQHPGG   99 (291)
T ss_pred             EcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----CeEEEEEecccCCHHHHHHhCCCC
Confidence            456799999999965432 22234567899999999999999999998644     46899999999888877654 356


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..
T Consensus       100 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (291)
T cd07870         100 LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT  179 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCC
Confidence            7889999999999999999999999999999999999999999999999886643322 223345688899999987645


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHhhCCCCccccccccccchHHHhhh-CCCCCCCCccccCC-
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSARFP-  236 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-  236 (316)
                      .++.++|||||||++|+|++|..||...+. .+.+..+....+.+............  .+... .............. 
T Consensus       180 ~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd07870         180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP--NYKPEWFLPCKPQQLRVVWKR  257 (291)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc--cccchhccccCCcchhhhccc
Confidence            678899999999999999999999987643 33444444444443322211110000  00000 00000000111111 


Q ss_pred             -CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          237 -NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       237 -~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                       ..+..+.+++.+||..||++|||++|++.||||
T Consensus       258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         258 LSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.3e-38  Score=273.73  Aligned_cols=236  Identities=25%  Similarity=0.491  Sum_probs=191.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|++...  .......+.+|+.+++.++||||+++++++...     ...++++||+. ++|.+++.. ++
T Consensus        40 ~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-~~  111 (285)
T cd06648          40 DKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIVTH-TR  111 (285)
T ss_pred             ECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEEEeccCCCCHHHHHHh-CC
Confidence            3568899999998543  333456688999999999999999999998654     45899999996 699998877 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.|++.||++||+.|++||||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+ .
T Consensus       112 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  190 (285)
T cd06648         112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-L  190 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC-C
Confidence            99999999999999999999999999999999999999999999999998765443221 223457889999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+||++|+|++|..||...+.......+....  ++ .                         ......++
T Consensus       191 ~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~-~-------------------------~~~~~~~~  242 (285)
T cd06648         191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PP-K-------------------------LKNLHKVS  242 (285)
T ss_pred             CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CC-C-------------------------CcccccCC
Confidence            68899999999999999999999997766544444333210  00 0                         00012367


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ..+.+++++||+.||++||++.++++||||++...
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            88999999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.6e-38  Score=271.51  Aligned_cols=238  Identities=29%  Similarity=0.444  Sum_probs=194.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++...... .....+..|+..+.+++|+||+++++++...     ...+++|||++ ++|.+++.....
T Consensus        22 ~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   95 (264)
T cd06623          22 HKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEISIVLEYMDGGSLADLLKKVGK   95 (264)
T ss_pred             EcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEEEEEEecCCCcHHHHHHHcCC
Confidence            4568999999999765332 4567789999999999999999999998654     56999999997 799999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc-ccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..+..++.|++.|+++||+ .|++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+ 
T Consensus        96 l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-  174 (264)
T cd06623          96 IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-  174 (264)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCC-
Confidence            9999999999999999999999 99999999999999999999999999988776544332 24567888999999877 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC-
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN-  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (316)
                      ..++.++|+||||+++|+|++|..||.....................                           ..... 
T Consensus       175 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  227 (264)
T cd06623         175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP---------------------------SLPAEE  227 (264)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---------------------------CCCccc
Confidence            67889999999999999999999999777421111112111111110                           00113 


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ++..+.++|++||+.+|++||++.++++||||+.++
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            688899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-38  Score=283.43  Aligned_cols=241  Identities=21%  Similarity=0.355  Sum_probs=191.8

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-C
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-H   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~   78 (316)
                      ++.+++.||+|++.... ........+..|+.++..++|++|+++++++...     ...|+||||+. |+|.+++.. .
T Consensus        22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~~~   96 (331)
T cd05624          22 MKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NYLYLVMDYYVGGDLLTLLSKFE   96 (331)
T ss_pred             ECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHhc
Confidence            46789999999996532 2233445677899999999999999999998654     56999999995 799999976 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........  ....++..|+|||.+.
T Consensus        97 ~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05624          97 DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ  176 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHh
Confidence            67999999999999999999999999999999999999999999999999998765443221  2356899999999986


Q ss_pred             CC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          157 NC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       157 ~~----~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +.    ..++.++|+||+||++|+|++|+.||...+.......+.......                          .+.
T Consensus       177 ~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~p  230 (331)
T cd05624         177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF--------------------------QFP  230 (331)
T ss_pred             ccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc--------------------------cCC
Confidence            42    356789999999999999999999998877655555443211100                          011


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~  273 (316)
                      .....++.++.++|.+||+.++.+  |++++++++||||+.+.
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            122357889999999999976654  56899999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-38  Score=271.86  Aligned_cols=236  Identities=25%  Similarity=0.389  Sum_probs=190.0

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      ..+|+.||+|++....... ....+.+|+.+++.++|+||+++++.+...     ...+++||++. ++|.+.+...   
T Consensus        23 ~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~   96 (267)
T cd06610          23 LPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELWLVMPYLSGGSLLDIMKSSYPR   96 (267)
T ss_pred             cCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEEEEEeccCCCcHHHHHHHhccc
Confidence            4578999999997543333 567789999999999999999999988654     56999999996 6999998764   


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCcc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPE  153 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE  153 (316)
                      ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........     .....++..|+|||
T Consensus        97 ~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe  176 (267)
T cd06610          97 GGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE  176 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChH
Confidence            4589999999999999999999999999999999999999999999999998876543322     13345788899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.....++.++|+|||||++++|++|..||...+...........   .+...                      ....
T Consensus       177 ~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~----------------------~~~~  231 (267)
T cd06610         177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL----------------------ETGA  231 (267)
T ss_pred             HHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc----------------------CCcc
Confidence            9877447889999999999999999999999776554433332221   10000                      0001


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ....++..+.+++.+||..||.+||++++|++||||
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            123678899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=278.72  Aligned_cols=259  Identities=32%  Similarity=0.550  Sum_probs=202.9

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC--CCC----ccceeeeecCCCCCCCCeEEEEEecCCCcHHHH
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--HEN----IIAIKDIIRPPQRETFNDVYIVYELMDTDLHQI   74 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~----i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~   74 (316)
                      +|.+++..||||+++.   -....++.+-|++++.++.  -|+    ++.+.++|...     ++.|||+|.+|-++++.
T Consensus       109 ~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-----ghiCivfellG~S~~dF  180 (415)
T KOG0671|consen  109 WDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-----GHICIVFELLGLSTFDF  180 (415)
T ss_pred             eecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-----CceEEEEeccChhHHHH
Confidence            4778899999999964   2234566788999999993  222    77788888444     67999999999999999


Q ss_pred             hhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc--------------------cCCCEEEeeecccc
Q 021181           75 IRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN--------------------ANCDLKIGDFGLAR  132 (316)
Q Consensus        75 l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~--------------------~~~~~~l~df~~~~  132 (316)
                      +..+.  +++...++.|++|+++++++||+.+++|.||||+||++.                    .+..++++|||.+.
T Consensus       181 lk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAt  260 (415)
T KOG0671|consen  181 LKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSAT  260 (415)
T ss_pred             hccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcc
Confidence            98764  589999999999999999999999999999999999983                    13458999999988


Q ss_pred             ccCCCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccccccc
Q 021181          133 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR  212 (316)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  212 (316)
                      ...+..  ...+.|..|.|||++.+ -+++..+||||+||+++|+++|...|+..+..+.++.++..+|+.+........
T Consensus       261 f~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~  337 (415)
T KOG0671|consen  261 FDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR  337 (415)
T ss_pred             eeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh
Confidence            765543  56788999999999998 789999999999999999999999999999999999999999987775543221


Q ss_pred             ccchHHHhhhCCCCCCCCc-----------------cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          213 SDNARRYVRMLPQFPKQNF-----------------SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ..  .-+.++...|+...-                 ..........+.+||++||..||.+|+|+.|+|.||||+..
T Consensus       338 ~~--Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  338 KE--KYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             hH--hhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence            00  001111111111000                 00011123448999999999999999999999999999864

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=290.58  Aligned_cols=237  Identities=28%  Similarity=0.424  Sum_probs=196.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHh--hcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII--RSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l--~~~~   79 (316)
                      +++|+-.-|-|+|.-  ....+...++-||++|..|.||+||++++.|...     +.+||+.|||+|.--+.+  .-..
T Consensus        53 nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwiliEFC~GGAVDaimlEL~r  125 (1187)
T KOG0579|consen   53 NKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWILIEFCGGGAVDAIMLELGR  125 (1187)
T ss_pred             cccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEEEEeecCCchHhHHHHHhcc
Confidence            567777778888843  4666788899999999999999999999998765     459999999986444433  3456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCccccc--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLL--  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~--  156 (316)
                      .+.+.++..+++|++.||.|||+++|+|||||..|||++-+|.++|.|||.+.... .......+.||++|+|||+..  
T Consensus       126 ~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCE  205 (1187)
T KOG0579|consen  126 VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCE  205 (1187)
T ss_pred             ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeec
Confidence            79999999999999999999999999999999999999999999999999876543 334456889999999999864  


Q ss_pred             --CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          157 --NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       157 --~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                        ...+|++++||||||+++.||..+.||-...+.+..+-.|.+.   -+++..                         .
T Consensus       206 T~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTLl-------------------------q  257 (1187)
T KOG0579|consen  206 TFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLL-------------------------Q  257 (1187)
T ss_pred             cccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCccc-------------------------C
Confidence              2378999999999999999999999999888887777666542   221111                         0


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...-+..+.+|+.+||..||..||++++||+||||+++.
T Consensus       258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            013466799999999999999999999999999999765

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.8e-38  Score=270.38  Aligned_cols=232  Identities=26%  Similarity=0.448  Sum_probs=190.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      +..+|+.||+|.+............+.+|+.+++.++||||+++++++...     ...++||||+. ++|.+.+.... 
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~   95 (256)
T cd08218          21 SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLYIVMDYCEGGDLYKKINAQRG   95 (256)
T ss_pred             EcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEEEEEecCCCCcHHHHHHhccC
Confidence            456899999999976544445567789999999999999999999998544     57999999996 69998886543 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccC
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~  157 (316)
                       .+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++++|||.+........ .....++..|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  175 (256)
T cd08218          96 VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN  175 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC
Confidence             578999999999999999999999999999999999999999999999998876544322 123456778999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ...+.++|+|||||++++|++|..||...+..+....+..  +..+                            .....
T Consensus       176 -~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~----------------------------~~~~~  224 (256)
T cd08218         176 -RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYP----------------------------PVSSH  224 (256)
T ss_pred             -CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCC----------------------------CCccc
Confidence             6788999999999999999999999987765555443322  1111                            01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++.++.++|.+||+.+|.+||++.++++||||
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            67889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.4e-38  Score=272.25  Aligned_cols=236  Identities=24%  Similarity=0.399  Sum_probs=185.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCC-CCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRE-TFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~-~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+++.||+|++....   .....+..|+.+++++ +|+||+++++++...... ....+|++|||++ ++|.+++...
T Consensus        27 ~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~  103 (272)
T cd06637          27 HVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT  103 (272)
T ss_pred             EcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc
Confidence            45688999999986542   2335678899999998 799999999998754321 2356899999996 6999988763


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccc
Q 021181           79 --QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 --~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~  155 (316)
                        ..+++..++.++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++...... .......++..|+|||++
T Consensus       104 ~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  183 (272)
T cd06637         104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  183 (272)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHh
Confidence              35899999999999999999999999999999999999999999999999998765432 223345678899999998


Q ss_pred             cC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          156 LN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       156 ~~----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      ..    ...++.++|+||+||++|+|++|..||...........+..   ...                          .
T Consensus       184 ~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~--------------------------~  234 (272)
T cd06637         184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPA--------------------------P  234 (272)
T ss_pred             ccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CCC--------------------------C
Confidence            53    23577899999999999999999999976543332222111   000                          0


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ......++..+.+++.+||+.||.+|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            00112467889999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-38  Score=274.22  Aligned_cols=239  Identities=25%  Similarity=0.425  Sum_probs=190.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+|+.||+|.++... .......+.+|+.++++++|+||+++++.+...     ..+++||||++ ++|..++...  
T Consensus        22 ~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~   95 (286)
T cd06622          22 HRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVYMCMEYMDAGSLDKLYAGGVA   95 (286)
T ss_pred             EcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEEEEEeecCCCCHHHHHHhccc
Confidence            45689999999986542 333456788999999999999999999988654     56999999997 5888887663  


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                       ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~  174 (286)
T cd06622          96 TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIK  174 (286)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-cccCCCccCccCcchhc
Confidence             378999999999999999999996 699999999999999999999999999886653322 23345677899999985


Q ss_pred             CCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          157 NCS-----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       157 ~~~-----~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      +..     .++.++|+|||||++|+|++|..||...........+........                           
T Consensus       175 ~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------  227 (286)
T cd06622         175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP---------------------------  227 (286)
T ss_pred             CCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC---------------------------
Confidence            422     347899999999999999999999976654333333322211111                           


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ....+.++.++.++|.+||+.+|.+||+++++++||||.....
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            1112347889999999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-38  Score=275.47  Aligned_cols=241  Identities=24%  Similarity=0.391  Sum_probs=187.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh----
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR----   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~----   76 (316)
                      +..+|+.||||++...... .....+.+|+.++.++. |+||+++++++...     ...+++||++++++.++..    
T Consensus        25 ~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~~~~e~~~~~l~~l~~~~~~   98 (288)
T cd06616          25 HKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCWICMELMDISLDKFYKYVYE   98 (288)
T ss_pred             ECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEEEEEecccCCHHHHHHHHHH
Confidence            4678999999999754332 34567889999999996 99999999988654     4589999999876654332    


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           77 -SHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        77 -~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                       ....+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++.............++..|+|||.
T Consensus        99 ~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~  178 (288)
T cd06616          99 VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER  178 (288)
T ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHH
Confidence             23679999999999999999999996 5999999999999999999999999999876544433344467888999999


Q ss_pred             ccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          155 LLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       155 ~~~~--~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +.+.  ..++.++||||+||++|+|++|++||....  .....+...........                       ..
T Consensus       179 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~-----------------------~~  233 (288)
T cd06616         179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL-----------------------SN  233 (288)
T ss_pred             hccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-----------------------CC
Confidence            8764  368899999999999999999999997654  12222222111111000                       00


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .....++.++.+||.+||+.||++|||++++++||||....
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            01124788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.2e-38  Score=271.85  Aligned_cols=236  Identities=29%  Similarity=0.500  Sum_probs=192.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||+|.+..... .......+..|++++++++|+||+++++.+...     ...|++|||+. ++|.+++.+.+
T Consensus        14 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   88 (265)
T cd05579          14 KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYLPGGDLASLLENVG   88 (265)
T ss_pred             ECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecCCCCcHHHHHHHcC
Confidence            356799999999975432 234557788999999999999999999988543     56999999996 69999998878


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---------cccccccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---------FMTEYVVTRWYR  150 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~~  150 (316)
                      .+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++.......         ......++..|+
T Consensus        89 ~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (265)
T cd05579          89 SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI  168 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCcccc
Confidence            89999999999999999999999999999999999999999999999999876543321         122345677899


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      +||.... ...+.++|+||||+++|++++|..||...........+..  +...                     .    
T Consensus       169 ~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---------------------~----  220 (265)
T cd05579         169 APEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE---------------------W----  220 (265)
T ss_pred             CHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC---------------------C----
Confidence            9999877 5588999999999999999999999987765554443322  0000                     0    


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITV---DEALCHPYLAPL  272 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~---~ell~~~~f~~~  272 (316)
                       .. ...++..+.+++++||+.+|++||++   .++++||||+++
T Consensus       221 -~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         221 -PE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             -Cc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence             00 01247889999999999999999999   999999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.3e-38  Score=274.55  Aligned_cols=238  Identities=25%  Similarity=0.377  Sum_probs=184.0

Q ss_pred             CCCCCceEEEEEecccccChh-HHHHHHHHHHHHh---hCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDNRI-DAKRTLREIKLLR---HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~---~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      +..+|+.||||.+........ .......|..+++   ...||+|+.+++.+...     ...++||||++ |+|.+++.
T Consensus        15 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~   89 (279)
T cd05633          15 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFILDLMNGGDLHYHLS   89 (279)
T ss_pred             ECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEEEecCCCCCHHHHHH
Confidence            457899999999976433222 2223344444433   34799999999998654     45899999996 69999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      ..+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.
T Consensus        90 ~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~  168 (279)
T cd05633          90 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ  168 (279)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhc
Confidence            88889999999999999999999999999999999999999999999999999886554322 22346788999999986


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +...++.++|+||+||++|+|++|..||.......... +.......                           .....+
T Consensus       169 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~---------------------------~~~~~~  220 (279)
T cd05633         169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTV---------------------------NVELPD  220 (279)
T ss_pred             CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhcC---------------------------CcCCcc
Confidence            54567899999999999999999999997654222111 11100000                           001113


Q ss_pred             CCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      .++.++.++|++||+.||.+|+     +++++++||||+.+.
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            5788999999999999999999     699999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=294.36  Aligned_cols=237  Identities=26%  Similarity=0.398  Sum_probs=197.8

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +|..|....|||-+...  +....+.+..|+.+.++|+|.|||+++|.+..+     +.+-|.||-++ |+|.+++++. 
T Consensus       595 RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqVPGGSLSsLLrskW  667 (1226)
T KOG4279|consen  595 RDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQVPGGSLSSLLRSKW  667 (1226)
T ss_pred             ccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecCCCCcHHHHHHhcc
Confidence            58889999999999653  344567788999999999999999999998655     46889999995 7999999764 


Q ss_pred             CCC--CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccC-CCCccccccccccccCccc
Q 021181           79 QDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        79 ~~~--~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~  154 (316)
                      +++  ++..+-.+..||++||.|||++.|||||||.+|+||+. .|-+||+|||.++... .+....++.||..|+|||+
T Consensus       668 GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEv  747 (1226)
T KOG4279|consen  668 GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEV  747 (1226)
T ss_pred             CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHh
Confidence            666  89999999999999999999999999999999999975 5889999999998754 4455678899999999999


Q ss_pred             ccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~-~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.. ...|+.++|||||||++.||.||+|||.....+....-.+.....-+                            .
T Consensus       748 IDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP----------------------------~  799 (1226)
T KOG4279|consen  748 IDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHP----------------------------P  799 (1226)
T ss_pred             hccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCC----------------------------C
Confidence            864 35789999999999999999999999987765544433322222111                            1


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ....+|.+++.||.+|+.+||.+||++.+||.+||++.-
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            112568889999999999999999999999999999876

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.9e-38  Score=274.08  Aligned_cols=238  Identities=24%  Similarity=0.366  Sum_probs=186.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR---   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~---   76 (316)
                      +..+|+.||+|.+...   ......+..|+.+++++ +|||++++++++...+.......++||||++ ++|.+++.   
T Consensus        43 ~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~  119 (291)
T cd06639          43 NKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL  119 (291)
T ss_pred             ECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhh
Confidence            4578999999998643   12335567899999998 8999999999987543333457899999996 69988775   


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccc
Q 021181           77 -SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL  154 (316)
Q Consensus        77 -~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~  154 (316)
                       ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.
T Consensus       120 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  199 (291)
T cd06639         120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  199 (291)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhh
Confidence             34578999999999999999999999999999999999999999999999999887654322 1233457788999999


Q ss_pred             ccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          155 LLNCS----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       155 ~~~~~----~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      +....    .++.++|+|||||++|+|++|++||...+.......+...   .....                       
T Consensus       200 ~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~-----------------------  253 (291)
T cd06639         200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTL-----------------------  253 (291)
T ss_pred             hcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCCC-----------------------
Confidence            76422    3578999999999999999999999876644443332211   00000                       


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                        ......+..+.++|.+||+.||++||++.++++||||+
T Consensus       254 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         254 --LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             --CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence              00123567799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.8e-38  Score=276.32  Aligned_cols=236  Identities=25%  Similarity=0.422  Sum_probs=189.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.+.....  .....+.+|+.+++.+.|+||+++++.+...     ...|+||||+. ++|.+++.. ..
T Consensus        41 ~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~  112 (296)
T cd06654          41 DVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TC  112 (296)
T ss_pred             ECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEEEeecccCCCCHHHHHHh-cC
Confidence            467899999999975432  2346688999999999999999999998654     46999999996 699998854 56


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ .
T Consensus       113 ~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  191 (296)
T cd06654         113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K  191 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcC-C
Confidence            8999999999999999999999999999999999999999999999999877643322 1233467889999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||++|+|++|.+||...+.......+.. .+.+.                           ......++
T Consensus       192 ~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~  243 (296)
T cd06654         192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE---------------------------LQNPEKLS  243 (296)
T ss_pred             CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC---------------------------CCCccccC
Confidence            678999999999999999999999976654332221111 00000                           00112467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ..+.+++.+||..||.+||++.++++||||...+.
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            88999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-38  Score=272.70  Aligned_cols=234  Identities=27%  Similarity=0.362  Sum_probs=184.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|++....  ......+.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++...++
T Consensus        30 ~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~  102 (267)
T cd06646          30 NLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLWICMEYCGGGSLQDIYHVTGP  102 (267)
T ss_pred             ECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCC
Confidence            45688999999996542  22345678999999999999999999998654     46899999997 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC--
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~--  157 (316)
                      +++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+..  
T Consensus       103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  182 (267)
T cd06646         103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK  182 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHccccc
Confidence            9999999999999999999999999999999999999999999999999987654322 2234567888999998742  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|+||+||++|+|++|..||...+.......+....                         .....+ .....
T Consensus       183 ~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~-~~~~~  236 (267)
T cd06646         183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN-------------------------FQPPKL-KDKTK  236 (267)
T ss_pred             CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC-------------------------CCCCCC-ccccc
Confidence            2456789999999999999999999986554222211111000                         000000 00124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPY  268 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~  268 (316)
                      ++..+.++|++||+.||++||+++++++|+|
T Consensus       237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            6788999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5e-38  Score=268.84  Aligned_cols=234  Identities=30%  Similarity=0.474  Sum_probs=190.7

Q ss_pred             CCCCCceEEEEEeccccc---ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFD---NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+++.||+|.+.....   .......+..|+.+++.++|+||+++++++...     ..++++|||++ ++|.+++.+
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~   95 (258)
T cd06632          21 NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----DNLYIFLELVPGGSLAKLLKK   95 (258)
T ss_pred             EcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----CeEEEEEEecCCCcHHHHHHh
Confidence            346899999999865321   233456788999999999999999999988544     46899999996 599999988


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+.+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.............++..|++||.+..
T Consensus        96 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~  175 (258)
T cd06632          96 YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ  175 (258)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcC
Confidence            88899999999999999999999999999999999999999999999999998877554443345567888999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|+|||||++|+|++|..||...........+..... .                            ......
T Consensus       176 ~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~  226 (258)
T cd06632         176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-L----------------------------PPIPDH  226 (258)
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-C----------------------------CCcCCC
Confidence            33488999999999999999999999977653333322211000 0                            011124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      +++.+.+++++||+.+|.+||+++++++|||+
T Consensus       227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         227 LSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            67889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.1e-38  Score=268.22  Aligned_cols=226  Identities=22%  Similarity=0.334  Sum_probs=185.2

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      ..+++.||+|+++...........+..|+.+++.+.||||+++++++..      ...++||||++ |+|.+++...+.+
T Consensus        19 ~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~   92 (257)
T cd05116          19 KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVMELAELGPLNKFLQKNKHV   92 (257)
T ss_pred             CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEecCCCCcHHHHHHhcCCC
Confidence            4678999999997665555566788999999999999999999998743      24689999997 6899999887889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----ccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~  157 (316)
                      ++..+..++.|++.||++||++|++|+||+|.||+++.++.++|+|||.+.........    ....++..|+|||.+..
T Consensus        93 ~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  172 (257)
T cd05116          93 TEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY  172 (257)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc
Confidence            99999999999999999999999999999999999999999999999998765443221    11223468999999866


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|+|||||++|||++ |.+||...+.......+......                              ....
T Consensus       173 -~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~------------------------------~~~~  221 (257)
T cd05116         173 -YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM------------------------------ECPQ  221 (257)
T ss_pred             -CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC------------------------------CCCC
Confidence             678889999999999999998 99999887665555544321110                              0112


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+++++.++|++||+.||.+||++++|..
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            57889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.3e-38  Score=273.88  Aligned_cols=237  Identities=26%  Similarity=0.392  Sum_probs=183.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHH-HhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~---   77 (316)
                      ++.+|+.||||+++....... ...+..|+.+ ++.++||||+++++++...     ...|++|||++|+|.+++..   
T Consensus        22 ~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~   95 (283)
T cd06617          22 HVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVWICMEVMDTSLDKFYKKVYD   95 (283)
T ss_pred             EcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEEEEhhhhcccHHHHHHHhcc
Confidence            567899999999976543333 3345556665 5667999999999998654     45899999999988777653   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                       ...+++..++.++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+
T Consensus        96 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  175 (283)
T cd06617          96 KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI  175 (283)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhc
Confidence             34689999999999999999999987 9999999999999999999999999998765443333334677889999988


Q ss_pred             cCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          156 LNC---SEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       156 ~~~---~~~~~~~DiwslG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      .+.   ..++.++|+|||||++|+|++|..||.... ....+.....  +..+.                          
T Consensus       176 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--------------------------  227 (283)
T cd06617         176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSPQ--------------------------  227 (283)
T ss_pred             CCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCCC--------------------------
Confidence            542   346789999999999999999999996532 2222222211  00000                          


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                       .....+|.++.++|.+||..||.+||+++++++||||.+..
T Consensus       228 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         228 -LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence             00124688899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.7e-38  Score=281.66  Aligned_cols=267  Identities=18%  Similarity=0.232  Sum_probs=191.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      |..+|+.||+|++..........+.+.+|+.+++.++||||+++++++...     ...+++|||+. ++|.+++...  
T Consensus        21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~   95 (328)
T cd08226          21 HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVISPFMAYGSANSLLKTYFP   95 (328)
T ss_pred             EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEEecccCCCHHHHHHhhcc
Confidence            567999999999976544555567888999999999999999999999765     45899999996 6999888764  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--------cccccccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--------TEYVVTRWYR  150 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~  150 (316)
                      ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++++||+...........        ....++..|+
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  175 (328)
T cd08226          96 EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL  175 (328)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCcc
Confidence            35899999999999999999999999999999999999999999999999754332211100        0112345699


Q ss_pred             CcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccc-------hHHHhhh
Q 021181          151 APELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN-------ARRYVRM  222 (316)
Q Consensus       151 aPE~~~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-------~~~~~~~  222 (316)
                      |||.+.+. ..++.++||||+||++|+|++|.+||..............  +.+............       .......
T Consensus       176 aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (328)
T cd08226         176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK--GPPYSPLDITTFPCEESRMKNSQSGVDSG  253 (328)
T ss_pred             ChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc--CCCCCCccccccchhhhhhccchhhhhcc
Confidence            99998653 3478999999999999999999999987765444332222  111100000000000       0000000


Q ss_pred             CC----------CCCCCCc-cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          223 LP----------QFPKQNF-SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       223 ~~----------~~~~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ..          ....... ......++..+.+||++||+.||++|||++|+++||||.++...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         254 IGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             cccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            00          0000000 01112467889999999999999999999999999999887644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.7e-38  Score=269.50  Aligned_cols=235  Identities=27%  Similarity=0.472  Sum_probs=187.4

Q ss_pred             CCCCCceEEEEEeccccc---ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFD---NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+|..||||.+.....   .......+.+|+.++++++||||+++++++....   ...++++|||++ ++|.+++..
T Consensus        23 ~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~   99 (265)
T cd06652          23 DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---ERTLSIFMEHMPGGSIKDQLKS   99 (265)
T ss_pred             EcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---CceEEEEEEecCCCcHHHHHHH
Confidence            467899999999864321   2234567888999999999999999999876532   145889999996 699999988


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----ccccccccccccCcc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPE  153 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE  153 (316)
                      .+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......    ......++..|+|||
T Consensus       100 ~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  179 (265)
T cd06652         100 YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE  179 (265)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChh
Confidence            7889999999999999999999999999999999999999999999999999887543211    122345778899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.+ ..++.++|+|||||++|+|++|+.||...+.......+.   ..+..                          ..
T Consensus       180 ~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~--------------------------~~  229 (265)
T cd06652         180 VISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN--------------------------PV  229 (265)
T ss_pred             hhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC--------------------------CC
Confidence            9877 678899999999999999999999997665443332221   11110                          00


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      ..+.++..+.++|++||. +|..||+++++++|||+.
T Consensus       230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            112467789999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.1e-38  Score=274.94  Aligned_cols=238  Identities=24%  Similarity=0.347  Sum_probs=190.8

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+...     ..++++|||++ ++|.+++...+
T Consensus        22 ~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~   96 (305)
T cd05609          22 HKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RHLCMVMEYVEGGDCATLLKNIG   96 (305)
T ss_pred             ECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHHcC
Confidence            457889999999875432 233456788999999999999999999998544     56899999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----------------ccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----------------FMTEY  143 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----------------~~~~~  143 (316)
                      .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......                .....
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (305)
T cd05609          97 ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV  176 (305)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCC
Confidence            89999999999999999999999999999999999999999999999999876321100                00123


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      .++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+....+....+.......+                   
T Consensus       177 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------  236 (305)
T cd05609         177 CGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-------------------  236 (305)
T ss_pred             ccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-------------------
Confidence            45778999999876 6789999999999999999999999987665444443322110000                   


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLH  273 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~  273 (316)
                               .....++.++.++|.+||+.||++||+   +.++++||||....
T Consensus       237 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         237 ---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             ---------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence                     011246888999999999999999998   78999999998755

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=289.01  Aligned_cols=234  Identities=26%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             CCCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-C
Q 021181            1 MNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-H   78 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~   78 (316)
                      +|..|.+.||||+...+.. ...-...+++|+..|++++|||++.+-|+|...     ...|+|||||=|+-.+++.- .
T Consensus        46 rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~TaWLVMEYClGSAsDlleVhk  120 (948)
T KOG0577|consen   46 RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHK  120 (948)
T ss_pred             eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chHHHHHHHHhccHHHHHHHHh
Confidence            4788999999999987643 333448899999999999999999999999754     45899999998877776653 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc--
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL--  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~--  156 (316)
                      +++.+.++..|..+.+.||+|||+.+.+|||||..|||+++.|.+||+|||.+.....   .++++||++|+|||++.  
T Consensus       121 KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAM  197 (948)
T KOG0577|consen  121 KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAM  197 (948)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhcccCCccccchhHheec
Confidence            6899999999999999999999999999999999999999999999999998877654   46889999999999974  


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ..+.|+-++||||||++..||...+||+..++.+..+-.|.+--.+.-       .                      -+
T Consensus       198 DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL-------q----------------------s~  248 (948)
T KOG0577|consen  198 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-------Q----------------------SN  248 (948)
T ss_pred             cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC-------C----------------------Cc
Confidence            346789999999999999999999999989887777766654211110       0                      12


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      .-|..+++|+..||++-|.+|||.++||+|+|+..
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            34778999999999999999999999999999865

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.7e-38  Score=271.27  Aligned_cols=235  Identities=24%  Similarity=0.357  Sum_probs=184.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...     ...++||||++ ++|...    ..
T Consensus        22 ~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~----~~   91 (279)
T cd06619          22 HLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISICTEFMDGGSLDVY----RK   91 (279)
T ss_pred             EcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEEEEecCCCCChHHh----hc
Confidence            56789999999986543 233456788999999999999999999999654     45899999997 466543    35


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..
T Consensus        92 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~  169 (279)
T cd06619          92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISG-EQ  169 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecC-CC
Confidence            789999999999999999999999999999999999999999999999998765432 2234577889999999977 67


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ---LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ++.++|+|||||++|+|++|..||........   .............                         .......
T Consensus       170 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~  224 (279)
T cd06619         170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-------------------------PVLPVGQ  224 (279)
T ss_pred             CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-------------------------CCCCCCc
Confidence            89999999999999999999999965321110   0000000000000                         0001124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .++++.+++.+||+.||.+||+++|+++||||....
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            678899999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=269.60  Aligned_cols=236  Identities=25%  Similarity=0.411  Sum_probs=186.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHH-hhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+|+.||||.++.... .......+..|..++ ...+|+|++++++++...     ..+|++|||++ ++|.+++...
T Consensus        17 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   91 (260)
T cd05611          17 KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVMEYLNGGDCASLIKTL   91 (260)
T ss_pred             ecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEEeccCCCCHHHHHHHc
Confidence            456899999999965422 122223344555444 455899999999998644     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......   ....++..|+|||.+.+ 
T Consensus        92 ~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~~pe~~~~-  167 (260)
T cd05611          92 GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILG-  167 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc---ccCCCCcCccChhhhcC-
Confidence            88999999999999999999999999999999999999999999999999988664432   23456778999999877 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++||||+|+++|+|++|.+||...+.......+.......                           .......+
T Consensus       168 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~  220 (260)
T cd05611         168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW---------------------------PEEVKEFC  220 (260)
T ss_pred             CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC---------------------------CCcccccC
Confidence            558899999999999999999999998776555444332211000                           00111257


Q ss_pred             ChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~  273 (316)
                      +..+.++|.+||+.||++||+   ++|+++||||++++
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            889999999999999999995   57999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-37  Score=267.43  Aligned_cols=236  Identities=30%  Similarity=0.466  Sum_probs=190.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||+|.++...........+..|+.+++.++|+||+++++.+...     ..+++++||++ ++|.+++...+.
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   95 (264)
T cd06626          21 NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVYIFMEYCSGGTLEELLEHGRI   95 (264)
T ss_pred             ECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEEEEEecCCCCcHHHHHhhcCC
Confidence            356789999999987654445678899999999999999999999987544     56999999996 699999988777


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc-----ccccccccccCcccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-----TEYVVTRWYRAPELL  155 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~  155 (316)
                      +++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........     ....++..|+|||.+
T Consensus        96 ~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~  175 (264)
T cd06626          96 LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI  175 (264)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhc
Confidence            999999999999999999999999999999999999999999999999988775443221     124567889999998


Q ss_pred             cCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          156 LNCS--EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       156 ~~~~--~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+..  ..+.++||||+|++++++++|..||...+........... +..+..                          .
T Consensus       176 ~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--------------------------~  228 (264)
T cd06626         176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPI--------------------------P  228 (264)
T ss_pred             cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCC--------------------------C
Confidence            7632  2788999999999999999999999776433332222111 111100                          0


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ....++..+.++|++||+.||.+||++.++++|||+
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            012357889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-38  Score=276.04  Aligned_cols=235  Identities=25%  Similarity=0.463  Sum_probs=190.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.+...  .......+.+|+.+++.++||||+++++.+...     ...+++|||++ ++|...+.. ..
T Consensus        42 ~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~-~~  113 (297)
T cd06659          42 EKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-TR  113 (297)
T ss_pred             EcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEEEEecCCCCCHHHHHhh-cC
Confidence            4568999999998653  223446678999999999999999999998654     46899999997 588876644 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+ .
T Consensus       114 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  192 (297)
T cd06659         114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-T  192 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHcc-C
Confidence            8999999999999999999999999999999999999999999999999886544322 2234567889999999976 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||++|+|++|..||...+.......+..   ....                         .......++
T Consensus       193 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~  244 (297)
T cd06659         193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPP-------------------------KLKNAHKIS  244 (297)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCCC-------------------------CccccCCCC
Confidence            789999999999999999999999987665444433321   1000                         001112467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..+.++|++||+.||.+||+++++++||||.+..
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            8899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-38  Score=275.65  Aligned_cols=238  Identities=26%  Similarity=0.440  Sum_probs=190.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.+....  ......+.+|+.+++.++|+||+++++++...     ...++||||++ ++|.+++.. ..
T Consensus        40 ~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~  111 (297)
T cd06656          40 DIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TC  111 (297)
T ss_pred             ECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEEEeecccCCCCHHHHHHh-CC
Confidence            45789999999996542  22346678999999999999999999998654     56899999996 699988865 56


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+ .
T Consensus       112 ~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  190 (297)
T cd06656         112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K  190 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC-C
Confidence            89999999999999999999999999999999999999999999999998876543322 233467888999999877 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||++|++++|..||...+.......+.. .+.+.                           ......++
T Consensus       191 ~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~  242 (297)
T cd06656         191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------------------------LQNPERLS  242 (297)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------------------------CCCccccC
Confidence            788999999999999999999999976543222111100 00000                           00112467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      ..+.+++.+||..||.+||+++++++||||+......
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence            8899999999999999999999999999998765433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=270.23  Aligned_cols=237  Identities=26%  Similarity=0.417  Sum_probs=186.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCC-CCCCeEEEEEecCC-CcHHHHhhc-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR-ETFNDVYIVYELMD-TDLHQIIRS-   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~-   77 (316)
                      ++.+++.|++|++....   .....+.+|+.+++++ .|+||+++++++..... .....++++|||++ ++|.+++.. 
T Consensus        27 ~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  103 (275)
T cd06608          27 HKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL  103 (275)
T ss_pred             ECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHH
Confidence            45678999999986542   2346688999999999 79999999999976432 23456899999997 588888764 


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcc
Q 021181           78 ---HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPE  153 (316)
Q Consensus        78 ---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE  153 (316)
                         ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||
T Consensus       104 ~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE  183 (275)
T cd06608         104 RKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPE  183 (275)
T ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHh
Confidence               3578999999999999999999999999999999999999999999999999886643322 223455788899999


Q ss_pred             cccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          154 LLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       154 ~~~~~----~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      .+...    ..++.++|||||||++|+|++|.+||...+.......+..   .....                       
T Consensus       184 ~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~-----------------------  237 (275)
T cd06608         184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT-----------------------  237 (275)
T ss_pred             HhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC-----------------------
Confidence            87532    3467889999999999999999999976654443333221   10000                       


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                        ......++..+.++|.+||..||++|||+.++++|||+
T Consensus       238 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 --LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             --CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence              00011367889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.5e-38  Score=271.88  Aligned_cols=234  Identities=26%  Similarity=0.400  Sum_probs=190.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+++.||||.+.... .......+.+|+.+++.+.|+||+++++.+...     ...++||||++ |+|.+++.. .+
T Consensus        25 ~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~-~~   97 (277)
T cd06640          25 DNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLWIIMEYLGGGSALDLLRA-GP   97 (277)
T ss_pred             EccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEEEecCCCCcHHHHHhc-CC
Confidence            45689999999987542 233457788999999999999999999998654     56999999996 699998865 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+....... ......++..|+|||.+.+ .
T Consensus        98 l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~  176 (277)
T cd06640          98 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-S  176 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhcc-C
Confidence            8999999999999999999999999999999999999999999999999987654432 2233456788999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++|+|||||++|+|++|.+||...+.......+..  +.+                            ......++
T Consensus       177 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~----------------------------~~~~~~~~  226 (277)
T cd06640         177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNP----------------------------PTLTGEFS  226 (277)
T ss_pred             CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC----------------------------CCCchhhh
Confidence            688999999999999999999999977654433322211  000                            11112457


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..+.+++.+||+.+|.+||+++++++|+||....
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            7899999999999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.3e-38  Score=270.63  Aligned_cols=238  Identities=26%  Similarity=0.390  Sum_probs=184.2

Q ss_pred             CCCCCceEEEEEecccccChhH-HHHHHHHH---HHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDNRID-AKRTLREI---KLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~-~~~~~~E~---~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      +..+|+.||+|.+......... ......|.   .+++...||+|+++++++...     ..+++||||+. |+|.+++.
T Consensus        15 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~g~~L~~~l~   89 (278)
T cd05606          15 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLS   89 (278)
T ss_pred             EecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEEEecCCCCcHHHHHH
Confidence            4568999999999764322111 12233333   344556899999999998654     46899999996 69999988


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      ..+.+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.
T Consensus        90 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~  168 (278)
T cd05606          90 QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ  168 (278)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhc
Confidence            88889999999999999999999999999999999999999999999999999886554322 23446788999999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +...++.++||||+||++|+|++|+.||....................                            ....
T Consensus       169 ~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~  220 (278)
T cd05606         169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----------------------------ELPD  220 (278)
T ss_pred             CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC----------------------------CCCC
Confidence            645688999999999999999999999977632221111111000000                            0112


Q ss_pred             CCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      .++.++.+++.+||..||.+||     ++.++++||||+.+.
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            3588999999999999999999     999999999998865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-37  Score=270.86  Aligned_cols=236  Identities=25%  Similarity=0.409  Sum_probs=184.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCC-CCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR-ETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+++.||+|.+...   ......+..|+.+++++ +|+||+++++++..... .....+|++|||++ |+|.+++...
T Consensus        37 ~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~  113 (282)
T cd06636          37 HVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT  113 (282)
T ss_pred             EcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc
Confidence            4568899999998543   23445678899999998 79999999999864321 23467999999997 5999888653


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccc
Q 021181           79 --QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 --~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~  155 (316)
                        ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+
T Consensus       114 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l  193 (282)
T cd06636         114 KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  193 (282)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhc
Confidence              35888899999999999999999999999999999999999999999999988765322 222345678899999987


Q ss_pred             cC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          156 LN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       156 ~~----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      ..    ...++.++|+|||||++|+|++|..||...........+..   ....                          
T Consensus       194 ~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~--------------------------  244 (282)
T cd06636         194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP--------------------------  244 (282)
T ss_pred             CcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CCCC--------------------------
Confidence            53    24577899999999999999999999976553332222111   0000                          


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ......++.++.++|++||+.||.+||++.||++||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            00112468889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-37  Score=268.61  Aligned_cols=238  Identities=28%  Similarity=0.450  Sum_probs=186.5

Q ss_pred             CCCCCceEEEEEecccccC--------hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHH
Q 021181            2 NSETREEVAIKKIGNAFDN--------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLH   72 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~   72 (316)
                      +..+|+.||||.++.....        ....+.+..|+.+++.++|+|++++++++...     ...++||||+. ++|.
T Consensus        22 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~   96 (272)
T cd06629          22 NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-----EYLSIFLEYVPGGSIG   96 (272)
T ss_pred             ecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-----CceEEEEecCCCCcHH
Confidence            4568999999998643111        11234677899999999999999999988544     56899999996 6999


Q ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccc
Q 021181           73 QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWY  149 (316)
Q Consensus        73 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~  149 (316)
                      +++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......   ......++..|
T Consensus        97 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y  176 (272)
T cd06629          97 SCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW  176 (272)
T ss_pred             HHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccc
Confidence            999888889999999999999999999999999999999999999999999999999886643221   12234567889


Q ss_pred             cCcccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          150 RAPELLLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       150 ~aPE~~~~~~-~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      +|||.+.... .++.++|+||||+++|++++|..||...+.......+..   ....                      .
T Consensus       177 ~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~----------------------~  231 (272)
T cd06629         177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KRSA----------------------P  231 (272)
T ss_pred             cCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---cccC----------------------C
Confidence            9999987633 478899999999999999999999965543332222111   0000                      0


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .......+.++..+.++|.+||..||.+||+++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            00011223578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-37  Score=273.51  Aligned_cols=234  Identities=25%  Similarity=0.379  Sum_probs=188.5

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      +..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...     ...++||||++|++.+.+.. ..
T Consensus        36 ~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~  110 (307)
T cd06607          36 DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDILEVHKK  110 (307)
T ss_pred             EcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeEEEEHHhhCCCHHHHHHHccc
Confidence            34679999999986542 2333446788999999999999999999998654     45899999999988887753 45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  157 (316)
                      .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......   ....++..|+|||.+.+  
T Consensus       111 ~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~  187 (307)
T cd06607         111 PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMD  187 (307)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccC
Confidence            7899999999999999999999999999999999999999999999999988665432   23456778999998742  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++||||||+++|+|++|.+||...+.......+...  ..+.                           .....
T Consensus       188 ~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~---------------------------~~~~~  238 (307)
T cd06607         188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT---------------------------LSSND  238 (307)
T ss_pred             CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC---------------------------CCchh
Confidence            256788999999999999999999999877654443332210  0000                           00113


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ++..+.++|.+||+.||.+||++.+++.||||..-
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            57789999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.2e-37  Score=266.70  Aligned_cols=233  Identities=26%  Similarity=0.405  Sum_probs=183.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..++..||+|.+...  .......+.+|+.+++.++|+||+++++++...     ...++++||++ ++|.+++... .
T Consensus        29 ~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  101 (268)
T cd06624          29 DLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFMEQVPGGSLSALLRSKWG  101 (268)
T ss_pred             ecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHHhcc
Confidence            4568889999988653  333556788999999999999999999998654     56999999996 6999988764 4


Q ss_pred             CC--CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCCC-ccccccccccccCcccc
Q 021181           80 DL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~--~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~  155 (316)
                      .+  ++..+..++.||+.||+|||+.||+|+||+|+||+++. ++.++|+|||.+....... ......++..|+|||.+
T Consensus       102 ~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~  181 (268)
T cd06624         102 PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI  181 (268)
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhh
Confidence            45  88889999999999999999999999999999999976 6789999999887654322 22234568889999998


Q ss_pred             cCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .+. ..++.++|+||+|+++|+|++|..||................+..                            ...
T Consensus       182 ~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~  233 (268)
T cd06624         182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH----------------------------PEI  233 (268)
T ss_pred             ccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC----------------------------CCC
Confidence            652 247889999999999999999999997654322211111000000                            011


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ...+++++.+++++||+.+|.+|||+.+++.||||
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            12567889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=259.55  Aligned_cols=241  Identities=23%  Similarity=0.367  Sum_probs=193.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      .+.||+-.|||..... .+.++.++++..+.++...+ +|+||+++|+|..+     ..++|.||.+...+..+++. .+
T Consensus       113 ~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~IcMelMs~C~ekLlkrik~  186 (391)
T KOG0983|consen  113 FRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVFICMELMSTCAEKLLKRIKG  186 (391)
T ss_pred             EcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHHHHHHHHHHHHHHHHHHhcC
Confidence            3568999999999776 46667888999999887774 99999999999865     34899999987555444433 35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++++.-+-.+...++.||.||. ..||+|||+||+|||+|..|++||||||.+..+..........|-+.|+|||.+...
T Consensus       187 piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~  266 (391)
T KOG0983|consen  187 PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPP  266 (391)
T ss_pred             CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCC
Confidence            7999999999999999999999 568999999999999999999999999999877665555556677789999998642


Q ss_pred             --CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          159 --SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       159 --~~~~~~~DiwslG~~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                        ..|+-.+||||||++++||.||+.||.+.+. .+.+..+..  ..++...                          ..
T Consensus       267 ~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L~--------------------------~~  318 (391)
T KOG0983|consen  267 DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLLP--------------------------GH  318 (391)
T ss_pred             CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCCC--------------------------cc
Confidence              4678899999999999999999999998653 333333332  1111110                          01


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      ...|+++.+|+..||.+|+.+||...+||+|||+..+....
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            24799999999999999999999999999999998876433

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=302.08  Aligned_cols=262  Identities=23%  Similarity=0.341  Sum_probs=216.3

Q ss_pred             CCCCCceEEEEEecc-cccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~   79 (316)
                      .+.|++.||.|++.+ ......+..-+..|-.+|...+.+=|+.++-.|.+.     .++|+||||+ ||+|..++.+..
T Consensus        96 ~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~-----~~LYlVMdY~pGGDlltLlSk~~  170 (1317)
T KOG0612|consen   96 HKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE-----RYLYLVMDYMPGGDLLTLLSKFD  170 (1317)
T ss_pred             eeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc-----cceEEEEecccCchHHHHHhhcC
Confidence            578999999999976 334455667788999999999999999999999766     5699999999 579999999988


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++++..+++++.+|+.||.-+|+.|+|||||||+|||+|..|.++|.|||.+-.+..+.  .....+|||-|+|||++..
T Consensus       171 ~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs  250 (1317)
T KOG0612|consen  171 RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQS  250 (1317)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHh
Confidence            99999999999999999999999999999999999999999999999999988776443  3456789999999999853


Q ss_pred             ---C-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          158 ---C-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       158 ---~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                         . +.|+...|.||+||++|||+.|.-||...+..++...|........-                          + 
T Consensus       251 ~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F--------------------------P-  303 (1317)
T KOG0612|consen  251 QGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF--------------------------P-  303 (1317)
T ss_pred             hcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC--------------------------C-
Confidence               1 56899999999999999999999999998888888887654222111                          1 


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHH
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEE  297 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (316)
                      -...+|+++++||++.++ +|+.|.+   ++++-+||||.+++= ...+....|+.+++..+..|.+
T Consensus       304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W-~~iR~~~pP~vPevssd~DTsn  368 (1317)
T KOG0612|consen  304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW-DNIRESVPPVVPEVSSDDDTSN  368 (1317)
T ss_pred             cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh-hhhhhcCCCCCCcCCCCCcccc
Confidence            002489999999999887 7888888   999999999999873 3334444556666655544433

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4e-38  Score=272.67  Aligned_cols=234  Identities=27%  Similarity=0.388  Sum_probs=188.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.++.... ......+.+|+.++++++||||+++++.+...     ...++||||++ ++|.+++.. ..
T Consensus        25 ~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~   97 (277)
T cd06642          25 DNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWIIMEYLGGGSALDLLKP-GP   97 (277)
T ss_pred             EcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceEEEEEccCCCcHHHHhhc-CC
Confidence            456889999999875432 33556788999999999999999999998654     46899999997 688888754 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++........ .....++..|+|||.+.+ .
T Consensus        98 ~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  176 (277)
T cd06642          98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-S  176 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc-C
Confidence            89999999999999999999999999999999999999999999999999876543322 223456788999999877 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||++|+|++|..||...........+...  .                            .......++
T Consensus       177 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~----------------------------~~~~~~~~~  226 (277)
T cd06642         177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--S----------------------------PPTLEGQYS  226 (277)
T ss_pred             CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--C----------------------------CCCCCcccC
Confidence            7889999999999999999999999765433322211100  0                            001112467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..+.++|.+||+.+|.+||++.++++||||.++.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            7899999999999999999999999999997643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.4e-37  Score=264.23  Aligned_cols=232  Identities=30%  Similarity=0.484  Sum_probs=193.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+++.||+|++............+.+|+++++.++|+|++++.+.+...     ...++++|+++ ++|.+.+...  
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   95 (258)
T cd08215          21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLCIVMEYADGGDLSQKIKKQKK   95 (258)
T ss_pred             EcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEEEEEEecCCCcHHHHHHHhhc
Confidence            456799999999977655556677889999999999999999999998654     56999999997 5999988763  


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccc
Q 021181           79 --QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 --~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~  155 (316)
                        ..+++.++..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+
T Consensus        96 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~  175 (258)
T cd08215          96 EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC  175 (258)
T ss_pred             cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHh
Confidence              679999999999999999999999999999999999999999999999999887655443 22345678889999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|+||+|+++++|++|..||...+............  .                            ....
T Consensus       176 ~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------------------------~~~~  224 (258)
T cd08215         176 QN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--Y----------------------------PPIP  224 (258)
T ss_pred             cc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--C----------------------------CCCC
Confidence            76 668899999999999999999999997776444443332110  0                            0011


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..++..+.+++++||..+|++||++.++++||||
T Consensus       225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         225 SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            2567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-37  Score=264.46  Aligned_cols=236  Identities=30%  Similarity=0.464  Sum_probs=194.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.|++|++............+.+|+.++++++|+||+++++.+....   ...+++++|+++ ++|.+++.....
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~   97 (260)
T cd06606          21 DKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSSLLKKFGK   97 (260)
T ss_pred             ECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEEEEEEecCCCcHHHHHHHcCC
Confidence            4568999999999776544556788899999999999999999999986542   256899999995 799999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~  157 (316)
                      +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........   .....++..|+|||.+..
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  177 (260)
T cd06606          98 LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence            99999999999999999999999999999999999999999999999999887765543   344567888999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ...+.++|+||||+++++|++|..||...+....  ........                          .........
T Consensus       178 -~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~--------------------------~~~~~~~~~  228 (260)
T cd06606         178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGSS--------------------------GEPPEIPEH  228 (260)
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhcccc--------------------------CCCcCCCcc
Confidence             5589999999999999999999999987762111  11111100                          000111124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .+..+.++|.+||+.||.+||++.++++||||
T Consensus       229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             cCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            57889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-37  Score=268.73  Aligned_cols=244  Identities=24%  Similarity=0.368  Sum_probs=186.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      +..+++.||+|.+..... ......+.+|++++++++||||+++++++....   ...+++||||++ ++|.+++..   
T Consensus        22 ~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~   97 (287)
T cd06621          22 LKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIGIAMEYCEGGSLDSIYKKVKK   97 (287)
T ss_pred             ECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEEEEEEecCCCCHHHHHHHHHh
Confidence            456899999999975432 345577889999999999999999999986432   256899999996 688776542   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                       ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.
T Consensus        98 ~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~  176 (287)
T cd06621          98 RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQ  176 (287)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhc
Confidence             3568999999999999999999999999999999999999999999999999876544322 12345678899999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      + ..++.++|+|||||++|+|++|..||.....  ..................                     ......
T Consensus       177 ~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~  234 (287)
T cd06621         177 G-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL---------------------KDEPGN  234 (287)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh---------------------ccCCCC
Confidence            6 6788999999999999999999999976532  111111111111000000                     000000


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ....++.+.++|.+||..||.+|||+.|+++||||++.
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            01346789999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-37  Score=269.42  Aligned_cols=237  Identities=24%  Similarity=0.356  Sum_probs=183.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR---   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~---   76 (316)
                      +..+|+.||+|+++...   .....+..|+.+++.+ +|+||+++++++...........+++|||++ ++|.+++.   
T Consensus        39 ~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  115 (286)
T cd06638          39 NKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL  115 (286)
T ss_pred             ECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhh
Confidence            45788999999885421   1234577899999999 6999999999886443233467999999996 68988764   


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccc
Q 021181           77 -SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL  154 (316)
Q Consensus        77 -~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~  154 (316)
                       ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.
T Consensus       116 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (286)
T cd06638         116 KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  195 (286)
T ss_pred             ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhh
Confidence             33568899999999999999999999999999999999999999999999999987654332 2233467889999998


Q ss_pred             ccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          155 LLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       155 ~~~----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      +..    ...++.++||||+||++|+|++|..||...+.......+...  ....                         
T Consensus       196 ~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~~-------------------------  248 (286)
T cd06638         196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPPT-------------------------  248 (286)
T ss_pred             hchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCCc-------------------------
Confidence            753    244788999999999999999999999776543322211110  0000                         


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                       ......++..+.++|.+||+.||++|||+.|+++|+||
T Consensus       249 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 -LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             -ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             00001357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.4e-37  Score=270.29  Aligned_cols=235  Identities=26%  Similarity=0.386  Sum_probs=189.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      +..+|+.||+|++..... .......+..|+.+++.++|||++++++++...     ...|++|||+.|++.+.+.. ..
T Consensus        42 ~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~  116 (313)
T cd06633          42 NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAWLVMEYCLGSASDLLEVHKK  116 (313)
T ss_pred             ECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEEecCCCCHHHHHHhcCC
Confidence            456899999999975432 233446688999999999999999999998654     46899999999988887765 45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  157 (316)
                      ++++.++..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....   .....++..|+|||.+..  
T Consensus       117 ~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~  193 (313)
T cd06633         117 PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMD  193 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccC
Confidence            689999999999999999999999999999999999999999999999998754322   234567888999999742  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|.+||...+.......+....  .+.                           .....
T Consensus       194 ~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~  244 (313)
T cd06633         194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPT---------------------------LQSNE  244 (313)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCC---------------------------CCccc
Confidence            2557889999999999999999999998776555544332210  000                           01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ++..+.+++.+||+.+|.+||++.++++||||....
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            567899999999999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=282.66  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=214.4

Q ss_pred             eEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcCCCCCHHH
Q 021181            8 EVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDH   85 (316)
Q Consensus         8 ~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~~~~~~~   85 (316)
                      .+|+|++++... +....+.+..|-.++..+++|+||++|..|.+.     ..+|++||.| +|.|...++..+.|.+..
T Consensus       447 ~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-----kyvYmLmEaClGGElWTiLrdRg~Fdd~t  521 (732)
T KOG0614|consen  447 TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-----KYVYMLMEACLGGELWTILRDRGSFDDYT  521 (732)
T ss_pred             HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-----hhhhhhHHhhcCchhhhhhhhcCCcccch
Confidence            478888877543 333456788999999999999999999999766     4599999999 789999999999999999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCCCCcc
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI  165 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (316)
                      .+.++.-+++|++|||++||++|||||+|.+++.+|-+||.|||+++.++....+.+++||+.|.|||++.+ +..+.++
T Consensus       522 arF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn-KGHD~av  600 (732)
T KOG0614|consen  522 ARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN-KGHDRAV  600 (732)
T ss_pred             hhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhc-cCcchhh
Confidence            999999999999999999999999999999999999999999999999999988899999999999999988 7899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHH
Q 021181          166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDL  245 (316)
Q Consensus       166 DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l  245 (316)
                      |.||||+++|||++|.+||.+.+.+.+...|.+......-                             ...++....++
T Consensus       601 DyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~-----------------------------Pr~I~k~a~~L  651 (732)
T KOG0614|consen  601 DYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF-----------------------------PRRITKTATDL  651 (732)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc-----------------------------ccccchhHHHH
Confidence            9999999999999999999999999998888764432110                             02567789999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCC-CCCCCCCCcccCCCCC
Q 021181          246 LEKMLVFDPNRRIT-----VDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPS  293 (316)
Q Consensus       246 i~~~L~~dP~~Rps-----~~ell~~~~f~~~~~~~~-~~~~~~~~~~~~~~~~  293 (316)
                      |+++...+|.+|..     +.+|-+|.||.+++=.+. ...-+.|+...+..|.
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt  705 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT  705 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence            99999999999996     889999999999872222 2333445555555554

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3e-37  Score=265.73  Aligned_cols=226  Identities=21%  Similarity=0.293  Sum_probs=181.9

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~   80 (316)
                      ..++..||+|+++.... ......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++... ..
T Consensus        30 ~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  103 (266)
T cd05064          30 SKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-----NTMMIVTEYMSNGALDSFLRKHEGQ  103 (266)
T ss_pred             CCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----CCcEEEEEeCCCCcHHHHHHhCCCC
Confidence            35678999999976532 33446788999999999999999999998654     46899999997 6888888764 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc--cccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~  158 (316)
                      +++.+++.++.||+.||+|||++|++|+||+|+||+++.++.++++|||.+..........  ...++..|+|||.+.+ 
T Consensus       104 l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  182 (266)
T cd05064         104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-  182 (266)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-
Confidence            8999999999999999999999999999999999999999999999999765543222111  2234567999999877 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||||||++|++++ |..||...+..+.+..+......+                              ....
T Consensus       183 ~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~  232 (266)
T cd05064         183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP------------------------------APRN  232 (266)
T ss_pred             CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC------------------------------CCCC
Confidence            778999999999999999875 999998877665555443211110                              1124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++..+.+++.+||+.+|.+||++++|++
T Consensus       233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         233 CPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            6788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.4e-37  Score=268.95  Aligned_cols=235  Identities=25%  Similarity=0.480  Sum_probs=190.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+|+.||||++...  .......+.+|+.+++.++|+||+++++.+...     ...+++|||++ ++|.+++. ...
T Consensus        41 ~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~~~  112 (292)
T cd06657          41 VKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVT-HTR  112 (292)
T ss_pred             EcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEecCCCCcHHHHHh-cCC
Confidence            3568999999998543  333456788999999999999999999998654     56999999996 58887764 457


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+ .
T Consensus       113 ~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~  191 (292)
T cd06657         113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-L  191 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcC-C
Confidence            8999999999999999999999999999999999999999999999999876554322 1233457888999998866 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+|+++|+|++|..||.+.+.......+.......                            ......++
T Consensus       192 ~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  243 (292)
T cd06657         192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK----------------------------LKNLHKVS  243 (292)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc----------------------------cCCcccCC
Confidence            67899999999999999999999998776554444332211100                            00112467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..+.+++.+||+.||.+||++.++++||||.+..
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            8899999999999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=267.64  Aligned_cols=236  Identities=23%  Similarity=0.383  Sum_probs=188.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC---CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+|+.||+|.++... .......+.+|+.+++.++   |||++++++++...     ...+++|||+. ++|.+++..
T Consensus        22 ~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~   95 (277)
T cd06917          22 HVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----PRLWIIMEYAEGGSVRTLMKA   95 (277)
T ss_pred             EcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----CEEEEEEecCCCCcHHHHHHc
Confidence            45789999999986542 2334566788999999996   99999999988544     56899999996 689988866


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCccccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~  156 (316)
                       +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.
T Consensus        96 -~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (277)
T cd06917          96 -GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT  174 (277)
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhc
Confidence             4789999999999999999999999999999999999999999999999998876544322 23346788899999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +...++.++|+|||||++|+|++|..||...........+..   ..+.                        .+  ...
T Consensus       175 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~------------------------~~--~~~  225 (277)
T cd06917         175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SKPP------------------------RL--EDN  225 (277)
T ss_pred             cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---CCCC------------------------CC--Ccc
Confidence            656678999999999999999999999976653332221110   0000                        00  001


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .++.++.+++++||+.||++||++.++++|+||++..
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         226 GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            2678899999999999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-37  Score=263.08  Aligned_cols=226  Identities=26%  Similarity=0.416  Sum_probs=188.1

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~----   78 (316)
                      .++..||+|.++...... ....+.+|+.+++.++|+||+++++++...     ..++++|||+ +++|.+++...    
T Consensus        21 ~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~   94 (262)
T cd00192          21 GKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVLEYMEGGDLLDYLRKSRPVF   94 (262)
T ss_pred             CCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEEEeccCCcHHHHHhhccccc
Confidence            348899999997654333 567889999999999999999999998653     5699999999 57999999875    


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---cccccccccccc
Q 021181           79 -----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYR  150 (316)
Q Consensus        79 -----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~  150 (316)
                           ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......   ......++..|+
T Consensus        95 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~  174 (262)
T cd00192          95 PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM  174 (262)
T ss_pred             cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCcccc
Confidence                 779999999999999999999999999999999999999999999999999987765432   123345677899


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      |||.+.. ..++.++|||||||++|+|++ |..||...........+.....                            
T Consensus       175 aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------  225 (262)
T cd00192         175 APESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR----------------------------  225 (262)
T ss_pred             CHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------------
Confidence            9999877 578999999999999999999 6999988865555554433100                            


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                        ......++.++.+++.+||+.||++|||+++++++
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         226 --LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              01112468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-38  Score=268.60  Aligned_cols=227  Identities=28%  Similarity=0.448  Sum_probs=180.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +...+..|+||.++.. ......+.+.+|++.+++++||||++++|++...     ...++||||+. |+|.+++...  
T Consensus        24 ~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~lv~e~~~~g~L~~~L~~~~~   97 (259)
T PF07714_consen   24 DNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLFLVMEYCPGGSLDDYLKSKNK   97 (259)
T ss_dssp             TTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEEEEEE--TTEBHHHHHHHTCT
T ss_pred             cCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccc-----cccccccccccccccccccccccc
Confidence            3567899999999553 3445578899999999999999999999999744     34899999997 7999999886  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~  155 (316)
                      ..+++.++..|+.||+.||.|||+.+++|++|++.||+++.++.+||+|||++........   .........|+|||.+
T Consensus        98 ~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~  177 (259)
T PF07714_consen   98 EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVL  177 (259)
T ss_dssp             TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            6799999999999999999999999999999999999999999999999999877633222   2234456789999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .. ..++.++||||||+++||+++ |+.||...+.......+.+.....                              .
T Consensus       178 ~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~------------------------------~  226 (259)
T PF07714_consen  178 KD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP------------------------------I  226 (259)
T ss_dssp             HH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT------------------------------S
T ss_pred             cc-ccccccccccccccccccccccccccccccccccccccccccccce------------------------------e
Confidence            77 568999999999999999999 789998887666555553321111                              1


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ...++..+.++|..||+.||.+||++.+|++
T Consensus       227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1256888999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4e-37  Score=265.14  Aligned_cols=226  Identities=23%  Similarity=0.349  Sum_probs=178.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|..+|+|.+.......       .|+.....+ +||||+++++.+...     ..+++||||++ ++|.+++....
T Consensus        37 ~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~  104 (267)
T PHA03390         37 HKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL-----KGHVLIMDYIKDGDLFDLLKKEG  104 (267)
T ss_pred             EcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----CeeEEEEEcCCCCcHHHHHHhcC
Confidence            45788999999986542221       122222222 799999999999655     46999999996 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.......   ...++..|+|||.+.+ 
T Consensus       105 ~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-  180 (267)
T PHA03390        105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKIKG-  180 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---cCCCCCcccChhhhcC-
Confidence            999999999999999999999999999999999999999998 99999999887664332   3457888999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ-LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|+||+|+++|+|++|..||........ ..........                            .....+.
T Consensus       181 ~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  232 (267)
T PHA03390        181 HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----------------------------KLPFIKN  232 (267)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc----------------------------cCCcccc
Confidence            6688999999999999999999999975543221 1111110000                            0111125


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-VDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-~~ell~~~~f~~  271 (316)
                      +++.+.++|.+||+.||.+|++ ++++++||||++
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            7899999999999999999996 699999999974

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7e-37  Score=260.34  Aligned_cols=231  Identities=30%  Similarity=0.490  Sum_probs=189.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..+|+.|++|++.....  .....+.+|+.+++.++|++++++++.+...     ...++++||++ ++|.+++... +
T Consensus        21 ~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~   93 (253)
T cd05122          21 HKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKSTNQ   93 (253)
T ss_pred             ECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEEecCCCCcHHHHHhhcCC
Confidence            345789999999966432  3557788999999999999999999998654     45899999997 6999998776 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+ .
T Consensus        94 ~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~  172 (253)
T cd05122          94 TLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K  172 (253)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcC-C
Confidence            799999999999999999999999999999999999999999999999998877655433345567888999999876 5


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||||+++|+|++|..||...+..........  ...+..                          .....++
T Consensus       173 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--------------------------~~~~~~~  224 (253)
T cd05122         173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGL--------------------------RNPEKWS  224 (253)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCc--------------------------CcccccC
Confidence            688999999999999999999999987654444333221  100000                          0001247


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPY  268 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~  268 (316)
                      ..+.++|.+||+.||++|||+.++++|||
T Consensus       225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         225 DEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            88999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=260.83  Aligned_cols=232  Identities=31%  Similarity=0.497  Sum_probs=192.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|.+............+.+|++++++++|+|++++++++...     ...+++||+++ ++|.+++.....
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~   95 (254)
T cd06627          21 NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLYIILEYAENGSLRQIIKKFGP   95 (254)
T ss_pred             EcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhccC
Confidence            456789999999987655555677899999999999999999999998654     56999999997 599999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||...+ .
T Consensus        96 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~  174 (254)
T cd06627          96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S  174 (254)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcC-C
Confidence            99999999999999999999999999999999999999999999999998877654332 234467888999999876 5


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+|+++|+|++|..||...+..........  ...                            ......++
T Consensus       175 ~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~----------------------------~~~~~~~~  224 (254)
T cd06627         175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--DDH----------------------------PPLPEGIS  224 (254)
T ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--cCC----------------------------CCCCCCCC
Confidence            588999999999999999999999976653333222211  000                            01112567


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ..+.+++.+||..+|++||++.++++||||
T Consensus       225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         225 PELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=261.97  Aligned_cols=231  Identities=29%  Similarity=0.499  Sum_probs=191.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~   79 (316)
                      +..+|+.||+|.+..... .......+..|+.++++++|+||+++++.+...     ...+++||++ +++|.+++....
T Consensus        14 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~   88 (250)
T cd05123          14 KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYAPGGELFSHLSKEG   88 (250)
T ss_pred             ECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecCCCCcHHHHHHhcC
Confidence            345789999999976533 233556788999999999999999999998544     5699999999 579999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||...+ 
T Consensus        89 ~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-  167 (250)
T cd05123          89 RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-  167 (250)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCC-
Confidence            8999999999999999999999999999999999999999999999999988775443 22344567888999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ...+.++|+||||+++|++++|..||...+.......+..  +..                             ......
T Consensus       168 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~-----------------------------~~~~~~  216 (250)
T cd05123         168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL-----------------------------RFPEFL  216 (250)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC-----------------------------CCCCCC
Confidence            5678899999999999999999999977765444333322  000                             001134


Q ss_pred             ChHHHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITV---DEALCHPYL  269 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~---~ell~~~~f  269 (316)
                      +..+.++|++||..||++||++   +++++||||
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            7889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-37  Score=263.79  Aligned_cols=232  Identities=29%  Similarity=0.471  Sum_probs=187.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      ++.+|+.||+|.+.....+......+.+|+.+++.++|+||+++++.+...     ...++++||+. ++|.+++.... 
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   95 (257)
T cd08225          21 AKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLFIVMEYCDGGDLMKRINRQRG   95 (257)
T ss_pred             EcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEEEEEecCCCCcHHHHHHhccC
Confidence            456789999999976543444556788999999999999999999988544     56999999996 69999886543 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC-EEEeeeccccccCCCCc-cccccccccccCccccc
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~  156 (316)
                       .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++++|||.+........ .....++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~  175 (257)
T cd08225          96 VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ  175 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHc
Confidence             4789999999999999999999999999999999999998864 69999998876544322 22345778899999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|+||||+++++|++|..||...+.......+...  .                            +....+
T Consensus       176 ~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------------------------~~~~~~  224 (257)
T cd08225         176 N-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--Y----------------------------FAPISP  224 (257)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--c----------------------------CCCCCC
Confidence            6 56889999999999999999999999776644443322210  0                            011123


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .++.++.++|.+||..+|++|||+.++++||||
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         225 NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.5e-37  Score=268.03  Aligned_cols=234  Identities=31%  Similarity=0.506  Sum_probs=190.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      +..+++.||+|++.....   ....+..|+++++.++|+|++++++.+...     ...++++||++ ++|.+++...+ 
T Consensus        40 ~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  111 (286)
T cd06614          40 DRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWVVMEYMDGGSLTDIITQNFV  111 (286)
T ss_pred             EccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHhcc
Confidence            345789999999965432   456788999999999999999999998655     56999999997 69999998876 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+ 
T Consensus       112 ~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-  190 (286)
T cd06614         112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-  190 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC-
Confidence            89999999999999999999999999999999999999999999999999876543321 1223346778999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|+||||+++|+|++|..||...+.......+...  ....                          ......+
T Consensus       191 ~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~  242 (286)
T cd06614         191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GIPP--------------------------LKNPEKW  242 (286)
T ss_pred             CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCC--------------------------CcchhhC
Confidence            67899999999999999999999999876654443333211  0000                          0001236


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +..+.++|++||+.+|.+||++.++++|+||++.
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            7889999999999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.8e-37  Score=265.20  Aligned_cols=226  Identities=27%  Similarity=0.412  Sum_probs=183.1

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      ..+++.||||.++... .......+.+|+++++.++|+||+++++++...     ...+++|||+. ++|.+++...+  
T Consensus        32 ~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~  105 (280)
T cd05049          32 ENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPD  105 (280)
T ss_pred             cCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-----CCeEEEEecCCCCCHHHHHHhcCCc
Confidence            3567899999997543 233457788999999999999999999998654     56999999996 79999987542  


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccccc
Q 021181           80 ------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYV  144 (316)
Q Consensus        80 ------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~  144 (316)
                                  .+++.++..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........   .....
T Consensus       106 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~  185 (280)
T cd05049         106 AAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM  185 (280)
T ss_pred             hhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCc
Confidence                        478899999999999999999999999999999999999999999999998875432221   12233


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      ++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+......                     
T Consensus       186 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  243 (280)
T cd05049         186 LPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL---------------------  243 (280)
T ss_pred             ccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC---------------------
Confidence            4678999999877 678999999999999999998 99999877766555544321110                     


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                               .....++..+.+++++||+.||.+||++.|+++
T Consensus       244 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         244 ---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                     001246788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.9e-37  Score=266.08  Aligned_cols=225  Identities=22%  Similarity=0.355  Sum_probs=182.5

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-----   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----   78 (316)
                      +++.||+|.+.... .......+.+|+.+++.++||||+++++++...     ...+++|||++ |+|.+++...     
T Consensus        34 ~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~l~~~~~~~~  107 (283)
T cd05048          34 SATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSD  107 (283)
T ss_pred             ceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-----CceEEEEecCCCCcHHHHHHhcCCCcc
Confidence            44789999986542 333456788999999999999999999998654     45899999996 7999998754     


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccccc
Q 021181           79 -----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYV  144 (316)
Q Consensus        79 -----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~  144 (316)
                                 ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........   .....
T Consensus       108 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~  187 (283)
T cd05048         108 VGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL  187 (283)
T ss_pred             cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCc
Confidence                       4578899999999999999999999999999999999999999999999999876533221   22344


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      ++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......                     
T Consensus       188 ~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------------  245 (283)
T cd05048         188 LPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL---------------------  245 (283)
T ss_pred             ccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---------------------
Confidence            5778999999876 678999999999999999998 99999887765554443321100                     


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                               .....+++++.+++.+||+.||.+||++.+++++
T Consensus       246 ---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         246 ---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             ---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     0113578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.5e-37  Score=262.09  Aligned_cols=231  Identities=29%  Similarity=0.434  Sum_probs=190.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      +..+|+.||+|.+............+.+|+.+++.++|+||+++++++...     ...++||||++ ++|.+++..   
T Consensus        21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~   95 (256)
T cd08530          21 RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKK   95 (256)
T ss_pred             ECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEEEEehhcCCCCHHHHHHHHHh
Confidence            457899999999976555555667788999999999999999999998654     56999999996 699888865   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                       ...+++..++.++.|++.||++||+.|++|+||+|.||+++.++.++|+|||.+...... ......++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~  174 (256)
T cd08530          96 KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWK  174 (256)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHC
Confidence             356899999999999999999999999999999999999999999999999988776544 223345778899999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|+||||+++++|++|+.||...+.......+....  .                            .....
T Consensus       175 ~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------------------------~~~~~  223 (256)
T cd08530         175 G-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--Y----------------------------PPIPP  223 (256)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--C----------------------------CCCch
Confidence            6 678889999999999999999999998776544333322100  0                            01112


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .++.++.+++.+||+.+|.+||++.++++||++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            467889999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.9e-37  Score=277.37  Aligned_cols=226  Identities=24%  Similarity=0.350  Sum_probs=177.2

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      .+++.||||+++.... ......+.+|+.+++.+ +|+||+++++++...     ...++||||+. |+|.+++...   
T Consensus        66 ~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~  139 (374)
T cd05106          66 DNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAET  139 (374)
T ss_pred             cccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhh
Confidence            4556899999976432 23456788999999999 899999999998654     45899999996 7999887542   


Q ss_pred             -------------------------------------------------------------------CCCCHHHHHHHHH
Q 021181           79 -------------------------------------------------------------------QDLTDDHCRYFLY   91 (316)
Q Consensus        79 -------------------------------------------------------------------~~~~~~~~~~i~~   91 (316)
                                                                                         .++++.+++.++.
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  219 (374)
T cd05106         140 FLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSS  219 (374)
T ss_pred             hccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHH
Confidence                                                                               2478888999999


Q ss_pred             HHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCcccccCCCCCCCcchHH
Q 021181           92 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIW  168 (316)
Q Consensus        92 qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (316)
                      ||+.||+|||++|++||||||+||+++.++.++|+|||++.........   ....++..|+|||++.+ ..++.++|||
T Consensus       220 qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw  298 (374)
T cd05106         220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVW  298 (374)
T ss_pred             HHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHH
Confidence            9999999999999999999999999999999999999998765432211   12234567999999876 6789999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHH
Q 021181          169 SVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLE  247 (316)
Q Consensus       169 slG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~  247 (316)
                      ||||++|+|++ |..||...................                             .....+++++.+++.
T Consensus       299 SlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~  349 (374)
T cd05106         299 SYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-----------------------------SRPDFAPPEIYSIMK  349 (374)
T ss_pred             HHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-----------------------------cCCCCCCHHHHHHHH
Confidence            99999999997 999997765433322222110000                             001235788999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 021181          248 KMLVFDPNRRITVDEALC  265 (316)
Q Consensus       248 ~~L~~dP~~Rps~~ell~  265 (316)
                      +||+.||.+||++.++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         350 MCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.9e-37  Score=268.14  Aligned_cols=232  Identities=25%  Similarity=0.369  Sum_probs=179.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      .++..||+|++.... .......+.+|+.++.+++||||+++++++...     ...+++|||+. |+|.+++...    
T Consensus        44 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  117 (304)
T cd05096          44 GRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDD  117 (304)
T ss_pred             CcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccc
Confidence            345689999987542 333456788999999999999999999998654     45899999996 6999988543    


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---c
Q 021181           79 ---------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---M  140 (316)
Q Consensus        79 ---------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~  140 (316)
                                     ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........   .
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~  197 (304)
T cd05096         118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ  197 (304)
T ss_pred             cccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEec
Confidence                           2367788999999999999999999999999999999999999999999999876543321   1


Q ss_pred             ccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHH
Q 021181          141 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR  218 (316)
Q Consensus       141 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  218 (316)
                      ....++..|+|||.+.. ..++.++|||||||++|+|++  +..||...+.......+.........             
T Consensus       198 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------  263 (304)
T cd05096         198 GRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGR-------------  263 (304)
T ss_pred             CcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccc-------------
Confidence            22344678999999876 678999999999999999986  56788776655544433221111000             


Q ss_pred             HhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          219 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                .......+.++..+.+++.+||+.||++|||+++|.+
T Consensus       264 ----------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         264 ----------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             ----------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence                      0001112356788999999999999999999999853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-37  Score=274.22  Aligned_cols=234  Identities=27%  Similarity=0.452  Sum_probs=186.0

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC-C
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL-T   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~-~   82 (316)
                      .+..||+|++.....+......+..|+.+|.+| .|..|++++++-...     +.+|+||||=+.+|..+|++.... +
T Consensus       384 ~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~  458 (677)
T KOG0596|consen  384 DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-----GYLYMVMECGDIDLNKILKKKKSIDP  458 (677)
T ss_pred             CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----ceEEEEeecccccHHHHHHhccCCCc
Confidence            457788888888778888899999999999999 599999999986543     569999998888999999876543 3


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCC-
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNC-  158 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-  158 (316)
                      .-.++.++.||+.|+.++|+.||||.||||.|+|+- .|.+||+|||.+..+..+..   ....+||..|+|||.+... 
T Consensus       459 ~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~  537 (677)
T KOG0596|consen  459 DWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMS  537 (677)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcc
Confidence            358899999999999999999999999999999984 47899999999988766543   3567899999999998531 


Q ss_pred             ---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          159 ---------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       159 ---------~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                               -..++++|||||||++|+|+.|++||...  ...+.++........  .                      
T Consensus       538 s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI~~P~~--~----------------------  591 (677)
T KOG0596|consen  538 SSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAITDPNH--E----------------------  591 (677)
T ss_pred             ccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhhcCCCc--c----------------------
Confidence                     12568999999999999999999999443  112222222221111  0                      


Q ss_pred             CccccCCCCC--hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          230 NFSARFPNKS--PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       230 ~~~~~~~~~s--~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                         -.++.++  .++.++++.||.+||.+||++.+||+|||++...
T Consensus       592 ---Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  592 ---IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             ---ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence               1122222  2299999999999999999999999999998744

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=282.57  Aligned_cols=237  Identities=25%  Similarity=0.405  Sum_probs=196.1

Q ss_pred             CCCCCCceEEEEEecccc--cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            1 MNSETREEVAIKKIGNAF--DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      .|..+|..||--.++...  .+....+++..|+.+|+.|+||||+++|+++.+...   ..+.+|+|.+. |+|+.++++
T Consensus        60 ~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk  136 (632)
T KOG0584|consen   60 FDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRKK  136 (632)
T ss_pred             cccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHHH
Confidence            366778788766665433  344455899999999999999999999999987643   67899999995 999999999


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccC-CCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                      .++.+...++.|++||+.||.|||++.  |+|||||=+||+|+++ |.+||+|+|++........ ....||+.|||||.
T Consensus       137 ~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEm  215 (632)
T KOG0584|consen  137 HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEM  215 (632)
T ss_pred             hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-ceeccCccccChHH
Confidence            999999999999999999999999886  9999999999999876 8999999999988765433 44799999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ-LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.  ..|.+.+||||||++++||.|+..||..-....+ .+++.....+....                           
T Consensus       216 YE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~---------------------------  266 (632)
T KOG0584|consen  216 YE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS---------------------------  266 (632)
T ss_pred             Hh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh---------------------------
Confidence            97  5799999999999999999999999987654444 44433322111110                           


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                        .--.+++++||.+||.. .++|||+.|||.||||..-.
T Consensus       267 --kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  267 --KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             --ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence              01267899999999999 99999999999999999863

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=291.39  Aligned_cols=228  Identities=25%  Similarity=0.373  Sum_probs=180.3

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeee-ecCCCCCC-CCeEEEEEecCC-CcHHHHhhc-
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDI-IRPPQRET-FNDVYIVYELMD-TDLHQIIRS-   77 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~~~~~~-~~~~~iv~e~~~-g~L~~~l~~-   77 (316)
                      ...|..||+|++-..  ++.....+.+|+.++++|. |+|||.++|. .....-.+ ...++|+||||. |+|.++|.. 
T Consensus        59 ~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~R  136 (738)
T KOG1989|consen   59 VKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTR  136 (738)
T ss_pred             cCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHH
Confidence            445589999998543  6667788999999999996 9999999994 33221111 246899999997 799999874 


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc----------ccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----------EYV  144 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~~  144 (316)
                       ..+|++.++++|++++++|+++||.+.  |+|||||-+|||++.+|..||||||.+..........          ...
T Consensus       137 lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~  216 (738)
T KOG1989|consen  137 LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKY  216 (738)
T ss_pred             HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhh
Confidence             356999999999999999999999988  9999999999999999999999999876543332111          123


Q ss_pred             ccccccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          145 VTRWYRAPELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       145 ~~~~~~aPE~~~--~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .|+.|+|||.+.  ++.+.++++|||+|||++|-||..+.||.......++..-.    ..                   
T Consensus       217 TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y----~~-------------------  273 (738)
T KOG1989|consen  217 TTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY----SF-------------------  273 (738)
T ss_pred             CCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc----cC-------------------
Confidence            488999999853  34678999999999999999999999997764332222110    00                   


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                ..++.++..+.+||+.||+.||.+||++.+++.
T Consensus       274 ----------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  274 ----------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ----------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                      112578999999999999999999999988876

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8e-37  Score=260.82  Aligned_cols=227  Identities=22%  Similarity=0.349  Sum_probs=179.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      ++.+|+.||+|.+.... .......+.+|+++++.++||||+++++++...     ...++||||+. ++|.+++... .
T Consensus        16 ~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   89 (252)
T cd05084          16 LRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGP   89 (252)
T ss_pred             EecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeeccCCcHHHHHHhCCC
Confidence            45689999999886442 334456788999999999999999999998654     45899999996 6999998654 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc---cccccccccCccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLL  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~  156 (316)
                      .+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........   ....+..|+|||.+.
T Consensus        90 ~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  169 (252)
T cd05084          90 RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN  169 (252)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhc
Confidence            58999999999999999999999999999999999999999999999999886543321111   112245699999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|+|++ |.+||...........+......                              ...
T Consensus       170 ~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~  218 (252)
T cd05084         170 Y-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL------------------------------PCP  218 (252)
T ss_pred             C-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC------------------------------CCc
Confidence            6 668899999999999999997 99999766544333332221000                              001


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..++..+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=263.00  Aligned_cols=232  Identities=21%  Similarity=0.315  Sum_probs=184.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      .++..||||+++...........+..|+..++.++||||+++++++..... ......+++|||+. |+|...+...   
T Consensus        25 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~  104 (273)
T cd05035          25 GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG  104 (273)
T ss_pred             CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhcc
Confidence            456889999998765555566788999999999999999999998865432 23345899999996 7998887432   


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCc
Q 021181           79 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAP  152 (316)
Q Consensus        79 ---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aP  152 (316)
                         ..+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||.+.........   .....+..|+||
T Consensus       105 ~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         105 GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCH
Confidence               35899999999999999999999999999999999999999999999999998765433211   122345679999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      |.+.+ ..++.++|||||||++|||++ |.+||.+....+....+.....                              
T Consensus       185 e~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------  233 (273)
T cd05035         185 ESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR------------------------------  233 (273)
T ss_pred             hhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------------------
Confidence            99866 678999999999999999999 9999987765554443322100                              


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ......++..+.+++++||+.||.+||++.|++++
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            01112567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-36  Score=264.61  Aligned_cols=238  Identities=22%  Similarity=0.368  Sum_probs=188.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|++.... .......+.+|+++++.++||||+++++.+...     ..+++||||++ ++|.+++...+.
T Consensus        26 ~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   99 (284)
T cd06620          26 HIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNICMCMEFMDCGSLDRIYKKGGP   99 (284)
T ss_pred             EcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEEEEEecCCCCCHHHHHHhccC
Confidence            35678999999986542 233457788999999999999999999998654     56999999996 699999888788


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+ .
T Consensus       100 ~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~-~  177 (284)
T cd06620         100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQG-G  177 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHcc-C
Confidence            9999999999999999999996 69999999999999999999999999987654222 1234567889999999876 5


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--------HHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ--------LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~--------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      .++.++|+||+||++|+|++|..||........        ............                        ..+
T Consensus       178 ~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~  233 (284)
T cd06620         178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------------------------PRL  233 (284)
T ss_pred             CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------------------------CCC
Confidence            788999999999999999999999986543211        111111110000                        000


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                        ....++..+.++|.+||+.||.+|||++|+++|+||.+..
T Consensus       234 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         234 --PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             --CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence              0012677899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.4e-37  Score=266.13  Aligned_cols=231  Identities=34%  Similarity=0.562  Sum_probs=190.0

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~   78 (316)
                      +..+|+.||+|++..... .......+..|+.+++++. |+||+++++++...     ...+++||++ +++|.+++...
T Consensus        22 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   96 (280)
T cd05581          22 EKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----ENLYFVLEYAPNGELLQYIRKY   96 (280)
T ss_pred             EcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----ceEEEEEcCCCCCcHHHHHHHc
Confidence            456899999999976432 3334467789999999998 99999999998544     5699999999 57999999988


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-------------------
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-------------------  139 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-------------------  139 (316)
                      +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++........                   
T Consensus        97 ~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (280)
T cd05581          97 GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR  176 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccc
Confidence            8999999999999999999999999999999999999999999999999998876543221                   


Q ss_pred             --cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchH
Q 021181          140 --MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR  217 (316)
Q Consensus       140 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (316)
                        .....++..|+|||.... ..++.++|+||||++++++++|..||...+.......+......               
T Consensus       177 ~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  240 (280)
T cd05581         177 RRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS---------------  240 (280)
T ss_pred             cccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC---------------
Confidence              122346788999999876 66889999999999999999999999877644333332211000               


Q ss_pred             HHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 021181          218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYL  269 (316)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f  269 (316)
                                      ....+++.+.++|++||+.||.+||++    +++++||||
T Consensus       241 ----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         241 ----------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             ----------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                            012457889999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-36  Score=268.33  Aligned_cols=233  Identities=26%  Similarity=0.388  Sum_probs=188.6

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      +..+|+.||+|++.... ........+.+|+++++.++|+|++++++++...     ...++||||+.|+|.+.+.. ..
T Consensus        46 ~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~  120 (317)
T cd06635          46 DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKK  120 (317)
T ss_pred             EcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeEEEEEeCCCCCHHHHHHHhcC
Confidence            45688999999986542 2333446788999999999999999999998654     45899999999988887754 45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  157 (316)
                      ++++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......   ....++..|+|||.+..  
T Consensus       121 ~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~  197 (317)
T cd06635         121 PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMD  197 (317)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCC
Confidence            6899999999999999999999999999999999999999999999999987654332   23457788999999742  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      .+.++.++|+|||||++|+|++|.+||...+.......+........                             ....
T Consensus       198 ~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~  248 (317)
T cd06635         198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-----------------------------QSNE  248 (317)
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-----------------------------CCcc
Confidence            24578899999999999999999999977665554444433111100                             0124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ++..+.++|.+||+.+|.+||++.++++|+|+..
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            5778999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-36  Score=265.42  Aligned_cols=225  Identities=27%  Similarity=0.411  Sum_probs=181.7

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      ..++..||+|.+...  .......+.+|++++++++||||+++++++...     ..++++|||++ ++|.+++...+  
T Consensus        32 ~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~  104 (288)
T cd05093          32 EQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPD  104 (288)
T ss_pred             CCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHHcCCc
Confidence            356778999998653  334456788999999999999999999998654     45899999996 79999987543  


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccc
Q 021181           80 -----------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVV  145 (316)
Q Consensus        80 -----------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~  145 (316)
                                 .+++.++..++.|++.||++||+.|++||||+|+||+++.++.++|+|||.+........   .....+
T Consensus       105 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  184 (288)
T cd05093         105 AVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML  184 (288)
T ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCc
Confidence                       489999999999999999999999999999999999999999999999999876533221   122334


Q ss_pred             cccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCC
Q 021181          146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP  224 (316)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (316)
                      +..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+.......+......                      
T Consensus       185 ~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~----------------------  241 (288)
T cd05093         185 PIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL----------------------  241 (288)
T ss_pred             cccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC----------------------
Confidence            667999999876 678999999999999999998 99999877765555444321100                      


Q ss_pred             CCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       225 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                              .....++.++.+++.+||+.||.+|||+.+++.
T Consensus       242 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         242 --------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                    001246788999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.5e-37  Score=269.04  Aligned_cols=240  Identities=25%  Similarity=0.440  Sum_probs=190.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||+|.+...  .......+..|+.+++.++||||+++++.+...     ...|+|+||+. ++|.+++.. ..
T Consensus        40 ~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~  111 (293)
T cd06647          40 DVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TC  111 (293)
T ss_pred             EcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEEEEEecCCCCcHHHHHhh-cC
Confidence            4568899999998643  223346688999999999999999999998654     45899999996 699988865 46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.. .
T Consensus       112 l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~  190 (293)
T cd06647         112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K  190 (293)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhcc-C
Confidence            8899999999999999999999999999999999999999999999999876544332 2233457788999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+||++|++++|..||...+.......+.. .+.+.                           ......++
T Consensus       191 ~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~  242 (293)
T cd06647         191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------------------------LQNPEKLS  242 (293)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------------------------CCCccccC
Confidence            688999999999999999999999976654332221110 00000                           00112457


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE  278 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~  278 (316)
                      ..+.++|++||..+|++||++.+++.|+||+.......-
T Consensus       243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~  281 (293)
T cd06647         243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSL  281 (293)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccc
Confidence            789999999999999999999999999999987755553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-36  Score=261.83  Aligned_cols=225  Identities=23%  Similarity=0.405  Sum_probs=181.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+++.||+|.+...   ......+.+|+.+++.++|+||+++++++...     ..++++|||++ ++|.+++...  
T Consensus        27 ~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~   98 (263)
T cd05052          27 WKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNR   98 (263)
T ss_pred             EecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEEEEEeCCCCcHHHHHHhCCC
Confidence            3567899999998643   33456788999999999999999999998654     45899999996 7999988654  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc--cccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..........  ....+..|+|||.+.
T Consensus        99 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  178 (263)
T cd05052          99 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  178 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhc
Confidence            358899999999999999999999999999999999999999999999999987654432211  122355799999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|+|++ |..||.+.+..+....+.....                              ....
T Consensus       179 ~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~  227 (263)
T cd05052         179 Y-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------------------------MERP  227 (263)
T ss_pred             c-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------------------------CCCC
Confidence            6 678899999999999999998 9999987765554443322110                              0111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..++..+.++|.+||+.||++||++.++++
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.1e-37  Score=275.15  Aligned_cols=228  Identities=25%  Similarity=0.347  Sum_probs=177.9

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      ..++..||||+++... .......+.+|+.+++.+ +||||+++++++...     ...++||||++ |+|.+++.... 
T Consensus        62 ~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~  135 (375)
T cd05104          62 SDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-----GPTLVITEYCCYGDLLNFLRRKRD  135 (375)
T ss_pred             CccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-----CcceeeehhccCCcHHHHHHhccc
Confidence            4567899999996543 233456788999999999 899999999998654     45899999996 79998886421 


Q ss_pred             --------------------------------------------------------------------------CCCHHH
Q 021181           80 --------------------------------------------------------------------------DLTDDH   85 (316)
Q Consensus        80 --------------------------------------------------------------------------~~~~~~   85 (316)
                                                                                                .+++..
T Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  215 (375)
T cd05104         136 SFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTED  215 (375)
T ss_pred             ccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHH
Confidence                                                                                      367888


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCcccccCCCCCC
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEYT  162 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  162 (316)
                      +..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.........   ....++..|+|||.+.+ ..++
T Consensus       216 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  294 (375)
T cd05104         216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYT  294 (375)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCC
Confidence            9999999999999999999999999999999999999999999998765433211   12233567999999977 6789


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          163 AAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       163 ~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      .++|||||||++|+|++ |..||...................                             ......+.+
T Consensus       295 ~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~  345 (375)
T cd05104         295 FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-----------------------------LSPECAPSE  345 (375)
T ss_pred             CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-----------------------------CCCCCCCHH
Confidence            99999999999999998 899997765433222221100000                             001135678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +.++|.+||+.||++|||+.++++.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=260.32  Aligned_cols=234  Identities=25%  Similarity=0.481  Sum_probs=187.5

Q ss_pred             CCCCCceEEEEEecccc---cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      |..+|+.||+|.+....   ........+.+|++++++++|+||+++++.+.....   ..+++++||++ ++|.+.+..
T Consensus        23 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~   99 (264)
T cd06653          23 DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---KKLSIFVEYMPGGSIKDQLKA   99 (264)
T ss_pred             EcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---CEEEEEEEeCCCCcHHHHHHH
Confidence            46789999999985432   123345678899999999999999999998865321   46889999996 699999988


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC----CccccccccccccCcc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPE  153 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~aPE  153 (316)
                      .+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......    .......++..|+|||
T Consensus       100 ~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  179 (264)
T cd06653         100 YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE  179 (264)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHh
Confidence            788999999999999999999999999999999999999999999999999988764321    1112345788899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.+ ..++.++|+|||||++|+|++|++||...........+   ...+...                          .
T Consensus       180 ~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~--------------------------~  229 (264)
T cd06653         180 VISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTKP--------------------------M  229 (264)
T ss_pred             hhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCCC--------------------------C
Confidence            9877 66889999999999999999999999776544333222   1111110                          1


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ....+++.+.++|.+||. +|..||++.++++|||+
T Consensus       230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            113578889999999999 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=260.06  Aligned_cols=223  Identities=21%  Similarity=0.303  Sum_probs=181.3

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCCH
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTD   83 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~   83 (316)
                      ++..||+|.+...... .....+..|+.+++.+.|+||+++++++..      ...+++|||+. |+|.+++...+.+++
T Consensus        22 ~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~   94 (257)
T cd05060          22 KEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVMELAPLGPLLKYLKKRREIPV   94 (257)
T ss_pred             CcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEEEeCCCCcHHHHHHhCCCCCH
Confidence            4479999999765433 455678899999999999999999998742      34799999996 799999988888999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc----cccccccccCcccccCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~  159 (316)
                      ..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+..........    ...++..|+|||.+.+ .
T Consensus        95 ~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  173 (257)
T cd05060          95 SDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-G  173 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-C
Confidence            9999999999999999999999999999999999999999999999987654332211    1112356999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|+|++ |.+||...+..+....+.....                              ......+
T Consensus       174 ~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~  223 (257)
T cd05060         174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------------------------LPRPEEC  223 (257)
T ss_pred             CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------------------------------CCCCCCC
Confidence            78999999999999999998 9999987765554444332110                              0111356


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +..+.++|.+||+.||.+||++.++++
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.9e-37  Score=261.38  Aligned_cols=219  Identities=22%  Similarity=0.347  Sum_probs=175.0

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +|+.+|+.||+|+++...       ....|...+....||||+++++++...     ...+++|||++ |+|.+++....
T Consensus        13 ~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   80 (237)
T cd05576          13 MDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHISKFL   80 (237)
T ss_pred             EEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHHHhc
Confidence            367899999999996542       122444555566799999999998654     56999999996 69999998878


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+......  .....++..|+|||.+.+ .
T Consensus        81 ~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~  157 (237)
T cd05576          81 NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI-S  157 (237)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCC-C
Confidence            8999999999999999999999999999999999999999999999999977655432  123345667999999866 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+||+|+++|+|++|..|+.......  .       ..                    ..      ....+.++
T Consensus       158 ~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~-------~~--------------------~~------~~~~~~~~  202 (237)
T cd05576         158 EETEACDWWSLGAILFELLTGKTLVECHPSGI--N-------TH--------------------TT------LNIPEWVS  202 (237)
T ss_pred             CCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c-------cc--------------------cc------cCCcccCC
Confidence            67899999999999999999998874321100  0       00                    00      00112468


Q ss_pred             hHHHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITV-----DEALCHPYL  269 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f  269 (316)
                      +.+.++|.+||+.||.+|+++     +++++||||
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            889999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.8e-37  Score=261.35  Aligned_cols=229  Identities=29%  Similarity=0.447  Sum_probs=186.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--H   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~   78 (316)
                      +..+++.||+|.++... .......+..|+.+++.++|+||+++++.+...     ..+|++|||++ ++|.+.+..  .
T Consensus        21 ~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~   94 (255)
T cd08219          21 HVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLYIVMEYCDGGDLMQKIKLQRG   94 (255)
T ss_pred             EcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEEeeCCCCcHHHHHHhccC
Confidence            45689999999986543 233556788999999999999999999998544     56999999996 699888764  3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++++|||.+....... ......++..|+|||++.+
T Consensus        95 ~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  174 (255)
T cd08219          95 KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN  174 (255)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHcc
Confidence            458999999999999999999999999999999999999999999999999987654332 2234567888999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+||||+++|+|++|..||...+.......+......                              .....
T Consensus       175 -~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  223 (255)
T cd08219         175 -MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK------------------------------PLPSH  223 (255)
T ss_pred             -CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC------------------------------CCCcc
Confidence             66899999999999999999999999877655544433221100                              01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHP  267 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~  267 (316)
                      ++..+.++|++||+.||.+||++.++++--
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence            677899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=277.08  Aligned_cols=221  Identities=33%  Similarity=0.509  Sum_probs=181.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..|++.+++|++.+...      ...+|+.++... +||||+++.+++.+.     .+.|+|||.+. +.+.+.+...+
T Consensus       343 ~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~~~v~e~l~g~ell~ri~~~~  411 (612)
T KOG0603|consen  343 SSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDG-----KEIYLVMELLDGGELLRRIRSKP  411 (612)
T ss_pred             ccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCC-----ceeeeeehhccccHHHHHHHhcc
Confidence            467889999999976522      234677666666 799999999999655     56999999996 57777777766


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE-ccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+. .++..|+++|+.|+.|||++|++||||||+|||+ +..++++|+|||..+.....  ....+-|..|.|||++.. 
T Consensus       412 ~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~-  487 (612)
T KOG0603|consen  412 EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAI-  487 (612)
T ss_pred             hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhcc-
Confidence            666 8888899999999999999999999999999999 68899999999998776544  445577889999999986 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..+++++|+||||+++|+|++|..||...... ++...+    +.+...                             ..
T Consensus       488 ~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s-----------------------------~~  534 (612)
T KOG0603|consen  488 QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS-----------------------------EC  534 (612)
T ss_pred             CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc-----------------------------cc
Confidence            88999999999999999999999999877544 222222    111100                             36


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      +|..+++||+.||+.||.+||++.+++.||||.
T Consensus       535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  535 VSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             cCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence            899999999999999999999999999999993

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-36  Score=267.12  Aligned_cols=234  Identities=24%  Similarity=0.377  Sum_probs=187.8

Q ss_pred             CCCCCceEEEEEeccc-ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      ++.+|+.||||.+... .........+.+|+.+++.++|+|++++++++...     ...++||||+.|++.+.+.. ..
T Consensus        36 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~  110 (308)
T cd06634          36 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKK  110 (308)
T ss_pred             EcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CeeEEEEEccCCCHHHHHHHcCC
Confidence            4568899999998653 22333456788999999999999999999998654     45899999999888887654 45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  157 (316)
                      .+++.++..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+......   ....++..|+|||.+.+  
T Consensus       111 ~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~  187 (308)
T cd06634         111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMD  187 (308)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcc
Confidence            6899999999999999999999999999999999999999999999999988665432   23456788999999752  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|..||...+.......+......                             ......
T Consensus       188 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~  238 (308)
T cd06634         188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----------------------------ALQSGH  238 (308)
T ss_pred             cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC-----------------------------CcCccc
Confidence            245788999999999999999999999776544433332211000                             000124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ++..+.++|.+||+.+|.+||+++++++|||+...
T Consensus       239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            67789999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=263.46  Aligned_cols=276  Identities=45%  Similarity=0.773  Sum_probs=230.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |..+|+.||+|++..-..+-...+.+.+|+.++..++|.|++..+++...+...-+..+|+++|.+..+|..+|-+...+
T Consensus        74 DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~L  153 (449)
T KOG0664|consen   74 DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQAL  153 (449)
T ss_pred             CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCC
Confidence            67889999999998776677777899999999999999999999998875543334568899999999999999998899


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC--CccccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +...++.+++||+.||.|||+.||.||||||.|.++++|..+||||||+++.....  ..+...+-|.+|.|||++++..
T Consensus       154 s~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaR  233 (449)
T KOG0664|consen  154 TPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGAR  233 (449)
T ss_pred             CcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcch
Confidence            99999999999999999999999999999999999999999999999999876544  3455667799999999999999


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC-CCccccCC--
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK-QNFSARFP--  236 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--  236 (316)
                      .|+.+.||||.||++.||+..+..|...+..+++..|..++|.+..+...+-..+.-...++...+.+. ..+...-.  
T Consensus       234 hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~  313 (449)
T KOG0664|consen  234 RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPD  313 (449)
T ss_pred             hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCc
Confidence            999999999999999999999999999999999999999999998876554443333333444333322 11111111  


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      ....+...++..||..||.+|.+.++.+.|++....+-...
T Consensus       314 ~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~  354 (449)
T KOG0664|consen  314 DKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFH  354 (449)
T ss_pred             ccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeee
Confidence            33456889999999999999999999999999988764433

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.7e-37  Score=266.58  Aligned_cols=239  Identities=25%  Similarity=0.375  Sum_probs=184.0

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      ..+|+.||||.++..... .....+..|+.++... .|+||+++++++...     ...|++|||+++++.+++.. ...
T Consensus        37 ~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~l~~~~~~~  110 (296)
T cd06618          37 KKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SDVFICMELMSTCLDKLLKRIQGP  110 (296)
T ss_pred             CCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC-----CeEEEEeeccCcCHHHHHHHhcCC
Confidence            456999999999754322 2345566677766666 599999999998654     45999999998888777655 457


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC-
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-  158 (316)
                      +++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+. 
T Consensus       111 l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  190 (296)
T cd06618         111 IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD  190 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCC
Confidence            8999999999999999999997 69999999999999999999999999998765443333344567789999998652 


Q ss_pred             --CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          159 --SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       159 --~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                        ..++.++|+||||+++|+|++|+.||...... +.+..+.   ......                   .      ...
T Consensus       191 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~-------------------~------~~~  242 (296)
T cd06618         191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL---QEEPPS-------------------L------PPN  242 (296)
T ss_pred             CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh---cCCCCC-------------------C------CCC
Confidence              24788999999999999999999999764322 2222211   111000                   0      000


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ..++.++.+++.+||+.||.+||+++++++||||......
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence            1467889999999999999999999999999999876533

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.4e-36  Score=263.14  Aligned_cols=233  Identities=26%  Similarity=0.414  Sum_probs=189.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||||++..... ......+.+|+.++++++||||+++++.+...     ...++||||++ ++|.+++.. ..
T Consensus        25 ~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~-~~   97 (277)
T cd06641          25 DNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GP   97 (277)
T ss_pred             ECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEEEEEeCCCCcHHHHHhc-CC
Confidence            456889999999865432 23446788999999999999999999998654     46899999997 588888764 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+........ .....++..|+|||.+.+ .
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~  176 (277)
T cd06641          98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-S  176 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhcc-C
Confidence            89999999999999999999999999999999999999999999999998876543321 223456788999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++|+||+||++|+|++|..||...........+...  ..                            ......++
T Consensus       177 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------------------------~~~~~~~~  226 (277)
T cd06641         177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP----------------------------PTLEGNYS  226 (277)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC----------------------------CCCCcccC
Confidence            6788999999999999999999999776544333332110  00                            01112467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      .++.++|.+||+.+|.+||++.++++||||.+.
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            889999999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-36  Score=268.95  Aligned_cols=229  Identities=25%  Similarity=0.379  Sum_probs=178.9

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ..+++.||+|+++... .......+.+|+.++.++ +|+||+++++++...+    ..++++|||+. ++|.+++...  
T Consensus        34 ~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~----~~~~~v~ey~~~~~L~~~i~~~~~  108 (337)
T cd05054          34 SASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEYCKFGNLSNYLRSKRE  108 (337)
T ss_pred             ccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC----CCEEEEEecCCCCCHHHHHHhccc
Confidence            4567899999997543 333456778999999999 8999999999886432    46899999996 6998887542  


Q ss_pred             -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 021181           79 -----------------------------------------------------------QDLTDDHCRYFLYQLLRGLKY   99 (316)
Q Consensus        79 -----------------------------------------------------------~~~~~~~~~~i~~qi~~~l~~   99 (316)
                                                                                 ..+++..+..++.||+.||+|
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  188 (337)
T cd05054         109 CFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF  188 (337)
T ss_pred             cccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHH
Confidence                                                                       257899999999999999999


Q ss_pred             hhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCCCCCCCcchHHHHHHHHHH
Q 021181          100 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE  176 (316)
Q Consensus       100 LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e  176 (316)
                      ||+.||+||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|+
T Consensus       189 lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~e  267 (337)
T cd05054         189 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWE  267 (337)
T ss_pred             HHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHH
Confidence            9999999999999999999999999999999876533221   122344567999999877 778999999999999999


Q ss_pred             HHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCC
Q 021181          177 IMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN  255 (316)
Q Consensus       177 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~  255 (316)
                      |++ |..||.+....+......... ..                            .......++++.+++.+||+.+|+
T Consensus       268 l~t~g~~p~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         268 IFSLGASPYPGVQIDEEFCRRLKEG-TR----------------------------MRAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             HHHcCCCCCCCCCccHHHHHHHhcc-CC----------------------------CCCCccCCHHHHHHHHHHccCChh
Confidence            998 999997654332222111100 00                            000124578899999999999999


Q ss_pred             CCCCHHHHhcC
Q 021181          256 RRITVDEALCH  266 (316)
Q Consensus       256 ~Rps~~ell~~  266 (316)
                      +||+++|++++
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-38  Score=267.36  Aligned_cols=234  Identities=24%  Similarity=0.388  Sum_probs=202.7

Q ss_pred             CCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            3 SETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +.|.+.||||+++++.. .+.+.+--+.|-++|... +-|.+++++..|...+     .+|+||||+. |+|--.|+.-+
T Consensus       371 kgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-----RLyFVMEyvnGGDLMyhiQQ~G  445 (683)
T KOG0696|consen  371 KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-----RLYFVMEYVNGGDLMYHIQQVG  445 (683)
T ss_pred             cCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-----heeeEEEEecCchhhhHHHHhc
Confidence            56788999999998753 333445556788888777 5788999999997664     5999999995 79999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc-cCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++.+..+..++.+|+.||-+||++||++||||..|||+|.+|.+||.|||+++. +.......+++||+.|+|||++.- 
T Consensus       446 kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-  524 (683)
T KOG0696|consen  446 KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-  524 (683)
T ss_pred             ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEe-
Confidence            999999999999999999999999999999999999999999999999999987 344555678999999999999987 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ++|+.++|+||+|+++|||+.|++||.+.+..+....|......-+                               ..+
T Consensus       525 qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP-------------------------------Ksl  573 (683)
T KOG0696|consen  525 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP-------------------------------KSL  573 (683)
T ss_pred             cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc-------------------------------ccc
Confidence            8999999999999999999999999999998888887765322111                               367


Q ss_pred             ChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~  273 (316)
                      |.++.++....|...|.+|..+     .++-.||||+.++
T Consensus       574 SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  574 SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            8999999999999999999965     5899999999988

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-37  Score=285.80  Aligned_cols=243  Identities=26%  Similarity=0.340  Sum_probs=175.7

Q ss_pred             HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-----CCCCHHHHHHHHHHHHHHH
Q 021181           23 DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-----QDLTDDHCRYFLYQLLRGL   97 (316)
Q Consensus        23 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l   97 (316)
                      ....+.+|+.++++++|+||+++++++...     ...|+++++++++|..++...     ......+++.++.||+.||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL  280 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAV  280 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999654     458999999999888877542     2345677889999999999


Q ss_pred             HHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCCCCCCcchHHHHHHHHH
Q 021181           98 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG  175 (316)
Q Consensus        98 ~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~  175 (316)
                      .|||++||+||||||+|||++.++.++|+|||++........  .....++..|+|||++.+ ..++.++|||||||++|
T Consensus       281 ~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~  359 (501)
T PHA03210        281 EYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILL  359 (501)
T ss_pred             HHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHH
Confidence            999999999999999999999999999999999977644322  234578999999999987 67899999999999999


Q ss_pred             HHHhCCCC-CCCC--CcHHHHHHHHHhhCCCCccccccccccchHHHhhhCC-CCCCCCccc--cCCCCChHHHHHHHHh
Q 021181          176 EIMTRQPL-FPGK--DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QFPKQNFSA--RFPNKSPGAVDLLEKM  249 (316)
Q Consensus       176 ell~g~~p-f~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~s~~l~~li~~~  249 (316)
                      ||++|..+ +...  +....+..+....+...... ... ......+..... ......+..  ....++.++.++|.+|
T Consensus       360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~km  437 (501)
T PHA03210        360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF-PDP-PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKM  437 (501)
T ss_pred             HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhc-CCc-HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHH
Confidence            99998754 4332  22333333333332211110 000 001111111100 000001111  1124677899999999


Q ss_pred             cccCCCCCCCHHHHhcCCCCCCCC
Q 021181          250 LVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       250 L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      |+.||.+|||+.|+|+||||....
T Consensus       438 L~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        438 LTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             hccCcccCcCHHHHhhChhhhcCC
Confidence            999999999999999999998754

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.3e-36  Score=260.92  Aligned_cols=232  Identities=24%  Similarity=0.397  Sum_probs=183.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      .++..||+|.+.... .......+.+|+.+++.++|+||+++++++...     ...+++|||++ |+|.+++...    
T Consensus        34 ~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~  107 (288)
T cd05061          34 EAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEA  107 (288)
T ss_pred             CcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcEEEEeCCCCCCHHHHHHHhcccc
Confidence            345689999986543 223345678899999999999999999998654     45899999996 7999998653    


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccc
Q 021181           79 ------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWY  149 (316)
Q Consensus        79 ------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~  149 (316)
                            ..++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.........   ....++..|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y  187 (288)
T cd05061         108 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  187 (288)
T ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccc
Confidence                  23467788999999999999999999999999999999999999999999988754332211   122345679


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      +|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+......                          
T Consensus       188 ~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------------  240 (288)
T cd05061         188 MAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL--------------------------  240 (288)
T ss_pred             cCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------------
Confidence            99999876 678999999999999999998 78999877655544433221000                          


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC------HPYLAPL  272 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~------~~~f~~~  272 (316)
                          ......++.+.+++.+||+.||++|||+.++++      ||||.++
T Consensus       241 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         241 ----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence                001245778999999999999999999999987      9999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.6e-36  Score=258.91  Aligned_cols=229  Identities=24%  Similarity=0.391  Sum_probs=181.1

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCC-CcHHHHhhc------C
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMD-TDLHQIIRS------H   78 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~------~   78 (316)
                      ..||+|.++...........+..|+.+++.++|+||+++++++..... ......+++|||+. |+|.+++..      .
T Consensus        27 ~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~  106 (272)
T cd05075          27 LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP  106 (272)
T ss_pred             eeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCc
Confidence            369999987765566667888999999999999999999998754321 22345799999996 799887742      2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~  155 (316)
                      ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+........   .....++..|++||..
T Consensus       107 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  186 (272)
T cd05075         107 QYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL  186 (272)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHc
Confidence            3478999999999999999999999999999999999999999999999999877543321   1122346679999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .+ ..++.++|||||||++|+|++ |++||.+.........+......                              ..
T Consensus       187 ~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~  235 (272)
T cd05075         187 AD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL------------------------------KQ  235 (272)
T ss_pred             cC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CC
Confidence            77 678999999999999999999 89999876654444433221000                              01


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .+.++..+.++|.+||+.||.+|||+.+|++.
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            12567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=248.58  Aligned_cols=235  Identities=27%  Similarity=0.343  Sum_probs=183.3

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      ..|++.||+|++...  ...+.+..++|++..++++|||+++++++.......+....||+++|.. |+|.+.+...   
T Consensus        43 ~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~k  120 (302)
T KOG2345|consen   43 LSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIK  120 (302)
T ss_pred             cCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhc
Confidence            468899999999765  4567788999999999999999999999988766556778999999995 8999888642   


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----------ccccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----------TEYVV  145 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~  145 (316)
                       ..+++.++..|+.+|.+||.+||+..  ++||||||.||++.+.+.+++.|||.+.........          .....
T Consensus       121 g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~C  200 (302)
T KOG2345|consen  121 GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERC  200 (302)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhC
Confidence             35999999999999999999999998  999999999999999999999999987654321110          12235


Q ss_pred             cccccCcccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          146 TRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       146 ~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      |..|+|||.+.-  ....++++|||||||++|.|+.|..||...         .+..++..                 ..
T Consensus       201 t~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~GgSla-----------------LA  254 (302)
T KOG2345|consen  201 TIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGGSLA-----------------LA  254 (302)
T ss_pred             CCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCCeEE-----------------Ee
Confidence            888999999743  234679999999999999999999999432         11011000                 00


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .......++.. ..+|+.+.++|..||+.||.+||++.+|+.+
T Consensus       255 v~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            00111111111 2489999999999999999999999999864

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.5e-36  Score=260.54  Aligned_cols=226  Identities=23%  Similarity=0.387  Sum_probs=179.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      .++..||||++.... .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++....   
T Consensus        34 ~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~  107 (277)
T cd05062          34 EPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEM  107 (277)
T ss_pred             CceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCeEEEEecCCCCCHHHHHHHcCccc
Confidence            456789999986532 233456688999999999999999999998544     45899999996 69999886532   


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccc
Q 021181           80 -------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWY  149 (316)
Q Consensus        80 -------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~  149 (316)
                             .++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........   ....++..|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y  187 (277)
T cd05062         108 ENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  187 (277)
T ss_pred             cccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhh
Confidence                   3577889999999999999999999999999999999999999999999988755332221   122346679


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      +|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+......                          
T Consensus       188 ~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------------  240 (277)
T cd05062         188 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL--------------------------  240 (277)
T ss_pred             cChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--------------------------
Confidence            99999876 678999999999999999998 78999877655554433221100                          


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                          .....++..+.+++.+||+.||++|||+.|++++
T Consensus       241 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 ----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                0012457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.3e-36  Score=256.70  Aligned_cols=224  Identities=20%  Similarity=0.310  Sum_probs=179.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~   81 (316)
                      .++..||+|++.... .......+.+|+.++++++|+||+++++++..      ...++||||++ ++|.+++.. ...+
T Consensus        20 ~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~   92 (257)
T cd05115          20 KKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEMASGGPLNKFLSGKKDEI   92 (257)
T ss_pred             CCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEeCCCCCHHHHHHhCCCCC
Confidence            456679999986542 34445678899999999999999999998743      34799999996 699998874 4578


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........    .....++..|+|||.+..
T Consensus        93 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  172 (257)
T cd05115          93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF  172 (257)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc
Confidence            9999999999999999999999999999999999999999999999999875443321    111223467999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|++++ |..||...........+.+....                              ....
T Consensus       173 -~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~  221 (257)
T cd05115         173 -RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL------------------------------DCPA  221 (257)
T ss_pred             -CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------------------------------CCCC
Confidence             668899999999999999996 99999887655544433321100                              0112


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+++++.++|.+||..||++||++.++.+
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            56889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-36  Score=257.40  Aligned_cols=222  Identities=21%  Similarity=0.350  Sum_probs=178.4

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~   83 (316)
                      +..||||.+.....   ....+.+|+.+++.++||||+++++++...     ...+++|||+. |+|.+++... ..+++
T Consensus        28 ~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~~~~~~~~   99 (256)
T cd05113          28 QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYIVTEYMSNGCLLNYLREHGKRFQP   99 (256)
T ss_pred             CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEEEEEcCCCCcHHHHHHhcCCCCCH
Confidence            45699999865322   235688999999999999999999998654     34899999996 6999998764 46899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      .+++.++.||+.||+|||+.|++|+||+|.||+++.++.++|+|||.+.........  ....++..|+|||.+.+ ..+
T Consensus       100 ~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~  178 (256)
T cd05113         100 SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-SKF  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc-Ccc
Confidence            999999999999999999999999999999999999999999999988765433221  12234567999999976 568


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|||||||++|+|++ |..||...+.......+.......                              .....+.
T Consensus       179 ~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~  228 (256)
T cd05113         179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY------------------------------RPHLASE  228 (256)
T ss_pred             cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC------------------------------CCCCCCH
Confidence            899999999999999998 999998776555444443211110                              0013578


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .+.+++.+||+.||.+||++.+|+.+
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            89999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.4e-37  Score=284.83  Aligned_cols=224  Identities=26%  Similarity=0.416  Sum_probs=192.8

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      ++...||||.++.. .+......|++|++++..++|||||+++|+|..++     .+++|+||+. |+|.++|+...   
T Consensus       514 ~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-----P~~MvFEYm~~GDL~eFLra~sP~a  587 (774)
T KOG1026|consen  514 QDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGD-----PLCMVFEYMDHGDLHEFLRARSPKA  587 (774)
T ss_pred             ccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-----eeEEEEEecccccHHHHHHhhCCcc
Confidence            45678999999764 34446788999999999999999999999998664     4999999997 99999996432   


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc---cccc
Q 021181           80 -----------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT---EYVV  145 (316)
Q Consensus        80 -----------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~  145 (316)
                                 +++..+.+.|+.||+.|+.||-++.+|||||-..|+||+++..+||+|||+++.+-..+++.   ...-
T Consensus       588 ~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~l  667 (774)
T KOG1026|consen  588 DKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLL  667 (774)
T ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCcee
Confidence                       38899999999999999999999999999999999999999999999999998875554433   2344


Q ss_pred             cccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCC
Q 021181          146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP  224 (316)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (316)
                      +.+|||||.+.. ++++.++||||+||++||+.+ |..||.+....+.++.+....-                       
T Consensus       668 PIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-----------------------  723 (774)
T KOG1026|consen  668 PIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-----------------------  723 (774)
T ss_pred             eeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-----------------------
Confidence            778999999988 789999999999999999998 9999999999999888765211                       


Q ss_pred             CCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 021181          225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL  264 (316)
Q Consensus       225 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell  264 (316)
                             .++-..++.++.+|+..||+.+|++||+++||=
T Consensus       724 -------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  724 -------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             -------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence                   122247899999999999999999999999874

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.7e-36  Score=261.61  Aligned_cols=224  Identities=26%  Similarity=0.402  Sum_probs=179.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      .++..|++|.++..  .......+.+|++++++++|+||+++++++...     ...++||||++ ++|.+++...+   
T Consensus        33 ~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~  105 (291)
T cd05094          33 KDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDA  105 (291)
T ss_pred             CcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCccc
Confidence            45677999988543  233446688999999999999999999998654     45899999996 79999986542   


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccc
Q 021181           80 -------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEY  143 (316)
Q Consensus        80 -------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~  143 (316)
                                   .+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........   ....
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~  185 (291)
T cd05094         106 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT  185 (291)
T ss_pred             ccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCC
Confidence                         378999999999999999999999999999999999999999999999999876543221   1233


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+....  .                   
T Consensus       186 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~-------------------  243 (291)
T cd05094         186 MLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR--V-------------------  243 (291)
T ss_pred             CcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC--C-------------------
Confidence            45678999999877 678899999999999999998 999998776555444332110  0                   


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                               ......++..+.+++.+||+.||++||++.++++
T Consensus       244 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         244 ---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             ---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                     0011245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-36  Score=261.71  Aligned_cols=237  Identities=20%  Similarity=0.365  Sum_probs=187.6

Q ss_pred             CCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            4 ETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      .+|+.||+|+++....  .......+..|+.+++++ +|++|+++++.+...     ..+++||||++ ++|.+++....
T Consensus        26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  100 (290)
T cd05613          26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-----TKLHLILDYINGGELFTHLSQRE  100 (290)
T ss_pred             CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-----CeEEEEEecCCCCcHHHHHHHcC
Confidence            5889999999975422  223446678899999999 699999999988544     46899999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.+
T Consensus       101 ~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  180 (290)
T cd05613         101 RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG  180 (290)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccC
Confidence            89999999999999999999999999999999999999999999999999887654322  1223457888999999865


Q ss_pred             C-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhh-CCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          158 C-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI-GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       158 ~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      . ..++.++||||||+++|+|++|..||...........+.... ...+                            ...
T Consensus       181 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~  232 (290)
T cd05613         181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----------------------------PYP  232 (290)
T ss_pred             CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC----------------------------CCC
Confidence            2 346789999999999999999999996543222222221111 0000                            001


Q ss_pred             CCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ..+++.+.+++++||+.||++||     ++++++.||||+.+.
T Consensus       233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            24678899999999999999997     889999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.8e-36  Score=256.68  Aligned_cols=222  Identities=22%  Similarity=0.363  Sum_probs=179.3

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      ++..||+|.+....   .....+..|+.+++.++||||+++++++...     ...+++|||++ |+|.+++... +.++
T Consensus        27 ~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~   98 (256)
T cd05114          27 AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLS   98 (256)
T ss_pred             cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhCccCCC
Confidence            45689999886432   2335678899999999999999999998654     45899999996 7999988653 4689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc--cccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~  160 (316)
                      +..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+..........  ...++..|+|||.+.+ ..
T Consensus        99 ~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  177 (256)
T cd05114          99 KDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SK  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-Cc
Confidence            99999999999999999999999999999999999999999999999887654332211  2234567999999876 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|+||+|+++|+|++ |+.||...+.......+........                              ....+
T Consensus       178 ~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~------------------------------~~~~~  227 (256)
T cd05114         178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR------------------------------PKLAS  227 (256)
T ss_pred             cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC------------------------------CCCCC
Confidence            8899999999999999999 9999988776666555543111000                              01346


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+.+++.+||+.||.+||+++++++
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            78999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-36  Score=256.43  Aligned_cols=222  Identities=26%  Similarity=0.395  Sum_probs=179.3

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC-CCcHHHHhhcCC--CC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ--DL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~--~~   81 (316)
                      +++.||||.++...   .....+.+|+.++++++||||+++++++...     ...+++|||+ +++|.+++....  .+
T Consensus        29 ~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~  100 (261)
T cd05068          29 NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIYIVTELMKYGSLLEYLQGGAGRAL  100 (261)
T ss_pred             CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCeeeeeecccCCcHHHHHhccCCCCC
Confidence            45789999986532   2345688999999999999999999988544     4589999999 579999987654  68


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........  .....+..|+|||.+.+ .
T Consensus       101 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  179 (261)
T cd05068         101 KLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-N  179 (261)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-C
Confidence            99999999999999999999999999999999999999999999999998776533211  11222457999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|+||||+++|+|++ |+.||.+.........+......+                              ....+
T Consensus       180 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  229 (261)
T cd05068         180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP------------------------------CPPGC  229 (261)
T ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CCCcC
Confidence            78999999999999999999 999998876555554443211100                              01246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +..+.+++.+||+.||.+||+++++++
T Consensus       230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         230 PKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.7e-36  Score=259.97  Aligned_cols=226  Identities=20%  Similarity=0.334  Sum_probs=180.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      ++++.||||+++... .......+..|+.+++.++||||+++++++...     ...++++||+. ++|.+++...    
T Consensus        33 ~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~  106 (283)
T cd05091          33 EQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-----QPLSMIFSYCSHSDLHEFLVMRSPHS  106 (283)
T ss_pred             CceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----CceEEEEEcCCCCcHHHHHHhcCCCc
Confidence            457889999997543 233456788999999999999999999998654     45899999996 6898887532    


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccc
Q 021181           79 ------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEY  143 (316)
Q Consensus        79 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~  143 (316)
                                  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........   ....
T Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  186 (283)
T cd05091         107 DVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS  186 (283)
T ss_pred             cccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCc
Confidence                        3478888999999999999999999999999999999999999999999998876543322   1223


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+......                    
T Consensus       187 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------------------  245 (283)
T cd05091         187 LLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--------------------  245 (283)
T ss_pred             cCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--------------------
Confidence            44678999999876 668999999999999999998 88899877655554444321110                    


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                .....++..+.+++.+||+.||.+||++++|+..
T Consensus       246 ----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         246 ----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             ----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence                      0112578889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.1e-36  Score=255.64  Aligned_cols=223  Identities=24%  Similarity=0.327  Sum_probs=181.6

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~   82 (316)
                      ...||||.++..... .....+.+|+.++++++||||+++++.+..      ...+++|||++ ++|.+++....  .++
T Consensus        23 ~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~   95 (257)
T cd05040          23 VIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFL   95 (257)
T ss_pred             ceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhcccccCc
Confidence            347999999765433 556788999999999999999999999854      45899999996 79999987754  689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~  158 (316)
                      +..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........    .....++..|+|||.+.+ 
T Consensus        96 ~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-  174 (257)
T cd05040          96 ISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-  174 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-
Confidence            999999999999999999999999999999999999999999999999877544211    112345678999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||||||++|+|++ |..||...+..+....+.......                             .....
T Consensus       175 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  225 (257)
T cd05040         175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----------------------------ERPEA  225 (257)
T ss_pred             cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-----------------------------CCCcc
Confidence            678999999999999999998 999998776655554443210000                             00124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++..+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            5788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.8e-36  Score=258.13  Aligned_cols=230  Identities=29%  Similarity=0.434  Sum_probs=181.0

Q ss_pred             CCCCCceEEEEEeccc-ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--
Q 021181            2 NSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--   77 (316)
                      ++.+|+.||||.++.. .........+..|+.+++.++||||+++++++...     ...++++||++ |+|.+++..  
T Consensus        23 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~   97 (267)
T cd08228          23 CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NELNIVLELADAGDLSQMIKYFK   97 (267)
T ss_pred             EeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----CeEEEEEEecCCCcHHHHHHHhh
Confidence            4568999999988653 23344456688999999999999999999998654     46899999997 689887753  


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCccc
Q 021181           78 --HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPEL  154 (316)
Q Consensus        78 --~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~  154 (316)
                        ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.
T Consensus        98 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~  177 (267)
T cd08228          98 KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhh
Confidence              34589999999999999999999999999999999999999999999999998876543322 223457788999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +.+ ..++.++|+||+|+++|+|++|..||.....  ......+.. .+.++                            
T Consensus       178 ~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~----------------------------  227 (267)
T cd08228         178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPP----------------------------  227 (267)
T ss_pred             hcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCC----------------------------
Confidence            877 6688999999999999999999999865432  122222111 11110                            


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .....++..+.+++.+||+.+|++||++.++++.
T Consensus       228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            0012457789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.8e-36  Score=258.76  Aligned_cols=225  Identities=23%  Similarity=0.370  Sum_probs=178.7

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----   79 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----   79 (316)
                      ++..||+|.+.... .......+..|+.+++.++|+||+++++++...     ...+++|||+. ++|.+++...+    
T Consensus        35 ~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~i~~~~~~~~  108 (277)
T cd05036          35 VELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-----LPRFILLELMAGGDLKSFLRENRPRPE  108 (277)
T ss_pred             CceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCcEEEEecCCCCCHHHHHHHhCCCCC
Confidence            77899999886542 233445688899999999999999999988654     34799999995 79999987643    


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccccCCCCcc---cccccccccc
Q 021181           80 ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETDFM---TEYVVTRWYR  150 (316)
Q Consensus        80 ---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~---~~~~~~~~~~  150 (316)
                         .+++..+..++.||+.||+|||+.+++|+||+|+||+++.++   .++|+|||.+.........   .....+..|+
T Consensus       109 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  188 (277)
T cd05036         109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM  188 (277)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhC
Confidence               488999999999999999999999999999999999998765   5899999998765332211   1222345799


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      |||.+.+ ..++.++|||||||++|+|++ |..||...+.......+......                           
T Consensus       189 aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------  240 (277)
T cd05036         189 PPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL---------------------------  240 (277)
T ss_pred             CHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---------------------------
Confidence            9999977 678999999999999999996 99999877655544433221000                           


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                         .....++..+.+++.+||+.||++||++.++++|
T Consensus       241 ---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 ---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               0012467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.9e-36  Score=259.13  Aligned_cols=242  Identities=23%  Similarity=0.281  Sum_probs=179.2

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      ..+++.||+|.++... .......+.+|+++++.++||||+++++++....   ...++++|||+. ++|.+++.. ..+
T Consensus        30 ~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~-~~l  104 (283)
T cd05080          30 DGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG---GKGLQLIMEYVPLGSLRDYLPK-HKL  104 (283)
T ss_pred             CCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---CceEEEEecCCCCCCHHHHHHH-cCC
Confidence            4578899999997643 2334567789999999999999999999876432   245899999996 699988866 469


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++.+++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++........    .....++..|+|||.+..
T Consensus       105 ~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  184 (283)
T cd05080         105 NLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE  184 (283)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc
Confidence            9999999999999999999999999999999999999999999999999876543221    112234567999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||||+++|+|++|..||........ ..+....+..        ..............      ......
T Consensus       185 -~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~  248 (283)
T cd05080         185 -NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM--------TVVRLIELLERGMR------LPCPKN  248 (283)
T ss_pred             -cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc--------chhhhhhhhhcCCC------CCCCCC
Confidence             6788999999999999999999999865432110 0000000000        00000000000000      011235


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++..+.+++.+||+.||++|||++++++
T Consensus       249 ~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         249 CPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            7889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.6e-36  Score=258.91  Aligned_cols=225  Identities=26%  Similarity=0.408  Sum_probs=180.6

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      ..++..||+|.+...  .......+.+|+++++.++|+||+++++++...     ...+++|||++ ++|.+++...+  
T Consensus        32 ~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~  104 (280)
T cd05092          32 EQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPD  104 (280)
T ss_pred             CCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----CceEEEEecCCCCCHHHHHHhcCcc
Confidence            456788999988643  344556789999999999999999999998654     45899999996 79999887643  


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccc
Q 021181           80 -------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEY  143 (316)
Q Consensus        80 -------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~  143 (316)
                                   .+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........   ....
T Consensus       105 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  184 (280)
T cd05092         105 AKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT  184 (280)
T ss_pred             hhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCc
Confidence                         478999999999999999999999999999999999999999999999998865433221   1122


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+....+......                    
T Consensus       185 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  243 (280)
T cd05092         185 MLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL--------------------  243 (280)
T ss_pred             cccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC--------------------
Confidence            34577999999876 678999999999999999998 99999776655544433221100                    


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                .....+++.+.++|.+||+.||.+||++++++.
T Consensus       244 ----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         244 ----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                      011246788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.1e-36  Score=261.29  Aligned_cols=223  Identities=24%  Similarity=0.309  Sum_probs=175.5

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-----
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-----   79 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----   79 (316)
                      ..+++|.++.. ........+..|+.+++++ +||||+++++++...     ..++++|||++ ++|.+++....     
T Consensus        30 ~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~  103 (297)
T cd05089          30 MNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----GYLYIAIEYAPYGNLLDFLRKSRVLETD  103 (297)
T ss_pred             ceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----CcceEEEEecCCCcHHHHHHhccccccc
Confidence            35788887632 2333456788999999999 799999999998644     45899999996 79999986532     


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccccccccc
Q 021181           80 -----------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW  148 (316)
Q Consensus        80 -----------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  148 (316)
                                 .+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++..............+..
T Consensus       104 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  183 (297)
T cd05089         104 PAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR  183 (297)
T ss_pred             cccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCcc
Confidence                       478899999999999999999999999999999999999999999999998764322211112223456


Q ss_pred             ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      |+|||...+ ..++.++|||||||++|+|++ |..||...........+......                         
T Consensus       184 y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~-------------------------  237 (297)
T cd05089         184 WMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM-------------------------  237 (297)
T ss_pred             ccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-------------------------
Confidence            999999876 678999999999999999997 99999887655544433221100                         


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                           .....++..+.++|.+||+.||.+||+++++++.
T Consensus       238 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 -----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                 0112468889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.1e-36  Score=258.73  Aligned_cols=227  Identities=21%  Similarity=0.376  Sum_probs=180.3

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      ..+++.||+|.+.... .......+.+|+.+++.++||||+++++++...     ...|++|||++ ++|.+++...   
T Consensus        31 ~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  104 (283)
T cd05090          31 MDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPH  104 (283)
T ss_pred             CCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----CceEEEEEcCCCCcHHHHHHhcCCC
Confidence            4577899999997532 333446788999999999999999999998654     45899999996 6999988532   


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cc
Q 021181           79 --------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MT  141 (316)
Q Consensus        79 --------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~  141 (316)
                                    ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........   ..
T Consensus       105 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  184 (283)
T cd05090         105 SDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP  184 (283)
T ss_pred             CccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceeccc
Confidence                          2378888999999999999999999999999999999999999999999999876533221   12


Q ss_pred             cccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHh
Q 021181          142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV  220 (316)
Q Consensus       142 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  220 (316)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+.......+......                  
T Consensus       185 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  245 (283)
T cd05090         185 KSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL------------------  245 (283)
T ss_pred             CCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC------------------
Confidence            2334567999999876 668999999999999999998 99999876654444433221100                  


Q ss_pred             hhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          221 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                  .....+++.+.+++.+||+.||.+||++.+++++
T Consensus       246 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         246 ------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             ------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                        0112467889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-35  Score=260.47  Aligned_cols=226  Identities=26%  Similarity=0.374  Sum_probs=179.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      .++..||||+++... .......+.+|+.+++++ +|+||+++++.+...     ...+++|||+. |+|.+++....  
T Consensus        63 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~  136 (302)
T cd05055          63 DAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG-----GPILVITEYCCYGDLLNFLRRKRES  136 (302)
T ss_pred             CceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-----CceEEEEEcCCCCcHHHHHHhCCCC
Confidence            456789999987542 233456788999999999 799999999998654     45899999996 79999987543  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~  156 (316)
                      .+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||.+........   .....++..|+|||.+.
T Consensus       137 ~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  216 (302)
T cd05055         137 FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF  216 (302)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhc
Confidence            389999999999999999999999999999999999999999999999999876543321   11233467799999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++||||+||++|+|++ |..||...................                             ...
T Consensus       217 ~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~  266 (302)
T cd05055         217 N-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-----------------------------AQP  266 (302)
T ss_pred             c-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-----------------------------CCC
Confidence            7 668999999999999999998 999998766444333222100000                             001


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ...+..+.+++.+||+.+|++||++.++++
T Consensus       267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            245788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.5e-36  Score=254.84  Aligned_cols=221  Identities=24%  Similarity=0.359  Sum_probs=178.1

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--C
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--D   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~   80 (316)
                      .+|..||+|.++..    .....+..|+.++++++|++++++++++...+    ...+++|||++ ++|.+++...+  .
T Consensus        27 ~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~   98 (256)
T cd05082          27 YRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSV   98 (256)
T ss_pred             EcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceEEEEECCCCCcHHHHHHhcCCCC
Confidence            35788999998543    23456889999999999999999999765332    45899999996 69999987644  3


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++.......  .....+..|+|||.+.+ ..
T Consensus        99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~  175 (256)
T cd05082          99 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KK  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHcc-CC
Confidence            7899999999999999999999999999999999999999999999999887654322  22334567999999876 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|||||||++|+|++ |++||...+.......+.+...                              ......++
T Consensus       176 ~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~  225 (256)
T cd05082         176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------------------MDAPDGCP  225 (256)
T ss_pred             CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------------------------CCCCCCCC
Confidence            8899999999999999997 9999987765554444322100                              01113568


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +.+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         226 PVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            89999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=303.53  Aligned_cols=238  Identities=28%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +|..||+--|+|.++-..........+.+|..++..++|||+|++||+=.+.+     .++|.||||+ |+|.+.++..+
T Consensus      1255 vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----kv~IFMEyC~~GsLa~ll~~gr 1329 (1509)
T KOG4645|consen 1255 VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----KVYIFMEYCEGGSLASLLEHGR 1329 (1509)
T ss_pred             ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----HHHHHHHHhccCcHHHHHHhcc
Confidence            46789999999999876555555677889999999999999999999976653     4899999995 89999999988


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPEL  154 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~  154 (316)
                      -.++...+.+..|++.|++|||+.|||||||||.||+++.+|.+|++|||.+..+..+..     .....||+-|+|||+
T Consensus      1330 i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEv 1409 (1509)
T KOG4645|consen 1330 IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEV 1409 (1509)
T ss_pred             hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchh
Confidence            899999999999999999999999999999999999999999999999999988766531     234678999999999


Q ss_pred             ccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          155 LLNCS--EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       155 ~~~~~--~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +.+.+  ....++|||||||++.||+||+.||...+...++...+.....|+..                          
T Consensus      1410 it~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-------------------------- 1463 (1509)
T KOG4645|consen 1410 ITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP-------------------------- 1463 (1509)
T ss_pred             hcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc--------------------------
Confidence            97643  45679999999999999999999999988777776655544333221                          


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                         ..+|.+.++||..||..||++|.++.||+.|.|-+.-
T Consensus      1464 ---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1464 ---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             ---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence               1378899999999999999999999999999987653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=256.62  Aligned_cols=243  Identities=21%  Similarity=0.363  Sum_probs=199.1

Q ss_pred             CCCCCceEEEEEeccc-ccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      .+.|.+-||+|+++++ ..++.+.+.++.|-.+..+- +||.+|.++.+|...     +.+++|.||+. |+|--.++.+
T Consensus       271 ~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-----srlffvieyv~ggdlmfhmqrq  345 (593)
T KOG0695|consen  271 LKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQ  345 (593)
T ss_pred             hcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----ceEEEEEEEecCcceeeehhhh
Confidence            4678999999999986 45566678889999999887 799999999999655     56999999995 7998888899


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc-cCCCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++++++.++.+..+|..||.|||+.||++||+|..|+|+|..|.+||+|+|.++. +...+..++++||+.|+|||++++
T Consensus       346 rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg  425 (593)
T KOG0695|consen  346 RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG  425 (593)
T ss_pred             hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcc
Confidence            9999999999999999999999999999999999999999999999999999987 455667788999999999999998


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..|+.++|.|+||++|+||+.|+.||.--.                    ...+..+.++++..+.-....   .....
T Consensus       426 -eeygfsvdwwalgvlmfemmagrspfdivg--------------------m~n~d~ntedylfqvilekqi---riprs  481 (593)
T KOG0695|consen  426 -EEYGFSVDWWALGVLMFEMMAGRSPFDIVG--------------------MDNPDMNTEDYLFQVILEKQI---RIPRS  481 (593)
T ss_pred             -cccCceehHHHHHHHHHHHHcCCCCcceec--------------------CCCcccchhHHHHHHHhhhcc---cccce
Confidence             889999999999999999999999995221                    011111222222221111100   01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT------VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps------~~ell~~~~f~~~~  273 (316)
                      +|-.+..+++.-|++||++|..      +.++..|+||+.++
T Consensus       482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            6677889999999999999984      68999999999887

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=253.83  Aligned_cols=220  Identities=24%  Similarity=0.367  Sum_probs=180.4

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~   81 (316)
                      .|+.||||.++....   ....+..|+.+++.++|+||+++++++...     ...++||||++ ++|.+++....  .+
T Consensus        28 ~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~   99 (256)
T cd05039          28 RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVI   99 (256)
T ss_pred             cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeEEEEEecCCCcHHHHHHhcCCCCC
Confidence            578999999975432   567788999999999999999999998653     55899999997 69999987665  68


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      ++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........  ....+..|.|||.+.. ..+
T Consensus       100 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~-~~~  176 (256)
T cd05039         100 TLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALRE-KKF  176 (256)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--cCCCcccccCchhhcC-CcC
Confidence            9999999999999999999999999999999999999999999999998877643322  2334567999999876 678


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|+||||+++|++++ |..||...........+.....                              ......+++
T Consensus       177 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~  226 (256)
T cd05039         177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR------------------------------MEAPEGCPP  226 (256)
T ss_pred             CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC------------------------------CCCccCCCH
Confidence            899999999999999997 9999977765444333321100                              001124678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.++|.+||..+|++||++++++.
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHH
Confidence            8999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.3e-36  Score=263.11  Aligned_cols=222  Identities=23%  Similarity=0.318  Sum_probs=176.8

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~   84 (316)
                      ..||+|.++.. ........+..|+.+++.++||||+++++++...      ..+++++|+. |+|.+.+... ..++..
T Consensus        37 ~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~------~~~~v~e~~~~g~l~~~l~~~~~~~~~~  109 (316)
T cd05108          37 IPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQ  109 (316)
T ss_pred             eeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC------CceeeeecCCCCCHHHHHHhccccCCHH
Confidence            35999998643 2334456788999999999999999999998643      2578999996 7999998764 458899


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCcccccCCCCC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      .+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.........   .....+..|+|||.+.+ ..+
T Consensus       110 ~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~  188 (316)
T cd05108         110 YLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIY  188 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCC
Confidence            99999999999999999999999999999999999999999999999876543221   12233567999999877 678


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|||||||++|+|++ |..||.+.........+.... ..+                             ..+.++.
T Consensus       189 ~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-----------------------------~~~~~~~  238 (316)
T cd05108         189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP-----------------------------QPPICTI  238 (316)
T ss_pred             CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCC-----------------------------CCCCCCH
Confidence            999999999999999997 999998765444322221110 000                             0124677


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++.+++.+||..||.+||++.+++.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            89999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-36  Score=254.98  Aligned_cols=223  Identities=19%  Similarity=0.310  Sum_probs=178.3

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      ++..+|+|.+.....   ....+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++... ..++
T Consensus        27 ~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~   98 (256)
T cd05059          27 GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFIVTEYMANGCLLNYLRERKGKLG   98 (256)
T ss_pred             CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEEEEecCCCCCHHHHHHhcccCCC
Confidence            466899999864322   234577899999999999999999988544     45899999996 6999998753 4689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc--cccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~  160 (316)
                      +..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+..........  ...++..|+|||.+.+ ..
T Consensus        99 ~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~  177 (256)
T cd05059          99 TEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SR  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-CC
Confidence            99999999999999999999999999999999999999999999999887654322111  1223457999999877 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|+||||+++|+|++ |.+||...+..+....+......                              .....++
T Consensus       178 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~  227 (256)
T cd05059         178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL------------------------------YRPKLAP  227 (256)
T ss_pred             CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC------------------------------CCCCCCC
Confidence            8899999999999999998 89999877655554443221110                              0112468


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ..+.+++.+||+.+|++|||+.++++.
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-35  Score=259.24  Aligned_cols=232  Identities=24%  Similarity=0.362  Sum_probs=182.7

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      ..+..||+|++.... .......+.+|+++++.++||||+++++++...     ...+++||++. ++|.+++....   
T Consensus        44 ~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  117 (296)
T cd05051          44 DAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAET  117 (296)
T ss_pred             CCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhccccc
Confidence            455779999987553 234557788999999999999999999998654     45899999996 69999987665   


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccccccccc
Q 021181           80 --------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRW  148 (316)
Q Consensus        80 --------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~  148 (316)
                              .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........   .....++..
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  197 (296)
T cd05051         118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR  197 (296)
T ss_pred             ccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCce
Confidence                    689999999999999999999999999999999999999999999999999876433221   223345678


Q ss_pred             ccCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~ell~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      |+|||.+.+ ..++.++|||||||++|+|++  |..||...+....+.............                    
T Consensus       198 y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------  256 (296)
T cd05051         198 WMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ--------------------  256 (296)
T ss_pred             ecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc--------------------
Confidence            999999876 678999999999999999998  778887766555544433221110000                    


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                         ......+.++.++.+++.+||+.||.+|||+.+|++
T Consensus       257 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         257 ---IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ---ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence               000111356789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.8e-36  Score=262.15  Aligned_cols=226  Identities=24%  Similarity=0.322  Sum_probs=175.4

Q ss_pred             CCCc--eEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            4 ETRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         4 ~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      .+|.  .+|+|.++.. ........+.+|+.++.++ +|+||+++++++...     ..+|++|||++ |+|.+++...+
T Consensus        30 ~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  103 (303)
T cd05088          30 KDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSR  103 (303)
T ss_pred             cCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----CCceEEEEeCCCCcHHHHHHhcc
Confidence            4554  4577776532 2334456788899999999 899999999998654     45899999996 79999986532


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccc
Q 021181           80 ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY  143 (316)
Q Consensus        80 ----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  143 (316)
                                      .+++.+++.++.||+.||++||+.|++||||+|+||+++.++.++|+|||++............
T Consensus       104 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  183 (303)
T cd05088         104 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG  183 (303)
T ss_pred             cccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccC
Confidence                            5789999999999999999999999999999999999999999999999988643221111122


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      ..+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+....  ..                  
T Consensus       184 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~------------------  242 (303)
T cd05088         184 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RL------------------  242 (303)
T ss_pred             CCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--cC------------------
Confidence            33567999998866 668899999999999999998 999997766544433321100  00                  


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                ......+.++.++|.+||+.+|++||++++++..
T Consensus       243 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         243 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      0011357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-35  Score=255.48  Aligned_cols=229  Identities=28%  Similarity=0.405  Sum_probs=181.0

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--   77 (316)
                      ++.+|+.||||.+.... .+......+.+|+.+++.++|+||+++++.+...     ...+++|||+. ++|.+++..  
T Consensus        23 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~   97 (267)
T cd08229          23 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFK   97 (267)
T ss_pred             ecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----CeEEEEEEecCCCCHHHHHHHhh
Confidence            45689999999886532 2334456788999999999999999999998654     45899999996 699888763  


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCccc
Q 021181           78 --HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPEL  154 (316)
Q Consensus        78 --~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~  154 (316)
                        ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++++|||.+........ .....++..|+|||.
T Consensus        98 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~  177 (267)
T cd08229          98 KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHH
Confidence              35689999999999999999999999999999999999999999999999998876543322 233467888999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV--HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +.+ ..++.++|+||||+++|+|++|..||.+....  .....+.... .+                            .
T Consensus       178 ~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------------------------~  227 (267)
T cd08229         178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YP----------------------------P  227 (267)
T ss_pred             hcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-CC----------------------------C
Confidence            876 67889999999999999999999999655322  1111111100 00                            0


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .....++..+.++|.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            011246788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=254.56  Aligned_cols=225  Identities=24%  Similarity=0.380  Sum_probs=181.3

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      +...||||.++... .......+..|+.+++.++||||+++++.+...     ...+++|||+. ++|.+++... +.++
T Consensus        31 ~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~  104 (266)
T cd05033          31 KEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-----RPVMIITEYMENGSLDKFLRENDGKFT  104 (266)
T ss_pred             CcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-----CceEEEEEcCCCCCHHHHHHhccCCCC
Confidence            45689999986543 333456788899999999999999999998654     45899999996 6999998664 4689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-cc--ccccccccccCcccccCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM--TEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~--~~~~~~~~~~aPE~~~~~~  159 (316)
                      +..+..++.|++.||++||+.||+|+||+|+||+++.++.++|+|||.+....... ..  ....++..|+|||.+.+ .
T Consensus       105 ~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~  183 (266)
T cd05033         105 VGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-R  183 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-C
Confidence            99999999999999999999999999999999999999999999999988764211 11  11233567999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++||||||+++|+|++ |..||...........+......+                              ....+
T Consensus       184 ~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  233 (266)
T cd05033         184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP------------------------------PPMDC  233 (266)
T ss_pred             CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CCCCC
Confidence            78999999999999999998 999997776555544443211110                              01246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +..+.+++.+||+.||++||++.+++++
T Consensus       234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         234 PSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.1e-36  Score=259.37  Aligned_cols=238  Identities=21%  Similarity=0.348  Sum_probs=186.0

Q ss_pred             CCCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            3 SETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ..+++.||||.++....  .......+..|+.++.++ +||+|+++++.+...     ..+++||||++ |+|.+.+...
T Consensus        25 ~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   99 (288)
T cd05583          25 HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD-----TKLHLILDYVNGGELFTHLYQR   99 (288)
T ss_pred             ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-----CEEEEEEecCCCCcHHHHHhhc
Confidence            35788999999875422  223446678999999999 699999999988544     46899999996 6999998877


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........  .....++..|+|||.+.
T Consensus       100 ~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (288)
T cd05583         100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR  179 (288)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhc
Confidence            7899999999999999999999999999999999999999999999999998876543321  12345688899999986


Q ss_pred             CCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-hhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          157 NCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE-LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       157 ~~~-~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      +.. ..+.++|+||||+++|+|++|..||...+.......+.+ .....                            ...
T Consensus       180 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~  231 (288)
T cd05583         180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK----------------------------PPF  231 (288)
T ss_pred             CCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC----------------------------CCC
Confidence            522 367899999999999999999999965432222121111 10000                            001


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~  273 (316)
                      ...++..+.++|.+||+.||++|||   +.++++||||+++.
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            1246788999999999999999998   56789999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-35  Score=254.54  Aligned_cols=223  Identities=23%  Similarity=0.396  Sum_probs=179.5

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--CCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--HQD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~   80 (316)
                      .+++.||+|.+...   ......+..|+.+++.++|+||+++++.+...     ...+++|||+. ++|.+++..  ...
T Consensus        28 ~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~   99 (261)
T cd05072          28 NNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGK   99 (261)
T ss_pred             cCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHHhcCCC
Confidence            35677999988643   22456788999999999999999999998654     45899999995 799998865  356


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.. 
T Consensus       100 ~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  178 (261)
T cd05072         100 VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-  178 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-
Confidence            88999999999999999999999999999999999999999999999999877543321  122334567999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||||||++|+|++ |..||...........+......                              .....
T Consensus       179 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  228 (261)
T cd05072         179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------------------------------PRMEN  228 (261)
T ss_pred             CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCCC
Confidence            668889999999999999998 99999877655544443321110                              11124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++.++.+++.+||+.||++||+++++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            6788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=252.13  Aligned_cols=223  Identities=26%  Similarity=0.392  Sum_probs=179.0

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~   83 (316)
                      |+.||+|+++..... .....+.+|+.++++++|+||+++++++...     ...+++|||++ ++|.+++... ..+++
T Consensus        19 ~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~   92 (251)
T cd05041          19 NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELVPGGSLLTFLRKKKNRLTV   92 (251)
T ss_pred             CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcCCCCcHHHHHHhcCCCCCH
Confidence            899999998765333 3556788999999999999999999998654     45899999995 6899988653 56899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCcccccCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~  160 (316)
                      ..+..++.+++.||++||++|++|+||+|+||+++.++.++|+|||.+.........   .....+..|+|||.+.+ ..
T Consensus        93 ~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~  171 (251)
T cd05041          93 KKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GR  171 (251)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CC
Confidence            999999999999999999999999999999999999999999999988765422111   11223556999999876 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|+|||||++|+|++ |..||...........+....+..                              ....++
T Consensus       172 ~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~  221 (251)
T cd05041         172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP------------------------------APQLCP  221 (251)
T ss_pred             CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC------------------------------CCccCC
Confidence            8999999999999999998 889997776444433332211000                              012457


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+.+++.+||+.+|.+||++.|+++
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHH
Confidence            88999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=255.62  Aligned_cols=225  Identities=24%  Similarity=0.402  Sum_probs=179.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      .++..||+|.+.... .......+.+|+.+++.++|+||+++++++...     ...+++|||++ |+|.+++...    
T Consensus        34 ~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~  107 (277)
T cd05032          34 EPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-----QPTLVVMELMAKGDLKSYLRSRRPEA  107 (277)
T ss_pred             CcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-----CCcEEEEecCCCCCHHHHHHhcccch
Confidence            456889999986542 223445678999999999999999999998654     45899999996 7999988643    


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccc
Q 021181           79 ------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWY  149 (316)
Q Consensus        79 ------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~  149 (316)
                            ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   .....++..|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  187 (277)
T cd05032         108 ENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  187 (277)
T ss_pred             hhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccc
Confidence                  2367889999999999999999999999999999999999999999999999876543321   1223456789


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      +|||.+.+ ..++.++|||||||++|++++ |.+||...+.......+..  +...                        
T Consensus       188 ~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~------------------------  240 (277)
T cd05032         188 MAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGHL------------------------  240 (277)
T ss_pred             cCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CCCC------------------------
Confidence            99999876 668999999999999999998 9999987765555443331  1000                        


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                          .....++..+.++|.+||+.+|++|||+.++++
T Consensus       241 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         241 ----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                011235788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=255.83  Aligned_cols=225  Identities=24%  Similarity=0.327  Sum_probs=175.2

Q ss_pred             CCCc--eEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            4 ETRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         4 ~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++|.  .+|+|.++.. ........+..|+.++.++ +||||+++++++...     ...+++|||+. |+|.+++....
T Consensus        18 ~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~   91 (270)
T cd05047          18 KDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSR   91 (270)
T ss_pred             CCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEEEeCCCCcHHHHHHhcc
Confidence            4454  5688888643 2334456788999999999 899999999998654     45899999996 79999986532


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccc
Q 021181           80 ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY  143 (316)
Q Consensus        80 ----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  143 (316)
                                      .+++.+++.++.|++.||+|||+.|++|+||+|+||+++.++.++++|||++............
T Consensus        92 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~  171 (270)
T cd05047          92 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG  171 (270)
T ss_pred             ccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCC
Confidence                            4789999999999999999999999999999999999999999999999987533221111122


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      ..+..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+.......+.....                     
T Consensus       172 ~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---------------------  229 (270)
T cd05047         172 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---------------------  229 (270)
T ss_pred             CCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC---------------------
Confidence            23556999999866 678999999999999999997 9999977665444433311000                     


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                               ......++.++.+++.+||+.||.+|||+.+++.
T Consensus       230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         230 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                     0011246778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-35  Score=259.21  Aligned_cols=225  Identities=27%  Similarity=0.454  Sum_probs=179.6

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-----   77 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-----   77 (316)
                      ....||+|.+.... .......+.+|+.+++++ +|+||+++++++...     ..++++|||+. |+|..++..     
T Consensus        41 ~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~  114 (293)
T cd05053          41 ETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPG  114 (293)
T ss_pred             CceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCc
Confidence            45789999987543 233456688999999999 899999999998654     45899999995 799998854     


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccc
Q 021181           78 -----------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEY  143 (316)
Q Consensus        78 -----------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~  143 (316)
                                 ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||.+........   ....
T Consensus       115 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  194 (293)
T cd05053         115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG  194 (293)
T ss_pred             cccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCC
Confidence                       24588999999999999999999999999999999999999999999999999876543321   1122


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......                    
T Consensus       195 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  253 (293)
T cd05053         195 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM--------------------  253 (293)
T ss_pred             CCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC--------------------
Confidence            33567999999876 678999999999999999997 99999877655544433221100                    


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                .....++..+.+++.+||..||.+|||+.+++++
T Consensus       254 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         254 ----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                      0112457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-35  Score=253.53  Aligned_cols=222  Identities=25%  Similarity=0.379  Sum_probs=180.8

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~   82 (316)
                      ++.||+|++...  .......+..|+.+++.++|+||+++++++...     ...+++|||++ ++|.+++...  ..++
T Consensus        30 ~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~  102 (261)
T cd05148          30 RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVYIITELMEKGSLLAFLRSPEGQVLP  102 (261)
T ss_pred             CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeEEEEeecccCCHHHHHhcCCCCCCC
Confidence            788999998654  233456788999999999999999999998654     45899999996 6999998753  4589


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      +..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.. ..+
T Consensus       103 ~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~  181 (261)
T cd05148         103 VASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTF  181 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCC
Confidence            999999999999999999999999999999999999999999999998876543321 122334567999999876 678


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|+||||+++|+|++ |..||...+.......+......                              .....+++
T Consensus       182 ~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~  231 (261)
T cd05148         182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------------------------PCPAKCPQ  231 (261)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC------------------------------CCCCCCCH
Confidence            899999999999999998 89999887755555544321110                              01135688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         232 EIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-35  Score=251.58  Aligned_cols=224  Identities=29%  Similarity=0.473  Sum_probs=182.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC--C
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--L   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--~   81 (316)
                      +++.||+|++.... .......+..|+.+++.++|+||+++++++...     ...+++||++. ++|.+++.....  +
T Consensus        27 ~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~i~e~~~~~~l~~~~~~~~~~~~  100 (258)
T smart00219       27 KEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPLMIVMEYMEGGDLLDYLRKNRPKEL  100 (258)
T ss_pred             CCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----CeeEEEEeccCCCCHHHHHHhhhhccC
Confidence            35899999996543 222567889999999999999999999998654     45999999996 699999876554  9


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccc--ccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~  159 (316)
                      ++.++..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...........  ..++..|+|||.+.+ .
T Consensus       101 ~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~  179 (258)
T smart00219      101 SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-G  179 (258)
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhcc-C
Confidence            9999999999999999999999999999999999999999999999999877654422221  235678999999865 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|+||||+++++|++ |.+||...+.......+......                              .....+
T Consensus       180 ~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~  229 (258)
T smart00219      180 KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL------------------------------PKPENC  229 (258)
T ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC------------------------------CCCCcC
Confidence            78999999999999999998 88999876655555444321110                              011236


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +.++.+++.+||..||++|||+.++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      230 PPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            888999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-37  Score=271.94  Aligned_cols=226  Identities=21%  Similarity=0.326  Sum_probs=185.5

Q ss_pred             eEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcC-CCCCHHH
Q 021181            8 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH-QDLTDDH   85 (316)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~-~~~~~~~   85 (316)
                      .||||++......+...+.+..|+..+++-+|.||+-+.|++..++      +.||+.+|+| +|+.++.-. -+|.+..
T Consensus       416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------~AIiTqwCeGsSLY~hlHv~etkfdm~~  489 (678)
T KOG0193|consen  416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------LAIITQWCEGSSLYTHLHVQETKFDMNT  489 (678)
T ss_pred             ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------eeeeehhccCchhhhhccchhhhhhHHH
Confidence            6999999998888888999999999999999999999999997664      5999999986 898888643 4699999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC---CCccccccccccccCcccccC--CCC
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN--CSE  160 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~--~~~  160 (316)
                      ...|+.||+.|+.|||.++|+|+|||..||++.++++|||+|||++.....   ........+...|+|||+++.  ..+
T Consensus       490 ~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nP  569 (678)
T KOG0193|consen  490 TIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNP  569 (678)
T ss_pred             HHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCC
Confidence            999999999999999999999999999999999999999999999865332   222344567788999999863  367


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +++.+||||||+++|||++|..||...+.+..+-.+-.....+                          +.......++.
T Consensus       570 fS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p--------------------------d~s~~~s~~pk  623 (678)
T KOG0193|consen  570 FSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP--------------------------DLSKIRSNCPK  623 (678)
T ss_pred             CCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc--------------------------cchhhhccCHH
Confidence            8999999999999999999999998554333332221111111                          11222346777


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++++|+..||..++++||++.+||.
T Consensus       624 ~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  624 AMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHhcCcccCccHHHHHH
Confidence            9999999999999999999998886

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-35  Score=255.01  Aligned_cols=221  Identities=19%  Similarity=0.226  Sum_probs=171.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~   81 (316)
                      .....||+|++...  .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|..++.. .+.+
T Consensus        42 ~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~  114 (274)
T cd05076          42 GRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRV  114 (274)
T ss_pred             CeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCC
Confidence            34457999998543  223345678899999999999999999998654     45899999997 688888865 4678


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-------CEEEeeeccccccCCCCccccccccccccCccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                      ++..+..++.||+.||+|||++||+||||||+||+++..+       .++++|||.+......   ....++..|+|||.
T Consensus       115 ~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~  191 (274)
T cd05076         115 PVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPEC  191 (274)
T ss_pred             CHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchh
Confidence            9999999999999999999999999999999999997644       3899999987543222   22345677999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIM-TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.+...++.++|||||||++|+|+ +|..||..................                               
T Consensus       192 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------  240 (274)
T cd05076         192 VPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRL-------------------------------  240 (274)
T ss_pred             hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCC-------------------------------
Confidence            876566899999999999999995 699999776543332221110000                               


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                       ....++.+.++|.+||+.+|++||++++++++
T Consensus       241 -~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         241 -PEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             01235679999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-35  Score=254.13  Aligned_cols=220  Identities=20%  Similarity=0.274  Sum_probs=170.8

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~   82 (316)
                      .+..||+|.+...  .......+.+|+.+++.++||||+++++++...     ...+++|||++ |+|..++.. ...++
T Consensus        31 ~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~  103 (262)
T cd05077          31 KEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-----VENIMVEEFVEFGPLDLFMHRKSDVLT  103 (262)
T ss_pred             hceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CCCEEEEecccCCCHHHHHHhcCCCCC
Confidence            3456899987543  233445678899999999999999999998654     34799999997 577777764 35689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC-------EEEeeeccccccCCCCccccccccccccCcccc
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                      +..+..++.||+.||+|||+.||+|+||+|+||+++.++.       ++++|||.+......   ....++..|+|||.+
T Consensus       104 ~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~  180 (262)
T cd05077         104 TPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECV  180 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhh
Confidence            9999999999999999999999999999999999987664       899999987654322   234567789999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIM-TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .....++.++|||||||++|+|+ .|..||......+..... .   ...                            ..
T Consensus       181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~---~~~----------------------------~~  228 (262)
T cd05077         181 EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-E---GQC----------------------------ML  228 (262)
T ss_pred             cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-h---cCc----------------------------cC
Confidence            75577899999999999999998 588888765432221111 0   000                            00


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ....+.++.++|.+||+.||.+||++.+|+++
T Consensus       229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            11235679999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.4e-35  Score=252.64  Aligned_cols=229  Identities=29%  Similarity=0.430  Sum_probs=180.7

Q ss_pred             CCCCCceEEEEEeccc-ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--
Q 021181            2 NSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--   77 (316)
                      +..+|+.||+|.++.. .........+.+|++++++++|++++++++.+...     ...+++|||++ |+|.+++..  
T Consensus        23 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~   97 (267)
T cd08224          23 CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NELNIVLELADAGDLSRMIKHFK   97 (267)
T ss_pred             EcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEEEecCCCCCHHHHHHHhc
Confidence            3468999999998753 23333467788999999999999999999998654     45899999996 699988854  


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccc
Q 021181           78 --HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL  154 (316)
Q Consensus        78 --~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~  154 (316)
                        ...+++.++..++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|.|||.
T Consensus        98 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~  177 (267)
T cd08224          98 KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHH
Confidence              3458999999999999999999999999999999999999999999999999887654332 1233457788999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV--HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +.+ ..++.++|+|||||++|+|++|..||......  .....+..  +..+                           .
T Consensus       178 ~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---------------------------~  227 (267)
T cd08224         178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--CDYP---------------------------P  227 (267)
T ss_pred             hcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc--CCCC---------------------------C
Confidence            876 67889999999999999999999999654311  11111111  0000                           0


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .....++..+.++|.+||..+|++||++.+|++
T Consensus       228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            001246778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.5e-35  Score=254.51  Aligned_cols=220  Identities=23%  Similarity=0.284  Sum_probs=176.1

Q ss_pred             eEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCHHH
Q 021181            8 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDH   85 (316)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~   85 (316)
                      .||+|.++... .......+.+|+.+++.+.|+||+++++++...      ..++++++++ |+|.+.+... +.+++.+
T Consensus        38 ~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~l~~~~~~~g~l~~~l~~~~~~~~~~~  110 (279)
T cd05109          38 PVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS------TVQLVTQLMPYGCLLDYVRENKDRIGSQD  110 (279)
T ss_pred             EEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC------CcEEEEEcCCCCCHHHHHhhccCCCCHHH
Confidence            58999986543 333456788999999999999999999988643      3678999996 7999998764 5689999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCcccccCCCCCC
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEYT  162 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  162 (316)
                      +..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.........   ....++..|+|||...+ ..++
T Consensus       111 ~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~  189 (279)
T cd05109         111 LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFT  189 (279)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCC
Confidence            9999999999999999999999999999999999999999999998766433221   12234567999999876 6789


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          163 AAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       163 ~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      .++|||||||++|||++ |.+||...........+..... .                             .....++.+
T Consensus       190 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~-----------------------------~~~~~~~~~  239 (279)
T cd05109         190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-L-----------------------------PQPPICTID  239 (279)
T ss_pred             chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-C-----------------------------CCCccCCHH
Confidence            99999999999999998 9999977654443333222100 0                             001246788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +.+++.+||+.||+.||++.+++.
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.8e-36  Score=240.63  Aligned_cols=265  Identities=32%  Similarity=0.627  Sum_probs=207.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~   79 (316)
                      +-.+++.++||+++     +--.+++.+|+.+|..|. ||||++++++..++..   ....+|+|++.. +...+.   +
T Consensus        59 ~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly---~  127 (338)
T KOG0668|consen   59 NITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQLY---P  127 (338)
T ss_pred             ccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cCchhHhhhhccccHHHHh---h
Confidence            45688999999984     335677999999999996 9999999999987642   568899999975 555544   4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .++..+++.++++++.||.|+|+.||.|||+||+|+++|.. -.++|+|+|++.+-......+-.+.+.+|-.||.+..-
T Consensus       128 tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy  207 (338)
T KOG0668|consen  128 TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDY  207 (338)
T ss_pred             hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeec
Confidence            68899999999999999999999999999999999999976 45999999999887666666667788999999999888


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHhhCCCCcccc-ccccccchHHHhhhCC---CCCCCCc--
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLP---QFPKQNF--  231 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~--  231 (316)
                      +.|+.+-|+|||||++..|+..+.|| .+.+..+++.+|.+.+|....... ..+.-.....+...+.   +.+...+  
T Consensus       208 ~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~  287 (338)
T KOG0668|consen  208 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFIN  287 (338)
T ss_pred             hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCC
Confidence            89999999999999999999977665 566888999999998886443211 1111111112222111   1122222  


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      .+...-.++++.+|+.++|..|-.+|+|+.|.+.||||..+.....
T Consensus       288 ~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~  333 (338)
T KOG0668|consen  288 SENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAES  333 (338)
T ss_pred             ccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhh
Confidence            1122245799999999999999999999999999999998765443

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-35  Score=267.14  Aligned_cols=226  Identities=25%  Similarity=0.355  Sum_probs=176.3

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      .++..||||+++.. ........+.+|+.+++++. ||||+++++++...     ...|+|||||. |+|.+++...   
T Consensus        65 ~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~  138 (400)
T cd05105          65 QPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-----GPIYIITEYCFYGDLVNYLHKNRDN  138 (400)
T ss_pred             CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CceEEEEEecCCCcHHHHHHHhhhh
Confidence            34567999999654 23344567899999999996 99999999999654     45899999996 7998887542   


Q ss_pred             --------------------------------------------------------------------------------
Q 021181           79 --------------------------------------------------------------------------------   78 (316)
Q Consensus        79 --------------------------------------------------------------------------------   78 (316)
                                                                                                      
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (400)
T cd05105         139 FLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSN  218 (400)
T ss_pred             hhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcc
Confidence                                                                                            


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccc
Q 021181           79 -------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTE  142 (316)
Q Consensus        79 -------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~  142 (316)
                                   ..+++.++..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++........   ...
T Consensus       219 ~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~  298 (400)
T cd05105         219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS  298 (400)
T ss_pred             hhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCC
Confidence                         2377888899999999999999999999999999999999999999999999876533221   122


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                      ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...................                  
T Consensus       299 ~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~------------------  359 (400)
T cd05105         299 TFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM------------------  359 (400)
T ss_pred             cCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC------------------
Confidence            345677999999877 678999999999999999997 999997754333222211100000                  


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                 .....++.++.+++.+||+.||++||++.+|.+
T Consensus       360 -----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         360 -----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             -----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                       011256788999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.1e-35  Score=256.06  Aligned_cols=226  Identities=22%  Similarity=0.308  Sum_probs=179.4

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      ..++..||+|+++... .......+.+|+.+++.+.||||+++++++...     ...+++|||++ |+|.+++...   
T Consensus        32 ~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  105 (288)
T cd05050          32 YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPR  105 (288)
T ss_pred             CCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----CccEEEEecCCCCCHHHHHHHcCcc
Confidence            4578899999987543 233456688999999999999999999998654     45899999996 6999998643   


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc
Q 021181           79 -------------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF  139 (316)
Q Consensus        79 -------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  139 (316)
                                         ..+++.+++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  185 (288)
T cd05050         106 AQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY  185 (288)
T ss_pred             ccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcc
Confidence                               2367888999999999999999999999999999999999999999999998875433221


Q ss_pred             ---cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccc
Q 021181          140 ---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       140 ---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                         ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....              
T Consensus       186 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~--------------  250 (288)
T cd05050         186 YKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV--------------  250 (288)
T ss_pred             ccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence               112233567999999876 678999999999999999997 8889977765554443322100              


Q ss_pred             hHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          216 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                      ......++..+.++|.+||+.||.+|||+.|+++
T Consensus       251 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         251 ----------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                            0011246788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.4e-35  Score=249.14  Aligned_cols=226  Identities=23%  Similarity=0.385  Sum_probs=179.7

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~   81 (316)
                      .++..||+|.++... .......+.+|+++++.++||||+++++++...     ...++||||++ ++|.+++... ..+
T Consensus        17 ~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~   90 (250)
T cd05085          17 KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELVPGGDFLSFLRKKKDEL   90 (250)
T ss_pred             cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECCCCCcHHHHHHhcCCCC
Confidence            357889999987543 333445688999999999999999999998654     45899999996 6999888653 467


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc--cccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........  ...++..|+|||.+.+ .
T Consensus        91 ~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  169 (250)
T cd05085          91 KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-G  169 (250)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-C
Confidence            999999999999999999999999999999999999999999999999886543322111  1233557999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++||||||+++|++++ |..||...........+......                              .....+
T Consensus       170 ~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~  219 (250)
T cd05085         170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM------------------------------SCPQKC  219 (250)
T ss_pred             CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCCCC
Confidence            78899999999999999998 99999877655444433221100                              011246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            7889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.1e-35  Score=251.64  Aligned_cols=225  Identities=24%  Similarity=0.373  Sum_probs=174.7

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      ++..||||.+... ........+.+|+.+++.++||||+++++++...+    ...+++|||+. |+|.+++... ...+
T Consensus        22 ~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~   96 (262)
T cd05058          22 QKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVLPYMKHGDLRNFIRSETHNPT   96 (262)
T ss_pred             ceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEEecCCCCCHHHHHHhcCCCCC
Confidence            4568999998543 23334567889999999999999999999775332    34789999996 7999998764 4467


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCcccccC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  157 (316)
                      +..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+........     .....++..|+|||.+.+
T Consensus        97 ~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  176 (262)
T cd05058          97 VKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT  176 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence            888899999999999999999999999999999999999999999998865432211     112334667999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|+|++ |.+||...+.......+...  ...                            ....
T Consensus       177 -~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~----------------------------~~~~  225 (262)
T cd05058         177 -QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRL----------------------------LQPE  225 (262)
T ss_pred             -CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC----------------------------CCCC
Confidence             678999999999999999999 57778766544443332211  000                            0001


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .++..+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         226 YCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            35778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=265.55  Aligned_cols=236  Identities=23%  Similarity=0.374  Sum_probs=177.1

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~   81 (316)
                      .|..||||++.......  ...+..|+.++.+++|||+|+++|+|.+.+    .+.++|+||+. |+|.+.+....  .+
T Consensus        98 ~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~----~~~~LVYEym~nGsL~d~L~~~~~~~L  171 (361)
T KOG1187|consen   98 DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGG----EHRLLVYEYMPNGSLEDHLHGKKGEPL  171 (361)
T ss_pred             CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCC----ceEEEEEEccCCCCHHHHhCCCCCCCC
Confidence            45899999886643332  445999999999999999999999997653    15899999996 89999997765  89


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCC---ceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccc-cccccccCccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEY-VVTRWYRAPELLL  156 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~-~~~~~~~aPE~~~  156 (316)
                      +|..+..|+.+++.||+|||...   |+|||||++|||+|++++.||+|||++..... ....... .||.+|++||...
T Consensus       172 ~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~  251 (361)
T KOG1187|consen  172 DWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS  251 (361)
T ss_pred             CHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhc
Confidence            99999999999999999999643   99999999999999999999999999976654 3333333 7899999999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc-
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS-  232 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (316)
                      . +..+.++||||||+++.||++|+.+.....   ................                  ...+....+. 
T Consensus       252 ~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~------------------~~eiiD~~l~~  312 (361)
T KOG1187|consen  252 T-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK------------------LREIVDPRLKE  312 (361)
T ss_pred             c-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc------------------hhheeCCCccC
Confidence            7 779999999999999999999998876532   1111111111111100                  0000011111 


Q ss_pred             ccCC--CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          233 ARFP--NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       233 ~~~~--~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..++  ..-..+..+...|++.+|.+||++.++++
T Consensus       313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1111  11223778889999999999999999754

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.7e-35  Score=251.08  Aligned_cols=222  Identities=23%  Similarity=0.388  Sum_probs=179.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~   80 (316)
                      .+++.||+|.+.....   ....+.+|+.++++++|+||+++++++..      ...+++|||+. ++|.+++...  ..
T Consensus        28 ~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05067          28 NGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIK   98 (260)
T ss_pred             CCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEEEEEcCCCCCHHHHHHhcCCCC
Confidence            4578899999865432   34568899999999999999999998743      34799999995 7999988653  45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~  158 (316)
                      ++..++..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........  ....++..|+|||.+.. 
T Consensus        99 ~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-  177 (260)
T cd05067          99 LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-
Confidence            899999999999999999999999999999999999999999999999998765422211  12334567999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++||||||+++|++++ |++||.+.+.......+......                              .....
T Consensus       178 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  227 (260)
T cd05067         178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------------------------------PRPDN  227 (260)
T ss_pred             CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC------------------------------CCCCC
Confidence            668899999999999999998 99999887765555544321111                              01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.++.++|++||+.+|++||+++++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         228 CPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.2e-35  Score=255.50  Aligned_cols=224  Identities=25%  Similarity=0.389  Sum_probs=177.2

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-----   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----   78 (316)
                      ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...     ...+++|||+. |+|.+++...     
T Consensus        29 ~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~  102 (290)
T cd05045          29 GYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRSFLRESRKVGP  102 (290)
T ss_pred             cceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CCcEEEEEecCCCCHHHHHHhcCCccc
Confidence            34678999886543 233456788999999999999999999998654     44899999996 7999887542     


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc
Q 021181           79 -------------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF  139 (316)
Q Consensus        79 -------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  139 (316)
                                         ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus       103 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~  182 (290)
T cd05045         103 SYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS  182 (290)
T ss_pred             cccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccc
Confidence                               2478899999999999999999999999999999999999999999999999875433221


Q ss_pred             ---cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccc
Q 021181          140 ---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       140 ---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                         .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+......             
T Consensus       183 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  248 (290)
T cd05045         183 YVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-------------  248 (290)
T ss_pred             hhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-------------
Confidence               122234567999999876 678999999999999999998 99999777654444333211100             


Q ss_pred             hHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          216 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                       .....++.++.+++..||+.||.+||+++++++
T Consensus       249 -----------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         249 -----------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                             011246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.2e-35  Score=257.32  Aligned_cols=224  Identities=26%  Similarity=0.431  Sum_probs=178.4

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      .+..||+|.++... .......+..|+.+++++ +||||+++++++...     ..++++|||+. |+|.+++...    
T Consensus        43 ~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~  116 (314)
T cd05099          43 QTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPG  116 (314)
T ss_pred             cceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCCCc
Confidence            45679999987542 233456788999999999 699999999998654     45899999996 7999998653    


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccc
Q 021181           79 ------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEY  143 (316)
Q Consensus        79 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~  143 (316)
                                  ..++..++..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.++........   ...
T Consensus       117 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  196 (314)
T cd05099         117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG  196 (314)
T ss_pred             ccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccC
Confidence                        34788999999999999999999999999999999999999999999999998765432211   112


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.....                     
T Consensus       197 ~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  254 (314)
T cd05099         197 RLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR---------------------  254 (314)
T ss_pred             CCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            23457999999876 678999999999999999998 8999987765555544332100                     


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                               ......++.++.+++.+||+.||++||++.++++
T Consensus       255 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         255 ---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                     0011256778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.3e-35  Score=251.16  Aligned_cols=219  Identities=25%  Similarity=0.396  Sum_probs=175.3

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CCCCH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLTD   83 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~~   83 (316)
                      ..||+|+++....   ....+.+|+++++.++|+||+++++.+..      ...++||||++ |+|.+++...  ..+++
T Consensus        31 ~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  101 (262)
T cd05071          31 TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRL  101 (262)
T ss_pred             ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEEEEEcCCCCcHHHHHhhccccCCCH
Confidence            4699999975332   23467899999999999999999998743      23689999996 6999998753  45889


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      ..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+.........  ....++..|+|||...+ ..+
T Consensus       102 ~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~  180 (262)
T cd05071         102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRF  180 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCC
Confidence            999999999999999999999999999999999999999999999998765433221  12345667999998876 678


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|||||||++|+|++ |.+||.+.........+......                              .....++.
T Consensus       181 ~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~  230 (262)
T cd05071         181 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------------------------PCPPECPE  230 (262)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC------------------------------CCccccCH
Confidence            999999999999999999 89999877655444433221000                              01124678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.+++.+||+.||.+||++++++.
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            8999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.2e-35  Score=251.85  Aligned_cols=224  Identities=25%  Similarity=0.378  Sum_probs=179.8

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      ++..||+|.++.... ......+..|+.++++++||||+++++++...     ...+++|||++ ++|.+++... +.++
T Consensus        31 ~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~  104 (267)
T cd05066          31 REIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDGQFT  104 (267)
T ss_pred             CceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHhcCCCCC
Confidence            345799999865432 33456788999999999999999999998644     45899999996 6999998764 4689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----ccccccccccCcccccCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~  158 (316)
                      ..++..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........    .....+..|+|||.+.+ 
T Consensus       105 ~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-  183 (267)
T cd05066         105 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-  183 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-
Confidence            9999999999999999999999999999999999999999999999998765433211    11122457999999976 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|+|||||++|++++ |..||...+..+....+......+                              ....
T Consensus       184 ~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~  233 (267)
T cd05066         184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP------------------------------APMD  233 (267)
T ss_pred             CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC------------------------------CCCC
Confidence            678999999999999999886 999998776555554443211100                              0124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +++.+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         234 CPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            6788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.4e-35  Score=258.20  Aligned_cols=225  Identities=26%  Similarity=0.422  Sum_probs=178.2

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      ++..||+|.++... .......+..|+.+++.+ +|+||+++++++...     ...|+||||++ |+|.+++...+   
T Consensus        49 ~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~  122 (307)
T cd05098          49 RVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPG  122 (307)
T ss_pred             ccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcc
Confidence            44679999997542 334456788899999999 799999999998654     45899999996 69999997542   


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccc
Q 021181           80 -------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEY  143 (316)
Q Consensus        80 -------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~  143 (316)
                                   .++..++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........   ...
T Consensus       123 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~  202 (307)
T cd05098         123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG  202 (307)
T ss_pred             cccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccC
Confidence                         4788999999999999999999999999999999999999999999999998765432211   112


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+.....                     
T Consensus       203 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  260 (307)
T cd05098         203 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR---------------------  260 (307)
T ss_pred             CCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC---------------------
Confidence            23467999999877 678899999999999999998 8899977664444433322100                     


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                               ......++.++.++|.+||+.+|.+||++.+++++
T Consensus       261 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         261 ---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                     00112467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.8e-35  Score=251.80  Aligned_cols=223  Identities=24%  Similarity=0.366  Sum_probs=178.2

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~   83 (316)
                      +..||||.++... .......+..|+.+++.++||||+++++++...     ...+++|||++ ++|.+++... +.+++
T Consensus        32 ~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~  105 (269)
T cd05065          32 EIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQNDGQFTV  105 (269)
T ss_pred             ceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----CceEEEEecCCCCcHHHHHhhCCCCCCH
Confidence            3469999987543 344557789999999999999999999998654     45899999996 6898888753 56899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccc----cc--ccccccCcccccC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YV--VTRWYRAPELLLN  157 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~----~~--~~~~~~aPE~~~~  157 (316)
                      .+++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...........    ..  .+..|+|||.+.+
T Consensus       106 ~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (269)
T cd05065         106 IQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY  185 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc
Confidence            99999999999999999999999999999999999999999999998866543221111    11  1346999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++||||+||++||+++ |..||...+.......+......+                              ...
T Consensus       186 -~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------------------------~~~  234 (269)
T cd05065         186 -RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP------------------------------PPM  234 (269)
T ss_pred             -CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC------------------------------Ccc
Confidence             678999999999999999886 999998776555544443211100                              012


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .++..+.+++.+||..+|.+||++++++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            46788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.6e-35  Score=250.62  Aligned_cols=222  Identities=23%  Similarity=0.386  Sum_probs=177.4

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~   80 (316)
                      +++..||+|.++....   ....+.+|+.++++++|++++++++++..      ...+++|||++ ++|.+++...  ..
T Consensus        28 ~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05070          28 NGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKDGEGRA   98 (260)
T ss_pred             cCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEEEEEecCCCcHHHHHHhcCCCC
Confidence            4567899999865432   23468899999999999999999998743      23789999996 6999998753  45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........  ....++..|+|||...+ 
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  177 (260)
T cd05070          99 LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-
Confidence            899999999999999999999999999999999999999999999999998765443221  12234567999999866 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|+||||+++|+|++ |.+||.+.+..+....+......                              .....
T Consensus       178 ~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  227 (260)
T cd05070         178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM------------------------------PCPQD  227 (260)
T ss_pred             CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCCc
Confidence            678899999999999999999 99999877655554443321000                              01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+..+.+++.+||..||.+|||+.++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         228 CPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            6788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.4e-35  Score=282.95  Aligned_cols=229  Identities=28%  Similarity=0.364  Sum_probs=177.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      |..+|+.||||+++.... .......+.+|+.+++.++||||+++++++...     ...+++|||++ |+|.+++... 
T Consensus        23 d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~lyLVMEY~eGGSL~~lL~s~~   97 (932)
T PRK13184         23 DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DPVYYTMPYIEGYTLKSLLKSVW   97 (932)
T ss_pred             ECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHHhh
Confidence            567899999999976433 233456788999999999999999999998654     56899999996 6999888631 


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-----------
Q 021181           79 ----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-----------  137 (316)
Q Consensus        79 ----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-----------  137 (316)
                                ...+...+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......           
T Consensus        98 ~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~  177 (932)
T PRK13184         98 QKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE  177 (932)
T ss_pred             hccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccc
Confidence                      23566788999999999999999999999999999999999999999999998765211           


Q ss_pred             --------CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccc
Q 021181          138 --------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG  209 (316)
Q Consensus       138 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  209 (316)
                              .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......  .....+..    
T Consensus       178 ~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~~----  250 (932)
T PRK13184        178 RNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPIE----  250 (932)
T ss_pred             ccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChhh----
Confidence                    00112468999999999877 6789999999999999999999999977543222111  00000000    


Q ss_pred             cccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL  264 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell  264 (316)
                                            ......+++.+.+++.+||+.||++|++..+.+
T Consensus       251 ----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        251 ----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence                                  001135788899999999999999998765544

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=268.44  Aligned_cols=223  Identities=25%  Similarity=0.415  Sum_probs=188.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~   81 (316)
                      ..+-.||||.-+.++..+ +.+.+++|+-+++.++||||++++|++....      .|||||.+. |.|..+++.++ .+
T Consensus       416 ge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e~P------~WivmEL~~~GELr~yLq~nk~sL  488 (974)
T KOG4257|consen  416 GERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------MWIVMELAPLGELREYLQQNKDSL  488 (974)
T ss_pred             CcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeeccc------eeEEEecccchhHHHHHHhccccc
Confidence            344568999887765444 5889999999999999999999999997654      799999998 99999998765 48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccc--cccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~--~~~~~aPE~~~~~~  159 (316)
                      +......+.+||..||+|||+.++|||||...||||.+...+||+|||+++.+.....+....+  +.-|+|||-+-- .
T Consensus       489 ~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-R  567 (974)
T KOG4257|consen  489 PLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-R  567 (974)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccch-h
Confidence            8999999999999999999999999999999999999999999999999999887766544333  556999998755 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||+||++|||++. |..||.+-...+.+..+.+..+.|                              ..+.+
T Consensus       568 rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------------------------------~P~nC  617 (974)
T KOG4257|consen  568 RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------------------------------CPPNC  617 (974)
T ss_pred             cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------------------------------CCCCC
Confidence            79999999999999999986 999999887666665554433222                              22578


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHh
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEAL  264 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell  264 (316)
                      ++.+..++.+||..||.+||.+.+|.
T Consensus       618 Pp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  618 PPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ChHHHHHHHHHhccCcccCCcHHHHH
Confidence            99999999999999999999876654

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.8e-35  Score=256.31  Aligned_cols=225  Identities=26%  Similarity=0.422  Sum_probs=179.6

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      ++..||+|.+.... .......+.+|+.+++.+ +||||+++++.+...     ...+++|||+. |+|.+++...    
T Consensus        46 ~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  119 (304)
T cd05101          46 EAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPG  119 (304)
T ss_pred             cceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcc
Confidence            45689999986542 334557788999999999 899999999998654     45899999996 6999998753    


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccc
Q 021181           79 ------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEY  143 (316)
Q Consensus        79 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~  143 (316)
                                  ..++..++..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.........   ...
T Consensus       120 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~  199 (304)
T cd05101         120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG  199 (304)
T ss_pred             cccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCC
Confidence                        24678889999999999999999999999999999999999999999999998765433211   122


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+....+......                    
T Consensus       200 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  258 (304)
T cd05101         200 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM--------------------  258 (304)
T ss_pred             CCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC--------------------
Confidence            34567999999877 678899999999999999998 88899777655554443221000                    


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                .....++..+.++|.+||+.+|.+||++.++++.
T Consensus       259 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         259 ----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                      0112567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7e-35  Score=253.23  Aligned_cols=244  Identities=23%  Similarity=0.385  Sum_probs=178.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..+|+.||||++...  .......+.+|+++++.++||||+++++++...+.   ..+++||||++ |+|.+++... .
T Consensus        29 ~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  103 (284)
T cd05081          29 QDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRE  103 (284)
T ss_pred             cCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC---CceEEEEEecCCCCHHHHHHhcCc
Confidence            5678999999998653  33445678899999999999999999998754322   45899999996 7999998654 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----ccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~  155 (316)
                      .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.........    ....++..|+|||.+
T Consensus       104 ~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  183 (284)
T cd05081         104 RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL  183 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHh
Confidence            6899999999999999999999999999999999999999999999999998765433211    112234459999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|+|||||++|+|++|..++...... ....    .+.....  ... ............      .....
T Consensus       184 ~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~----~~~~~~~--~~~-~~~~~~~~~~~~------~~~~~  248 (284)
T cd05081         184 TE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM----MGNDKQG--QMI-VYHLIELLKNNG------RLPAP  248 (284)
T ss_pred             cc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh----ccccccc--ccc-hHHHHHHHhcCC------cCCCC
Confidence            76 67889999999999999999987766443211 1100    0000000  000 000000000000      01112


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..++.++.++|.+||..+|++|||+.++++
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         249 PGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-35  Score=253.91  Aligned_cols=244  Identities=26%  Similarity=0.398  Sum_probs=179.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~   80 (316)
                      ..++..||+|.++... .......+.+|+.+++.++||||+++++++...+   ....+++|||++ ++|.+++... ..
T Consensus        30 ~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~g~~L~~~l~~~~~~  105 (284)
T cd05079          30 DNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GNGIKLIMEFLPSGSLKEYLPRNKNK  105 (284)
T ss_pred             CCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---CCceEEEEEccCCCCHHHHHHhccCC
Confidence            5689999999986543 3334567899999999999999999999886532   145899999995 6999998664 35


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~  156 (316)
                      +++.++..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+........    .....++..|+|||.+.
T Consensus       106 ~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         106 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence            89999999999999999999999999999999999999999999999999876543221    12344566799999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|||||||++|+|+++..|+...-.  .   ..+..+.....       .............   .......
T Consensus       186 ~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~---~~~~~~~~~~~-------~~~~~~~~~~~~~---~~~~~~~  249 (284)
T cd05079         186 Q-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--L---FLKMIGPTHGQ-------MTVTRLVRVLEEG---KRLPRPP  249 (284)
T ss_pred             c-CCCCccccchhhhhhhhhhhcCCCCCccccc--h---hhhhccccccc-------ccHHHHHHHHHcC---ccCCCCC
Confidence            6 6788999999999999999998766433210  0   00111100000       0000000000000   0011123


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .++..+.+|+.+||+.||.+||+++++++.
T Consensus       250 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         250 NCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.9e-35  Score=247.32  Aligned_cols=232  Identities=38%  Similarity=0.663  Sum_probs=189.9

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL   81 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~   81 (316)
                      ..+|+.||+|++........ ...+.+|++.+++++|+||+++++.+...     ...++++|++++ +|.+++.....+
T Consensus        11 ~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~   84 (244)
T smart00220       11 KKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKKRGRL   84 (244)
T ss_pred             CCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHhccCC
Confidence            45789999999976433222 67889999999999999999999998654     468999999975 999999877669


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      +...+..++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+.............++..|++||.+.. ...
T Consensus        85 ~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~  163 (244)
T smart00220       85 SEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG-KGY  163 (244)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc-CCC
Confidence            9999999999999999999999999999999999999999999999999887765544455667888999999876 667


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMTRQPLFPGK-DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|+||+|++++++++|..||... +.......+........                            .....++.
T Consensus       164 ~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  215 (244)
T smart00220      164 GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP----------------------------PPEWKISP  215 (244)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc----------------------------cccccCCH
Confidence            88999999999999999999999774 33322222221111100                            00011678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ++.+++.+||..||.+||++.++++||||
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            89999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=253.55  Aligned_cols=230  Identities=23%  Similarity=0.372  Sum_probs=178.1

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-----
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-----   79 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----   79 (316)
                      ...||+|+++... .......+.+|++++++++|+|++++++++...     ...++||||+. ++|.+++....     
T Consensus        44 ~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~  117 (295)
T cd05097          44 PVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTF  117 (295)
T ss_pred             ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccc
Confidence            3469999987542 334456788999999999999999999999654     45899999996 69998885432     


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccc
Q 021181           80 -------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWY  149 (316)
Q Consensus        80 -------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~  149 (316)
                             .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........   .....++..|
T Consensus       118 ~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  197 (295)
T cd05097         118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW  197 (295)
T ss_pred             cccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceee
Confidence                   368889999999999999999999999999999999999999999999998876432221   1222346689


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      +|||.+.+ ..++.++|+|||||++|+|++  |..||...+....+..+.........                      
T Consensus       198 ~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------------  254 (295)
T cd05097         198 MAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR----------------------  254 (295)
T ss_pred             cChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccc----------------------
Confidence            99999876 678999999999999999988  67888877655555443322111000                      


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                       .......+.+++.+.+++++||+.||++|||++++++
T Consensus       255 -~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         255 -QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             -cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             0001112346788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.9e-35  Score=251.02  Aligned_cols=233  Identities=22%  Similarity=0.336  Sum_probs=181.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCC-CCeEEEEEecCC-CcHHHHhhcC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET-FNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~-~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ..+|+.||||++..........+.+.+|+.+++.++||||+++++++......+ ....+++++|+. |+|.+++...  
T Consensus        24 ~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  103 (273)
T cd05074          24 DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI  103 (273)
T ss_pred             CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcc
Confidence            457899999999776555556777899999999999999999999887543221 123578899996 7888776432  


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccC
Q 021181           79 ----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRA  151 (316)
Q Consensus        79 ----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~a  151 (316)
                          ..++...++.++.|++.||+|||+.||+|+||+|+||+++.++.++++|||.+........   .....++..|++
T Consensus       104 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  183 (273)
T cd05074         104 GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA  183 (273)
T ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcC
Confidence                2478899999999999999999999999999999999999999999999998876533221   112234567899


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          152 PELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      ||.+.. ..++.++|||||||++|+|++ |.+||.+.+.......+......                            
T Consensus       184 pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------  234 (273)
T cd05074         184 LESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL----------------------------  234 (273)
T ss_pred             HhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC----------------------------
Confidence            999876 678899999999999999998 89999877654443333221000                            


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                        ...+..+..+.+++.+||+.+|++|||+.+++..
T Consensus       235 --~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 --KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              0012467889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=268.49  Aligned_cols=222  Identities=24%  Similarity=0.350  Sum_probs=187.0

Q ss_pred             EEEEEeccc-ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC-CCHHH
Q 021181            9 VAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-LTDDH   85 (316)
Q Consensus         9 vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-~~~~~   85 (316)
                      ||||..+.+ .........+++|+++++.++|||||++||+....+     .++||||+|. |+|.++|++.+. ++..+
T Consensus       189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-----Pl~ivmEl~~gGsL~~~L~k~~~~v~~~e  263 (474)
T KOG0194|consen  189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-----PLMLVMELCNGGSLDDYLKKNKKSLPTLE  263 (474)
T ss_pred             eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ccEEEEEecCCCcHHHHHHhCCCCCCHHH
Confidence            999999863 356777788999999999999999999999997764     4999999995 799999999875 99999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc-cccccccccCcccccCCCCCCCc
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAA  164 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~  164 (316)
                      ...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||++.......... ..--+..|+|||.+.. ..++.+
T Consensus       264 k~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~k  342 (474)
T KOG0194|consen  264 KLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFK  342 (474)
T ss_pred             HHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhcc-Cccccc
Confidence            99999999999999999999999999999999999999999999987765322222 2234678999999988 689999


Q ss_pred             chHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHH
Q 021181          165 IDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV  243 (316)
Q Consensus       165 ~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  243 (316)
                      +||||+||++||+.+ |..||.+....+....+.......+.                             ....+..+.
T Consensus       343 TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~-----------------------------~~~~p~~~~  393 (474)
T KOG0194|consen  343 TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI-----------------------------PSKTPKELA  393 (474)
T ss_pred             cchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-----------------------------CCCCHHHHH
Confidence            999999999999998 88899999887777766332111110                             014577899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 021181          244 DLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       244 ~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .++.+||..||++||++.++.+
T Consensus       394 ~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  394 KVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999988775

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.9e-35  Score=248.84  Aligned_cols=220  Identities=23%  Similarity=0.374  Sum_probs=177.4

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      ..+++.||+|.++...    ....+.+|+.+++.++|||++++++++...      ..+++|||+. ++|.+++....  
T Consensus        26 ~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~   95 (254)
T cd05083          26 EYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYIVMELMSKGNLVNFLRTRGRA   95 (254)
T ss_pred             ccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEEEEECCCCCCHHHHHHhcCcC
Confidence            3478899999986432    345688999999999999999999998643      2689999996 69999987643  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+......  ......+..|+|||.+.+ .
T Consensus        96 ~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~-~  172 (254)
T cd05083          96 LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH-K  172 (254)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhcc-C
Confidence            4789999999999999999999999999999999999999999999999988654322  122233567999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|+|||||++|+|++ |.+||...+.......+.+....                              .....+
T Consensus       173 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~  222 (254)
T cd05083         173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM------------------------------EPPEGC  222 (254)
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC------------------------------CCCCcC
Confidence            78899999999999999997 99999877655444333221000                              001256


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +..+.+++++||+.+|..||++++++.
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-34  Score=249.96  Aligned_cols=222  Identities=23%  Similarity=0.376  Sum_probs=178.2

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~   84 (316)
                      ..||+|.++... .......+..|+.+++.++|+||+++++++...     ...+++|||++ ++|.+++.. .+.+++.
T Consensus        34 ~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  107 (268)
T cd05063          34 VAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----KPAMIITEYMENGALDKYLRDHDGEFSSY  107 (268)
T ss_pred             eEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHH
Confidence            479999986542 233456788999999999999999999998654     45899999997 699888865 3578999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----ccccccccccCcccccCCCC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~  160 (316)
                      ++..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+.........    .....+..|+|||.+.. ..
T Consensus       108 ~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~  186 (268)
T cd05063         108 QLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RK  186 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CC
Confidence            99999999999999999999999999999999999999999999988765432211    11122456999999876 66


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|||||||++|+|++ |..||...+.......+......+.                              ...++
T Consensus       187 ~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~------------------------------~~~~~  236 (268)
T cd05063         187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA------------------------------PMDCP  236 (268)
T ss_pred             cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC------------------------------CCCCC
Confidence            8899999999999999997 9999987766555555433211100                              11457


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+.+++.+||+.||.+||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            78999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1e-34  Score=250.18  Aligned_cols=229  Identities=23%  Similarity=0.314  Sum_probs=173.7

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----   79 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----   79 (316)
                      .+..+|+|.+.... .......+.+|+.+++.++|+||+++++.+...     ..+++||||++ |+|.+++....    
T Consensus        21 ~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~   94 (269)
T cd05042          21 SKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVA   94 (269)
T ss_pred             CCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEEeCCCCcHHHHHHhcccccc
Confidence            45678999876432 333456678999999999999999999998654     45899999996 69999987643    


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccc
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~  155 (316)
                       ..++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+........   .....++..|+|||++
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (269)
T cd05042          95 QMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV  174 (269)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHH
Confidence             246778899999999999999999999999999999999999999999998865332211   1223345679999987


Q ss_pred             cC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          156 LN------CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       156 ~~------~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      ..      ...++.++|||||||++|+|++ |.+||......+..............                      .
T Consensus       175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~  232 (269)
T cd05042         175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP----------------------K  232 (269)
T ss_pred             hhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC----------------------C
Confidence            43      2356789999999999999999 88899777655544433221111000                      0


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                         ......++..+.+++..|+ .||++|||+++|++
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 ---PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ---CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence               0111256788899999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.6e-35  Score=249.21  Aligned_cols=220  Identities=24%  Similarity=0.396  Sum_probs=174.9

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~   82 (316)
                      +..||+|.+....   .....+.+|+.+++.++|++++++++++..      ...+++|||+. ++|.+++...  ..++
T Consensus        30 ~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~  100 (260)
T cd05069          30 TTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYIVTEFMGKGSLLDFLKEGDGKYLK  100 (260)
T ss_pred             CceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEEEEEcCCCCCHHHHHhhCCCCCCC
Confidence            3469999886432   233567889999999999999999998743      23689999997 6999998754  3478


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........  ....++..|+|||...+ ..
T Consensus       101 ~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~  179 (260)
T cd05069         101 LPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR  179 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CC
Confidence            9999999999999999999999999999999999999999999999998765433221  12334567999998876 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|+||||+++|+|++ |.+||.+....+....+......                              ......+
T Consensus       180 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~  229 (260)
T cd05069         180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM------------------------------PCPQGCP  229 (260)
T ss_pred             cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCcccC
Confidence            8999999999999999999 99999877655544433221000                              0012467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+.+++++||..||.+||+++++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            88999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-35  Score=249.69  Aligned_cols=222  Identities=27%  Similarity=0.419  Sum_probs=178.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~   81 (316)
                      +++.||||.+....   .....+..|+.+++.++|+||+++++++...     ...+++|||++ ++|.+++....  .+
T Consensus        29 ~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~~  100 (261)
T cd05034          29 GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EPIYIVTEYMSKGSLLDFLKSGEGKKL  100 (261)
T ss_pred             CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----CceEEEEeccCCCCHHHHHhccccCCC
Confidence            45779999986532   2345688999999999999999999998543     45899999996 69999987643  68


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~  159 (316)
                      +...+..++.+++.||++||++|++|+||+|+||+++.++.++|+|||.+.........  .....+..|+|||.+.+ .
T Consensus       101 ~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~  179 (261)
T cd05034         101 RLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-G  179 (261)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-C
Confidence            99999999999999999999999999999999999999999999999988765432211  12223567999999876 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|+||+|+++|+|++ |+.||.+.........+......+                              .....
T Consensus       180 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  229 (261)
T cd05034         180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------------------------------RPPNC  229 (261)
T ss_pred             CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CCCCC
Confidence            78899999999999999998 999998776555555443211110                              01234


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +..+.+++.+||+.+|++||+++++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         230 PEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-34  Score=250.16  Aligned_cols=224  Identities=26%  Similarity=0.402  Sum_probs=179.0

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~~   82 (316)
                      +...||||...... .....+.+.+|+.+++.++||||+++++++...      ..++||||+. |+|.+++.... .++
T Consensus        33 ~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~  105 (270)
T cd05056          33 EKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------PVWIVMELAPLGELRSYLQVNKYSLD  105 (270)
T ss_pred             CCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------CcEEEEEcCCCCcHHHHHHhCCCCCC
Confidence            34579999886543 234556788999999999999999999988643      3689999996 79999987643 589


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc--cccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~  160 (316)
                      +..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..........  ...++..|+|||.+.. ..
T Consensus       106 ~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  184 (270)
T cd05056         106 LASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RR  184 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CC
Confidence            99999999999999999999999999999999999999999999999887654332211  2223457999999866 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++||||||+++|++++ |..||...+..+....+......                              ...+.++
T Consensus       185 ~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~  234 (270)
T cd05056         185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------------------------PMPPNCP  234 (270)
T ss_pred             CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------------------------------CCCCCCC
Confidence            8999999999999999986 99999887655544433221100                              0113567


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ..+.+++.+||..+|.+|||+.+++..
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.4e-35  Score=251.86  Aligned_cols=224  Identities=28%  Similarity=0.412  Sum_probs=177.3

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-----   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----   78 (316)
                      +++.||||.+.... .......+.+|+.+++.++||||+++++++...     ...+++|||++ ++|.+++...     
T Consensus        25 ~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~   98 (269)
T cd05044          25 GPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERF   98 (269)
T ss_pred             cceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeEEEEeccCCCcHHHHHHHhhhccc
Confidence            44789999886532 233456788999999999999999999998654     45899999996 6999988642     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-----CEEEeeeccccccCCCCc---ccccccccc
Q 021181           79 --QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-----DLKIGDFGLARTTSETDF---MTEYVVTRW  148 (316)
Q Consensus        79 --~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-----~~~l~df~~~~~~~~~~~---~~~~~~~~~  148 (316)
                        ..+++.++..++.|++.||+|||+.+++|+||+|+||+++.++     .++++|||++........   .....++..
T Consensus        99 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  178 (269)
T cd05044          99 GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR  178 (269)
T ss_pred             CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCcc
Confidence              3478899999999999999999999999999999999999887     899999999876533221   112234567


Q ss_pred             ccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      |+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+.....                          
T Consensus       179 y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------------------  231 (269)
T cd05044         179 WMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR--------------------------  231 (269)
T ss_pred             ccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc--------------------------
Confidence            999999877 678999999999999999998 9999987665544433321000                          


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                          ......++..+.++|.+||..+|.+||+++++++
T Consensus       232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 ----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                0011246788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.3e-35  Score=259.55  Aligned_cols=229  Identities=25%  Similarity=0.401  Sum_probs=176.4

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ..+++.||||+++... .......+.+|+.++.++ +|+||+++++++...+    ..++++|||++ |+|.+++...  
T Consensus        34 ~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~i~~~~~  108 (343)
T cd05103          34 TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSNYLRSKRG  108 (343)
T ss_pred             cccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC----CceEEEEeccCCCcHHHHHHhcCC
Confidence            4578899999997543 233456788999999999 6899999999885432    45899999996 7999888642  


Q ss_pred             -----------------------------------------------------------------CCCCHHHHHHHHHHH
Q 021181           79 -----------------------------------------------------------------QDLTDDHCRYFLYQL   93 (316)
Q Consensus        79 -----------------------------------------------------------------~~~~~~~~~~i~~qi   93 (316)
                                                                                       ..++..++..++.||
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi  188 (343)
T cd05103         109 EFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQV  188 (343)
T ss_pred             ccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHH
Confidence                                                                             136778889999999


Q ss_pred             HHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCCCCCCCcchHHHH
Q 021181           94 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSV  170 (316)
Q Consensus        94 ~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (316)
                      +.||+|||+.||+|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|||||
T Consensus       189 ~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl  267 (343)
T cd05103         189 AKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF  267 (343)
T ss_pred             HHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHH
Confidence            9999999999999999999999999999999999998876432211   112234567999999876 678999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHh
Q 021181          171 GCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKM  249 (316)
Q Consensus       171 G~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~  249 (316)
                      |+++|+|++ |..||............... +...                            ......++++.+++.+|
T Consensus       268 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~----------------------------~~~~~~~~~~~~~~~~c  318 (343)
T cd05103         268 GVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRM----------------------------RAPDYTTPEMYQTMLDC  318 (343)
T ss_pred             HHHHHHHHHCCCCCCCCccccHHHHHHHhc-cCCC----------------------------CCCCCCCHHHHHHHHHH
Confidence            999999997 99999765433222211110 0000                            00013567899999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q 021181          250 LVFDPNRRITVDEALCH  266 (316)
Q Consensus       250 L~~dP~~Rps~~ell~~  266 (316)
                      |+.||.+||++.+|++|
T Consensus       319 l~~~p~~Rps~~eil~~  335 (343)
T cd05103         319 WHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-35  Score=252.07  Aligned_cols=219  Identities=17%  Similarity=0.256  Sum_probs=171.6

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~~~   83 (316)
                      +..||+|.+...  .......+..|+.+++.+.||||+++++++...     ...++||||++ |+|.+++...+ .+++
T Consensus        27 ~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~   99 (258)
T cd05078          27 KTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIMVQEYVKFGSLDTYLKKNKNLINI   99 (258)
T ss_pred             cchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEEEEecCCCCcHHHHHhcCCCCCCH
Confidence            455888887543  233446778899999999999999999998754     34799999996 69999987654 5899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC--------EEEeeeccccccCCCCccccccccccccCcccc
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                      ..+..++.||+.||+|||++||+|+||||+||+++.++.        ++++|||.+......   ....++..|+|||.+
T Consensus       100 ~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~  176 (258)
T cd05078         100 SWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECI  176 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhc
Confidence            999999999999999999999999999999999987765        689999987654332   234567789999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .+...++.++|||||||++|+|++| .+||...+..........    ..                            ..
T Consensus       177 ~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~----~~----------------------------~~  224 (258)
T cd05078         177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED----RH----------------------------QL  224 (258)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc----cc----------------------------cC
Confidence            7756678999999999999999998 566655543332221110    00                            00


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ....+.++.+++.+||+.||++|||++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            11345779999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-34  Score=251.18  Aligned_cols=220  Identities=23%  Similarity=0.311  Sum_probs=173.0

Q ss_pred             eEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCCCHHH
Q 021181            8 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDH   85 (316)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~   85 (316)
                      .|++|.+... ........+..|+..++.+.||||+++++++..      ...++++||+. |+|.+++.. .+.+++..
T Consensus        38 ~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~  110 (279)
T cd05111          38 PVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ASLQLVTQLSPLGSLLDHVRQHRDSLDPQR  110 (279)
T ss_pred             EEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------CccEEEEEeCCCCcHHHHHHhcccCCCHHH
Confidence            5788887532 223344667788889999999999999998743      23678999996 799999975 35689999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcccccCCCCCC
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYT  162 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~  162 (316)
                      +..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......   ......++..|+|||.+.+ ..++
T Consensus       111 ~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~  189 (279)
T cd05111         111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYT  189 (279)
T ss_pred             HHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcC
Confidence            99999999999999999999999999999999999999999999987653322   1223345678999999876 6789


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          163 AAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       163 ~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      .++|||||||++||+++ |..||.+.........+.... ..+                             ....++.+
T Consensus       190 ~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-----------------------------~~~~~~~~  239 (279)
T cd05111         190 HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLA-----------------------------QPQICTID  239 (279)
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCC-----------------------------CCCCCCHH
Confidence            99999999999999998 999998776444333322110 000                             00134677


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +.+++.+||..||.+|||+.|+++
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.2e-34  Score=248.26  Aligned_cols=231  Identities=21%  Similarity=0.279  Sum_probs=174.3

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      ..++..+|+|.++.... ......+.+|+.+++.++||||+++++.+...     ...++||||++ |+|.+++....  
T Consensus        19 ~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~   92 (269)
T cd05087          19 GYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVMEFCPLGDLKGYLRSCRKA   92 (269)
T ss_pred             CCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEECCCCCcHHHHHHHhhhc
Confidence            35667899999876532 23345688899999999999999999988654     45899999996 79999986532  


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcc
Q 021181           80 ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPE  153 (316)
Q Consensus        80 ---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE  153 (316)
                         ..++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........   .....++..|+|||
T Consensus        93 ~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  172 (269)
T cd05087          93 ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE  172 (269)
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHh
Confidence               356778889999999999999999999999999999999999999999998865433221   12234567799999


Q ss_pred             cccCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          154 LLLNC------SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       154 ~~~~~------~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      ++...      ..++.++|+||||+++|+|++ |..||......+.............                      
T Consensus       173 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------  230 (269)
T cd05087         173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL----------------------  230 (269)
T ss_pred             HhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC----------------------
Confidence            98542      135789999999999999996 9999977654443332211100000                      


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +   ........+..+.++++.|+ .+|++|||++||+.
T Consensus       231 ~---~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         231 P---KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             C---CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            0   00111245778999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-34  Score=251.45  Aligned_cols=225  Identities=24%  Similarity=0.361  Sum_probs=179.5

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-----   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----   78 (316)
                      +++.|++|++... ........+.+|+.+++.++|+||+++++++...+    ...+++++|++ |+|.+++...     
T Consensus        34 ~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~~~~~~~~~~~~L~~~l~~~~~~~~  108 (280)
T cd05043          34 KEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEA  108 (280)
T ss_pred             ceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----CCCEEEEEcCCCCcHHHHHHhcccccc
Confidence            4788999988643 34445677889999999999999999999876432    45789999996 7999988653     


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCc
Q 021181           79 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAP  152 (316)
Q Consensus        79 ---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aP  152 (316)
                         ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||+++.......   .....++..|+||
T Consensus       109 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         109 NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence               3588999999999999999999999999999999999999999999999999876533221   1123346679999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      |.+.+ ..++.++|||||||++|++++ |..||...+..+....+......                             
T Consensus       189 E~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------  238 (280)
T cd05043         189 ESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL-----------------------------  238 (280)
T ss_pred             HHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC-----------------------------
Confidence            99876 678999999999999999998 99999877654443333221000                             


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                       .....+++++.+++.+||+.||++|||+.++++
T Consensus       239 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 -AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             001245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=281.36  Aligned_cols=223  Identities=25%  Similarity=0.384  Sum_probs=189.7

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC------
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH------   78 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~------   78 (316)
                      -..||||.++.. .+......+++|..+++.++|||||+++|++.+.     ...+|++|||. |+|..+|++.      
T Consensus       722 ~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-----~~~~i~leyM~gGDL~sflr~~r~~~~~  795 (1025)
T KOG1095|consen  722 PIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-----GPPLILLEYMEGGDLLSFLRESRPAPFQ  795 (1025)
T ss_pred             ceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-----CCcEEEehhcccCcHHHHHHhcccccCC
Confidence            346999999765 4566788999999999999999999999999875     45899999995 7999999876      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccc---ccccccccCccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPEL  154 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~aPE~  154 (316)
                       ..+++.+...++.+|+.|..||+++++|||||..+|+|++....+||+|||+++.+-.......   ......|+|||.
T Consensus       796 ~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEs  875 (1025)
T KOG1095|consen  796 PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPES  875 (1025)
T ss_pred             CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHH
Confidence             3489999999999999999999999999999999999999999999999999986544433221   133567999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.. ..++.++|||||||++||+++ |..||.+.+..+.+.......+-.+                             
T Consensus       876 l~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~-----------------------------  925 (1025)
T KOG1095|consen  876 LKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP-----------------------------  925 (1025)
T ss_pred             Hhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC-----------------------------
Confidence            998 889999999999999999998 9999999987777664443222111                             


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                       .+.++..+.+++..||+.+|++||++..|++
T Consensus       926 -P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 -PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence             1368888999999999999999999999986

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-34  Score=257.28  Aligned_cols=224  Identities=26%  Similarity=0.426  Sum_probs=178.9

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC----
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----   79 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----   79 (316)
                      +..||+|.++.. ........+.+|+.+++++ +||||+++++++...     ...+++|||++ |+|.+++....    
T Consensus        44 ~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~  117 (334)
T cd05100          44 PVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGM  117 (334)
T ss_pred             ceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCccc
Confidence            347999988653 2344567788999999999 799999999998654     45899999996 69999986532    


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---cccc
Q 021181           80 ------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYV  144 (316)
Q Consensus        80 ------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~  144 (316)
                                  .++..++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.++........   ....
T Consensus       118 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  197 (334)
T cd05100         118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR  197 (334)
T ss_pred             ccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCC
Confidence                        3778889999999999999999999999999999999999999999999998765432211   1222


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      ++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....                      
T Consensus       198 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------  254 (334)
T cd05100         198 LPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------  254 (334)
T ss_pred             cCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence            3457999999977 678899999999999999998 8999987765555444322100                      


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                              ......++..+.+++.+||+.+|.+||++.+++++
T Consensus       255 --------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         255 --------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                    00112467789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.7e-34  Score=249.58  Aligned_cols=227  Identities=19%  Similarity=0.332  Sum_probs=180.5

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      .+.+.|++|.+.... .......+..|++++++++|+||+++++++...     ...++||||++ |+|.+++....   
T Consensus        33 ~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~  106 (275)
T cd05046          33 GGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-----EPHYMILEYTDLGDLKQFLRATKSKD  106 (275)
T ss_pred             CCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-----CcceEEEEecCCCcHHHHHHhccccc
Confidence            356789999885432 233456788999999999999999999988554     45899999997 79999997765   


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccC
Q 021181           80 ------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRA  151 (316)
Q Consensus        80 ------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a  151 (316)
                            .+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++++|||.+.......  ......++..|+|
T Consensus       107 ~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~  186 (275)
T cd05046         107 EKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA  186 (275)
T ss_pred             ccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecC
Confidence                  68999999999999999999999999999999999999999999999999876543221  1223355677999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          152 PELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      ||.+.+ ...+.++||||||+++|+|++ |..||...........+......                       +    
T Consensus       187 PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-----------------------~----  238 (275)
T cd05046         187 PEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-----------------------L----  238 (275)
T ss_pred             hhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-----------------------C----
Confidence            999876 567899999999999999998 88899776544444333210000                       0    


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                        .....++..+.+++.+||+.||.+||++.+++..
T Consensus       239 --~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 --PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence              0112467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-34  Score=251.36  Aligned_cols=231  Identities=23%  Similarity=0.367  Sum_probs=177.3

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC----
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----   79 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----   79 (316)
                      ++..||+|++.... .......+.+|+.+++.++|+||+++++++...     ...+++|||++ |+|.+++....    
T Consensus        45 ~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~  118 (296)
T cd05095          45 QPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEA  118 (296)
T ss_pred             ceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccc
Confidence            45679999986542 344456788999999999999999999998654     34899999996 69999887643    


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccc
Q 021181           80 -------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWY  149 (316)
Q Consensus        80 -------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~  149 (316)
                             .+++.++..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+........   ......+..|
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~  198 (296)
T cd05095         119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW  198 (296)
T ss_pred             cccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCcccc
Confidence                   366778999999999999999999999999999999999999999999999876533221   1122335679


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      ++||...+ ..++.++|+|||||++|+|++  |..||...+..+..............                      
T Consensus       199 ~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------------  255 (296)
T cd05095         199 MSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR----------------------  255 (296)
T ss_pred             CCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc----------------------
Confidence            99998766 678999999999999999998  77898776654444322111100000                      


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                       .........++..+.+++.+||+.||.+||++.++++
T Consensus       256 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         256 -QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             -cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             0000111346788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-34  Score=260.97  Aligned_cols=228  Identities=25%  Similarity=0.354  Sum_probs=178.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      ..+++.||||+++... .......+.+|+.++.++. ||||+++++++...     ...++||||+. |+|.+++...+ 
T Consensus        64 ~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-----~~~~iv~E~~~~g~L~~~l~~~~~  137 (401)
T cd05107          64 SQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-----GPIYIITEYCRYGDLVDYLHRNKH  137 (401)
T ss_pred             CCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-----CCcEEEEeccCCCcHHHHHHhccc
Confidence            4567789999997653 2334457889999999997 99999999998654     45899999996 79999886432 


Q ss_pred             --------------------------------------------------------------------------------
Q 021181           80 --------------------------------------------------------------------------------   79 (316)
Q Consensus        80 --------------------------------------------------------------------------------   79 (316)
                                                                                                      
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (401)
T cd05107         138 TFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYL  217 (401)
T ss_pred             cchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhh
Confidence                                                                                            


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---
Q 021181           80 -----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---  139 (316)
Q Consensus        80 -----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---  139 (316)
                                       .++...+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++........   
T Consensus       218 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~  297 (401)
T cd05107         218 PSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS  297 (401)
T ss_pred             cccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccccc
Confidence                             256777889999999999999999999999999999999999999999999876432211   


Q ss_pred             cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHH
Q 021181          140 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR  218 (316)
Q Consensus       140 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  218 (316)
                      .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+........ +...              
T Consensus       298 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~~--------------  361 (401)
T cd05107         298 KGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYRM--------------  361 (401)
T ss_pred             CCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCCC--------------
Confidence            122345678999999876 668899999999999999998 89999776544433222110 0000              


Q ss_pred             HhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          219 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                    .....++.++.+++.+||+.||.+||++++|++.
T Consensus       362 --------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         362 --------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             --------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                          0112467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-34  Score=246.02  Aligned_cols=223  Identities=20%  Similarity=0.374  Sum_probs=178.5

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      ++..+|+|.++....   ....+..|++++++++||+++++++++...     ...+++|||+. ++|.+++... +.++
T Consensus        27 ~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~   98 (256)
T cd05112          27 EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICLVFEFMEHGCLSDYLRAQRGKFS   98 (256)
T ss_pred             CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEEEEEcCCCCcHHHHHHhCccCCC
Confidence            467899999865432   234578899999999999999999998544     45899999996 6899888754 4689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+.........  .....+..|+|||.+.+ ..
T Consensus        99 ~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~  177 (256)
T cd05112          99 QETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SK  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CC
Confidence            9999999999999999999999999999999999999999999999988765433221  12234567999999876 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|+||||+++|+|++ |..||...........+.......                              .....+
T Consensus       178 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~  227 (256)
T cd05112         178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY------------------------------KPRLAS  227 (256)
T ss_pred             cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC------------------------------CCCCCC
Confidence            8899999999999999998 999998776555554432211000                              001357


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ..+.+++.+||+.+|++||++.++++.
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=254.75  Aligned_cols=268  Identities=31%  Similarity=0.508  Sum_probs=194.9

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC--------CCCccceeeeecCCCCCCCCeEEEEEecCCCcHH
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLH   72 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~   72 (316)
                      +|.+++..||+|+.+..   +-..+..+.||.+|++++        ..+||++++.|...+ .+..|+|+|+|+++.+|.
T Consensus        98 wDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLL  173 (590)
T KOG1290|consen   98 WDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLL  173 (590)
T ss_pred             eeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHH
Confidence            47889999999998643   335577889999999983        346999999998776 455789999999999999


Q ss_pred             HHhhcC--CCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccC-----------------------------
Q 021181           73 QIIRSH--QDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNAN-----------------------------  120 (316)
Q Consensus        73 ~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~-----------------------------  120 (316)
                      .+|+..  ++++...++.|++||+.||.||| .+||+|.||||+|||+..+                             
T Consensus       174 klI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~  253 (590)
T KOG1290|consen  174 KLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTR  253 (590)
T ss_pred             HHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCccccccc
Confidence            999765  67999999999999999999999 7899999999999998300                             


Q ss_pred             ---------------------------------------------------------C----------------------
Q 021181          121 ---------------------------------------------------------C----------------------  121 (316)
Q Consensus       121 ---------------------------------------------------------~----------------------  121 (316)
                                                                               +                      
T Consensus       254 ~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n  333 (590)
T KOG1290|consen  254 PDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNREN  333 (590)
T ss_pred             ccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCcc
Confidence                                                                     0                      


Q ss_pred             ----------------------------------------------------------CEEEeeeccccccCCCCccccc
Q 021181          122 ----------------------------------------------------------DLKIGDFGLARTTSETDFMTEY  143 (316)
Q Consensus       122 ----------------------------------------------------------~~~l~df~~~~~~~~~~~~~~~  143 (316)
                                                                                ++||.|||.+-....  ..+.-
T Consensus       334 ~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~D  411 (590)
T KOG1290|consen  334 LPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTED  411 (590)
T ss_pred             ccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh--hhchh
Confidence                                                                      011222221111100  01112


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC------CcHHHHHHHHHhhCCCCccccc-------c
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK------DYVHQLRLITELIGSPDETSLG-------F  210 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~-------~  210 (316)
                      ..|..|+|||++.+ ..|+..+||||++|+++||+||..+|...      .+++.++.|..++|..+.....       +
T Consensus       412 IQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdF  490 (590)
T KOG1290|consen  412 IQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDF  490 (590)
T ss_pred             hhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhh
Confidence            34677999999999 78999999999999999999999999643      3678899999999987764331       1


Q ss_pred             ccccchHHHhhhCCCCCCCCc-cccCC---CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          211 LRSDNARRYVRMLPQFPKQNF-SARFP---NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      .+..+.-...+.+..|+..+. .+.+.   ....++.+||.-||+.+|++||||.++|+|||+.++...
T Consensus       491 Fnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  491 FNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             hccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            111111111111222222111 11111   224568999999999999999999999999999987754

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=243.78  Aligned_cols=245  Identities=23%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh----
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR----   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~----   76 (316)
                      ++.+|+..|||+|+.... ..+..+++.|.+...+- ++||||++||+....     +..||.||.++-+|..+.+    
T Consensus        85 hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCMELMd~SlDklYk~vy~  158 (361)
T KOG1006|consen   85 HKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICMELMDISLDKLYKRVYS  158 (361)
T ss_pred             cCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeHHHHhhhHHHHHHHHHH
Confidence            688999999999987643 45667788888876555 799999999998755     3489999999877655442    


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           77 -SHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        77 -~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                       ....+++.-+-.|..-.+.||.||. ..+|+|||+||+|||++..|.+||||||.+......-..+.-.|-..|+|||.
T Consensus       159 vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPER  238 (361)
T KOG1006|consen  159 VQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPER  238 (361)
T ss_pred             HHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhc
Confidence             3356899988899999999999999 67999999999999999999999999999877655444444566677999999


Q ss_pred             ccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh-hCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          155 LLNCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       155 ~~~~~~-~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +..... |+-++||||||+++||+.||..||...+.  ....+... .|.++....                       .
T Consensus       239 i~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~-----------------------~  293 (361)
T KOG1006|consen  239 IDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF-----------------------D  293 (361)
T ss_pred             cCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC-----------------------c
Confidence            976555 88999999999999999999999977653  44444333 233332211                       1


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      ...-+++..+..+|..||.+|-.+||...+|+++||++-+.....
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~  338 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP  338 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence            111257899999999999999999999999999999987754433

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.5e-34  Score=245.06  Aligned_cols=222  Identities=23%  Similarity=0.407  Sum_probs=177.2

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~   80 (316)
                      ..+..||+|.+...   ......+.+|+.+++.++|+||+++++.+..      ...+++|||++ ++|.+++...  ..
T Consensus        28 ~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05073          28 NKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSK   98 (260)
T ss_pred             cCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhCCccc
Confidence            34567999988643   2245678899999999999999999999854      34799999996 6999998763  45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.. 
T Consensus        99 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-  177 (260)
T cd05073          99 QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-  177 (260)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-
Confidence            78889999999999999999999999999999999999999999999998876543221  112234567999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|+|||||++|++++ |..||...+.......+......                              .....
T Consensus       178 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  227 (260)
T cd05073         178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------------------------------PRPEN  227 (260)
T ss_pred             CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC------------------------------CCccc
Confidence            678889999999999999998 99999887655554443221100                              11135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.++.+++.+||+.||.+||++.++++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            6788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.9e-35  Score=277.88  Aligned_cols=239  Identities=33%  Similarity=0.471  Sum_probs=181.9

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC---------------------------
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ---------------------------   53 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---------------------------   53 (316)
                      +|+-+|..||||+|.... ++....++.+|+.++++|+|||||++|..+....                           
T Consensus       499 RNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~  577 (1351)
T KOG1035|consen  499 RNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVD  577 (1351)
T ss_pred             eecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccce
Confidence            477899999999998876 6777899999999999999999999998764321                           


Q ss_pred             --------------------------C---------------------------------------------------CC
Q 021181           54 --------------------------R---------------------------------------------------ET   56 (316)
Q Consensus        54 --------------------------~---------------------------------------------------~~   56 (316)
                                                .                                                   +.
T Consensus       578 ~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n  657 (1351)
T KOG1035|consen  578 IRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTEN  657 (1351)
T ss_pred             eeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCC
Confidence                                      0                                                   00


Q ss_pred             --C--------CeEEEEEecCCCcH-HHHhhcCCCC-CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEE
Q 021181           57 --F--------NDVYIVYELMDTDL-HQIIRSHQDL-TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK  124 (316)
Q Consensus        57 --~--------~~~~iv~e~~~g~L-~~~l~~~~~~-~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~  124 (316)
                        .        ..+||=||||+.++ .+++..+... .....++++++|++||+|+|++||+||||||.||+++.++.+|
T Consensus       658 ~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VK  737 (1351)
T KOG1035|consen  658 SSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVK  737 (1351)
T ss_pred             ccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCee
Confidence              0        24789999998655 5555554433 4788999999999999999999999999999999999999999


Q ss_pred             EeeeccccccC-------------------CCCccccccccccccCcccccCCC--CCCCcchHHHHHHHHHHHHhCCCC
Q 021181          125 IGDFGLARTTS-------------------ETDFMTEYVVTRWYRAPELLLNCS--EYTAAIDIWSVGCILGEIMTRQPL  183 (316)
Q Consensus       125 l~df~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~~l~ell~g~~p  183 (316)
                      |+|||++....                   .....+..+||..|+|||++.+..  .|+.++|+||||++++||+.   |
T Consensus       738 IGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---P  814 (1351)
T KOG1035|consen  738 IGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---P  814 (1351)
T ss_pred             ecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---c
Confidence            99999986611                   111345678899999999998755  69999999999999999986   3


Q ss_pred             CCCCCcHHHHHHHHHhhC-CCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHH
Q 021181          184 FPGKDYVHQLRLITELIG-SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE  262 (316)
Q Consensus       184 f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e  262 (316)
                      |...  ++-...+..+.. ..+.. .                        .-+..--+.-..+|+.||+.||.+||||.|
T Consensus       815 F~Ts--MERa~iL~~LR~g~iP~~-~------------------------~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  815 FGTS--MERASILTNLRKGSIPEP-A------------------------DFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             CCch--HHHHHHHHhcccCCCCCC-c------------------------ccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            5432  222222222211 11110 0                        001122344679999999999999999999


Q ss_pred             HhcCCCCC
Q 021181          263 ALCHPYLA  270 (316)
Q Consensus       263 ll~~~~f~  270 (316)
                      ||++.||-
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999997

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.8e-34  Score=246.00  Aligned_cols=227  Identities=25%  Similarity=0.433  Sum_probs=181.0

Q ss_pred             CCceEEEEEecccc--------cChhHHHHHHHHHHHHhh-CCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHH
Q 021181            5 TREEVAIKKIGNAF--------DNRIDAKRTLREIKLLRH-MDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQI   74 (316)
Q Consensus         5 ~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~   74 (316)
                      +++.||+|.+....        ........+..|+.++.. ++||||+++++++...     ...+++|||++ ++|.++
T Consensus        25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~   99 (269)
T cd08528          25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN-----DRLYIVMDLIEGAPLGEH   99 (269)
T ss_pred             CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-----CeEEEEEecCCCCcHHHH
Confidence            67899999986432        223344567788888865 7999999999998654     56999999996 588877


Q ss_pred             hh----cCCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccc
Q 021181           75 IR----SHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWY  149 (316)
Q Consensus        75 l~----~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (316)
                      +.    ....+++..++.++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  179 (269)
T cd08528         100 FNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY  179 (269)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccC
Confidence            63    23568999999999999999999995 78999999999999999999999999998776554433455678889


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      ++||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+......+.                         
T Consensus       180 ~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------  233 (269)
T cd08528         180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-------------------------  233 (269)
T ss_pred             cChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-------------------------
Confidence            99999976 6689999999999999999999999987765555444432111110                         


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                          ....+++.+.++|++||+.||++||++.|+..+
T Consensus       234 ----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 ----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                001457889999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.5e-34  Score=274.85  Aligned_cols=126  Identities=23%  Similarity=0.402  Sum_probs=110.8

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||+++... ........+..|+.++..++|+||+++++.+...     ..+|+||||+. ++|.+++...+
T Consensus        25 ~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lVmEy~~g~~L~~li~~~~   99 (669)
T cd05610          25 KKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----NNVYLVMEYLIGGDVKSLLHIYG   99 (669)
T ss_pred             ECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CEEEEEEeCCCCCCHHHHHHhcC
Confidence            45689999999997542 3344457788999999999999999999888544     56999999995 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      .+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||+++
T Consensus       100 ~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         100 YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            89999999999999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.1e-35  Score=260.32  Aligned_cols=261  Identities=33%  Similarity=0.567  Sum_probs=202.6

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC------CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHH
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQI   74 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~   74 (316)
                      +|+.-|+.||||+|...   +.-...=+.|+++|++|+      --|+++++..|.+.     +|+|+|+|.+.-+|.++
T Consensus       452 ~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk-----nHLClVFE~LslNLRev  523 (752)
T KOG0670|consen  452 RDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK-----NHLCLVFEPLSLNLREV  523 (752)
T ss_pred             cccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-----ceeEEEehhhhchHHHH
Confidence            46778889999999653   222233468999999995      46799999998554     78999999999999999


Q ss_pred             hhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCCcccccccccccc
Q 021181           75 IRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYR  150 (316)
Q Consensus        75 l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (316)
                      +++.+   ++....++.++.|+..||..|..+||+|.||||.||||++. ..+||||||.+...+.+..+ .+.-+..|.
T Consensus       524 LKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit-PYLVSRFYR  602 (752)
T KOG0670|consen  524 LKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT-PYLVSRFYR  602 (752)
T ss_pred             HHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccccc-HHHHHHhcc
Confidence            98765   58999999999999999999999999999999999999876 45899999999888776543 344567899


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccc--cccchH-H--H------
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL--RSDNAR-R--Y------  219 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~-~--~------  219 (316)
                      |||++.+ -+|+...|+||.||++|||.||+..|++.....++.....+.|..+......-  ...... .  |      
T Consensus       603 aPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D  681 (752)
T KOG0670|consen  603 APEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVD  681 (752)
T ss_pred             Ccceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecc
Confidence            9999998 88999999999999999999999999999999999999998888877654210  000000 0  0      


Q ss_pred             -------hhhCCC-CCCCCccccCC---CC-------ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          220 -------VRMLPQ-FPKQNFSARFP---NK-------SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       220 -------~~~~~~-~~~~~~~~~~~---~~-------s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                             ...+.. .|..++.....   .+       -..+.+||.+||..||++|.|+.+.|.||||+.
T Consensus       682 ~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  682 KVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                   000000 00011111110   12       234899999999999999999999999999974

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-34  Score=249.48  Aligned_cols=243  Identities=25%  Similarity=0.381  Sum_probs=179.5

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-C
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-D   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~   80 (316)
                      ..+++.||||+++..... .....+.+|+.+++.+.|+||+++++++...+   ....+++|||+. ++|.+++.... .
T Consensus        30 ~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~l~~~~~~  105 (284)
T cd05038          30 DNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG---GRSLRLIMEYLPSGSLRDYLQRHRDQ  105 (284)
T ss_pred             CCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC---CCceEEEEecCCCCCHHHHHHhCccc
Confidence            457899999999765333 35677899999999999999999999886532   256899999996 69999987654 6


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----ccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~  156 (316)
                      +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........    ....++..|++||.+.
T Consensus       106 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  185 (284)
T cd05038         106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR  185 (284)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence            899999999999999999999999999999999999999999999999998776532211    1123355699999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|+|||||++++|++|..|+.........     ..+.....    ................      ....
T Consensus       186 ~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~~~~~------~~~~  249 (284)
T cd05038         186 T-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-----MIGIAQGQ----MIVTRLLELLKEGERL------PRPP  249 (284)
T ss_pred             c-CCCCcccchHHHhhhhheeeccCCCcccccchhcc-----cccccccc----ccHHHHHHHHHcCCcC------CCCc
Confidence            6 57889999999999999999999888654221100     00000000    0000000000000000      0112


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .++.++.+++.+||+.+|.+||++.|+++
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         250 SCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            45688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-34  Score=246.35  Aligned_cols=221  Identities=25%  Similarity=0.329  Sum_probs=176.9

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~   84 (316)
                      ..||+|.+.... .......+.+|+.++++++||||+++++++..      ...+++|||+. |+|.+.+... ..+++.
T Consensus        37 ~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~  109 (279)
T cd05057          37 IPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQ  109 (279)
T ss_pred             eEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHhccCCCCHH
Confidence            369999886553 24455678899999999999999999998864      34899999996 7999988764 468999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc---cccccccccCcccccCCCCC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~  161 (316)
                      .+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+..........   ....+..|+|||.+.. ..+
T Consensus       110 ~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~  188 (279)
T cd05057         110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIY  188 (279)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCc
Confidence            999999999999999999999999999999999999999999999987654332111   1223457999999866 678


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|+|||||++|++++ |..||.+....+....+..... .                             ......+.
T Consensus       189 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~-----------------------------~~~~~~~~  238 (279)
T cd05057         189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-L-----------------------------PQPPICTI  238 (279)
T ss_pred             CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-C-----------------------------CCCCCCCH
Confidence            899999999999999998 9999988765544433332110 0                             00123567


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.+++.+||..||.+||++.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            8999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-35  Score=264.51  Aligned_cols=235  Identities=26%  Similarity=0.423  Sum_probs=189.2

Q ss_pred             CCceEEEEEecc-cccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~   82 (316)
                      |+..||.|.+++ +.........+..|-.||..-.++-||++|-.|.+.     ..+|+||+|+. |++-.+|.+.+-|.
T Consensus       653 T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----dnLYFVMdYIPGGDmMSLLIrmgIFe  727 (1034)
T KOG0608|consen  653 TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFE  727 (1034)
T ss_pred             hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----CceEEEEeccCCccHHHHHHHhccCH
Confidence            567788888866 344555667778899999999999999999999766     45999999995 79999998889999


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---------C---------------
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---------D---------------  138 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---------~---------------  138 (316)
                      +..+++++.++..|+++.|..|++||||||+|||||.+|.+||+|||++.-+...         .               
T Consensus       728 E~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d  807 (1034)
T KOG0608|consen  728 EDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWAD  807 (1034)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhcc
Confidence            9999999999999999999999999999999999999999999999998543110         0               


Q ss_pred             -------------------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh
Q 021181          139 -------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL  199 (316)
Q Consensus       139 -------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~  199 (316)
                                         .....+||+.|+|||++.. ..++...|.||.||++|||+.|++||-.....++..++..+
T Consensus       808 ~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  808 ISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             ccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence                               0012468999999999988 77999999999999999999999999777654444333221


Q ss_pred             hCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 021181          200 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLH  273 (316)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~~~~f~~~~  273 (316)
                      ...                 +.-          ..-..+|.++.++|.++++ ++++|.   .++++..||||+.++
T Consensus       887 ~~~-----------------l~~----------~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  887 RNF-----------------LHI----------PYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hhc-----------------ccc----------ccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence            111                 000          0113689999999998655 788888   467899999999997

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-34  Score=245.41  Aligned_cols=215  Identities=19%  Similarity=0.283  Sum_probs=169.8

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~   84 (316)
                      ..|++|.+.....   ....+.+|+.+++.++||||+++++++.. .     ..++||||++ |+|.+++...+ .++..
T Consensus        31 ~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~  101 (259)
T cd05037          31 VSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----ENIMVEEYVKFGPLDVFLHREKNNVSLH  101 (259)
T ss_pred             eeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-C-----CcEEEEEcCCCCcHHHHHHhhccCCCHH
Confidence            4588887754321   15778899999999999999999998865 2     3689999996 69999988766 78999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-------CEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+..++.||+.||+|||++||+|+||||+||+++.++       .++|+|||.+......   ....++..|+|||.+..
T Consensus       102 ~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~  178 (259)
T cd05037         102 WKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR---EERVERIPWIAPECIRN  178 (259)
T ss_pred             HHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc---cccccCCCccChhhhcC
Confidence            9999999999999999999999999999999999887       7999999988765432   23345667999999876


Q ss_pred             C-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          158 C-SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       158 ~-~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      . ..++.++|||||||++|+|++ |..||...+..........    ...                    .        .
T Consensus       179 ~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~~~--------------------~--------~  226 (259)
T cd05037         179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----QHR--------------------L--------P  226 (259)
T ss_pred             CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----CCC--------------------C--------C
Confidence            3 368899999999999999999 5788866653222221110    000                    0        0


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ......+.++|.+||..+|.+||++.++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            011267999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.9e-34  Score=249.86  Aligned_cols=221  Identities=22%  Similarity=0.314  Sum_probs=174.0

Q ss_pred             eEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CCCHHH
Q 021181            8 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDH   85 (316)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~   85 (316)
                      .||+|.+.... .......+.+|+.+++.++||||+++++++...      ..+++++|+. |+|.+.+.... .+++..
T Consensus        38 ~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------~~~~v~e~~~~g~l~~~~~~~~~~~~~~~  110 (303)
T cd05110          38 PVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVHEHKDNIGSQL  110 (303)
T ss_pred             eEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC------CceeeehhcCCCCHHHHHHhcccCCCHHH
Confidence            57999886543 233345678999999999999999999988543      2578999996 79999887644 589999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCCCCCC
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYT  162 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  162 (316)
                      +..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++
T Consensus       111 ~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~  189 (303)
T cd05110         111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFT  189 (303)
T ss_pred             HHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCC
Confidence            999999999999999999999999999999999999999999999876543221   112334668999999876 6789


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          163 AAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       163 ~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      .++|||||||++|+|++ |..||.+.........+... ...+                             ..+.++..
T Consensus       190 ~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-----------------------------~~~~~~~~  239 (303)
T cd05110         190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ERLP-----------------------------QPPICTID  239 (303)
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCC-----------------------------CCCCCCHH
Confidence            99999999999999997 89999776543333322211 0000                             01245778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +.+++.+||..||.+||+++++++.
T Consensus       240 ~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.9e-33  Score=242.31  Aligned_cols=228  Identities=19%  Similarity=0.254  Sum_probs=171.7

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----CC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----QD   80 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~   80 (316)
                      ...+++|.++... .......+.+|+.+++.++||||+++++.+...     ...++||||+. |+|.+++...    ..
T Consensus        22 ~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~   95 (268)
T cd05086          22 VARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFEYCELGDLKSYLSQEQWHRRN   95 (268)
T ss_pred             cceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEecCCCCcHHHHHHhhhccccc
Confidence            4456777765432 233457789999999999999999999998654     45899999997 6999998753    34


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+...++.++.||+.||+|||+.+++|+||||+||+++.++.++|+|||.+.......   ......++..|+|||++..
T Consensus        96 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (268)
T cd05086          96 SQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE  175 (268)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhccc
Confidence            5677888999999999999999999999999999999999999999999875432211   1223456788999998743


Q ss_pred             C------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          158 C------SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       158 ~------~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      .      ..++.++|||||||++|+|++ |.+||...+..+....+........                      ..  
T Consensus       176 ~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~--  231 (268)
T cd05086         176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL----------------------FK--  231 (268)
T ss_pred             ccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc----------------------CC--
Confidence            1      235678999999999999997 5778877665554444322111000                      00  


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                       ......+++.+.++++.|| .+|.+||+++++++
T Consensus       232 -~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         232 -PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence             0111246788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.6e-34  Score=244.87  Aligned_cols=230  Identities=29%  Similarity=0.473  Sum_probs=178.3

Q ss_pred             CCCCceEEEEEeccc---ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-
Q 021181            3 SETREEVAIKKIGNA---FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-   77 (316)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-   77 (316)
                      ..++..+++|.++..   .........+..|+.+++.++||||+++++.+...     ...+++|||+. ++|.+++.. 
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   96 (260)
T cd08222          22 KKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----DAFCIITEYCEGRDLDCKLEEL   96 (260)
T ss_pred             cCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----CceEEEEEeCCCCCHHHHHHHH
Confidence            344555666665432   22233445677899999999999999999998654     45899999996 688887753 


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcc
Q 021181           78 ---HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPE  153 (316)
Q Consensus        78 ---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE  153 (316)
                         ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+....... ......++..|+|||
T Consensus        97 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe  175 (260)
T cd08222          97 KHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE  175 (260)
T ss_pred             hhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHH
Confidence               456899999999999999999999999999999999999975 569999999886653322 223345678899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.+ ..++.++|+||+|+++|+|++|..||...........+..  +..+                            .
T Consensus       176 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~----------------------------~  224 (260)
T cd08222         176 ALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP----------------------------S  224 (260)
T ss_pred             HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC----------------------------C
Confidence            9866 6678899999999999999999999976654333332211  1110                            1


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      ....++.++.++|.+||..||++||++.++++||||
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            112567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=266.04  Aligned_cols=189  Identities=30%  Similarity=0.396  Sum_probs=162.4

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC-CCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +|++||..||||.++... .....+..-+|++++++++|+|||+++++-.... ........++||||. |+|...+.+.
T Consensus        33 rnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P  111 (732)
T KOG4250|consen   33 RNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP  111 (732)
T ss_pred             cccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc
Confidence            579999999999997754 4446677889999999999999999999864332 011245789999995 7999999754


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC--C--CEEEeeeccccccCCCCccccccccccccC
Q 021181           79 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--C--DLKIGDFGLARTTSETDFMTEYVVTRWYRA  151 (316)
Q Consensus        79 ---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~--~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~a  151 (316)
                         .++++.+++.++..+..||.+||++||+||||||.||++...  |  ..||+|||.++....+....+..||..|++
T Consensus       112 EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLh  191 (732)
T KOG4250|consen  112 ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLH  191 (732)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcC
Confidence               569999999999999999999999999999999999998432  3  379999999999999988899999999999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 021181          152 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV  190 (316)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~  190 (316)
                      ||++...+.|+..+|.|||||++|++.||..||.....+
T Consensus       192 Pel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  192 PELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             hHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            999986688999999999999999999999999765433

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=262.68  Aligned_cols=239  Identities=25%  Similarity=0.403  Sum_probs=195.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      ++.+|+..|+|+......   ..+.+..|.++++.+ .|||++.+|++|...+......+|+|||||+ |+.-++++.. 
T Consensus        40 ~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~  116 (953)
T KOG0587|consen   40 HVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK  116 (953)
T ss_pred             eeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc
Confidence            567889999998865433   334577899999888 7999999999998766566678999999996 7888888754 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCccccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  156 (316)
                       ..+.+..+..|++.++.||.+||...++|||||-.|||++.++.+||+|||.+...... ..+.+..||+.|+|||++.
T Consensus       117 g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEVia  196 (953)
T KOG0587|consen  117 GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIA  196 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeee
Confidence             56889999999999999999999999999999999999999999999999998776543 3456789999999999986


Q ss_pred             CC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          157 NC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       157 ~~----~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      ..    ..|+..+|+||||++..||.-|.+|+-++..+..+-.|   ...|+++..                        
T Consensus       197 c~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkLk------------------------  249 (953)
T KOG0587|consen  197 CDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKLK------------------------  249 (953)
T ss_pred             cccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcccc------------------------
Confidence            43    34678899999999999999999999887755544332   222222211                        


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                       ....-+.++.+||..||..|-+.||+..++|+|||++.
T Consensus       250 -rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  250 -RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             -chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence             01133678999999999999999999999999999984

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=251.47  Aligned_cols=230  Identities=23%  Similarity=0.367  Sum_probs=188.0

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~   82 (316)
                      +..||||+++... ..-....+.+|+++|.+|+||||+.++|+|...+     .+++|+||++ |+|.+++..+  +...
T Consensus       562 ~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----PicmI~EYmEnGDLnqFl~aheapt~~  635 (807)
T KOG1094|consen  562 PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCMITEYMENGDLNQFLSAHELPTAE  635 (807)
T ss_pred             ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHHHHHHHhcCcHHHHHHhccCcccc
Confidence            5789999997653 4445688999999999999999999999998663     4899999997 8999999877  3345


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .....+|+.||+.|++||.+.++||||+.+.|+|++.++++||+|||+++..-..+.   ....+-+..|+|+|.+.. +
T Consensus       636 t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill-g  714 (807)
T KOG1094|consen  636 TAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL-G  714 (807)
T ss_pred             cchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-c
Confidence            666778999999999999999999999999999999999999999999986543332   223456788999999887 7


Q ss_pred             CCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      +++.++|+|++|+++||+++  ...||....+++..+.............                       ...+.+-
T Consensus       715 kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~-----------------------~l~~P~~  771 (807)
T KOG1094|consen  715 KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV-----------------------VLSRPPA  771 (807)
T ss_pred             cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce-----------------------eccCCCc
Confidence            89999999999999999865  7789988887777665554443322211                       1222246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++..+.+++..||..|-++|||+++|-.
T Consensus       772 cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  772 CPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            7888999999999999999999999854

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=265.71  Aligned_cols=228  Identities=29%  Similarity=0.358  Sum_probs=174.5

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC---
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD---   80 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~---   80 (316)
                      .|+.||||++-.+     ....+.+|+..++.- +||||+++|+.-.+.     ...||+.|.|..+|.++++..+.   
T Consensus       532 e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~-----qF~YIalELC~~sL~dlie~~~~d~~  601 (903)
T KOG1027|consen  532 EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDR-----QFLYIALELCACSLQDLIESSGLDVE  601 (903)
T ss_pred             CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCC-----ceEEEEehHhhhhHHHHHhccccchh
Confidence            4778999988433     334577999999988 699999999875443     56999999999999999987421   


Q ss_pred             -CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---C--CCEEEeeeccccccCCCCc----ccccccccccc
Q 021181           81 -LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---N--CDLKIGDFGLARTTSETDF----MTEYVVTRWYR  150 (316)
Q Consensus        81 -~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~--~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~  150 (316)
                       ......+.++.|++.||++||+.+|+||||||+||||+.   +  .+++|+|||+++.......    .....||.+|+
T Consensus       602 ~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~  681 (903)
T KOG1027|consen  602 MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQ  681 (903)
T ss_pred             hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCccccc
Confidence             122445788999999999999999999999999999976   3  4689999999998765432    34567899999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      |||.+.. ..-..++|||||||++|+.++| .-||...-..+  ..|.....                            
T Consensus       682 APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~----------------------------  730 (903)
T KOG1027|consen  682 APEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNY----------------------------  730 (903)
T ss_pred             CHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcc----------------------------
Confidence            9999987 5567799999999999999985 88996542111  11111000                            


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .+....+....++.+||.+|+++||..||+|.++|.||||=...
T Consensus       731 ~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  731 TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence            00000111112799999999999999999999999999996543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=251.01  Aligned_cols=219  Identities=23%  Similarity=0.408  Sum_probs=184.9

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CCCH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DLTD   83 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~   83 (316)
                      -.||||.++.   +......++.|+.+++.++|||+|+++|+|....     .+|||+|||. |+|.++++...  .++.
T Consensus       293 lTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFYIiTEfM~yGNLLdYLRecnr~ev~a  364 (1157)
T KOG4278|consen  293 LTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFYIITEFMCYGNLLDYLRECNRSEVPA  364 (1157)
T ss_pred             eeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeEEEEecccCccHHHHHHHhchhhcch
Confidence            4588998864   3456788999999999999999999999998653     4899999995 89999998754  3777


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccc--cccccccCcccccCCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY--VVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~--~~~~~~~aPE~~~~~~~~  161 (316)
                      -..++|+.||..|+.||..++++||||...|+||.++..+|+.|||+++.+..+.+....  ....-|.|||-+.- +.+
T Consensus       365 vvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtF  443 (1157)
T KOG4278|consen  365 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTF  443 (1157)
T ss_pred             hHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccc-ccc
Confidence            788899999999999999999999999999999999999999999999998776554322  23556999999877 779


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|||+|||++||+.| |-.||.+.+.......+.+..+-                              +....|++
T Consensus       444 SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM------------------------------~~PeGCPp  493 (1157)
T KOG4278|consen  444 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM------------------------------DGPEGCPP  493 (1157)
T ss_pred             ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc------------------------------cCCCCCCH
Confidence            999999999999999998 88999999877766665543221                              11137899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHh
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEAL  264 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell  264 (316)
                      .+.+|++.||+|.|.+||++.|+-
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHH
Confidence            999999999999999999998764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=253.49  Aligned_cols=227  Identities=25%  Similarity=0.322  Sum_probs=192.8

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--CCCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--HQDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~~   82 (316)
                      -..||||+++...... ....+++|+.++.+|+|+|++++||+..+..      ..+|||.+. |+|.+.+.+  ...|.
T Consensus       138 ~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp------~mMV~ELaplGSLldrLrka~~~~ll  210 (1039)
T KOG0199|consen  138 HVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP------AMMVFELAPLGSLLDRLRKAKKAILL  210 (1039)
T ss_pred             EEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch------hhHHhhhcccchHHHHHhhcccccee
Confidence            3478999998765444 7789999999999999999999999997643      689999997 899999987  34588


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccccc----ccccccCcccccCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV----VTRWYRAPELLLNC  158 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~----~~~~~~aPE~~~~~  158 (316)
                      ......++.||+.|+.||..+++|||||-..|+++-....+||+|||+++..+.+..+....    -...|+|||.+.. 
T Consensus       211 v~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-  289 (1039)
T KOG0199|consen  211 VSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-  289 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-
Confidence            99999999999999999999999999999999999999999999999999987765543222    2456999999988 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||++||++|||++ |+.||.+......++.|.....                              ..+-+.
T Consensus       290 ~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er------------------------------LpRPk~  339 (1039)
T KOG0199|consen  290 RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER------------------------------LPRPKY  339 (1039)
T ss_pred             ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc------------------------------CCCCCC
Confidence            789999999999999999998 8999999998888877753221                              122247


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      ++.++.+++..||..+|.+||++..|...-+..
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            899999999999999999999999987554443

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.1e-32  Score=236.54  Aligned_cols=209  Identities=16%  Similarity=0.147  Sum_probs=158.5

Q ss_pred             HHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceecc
Q 021181           30 EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD  109 (316)
Q Consensus        30 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d  109 (316)
                      +...+..+.|++++++++.+.... ......+++++++..++.+.+......++..++.++.|++.||+|||+.+|+|||
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrD  151 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGD  151 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            334456678999999998765432 1112457889988778877777666678899999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeeccccccCCCC--------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 021181          110 LKPSNLLLNANCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       110 l~p~nil~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~  181 (316)
                      |||+||+++.++.++|+|||+++......        ......+|..|+|||...+ ..++.++|||||||++|+|++|.
T Consensus       152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~  230 (294)
T PHA02882        152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIK  230 (294)
T ss_pred             CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999987653211        1123468999999999877 67899999999999999999999


Q ss_pred             CCCCCCCc-HHHHHHHHH-hhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCC
Q 021181          182 PLFPGKDY-VHQLRLITE-LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT  259 (316)
Q Consensus       182 ~pf~~~~~-~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps  259 (316)
                      +||.+... ......... ........                         ....+..+..+.+++..|+..+|++||+
T Consensus       231 ~P~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~  285 (294)
T PHA02882        231 LPWKGFGHNGNLIHAAKCDFIKRLHEG-------------------------KIKIKNANKFIYDFIECVTKLSYEEKPD  285 (294)
T ss_pred             CCCCccccchHHHHHhHHHHHHHhhhh-------------------------hhccCCCCHHHHHHHHHHHhCCCCCCCC
Confidence            99987732 222221111 00000000                         0012356788999999999999999999


Q ss_pred             HHHHhc
Q 021181          260 VDEALC  265 (316)
Q Consensus       260 ~~ell~  265 (316)
                      .++|++
T Consensus       286 ~~~l~~  291 (294)
T PHA02882        286 YDALIK  291 (294)
T ss_pred             HHHHHH
Confidence            999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=255.93  Aligned_cols=223  Identities=25%  Similarity=0.389  Sum_probs=195.0

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~   83 (316)
                      -..||||.++... .+.....++.|+.++.++.||||+++.|+....     ..+.||+|||+ |+|..+|+.+ +.|+.
T Consensus       657 e~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~DGqftv  730 (996)
T KOG0196|consen  657 EITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQNDGQFTV  730 (996)
T ss_pred             ceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcCCceEe
Confidence            4679999997654 445678899999999999999999999999765     34899999996 8999999765 66999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccc--cccccCcccccCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVV--TRWYRAPELLLNCS  159 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~--~~~~~aPE~~~~~~  159 (316)
                      .++.-|++-|+.|+.||-+.|+|||||...||||+.+-.+|++|||+++....+.  ......|  +.+|.|||.+.. .
T Consensus       731 iQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-R  809 (996)
T KOG0196|consen  731 IQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-R  809 (996)
T ss_pred             ehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-c
Confidence            9999999999999999999999999999999999999999999999999775443  1222222  568999999988 7


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      +++.++||||+|++|||.++ |+.||=++..-+.++.|.+..+.|++                              .++
T Consensus       810 KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP------------------------------mDC  859 (996)
T KOG0196|consen  810 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP------------------------------MDC  859 (996)
T ss_pred             ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC------------------------------CCC
Confidence            89999999999999999987 99999999999999999888776664                              268


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +..+.+|+..||++|-..||.+.+|++
T Consensus       860 P~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            999999999999999999999888765

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-32  Score=234.89  Aligned_cols=242  Identities=25%  Similarity=0.443  Sum_probs=189.1

Q ss_pred             CCCCCceEEEEEecccccChh-----HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHh
Q 021181            2 NSETREEVAIKKIGNAFDNRI-----DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQII   75 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l   75 (316)
                      |......||||+-........     ..+...+|..+.+.|.||.||++|++|.-..    ..+|.|+|||+| +|.-++
T Consensus       484 Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt----dsFCTVLEYceGNDLDFYL  559 (775)
T KOG1151|consen  484 DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT----DSFCTVLEYCEGNDLDFYL  559 (775)
T ss_pred             ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc----ccceeeeeecCCCchhHHH
Confidence            667788999998755432221     2255678999999999999999999997432    568999999986 888889


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHhhcC--CceeccCCCCcEEEc---cCCCEEEeeeccccccCCCCc--------ccc
Q 021181           76 RSHQDLTDDHCRYFLYQLLRGLKYVHSA--NVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETDF--------MTE  142 (316)
Q Consensus        76 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~--------~~~  142 (316)
                      +.++-+++.+++.|+.||+.||.||...  -|+|-||||.|||+-   .-|.+||+|||+++.+.....        ...
T Consensus       560 KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQ  639 (775)
T KOG1151|consen  560 KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQ  639 (775)
T ss_pred             HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecc
Confidence            8889999999999999999999999966  499999999999984   347899999999998765432        345


Q ss_pred             ccccccccCcccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHH
Q 021181          143 YVVTRWYRAPELLLNC---SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY  219 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  219 (316)
                      ..||.||++||.+.-.   ...+.++||||+||++|.++.|+.||...-.-..+-..-..+...                
T Consensus       640 gAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt----------------  703 (775)
T KOG1151|consen  640 GAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT----------------  703 (775)
T ss_pred             cCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce----------------
Confidence            6789999999987532   345789999999999999999999997653222221111111000                


Q ss_pred             hhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          220 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                              .-. -...|-++.++++||++||+.--++|..+.+|-.||||..-
T Consensus       704 --------EVq-FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  704 --------EVQ-FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             --------ecc-CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence                    000 01124678999999999999999999999999999999873

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=1.4e-31  Score=251.29  Aligned_cols=249  Identities=18%  Similarity=0.252  Sum_probs=154.5

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC-CCCCCeEEEEEecCC-CcHHHHhhcCCC---
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMD-TDLHQIIRSHQD---   80 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~iv~e~~~-g~L~~~l~~~~~---   80 (316)
                      +..||||++.....    ......+  .++...+.++..+...+.... ......+++||||++ ++|.+++.....   
T Consensus       161 ~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~  234 (566)
T PLN03225        161 EGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYN  234 (566)
T ss_pred             CcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchh
Confidence            89999999854211    1111111  122222333333332222111 123356999999997 689988865321   


Q ss_pred             -----------------CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCC--Ccc
Q 021181           81 -----------------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSET--DFM  140 (316)
Q Consensus        81 -----------------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~--~~~  140 (316)
                                       .....+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++......  ...
T Consensus       235 v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~  314 (566)
T PLN03225        235 VEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP  314 (566)
T ss_pred             HHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCC
Confidence                             123446789999999999999999999999999999986 578999999999764322  223


Q ss_pred             ccccccccccCcccccCCC---------------------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh
Q 021181          141 TEYVVTRWYRAPELLLNCS---------------------EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL  199 (316)
Q Consensus       141 ~~~~~~~~~~aPE~~~~~~---------------------~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~  199 (316)
                      ....+++.|+|||.+....                     .++.++||||+||++|||+++..++.  +.......+...
T Consensus       315 ~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~  392 (566)
T PLN03225        315 KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKR  392 (566)
T ss_pred             cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHh
Confidence            4567789999999754311                     13345699999999999998765532  222222222211


Q ss_pred             hCCCCccccccccccchHHHhhhCCCCCCCCc---cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          200 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNF---SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      .+....            .+............   .+.....+....+||.+||+.||++|||++++|+||||++...
T Consensus       393 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        393 NDYDLV------------AWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             cCCcHH------------HHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence            111100            00000000000000   0111123445779999999999999999999999999988653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=246.97  Aligned_cols=223  Identities=28%  Similarity=0.453  Sum_probs=184.5

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC----
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----   79 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----   79 (316)
                      ...||||.++..... .+.+.+..|+.+++.+ .|+||+.++|++...     +.+++|+||+. |+|..+++..+    
T Consensus       328 ~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~  401 (609)
T KOG0200|consen  328 YVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTES  401 (609)
T ss_pred             eEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC-----CceEEEEEeccCCcHHHHHHhcccccc
Confidence            678999999876554 7788999999999999 699999999999763     55999999997 89999998766    


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccc--cc-
Q 021181           80 ------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YV-  144 (316)
Q Consensus        80 ------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~-  144 (316)
                                  .++..+...+++||+.|++||++.+++||||-..|||+..+..+|++|||+++..........  .. 
T Consensus       402 ~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~  481 (609)
T KOG0200|consen  402 IDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAG  481 (609)
T ss_pred             ccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCC
Confidence                        388999999999999999999999999999999999999999999999999987655443321  11 


Q ss_pred             -ccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC-cHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          145 -VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       145 -~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                       -+..|+|||.+.. ..++.++||||+|+++||+.+ |..||.+.. ..+....+......                   
T Consensus       482 ~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~-------------------  541 (609)
T KOG0200|consen  482 TLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM-------------------  541 (609)
T ss_pred             ccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC-------------------
Confidence             3456999999988 889999999999999999998 899998854 33343333322111                   


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                 +....++.++.++++.||+.+|++||++.++..
T Consensus       542 -----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  542 -----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                       111257899999999999999999999988764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=247.27  Aligned_cols=239  Identities=26%  Similarity=0.369  Sum_probs=202.5

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +|+.+++..|+|+++....+  +.+-+++|+.+++.++||||+.+++.|...+     .+||+||||+ |+|.+...-.+
T Consensus        35 Rd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~d-----klwicMEycgggslQdiy~~Tg  107 (829)
T KOG0576|consen   35 RDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLWICMEYCGGGSLQDIYHVTG  107 (829)
T ss_pred             cccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhc-----CcEEEEEecCCCcccceeeecc
Confidence            68999999999999886443  4556789999999999999999999998664     3999999997 69999988889


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCccccc--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLL--  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~--  156 (316)
                      ++++.++..+.++.+.||+|||++|-+|||||-.||+++..|.+|+.|||.+..++.. ..+..+.||++|+|||+..  
T Consensus       108 plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaave  187 (829)
T KOG0576|consen  108 PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE  187 (829)
T ss_pred             cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHH
Confidence            9999999999999999999999999999999999999999999999999988665433 3356789999999999852  


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ....|...+|+|++|++..|+-..++|.........+..+.+....++.....                          .
T Consensus       188 rkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk--------------------------~  241 (829)
T KOG0576|consen  188 RKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK--------------------------T  241 (829)
T ss_pred             hcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC--------------------------c
Confidence            33578899999999999999999999987777777776665544444332111                          1


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      .-++.+.+|++.+|..+|++||+++.+|.|||+..-
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            236679999999999999999999999999998754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=207.03  Aligned_cols=191  Identities=25%  Similarity=0.402  Sum_probs=155.6

Q ss_pred             CCCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHH----Hh
Q 021181            1 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQ----II   75 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~----~l   75 (316)
                      ++..+|+-.|+|.+..... .....+.+.|+.+..+. .+|++|.+||.+...     ..++|.||.++.+|..    .+
T Consensus        66 rh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-----gdvwIcME~M~tSldkfy~~v~  139 (282)
T KOG0984|consen   66 RHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-----GDVWICMELMDTSLDKFYRKVL  139 (282)
T ss_pred             eeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-----ccEEEeHHHhhhhHHHHHHHHH
Confidence            4678999999999987755 44667788888887776 799999999988654     4599999999877754    45


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           76 RSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        76 ~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                      .+++..++..+-+|+.+++.||.||| +..++|||+||+|||++..|++|+||||.+......-..+--.|-..|+|||.
T Consensus       140 ~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEr  219 (282)
T KOG0984|consen  140 KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPER  219 (282)
T ss_pred             hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhh
Confidence            56778999999999999999999999 55899999999999999999999999999977655433332345567999998


Q ss_pred             ccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHH
Q 021181          155 LLN---CSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLIT  197 (316)
Q Consensus       155 ~~~---~~~~~~~~DiwslG~~l~ell~g~~pf~~~~-~~~~~~~i~  197 (316)
                      +..   ...|+-++||||||+++.||.+++.||.... ..++++.++
T Consensus       220 i~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV  266 (282)
T KOG0984|consen  220 INPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV  266 (282)
T ss_pred             cCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence            743   2468899999999999999999999997753 444555444

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=8.4e-30  Score=234.07  Aligned_cols=250  Identities=18%  Similarity=0.273  Sum_probs=165.2

Q ss_pred             CCCceEEEEEecccccCh------------hHHHHHHHHHHHHhhCCCCC-----ccceeeeecCCCC---CCCCeEEEE
Q 021181            4 ETREEVAIKKIGNAFDNR------------IDAKRTLREIKLLRHMDHEN-----IIAIKDIIRPPQR---ETFNDVYIV   63 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~-----i~~~~~~~~~~~~---~~~~~~~iv   63 (316)
                      ..+..||||++.......            ...+....|+.++.+++|.+     +++++++|.....   ......++|
T Consensus       184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV  263 (507)
T PLN03224        184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLV  263 (507)
T ss_pred             ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEE
Confidence            456789999986532110            01122334677777776554     4677777654211   123468999


Q ss_pred             EecCC-CcHHHHhhcCC------------------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc
Q 021181           64 YELMD-TDLHQIIRSHQ------------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN  118 (316)
Q Consensus        64 ~e~~~-g~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~  118 (316)
                      |||++ ++|.+++....                        .+++..++.++.|++.||.|||+.+|+||||||+||+++
T Consensus       264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~  343 (507)
T PLN03224        264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT  343 (507)
T ss_pred             EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC
Confidence            99996 69988875321                        235677889999999999999999999999999999999


Q ss_pred             cCCCEEEeeeccccccCCCCcccc--ccccccccCcccccCCCC---------------------CCCcchHHHHHHHHH
Q 021181          119 ANCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNCSE---------------------YTAAIDIWSVGCILG  175 (316)
Q Consensus       119 ~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~---------------------~~~~~DiwslG~~l~  175 (316)
                      .++.++|+|||++...........  ...++.|+|||.+.....                     .....|+||+||++|
T Consensus       344 ~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~  423 (507)
T PLN03224        344 VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLM  423 (507)
T ss_pred             CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHH
Confidence            999999999999866543322222  234788999998754211                     123479999999999


Q ss_pred             HHHhCCC-CCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCC
Q 021181          176 EIMTRQP-LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDP  254 (316)
Q Consensus       176 ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP  254 (316)
                      +|++|.. ||.............   .            .....+. .... ....+ ......++..++++.+||..+|
T Consensus       424 em~~~~l~p~~~~~~f~~~~~~~---~------------~~~~~~r-~~~~-~~~~~-~~~d~~s~~~~dLi~~LL~~~~  485 (507)
T PLN03224        424 QMCVPELRPVANIRLFNTELRQY---D------------NDLNRWR-MYKG-QKYDF-SLLDRNKEAGWDLACKLITKRD  485 (507)
T ss_pred             HHHhCCCCCccchhhhhhHHhhc---c------------chHHHHH-hhcc-cCCCc-ccccccChHHHHHHHHHhccCC
Confidence            9999875 665432111100000   0            0000000 0000 00011 1234578899999999999876


Q ss_pred             ---CCCCCHHHHhcCCCCCC
Q 021181          255 ---NRRITVDEALCHPYLAP  271 (316)
Q Consensus       255 ---~~Rps~~ell~~~~f~~  271 (316)
                         .+|+|++|+|+||||..
T Consensus       486 ~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        486 QANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCcccCCCHHHHhCCCCcCC
Confidence               68999999999999964

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=3e-31  Score=260.17  Aligned_cols=207  Identities=15%  Similarity=0.221  Sum_probs=149.3

Q ss_pred             HhhCCC-CCccceeeeecCCCC--CCCCeEEEEEecCCCcHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCceecc
Q 021181           34 LRHMDH-ENIIAIKDIIRPPQR--ETFNDVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD  109 (316)
Q Consensus        34 l~~l~h-~~i~~~~~~~~~~~~--~~~~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d  109 (316)
                      .+.++| +||+++++.|.....  .....++.++|+++++|.+++.. ...+++.+++.+++||+.||+|||++||+|||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            345556 688888888743321  11235788899999999999965 35699999999999999999999999999999


Q ss_pred             CCCCcEEEccCCC-------------------EEEeeeccccccCCCC-----------------ccccccccccccCcc
Q 021181          110 LKPSNLLLNANCD-------------------LKIGDFGLARTTSETD-----------------FMTEYVVTRWYRAPE  153 (316)
Q Consensus       110 l~p~nil~~~~~~-------------------~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE  153 (316)
                      |||+|||++..+.                   +|++|||+++......                 ......+|++|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            9999999965444                   5555555554321100                 001134688899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      ++.+ ..++.++|||||||++|||++|.+|+....  .....+..... ++                             
T Consensus       186 ~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~-----------------------------  232 (793)
T PLN00181        186 EDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PP-----------------------------  232 (793)
T ss_pred             hhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-Ch-----------------------------
Confidence            9887 678999999999999999999988874321  11111111000 00                             


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ......+....++.+||+.||.+||++.|+++||||.+..
T Consensus       233 ~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        233 QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            0001234567899999999999999999999999998754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=5.9e-30  Score=256.99  Aligned_cols=230  Identities=17%  Similarity=0.266  Sum_probs=163.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      +.+|..||||+++.....      ...|++.+++++||||+++++++...     ...++||||++ |+|.++++   .+
T Consensus       712 ~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~---~l  777 (968)
T PLN00113        712 IKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLR---NL  777 (968)
T ss_pred             CCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHh---cC
Confidence            468899999998643211      12568889999999999999999654     34899999996 79999985   48


Q ss_pred             CHHHHHHHHHHHHHHHHHhh---cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVH---SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++.++..++.|++.|++|||   +.+|+||||||+||+++.++..++. ++........   ....++..|+|||.+.+ 
T Consensus       778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~-  852 (968)
T PLN00113        778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRET-  852 (968)
T ss_pred             CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---CCccccccccCcccccC-
Confidence            89999999999999999999   6699999999999999998887765 5544332111   22356789999999877 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ..++.++||||+||++|||++|+.||.....  ..............           ......+.....   . .....
T Consensus       853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~---~-~~~~~  917 (968)
T PLN00113        853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-----------HLDMWIDPSIRG---D-VSVNQ  917 (968)
T ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-----------chhheeCccccC---C-CCccH
Confidence            7789999999999999999999999854311  11111110000000           000000000000   0 00001


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ....++.+++.+||+.||++||+++|+++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            122357889999999999999999999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.3e-29  Score=217.73  Aligned_cols=257  Identities=30%  Similarity=0.454  Sum_probs=188.7

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      ++..||+|.+....    .-..+..|+++|..+ .+.||+++.+.+..+     .+..+|+||++. +..+++.   .++
T Consensus        63 ~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn-----d~v~ivlp~~~H~~f~~l~~---~l~  130 (418)
T KOG1167|consen   63 KRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN-----DQVAIVLPYFEHDRFRDLYR---SLS  130 (418)
T ss_pred             ccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccC-----CeeEEEecccCccCHHHHHh---cCC
Confidence            67899999995532    335588999999999 699999999998665     569999999984 6666654   567


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeecccccc-----------------CC----C---
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTT-----------------SE----T---  137 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~-----------------~~----~---  137 (316)
                      ..+++.+++.++.||.++|.+||+||||||+|++.+.. +.-.|+|||++...                 ..    .   
T Consensus       131 ~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~  210 (418)
T KOG1167|consen  131 LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHC  210 (418)
T ss_pred             HHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccc
Confidence            99999999999999999999999999999999999754 66889999988510                 00    0   


Q ss_pred             ----------C-----------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC-CCCcHHHHHH
Q 021181          138 ----------D-----------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP-GKDYVHQLRL  195 (316)
Q Consensus       138 ----------~-----------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~-~~~~~~~~~~  195 (316)
                                .           ......||++|.|||++.....-++++||||.|+++..++++..||- ..++...+.+
T Consensus       211 ~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~e  290 (418)
T KOG1167|consen  211 QSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAE  290 (418)
T ss_pred             cccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHH
Confidence                      0           00123579999999999988888999999999999999999998864 4566777777


Q ss_pred             HHHhhCCCCcccc-----c--ccccc---chHHHhhh--------CCCCCC--CCccccCCCCChHHHHHHHHhcccCCC
Q 021181          196 ITELIGSPDETSL-----G--FLRSD---NARRYVRM--------LPQFPK--QNFSARFPNKSPGAVDLLEKMLVFDPN  255 (316)
Q Consensus       196 i~~~~~~~~~~~~-----~--~~~~~---~~~~~~~~--------~~~~~~--~~~~~~~~~~s~~l~~li~~~L~~dP~  255 (316)
                      +....|......-     .  .++..   .+......        +.....  .....-....+..+.+++.+||..||.
T Consensus       291 i~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~  370 (418)
T KOG1167|consen  291 IATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQ  370 (418)
T ss_pred             HHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChh
Confidence            7666653221110     0  11100   11111111        111011  011111224566899999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q 021181          256 RRITVDEALCHPYLAPLH  273 (316)
Q Consensus       256 ~Rps~~ell~~~~f~~~~  273 (316)
                      +|.|+++.|+||||...+
T Consensus       371 kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  371 KRITAEDALKHPFFDEAD  388 (418)
T ss_pred             hcccHHHHhcCcCCcchh
Confidence            999999999999999765

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=231.41  Aligned_cols=222  Identities=24%  Similarity=0.315  Sum_probs=185.3

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~   83 (316)
                      +-+||||++... ........+++|+-++.+++|||++++++++..+.      +.||++|++ |+|.++++.+ .++-.
T Consensus       725 KipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~qlvtq~mP~G~LlDyvr~hr~~igs  797 (1177)
T KOG1025|consen  725 KIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------LQLVTQLMPLGCLLDYVREHRDNIGS  797 (1177)
T ss_pred             cceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------HHHHHHhcccchHHHHHHHhhccccH
Confidence            457999988654 34445678999999999999999999999997542      789999997 8999998765 56889


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccc---ccccccccCcccccCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~  160 (316)
                      +..+.|.+||+.|+.|||.++++||||-..||||.+-..+|+.|||+++..........   ..-..-|+|-|.+.. ..
T Consensus       798 q~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~  876 (1177)
T KOG1025|consen  798 QDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RK  876 (1177)
T ss_pred             HHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cC
Confidence            99999999999999999999999999999999999999999999999988765543322   222456888888877 78


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++||||+||++||++| |..|+.+....+.-..+.+..+-.                              ..+.++
T Consensus       877 ~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs------------------------------qPpiCt  926 (1177)
T KOG1025|consen  877 YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS------------------------------QPPICT  926 (1177)
T ss_pred             CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC------------------------------CCCCcc
Confidence            9999999999999999998 999999988766666555433311                              114678


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .++..++.+||..|+..||+++++..
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHH
Confidence            89999999999999999999988764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-30  Score=227.20  Aligned_cols=180  Identities=27%  Similarity=0.401  Sum_probs=156.5

Q ss_pred             CCCCCCceEEEEEeccccc--C----hhHHHHHHHHHHHHhhCC---CCCccceeeeecCCCCCCCCeEEEEEecCC-C-
Q 021181            1 MNSETREEVAIKKIGNAFD--N----RIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMD-T-   69 (316)
Q Consensus         1 ~d~~~~~~vavK~~~~~~~--~----~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g-   69 (316)
                      +++++...|+||.|.++..  +    +...-.+-.|+++|..++   |+||++++++|.+.     +.+||+||.-+ | 
T Consensus       581 i~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd-----d~yyl~te~hg~gI  655 (772)
T KOG1152|consen  581 IHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD-----DYYYLETEVHGEGI  655 (772)
T ss_pred             eecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC-----CeeEEEecCCCCCc
Confidence            3678899999999977531  1    111223457999999997   99999999999554     56999999986 5 


Q ss_pred             cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccc
Q 021181           70 DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWY  149 (316)
Q Consensus        70 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (316)
                      +|+++|...+.+++.+++.|+.|++.|++.||++||+|||||-+|+.++.+|-+||+|||.+...... +...+.||..|
T Consensus       656 DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg-pfd~f~gtv~~  734 (772)
T KOG1152|consen  656 DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDY  734 (772)
T ss_pred             chhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCC-Ccceeeeeccc
Confidence            99999999999999999999999999999999999999999999999999999999999988776543 45678999999


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG  186 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~  186 (316)
                      .|||++.+....+...|||+||+++|.+.....||..
T Consensus       735 aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  735 AAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999977788999999999999999999988853

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.2e-27  Score=197.27  Aligned_cols=196  Identities=37%  Similarity=0.638  Sum_probs=167.3

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~   81 (316)
                      .+|+.+++|++....... ....+.+|+..++.+.|++|+++++++...     ...++++|+++ ++|.+++... ..+
T Consensus        16 ~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~~   89 (215)
T cd00180          16 KTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEGGSLKDLLKENEGKL   89 (215)
T ss_pred             CCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCCCcHHHHHHhccCCC
Confidence            468999999997543222 456788999999999999999999998654     46899999998 7999998765 578


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +...+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|.+||.+....
T Consensus        90 ~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  169 (215)
T cd00180          90 SEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG  169 (215)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccC
Confidence            99999999999999999999999999999999999999 8999999999887654432 123345677899999987633


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++|+|++|++++++                                                              
T Consensus       170 ~~~~~~D~~~lg~~~~~l--------------------------------------------------------------  187 (215)
T cd00180         170 YYSEKSDIWSLGVILYEL--------------------------------------------------------------  187 (215)
T ss_pred             CCCchhhhHHHHHHHHHH--------------------------------------------------------------
Confidence            788999999999999999                                                              


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHP  267 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~  267 (316)
                      ..+.+++.+|++.||.+||+++++++++
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            1278999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-28  Score=212.50  Aligned_cols=171  Identities=25%  Similarity=0.328  Sum_probs=140.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC--CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM--DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      -+++.||||++.     ..+.+.+..|-++++..  +|+||++++++-.... .....++||++|.+ |+|.++++. ..
T Consensus       231 L~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt~fh~kGsL~dyL~~-nt  303 (534)
T KOG3653|consen  231 LDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVTEFHPKGSLCDYLKA-NT  303 (534)
T ss_pred             ccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEeeeccCCcHHHHHHh-cc
Confidence            357899999984     44566677787777765  8999999998765433 22356999999997 999999976 56


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcC---------CceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccccccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSA---------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRW  148 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~---------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~  148 (316)
                      .++.+..+++..|+.||+|||+.         .|+|||||+.||||..++++.|+|||++........   ....+||.+
T Consensus       304 isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~R  383 (534)
T KOG3653|consen  304 ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRR  383 (534)
T ss_pred             ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhh
Confidence            89999999999999999999954         499999999999999999999999999977654322   234789999


Q ss_pred             ccCcccccCCCCCC-----CcchHHHHHHHHHHHHhCC
Q 021181          149 YRAPELLLNCSEYT-----AAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       149 ~~aPE~~~~~~~~~-----~~~DiwslG~~l~ell~g~  181 (316)
                      |+|||++.+.-...     .+.||||+|.++|||++..
T Consensus       384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            99999998744444     4689999999999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=9.7e-29  Score=199.49  Aligned_cols=165  Identities=22%  Similarity=0.287  Sum_probs=127.5

Q ss_pred             CcHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccc
Q 021181           69 TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR  147 (316)
Q Consensus        69 g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (316)
                      |+|.+++.. ..++++.+++.++.||+.||.|||+.+      ||+||+++.++.+++  ||.+.......    ..++.
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            689999986 456999999999999999999999998      999999999999999  99887654432    25789


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      .|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+............                  
T Consensus        69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------  129 (176)
T smart00750       69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR------------------  129 (176)
T ss_pred             cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc------------------
Confidence            9999999987 77899999999999999999999999765432 222222221111100000                  


Q ss_pred             CCCCccccCCCCCh--HHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          227 PKQNFSARFPNKSP--GAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       227 ~~~~~~~~~~~~s~--~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                            .....++.  .+.++|.+||..||.+||++.++++|+|+.
T Consensus       130 ------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      130 ------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                  00011222  699999999999999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-28  Score=207.67  Aligned_cols=223  Identities=20%  Similarity=0.302  Sum_probs=184.1

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-------
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-------   78 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------   78 (316)
                      +.|-+|.++. ..++.....+++|..++.-+.|||+..+.+++...    ....++++.+.+ |+|..++...       
T Consensus       315 q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~  389 (563)
T KOG1024|consen  315 QEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED----YATPFVLYPATGVGNLKSFLQICRGDDPSY  389 (563)
T ss_pred             HHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec----cCcceEEEeccCcchHHHHHHHhccCCCcc
Confidence            4455555543 24555667788999999999999999999998743    256889999998 8999998721       


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPEL  154 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~  154 (316)
                       ..++..+...++.|++.|+++||+.|++|.||...|.++|+.-++||+|-.+++.....+..   .....+..|+|||.
T Consensus       390 aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEa  469 (563)
T KOG1024|consen  390 AQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEA  469 (563)
T ss_pred             ccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHH
Confidence             23778889999999999999999999999999999999999999999999998876554332   12234667999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.+ ..++.++|+||||+++|||+| |+.||..-++.++...+.+..+...+                            
T Consensus       470 l~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP----------------------------  520 (563)
T KOG1024|consen  470 LQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP----------------------------  520 (563)
T ss_pred             Hhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC----------------------------
Confidence            988 789999999999999999998 99999999988888877665443322                            


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                        -++++++..++..||..+|++||+++++..
T Consensus       521 --~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  521 --FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             --CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence              268999999999999999999999999874

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-27  Score=206.03  Aligned_cols=228  Identities=22%  Similarity=0.310  Sum_probs=163.0

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHh--hCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLR--HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~--~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      -|+.||||++...     +.....+|.++++  -|+|+||+.+++.-.... .+-..+|+|++|-+ |+|+|++.. ..+
T Consensus       233 rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv  305 (513)
T KOG2052|consen  233 RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTV  305 (513)
T ss_pred             cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-ccC
Confidence            4899999999542     1222345555554  559999999998755432 34467999999997 999999977 779


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcC--------CceeccCCCCcEEEccCCCEEEeeeccccccCCC-----Ccccccccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-----DFMTEYVVTRW  148 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~  148 (316)
                      +.....+++.+++.||++||..        .|+|||||+.||||..++.+.|+|+|++......     ...+..+||.+
T Consensus       306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR  385 (513)
T KOG2052|consen  306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR  385 (513)
T ss_pred             CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence            9999999999999999999943        3999999999999999999999999998765443     22356789999


Q ss_pred             ccCcccccCCCCCC-----CcchHHHHHHHHHHHHhC----------CCCCCCCC----cHHHHHHHHHhhCCCCccccc
Q 021181          149 YRAPELLLNCSEYT-----AAIDIWSVGCILGEIMTR----------QPLFPGKD----YVHQLRLITELIGSPDETSLG  209 (316)
Q Consensus       149 ~~aPE~~~~~~~~~-----~~~DiwslG~~l~ell~g----------~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~  209 (316)
                      |+|||++...-...     ..+||||||.++||++..          ++||.+.-    ..+....++......+..   
T Consensus       386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i---  462 (513)
T KOG2052|consen  386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI---  462 (513)
T ss_pred             ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCC---
Confidence            99999997532211     368999999999999762          46765432    112222222111111110   


Q ss_pred             cccccchHHHhhhCCCCCCCCccccCCC--CChHHHHHHHHhcccCCCCCCCHHHHh
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSARFPN--KSPGAVDLLEKMLVFDPNRRITVDEAL  264 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rps~~ell  264 (316)
                                            +.+...  .-..+..+++.||..+|.-|.|+-.+-
T Consensus       463 ----------------------pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  463 ----------------------PNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             ----------------------CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence                                  001111  112377889999999999999875543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.7e-26  Score=193.02  Aligned_cols=178  Identities=36%  Similarity=0.639  Sum_probs=152.4

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC-
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~-   80 (316)
                      ..+++.||+|.+...... .....+.+|+..++.++|+|++++++.+...     ...++++|++++ +|.+++..... 
T Consensus        21 ~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~   94 (225)
T smart00221       21 KGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLVMEYCEGGDLFDYLRKKGGK   94 (225)
T ss_pred             cCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEEEeccCCCCHHHHHHhcccC
Confidence            346899999999764332 2467788999999999999999999988644     458999999975 99999987766 


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+.......  ......++..|++||.+...
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  174 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGG  174 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCC
Confidence            8999999999999999999999999999999999999999999999999887765442  33445667789999998433


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPG  186 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~  186 (316)
                      ..++.++|+|+||+++++|++|+.||..
T Consensus       175 ~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      175 KGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            6778899999999999999999999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-27  Score=192.22  Aligned_cols=236  Identities=21%  Similarity=0.305  Sum_probs=174.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+++.+|+|.+..+   ......+.+|..---.| .|.||+.-|++....    .+.+++++||++ |+|..-+.. .
T Consensus        45 Hr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~YvF~qE~aP~gdL~snv~~-~  116 (378)
T KOG1345|consen   45 HRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDAYVFVQEFAPRGDLRSNVEA-A  116 (378)
T ss_pred             ccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc----CceEEEeeccCccchhhhhcCc-c
Confidence            6789999999999653   34556788887765555 599999988876533    356899999998 899988766 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc--CCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++-+...+.++.|+++||.|||++++||||||.+|||+..  ..++||||||.+...+..-...  .....|.+||++..
T Consensus       117 GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~--~~~~~y~~pe~~~~  194 (378)
T KOG1345|consen  117 GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYL--EYVNNYHAPELCDT  194 (378)
T ss_pred             cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehhh--hhhcccCCcHHHhh
Confidence            6889999999999999999999999999999999999843  2479999999998766543222  23456889998754


Q ss_pred             C----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          158 C----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       158 ~----~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .    -...+.+|+|.||+++|.+++|.+||+.....+.                      ..+.+...... .....+.
T Consensus       195 ~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~----------------------~Y~~~~~w~~r-k~~~~P~  251 (378)
T KOG1345|consen  195 VVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK----------------------PYWEWEQWLKR-KNPALPK  251 (378)
T ss_pred             ccccceEecccccchheeeeeeeeecCCCcchhhhccCc----------------------hHHHHHHHhcc-cCccCch
Confidence            2    1246789999999999999999999974421111                      00111111110 0113345


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRR---ITVDEALCHPYLA  270 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~R---ps~~ell~~~~f~  270 (316)
                      .+...|+.+..+.++-|.+++++|   -+++......|..
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            566789999999999999999999   5666666665543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4e-27  Score=220.82  Aligned_cols=220  Identities=27%  Similarity=0.309  Sum_probs=173.2

Q ss_pred             HHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCce
Q 021181           27 TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVL  106 (316)
Q Consensus        27 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  106 (316)
                      +..|+.+-..+.|++++.....+.....     ..-.||||+++|+..+...+.+...++..++.|++.|++|+|+.||.
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Gia  442 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDG-----ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLA  442 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhccc-----chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCce
Confidence            6678888889999999888777764431     33349999889999999988999999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCEEEeeeccccccCCC-----CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 021181          107 HRDLKPSNLLLNANCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       107 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~  181 (316)
                      |||+|++|+++..+|.+|++|||.+......     ......+|+..|+|||++.....-....||||.|+++..|.+|+
T Consensus       443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~  522 (601)
T KOG0590|consen  443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR  522 (601)
T ss_pred             eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence            9999999999999999999999987664322     22356788999999999998555567899999999999999999


Q ss_pred             CCCCCCCcHHHHH-HHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCH
Q 021181          182 PLFPGKDYVHQLR-LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV  260 (316)
Q Consensus       182 ~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~  260 (316)
                      .||......+... ....                       ................++...+.+|.+||++||.+|.++
T Consensus       523 ~~Wk~a~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti  579 (601)
T KOG0590|consen  523 FPWKVAKKSDNSFKTNNY-----------------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITI  579 (601)
T ss_pred             Cccccccccccchhhhcc-----------------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecH
Confidence            9997664332211 0000                       000000111112223567779999999999999999999


Q ss_pred             HHHhcCCCCCCCCC
Q 021181          261 DEALCHPYLAPLHD  274 (316)
Q Consensus       261 ~ell~~~~f~~~~~  274 (316)
                      ++|++.+||+.+..
T Consensus       580 ~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  580 EQILNDEWIRSIEC  593 (601)
T ss_pred             HHHhhChHhhhcce
Confidence            99999999998863

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.4e-24  Score=193.23  Aligned_cols=224  Identities=22%  Similarity=0.337  Sum_probs=185.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      ..|+-||.|.+++.............|-.++..++ ||++++++..+...     ...++++++.. |.|...+.....+
T Consensus        20 da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ld~~rgg~lft~l~~~~~f   94 (612)
T KOG0603|consen   20 DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLILDFLRGGDLFTRLSKEVMF   94 (612)
T ss_pred             cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHhhhhcccchhhhccccCCch
Confidence            45777888888765332222235567888888886 99999999988654     55899999995 6999999888999


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      .+.....+..+++-+++.+|+.+++|+|+|++||+++.+|.+++.|||+++..-.....   +|+..|+|||+..   ..
T Consensus        95 ~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~---gh  168 (612)
T KOG0603|consen   95 DELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN---GH  168 (612)
T ss_pred             HHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh---cc
Confidence            99999999999999999999999999999999999999999999999999876544322   8999999999985   47


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          162 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      ..++|.||+|+++++|++|..||..    +....|.+..-..+                               ...+..
T Consensus       169 ~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p-------------------------------~~l~~~  213 (612)
T KOG0603|consen  169 LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP-------------------------------RELSAE  213 (612)
T ss_pred             CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------------------------hhhhHH
Confidence            8899999999999999999999987    44444443211111                               145777


Q ss_pred             HHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 021181          242 AVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH  273 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~  273 (316)
                      ++++++.++..+|..|...     .|+++|+||..+.
T Consensus       214 a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  214 ARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             HHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence            9999999999999999954     7999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-23  Score=195.97  Aligned_cols=226  Identities=23%  Similarity=0.361  Sum_probs=160.3

Q ss_pred             CCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            4 ETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      .+|. |+||++-+...  +-....+-+.|++ ....++||++.+.-+....     ...|+|-+|+..+|+|.+..++-+
T Consensus        45 ~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----kAAylvRqyvkhnLyDRlSTRPFL  117 (1431)
T KOG1240|consen   45 REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----KAAYLVRQYVKHNLYDRLSTRPFL  117 (1431)
T ss_pred             CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----HHHHHHHHHHhhhhhhhhccchHH
Confidence            3455 99999865432  1122233344555 6666999999988775332     457899999999999999998889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc--cCCCCc--c----ccccccccccCcc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART--TSETDF--M----TEYVVTRWYRAPE  153 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~--~~~~~~--~----~~~~~~~~~~aPE  153 (316)
                      ..-+.+.|+.||+.||.-+|..||+|||||.+|||++.=..+.|+||..-+.  ...+.+  .    .+.....+|+|||
T Consensus       118 ~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPE  197 (1431)
T KOG1240|consen  118 VLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPE  197 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChH
Confidence            9999999999999999999999999999999999999998999999975432  111111  1    1112344699999


Q ss_pred             cccCC---------CC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          154 LLLNC---------SE-YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       154 ~~~~~---------~~-~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .+-..         .. .+++.||||+||++.||++ |++||.-.    ++-..+..  .          ....+..++.
T Consensus       198 RFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~--~----------~~~~e~~Le~  261 (1431)
T KOG1240|consen  198 RFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSG--N----------ADDPEQLLEK  261 (1431)
T ss_pred             hhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhcc--C----------ccCHHHHHHh
Confidence            87541         12 5688999999999999987 89999322    11111100  0          0001111111


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +              .+..++.+|..|++.||++|.|+++.|+.
T Consensus       262 I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  262 I--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             C--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1              13359999999999999999999999984

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=1.5e-20  Score=165.18  Aligned_cols=243  Identities=32%  Similarity=0.525  Sum_probs=186.4

Q ss_pred             ceEEEEEecccccChh-HHHHHHHHHHHHhhCCCC-CccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---C
Q 021181            7 EEVAIKKIGNAFDNRI-DAKRTLREIKLLRHMDHE-NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---D   80 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---~   80 (316)
                      ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+.+...     ...+++++++. +++.+.+....   .
T Consensus        23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~   97 (384)
T COG0515          23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGP   97 (384)
T ss_pred             cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEEEEEEecCCCCcHHHHHHhcccccC
Confidence            4689999977655443 567889999999999988 799999999433     34799999997 58887777665   7


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCC-------ccccccccccccCc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETD-------FMTEYVVTRWYRAP  152 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~aP  152 (316)
                      ++......++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.+.......       ......++..|.+|
T Consensus        98 ~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515          98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCH
Confidence            99999999999999999999999999999999999999998 69999999987544332       23567889999999


Q ss_pred             ccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhhCC-CCccccccccccchHHHhhhCCC
Q 021181          153 ELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGS-PDETSLGFLRSDNARRYVRMLPQ  225 (316)
Q Consensus       153 E~~~~~--~~~~~~~DiwslG~~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  225 (316)
                      |.+.+.  .......|+||+|++++++++|..||.....    ......+...... ........               
T Consensus       178 e~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  242 (384)
T COG0515         178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS---------------  242 (384)
T ss_pred             HHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCcc---------------
Confidence            999774  4788999999999999999999999877653    2222222221111 00000000               


Q ss_pred             CCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       226 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                           ..   ......+.+++..++..+|..|.+..+...+++.........
T Consensus       243 -----~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~  286 (384)
T COG0515         243 -----NP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES  286 (384)
T ss_pred             -----cc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence                 00   122357899999999999999999999998877666553333

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=4.8e-22  Score=168.72  Aligned_cols=219  Identities=22%  Similarity=0.284  Sum_probs=137.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCC----------CCCccceeeeecCCCC-------CCCC-----
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD----------HENIIAIKDIIRPPQR-------ETFN-----   58 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~----------h~~i~~~~~~~~~~~~-------~~~~-----   58 (316)
                      |.+||+.+|||++..... .....+.+.+|.-....+.          |-+++..++.....+.       .+..     
T Consensus        33 d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~  112 (288)
T PF14531_consen   33 DVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVL  112 (288)
T ss_dssp             ETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEE
T ss_pred             EccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceee
Confidence            678999999999976432 2224455666655444432          2334444444432210       0111     


Q ss_pred             eEEEEEecCCCcHHHHhh---cCCC----CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181           59 DVYIVYELMDTDLHQIIR---SHQD----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus        59 ~~~iv~e~~~g~L~~~l~---~~~~----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      ..+++|+-+.++|.+++.   ....    +.......+..|++..+++||+.|++|+||+|+|++++.+|.++|+||+..
T Consensus       113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            247889988888877753   2221    233344566689999999999999999999999999999999999999877


Q ss_pred             cccCCCCccccccccccccCcccccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC
Q 021181          132 RTTSETDFMTEYVVTRWYRAPELLLNC-------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD  204 (316)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  204 (316)
                      ...+.....  ...+..|.+||.....       -.++.+.|.|+||+++|.|.+|..||........            
T Consensus       193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~------------  258 (288)
T PF14531_consen  193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD------------  258 (288)
T ss_dssp             EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST------------
T ss_pred             eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc------------
Confidence            665543222  3345678899876442       2467899999999999999999999965531111            


Q ss_pred             ccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCC
Q 021181          205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR  257 (316)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R  257 (316)
                                            ....+..+. ++++.++.||+++|++||.+|
T Consensus       259 ----------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  259 ----------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ----------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ----------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                                  000345555 889999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=6.9e-21  Score=163.24  Aligned_cols=206  Identities=22%  Similarity=0.300  Sum_probs=148.8

Q ss_pred             CCCCccceeeeecCCC----------------------CCCCCeEEEEEecCCCcHHHHhhcCCCCCHHHHHHHHHHHHH
Q 021181           38 DHENIIAIKDIIRPPQ----------------------RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLR   95 (316)
Q Consensus        38 ~h~~i~~~~~~~~~~~----------------------~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~   95 (316)
                      +|||||++.+.|.+.-                      .....++|+||...+.+|.+++-. ...+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-RHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-CCCchHHHHHHHHHHHH
Confidence            5999999999987631                      122356999999999999999866 45677778889999999


Q ss_pred             HHHHhhcCCceeccCCCCcEEEc--cC--CCEEEeeeccccccCCC-------CccccccccccccCcccccCCCCC---
Q 021181           96 GLKYVHSANVLHRDLKPSNLLLN--AN--CDLKIGDFGLARTTSET-------DFMTEYVVTRWYRAPELLLNCSEY---  161 (316)
Q Consensus        96 ~l~~LH~~~i~H~dl~p~nil~~--~~--~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~---  161 (316)
                      |+.+||++|+.|||+|++|||+.  .+  ..+.+.|||++-.-...       .......|....+|||+.......   
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999983  33  34889999987432221       112334566778999998542111   


Q ss_pred             --CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          162 --TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       162 --~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                        =.++|.|+.|.+.||+++...||.+......--                             .......++.....++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-----------------------------r~Yqe~qLPalp~~vp  483 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-----------------------------RTYQESQLPALPSRVP  483 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchheech-----------------------------hhhhhhhCCCCcccCC
Confidence              257899999999999999999997732111100                             0011111222234678


Q ss_pred             hHHHHHHHHhcccCCCCCCCHH---HHhc------CCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVD---EALC------HPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~---ell~------~~~f~~~~  273 (316)
                      +.+++++..+|+.||++|+|+.   .+++      +.|++.+.
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~  526 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMM  526 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhc
Confidence            9999999999999999999853   4554      55555544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-19  Score=159.38  Aligned_cols=227  Identities=19%  Similarity=0.171  Sum_probs=166.9

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCC----CCCccceeeeec-CCCCCCCCeEEEEEecCCCcHHHHhhcC--
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD----HENIIAIKDIIR-PPQRETFNDVYIVYELMDTDLHQIIRSH--   78 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~----h~~i~~~~~~~~-~~~~~~~~~~~iv~e~~~g~L~~~l~~~--   78 (316)
                      ++.+|+|.-.........  .+..|..++..+.    ..++..+++.+. ..     ..-|+||+.++.+|.++....  
T Consensus        44 ~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~-----~~~~iVM~l~G~sL~dl~~~~~~  116 (322)
T KOG1164|consen   44 NKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE-----DFNFIVMSLLGPSLEDLRKRNPP  116 (322)
T ss_pred             CeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----ceeEEEEeccCccHHHHHHhCCC
Confidence            357888877554222211  5778888888886    368999998884 32     457999999999999988554  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-----CCEEEeeecccc--ccC-CC-----Cc---ccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-----CDLKIGDFGLAR--TTS-ET-----DF---MTE  142 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-----~~~~l~df~~~~--~~~-~~-----~~---~~~  142 (316)
                      +.++...+..++.|++.+|.+||+.|++||||||.|+++...     ..+.|.|||+++  ... ..     ..   ...
T Consensus       117 ~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~  196 (322)
T KOG1164|consen  117 GRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGL  196 (322)
T ss_pred             CCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccC
Confidence            579999999999999999999999999999999999999865     359999999998  311 11     01   123


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      ..||..|.|+....+ ...+...|+||++.++.++..|..||.............+.........               
T Consensus       197 ~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~---------------  260 (322)
T KOG1164|consen  197 FRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR---------------  260 (322)
T ss_pred             CCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc---------------
Confidence            458999999998877 7789999999999999999999999977654333333222111110000               


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                 .....+..+..+...+-..+...+|....+...
T Consensus       261 -----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  261 -----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             -----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence                       112345667777777777888889987665443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=7.3e-21  Score=155.62  Aligned_cols=220  Identities=19%  Similarity=0.261  Sum_probs=166.8

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC--C
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--L   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--~   81 (316)
                      .|..++.|++........-.+.+..|.-.++-+.||||+.+++.|..+     .++.++..|++ |+|+.++.....  .
T Consensus       212 qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq~mp~gslynvlhe~t~vvv  286 (448)
T KOG0195|consen  212 QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQYMPFGSLYNVLHEQTSVVV  286 (448)
T ss_pred             cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEeeeeccchHHHHHHhcCccEEE
Confidence            567788888876544444556788899999999999999999999765     45899999998 899999976544  5


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccCCCEEEe--eeccccccCCCCccccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +..++.+++..++.|++|||+..  |.--.+.+..+++|++.+.+|+  |-.++..      .....-.+.|+|||.+..
T Consensus       287 d~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e~gr~y~pawmspealqr  360 (448)
T KOG0195|consen  287 DHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQR  360 (448)
T ss_pred             ecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------ccccccCcccCCHHHHhc
Confidence            77889999999999999999875  4445688999999998776543  3222211      112234678999999976


Q ss_pred             CCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          158 CSE--YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       158 ~~~--~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      ...  .-.++|+|||++++|||-|...||......+.-.++. +.|..                            ....
T Consensus       361 kped~n~raadmwsfaillwel~trevpfadlspmecgmkia-leglr----------------------------v~ip  411 (448)
T KOG0195|consen  361 KPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-LEGLR----------------------------VHIP  411 (448)
T ss_pred             CchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-hcccc----------------------------ccCC
Confidence            322  2368999999999999999999998887665543331 11111                            1223


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEAL  264 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell  264 (316)
                      |.+|..+..++.-|++.||.+||.++.++
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            57899999999999999999999987654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.7e-19  Score=158.27  Aligned_cols=137  Identities=20%  Similarity=0.273  Sum_probs=102.7

Q ss_pred             CCceEEEEEeccccc---ChhHHHHHHHHHHHHhhCCCCCccc-eeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCC
Q 021181            5 TREEVAIKKIGNAFD---NRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ   79 (316)
Q Consensus         5 ~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~   79 (316)
                      +|+.||||++.....   .......+.+|++++++++|++++. +++.         ...|+||||++| +|.. +..  
T Consensus        43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---------~~~~LVmE~~~G~~L~~-~~~--  110 (365)
T PRK09188         43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---------GKDGLVRGWTEGVPLHL-ARP--  110 (365)
T ss_pred             CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---------CCcEEEEEccCCCCHHH-hCc--
Confidence            678889998753311   2334566889999999999999985 4432         236999999975 6752 221  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccC-CCCcEEEccCCCEEEeeeccccccCCCCcc---------ccccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDL-KPSNLLLNANCDLKIGDFGLARTTSETDFM---------TEYVVTRWY  149 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl-~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~  149 (316)
                       ..   ...++.+++.||.+||+.||+|||| ||+||+++.++.++|+|||+++........         ....++..|
T Consensus       111 -~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~  186 (365)
T PRK09188        111 -HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRT  186 (365)
T ss_pred             -cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCcc
Confidence             11   1467899999999999999999999 999999999999999999999865443211         233456778


Q ss_pred             cCcccccC
Q 021181          150 RAPELLLN  157 (316)
Q Consensus       150 ~aPE~~~~  157 (316)
                      .+||.+..
T Consensus       187 ~~pe~~~~  194 (365)
T PRK09188        187 YAPDALTP  194 (365)
T ss_pred             CCcccCCh
Confidence            99998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=6.1e-20  Score=173.98  Aligned_cols=168  Identities=27%  Similarity=0.374  Sum_probs=133.1

Q ss_pred             CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---------
Q 021181           69 TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---------  139 (316)
Q Consensus        69 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---------  139 (316)
                      |+=...++..+.++..-        +.+++|||+.||+|+|+||+|.+|..-|.+|++|||+++.......         
T Consensus       136 gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~  207 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE  207 (1205)
T ss_pred             chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence            43344444444444433        7789999999999999999999999999999999999876433211         


Q ss_pred             -------cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccccccc
Q 021181          140 -------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR  212 (316)
Q Consensus       140 -------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  212 (316)
                             ....++|+.|+|||++.. +.|+..+|+|++|+++|+.+.|..||.+...++...........-+        
T Consensus       208 k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp--------  278 (1205)
T KOG0606|consen  208 KDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP--------  278 (1205)
T ss_pred             HHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc--------
Confidence                   134588999999999988 7899999999999999999999999999888777766544222211        


Q ss_pred             ccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 021181          213 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLH  273 (316)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~~~~f~~~~  273 (316)
                                          +.-..+.++++++|..+|..+|-.|.   ++-++.+|+||+.++
T Consensus       279 --------------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  279 --------------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             --------------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence                                11235788999999999999999998   456889999999887

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1e-19  Score=150.18  Aligned_cols=153  Identities=14%  Similarity=0.191  Sum_probs=112.0

Q ss_pred             CCceEEEEEecccccChhHH-HH------HHHHHHHHhhCCCCCccceeeeecCCCCC---CCCeEEEEEecCCC-cHHH
Q 021181            5 TREEVAIKKIGNAFDNRIDA-KR------TLREIKLLRHMDHENIIAIKDIIRPPQRE---TFNDVYIVYELMDT-DLHQ   73 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~-~~------~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---~~~~~~iv~e~~~g-~L~~   73 (316)
                      ++..||||.+.......... ..      +.+|+..+.++.|++|..+.+++......   -....+++|||++| +|.+
T Consensus        53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~  132 (232)
T PRK10359         53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND  132 (232)
T ss_pred             CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence            46689999997654333322 22      57899999999999999999887644211   12458999999986 7877


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                      +.    .+++    ....+++.++..+|+.|++|||++|+||+++.+| ++++|||.............           
T Consensus       133 ~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d~-----------  192 (232)
T PRK10359        133 MP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKDR-----------  192 (232)
T ss_pred             hh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHHH-----------
Confidence            63    2333    2456999999999999999999999999999988 99999998755432211111           


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHH
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIM  178 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell  178 (316)
                      .... ..+..++|+||||+++..+.
T Consensus       193 ~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        193 IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HHHH-hHhcccccccceeEeehHHH
Confidence            1222 44668999999999876554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=2.5e-19  Score=145.76  Aligned_cols=124  Identities=19%  Similarity=0.230  Sum_probs=94.0

Q ss_pred             CCceEEEEEecccccChhH------------------------HHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeE
Q 021181            5 TREEVAIKKIGNAFDNRID------------------------AKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV   60 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   60 (316)
                      +|+.||||+++........                        ......|+..+.++.++++.....+...       ..
T Consensus        20 ~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~-------~~   92 (190)
T cd05147          20 NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK-------SH   92 (190)
T ss_pred             CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec-------CC
Confidence            8999999999764321111                        1233459999999988887544333211       13


Q ss_pred             EEEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           61 YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV-HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        61 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      ++||||++| ++...+...++++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.++|+|||++.....
T Consensus        93 ~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147          93 VLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             EEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCCC
Confidence            899999986 5544434457899999999999999999999 699999999999999998 47899999999865533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=3.7e-18  Score=143.39  Aligned_cols=197  Identities=18%  Similarity=0.234  Sum_probs=156.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      |.-++++||||.=.    ..+++-++..|....+.| ..++|+.+|-+..++     -+-.+|+|.++.+|.++..- .+
T Consensus        49 Nl~nne~VAIKfEP----rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-----~~NiLVidLLGPSLEDLFD~CgR  119 (449)
T KOG1165|consen   49 NLYNNEPVAIKFEP----RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG-----KYNILVIDLLGPSLEDLFDLCGR  119 (449)
T ss_pred             ccccCceEEEEecc----ccCCcchHHHHHHHHHHHcCCCCCCceeeecccc-----chhhhhhhhhCcCHHHHHHHhcC
Confidence            44579999999653    344566788999999999 589999988766443     34578999999888777754 45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-----CEEEeeeccccccCCCCc--------ccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-----DLKIGDFGLARTTSETDF--------MTEYVVT  146 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-----~~~l~df~~~~~~~~~~~--------~~~~~~~  146 (316)
                      +|+...+.-++.|++.-++++|++.+++|||||+|+||...+     .+.++|||+++.-.....        ..+..||
T Consensus       120 ~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGT  199 (449)
T KOG1165|consen  120 RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGT  199 (449)
T ss_pred             cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccc
Confidence            799999999999999999999999999999999999996543     389999999976433322        2356789


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccc
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL  208 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  208 (316)
                      ..|+|-....+ ..-+...|+=|||-++.+.|-|..||++......-.+.+++...-..+..
T Consensus       200 ARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  200 ARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             eeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            99999988877 66789999999999999999999999998765555555555444333333

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=7.8e-19  Score=158.37  Aligned_cols=203  Identities=24%  Similarity=0.334  Sum_probs=151.7

Q ss_pred             HhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCc-eeccC
Q 021181           34 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANV-LHRDL  110 (316)
Q Consensus        34 l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i-~H~dl  110 (316)
                      |+.+.|.|+.+++|.+.+.     ...++|.+||. |+|.+.+.. .-.++..-...+++.|+.||+|||.--| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            3578899999999999876     45899999997 899999977 4567888888999999999999996654 99999


Q ss_pred             CCCcEEEccCCCEEEeeeccccccCC---CCccccccccccccCcccccCCC------CCCCcchHHHHHHHHHHHHhCC
Q 021181          111 KPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCS------EYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       111 ~p~nil~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~DiwslG~~l~ell~g~  181 (316)
                      ++.|.++|.+..+|++|||+......   ............|.|||.+....      ..+.+.|+||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999998876642   11122233466799999987631      1466799999999999999999


Q ss_pred             CCCCCCCcH----HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCC
Q 021181          182 PLFPGKDYV----HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR  257 (316)
Q Consensus       182 ~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R  257 (316)
                      .||......    +.+..+.+ .+..+.  .+.                    ... .....+++..+++.||..+|.+|
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~-~~~~~~--rP~--------------------i~~-~~e~~~~l~~l~~~cw~e~P~~r  211 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK-GGSNPF--RPS--------------------IEL-LNELPPELLLLVARCWEEIPEKR  211 (484)
T ss_pred             CccccccccCChHHHHHHHHh-cCCCCc--Ccc--------------------hhh-hhhcchHHHHHHHHhcccChhhC
Confidence            999764321    22222222 111100  000                    000 00344579999999999999999


Q ss_pred             CCHHHHhc
Q 021181          258 ITVDEALC  265 (316)
Q Consensus       258 ps~~ell~  265 (316)
                      |+++++-.
T Consensus       212 Ps~~~i~~  219 (484)
T KOG1023|consen  212 PSIEQIRS  219 (484)
T ss_pred             ccHHHHHh
Confidence            99988754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.5e-19  Score=160.39  Aligned_cols=175  Identities=29%  Similarity=0.484  Sum_probs=133.1

Q ss_pred             CeEEEEEecCC-CcHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181           58 NDVYIVYELMD-TDLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus        58 ~~~~iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      .++||.|++|. .+|.+||....   ..+....+.++.|++.|+.|   +|.+|+|++|.||+...+..++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            46899999997 79999997543   36788889999999999999   9999999999999999999999999999877


Q ss_pred             cCCCC-------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCc
Q 021181          134 TSETD-------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDE  205 (316)
Q Consensus       134 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~  205 (316)
                      .....       ......+|.+|++||.+.+ +.|+.++||||||++++|++.. .-.|...   .....+..  |..+ 
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~--g~ip-  478 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRD--GIIP-  478 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhhc--CCCC-
Confidence            65544       3456678999999999998 8899999999999999999982 2122111   11111110  0000 


Q ss_pred             cccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          206 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                                                 ..+..--+.-..|+.+||...|.+||++.+.--|.|.
T Consensus       479 ---------------------------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  479 ---------------------------PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ---------------------------hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                       0001112335689999999999999988877777764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=5.2e-18  Score=137.23  Aligned_cols=165  Identities=16%  Similarity=0.050  Sum_probs=117.2

Q ss_pred             CCceEEEEEeccccc--ChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            5 TREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         5 ~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      .+.+|+.+.+.....  .......+.+|++++++|. ++++++++++.         ..+++|+|+.| +|.+.+..   
T Consensus        24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~lvmeyI~G~~L~~~~~~---   91 (218)
T PRK12274         24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRHLDRSYLAGAAMYQRPPR---   91 (218)
T ss_pred             CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEEEEEeeecCccHHhhhhh---
Confidence            566777777755432  1122335789999999994 58899998862         26999999976 66544321   


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccC-CCCcEEEccCCCEEEeeeccccccCCCCcc--------------ccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDL-KPSNLLLNANCDLKIGDFGLARTTSETDFM--------------TEYVV  145 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl-~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------------~~~~~  145 (316)
                          ....++.|++.+|.++|++||+|||| ||+||+++.++.++|+|||++.........              .....
T Consensus        92 ----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y  167 (218)
T PRK12274         92 ----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMY  167 (218)
T ss_pred             ----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhc
Confidence                12357889999999999999999999 799999999999999999999865443310              00112


Q ss_pred             cccccCcccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCC
Q 021181          146 TRWYRAPELLLNCSEYT-AAIDIWSVGCILGEIMTRQPLFP  185 (316)
Q Consensus       146 ~~~~~aPE~~~~~~~~~-~~~DiwslG~~l~ell~g~~pf~  185 (316)
                      ++.+++|+.-.-....+ ...+.++.|+.+|.++|+..++-
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        168 CPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             CCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            55566666533222233 45677778999999999988763

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.76  E-value=5.3e-18  Score=138.40  Aligned_cols=124  Identities=16%  Similarity=0.154  Sum_probs=95.3

Q ss_pred             CCceEEEEEecccccChh------------------------HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeE
Q 021181            5 TREEVAIKKIGNAFDNRI------------------------DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV   60 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   60 (316)
                      +|+.||||+++.......                        .......|...+.++.++++.....+...       ..
T Consensus        20 ~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-------~~   92 (190)
T cd05145          20 DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK-------KN   92 (190)
T ss_pred             CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec-------CC
Confidence            899999999976421100                        01233578999999999987555444321       14


Q ss_pred             EEEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           61 YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        61 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      ++||||++| ++........+++..++..++.|++.++.++|+ .||+|+||||+||+++ ++.++|+|||++.....
T Consensus        93 ~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145          93 VLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            899999976 344332344678889999999999999999999 9999999999999999 88999999999876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=1.2e-17  Score=134.61  Aligned_cols=188  Identities=24%  Similarity=0.291  Sum_probs=145.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh-cCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR-SHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~   79 (316)
                      +-.+|+.||||.=+.....    ..+..|..+.+.|+ ..+|+.+..+....     ..-.+||+..+.+|.++.. ..+
T Consensus        36 ~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~ynvlVMdLLGPsLEdLfnfC~R  106 (341)
T KOG1163|consen   36 SITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEK-----DYNVLVMDLLGPSLEDLFNFCSR  106 (341)
T ss_pred             eccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccc-----ccceeeeeccCccHHHHHHHHhh
Confidence            3568999999976543322    34678999999996 46677777666443     4568999999988888775 346


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC---CCEEEeeeccccccCCCCc--------ccccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDF--------MTEYVVTRW  148 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~--------~~~~~~~~~  148 (316)
                      .++...++-.+.|++.-++|+|..+++||||||+|+|+.-+   ..+.++|||+++..-....        .....||..
T Consensus       107 ~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaR  186 (341)
T KOG1163|consen  107 RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTAR  186 (341)
T ss_pred             hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeee
Confidence            79999999999999999999999999999999999999643   4689999999977433221        134567888


Q ss_pred             ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh
Q 021181          149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL  199 (316)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~  199 (316)
                      |.|-....+ ..-+...|+=|+|.++..+..|..||++........+..+.
T Consensus       187 YASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  187 YASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             ehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            888776655 45678899999999999999999999998655544444433

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=6.3e-17  Score=133.06  Aligned_cols=120  Identities=20%  Similarity=0.218  Sum_probs=91.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-----CCCCccceeeeecCCCCCCCCe-EEEEEecCC---CcHH
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-----DHENIIAIKDIIRPPQRETFND-VYIVYELMD---TDLH   72 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~-~~iv~e~~~---g~L~   72 (316)
                      +.+++.. +||++....  ....+.+.+|+.+++.+     .||||+++++++..+.  +.+. +.+||||++   |+|.
T Consensus        21 hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~~I~e~~G~~~~tL~   95 (210)
T PRK10345         21 HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYDVIADFDGKPSITLT   95 (210)
T ss_pred             CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEEEEecCCCCcchhHH
Confidence            3455555 699886532  22446789999999999     5799999999997652  1133 337899954   6999


Q ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHH-HHhhcCCceeccCCCCcEEEcc----CCCEEEeeec
Q 021181           73 QIIRSHQDLTDDHCRYFLYQLLRGL-KYVHSANVLHRDLKPSNLLLNA----NCDLKIGDFG  129 (316)
Q Consensus        73 ~~l~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~i~H~dl~p~nil~~~----~~~~~l~df~  129 (316)
                      ++++. ..+++.  ..++.+++.++ +|||+.+|+||||||+||+++.    ++.++|+|++
T Consensus        96 ~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         96 EFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             HHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99976 346655  35678888887 9999999999999999999974    3479999954

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=2.2e-17  Score=138.69  Aligned_cols=213  Identities=21%  Similarity=0.243  Sum_probs=152.2

Q ss_pred             HHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021181           30 EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSAN  104 (316)
Q Consensus        30 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~  104 (316)
                      -...+-++.|.|||+++.++.+...++.....++.||+. |++.++|++.    ..+.....++|+.||+.||.|||++.
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            344455667999999999998887667788999999996 8999988754    45888889999999999999999885


Q ss_pred             --ceeccCCCCcEEEccCCCEEEeeeccccccC-----CCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHH
Q 021181          105 --VLHRDLKPSNLLLNANCDLKIGDFGLARTTS-----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI  177 (316)
Q Consensus       105 --i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~el  177 (316)
                        |+|+++.-..|++..+|-+|++--.-.....     .........+-++|.+||.-.. ....-++|||++|.+..+|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence              9999999999999999988876422111100     0001112334677899987654 4567789999999999999


Q ss_pred             HhCCCCC-CCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCC
Q 021181          178 MTRQPLF-PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR  256 (316)
Q Consensus       178 l~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~  256 (316)
                      ..|..-- .+.+.......+.....                                  ..-..--++++++||+..|..
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~----------------------------------~len~lqr~~i~kcl~~eP~~  321 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVII----------------------------------GLENGLQRGSITKCLEGEPNG  321 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhee----------------------------------eccCccccCcCcccccCCCCC
Confidence            8877432 22221111111111000                                  001112357899999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCCCC
Q 021181          257 RITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       257 Rps~~ell~~~~f~~~~~~~~  277 (316)
                      ||++.+++.||..-+++....
T Consensus       322 rp~ar~llfHpllfeVhslkl  342 (458)
T KOG1266|consen  322 RPDARLLLFHPLLFEVHSLKL  342 (458)
T ss_pred             CcchhhhhcCceeeecchHHH
Confidence            999999999999998885443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=3.2e-17  Score=154.28  Aligned_cols=237  Identities=24%  Similarity=0.347  Sum_probs=183.8

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHh-hcCC-
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQII-RSHQ-   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l-~~~~-   79 (316)
                      .+...+|+|.+............+..|..+-..+. |.|++.+++....+     ...++++++.. ++++..+ .... 
T Consensus        44 ~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~~~~~~~~~s~g~~~f~~i~~~~~~  118 (601)
T KOG0590|consen   44 DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----RSYLLSLSYSDGGSLFSKISHPDST  118 (601)
T ss_pred             CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----cccccccCcccccccccccccCCcc
Confidence            34456677777655444445566677888888886 99999999988655     45899999985 6888888 5554 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCC-CEEEeeeccccccCC-CC---ccccccc-cccccCc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSE-TD---FMTEYVV-TRWYRAP  152 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~-~~---~~~~~~~-~~~~~aP  152 (316)
                      ..+......++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++..... ..   .....+| +..|.||
T Consensus       119 ~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  119 GTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAP  198 (601)
T ss_pred             CCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCc
Confidence            6788889999999999999999 99999999999999999999 999999999877654 22   2234567 9999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |...+.+...+..|+||.|+++.-+++|..|+..........  ...                        .......-.
T Consensus       199 E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~~------------------------~~~~~~~~~  252 (601)
T KOG0590|consen  199 EHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SSW------------------------KSNKGRFTQ  252 (601)
T ss_pred             ccccchhhcCCCcccccccccccccccCCCCccccccccccc--eee------------------------ccccccccc
Confidence            999875667899999999999999999999986654222100  000                        000000012


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ..+..++....+++.+++..+|..|.+.+++-.++|+..
T Consensus       253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            223467888999999999999999999999999999998

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=5.5e-16  Score=130.45  Aligned_cols=125  Identities=13%  Similarity=0.104  Sum_probs=94.0

Q ss_pred             CCCCCceEEEEEecccccCh----------------------hHHHHHHHHHHHHhhCCCC--CccceeeeecCCCCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNR----------------------IDAKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRETF   57 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~~   57 (316)
                      +..+|+.||||+++......                      .....+..|+..++++.+.  .++++++.   .     
T Consensus        50 ~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-----  121 (237)
T smart00090       50 FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW---R-----  121 (237)
T ss_pred             cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe---c-----
Confidence            45789999999997532110                      0112356899999999753  34444442   1     


Q ss_pred             CeEEEEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-ceeccCCCCcEEEccCCCEEEeeeccccccC
Q 021181           58 NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTS  135 (316)
Q Consensus        58 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  135 (316)
                       ..++||||++| +|.........+...++..++.||+.++.+||+.| ++|+||+|+||+++ ++.++|+|||.+...+
T Consensus       122 -~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      122 -RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence             24899999986 66655544556777778899999999999999999 99999999999999 8899999999876544


Q ss_pred             C
Q 021181          136 E  136 (316)
Q Consensus       136 ~  136 (316)
                      .
T Consensus       200 ~  200 (237)
T smart00090      200 H  200 (237)
T ss_pred             C
Confidence            3

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.63  E-value=1.3e-14  Score=132.76  Aligned_cols=164  Identities=20%  Similarity=0.375  Sum_probs=126.7

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT   82 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~   82 (316)
                      +.++.+|.|+..+....  .....+.+-+..++.++||+|+++++.+...     .+.|||+|.+. .|..+++.   +.
T Consensus        34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~-Pl~~~lk~---l~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVR-PLETVLKE---LG  102 (690)
T ss_pred             eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeeccc-cHHHHHHH---hH
Confidence            56789999999876532  4456778889999999999999999988543     57999999995 33334433   23


Q ss_pred             HHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      ...+...+.||+.||.||| +++++|++|.-..|+|+..|..||++|..+........ ......-..|..|+....   
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---
Confidence            7788889999999999998 88999999999999999999999999998765443321 122223334666766533   


Q ss_pred             CCCcchHHHHHHHHHHHHhC
Q 021181          161 YTAAIDIWSVGCILGEIMTR  180 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g  180 (316)
                      -.-..|.|.|||++++++.|
T Consensus       180 s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccchhhhhHHHHHHHHhCc
Confidence            12567999999999999999

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=2e-15  Score=145.63  Aligned_cols=165  Identities=19%  Similarity=0.250  Sum_probs=128.2

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCC---CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      |+.||||+=+-...-+     +.-=.+++.+|+   -+.|..+...+...     +.-++|++|.+ |+|.+++...+.+
T Consensus       722 ~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~-----~~S~lv~ey~~~Gtlld~~N~~~~m  791 (974)
T KOG1166|consen  722 GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ-----NASVLVSEYSPYGTLLDLINTNKVM  791 (974)
T ss_pred             CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccC-----CcceeeeeccccccHHHhhccCCCC
Confidence            8999999754432211     222223344444   23444454444433     33689999998 8999999999999


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-------CCCEEEeeecccccc---CCCCccccccccccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRA  151 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-------~~~~~l~df~~~~~~---~~~~~~~~~~~~~~~~a  151 (316)
                      ++..+..++.|++..+..||.++||||||||+|+|+..       +.-++|+|||.+..+   .........+.|..+--
T Consensus       792 ~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C  871 (974)
T KOG1166|consen  792 DEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDC  871 (974)
T ss_pred             CchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchh
Confidence            99999999999999999999999999999999999942       345999999998654   23334556778888999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 021181          152 PELLLNCSEYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~ell~g~  181 (316)
                      +|...+ .++++..|.|.|+.+++.|+.|+
T Consensus       872 ~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  872 IEMREG-RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             HHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence            999988 89999999999999999999997

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.59  E-value=1.5e-14  Score=120.01  Aligned_cols=119  Identities=24%  Similarity=0.282  Sum_probs=94.8

Q ss_pred             CCceEEEEEecccccCh------hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhc
Q 021181            5 TREEVAIKKIGNAFDNR------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRS   77 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~   77 (316)
                      +|..|+||+........      .....+.+|+.++..+.|++++....++...     ...+++|||++| +|.+++..
T Consensus        18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~e~~~G~~L~~~~~~   92 (211)
T PRK14879         18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINS   92 (211)
T ss_pred             CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCCEEEEEEeCCcCHHHHHHh
Confidence            67889999865432111      1234577899999999999987776665433     347899999975 89888865


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ...    ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        93 ~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         93 NGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             ccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            332    7889999999999999999999999999999999 78899999998765

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=4e-14  Score=119.35  Aligned_cols=123  Identities=17%  Similarity=0.240  Sum_probs=91.4

Q ss_pred             CCceEEEEEecccc-----------cChhHHHHHHHHHHHHhhCCCCCc--cceeeeecCCCCCCCCeEEEEEecCCC--
Q 021181            5 TREEVAIKKIGNAF-----------DNRIDAKRTLREIKLLRHMDHENI--IAIKDIIRPPQRETFNDVYIVYELMDT--   69 (316)
Q Consensus         5 ~~~~vavK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~~~iv~e~~~g--   69 (316)
                      .|..+|||.+....           .+......+.+|+.++.++.|++|  +..+++..... ......++|||+++|  
T Consensus        54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~-~~~~~~~lV~e~l~G~~  132 (239)
T PRK01723         54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH-GLFYRADILIERIEGAR  132 (239)
T ss_pred             CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec-CcceeeeEEEEecCCCC
Confidence            36788999885321           012334667899999999998885  66666543321 111234699999974  


Q ss_pred             cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181           70 DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus        70 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      +|.+++.. ..+++..    +.+|+.+|.+||++||+|+||+|.|||++.++.++|+|||.+..
T Consensus       133 ~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        133 DLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            88888765 4455543    57899999999999999999999999999989999999997754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.55  E-value=3.3e-14  Score=116.91  Aligned_cols=117  Identities=26%  Similarity=0.343  Sum_probs=88.8

Q ss_pred             CCceEEEEEecccc-cC-----hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            5 TREEVAIKKIGNAF-DN-----RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         5 ~~~~vavK~~~~~~-~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +|..|++|+..... ..     ......+.+|+.++..+.++++.....++...     ...+++|||++ ++|.+.+..
T Consensus        16 ~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~e~~~g~~l~~~~~~   90 (199)
T TIGR03724        16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKTIVMEYIEGKPLKDVIEE   90 (199)
T ss_pred             CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCEEEEEEECCccHHHHHhh
Confidence            57889999865321 11     11235677899999999887755444443322     23689999996 588887754


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT  134 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  134 (316)
                      ...       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus        91 ~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        91 GND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             cHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            321       7899999999999999999999999999999 889999999987553

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.52  E-value=6.2e-14  Score=115.21  Aligned_cols=118  Identities=19%  Similarity=0.197  Sum_probs=87.5

Q ss_pred             CCCceEEEEEecccccCh--------------------hHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeEE
Q 021181            4 ETREEVAIKKIGNAFDNR--------------------IDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVY   61 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~   61 (316)
                      .+|+.||||+++......                    ........|+.++..+.+++  ++.+++.         ...+
T Consensus        37 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~---------~~~~  107 (198)
T cd05144          37 PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW---------NRHA  107 (198)
T ss_pred             CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec---------CCce
Confidence            379999999876532110                    01123567888999887764  4444432         2358


Q ss_pred             EEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           62 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        62 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      ++|||++| +|......      .....++.+++.++.++|+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       108 lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         108 VVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            99999975 66654321      34567889999999999999999999999999999999999999998855443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=4.2e-14  Score=128.11  Aligned_cols=234  Identities=26%  Similarity=0.281  Sum_probs=175.5

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC-
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~-   80 (316)
                      .+++..+|+|+-+...........-.+|+.-.+.+ .|++.++.+..+.     +....|+-+|+|+.+|..+...... 
T Consensus       140 ~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e-----~~~~lfiqtE~~~~sl~~~~~~~~~~  214 (524)
T KOG0601|consen  140 SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE-----GSGILFIQTELCGESLQSYCHTPCNF  214 (524)
T ss_pred             ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc-----cCCcceeeeccccchhHHhhhccccc
Confidence            57888999998554443333444445677777777 4899999777774     3467999999999998888766555 


Q ss_pred             CCHHHHHHHHHHHHH----HHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCCcc-c-----cccccccc
Q 021181           81 LTDDHCRYFLYQLLR----GLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFM-T-----EYVVTRWY  149 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~----~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~-~-----~~~~~~~~  149 (316)
                      ++...++..+.+...    ||..+|..+++|.|++|.||+...+ ..++++|||+...++..... .     ...+...|
T Consensus       215 ~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y  294 (524)
T KOG0601|consen  215 LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIY  294 (524)
T ss_pred             CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceE
Confidence            788889999999999    9999999999999999999999999 88999999999887665421 1     12567779


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      ++||...+  .++...|++++|.++.+..+|..+......                ..|.         ..+.     ..
T Consensus       295 ~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------------~~W~---------~~r~-----~~  342 (524)
T KOG0601|consen  295 AAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKN----------------SSWS---------QLRQ-----GY  342 (524)
T ss_pred             eChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCC----------------CCcc---------cccc-----cc
Confidence            99999865  679999999999999998887655433200                0000         0000     00


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...+...+.+..+...+..|+..+|..|++++.++.++++....
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence            11222235567788899999999999999999999999988654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.46  E-value=4.1e-13  Score=126.62  Aligned_cols=97  Identities=24%  Similarity=0.338  Sum_probs=82.2

Q ss_pred             HHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021181           24 AKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS  102 (316)
Q Consensus        24 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~  102 (316)
                      ...+.+|+.+++.++|++++....++...     ...++||||++ ++|.+++.        ....++.+++.+|.+||+
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~  446 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDP-----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK  446 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeC-----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh
Confidence            45678999999999999998876665443     23689999996 58888875        456789999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeecccccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTT  134 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  134 (316)
                      .|++|||+||+||++ .++.++|+|||+++..
T Consensus       447 ~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        447 AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999999999999 6788999999988654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.43  E-value=1e-12  Score=106.88  Aligned_cols=120  Identities=20%  Similarity=0.239  Sum_probs=81.8

Q ss_pred             CCceEEEEEecccccChhHHHH----------------------HHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeE
Q 021181            5 TREEVAIKKIGNAFDNRIDAKR----------------------TLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDV   60 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~   60 (316)
                      +|+.||||++............                      ...|...+..+.+.+  ++++++.         ...
T Consensus        20 ~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~---------~~~   90 (187)
T cd05119          20 DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL---------NRH   90 (187)
T ss_pred             CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---------CCC
Confidence            7899999998754322111111                      135566666664433  4444443         125


Q ss_pred             EEEEecCCC-cHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           61 YIVYELMDT-DLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        61 ~iv~e~~~g-~L~-~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      +++|||++| .+. ..+.... . ..+++.++.+++.++.++|. .||+|+||+|+||+++ ++.++++|||.+.....
T Consensus        91 ~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119          91 VLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence            899999976 221 1111111 1 16788999999999999998 9999999999999999 88999999998865433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.37  E-value=4.5e-12  Score=98.86  Aligned_cols=112  Identities=20%  Similarity=0.237  Sum_probs=89.7

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCC--CCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      +..+++|.......    ...+..|+..++.+.+  .+++++++++...     +..+++|||++| .+...       +
T Consensus        21 ~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~e~~~g~~~~~~-------~   84 (155)
T cd05120          21 DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLMEWIEGETLDEV-------S   84 (155)
T ss_pred             CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEEEecCCeecccC-------C
Confidence            46899998865432    4567899999999976  5888888877433     458999999976 34322       5


Q ss_pred             HHHHHHHHHHHHHHHHHhhcC---CceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181           83 DDHCRYFLYQLLRGLKYVHSA---NVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ......++.+++.+++.+|..   +++|+|++|.||+++..+.++++||+.+..
T Consensus        85 ~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          85 EEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            567778899999999999975   799999999999999989999999997643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.36  E-value=4.5e-13  Score=128.02  Aligned_cols=187  Identities=26%  Similarity=0.356  Sum_probs=148.5

Q ss_pred             CeEEEEEecCC-CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           58 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        58 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      ...+++++|.+ ++|...++..+..+..-.+..+..+..++++||...+.|+|++|.|.+...+|..++.||+.....+.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            44899999996 69999998888888888899999999999999999999999999999999999999999973322110


Q ss_pred             C--------------------------------CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 021181          137 T--------------------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF  184 (316)
Q Consensus       137 ~--------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf  184 (316)
                      .                                .......+++.|.+||...+ ......+|+|+.|+++++.++|.+||
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0                                00122456888999999988 77889999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHH---
Q 021181          185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD---  261 (316)
Q Consensus       185 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~---  261 (316)
                      ...........+..                            ....+.......+...++++...|..+|.+|..+.   
T Consensus      1036 na~tpq~~f~ni~~----------------------------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN----------------------------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred             CCcchhhhhhcccc----------------------------CCCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence            77754433322211                            01112222235688899999999999999999887   


Q ss_pred             HHhcCCCCCCCC
Q 021181          262 EALCHPYLAPLH  273 (316)
Q Consensus       262 ell~~~~f~~~~  273 (316)
                      ++-.|+||+.+.
T Consensus      1088 e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVD 1099 (1205)
T ss_pred             ccccCCccCCCC
Confidence            999999999987

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.35  E-value=2.7e-11  Score=108.30  Aligned_cols=205  Identities=13%  Similarity=0.187  Sum_probs=149.2

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC--CcHHHHhh----
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQIIR----   76 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~~l~----   76 (316)
                      ..+|..|++|++.-.  ......+...-+++++++.|+|+|++.++|.... -+...+++|++|.+  ++|.+..-    
T Consensus       298 ~~DG~~YvLkRlhg~--r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d~~F~~~~  374 (655)
T KOG3741|consen  298 NVDGNAYVLKRLHGD--RDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYDLYFANPP  374 (655)
T ss_pred             ccCCceeeeeeeccc--cccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHHHHccCCc
Confidence            568999999999332  1122233446678899999999999999998432 34577999999996  58877652    


Q ss_pred             -----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccc
Q 021181           77 -----------SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV  145 (316)
Q Consensus        77 -----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  145 (316)
                                 .+.+.++..+|.++.|+..||.++|+.|+..+-|.|.+|+++++.+++|+.-|.......+.       
T Consensus       375 ~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------  447 (655)
T KOG3741|consen  375 FTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------  447 (655)
T ss_pred             cccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------
Confidence                       22357889999999999999999999999999999999999999989888766554443322       


Q ss_pred             cccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ--LRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                          .  +.+.    -..+.|.=.||.+++.|.+|..--...+....  +..                            
T Consensus       448 ----~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~----------------------------  489 (655)
T KOG3741|consen  448 ----T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR----------------------------  489 (655)
T ss_pred             ----C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH----------------------------
Confidence                0  1111    13467899999999999999643222221111  111                            


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                ..+.+|.+++++|.-....++.+ -++.+++.+
T Consensus       490 ----------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 ----------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ----------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                      22367888999999999888876 778887753

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=1.1e-11  Score=100.33  Aligned_cols=99  Identities=17%  Similarity=0.247  Sum_probs=74.7

Q ss_pred             HHHHHHHhhCCC--CCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh-hcC
Q 021181           28 LREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV-HSA  103 (316)
Q Consensus        28 ~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~  103 (316)
                      .+|+..|+++..  -.+++++++.         .-+|||||+++ .+..-..+...++..+...+..+++.++..| |+.
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~  144 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC  144 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC
Confidence            389999999954  4566666642         24899999975 3322112223456667778889999999998 899


Q ss_pred             CceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      |++||||++.||+++ ++.+.++|||.+.....
T Consensus       145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            999999999999997 46899999998766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=8.6e-13  Score=121.50  Aligned_cols=160  Identities=23%  Similarity=0.303  Sum_probs=117.7

Q ss_pred             HHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccc----------cccccccccCccc
Q 021181           86 CRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----------EYVVTRWYRAPEL  154 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~aPE~  154 (316)
                      ...=+.+++.|+.++| +.++||++|.|++|.++.++.+||+.|+.+..........          .......|.|||.
T Consensus       101 ~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~  180 (700)
T KOG2137|consen  101 GFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY  180 (700)
T ss_pred             hhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence            3333456669999999 7799999999999999999999999999876654421110          1123556999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIM-TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.. ...+.++|++|+||++|.+. .|+..+................+.....                           
T Consensus       181 ~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~---------------------------  232 (700)
T KOG2137|consen  181 LLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFG---------------------------  232 (700)
T ss_pred             hcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccc---------------------------
Confidence            987 77889999999999999998 5666665554333332222211111100                           


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .-..++.++++=+.++|..++..||++.+++..|||.+..
T Consensus       233 ~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  233 YSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             ccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            0136789999999999999999999999999999998643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.24  E-value=1.1e-10  Score=99.58  Aligned_cols=129  Identities=13%  Similarity=0.108  Sum_probs=91.4

Q ss_pred             CCceEEEEEecccccCh---------hHHHHHHHHHHHHhhCCCCCccc--eeeeecCCCCCCCCeEEEEEecCCC--cH
Q 021181            5 TREEVAIKKIGNAFDNR---------IDAKRTLREIKLLRHMDHENIIA--IKDIIRPPQRETFNDVYIVYELMDT--DL   71 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~--~~~~~~~~~~~~~~~~~iv~e~~~g--~L   71 (316)
                      .|+.|.||.........         .-...+.+|...+.+|..-+|..  +.+++...........++|||+++|  +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            46789999774322111         01114778999998885444433  3444432211112457899999986  78


Q ss_pred             HHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-------CCCEEEeeeccccc
Q 021181           72 HQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------NCDLKIGDFGLART  133 (316)
Q Consensus        72 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-------~~~~~l~df~~~~~  133 (316)
                      .+++..  ....+......++.+++..++-||..||+|+|+++.|||++.       ++.+.++||+.+..
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            888753  345667788899999999999999999999999999999975       46799999997743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=9.2e-12  Score=113.09  Aligned_cols=227  Identities=23%  Similarity=0.214  Sum_probs=162.7

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ..++..|++|.+........+...-..|+.+...+ .|.+++.++..+...     ...||-.|||. +++...+.....
T Consensus       288 ~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-----r~~~ip~e~~~~~s~~l~~~~~~~  362 (524)
T KOG0601|consen  288 PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-----RQGYIPLEFCEGGSSSLRSVTSQM  362 (524)
T ss_pred             CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----ccccCchhhhcCcchhhhhHHHHh
Confidence            36788899998877655555555556788877777 588988888777543     33679999996 555544444457


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCCcccccccccccc-CcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYR-APELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~-aPE~~~~~  158 (316)
                      +.+..++++..|++.++.++|+..++|+|++|+||++..+ +..+++||++...+.-.  ........++. ..|++...
T Consensus       363 ~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~  440 (524)
T KOG0601|consen  363 LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLED  440 (524)
T ss_pred             cCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--cccccccccccccchhhccc
Confidence            8889999999999999999999999999999999999876 77889999987542111  11122233333 35565555


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..+..+.|++|||..+.+.++|.+.-.....-..+.                                  .......+..
T Consensus       441 ~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~----------------------------------~~~~p~~~~~  486 (524)
T KOG0601|consen  441 YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR----------------------------------SGDTPNLPGL  486 (524)
T ss_pred             cccccccccccccccccccccCcccCcccccceeee----------------------------------cccccCCCch
Confidence            788899999999999999999886543322100000                                  0011122344


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      ..+++.+.+.|...|+..||++.++..|.=|.
T Consensus       487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  487 KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            57789999999999999999999998886554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=2.5e-10  Score=92.04  Aligned_cols=121  Identities=24%  Similarity=0.299  Sum_probs=78.0

Q ss_pred             CCCceEEEEEecccccC------------------------hhHHHHHHHHHHHHhhCCCC--CccceeeeecCCCCCCC
Q 021181            4 ETREEVAIKKIGNAFDN------------------------RIDAKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRETF   57 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~~   57 (316)
                      .+|..+|||+.+....+                        ........+|.+.|.++..-  ++++++++..       
T Consensus         8 ~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~-------   80 (188)
T PF01163_consen    8 PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR-------   80 (188)
T ss_dssp             CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET-------
T ss_pred             CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC-------
Confidence            46789999988543110                        11234567899999999765  4677776531       


Q ss_pred             CeEEEEEecCC--CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-hhcCCceeccCCCCcEEEccCCCEEEeeecccccc
Q 021181           58 NDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY-VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT  134 (316)
Q Consensus        58 ~~~~iv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  134 (316)
                        -+|||||++  |.....+.. ..++......++.+++..+.. +|..||+|||+++.||+++.+ .+.++|||.+...
T Consensus        81 --~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen   81 --NVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             --TEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             --CEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence              379999998  733322322 122245567778888885555 689999999999999999887 8999999987665


Q ss_pred             C
Q 021181          135 S  135 (316)
Q Consensus       135 ~  135 (316)
                      .
T Consensus       157 ~  157 (188)
T PF01163_consen  157 S  157 (188)
T ss_dssp             T
T ss_pred             C
Confidence            4

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=3.2e-10  Score=89.10  Aligned_cols=113  Identities=22%  Similarity=0.309  Sum_probs=79.5

Q ss_pred             CceEEEEEe-cccccChh-----HHHHHHHHHHHHhhCCCCCccc--eeeeecCCCCCCCCeEEEEEecCCC-cHHHHhh
Q 021181            6 REEVAIKKI-GNAFDNRI-----DAKRTLREIKLLRHMDHENIIA--IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR   76 (316)
Q Consensus         6 ~~~vavK~~-~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~--~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~   76 (316)
                      |.++++|.- ++....+.     ......+|+.++.++.--+|..  ++++...       ...|+|||++| .|.+.+.
T Consensus        19 g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-------~~~I~me~I~G~~lkd~l~   91 (204)
T COG3642          19 GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-------NGLIVMEYIEGELLKDALE   91 (204)
T ss_pred             CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-------CCEEEEEEeCChhHHHHHH
Confidence            445666643 23333332     2344567999999986555543  4444332       25799999988 5667876


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ..       ...++..+-.-+.-||..||+|||+.++||++...+ +.++|||++..
T Consensus        92 ~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          92 EA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             hc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            64       145566777778899999999999999999997765 99999998754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.16  E-value=1.1e-10  Score=93.24  Aligned_cols=109  Identities=19%  Similarity=0.170  Sum_probs=77.2

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC-ccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      .|+.|+||.......   .......|+..++.+.+.+ +++++.....       ..++|||+++| ++.+.        
T Consensus        20 ~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~-------~~~lv~e~i~G~~l~~~--------   81 (170)
T cd05151          20 ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE-------TGVLITEFIEGSELLTE--------   81 (170)
T ss_pred             CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC-------CCeEEEEecCCCccccc--------
Confidence            467899998754321   1223568889888885444 4455554321       24799999986 44322        


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCc-----eeccCCCCcEEEccCCCEEEeeecccc
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANV-----LHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i-----~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      ......++.+++.+|+.||..++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        82 ~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          82 DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            11123456899999999998885     9999999999999 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.13  E-value=3.7e-10  Score=103.42  Aligned_cols=75  Identities=25%  Similarity=0.343  Sum_probs=57.1

Q ss_pred             eEEEEEecCCC-cHHHHhhcC-CCCCHHHHHHHHHHHHH-HHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC
Q 021181           59 DVYIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLR-GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS  135 (316)
Q Consensus        59 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  135 (316)
                      ..++||||++| +|.+..... ...   ....++.+++. .+..+|..|++|+|++|.||+++.++.++++|||++...+
T Consensus       232 ~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       232 ERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            36899999975 777665421 122   23445566665 4678899999999999999999999999999999987664


Q ss_pred             C
Q 021181          136 E  136 (316)
Q Consensus       136 ~  136 (316)
                      .
T Consensus       309 ~  309 (437)
T TIGR01982       309 E  309 (437)
T ss_pred             H
Confidence            3

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.11  E-value=6.5e-10  Score=87.08  Aligned_cols=125  Identities=25%  Similarity=0.325  Sum_probs=89.4

Q ss_pred             CCceEEEEEecc-cc-----cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC--cHHHHhh
Q 021181            5 TREEVAIKKIGN-AF-----DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQIIR   76 (316)
Q Consensus         5 ~~~~vavK~~~~-~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~   76 (316)
                      .|+.++||.-.. ..     +......+..+|+.++.++.--+|....-++.+.     +.-.|+|||++|  ++.+++.
T Consensus        29 ~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~~~~i~ME~~~g~~~vk~~i~  103 (229)
T KOG3087|consen   29 SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----YGGQIYMEFIDGASTVKDFIL  103 (229)
T ss_pred             CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----CCCeEEEEeccchhHHHHHHH
Confidence            567777775422 21     2233456678899999999755665444445433     335899999988  8888887


Q ss_pred             cCCC--CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC---EEEeeecccccc
Q 021181           77 SHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTT  134 (316)
Q Consensus        77 ~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~  134 (316)
                      ....  .........+..|-+.+..||..+|+||||..+||++..++.   +.++|||++...
T Consensus       104 ~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  104 STMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            6432  233333678889999999999999999999999999976553   589999987543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=9.7e-10  Score=90.73  Aligned_cols=128  Identities=20%  Similarity=0.266  Sum_probs=94.1

Q ss_pred             CCceEEEEEeccccc-----ChhHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeEEEEEecCCC--cHHHHh
Q 021181            5 TREEVAIKKIGNAFD-----NRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQII   75 (316)
Q Consensus         5 ~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l   75 (316)
                      .++.|-+|.......     .........+|...+..|..-+  +++.+++..... ......++|+|+++|  +|.+++
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~  109 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLL  109 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHH
Confidence            345566665432211     1134456788888888885444  345555554332 122457899999975  799998


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccc
Q 021181           76 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLART  133 (316)
Q Consensus        76 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~  133 (316)
                      ......+......++.+++..++-||..||+|+|+++.|||++.++   .+.++||+.+..
T Consensus       110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            8755578888899999999999999999999999999999999887   899999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.06  E-value=6e-09  Score=91.48  Aligned_cols=128  Identities=14%  Similarity=0.133  Sum_probs=102.8

Q ss_pred             EEEEEecCCC--cHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181           60 VYIVYELMDT--DLHQIIR------SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus        60 ~~iv~e~~~g--~L~~~l~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      ..++|+.+.|  .+..++.      +.+...+.-..++++.++.+.+.||..|.+-||++++|+|+++++.+.|.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            7889999864  5555542      3355889999999999999999999999999999999999999999999986544


Q ss_pred             cccCCCCccccccccccccCcccccC----CCCCCCcchHHHHHHHHHHHHhC-CCCCCCC
Q 021181          132 RTTSETDFMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTR-QPLFPGK  187 (316)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~~l~ell~g-~~pf~~~  187 (316)
                      ..-.........++...|.+||...-    ...-+...|.|.||+++++++.| +-||.+-
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            44444444556788999999998641    12346789999999999999885 8999764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.01  E-value=5.4e-10  Score=103.83  Aligned_cols=72  Identities=19%  Similarity=0.384  Sum_probs=53.5

Q ss_pred             CeEEEEEecCCC-cHHHH--hhcCC----CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC----CEEEe
Q 021181           58 NDVYIVYELMDT-DLHQI--IRSHQ----DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIG  126 (316)
Q Consensus        58 ~~~~iv~e~~~g-~L~~~--l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~  126 (316)
                      ..-++||||++| .+.+.  +...+    .+.+..+..++.|++       ..|++|+|++|.||+++.+|    .++++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~ll  306 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIAL  306 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence            346899999975 77653  33322    244444555555554       48999999999999999888    99999


Q ss_pred             eeccccccCC
Q 021181          127 DFGLARTTSE  136 (316)
Q Consensus       127 df~~~~~~~~  136 (316)
                      |||++...+.
T Consensus       307 DFGivg~l~~  316 (537)
T PRK04750        307 DFGIVGSLNK  316 (537)
T ss_pred             ecceEEECCH
Confidence            9999877654

>PRK09902 hypothetical protein; Provisional

Probab=98.87  E-value=4.3e-08  Score=79.74  Aligned_cols=127  Identities=15%  Similarity=0.200  Sum_probs=91.9

Q ss_pred             CceEEEEEecc-cccC---hhHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeEEEEEecCCC--cHHHHhhc
Q 021181            6 REEVAIKKIGN-AFDN---RIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQIIRS   77 (316)
Q Consensus         6 ~~~vavK~~~~-~~~~---~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~~   77 (316)
                      |+.|=||+-.. -..+   +.....+.+|+..+.+|..-+  ++++. ++..........-+||+|-++|  +|.+++..
T Consensus        41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~  119 (216)
T PRK09902         41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQ  119 (216)
T ss_pred             CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhc
Confidence            44577777642 1111   335567889999999985433  44444 2221111234568899999974  89998866


Q ss_pred             C--CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC--EEEeeeccccc
Q 021181           78 H--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--LKIGDFGLART  133 (316)
Q Consensus        78 ~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~df~~~~~  133 (316)
                      .  .+.+......++.+++.+++-||+.|+.|+|+.+.||+++..+.  +.++||.-++.
T Consensus       120 ~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        120 HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            3  34578888899999999999999999999999999999986677  99999986544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.85  E-value=2e-08  Score=83.62  Aligned_cols=124  Identities=19%  Similarity=0.267  Sum_probs=85.6

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      |+.|++|........ .....+..|+++++.+.+.+  +++++.+.....  ..+..++|||+++| ++.+.+.. ..++
T Consensus        22 g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~i~G~~l~~~~~~-~~~~   97 (223)
T cd05154          22 GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMERVDGRVLRDRLLR-PELS   97 (223)
T ss_pred             CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEEeCCEecCCCCCC-CCCC
Confidence            578999987553221 23456789999999997544  577777654321  11346899999976 55443321 3456


Q ss_pred             HHHHHHHHHHHHHHHHHhhc--------------------------------------------------------CCce
Q 021181           83 DDHCRYFLYQLLRGLKYVHS--------------------------------------------------------ANVL  106 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~--------------------------------------------------------~~i~  106 (316)
                      ..+...++.+++.+|..||+                                                        ..++
T Consensus        98 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  177 (223)
T cd05154          98 PEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLV  177 (223)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEE
Confidence            66666667777777777763                                                        2368


Q ss_pred             eccCCCCcEEEcc--CCCEEEeeeccccc
Q 021181          107 HRDLKPSNLLLNA--NCDLKIGDFGLART  133 (316)
Q Consensus       107 H~dl~p~nil~~~--~~~~~l~df~~~~~  133 (316)
                      |+|+++.||+++.  ++.+.++||+.+..
T Consensus       178 HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         178 HGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            9999999999998  56688999987644

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=6.3e-08  Score=79.07  Aligned_cols=119  Identities=16%  Similarity=0.180  Sum_probs=71.9

Q ss_pred             CCceEEEEEecccccChhHH-H------HHHHHHHHHhhCCC---CCccceeeeecCCCCCCCCeEEEEEecCCC-cHHH
Q 021181            5 TREEVAIKKIGNAFDNRIDA-K------RTLREIKLLRHMDH---ENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQ   73 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~-~------~~~~E~~~l~~l~h---~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~   73 (316)
                      +|+.+++|..+......+.. .      ...+.+..+.++..   .....++.+.......-....+++|||++| .|.+
T Consensus        53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d  132 (229)
T PF06176_consen   53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND  132 (229)
T ss_pred             CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence            57888999886543221111 1      12234444444433   333333333322211112346689999987 5654


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      ..    .+++    .+...+.+++.-+|+.|++|||.+|.|++++.+ .++++|++..+
T Consensus       133 ~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  133 IE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             ch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            42    1222    244677788999999999999999999999865 49999997543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.73  E-value=7.5e-08  Score=94.20  Aligned_cols=212  Identities=20%  Similarity=0.245  Sum_probs=147.7

Q ss_pred             HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh
Q 021181           23 DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH  101 (316)
Q Consensus        23 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH  101 (316)
                      .......|+..+..+.|+|++.++.+-......+ -...+..++|.+ ++...++.-+..+....+.+..++++||+++|
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3444456777788889999999998876542211 123345567764 88889888899999999999999999999999


Q ss_pred             cCCceeccCCCC---cEEEccCCCEEEe--eeccccccCCCCccccccccccccCcccccCCCCCC--CcchHHHHHHHH
Q 021181          102 SANVLHRDLKPS---NLLLNANCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT--AAIDIWSVGCIL  174 (316)
Q Consensus       102 ~~~i~H~dl~p~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~~DiwslG~~l  174 (316)
                      +....|.-+..+   +--++..+...++  ||+.+..............+..+.++|.... +...  ...|+|++|...
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHH
Confidence            886555554444   3334555566666  8888777666555445555667788887755 3333  447999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh-HHHHHHHHhcccC
Q 021181          175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP-GAVDLLEKMLVFD  253 (316)
Q Consensus       175 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~l~~li~~~L~~d  253 (316)
                      ..+..|..+-.........      +                                   +..+. ...+.+.+|+..|
T Consensus       383 ~~~~~~~~i~~~~~~~~~~------l-----------------------------------~~~~~~~~~d~~~~~~~~~  421 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVPVSL------L-----------------------------------DVLSTSELLDALPKCLDED  421 (1351)
T ss_pred             hhhhhcCcccccccchhhh------h-----------------------------------ccccchhhhhhhhhhcchh
Confidence            9998886543221100000      0                                   01111 5788999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          254 PNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       254 P~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      +++|+++.+++.|+|.+.-.....
T Consensus       422 ~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  422 SEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhccchhhhhhchhccccccccc
Confidence            999999999999999876654444

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.70  E-value=1.3e-07  Score=78.96  Aligned_cols=98  Identities=20%  Similarity=0.265  Sum_probs=74.4

Q ss_pred             HHHHHHHHHHHhhCCCC--CccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh
Q 021181           24 AKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV  100 (316)
Q Consensus        24 ~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L  100 (316)
                      .....+|.+.|..|...  .+++.+++         +...+|||+++| .|...     ++.......++..|++-+..+
T Consensus       153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~  218 (304)
T COG0478         153 RLAAEREFEALQRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKA  218 (304)
T ss_pred             HHHHHHHHHHHHHhhhcCCCCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHH
Confidence            35567899999999655  67777765         346899999988 44322     224555666677777766666


Q ss_pred             hcCCceeccCCCCcEEEccCCCEEEeeeccccccC
Q 021181          101 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS  135 (316)
Q Consensus       101 H~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  135 (316)
                      =..|++|||+++-||+++.+|.+.++||-.+...+
T Consensus       219 ~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         219 YRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             HHcCccccCCchheEEEecCCCEEEEeCcccccCC
Confidence            69999999999999999999999999997654443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.38  E-value=2.8e-06  Score=70.39  Aligned_cols=122  Identities=16%  Similarity=0.158  Sum_probs=82.4

Q ss_pred             CCCceEEEEEecccccCh----------------------hHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCe
Q 021181            4 ETREEVAIKKIGNAFDNR----------------------IDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFND   59 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~   59 (316)
                      .++..||||+++......                      .......+|+.-|+++...+  +++.+++.         .
T Consensus        70 ~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~  140 (268)
T COG1718          70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR---------N  140 (268)
T ss_pred             CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec---------C
Confidence            358899999986542111                      11123356777777774443  44445443         2


Q ss_pred             EEEEEecCCCc--HHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           60 VYIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        60 ~~iv~e~~~g~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      -.+||||++..  -.-.|+. .++...+...+..+++..+.-|=. +++||+||+.-|||+. ++.+.++|++.+.....
T Consensus       141 nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         141 NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            48999999742  1112211 123344678888899998888775 9999999999999999 78999999998766553

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.15  E-value=6.7e-05  Score=60.79  Aligned_cols=98  Identities=18%  Similarity=0.124  Sum_probs=78.0

Q ss_pred             HHHHHHHhhCCC-CCccceeeeecCCCCCCCCeEEEEEecCC-CcHHH---HhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021181           28 LREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQ---IIRSHQDLTDDHCRYFLYQLLRGLKYVHS  102 (316)
Q Consensus        28 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~---~l~~~~~~~~~~~~~i~~qi~~~l~~LH~  102 (316)
                      ..|.-+++.+.+ +++++++|+|.         -+++.||.+ +++..   .+......++..+..++.++++.+.+|+.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            368888889965 69999999982         267899997 45432   11222356899999999999999999996


Q ss_pred             ---CCceeccCCCCcEEEccCCCEEEeeecccccc
Q 021181          103 ---ANVLHRDLKPSNLLLNANCDLKIGDFGLARTT  134 (316)
Q Consensus       103 ---~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  134 (316)
                         ..+.-.|++++|+-++.+|+++++|.......
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence               34888899999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.12  E-value=4.4e-05  Score=63.89  Aligned_cols=117  Identities=18%  Similarity=0.183  Sum_probs=67.3

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeEEEEEecCCCc--HHHHh------
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQII------   75 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~iv~e~~~g~--L~~~l------   75 (316)
                      |..+++|......    ....+.+|.++++.+..-+  +++++++....     +..++||++++|.  +...+      
T Consensus        22 ~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-----~~~glv~e~i~G~~~~~~~~~~~~~~   92 (226)
T TIGR02172        22 TGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDG-----GRLGLIYELIVGKRSFSRIISDNPSR   92 (226)
T ss_pred             CCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-----CeeeeeeeecCCccchhhhhcCCHHH
Confidence            5567888775322    3345689999999986444  46677766433     3468899999873  11111      


Q ss_pred             ---------------hcC--CCCCHHHH-HHHHHH----------HHHH-HHHhh----cCCceeccCCCCcEEEccCCC
Q 021181           76 ---------------RSH--QDLTDDHC-RYFLYQ----------LLRG-LKYVH----SANVLHRDLKPSNLLLNANCD  122 (316)
Q Consensus        76 ---------------~~~--~~~~~~~~-~~i~~q----------i~~~-l~~LH----~~~i~H~dl~p~nil~~~~~~  122 (316)
                                     ..-  ........ ..+..+          +... ..+|.    ...++|+|+.|.||+++.++ 
T Consensus        93 ~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-  171 (226)
T TIGR02172        93 LEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-  171 (226)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-
Confidence                           000  01111110 011000          0111 11121    22478999999999999888 


Q ss_pred             EEEeeecccc
Q 021181          123 LKIGDFGLAR  132 (316)
Q Consensus       123 ~~l~df~~~~  132 (316)
                      +.++||+.+.
T Consensus       172 ~~iIDwe~a~  181 (226)
T TIGR02172       172 TYWIDLGDFG  181 (226)
T ss_pred             cEEEechhcC
Confidence            9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.11  E-value=2e-05  Score=73.29  Aligned_cols=75  Identities=20%  Similarity=0.386  Sum_probs=51.6

Q ss_pred             eEEEEEecCCC-cHHHH--hhcCCCCCHHHHHHHHHHHHHH-HHHhhcCCceeccCCCCcEEEccCCCEEEeeecccccc
Q 021181           59 DVYIVYELMDT-DLHQI--IRSHQDLTDDHCRYFLYQLLRG-LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT  134 (316)
Q Consensus        59 ~~~iv~e~~~g-~L~~~--l~~~~~~~~~~~~~i~~qi~~~-l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  134 (316)
                      .-.++|||++| .+.+.  ++. .+.+...+   +..++.+ +.-+=..|++|.|.+|.||+++.+|++.+.|||.....
T Consensus       240 ~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         240 RRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            35899999987 56554  444 44553332   2222221 11122489999999999999999999999999998776


Q ss_pred             CCC
Q 021181          135 SET  137 (316)
Q Consensus       135 ~~~  137 (316)
                      +..
T Consensus       316 ~~~  318 (517)
T COG0661         316 DPK  318 (517)
T ss_pred             CHH
Confidence            543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.92  E-value=2.1e-06  Score=79.50  Aligned_cols=207  Identities=19%  Similarity=0.135  Sum_probs=132.2

Q ss_pred             HHHHHHHHHhhCCCCC-ccceeeeecCCCCCCCCeEEEEEecCCCc--HHHHh-hcCCCCCHHHHHHHHHHHHHHHHHhh
Q 021181           26 RTLREIKLLRHMDHEN-IIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQII-RSHQDLTDDHCRYFLYQLLRGLKYVH  101 (316)
Q Consensus        26 ~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~~~~~iv~e~~~g~--L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH  101 (316)
                      ...-++++|.+++||| .+..++-+     +.....++.|+++++.  ....+ ...-.+...+.....+.-+.+++++|
T Consensus       279 ~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~  353 (829)
T KOG0576|consen  279 SRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH  353 (829)
T ss_pred             hhHHHHHHHHHccCCCCcccccccC-----CcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc
Confidence            3456889999999999 44444433     2335689999999742  22111 01112344455566667778899999


Q ss_pred             cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 021181          102 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       102 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~  181 (316)
                      +.--+|+|    ||+..+ +..+..+|+...............+++.++|||+... +.+....|.|++|.-..++.-|.
T Consensus       354 ~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~  427 (829)
T KOG0576|consen  354 SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGL  427 (829)
T ss_pred             cccccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCC
Confidence            87668888    666544 6789999988766655545567788999999998877 67889999999998888888887


Q ss_pred             CCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHH-HHHHHhcccCCCCCCCH
Q 021181          182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV-DLLEKMLVFDPNRRITV  260 (316)
Q Consensus       182 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~-~li~~~L~~dP~~Rps~  260 (316)
                      +|-...-  ....    ..|..+       .+.....-         ..+       ++... ++...|+..-|..|+..
T Consensus       428 pPr~~P~--~~~~----~~g~~p-------~s~~L~~~---------~aw-------~~~~~~~~~~~~~~g~P~~pkv~  478 (829)
T KOG0576|consen  428 PPRSSPP--AVLP----MIGNGP-------NSPMLTDK---------SAW-------SPVFHRDFPAPCLNGLPPTPKVH  478 (829)
T ss_pred             CCCCCCc--cccC----CCCCCC-------Cccccchh---------hhc-------CcccccCCcccccCCCCCCCcch
Confidence            7764410  0000    000000       00000000         000       01111 46778889999999998


Q ss_pred             HHHhcCCCCCCC
Q 021181          261 DEALCHPYLAPL  272 (316)
Q Consensus       261 ~ell~~~~f~~~  272 (316)
                      -..+.|.+|..-
T Consensus       479 mgacfsKvfngC  490 (829)
T KOG0576|consen  479 MGACFSKVFNGC  490 (829)
T ss_pred             hhHHHHHHhccC
Confidence            888888888653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.92  E-value=0.00011  Score=62.25  Aligned_cols=57  Identities=11%  Similarity=0.054  Sum_probs=37.5

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLH   72 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~   72 (316)
                      +..++||+.....     ...+.+|+++++.+. +--+++++++....     +..++||++++| ++.
T Consensus        22 ~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~i~G~~l~   80 (244)
T cd05150          22 NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTSAVPGVPAA   80 (244)
T ss_pred             CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEEeeCCccHh
Confidence            3678888775431     334668999888883 34456677766432     346899999977 443

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.79  E-value=7.8e-05  Score=67.96  Aligned_cols=176  Identities=22%  Similarity=0.272  Sum_probs=113.6

Q ss_pred             HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021181           23 DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS  102 (316)
Q Consensus        23 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~  102 (316)
                      ...+++--..+++.+.|++...++++.....    ....+|||+++.+|.+.++.+. +-.....              .
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~   85 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------A   85 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------c
Confidence            4556777788899999999999998764322    4589999999999999887644 2221111              1


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP  182 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~  182 (316)
                      .|+.|     .|       .++.+|--.++                |  |      .+.++++||||+|.++.++..|..
T Consensus        86 ~~~~~-----~~-------~~~~td~~~t~----------------~--~------~~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   86 HGVLH-----LN-------IIYITDHFLTK----------------Y--P------SPIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             cccce-----eh-------hhhcccccccc----------------C--C------CCCCcchhhhhHHHHHHHHHHhhH
Confidence            12211     11       12333310000                0  0      112259999999999999999998


Q ss_pred             CCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHH
Q 021181          183 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE  262 (316)
Q Consensus       183 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e  262 (316)
                      .+......+....+.+..........-...                   ......++..+..+..+|+-..|..||...+
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-------------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAME-------------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHH-------------------HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            887776666666665543332221110000                   0111245667889999999999999999999


Q ss_pred             HhcCCCCCCC
Q 021181          263 ALCHPYLAPL  272 (316)
Q Consensus       263 ll~~~~f~~~  272 (316)
                      +.+++-|..+
T Consensus       191 ~~k~~i~~ev  200 (725)
T KOG1093|consen  191 LSKRCSFTEV  200 (725)
T ss_pred             HhcCccHHHH
Confidence            9999999876

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.74  E-value=0.00077  Score=54.98  Aligned_cols=111  Identities=20%  Similarity=0.317  Sum_probs=75.7

Q ss_pred             ceEEEEEecccc--------------cChhHHHHHHHHHHHHhhCC------CCCccceeeeecCCCCCCCCeEEEEEec
Q 021181            7 EEVAIKKIGNAF--------------DNRIDAKRTLREIKLLRHMD------HENIIAIKDIIRPPQRETFNDVYIVYEL   66 (316)
Q Consensus         7 ~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~~~~~~iv~e~   66 (316)
                      ...+||+.....              ..........+|+.-...+.      +.+|.+++|+...+     ....+|+|.
T Consensus        24 p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~-----~G~Glv~e~   98 (199)
T PF10707_consen   24 PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETN-----LGLGLVVEL   98 (199)
T ss_pred             CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecC-----CceEEEEEE
Confidence            346788776543              11223456667777666665      89999999998544     457888888


Q ss_pred             C---CC----cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC----CEEEee
Q 021181           67 M---DT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGD  127 (316)
Q Consensus        67 ~---~g----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~d  127 (316)
                      +   +|    +|.++++. +.++. ....   .+-+-..+|-+.+|+.+|++|+||++....    .+.|+|
T Consensus        99 I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen   99 IRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            6   23    67888755 44655 4333   333445677889999999999999996432    477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.74  E-value=0.00024  Score=59.87  Aligned_cols=29  Identities=34%  Similarity=0.446  Sum_probs=24.5

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      .+++|+|+.+.|++++.++..-++||+.+
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            35899999999999987655679999865

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.71  E-value=0.00044  Score=57.74  Aligned_cols=61  Identities=18%  Similarity=0.175  Sum_probs=38.6

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCC--CccceeeeecCCCCCCCCeEEEEEecCCC-cHHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQ   73 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~   73 (316)
                      ..+++|.....    .....+..|..+++.+...  .+++++......  ......+++|++++| .+..
T Consensus        21 ~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   21 GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEEEEEESSEEHHH
T ss_pred             cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEEEEEeccccccc
Confidence            48999986432    4556778999998888533  356676644322  222457999999987 4444

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.65  E-value=0.00059  Score=68.08  Aligned_cols=61  Identities=13%  Similarity=0.217  Sum_probs=40.6

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCc--cceeeeecCCCCCCCCeEEEEEecCCCc
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENI--IAIKDIIRPPQRETFNDVYIVYELMDTD   70 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~~~~~~~~~~iv~e~~~g~   70 (316)
                      ..+++|+...... ......+.+|+.+++.+. |+++  ++++.++.+.  ...+..|+|||+++|.
T Consensus        66 ~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~flVME~v~G~  129 (822)
T PLN02876         66 KRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAFYIMEYLEGR  129 (822)
T ss_pred             eeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCceEEEEecCCc
Confidence            4678887654321 123456789999999995 6665  7777776543  2224578999999874

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.41  E-value=0.0009  Score=52.82  Aligned_cols=109  Identities=24%  Similarity=0.266  Sum_probs=74.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCc-cceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      .|..+|+|+-+.+    +....+..|++++..++-.++ .++|.+..         -++.|||+.| .|.++-...   .
T Consensus        44 ~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~---------~~i~me~i~G~~L~~~~~~~---~  107 (201)
T COG2112          44 RGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE---------DFIRMEYIDGRPLGKLEIGG---D  107 (201)
T ss_pred             cCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech---------hhhhhhhhcCcchhhhhhcc---c
Confidence            4668999976433    344567899999999976665 44555432         3567999987 776553321   1


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCC-C-CcEEEccCCCEEEeeecccccc
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLK-P-SNLLLNANCDLKIGDFGLARTT  134 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~-p-~nil~~~~~~~~l~df~~~~~~  134 (316)
                          +.-+..++++..-|-..||-|+.++ | .||+++ ++.+.|+||..++..
T Consensus       108 ----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k  156 (201)
T COG2112         108 ----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATFK  156 (201)
T ss_pred             ----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCcEEEEEccchhhc
Confidence                2334566777677889999999998 4 455554 448999999987643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.39  E-value=0.00011  Score=74.67  Aligned_cols=215  Identities=18%  Similarity=0.056  Sum_probs=136.8

Q ss_pred             HHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC----CCCHHHHHHHHHHH-HHHH
Q 021181           24 AKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----DLTDDHCRYFLYQL-LRGL   97 (316)
Q Consensus        24 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi-~~~l   97 (316)
                      .+....|..-++...|+++...+.-....   .....++.++++. |.+++.|.++-    +.... .....+++ +.+.
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~-~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRS-PVHLRHKVSVLNR 1348 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhc-hHHHHHHHHHhcc
Confidence            34444555555667888887776655432   2245789999995 89999886642    22222 23333444 5555


Q ss_pred             HHhhcC-C----ceeccCCCCcEEEccCCCEEEeeeccccc-cCCCCccccccccccccCcccccCCCCCCCcchHHHHH
Q 021181           98 KYVHSA-N----VLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG  171 (316)
Q Consensus        98 ~~LH~~-~----i~H~dl~p~nil~~~~~~~~l~df~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (316)
                      .-+|+. |    -+|+++++-|.++..+..++++++|+.+. ...........+++.|++|+..-. -.++.++|+|..|
T Consensus      1349 ~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRS 1427 (2724)
T ss_pred             chhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHH
Confidence            555533 2    68999999999999999999999999883 222333445567778888887644 4566679999999


Q ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcc
Q 021181          172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLV  251 (316)
Q Consensus       172 ~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~  251 (316)
                      +.+|.+.-|..+|.....    ....+.........                          ...-.|.+.-.....+|-
T Consensus      1428 ~~ly~rs~~n~~fi~flq----~~Lkgiidn~tf~s--------------------------Ie~l~pgdaNve~~~~Ll 1477 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIFFLQ----PALKGIIDNHTFFS--------------------------IEKLKPGDANVEALHRLL 1477 (2724)
T ss_pred             HHHHHHhcccHHHHHHHH----HHHcCccccccccc--------------------------ccccCCCcccHHHHHHHH
Confidence            999999999887732211    11111111100000                          011234445566666777


Q ss_pred             cCCCCCCCHHHHhcCCCCCCCC
Q 021181          252 FDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       252 ~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +.-..||+-...+..+.|....
T Consensus      1478 ~K~~~rp~q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1478 WKYMERPGQYISLSRDHFAVGL 1499 (2724)
T ss_pred             HHhhhcchhhhhcccccccccc
Confidence            7777889888888877765443

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.38  E-value=0.0013  Score=57.96  Aligned_cols=125  Identities=19%  Similarity=0.272  Sum_probs=85.5

Q ss_pred             CCCCceEEEEEecccc---cC---------------------hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCC
Q 021181            3 SETREEVAIKKIGNAF---DN---------------------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN   58 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~---~~---------------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   58 (316)
                      ..+|..+|||+++.+-   .+                     ....-.+.+|+.-|.+++..+|+..--+....      
T Consensus       165 ~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk~------  238 (520)
T KOG2270|consen  165 EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLKN------  238 (520)
T ss_pred             cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceeeec------
Confidence            3678889999986431   00                     11223345788889999888876555444432      


Q ss_pred             eEEEEEecCCC-c-HHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccC
Q 021181           59 DVYIVYELMDT-D-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS  135 (316)
Q Consensus        59 ~~~iv~e~~~g-~-L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  135 (316)
                       ..|||+++++ . -.-.| +...++...+..+-.+++.-+.-|- .+++||.||.--|+|+- +|.+.++|.+.+....
T Consensus       239 -hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  239 -HVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             -ceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEEEccccccCC
Confidence             4899999973 2 12222 2245777777777777777766654 78999999999999984 5689999998775544


Q ss_pred             C
Q 021181          136 E  136 (316)
Q Consensus       136 ~  136 (316)
                      .
T Consensus       316 H  316 (520)
T KOG2270|consen  316 H  316 (520)
T ss_pred             C
Confidence            3

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.30  E-value=0.0019  Score=60.26  Aligned_cols=74  Identities=18%  Similarity=0.316  Sum_probs=50.5

Q ss_pred             EEEEEecCCC-cH--HHHhhcCCCCCHHHHHHHHHHHHHHHHH-hhcCCceeccCCCCcEEEcc----CCCEEEeeeccc
Q 021181           60 VYIVYELMDT-DL--HQIIRSHQDLTDDHCRYFLYQLLRGLKY-VHSANVLHRDLKPSNLLLNA----NCDLKIGDFGLA  131 (316)
Q Consensus        60 ~~iv~e~~~g-~L--~~~l~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~i~H~dl~p~nil~~~----~~~~~l~df~~~  131 (316)
                      -.++||||+| .+  .+.|.+ .+++...+.   ..+.++... +=..|++|+|-+|.||+++.    ++.+.+.|||+.
T Consensus       277 RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~  352 (538)
T KOG1235|consen  277 RVLTMEYVDGIKINDLDAIDK-RGISPHDIL---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLY  352 (538)
T ss_pred             eEEEEEecCCccCCCHHHHHH-cCCCHHHHH---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence            5899999986 33  244444 345555433   333333222 22578999999999999984    678999999998


Q ss_pred             cccCCC
Q 021181          132 RTTSET  137 (316)
Q Consensus       132 ~~~~~~  137 (316)
                      ..+...
T Consensus       353 ~~is~~  358 (538)
T KOG1235|consen  353 AVISHK  358 (538)
T ss_pred             ccccHH
Confidence            777654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.11  E-value=0.0082  Score=52.55  Aligned_cols=127  Identities=13%  Similarity=0.176  Sum_probs=73.9

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCc--cceeeeecCCCCCCCCeEEEEEecCCC-cH-----------
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI--IAIKDIIRPPQRETFNDVYIVYELMDT-DL-----------   71 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L-----------   71 (316)
                      ++.++|. .+.....-.......+|+.+++.+.---+  ...++++...  . ....|.||+++.| .+           
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~--~-~g~pf~v~~~veGe~~~~~~~~~~~~~  123 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEG--Y-LGTPFYVMEWVEGEVVWSALPPESLGR  123 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccC--C-CCCceEEEEEecceeccCcCCcccchH
Confidence            6778888 33222334455667788998888854333  3445544332  1 3567999999977 11           


Q ss_pred             -------HHHhh---c-----------CCCCCHHHHHHHHHHH--------------HHHHHHhhcC--------Cceec
Q 021181           72 -------HQIIR---S-----------HQDLTDDHCRYFLYQL--------------LRGLKYVHSA--------NVLHR  108 (316)
Q Consensus        72 -------~~~l~---~-----------~~~~~~~~~~~i~~qi--------------~~~l~~LH~~--------~i~H~  108 (316)
                             .+.|.   +           .......++..+..+.              .....+++..        .++||
T Consensus       124 ~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHG  203 (321)
T COG3173         124 QFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHG  203 (321)
T ss_pred             HHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeC
Confidence                   11110   0           0001222233333333              1123334322        48999


Q ss_pred             cCCCCcEEEccCCCEEEeeeccccccCC
Q 021181          109 DLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus       109 dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      |+++.|++++..+.+-+.||+.+.....
T Consensus       204 D~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         204 DYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CcccCCEEEeCCCeeEEEeccccccCCc
Confidence            9999999999998899999998866543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.06  E-value=0.0035  Score=54.68  Aligned_cols=30  Identities=30%  Similarity=0.348  Sum_probs=26.1

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeecccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      .+++|+|+.|.|++++.++.+.++||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999987777899998653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.02  E-value=0.0035  Score=53.46  Aligned_cols=29  Identities=31%  Similarity=0.436  Sum_probs=25.3

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      .++|+|+.|.||+++.++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999877 78999987644

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.75  E-value=0.014  Score=51.06  Aligned_cols=28  Identities=36%  Similarity=0.415  Sum_probs=25.2

Q ss_pred             CceeccCCCCcEEEccC----CCEEEeeeccc
Q 021181          104 NVLHRDLKPSNLLLNAN----CDLKIGDFGLA  131 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~----~~~~l~df~~~  131 (316)
                      +++|+|+.+.||+++.+    +.+.++||..+
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            58999999999999985    78999999866

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.73  E-value=0.023  Score=50.13  Aligned_cols=29  Identities=31%  Similarity=0.355  Sum_probs=24.9

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      .+++|+|+.+.||+++.+...-++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccc
Confidence            47999999999999986655679999865

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.55  E-value=0.023  Score=49.06  Aligned_cols=30  Identities=23%  Similarity=0.495  Sum_probs=24.7

Q ss_pred             CceeccCCCCcEEEccCCC-EEEeeeccccc
Q 021181          104 NVLHRDLKPSNLLLNANCD-LKIGDFGLART  133 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~-~~l~df~~~~~  133 (316)
                      .++|+|+++.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997565 46999997643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.47  E-value=0.012  Score=51.91  Aligned_cols=104  Identities=16%  Similarity=0.258  Sum_probs=70.8

Q ss_pred             CeEEEEEecCCCcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           58 NDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        58 ~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      ...|++|++-++++.-.    ..-...++..++.+.+..++-+. ...+-|||+...||+++ +|++.|+||.+++....
T Consensus       299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            45788999887766432    23457788888898888888887 45799999999999999 99999999999985332


Q ss_pred             CCccccccccccccCcccccCCCCCCCcchHHHHHH
Q 021181          137 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC  172 (316)
Q Consensus       137 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  172 (316)
                      ...    .....+--|-.+.+  ..+..-+||-+--
T Consensus       374 q~~----isy~rldhp~lF~G--~dd~QFeIYrlMr  403 (488)
T COG5072         374 QGI----ISYNRLDHPDLFNG--VDDYQFEIYRLMR  403 (488)
T ss_pred             Cce----eeccccCchhhhcC--ccceeeeHHHHHH
Confidence            211    11112233444443  3355666665433

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.44  E-value=0.0096  Score=48.45  Aligned_cols=90  Identities=22%  Similarity=0.307  Sum_probs=62.9

Q ss_pred             HHHHHHHHHHhhCC---CCCc--cceeeeecCCC-C------------CCCCeEEEEEecCCCcHHHHhhcCCCCCHHHH
Q 021181           25 KRTLREIKLLRHMD---HENI--IAIKDIIRPPQ-R------------ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC   86 (316)
Q Consensus        25 ~~~~~E~~~l~~l~---h~~i--~~~~~~~~~~~-~------------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~   86 (316)
                      ..+..|.+...+|+   +.++  |+++|+..-.. .            .......||-||+...-        .++... 
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~-  169 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD-  169 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH-
Confidence            45677888887774   5566  99999885331 0            11233578888875321        233333 


Q ss_pred             HHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181           87 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus        87 ~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                         +.+|++-+..+|..||+-+|+++.|..     .-+|+|||.+
T Consensus       170 ---~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  170 ---IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence               567778889999999999999999987     3489999864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.43  E-value=0.0063  Score=52.91  Aligned_cols=95  Identities=18%  Similarity=0.237  Sum_probs=68.3

Q ss_pred             HHHHHHHHHhhCCC--CCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021181           26 RTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS  102 (316)
Q Consensus        26 ~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~  102 (316)
                      ...+|..-++.|..  --+++.+++         +..++|||++.| .|.+.-.      ...+..+...++.-+--|-.
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~  220 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLAN  220 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcccc---------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHH
Confidence            34678888888843  224555554         346899999976 6654421      12233455666667777889


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccccccC
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS  135 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  135 (316)
                      .|++|||+.-=||+++.++.++++||-.+...+
T Consensus       221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             cCceecccchheeEEecCCCEEEeechHhhccC
Confidence            999999999999999999999999997655443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.31  E-value=0.1  Score=47.37  Aligned_cols=31  Identities=23%  Similarity=0.355  Sum_probs=25.3

Q ss_pred             cCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          102 SANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       102 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ...++|||+++.||++..+ .++++||..+..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            3468999999999999776 589999976533

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.13  E-value=0.021  Score=46.98  Aligned_cols=81  Identities=19%  Similarity=0.244  Sum_probs=56.2

Q ss_pred             HHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC--cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh--c
Q 021181           27 TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH--S  102 (316)
Q Consensus        27 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--~  102 (316)
                      +..+..++.++  -+|+++..       .+...+.++.|.|-.  .+.              ..++.--+.+|..+|  +
T Consensus       105 y~nky~v~Arm--hGilrL~N-------Dn~~~yGvIlE~Cy~~~i~~--------------~N~i~agi~~L~~fH~~~  161 (308)
T PF07387_consen  105 YFNKYRVFARM--HGILRLKN-------DNNYKYGVILERCYKIKINF--------------SNFITAGIKDLMDFHSEN  161 (308)
T ss_pred             hhhhhhHHHHh--hheeEeec-------CCCceeEEEEeeccCcccch--------------hHHHHHhHHHHHHhhccC
Confidence            45667777766  34555541       233568999999942  111              112233356788899  4


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeecc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGL  130 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~  130 (316)
                      .+..|||..|+|||-|+.|.+||.|=++
T Consensus       162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  162 QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             CCeecCCCChhheeecCCCCEEecChhh
Confidence            5799999999999999999999999764

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.76  E-value=0.055  Score=48.08  Aligned_cols=29  Identities=34%  Similarity=0.439  Sum_probs=25.1

Q ss_pred             ceeccCCCCcEEEcc-CCCEEEeeeccccc
Q 021181          105 VLHRDLKPSNLLLNA-NCDLKIGDFGLART  133 (316)
Q Consensus       105 i~H~dl~p~nil~~~-~~~~~l~df~~~~~  133 (316)
                      ++|+|+.+.||+++. ++.++++||+.+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            899999999999975 47899999987644

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.33  E-value=0.29  Score=44.52  Aligned_cols=28  Identities=18%  Similarity=0.342  Sum_probs=23.3

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeecccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      ..+|||+.+.||+++.++ .+++|..++.
T Consensus       231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        231 ALVHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             ceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence            589999999999998875 7888876553

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.04  E-value=0.038  Score=46.33  Aligned_cols=29  Identities=28%  Similarity=0.402  Sum_probs=25.6

Q ss_pred             CCceeccCCCCcEEEcc-CCCEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNA-NCDLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~-~~~~~l~df~~~  131 (316)
                      .+++|+|+.+.||+++. ++.+.++||..+
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            36999999999999998 578999999865

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.00  E-value=0.36  Score=43.18  Aligned_cols=31  Identities=23%  Similarity=0.313  Sum_probs=24.9

Q ss_pred             cCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          102 SANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       102 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ...++|||+.+.||+++.++ ++++|+..+..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            34689999999999997754 77999876543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK06148 hypothetical protein; Provisional

Probab=94.86  E-value=0.23  Score=50.97  Aligned_cols=31  Identities=35%  Similarity=0.523  Sum_probs=25.7

Q ss_pred             CCceeccCCCCcEEEccCC--CEE-Eeeeccccc
Q 021181          103 ANVLHRDLKPSNLLLNANC--DLK-IGDFGLART  133 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~--~~~-l~df~~~~~  133 (316)
                      .+++|+|+.+.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  555 999997633

>PTZ00384 choline kinase; Provisional

Probab=94.77  E-value=0.19  Score=45.60  Aligned_cols=30  Identities=27%  Similarity=0.182  Sum_probs=24.5

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ..++|.|+.+.||+.+. +.+.++||..+..
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            46899999999999754 4699999987643

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.66  E-value=0.078  Score=46.51  Aligned_cols=28  Identities=25%  Similarity=0.400  Sum_probs=24.8

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      .+++|||+.+.||+++. +.+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            57899999999999987 67899999855

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.16  E-value=0.1  Score=44.89  Aligned_cols=46  Identities=35%  Similarity=0.361  Sum_probs=35.1

Q ss_pred             HHHHHHHHHHHHhhcC--CceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181           88 YFLYQLLRGLKYVHSA--NVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus        88 ~i~~qi~~~l~~LH~~--~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ..+..+-.++.-.+..  -++|+|+.|.|++.++.+.++|+||..+..
T Consensus       136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3444555555555533  699999999999999999999999987644

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.01  E-value=0.084  Score=46.31  Aligned_cols=29  Identities=34%  Similarity=0.531  Sum_probs=26.2

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      .+++|+|+++.|++++.++.+.++||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccc
Confidence            68999999999999998876789999866

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.67  E-value=0.064  Score=43.20  Aligned_cols=30  Identities=30%  Similarity=0.409  Sum_probs=25.6

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeecccccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLARTT  134 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  134 (316)
                      ..+|+|+.|.|+++++++ ++++||+.+...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            479999999999998877 999999977443

>PRK10593 hypothetical protein; Provisional

Probab=93.66  E-value=0.52  Score=41.20  Aligned_cols=85  Identities=9%  Similarity=0.030  Sum_probs=56.6

Q ss_pred             eEEEEEecccccChhHHHHHHHHHHHHhhCCC---CCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCCH
Q 021181            8 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH---ENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTD   83 (316)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~   83 (316)
                      .+++|..+.    ......+..|...++.+..   -.++++++++...  ...+..++|||+++| ++.+ .    ..+.
T Consensus        39 ~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE~i~G~~~~~-~----~~~~  107 (297)
T PRK10593         39 NPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLERLRGVSVEA-P----ARTP  107 (297)
T ss_pred             CEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEeccCCEecCC-C----CCCH
Confidence            566776432    1123467899999999853   3678888877543  122457999999986 4443 1    1234


Q ss_pred             HHHHHHHHHHHHHHHHhhcC
Q 021181           84 DHCRYFLYQLLRGLKYVHSA  103 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~  103 (316)
                      .....+..+++.+|+-||+.
T Consensus       108 ~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593        108 ERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             HHHHHHHHHHHHHHHHHhCC
Confidence            45566778888999999975

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.22  E-value=0.093  Score=43.26  Aligned_cols=30  Identities=37%  Similarity=0.604  Sum_probs=21.0

Q ss_pred             CCceeccCCCCcEEE-ccCCCEEEeeecccc
Q 021181          103 ANVLHRDLKPSNLLL-NANCDLKIGDFGLAR  132 (316)
Q Consensus       103 ~~i~H~dl~p~nil~-~~~~~~~l~df~~~~  132 (316)
                      ..++|+|+.+.||++ +.++.++++||..+.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            358999999999999 888999999998663

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.01  E-value=0.22  Score=43.91  Aligned_cols=75  Identities=19%  Similarity=0.266  Sum_probs=46.0

Q ss_pred             EEEEEecCCC-----cHHHHhhcCCCCCHHHHHHHHHHHHHHHHH---hh-cCCceeccCCCCcEEEccCC---------
Q 021181           60 VYIVYELMDT-----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY---VH-SANVLHRDLKPSNLLLNANC---------  121 (316)
Q Consensus        60 ~~iv~e~~~g-----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~---LH-~~~i~H~dl~p~nil~~~~~---------  121 (316)
                      -.||++.+-+     ++....+.+-..-.+-++.++.||+--.-.   |- ..+++|.||||.|||+....         
T Consensus       246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~  325 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN  325 (434)
T ss_pred             cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence            4588887643     233332222223345578888888764422   32 44799999999999995432         


Q ss_pred             ---------CEEEeeecccccc
Q 021181          122 ---------DLKIGDFGLARTT  134 (316)
Q Consensus       122 ---------~~~l~df~~~~~~  134 (316)
                               .++|.||.+|+..
T Consensus       326 ~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  326 RNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             eEEEecccceeeecccCHHHhc
Confidence                     2567777766553

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PLN02236 choline kinase

Probab=92.71  E-value=0.2  Score=44.73  Aligned_cols=30  Identities=23%  Similarity=0.411  Sum_probs=25.8

Q ss_pred             CceeccCCCCcEEEcc-CCCEEEeeeccccc
Q 021181          104 NVLHRDLKPSNLLLNA-NCDLKIGDFGLART  133 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~-~~~~~l~df~~~~~  133 (316)
                      .++|+|+++.||+++. ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986 46799999987643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.66  E-value=0.18  Score=44.27  Aligned_cols=29  Identities=21%  Similarity=0.200  Sum_probs=26.4

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeecccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      +++|+|+.++|+++++++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=92.13  E-value=1.1  Score=38.85  Aligned_cols=55  Identities=9%  Similarity=0.082  Sum_probs=32.7

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMD   68 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~   68 (316)
                      .+++.|.||+-..     .....+..|++-|+.|   .--.+++++++....+     ..+++|||++
T Consensus        38 ~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~fLlle~l~   95 (288)
T PF03881_consen   38 TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DAFLLLEFLE   95 (288)
T ss_dssp             TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CCEEEEE---
T ss_pred             CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----CceEEEEeec
Confidence            4678899998642     2234567788877777   3455778888775442     2489999985

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.13  E-value=0.4  Score=39.07  Aligned_cols=29  Identities=28%  Similarity=0.425  Sum_probs=24.3

Q ss_pred             CCceeccCCCCcEEEccCC-----CEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNANC-----DLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~-----~~~l~df~~~  131 (316)
                      ..++|||+.+.|+++..++     .+.++||..+
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~  153 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS  153 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence            4699999999999997543     5899999865

subfamily of choline kinases

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=92.04  E-value=0.64  Score=40.84  Aligned_cols=75  Identities=21%  Similarity=0.203  Sum_probs=56.9

Q ss_pred             EEEEEecCC-CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCceeccCCCCcEEEccCCCEEEeeeccccccC
Q 021181           60 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV-HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS  135 (316)
Q Consensus        60 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  135 (316)
                      ..+||.++| ..+..---+.-.++..+.+..-.|+..++.-| |.+-+||-|+.-.|+|+..+ .+-++|...+....
T Consensus       358 hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsvep~  434 (531)
T KOG2269|consen  358 HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG-KVWVIDVSQSVEPS  434 (531)
T ss_pred             ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC-ceEEEechhccCCC
Confidence            478999997 33322212334688899998889999888776 47889999999999999776 89999987664443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	316
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-95
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-95
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-91
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-91
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-91
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-91
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-91
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-91
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-91
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-91
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-91
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-91
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-91
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-91
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-90
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-90
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-90
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-90
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-90
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-89
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-89
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-89
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-89
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-89
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-89
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-88
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-88
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-87
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-87
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-87
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-87
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-87
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-87
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-87
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-87
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-87
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-87
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-87
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-87
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-87
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-87
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-87
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-87
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-87
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-87
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-87
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-87
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-87
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-87
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-87
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-87
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-87
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-87
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-87
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-87
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-87
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-87
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-87
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-87
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-87
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-87
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-87
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-87
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-87
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-87
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-87
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-87
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-87
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-86
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-86
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-86
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-86
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-86
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-86
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-86
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-86
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-86
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-86
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-86
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-86
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-86
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-86
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-86
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-86
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-86
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-86
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-86
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-86
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-81
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-80
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-80
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-79
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-78
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-76
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-67
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-66
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-65
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-65
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-65
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-65
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-65
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-65
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-65
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-65
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-65
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-65
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-65
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-65
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-65
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-65
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-64
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-64
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-64
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-64
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-64
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-64
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-64
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-64
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-64
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-63
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-63
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-63
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-63
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-63
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-62
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-62
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-61
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-61
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-58
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-56
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-55
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-55
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-55
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-49
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-49
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-49
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-49
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-49
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-49
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-49
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-49
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-49
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-49
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-49
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-49
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-49
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-49
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-49
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-49
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-49
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-49
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-49
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-49
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-49
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-49
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-49
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-49
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-49
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-49
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-49
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-49
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-49
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-49
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-48
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-48
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-48
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-48
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-48
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-46
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-46
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-45
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-44
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-44
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-43
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-43
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-43
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-43
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-42
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-41
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-40
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-39
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-39
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-39
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-39
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-39
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-39
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-38
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-38
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-38
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-38
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-38
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-38
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-38
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-38
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-38
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-38
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-38
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-38
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-38
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-37
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-37
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-37
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-37
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-37
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-37
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-37
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-37
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-37
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-37
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-37
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-36
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-36
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-36
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-35
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-35
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-34
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-31
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-31
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-30
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-29
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-28
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-28
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-28
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-28
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-28
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-28
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		7e-28
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-27
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-27
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-26
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-26
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-26
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-26
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-25
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-25
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-25
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-24
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-23
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-21
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-21
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-21
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		9e-21
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-20
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-20
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-20
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-20
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-20
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-20
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-20
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-19
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-19
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-19
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-19
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-19
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-19
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-19
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-19
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-19
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-19
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-19
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-19
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-19
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-19
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-19
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-19
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-19
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-19
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-19
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-19
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-18
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-18
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-18
3soa_A	444	Full-Length Human Camkii Length = 444		6e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-18
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-17
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-17
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-17
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-16
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-16
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-16
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-15
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-15
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-15
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-15
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-15
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-15
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-14
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		6e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-08

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  343 bits (880), Expect = 7e-95,   Method: Compositional matrix adjust.
 Identities = 174/314 (55%), Positives = 223/314 (71%), Gaps = 8/314 (2%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP--PQRETFNDVYI 62
           T ++VAIKKI NAFD   +AKRTLRE+K+L+H  H+NIIAIKDI+RP  P  E F  VY+
Sbjct: 78  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE-FKSVYV 136
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           V +LM++DLHQII S Q LT +H RYFLYQLLRGLKY+HSA V+HRDLKPSNLL+N NC+
Sbjct: 137 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE 196
Query: 123 LKIGDFGLART--TSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           LKIGDFG+AR   TS  +   FMTEYV TRWYRAPEL+L+  EYT AID+WSVGCI GE+
Sbjct: 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 256
Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           + R+ LFPGK+YVHQL+LI  ++G+P    +  + ++  R Y++ LP      +   +P 
Sbjct: 257 LARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPG 316
Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEE 297
               A+ LL +ML F+P+ RI+   AL HP+LA  HD ++EP C  PF F F+  + T E
Sbjct: 317 ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRE 376
Query: 298 NIKELIYRESVKFN 311
            IKE I  E   F+
Sbjct: 377 RIKEAIVAEIEDFH 390

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  343 bits (879), Expect = 9e-95,   Method: Compositional matrix adjust.
 Identities = 174/314 (55%), Positives = 223/314 (71%), Gaps = 8/314 (2%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP--PQRETFNDVYI 62
           T ++VAIKKI NAFD   +AKRTLRE+K+L+H  H+NIIAIKDI+RP  P  E F  VY+
Sbjct: 79  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE-FKSVYV 137
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           V +LM++DLHQII S Q LT +H RYFLYQLLRGLKY+HSA V+HRDLKPSNLL+N NC+
Sbjct: 138 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE 197
Query: 123 LKIGDFGLART--TSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           LKIGDFG+AR   TS  +   FMTEYV TRWYRAPEL+L+  EYT AID+WSVGCI GE+
Sbjct: 198 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 257
Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           + R+ LFPGK+YVHQL+LI  ++G+P    +  + ++  R Y++ LP      +   +P 
Sbjct: 258 LARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPG 317
Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEE 297
               A+ LL +ML F+P+ RI+   AL HP+LA  HD ++EP C  PF F F+  + T E
Sbjct: 318 ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRE 377
Query: 298 NIKELIYRESVKFN 311
            IKE I  E   F+
Sbjct: 378 RIKEAIVAEIEDFH 391

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  332 bits (850), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 167/308 (54%), Positives = 219/308 (71%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 53  VAIKKI-SPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 112 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 170
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 171 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 231 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 290
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYLA  +D ++EP+   PF FD E     +E +KELI+
Sbjct: 291 LLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 350
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 351 EETARFQP 358

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  330 bits (847), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 219/308 (71%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 49  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 107
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 108 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 166
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 167 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP++  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 227 PGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 286
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 287 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 346
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 347 EETARFQP 354

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 49  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 107
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 108 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 166
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 167 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 227 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 286
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 287 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 346
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 347 EETARFQP 354

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  330 bits (845), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 53  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 112 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 170
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 171 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 231 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 290
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 291 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 350
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 351 EETARFQP 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  330 bits (845), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 71  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 129
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 130 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 188
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 249 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 308
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 309 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 368
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 369 EETARFQP 376

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  330 bits (845), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 59  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 117
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 118 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 176
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 177 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 237 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 296
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 297 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 356
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 357 EETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  330 bits (845), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 51  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 110 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 168
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 229 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 288
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 289 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 348
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 349 EETARFQP 356

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  330 bits (845), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 51  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 110 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 168
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 229 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 288
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 289 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 348
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 349 EETARFQP 356

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  330 bits (845), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 56  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 114
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 115 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 173
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 174 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 234 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 293
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 294 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 353
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 354 EETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  330 bits (845), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 57  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 115
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 116 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 174
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 175 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 235 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 294
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 295 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 354
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 355 EETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  330 bits (845), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 48  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 106
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 107 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 165
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 166 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 226 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 285
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 286 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 345
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 346 EETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  330 bits (845), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 55  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 114 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 292
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 352
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 353 EETARFQP 360

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  329 bits (843), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 217/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 55  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL+++++  Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 114 TDLYKLLKC-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 292
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 352
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 353 EETARFQP 360

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  328 bits (842), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 162/311 (52%), Positives = 219/311 (70%), Gaps = 6/311 (1%)
Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           +  VAIKKI + F+++   +RTLREI++L    HEN+I I+DI+R    E   DVYIV +
Sbjct: 68  KTRVAIKKI-SPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQD 126
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           LM+TDL+++++S Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLL+N  CDLKI
Sbjct: 127 LMETDLYKLLKSQQ-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKI 185
Query: 126 GDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            DFGLAR        T F+TE V TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +
Sbjct: 186 CDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           P+FPGK Y+ QL  I  ++GSP +  L  + +  AR Y++ LP   K  ++  FP     
Sbjct: 246 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSK 305
Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 301
           A+DLL++ML F+PN+RITV+EAL HPYL   +D  +EPV   PF+F  E     +E +KE
Sbjct: 306 ALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKE 365
Query: 302 LIYRESVKFNP 312
           LI++E+ +F P
Sbjct: 366 LIFQETARFQP 376

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  328 bits (842), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 165/308 (53%), Positives = 218/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAI+KI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 55  VAIRKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 114 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 292
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 352
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 353 EETARFQP 360

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  327 bits (837), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 166/308 (53%), Positives = 217/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 53  VAIKKI-SPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN   DLKI DF
Sbjct: 112 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDF 170
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 171 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L    +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 231 PGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 290
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYLA  +D ++EP+   PF FD E     +E +KELI+
Sbjct: 291 LLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 350
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 351 EETARFQP 358

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  327 bits (837), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 165/308 (53%), Positives = 217/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 51  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN   DLKI DF
Sbjct: 110 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDF 168
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 229 PGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 288
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 289 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 348
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 349 EETARFQP 356

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  326 bits (836), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 165/308 (53%), Positives = 217/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 51  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN   DLKI DF
Sbjct: 110 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDF 168
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 229 PGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 288
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 289 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 348
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 349 EETARFQP 356

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  325 bits (834), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 165/308 (53%), Positives = 217/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 51  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN   DLKI DF
Sbjct: 110 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDF 168
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 229 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 288
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 289 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 348
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 349 EETARFQP 356

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  325 bits (834), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 165/308 (53%), Positives = 217/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 55  VAIKKI-SPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN   DLKI DF
Sbjct: 114 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDF 172
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 292
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 352
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 353 EETARFQP 360

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  325 bits (834), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 165/308 (53%), Positives = 217/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 55  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN   DLKI DF
Sbjct: 114 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDF 172
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 292
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 352
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 353 EETARFQP 360

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  325 bits (832), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 164/308 (53%), Positives = 216/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 55  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 114 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+ E V TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 173 GLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 292
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 352
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 353 EETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  325 bits (832), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 164/308 (53%), Positives = 216/308 (70%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVYIV +LM+
Sbjct: 56  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 114
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  CDLKI DF
Sbjct: 115 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 173
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+ E V TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 174 GLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 234 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 293
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 294 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 353
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 354 EETARFQP 361

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  322 bits (825), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 163/308 (52%), Positives = 214/308 (69%), Gaps = 6/308 (1%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DVY+V  LM 
Sbjct: 71  VAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 129
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            DL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN   DLKI DF
Sbjct: 130 ADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDF 188
Query: 129 GLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++ +P+F
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
           PGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FPN    A+D
Sbjct: 249 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 308
Query: 245 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 304
           LL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +E +KELI+
Sbjct: 309 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 368
Query: 305 RESVKFNP 312
            E+ +F P
Sbjct: 369 EETARFQP 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  320 bits (820), Expect = 6e-88,   Method: Compositional matrix adjust.
 Identities = 165/318 (51%), Positives = 215/318 (67%), Gaps = 18/318 (5%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T E VAIKKI   FD  + A RTLREIK+L+H  HENII I +I RP   E FN+VYI+ 
Sbjct: 35  TGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93
Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           ELM TDLH++I S Q L+DDH +YF+YQ LR +K +H +NV+HRDLKPSNLL+N+NCDLK
Sbjct: 94  ELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152
Query: 125 IGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           + DFGLAR            T +   MTEYV TRWYRAPE++L  ++Y+ A+D+WS GCI
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212
Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           L E+  R+P+FPG+DY HQL LI  +IG+P  +  L  + S  AR Y++ LP +P     
Sbjct: 213 LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE 272
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE----EPVCPRPFSFD 288
             FP  +P  +DLL++MLVFDP +RIT  EAL HPYL   HD N+    EP+ P  F FD
Sbjct: 273 KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332
Query: 289 FEHPSFTEENIKELIYRE 306
               + T +++K+LI+ E
Sbjct: 333 HYKEALTTKDLKKLIWNE 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  320 bits (819), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 159/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   PF   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PFDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 49  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 109 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 168 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 226 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 285
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 286 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 344
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 345 SLTYDEVISFVPPP 358

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 63  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 122
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 123 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 181
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 182 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 240 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 299
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 300 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 358
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 359 SLTYDEVISFVPPP 372

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 53  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 112
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 113 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 171
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 172 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 230 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 289
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 290 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 348
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 349 SLTYDEVISFVPPP 362

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 214/314 (68%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 110 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 169 CELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 227 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 286
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 287 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 345
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 346 SLTYDEVISFVPPP 359

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 62  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 121
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 122 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 180
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 181 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 239 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 298
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 299 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 357
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 358 SLTYDEVISFVPPP 371

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  319 bits (817), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 39  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 99  YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 158 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 275
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 334
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 335 SLTYDEVISFVPPP 348

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  319 bits (817), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  319 bits (817), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  318 bits (816), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 55  DTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 115 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 173
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 174 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 232 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 291
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 292 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 350
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 351 SLTYDEVISFVPPP 364

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  318 bits (816), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 49  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 109 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 168 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 226 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 285
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 286 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 344
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 345 SLTYDEVISFVPPP 358

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  318 bits (816), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 55  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 115 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 173
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 174 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 232 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 291
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 292 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 350
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 351 SLTYDEVISFVPPP 364

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  318 bits (816), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 55  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 115 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 173
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 174 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 232 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 291
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 292 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 350
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 351 SLTYDEVISFVPPP 364

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  318 bits (816), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 105 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 163
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 164 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 222 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 281
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 282 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 340
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 341 SLTYDEVISFVPPP 354

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 66  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 125
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 126 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 184
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 185 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 243 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 302
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 303 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 361
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 362 SLTYDEVISFVPPP 375

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 49  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 109 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 168 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 226 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 285
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 286 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 344
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 345 SLTYDEVISFVPPP 358

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 108 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 166
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 167 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 225 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 284
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 285 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 343
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 344 SLTYDEVISFVPPP 357

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 110 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 169 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 227 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 286
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 287 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 345
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 346 SLTYDEVISFVPPP 359

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 108 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 166
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 167 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 225 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 284
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 285 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 343
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 344 SLTYDEVISFVPPP 357

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 42  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 101
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 102 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 160
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 161 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 219 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 278
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 279 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 337
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 338 SLTYDEVISFVPPP 351

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 105 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 163
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 164 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 222 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 281
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 282 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 340
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 341 SLTYDEVISFVPPP 354

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 54  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 113
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 114 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 172
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 173 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 231 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 290
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 291 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 349
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 350 SLTYDEVISFVPPP 363

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 63  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 122
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 123 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 181
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 182 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 240 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 299
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 300 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 358
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 359 SLTYDEVISFVPPP 372

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  318 bits (815), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 62  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 121
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 122 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 180
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 181 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 239 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 298
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 299 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 357
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 358 SLTYDEVISFVPPP 371

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 105 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 163
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 164 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 222 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 281
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 282 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 340
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 341 SLTYDEVISFVPPP 354

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 40  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 99
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 100 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 158
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 159 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 217 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 276
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 277 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 335
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 336 SLTYDEVISFVPPP 349

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 41  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 100
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 101 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 159
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 160 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 218 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 277
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 278 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 336
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 337 SLTYDEVISFVPPP 350

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 40  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 99
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 100 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 158
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 159 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 217 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 276
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 277 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 335
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 336 SLTYDEVISFVPPP 349

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  317 bits (813), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 39  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 99  YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 158 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 275
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 334
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 335 SLTYDEVISFVPPP 348

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  317 bits (813), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 110 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 169 CELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 227 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 286
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+    E      +  K
Sbjct: 287 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWK 345
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 346 SLTYDEVISFVPPP 359

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  317 bits (812), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 39  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  + LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 99  YLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 158 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 275
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 334
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 335 SLTYDEVISFVPPP 348

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  317 bits (812), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI D+GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDYGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  317 bits (812), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 164/318 (51%), Positives = 214/318 (67%), Gaps = 18/318 (5%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T E VAIKKI   FD  + A RTLREIK+L+H  HENII I +I RP   E FN+VYI+ 
Sbjct: 35  TGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93
Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           ELM TDLH++I S Q L+DDH +YF+YQ LR +K +H +NV+HRDLKPSNLL+N+NCDLK
Sbjct: 94  ELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152
Query: 125 IGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           + DFGLAR            T +   MTE V TRWYRAPE++L  ++Y+ A+D+WS GCI
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212
Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           L E+  R+P+FPG+DY HQL LI  +IG+P  +  L  + S  AR Y++ LP +P     
Sbjct: 213 LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE 272
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE----EPVCPRPFSFD 288
             FP  +P  +DLL++MLVFDP +RIT  EAL HPYL   HD N+    EP+ P  F FD
Sbjct: 273 KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332
Query: 289 FEHPSFTEENIKELIYRE 306
               + T +++K+LI+ E
Sbjct: 333 HYKEALTTKDLKKLIWNE 350

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  317 bits (812), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 163/318 (51%), Positives = 214/318 (67%), Gaps = 18/318 (5%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T E VAIKKI   FD  + A RTLREIK+L+H  HENII I +I RP   E FN+VYI+ 
Sbjct: 35  TGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93
Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           ELM TDLH++I S Q L+DDH +YF+YQ LR +K +H +NV+HRDLKPSNLL+N+NCDLK
Sbjct: 94  ELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152
Query: 125 IGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           + DFGLAR            T +   M E+V TRWYRAPE++L  ++Y+ A+D+WS GCI
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212
Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           L E+  R+P+FPG+DY HQL LI  +IG+P  +  L  + S  AR Y++ LP +P     
Sbjct: 213 LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE 272
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE----EPVCPRPFSFD 288
             FP  +P  +DLL++MLVFDP +RIT  EAL HPYL   HD N+    EP+ P  F FD
Sbjct: 273 KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332
Query: 289 FEHPSFTEENIKELIYRE 306
               + T +++K+LI+ E
Sbjct: 333 HYKEALTTKDLKKLIWNE 350

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  316 bits (810), Expect = 9e-87,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 213/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 110 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 169 CELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 227 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 286
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+    E      +  K
Sbjct: 287 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSSESRDLLIDEWK 345
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 346 SLTYDEVISFVPPP 359

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  316 bits (810), Expect = 9e-87,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P    FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PTDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  316 bits (810), Expect = 9e-87,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 66  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 125
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 126 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 184
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D M  YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 185 CELKILDFGLARHTD--DEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 243 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 302
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 303 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 361
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 362 SLTYDEVISFVPPP 375

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 160/315 (50%), Positives = 214/315 (67%), Gaps = 7/315 (2%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC-PRPFSFDFEHPSFTEENI 299
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV  PR  S  FE      +  
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPRDQS--FESRDLLIDEW 337
Query: 300 KELIYRESVKFNPDP 314
           K L Y E + F P P
Sbjct: 338 KSLTYDEVISFVPPP 352

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 156/314 (49%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D M  +V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 158/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P    FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PQDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI  FGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILGFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 156/314 (49%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 39  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 99  YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D M  +V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 158 CELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 275
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 334
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 335 SLTYDEVISFVPPP 348

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 156/314 (49%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D M  +V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 49  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 109 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 168 SELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 226 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 285
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 286 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 344
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 345 SLTYDEVISFVPPP 358

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI D GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDAGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DF LAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFYLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI D GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDGGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D MT  V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDFGLARHTD--DEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 XELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  315 bits (806), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 105 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 163
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 164 SELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 222 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 281
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 282 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 340
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 341 SLTYDEVISFVPPP 354

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI D GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 CELKILDRGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  314 bits (805), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 54  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 113
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 114 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 172
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 173 XELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 231 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 290
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 291 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 349
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 350 SLTYDEVISFVPPP 363

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 108 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 166
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 167 XELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 225 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 284
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 285 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 343
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 344 SLTYDEVISFVPPP 357

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 157/314 (50%), Positives = 212/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 108 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 166
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 167 XELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 225 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 284
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 285 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 343
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 344 SLTYDEVISFVPPP 357

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  314 bits (804), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 156/314 (49%), Positives = 211/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 63  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 122
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 123 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 181
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR T   D M   V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 182 CELKILDFGLARHTD--DEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 240 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANP 299
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  K
Sbjct: 300 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 358
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 359 SLTYDEVISFVPPP 372

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  313 bits (802), Expect = 8e-86,   Method: Compositional matrix adjust.
 Identities = 155/308 (50%), Positives = 206/308 (66%), Gaps = 5/308 (1%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYEL 66
           ++A+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P    E FNDVY+V  L
Sbjct: 78  KIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHL 137
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           M  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +C+LKI 
Sbjct: 138 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 196
Query: 127 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 186
           DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T + LFPG
Sbjct: 197 DFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPG 254
Query: 187 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 246
            D+++QL+ I  L G+P  + +  + S  AR Y+  LPQ PK+NF+  F   +P AVDLL
Sbjct: 255 TDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLL 314
Query: 247 EKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRE 306
           EKMLV D ++RIT  EAL HPY +  HD ++EP    P+   FE      E  K L Y E
Sbjct: 315 EKMLVLDTDKRITASEALAHPYFSQYHDPDDEPES-EPYDQSFESRQLEIEEWKRLTYEE 373
Query: 307 SVKFNPDP 314
              F   P
Sbjct: 374 VCSFETPP 381

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  313 bits (802), Expect = 8e-86,   Method: Compositional matrix adjust.
 Identities = 156/314 (49%), Positives = 211/314 (67%), Gaps = 5/314 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FNDV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++S Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +
Sbjct: 103 YLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +LKI DFGL R T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T 
Sbjct: 162 SELKILDFGLCRHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +P
Sbjct: 220 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+    E      +  K
Sbjct: 280 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWK 338
Query: 301 ELIYRESVKFNPDP 314
            L Y E + F P P
Sbjct: 339 SLTYDEVISFVPPP 352

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  299 bits (766), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 142/312 (45%), Positives = 209/312 (66%), Gaps = 5/312 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           ++  R++VA+KK+   F + I A+RT RE++LL+H+ HEN+I + D+  P    E F++V
Sbjct: 41  DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEV 100
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q L+D+H ++ +YQLLRGLKY+HSA ++HRDLKPSN+ +N +
Sbjct: 101 YLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 159
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++  
Sbjct: 160 CELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP  P+++ S+ F   +P
Sbjct: 218 KALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANP 277
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DLL +MLV D ++R++  EAL H Y +  HD  +EP    P+    E    T E  K
Sbjct: 278 LAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLEEWK 336
Query: 301 ELIYRESVKFNP 312
           EL Y+E + F P
Sbjct: 337 ELTYQEVLSFKP 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  296 bits (758), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 141/310 (45%), Positives = 208/310 (67%), Gaps = 5/310 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           ++  R++VA+KK+   F + I A+RT RE++LL+H+ HEN+I + D+  P    E F++V
Sbjct: 49  DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEV 108
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++S Q L+D+H ++ +YQLLRGLKY+HSA ++HRDLKPSN+ +N +
Sbjct: 109 YLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 167
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++  
Sbjct: 168 SELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP  P+++ S+ F   +P
Sbjct: 226 KALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANP 285
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DLL +MLV D ++R++  EAL H Y +  HD  +EP    P+    E    T E  K
Sbjct: 286 LAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLEEWK 344
Query: 301 ELIYRESVKF 310
           EL Y+E + F
Sbjct: 345 ELTYQEVLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  293 bits (751), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 140/310 (45%), Positives = 207/310 (66%), Gaps = 5/310 (1%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           ++  R++VA+KK+   F + I A+RT RE++LL+H+ HEN+I + D+  P    E F++V
Sbjct: 49  DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEV 108
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL+ I++  Q L+D+H ++ +YQLLRGLKY+HSA ++HRDLKPSN+ +N +
Sbjct: 109 YLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 167
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++  
Sbjct: 168 SELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP  P+++ S+ F   +P
Sbjct: 226 KALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANP 285
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A+DLL +MLV D ++R++  EAL H Y +  HD  +EP    P+    E    T E  K
Sbjct: 286 LAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLEEWK 344
Query: 301 ELIYRESVKF 310
           EL Y+E + F
Sbjct: 345 ELTYQEVLSF 354

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  290 bits (741), Expect = 9e-79,   Method: Compositional matrix adjust.
 Identities = 142/313 (45%), Positives = 198/313 (63%), Gaps = 5/313 (1%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
           ++  + E+VAIKK+   F + I AKR  RE+ LL+HM HEN+I + D+  P      F D
Sbjct: 62  IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            Y+V   M TDL +I+    + +++  +Y +YQ+L+GLKY+HSA V+HRDLKP NL +N 
Sbjct: 122 FYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR       MT YVVTRWYRAPE++L+   Y   +DIWSVGCI+ E++T
Sbjct: 180 DCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LPQ P+++F+  FP  S
Sbjct: 238 GKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRAS 297
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P A DLLEKML  D ++R+T  +AL HP+  P  D  EE    +PF    EH   T +  
Sbjct: 298 PQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 357
Query: 300 KELIYRESVKFNP 312
           K+ IY+E V F+P
Sbjct: 358 KQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  288 bits (738), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 142/313 (45%), Positives = 197/313 (62%), Gaps = 5/313 (1%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
           ++  + E+VAIKK+   F + I AKR  RE+ LL+HM HEN+I + D+  P      F D
Sbjct: 44  IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            Y+V   M TDL +I+      +++  +Y +YQ+L+GLKY+HSA V+HRDLKP NL +N 
Sbjct: 104 FYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR       MT YVVTRWYRAPE++L+   Y   +DIWSVGCI+ E++T
Sbjct: 162 DCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LPQ P+++F+  FP  S
Sbjct: 220 GKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRAS 279
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P A DLLEKML  D ++R+T  +AL HP+  P  D  EE    +PF    EH   T +  
Sbjct: 280 PQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339
Query: 300 KELIYRESVKFNP 312
           K+ IY+E V F+P
Sbjct: 340 KQHIYKEIVNFSP 352

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  280 bits (717), Expect = 5e-76,   Method: Compositional matrix adjust.
 Identities = 136/313 (43%), Positives = 204/313 (65%), Gaps = 5/313 (1%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
           ++  T  +VAIKK+   F + + AKR  RE++LL+HM HEN+I + D+  P +  + F D
Sbjct: 45  VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            Y+V   M TDL ++++ H+ L +D  ++ +YQ+L+GL+Y+H+A ++HRDLKP NL +N 
Sbjct: 105 FYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 163
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR       M   VVTRWYRAPE++LN   YT  +DIWSVGCI+ E++T
Sbjct: 164 DCELKILDFGLARQADSE--MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LF G D++ QL+ I ++ G+P    +  L+SD A+ Y++ LP+  K++F++   N S
Sbjct: 222 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 281
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P AV+LLEKMLV D  +R+T  EAL HPY   LHD  +EP   + +   F+    T +  
Sbjct: 282 PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK-YDDSFDDVDRTLDEW 340
Query: 300 KELIYRESVKFNP 312
           K + Y+E + F P
Sbjct: 341 KRVTYKEVLSFKP 353

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  250 bits (638), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 194/316 (61%), Gaps = 18/316 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VA+KK+   F N+  AKR  RE+ LL+ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I  H +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART      MT YVVTR+YRAPE++L    Y A +DIWSVGCI+GE++    +F G 
Sbjct: 170 FGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++P   F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSAEFMAALQP-TVRNYVENRPKYPGIKFEELFPDWIFPSESERD 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP++RI+VDEAL HPY+   +D  E E   P+ +    E    
Sbjct: 288 KIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREH 347
Query: 295 TEENIKELIYRESVKF 310
             E  KELIY+E + +
Sbjct: 348 AIEEWKELIYKEVMDW 363

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  249 bits (636), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 136/312 (43%), Positives = 191/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VA+KK+   F N+  AKR  RE+ LL+ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I  H +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 110 DANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 167
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART S    MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    +F G 
Sbjct: 168 FGLARTASTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGT 226
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P +P   F   FP+          
Sbjct: 227 DHIDQWNKVIEQLGTPSAEFMAALQP-TVRNYVENRPAYPGIAFEELFPDWIFPSESERD 285
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP++RI+VDEAL HPY+   +D  E E   P+ +    E    
Sbjct: 286 KIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREH 345
Query: 295 TEENIKELIYRE 306
             E  KELIY+E
Sbjct: 346 AIEEWKELIYKE 357

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  245 bits (626), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 150 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 266
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 267 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 385
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 386 TIEEWKELIYKE 397

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  245 bits (626), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 150 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 266
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 267 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 385
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 386 TIEEWKELIYKE 397

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  245 bits (625), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 110
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 111 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 168
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 169 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 227
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 228 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 286
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 287 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 346
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 347 TIEEWKELIYKE 358

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  245 bits (625), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 288 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  245 bits (625), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 113 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 288
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 289 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 348
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 349 TIEEWKELIYKE 360

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  245 bits (625), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 113 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 288
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 289 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 348
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 349 TIEEWKELIYKE 360

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  245 bits (625), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 288 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  244 bits (624), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 105 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 162
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 340
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 341 TIEEWKELIYKE 352

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  244 bits (624), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 106 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 163
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 164 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 281
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 282 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 341
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 342 TIEEWKELIYKE 353

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  244 bits (624), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 106 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 163
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 164 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 281
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 282 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 341
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 342 TIEEWKELIYKE 353

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  244 bits (623), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 134/312 (42%), Positives = 193/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 288 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  244 bits (622), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 117 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 174
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI+GE++  + LFPG+
Sbjct: 175 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGR 233
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 234 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 292
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 293 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 352
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 353 TIEEWKELIYKE 364

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  244 bits (622), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 192/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  244 bits (622), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 194/312 (62%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 106 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 163
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI+GE++  + LFPG+
Sbjct: 164 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGR 222
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 281
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 282 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 341
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 342 TIEEWKELIYKE 353

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 134/312 (42%), Positives = 193/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 288 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 192/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 134/312 (42%), Positives = 193/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 105 DANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILD 162
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E E   P+ +    +    
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 340
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 341 TIEEWKELIYKE 352

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 134/312 (42%), Positives = 191/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  241 bits (615), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 192/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 113 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 230 DHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 288
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 289 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 348
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 349 TIEEWKELIYKE 360

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  241 bits (615), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 135/312 (43%), Positives = 192/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  241 bits (614), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 134/312 (42%), Positives = 191/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  240 bits (613), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 134/312 (42%), Positives = 191/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  240 bits (613), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 134/312 (42%), Positives = 192/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  M   VVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPAFMKKLQP-TVRNYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  239 bits (611), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 136/321 (42%), Positives = 194/321 (60%), Gaps = 18/321 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT  VVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 ALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRESVKFNPDPT 315
           T E  KELIY+E +     PT
Sbjct: 348 TIEEWKELIYKEVMDLPKRPT 368

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 133/312 (42%), Positives = 190/312 (60%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVG I+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  238 bits (608), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 133/312 (42%), Positives = 190/312 (60%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVG I+GE++    LFPG 
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGT 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  238 bits (608), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 133/312 (42%), Positives = 192/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  M   VVTR+YRAPE++L    Y   +D+WSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 288 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 347
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 348 TIEEWKELIYKE 359

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  238 bits (607), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 133/312 (42%), Positives = 191/312 (61%), Gaps = 18/312 (5%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F DVYIV ELM
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI D
Sbjct: 114 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 171
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  M  +VVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG 
Sbjct: 172 FGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGT 230
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           D++ Q   + E +G+P    +  L+    R YV   P++   +F   FP+          
Sbjct: 231 DHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 289
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSF 294
             K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E E   P+      +    
Sbjct: 290 KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREH 349
Query: 295 TEENIKELIYRE 306
           T E  KELIY+E
Sbjct: 350 TIEEWKELIYKE 361

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 125/320 (39%), Positives = 182/320 (56%), Gaps = 59/320 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIKKI   F++ ID KR LREI +L  ++H++++ + DI+ P   E F+++Y+V E+ D
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD 140
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
           +D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHRDLKP+N L+N +C +K+ DF
Sbjct: 141 SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDF 200
Query: 129 GLARTTS--------------ETDF--------------MTEYVVTRWYRAPELLLNCSE 160
           GLART                E D               +T +VVTRWYRAPEL+L    
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260
Query: 161 YTAAIDIWSVGCILGEIMT-----------RQPLFPGKDYV------------------- 190
           YT AID+WS+GCI  E++            R PLFPG                       
Sbjct: 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGN 320
Query: 191 -HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKM 249
             QL +I  ++G+P E  +  L  ++A+RY+R+ P+    + + RFP  S  A+ LL++M
Sbjct: 321 RDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRM 380
Query: 250 LVFDPNRRITVDEALCHPYL 269
           LVF+PN+RIT++E L HP+ 
Sbjct: 381 LVFNPNKRITINECLAHPFF 400

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 134/311 (43%), Positives = 191/311 (61%), Gaps = 25/311 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFT 295
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +D    P        + EH   T
Sbjct: 288 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD----PAXXXXXD-EREH---T 339
Query: 296 EENIKELIYRE 306
            E  KELIY+E
Sbjct: 340 IEEWKELIYKE 350

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  232 bits (592), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 132/311 (42%), Positives = 189/311 (60%), Gaps = 27/311 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELM 67
           VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F DVY+V ELM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 68  DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
           D +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++  LKI D
Sbjct: 112 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILD 169
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+
Sbjct: 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---------- 237
           DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+          
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 287
Query: 238 --KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFT 295
             K+  A DLL KMLV DP +RI+VD+AL HPY+   +              + EH   T
Sbjct: 288 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYXXXXX-------XDEREH---T 337
Query: 296 EENIKELIYRE 306
            E  KELIY+E
Sbjct: 338 IEEWKELIYKE 348

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  231 bits (589), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 132/349 (37%), Positives = 208/349 (59%), Gaps = 50/349 (14%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFND 59
           ++  T E VA+KKI +AF N  DA+RT REI +L  +  HENI+ + +++R    +   D
Sbjct: 29  IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDRD 85
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           VY+V++ M+TDLH +IR++  L   H +Y +YQL++ +KY+HS  +LHRD+KPSN+LLNA
Sbjct: 86  VYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA 144
Query: 120 NCDLKIGDFGLART------------------TSETD----FMTEYVVTRWYRAPELLLN 157
            C +K+ DFGL+R+                  T   D     +T+YV TRWYRAPE+LL 
Sbjct: 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204
Query: 158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
            ++YT  ID+WS+GCILGEI+  +P+FPG   ++QL  I  +I  P    +  ++S  A+
Sbjct: 205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAK 264
Query: 218 RYVRMLP------QFPKQNFSARFPNK----------SPGAVDLLEKMLVFDPNRRITVD 261
             +  L       Q  K++   ++ N           +  A+DLL+K+L F+PN+RI+ +
Sbjct: 265 TMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324
Query: 262 EALCHPYLAPLHDINEEPVCPR----PFSFDFEHPSFTEENIKELIYRE 306
           +AL HP+++  H+ NEEP C      P + + +H   + ++ + L+Y E
Sbjct: 325 DALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH---SIDDYRNLVYSE 370

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  221 bits (563), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 129/364 (35%), Positives = 193/364 (53%), Gaps = 52/364 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +  T + VAIKK+   F++ ID KR LREI +L  +  + II + D+I P     F+++Y
Sbjct: 47  DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           IV E+ D+DL ++ ++   LT++H +  LY LL G  ++H + ++HRDLKP+N LLN +C
Sbjct: 107 IVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC 166
Query: 122 DLKIGDFGLART-TSETDF----------------------MTEYVVTRWYRAPELLLNC 158
            +K+ DFGLART  SE D                       +T +VVTRWYRAPEL+L  
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 159 SEYTAAIDIWSVGCILGEIM-----------TRQPLFPGKD-----------YVH----- 191
             YT +IDIWS GCI  E++            R PLFPG              VH     
Sbjct: 227 ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR 286
Query: 192 -QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKML 250
            QL +I  +IG+P E  L  +      +Y+++ P     N   ++P+ S   ++LLE ML
Sbjct: 287 DQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESML 346
Query: 251 VFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEH-PSFTEENIKELIYRESVK 309
            F+PN+RIT+D+AL HPYL  +     E    +     F+     +E  ++ +  +E   
Sbjct: 347 KFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQS 406
Query: 310 FNPD 313
           F+P+
Sbjct: 407 FHPE 410

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  214 bits (544), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 128/367 (34%), Positives = 189/367 (51%), Gaps = 55/367 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +    + VAIKK+   F++ ID KR LREI +L  +  + II + D+I P     F+++Y
Sbjct: 49  DKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELY 108
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           IV E+ D+DL ++ ++   LT+ H +  LY LL G K++H + ++HRDLKP+N LLN +C
Sbjct: 109 IVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDC 168
Query: 122 DLKIGDFGLART-TSETDF-------------------------MTEYVVTRWYRAPELL 155
            +KI DFGLART  S+ D                          +T +VVTRWYRAPEL+
Sbjct: 169 SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 228
Query: 156 LNCSEYTAAIDIWSVGCILGEIM-----------TRQPLFPGKD-----------YVH-- 191
           L    YT +IDIWS GCI  E++            R PLFPG              VH  
Sbjct: 229 LLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEK 288
Query: 192 ----QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLE 247
               QL +I  +IG+P E  L  +      +Y+++ P     + S ++ + S   +DLLE
Sbjct: 289 SNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLE 348
Query: 248 KMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEH-PSFTEENIKELIYRE 306
            ML F+  +RIT+D+AL HPYL  +   N E          F+     +E  ++ +  +E
Sbjct: 349 SMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMVLSETQLRYIFLKE 408
Query: 307 SVKFNPD 313
              F+ D
Sbjct: 409 IQSFHAD 415

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/277 (40%), Positives = 160/277 (57%), Gaps = 11/277 (3%)
Query: 9   VAIKKIGNA---------FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           VAIK++ N            +    KR LREI+LL H  H NI+ ++DI    +    + 
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 60  VYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V ELM TDL Q+I   +  ++  H +YF+Y +L GL  +H A V+HRDL P N+LL 
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            N D+ I DF LAR  +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+ 
Sbjct: 169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR-MLPQFPKQNFSARFPN 237
            R+ LF G  + +QL  I E++G+P    +    S +AR Y+R  L   P + ++A  P 
Sbjct: 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT 288
Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
             P A+DL+ KML F+P RRI+ ++AL HPY   L D
Sbjct: 289 ADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  212 bits (539), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/277 (40%), Positives = 160/277 (57%), Gaps = 11/277 (3%)
Query: 9   VAIKKIGNA---------FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           VAIK++ N            +    KR LREI+LL H  H NI+ ++DI    +    + 
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 60  VYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V ELM TDL Q+I   +  ++  H +YF+Y +L GL  +H A V+HRDL P N+LL 
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            N D+ I DF LAR  +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+ 
Sbjct: 169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR-MLPQFPKQNFSARFPN 237
            R+ LF G  + +QL  I E++G+P    +    S +AR Y+R  L   P + ++A  P 
Sbjct: 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT 288
Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
             P A+DL+ KML F+P RRI+ ++AL HPY   L D
Sbjct: 289 ADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  210 bits (535), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 119/301 (39%), Positives = 178/301 (59%), Gaps = 32/301 (10%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET---- 56
           ++++  + VAIKKI     +    K  LREIK++R +DH+NI+ + +I+ P   +     
Sbjct: 31  VDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88
Query: 57  -----FNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
                 N VYIV E M+TDL  ++     L ++H R F+YQLLRGLKY+HSANVLHRDLK
Sbjct: 89  GSLTELNSVYIVQEYMETDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLK 147
Query: 112 PSNLLLNA-NCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCSEYTAAID 166
           P+NL +N  +  LKIGDFGLAR      S    ++E +VT+WYR+P LLL+ + YT AID
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID 207
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +W+ GCI  E++T + LF G   + Q++LI E        S+  +  ++ +  + ++P +
Sbjct: 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLILE--------SIPVVHEEDRQELLSVIPVY 259
Query: 227 -------PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
                  P +  +   P  S  AVD LE++L F P  R+T +EAL HPY++      +EP
Sbjct: 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319
Query: 280 V 280
           +
Sbjct: 320 I 320

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 31  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 85
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 86  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 145
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 146 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 205
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 206 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 263
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 264 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  192 bits (489), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  192 bits (489), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 28  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 82
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 83  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 142
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 143 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 203 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 260
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 261 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  192 bits (489), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  192 bits (489), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 23  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 77
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 255
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 25  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 79
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 140 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 257
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 23  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 77
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 255
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  192 bits (487), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 27  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 81
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +D DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 82  LVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 142 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 259
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  191 bits (485), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 27  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 81
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 82  LVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 141
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 142 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 259
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  191 bits (485), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 25  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 79
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 80  LVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 139
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 140 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 257
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 27  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 81
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 82  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 142 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 259
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 26  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 80
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 81  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 141 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 258
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 26  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 80
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 81  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 141 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 258
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 23  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 77
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 255
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 26  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 80
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 81  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 140
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 141 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 258
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 25  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 79
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 140 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 257
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 27  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 81
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 82  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 142 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 259
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 25  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 79
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 140 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 257
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 28  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 82
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 83  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 142
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 143 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 203 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 260
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 261 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  190 bits (483), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 151/271 (55%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 27  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 81
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 82  LVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 142 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 259
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 25  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 79
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 139
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 140 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 257
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+ KI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+ KI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 23  NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 77
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 255
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 23  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 77
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 255
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  190 bits (482), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 151/271 (55%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 26  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 80
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 81  LVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 141 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 258
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 23  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 77
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 78  LVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 255
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 151/271 (55%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 27  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 81
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 82  LVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 142 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 259
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 151/271 (55%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  189 bits (479), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 31  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 85
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 86  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 145
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+DIWS+GCI  E++
Sbjct: 146 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 205
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 206 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 263
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 264 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 10/271 (3%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+I      T N +Y
Sbjct: 24  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 78
Query: 62  IVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 120 NCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+DIWS+GCI  E++
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 198
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE     + S     Y    P++ +Q+FS   P  
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL 256
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 LL +ML +DPN+RI+   AL HP+ 
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 155/266 (58%), Gaps = 8/266 (3%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VA+K+I    ++       +REI LL+ + H NI+++ D+I   +  T     +V+E M+
Sbjct: 48  VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT-----LVFEFME 102
Query: 69  TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
            DL +++  ++  L D   + +LYQLLRG+ + H   +LHRDLKP NLL+N++  LK+ D
Sbjct: 103 KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLAD 162
Query: 128 FGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 186
           FGLAR         T  VVT WYRAP++L+   +Y+ ++DIWS+GCI  E++T +PLFPG
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 187 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 246
                QL  I  ++G+P+      ++     +  R    F K+ +S+  P      +DLL
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 247 EKMLVFDPNRRITVDEALCHPYLAPL 272
             ML FDPN+RI+  +A+ HPY   L
Sbjct: 282 SNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 155/266 (58%), Gaps = 8/266 (3%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VA+K+I    ++       +REI LL+ + H NI+++ D+I   +  T     +V+E M+
Sbjct: 48  VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT-----LVFEFME 102
Query: 69  TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
            DL +++  ++  L D   + +LYQLLRG+ + H   +LHRDLKP NLL+N++  LK+ D
Sbjct: 103 KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLAD 162
Query: 128 FGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 186
           FGLAR         T  VVT WYRAP++L+   +Y+ ++DIWS+GCI  E++T +PLFPG
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 187 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 246
                QL  I  ++G+P+      ++     +  R    F K+ +S+  P      +DLL
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 247 EKMLVFDPNRRITVDEALCHPYLAPL 272
             ML FDPN+RI+  +A+ HPY   L
Sbjct: 282 SNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 98/251 (39%), Positives = 144/251 (57%), Gaps = 10/251 (3%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH- 85
            +RE+ LL+ + H NI+ + DII   +  T     +V+E +D DL Q +    ++ + H 
Sbjct: 47  AIREVSLLKDLKHANIVTLHDIIHTEKSLT-----LVFEYLDKDLKQYLDDCGNIINMHN 101
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYV 144
            + FL+QLLRGL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T      V
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP- 203
           VT WYR P++LL  ++Y+  ID+W VGCI  E+ T +PLFPG     QL  I  ++G+P 
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           +ET  G L ++  + Y    P++  +   +  P       DLL K+L F+   RI+ ++A
Sbjct: 222 EETWPGILSNEEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 264 LCHPYLAPLHD 274
           + HP+   L +
Sbjct: 280 MKHPFFLSLGE 290

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 103/283 (36%), Positives = 160/283 (56%), Gaps = 22/283 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRT-LREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T   VA+K++    D+      T +REI L++ + HENI+ + D+I      T N 
Sbjct: 25  LNKTTGVYVALKEV--KLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK 77
Query: 60  VYIVYELMDTDLHQIIRSH------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           + +V+E MD DL + + S       + L  +  +YF +QLL+GL + H   +LHRDLKP 
Sbjct: 78  LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQ 137
Query: 114 NLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           NLL+N    LK+GDFGLAR      +  +  VVT WYRAP++L+    Y+ +IDIWS GC
Sbjct: 138 NLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGC 197
Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           IL E++T +PLFPG +   QL+LI +++G+P+E+   +       +Y   + Q P ++  
Sbjct: 198 ILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL--WPSVTKLPKYNPNIQQRPPRDLR 255
Query: 233 ARFP--NKSP---GAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                  K P     +D L  +L  +P+ R++  +AL HP+ A
Sbjct: 256 QVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 107/279 (38%), Positives = 153/279 (54%), Gaps = 24/279 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET E VA+K++    D+       LREI LL+ + H+NI+ + D++   ++ T     
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT----- 77
Query: 62  IVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E  D DL +   S + DL  +  + FL+QLL+GL + HS NVLHRDLKP NLL+N N
Sbjct: 78  LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137
Query: 121 CDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM- 178
            +LK+ DFGLAR         +  VVT WYR P++L     Y+ +ID+WS GCI  E+  
Sbjct: 138 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ-------FPKQNF 231
             +PLFPG D   QL+ I  L+G+P E     +      +   M P         PK N 
Sbjct: 198 AARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
           + R         DLL+ +L  +P +RI+ +EAL HPY +
Sbjct: 258 TGR---------DLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 106/279 (37%), Positives = 153/279 (54%), Gaps = 24/279 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET E VA+K++    D+       LREI LL+ + H+NI+ + D++   ++ T     
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT----- 77
Query: 62  IVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E  D DL +   S + DL  +  + FL+QLL+GL + HS NVLHRDLKP NLL+N N
Sbjct: 78  LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137
Query: 121 CDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM- 178
            +LK+ +FGLAR         +  VVT WYR P++L     Y+ +ID+WS GCI  E+  
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ-------FPKQNF 231
             +PLFPG D   QL+ I  L+G+P E     +      +   M P         PK N 
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
           + R         DLL+ +L  +P +RI+ +EAL HPY +
Sbjct: 258 TGR---------DLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 146/275 (53%), Gaps = 29/275 (10%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           E  A+KKI    ++      T+REI +L+ + H NI+ + D+I   +R     + +V+E 
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLVFEH 81
Query: 67  MDTDLHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +D DL +++      L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 126 GDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFGLAR         T  VVT WYRAP++L+   +Y+  IDIWSVGCI  E++   PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY--VRMLPQFPKQNFSARFP------ 236
           PG     QL  I  ++G+P           N++ +  V  LP++   NF+   P      
Sbjct: 202 PGVSEADQLMRIFRILGTP-----------NSKNWPNVTELPKY-DPNFTVYEPLPWESF 249
Query: 237 --NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   +DLL KML  DPN+RIT  +AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 146/275 (53%), Gaps = 29/275 (10%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           E  A+KKI    ++      T+REI +L+ + H NI+ + D+I   +R     + +V+E 
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLVFEH 81
Query: 67  MDTDLHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +D DL +++      L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 126 GDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFGLAR         T  VVT WYRAP++L+   +Y+  IDIWSVGCI  E++   PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLF 201
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY--VRMLPQFPKQNFSARFP------ 236
           PG     QL  I  ++G+P           N++ +  V  LP++   NF+   P      
Sbjct: 202 PGVSEADQLMRIFRILGTP-----------NSKNWPNVTELPKY-DPNFTVYEPLPWESF 249
Query: 237 --NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   +DLL KML  DPN+RIT  +AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  170 bits (431), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 104/275 (37%), Positives = 146/275 (53%), Gaps = 29/275 (10%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           E  A+KKI    ++      T+REI +L+ + H NI+ + D+I   +R     + +V+E 
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLVFEH 81
Query: 67  MDTDLHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +D DL +++      L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 126 GDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFGLAR         T  +VT WYRAP++L+   +Y+  IDIWSVGCI  E++   PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY--VRMLPQFPKQNFSARFP------ 236
           PG     QL  I  ++G+P           N++ +  V  LP++   NF+   P      
Sbjct: 202 PGVSEADQLMRIFRILGTP-----------NSKNWPNVTELPKY-DPNFTVYEPLPWESF 249
Query: 237 --NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   +DLL KML  DPN+RIT  +AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 108/290 (37%), Positives = 157/290 (54%), Gaps = 17/290 (5%)
Query: 2   NSETREEVAIKKI--GNAFDNRIDAKRT-LREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
           +  T + VAIKKI  G+  + +    RT LREIKLL+ + H NII + D          +
Sbjct: 31  DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----S 85
Query: 59  DVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           ++ +V++ M+TDL  II+ +   LT  H + ++   L+GL+Y+H   +LHRDLKP+NLLL
Sbjct: 86  NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145
Query: 118 NANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + N  LK+ DFGLA++  S        VVTRWYRAPELL     Y   +D+W+VGCIL E
Sbjct: 146 DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 205
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++ R P  PG   + QL  I E +G+P E     + S       +  P  P  +    F 
Sbjct: 206 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI---FS 262
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC--PRP 284
                 +DL++ + +F+P  RIT  +AL   Y +  +     P C  PRP
Sbjct: 263 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFS--NRPGPTPGCQLPRP 310

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 157/278 (56%), Gaps = 7/278 (2%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N +T + VAIKK   + D+ +  K  LREI++L+ + H N++ + ++ R  +R     ++
Sbjct: 24  NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR-----LH 78
Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E  D T LH++ R  + + +   +   +Q L+ + + H  N +HRD+KP N+L+  +
Sbjct: 79  LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138
Query: 121 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG AR  T  +D+  + V TRWYR+PELL+  ++Y   +D+W++GC+  E+++
Sbjct: 139 SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             PL+PGK  V QL LI + +G           ++     V++      +    +FPN S
Sbjct: 199 GVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNIS 258
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 277
             A+ LL+  L  DP  R+T ++ L HPY   + +I +
Sbjct: 259 YPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 153/286 (53%), Gaps = 32/286 (11%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++ T E VAIK+I    +        +RE+ LL+ + H NII +K +I    R     +
Sbjct: 54  IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-----L 108
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++++E  + DL + +  + D++    + FLYQL+ G+ + HS   LHRDLKP NLLL+ +
Sbjct: 109 HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168
Query: 121 CD-----LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
                  LKIGDFGLAR         T  ++T WYR PE+LL    Y+ ++DIWS+ CI 
Sbjct: 169 DASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP----QFPKQN 230
            E++ + PLFPG   + QL  I E++G PD+T+            V  LP     FPK  
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW---------PGVTALPDWKQSFPK-- 277
Query: 231 FSARFPNKSPGA------VDLLEKMLVFDPNRRITVDEALCHPYLA 270
           F  +   +  GA      +DLL  ML  DP +RI+   AL HPY +
Sbjct: 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 154/283 (54%), Gaps = 22/283 (7%)
Query: 4   ETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           ++ E VAIKK+  G AF NR        E++++R +DH NI+ ++        E  ++VY
Sbjct: 43  DSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVY 93
Query: 62  I--VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NL
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 116 LLNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           LL+ +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
            E++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFAFPQIKAHPWTKV 270
Query: 235 F-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           F P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 148/271 (54%), Gaps = 18/271 (6%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI--VY 64
           +EVAIKK+        D +   RE++++R + H N++ +K        +  ++V++  V 
Sbjct: 65  DEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFFYS-NGDKKDEVFLNLVL 117
Query: 65  ELMDTDLHQIIRSHQDLTDDH----CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           E +   +++  R +  L         + ++YQLLR L Y+HS  + HRD+KP NLLL+  
Sbjct: 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP 177
Query: 121 CD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              LK+ DFG A+     +     + +R+YRAPEL+   + YT  IDIWS GC++ E+M 
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF-PNK 238
            QPLFPG+  + QL  I +++G+P       +++ N        PQ     FS  F P  
Sbjct: 238 GQPLFPGESGIDQLVEIIKVLGTPSREQ---IKTMNPNYMEHKFPQIRPHPFSKVFRPRT 294
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            P A+DL+ ++L + P+ R+T  EALCHP+ 
Sbjct: 295 PPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 154/283 (54%), Gaps = 22/283 (7%)
Query: 4   ETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           ++ E VAIKK+  G AF NR        E++++R +DH NI+ ++        E  ++VY
Sbjct: 43  DSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVY 93
Query: 62  I--VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NL
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 116 LLNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           LL+ +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
            E++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKV 270
Query: 235 F-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           F P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 94/283 (33%), Positives = 153/283 (54%), Gaps = 22/283 (7%)
Query: 4   ETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           ++ E VAIKK+  G AF NR        E++++R +DH NI+ ++        E  ++VY
Sbjct: 43  DSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVY 93
Query: 62  I--VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NL
Sbjct: 94  LNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 116 LLNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           LL+ +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
            E++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFAFPQIKAHPWTKV 270
Query: 235 F-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           F P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 149/282 (52%), Gaps = 26/282 (9%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYE 65
           VA+K++            T+RE+ +LRH++   H N++ + D+    + +    + +V+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 66  LMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            +D DL   +       +  +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +
Sbjct: 100 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           K+ DFGLAR  S    +T  VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PL
Sbjct: 160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G   V QL  I ++IG P E        ++  R V +    P+Q F ++        V
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGE--------EDWPRDVAL----PRQAFHSKSAQPIEKFV 266
Query: 244 --------DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 277
                   DLL K L F+P +RI+   AL HPY   L    E
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 149/282 (52%), Gaps = 26/282 (9%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYE 65
           VA+K++            T+RE+ +LRH++   H N++ + D+    + +    + +V+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 66  LMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            +D DL   +       +  +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +
Sbjct: 100 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           K+ DFGLAR  S    +T  VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PL
Sbjct: 160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G   V QL  I ++IG P E        ++  R V +    P+Q F ++        V
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGE--------EDWPRDVAL----PRQAFHSKSAQPIEKFV 266
Query: 244 --------DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 277
                   DLL K L F+P +RI+   AL HPY   L    E
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 147/274 (53%), Gaps = 26/274 (9%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYE 65
           VA+K++            T+RE+ +LRH++   H N++ + D+    + +    + +V+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 66  LMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            +D DL   +       +  +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +
Sbjct: 100 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           K+ DFGLAR  S    +T  VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PL
Sbjct: 160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G   V QL  I ++IG P E        ++  R V +    P+Q F ++        V
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGE--------EDWPRDVAL----PRQAFHSKSAQPIEKFV 266
Query: 244 --------DLLEKMLVFDPNRRITVDEALCHPYL 269
                   DLL K L F+P +RI+   AL HPY 
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 71  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 123
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 124 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 183
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 184 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 243
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 244 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 300
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 301 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 341

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 43  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 95
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 79  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 131
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 132 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 191
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 192 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 251
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 252 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 308
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 309 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 349

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 81  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 133
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 134 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 193
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 194 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 253
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 254 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 310
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 311 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 351

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 77  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 129
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 306
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 307 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 56  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 108
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 109 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 168
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 169 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 228
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 229 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 285
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 286 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 326

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 48  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 100
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 101 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 160
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 161 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 220
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 221 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 277
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 278 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 318

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 152/281 (54%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 122 DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 174
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 175 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 234
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 235 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 294
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 295 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 351
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 352 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 392

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 150/278 (53%), Gaps = 14/278 (5%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR---PPQRETFNDV 60
           +T ++VA+KK+    +        LREIK+L+ + HEN++ + +I R    P       +
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 100
Query: 61  YIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++  + DL  ++ +     T    +  +  LL GL Y+H   +LHRD+K +N+L+  
Sbjct: 101 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 120 NCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +  LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W  GCI+
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSA 233
            E+ TR P+  G    HQL LI++L GS   T   +   DN   Y ++ L +  K+    
Sbjct: 221 AEMWTRSPIMQGNTEQHQLALISQLCGSI--TPEVWPNVDNYELYEKLELVKGQKRKVKD 278
Query: 234 RFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           R     + P A+DL++K+LV DP +RI  D+AL H + 
Sbjct: 279 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 150/278 (53%), Gaps = 14/278 (5%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR---PPQRETFNDV 60
           +T ++VA+KK+    +        LREIK+L+ + HEN++ + +I R    P       +
Sbjct: 40  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99
Query: 61  YIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++  + DL  ++ +     T    +  +  LL GL Y+H   +LHRD+K +N+L+  
Sbjct: 100 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 159
Query: 120 NCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +  LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W  GCI+
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSA 233
            E+ TR P+  G    HQL LI++L GS   T   +   DN   Y ++ L +  K+    
Sbjct: 220 AEMWTRSPIMQGNTEQHQLALISQLCGSI--TPEVWPNVDNYELYEKLELVKGQKRKVKD 277
Query: 234 RFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           R     + P A+DL++K+LV DP +RI  D+AL H + 
Sbjct: 278 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 150/278 (53%), Gaps = 14/278 (5%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR---PPQRETFNDV 60
           +T ++VA+KK+    +        LREIK+L+ + HEN++ + +I R    P       +
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 100
Query: 61  YIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++  + DL  ++ +     T    +  +  LL GL Y+H   +LHRD+K +N+L+  
Sbjct: 101 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 120 NCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +  LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W  GCI+
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSA 233
            E+ TR P+  G    HQL LI++L GS   T   +   DN   Y ++ L +  K+    
Sbjct: 221 AEMWTRSPIMQGNTEQHQLALISQLCGSI--TPEVWPNVDNYELYEKLELVKGQKRKVKD 278
Query: 234 RFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           R     + P A+DL++K+LV DP +RI  D+AL H + 
Sbjct: 279 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  153 bits (387), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 149/270 (55%), Gaps = 7/270 (2%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N +T   VAIKK   + D+++  K  +REIKLL+ + HEN++ + ++ +  +R      Y
Sbjct: 46  NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR-----WY 100
Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E +D T L  +      L     + +L+Q++ G+ + HS N++HRD+KP N+L++ +
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS 160
Query: 121 CDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG ART +   +   + V TRWYRAPELL+   +Y  A+D+W++GC++ E+  
Sbjct: 161 GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +PLFPG   + QL  I   +G+           +     VR+     ++    R+P  S
Sbjct: 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              +DL +K L  DP++R    E L H + 
Sbjct: 281 EVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 150/278 (53%), Gaps = 14/278 (5%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR---PPQRETFNDV 60
           +T ++VA+KK+    +        LREIK+L+ + HEN++ + +I R    P       +
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASI 100
Query: 61  YIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++  + DL  ++ +     T    +  +  LL GL Y+H   +LHRD+K +N+L+  
Sbjct: 101 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 120 NCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +  LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W  GCI+
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220
Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSA 233
            E+ TR P+  G    HQL LI++L GS   T   +   DN   Y ++ L +  K+    
Sbjct: 221 AEMWTRSPIMQGNTEQHQLALISQLCGSI--TPEVWPNVDNYELYEKLELVKGQKRKVKD 278
Query: 234 RFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           R     + P A+DL++K+LV DP +RI  D+AL H + 
Sbjct: 279 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 51  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 103
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 104 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 163
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 164 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 223
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 224 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 280
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 281 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 321

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 43  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 95
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 62  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 114
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 115 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 174
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 175 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 234
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 235 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 291
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 292 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 332

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 77  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 129
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 306
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 307 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 55  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 107
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 108 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 167
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 168 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 227
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 228 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 284
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 285 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 43  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 95
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 55  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 107
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 108 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 167
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 168 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 227
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 228 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 284
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 285 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 44  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 96
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 97  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 156
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 157 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 216
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 217 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 273
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 274 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 314

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 151/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  ++VY+ 
Sbjct: 47  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLN 99
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 100 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 159
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 160 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 219
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 220 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 276
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 277 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 317

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 164/319 (51%), Gaps = 54/319 (16%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD---------------- 47
           E+ +  A+KK+        D +   RE+ +++ +DH NII + D                
Sbjct: 30  ESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83
Query: 48  --------------------IIRPPQRETFNDVYIVYELMDTDLHQI----IRSHQDLTD 83
                               I+ P Q +  N   ++ E +   LH++    IRS + +  
Sbjct: 84  DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN---VIMEYVPDTLHKVLKSFIRSGRSIPM 140
Query: 84  DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTE 142
           +    ++YQL R + ++HS  + HRD+KP NLL+N+  + LK+ DFG A+    ++    
Sbjct: 141 NLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200
Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 202
            + +R+YRAPEL+L  +EYT +ID+WS+GC+ GE++  +PLF G+  + QL  I +++G+
Sbjct: 201 XICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT 260
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG-AVDLLEKMLVFDPNRRITVD 261
           P +  +  +R +     VR  P    +++    P  +P  A+DLLE++L ++P+ RI   
Sbjct: 261 PTKEQM--IRMNPHYTEVR-FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317
Query: 262 EALCHPYLAPLHDINEEPV 280
           EA+ HP+   L +  E  V
Sbjct: 318 EAMAHPFFDHLRNSYESEV 336

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 150/281 (53%), Gaps = 18/281 (6%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI- 62
           ++ E VAIKK+        D +   RE++++R +DH NI+ ++        E  + VY+ 
Sbjct: 43  DSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDVVYLN 95
Query: 63  -VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 118 NANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +   LK+ DFG A+     +     + +R+YRAPEL+   ++YT++ID+WS GC+L E
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF- 235
           ++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F 
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 276
           P   P A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/256 (36%), Positives = 136/256 (53%), Gaps = 26/256 (10%)
Query: 27  TLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDL 81
           T+RE+ LLR ++   H N++ + D+    + +    V +V+E +D DL   +       L
Sbjct: 58  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 117
Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177
Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
             VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 178 PVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 202 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV--------DLLEKMLVFD 253
            P E        D+  R V +    P+  F  R P      V         LL +ML F+
Sbjct: 237 LPPE--------DDWPRDVSL----PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 284
Query: 254 PNRRITVDEALCHPYL 269
           P++RI+   AL H YL
Sbjct: 285 PHKRISAFRALQHSYL 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 93/256 (36%), Positives = 135/256 (52%), Gaps = 26/256 (10%)
Query: 27  TLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDL 81
           T+RE+ LLR ++   H N++ + D+    + +    V +V+E +D DL   +       L
Sbjct: 50  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    + 
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALA 169
Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
             VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 170 PVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 228
Query: 202 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV--------DLLEKMLVFD 253
            P E        D+  R V +    P+  F  R P      V         LL +ML F+
Sbjct: 229 LPPE--------DDWPRDVSL----PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 276
Query: 254 PNRRITVDEALCHPYL 269
           P++RI+   AL H YL
Sbjct: 277 PHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/256 (36%), Positives = 135/256 (52%), Gaps = 26/256 (10%)
Query: 27  TLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDL 81
           T+RE+ LLR ++   H N++ + D+    + +    V +V+E +D DL   +       L
Sbjct: 50  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    + 
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALD 169
Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
             VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 170 PVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 228
Query: 202 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV--------DLLEKMLVFD 253
            P E        D+  R V +    P+  F  R P      V         LL +ML F+
Sbjct: 229 LPPE--------DDWPRDVSL----PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 276
Query: 254 PNRRITVDEALCHPYL 269
           P++RI+   AL H YL
Sbjct: 277 PHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/256 (36%), Positives = 135/256 (52%), Gaps = 26/256 (10%)
Query: 27  TLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDL 81
           T+RE+ LLR ++   H N++ + D+    + +    V +V+E +D DL   +       L
Sbjct: 50  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 141
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    + 
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF 169
Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
             VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 170 PVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 228
Query: 202 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV--------DLLEKMLVFD 253
            P E        D+  R V +    P+  F  R P      V         LL +ML F+
Sbjct: 229 LPPE--------DDWPRDVSL----PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 276
Query: 254 PNRRITVDEALCHPYL 269
           P++RI+   AL H YL
Sbjct: 277 PHKRISAFRALQHSYL 292

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 142/280 (50%), Gaps = 13/280 (4%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY--I 62
           T   VAIKK+    D R    R L+ ++ L  + H NI+ ++            D+Y  +
Sbjct: 47  TGMSVAIKKVIQ--DPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103
Query: 63  VYELMDTDLHQIIRSHQDLTDDH----CRYFLYQLLRGLKYVH--SANVLHRDLKPSNLL 116
           V E +   LH+  R++            + FL+QL+R +  +H  S NV HRD+KP N+L
Sbjct: 104 VMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL 163
Query: 117 LN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           +N A+  LK+ DFG A+  S ++    Y+ +R+YRAPEL+     YT A+DIWSVGCI  
Sbjct: 164 VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA 223
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN-FSAR 234
           E+M  +P+F G +   QL  I  ++G P    L  L   +    +      P  N FS  
Sbjct: 224 EMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDH 283
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
               +  A DLL  +L + P  R+   EALCHPY   LHD
Sbjct: 284 SLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 142/254 (55%), Gaps = 27/254 (10%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + D ++ P  +T     +V+E ++ TD  Q+   +Q LTD   R+++Y+LL+ L Y
Sbjct: 94  NIIKLIDTVKDPVSKT---PALVFEYINNTDFKQL---YQILTDFDIRFYMYELLKALDY 147
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 148 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 207
Query: 159 SEYTAAIDIWSVGCILGE-IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L   I  R+P F G+D   QL  I +++G+  E   G+L+    +
Sbjct: 208 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLK----K 261
Query: 218 RYVRMLPQFP---KQNFSARFPN---------KSPGAVDLLEKMLVFDPNRRITVDEALC 265
            ++ + P F     Q+   R+ N          SP A+DLL+K+L +D  +R+T  EA+ 
Sbjct: 262 YHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAME 321
Query: 266 HPYLAPLHDINEEP 279
           HPY  P+     +P
Sbjct: 322 HPYFYPVVKEQSQP 335

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 140/247 (56%), Gaps = 27/247 (10%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + D ++ P  +T     +V+E ++ TD  Q+   +Q LTD   R+++Y+LL+ L Y
Sbjct: 99  NIIKLIDTVKDPVSKT---PALVFEYINNTDFKQL---YQILTDFDIRFYMYELLKALDY 152
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 153 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 212
Query: 159 SEYTAAIDIWSVGCILGE-IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L   I  R+P F G+D   QL  I +++G+  E   G+L+    +
Sbjct: 213 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLK----K 266
Query: 218 RYVRMLPQFP---KQNFSARFPN---------KSPGAVDLLEKMLVFDPNRRITVDEALC 265
            ++ + P F     Q+   R+ N          SP A+DLL+K+L +D  +R+T  EA+ 
Sbjct: 267 YHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAME 326
Query: 266 HPYLAPL 272
           HPY  P+
Sbjct: 327 HPYFYPV 333

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 155/282 (54%), Gaps = 27/282 (9%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
           +N    E+V +K +     N+I      REIK+L ++    NII + DI++ P   T   
Sbjct: 57  INITNNEKVVVKILKPVKKNKIK-----REIKILENLRGGPNIITLADIVKDPVSRT--- 108
Query: 60  VYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
             +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y HS  ++HRD+KP N++++
Sbjct: 109 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 119 -ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
             +  L++ D+GLA            V +R+++ PELL++   Y  ++D+WS+GC+L  +
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 178 MTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR---RYVRMLPQFPKQNFSA 233
           + R +P F G D   QL  I +++G+ D     ++   N     R+  +L +  ++ +  
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIELDPRFNDILGRHSRKRWE- 282
Query: 234 RFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           RF +       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 138/276 (50%), Gaps = 40/276 (14%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--------- 79
           REI LLR + H N+I+++ +           V+++++  + DL  II+ H+         
Sbjct: 67  REIALLRELKHPNVISLQKVFL---SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTS 135
            L     +  LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 136 E----TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD--- 188
                   +   VVT WYRAPELLL    YT AIDIW++GCI  E++T +P+F  +    
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 189 -----YVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS----ARFPNK 238
                Y H QL  I  ++G P +     ++      +  ++  F +  ++     ++  K
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIK--KMPEHSTLMKDFRRNTYTNCSLIKYMEK 301
Query: 239 -----SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   A  LL+K+L  DP +RIT ++A+  PY 
Sbjct: 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  124 bits (310), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 140/253 (55%), Gaps = 21/253 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 LAPLHDINEEPVC 281
             P+     +P  
Sbjct: 324 FYPVVKEQSQPCA 336

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 134/270 (49%), Gaps = 40/270 (14%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T++E A+K I  A     D    LRE++LL+ +DH NI+ + +I+     E  +  YIV 
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVG 100
Query: 65  ELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
           EL        +II+  +    D  R  + Q+  G+ Y+H  N++HRDLKP N+LL +   
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS 217
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F GK+    L+ +        ET           +Y   LPQ         +   S
Sbjct: 218 GTPPFYGKNEYDILKRV--------ETG----------KYAFDLPQ---------WRTIS 250
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             A DL+ KML F P+ RIT  + L HP++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 134/270 (49%), Gaps = 40/270 (14%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T++E A+K I  A     D    LRE++LL+ +DH NI+ + +I+     E  +  YIV 
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVG 100
Query: 65  ELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
           EL        +II+  +    D  R  + Q+  G+ Y+H  N++HRDLKP N+LL +   
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS 217
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F GK+    L+ +        ET           +Y   LPQ         +   S
Sbjct: 218 GTPPFYGKNEYDILKRV--------ETG----------KYAFDLPQ---------WRTIS 250
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             A DL+ KML F P+ RIT  + L HP++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 134/270 (49%), Gaps = 40/270 (14%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T++E A+K I  A     D    LRE++LL+ +DH NI+ + +I+     E  +  YIV 
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVG 100
Query: 65  ELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
           EL        +II+  +    D  R  + Q+  G+ Y+H  N++HRDLKP N+LL +   
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS 217
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F GK+    L+ +        ET           +Y   LPQ         +   S
Sbjct: 218 GTPPFYGKNEYDILKRV--------ETG----------KYAFDLPQ---------WRTIS 250
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             A DL+ KML F P+ RIT  + L HP++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N+L++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  121 bits (303), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 91  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 144
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 262
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 263 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 269 L 269
Sbjct: 322 F 322

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 92  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 145
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 263
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 264 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 269 L 269
Sbjct: 323 F 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 92  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 145
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 263
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 264 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 269 L 269
Sbjct: 323 F 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 136/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+   +Q LTD   R+++Y++L+ L Y
Sbjct: 98  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDY 151
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 152 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 269
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 270 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328
Query: 269 L 269
Sbjct: 329 F 329

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 135/241 (56%), Gaps = 21/241 (8%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 99
           NII + DI++ P   T     +V+E + +TD  Q+    Q LTD   R+++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDY 146
Query: 100 VHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 158
            HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 159 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
             Y  ++D+WS+GC+L  ++ R +P F G D   QL  I +++G+ D     ++   N  
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED--LYDYIDKYNIE 264
Query: 218 ---RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              R+  +L +  ++ +  RF +       SP A+D L+K+L +D   R+T  EA+ HPY
Sbjct: 265 LDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 269 L 269
Sbjct: 324 F 324

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 142/279 (50%), Gaps = 46/279 (16%)
Query: 4   ETREEVAIKKIGN---AFDNRIDAKRTLR---EIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +T ++VAIK I     A  +  +A   L    EI++L+ ++H  II IK+          
Sbjct: 33  KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA------ 86
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            D YIV ELM+  +L   +  ++ L +  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146
Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVG 171
           L++   +C +KI DFG ++   ET  M     T  Y APE+L++   + Y  A+D WS+G
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            IL   ++  P  P  ++  Q+ L        D+ + G                  K NF
Sbjct: 207 VILFICLSGYP--PFSEHRTQVSL-------KDQITSG------------------KYNF 239
Query: 232 SAR-FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               +   S  A+DL++K+LV DP  R T +EAL HP+L
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 142/279 (50%), Gaps = 46/279 (16%)
Query: 4   ETREEVAIKKIGN---AFDNRIDAKRTLR---EIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +T ++VAIK I     A  +  +A   L    EI++L+ ++H  II IK+          
Sbjct: 32  KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA------ 85
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            D YIV ELM+  +L   +  ++ L +  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 86  EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 145
Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVG 171
           L++   +C +KI DFG ++   ET  M     T  Y APE+L++   + Y  A+D WS+G
Sbjct: 146 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 205
Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            IL   ++  P  P  ++  Q+ L        D+ + G                  K NF
Sbjct: 206 VILFICLSGYP--PFSEHRTQVSL-------KDQITSG------------------KYNF 238
Query: 232 SAR-FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               +   S  A+DL++K+LV DP  R T +EAL HP+L
Sbjct: 239 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 142/279 (50%), Gaps = 46/279 (16%)
Query: 4   ETREEVAIKKIGN---AFDNRIDAKRTLR---EIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +T ++VAIK I     A  +  +A   L    EI++L+ ++H  II IK+          
Sbjct: 39  KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA------ 92
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            D YIV ELM+  +L   +  ++ L +  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 93  EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 152
Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVG 171
           L++   +C +KI DFG ++   ET  M     T  Y APE+L++   + Y  A+D WS+G
Sbjct: 153 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 212
Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            IL   ++  P  P  ++  Q+ L        D+ + G                  K NF
Sbjct: 213 VILFICLSGYP--PFSEHRTQVSL-------KDQITSG------------------KYNF 245
Query: 232 SAR-FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               +   S  A+DL++K+LV DP  R T +EAL HP+L
Sbjct: 246 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 142/279 (50%), Gaps = 46/279 (16%)
Query: 4   ETREEVAIKKIGN---AFDNRIDAKRTLR---EIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +T ++VAIK I     A  +  +A   L    EI++L+ ++H  II IK+          
Sbjct: 33  KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA------ 86
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            D YIV ELM+  +L   +  ++ L +  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146
Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVG 171
           L++   +C +KI DFG ++   ET  M     T  Y APE+L++   + Y  A+D WS+G
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            IL   ++  P  P  ++  Q+ L        D+ + G                  K NF
Sbjct: 207 VILFICLSGYP--PFSEHRTQVSL-------KDQITSG------------------KYNF 239
Query: 232 SAR-FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               +   S  A+DL++K+LV DP  R T +EAL HP+L
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 142/279 (50%), Gaps = 46/279 (16%)
Query: 4   ETREEVAIKKIGN---AFDNRIDAKRTLR---EIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +T ++VAIK I     A  +  +A   L    EI++L+ ++H  II IK+          
Sbjct: 33  KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA------ 86
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            D YIV ELM+  +L   +  ++ L +  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146
Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVG 171
           L++   +C +KI DFG ++   ET  M     T  Y APE+L++   + Y  A+D WS+G
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            IL   ++  P  P  ++  Q+ L        D+ + G                  K NF
Sbjct: 207 VILFICLSGYP--PFSEHRTQVSL-------KDQITSG------------------KYNF 239
Query: 232 SAR-FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               +   S  A+DL++K+LV DP  R T +EAL HP+L
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 128/247 (51%), Gaps = 40/247 (16%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI++L+ ++H  II IK+           D YIV ELM+  +L   +  ++ L +  C+ 
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKL 257
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVV 145
           + YQ+L  ++Y+H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M     
Sbjct: 258 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 317
Query: 146 TRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
           T  Y APE+L++   + Y  A+D WS+G IL   ++  P  P  ++  Q+ L        
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL-------K 368
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSAR-FPNKSPGAVDLLEKMLVFDPNRRITVDE 262
           D+ + G                  K NF    +   S  A+DL++K+LV DP  R T +E
Sbjct: 369 DQITSG------------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 410
Query: 263 ALCHPYL 269
           AL HP+L
Sbjct: 411 ALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 81/247 (32%), Positives = 128/247 (51%), Gaps = 40/247 (16%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI++L+ ++H  II IK+           D YIV ELM+  +L   +  ++ L +  C+ 
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKL 243
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVV 145
           + YQ+L  ++Y+H   ++HRDLKP N+LL++   +C +KI DFG ++   ET  M     
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303
Query: 146 TRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
           T  Y APE+L++   + Y  A+D WS+G IL   ++  P  P  ++  Q+ L        
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL-------K 354
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSAR-FPNKSPGAVDLLEKMLVFDPNRRITVDE 262
           D+ + G                  K NF    +   S  A+DL++K+LV DP  R T +E
Sbjct: 355 DQITSG------------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 263 ALCHPYL 269
           AL HP+L
Sbjct: 397 ALRHPWL 403

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 133/242 (54%), Gaps = 15/242 (6%)
Query: 37  MDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRG 96
           M   NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ 
Sbjct: 83  MGGPNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKA 137
Query: 97  LKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 155
           L Y HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 156 LNCSEYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRS 213
           ++  +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R 
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 214 DNARRYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHP 267
           +   +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HP
Sbjct: 258 ELDPQLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 268 YL 269
           Y 
Sbjct: 317 YF 318

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 141
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 262 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 129/245 (52%), Gaps = 29/245 (11%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 108 NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 162
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 218
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      G     N  R
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNAYLNKYR 277
Query: 219 YVRMLPQFPKQNFSARFPNK--------------SPGAVDLLEKMLVFDPNRRITVDEAL 264
            + + PQ   +    R   K              SP A+D L+K+L +D   R+T  EA+
Sbjct: 278 -IELDPQL--EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 334
Query: 265 CHPYL 269
            HPY 
Sbjct: 335 THPYF 339

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 142
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 263 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 141
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 262 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 141
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 262 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 141
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 262 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 142
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 263 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 141
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 262 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 132/238 (55%), Gaps = 15/238 (6%)
Query: 41  NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 100
           NI+ + DI+R    +T +   +++E ++    +++  +  LTD   RY++Y+LL+ L Y 
Sbjct: 89  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 143
Query: 101 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 160 EYTAAIDIWSVGCIL-GEIMTRQPLFPGKDYVHQLRLITELIGSPD-ETSLGFLRSDNAR 217
           +Y  ++D+WS+GC+  G I  ++P F G D   QL  I +++G+      L   R +   
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 263
Query: 218 RYVRMLPQFPKQNFSARFPNK------SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +   ++ +  ++ +  +F N       SP A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 264 QLEALVGRHSRKPW-LKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 320

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 144/310 (46%), Gaps = 47/310 (15%)
Query: 4   ETREEVAIKKIGNAFDNRIDAK-RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           +T+++VA+K I      + D   R  REI  L+ + H +II + D+I  P      D+ +
Sbjct: 32  KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TDIVM 86
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           V E    +L   I   + +T+D  R F  Q++  ++Y H   ++HRDLKP NLLL+ N +
Sbjct: 87  VIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN 146
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA-AIDIWSVGCILGEIMTRQ 181
           +KI DFGL+   ++ +F+     +  Y APE ++N   Y    +D+WS G +L  ++  +
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
             F                   DE      +  N+  YV  +P F            SPG
Sbjct: 206 LPF------------------DDEFIPNLFKKVNSCVYV--MPDF-----------LSPG 234
Query: 242 AVDLLEKMLVFDPNRRITVDEALCHP--------YLAPLHDINEEPVCPRPFSFDFEHPS 293
           A  L+ +M+V DP +RIT+ E    P        YL P+ ++       R  S   E   
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMG 294
Query: 294 FTEENIKELI 303
           F+E+ I E +
Sbjct: 295 FSEDYIVEAL 304

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 146/299 (48%), Gaps = 39/299 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-NDVYI 62
           +  + VA+K + N       A   +R ++ LR  D +N +   ++I   +  TF N + +
Sbjct: 120 KVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM---NVIHMLENFTFRNHICM 176
Query: 63  VYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--N 118
            +EL+  +L+++I+ +  Q  +    R F + +L+ L  +H   ++H DLKP N+LL   
Sbjct: 177 TFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ 236
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               +K+ DFG   +  E   +   + +R+YRAPE++L  + Y   ID+WS+GCIL E++
Sbjct: 237 GRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELL 293
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSL-------------GF--------------- 210
           T  PL PG+D   QL  + EL+G P +  L             G+               
Sbjct: 294 TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVV 353
Query: 211 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           L    +RR     P   ++  +A      P  +D L++ L +DP  R+T  +AL HP+L
Sbjct: 354 LNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 146/299 (48%), Gaps = 39/299 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-NDVYI 62
           +  + VA+K + N       A   +R ++ LR  D +N +   ++I   +  TF N + +
Sbjct: 120 KVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM---NVIHMLENFTFRNHICM 176
Query: 63  VYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--N 118
            +EL+  +L+++I+ +  Q  +    R F + +L+ L  +H   ++H DLKP N+LL   
Sbjct: 177 TFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ 236
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               +K+ DFG   +  E   +   + +R+YRAPE++L  + Y   ID+WS+GCIL E++
Sbjct: 237 GRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELL 293
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSL-------------GF--------------- 210
           T  PL PG+D   QL  + EL+G P +  L             G+               
Sbjct: 294 TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVV 353
Query: 211 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           L    +RR     P   ++  +A      P  +D L++ L +DP  R+T  +AL HP+L
Sbjct: 354 LNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 146/299 (48%), Gaps = 39/299 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-NDVYI 62
           +  + VA+K + N       A   +R ++ LR  D +N +   ++I   +  TF N + +
Sbjct: 120 KVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM---NVIHMLENFTFRNHICM 176
Query: 63  VYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--N 118
            +EL+  +L+++I+ +  Q  +    R F + +L+ L  +H   ++H DLKP N+LL   
Sbjct: 177 TFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ 236
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               +K+ DFG   +  E   +   + +R+YRAPE++L  + Y   ID+WS+GCIL E++
Sbjct: 237 GRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELL 293
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSL-------------GF--------------- 210
           T  PL PG+D   QL  + EL+G P +  L             G+               
Sbjct: 294 TGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVV 353
Query: 211 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           L    +RR     P   ++  +A      P  +D L++ L +DP  R+T  +AL HP+L
Sbjct: 354 LNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 128/280 (45%), Gaps = 38/280 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-NDVYIV 63
           T  E AIK I     +     + L E+ +L+ +DH NI+ + D     +      + Y  
Sbjct: 61  THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 64  YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---N 120
            EL D  +H++  +  D         + Q+L G+ Y+H  N++HRDLKP NLLL +   +
Sbjct: 121 GELFDEIIHRMKFNEVD-----AAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKD 175
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             +KI DFGL+        M E + T +Y APE+L    +Y    D+WS+G IL  ++  
Sbjct: 176 ALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAG 233
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
            P F G                  +T    LR     +Y    P+         + N S 
Sbjct: 234 YPPFGG------------------QTDQEILRKVEKGKYTFDSPE---------WKNVSE 266
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           GA DL+++ML FD  RRI+  +AL HP++  +    E  +
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGI 306

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 37/264 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAK-RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ T ++VA+K I      + D + R  REI  LR + H +II + D+I+     + +++
Sbjct: 25  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDEI 79
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            +V E    +L   I     +++   R F  Q++  ++Y H   ++HRDLKP NLLL+ +
Sbjct: 80  IMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 139
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++ R
Sbjct: 140 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 199
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +  F                   D+ S+  L   N    V  LP+F            SP
Sbjct: 200 RLPF-------------------DDESIPVLFK-NISNGVYTLPKF-----------LSP 228
Query: 241 GAVDLLEKMLVFDPNRRITVDEAL 264
           GA  L+++ML+ +P  RI++ E +
Sbjct: 229 GAAGLIKRMLIVNPLNRISIHEIM 252

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 37/264 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAK-RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ T ++VA+K I      + D + R  REI  LR + H +II + D+I+     + +++
Sbjct: 29  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDEI 83
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            +V E    +L   I     +++   R F  Q++  ++Y H   ++HRDLKP NLLL+ +
Sbjct: 84  IMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 143
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++ R
Sbjct: 144 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 203
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +  F                   D+ S+  L   N    V  LP+F            SP
Sbjct: 204 RLPF-------------------DDESIPVLFK-NISNGVYTLPKF-----------LSP 232
Query: 241 GAVDLLEKMLVFDPNRRITVDEAL 264
           GA  L+++ML+ +P  RI++ E +
Sbjct: 233 GAAGLIKRMLIVNPLNRISIHEIM 256

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 37/264 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAK-RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ T ++VA+K I      + D + R  REI  LR + H +II + D+I+       +++
Sbjct: 34  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEI 88
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            +V E    +L   I     +++   R F  Q++  ++Y H   ++HRDLKP NLLL+ +
Sbjct: 89  IMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 148
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++ R
Sbjct: 149 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +  F                   D+ S+  L   N    V  LP+F            SP
Sbjct: 209 RLPF-------------------DDESIPVLFK-NISNGVYTLPKFL-----------SP 237
Query: 241 GAVDLLEKMLVFDPNRRITVDEAL 264
           GA  L+++ML+ +P  RI++ E +
Sbjct: 238 GAAGLIKRMLIVNPLNRISIHEIM 261

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 37/264 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAK-RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ T ++VA+K I      + D + R  REI  LR + H +II + D+I+       +++
Sbjct: 35  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEI 89
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            +V E    +L   I     +++   R F  Q++  ++Y H   ++HRDLKP NLLL+ +
Sbjct: 90  IMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 149
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
            ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++ R
Sbjct: 150 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 209
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +  F                   D+ S+  L   N    V  LP+F            SP
Sbjct: 210 RLPF-------------------DDESIPVLFK-NISNGVYTLPKFL-----------SP 238
Query: 241 GAVDLLEKMLVFDPNRRITVDEAL 264
           GA  L+++ML+ +P  RI++ E +
Sbjct: 239 GAAGLIKRMLIVNPLNRISIHEIM 262

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 39/270 (14%)
Query: 5   TREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYI 62
           T +E A+K I       + D +  LRE++LL+ +DH NI+ + +            +VY 
Sbjct: 73  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 132
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
             EL D      I S +  ++      + Q+L G+ Y+H   ++HRDLKP NLLL +   
Sbjct: 133 GGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK 187
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 188 DANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLS 245
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F G +    L+ + +                   +Y   LPQ+ K + SA+     
Sbjct: 246 GCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKVSESAK----- 282
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               DL+ KML + P+ RI+  +AL H ++
Sbjct: 283 ----DLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 39/270 (14%)
Query: 5   TREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYI 62
           T +E A+K I       + D +  LRE++LL+ +DH NI+ + +            +VY 
Sbjct: 74  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 133
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
             EL D      I S +  ++      + Q+L G+ Y+H   ++HRDLKP NLLL +   
Sbjct: 134 GGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK 188
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 189 DANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLS 246
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F G +    L+ + +                   +Y   LPQ+ K + SA+     
Sbjct: 247 GCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKVSESAK----- 283
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               DL+ KML + P+ RI+  +AL H ++
Sbjct: 284 ----DLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 39/270 (14%)
Query: 5   TREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYI 62
           T +E A+K I       + D +  LRE++LL+ +DH NI+ + +            +VY 
Sbjct: 56  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 115
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
             EL D      I S +  ++      + Q+L G+ Y+H   ++HRDLKP NLLL +   
Sbjct: 116 GGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK 170
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 171 DANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLS 228
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F G +                      L+     +Y   LPQ+ K + SA+     
Sbjct: 229 GCPPFNGAN------------------EYDILKKVEKGKYTFELPQWKKVSESAK----- 265
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               DL+ KML + P+ RI+  +AL H ++
Sbjct: 266 ----DLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 39/270 (14%)
Query: 5   TREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYI 62
           T +E A+K I       + D +  LRE++LL+ +DH NI+ + +            +VY 
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
             EL D      I S +  ++      + Q+L G+ Y+H   ++HRDLKP NLLL +   
Sbjct: 110 GGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK 164
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 165 DANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLS 222
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F G +    L+ + +                   +Y   LPQ+ K + SA+     
Sbjct: 223 GCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKVSESAK----- 259
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               DL+ KML + P+ RI+  +AL H ++
Sbjct: 260 ----DLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 135/300 (45%), Gaps = 49/300 (16%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR----ETFNDVYIVY 64
           VA+K + N  D   +A R+  EI++L H+   N        R  Q     E    + IV+
Sbjct: 43  VAVKIVKNV-DRYCEAARS--EIQVLEHL---NTTDPNSTFRCVQMLEWFEHHGHICIVF 96
Query: 65  ELMDTDLHQIIRSHQDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
           EL+    +  I+ +  L    DH R   YQ+ + + ++HS  + H DLKP N+L      
Sbjct: 97  ELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDY 156
Query: 120 ----------------NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 163
                           N D+K+ DFG A  T + +  +  V TR YRAPE++L    ++ 
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILALG-WSQ 213
Query: 164 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS---------- 213
             D+WS+GCIL E      +FP  D    L ++  ++G   +  +   R           
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLD 273
Query: 214 ----DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                +A RYV    + P + F      +     DL++KML +DP +RIT+ EAL HP+ 
Sbjct: 274 WDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 39/270 (14%)
Query: 5   TREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYI 62
           T +E A+K I       + D +  LRE++LL+ +DH NI  + +            +VY 
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYT 109
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
             EL D      I S +  ++      + Q+L G+ Y H   ++HRDLKP NLLL +   
Sbjct: 110 GGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSK 164
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +++I DFGL+     +    + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 165 DANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLS 222
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F G +    L+ + +                   +Y   LPQ+ K + SA+     
Sbjct: 223 GCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKVSESAK----- 259
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               DL+ K L + P+ RI+  +AL H ++
Sbjct: 260 ----DLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 143/309 (46%), Gaps = 51/309 (16%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           +E A K I     +  D ++  RE ++ R + H NI+ + D I     E F+  Y+V++L
Sbjct: 57  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI---SEEGFH--YLVFDL 111
Query: 67  M-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--- 122
           +   +L + I + +  ++    + ++Q+L  + ++H  +++HRDLKP NLLL + C    
Sbjct: 112 VTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAA 171
Query: 123 LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +K+ DFGLA     E      +  T  Y +PE+L     Y   +DIW+ G IL  ++   
Sbjct: 172 VKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDIWACGVILYILLVGY 230
Query: 182 PLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           P F  +D   Q +L  ++  G+ D                     FP    S  +   +P
Sbjct: 231 PPFWDED---QHKLYQQIKAGAYD---------------------FP----SPEWDTVTP 262
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            A +L+ +ML  +P +RIT D+AL HP+           VC R       H   T E ++
Sbjct: 263 EAKNLINQMLTINPAKRITADQALKHPW-----------VCQRSTVASMMHRQETVECLR 311
Query: 301 ELIYRESVK 309
           +   R  +K
Sbjct: 312 KFNARRKLK 320

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 37/273 (13%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++  T  E A K I     +  D ++  RE ++ R + H NI+ + D I   Q E+F+  
Sbjct: 26  VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI---QEESFH-- 80
Query: 61  YIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL +
Sbjct: 81  YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 140
Query: 120 NCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  +DIW+ G IL  
Sbjct: 141 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYI 199
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++   P F  +D   Q RL  ++                A  Y      +P    S  + 
Sbjct: 200 LLVGYPPFWDED---QHRLYAQI---------------KAGAY-----DYP----SPEWD 232
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             +P A  L++ ML  +P +RIT D+AL  P++
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR----ETFNDVYIVY 64
           VA+K + N  D   +A R+  EI++L H+   N        R  Q     E    + IV+
Sbjct: 43  VAVKIVKNV-DRYCEAARS--EIQVLEHL---NTTDPNSTFRCVQMLEWFEHHGHICIVF 96
Query: 65  ELMDTDLHQIIRSHQDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
           EL+    +  I+ +  L    DH R   YQ+ + + ++HS  + H DLKP N+L      
Sbjct: 97  ELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDY 156
Query: 120 ----------------NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 163
                           N D+K+ DFG A  T + +  +  V  R YRAPE++L    ++ 
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPEVILALG-WSQ 213
Query: 164 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS---------- 213
             D+WS+GCIL E      +FP  D    L ++  ++G   +  +   R           
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLD 273
Query: 214 ----DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                +A RYV    + P + F      +     DL++KML +DP +RIT+ EAL HP+ 
Sbjct: 274 WDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 37/273 (13%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++  T  E A K I     +  D ++  RE ++ R + H NI+ + D I   Q E+F+  
Sbjct: 26  VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI---QEESFH-- 80
Query: 61  YIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL +
Sbjct: 81  YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 140
Query: 120 NCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  +DIW+ G IL  
Sbjct: 141 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYI 199
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++   P F  +D   Q RL  ++                A  Y      +P    S  + 
Sbjct: 200 LLVGYPPFWDED---QHRLYAQI---------------KAGAY-----DYP----SPEWD 232
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             +P A  L++ ML  +P +RIT D+AL  P++
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 37/273 (13%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++  T  E A K I     +  D ++  RE ++ R + H NI+ + D I   Q E+F+  
Sbjct: 25  VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI---QEESFH-- 79
Query: 61  YIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL +
Sbjct: 80  YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 139
Query: 120 NCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  +DIW+ G IL  
Sbjct: 140 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYI 198
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++   P F  +D   Q RL  ++                A  Y      +P    S  + 
Sbjct: 199 LLVGYPPFWDED---QHRLYAQI---------------KAGAY-----DYP----SPEWD 231
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             +P A  L++ ML  +P +RIT D+AL  P++
Sbjct: 232 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 49/280 (17%)
Query: 12  KKIGNAFDNRIDAKRTLR--------EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           K  G  F  +   K+ L+        EI +LR + HENI+A++DI   P     N +Y+V
Sbjct: 44  KATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESP-----NHLYLV 98
Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
            +L+   +L   I      T+      + Q+L  + Y+H   ++HRDLKP NLL    + 
Sbjct: 99  MQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDE 158
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              + I DFGL++   + D M+    T  Y APE+L     Y+ A+D WS+G I   ++ 
Sbjct: 159 ESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLC 217
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLR--SDNARRYVRMLPQFPKQNFSARFPN 237
             P F  ++     +L  +++ +  E    +    SD+A+ ++R                
Sbjct: 218 GYPPFYDEN---DSKLFEQILKAEYEFDSPYWDDISDSAKDFIR---------------- 258
Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 277
                 +L+EK    DPN+R T ++A  HP++A    +N+
Sbjct: 259 ------NLMEK----DPNKRYTCEQAARHPWIAGDTALNK 288

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 133/270 (49%), Gaps = 39/270 (14%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T  E A K I     +  D ++  RE ++ R + H NI+ + D I   Q E+F+  Y+V+
Sbjct: 53  TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI---QEESFH--YLVF 107
Query: 65  ELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD- 122
           +L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL +    
Sbjct: 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKG 167
Query: 123 --LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  +DIW+ G IL  ++  
Sbjct: 168 AAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVG 226
Query: 181 QPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            P F  +D   Q RL  ++  G+ D                     +P    S  +   +
Sbjct: 227 YPPFWDED---QHRLYAQIKAGAYD---------------------YP----SPEWDTVT 258
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           P A  L++ ML  +P +RIT D+AL  P++
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 41/306 (13%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           ++  + +VA+K I N    R  A+  +  +K ++  D EN      ++          + 
Sbjct: 50  HARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC--VLMSDWFNFHGHMC 107
Query: 62  IVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL-LN 118
           I +EL+  +  + ++ +  Q     H R+  YQL   L+++H   + H DLKP N+L +N
Sbjct: 108 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 167
Query: 119 A------------------NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 160
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 168 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 224
Query: 161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL------------ 208
           +    D+WS+GCIL E      LF   +    L ++ +++G      +            
Sbjct: 225 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 284
Query: 209 GFLRSDNAR--RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
           G +  +N+   RYV+   + P +++  +   +     DL+ +ML FDP +RIT+ EAL H
Sbjct: 285 GLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 343
Query: 267 PYLAPL 272
           P+ A L
Sbjct: 344 PFFAGL 349

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 41/306 (13%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           ++  + +VA+K I N    R  A+  +  +K ++  D EN      ++          + 
Sbjct: 41  HARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC--VLMSDWFNFHGHMC 98
Query: 62  IVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN- 118
           I +EL+  +  + ++ +  Q     H R+  YQL   L+++H   + H DLKP N+L   
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
Query: 119 ------------------ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 160
                              N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215
Query: 161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL------------ 208
           +    D+WS+GCIL E      LF   +    L ++ +++G      +            
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275
Query: 209 GFLRSDNAR--RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
           G +  +N+   RYV+   + P +++  +   +     DL+ +ML FDP +RIT+ EAL H
Sbjct: 276 GLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334
Query: 267 PYLAPL 272
           P+ A L
Sbjct: 335 PFFAGL 340

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 142/307 (46%), Gaps = 43/307 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           ++  + +VA+K I N    R  A+  +  +K ++  D EN      ++          + 
Sbjct: 73  HARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC--VLMSDWFNFHGHMC 130
Query: 62  IVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL-LN 118
           I +EL+  +  + ++ +  Q     H R+  YQL   L+++H   + H DLKP N+L +N
Sbjct: 131 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 190
Query: 119 A------------------NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 160
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 191 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 247
Query: 161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL------------ 208
           +    D+WS+GCIL E      LF   +    L ++ +++G P  + +            
Sbjct: 248 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYK 306
Query: 209 -GFLRSDNAR--RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 265
            G +  +N+   RYV+   + P +++  +   +     DL+ +ML FDP +RIT+ EAL 
Sbjct: 307 GGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 365
Query: 266 HPYLAPL 272
           HP+ A L
Sbjct: 366 HPFFAGL 372

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 41/251 (16%)
Query: 27  TLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDD 84
           T RE  +LR +  H +II + D       E+ + +++V++LM   +L   +     L++ 
Sbjct: 146 TRRETHILRQVAGHPHIITLID-----SYESSSFMFLVFDLMRKGELFDYLTEKVALSEK 200
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
             R  +  LL  + ++H+ N++HRDLKP N+LL+ N  +++ DFG +      + + E  
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 145 VTRWYRAPELLLNCS------EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
            T  Y APE+L  CS       Y   +D+W+ G IL  ++   P F  +  +  LR+I E
Sbjct: 261 GTPGYLAPEIL-KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 199 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                                     Q+  Q  S  + ++S    DL+ ++L  DP  R+
Sbjct: 320 -------------------------GQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARL 352
Query: 259 TVDEALCHPYL 269
           T ++AL HP+ 
Sbjct: 353 TAEQALQHPFF 363

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/311 (27%), Positives = 139/311 (44%), Gaps = 51/311 (16%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T  E A K I     +  D ++  RE ++ R + H NI+ + D I     E F+  Y+V+
Sbjct: 28  TGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSI---SEEGFH--YLVF 82
Query: 65  ELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD- 122
           +L+   +L + I + +  ++    + + Q+L  + + H   V+HRDLKP NLLL + C  
Sbjct: 83  DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKG 142
Query: 123 --LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFGLA     +      +  T  Y +PE+L     Y   +DIW+ G IL  ++ 
Sbjct: 143 AAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-EAYGKPVDIWACGVILYILLV 201
Query: 180 RQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
             P F  +D   Q +L  ++  G+ D                     FP    S  +   
Sbjct: 202 GYPPFWDED---QHKLYQQIKAGAYD---------------------FP----SPEWDTV 233
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEEN 298
           +P A +L+ +ML  +P +RIT  EAL HP+           VC R       H   T E 
Sbjct: 234 TPEAKNLINQMLTINPAKRITAHEALKHPW-----------VCQRSTVASMMHRQETVEC 282
Query: 299 IKELIYRESVK 309
           +K+   R  +K
Sbjct: 283 LKKFNARRKLK 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 120/238 (50%), Gaps = 41/238 (17%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + R + H++++           E  + V++V EL     L ++ +  + LT+   RY
Sbjct: 91  EISIHRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 145
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--T 146
           +L Q++ G +Y+H   V+HRDLK  NL LN + ++KIGDFGLA T  E D   + V+  T
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGT 204
Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE+L +   ++  +D+WS+GCI+  ++  +P                    P ET
Sbjct: 205 PNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET 243
Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           S           Y+R+     K+N  +   + +P A  L++KML  DP  R T++E L
Sbjct: 244 SC------LKETYLRI-----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 45/274 (16%)
Query: 5   TREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           T  E AIK I  ++     ++   L E+ +L+ +DH NI+ + +       E   + Y+V
Sbjct: 45  TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFF-----EDKRNYYLV 99
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E+    +L   I   Q  ++      + Q+L G  Y+H  N++HRDLKP NLLL +   
Sbjct: 100 MEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSR 159
Query: 123 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              +KI DFGL+        M E + T +Y APE+L    +Y    D+WS G IL  ++ 
Sbjct: 160 DALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--KYDEKCDVWSCGVILYILLC 217
Query: 180 RQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
             P F G+     L+ + +   S   PD T +    SD A++ V++              
Sbjct: 218 GYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV----SDEAKQLVKL-------------- 259
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                       ML ++P++RI+ +EAL HP++ 
Sbjct: 260 ------------MLTYEPSKRISAEEALNHPWIV 281

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 120/238 (50%), Gaps = 41/238 (17%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + R + H++++           E  + V++V EL     L ++ +  + LT+   RY
Sbjct: 89  EISIHRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 143
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--T 146
           +L Q++ G +Y+H   V+HRDLK  NL LN + ++KIGDFGLA T  E D   + V+  T
Sbjct: 144 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGT 202
Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE+L +   ++  +D+WS+GCI+  ++  +P                    P ET
Sbjct: 203 PNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET 241
Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           S           Y+R+     K+N  +   + +P A  L++KML  DP  R T++E L
Sbjct: 242 SC------LKETYLRI-----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 120/238 (50%), Gaps = 41/238 (17%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + R + H++++           E  + V++V EL     L ++ +  + LT+   RY
Sbjct: 65  EISIHRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 119
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--T 146
           +L Q++ G +Y+H   V+HRDLK  NL LN + ++KIGDFGLA T  E D   + V+  T
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGT 178
Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE+L +   ++  +D+WS+GCI+  ++  +P                    P ET
Sbjct: 179 PNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET 217
Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           S           Y+R+     K+N  +   + +P A  L++KML  DP  R T++E L
Sbjct: 218 SC------LKETYLRI-----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 125/260 (48%), Gaps = 37/260 (14%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQI 74
           G     R   ++  +EI +L+ +DH N++ + +++  P     + +Y+V+EL++      
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVME 127
Query: 75  IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 134
           + + + L++D  R++   L++G++Y+H   ++HRD+KPSNLL+  +  +KI DFG++   
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 135 SETD-FMTEYVVTRWYRAPELLLNCSEYTA--AIDIWSVGCILGEIMTRQ-PLFPGKDYV 190
             +D  ++  V T  + APE L    +  +  A+D+W++G  L   +  Q P    +   
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 191 HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKML 250
              ++ ++ +  PD+                              P+ +    DL+ +ML
Sbjct: 248 LHSKIKSQALEFPDQ------------------------------PDIAEDLKDLITRML 277
Query: 251 VFDPNRRITVDEALCHPYLA 270
             +P  RI V E   HP++ 
Sbjct: 278 DKNPESRIVVPEIKLHPWVT 297

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 116/251 (46%), Gaps = 41/251 (16%)
Query: 27  TLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDD 84
           TL+E+ +LR +  H NII +KD       ET    ++V++LM   +L   +     L++ 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 124
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
             R  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E  
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 145 VTRWYRAPELLLNCS------EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
            T  Y APE++  CS       Y   +D+WS G I+  ++   P F  +  +  LR+I  
Sbjct: 185 GTPSYLAPEII-ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM- 242
Query: 199 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                         S N             Q  S  + + S    DL+ + LV  P +R 
Sbjct: 243 --------------SGNY------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 259 TVDEALCHPYL 269
           T +EAL HP+ 
Sbjct: 277 TAEEALAHPFF 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 116/251 (46%), Gaps = 41/251 (16%)
Query: 27  TLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDD 84
           TL+E+ +LR +  H NII +KD       ET    ++V++LM   +L   +     L++ 
Sbjct: 57  TLKEVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
             R  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E  
Sbjct: 112 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 171
Query: 145 VTRWYRAPELLLNCS------EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
            T  Y APE++  CS       Y   +D+WS G I+  ++   P F  +  +  LR+I  
Sbjct: 172 GTPSYLAPEII-ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM- 229
Query: 199 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                         S N             Q  S  + + S    DL+ + LV  P +R 
Sbjct: 230 --------------SGNY------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 263
Query: 259 TVDEALCHPYL 269
           T +EAL HP+ 
Sbjct: 264 TAEEALAHPFF 274

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 45/276 (16%)
Query: 5   TREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           T  E AIK I  ++     ++   L E+ +L+ +DH NI+ + +       E   + Y+V
Sbjct: 28  TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFF-----EDKRNYYLV 82
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--- 119
            E+    +L   I   Q  ++      + Q+L G  Y+H  N++HRDLKP NLLL +   
Sbjct: 83  MEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSR 142
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  +KI DFGL+        M E + T +Y APE+L    +Y    D+WS G IL  ++ 
Sbjct: 143 DALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--KYDEKCDVWSCGVILYILLC 200
Query: 180 RQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
             P F G+     L+ + +   S   PD T +    SD A++ V++              
Sbjct: 201 GYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV----SDEAKQLVKL-------------- 242
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 272
                       ML ++P++RI+ +EAL HP++   
Sbjct: 243 ------------MLTYEPSKRISAEEALNHPWIVKF 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 147/308 (47%), Gaps = 42/308 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T +EVA+K I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G++ + +LR                       R +R   + P           S    
Sbjct: 213 FDGQN-LKELR----------------------ERVLRGKYRIPFY--------MSTDCE 241
Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EP-VCPRPFSFDFEHPSFTEENIKE 301
           +LL+K L+ +P++R T+++ +   ++   H+ +E +P V P P   D++ P  TE  +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVAPLP---DYKDPRRTELMVSM 298
Query: 302 LIYRESVK 309
              RE ++
Sbjct: 299 GYTREEIQ 306

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 148/308 (48%), Gaps = 42/308 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T +EVA++ I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y+V 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + + E+  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G++ + +LR                       R +R   + P           S    
Sbjct: 213 FDGQN-LKELR----------------------ERVLRGKYRIPFY--------MSTDCE 241
Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EP-VCPRPFSFDFEHPSFTEENIKE 301
           +LL+K L+ +P++R T+++ +   ++   H+ +E +P V P P   D++ P  TE  +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP---DYKDPRRTELMVSM 298
Query: 302 LIYRESVK 309
              RE ++
Sbjct: 299 GYTREEIQ 306

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 51/274 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
            ++L HP++ P           +  S  + HP F
Sbjct: 267 QDSLQHPWIKPKD-------TQQALSSAWSHPQF 293

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 51/274 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
            ++L HP++ P           +  S  + HP F
Sbjct: 267 QDSLQHPWIKPKD-------TQQALSSAWSHPQF 293

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 51/274 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 62  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 173
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 174 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 218
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 219 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 265
Query: 261 DEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
            ++L HP++ P           +  S  + HP F
Sbjct: 266 QDSLQHPWIKPKD-------TQQALSSAWSHPQF 292

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 51/274 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
            ++L HP++ P           +  S  + HP F
Sbjct: 267 QDSLQHPWIKPKD-------TQQALSSAWSHPQF 293

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 119/238 (50%), Gaps = 41/238 (17%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + R + H++++           E  + V++V EL     L ++ +  + LT+   RY
Sbjct: 67  EISIHRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 121
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--T 146
           +L Q++ G +Y+H   V+HRDLK  NL LN + ++KIGDFGLA T  E D   +  +  T
Sbjct: 122 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGT 180
Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE+L +   ++  +D+WS+GCI+  ++  +P                    P ET
Sbjct: 181 PNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET 219
Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           S           Y+R+     K+N  +   + +P A  L++KML  DP  R T++E L
Sbjct: 220 SC------LKETYLRI-----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 119/238 (50%), Gaps = 41/238 (17%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + R + H++++           E  + V++V EL     L ++ +  + LT+   RY
Sbjct: 71  EISIHRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 125
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--T 146
           +L Q++ G +Y+H   V+HRDLK  NL LN + ++KIGDFGLA T  E D   +  +  T
Sbjct: 126 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGT 184
Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE+L +   ++  +D+WS+GCI+  ++  +P                    P ET
Sbjct: 185 PNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET 223
Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           S           Y+R+     K+N  +   + +P A  L++KML  DP  R T++E L
Sbjct: 224 SC------LKETYLRI-----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 114/253 (45%), Gaps = 38/253 (15%)
Query: 22  IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN-DVYIVYELMDTDLHQIIRSHQD 80
           +D K    EI +L  + H NII +K+I   P   +   ++    EL D  + +   S +D
Sbjct: 90  VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSET 137
             D      + Q+L  + Y+H   ++HRDLKP NLL      +  LKI DFGL++     
Sbjct: 150 AADA-----VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 138 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLI 196
             M     T  Y APE+L  C+ Y   +D+WSVG I   ++   +P +  +      R I
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263
Query: 197 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 256
                                 Y  + P + + + +A+         DL+ K++V DP +
Sbjct: 264 LNC------------------EYYFISPWWDEVSLNAK---------DLVRKLIVLDPKK 296
Query: 257 RITVDEALCHPYL 269
           R+T  +AL HP++
Sbjct: 297 RLTTFQALQHPWV 309

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 119/238 (50%), Gaps = 41/238 (17%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + R + H++++           E  + V++V EL     L ++ +  + LT+   RY
Sbjct: 67  EISIHRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 121
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--T 146
           +L Q++ G +Y+H   V+HRDLK  NL LN + ++KIGDFGLA T  E D   +  +  T
Sbjct: 122 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGT 180
Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 206
             Y APE+L +   ++  +D+WS+GCI+  ++  +P                    P ET
Sbjct: 181 PNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET 219
Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           S           Y+R+     K+N  +   + +P A  L++KML  DP  R T++E L
Sbjct: 220 SC------LKETYLRI-----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 38/249 (15%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H NII + DI      E   DV ++ EL+   +L   +   + LT+D   
Sbjct: 57  REVNILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N++L      N  +K+ DFG+A      +     
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G                 
Sbjct: 172 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG----------------- 213
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
            ET    L + +A  Y      F ++ FS    N S  A D + ++LV DP RR+T+ ++
Sbjct: 214 -ETKQETLTNISAVNY-----DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQS 263
Query: 264 LCHPYLAPL 272
           L H ++  +
Sbjct: 264 LEHSWIKAI 272

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 51/274 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 62  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 173
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 174 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 218
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 219 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 265
Query: 261 DEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
            ++L HP++ P           +  S  + HP F
Sbjct: 266 QDSLQHPWIKPKD-------TQQALSSAWSHPQF 292

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 51/315 (16%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M   T +E A K I     +  D ++  RE ++ R + H NI+ + D I     E F+  
Sbjct: 24  MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI---SEEGFH-- 78
Query: 61  YIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++HRDLKP NLLL +
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLAS 138
Query: 120 ---NCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
                 +K+ DFGLA     +      +  T  Y +PE+L     Y   +D+W+ G IL 
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDMWACGVILY 197
Query: 176 EIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
            ++   P F  +D   Q RL  ++  G+ D                     FP    S  
Sbjct: 198 ILLVGYPPFWDED---QHRLYQQIKAGAYD---------------------FP----SPE 229
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
           +   +P A DL+ KML  +P +RIT  EAL HP+           +C R       H   
Sbjct: 230 WDTVTPEAKDLINKMLTINPAKRITASEALKHPW-----------ICQRSTVASMMHRQE 278
Query: 295 TEENIKELIYRESVK 309
           T + +K+   R  +K
Sbjct: 279 TVDCLKKFNARRKLK 293

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 51/315 (16%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M   T +E A K I     +  D ++  RE ++ R + H NI+ + D I     E F+  
Sbjct: 24  MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI---SEEGFH-- 78
Query: 61  YIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++HRDLKP NLLL +
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLAS 138
Query: 120 ---NCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
                 +K+ DFGLA     +      +  T  Y +PE+L     Y   +D+W+ G IL 
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDMWACGVILY 197
Query: 176 EIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
            ++   P F  +D   Q RL  ++  G+ D                     FP    S  
Sbjct: 198 ILLVGYPPFWDED---QHRLYQQIKAGAYD---------------------FP----SPE 229
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
           +   +P A DL+ KML  +P +RIT  EAL HP+           +C R       H   
Sbjct: 230 WDTVTPEAKDLINKMLTINPAKRITASEALKHPW-----------ICQRSTVASMMHRQE 278
Query: 295 TEENIKELIYRESVK 309
           T + +K+   R  +K
Sbjct: 279 TVDCLKKFNARRKLK 293

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 51/274 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
            ++L HP++ P           +  S  + HP F
Sbjct: 267 QDSLQHPWIKPKD-------TQQALSSAWSHPQF 293

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F               +
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF---------------L 218
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
           G   + +L  + + N         +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 219 GDTKQETLANVSAVNY--------EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 132/282 (46%), Gaps = 42/282 (14%)
Query: 12  KKIGNAFDNRIDAKR----TLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYEL 66
           KK   AF  +I +KR    T +EI  L+  + H NI+ + ++    Q  TF    +V EL
Sbjct: 33  KKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTF----LVMEL 87
Query: 67  MDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCD 122
           ++  +L + I+  +  ++    Y + +L+  + ++H   V+HRDLKP NLL    N N +
Sbjct: 88  LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLE 147
Query: 123 LKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +KI DFG AR    +   +     T  Y APE LLN + Y  + D+WS+G IL  +++ Q
Sbjct: 148 IKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQ 206
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS---ARFPNK 238
             F   D                       RS      V ++ +  K +FS     + N 
Sbjct: 207 VPFQSHD-----------------------RSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           S  A DL++ +L  DPN+R+ +     + +L     ++  P+
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 44/270 (16%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           E  IK I N   +++  ++   EI++L+ +DH NII I ++      E ++++YIV E  
Sbjct: 49  ERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETC 102
Query: 68  DTD--LHQIIRSH---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
           +    L +I+ +    + L++ +    + Q++  L Y HS +V+H+DLKP N+L    + 
Sbjct: 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSP 162
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  +KI DFGLA      +  T    T  Y APE+     + T   DIWS G ++  ++T
Sbjct: 163 HSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLT 220
Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
               F G                   TSL           V+    + + N++      +
Sbjct: 221 GCLPFTG-------------------TSL---------EEVQQKATYKEPNYAVECRPLT 252
Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           P AVDLL++ML  DP RR +  + L H + 
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 41/251 (16%)
Query: 27  TLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDD 84
           TL+E+ +LR +  H NII +KD       ET    ++V++LM   +L   +     L++ 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 124
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
             R  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + +    
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC 184
Query: 145 VTRWYRAPELLLNCS------EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
            T  Y APE++  CS       Y   +D+WS G I+  ++   P F  +  +  LR+I  
Sbjct: 185 GTPSYLAPEII-ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM- 242
Query: 199 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                         S N             Q  S  + + S    DL+ + LV  P +R 
Sbjct: 243 --------------SGNY------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 259 TVDEALCHPYL 269
           T +EAL HP+ 
Sbjct: 277 TAEEALAHPFF 287

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 146/313 (46%), Gaps = 54/313 (17%)
Query: 6   REEVAIKKIGN--AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-NDVYI 62
           +E VAIK I N  AF N+        E++LL  M+  +      I+   +   F N + +
Sbjct: 60  QEWVAIKIIKNKKAFLNQAQI-----EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 114
Query: 63  VYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHS--ANVLHRDLKPSNLLLN 118
           V+E++  +L+ ++R+   + ++ +  R F  Q+   L ++ +   +++H DLKP N+LL 
Sbjct: 115 VFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC 174
Query: 119 --ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCIL E
Sbjct: 175 NPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVE 231
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP---KQNFSA 233
           + T +PLF G + V Q+  I E++G P    L   ++  AR++   LP      K+    
Sbjct: 232 MHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLPDGTWNLKKTKDG 289
Query: 234 RFPNKSPGA--------------------------------VDLLEKMLVFDPNRRITVD 261
           +   K PG                                  DL+ +ML +DP  RI   
Sbjct: 290 KREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 349
Query: 262 EALCHPYLAPLHD 274
            AL H +     D
Sbjct: 350 YALQHSFFKKTAD 362

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 147/308 (47%), Gaps = 42/308 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T +EVA+K I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G++ + +LR                       R +R   + P           S    
Sbjct: 213 FDGQN-LKELR----------------------ERVLRGKYRIPFY--------MSTDCE 241
Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EP-VCPRPFSFDFEHPSFTEENIKE 301
           +LL+K L+ +P++R T+++ +   ++   H+ +E +P V P P   D++ P  TE  +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP---DYKDPRRTELMVSM 298
Query: 302 LIYRESVK 309
              RE ++
Sbjct: 299 GYTREEIQ 306

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
               +T    L + +A  Y     +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 220 ----DTKQETLANVSAVNY-----EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F               +
Sbjct: 175 KNIFGTPAFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF---------------L 218
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
           G   + +L  + + N         +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 219 GDTKQETLANVSAVNY--------EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 146/313 (46%), Gaps = 54/313 (17%)
Query: 6   REEVAIKKIGN--AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-NDVYI 62
           +E VAIK I N  AF N+        E++LL  M+  +      I+   +   F N + +
Sbjct: 79  QEWVAIKIIKNKKAFLNQAQI-----EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133
Query: 63  VYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHS--ANVLHRDLKPSNLLLN 118
           V+E++  +L+ ++R+   + ++ +  R F  Q+   L ++ +   +++H DLKP N+LL 
Sbjct: 134 VFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC 193
Query: 119 --ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCIL E
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVE 250
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP---KQNFSA 233
           + T +PLF G + V Q+  I E++G P    L   ++  AR++   LP      K+    
Sbjct: 251 MHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLPDGTWNLKKTKDG 308
Query: 234 RFPNKSPGA--------------------------------VDLLEKMLVFDPNRRITVD 261
           +   K PG                                  DL+ +ML +DP  RI   
Sbjct: 309 KREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368
Query: 262 EALCHPYLAPLHD 274
            AL H +     D
Sbjct: 369 YALQHSFFKKTAD 381

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 44/251 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+ +L+ + H N+I + ++      E   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 144 ---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
                T  + APE ++N        D+WS+G I   +++    F               +
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF---------------L 218
Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 260
           G   + +L  + + N         +F  + FS    N S  A D + ++LV DP +R+T+
Sbjct: 219 GDTKQETLANVSAVNY--------EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTI 266
Query: 261 DEALCHPYLAP 271
            ++L HP++ P
Sbjct: 267 QDSLQHPWIKP 277

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 148/316 (46%), Gaps = 60/316 (18%)
Query: 6   REEVAIKKIGN--AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-NDVYI 62
           +E VAIK I N  AF N+        E++LL  M+  +      I+   +   F N + +
Sbjct: 79  QEWVAIKIIKNKKAFLNQAQI-----EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133
Query: 63  VYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHS--ANVLHRDLKPSNLLLN 118
           V+E++  +L+ ++R+   + ++ +  R F  Q+   L ++ +   +++H DLKP N+LL 
Sbjct: 134 VFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL- 192
Query: 119 ANCD-----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
             C+     +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCI
Sbjct: 193 --CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCI 247
Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP---KQN 230
           L E+ T +PLF G + V Q+  I E++G P    L   ++  AR++   LP      K+ 
Sbjct: 248 LVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLPDGTWNLKKT 305
Query: 231 FSARFPNKSPGA--------------------------------VDLLEKMLVFDPNRRI 258
              +   K PG                                  DL+ +ML +DP  RI
Sbjct: 306 KDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365
Query: 259 TVDEALCHPYLAPLHD 274
               AL H +     D
Sbjct: 366 QPYYALQHSFFKKTAD 381

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 146/308 (47%), Gaps = 42/308 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T +EVA+K I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + +  +     Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G++ + +LR                       R +R   + P           S    
Sbjct: 213 FDGQN-LKELR----------------------ERVLRGKYRIPFY--------MSTDCE 241
Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EP-VCPRPFSFDFEHPSFTEENIKE 301
           +LL+K L+ +P++R T+++ +   ++   H+ +E +P V P P   D++ P  TE  +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP---DYKDPRRTELMVSM 298
Query: 302 LIYRESVK 309
              RE ++
Sbjct: 299 GYTREEIQ 306

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 40/270 (14%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           +E A K I     +  D ++  RE ++ R + H NI+ + D I           Y++++L
Sbjct: 48  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH-----YLIFDL 102
Query: 67  M-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCD 122
           +   +L + I + +  ++    + + Q+L  + + H   V+HRDLKP NLLL +      
Sbjct: 103 VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAA 162
Query: 123 LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +K+ DFGLA     E      +  T  Y +PE+L     Y   +D+W+ G IL  ++   
Sbjct: 163 VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGY 221
Query: 182 PLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           P F  +D   Q RL  ++  G+ D                     FP    S  +   +P
Sbjct: 222 PPFWDED---QHRLYQQIKAGAYD---------------------FP----SPEWDTVTP 253
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
            A DL+ KML  +P++RIT  EAL HP+++
Sbjct: 254 EAKDLINKMLTINPSKRITAAEALKHPWIS 283

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 147/308 (47%), Gaps = 42/308 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T +EVA++ I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y+V 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G++ + +LR                       R +R   + P           S    
Sbjct: 213 FDGQN-LKELR----------------------ERVLRGKYRIPFY--------MSTDCE 241
Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EP-VCPRPFSFDFEHPSFTEENIKE 301
           +LL+K L+ +P++R T+++ +   ++   H+ +E +P V P P   D++ P  TE  +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP---DYKDPRRTELMVSM 298
Query: 302 LIYRESVK 309
              RE ++
Sbjct: 299 GYTREEIQ 306

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 147/308 (47%), Gaps = 42/308 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T +EVA+K I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y+V 
Sbjct: 31  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 85
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 86  EYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 145
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 146 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G++ + +LR                       R +R   + P           S    
Sbjct: 206 FDGQN-LKELR----------------------ERVLRGKYRIPFY--------MSTDCE 234
Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EP-VCPRPFSFDFEHPSFTEENIKE 301
           +LL+K L+ +P++R T+++ +   ++   H+ +E +P V P P   D++ P  TE  +  
Sbjct: 235 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP---DYKDPRRTELMVSM 291
Query: 302 LIYRESVK 309
              RE ++
Sbjct: 292 GYTREEIQ 299

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 38/249 (15%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H NII + DI      E   DV ++ EL+   +L   +   + LT+D   
Sbjct: 78  REVNILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +K+ DFG+A      +     
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 192
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G                 
Sbjct: 193 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG----------------- 234
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
            ET    L + +A  Y      F ++ FS    N S  A D + ++LV DP RR+ + ++
Sbjct: 235 -ETKQETLTNISAVNY-----DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMXIAQS 284
Query: 264 LCHPYLAPL 272
           L H ++  +
Sbjct: 285 LEHSWIKAI 293

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H NII + DI      E   DV ++ EL+   +L   +   + LT+D   
Sbjct: 64  REVNILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEY 143
            FL Q+L G+ Y+HS  + H DLKP N++L      N  +K+ DFG+A      +     
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 178
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G                 
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG----------------- 220
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
            ET    L + +A  Y      F ++ FS    N S  A D + ++LV DP RR+ + ++
Sbjct: 221 -ETKQETLTNISAVNY-----DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMXIAQS 270
Query: 264 LCHPYL 269
           L H ++
Sbjct: 271 LEHSWI 276

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 48/264 (18%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHC- 86
           EI LL+ +DH NII + D+    +       Y+V E  +      QII  H+    D C 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKF---DECD 147
Query: 87  -RYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTE 142
               + Q+L G+ Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + +
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 202
            + T +Y APE+L    +Y    D+WS G I+  ++   P F G++         ++I  
Sbjct: 208 RLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-------DQDIIKK 258
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
            ++    F  +D                    + N S  A +L++ ML +D N+R T +E
Sbjct: 259 VEKGKYYFDFND--------------------WKNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 263 AL----CHPYLAPLHDINEEPVCP 282
           AL       Y   ++  +++ +C 
Sbjct: 299 ALNSRWIKKYANNINKSDQKTLCG 322

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + + +D+ +++           E  + VY+V E+     L ++ +  + +T+   RY
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVVTR 147
           F+ Q ++G++Y+H+  V+HRDLK  NL LN + D+KIGDFGLA +   + +   +   T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 207 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 44/276 (15%)
Query: 2   NSETREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T++ VAIK I   A + +  +     EI +L  + H NI+A+ DI      E+   +
Sbjct: 39  DKRTQKLVAIKCIAKKALEGKEGSMEN--EIAVLHKIKHPNIVALDDIY-----ESGGHL 91
Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL--- 116
           Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++HRDLKP NLL   
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           L+ +  + I DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I   
Sbjct: 152 LDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYI 210
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR--SDNARRYVRMLPQFPKQNFSAR 234
           ++   P F  ++     +L  +++ +  E    +    SD+A+ ++R             
Sbjct: 211 LLCGYPPFYDEN---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH------------ 255
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                     L+EK    DP +R T ++AL HP++A
Sbjct: 256 ----------LMEK----DPEKRFTCEQALQHPWIA 277

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + + +D+ +++           E  + VY+V E+     L ++ +  + +T+   RY
Sbjct: 76  EIAIHKSLDNPHVVGFHGFF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 130
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVVTR 147
           F+ Q ++G++Y+H+  V+HRDLK  NL LN + D+KIGDFGLA +   + +   +   T 
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 191 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 96/185 (51%), Gaps = 6/185 (3%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T  EVAIK I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y++ 
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLIM 90
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 91  EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNI 150
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +    +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 151 KIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210
Query: 184 FPGKD 188
           F G++
Sbjct: 211 FDGQN 215

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 40/268 (14%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H N+I + D+      E   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           DE                   +F        F + S  A D + K+LV +  +R+T+ EA
Sbjct: 238 DE-------------------EF--------FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 264 LCHPYLAPLHDINEEPVCPRPFSFDFEH 291
           L HP++ P+   N++ +  R    + E+
Sbjct: 271 LRHPWITPVD--NQQAMVRRESVVNLEN 296

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 38/249 (15%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H N+I + D+      E   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           DE                   +F        F + S  A D + K+LV +  +R+T+ EA
Sbjct: 238 DE-------------------EF--------FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 264 LCHPYLAPL 272
           L HP++ P+
Sbjct: 271 LRHPWITPV 279

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 93/169 (55%), Gaps = 9/169 (5%)
Query: 25  KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTD 83
           KR  RE+     + H+NI+++ D+      E  +  Y+V E ++   L + I SH  L+ 
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDV-----DEEDDCYYLVMEYIEGPTLSEYIESHGPLSV 110
Query: 84  DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTE 142
           D    F  Q+L G+K+ H   ++HRD+KP N+L+++N  LKI DFG+A+  SET    T 
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 143 YVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 190
           +V+ T  Y +PE            DI+S+G +L E++  +P F G+  V
Sbjct: 171 HVLGTVQYFSPE-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 91/158 (57%), Gaps = 10/158 (6%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + + +D+ +++           E  + VY+V E+     L ++ +  + +T+   RY
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--T 146
           F+ Q ++G++Y+H+  V+HRDLK  NL LN + D+KIGDFGLA T  E D   +  +  T
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKTLCGT 205
Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
             Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 206 PNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 40/268 (14%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H N+I + D+      E   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           DE                   +F        F   S  A D + K+LV +  +R+T+ EA
Sbjct: 238 DE-------------------EF--------FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 264 LCHPYLAPLHDINEEPVCPRPFSFDFEH 291
           L HP++ P+   N++ +  R    + E+
Sbjct: 271 LRHPWITPVD--NQQAMVRRESVVNLEN 296

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 46/277 (16%)
Query: 2   NSETREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T++ VAIK I   A + +  +     EI +L  + H NI+A+ DI      E+   +
Sbjct: 39  DKRTQKLVAIKCIAKEALEGKEGSMEN--EIAVLHKIKHPNIVALDDIY-----ESGGHL 91
Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL--- 116
           Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++HRDLKP NLL   
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           L+ +  + I DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I   
Sbjct: 152 LDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYI 210
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF---SA 233
           ++   P F                   DE               ++  Q  K  +   S 
Sbjct: 211 LLCGYPPF------------------YDEND------------AKLFEQILKAEYEFDSP 240
Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
            + + S  A D +  ++  DP +R T ++AL HP++A
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 40/268 (14%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H N+I + D+      E   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           DE                   +F        F   S  A D + K+LV +  +R+T+ EA
Sbjct: 238 DE-------------------EF--------FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 264 LCHPYLAPLHDINEEPVCPRPFSFDFEH 291
           L HP++ P+   N++ +  R    + E+
Sbjct: 271 LRHPWITPVD--NQQAMVRRESVVNLEN 296

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 44/276 (15%)
Query: 2   NSETREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T++ VAIK I   A + +  +     EI +L  + H NI+A+ DI      E+   +
Sbjct: 39  DKRTQKLVAIKCIAKEALEGKEGSMEN--EIAVLHKIKHPNIVALDDIY-----ESGGHL 91
Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL--- 116
           Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++HRDLKP NLL   
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           L+ +  + I DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I   
Sbjct: 152 LDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYI 210
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR--SDNARRYVRMLPQFPKQNFSAR 234
           ++   P F  ++     +L  +++ +  E    +    SD+A+ ++R             
Sbjct: 211 LLCGYPPFYDEN---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH------------ 255
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                     L+EK    DP +R T ++AL HP++A
Sbjct: 256 ----------LMEK----DPEKRFTCEQALQHPWIA 277

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 87/166 (52%), Gaps = 15/166 (9%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQII----RSHQDLTDD 84
           E+ LLR + H NI+   D I      T   +YIV E  +  DL  +I    +  Q L ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 85  HCRYFLYQLLRGLKYVH-----SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETD 138
                + QL   LK  H        VLHRDLKP+N+ L+   ++K+GDFGLAR  + + D
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           F  E+V T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 172 FAKEFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 6/185 (3%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T  EVAIK I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y++ 
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLIM 93
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 94  EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNI 153
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +    +  +     Y APEL          +D+WS+G IL  +++    
Sbjct: 154 KIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 184 FPGKD 188
           F G++
Sbjct: 214 FDGQN 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 44/276 (15%)
Query: 2   NSETREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T++ VAIK I   A + +  +     EI +L  + H NI+A+ DI      E+   +
Sbjct: 39  DKRTQKLVAIKCIAKEALEGKEGSMEN--EIAVLHKIKHPNIVALDDIY-----ESGGHL 91
Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL--- 116
           Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++HRDLKP NLL   
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           L+ +  + I DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I   
Sbjct: 152 LDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYI 210
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR--SDNARRYVRMLPQFPKQNFSAR 234
           ++   P F  ++     +L  +++ +  E    +    SD+A+ ++R             
Sbjct: 211 LLCGYPPFYDEN---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH------------ 255
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                     L+EK    DP +R T ++AL HP++A
Sbjct: 256 ----------LMEK----DPEKRFTCEQALQHPWIA 277

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 40/268 (14%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H N+I + D+      E   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           DE                   +F        F + S  A D + K+LV +  +R+T+ EA
Sbjct: 238 DE-------------------EF--------FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 264 LCHPYLAPLHDINEEPVCPRPFSFDFEH 291
           L HP++ P+   N++ +  R    + E+
Sbjct: 271 LRHPWITPVD--NQQAMVRRESVVNLEN 296

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 8/157 (5%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI + + +D+ +++           E  + VY+V E+     L ++ +  + +T+   RY
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF-----EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVVTR 147
           F+ Q ++G++Y+H+  V+HRDLK  NL LN + D+KIGDFGLA +   + +       T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 207 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 40/254 (15%)
Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDL 81
           D ++  RE ++ R + H NI+ + D I           Y++++L+   +L + I + +  
Sbjct: 53  DHQKLEREARICRLLKHPNIVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYY 107
Query: 82  TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLA-RTTSET 137
           ++    + + Q+L  + + H   V+HR+LKP NLLL +      +K+ DFGLA     E 
Sbjct: 108 SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 138 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 197
                +  T  Y +PE+L     Y   +D+W+ G IL  ++   P F  +D   Q RL  
Sbjct: 168 QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQ 223
Query: 198 EL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 256
           ++  G+ D                     FP    S  +   +P A DL+ KML  +P++
Sbjct: 224 QIKAGAYD---------------------FP----SPEWDTVTPEAKDLINKMLTINPSK 258
Query: 257 RITVDEALCHPYLA 270
           RIT  EAL HP+++
Sbjct: 259 RITAAEALKHPWIS 272

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 114/249 (45%), Gaps = 38/249 (15%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 87
           RE+ +LR + H NII + D+      E   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSN-LLLNANC---DLKIGDFGLARTTSETDFMTEY 143
            F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
           DE                   +F        F   S  A D + K+LV +  +R+T+ EA
Sbjct: 238 DE-------------------EF--------FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 264 LCHPYLAPL 272
           L HP++ P+
Sbjct: 271 LRHPWITPV 279

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 6/185 (3%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T  EVA+K I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y+V 
Sbjct: 39  TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLVM 93
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+ + ++
Sbjct: 94  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNI 153
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 154 KIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 184 FPGKD 188
           F G++
Sbjct: 214 FDGQN 218

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 142/308 (46%), Gaps = 42/308 (13%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           T +EVA+K I     N    ++  RE+++ + ++H NI+ + ++I     ET   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVI-----ETEKTLYLVX 92
Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           E     ++   + +H    +   R    Q++  ++Y H   ++HRDLK  NLLL+A+ ++
Sbjct: 93  EYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNI 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           KI DFG +   +  + +  +     Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G++ + +LR                       R +R   + P           S    
Sbjct: 213 FDGQN-LKELR----------------------ERVLRGKYRIPFY--------XSTDCE 241
Query: 244 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EP-VCPRPFSFDFEHPSFTEENIKE 301
           +LL+K L+ +P++R T+++     +    H+ +E +P V P P   D++ P  TE  +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIXKDRWXNVGHEDDELKPYVEPLP---DYKDPRRTELXVSX 298
Query: 302 LIYRESVK 309
              RE ++
Sbjct: 299 GYTREEIQ 306

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 120/248 (48%), Gaps = 46/248 (18%)
Query: 33  LLRHMDHENIIAIKDIIRPPQRETFND---VYIVYELMDTD--LHQIIRSHQDLTDDHCR 87
           LLR+  H NII +KD+        ++D   VY+V ELM     L +I+R  +  ++    
Sbjct: 69  LLRYGQHPNIITLKDV--------YDDGKYVYVVTELMKGGELLDKILR-QKFFSEREAS 119
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCD-LKIGDFGLARTT-SETDFMTE 142
             L+ + + ++Y+H+  V+HRDLKPSN+L    + N + ++I DFG A+   +E   +  
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 202
              T  + APE +L    Y AA DIWS+G +L  ++T                 T     
Sbjct: 180 PCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG---------------YTPFANG 223
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVD 261
           PD+T    L    + ++          + S  + N  S  A DL+ KML  DP++R+T  
Sbjct: 224 PDDTPEEILARIGSGKF----------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 262 EALCHPYL 269
             L HP++
Sbjct: 274 LVLRHPWI 281

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 47/268 (17%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++V E 
Sbjct: 179 VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 229
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++      I +H  + ++        +L+ L  +H+  V+HRD+K  ++LL  +  +K+ 
Sbjct: 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 289
Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  +P + 
Sbjct: 290 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 348
Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---KSPGA 242
            +  +  +++I                               + N   R  N    SP  
Sbjct: 349 NEPPLKAMKMI-------------------------------RDNLPPRLKNLHKVSPSL 377
Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYLA 270
              L+++LV DP +R T  E L HP+LA
Sbjct: 378 KGFLDRLLVRDPAQRATAAELLKHPFLA 405

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 89/172 (51%), Gaps = 7/172 (4%)
Query: 5   TREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           T  +VA+K +       +D   +  REI+ L+   H +II +  +I  P     +D+++V
Sbjct: 40  TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----SDIFMV 94
Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   +L   I  +  L +   R    Q+L G+ Y H   V+HRDLKP N+LL+A+ +
Sbjct: 95  MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN 154
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
            KI DFGL+   S+ +F+     +  Y APE++         +DIWS G IL
Sbjct: 155 AKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 47/268 (17%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++V E 
Sbjct: 102 VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 152
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++      I +H  + ++        +L+ L  +H+  V+HRD+K  ++LL  +  +K+ 
Sbjct: 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 212
Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  +P + 
Sbjct: 213 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 271
Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---KSPGA 242
            +  +  +++I                               + N   R  N    SP  
Sbjct: 272 NEPPLKAMKMI-------------------------------RDNLPPRLKNLHKVSPSL 300
Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYLA 270
              L+++LV DP +R T  E L HP+LA
Sbjct: 301 KGFLDRLLVRDPAQRATAAELLKHPFLA 328

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/166 (36%), Positives = 86/166 (51%), Gaps = 15/166 (9%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQII----RSHQDLTDD 84
           E+ LLR + H NI+   D I      T   +YIV E  +  DL  +I    +  Q L ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 85  HCRYFLYQLLRGLKYVH-----SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETD 138
                + QL   LK  H        VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           F   +V T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 172 FAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/166 (36%), Positives = 86/166 (51%), Gaps = 15/166 (9%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQII----RSHQDLTDD 84
           E+ LLR + H NI+   D I      T   +YIV E  +  DL  +I    +  Q L ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 85  HCRYFLYQLLRGLKYVH-----SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETD 138
                + QL   LK  H        VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           F   +V T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 172 FAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 137
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 198 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 247
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 248 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 282

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 135/284 (47%), Gaps = 52/284 (18%)
Query: 1   MNSETREEVAIKKIGNA-FDNR--IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +N ET ++ A+K +  A F +   +  +   RE  +   + H +I+ +         ET+
Sbjct: 44  INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL--------LETY 95
Query: 58  ND---VYIVYELMD-TDLHQIIRSHQDL----TDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           +    +Y+V+E MD  DL   I    D     ++    +++ Q+L  L+Y H  N++HRD
Sbjct: 96  SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRD 155
Query: 110 LKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEY-VVTRWYRAPELLLNCSEYTAAI 165
           +KP N+LL +   +  +K+GDFG+A    E+  +    V T  + APE++     Y   +
Sbjct: 156 VKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPV 214
Query: 166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           D+W  G IL  +++    F    Y  + RL   +I                +   +M P+
Sbjct: 215 DVWGCGVILFILLSGCLPF----YGTKERLFEGII----------------KGKYKMNPR 254
Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   ++ + S  A DL+ +ML+ DP  RITV EAL HP+L
Sbjct: 255 --------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 112/246 (45%), Gaps = 40/246 (16%)
Query: 33  LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCRYFL 90
           LLR+  H NII +KD+      +    VY+V ELM     L +I+R  +  ++    + L
Sbjct: 74  LLRYGQHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVL 127
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLL-----NANCDLKIGDFGLARTT-SETDFMTEYV 144
           + + + ++Y+HS  V+HRDLKPSN+L      N  C L+I DFG A+   +E   +    
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPC 186
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  + APE+L     Y    DIWS+G +L  ++                  T     P 
Sbjct: 187 YTANFVAPEVLKR-QGYDEGCDIWSLGILLYTMLAG---------------YTPFANGPS 230
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           +T    L    + ++               +   S  A DL+ KML  DP++R+T  + L
Sbjct: 231 DTPEEILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVL 281
Query: 265 CHPYLA 270
            HP++ 
Sbjct: 282 QHPWVT 287

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 112/246 (45%), Gaps = 40/246 (16%)
Query: 33  LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCRYFL 90
           LLR+  H NII +KD+      +    VY+V ELM     L +I+R  +  ++    + L
Sbjct: 74  LLRYGQHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVL 127
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLL-----NANCDLKIGDFGLARTT-SETDFMTEYV 144
           + + + ++Y+HS  V+HRDLKPSN+L      N  C L+I DFG A+   +E   +    
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPC 186
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  + APE+L     Y    DIWS+G +L  ++                  T     P 
Sbjct: 187 YTANFVAPEVLKR-QGYDEGCDIWSLGILLYTMLAG---------------YTPFANGPS 230
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           +T    L    + ++               +   S  A DL+ KML  DP++R+T  + L
Sbjct: 231 DTPEEILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVL 281
Query: 265 CHPYLA 270
            HP++ 
Sbjct: 282 QHPWVT 287

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 133
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 134 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 194 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 243
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 244 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 278

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 134
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 195 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 244
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 245 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 279

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 47/268 (17%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++V E 
Sbjct: 59  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 109
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++      I +H  + ++        +L+ L  +H+  V+HRD+K  ++LL  +  +K+ 
Sbjct: 110 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 169
Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  +P + 
Sbjct: 170 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 228
Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---KSPGA 242
            +  +  +++I                               + N   R  N    SP  
Sbjct: 229 NEPPLKAMKMI-------------------------------RDNLPPRLKNLHKVSPSL 257
Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYLA 270
              L+++LV DP +R T  E L HP+LA
Sbjct: 258 KGFLDRLLVRDPAQRATAAELLKHPFLA 285

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 134
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 195 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 244
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 245 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 279

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 106/193 (54%), Gaps = 29/193 (15%)
Query: 9   VAIKKIGNAFDNRIDAKR---TLREIKLLRHMDHENIIA-----IKDIIRPPQRETFNDV 60
           VA+KK+   FD  +DAK     ++EI LL+ ++H N+I      I+D          N++
Sbjct: 60  VALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----------NEL 107
Query: 61  YIVYELMDT-DLHQIIR---SHQDLTDDHC--RYFLYQLLRGLKYVHSANVLHRDLKPSN 114
            IV EL D  DL ++I+     + L  +    +YF+ QL   L+++HS  V+HRD+KP+N
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV-QLCSALEHMHSRRVMHRDIKPAN 166
Query: 115 LLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           + + A   +K+GD GL R  +S+T      V T +Y +PE +   + Y    DIWS+GC+
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCL 225
Query: 174 LGEIMTRQPLFPG 186
           L E+   Q  F G
Sbjct: 226 LYEMAALQSPFYG 238

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 58  NDVYIVYELMDTDL----HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKP 112
            DV+I  ELMDT L     Q+I   Q + +D        +++ L+++HS  +V+HRD+KP
Sbjct: 123 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 182
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCSEYTAAIDIWS 169
           SN+L+NA   +K+ DFG++    ++   T     + Y APE +   LN   Y+   DIWS
Sbjct: 183 SNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G  + E+   +  FP   +    + + +++  P                    PQ P  
Sbjct: 243 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 281
Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
            FSA F       VD   + L  +   R T  E + HP+   LH+
Sbjct: 282 KFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFFT-LHE 318

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 134
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 195 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 244
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 245 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 279

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 136
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 197 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 246
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 247 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 281

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 136
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 197 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 246
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 247 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 281

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 137
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 198 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 247
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 248 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 282

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 134
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 195 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 244
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 245 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 279

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 113
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 114 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 174 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 223
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 224 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 133
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 134 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 194 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 243
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 244 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 278

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 47/268 (17%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++V E 
Sbjct: 57  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 107
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++      I +H  + ++        +L+ L  +H+  V+HRD+K  ++LL  +  +K+ 
Sbjct: 108 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 167
Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  +P + 
Sbjct: 168 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 226
Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---KSPGA 242
            +  +  +++I                               + N   R  N    SP  
Sbjct: 227 NEPPLKAMKMI-------------------------------RDNLPPRLKNLHKVSPSL 255
Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYLA 270
              L+++LV DP +R T  E L HP+LA
Sbjct: 256 KGFLDRLLVRDPAQRATAAELLKHPFLA 283

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 114
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 115 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 175 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 224
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 225 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 259

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 112
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 173 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 222
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 223 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 257

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 86  RERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 141
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 142 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 202 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 251
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 252 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 286

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 38/244 (15%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 88
           EI +L+ + HENI+ ++DI      E+    Y+V +L+   +L   I      T+     
Sbjct: 56  EIAVLKKIKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL 110
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVV 145
            + Q+L  +KY+H   ++HRDLKP NLL      N  + I DFGL++   +   M+    
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACG 169
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 205
           T  Y APE+L     Y+ A+D WS+G I   ++   P F  +        I E       
Sbjct: 170 TPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE------- 221
Query: 206 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 265
              G+   +                 S  + + S  A D +  +L  DPN R T ++AL 
Sbjct: 222 ---GYYEFE-----------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261
Query: 266 HPYL 269
           HP++
Sbjct: 262 HPWI 265

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 63  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 118
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 119 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 179 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 228
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 229 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 263

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 111
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 112 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 172 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 221
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 222 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 256

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 136
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 197 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 246
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 247 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 281

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 47/268 (17%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++V E 
Sbjct: 48  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 98
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++      I +H  + ++        +L+ L  +H+  V+HRD+K  ++LL  +  +K+ 
Sbjct: 99  LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158
Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  +P + 
Sbjct: 159 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 217
Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---KSPGA 242
            +  +  +++I                               + N   R  N    SP  
Sbjct: 218 NEPPLKAMKMI-------------------------------RDNLPPRLKNLHKVSPSL 246
Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYLA 270
              L+++LV DP +R T  E L HP+LA
Sbjct: 247 KGFLDRLLVRDPAQRATAAELLKHPFLA 274

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 47/268 (17%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D R   +R L   E+ ++R   HEN++ + +          +++++V E 
Sbjct: 52  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 102
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           ++      I +H  + ++        +L+ L  +H+  V+HRD+K  ++LL  +  +K+ 
Sbjct: 103 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 162
Query: 127 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  +P + 
Sbjct: 163 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 221
Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN---KSPGA 242
            +  +  +++I                               + N   R  N    SP  
Sbjct: 222 NEPPLKAMKMI-------------------------------RDNLPPRLKNLHKVSPSL 250
Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYLA 270
              L+++LV DP +R T  E L HP+LA
Sbjct: 251 KGFLDRLLVRDPAQRATAAELLKHPFLA 278

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 133/290 (45%), Gaps = 45/290 (15%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           T ++VA+KK+    D R   +R L   E+ ++R   H+N++ +            +++++
Sbjct: 69  TGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYHHDNVVDMYS-----SYLVGDELWV 119
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           V E ++      I +H  + ++        +LR L Y+H+  V+HRD+K  ++LL ++  
Sbjct: 120 VMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 179
Query: 123 LKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +K+ DFG  A+ + E       V T ++ APE++     Y   +DIWS+G ++ E++  +
Sbjct: 180 IKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGE 238
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           P +  +  +  +R I +                        LP  P+     +  +   G
Sbjct: 239 PPYFNEPPLQAMRRIRD-----------------------SLP--PRVKDLHKVSSVLRG 273
Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEH 291
            +DL   MLV +P++R T  E L HP+L     +   P C  P    + H
Sbjct: 274 FLDL---MLVREPSQRATAQELLGHPFL----KLAGPPSCIVPLMRQYRH 316

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 122/274 (44%), Gaps = 48/274 (17%)
Query: 5   TREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           T+E VA+K I  G A D  +      REI   R + H NI+  K++I  P       + I
Sbjct: 44  TKELVAVKYIERGAAIDENVQ-----REIINHRSLRHPNIVRFKEVILTPTH-----LAI 93
Query: 63  VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           + E     +L++ I +    ++D  R+F  QLL G+ Y HS  + HRDLK  N LL+ + 
Sbjct: 94  IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP 153
Query: 122 D--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI-DIWSVGCILGEIM 178
              LKI DFG ++++         V T  Y APE+LL   EY   I D+WS G  L    
Sbjct: 154 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTL---- 208
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
                     YV        L+G     +  F   +  R Y + + +     +S   P+ 
Sbjct: 209 ----------YVM-------LVG-----AYPFEDPEEPRDYRKTIQRILSVKYS--IPDD 244
Query: 239 ---SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              SP    L+ ++ V DP  RI++ E   H + 
Sbjct: 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 16/190 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           ++E   +  IK+I  +  +  + + + RE+ +L +M H NI+          RE+F +  
Sbjct: 45  STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY--------RESFEENG 96
Query: 62  IVYELMD----TDLHQIIRSHQDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
            +Y +MD     DL + I + + +   +D    +  Q+   LK+VH   +LHRD+K  N+
Sbjct: 97  SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156
Query: 116 LLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
            L  +  +++GDFG+AR  + T +     + T +Y +PE+  N   Y    DIW++GC+L
Sbjct: 157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVL 215
Query: 175 GEIMTRQPLF 184
            E+ T +  F
Sbjct: 216 YELCTLKHAF 225

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 139
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 140 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 200 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 249
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP   F        P A DL+EK+LV D  +R+  +E
Sbjct: 250 ---------------IKLEYDFPAAFF--------PKARDLVEKLLVLDATKRLGCEE 284

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 112/238 (47%), Gaps = 41/238 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      +  L + IR      +   R+
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGCLLKYIRKIGSFDETCTRF 136
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPD 204
           T  Y +PELL   S  + + D+W++GCI+ +++   P F  G +Y     LI + I    
Sbjct: 197 TAQYVSPELLTEKSA-SKSSDLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKI---- 246
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                          +++   FP++ F        P A DL+EK+LV D  +R+  +E
Sbjct: 247 ---------------IKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCEE 281

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 87/172 (50%), Gaps = 7/172 (4%)
Query: 5   TREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           T  +VA+K +       +D   +  REI+ L+   H +II +  +I  P      D ++V
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----TDFFMV 89
Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   +L   I  H  + +   R    Q+L  + Y H   V+HRDLKP N+LL+A+ +
Sbjct: 90  MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN 149
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
            KI DFGL+   S+ +F+ +   +  Y APE++         +DIWS G IL
Sbjct: 150 AKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 37/219 (16%)
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLL-LNANCDL------------------KIGD 127
           R+  +QL + +K++H   + H DLKP N+L +N++ +L                  ++ D
Sbjct: 140 RHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVD 199
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FG A  T + +  +  V TR YRAPE++L    ++   D+WS+GCI+ E      LF   
Sbjct: 200 FGSA--TFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTH 256
Query: 188 DYVHQLRLITELIGS-PDET-------------SLGFLRSDNARRYVRMLPQFPKQNFSA 233
           D    L ++  ++G  P                 L +  + +A RYVR   + P + +  
Sbjct: 257 DNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLT 315
Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 272
               +     DL+E ML ++P +R+T+ EAL HP+ A L
Sbjct: 316 SEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARL 354

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 110/241 (45%), Gaps = 47/241 (19%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 136
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 205
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F                     
Sbjct: 197 TAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPF--------------------- 234
Query: 206 TSLGFLRSDNA----RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 261
                 R+ N      + +++   FP++ F        P A DL+EK+LV D  +R+  +
Sbjct: 235 ------RAGNEGLIFAKIIKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCE 280
Query: 262 E 262
           E
Sbjct: 281 E 281

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 7/172 (4%)
Query: 5   TREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           T  +VA+K +       +D   +  REI+ L+   H +II +  +I  P      D ++V
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----TDFFMV 89
Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   +L   I  H  + +   R    Q+L  + Y H   V+HRDLKP N+LL+A+ +
Sbjct: 90  MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN 149
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
            KI DFGL+   S+ +F+     +  Y APE++         +DIWS G IL
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 110/241 (45%), Gaps = 47/241 (19%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           RE  ++  +DH   + +    +  ++  F   Y      + +L + IR      +   R+
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRF 136
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVV 145
           +  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+      +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 205
           T  Y +PELL   S   ++ D+W++GCI+ +++   P F                     
Sbjct: 197 TAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF--------------------- 234
Query: 206 TSLGFLRSDNA----RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 261
                 R+ N      + +++   FP++ F        P A DL+EK+LV D  +R+  +
Sbjct: 235 ------RAGNEGLIFAKIIKLEYDFPEKFF--------PKARDLVEKLLVLDATKRLGCE 280
Query: 262 E 262
           E
Sbjct: 281 E 281

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 61  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +N +LKI DFG +   + +   T   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLC 171
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE ++    +   +D+WS+G +  E +   P F    Y               
Sbjct: 172 GTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY--------------- 215
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  RR  R+   FP  +F       + GA DL+ ++L  + ++R+T+ E L
Sbjct: 216 --------QETYRRISRVEFTFP--DFV------TEGARDLISRLLKHNASQRLTLAEVL 259
Query: 265 CHPYL 269
            HP++
Sbjct: 260 EHPWI 264

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 117/248 (47%), Gaps = 46/248 (18%)
Query: 33  LLRHMDHENIIAIKDIIRPPQRETFND---VYIVYELMDTD--LHQIIRSHQDLTDDHCR 87
           LLR+  H NII +KD+        ++D   VY+V EL      L +I+R  +  ++    
Sbjct: 69  LLRYGQHPNIITLKDV--------YDDGKYVYVVTELXKGGELLDKILR-QKFFSEREAS 119
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCD-LKIGDFGLARTT-SETDFMTE 142
             L+ + + ++Y+H+  V+HRDLKPSN+L    + N + ++I DFG A+   +E   +  
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 202
              T  + APE+L     Y AA DIWS+G +L   +T                 T     
Sbjct: 180 PCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTXLTG---------------YTPFANG 223
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVD 261
           PD+T    L    + ++          + S  + N  S  A DL+ K L  DP++R+T  
Sbjct: 224 PDDTPEEILARIGSGKF----------SLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAA 273
Query: 262 EALCHPYL 269
             L HP++
Sbjct: 274 LVLRHPWI 281

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 118/276 (42%), Gaps = 48/276 (17%)
Query: 9   VAIKKIGNAFDNRI-------DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           V  +  GN F  +        D +   +EI+ +  + H  ++ + D       E  N++ 
Sbjct: 70  VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 124
Query: 62  IVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++YE M       ++   H  +++D    ++ Q+ +GL ++H  N +H DLKP N++   
Sbjct: 125 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 184
Query: 120 --NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILG 175
             + +LK+ DFGL         +     T  + APE+        YT   D+WSVG +  
Sbjct: 185 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVGVLSY 241
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
            +++    F G++    LR +     + D+++   +  D                     
Sbjct: 242 ILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK------------------- 282
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                   D + K+L+ DPN R+T+ +AL HP+L P
Sbjct: 283 --------DFIRKLLLADPNTRMTIHQALEHPWLTP 310

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 118/276 (42%), Gaps = 48/276 (17%)
Query: 9   VAIKKIGNAFDNRI-------DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           V  +  GN F  +        D +   +EI+ +  + H  ++ + D       E  N++ 
Sbjct: 176 VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230
Query: 62  IVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++YE M       ++   H  +++D    ++ Q+ +GL ++H  N +H DLKP N++   
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 120 --NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILG 175
             + +LK+ DFGL         +     T  + APE+        YT   D+WSVG +  
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVGVLSY 347
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
            +++    F G++    LR +     + D+++   +  D                     
Sbjct: 348 ILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK------------------- 388
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                   D + K+L+ DPN R+T+ +AL HP+L P
Sbjct: 389 --------DFIRKLLLADPNTRMTIHQALEHPWLTP 416

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   TE  
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELC 167
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 212 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 255
Query: 265 CHPYL 269
            HP++
Sbjct: 256 EHPWI 260

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 132/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 37  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 81
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +TE   T +Y APE +L   +Y  + D+
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDM 200
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 201 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 241 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 133/284 (46%), Gaps = 52/284 (18%)
Query: 1   MNSETREEVAIKKIGNA-FDNR--IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +N ET ++ A+K +  A F +   +  +   RE  +   + H +I+ +         ET+
Sbjct: 46  INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL--------LETY 97
Query: 58  ND---VYIVYELMD-TDLHQIIRSHQDL----TDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           +    +Y+V+E MD  DL   I    D     ++    +++ Q+L  L+Y H  N++HRD
Sbjct: 98  SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRD 157
Query: 110 LKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEY-VVTRWYRAPELLLNCSEYTAAI 165
           +KP  +LL +   +  +K+G FG+A    E+  +    V T  + APE++     Y   +
Sbjct: 158 VKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPV 216
Query: 166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           D+W  G IL  +++    F    Y  + RL   +I                +   +M P+
Sbjct: 217 DVWGCGVILFILLSGCLPF----YGTKERLFEGII----------------KGKYKMNPR 256
Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   ++ + S  A DL+ +ML+ DP  RITV EAL HP+L
Sbjct: 257 --------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 58  NDVYIVYELMDTDL----HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKP 112
            DV+I  ELMDT L     Q+I   Q + +D        +++ L+++HS  +V+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCSEYTAAIDIWS 169
           SN+L+NA   +K+ DFG++    +          + Y APE +   LN   Y+   DIWS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G  + E+   +  FP   +    + + +++  P                    PQ P  
Sbjct: 199 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 237
Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
            FSA F       VD   + L  +   R T  E + HP+   LH+
Sbjct: 238 KFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFFT-LHE 274

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 41/266 (15%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 88
           +EI+LLR + H+N+I + D++     E    +Y+V E     + +++ S  +     C+ 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVL---YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA 111
Query: 89  FLY--QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT---SETDFMTEY 143
             Y  QL+ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D     
Sbjct: 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 144 VVTRWYRAPELLLNCSEYTA-AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 202
             +  ++ PE+      ++   +DIWS G  L  I T    F G D +++L         
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKL--------- 221
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                      +N  +    +P            +  P   DLL+ ML ++P +R ++ +
Sbjct: 222 ----------FENIGKGSYAIPG-----------DCGPPLSDLLKGMLEYEPAKRFSIRQ 260
Query: 263 ALCHPYLAPLHDINEEPVCPRPFSFD 288
              H +    H   E PV P P S D
Sbjct: 261 IRQHSWFRKKHPPAEAPV-PIPPSPD 285

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 133/284 (46%), Gaps = 52/284 (18%)
Query: 1   MNSETREEVAIKKIGNA-FDNR--IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +N ET ++ A+K +  A F +   +  +   RE  +   + H +I+ +         ET+
Sbjct: 44  INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL--------LETY 95
Query: 58  ND---VYIVYELMD-TDLHQIIRSHQDL----TDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           +    +Y+V+E MD  DL   I    D     ++    +++ Q+L  L+Y H  N++HRD
Sbjct: 96  SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRD 155
Query: 110 LKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEY-VVTRWYRAPELLLNCSEYTAAI 165
           +KP  +LL +   +  +K+G FG+A    E+  +    V T  + APE++     Y   +
Sbjct: 156 VKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPV 214
Query: 166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           D+W  G IL  +++    F    Y  + RL   +I                +   +M P+
Sbjct: 215 DVWGCGVILFILLSGCLPF----YGTKERLFEGII----------------KGKYKMNPR 254
Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   ++ + S  A DL+ +ML+ DP  RITV EAL HP+L
Sbjct: 255 --------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 112/247 (45%), Gaps = 49/247 (19%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 61  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA--RTTSETDFMTE 142
               ++ +L   L Y HS  V+HRD+KP NLLL +N +LKI DFG +    +S  D +  
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCG 172
Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 202
              T  Y  PE ++    +   +D+WS+G +  E +   P F    Y             
Sbjct: 173 ---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY------------- 215
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                      +  RR  R+   FP  +F       + GA DL+ ++L  + ++R+T+ E
Sbjct: 216 ----------QETYRRISRVEFTFP--DFV------TEGARDLISRLLKHNASQRLTLAE 257
Query: 263 ALCHPYL 269
            L HP++
Sbjct: 258 VLEHPWI 264

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 83  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 134
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 135 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 193
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+       
Sbjct: 194 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------- 245
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                        R     P F  +           GA DL+ ++L  +P++R  + E L
Sbjct: 246 -------------RVEFTFPDFVTE-----------GARDLISRLLKHNPSQRPMLREVL 281
Query: 265 CHPYL 269
            HP++
Sbjct: 282 EHPWI 286

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 115/269 (42%), Gaps = 40/269 (14%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           TR   A KKI   F   +D  R  +EI++++ +DH NII + +       E   D+Y+V 
Sbjct: 33  TRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIYLVM 85
Query: 65  EL-MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NAN 120
           EL    +L + +   +   +      +  +L  + Y H  NV HRDLKP N L    + +
Sbjct: 86  ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             LK+ DFGLA        M   V T +Y +P++L     Y    D WS G ++  ++  
Sbjct: 146 SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCG 203
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
            P F        +  I E   +                       FP++++     N SP
Sbjct: 204 YPPFSAPTDXEVMLKIREGTFT-----------------------FPEKDWL----NVSP 236
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            A  L+ ++L   P +RIT  +AL H + 
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWF 265

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 115/269 (42%), Gaps = 40/269 (14%)
Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
           TR   A KKI   F   +D  R  +EI++++ +DH NII + +       E   D+Y+V 
Sbjct: 50  TRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIYLVM 102
Query: 65  EL-MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NAN 120
           EL    +L + +   +   +      +  +L  + Y H  NV HRDLKP N L    + +
Sbjct: 103 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 162
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
             LK+ DFGLA        M   V T +Y +P++L     Y    D WS G ++  ++  
Sbjct: 163 SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCG 220
Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
            P F        +  I E   +                       FP++++     N SP
Sbjct: 221 YPPFSAPTDXEVMLKIREGTFT-----------------------FPEKDWL----NVSP 253
Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            A  L+ ++L   P +RIT  +AL H + 
Sbjct: 254 QAESLIRRLLTKSPKQRITSLQALEHEWF 282

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 5   TREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           T  EVAIK I   A       +R   E+K+   + H +I+ + +       E  N VY+V
Sbjct: 35  TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSNYVYLV 89
Query: 64  YELM-DTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
            E+  + ++++ +++  +  +++  R+F++Q++ G+ Y+HS  +LHRDL  SNLLL  N 
Sbjct: 90  LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM 149
Query: 122 DLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           ++KI DFGLA T  +      Y +  T  Y +PE+    S +    D+WS+GC+   ++ 
Sbjct: 150 NIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLI 207
Query: 180 RQPLF 184
            +P F
Sbjct: 208 GRPPF 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 11/194 (5%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ +T E+VAIK+       + + +R   EI++++ ++H N+++ +++    Q+   ND+
Sbjct: 34  IHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92
Query: 61  -YIVYELMDT-DLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             +  E  +  DL + +   ++   L +   R  L  +   L+Y+H   ++HRDLKP N+
Sbjct: 93  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152
Query: 116 LLNANCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           +L         KI D G A+   + +  TE+V T  Y APELL    +YT  +D WS G 
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGT 211
Query: 173 ILGEIMTR-QPLFP 185
           +  E +T  +P  P
Sbjct: 212 LAFECITGFRPFLP 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 11/194 (5%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ +T E+VAIK+       + + +R   EI++++ ++H N+++ +++    Q+   ND+
Sbjct: 35  IHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 93
Query: 61  -YIVYELMDT-DLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             +  E  +  DL + +   ++   L +   R  L  +   L+Y+H   ++HRDLKP N+
Sbjct: 94  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 153
Query: 116 LLNANCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           +L         KI D G A+   + +  TE+V T  Y APELL    +YT  +D WS G 
Sbjct: 154 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGT 212
Query: 173 ILGEIMTR-QPLFP 185
           +  E +T  +P  P
Sbjct: 213 LAFECITGFRPFLP 226

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 58  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 109
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T+  
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 168
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 169 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 212
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 213 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 256
Query: 265 CHPYL 269
            HP++
Sbjct: 257 EHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 111/246 (45%), Gaps = 45/246 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T+  
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 167
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 212 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 255
Query: 265 CHPYLA 270
            HP++ 
Sbjct: 256 EHPWIT 261

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 44  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 88
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 89  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 148
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 207
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 208 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 247
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 248 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 74  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 125
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 126 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 184
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 185 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 228
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 229 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 272
Query: 265 CHPYL 269
            HP++
Sbjct: 273 EHPWI 277

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 113
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T+  
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 172
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 173 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 216
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 217 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 260
Query: 265 CHPYL 269
            HP++
Sbjct: 261 EHPWI 265

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 43  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 87
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 88  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 147
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 206
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 207 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 246
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 247 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 296

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T+  
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 167
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 212 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 255
Query: 265 CHPYL 269
            HP++
Sbjct: 256 EHPWI 260

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 53  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 97
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 98  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 157
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 216
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 217 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 256
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 257 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 45/274 (16%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ++ ET + VAIK++        D +  ++EI +++  D  +++               D+
Sbjct: 49  IHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVVKYYG-----SYFKNTDL 99
Query: 61  YIVYELMDT-DLHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +IV E      +  IIR  ++ LT+D     L   L+GL+Y+H    +HRD+K  N+LLN
Sbjct: 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN 159
Query: 119 ANCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
                K+ DFG+A     TD M +    + T ++ APE++     Y    DIWS+G    
Sbjct: 160 TEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAI 216
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E+   +P  P  D +H +R I  +  +P  T   F +           P+    NF+   
Sbjct: 217 EMAEGKP--PYAD-IHPMRAIFMIPTNPPPT---FRK-----------PELWSDNFT--- 256
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   D +++ LV  P +R T  + L HP++
Sbjct: 257 --------DFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 45  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 89
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 90  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 149
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 208
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 209 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 248
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 249 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 298

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 170
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 214
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 215 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 258
Query: 265 CHPYL 269
            HP++
Sbjct: 259 EHPWI 263

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 167
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 212 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 255
Query: 265 CHPYL 269
            HP++
Sbjct: 256 EHPWI 260

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 38  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 82
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 83  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 142
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 201
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 202 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 241
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 242 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 113
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 172
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 173 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 216
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 217 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 260
Query: 265 CHPYL 269
            HP++
Sbjct: 261 EHPWI 265

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 37  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 81
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 200
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 201 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 241 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 39  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 83
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 202
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 203 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 243 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 113/225 (50%), Gaps = 15/225 (6%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
            S+ R+  A+K +  A     D  RT  E  +L  ++H  I+ +         +T   +Y
Sbjct: 48  GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTEGKLY 102
Query: 62  IVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ + +   DL   +      T++  +++L +L   L ++HS  +++RDLKP N+LL+  
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162
Query: 121 CDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFGL++ + + +     +  T  Y APE ++N   +T + D WS G ++ E++T
Sbjct: 163 GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 180 RQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRML 223
               F GKD    + +I +  +G P      FL S  A+  +RML
Sbjct: 222 GTLPFQGKDRKETMTMILKAKLGMPQ-----FL-SPEAQSLLRML 260

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 29/198 (14%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-------REIKLLRHMDHENIIAIKDIIRPPQ 53
           +N  T E VA+K +        D KR +       +EI + + ++HEN++          
Sbjct: 27  VNRVTEEAVAVKIV--------DMKRAVDCPENIKKEIXINKMLNHENVVKFYG-----H 73
Query: 54  RETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           R   N  Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 113 SNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
            NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 170 VGCIL-----GEIMTRQP 182
            G +L     GE+   QP
Sbjct: 194 CGIVLTAMLAGELPWDQP 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 170
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 214
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 215 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 258
Query: 265 CHPYL 269
            HP++
Sbjct: 259 EHPWI 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQP 182
               GE+   QP
Sbjct: 199 AMLAGELPWDQP 210

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 83  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 127
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 246
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 247 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 286
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 287 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 29/198 (14%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-------REIKLLRHMDHENIIAIKDIIRPPQ 53
           +N  T E VA+K +        D KR +       +EI + + ++HEN++          
Sbjct: 26  VNRVTEEAVAVKIV--------DMKRAVDCPENIKKEIXINKMLNHENVVKFYG-----H 72
Query: 54  RETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           R   N  Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 113 SNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
            NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 170 VGCIL-----GEIMTRQP 182
            G +L     GE+   QP
Sbjct: 193 CGIVLTAMLAGELPWDQP 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 56  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 107
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 108 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 166
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 167 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 210
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 211 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 254
Query: 265 CHPYL 269
            HP++
Sbjct: 255 EHPWI 259

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 61  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 112
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 171
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 172 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 215
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 216 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 259
Query: 265 CHPYL 269
            HP++
Sbjct: 260 EHPWI 264

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLC 167
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 212 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 255
Query: 265 CHPYL 269
            HP++
Sbjct: 256 EHPWI 260

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 39  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 83
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 202
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 203 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 243 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 83  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 134
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +    +  
Sbjct: 135 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLC 193
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+       
Sbjct: 194 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------- 245
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                        R     P F  +           GA DL+ ++L  +P++R  + E L
Sbjct: 246 -------------RVEFTFPDFVTE-----------GARDLISRLLKHNPSQRPMLREVL 281
Query: 265 CHPYL 269
            HP++
Sbjct: 282 EHPWI 286

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 113
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 172
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE +     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 173 GTLDYLPPEXI-EGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 216
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 217 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPXLREVL 260
Query: 265 CHPYL 269
            HP++
Sbjct: 261 EHPWI 265

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 89  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 133
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 134 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 193
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDM 252
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 253 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 292
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 293 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 342

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 58  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 109
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLS 168
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 169 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 212
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 213 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 256
Query: 265 CHPYL 269
            HP++
Sbjct: 257 EHPWI 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 54  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 105
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T   
Sbjct: 106 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 164
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 165 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 208
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 209 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 252
Query: 265 CHPYL 269
            HP++
Sbjct: 253 EHPWI 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT---DDH 85
           RE+++  H+ H NI+ +        R     VY++ E     L  + R  Q L+   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTR-----VYLILEY--APLGTVYRELQKLSKFDEQR 109
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV 145
              ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +        
Sbjct: 110 TATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCG 168
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 205
           T  Y  PE++     +   +D+WS+G +  E +  +P F    Y                
Sbjct: 169 TLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------------- 211
Query: 206 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 265
                   D  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L 
Sbjct: 212 -------QDTYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVLE 256
Query: 266 HPYL 269
           HP++
Sbjct: 257 HPWI 260

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 27  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 79
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 80  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 175 ----GEIMTRQP 182
               GE+   QP
Sbjct: 200 AMLAGELPWDQP 211

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 29/198 (14%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-------REIKLLRHMDHENIIAIKDIIRPPQ 53
           +N  T E VA+K +        D KR +       +EI + + ++HEN++          
Sbjct: 26  VNRVTEEAVAVKIV--------DMKRAVDCPENIKKEICINKMLNHENVVKFYG-----H 72
Query: 54  RETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           R   N  Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 113 SNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
            NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 170 VGCIL-----GEIMTRQP 182
            G +L     GE+   QP
Sbjct: 193 CGIVLTAMLAGELPWDQP 210

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 120/274 (43%), Gaps = 42/274 (15%)
Query: 2   NSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           + +  E VA+K I  G   D  +      REI   R + H NI+  K++I  P       
Sbjct: 40  DKQANELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTPTH----- 89
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           + IV E     +L + I +    ++D  R+F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 90  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLD 149
Query: 119 ANCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI-DIWSVGCILG 175
            +    LKI DFG ++ +         V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 150 GSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 208
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
            ++     +P +D              P+E         N R+ +  +     Q     +
Sbjct: 209 VMLVGA--YPFED--------------PEEPK-------NFRKTIHRILNV--QYAIPDY 243
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            + SP    L+ ++ V DP +RI++ E   H + 
Sbjct: 244 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 34/208 (16%)
Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T  +++ V E ++  DL   I+S          ++  +++ GL+++HS  +++RDLK  
Sbjct: 89  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 148
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+ +  +KI DFG+ +     D  T E+  T  Y APE+LL   +Y  ++D WS G 
Sbjct: 149 NILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFGV 207
Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +L E++  Q  F G+D               +E     +R DN        P +P     
Sbjct: 208 LLYEMLIGQSPFHGQD---------------EEELFHSIRMDN--------PFYP----- 239
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITV 260
            R+  K   A DLL K+ V +P +R+ V
Sbjct: 240 -RWLEKE--AKDLLVKLFVREPEKRLGV 264

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH---C 86
           EI L +H+ H+NI+     +       F  +++  ++    L  ++RS      D+    
Sbjct: 69  EIALHKHLKHKNIV---QYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTE-YV 144
            ++  Q+L GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  TE + 
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184
Query: 145 VTRWYRAPELL-LNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            T  Y APE++      Y  A DIWS+GC + E+ T +P F
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 27  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 79
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 80  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 200 AMLAGELPWDQPSDSCQEY 218

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 27  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 79
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 80  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 200 AMLAGELPWDQPSDSCQEY 218

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 27  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 79
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 80  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 200 AMLAGELPWDQPSDSCQEY 218

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH---C 86
           EI L +H+ H+NI+     +       F  +++  ++    L  ++RS      D+    
Sbjct: 55  EIALHKHLKHKNIV---QYLGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTI 110
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTE-YV 144
            ++  Q+L GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  TE + 
Sbjct: 111 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 170
Query: 145 VTRWYRAPELL-LNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            T  Y APE++      Y  A DIWS+GC + E+ T +P F
Sbjct: 171 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 113/225 (50%), Gaps = 15/225 (6%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
            S+ R+  A+K +  A     D  RT  E  +L  ++H  I+ +         +T   +Y
Sbjct: 49  GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTEGKLY 103
Query: 62  IVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ + +   DL   +      T++  +++L +L   L ++HS  +++RDLKP N+LL+  
Sbjct: 104 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 163
Query: 121 CDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFGL++ + + +     +  T  Y APE ++N   +T + D WS G ++ E++T
Sbjct: 164 GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLT 222
Query: 180 RQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRML 223
               F GKD    + +I +  +G P      FL S  A+  +RML
Sbjct: 223 GTLPFQGKDRKETMTMILKAKLGMPQ-----FL-SPEAQSLLRML 261

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 113/225 (50%), Gaps = 15/225 (6%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
            S+ R+  A+K +  A     D  RT  E  +L  ++H  I+ +         +T   +Y
Sbjct: 48  GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTEGKLY 102
Query: 62  IVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ + +   DL   +      T++  +++L +L   L ++HS  +++RDLKP N+LL+  
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162
Query: 121 CDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFGL++ + + +     +  T  Y APE ++N   +T + D WS G ++ E++T
Sbjct: 163 GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 180 RQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRML 223
               F GKD    + +I +  +G P      FL S  A+  +RML
Sbjct: 222 GTLPFQGKDRKETMTMILKAKLGMPQ-----FL-SPEAQSLLRML 260

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 199 AMLAGELPWDQPSDSCQEY 217

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 27  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 79
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 80  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 200 AMLAGELPWDQPSDSCQEY 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-------REIKLLRHMDHENIIAIKDIIRPPQ 53
           +N  T E VA+K +        D KR +       +EI + + ++HEN++          
Sbjct: 26  VNRVTEEAVAVKIV--------DMKRAVDCPENIKKEICINKMLNHENVVKFYG-----H 72
Query: 54  RETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           R   N  Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 113 SNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
            NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 170 VGCIL-----GEIMTRQPLFPGKDY 189
            G +L     GE+   QP    ++Y
Sbjct: 193 CGIVLTAMLAGELPWDQPSDSXQEY 217

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 199 AMLAGELPWDQPSDSCQEY 217

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 25  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 77
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 78  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 197
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 198 AMLAGELPWDQPSDSCQEY 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 122/274 (44%), Gaps = 42/274 (15%)
Query: 2   NSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           + ++ E VA+K I  G   D  +      REI   R + H NI+  K++I  P       
Sbjct: 39  DKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTPTH----- 88
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           + IV E     +L + I +    ++D  R+F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 89  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 148
Query: 119 ANCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI-DIWSVGCILG 175
            +    LKI DFG ++++         V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 149 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 207
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
            ++     +P +D              P+E         N R+ +  +     Q     +
Sbjct: 208 VMLVGA--YPFED--------------PEEPK-------NFRKTIHRILNV--QYAIPDY 242
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            + SP    L+ ++ V DP +RI++ E   H + 
Sbjct: 243 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 199 AMLAGELPWDQPSDSCQEY 217

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 108/242 (44%), Gaps = 39/242 (16%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+++  H+ H NI+ +        R     VY++ E     ++++ ++      +    
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTA 116
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
            ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +   T    T 
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTL 175
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 207
            Y  PE++     +   +D+WS+G +  E +  +P F    Y                  
Sbjct: 176 DYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------------ 216
Query: 208 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                 +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L HP
Sbjct: 217 -----QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVLEHP 263
Query: 268 YL 269
           ++
Sbjct: 264 WI 265

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 41/265 (15%)
Query: 8   EVAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           +VA+K +    D R   +R L   E+ ++R   H N++ +             +++++ E
Sbjct: 72  QVAVKMM----DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-----SYLVGEELWVLME 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
            +       I S   L ++        +L+ L Y+H+  V+HRD+K  ++LL  +  +K+
Sbjct: 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 126 GDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG  A+ + +       V T ++ APE +++ S Y   +DIWS+G ++ E++  +P +
Sbjct: 183 SDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
Query: 185 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 244
                V  ++ + +   SP                       PK   S +    SP   D
Sbjct: 242 FSDSPVQAMKRLRD---SPP----------------------PKLKNSHKV---SPVLRD 273
Query: 245 LLEKMLVFDPNRRITVDEALCHPYL 269
            LE+MLV DP  R T  E L HP+L
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFL 298

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 199 AMLAGELPWDQPSDSCQEY 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQP 182
               GE+   QP
Sbjct: 199 AMLAGELPWDQP 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 27  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 79
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 80  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 200 AMLAGELPWDQPSDSCQEY 218

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 199 AMLAGELPWDQPSDSCQEY 217

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 199 AMLAGELPWDQPSDSCQEY 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI + + ++HEN++          R   N 
Sbjct: 26  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNI 78
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 199 AMLAGELPWDQPSDSCQEY 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 59  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 110
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI +FG +   + +   T   
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLC 169
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 170 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 213
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 214 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 257
Query: 265 CHPYL 269
            HP++
Sbjct: 258 EHPWI 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 45/246 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI +FG +   + +   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLC 170
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 214
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 215 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 258
Query: 265 CHPYLA 270
            HP++ 
Sbjct: 259 EHPWIT 264

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 13/186 (6%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
            ++ R + AIK +    + +   +  LRE  L+R ++H N++A+  I+ PP  E    V 
Sbjct: 45  QAQNRIQCAIKSLSRITEMQ-QVEAFLREGLLMRGLNHPNVLALIGIMLPP--EGLPHVL 101
Query: 62  IVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           + Y +   DL Q IRS Q + T      F  Q+ RG++Y+     +HRDL   N +L+ +
Sbjct: 102 LPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES 160
Query: 121 CDLKIGDFGLARTTSETDFMT------EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
             +K+ DFGLAR   + ++ +        +  +W       L    +T   D+WS G +L
Sbjct: 161 FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES--LQTYRFTTKSDVWSFGVLL 218
Query: 175 GEIMTR 180
            E++TR
Sbjct: 219 WELLTR 224

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 37/252 (14%)
Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQD 80
           D +    EI ++  +DH N+I + D       E+ ND+ +V E +D      +II    +
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYN 183
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL-LNANC-DLKIGDFGLARTTSETD 138
           LT+     F+ Q+  G++++H   +LH DLKP N+L +N +   +KI DFGLAR     +
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
            +     T  + APE ++N    +   D+WSVG I   +++    F G +    L  I  
Sbjct: 244 KLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 199 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                ++                             F + S  A + + K+L+ + + RI
Sbjct: 303 CRWDLEDE---------------------------EFQDISEEAKEFISKLLIKEKSWRI 335
Query: 259 TVDEALCHPYLA 270
           +  EAL HP+L+
Sbjct: 336 SASEALKHPWLS 347

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +       
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALC 170
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 214
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 215 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 258
Query: 265 CHPYL 269
            HP++
Sbjct: 259 EHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +       
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALC 167
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 212 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 255
Query: 265 CHPYL 269
            HP++
Sbjct: 256 EHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 59  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 110
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +       
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLC 169
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 170 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 213
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 214 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 257
Query: 265 CHPYL 269
            HP++
Sbjct: 258 EHPWI 262

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +    +  
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLC 170
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 214
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 215 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 258
Query: 265 CHPYL 269
            HP++
Sbjct: 259 EHPWI 263

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 49/247 (19%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 58  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 109
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA--RTTSETDFMTE 142
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +    +S  D +  
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCG 169
Query: 143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 202
              T  Y  PE++     +   +D+WS+G +  E +  +P F    Y             
Sbjct: 170 ---TLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------- 212
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 262
                      +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E
Sbjct: 213 ----------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLRE 254
Query: 263 ALCHPYL 269
            L HP++
Sbjct: 255 VLEHPWI 261

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 31/184 (16%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDFMTEYVV 145
            + Q+L G+ Y+H  N++H DLKP N+LL++     D+KI DFG++R       + E + 
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 205
           T  Y APE +LN    T A D+W++G I   ++T    F G+                  
Sbjct: 196 TPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE------------------ 236
Query: 206 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 265
                   DN   Y+  + Q         F + S  A D ++ +LV +P +R T +  L 
Sbjct: 237 --------DNQETYLN-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
Query: 266 HPYL 269
           H +L
Sbjct: 288 HSWL 291

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 122/272 (44%), Gaps = 38/272 (13%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + ++ E VA+K I      +I A    REI   R + H NI+  K++I  P       + 
Sbjct: 40  DKQSNELVAVKYIERG--EKI-AANVKREIINHRSLRHPNIVRFKEVILTPTH-----LA 91
Query: 62  IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           IV E     +L + I +    ++D  R+F  QL+ G+ Y H+  V HRDLK  N LL+ +
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 151
Query: 121 CD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI-DIWSVGCILGEI 177
               LKI DFG ++++         V T  Y APE+LL   EY   + D+WS G  L  +
Sbjct: 152 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLYVM 210
Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +     +P +D              P+E         N R+ +  +     Q     + +
Sbjct: 211 LVGA--YPFED--------------PEEPK-------NFRKTIHRILNV--QYAIPDYVH 245
Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            SP    L+ ++ V DP +RI++ E   H + 
Sbjct: 246 ISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 39/242 (16%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           REI++  H+ H NI+ + +     +R     +Y++ E     +L++ ++ H    +    
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSA 118
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
            F+ +L   L Y H   V+HRD+KP NLL+    +LKI DFG +   + +        T 
Sbjct: 119 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTL 177
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 207
            Y  PE ++    +   +D+W  G +  E +   P F                 SP  T 
Sbjct: 178 DYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPF----------------DSPSHT- 219
Query: 208 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                 +  RR V +  +FP        P  S G+ DL+ K+L + P +R+ +   + HP
Sbjct: 220 ------ETHRRIVNVDLKFP--------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 265
Query: 268 YL 269
           ++
Sbjct: 266 WV 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 39/242 (16%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           REI++  H+ H NI+ + +     +R     +Y++ E     +L++ ++ H    +    
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
            F+ +L   L Y H   V+HRD+KP NLL+    +LKI DFG +   + +        T 
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTL 176
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 207
            Y  PE ++    +   +D+W  G +  E +   P F                 SP  T 
Sbjct: 177 DYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPF----------------DSPSHT- 218
Query: 208 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                 +  RR V +  +FP        P  S G+ DL+ K+L + P +R+ +   + HP
Sbjct: 219 ------ETHRRIVNVDLKFP--------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 268 YL 269
           ++
Sbjct: 265 WV 266

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +       
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLC 170
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 214
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 215 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 258
Query: 265 CHPYL 269
            HP++
Sbjct: 259 EHPWI 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 45/245 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT---DD 84
           RE+++  H+ H NI+ +           F+D   VY +++   L  + R  Q L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
               ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +       
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLC 167
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                    +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L
Sbjct: 212 --------QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVL 255
Query: 265 CHPYL 269
            HP++
Sbjct: 256 EHPWI 260

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLR-EIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +N  T E VA+K +       +D    ++ EI +   ++HEN++          R   N 
Sbjct: 27  VNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINAMLNHENVVKFYG-----HRREGNI 79
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            Y+  E     +L   I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 80  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 119 ANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL- 174
              +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 175 ----GEIMTRQPLFPGKDY 189
               GE+   QP    ++Y
Sbjct: 200 AMLAGELPWDQPSDSCQEY 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 34/208 (16%)
Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T  +++ V E ++  DL   I+S          ++  +++ GL+++HS  +++RDLK  
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+ +  +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G 
Sbjct: 148 NILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFGV 206
Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +L E++  Q  F G+D               +E     +R DN        P +P     
Sbjct: 207 LLYEMLIGQSPFHGQD---------------EEELFHSIRMDN--------PFYP----- 238
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITV 260
            R+  K   A DLL K+ V +P +R+ V
Sbjct: 239 -RWLEKE--AKDLLVKLFVREPEKRLGV 263

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+K +      ++ +    REI++LR + HE+I+  K      + +    V 
Sbjct: 33  NDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILRTLYHEHIVKYKGCC---EDQGEKSVQ 88
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHC------RYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +V E +       + S +D    HC        F  Q+  G+ Y+H+ + +HR L   N+
Sbjct: 89  LVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNV 142
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDI 167
           LL+ +  +KIGDFGLA+   E     EY   R        WY APE L  C  Y A+ D+
Sbjct: 143 LLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-APECLKECKFYYAS-DV 197
Query: 168 WSVGCILGEIMT 179
           WS G  L E++T
Sbjct: 198 WSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+K +      ++ +    REI++LR + HE+I+  K      + +    V 
Sbjct: 34  NDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILRTLYHEHIVKYKGCC---EDQGEKSVQ 89
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHC------RYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +V E +       + S +D    HC        F  Q+  G+ Y+H+ + +HR L   N+
Sbjct: 90  LVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNV 143
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDI 167
           LL+ +  +KIGDFGLA+   E     EY   R        WY APE L  C  Y A+ D+
Sbjct: 144 LLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-APECLKECKFYYAS-DV 198
Query: 168 WSVGCILGEIMT 179
           WS G  L E++T
Sbjct: 199 WSFGVTLYELLT 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 12/180 (6%)
Query: 7   EEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           E VAIKK+  +   +    +  ++E++ L+ + H N I  +       RE  +  ++V E
Sbjct: 80  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL---RE--HTAWLVME 134
Query: 66  LMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   ++  H+  L +       +  L+GL Y+HS N++HRD+K  N+LL+    +K
Sbjct: 135 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 194
Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMTRQP 182
           +GDFG A   +  +    +V T ++ APE++L   E  Y   +D+WS+G    E+  R+P
Sbjct: 195 LGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 100/192 (52%), Gaps = 16/192 (8%)
Query: 11  IKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR----------ETFND 59
           ++K+  A   +I A + L++  ++R+  D  +  A ++I+   +           +T   
Sbjct: 36  VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95
Query: 60  VYIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           +Y++ E +       Q+ R    + D  C ++L ++   L ++H   +++RDLKP N++L
Sbjct: 96  LYLILEYLSGGELFMQLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 118 NANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           N    +K+ DFGL + +     +T  +  T  Y APE+L+  S +  A+D WS+G ++ +
Sbjct: 155 NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYD 213
Query: 177 IMTRQPLFPGKD 188
           ++T  P F G++
Sbjct: 214 MLTGAPPFTGEN 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 100/192 (52%), Gaps = 16/192 (8%)
Query: 11  IKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR----------ETFND 59
           ++K+  A   +I A + L++  ++R+  D  +  A ++I+   +           +T   
Sbjct: 36  VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95
Query: 60  VYIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           +Y++ E +       Q+ R    + D  C ++L ++   L ++H   +++RDLKP N++L
Sbjct: 96  LYLILEYLSGGELFMQLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 118 NANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           N    +K+ DFGL + +     +T  +  T  Y APE+L+  S +  A+D WS+G ++ +
Sbjct: 155 NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYD 213
Query: 177 IMTRQPLFPGKD 188
           ++T  P F G++
Sbjct: 214 MLTGAPPFTGEN 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 31/197 (15%)
Query: 9   VAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           VA+K + +A DN   A++   RE +LL ++ HE+I+    +         + + +V+E M
Sbjct: 46  VAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYM 97
Query: 68  D-TDLHQIIRSH-------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
              DL++ +R+H              +LT     +   Q+  G+ Y+ S + +HRDL   
Sbjct: 98  KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 157
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCSEYTAAIDIWS 169
           N L+  N  +KIGDFG++R    TD+        +  RW   PE ++   ++T   D+WS
Sbjct: 158 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWS 215
Query: 170 VGCILGEIMT--RQPLF 184
           +G +L EI T  +QP +
Sbjct: 216 LGVVLWEIFTYGKQPWY 232

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 39/242 (16%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           RE+++  H+ H NI+ +        R     VY++ E     ++++ ++      +    
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTA 116
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
            ++ +L   L Y HS  V+HRD+KP NLLL +  +LKI DFG +   + +        T 
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTL 175
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 207
            Y  PE++     +   +D+WS+G +  E +  +P F    Y                  
Sbjct: 176 DYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------------ 216
Query: 208 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                 +  +R  R+   FP  +F       + GA DL+ ++L  +P++R  + E L HP
Sbjct: 217 -----QETYKRISRVEFTFP--DFV------TEGARDLISRLLKHNPSQRPMLREVLEHP 263
Query: 268 YL 269
           ++
Sbjct: 264 WI 265

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 42/274 (15%)
Query: 2   NSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           + ++ E VA+K I  G   D  +      REI   R + H NI+  K++I  P       
Sbjct: 40  DKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTPTH----- 89
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           + IV E     +L + I +    ++D  R+F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 90  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 149
Query: 119 ANCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI-DIWSVGCILG 175
            +    LKI  FG ++++       + V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 150 GSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 208
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
            ++     +P +D              P+E         N R+ +  +     Q     +
Sbjct: 209 VMLVGA--YPFED--------------PEEPK-------NFRKTIHRILNV--QYAIPDY 243
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            + SP    L+ ++ V DP +RI++ E   H + 
Sbjct: 244 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E M  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            D+   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +K+ DF
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E M  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            D+   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +K+ DF
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 42/274 (15%)
Query: 2   NSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           + ++ E VA+K I  G   D  +      REI   R + H NI+  K++I  P       
Sbjct: 40  DKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTPTH----- 89
Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           + IV E     +L + I +    ++D  R+F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 90  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 149
Query: 119 ANCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI-DIWSVGCILG 175
            +    LKI  FG ++++         V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 150 GSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 208
Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
            ++     +P +D              P+E         N R+ +  +     Q     +
Sbjct: 209 VMLVGA--YPFED--------------PEEPK-------NFRKTIHRILNV--QYAIPDY 243
Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            + SP    L+ ++ V DP +RI++ E   H + 
Sbjct: 244 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 12/180 (6%)
Query: 7   EEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           E VAIKK+  +   +    +  ++E++ L+ + H N I  +       RE  +  ++V E
Sbjct: 41  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL---RE--HTAWLVME 95
Query: 66  LMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   ++  H+  L +       +  L+GL Y+HS N++HRD+K  N+LL+    +K
Sbjct: 96  YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 155
Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMTRQP 182
           +GDFG A   +  +    +V T ++ APE++L   E  Y   +D+WS+G    E+  R+P
Sbjct: 156 LGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 124/285 (43%), Gaps = 42/285 (14%)
Query: 11  IKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD 70
           ++++ +A + + D+      +KLL H +H+    +              V +V+E++  +
Sbjct: 69  LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH-------------VVMVFEVLGEN 115
Query: 71  LHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNAN------C 121
           L  +I+   H+ +   + +    QLL GL Y+H    ++H D+KP N+L+          
Sbjct: 116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175
Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            +KI D G A    E    T  + TR YR+PE+LL  + +    DIWS  C++ E++T  
Sbjct: 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGD 232
Query: 182 PLF---PGKDYVH---QLRLITELIGS-------PDETSLGFLRSDNARRYVRMLPQFPK 228
            LF    G  Y      +  I EL+G          + +  F  S    R +  L  +P 
Sbjct: 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292
Query: 229 QNF---SARFPNKSPGAV-DLLEKMLVFDPNRRITVDEALCHPYL 269
           ++      +F       + D L  ML  DP +R      + HP+L
Sbjct: 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 34  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 89
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 148
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSV 170
               +KIGDFGL +   +     E+   +        WY APE L   S+++ A D+WS 
Sbjct: 149 NENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWY-APESLTE-SKFSVASDVWSF 203
Query: 171 GCILGEIMT 179
           G +L E+ T
Sbjct: 204 GVVLYELFT 212

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 124/285 (43%), Gaps = 42/285 (14%)
Query: 11  IKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD 70
           ++++ +A + + D+      +KLL H +H+    +              V +V+E++  +
Sbjct: 69  LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH-------------VVMVFEVLGEN 115
Query: 71  LHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNAN------C 121
           L  +I+   H+ +   + +    QLL GL Y+H    ++H D+KP N+L+          
Sbjct: 116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175
Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            +KI D G A    E    T  + TR YR+PE+LL  + +    DIWS  C++ E++T  
Sbjct: 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGD 232
Query: 182 PLF---PGKDYVH---QLRLITELIGS-------PDETSLGFLRSDNARRYVRMLPQFPK 228
            LF    G  Y      +  I EL+G          + +  F  S    R +  L  +P 
Sbjct: 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292
Query: 229 QNF---SARFPNKSPGAV-DLLEKMLVFDPNRRITVDEALCHPYL 269
           ++      +F       + D L  ML  DP +R      + HP+L
Sbjct: 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 89/173 (51%), Gaps = 13/173 (7%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHE----NIIAIKDIIRPPQRETFNDVYIVYELMD-- 68
           G  +  ++  K  +  +K + H + E    +I+    IIR     TF D   ++ +MD  
Sbjct: 31  GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR--MWGTFQDAQQIFMIMDYI 88
Query: 69  --TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              +L  ++R  Q   +   +++  ++   L+Y+HS ++++RDLKP N+LL+ N  +KI 
Sbjct: 89  EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKIT 148
Query: 127 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFG A+   +  +      T  Y APE +++   Y  +ID WS G ++ E++ 
Sbjct: 149 DFGFAKYVPDVTYXL--CGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 58  NDVYIVYELMDTDL----HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKP 112
            DV+I  EL DT L     Q+I   Q + +D        +++ L+++HS  +V+HRD+KP
Sbjct: 106 GDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 165
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCSEYTAAIDIWS 169
           SN+L+NA   +K  DFG++    +          + Y APE +   LN   Y+   DIWS
Sbjct: 166 SNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G    E+   +  FP   +    + + +++  P                    PQ P  
Sbjct: 226 LGITXIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 264
Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
            FSA F       VD   + L  +   R T  E   HP+   LH+
Sbjct: 265 KFSAEF-------VDFTSQCLKKNSKERPTYPELXQHPFFT-LHE 301

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 51/274 (18%)
Query: 11  IKKIGNAFDNRIDAKRTLR-----------EIKLLRHMDHENIIAI-------KDIIRP- 51
           + K  NA D+R  A + +R           E+ LL  ++H+ ++         ++ ++P 
Sbjct: 22  VVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81
Query: 52  PQRETFNDVYIVYELMDTD-LHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
              +  + ++I  E  +   L+ +I S       D++ R F  Q+L  L Y+HS  ++HR
Sbjct: 82  TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHR 140
Query: 109 DLKPSNLLLNANCDLKIGDFGLARTT---------------SETDFMTEYVVTRWYRAPE 153
           DLKP N+ ++ + ++KIGDFGLA+                   +D +T  + T  Y A E
Sbjct: 141 DLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200
Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLR 212
           +L     Y   ID++S+G I  E++   P   G + V+ L+ +  + I  P +     ++
Sbjct: 201 VLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPDFDDNKMK 258
Query: 213 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 246
            +  ++ +R+L            PNK PGA  LL
Sbjct: 259 VE--KKIIRLLIDHD--------PNKRPGARTLL 282

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 51/274 (18%)
Query: 11  IKKIGNAFDNRIDAKRTLR-----------EIKLLRHMDHENIIAI-------KDIIRP- 51
           + K  NA D+R  A + +R           E+ LL  ++H+ ++         ++ ++P 
Sbjct: 22  VVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81
Query: 52  PQRETFNDVYIVYELMDT-DLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
              +  + ++I  E  +   L+ +I S       D++ R F  Q+L  L Y+HS  ++HR
Sbjct: 82  TAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHR 140
Query: 109 DLKPSNLLLNANCDLKIGDFGLARTT---------------SETDFMTEYVVTRWYRAPE 153
           DLKP N+ ++ + ++KIGDFGLA+                   +D +T  + T  Y A E
Sbjct: 141 DLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200
Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLR 212
           +L     Y   ID++S+G I  E++   P   G + V+ L+ +  + I  P +     ++
Sbjct: 201 VLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPDFDDNKMK 258
Query: 213 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 246
            +  ++ +R+L            PNK PGA  LL
Sbjct: 259 VE--KKIIRLLIDHD--------PNKRPGARTLL 282

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 35  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 90
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HR+L   N+L+ 
Sbjct: 91  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVE 149
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSV 170
               +KIGDFGL +   +     EY   +        WY APE L   S+++ A D+WS 
Sbjct: 150 NENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWY-APESLTE-SKFSVASDVWSF 204
Query: 171 GCILGEIMT 179
           G +L E+ T
Sbjct: 205 GVVLYELFT 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 11/172 (6%)
Query: 26  RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV--YIVYELMD-TDLHQIIRSHQDLT 82
           R  RE +    ++H  I+A+ D     + ET      YIV E +D   L  I+ +   +T
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 114
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---F 139
                  +    + L + H   ++HRD+KP+N+L++A   +K+ DFG+AR  +++     
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 140 MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 190
            T  V+ T  Y +PE     S   A  D++S+GC+L E++T +P F G   V
Sbjct: 175 QTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 37  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 92
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLL 117
            ++ E +    L + ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+
Sbjct: 93  -LIMEFLPYGSLREYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 150
Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGC 172
                +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G 
Sbjct: 151 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGV 208
Query: 173 ILGEIMT 179
           +L E+ T
Sbjct: 209 VLYELFT 215

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 10  AIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-D 68
           A+K +  A     D  RT  E  +L  ++H  ++ +         +T   +Y++ + +  
Sbjct: 60  AMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAF-----QTEGKLYLILDFLRG 114
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            DL   +      T++  +++L +L  GL ++HS  +++RDLKP N+LL+    +K+ DF
Sbjct: 115 GDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDF 174
Query: 129 GLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           GL++   + +     +  T  Y APE ++N   ++ + D WS G ++ E++T    F GK
Sbjct: 175 GLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGK 233
Query: 188 DYVHQLRLITEL-IGSP 203
           D    + LI +  +G P
Sbjct: 234 DRKETMTLILKAKLGMP 250

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT 82
           +   T+ E ++L++  H  + A+K   +   R  F    ++      +L   +   +  T
Sbjct: 48  EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFT 103
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMT 141
           ++  R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M 
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL 199
            +  T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+
Sbjct: 164 XFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 200 ----IGSPDETSL--GFLRSDNARR 218
                 SP+  SL  G L+ D  +R
Sbjct: 223 RFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           T+ E ++L++  H  + A+K   +   R  F    ++      +L   +   +  T++  
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERA 107
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVV 145
           R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M  +  
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL---- 199
           T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+    
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226
Query: 200 IGSPDETSL--GFLRSDNARR 218
             SP+  SL  G L+ D  +R
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQR 247

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 39  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 94
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 95  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 153
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 154 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 211
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 212 LYELFT 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 11/172 (6%)
Query: 26  RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV--YIVYELMD-TDLHQIIRSHQDLT 82
           R  RE +    ++H  I+A+ D     + ET      YIV E +D   L  I+ +   +T
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 114
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---F 139
                  +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++     
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 140 MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 190
            T  V+ T  Y +PE     S   A  D++S+GC+L E++T +P F G   V
Sbjct: 175 QTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 55  ETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           ET + + +V  LM   D   H          +    ++  ++  GL+ +H   +++RDLK
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313
Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+LL+ +  ++I D GLA    E   +   V T  Y APE++ N   YT + D W++G
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALG 372
Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           C+L E++  Q                    SP +     ++ +   R V+ +P    + +
Sbjct: 373 CLLYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP----EEY 408
Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRI 258
           S RF   SP A  L  ++L  DP  R+
Sbjct: 409 SERF---SPQARSLCSQLLCKDPAERL 432

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           T+ E ++L++  H  + A+K   +   R  F    ++      +L   +   +  T++  
Sbjct: 57  TVTESRVLQNTRHPFLTALKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERA 112
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVV 145
           R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M  +  
Sbjct: 113 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 172
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL---- 199
           T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+    
Sbjct: 173 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 231
Query: 200 IGSPDETSL--GFLRSDNARR 218
             SP+  SL  G L+ D  +R
Sbjct: 232 TLSPEAKSLLAGLLKKDPKQR 252

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 86/169 (50%), Gaps = 11/169 (6%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDV--YIVYELMD-TDLHQIIRSHQDLTDDH 85
           RE +    ++H  I+A+ D     + ET      YIV E +D   L  I+ +   +T   
Sbjct: 61  REAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
               +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++      T 
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 143 YVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 190
            V+ T  Y +PE     S   A  D++S+GC+L E++T +P F G   V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 38  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 93
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 94  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 152
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 153 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 210
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 211 LYELFT 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 41  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 96
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 97  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 155
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 156 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 213
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 214 LYELFT 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 26  RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV--YIVYELMD-TDLHQIIRSHQDLT 82
           R  RE +    ++H  I+A+ D     + ET      YIV E +D   L  I+ +   +T
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 114
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---F 139
                  +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++     
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 140 MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 186
            T  V+ T  Y +PE     S   A  D++S+GC+L E++T +P F G
Sbjct: 175 QTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 65  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 120
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 179
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 237
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 238 LYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 37  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 92
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 93  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 151
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 209
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 210 LYELFT 215

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           T+ E ++L++  H  + A+K   +   R  F    ++      +L   +   +  T++  
Sbjct: 55  TVTESRVLQNTRHPFLTALKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERA 110
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVV 145
           R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M  +  
Sbjct: 111 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 170
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL---- 199
           T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+    
Sbjct: 171 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 229
Query: 200 IGSPDETSL--GFLRSDNARR 218
             SP+  SL  G L+ D  +R
Sbjct: 230 TLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT 82
           +   T+ E ++L++  H  + A+K   +   R  F    ++      +L   +   +  T
Sbjct: 48  EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFT 103
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMT 141
           ++  R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M 
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL 199
            +  T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+
Sbjct: 164 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 200 ----IGSPDETSL--GFLRSDNARR 218
                 SP+  SL  G L+ D  +R
Sbjct: 223 RFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 40  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 95
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 96  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 154
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 155 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 212
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 213 LYELFT 218

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           T+ E ++L++  H  + A+K   +   R  F    ++      +L   +   +  T++  
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERA 107
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVV 145
           R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M  +  
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL---- 199
           T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+    
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226
Query: 200 IGSPDETSL--GFLRSDNARR 218
             SP+  SL  G L+ D  +R
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           T+ E ++L++  H  + A+K   +   R  F    ++      +L   +   +  T++  
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCF----VMEYANGGELFFHLSRERVFTEERA 107
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVV 145
           R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M  +  
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL---- 199
           T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+    
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226
Query: 200 IGSPDETSL--GFLRSDNARR 218
             SP+  SL  G L+ D  +R
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQR 247

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 34  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 89
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 148
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 206
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 207 LYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 32  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 87
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 88  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 146
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 147 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 204
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 205 LYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 33  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 88
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 89  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 147
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 148 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 205
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 206 LYELFT 211

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 55  ETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           ET + + +V  LM   D   H          +    ++  ++  GL+ +H   +++RDLK
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313
Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+LL+ +  ++I D GLA    E   +   V T  Y APE++ N   YT + D W++G
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALG 372
Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           C+L E++  Q                    SP +     ++ +   R V+ +P    + +
Sbjct: 373 CLLYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP----EEY 408
Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRI 258
           S RF   SP A  L  ++L  DP  R+
Sbjct: 409 SERF---SPQARSLCSQLLCKDPAERL 432

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 34  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 89
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 148
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 206
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 207 LYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 37  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 92
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   +++H +  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 93  LIMEYLPYGSLRDYLQAHAERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 151
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 209
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 210 LYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 52  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 107
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 108 LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 166
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 167 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 224
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 225 LYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +  +  +   REI++L+ + H+NI+  K +     R      
Sbjct: 52  LQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-- 107
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+  L    L   ++ H++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 108 LIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 166
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCSEYTAAIDIWSVGCI 173
               +KIGDFGL +   +     +          WY APE L   S+++ A D+WS G +
Sbjct: 167 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVV 224
Query: 174 LGEIMT 179
           L E+ T
Sbjct: 225 LYELFT 230

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 96  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 155
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  + Y+   DIWS+G  L 
Sbjct: 156 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 213
Query: 176 EI-MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
           E+ + R P+  G   +    L+  ++  P                    P+ P   FS  
Sbjct: 214 EMAVGRYPIGSGSGSMAIFELLDYIVNEPP-------------------PKLPSGVFSLE 254
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           F        D + K L+ +P  R  + + + H ++
Sbjct: 255 FQ-------DFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 21/181 (11%)
Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VAIK  K G     R+D    L E  ++    H NII ++ +I       +  + I+ E 
Sbjct: 76  VAIKTLKAGYTEKQRVD---FLGEAGIMGQFSHHNIIRLEGVI-----SKYKPMMIITEY 127
Query: 67  MDTD-LHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           M+   L + +R    + +       L  +  G+KY+ + N +HRDL   N+L+N+N   K
Sbjct: 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK 187
Query: 125 IGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           + DFGL+R   E D    Y  +      RW  APE  ++  ++T+A D+WS G ++ E+M
Sbjct: 188 VSDFGLSRVL-EDDPEATYTTSGGKIPIRW-TAPE-AISYRKFTSASDVWSFGIVMWEVM 244
Query: 179 T 179
           T
Sbjct: 245 T 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN F  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 60  VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMV 119
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 236
Query: 183 LF 184
            F
Sbjct: 237 PF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN F  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 60  VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMV 119
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 236
Query: 183 LF 184
            F
Sbjct: 237 PF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN F  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 60  VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMV 119
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 236
Query: 183 LF 184
            F
Sbjct: 237 PF 238

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 26  RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV--YIVYELMD-TDLHQIIRSHQDLT 82
           R  RE +    ++H  I+A+ D     + ET      YIV E +D   L  I+ +   +T
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 131
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---F 139
                  +    + L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++     
Sbjct: 132 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 140 MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 186
            T  V+ T  Y +PE     S   A  D++S+GC+L E++T +P F G
Sbjct: 192 QTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRD---FLGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGLAR      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E     ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 121 LEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +K+ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IKVADFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 237
Query: 183 LF 184
            F
Sbjct: 238 PF 239

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 19/185 (10%)
Query: 5   TREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           T E+VA+K +   +  ++  D K+   EI++LR++ HENI+  K I      +  N + +
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGIC---TEDGGNGIKL 102
Query: 63  VYELMDT-DLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           + E + +  L + + ++   +       +  Q+ +G+ Y+ S   +HRDL   N+L+ + 
Sbjct: 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162
Query: 121 CDLKIGDFGLARTTSETDFMTEYVV------TRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
             +KIGDFGL +   ETD     V         WY APE L+  S++  A D+WS G  L
Sbjct: 163 HQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY-APECLMQ-SKFYIASDVWSFGVTL 219
Query: 175 GEIMT 179
            E++T
Sbjct: 220 HELLT 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 38  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 90
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 91  LGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 148
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 149 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 203
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 204 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 237
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 238 LYSLMTKCWAYDPSRR 253

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 41  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 93
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 94  LGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 151
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 152 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 206
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 207 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 240
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 69  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 121
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 122 LGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 179
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 180 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 234
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 235 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 268
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 269 LYSLMTKCWAYDPSRR 284

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 43  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 95
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 96  LGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 153
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 154 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 208
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 209 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 242
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 243 LYSLMTKCWAYDPSRR 258

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 19/185 (10%)
Query: 5   TREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           T E+VA+K +   +  ++  D K+   EI++LR++ HENI+  K I      +  N + +
Sbjct: 37  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGIC---TEDGGNGIKL 90
Query: 63  VYELMDT-DLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           + E + +  L + + ++   +       +  Q+ +G+ Y+ S   +HRDL   N+L+ + 
Sbjct: 91  IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 150
Query: 121 CDLKIGDFGLARTTSETDFMTEYVV------TRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
             +KIGDFGL +   ETD     V         WY APE L+  S++  A D+WS G  L
Sbjct: 151 HQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY-APECLMQ-SKFYIASDVWSFGVTL 207
Query: 175 GEIMT 179
            E++T
Sbjct: 208 HELLT 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAY-RKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 41  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 93
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 94  LGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 151
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 152 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 206
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 207 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 240
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 44  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 96
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 97  LGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 154
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 155 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 209
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 210 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 243
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 244 LYSLMTKCWAYDPSRR 259

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 46  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 98
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 99  LGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 156
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 157 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 211
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 212 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 245
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 246 LYSLMTKCWAYDPSRR 261

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 66/109 (60%), Gaps = 5/109 (4%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTR 147
            L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T 
Sbjct: 125 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 184
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 196
           ++ APE ++  S Y +  DIWS+G    E+   +P  P  D +H +R++
Sbjct: 185 FWMAPE-VIQQSAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVL 229

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M+  T +EVAI+++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 40  MDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDEL 92
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L+++HS  V+HRD+K  N+LL  +
Sbjct: 93  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 121 CDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG  A+ T E    +E V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIE 211
Query: 180 RQPLFPGKDYVHQLRLITELIGSPD 204
            +P +  ++ +  L LI    G+P+
Sbjct: 212 GEPPYLNENPLRALYLIA-TNGTPE 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +K+ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 421 VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 473
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 474 LGELRSFLQVRKFSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 531
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 532 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 586
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 587 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 620
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 72/135 (53%), Gaps = 6/135 (4%)
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           YIV E +D   L  I+ +   +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 120 NCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 176 EIMTRQPLFPGKDYV 190
           E++T +P F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYEL 66
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 67  MD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           M+     ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    
Sbjct: 121 MEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY 180
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +K+ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 237
Query: 183 LF 184
            F
Sbjct: 238 PF 239

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK + + +  +   +  L E  ++   DH N+I ++ ++          V I+ E M+
Sbjct: 64  VAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----TPVMIITEFME 117
Query: 69  T-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R +    T       L  +  G+KY+   N +HRDL   N+L+N+N   K+ 
Sbjct: 118 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVS 177
Query: 127 DFGLAR----TTSE---TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGL+R     TS+   T  +   +  RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 178 DFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAY-RKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 25/194 (12%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRT-LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           ET E + +K++   FD   + +RT L+E+K++R ++H N++    ++   +R  F   YI
Sbjct: 33  ETGEVMVMKEL-IRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89
Query: 63  VYELMDTDLHQIIRSHQDLTDDHCRY-FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
                   L  II+S         R  F   +  G+ Y+HS N++HRDL   N L+  N 
Sbjct: 90  ----KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK 145
Query: 122 DLKIGDFGLA-------------RTTSETDFMTEYVVTR--WYRAPELLLNCSEYTAAID 166
           ++ + DFGLA             R+  + D    Y V    ++ APE ++N   Y   +D
Sbjct: 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE-MINGRSYDEKVD 204
Query: 167 IWSVGCILGEIMTR 180
           ++S G +L EI+ R
Sbjct: 205 VFSFGIVLCEIIGR 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 55/295 (18%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFND 59
            N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + +
Sbjct: 82  FNKRTQEKFALKXLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YEN 126
Query: 60  VY-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           +Y       IV E +D  +L   I  R  Q  T+         +   ++Y+HS N+ HRD
Sbjct: 127 LYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRD 186
Query: 110 LKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAID 166
           +KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCD 245
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-Q 225
            WS+G I   ++   P F                     ++ G   S   +  +R    +
Sbjct: 246 XWSLGVIXYILLCGYPPF--------------------YSNHGLAISPGXKTRIRXGQYE 285
Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           FP   +S      S     L+  +L  +P +R T+ E   HP++     + + P+
Sbjct: 286 FPNPEWS----EVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPL 336

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 68  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 119
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 120 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 179
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 180 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIV 237
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 238 LWEVMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 41  SKKEISVAIKTLKVGYTEKQRRD---FLGEASIMGQFDHPNIIRLEGVVTKSK-----PV 92
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 93  MIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 152
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 153 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAY-RKFTSASDVWSYGIV 210
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 211 LWEVMS 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 41  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 93
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L++A   +K
Sbjct: 94  LGELRSFLQVRKFSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVK 151
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 152 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 206
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 207 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 240
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 237
Query: 183 LF 184
            F
Sbjct: 238 PF 239

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAY-RKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 81  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 140
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 141 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 200
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 201 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 257
Query: 183 LF 184
            F
Sbjct: 258 PF 259

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 41  SKKEISVAIKTLKVGYTEKQRRD---FLGEASIMGQFDHPNIIRLEGVVTKSK-----PV 92
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 93  MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 152
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 153 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAY-RKFTSASDVWSYGIV 210
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 211 LWEVMS 216

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 237
Query: 183 LF 184
            F
Sbjct: 238 PF 239

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRDF---LGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIV 239
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 240 LWEVMS 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 237
Query: 183 LF 184
            F
Sbjct: 238 PF 239

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 3   SETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           S+    VAIK  K+G     R D    L E  ++   DH NII ++ ++   +      V
Sbjct: 58  SKKEISVAIKTLKVGYTEKQRRD---FLGEASIMGQFDHPNIIRLEGVVTKSK-----PV 109
Query: 61  YIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            IV E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N
Sbjct: 110 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 169
Query: 119 ANCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R      E  + T    +  RW  +PE +    ++T+A D+WS G +
Sbjct: 170 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAY-RKFTSASDVWSYGIV 227
Query: 174 LGEIMT 179
           L E+M+
Sbjct: 228 LWEVMS 233

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 144 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 203
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 204 TDFGFAKRVKGATWTL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 53  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 112
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 113 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 172
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 173 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 229
Query: 183 LF 184
            F
Sbjct: 230 PF 231

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    +K+ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLA+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GLAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--AGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 421 VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 473
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L++A   +K
Sbjct: 474 LGELRSFLQVRKFSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVK 531
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++ +       +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 532 LGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 586
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 587 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 620
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 75/131 (57%), Gaps = 5/131 (3%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++  + + ++        +LRGL Y+   + ++HRD+KPSN+
Sbjct: 87  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 146
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    ++     +V TR Y APE  L  + Y+   DIWS+G  L 
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLSLV 204
Query: 176 EI-MTRQPLFP 185
           E+ + R P+ P
Sbjct: 205 ELAVGRYPIPP 215

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 7   EEVAIKKIGNAFDNRIDA--KRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIV 63
           +EVA+K   +  D  I    +   +E KL   + H NIIA++ + ++ P      ++ +V
Sbjct: 31  DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP------NLCLV 84
Query: 64  YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV---LHRDLKPSNLLL--- 117
            E         + S + +  D    +  Q+ RG+ Y+H   +   +HRDLK SN+L+   
Sbjct: 85  MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 118 -----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
                 +N  LKI DFGLAR    T  M+      W  APE ++  S ++   D+WS G 
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWM-APE-VIRASMFSKGSDVWSYGV 202
Query: 173 ILGEIMTRQPLFPGKD 188
           +L E++T +  F G D
Sbjct: 203 LLWELLTGEVPFRGID 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 131/292 (44%), Gaps = 51/292 (17%)
Query: 11  IKKIGNAFDNRIDAKRTLR-----------EIKLLRHMDHENIIAI-------KDIIRPP 52
           + K  NA D+R  A + +R           E+ LL  ++H+ ++         ++ ++P 
Sbjct: 22  VVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLERRNFVKPX 81
Query: 53  QR-ETFNDVYIVYELMDT-DLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
              +  + ++I  E  +   L+ +I S       D++ R F  Q+L  L Y+HS  ++HR
Sbjct: 82  TAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHR 140
Query: 109 DLKPSNLLLNANCDLKIGDFGLARTT---------------SETDFMTEYVVTRWYRAPE 153
           +LKP N+ ++ + ++KIGDFGLA+                   +D +T  + T  Y A E
Sbjct: 141 NLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATE 200
Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLR 212
           +L     Y   ID +S+G I  E +   P   G + V+ L+ +  + I  P +      +
Sbjct: 201 VLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRSVSIEFPPDFDDNKXK 258
Query: 213 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
            +  ++ +R+L            PNK PGA  LL    +   ++   + EAL
Sbjct: 259 VE--KKIIRLLIDHD--------PNKRPGARTLLNSGWLPVKHQDEVIKEAL 300

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    +K+ DF
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 187 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    +K+ DF
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 187 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 68/117 (58%), Gaps = 5/117 (4%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L + +    L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 141 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 196
              +V T ++ APE ++  S Y    DIWS+G    E+   +P  P  D +H +R++
Sbjct: 173 RNXFVGTPFWMAPE-VIKQSAYDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVL 225

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 30/179 (16%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD----LTD 83
           RE +LL ++ HE+I+    +         + + +V+E M   DL++ +R+H      L D
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 84  DHCR------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 131
              R            +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KIGDFG++
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 132 RTTSETDFMT----EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 184
           R    TD+        +  RW   PE ++   ++T   D+WS G IL EI T  +QP F
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 120/282 (42%), Gaps = 60/282 (21%)
Query: 16  NAFDNR-IDAKRTL--------REIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYE 65
             FDNR +  KR L        RE++LLR  D H N+I      +  Q +     YI  E
Sbjct: 44  GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQ-----YIAIE 98
Query: 66  LMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---N 118
           L    L + +     +H  L        L Q   GL ++HS N++HRDLKP N+L+   N
Sbjct: 99  LCAATLQEYVEQKDFAHLGLEPI---TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
Query: 119 ANCDLK--IGDFGLAR--TTSETDFMTEYVV--TRWYRAPELLL-NCSEY-TAAIDIWSV 170
           A+  +K  I DFGL +        F     V  T  + APE+L  +C E  T  +DI+S 
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 171 GCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN 230
           GC+   +++      GK    Q  +   L+G+    SL  L  +     +          
Sbjct: 216 GCVFYYVISEGSHPFGKSLQRQANI---LLGA---CSLDCLHPEKHEDVI---------- 259
Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 272
                      A +L+EKM+  DP +R +    L HP+   L
Sbjct: 260 -----------ARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK   N   + +  K  L+E   +R  DH +I+ +  +I      T N V+I+ EL  
Sbjct: 41  VAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVI------TENPVWIIMELCT 93
Query: 69  T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
                   Q+ +   DL       + YQL   L Y+ S   +HRD+   N+L+++N  +K
Sbjct: 94  LGELRSFLQVRKFSLDLAS--LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 151
Query: 125 IGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           +GDFGL+R   ++         +  +W  APE  +N   +T+A D+W  G  + EI+   
Sbjct: 152 LGDFGLSRYMEDSTXXKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEIL--- 206
Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                      +  +    G  +   +G  R +N  R    LP  P        PN  P 
Sbjct: 207 -----------MHGVKPFQGVKNNDVIG--RIENGER----LP-MP--------PNCPPT 240
Query: 242 AVDLLEKMLVFDPNRR 257
              L+ K   +DP+RR
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 64  YE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--XGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 236
Query: 183 LF 184
            F
Sbjct: 237 PF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 22/193 (11%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T+  V   K G+     +  +  L E  +++ + H+ ++ +  ++      T   +Y
Sbjct: 37  NKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVV------TKEPIY 85
Query: 62  IVYELM-DTDLHQIIRSHQDLTDDHCRY--FLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           I+ E M    L   ++S +       +   F  Q+  G+ ++   N +HRDL+ +N+L++
Sbjct: 86  IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 145
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           A+   KI DFGLAR   + ++          +W  APE  +N   +T   D+WS G +L 
Sbjct: 146 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGILLM 203
Query: 176 EIMT--RQPLFPG 186
           EI+T  R P +PG
Sbjct: 204 EIVTYGRIP-YPG 215

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 64  YE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 236
Query: 183 LF 184
            F
Sbjct: 237 PF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 53  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 112
Query: 64  YELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 113 MEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 172
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 173 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 229
Query: 183 LF 184
            F
Sbjct: 230 PF 231

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 55  ETFNDVYIVYELMDTD-----LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           ET  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  N+++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIW 168
           LKP N+LL+ + +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           ++G  L E++  +  F  +                        + +N     R+L Q   
Sbjct: 374 ALGVTLYEMIAARGPFRARGE----------------------KVENKELKQRVLEQ--- 408
Query: 229 QNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALC 265
              +  +P+K SP + D  E +L  DP +R+   +  C
Sbjct: 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 47  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 106
Query: 64  YE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 107 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGY 166
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 167 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 223
Query: 183 LF 184
            F
Sbjct: 224 PF 225

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    +K+ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 55  ETFNDVYIVYELMDTD-----LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           ET  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  N+++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIW 168
           LKP N+LL+ + +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           ++G  L E++  +  F  +                        + +N     R+L Q   
Sbjct: 374 ALGVTLYEMIAARGPFRARGE----------------------KVENKELKQRVLEQ--- 408
Query: 229 QNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALC 265
              +  +P+K SP + D  E +L  DP +R+   +  C
Sbjct: 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 91/191 (47%), Gaps = 30/191 (15%)
Query: 57  FNDVYIVYELMDTDLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           ++ + +++E +   L++II   ++     +  + +  ++L+ L Y+   ++ H DLKP N
Sbjct: 108 YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167
Query: 115 LLLN-------------------------ANCDLKIGDFGLARTTSETDFMTEYVVTRWY 149
           +LL+                          +  +K+ DFG A  T ++D+    + TR Y
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQY 225
Query: 150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 209
           RAPE++LN   +  + D+WS GC+L E+ T   LF   +++  L ++  +I    +  L 
Sbjct: 226 RAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 210 FLRSDNARRYV 220
                N  +YV
Sbjct: 285 EATKTNGSKYV 295

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 61  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 64  YE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 121 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 237
Query: 183 LF 184
            F
Sbjct: 238 PF 239

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 76  RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLAR 132
           R  Q  T+      +  +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 133 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 192
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P          
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFP---------- 227
Query: 193 LRLITELIGSPDETSLGFLRSDNARRYVRMLP-QFPKQNFSARFPNKSPGAVDLLEKMLV 251
                     P  ++ G   S   +R +R+    FP   +S      S  A  L+  +L 
Sbjct: 228 ----------PFYSNTGQAISPGMKRRIRLGQYGFPNPEWS----EVSEDAKQLIRLLLK 273
Query: 252 FDPNRRITVDEALCHPYLAPLHDINEEPVCPR 283
            DP  R+T+ + + HP+      IN+  V P+
Sbjct: 274 TDPTERLTITQFMNHPW------INQSMVVPQ 299

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 76  RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLAR 132
           R  Q  T+      +  +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 133 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 192
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P          
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFP---------- 208
Query: 193 LRLITELIGSPDETSLGFLRSDNARRYVRMLP-QFPKQNFSARFPNKSPGAVDLLEKMLV 251
                     P  ++ G   S   +R +R+    FP   +S      S  A  L+  +L 
Sbjct: 209 ----------PFYSNTGQAISPGMKRRIRLGQYGFPNPEWS----EVSEDAKQLIRLLLK 254
Query: 252 FDPNRRITVDEALCHPYLAPLHDINEEPVCPR 283
            DP  R+T+ + + HP+      IN+  V P+
Sbjct: 255 TDPTERLTITQFMNHPW------INQSMVVPQ 280

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 55  ETFNDVYIVYELMDTD-----LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           ET  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  N+++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIW 168
           LKP N+LL+ + +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           ++G  L E++  +  F  +                        + +N     R+L Q   
Sbjct: 374 ALGVTLYEMIAARGPFRARGE----------------------KVENKELKQRVLEQ--- 408
Query: 229 QNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALC 265
              +  +P+K SP + D  E +L  DP +R+   +  C
Sbjct: 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK +   +  R   +  L E  ++   +H NII ++ ++          V I+ E M+
Sbjct: 47  VAIKTLKGGYTER-QRREFLSEASIMGQFEHPNIIRLEGVVTNSM-----PVMILTEFME 100
Query: 69  TD-LHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R +    T       L  +  G++Y+   + +HRDL   N+L+N+N   K+ 
Sbjct: 101 NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVS 160
Query: 127 DFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGL+R         +ET  +   +  RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 161 DFGLSRFLEENSSDPTETSSLGGKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 218
Query: 180 --RQPLF--PGKDYVHQLRLITELIGSPD-ETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
              +P +    +D ++ +     L   PD  TSL  L  D  ++     P+FP+      
Sbjct: 219 FGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQ------ 272
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDE--ALCHPYL 269
                   V  L+KM+    + +I   E     HP L
Sbjct: 273 -------VVSALDKMIRNPASLKIVARENGGASHPLL 302

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 55  ETFNDVYIVYELMDTD-----LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           ET  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  N+++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIW 168
           LKP N+LL+ + +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           ++G  L E++  +  F  +                        + +N     R+L Q   
Sbjct: 374 ALGVTLYEMIAARGPFRARGE----------------------KVENKELKQRVLEQ--- 408
Query: 229 QNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALC 265
              +  +P+K SP + D  E +L  DP +R+   +  C
Sbjct: 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           GLA+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GLAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 21/181 (11%)
Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VAIK  K+G     R D    L E  ++   DH N++ ++ ++   +      V IV E 
Sbjct: 74  VAIKTLKVGYTEKQRRD---FLCEASIMGQFDHPNVVHLEGVVTRGK-----PVMIVIEF 125
Query: 67  MDTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           M+   L   +R H    T       L  +  G++Y+     +HRDL   N+L+N+N   K
Sbjct: 126 MENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCK 185
Query: 125 IGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           + DFGL+R   E D    Y  T      RW  APE  +   ++T+A D+WS G ++ E+M
Sbjct: 186 VSDFGLSRVI-EDDPEAVYTTTGGKIPVRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVM 242
Query: 179 T 179
           +
Sbjct: 243 S 243

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 89/176 (50%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NL+++    +K+ DF
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 187 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M+  T +EVAI+++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 41  MDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDEL 93
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L+++HS  V+HRD+K  N+LL  +
Sbjct: 94  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 153
Query: 121 CDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 154 GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIE 212
Query: 180 RQPLFPGKDYVHQLRLITELIGSPD 204
            +P +  ++ +  L LI    G+P+
Sbjct: 213 GEPPYLNENPLRALYLIAT-NGTPE 236

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 144 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 203
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 204 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 187 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M+  T +EVAI+++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 40  MDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDEL 92
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L+++HS  V+HRD+K  N+LL  +
Sbjct: 93  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 121 CDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIE 211
Query: 180 RQPLFPGKDYVHQLRLITELIGSPD 204
            +P +  ++ +  L LI    G+P+
Sbjct: 212 GEPPYLNENPLRALYLIAT-NGTPE 235

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           TL E ++L++  H  + A+K   +   R  F    ++      +L   +   +  ++D  
Sbjct: 57  TLTENRVLQNSRHPFLTALKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRA 112
Query: 87  RYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYV 144
           R++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +   M  + 
Sbjct: 113 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC 172
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL--- 199
            T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+   
Sbjct: 173 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 231
Query: 200 -IGSPDETSL--GFLRSDNARR 218
               P+  SL  G L+ D  +R
Sbjct: 232 RTLGPEAKSLLSGLLKKDPKQR 253

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 187 GFAKRVKGRTWTL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 55  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 114
Query: 64  YE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 115 MEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 174
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 175 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 231
Query: 183 LF 184
            F
Sbjct: 232 PF 233

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M+  T +EVAI+++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 40  MDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDEL 92
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L+++HS  V+HRD+K  N+LL  +
Sbjct: 93  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 121 CDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIE 211
Query: 180 RQPLFPGKDYVHQLRLITELIGSPD 204
            +P +  ++ +  L LI    G+P+
Sbjct: 212 GEPPYLNENPLRALYLIAT-NGTPE 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 62/275 (22%)
Query: 27  TLREIKLLRHMD-HENIIAIKDIIRPPQRETFND-VYIVYELMDTDLHQIIRSHQDLTDD 84
            L EIKLL   D H N+I      R    ET +  +YI  EL + +L  ++ S ++++D+
Sbjct: 73  ALMEIKLLTESDDHPNVI------RYYCSETTDRFLYIALELCNLNLQDLVES-KNVSDE 125
Query: 85  HCRY--------FLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------------NCDL 123
           + +          L Q+  G+ ++HS  ++HRDLKP N+L++              N  +
Sbjct: 126 NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 185
Query: 124 KIGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGE 176
            I DFGL +   + +  F   +     T  +RAPELL   ++   T +IDI+S+GC+   
Sbjct: 186 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYY 245
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           I+++     G  Y  +  +I  +  S DE      RS  A                    
Sbjct: 246 ILSKGKHPFGDKYSRESNIIRGIF-SLDEMKCLHDRSLIAE------------------- 285
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                A DL+ +M+  DP +R T  + L HP   P
Sbjct: 286 -----ATDLISQMIDHDPLKRPTAMKVLRHPLFWP 315

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           TL E ++L++  H  + A+K   +   R  F    ++      +L   +   +  ++D  
Sbjct: 56  TLTENRVLQNSRHPFLTALKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRA 111
Query: 87  RYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYV 144
           R++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +   M  + 
Sbjct: 112 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC 171
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL--- 199
            T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+   
Sbjct: 172 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 230
Query: 200 -IGSPDETSL--GFLRSDNARR 218
               P+  SL  G L+ D  +R
Sbjct: 231 RTLGPEAKSLLSGLLKKDPKQR 252

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 22/193 (11%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T+  V   K G+     +  +  L E  +++ + H+ ++ +  ++      T   +Y
Sbjct: 210 NKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVV------TKEPIY 258
Query: 62  IVYELM-DTDLHQIIRSHQDLTDDHCRY--FLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           I+ E M    L   ++S +       +   F  Q+  G+ ++   N +HRDL+ +N+L++
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 318
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           A+   KI DFGLAR   + ++          +W  APE  +N   +T   D+WS G +L 
Sbjct: 319 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGILLM 376
Query: 176 EIMT--RQPLFPG 186
           EI+T  R P +PG
Sbjct: 377 EIVTYGRIP-YPG 388

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 23  DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT 82
           +   TL E ++L++  H  + A+K   +   R  F    ++      +L   +   +  +
Sbjct: 51  EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFS 106
Query: 83  DDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFM 140
           +D  R++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +   M
Sbjct: 107 EDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 166
Query: 141 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITE 198
             +  T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E
Sbjct: 167 KXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 225
Query: 199 L----IGSPDETSL--GFLRSDNARR 218
           +       P+  SL  G L+ D  +R
Sbjct: 226 IRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 52  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 111
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 112 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 171
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 172 GFAKRVKGRTWTL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE-LMD 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 62/275 (22%)
Query: 27  TLREIKLLRHMD-HENIIAIKDIIRPPQRETFND-VYIVYELMDTDLHQIIRSHQDLTDD 84
            L EIKLL   D H N+I      R    ET +  +YI  EL + +L  ++ S ++++D+
Sbjct: 73  ALMEIKLLTESDDHPNVI------RYYCSETTDRFLYIALELCNLNLQDLVES-KNVSDE 125
Query: 85  HCRY--------FLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------------NCDL 123
           + +          L Q+  G+ ++HS  ++HRDLKP N+L++              N  +
Sbjct: 126 NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 185
Query: 124 KIGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGE 176
            I DFGL +   + +  F   +     T  +RAPELL   ++   T +IDI+S+GC+   
Sbjct: 186 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYY 245
Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           I+++     G  Y  +  +I  +  S DE      RS  A                    
Sbjct: 246 ILSKGKHPFGDKYSRESNIIRGIF-SLDEMKCLHDRSLIAE------------------- 285
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                A DL+ +M+  DP +R T  + L HP   P
Sbjct: 286 -----ATDLISQMIDHDPLKRPTAMKVLRHPLFWP 315

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 66/279 (23%)
Query: 27  TLREIKLLRHMD-HENIIAIKDIIRPPQRETFND-VYIVYELMDTDLHQIIRSHQDLTDD 84
            L EIKLL   D H N+I      R    ET +  +YI  EL + +L  ++ S ++++D+
Sbjct: 55  ALMEIKLLTESDDHPNVI------RYYCSETTDRFLYIALELCNLNLQDLVES-KNVSDE 107
Query: 85  HCRY--------FLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------------NCDL 123
           + +          L Q+  G+ ++HS  ++HRDLKP N+L++              N  +
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 124 KIGDFGLART--TSETDFMTEY---VVTRWYRAPELLLNCSE------YTAAIDIWSVGC 172
            I DFGL +   + ++ F T       T  +RAPELL   +        T +IDI+S+GC
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +   I+++     G  Y  +  +I   I S DE      RS  A                
Sbjct: 228 VFYYILSKGKHPFGDKYSRESNIIRG-IFSLDEMKCLHDRSLIAE--------------- 271
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                    A DL+ +M+  DP +R T  + L HP   P
Sbjct: 272 ---------ATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 74/124 (59%), Gaps = 2/124 (1%)
Query: 56  TFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           T + +  + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +LL+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 175 GEIM 178
            +++
Sbjct: 382 FKLL 385

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 74/124 (59%), Gaps = 2/124 (1%)
Query: 56  TFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           T + +  + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+N
Sbjct: 262 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 321
Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +LL+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 322 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 380
Query: 175 GEIM 178
            +++
Sbjct: 381 FKLL 384

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 89/176 (50%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NL+++    +K+ DF
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           TL E ++L++  H  + A+K   +   R  F    ++      +L   +   +  ++D  
Sbjct: 198 TLTENRVLQNSRHPFLTALKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRA 253
Query: 87  RYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYV 144
           R++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +   M  + 
Sbjct: 254 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 313
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL--- 199
            T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+   
Sbjct: 314 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 372
Query: 200 -IGSPDETSL--GFLRSDNARR 218
               P+  SL  G L+ D  +R
Sbjct: 373 RTLGPEAKSLLSGLLKKDPKQR 394

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 74/124 (59%), Gaps = 2/124 (1%)
Query: 56  TFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           T + +  + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +LL+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 175 GEIM 178
            +++
Sbjct: 382 FKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 74/124 (59%), Gaps = 2/124 (1%)
Query: 56  TFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           T + +  + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +LL+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 175 GEIM 178
            +++
Sbjct: 382 FKLL 385

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIV 63
           V  K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 64  YE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            E +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 123 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ ++    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYQMAAGYP 236
Query: 183 LF 184
            F
Sbjct: 237 PF 238

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 86
           TL E ++L++  H  + A+K   +   R  F    ++      +L   +   +  ++D  
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCF----VMEYANGGELFFHLSRERVFSEDRA 250
Query: 87  RYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYV 144
           R++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +   M  + 
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 310
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITEL--- 199
            T  Y APE+L + ++Y  A+D W +G ++ E+M  +  F  +D+  + +L L+ E+   
Sbjct: 311 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 369
Query: 200 -IGSPDETSL--GFLRSDNARR 218
               P+  SL  G L+ D  +R
Sbjct: 370 RTLGPEAKSLLSGLLKKDPKQR 391

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 21  RIDAKRTLREIKLLRHMDHENIIAIKDIIRPP------QRETFNDVYIVYELMDT-DLHQ 73
           ++  K+ + + K  +H+  E  + +K++  P         +T + +Y V + ++  +L  
Sbjct: 69  KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 128
Query: 74  IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 133
            ++  +   +   R++  ++   L Y+HS N+++RDLKP N+LL++   + + DFGL + 
Sbjct: 129 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188
Query: 134 TSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 192
             E +  T  +  T  Y APE +L+   Y   +D W +G +L E++   P F  ++    
Sbjct: 189 NIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
Query: 193 --------LRLITELIGSPDETSLGFLRSDNARR 218
                   L+L   +  S      G L+ D  +R
Sbjct: 248 YDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L +      L ++L+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 141 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
              +V T ++ APE ++  S Y +  DIWS+G    E+   +P
Sbjct: 176 RNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELARGEP 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYELMD---- 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y +M+    
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 187 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK + + +  +   +  L E  ++   DH N+I ++ ++          V I+ E M+
Sbjct: 38  VAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----TPVMIITEFME 91
Query: 69  T-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R +    T       L  +  G+KY+   N +HR L   N+L+N+N   K+ 
Sbjct: 92  NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVS 151
Query: 127 DFGLAR----TTSE---TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGL+R     TS+   T  +   +  RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 15  GNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYELM-D 68
           GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E +  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 69  TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 128
            ++   +R      + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DF
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           G A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 186 GFAKRVKGRTWXL--CGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L +      L ++L+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 141 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
              +V T ++ APE ++  S Y +  DIWS+G    E+   +P
Sbjct: 161 RNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELARGEP 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L +      L ++L+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 141 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
              +V T ++ APE ++  S Y +  DIWS+G    E+   +P
Sbjct: 161 RNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELARGEP 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L +      L ++L+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 141 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
              +V T ++ APE ++  S Y +  DIWS+G    E+   +P
Sbjct: 181 RNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELARGEP 222

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NL+++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y APE++++   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPEIIISKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 22/234 (9%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK +   +  R   +  L E  ++   +H NII ++ ++          V I+ E M+
Sbjct: 45  VAIKTLKGGYTER-QRREFLSEASIMGQFEHPNIIRLEGVVTNSM-----PVMILTEFME 98
Query: 69  TD-LHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R +    T       L  +  G++Y+   + +HRDL   N+L+N+N   K+ 
Sbjct: 99  NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVS 158
Query: 127 DFGLARTTSE-------TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGL+R   E       T  +   +  RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 159 DFGLSRFLEENSSDPTYTSSLGGKIPIRW-TAPEAIA-FRKFTSASDAWSYGIVMWEVMS 216
Query: 180 --RQPLF--PGKDYVHQLRLITELIGSPD-ETSLGFLRSDNARRYVRMLPQFPK 228
              +P +    +D ++ +     L   PD  TSL  L  D  ++     P+FP+
Sbjct: 217 FGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQ 270

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 66  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + ++     
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 179
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 180 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 61  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + ++     
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 174
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 175 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T  Y AP ++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEYLAPAIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + ++     
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 175
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 176 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 270 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 300

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 80  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 139
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    + +   E+V TR Y +PE  L  + Y+   DIWS+G  L 
Sbjct: 140 LVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 197
Query: 176 EI-MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
           E+ + R P  P    +    L+  ++  P                    P+ P   FS  
Sbjct: 198 EMAVGRYPRPP----MAIFELLDYIVNEPP-------------------PKLPSAVFSLE 234
Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           F        D + K L+ +P  R  + + + H ++
Sbjct: 235 FQ-------DFVNKCLIKNPAERADLKQLMVHAFI 262

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 51  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 104
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + ++     
Sbjct: 105 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 164
Query: 145 V---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 165 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 50/291 (17%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           ++VAIK+I    ++  + K  + E++ L  ++H NI+ +            N V +V E 
Sbjct: 32  KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYG-------ACLNPVCLVMEY 80
Query: 67  MDT-DLHQIIRSHQDL---TDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLNA 119
            +   L+ ++   + L   T  H   +  Q  +G+ Y+HS     ++HRDLKP NLLL A
Sbjct: 81  AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140
Query: 120 NCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               LKI DFG A        MT    +  + APE+    S Y+   D++S G IL E++
Sbjct: 141 GGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVI 197
Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+  F             + IG P    +  + +      ++ LP+ P ++   R  +K
Sbjct: 198 TRRKPF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK-PIESLMTRCWSK 243
Query: 239 SPGA-------VDLLEKMLVFDPNRRITVDEAL---CHPYLAPLHDINEEP 279
            P         V ++  ++ + P      DE L   C   L P  D   EP
Sbjct: 244 DPSQRPSMEEIVKIMTHLMRYFPG----ADEPLQYPCQHSLPPGEDGRVEP 290

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 22/186 (11%)
Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           ++VAIK+I    ++  + K  + E++ L  ++H NI+ +            N V +V E 
Sbjct: 33  KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYG-------ACLNPVCLVMEY 81
Query: 67  MDT-DLHQIIRSHQDL---TDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLNA 119
            +   L+ ++   + L   T  H   +  Q  +G+ Y+HS     ++HRDLKP NLLL A
Sbjct: 82  AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 141
Query: 120 NCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               LKI DFG A        MT    +  + APE+    S Y+   D++S G IL E++
Sbjct: 142 GGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVI 198
Query: 179 TRQPLF 184
           TR+  F
Sbjct: 199 TRRKPF 204

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 59/112 (52%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 212
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G ++ EI T     +PG       +L+ E
Sbjct: 213 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 263

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 111/257 (43%), Gaps = 39/257 (15%)
Query: 22  IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-D 80
           +D      EI ++  + H  +I + D       + +  V I+  L   +L   I +    
Sbjct: 90  LDKYTVKNEISIMNQLHHPKLINLHDAFE----DKYEMVLILEFLSGGELFDRIAAEDYK 145
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--CDLKIGDFGLARTTSETD 138
           +++     ++ Q   GLK++H  +++H D+KP N++        +KI DFGLA   +  +
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
Query: 139 FMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 196
            +     T  + APE++       YT   D+W++G +   +++    F G+D +  L+ +
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYT---DMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262
Query: 197 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 256
                  DE +                           F + SP A D ++ +L  +P +
Sbjct: 263 KRCDWEFDEDA---------------------------FSSVSPEAKDFIKNLLQKEPRK 295
Query: 257 RITVDEALCHPYLAPLH 273
           R+TV +AL HP+L   H
Sbjct: 296 RLTVHDALEHPWLKGDH 312

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 59/112 (52%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 215
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G ++ EI T     +PG       +L+ E
Sbjct: 216 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 266

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 210
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 241

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M+  T +EVAI+++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 41  MDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDEL 93
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L+++HS  V+HR++K  N+LL  +
Sbjct: 94  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMD 153
Query: 121 CDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 154 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIE 212
Query: 180 RQPLFPGKDYVHQLRLITELIGSPD 204
            +P +  ++ +  L LI    G+P+
Sbjct: 213 GEPPYLNENPLRALYLIAT-NGTPE 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET    A K I    +  ++    + EI +L   DH NI+ + D          N+++
Sbjct: 58  NKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKLLDAFYYE-----NNLW 110
Query: 62  IVYEL-----MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           I+ E      +D  + ++ R    LT+   +    Q L  L Y+H   ++HRDLK  N+L
Sbjct: 111 ILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 167
Query: 117 LNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSV 170
              + D+K+ DFG+ A+ T        ++ T ++ APE+++ C       Y    D+WS+
Sbjct: 168 FTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVM-CETSKDRPYDYKADVWSL 226
Query: 171 GCILGEIMTRQP 182
           G  L E+   +P
Sbjct: 227 GITLIEMAEIEP 238

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + ++     
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 145 V---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 92/190 (48%), Gaps = 26/190 (13%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T+  V   K G+     +  +  L E  +++ + H+ ++ +  ++      T   +Y
Sbjct: 204 NKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVV------TKEPIY 252
Query: 62  IVYELM-DTDLHQIIRSHQDLTDDHCRY--FLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           I+ E M    L   ++S +       +   F  Q+  G+ ++   N +HRDL+ +N+L++
Sbjct: 253 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 312
Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           A+   KI DFGLAR  ++          +W  APE  +N   +T   D+WS G +L EI+
Sbjct: 313 ASLVCKIADFGLARVGAK-------FPIKW-TAPE-AINFGSFTIKSDVWSFGILLMEIV 363
Query: 179 T--RQPLFPG 186
           T  R P +PG
Sbjct: 364 TYGRIP-YPG 372

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 289 NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 337
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M      ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 338 IVTEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS G +
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 453
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 454 LTELTTKGRVPYPG 467

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET    A K I    +  ++    + EI +L   DH NI+ + D          N+++
Sbjct: 58  NKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKLLDAFYYE-----NNLW 110
Query: 62  IVYEL-----MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           I+ E      +D  + ++ R    LT+   +    Q L  L Y+H   ++HRDLK  N+L
Sbjct: 111 ILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 167
Query: 117 LNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSV 170
              + D+K+ DFG+ A+ T        ++ T ++ APE+++ C       Y    D+WS+
Sbjct: 168 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM-CETSKDRPYDYKADVWSL 226
Query: 171 GCILGEIMTRQP 182
           G  L E+   +P
Sbjct: 227 GITLIEMAEIEP 238

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 15/178 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK +   + ++   +  L E  ++   DH NII ++ ++          V I+ E M+
Sbjct: 60  VAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHLEGVV-----TKCKPVMIITEYME 113
Query: 69  T-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R +    T       L  +  G+KY+   + +HRDL   N+L+N+N   K+ 
Sbjct: 114 NGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVS 173
Query: 127 DFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFG++R      E  + T    +  RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 174 DFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 229

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 33  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 81
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M      ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 82  IVTEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 139
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS G +
Sbjct: 140 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 197
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 198 LTELTTKGRVPYPG 211

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDH 85
           +RE+  +  +DH N+I +  ++  P  +   ++  +  L+D      +R HQ   L    
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTL 123
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
            RY + Q+  G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E
Sbjct: 124 SRYAV-QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE 182
Query: 143 Y-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  V   + APE  L    ++ A D W  G  L E+ T
Sbjct: 183 HRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+       R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 37  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 85
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M+     ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 86  IVTEYMNKG--SLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANIL 143
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS G +
Sbjct: 144 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 201
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 202 LTELTTKGRVPYPG 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N ET    A K I    +  ++    + EI +L   DH NI+ + D          N+++
Sbjct: 58  NKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKLLDAFYYE-----NNLW 110
Query: 62  IVYEL-----MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           I+ E      +D  + ++ R    LT+   +    Q L  L Y+H   ++HRDLK  N+L
Sbjct: 111 ILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 167
Query: 117 LNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSV 170
              + D+K+ DFG+ A+ T        ++ T ++ APE+++ C       Y    D+WS+
Sbjct: 168 FTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVM-CETSKDRPYDYKADVWSL 226
Query: 171 GCILGEIMTRQP 182
           G  L E+   +P
Sbjct: 227 GITLIEMAEIEP 238

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDH 85
           +RE+  +  +DH N+I +  ++  P  +   ++  +  L+D      +R HQ   L    
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTL 123
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
            RY + Q+  G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E
Sbjct: 124 SRYAV-QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 143 Y-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  V   + APE  L    ++ A D W  G  L E+ T
Sbjct: 183 HRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  +   K GN     +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 207 NGTTRVAIKTLKPGN-----MSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 255
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 256 IVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 309
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGL R   + ++          +W  APE  L    +T   D+WS
Sbjct: 310 ANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 367
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 368 FGILLTELTTKGRVPYPG 385

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 1/87 (1%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 151
           Q+ +G+ Y+HS  ++HRDLKPSN+ L     +KIGDFGL  +       T    T  Y +
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 152 PELLLNCSEYTAAIDIWSVGCILGEIM 178
           PE  ++  +Y   +D++++G IL E++
Sbjct: 204 PE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFND---VYIVYE- 65
           K+ GN +  +I  K+ + ++K + H  +E  I  A+          +F D   +Y+V E 
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 66  LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++    +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
            DFG A+      +      T    APE++L+   Y  A+D W++G ++ E+    P F
Sbjct: 183 TDFGFAKRVKGRTWXL--CGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 89  IVMEYMSKGCLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 206 NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 254
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M      ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 255 IVTEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS G +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 370
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 371 LTELTTKGRVPYPG 384

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDH 85
           +RE+  +  +DH N+I +  ++  P  +   ++  +  L+D      +R HQ   L    
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTL 113
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
            RY + Q+  G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E
Sbjct: 114 SRYAV-QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE 172
Query: 143 Y-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  V   + APE  L    ++ A D W  G  L E+ T
Sbjct: 173 HRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 29  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 77
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 78  IVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 131
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 132 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 189
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 190 FGILLTELTTKGRVPYPG 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDH 85
           +RE+  +  +DH N+I +  ++  P  +   ++  +  L+D      +R HQ   L    
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTL 113
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
            RY + Q+  G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E
Sbjct: 114 SRYAV-QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 143 Y-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  V   + APE  L    ++ A D W  G  L E+ T
Sbjct: 173 HRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 115/259 (44%), Gaps = 22/259 (8%)
Query: 26  RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDD 84
           + +RE+++L   +   I+            +  ++ I  E MD   L Q+++    + + 
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKKAGRIPEQ 166
Query: 85  HCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 143
                   +++GL Y+   + ++HRD+KPSN+L+N+  ++K+ DFG++    ++     +
Sbjct: 167 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 225
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI-MTRQPLFPGKDYVHQLRLITELIGS 202
           V TR Y +PE  L  + Y+   DIWS+G  L E+ + R P+ P      +L    ++ G 
Sbjct: 226 VGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 284
Query: 203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSA------RFPNKSPGAV------DLLEKML 250
             ET               M  + P   F          P K P AV      D + K L
Sbjct: 285 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCL 344
Query: 251 VFDPNRRITVDEALCHPYL 269
           + +P  R  + + + H ++
Sbjct: 345 IKNPAERADLKQLMVHAFI 363

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 206 NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 254
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M      ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 255 IVTEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS G +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 370
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 371 LTELTTKGRVPYPG 384

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 37  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 85
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M+     ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 86  IVTEYMNKG--SLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANIL 143
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS G +
Sbjct: 144 VGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 201
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 202 LTELTTKGRVPYPG 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 31  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 79
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 80  IVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 133
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 134 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 191
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 192 FGILLTELTTKGRVPYPG 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 89  IVIEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 89  IVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  ++I DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDH 85
           +RE+  +  +DH N+I +  ++  P  +   ++  +  L+D      +R HQ   L    
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTL 113
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
            RY + Q+  G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E
Sbjct: 114 SRYAV-QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 143 Y-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  V   + APE  L    ++ A D W  G  L E+ T
Sbjct: 173 HRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 89  IVCEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 89  IVTEYMSKGCLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDH 85
           +RE+  +  +DH N+I +  ++  P  +   ++  +  L+D      +R HQ   L    
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTL 117
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
            RY + Q+  G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E
Sbjct: 118 SRYAV-QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 143 Y-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  V   + APE  L    ++ A D W  G  L E+ T
Sbjct: 177 HRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 66/279 (23%)
Query: 27  TLREIKLLRHMD-HENIIAIKDIIRPPQRETFND-VYIVYELMDTDLHQIIRSHQDLTDD 84
            L EIKLL   D H N+I      R    ET +  +YI  EL + +L  ++ S ++++D+
Sbjct: 55  ALMEIKLLTESDDHPNVI------RYYCSETTDRFLYIALELCNLNLQDLVES-KNVSDE 107
Query: 85  HCRY--------FLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------------NCDL 123
           + +          L Q+  G+ ++HS  ++HRDLKP N+L++              N  +
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 124 KIGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCSE------YTAAIDIWSVGC 172
            I DFGL +   + +  F   +     T  +RAPELL   +        T +IDI+S+GC
Sbjct: 168 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +   I+++     G  Y  +  +I   I S DE      RS  A                
Sbjct: 228 VFYYILSKGKHPFGDKYSRESNIIRG-IFSLDEMKCLHDRSLIAE--------------- 271
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                    A DL+ +M+  DP +R T  + L HP   P
Sbjct: 272 ---------ATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDH 85
           +RE+  +  +DH N+I +  ++  P  +   ++  +  L+D      +R HQ   L    
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTL 117
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 142
            RY + Q+  G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E
Sbjct: 118 SRYAV-QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 143 Y-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  V   + APE  L    ++ A D W  G  L E+ T
Sbjct: 177 HRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 206 NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 254
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M      ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 255 IVGEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS G +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 370
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 371 LTELTTKGRVPYPG 384

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG 169
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 117/259 (45%), Gaps = 42/259 (16%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYF 89
           E++++  + +E  +  + II       +++VYI+YE M+ D       +  + D +   F
Sbjct: 93  ELQIITDIKNEYCLTCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 90  L---------YQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 139
           +           +L    Y+H+  N+ HRD+KPSN+L++ N  +K+ DFG      E+++
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG------ESEY 201
Query: 140 MTEYVV-----TRWYRAPELLLNCSEYTAA-IDIWSVGCILGEIMTRQPLFPGKDYVHQL 193
           M +  +     T  +  PE   N S Y  A +DIWS+G  L  +      F  K     +
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK-----I 256
Query: 194 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK--SPGAVDLLEKMLV 251
            L+ EL  +    ++ +    N   Y       P  N  +   N   S   +D L+  L 
Sbjct: 257 SLV-ELFNNIRTKNIEYPLDRNHFLY-------PLTNKKSTCSNNFLSNEDIDFLKLFLR 308
Query: 252 FDPNRRITVDEALCHPYLA 270
            +P  RIT ++AL H +LA
Sbjct: 309 KNPAERITSEDALKHEWLA 327

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQL RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            + APE L +   YT   D+WS G ++ EI T
Sbjct: 224 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 15/178 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK +   + ++   +  L E  ++   DH NII ++ ++   +      V I+ E M+
Sbjct: 45  VAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKCK-----PVMIITEYME 98
Query: 69  T-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R +    T       L  +  G+KY+   + +HRDL   N+L+N+N   K+ 
Sbjct: 99  NGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVS 158
Query: 127 DFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFG++R      E  + T    +  RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 159 DFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 65  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 118
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 179 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 64  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 178 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 72/136 (52%), Gaps = 3/136 (2%)
Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + +Y V E ++  DL   I+      +    ++  ++  GL ++H   +++RDLK  
Sbjct: 90  QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLD 149
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N++L++   +KI DFG+ +        T E+  T  Y APE++     Y  ++D W+ G 
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY-QPYGKSVDWWAYGV 208
Query: 173 ILGEIMTRQPLFPGKD 188
           +L E++  QP F G+D
Sbjct: 209 LLYEMLAGQPPFDGED 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 89  IVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 176 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 15/178 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK +   + ++   +  L E  ++   DH NII ++ ++   +      V I+ E M+
Sbjct: 39  VAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKCK-----PVMIITEYME 92
Query: 69  T-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R +    T       L  +  G+KY+   + +HRDL   N+L+N+N   K+ 
Sbjct: 93  NGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVS 152
Query: 127 DFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFG++R      E  + T    +  RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 153 DFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 208

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 52  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 105
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HR+L+ +N+L++     KI DFGLAR   + ++     
Sbjct: 106 KLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 165
Query: 145 V---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 166 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  + Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 176 EI-MTRQPLFP--GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           E+ + R P+ P   K+       I EL        L ++ ++         P+ P   FS
Sbjct: 195 EMAVGRYPIPPPDAKEDSRPPMAIFEL--------LDYIVNEPP-------PKLPSGVFS 239
Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             F        D + K L+ +P  R  + + + H ++
Sbjct: 240 LEFQ-------DFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VAIK  K+G     R D    L E  ++   DH NII ++ ++   +       Y+    
Sbjct: 53  VAIKTLKVGYTEKQRRD---FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGS 109
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
           +DT L    ++    T       L  +  G+KY+     +HRDL   N+L+N+N   K+ 
Sbjct: 110 LDTFLK---KNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVS 166
Query: 127 DFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGL+R      E  + T    +  RW  APE +    ++T+A D+WS G ++ E+++
Sbjct: 167 DFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIA-FRKFTSASDVWSYGIVMWEVVS 222

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 58  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 111
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 112 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 171
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 172 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 21/188 (11%)
Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           N  T E VA+K  K      +R   K+   EI +LR + HE+II  K        ++   
Sbjct: 39  NDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQ- 94
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
             +V E +     +       +       F  Q+  G+ Y+HS + +HR+L   N+LL+ 
Sbjct: 95  --LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDN 152
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSVG 171
           +  +KIGDFGLA+   E     EY   R        WY APE L     Y A+ D+WS G
Sbjct: 153 DRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-APECLKEYKFYYAS-DVWSFG 207
Query: 172 CILGEIMT 179
             L E++T
Sbjct: 208 VTLYELLT 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 57  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 110
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 111 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 171 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 46  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 101
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 102 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 160
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 161 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 218
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 219 LWELMTRGAPPYP 231

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCR 87
           E+ +LR   H NI+        PQ      + IV +  +     H +  S          
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLI 123
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA----RTTSETDFMTEY 143
               Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA    R +    F    
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 144 VVTRWYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
               W  APE+  + + + Y+   D+++ G +L E+MT Q  +   +   Q   I E++G
Sbjct: 184 GSILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVG 239
Query: 202 ----SPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR--FP 236
               SPD   L  +RS+  +R  R++ +  K+    R  FP
Sbjct: 240 RGSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 52  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 107
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 166
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 167 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 224
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 225 LWELMTRGAPPYP 237

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR--SHQDLTDD 84
           L E  L++ + H+ ++ +  ++      T   +YI+ E M+   L   ++  S   LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
                  Q+  G+ ++   N +HRDL+ +N+L++     KI DFGLAR   + +      
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 168
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 169 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 226
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 227 LWELMTRGAPPYP 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 49  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 104
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 163
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 221
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 222 LWELMTRGAPPYP 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 72  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 127
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 128 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 186
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 187 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 244
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 245 LWELMTRGAPPYP 257

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 21  RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ 79
           R + +   +E+++++ ++H  ++ +    +  +     D+++V +L+   DL   ++ + 
Sbjct: 56  RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-----DMFMVVDLLLGGDLRYHLQQNV 110
Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 139
              ++  + F+ +L+  L Y+ +  ++HRD+KP N+LL+ +  + I DF +A        
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 140 MTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIM-TRQP 182
           +T    T+ Y APE+  +   + Y+ A+D WS+G    E++  R+P
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 73  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 128
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 129 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 187
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 188 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 245
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 246 LWELMTRGAPPYP 258

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 53  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 108
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 167
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 168 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 225
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 226 LWELMTRGAPPYP 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 51  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 106
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 165
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 166 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 223
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 224 LWELMTRGAPPYP 236

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 168
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +
Sbjct: 169 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 226
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 227 LWELMTRGAPPYP 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 29/198 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N+ T+  V   K G      +  +  L E  L++ + H+ ++ +  ++    RE    +Y
Sbjct: 35  NNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVV---TRE--EPIY 84
Query: 62  IVYELM-DTDLHQIIRSHQD-------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           I+ E M    L   ++S +        L D     F  Q+  G+ Y+   N +HRDL+ +
Sbjct: 85  IITEYMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIHRDLRAA 139
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSV 170
           N+L++ +   KI DFGLAR   + ++          +W  APE  +N   +T   D+WS 
Sbjct: 140 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGCFTIKSDVWSF 197
Query: 171 GCILGEIMTRQPL-FPGK 187
           G +L EI+T   + +PG+
Sbjct: 198 GILLYEIVTYGKIPYPGR 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL  
Sbjct: 89  IVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLAA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + ++          +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCR 87
           E+ +LR   H NI+        PQ      + IV +  +     H +  S          
Sbjct: 58  EVGVLRKTRHVNILLFMGYSTKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLI 111
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---V 144
               Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++    
Sbjct: 112 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS 171
Query: 145 VTRWYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG- 201
            +  + APE+  + + + Y+   D+++ G +L E+MT Q  +   +   Q   I E++G 
Sbjct: 172 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGR 228
Query: 202 ---SPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR--FP 236
              SPD   L  +RS+  +R  R++ +  K+    R  FP
Sbjct: 229 GSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 265

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCR 87
           E+ +LR   H NI+        PQ      + IV +  +     H +  S          
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLI 123
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA----RTTSETDFMTEY 143
               Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA    R +    F    
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 144 VVTRWYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 201
               W  APE+  + + + Y+   D+++ G +L E+MT Q  +   +   Q   I E++G
Sbjct: 184 GSILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVG 239
Query: 202 ----SPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR--FP 236
               SPD   L  +RS+  +R  R++ +  K+    R  FP
Sbjct: 240 RGSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  + Y+   DIWS+G  L 
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221
Query: 176 EI-MTRQPLFP 185
           E+ + R P+ P
Sbjct: 222 EMAVGRYPIPP 232

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 29  REIKLLRHMDHENIIAIKDII-----------RPPQRETFNDVYIVYELMDTD-LHQII- 75
           RE+K L  +DH NI+                 +   R     ++I  E  D   L Q I 
Sbjct: 53  REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 76  -RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 134
            R  + L          Q+ +G+ Y+HS  +++RDLKPSN+ L     +KIGDFGL  + 
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 135 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
                      T  Y +PE  ++  +Y   +D++++G IL E++
Sbjct: 173 KNDGKRXRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 31/154 (20%)
Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETD 138
            L+    R ++  L + LK +H   ++HRD+KPSN L N       + DFGLA+ T +T 
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 139 F-MTEYVV----------------------------TRWYRAPELLLNCSEYTAAIDIWS 169
             + ++V                             T  +RAPE+L  C   T AID+WS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 170 VGCILGEIMT-RQPLFPGKDYVHQLRLITELIGS 202
            G I   +++ R P +   D +  L  I  + GS
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS 266

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 24/191 (12%)
Query: 1   MNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +   T   VA+K++ ++  D + D +R   EI++L+ +  + I+  + +   P R++   
Sbjct: 47  LGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILKALHSDFIVKYRGVSYGPGRQSLR- 102
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLL 116
             +V E + +  L   ++ H+   D   R  LY  Q+ +G++Y+ S   +HRDL   N+L
Sbjct: 103 --LVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIW 168
           + +   +KI DFGLA+         +Y V R        WY APE L + + ++   D+W
Sbjct: 160 VESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVW 214
Query: 169 SVGCILGEIMT 179
           S G +L E+ T
Sbjct: 215 SFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 24/191 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +   T   VA+K++ ++     D +R   REI++L+ +  + I+  + +   P R++   
Sbjct: 35  LGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR- 90
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLL 116
             +V E + +  L   ++ H+   D   R  LY  Q+ +G++Y+ S   +HRDL   N+L
Sbjct: 91  --LVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 147
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIW 168
           + +   +KI DFGLA+         +Y V R        WY APE L + + ++   D+W
Sbjct: 148 VESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVW 202
Query: 169 SVGCILGEIMT 179
           S G +L E+ T
Sbjct: 203 SFGVVLYELFT 213

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 36/262 (13%)
Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA------IKDIIRPPQRETFND 59
           +E+VAIK+I N    +      L+EI+ +    H NI++      +KD           +
Sbjct: 35  KEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----------E 82
Query: 60  VYIVYELM------DTDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           +++V +L+      D   H + +       L +      L ++L GL+Y+H    +HRD+
Sbjct: 83  LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV 142
Query: 111 KPSNLLLNANCDLKIGDFGLARTTSETDFMTE------YVVTRWYRAPELLLNCSEYTAA 164
           K  N+LL  +  ++I DFG++   +    +T       +V T  + APE++     Y   
Sbjct: 143 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK 202
Query: 165 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 224
            DIWS G    E+ T     P   Y     L+  L   P     G    +  ++Y +   
Sbjct: 203 ADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR 260
Query: 225 QFPKQNFSARFPNKSPGAVDLL 246
           +        + P K P A +LL
Sbjct: 261 KMISLCLQ-KDPEKRPTAAELL 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 36/262 (13%)
Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA------IKDIIRPPQRETFND 59
           +E+VAIK+I N    +      L+EI+ +    H NI++      +KD           +
Sbjct: 40  KEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----------E 87
Query: 60  VYIVYELM------DTDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           +++V +L+      D   H + +       L +      L ++L GL+Y+H    +HRD+
Sbjct: 88  LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV 147
Query: 111 KPSNLLLNANCDLKIGDFGLARTTSETDFMTE------YVVTRWYRAPELLLNCSEYTAA 164
           K  N+LL  +  ++I DFG++   +    +T       +V T  + APE++     Y   
Sbjct: 148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK 207
Query: 165 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 224
            DIWS G    E+ T     P   Y     L+  L   P     G    +  ++Y +   
Sbjct: 208 ADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR 265
Query: 225 QFPKQNFSARFPNKSPGAVDLL 246
           +        + P K P A +LL
Sbjct: 266 KMISLCLQ-KDPEKRPTAAELL 286

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 24/191 (12%)
Query: 1   MNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +   T   VA+K++ ++  D + D +R   EI++L+ +  + I+  + +   P R++   
Sbjct: 34  LGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILKALHSDFIVKYRGVSYGPGRQSLR- 89
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLL 116
             +V E + +  L   ++ H+   D   R  LY  Q+ +G++Y+ S   +HRDL   N+L
Sbjct: 90  --LVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 146
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIW 168
           + +   +KI DFGLA+         +Y V R        WY APE L + + ++   D+W
Sbjct: 147 VESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVW 201
Query: 169 SVGCILGEIMT 179
           S G +L E+ T
Sbjct: 202 SFGVVLYELFT 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 21/188 (11%)
Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           N  T E VA+K  K      +R   K+   EI +LR + HE+II  K        ++   
Sbjct: 39  NDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQ- 94
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
             +V E +     +       +       F  Q+  G+ Y+H+ + +HR+L   N+LL+ 
Sbjct: 95  --LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDN 152
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSVG 171
           +  +KIGDFGLA+   E     EY   R        WY APE L     Y A+ D+WS G
Sbjct: 153 DRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-APECLKEYKFYYAS-DVWSFG 207
Query: 172 CILGEIMT 179
             L E++T
Sbjct: 208 VTLYELLT 215

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 113 NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 168
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 227
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +
Sbjct: 228 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 285
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 286 LWELMTRGAPPYP 298

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 3/146 (2%)
Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + +Y V E ++  DL   I+      + H  ++  ++  GL ++ S  +++RDLK  
Sbjct: 91  QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY-QPYGKSVDWWAFGV 209
Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITE 198
           +L E++  Q  F G+D     + I E
Sbjct: 210 LLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 3/146 (2%)
Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + +Y V E ++  DL   I+      + H  ++  ++  GL ++ S  +++RDLK  
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY-QPYGKSVDWWAFGV 530
Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITE 198
           +L E++  Q  F G+D     + I E
Sbjct: 531 LLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 32/198 (16%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +Y
Sbjct: 40  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIY 88
Query: 62  IVYELMD---------TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           IV E M           ++ + +R  Q L D        Q+  G+ YV   N +HRDL+ 
Sbjct: 89  IVIEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-----MAAQIASGMAYVERMNYVHRDLRA 142
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWS 169
           +N+L+  N   K+ DFGLAR   + +           +W  APE  L    +T   D+WS
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWS 200
Query: 170 VGCILGEIMTRQPL-FPG 186
            G +L E+ T+  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 168
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +
Sbjct: 169 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 226
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 227 LWELMTRGAPPYP 239

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N+ T+  V   K G      +  +  L E  L++ + H+ ++ +  ++   +      +Y
Sbjct: 34  NNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PIY 83
Query: 62  IVYELM-DTDLHQIIRSHQD-------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           I+ E M    L   ++S +        L D     F  Q+  G+ Y+   N +HRDL+ +
Sbjct: 84  IITEFMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIHRDLRAA 138
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSV 170
           N+L++ +   KI DFGLAR   + ++          +W  APE  +N   +T   ++WS 
Sbjct: 139 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGCFTIKSNVWSF 196
Query: 171 GCILGEIMTRQPL-FPGK 187
           G +L EI+T   + +PG+
Sbjct: 197 GILLYEIVTYGKIPYPGR 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 85/163 (52%), Gaps = 10/163 (6%)
Query: 26  RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDD 84
           + +RE+++L   +   I+            +  ++ I  E MD   L Q+++    + + 
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104
Query: 85  HCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 143
                   +++GL Y+   + ++HRD+KPSN+L+N+  ++K+ DFG++    ++     +
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 163
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI-MTRQPLFP 185
           V TR Y +PE  L  + Y+   DIWS+G  L E+ + R P+ P
Sbjct: 164 VGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  + Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 176 EI-MTRQPLFP 185
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK +   +  R   +  L E  ++   DH NII ++ ++   +        IV E M+
Sbjct: 80  VAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL-----AMIVTEYME 133
Query: 69  T-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R+H    T       L  +  G++Y+     +HRDL   N+L+++N   K+ 
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 127 DFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGL+R   E D    Y  T      RW  APE  +    +++A D+WS G ++ E++ 
Sbjct: 194 DFGLSRVL-EDDPDAAYTTTGGKIPIRW-TAPE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 16/183 (8%)
Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+K  K     DN+   ++ + E  +++++DH +I+ +  II         ++Y   EL
Sbjct: 55  VAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGEL 111
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
                H + R+   L       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+G
Sbjct: 112 G----HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 167
Query: 127 DFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQ 181
           DFGL+R   + D+    V     +W  +PE  +N   +T A D+W     + EI++  +Q
Sbjct: 168 DFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQ 225
Query: 182 PLF 184
           P F
Sbjct: 226 PFF 228

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 59  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 114
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 115 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 173
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +
Sbjct: 174 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 231
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 232 LWELMTRGAPPYP 244

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 16/183 (8%)
Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+K  K     DN+   ++ + E  +++++DH +I+ +  II         ++Y   EL
Sbjct: 39  VAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGEL 95
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
                H + R+   L       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+G
Sbjct: 96  G----HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 151
Query: 127 DFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQ 181
           DFGL+R   + D+    V     +W  +PE  +N   +T A D+W     + EI++  +Q
Sbjct: 152 DFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQ 209
Query: 182 PLF 184
           P F
Sbjct: 210 PFF 212

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 16/183 (8%)
Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+K  K     DN+   ++ + E  +++++DH +I+ +  II         ++Y   EL
Sbjct: 43  VAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGEL 99
Query: 67  MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
                H + R+   L       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+G
Sbjct: 100 G----HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 155
Query: 127 DFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQ 181
           DFGL+R   + D+    V     +W  +PE  +N   +T A D+W     + EI++  +Q
Sbjct: 156 DFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQ 213
Query: 182 PLF 184
           P F
Sbjct: 214 PFF 216

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 146 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 205
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 206 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 256

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  + Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 176 EI-MTRQPLFP 185
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 115
            ++ I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  + Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 176 EI-MTRQPLFP 185
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 4/151 (2%)
Query: 24  AKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTD 83
            K TL EI +L  ++H NII + DI    + + F  + +       DL   I  H  L +
Sbjct: 74  GKVTL-EIAILSRVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE 129
Query: 84  DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 143
               Y   QL+  + Y+   +++HRD+K  N+++  +  +K+ DFG A           +
Sbjct: 130 PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189
Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
             T  Y APE+L+        +++WS+G  L
Sbjct: 190 CGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 201
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 202 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 150 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 209
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 210 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 260

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +++  +   DL   ++  + L ++H R++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 121 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 147 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 205
Query: 180 RQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
            +  F             +++GS   PD+ +  +L      + +R+    P+        
Sbjct: 206 GRSPF-------------DIVGSSDNPDQNTEDYLFQVILEKQIRI----PR-------- 240
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
           + S  A  +L+  L  DP  R+      CHP      DI   P
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLG-----CHPQTG-FADIQGHP 277

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 52  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 107
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 166
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +
Sbjct: 167 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 224
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 225 LWELMTRGAPPYP 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 55  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 110
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 169
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +
Sbjct: 170 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 227
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 228 LWELMTRGAPPYP 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 157 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 216
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 217 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 267

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 149 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 208
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 209 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 259

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +++  +   DL   ++  + L ++H R++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 121 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 143 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 201
Query: 180 RQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
            +  F             +++GS   PD+ +  +L      + +R+    P+        
Sbjct: 202 GRSPF-------------DIVGSSDNPDQNTEDYLFQVILEKQIRI----PR-------- 236
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
           + S  A  +L+  L  DP  R+      CHP      DI   P
Sbjct: 237 SLSVKAASVLKSFLNKDPKERLG-----CHPQTG-FADIQGHP 273

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 168
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +
Sbjct: 169 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 226
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 227 LWELMTRGAPPYP 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 157 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 216
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 217 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 267

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 157 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 216
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 217 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 267

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +++  +   DL   ++  + L ++H R++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 121 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 190 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 180 RQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
            +  F             +++GS   PD+ +  +L      + +R+    P+        
Sbjct: 249 GRSPF-------------DIVGSSDNPDQNTEDYLFQVILEKQIRI----PR-------- 283
Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
           + S  A  +L+  L  DP  R+      CHP      DI   P
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLG-----CHPQTG-FADIQGHP 320

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 31/172 (18%)
Query: 28  LREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR--SHQDLTDD 84
           + E+K++ H+  HENI+ +               Y  Y     DL   +R  +  DL  +
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKAEADLDKE 144
Query: 85  HCR--------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 136
             R        +F  Q+ +G+ ++ S N +HRD+   N+LL      KIGDFGLAR    
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---- 200
Query: 137 TDFM--TEYVV-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 201 -DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 31/172 (18%)
Query: 28  LREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR--SHQDLTDD 84
           + E+K++ H+  HENI+ +               Y  Y     DL   +R  +  DL  +
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKAEADLDKE 152
Query: 85  HCR--------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 136
             R        +F  Q+ +G+ ++ S N +HRD+   N+LL      KIGDFGLAR    
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---- 208
Query: 137 TDFM--TEYVV-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 209 -DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 53  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 108
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+KY+ S   +HRDL   N +L+ 
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 167
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +  + +  T      +W       L   ++T   D+WS G +
Sbjct: 168 KFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 225
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 226 LWELMTRGAPPYP 238

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 84/187 (44%), Gaps = 19/187 (10%)
Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           N  T E VA+K  K      +R   K+   EI +LR + HE+II  K         +   
Sbjct: 56  NDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQ- 111
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
             +V E +     +       +       F  Q+  G+ Y+H+ + +HRDL   N+LL+ 
Sbjct: 112 --LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN 169
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTR-------WYRAPELLLNCSEYTAAIDIWSVGC 172
           +  +KIGDFGLA+   E      Y V         WY APE L     Y A+ D+WS G 
Sbjct: 170 DRLVKIGDFGLAKAVPEGH--EXYRVREDGDSPVFWY-APECLKEYKFYYAS-DVWSFGV 225
Query: 173 ILGEIMT 179
            L E++T
Sbjct: 226 TLYELLT 232

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 257
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 258 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I     R   + + 
Sbjct: 55  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 110
Query: 62  IVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++  +   DL   IR  +H     D   + L Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 169
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCI 173
              +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +
Sbjct: 170 KFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVL 227
Query: 174 LGEIMTR-QPLFP 185
           L E+MTR  P +P
Sbjct: 228 LWELMTRGAPPYP 240

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 107/215 (49%), Gaps = 38/215 (17%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR--TTSETD 138
            T+   + ++ +++  L+++H   +++RD+K  N+LL++N  + + DFGL++     ET+
Sbjct: 156 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 139 FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 197
              ++  T  Y AP+++    S +  A+D WS+G ++ E++T    F             
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT------------ 263
Query: 198 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 257
            + G  +       +++ +RR ++  P +P Q  SA        A DL++++L+ DP +R
Sbjct: 264 -VDGEKNS------QAEISRRILKSEPPYP-QEMSAL-------AKDLIQRLLMKDPKKR 308
Query: 258 IT-----VDEALCHPYLAPLH--DINEEPVCPRPF 285
           +       DE   H +   ++  D+  + V P PF
Sbjct: 309 LGCGPRDADEIKEHLFFQKINWDDLAAKKV-PAPF 342

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 29/173 (16%)
Query: 28  LREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVY-----------ELMDTDLHQII 75
           + E+K++ H+  HENI+ +               Y  Y            +++TD    I
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 76  RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 135
            +    T D   +F  Q+ +G+ ++ S N +HRD+   N+LL      KIGDFGLAR   
Sbjct: 157 ANSTASTRD-LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--- 212
Query: 136 ETDFM--TEYVV-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 213 --DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 57/112 (50%), Gaps = 5/112 (4%)
Query: 91  YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 148
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D   +    R   
Sbjct: 157 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPV 216
Query: 149 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 198
            + APE L +   YT   D+WS G +L EI T     +PG       +L+ E
Sbjct: 217 KWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 267

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK +    + + D +  +RE +++  +D+  I+ +  + +         + +V E+ 
Sbjct: 39  DVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMA 91
Query: 68  DTD-LHQ-IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
               LH+ ++   +++   +    L+Q+  G+KY+   N +HRDL   N+LL      KI
Sbjct: 92  GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 151
Query: 126 GDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            DFGL++     D + T     +W   + APE  +N  ++++  D+WS G  + E ++
Sbjct: 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 29/173 (16%)
Query: 28  LREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVY-----------ELMDTDLHQII 75
           + E+K++ H+  HENI+ +               Y  Y            +++TD    I
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 76  RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 135
            ++  L+     +F  Q+ +G+ ++ S N +HRD+   N+LL      KIGDFGLAR   
Sbjct: 157 -ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--- 212
Query: 136 ETDFM--TEYVV-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 213 --DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D   +  +    +EIK++    HEN++ +            +D+ +VY  
Sbjct: 57  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF-----SSDGDDLCLVYVY 111
Query: 67  MDTDLHQIIRSHQDLT---DDHCRYFLYQ-LLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           M         S  D T     H R  + Q    G+ ++H  + +HRD+K +N+LL+    
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171
Query: 123 LKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            KI DFGLAR +   ++T   +  V T  Y APE L    E T   DI+S G +L EI+T
Sbjct: 172 AKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIIT 229
Query: 180 RQP 182
             P
Sbjct: 230 GLP 232

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK +    + + D +  +RE +++  +D+  I+ +  + +         + +V E+ 
Sbjct: 365 DVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMA 417
Query: 68  DTD-LHQ-IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
               LH+ ++   +++   +    L+Q+  G+KY+   N +HR+L   N+LL      KI
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKI 477
Query: 126 GDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            DFGL++     D + T     +W   + APE  +N  ++++  D+WS G  + E ++
Sbjct: 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 35/191 (18%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNAN--CDLKIGDFGLAR-----TTSETDFMTEYV 144
           Q+   L Y+H+  + HRD+KP N L + N   ++K+ DFGL++        E   MT   
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 145 VTRWYRAPELLLNCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
            T ++ APE+L   +E Y    D WS G +L  ++     FPG   V+    I++++   
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG---VNDADTISQVLNK- 291
Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
                            ++  + P  N        SP A DLL  +L  + + R     A
Sbjct: 292 -----------------KLCFENPNYNVL------SPLARDLLSNLLNRNVDERFDAMRA 328
Query: 264 LCHPYLAPLHD 274
           L HP+++   D
Sbjct: 329 LQHPWISQFSD 339

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 46/268 (17%)
Query: 25  KRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLT 82
            R  RE+++L +   H N++ + +      R      Y+V+E M    +   I   +   
Sbjct: 55  SRVFREVEMLYQCQGHRNVLELIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFN 109
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLART------ 133
           +      +  +   L ++H+  + HRDLKP N+L    N    +KI DFGL         
Sbjct: 110 ELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGD 169
Query: 134 ---TSETDFMTEYVVTRWYRAPELLLNCSE----YTAAIDIWSVGCILGEIMTRQPLFPG 186
               S  + +T    +  Y APE++   SE    Y    D+WS+G IL  +++  P F G
Sbjct: 170 CSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 187 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-----SPG 241
           +             GS      G+ R +       ML +   Q     FP+K     S  
Sbjct: 229 R------------CGS----DCGWDRGEACPACQNMLFE-SIQEGKYEFPDKDWAHISCA 271
Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYL 269
           A DL+ K+LV D  +R++  + L HP++
Sbjct: 272 AKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 5/157 (3%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           LRE+ +++ + H NI+     +  P   +    Y+    +   LH+   + + L +    
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRL 140
Query: 88  YFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV 145
              Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K+ DFGL+R  + T   ++   
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 146 -TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            T  + APE+L +      + D++S G IL E+ T Q
Sbjct: 201 GTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQ 236

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           LRE+ +++ + H NI+     +  P   +    Y+    +   LH+   + + L +    
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRL 140
Query: 88  YFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV 145
              Y + +G+ Y+H+ N  ++HRDLK  NLL++    +K+ DFGL+R  +     ++   
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA 200
Query: 146 -TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            T  + APE+L +      + D++S G IL E+ T Q
Sbjct: 201 GTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQ 236

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/264 (21%), Positives = 117/264 (44%), Gaps = 38/264 (14%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +++  +   DL   ++  + L ++H R++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 121 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 158 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 216
Query: 180 RQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
            +  F             +++GS   PD+ +  +L      + +R+    P+        
Sbjct: 217 GRSPF-------------DIVGSSDNPDQNTEDYLFQVILEKQIRI----PR-------- 251
Query: 237 NKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLH-DINEEPVCPRPFSFDF 289
           + S  A  +L+  L  DP  R+         +   HP+   +  D+ E+     PF  + 
Sbjct: 252 SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 311
Query: 290 EHPSFTEENIKELIYRESVKFNPD 313
               F  +N       E V+  PD
Sbjct: 312 SG-EFGLDNFDSQFTNERVQLXPD 334

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 24/194 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  TR  VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   + 
Sbjct: 30  NGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIX 78
Query: 62  IVYELMDTDLHQIIRSHQDLTDDHCRY-----FLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           IV E M      ++   +  T  + R         Q+  G+ YV   N +HRDL+ +N+L
Sbjct: 79  IVTEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 136
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCI 173
           +  N   K+ DFGLAR   + +           +W  APE  L    +T   D+WS G +
Sbjct: 137 VGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGIL 194
Query: 174 LGEIMTRQPL-FPG 186
           L E+ T+  + +PG
Sbjct: 195 LTELTTKGRVPYPG 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 10  AIKKIGNAFDNRIDAK-RTLREIKLLRHMDHENIIA---------IKDIIRPPQRETFND 59
           AIK+I     NR  A+ + +RE+K L  ++H  I+            + ++P   + +  
Sbjct: 34  AIKRI--RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY-- 89
Query: 60  VYIVYELM-DTDLHQIIRSHQDLTDDH---CRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +YI  +L    +L   +     + +     C +   Q+   ++++HS  ++HRDLKPSN+
Sbjct: 90  LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNI 149
Query: 116 LLNANCDLKIGDFGLARTTSETD-------------FMTEYVVTRWYRAPELLLNCSEYT 162
               +  +K+GDFGL     + +               T  V T+ Y +PE  ++ + Y+
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE-QIHGNSYS 208
Query: 163 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 199
             +DI+S+G IL E+     L+P    + ++R +T++
Sbjct: 209 HKVDIFSLGLILFEL-----LYPFSTQMERVRTLTDV 240

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D   +  +    +EIK++    HEN++ +            +D+ +VY  
Sbjct: 57  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF-----SSDGDDLCLVYVY 111
Query: 67  MDTDLHQIIRSHQDLT---DDHCRYFLYQ-LLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           M         S  D T     H R  + Q    G+ ++H  + +HRD+K +N+LL+    
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171
Query: 123 LKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            KI DFGLAR +   ++T      V T  Y APE L    E T   DI+S G +L EI+T
Sbjct: 172 AKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIIT 229
Query: 180 RQP 182
             P
Sbjct: 230 GLP 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 88
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 149 KVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 206
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 207 GMSPYPGID 215

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 37/178 (20%)
Query: 28  LREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR---------- 76
           + E+K++ H+  HENI+ +               Y  Y     DL   +R          
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKRPPGLEYS 152
Query: 77  ---SH---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 130
              SH   + L+     +F  Q+ +G+ ++ S N +HRD+   N+LL      KIGDFGL
Sbjct: 153 YNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 212
Query: 131 ARTTSETDFM--TEYVV-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           AR     D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 213 AR-----DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 88
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 149 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 206
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 207 GMSPYPGID 215

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 96  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 214 GMSPYPGIDLSQVYELL 230

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 88
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 149 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 206
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 207 GMSPYPGID 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 90
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 209 GMSPYPGID 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VA+K I     N   A+  L E  ++  + H N++ +  +I     E    +YIV E M
Sbjct: 37  KVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYM 88
Query: 68  -DTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   +RS     L  D    F   +   ++Y+   N +HRDL   N+L++ +   K
Sbjct: 89  AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 148
Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ--- 181
           + DFGL +  S T   T  +  +W  APE L   + ++   D+WS G +L EI +     
Sbjct: 149 VSDFGLTKEASSTQ-DTGKLPVKW-TAPEALREAA-FSTKSDVWSFGILLWEIYSFGRVP 205
Query: 182 -PLFPGKDYV 190
            P  P KD V
Sbjct: 206 YPRIPLKDVV 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VA+K I     N   A+  L E  ++  + H N++ +  +I     E    +YIV E M
Sbjct: 218 KVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYM 269
Query: 68  -DTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   +RS     L  D    F   +   ++Y+   N +HRDL   N+L++ +   K
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329
Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ--- 181
           + DFGL +  S T   T  +  +W  APE L    +++   D+WS G +L EI +     
Sbjct: 330 VSDFGLTKEASSTQ-DTGKLPVKW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 386
Query: 182 -PLFPGKDYV 190
            P  P KD V
Sbjct: 387 YPRIPLKDVV 396

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 209 GMSPYPGIDLSQVYELL 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 123/279 (44%), Gaps = 48/279 (17%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDV 60
           +T +  AIK +    D   + K+ +  +K   H  H NI           PP  +  + +
Sbjct: 47  KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGAFIKKNPPGMD--DQL 102
Query: 61  YIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           ++V E       TDL +  + +  L ++   Y   ++LRGL ++H   V+HRD+K  N+L
Sbjct: 103 WLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161
Query: 117 LNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSV 170
           L  N ++K+ DFG++     T      ++ T ++ APE++  C E     Y    D+WS+
Sbjct: 162 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA-CDENPDATYDFKSDLWSL 220
Query: 171 GCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN 230
           G    E+    P  P  D +H +R +             FL   N        P+   + 
Sbjct: 221 GITAIEMAEGAP--PLCD-MHPMRAL-------------FLIPRNP------APRLKSKK 258
Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           +S +F +        +E  LV + ++R   ++ + HP++
Sbjct: 259 WSKKFQS-------FIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 59/110 (53%), Gaps = 7/110 (6%)
Query: 79  QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSET 137
           + LT+   +    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+     
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171
Query: 138 DFMTEYVVTRWYRAPELLLNC-----SEYTAAIDIWSVGCILGEIMTRQP 182
                ++ T ++ APE+++ C     + Y    DIWS+G  L E+   +P
Sbjct: 172 QKRDSFIGTPYWMAPEVVM-CETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK +   +  R   +  L E  ++   DH NII ++ ++   +        IV E M+
Sbjct: 80  VAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL-----AMIVTEYME 133
Query: 69  T-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R+H    T       L  +  G++Y+     +HRDL   N+L+++N   K+ 
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 127 DFGLARTT-----SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGL+R       +        +  RW  APE  +    +++A D+WS G ++ E++ 
Sbjct: 194 DFGLSRVLEDDPDAAXTTTGGKIPIRW-TAPE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 209 GMSPYPGIDLSQVYELL 225

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 59/110 (53%), Gaps = 7/110 (6%)
Query: 79  QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSET 137
           + LT+   +    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+     
Sbjct: 104 RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 163
Query: 138 DFMTEYVVTRWYRAPELLLNC-----SEYTAAIDIWSVGCILGEIMTRQP 182
                ++ T ++ APE+++ C     + Y    DIWS+G  L E+   +P
Sbjct: 164 QKRDSFIGTPYWMAPEVVM-CETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 90
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 209 GMSPYPGID 217

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VA+K I     N   A+  L E  ++  + H N++ +  +I     E    +YIV E M
Sbjct: 46  KVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYM 97
Query: 68  -DTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   +RS     L  D    F   +   ++Y+   N +HRDL   N+L++ +   K
Sbjct: 98  AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 157
Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ--- 181
           + DFGL +  S T   T  +  +W  APE L    +++   D+WS G +L EI +     
Sbjct: 158 VSDFGLTKEASSTQ-DTGKLPVKW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 214
Query: 182 -PLFPGKDYV 190
            P  P KD V
Sbjct: 215 YPRIPLKDVV 224

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 26/183 (14%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VA+K         + AK  L+E ++L+   H NI+ +  +    Q      +YIV EL+ 
Sbjct: 142 VAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELVQ 195
Query: 69  T-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYVHSANVLHRDLKPSNLLLNAN 120
             D    +R+      +  R  +  LL+       G++Y+ S   +HRDL   N L+   
Sbjct: 196 GGDFLTFLRT------EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK 249
Query: 121 CDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             LKI DFG++R  ++  +        V  +W  APE  LN   Y++  D+WS G +L E
Sbjct: 250 NVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-ALNYGRYSSESDVWSFGILLWE 307
Query: 177 IMT 179
             +
Sbjct: 308 TFS 310

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--- 145
           F YQ+ +G+ ++ S N +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 222
Query: 146 ----TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 223 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--- 145
           F YQ+ +G+ ++ S N +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 229
Query: 146 ----TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--- 145
           F YQ+ +G+ ++ S N +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 224
Query: 146 ----TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 225 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 91
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 92  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 151
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 152 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 209
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 210 GMSPYPGIDLSQVYELL 226

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 214 GMSPYPGIDLSQVYELL 230

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 86/190 (45%), Gaps = 18/190 (9%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VA+K I     N   A+  L E  ++  + H N++ +  +I     E    +YIV E M
Sbjct: 31  KVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYM 82
Query: 68  -DTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   +RS     L  D    F   +   ++Y+   N +HRDL   N+L++ +   K
Sbjct: 83  AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 142
Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ--- 181
           + DFGL +  S T    +  V   + APE L    +++   D+WS G +L EI +     
Sbjct: 143 VSDFGLTKEASSTQDTGKLPVK--WTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 199
Query: 182 -PLFPGKDYV 190
            P  P KD V
Sbjct: 200 YPRIPLKDVV 209

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 95
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 214 GMSPYPGID 222

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 72/279 (25%)
Query: 60  VYIVYELMDTDL-HQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLL 116
           + +V+E++   L   II+S +Q L     +  + Q+L+GL Y+H+   ++H D+KP N+L
Sbjct: 104 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 163
Query: 117 LNAN-------------------------------------------------CDLKIGD 127
           L+ N                                                   +KI D
Sbjct: 164 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 223
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF--- 184
            G A    +    TE + TR YR+ E+L+  S Y    DIWS  C+  E+ T   LF   
Sbjct: 224 LGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPH 280
Query: 185 PGKDYVH---QLRLITELIGS-PDETSLG-------FLRSDNARRYVRMLPQFPKQNFSA 233
            G++Y      + LI EL+G  P +  +        F +  + +   ++ P    +    
Sbjct: 281 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 340
Query: 234 RF---PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           ++     ++ G  D L  ML   P +R T  E L HP+L
Sbjct: 341 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 379

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 72/279 (25%)
Query: 60  VYIVYELMDTDL-HQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLL 116
           + +V+E++   L   II+S +Q L     +  + Q+L+GL Y+H+   ++H D+KP N+L
Sbjct: 120 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 117 LNAN-------------------------------------------------CDLKIGD 127
           L+ N                                                   +KI D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF--- 184
            G A    +    TE + TR YR+ E+L+  S Y    DIWS  C+  E+ T   LF   
Sbjct: 240 LGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 185 PGKDYVH---QLRLITELIGS-PDETSLG-------FLRSDNARRYVRMLPQFPKQNFSA 233
            G++Y      + LI EL+G  P +  +        F +  + +   ++ P    +    
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 234 RF---PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           ++     ++ G  D L  ML   P +R T  E L HP+L
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--- 145
           F YQ+ +G+ ++ S N +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 206
Query: 146 ----TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 207 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 16/101 (15%)
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVV 145
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KIGDFGLAR     D M  + Y+V
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 216
Query: 146 -------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                   +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 217 KGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 255

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI--IRPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +  + PP        YIV E 
Sbjct: 60  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPP-------FYIVTEY 109
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + +++T     Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 110 MPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVV 169
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   + ++   D+W+ G +L EI T 
Sbjct: 170 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATY 227
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 228 GMSPYPGID 236

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--- 145
           F YQ+ +G+ ++ S N +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGN 229
Query: 146 ----TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 45  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 94
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 95  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 155 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 212
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 213 GMSPYPGIDLSQVYELL 229

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 214 GMSPYPGIDLSQVYELL 230

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 214 GMSPYPGIDLSQVYELL 230

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 77/187 (41%), Gaps = 9/187 (4%)
Query: 10  AIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMD 68
           A+K+  + F    D  R L E+       HE +      +R  Q  E    +Y+  EL  
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVG-----SHEKVGQHPCCVRLEQAWEEGGILYLQTELCG 140
Query: 69  TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 127
             L Q   +    L +     +L   L  L ++HS  ++H D+KP+N+ L      K+GD
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGD 200
Query: 128 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
           FGL                  Y APELL     Y  A D++S+G  + E+     L  G 
Sbjct: 201 FGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG 258
Query: 188 DYVHQLR 194
           +   QLR
Sbjct: 259 EGWQQLR 265

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 209 GMSPYPGID 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 54  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 103
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 104 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 163
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 164 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 221
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 222 GMSPYPGID 230

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 39/242 (16%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCR 87
           REI++  H+ H NI+ + +     +R     +Y++ E     +L++ ++      +    
Sbjct: 72  REIEIQAHLHHPNILRLYNYFYDRRR-----IYLILEYAPRGELYKELQKSCTFDEQRTA 126
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 147
             + +L   L Y H   V+HRD+KP NLLL    +LKI DFG +         T    T 
Sbjct: 127 TIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTL 185
Query: 148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 207
            Y  PE ++    +   +D+W +G +  E++   P F    +                  
Sbjct: 186 DYLPPE-MIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASH------------------ 226
Query: 208 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                ++  RR V++  +FP     A  P    GA DL+ K+L  +P+ R+ + +   HP
Sbjct: 227 -----NETYRRIVKVDLKFP-----ASVPT---GAQDLISKLLRHNPSERLPLAQVSAHP 273
Query: 268 YL 269
           ++
Sbjct: 274 WV 275

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 5/130 (3%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E M       + S+ D+ +   +++  +++  L  +HS  ++HRD+KP N+LL+ 
Sbjct: 150 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 209
Query: 120 NCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSE---YTAAIDIWSVGCIL 174
           +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 269
Query: 175 GEIMTRQPLF 184
            E++     F
Sbjct: 270 FEMLVGDTPF 279

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 209 GMSPYPGID 217

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 68/127 (53%), Gaps = 19/127 (14%)
Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF------ 139
           C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+GDFGL     + +       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 140 -MTEY------VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 192
            M  Y      V T+ Y +PE  ++ + Y+  +DI+S+G IL E+     L+     + +
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFEL-----LYSFSTQMER 279
Query: 193 LRLITEL 199
           +R+IT++
Sbjct: 280 VRIITDV 286

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 153 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 210
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 211 GMSPYPGID 219

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 55  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 106
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 107 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 166
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 224
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 225 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 263

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 153 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 210
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 211 GMSPYPGIDLSQVYELL 227

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--LTDD 84
           L E ++++ + H+ ++ +  ++      +   +YIV E M+   L   ++  +   L   
Sbjct: 52  LEEAQIMKKLKHDKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLP 105
Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 144
           +      Q+  G+ Y+   N +HRDL+ +N+L+      KI DFGLAR   + +      
Sbjct: 106 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQG 165
Query: 145 VT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 186
                +W  APE  L    +T   D+WS G +L E++T+  + +PG
Sbjct: 166 AKFPIKW-TAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPG 209

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 23  DAKRTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQIIRSH 78
           +  R   E+ LL+ +      +I + D    P     +   ++ E M+   DL   I   
Sbjct: 54  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERMEPVQDLFDFITER 108
Query: 79  QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSET 137
             L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DFG      +T
Sbjct: 109 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 168
Query: 138 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
            + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 169 VY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 204

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 48  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 99
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 100 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 159
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 160 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 217
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 218 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 256

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 46  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 97
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 98  MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 157
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 158 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 215
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 216 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 254

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 49  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 100
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 101 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 160
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 161 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 218
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 219 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 257

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 248 VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 297
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q+++     Y   Q+   ++Y+   N +HR+L   N L+  N  +
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 358 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATY 415
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 416 GMSPYPGIDLSQVYELL 432

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 48  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 99
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 100 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 159
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 160 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 217
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 218 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 256

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 55  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 106
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +    ++                ++  G+ Y+++   +HRDL  
Sbjct: 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 166
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 224
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 225 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 263

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 42  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 93
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 94  MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 153
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 154 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 211
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 212 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 250

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 9/123 (7%)
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 119 ANCD-LKIGDFGLARTTS----ETDFMT-EYV-VTRWYRAPELLLNCSEYTAAIDIWSVG 171
           ++     + DFG A          D +T +Y+  T  + APE++L  S   A +D+WS  
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSC 259
Query: 172 CIL 174
           C++
Sbjct: 260 CMM 262

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 227

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 24/191 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +   T   VA+K++ ++     D +R   REI++L+ +  + I+  + +   P R    +
Sbjct: 31  LGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRP---E 84
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVHSANVLHRDLKPSNLL 116
           + +V E + +  L   ++ H+   D   R  LY  Q+ +G++Y+ S   +HRDL   N+L
Sbjct: 85  LRLVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 143
Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIW 168
           + +   +KI DFGLA+         +  V R        WY APE L + + ++   D+W
Sbjct: 144 VESEAHVKIADFGLAKLLP---LDKDXXVVREPGQSPIFWY-APESLSD-NIFSRQSDVW 198
Query: 169 SVGCILGEIMT 179
           S G +L E+ T
Sbjct: 199 SFGVVLYELFT 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 77  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 128
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 129 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 188
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 189 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 246
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 247 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 285

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 76/294 (25%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T+E+ A+K +        D  +  RE++L  R     +I+ I D+        + ++
Sbjct: 39  NKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDV--------YENL 83
Query: 61  Y-------IVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           Y       IV E +D  +L   I  R  Q  T+      +  +   ++Y+HS N+ HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 111 KPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           KP NLL  +   N  LK+ DFG A+ T+                        +Y  + D+
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDM 181
Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-QF 226
           WS+G I+  ++   P                    P  ++ G   S   +  +RM   +F
Sbjct: 182 WSLGVIMYILLCGYP--------------------PFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P   +S      S     L+  +L  +P +R+T+ E + HP++     + + P+
Sbjct: 222 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 68/124 (54%), Gaps = 11/124 (8%)
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 119 ANCD-LKIGDFGLARTTSETDFMTEYVVTRWY-------RAPELLLNCSEYTAAIDIWSV 170
           ++     + DFG A    + D + + ++T  Y        APE++L  S   A +D+WS 
Sbjct: 220 SDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSS 277
Query: 171 GCIL 174
            C++
Sbjct: 278 CCMM 281

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 204

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 39/202 (19%)
Query: 9   VAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVY 64
           VA+K +  A ++ R D +R   E +LL  + H++I+    +    RP        + +V+
Sbjct: 74  VAVKALKEASESARQDFQR---EAELLTMLQHQHIVRFFGVCTEGRP--------LLMVF 122
Query: 65  ELM-DTDLHQIIRSHQD---------------LTDDHCRYFLYQLLRGLKYVHSANVLHR 108
           E M   DL++ +RSH                 L          Q+  G+ Y+   + +HR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCSEYTAA 164
           DL   N L+     +KIGDFG++R    TD+      T    RW   PE +L   ++T  
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTE 240
Query: 165 IDIWSVGCILGEIMT--RQPLF 184
            D+WS G +L EI T  +QP +
Sbjct: 241 SDVWSFGVVLWEIFTYGKQPWY 262

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           VA+KK+    D   +  +    +EIK++    HEN++ +            +D+ +VY  
Sbjct: 51  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF-----SSDGDDLCLVYVY 105
Query: 67  MDTDLHQIIRSHQDLT---DDHCRYFLYQ-LLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           M         S  D T     H R  + Q    G+ ++H  + +HRD+K +N+LL+    
Sbjct: 106 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 165
Query: 123 LKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            KI DFGLAR +   ++       V T  Y APE L    E T   DI+S G +L EI+T
Sbjct: 166 AKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIIT 223
Query: 180 RQP 182
             P
Sbjct: 224 GLP 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 203

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 45  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 96
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +    ++                ++  G+ Y+++   +HRDL  
Sbjct: 97  MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 156
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 157 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 214
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 215 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 253

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 252

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 14/185 (7%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIVYEL 66
           +VA+K +        D +  LRE   ++  DH ++  +  + +R   +       ++   
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 67  MD-TDLHQIIRSHQ------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           M   DLH  + + +      +L       F+  +  G++Y+ S N +HRDL   N +L  
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           +  + + DFGL+R     D+  +   +    +W     L  N   YT   D+W+ G  + 
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL--YTVHSDVWAFGVTMW 230
Query: 176 EIMTR 180
           EIMTR
Sbjct: 231 EIMTR 235

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 26/183 (14%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VA+K         + AK  L+E ++L+   H NI+ +  +    Q      +YIV EL+ 
Sbjct: 142 VAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELVQ 195
Query: 69  T-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYVHSANVLHRDLKPSNLLLNAN 120
             D    +R+      +  R  +  LL+       G++Y+ S   +HRDL   N L+   
Sbjct: 196 GGDFLTFLRT------EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK 249
Query: 121 CDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             LKI DFG++R  ++           V  +W  APE  LN   Y++  D+WS G +L E
Sbjct: 250 NVLKISDFGMSREEADGVXAASGGLRQVPVKW-TAPE-ALNYGRYSSESDVWSFGILLWE 307
Query: 177 IMT 179
             +
Sbjct: 308 TFS 310

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 39/202 (19%)
Query: 9   VAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVY 64
           VA+K +  A ++ R D +R   E +LL  + H++I+    +    RP        + +V+
Sbjct: 51  VAVKALKEASESARQDFQR---EAELLTMLQHQHIVRFFGVCTEGRP--------LLMVF 99
Query: 65  ELM-DTDLHQIIRSHQD---------------LTDDHCRYFLYQLLRGLKYVHSANVLHR 108
           E M   DL++ +RSH                 L          Q+  G+ Y+   + +HR
Sbjct: 100 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 159
Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCSEYTAA 164
           DL   N L+     +KIGDFG++R    TD+      T    RW   PE +L   ++T  
Sbjct: 160 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTE 217
Query: 165 IDIWSVGCILGEIMT--RQPLF 184
            D+WS G +L EI T  +QP +
Sbjct: 218 SDVWSFGVVLWEIFTYGKQPWY 239

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 39/202 (19%)
Query: 9   VAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVY 64
           VA+K +  A ++ R D +R   E +LL  + H++I+    +    RP        + +V+
Sbjct: 45  VAVKALKEASESARQDFQR---EAELLTMLQHQHIVRFFGVCTEGRP--------LLMVF 93
Query: 65  ELM-DTDLHQIIRSHQD---------------LTDDHCRYFLYQLLRGLKYVHSANVLHR 108
           E M   DL++ +RSH                 L          Q+  G+ Y+   + +HR
Sbjct: 94  EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 153
Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCSEYTAA 164
           DL   N L+     +KIGDFG++R    TD+      T    RW   PE +L   ++T  
Sbjct: 154 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTE 211
Query: 165 IDIWSVGCILGEIMT--RQPLF 184
            D+WS G +L EI T  +QP +
Sbjct: 212 SDVWSFGVVLWEIFTYGKQPWY 233

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDF 128
           DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 129 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 49  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 100
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 101 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 160
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD   +     +  RW  +PE L +   +T   D+W
Sbjct: 161 RNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 218
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 219 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 257

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 287 VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 336
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HR+L   N L+  N  +
Sbjct: 337 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 396
Query: 124 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +  D  T +   ++   + APE L   ++++   D+W+ G +L EI T 
Sbjct: 397 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATY 454
Query: 180 RQPLFPGKD 188
               +PG D
Sbjct: 455 GMSPYPGID 463

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 40  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 91
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 92  MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 151
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N ++  +  +KIGDFG+ R   ETD   +     +  RW  +PE L +   +T   D+W
Sbjct: 152 RNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 209
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 210 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 248

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YV 144
           F +Q+ +G++Y+   +++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 155 FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGS 202
             +W     L  +   YT   D+WS G +L EI+T    P +PG   +   RL   L   
Sbjct: 215 PVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP-YPG---IPPERLFNLL--- 265
Query: 203 PDETSLGFLRSDN-ARRYVRMLPQFPKQNFSARFPNKSPGAVDL---LEKMLV 251
             +T     R DN +    R++ Q  KQ      P+K P   D+   LEKM+V
Sbjct: 266 --KTGHRMERPDNCSEEMYRLMLQCWKQE-----PDKRPVFADISKDLEKMMV 311

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 81/174 (46%), Gaps = 28/174 (16%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW 148
           F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D    YV    
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED---SYVKRSQ 211
Query: 149 YRAPELLLNCSE-----YTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIG 201
            R P   +         YT   D+WS G +L EI+T    P +PG   +   RL   L  
Sbjct: 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG---IPPERLFNLL-- 265
Query: 202 SPDETSLGFLRSDN-ARRYVRMLPQFPKQNFSARFPNKSPGAVDL---LEKMLV 251
              +T     R DN +    R++ Q  KQ      P+K P   D+   LEKM+V
Sbjct: 266 ---KTGHRMERPDNCSEEMYRLMLQCWKQE-----PDKRPVFADISKDLEKMMV 311

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 46/268 (17%)
Query: 25  KRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLT 82
            R  RE+++L +   H N++ + +      R      Y+V+E M    +   I   +   
Sbjct: 55  SRVFREVEMLYQCQGHRNVLELIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFN 109
Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLART------ 133
           +      +  +   L ++H+  + HRDLKP N+L    N    +KI DF L         
Sbjct: 110 ELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 134 ---TSETDFMTEYVVTRWYRAPELLLNCSE----YTAAIDIWSVGCILGEIMTRQPLFPG 186
               S  + +T    +  Y APE++   SE    Y    D+WS+G IL  +++  P F G
Sbjct: 170 CSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 187 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-----SPG 241
           +             GS      G+ R +       ML +   Q     FP+K     S  
Sbjct: 229 R------------CGS----DCGWDRGEACPACQNMLFE-SIQEGKYEFPDKDWAHISCA 271
Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYL 269
           A DL+ K+LV D  +R++  + L HP++
Sbjct: 272 AKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 26/173 (15%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YV 144
           F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGS 202
             +W     L  +   YT   D+WS G +L EI+T    P +PG   +   RL   L   
Sbjct: 215 PVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP-YPG---IPPERLFNLL--- 265
Query: 203 PDETSLGFLRSDN-ARRYVRMLPQFPKQNFSARFPNKSPGAVDL---LEKMLV 251
             +T     R DN +    R++ Q  KQ      P+K P   D+   LEKM+V
Sbjct: 266 --KTGHRMERPDNCSEEMYRLMLQCWKQE-----PDKRPVFADISKDLEKMMV 311

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 91
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 92  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 151
Query: 124 KIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +   +          +W  APE L   ++++   D+W+ G +L EI T 
Sbjct: 152 KVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPESLAY-NKFSIKSDVWAFGVLLWEIATY 209
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 210 GMSPYPGIDLSQVYELL 226

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 21/197 (10%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYEL 66
           VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 67  MD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M   +L   +R  + Q++      Y   Q+   ++Y+   N +HRDL   N L+  N  +
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 124 KIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 179
           K+ DFGL+R  +   +          +W  APE L   ++++   D+W+ G +L EI T 
Sbjct: 153 KVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPESLAY-NKFSIKSDVWAFGVLLWEIATY 210
Query: 180 RQPLFPGKDYVHQLRLI 196
               +PG D      L+
Sbjct: 211 GMSPYPGIDLSQVYELL 227

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDV 60
           EVA+ K+ N    RI A + L + ++L+  +       +D++     +        F D 
Sbjct: 89  EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDE 146
Query: 61  YIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             +Y +MD     DL  ++   +D L +D  R+++ +++  +  +H  + +HRD+KP N+
Sbjct: 147 NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 206
Query: 116 LLNANCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL----NCSEYTAAIDIWS 169
           LL+ N  +++ DFG  L      T   +  V T  Y +PE+L        +Y    D WS
Sbjct: 207 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 266
Query: 170 VGCILGEIMTRQPLFPGKDYV 190
           +G  + E++  +  F  +  V
Sbjct: 267 LGVCMYEMLYGETPFYAESLV 287

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           ETR  VAIK +  A   R +    L E  +++  +  +++ +  ++   Q        ++
Sbjct: 42  ETR--VAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PTLVI 93
Query: 64  YELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS +   +++                ++  G+ Y+++   +HRDL  
Sbjct: 94  MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 153
Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIW 168
            N  +  +  +KIGDFG+ R   ETD+  +     +  RW  +PE L +   +T   D+W
Sbjct: 154 RNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVW 211
Query: 169 SVGCILGEIMT--RQPLFPGKDYVHQLRLITE--LIGSPD 204
           S G +L EI T   QP + G      LR + E  L+  PD
Sbjct: 212 SFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPD 250

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDV 60
           EVA+ K+ N    RI A + L + ++L+  +       +D++     +        F D 
Sbjct: 105 EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDE 162
Query: 61  YIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             +Y +MD     DL  ++   +D L +D  R+++ +++  +  +H  + +HRD+KP N+
Sbjct: 163 NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 222
Query: 116 LLNANCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL----NCSEYTAAIDIWS 169
           LL+ N  +++ DFG  L      T   +  V T  Y +PE+L        +Y    D WS
Sbjct: 223 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 282
Query: 170 VGCILGEIMTRQPLFPGKDYV 190
           +G  + E++  +  F  +  V
Sbjct: 283 LGVCMYEMLYGETPFYAESLV 303

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 418 LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 472
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 473 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 533 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 419 LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 473
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 474 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 533
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 534 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 120 NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSE----------YTAAID 166
           +  LK+ DFG+A      + +      V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GCIL  +   +   P +  ++Q+  +  +I    E                  P  
Sbjct: 250 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE---------------FPDI 292
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
           P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 293 PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 333

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 120 NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSE----------YTAAID 166
           +  LK+ DFG+A      + +      V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GCIL  +   +  F  +  ++Q+  +  +I    E                  P  
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE---------------FPDI 292
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
           P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 293 PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 333

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRW 148
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++     +  
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           + APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRW 148
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           + APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 145
Query: 120 NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSE----------YTAAID 166
           +  LK+ DFG+A      + +      V T  Y  PE + + S            +   D
Sbjct: 146 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 205
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GCIL  +   +   P +  ++Q+  +  +I    E                  P  
Sbjct: 206 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE---------------FPDI 248
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
           P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 249 PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 289

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 84  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 142
Query: 120 NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSE----------YTAAID 166
           +  LK+ DFG+A      + +      V T  Y  PE + + S            +   D
Sbjct: 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GCIL  +   +   P +  ++Q+  +  +I    E                  P  
Sbjct: 203 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE---------------FPDI 245
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
           P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 246 PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 286

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRW 148
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++     +  
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           + APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE-NIIAIKDIIRPPQRETFNDV 60
            + T   VA+K +     +  + +  + E+K+L H+ H  N++ +      P       +
Sbjct: 53  KTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPL 107
Query: 61  YIVYELMD-TDLHQIIRSHQD------------LTDDHCRYFLYQLLRGLKYVHSANVLH 107
            ++ E     +L   +RS ++            LT +H   + +Q+ +G++++ S   +H
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIH 167
Query: 108 RDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCSEYTA 163
           RDL   N+LL+    +KI DFGLAR    + D++ +    +  +W  APE + +   YT 
Sbjct: 168 RDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFD-RVYTI 225
Query: 164 AIDIWSVGCILGEIMT 179
             D+WS G +L EI +
Sbjct: 226 QSDVWSFGVLLWEIFS 241

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRW 148
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           + APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRW 148
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++     +  
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           + APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-------TFNDV 60
           EVA+ K+ NA  +++ A + L + ++L+  +       +D++     +        F D 
Sbjct: 89  EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146
Query: 61  YIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             +Y +MD     DL  ++   +D L ++  R++L +++  +  VH  + +HRD+KP N+
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLL----NCSEYTAAIDIWS 169
           L++ N  +++ DFG      E   +   V   T  Y +PE+L         Y    D WS
Sbjct: 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 170 VGCILGEIMTRQPLFPGKDYV 190
           +G  + E++  +  F  +  V
Sbjct: 267 LGVCMYEMLYGETPFYAESLV 287

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 96  GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 152
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           E L    E T   DI+S G +L EI+T  P
Sbjct: 196 EALR--GEITPKSDIYSFGVVLLEIITGLP 223

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRW 148
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           + APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRW 148
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA   S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           + APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA----RTTSETDFMTEYVVTR 147
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA    R +    F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 148 WYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           W  APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA----RTTSETDFMTEYVVTR 147
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA    R +    F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 148 WYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           W  APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 120 NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSE----------YTAAID 166
           +  LK+ DFG+A      + +      V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GCIL  +   +   P +  ++Q+  +  +I    E                  P  
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE---------------FPDI 264
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
           P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 265 PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 47/206 (22%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYE- 65
           +VA+K +    D+  + +  + E+K++  +  HENI+ +              +Y+++E 
Sbjct: 77  QVAVKMLKEKADSS-EREALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEY 130
Query: 66  LMDTDLHQIIRSHQD-LTDDHCRY----------------------FLYQLLRGLKYVHS 102
               DL   +RS ++  ++D   Y                      F YQ+ +G++++  
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190
Query: 103 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVV-------TRWYRAPE 153
            + +HRDL   N+L+     +KI DFGLAR     D M++  YVV        +W  APE
Sbjct: 191 KSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIMSDSNYVVRGNARLPVKW-MAPE 244
Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMT 179
            L     YT   D+WS G +L EI +
Sbjct: 245 SLFE-GIYTIKSDVWSYGILLWEIFS 269

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 141
Query: 120 NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSE----------YTAAID 166
           +  LK+ DFG+A      + +      V T  Y  PE + + S            +   D
Sbjct: 142 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 201
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GCIL  +   +   P +  ++Q+  +  +I    E                  P  
Sbjct: 202 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE---------------FPDI 244
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
           P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 245 PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 285

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRW 148
           Q  +G+ Y+H+ N++HRD+K +N+ L+    +KIGDFGLA   S    +  + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 149 YRAPEL--LLNCSEYTAAIDIWSVGCILGEIMT 179
           + APE+  + + + ++   D++S G +L E+MT
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA----RTTSETDFMTEYVVTR 147
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KIGDFGLA    R +    F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 148 WYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           W  APE+  + + + Y+   D+++ G +L E+MT Q
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 60  VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V E M   DL  ++ S+ D+ +   R++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 119 ANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSE---YTAAIDIWSVGCI 173
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 174 LGEIMTRQPLF 184
           L E++     F
Sbjct: 268 LYEMLVGDTPF 278

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE-NIIAIKDIIRPPQRETFNDV 60
            + T   VA+K +     +  + +  + E+K+L H+ H  N++ +      P       +
Sbjct: 53  KTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPL 107
Query: 61  YIVYELMD-TDLHQIIRSHQD------------LTDDHCRYFLYQLLRGLKYVHSANVLH 107
            ++ E     +L   +RS ++            LT +H   + +Q+ +G++++ S   +H
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIH 167
Query: 108 RDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCSEYTA 163
           RDL   N+LL+    +KI DFGLAR    + D++ +    +  +W  APE + +   YT 
Sbjct: 168 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFD-RVYTI 225
Query: 164 AIDIWSVGCILGEIMT 179
             D+WS G +L EI +
Sbjct: 226 QSDVWSFGVLLWEIFS 241

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 60  VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V E M   DL  ++ S+ D+ +   R++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 144 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 119 ANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSE---YTAAIDIWSVGCI 173
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 174 LGEIMTRQPLF 184
           L E++     F
Sbjct: 263 LYEMLVGDTPF 273

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 74  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 128
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 129 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 188
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 189 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 60  VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+V E M   DL  ++ S+ D+ +   R++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 119 ANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSE---YTAAIDIWSVGCI 173
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 174 LGEIMTRQPLF 184
           L E++     F
Sbjct: 268 LYEMLVGDTPF 278

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 111/277 (40%), Gaps = 70/277 (25%)
Query: 60  VYIVYELMDTDL-HQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLL 116
           V +V+E++   L   II+S +Q L     +  + Q+L+GL Y+HS   ++H D+KP N+L
Sbjct: 114 VCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENIL 173
Query: 117 LNA--------------------------------------------NCD---LKIGDFG 129
           +                                              N D   +KI D G
Sbjct: 174 MCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLG 233
Query: 130 LARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF---PG 186
            A    +    TE + TR YR+ E+L+    Y+   DIWS  C+  E+ T   LF    G
Sbjct: 234 NACWVHK--HFTEDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSG 290
Query: 187 KDYVH---QLRLITELIGS-PDETSLG-------FLRSDNARRYVRMLPQ--FPKQNFSA 233
           +DY      +  I EL+GS P   +L        F R    R   ++ P   F       
Sbjct: 291 EDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKY 350
Query: 234 RFPNKSPGA-VDLLEKMLVFDPNRRITVDEALCHPYL 269
            +P++      D L  ML   P +R +  E L HP+L
Sbjct: 351 GWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWL 387

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 76  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 130
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 131 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 191 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 15/126 (11%)
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 119 AN------CD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 168
           ++      CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 240
Query: 169 SVGCIL 174
           S  C++
Sbjct: 241 SSCCMM 246

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 76  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 130
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 131 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 191 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 15/126 (11%)
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 119 AN------CD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 168
           ++      CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 201 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 256
Query: 169 SVGCIL 174
           S  C++
Sbjct: 257 SSCCMM 262

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 61/114 (53%), Gaps = 9/114 (7%)
Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW 148
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KI DFGLAR   +         TR 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 149 ---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPG----KDYVHQLR 194
              + APE + +   Y+   D+WS G +L EI +     +PG    +D+  +LR
Sbjct: 264 PLKWMAPESIFD-KIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLR 316

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 15/126 (11%)
Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 119 AN------CD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 168
           ++      CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 199 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 254
Query: 169 SVGCIL 174
           S  C++
Sbjct: 255 SSCCMM 260

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 42  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 95
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HRD
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 155
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ETD+  +     +  RW  APE L +   +T + 
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-APESLKD-GVFTTSS 213
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 214 DMWSFGVVLWEITSLAEQP 232

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 43/232 (18%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 120 NCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCSE----------YTAAID 166
           +  LK+ DFG+A               V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GCIL  +   +   P +  ++Q+  +  +I    E                  P  
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE---------------FPDI 264
Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
           P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 265 PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 120 NCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCSE----------YTAA 164
           +  LK+ DFG+A      TTS         V   Y  PE + + S            +  
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN--YMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 165 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 224
            D+WS+GCIL  +   +  F  +  ++Q+  +  +I    E                  P
Sbjct: 248 SDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE---------------FP 290
Query: 225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA-PLHDINE 277
             P+++             D+L+  L  DP +RI++ E L HPY+    H +N+
Sbjct: 291 DIPEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 333

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 41  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 94
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HRD
Sbjct: 95  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 154
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ETD+  +     +  RW  APE L +   +T + 
Sbjct: 155 LAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-APESLKD-GVFTTSS 212
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 213 DMWSFGVVLWEITSLAEQP 231

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 60  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 114
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 115 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 174
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 175 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 66  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 120
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 181 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLR-HMDHENIIAIKDIIRPPQRETFNDVY 61
            E  + VAIK + +  +  +  +   R   +LR  + H N++ +  ++   Q  +    Y
Sbjct: 53  GEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110
Query: 62  IVYELMDTDLHQ--IIRS-HQDL--TDDH-----------CRYFLYQLLRGLKYVHSANV 105
             +     DLH+  ++RS H D+  TDD              + + Q+  G++Y+ S +V
Sbjct: 111 CSH----GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV 166
Query: 106 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEY 161
           +H+DL   N+L+    ++KI D GL R     D+        +  RW  APE ++   ++
Sbjct: 167 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-APEAIMY-GKF 224
Query: 162 TAAIDIWSVGCILGEIMTR--QPL--FPGKDYVHQLR 194
           +   DIWS G +L E+ +   QP   +  +D V  +R
Sbjct: 225 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 46/267 (17%)
Query: 26  RTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTD 83
           R  RE++ L +   ++NI+ + +      R      Y+V+E L    +   I+  +   +
Sbjct: 56  RVFREVETLYQCQGNKNILELIEFFEDDTR-----FYLVFEKLQGGSILAHIQKQKHFNE 110
Query: 84  DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--------CDLKIGDFGLARTTS 135
                 +  +   L ++H+  + HRDLKP N+L  +         CD  +G  G+    S
Sbjct: 111 REASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGS-GMKLNNS 169
Query: 136 ETDFMTEYVVT----RWYRAPELLL----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 187
            T   T  + T      Y APE++       + Y    D+WS+G +L  +++  P F G 
Sbjct: 170 CTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGH 229
Query: 188 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-----SPGA 242
                        G+      G+ R +  R     L +   Q     FP+K     S  A
Sbjct: 230 ------------CGA----DCGWDRGEVCRVCQNKLFE-SIQEGKYEFPDKDWAHISSEA 272
Query: 243 VDLLEKMLVFDPNRRITVDEALCHPYL 269
            DL+ K+LV D  +R++  + L HP++
Sbjct: 273 KDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 54  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 108
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 109 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 168
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 169 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 121 CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 176 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWE 233
Query: 177 IMT 179
           I +
Sbjct: 234 IFS 236

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 56  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 110
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVT 146
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++   ++ ++       
Sbjct: 111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 147 RW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 171 KWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 121 CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWE 242
Query: 177 IMT 179
           I +
Sbjct: 243 IFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 121 CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 176 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWE 233
Query: 177 IMT 179
           I +
Sbjct: 234 IFS 236

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLR-HMDHENIIAIKDIIRPPQRETFNDVY 61
            E  + VAIK + +  +  +  +   R   +LR  + H N++ +  ++   Q  +    Y
Sbjct: 36  GEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 93
Query: 62  IVYELMDTDLHQ--IIRS-HQDL--TDDH-----------CRYFLYQLLRGLKYVHSANV 105
             +     DLH+  ++RS H D+  TDD              + + Q+  G++Y+ S +V
Sbjct: 94  CSH----GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV 149
Query: 106 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEY 161
           +H+DL   N+L+    ++KI D GL R     D+        +  RW  APE ++   ++
Sbjct: 150 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-APEAIMY-GKF 207
Query: 162 TAAIDIWSVGCILGEIMTR--QPL--FPGKDYVHQLR 194
           +   DIWS G +L E+ +   QP   +  +D V  +R
Sbjct: 208 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 167 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221
Query: 121 CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWE 279
Query: 177 IMT 179
           I +
Sbjct: 280 IFS 282

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE-NIIAIKDIIRPPQRETFNDV 60
            + T   VA+K +     +  + +  + E+K+L H+ H  N++ +      P       +
Sbjct: 55  KTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPL 109
Query: 61  YIVYELMD-TDLHQIIRSHQD--------------LTDDHCRYFLYQLLRGLKYVHSANV 105
            ++ E     +L   +RS ++              LT +H   + +Q+ +G++++ S   
Sbjct: 110 MVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKX 169
Query: 106 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYT 162
           +HRDL   N+LL+    +KI DFGLAR   +          R    + APE + +   YT
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYT 228
Query: 163 AAIDIWSVGCILGEIMT 179
              D+WS G +L EI +
Sbjct: 229 IQSDVWSFGVLLWEIFS 245

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 42  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 95
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HRD
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 155
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ETD   +     +  RW  APE L +   +T + 
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM-APESLKD-GVFTTSS 213
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 214 DMWSFGVVLWEITSLAEQP 232

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDF 139
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 255 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 295

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 27/183 (14%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK I    +  +     + E K++ ++ HE ++ +  +    QR  F    I+ E M
Sbjct: 50  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIF----IITEYM 101
Query: 68  DT--------DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
                     ++    ++ Q L  + C+     +   ++Y+ S   LHRDL   N L+N 
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVND 155
Query: 120 NCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +K+ DFGL+R      ET  +      RW   PE+L+  S++++  DIW+ G ++ E
Sbjct: 156 QGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWE 213
Query: 177 IMT 179
           I +
Sbjct: 214 IYS 216

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDF 139
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 250 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDF 139
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 257 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 297

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 42  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 95
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HRD
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 155
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ETD   +     +  RW  APE L +   +T + 
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM-APESLKD-GVFTTSS 213
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 214 DMWSFGVVLWEITSLAEQP 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 39  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 92
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HRD
Sbjct: 93  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 152
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ETD   +     +  RW  APE L +   +T + 
Sbjct: 153 LAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM-APESLKD-GVFTTSS 210
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 211 DMWSFGVVLWEITSLAEQP 229

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDF 139
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 248 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 288

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 56  TFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPS 113
           T  DV+I  ELM T   ++ +  Q  + +         +++ L Y+     V+HRD+KPS
Sbjct: 95  TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL----LNCSEYTAAIDIWS 169
           N+LL+    +K+ DFG++    +            Y APE +        +Y    D+WS
Sbjct: 155 NILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
           +G  L E+ T Q  FP K+      ++T+++
Sbjct: 215 LGISLVELATGQ--FPYKNCKTDFEVLTKVL 243

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEI 177
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 243
Query: 178 MT 179
            +
Sbjct: 244 FS 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEI 177
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 234
Query: 178 MT 179
            +
Sbjct: 235 FS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEI 177
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 234
Query: 178 MT 179
            +
Sbjct: 235 FS 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDF 139
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 140 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 207 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 247

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 34/179 (18%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS----------H 78
           RE  L+   D+ NI+ +  +    +       Y+ Y     DL++ +RS          H
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY----GDLNEFLRSMSPHTVCSLSH 154
Query: 79  QDLTDD-----------HCRYFLY---QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
            DL+              C   L    Q+  G+ Y+     +HRDL   N L+  N  +K
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 214
Query: 125 IGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           I DFGL+R     D+      + +  RW     +  N   YT   D+W+ G +L EI +
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 101/233 (43%), Gaps = 17/233 (7%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++ET  EVA  ++ +    + + +R   E + L+ + H NI+   D      +     V
Sbjct: 46  LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIV 105
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLN 118
            +        L   ++  +       R +  Q+L+GL+++H+    ++HRDLK  N+ + 
Sbjct: 106 LVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165
Query: 119 A-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG-CILGE 176
                +KIGD GLA T     F    + T  + APE      +Y  ++D+++ G C L  
Sbjct: 166 GPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEE--KYDESVDVYAFGXCXLEX 222
Query: 177 IMTRQPLFPGKDYVHQLRLITELI--GSPDETSL--------GFLRSDNARRY 219
             +  P    ++     R +T  +   S D+ ++        G +R +   RY
Sbjct: 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 69/136 (50%), Gaps = 3/136 (2%)
Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +T + ++ V E ++  DL   I+  +   +   R++  +++  L ++H   +++RDLK  
Sbjct: 94  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153
Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL+     K+ DFG+ +        T  +  T  Y APE+L     Y  A+D W++G 
Sbjct: 154 NVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGV 212
Query: 173 ILGEIMTRQPLFPGKD 188
           +L E++     F  ++
Sbjct: 213 LLYEMLCGHAPFEAEN 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +A+K+I +  D + + K+ L ++ + +R  D   I+     +    RE   D +I  ELM
Sbjct: 50  MAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALF---RE--GDCWICMELM 103
Query: 68  DTDLHQIIRSHQDLTDDHC-----RYFLYQLLRGLKYV-HSANVLHRDLKPSNLLLNANC 121
            T   +  +    + DD              ++ L ++  +  ++HRD+KPSN+LL+ + 
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG 163
Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCSEYTAAIDIWSVGCILGEIM 178
           ++K+ DFG++    ++   T     R Y APE +    +   Y    D+WS+G  L E+ 
Sbjct: 164 NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 179 TRQPLFPGKDYVHQLRLITELI-GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           T +  FP   +      +T+++ G P +     L +   R +                  
Sbjct: 224 TGR--FPYPKWNSVFDQLTQVVKGDPPQ-----LSNSEEREF------------------ 258
Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC 281
            SP  ++ +   L  D ++R    E L HP++    +   E  C
Sbjct: 259 -SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 28  LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 87
           L E  +++ +D+  I+ +  I    + E++  V  + EL    L++ ++ ++ + D +  
Sbjct: 60  LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAEL--GPLNKYLQQNRHVKDKNII 114
Query: 88  YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART--TSETDFMTEY-- 143
             ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL++     E  +  +   
Sbjct: 115 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 144 -VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
               +WY APE  +N  ++++  D+WS G ++ E  +
Sbjct: 175 KWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEI 177
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 243
Query: 178 MT 179
            +
Sbjct: 244 FS 245

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/245 (22%), Positives = 108/245 (44%), Gaps = 37/245 (15%)
Query: 29  REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ-DLTDDHC 86
           +EI +L    H NI+ + +       E+  ++ +++E +   D+ + I +   +L +   
Sbjct: 50  KEISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREI 104
Query: 87  RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYV 144
             +++Q+   L+++HS N+ H D++P N++     +  +KI +FG AR     D      
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 204
               Y APE+  +    + A D+WS+G ++  +++    F  +     +  I     + D
Sbjct: 165 TAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           E +                           F   S  A+D ++++LV +   R+T  EAL
Sbjct: 224 EEA---------------------------FKEISIEAMDFVDRLLVKERKSRMTASEAL 256
Query: 265 CHPYL 269
            HP+L
Sbjct: 257 QHPWL 261

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE-NIIAIKDIIRPPQRETFNDV 60
            + T   VA+K +     +  + +  + E+K+L H+ H  N++ +      P       +
Sbjct: 54  KTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPL 108
Query: 61  YIVYELMD-TDLHQIIRSHQD---------------LTDDHCRYFLYQLLRGLKYVHSAN 104
            ++ E     +L   +RS ++               LT +H   + +Q+ +G++++ S  
Sbjct: 109 MVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 105 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEY 161
            +HRDL   N+LL+    +KI DFGLAR   +          R    + APE + +   Y
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVY 227
Query: 162 TAAIDIWSVGCILGEIMT 179
           T   D+WS G +L EI +
Sbjct: 228 TIQSDVWSFGVLLWEIFS 245

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 42  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 95
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HR+
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRN 155
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ETD+  +     +  RW  APE L +   +T + 
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-APESLKD-GVFTTSS 213
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 214 DMWSFGVVLWEITSLAEQP 232

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 43  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 96
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HR+
Sbjct: 97  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRN 156
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ETD+  +     +  RW  APE L +   +T + 
Sbjct: 157 LAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-APESLKD-GVFTTSS 214
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 215 DMWSFGVVLWEITSLAEQP 233

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK I    +  +     + E K++ ++ HE ++ +  +    QR  F    I+ E M
Sbjct: 30  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIF----IITEYM 81
Query: 68  DT--------DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
                     ++    ++ Q L  + C+     +   ++Y+ S   LHRDL   N L+N 
Sbjct: 82  ANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVND 135
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +K+ DFGL+R   + ++ +        RW   PE+L+  S++++  DIW+ G ++ E
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWE 193
Query: 177 IMT 179
           I +
Sbjct: 194 IYS 196

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/185 (22%), Positives = 90/185 (48%), Gaps = 19/185 (10%)
Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIV 63
           +++VAIK I    +  +  +  + E +++  + H  ++ +  +   + P       + +V
Sbjct: 31  KDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-------ICLV 80
Query: 64  YELMDTD-LHQIIRSHQDL-TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           +E M+   L   +R+ + L   +        +  G+ Y+  A+V+HRDL   N L+  N 
Sbjct: 81  FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQ 140
Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  D+WS G ++ E+ 
Sbjct: 141 VIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLMWEVF 198
Query: 179 TRQPL 183
           +   +
Sbjct: 199 SEGKI 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK I    +  +     + E K++ ++ HE ++ +  +    QR  F    I+ E M
Sbjct: 50  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIF----IITEYM 101
Query: 68  DT--------DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
                     ++    ++ Q L  + C+     +   ++Y+ S   LHRDL   N L+N 
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVND 155
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +K+ DFGL+R   + ++ +        RW   PE+L+  S++++  DIW+ G ++ E
Sbjct: 156 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWE 213
Query: 177 IMT 179
           I +
Sbjct: 214 IYS 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK I    +  +     + E K++ ++ HE ++ +  +    QR  F    I+ E M
Sbjct: 41  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIF----IITEYM 92
Query: 68  DT--------DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
                     ++    ++ Q L  + C+     +   ++Y+ S   LHRDL   N L+N 
Sbjct: 93  ANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVND 146
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +K+ DFGL+R   + ++ +        RW   PE+L+  S++++  DIW+ G ++ E
Sbjct: 147 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWE 204
Query: 177 IMT 179
           I +
Sbjct: 205 IYS 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK I    +  +     + E K++ ++ HE ++ +  +    QR  F    I+ E M
Sbjct: 35  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIF----IITEYM 86
Query: 68  DT--------DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
                     ++    ++ Q L  + C+     +   ++Y+ S   LHRDL   N L+N 
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVND 140
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +K+ DFGL+R   + ++ +        RW   PE+L+  S++++  DIW+ G ++ E
Sbjct: 141 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWE 198
Query: 177 IMT 179
           I +
Sbjct: 199 IYS 201

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK I    +  +     + E K++ ++ HE ++ +  +    QR  F    I+ E M
Sbjct: 34  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIF----IITEYM 85
Query: 68  DT--------DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
                     ++    ++ Q L  + C+     +   ++Y+ S   LHRDL   N L+N 
Sbjct: 86  ANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVND 139
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +K+ DFGL+R   + ++ +        RW   PE+L+  S++++  DIW+ G ++ E
Sbjct: 140 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWE 197
Query: 177 IMT 179
           I +
Sbjct: 198 IYS 200

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 48  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLIMQLMP 100
Query: 69  -TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 101 FGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 160
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 161 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 215

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +  +   R +    L E  +++     +++ +  ++   Q       
Sbjct: 42  IKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PT 95
Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDH----------CRYFLYQLLRGLKYVHSANVLHRD 109
            +V ELM   DL   +RS +   +++                ++  G+ Y+++   +HRD
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 155
Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAI 165
           L   N ++  +  +KIGDFG+ R   ET +  +     +  RW  APE L +   +T + 
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM-APESLKD-GVFTTSS 213
Query: 166 DIWSVGCILGEI--MTRQP 182
           D+WS G +L EI  +  QP
Sbjct: 214 DMWSFGVVLWEITSLAEQP 232

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 51  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLIMQLMP 103
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 104 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 163
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 164 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 48  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLIMQLMP 100
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 101 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 160
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 161 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLITQLMP 99
Query: 69  -TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 100 FGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VAIK I    +  +     + E K++ ++ HE ++ +  +    QR  F    I+ E M
Sbjct: 35  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIF----IITEYM 86
Query: 68  DT--------DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
                     ++    ++ Q L  + C+     +   ++Y+ S   LHRDL   N L+N 
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVND 140
Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +K+ DFGL+R   + ++ +        RW   PE+L+  S++++  DIW+ G ++ E
Sbjct: 141 QGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWE 198
Query: 177 IMT 179
           I +
Sbjct: 199 IYS 201

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 49  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLIMQLMP 101
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 102 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 161
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 162 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 50  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLIMQLMP 102
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 103 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 162
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 163 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 217

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L+     +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R        
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 141 T-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           T   +  RW       LN S YT   D+WS G +L EI++
Sbjct: 189 TMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 140
           L+     +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R        
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 141 T-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           T   +  RW       LN S YT   D+WS G +L EI++
Sbjct: 199 TMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 54  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLIMQLMP 106
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 107 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 166
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 167 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLIMQLMP 99
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 50  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLITQLMP 102
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 103 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 162
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 163 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 57  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLITQLMP 109
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 110 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 169
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 170 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 68
           VAIK++  A   + + K  L E  ++  +D+ ++  +  I         + V ++ +LM 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLITQLMP 99
Query: 69  TD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
              L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI 
Sbjct: 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159
Query: 127 DFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           DFGLA+     E ++  E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	316
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	0.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	0.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	0.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	0.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	0.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	0.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	0.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	0.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	0.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-169
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-161
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-158
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-158
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-150
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-127
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-114
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-105
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-105
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-104
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-104
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-104
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-103
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-103
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-102
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-101
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-101
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-100
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-59
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-59
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-57
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-57
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-55
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-55
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-55
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-55
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-55
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-55
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-54
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-54
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-54
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-54
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-54
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-53
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-53
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-53
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-53
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-52
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-52
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-52
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-52
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-52
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-52
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-51
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-51
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-51
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-51
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-51
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-50
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-50
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-49
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-49
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-49
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-49
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-49
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-48
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-48
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-48
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-48
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-47
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-47
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-47
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-47
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-47
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-46
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-46
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-46
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-45
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-45
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-45
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-45
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-45
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-45
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-44
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-44
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-44
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-43
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-43
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-42
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-42
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-42
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-42
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-41
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-41
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-40
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-40
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-38
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-38
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-33
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-33
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-32
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-31
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-23
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-22
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-07
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  572 bits (1477), Expect = 0.0
 Identities = 166/317 (52%), Positives = 221/317 (69%), Gaps = 6/317 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            ++  +  VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DV
Sbjct: 47  YDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  
Sbjct: 106 YIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 164

Query: 121 CDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +++ +P+FPGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FP
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 284

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTE 296
           N    A+DLL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +
Sbjct: 285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPK 344

Query: 297 ENIKELIYRESVKFNPD 313
           E +KELI+ E+ +F P 
Sbjct: 345 EKLKELIFEETARFQPG 361

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  559 bits (1442), Expect = 0.0
 Identities = 162/322 (50%), Positives = 214/322 (66%), Gaps = 18/322 (5%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            +  T E VAIKKI   FD  + A RTLREIK+L+H  HENII I +I RP   E FN+V
Sbjct: 31  THKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YI+ ELM TDLH++I + Q L+DDH +YF+YQ LR +K +H +NV+HRDLKPSNLL+N+N
Sbjct: 90  YIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN 148

Query: 121 CDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
           CDLK+ DFGLAR            T +   M E+V TRWYRAPE++L  ++Y+ A+D+WS
Sbjct: 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS 208

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLPQFPK 228
            GCIL E+  R+P+FPG+DY HQL LI  +IG+P  +  L  + S  AR Y++ LP +P 
Sbjct: 209 CGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268

Query: 229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC----PRP 284
                 FP  +P  +DLL++MLVFDP +RIT  EAL HPYL   HD N+EP      P  
Sbjct: 269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSF 328

Query: 285 FSFDFEHPSFTEENIKELIYRE 306
           F FD    + T +++K+LI+ E
Sbjct: 329 FEFDHYKEALTTKDLKKLIWNE 350

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  555 bits (1433), Expect = 0.0
 Identities = 142/313 (45%), Positives = 197/313 (62%), Gaps = 5/313 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
           ++  + E+VAIKK+   F + I AKR  RE+ LL+HM HEN+I + D+  P      F D
Sbjct: 44  IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            Y+V   M TDL +I+      +++  +Y +YQ+L+GLKY+HSA V+HRDLKP NL +N 
Sbjct: 104 FYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR       MT YVVTRWYRAPE++L+   Y   +DIWSVGCI+ E++T
Sbjct: 162 DCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LPQ P+++F+  FP  S
Sbjct: 220 GKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRAS 279

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P A DLLEKML  D ++R+T  +AL HP+  P  D  EE    +PF    EH   T +  
Sbjct: 280 PQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339

Query: 300 KELIYRESVKFNP 312
           K+ IY+E V F+P
Sbjct: 340 KQHIYKEIVNFSP 352

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  555 bits (1431), Expect = 0.0
 Identities = 157/315 (49%), Positives = 213/315 (67%), Gaps = 5/315 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
            +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FND
Sbjct: 49  FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           VY+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N 
Sbjct: 109 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T
Sbjct: 168 DCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 285

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+    E      +  
Sbjct: 286 PLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEW 344

Query: 300 KELIYRESVKFNPDP 314
           K L Y E + F P P
Sbjct: 345 KSLTYDEVISFVPPP 359

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  554 bits (1430), Expect = 0.0
 Identities = 137/315 (43%), Positives = 204/315 (64%), Gaps = 5/315 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFND 59
           ++  T  +VAIKK+   F + + AKR  RE++LL+HM HEN+I + D+  P +  + F D
Sbjct: 45  VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            Y+V   M TDL ++++  + L +D  ++ +YQ+L+GL+Y+H+A ++HRDLKP NL +N 
Sbjct: 105 FYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 163

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR       MT YVVTRWYRAPE++LN   YT  +DIWSVGCI+ E++T
Sbjct: 164 DCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LF G D++ QL+ I ++ G+P    +  L+SD A+ Y++ LP+  K++F++   N S
Sbjct: 222 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 281

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P AV+LLEKMLV D  +R+T  EAL HPY   LHD  +EP     +   F+    T +  
Sbjct: 282 PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEW 340

Query: 300 KELIYRESVKFNPDP 314
           K + Y+E + F P  
Sbjct: 341 KRVTYKEVLSFKPPR 355

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  553 bits (1428), Expect = 0.0
 Identities = 116/318 (36%), Positives = 172/318 (54%), Gaps = 12/318 (3%)

Query: 5   TREEVAIKKIGNA---------FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 55
               VAIK++ N            +    KR LREI+LL H  H NI+ ++DI    +  
Sbjct: 45  EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104

Query: 56  TFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
             + +Y+V ELM TDL Q+I   +  ++  H +YF+Y +L GL  +H A V+HRDL P N
Sbjct: 105 AMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN 164

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           +LL  N D+ I DF LAR  +     T YV  RWYRAPEL++    +T  +D+WS GC++
Sbjct: 165 ILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR-MLPQFPKQNFSA 233
            E+  R+ LF G  + +QL  I E++G+P    +    S +AR Y+R  L   P + ++A
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS 293
             P   P A+DL+ KML F+P RRI+ ++AL HPY   L D  +         F F+   
Sbjct: 285 VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESV 343

Query: 294 FTEENIKELIYRESVKFN 311
               ++ ++   E  +FN
Sbjct: 344 TDVYDMHKIFTAEVERFN 361

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  551 bits (1421), Expect = 0.0
 Identities = 125/365 (34%), Positives = 190/365 (52%), Gaps = 52/365 (14%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            +  T + VAIKK+   F++ ID KR LREI +L  +  + II + D+I P     F+++
Sbjct: 46  YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           YIV E+ D+DL ++ ++   LT++H +  LY LL G  ++H + ++HRDLKP+N LLN +
Sbjct: 106 YIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD 165

Query: 121 CDLKIGDFGLARTTS-----------------------ETDFMTEYVVTRWYRAPELLLN 157
           C +K+ DFGLART +                           +T +VVTRWYRAPEL+L 
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225

Query: 158 CSEYTAAIDIWSVGCILGEIMT-----------RQPLFPG-----------------KDY 189
              YT +IDIWS GCI  E++            R PLFPG                 K  
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN 285

Query: 190 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKM 249
             QL +I  +IG+P E  L  +      +Y+++ P     N   ++P+ S   ++LLE M
Sbjct: 286 RDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESM 345

Query: 250 LVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFE-HPSFTEENIKELIYRESV 308
           L F+PN+RIT+D+AL HPYL  +     E    +     F+     +E  ++ +  +E  
Sbjct: 346 LKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQ 405

Query: 309 KFNPD 313
            F+P+
Sbjct: 406 SFHPE 410

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  545 bits (1405), Expect = 0.0
 Identities = 128/373 (34%), Positives = 197/373 (52%), Gaps = 60/373 (16%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            +   +  VAIKKI   F++ ID KR LREI +L  ++H++++ + DI+ P   E F+++
Sbjct: 73  YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V E+ D+D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHRDLKP+N L+N +
Sbjct: 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD 192

Query: 121 CDLKIGDFGLARTTSETD----------------------------FMTEYVVTRWYRAP 152
           C +K+ DFGLART    +                             +T +VVTRWYRAP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252

Query: 153 ELLLNCSEYTAAIDIWSVGCILGEIMT-----------RQPLFPGKDYV----------- 190
           EL+L    YT AID+WS+GCI  E++            R PLFPG               
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGND 312

Query: 191 ---------HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
                     QL +I  ++G+P E  +  L  ++A+RY+R+ P+    + + RFP  S  
Sbjct: 313 FKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD 372

Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFE-HPSFTEENIK 300
           A+ LL++MLVF+PN+RIT++E L HP+   +     E          F    +  E  ++
Sbjct: 373 AIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLR 432

Query: 301 ELIYRESVKFNPD 313
               +E  +++P+
Sbjct: 433 YAFVKEIQRYHPE 445

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  533 bits (1376), Expect = 0.0
 Identities = 126/353 (35%), Positives = 203/353 (57%), Gaps = 44/353 (12%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
           ++  T E VA+KKI +AF N  DA+RT REI +L  +  HENI+ + +++R        D
Sbjct: 29  IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD 85

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           VY+V++ M+TDLH +IR+   L   H +Y +YQL++ +KY+HS  +LHRD+KPSN+LLNA
Sbjct: 86  VYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA 144

Query: 120 NCDLKIGDFGLART----------------------TSETDFMTEYVVTRWYRAPELLLN 157
            C +K+ DFGL+R+                        +   +T+YV TRWYRAPE+LL 
Sbjct: 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204

Query: 158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
            ++YT  ID+WS+GCILGEI+  +P+FPG   ++QL  I  +I  P    +  ++S  A+
Sbjct: 205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAK 264

Query: 218 RYVRMLPQFPKQNFSARF----------------PNKSPGAVDLLEKMLVFDPNRRITVD 261
             +  L +  +   S +                  + +  A+DLL+K+L F+PN+RI+ +
Sbjct: 265 TMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324

Query: 262 EALCHPYLAPLHDINEEPVCPRPFSFDF-EHPSFTEENIKELIYRESVKFNPD 313
           +AL HP+++  H+ NEEP C    +    ++   + ++ + L+Y E  +   +
Sbjct: 325 DALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKRE 377

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  522 bits (1346), Expect = 0.0
 Identities = 135/330 (40%), Positives = 194/330 (58%), Gaps = 18/330 (5%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFND 59
            ++     VAIKK+   F N+  AKR  RE+ L++ ++H+NII + ++  P +  E F D
Sbjct: 45  YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           VYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ +
Sbjct: 105 VYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++ 
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 221

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN-- 237
              LFPG D++ Q   + E +G+P    +  L     R YV   P++   +F   FP+  
Sbjct: 222 GGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVL 280

Query: 238 ----------KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC-PRPFS 286
                     K+  A DLL KMLV D ++RI+VDEAL HPY+   +D +E     P+   
Sbjct: 281 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD 340

Query: 287 FDFEHPSFTEENIKELIYRESVKFNPDPTH 316
              +    T E  KELIY+E +       H
Sbjct: 341 KQLDEREHTIEEWKELIYKEVMDLEHHHHH 370

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  521 bits (1343), Expect = 0.0
 Identities = 134/326 (41%), Positives = 195/326 (59%), Gaps = 18/326 (5%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFND 59
            ++     VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F D
Sbjct: 82  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           VY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ +
Sbjct: 142 VYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++ 
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 258

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN-- 237
            + LFPG+DY+ Q   + E +G+P    +  L     R YV   P++    F   FP+  
Sbjct: 259 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSL 317

Query: 238 ----------KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN-EEPVCPRPFS 286
                     K+  A DLL KMLV DP +RI+VD+AL HPY+   +D    E   P+ + 
Sbjct: 318 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYD 377

Query: 287 FDFEHPSFTEENIKELIYRESVKFNP 312
              +    T E  KELIY+E +    
Sbjct: 378 KQLDEREHTIEEWKELIYKEVMNSEE 403

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  509 bits (1314), Expect = 0.0
 Identities = 122/294 (41%), Positives = 172/294 (58%), Gaps = 18/294 (6%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR------ 54
           ++++  + VAIKKI     +    K  LREIK++R +DH+NI+ + +I+ P         
Sbjct: 31  VDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88

Query: 55  ---ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
                 N VYIV E M+TDL  ++     L ++H R F+YQLLRGLKY+HSANVLHRDLK
Sbjct: 89  GSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLK 147

Query: 112 PSNLLLNA-NCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCSEYTAAID 166
           P+NL +N  +  LKIGDFGLAR           ++E +VT+WYR+P LLL+ + YT AID
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID 207

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +W+ GCI  E++T + LF G   + Q++LI E I    E     L S     Y+R     
Sbjct: 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS-VIPVYIRNDMTE 266

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           P +  +   P  S  AVD LE++L F P  R+T +EAL HPY++      +EP+
Sbjct: 267 PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  472 bits (1217), Expect = e-169
 Identities = 100/320 (31%), Positives = 149/320 (46%), Gaps = 18/320 (5%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
              T   VAIKK+     +     R L+ ++ L  + H NI+ ++            D+Y
Sbjct: 44  EKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100

Query: 62  --IVYELMDTDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVH--SANVLHRDLKPS 113
             +V E +   LH+  R++            + FL+QL+R +  +H  S NV HRD+KP 
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160

Query: 114 NLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+L+N A+  LK+ DFG A+  S ++    Y+ +R+YRAPEL+     YT A+DIWSVGC
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC 220

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNF 231
           I  E+M  +P+F G +   QL  I  ++G P    L  L   +    +      P    F
Sbjct: 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVF 280

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE-----PVCPRPFS 286
           S      +  A DLL  +L + P  R+   EALCHPY   LHD   +      +    F 
Sbjct: 281 SDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFR 340

Query: 287 FDFEHPSFTEENIKELIYRE 306
           F         E  K  + R+
Sbjct: 341 FLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  452 bits (1165), Expect = e-161
 Identities = 93/363 (25%), Positives = 169/363 (46%), Gaps = 61/363 (16%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR----------- 50
           + E+ +  A+KK+        D +   RE+ +++ +DH NII + D              
Sbjct: 28  DIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81

Query: 51  ----------------------PPQRETFNDVYIVYELMDTDLHQIIR----SHQDLTDD 84
                                          + ++ E +   LH++++    S + +  +
Sbjct: 82  PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMN 141

Query: 85  HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTEY 143
               ++YQL R + ++HS  + HRD+KP NLL+N+  + LK+ DFG A+    ++    Y
Sbjct: 142 LISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY 201

Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
           + +R+YRAPEL+L  +EYT +ID+WS+GC+ GE++  +PLF G+  + QL  I +++G+P
Sbjct: 202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP 261

Query: 204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP-GAVDLLEKMLVFDPNRRITVDE 262
            +  +  +            P    +++    P  +P  A+DLLE++L ++P+ RI   E
Sbjct: 262 TKEQMIRMNPHYTEVR---FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318

Query: 263 ALCHPYLAPLHDINEEPVC-------------PRPFSFDFEHPSFTEENIKELIYRESVK 309
           A+ HP+   L +  E  V              P+ F+F     S    N+   I  ++  
Sbjct: 319 AMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS 378

Query: 310 FNP 312
            N 
Sbjct: 379 PNY 381

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  448 bits (1155), Expect = e-158
 Identities = 95/313 (30%), Positives = 160/313 (51%), Gaps = 20/313 (6%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP-QRETFNDV 60
             ++ E VAIKK+        D +   RE++++R +DH NI+ ++       +++    +
Sbjct: 75  LCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128

Query: 61  YIVYELMDTDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            +V + +   ++++ R +    Q L   + + ++YQL R L Y+HS  + HRD+KP NLL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188

Query: 117 LNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+ +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L 
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F
Sbjct: 249 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKAHPWTKVF 305

Query: 236 -PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRP----FSFDFE 290
            P   P A+ L  ++L + P  R+T  EA  H +   L D N +    R     F+F  +
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 365

Query: 291 HPSFTEENIKELI 303
             S        LI
Sbjct: 366 ELSSNPPLATILI 378

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  446 bits (1149), Expect = e-158
 Identities = 100/317 (31%), Positives = 162/317 (51%), Gaps = 21/317 (6%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP-QRETFNDV 60
             E+ E VAIKK+        D +   RE++++R + H N++ +K        ++    +
Sbjct: 61  LVESDE-VAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 61  YIVYELMDTDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            +V E +   +++  R +    Q +     + ++YQLLR L Y+HS  + HRD+KP NLL
Sbjct: 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173

Query: 117 LNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+     LK+ DFG A+     +    Y+ +R+YRAPEL+   + YT  IDIWS GC++ 
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E+M  QPLFPG+  + QL  I +++G+P       +++ N        PQ     FS  F
Sbjct: 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSRE---QIKTMNPNYMEHKFPQIRPHPFSKVF 290

Query: 236 -PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE----PVCPRPFSFDFE 290
            P   P A+DL+ ++L + P+ R+T  EALCHP+   L             P  F++  E
Sbjct: 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKE 350

Query: 291 HPSFTEENIKELIYRES 307
             S   + I  L+ + +
Sbjct: 351 ELSVRPDLISRLVPQHA 367

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  424 bits (1093), Expect = e-150
 Identities = 81/283 (28%), Positives = 150/283 (53%), Gaps = 19/283 (6%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
           +N    E+V +K +       +  K+  REIK+L ++    NII + DI++ P   +   
Sbjct: 56  INITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTP 108

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN- 118
             +   + +TD  Q+    Q LTD   R+++Y++L+ L Y HS  ++HRD+KP N++++ 
Sbjct: 109 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            +  L++ D+GLA            V +R+++ PELL++   Y  ++D+WS+GC+L  ++
Sbjct: 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

Query: 179 TR-QPLFPGKDYVHQLRLITELIGSPDETS-LGFLRSDNARRYVRMLPQFPKQNFSARFP 236
            R +P F G D   QL  I +++G+ D    +     +   R+  +L +  ++ +     
Sbjct: 226 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 285

Query: 237 NK-----SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
           ++     SP A+D L+K+L +D   R+T  EA+ HPY   +  
Sbjct: 286 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  364 bits (936), Expect = e-127
 Identities = 84/287 (29%), Positives = 153/287 (53%), Gaps = 7/287 (2%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N +T + VAIKK   + D+ +  K  LREI++L+ + H N++ + ++ R         ++
Sbjct: 24  NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRLH 78

Query: 62  IVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E  D  +   +  + + + +   +   +Q L+ + + H  N +HRD+KP N+L+  +
Sbjct: 79  LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138

Query: 121 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG AR  T  +D+  + V TRWYR+PELL+  ++Y   +D+W++GC+  E+++
Sbjct: 139 SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             PL+PGK  V QL LI + +G           ++     V++      +    +FPN S
Sbjct: 199 GVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNIS 258

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFS 286
             A+ LL+  L  DP  R+T ++ L HPY   + +I +        +
Sbjct: 259 YPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPA 305

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  331 bits (852), Expect = e-114
 Identities = 85/269 (31%), Positives = 146/269 (54%), Gaps = 7/269 (2%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N +T   VAIKK   + D+++  K  +REIKLL+ + HEN++ + ++ +          Y
Sbjct: 46  NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKRWY 100

Query: 62  IVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V+E +D  +   +      L     + +L+Q++ G+ + HS N++HRD+KP N+L++ +
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS 160

Query: 121 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG ART  +  +   + V TRWYRAPELL+   +Y  A+D+W++GC++ E+  
Sbjct: 161 GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +PLFPG   + QL  I   +G+           +     VR+     ++    R+P  S
Sbjct: 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPY 268
              +DL +K L  DP++R    E L H +
Sbjct: 281 EVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  308 bits (791), Expect = e-105
 Identities = 101/280 (36%), Positives = 143/280 (51%), Gaps = 33/280 (11%)

Query: 3   SETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQRET 56
           +   E  A+KKI      R++ +       T+REI +L+ + H NI+ + D+I      T
Sbjct: 23  NNYGETFALKKI------RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----T 71

Query: 57  FNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
              + +V+E +D DL +++      L     + FL QLL G+ Y H   VLHRDLKP NL
Sbjct: 72  KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131

Query: 116 LLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           L+N   +LKI DFGLAR         T  +VT WYRAP++L+   +Y+  IDIWSVGCI 
Sbjct: 132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDE------TSLGFLRSDNARRYVRMLPQFPK 228
            E++   PLFPG     QL  I  ++G+P+       T L         +Y      +  
Sbjct: 192 AEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--------PKYDPNFTVYEP 243

Query: 229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
             + +         +DLL KML  DPN+RIT  +AL H Y
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  307 bits (788), Expect = e-104
 Identities = 101/277 (36%), Positives = 155/277 (55%), Gaps = 22/277 (7%)

Query: 5   TREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
               VA+K+I      R+DA+        +REI LL+ + H NI+++ D+I      +  
Sbjct: 44  QGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SER 92

Query: 59  DVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            + +V+E M+ DL +++  +   L D   + +LYQLLRG+ + H   +LHRDLKP NLL+
Sbjct: 93  CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152

Query: 118 NANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           N++  LK+ DFGLAR         T  VVT WYRAP++L+   +Y+ ++DIWS+GCI  E
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNFSARF 235
           ++T +PLFPG     QL  I  ++G+P+             ++       F K+ +S+  
Sbjct: 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT--FQVFEKKPWSSII 270

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 272
           P      +DLL  ML FDPN+RI+  +A+ HPY   L
Sbjct: 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  307 bits (789), Expect = e-104
 Identities = 103/275 (37%), Positives = 148/275 (53%), Gaps = 19/275 (6%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHENIIAIKDIIRPPQRET 56
           +  T + VAIKKI     +R +AK       LREIKLL+ + H NII + D         
Sbjct: 31  DKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GH 83

Query: 57  FNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
            +++ +V++ M+TDL  II+ +   LT  H + ++   L+GL+Y+H   +LHRDLKP+NL
Sbjct: 84  KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143

Query: 116 LLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
           LL+ N  LK+ DFGLA++  S     T  VVTRWYRAPELL     Y   +D+W+VGCIL
Sbjct: 144 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 203

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNFSA 233
            E++ R P  PG   + QL  I E +G+P E          +   +      FP      
Sbjct: 204 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF----KSFPGIPLHH 259

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
            F       +DL++ + +F+P  RIT  +AL   Y
Sbjct: 260 IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  306 bits (785), Expect = e-104
 Identities = 106/320 (33%), Positives = 162/320 (50%), Gaps = 26/320 (8%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAK-----RTLREIKLLRHMDHENIIAIKDIIRPPQRE 55
            +  T   VA+K+I      R++ +       +RE+ LL+ + H NI+ + DII      
Sbjct: 22  KSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH----- 70

Query: 56  TFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           T   + +V+E +D DL Q +      +   + + FL+QLLRGL Y H   VLHRDLKP N
Sbjct: 71  TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQN 130

Query: 115 LLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           LL+N   +LK+ DFGLAR  +  T      VVT WYR P++LL  ++Y+  ID+W VGCI
Sbjct: 131 LLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 190

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNFS 232
             E+ T +PLFPG     QL  I  ++G+P E +  G L ++  + Y    P++  +   
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--NYPKYRAEALL 248

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP 292
           +  P       DLL K+L F+   RI+ ++A+ HP+   L +   +   P   S      
Sbjct: 249 SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKL--PDTTS---IFA 303

Query: 293 SFTEENIKELIYRESVKFNP 312
               +  KE   R +   + 
Sbjct: 304 LKEIQLQKEASLRSAHHHHH 323

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  304 bits (780), Expect = e-103
 Identities = 99/295 (33%), Positives = 153/295 (51%), Gaps = 34/295 (11%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQRE 55
           ++ T E VAIK+I      R++ +        +RE+ LL+ + H NII +K +I      
Sbjct: 55  DTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH----- 103

Query: 56  TFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             + +++++E  + DL + +  + D++    + FLYQL+ G+ + HS   LHRDLKP NL
Sbjct: 104 HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163

Query: 116 LLNANCD-----LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
           LL+ +       LKIGDFGLAR         T  ++T WYR PE+LL    Y+ ++DIWS
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWS 223

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPK 228
           + CI  E++ + PLFPG   + QL  I E++G PD+T+  G     +   + +  P+F  
Sbjct: 224 IACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD---WKQSFPKFRG 280

Query: 229 QNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP 282
           +              +DLL  ML  DP +RI+   AL HPY       +     P
Sbjct: 281 KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF------SHNDFDP 329

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  303 bits (778), Expect = e-103
 Identities = 91/278 (32%), Positives = 137/278 (49%), Gaps = 19/278 (6%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHM---DHENIIAIKDIIRPPQ 53
           +  +   VA+K +     N           T+RE+ LLR +   +H N++ + D+    +
Sbjct: 30  DPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87

Query: 54  RETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
            +    V +V+E +D DL   +       L  +  +  + Q LRGL ++H+  ++HRDLK
Sbjct: 88  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 147

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+LL  S Y   +D+WSVG
Sbjct: 148 PENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVG 206

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQN 230
           CI  E+  R+PLF G     QL  I +LIG P E      +            P    + 
Sbjct: 207 CIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA-----FPPRGPRP 261

Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
             +  P        LL +ML F+P++RI+   AL H Y
Sbjct: 262 VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  301 bits (774), Expect = e-102
 Identities = 96/306 (31%), Positives = 145/306 (47%), Gaps = 30/306 (9%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHM---DHENIIAIKDIIRPPQR 54
                VA+K++      R+          T+RE+ +LRH+   +H N++ + D+    + 
Sbjct: 35  NGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88

Query: 55  ETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           +    + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS  V+HRDLKP
Sbjct: 89  DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148

Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
            N+L+ ++  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  S Y   +D+WSVGC
Sbjct: 149 QNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGC 207

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNF 231
           I  E+  R+PLF G   V QL  I ++IG P E      +                 Q  
Sbjct: 208 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-----FHSKSAQPI 262

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEH 291
                +      DLL K L F+P +RI+   AL HPY        +   C          
Sbjct: 263 EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF------QDLERCKENLDSHLPP 316

Query: 292 PSFTEE 297
              T E
Sbjct: 317 SQNTSE 322

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  297 bits (764), Expect = e-101
 Identities = 104/278 (37%), Positives = 152/278 (54%), Gaps = 26/278 (9%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDIIRPPQRE 55
           N ET E VA+K++      R+D          LREI LL+ + H+NI+ + D++      
Sbjct: 23  NRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH----- 71

Query: 56  TFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           +   + +V+E  D DL +   S   DL  +  + FL+QLL+GL + HS NVLHRDLKP N
Sbjct: 72  SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131

Query: 115 LLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           LL+N N +LK+ +FGLAR         +  VVT WYR P++L     Y+ +ID+WS GCI
Sbjct: 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191

Query: 174 LGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFP-KQN 230
             E+    +PLFPG D   QL+ I  L+G+P E       +  + + Y    P +P   +
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY----PMYPATTS 247

Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 268
                P  +    DLL+ +L  +P +RI+ +EAL HPY
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  298 bits (766), Expect = e-101
 Identities = 104/314 (33%), Positives = 161/314 (51%), Gaps = 47/314 (14%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHENIIAIKDIIRPPQRET 56
           N  T   VA+K++      ++D++       +REI L++ + HENI+ + D+I      T
Sbjct: 26  NKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----T 74

Query: 57  FNDVYIVYELMDTDLHQIIRSH------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
            N + +V+E MD DL + + S       + L  +  +YF +QLL+GL + H   +LHRDL
Sbjct: 75  ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134

Query: 111 KPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
           KP NLL+N    LK+GDFGLAR      +  +  VVT WYRAP++L+    Y+ +IDIWS
Sbjct: 135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWS 194

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------TSLGFLRSDNARRYVRML 223
            GCIL E++T +PLFPG +   QL+LI +++G+P+E      T L         +Y   +
Sbjct: 195 CGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL--------PKYNPNI 246

Query: 224 PQFPKQNFSARFPNK-----SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 278
            Q P ++                 +D L  +L  +P+ R++  +AL HP+ A        
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA-----EYY 301

Query: 279 PVCPRPFSFDFEHP 292
                  S    H 
Sbjct: 302 HHASMGGSRSHHHH 315

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  297 bits (763), Expect = e-100
 Identities = 97/312 (31%), Positives = 157/312 (50%), Gaps = 29/312 (9%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAIKDII---RPP 52
           + +T ++VA+KK+       ++ ++       LREIK+L+ + HEN++ + +I      P
Sbjct: 38  HRKTGQKVALKKV------LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91

Query: 53  QRETFNDVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
                  +Y+V++  + DL  ++ +     T    +  +  LL GL Y+H   +LHRD+K
Sbjct: 92  YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151

Query: 112 PSNLLLNANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAID 166
            +N+L+  +  LK+ DFGLAR       S+ +  T  VVT WYR PELLL   +Y   ID
Sbjct: 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID 211

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQ 225
           +W  GCI+ E+ TR P+  G    HQL LI++L GS            +   +    L +
Sbjct: 212 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL--ELVK 269

Query: 226 FPKQNFSARFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL--APL-HDINEEPV 280
             K+    R     + P A+DL++K+LV DP +RI  D+AL H +    P+  D+     
Sbjct: 270 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 329

Query: 281 CPRPFSFDFEHP 292
                 F++  P
Sbjct: 330 THLTSMFEYLAP 341

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  272 bits (696), Expect = 2e-89
 Identities = 92/324 (28%), Positives = 148/324 (45%), Gaps = 50/324 (15%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + +  ++ A+K+I         +    REI LLR + H N+I+++ +           V+
Sbjct: 44  DGKDDKDYALKQIE--GTGISMS--ACREIALLRELKHPNVISLQKVFLSH---ADRKVW 96

Query: 62  IVYELMDTDLHQIIRSHQD---------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
           ++++  + DL  II+ H+          L     +  LYQ+L G+ Y+H+  VLHRDLKP
Sbjct: 97  LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156

Query: 113 SNLLLNANCD----LKIGDFGLARTTSE-----TDFMTEYVVTRWYRAPELLLNCSEYTA 163
           +N+L+         +KI D G AR  +       D     VVT WYRAPELLL    YT 
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VVTFWYRAPELLLGARHYTK 215

Query: 164 AIDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRLITELIGSPDETSL-GFLRS 213
           AIDIW++GCI  E++T +P+F  +          +  QL  I  ++G P +         
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI--- 272

Query: 214 DNARRYVRMLPQFPKQNFS---------ARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                +  ++  F +  ++                  A  LL+K+L  DP +RIT ++A+
Sbjct: 273 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332

Query: 265 CHPYL--APLHDINEEPVCPRPFS 286
             PY    PL   +    C  P+ 
Sbjct: 333 QDPYFLEDPLPTSDVFAGCQIPYP 356

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  192 bits (490), Expect = 1e-59
 Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 49/287 (17%)

Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDV 60
           +E ++  AIK +     +         EI  L  +    + II + D        T   +
Sbjct: 49  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYI 103

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  +
Sbjct: 104 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 162

Query: 121 CDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCS----------EYTAAIDI 167
             LK+ DFG+A        +      V T  Y  PE + + S          + +   D+
Sbjct: 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           WS+GCIL  +   +  F     ++Q+  +  +I    E                   +FP
Sbjct: 223 WSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHE------------------IEFP 262

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
                           D+L+  L  DP +RI++ E L HPY+     
Sbjct: 263 --------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  194 bits (495), Expect = 4e-59
 Identities = 81/309 (26%), Positives = 145/309 (46%), Gaps = 55/309 (17%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM------DHENIIAIKDIIRPPQRE 55
           + +  + VA+K + N    +   ++   EI++L H+      +  N+I + +        
Sbjct: 118 DHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE-------- 166

Query: 56  TF---NDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
            F   N + + +EL+  +L+++I+ ++    +    R F + +L+ L  +H   ++H DL
Sbjct: 167 NFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDL 226

Query: 111 KPSNLLLN--ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 168
           KP N+LL       +K+ DFG +    E   +  Y+ +R+YRAPE++L    Y   ID+W
Sbjct: 227 KPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGAR-YGMPIDMW 283

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE-------------TSLGFLRSDN 215
           S+GCIL E++T  PL PG+D   QL  + EL+G P +             +S G+ R   
Sbjct: 284 SLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCT 343

Query: 216 A-----RRYVRMLPQFPKQNFSARFPNKSPGA----------VDLLEKMLVFDPNRRITV 260
                    V    +  +        ++  G           +D L++ L +DP  R+T 
Sbjct: 344 VTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403

Query: 261 DEALCHPYL 269
            +AL HP+L
Sbjct: 404 GQALRHPWL 412

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  186 bits (474), Expect = 2e-57
 Identities = 67/297 (22%), Positives = 114/297 (38%), Gaps = 57/297 (19%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD--------IIRPPQ 53
           N+      AIKKI +           L E+ LL  ++H+ ++            +     
Sbjct: 27  NALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83

Query: 54  RETFNDVYIVYELMDT-DLHQIIRSHQDLTD-DHCRYFLYQLLRGLKYVHSANVLHRDLK 111
            +  + ++I  E  +   L+ +I S       D       Q+L  L Y+HS  ++HRDLK
Sbjct: 84  VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLK 143

Query: 112 PSNLLLNANCDLKIGDFGLARTTSET---------------DFMTEYVVTRWYRAPELLL 156
           P N+ ++ + ++KIGDFGLA+    +               D +T  + T  Y A E+L 
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203

Query: 157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 216
               Y   ID++S+G I  E++   P   G + V+ L+ +                    
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLR------------------- 242

Query: 217 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 273
              +   P F          NK      ++  ++  DPN+R      L   +L   H
Sbjct: 243 SVSIEFPPDFDD--------NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  187 bits (476), Expect = 3e-57
 Identities = 62/294 (21%), Positives = 110/294 (37%), Gaps = 53/294 (18%)

Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDV 60
           +E ++  AIK +     +         EI  L  +    + II + D        T   +
Sbjct: 30  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYI 84

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  +
Sbjct: 85  YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 143

Query: 121 CDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN----------CSEYTAAIDI 167
             LK+ DFG+A        +      V T  Y  PE + +           S+ +   D+
Sbjct: 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203

Query: 168 WSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           WS+GCIL  +   +  F    + + +L  I                              
Sbjct: 204 WSLGCILYYMTYGKTPFQQIINQISKLHAII----------------------------- 234

Query: 227 PKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
              N    FP+       D+L+  L  DP +RI++ E L HPY+        + 
Sbjct: 235 -DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  187 bits (476), Expect = 1e-56
 Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 49/292 (16%)

Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDV 60
           +E ++  AIK +     +         EI  L  +    + II + D        T   +
Sbjct: 77  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYI 131

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  +
Sbjct: 132 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 190

Query: 121 CDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCS----------EYTAAIDI 167
             LK+ DFG+A        +      V    Y  PE + + S          + +   D+
Sbjct: 191 GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           WS+GCIL  +   +  F     ++Q+  +  +I    E                   +FP
Sbjct: 251 WSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHE------------------IEFP 290

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
                           D+L+  L  DP +RI++ E L HPY+        + 
Sbjct: 291 --------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  183 bits (466), Expect = 1e-55
 Identities = 47/303 (15%), Positives = 83/303 (27%), Gaps = 54/303 (17%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR---------- 50
           + E  E+ A+K     A ++R + +R          +  E+    +D  R          
Sbjct: 83  DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142

Query: 51  -----------PPQRETFNDVYIVYELMDTDLHQIIR-------SHQDLTDDHCRYFLYQ 92
                              +  ++      DL  +            D           Q
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202

Query: 93  LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 152
           L+R    + S  ++H    P NL +  +  L +GD                 V   Y   
Sbjct: 203 LIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPR 260

Query: 153 ELL-LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 211
           E L  + + +T A++ W +G  +  +      F       +       +  P   SL F 
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF- 319

Query: 212 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                                            L+ + L FD  RR+   EA+  P    
Sbjct: 320 ---------------------GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

Query: 272 LHD 274
           L +
Sbjct: 359 LQN 361

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  181 bits (462), Expect = 2e-55
 Identities = 63/271 (23%), Positives = 94/271 (34%), Gaps = 41/271 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
            + E     A+K+  + F    D  R L E+     +  H   + ++        E    
Sbjct: 77  RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131

Query: 60  VYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y+  EL    L Q        L +     +L   L  L ++HS  ++H D+KP+N+ L 
Sbjct: 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
                K+GDFGL                  Y APELL     Y  A D++S+G  + E+ 
Sbjct: 192 PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVA 249

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
               L  G +   QLR                           + P+F            
Sbjct: 250 CNMELPHGGEGWQQLRQG------------------------YLPPEFT--------AGL 277

Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           S     +L  ML  DP  R T +  L  P L
Sbjct: 278 SSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  181 bits (461), Expect = 3e-55
 Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 52/283 (18%)

Query: 4   ETREEVAIKKI------GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +T ++VAIK I        +      A     EI++L+ ++H  II IK+       +  
Sbjct: 33  KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----DA- 86

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            D YIV ELM+  +L   +  ++ L +  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146

Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVG 171
           L++   +C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D WS+G
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSP----DETSLGFLRSDNARRYVRMLPQFP 227
            IL              ++        L G P      T +       + +Y      F 
Sbjct: 207 VIL--------------FI--C-----LSGYPPFSEHRTQVSLKDQITSGKY-----NFI 240

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                  +   S  A+DL++K+LV DP  R T +EAL HP+L 
Sbjct: 241 ----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  182 bits (465), Expect = 3e-55
 Identities = 77/324 (23%), Positives = 129/324 (39%), Gaps = 48/324 (14%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR-----------HMDHENIIAIKD--I 48
           +      VA+K +     +++  +    EIKLL+            M   +I+ + D   
Sbjct: 40  DMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96

Query: 49  IRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHS-ANV 105
            + P       V +V+E++  +L  +I+ ++   +   + +    QLL GL Y+H    +
Sbjct: 97  HKGPNGV---HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI 153

Query: 106 LHRDLKPSNLLLNANCD------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 159
           +H D+KP N+L+           +KI D G A    E    T  + TR YR+PE+LL   
Sbjct: 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP 211

Query: 160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDY------VHQLRLITELIGSPD-------ET 206
            +    DIWS  C++ E++T   LF   +          +  I EL+G          + 
Sbjct: 212 -WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 270

Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGA----VDLLEKMLVFDPNRRITVDE 262
           +  F  S    R +  L  +P ++        S        D L  ML  DP +R     
Sbjct: 271 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330

Query: 263 ALCHPYLAPLHDINEEPVCPRPFS 286
            + HP+L     + E  V  R   
Sbjct: 331 LVNHPWLKDTLGMEEIRVPDRELY 354

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  183 bits (466), Expect = 5e-55
 Identities = 84/283 (29%), Positives = 134/283 (47%), Gaps = 52/283 (18%)

Query: 4   ETREEVAIKKI------GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
           +T ++VAI+ I        +      A     EI++L+ ++H  II IK+       +  
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----DA- 211

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            D YIV ELM+  +L   +  ++ L +  C+ + YQ+L  ++Y+H   ++HRDLKP N+L
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271

Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVG 171
           L++   +C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D WS+G
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSP----DETSLGFLRSDNARRYVRMLPQFP 227
            IL              ++        L G P      T +       + +Y      F 
Sbjct: 332 VIL--------------FI--C-----LSGYPPFSEHRTQVSLKDQITSGKY-----NFI 365

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
                  +   S  A+DL++K+LV DP  R T +EAL HP+L 
Sbjct: 366 ----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  182 bits (463), Expect = 7e-55
 Identities = 79/310 (25%), Positives = 138/310 (44%), Gaps = 50/310 (16%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF---N 58
           +   +E VAIK I N    +    +   E++LL  M+  +      I+    +  F   N
Sbjct: 75  DRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL--KRHFMFRN 129

Query: 59  DVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHS--ANVLHRDLKPSN 114
            + +V+E++  +L+ ++R+   + ++ +  R F  Q+   L ++ +   +++H DLKP N
Sbjct: 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189

Query: 115 LLL--NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           +LL       +KI DFG +        + +Y+ +R+YR+PE+LL    Y  AID+WS+GC
Sbjct: 190 ILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGC 246

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------------------TSLGFLRSD 214
           IL E+ T +PLF G + V Q+  I E++G P                     +    ++ 
Sbjct: 247 ILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTK 306

Query: 215 NARRYVRMLPQFPKQNFSARFPNKSPGA---------------VDLLEKMLVFDPNRRIT 259
           + +R  +        N          G                 DL+ +ML +DP  RI 
Sbjct: 307 DGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366

Query: 260 VDEALCHPYL 269
              AL H + 
Sbjct: 367 PYYALQHSFF 376

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  182 bits (464), Expect = 1e-54
 Identities = 66/278 (23%), Positives = 105/278 (37%), Gaps = 50/278 (17%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 63
              +VA+K+I     +  D     RE++LLR  D H N+I           +     YI 
Sbjct: 47  DNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCTE-----KDRQFQYIA 96

Query: 64  YELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----- 117
            EL    L + +               L Q   GL ++HS N++HRDLKP N+L+     
Sbjct: 97  IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA 156

Query: 118 NANCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVG 171
           +      I DFGL +            +    T  + APE+L    +   T  +DI+S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           C+   +++      GK    Q      L+G+                           + 
Sbjct: 217 CVFYYVISEGSHPFGKSLQRQAN---ILLGACS------------------------LDC 249

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                ++   A +L+EKM+  DP +R +    L HP+ 
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  179 bits (455), Expect = 2e-54
 Identities = 52/284 (18%), Positives = 107/284 (37%), Gaps = 27/284 (9%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + +T +  AIK   N    R      +RE ++L+ ++H+NI+ +  I    +  T     
Sbjct: 30  HKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIE---EETTTRHKV 85

Query: 62  IVYELMDT-DLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           ++ E      L+ ++        L +      L  ++ G+ ++    ++HR++KP N++ 
Sbjct: 86  LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145

Query: 118 NANCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL-------LNCSEYTAAID 166
               D     K+ DFG AR   + +       T  Y  P++         +  +Y A +D
Sbjct: 146 VIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI--GSPDETSLGFLRSDNAR-RYVRML 223
           +WS+G       T    F   +   + + +   I  G P     G  +++N    +   +
Sbjct: 206 LWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265

Query: 224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
           P     +   +          +L  +L  D  +    D+     
Sbjct: 266 PVSCSLSRGLQVLLT-----PVLANILEADQEKCWGFDQFFAET 304

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  177 bits (452), Expect = 2e-54
 Identities = 60/284 (21%), Positives = 101/284 (35%), Gaps = 56/284 (19%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD-----------IIR 50
           +    +   IK++      + + ++  RE+K L  +DH NI+                 +
Sbjct: 32  HRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85

Query: 51  PPQRETFNDVYIVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 107
              R     ++I  E  D   L Q I  R  + L          Q+ +G+ Y+HS  +++
Sbjct: 86  NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIN 145

Query: 108 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 167
           RDLKPSN+ L     +KIGDFGL  +       T    T  Y +PE + +  +Y   +D+
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDL 204

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           +++G IL E++         +       +                               
Sbjct: 205 YALGLILAELLH--VCDTAFETSKFFTDL------------------------------R 232

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
               S  F         LL+K+L   P  R    E L    +  
Sbjct: 233 DGIISDIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  178 bits (453), Expect = 3e-54
 Identities = 79/283 (27%), Positives = 126/283 (44%), Gaps = 52/283 (18%)

Query: 4   ETREEVAIKKI-------GNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRE 55
            T +E A+K I        +A + +   + TL+E+ +LR +  H NII +KD       E
Sbjct: 40  PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-----E 94

Query: 56  TFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           T    ++V++LM   +L   +     L++   R  +  LL  +  +H  N++HRDLKP N
Sbjct: 95  TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWS 169
           +LL+ + ++K+ DFG +      + + E   T  Y APE++          Y   +D+WS
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQF 226
            G I+              Y     L   L GSP       +  LR   +  Y     QF
Sbjct: 215 TGVIM--------------YT----L---LAGSPPFWHRKQMLMLRMIMSGNY-----QF 248

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                S  + + S    DL+ + LV  P +R T +EAL HP+ 
Sbjct: 249 G----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  178 bits (454), Expect = 8e-54
 Identities = 77/311 (24%), Positives = 132/311 (42%), Gaps = 47/311 (15%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF---N 58
           ++  + +VA+K I N    R  A+    EI +L+ +  ++       +     + F    
Sbjct: 41  HARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKFLCVL--MSDWFNFHG 95

Query: 59  DVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            + I +EL+  +  + ++ +        H R+  YQL   L+++H   + H DLKP N+L
Sbjct: 96  HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155

Query: 117 LN-------------------ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 157
                                 N  +++ DFG A  T + +  T  V TR YR PE++L 
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE 213

Query: 158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD------------- 204
              +    D+WS+GCIL E      LF   +    L ++ +++G                
Sbjct: 214 LG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYF 272

Query: 205 -ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
            +  L +  + +  RYV+   +  K         +     DL+ +ML FDP +RIT+ EA
Sbjct: 273 YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL-EHVQLFDLMRRMLEFDPAQRITLAEA 331

Query: 264 LCHPYLAPLHD 274
           L HP+ A L  
Sbjct: 332 LLHPFFAGLTP 342

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  176 bits (448), Expect = 1e-53
 Identities = 75/271 (27%), Positives = 125/271 (46%), Gaps = 43/271 (15%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T  E A K I     +  D ++  RE ++ R + H NI+ + D I     +  +  Y+V
Sbjct: 29  TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLV 83

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           ++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL +   
Sbjct: 84  FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 143

Query: 123 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              +K+ DFGLA   ++++    +  T  Y +PE +L    Y+  +DIW+ G IL     
Sbjct: 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVIL----- 197

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    Y+  L     L+G P   DE          A  Y      +P    S  + 
Sbjct: 198 ---------YI--L-----LVGYPPFWDEDQHRLYAQIKAGAY-----DYP----SPEWD 232

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
             +P A  L++ ML  +P +RIT D+AL  P
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVP 263

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  176 bits (449), Expect = 3e-53
 Identities = 82/306 (26%), Positives = 134/306 (43%), Gaps = 47/306 (15%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF---NDVY 61
               VA+K + N       A+    EI++L H++  +  +    ++    E F     + 
Sbjct: 39  GGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTFRCVQ--MLEWFEHHGHIC 93

Query: 62  IVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN- 118
           IV+EL+    +  I+ +       DH R   YQ+ + + ++HS  + H DLKP N+L   
Sbjct: 94  IVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153

Query: 119 ------------------ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 160
                              N D+K+ DFG A  T + +  +  V TR YRAPE++L    
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILAL-G 210

Query: 161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP--------------DET 206
           ++   D+WS+GCIL E      +FP  D    L ++  ++G                   
Sbjct: 211 WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHD 270

Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
            L +    +A RYV    +  K+   ++         DL++KML +DP +RIT+ EAL H
Sbjct: 271 RLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH-ERLFDLIQKMLEYDPAKRITLREALKH 329

Query: 267 PYLAPL 272
           P+   L
Sbjct: 330 PFFDLL 335

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  176 bits (449), Expect = 4e-53
 Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 40/272 (14%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           E   +  IK+I  +  +  + + + RE+ +L +M H NI+  ++       E    +YIV
Sbjct: 47  EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSLYIV 101

Query: 64  YELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            +  +  DL + I + +     +D    +  Q+   LK+VH   +LHRD+K  N+ L  +
Sbjct: 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 161

Query: 121 CDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +++GDFG+AR  + T  +    + T +Y +PE+  N   Y    DIW++GC+L E+ T
Sbjct: 162 GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCT 220

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +  F      + +  I    GS    SL +                            S
Sbjct: 221 LKHAFEAGSMKNLVLKIIS--GSFPPVSLHY----------------------------S 250

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                L+ ++   +P  R +V+  L   ++A 
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  176 bits (449), Expect = 5e-53
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 51/280 (18%)

Query: 4   ETREEVAIKKI------GNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRET 56
            T  E A+K +       +        + T RE  +LR +  H +II + D       E+
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ES 171

Query: 57  FNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
            + +++V++LM   +L   +     L++   R  +  LL  + ++H+ N++HRDLKP N+
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENI 231

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE-----YTAAIDIWSV 170
           LL+ N  +++ DFG +      + + E   T  Y APE+L    +     Y   +D+W+ 
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291

Query: 171 GCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFP 227
           G IL              +   L     L GSP       +  LR     +Y     QF 
Sbjct: 292 GVIL--------------FT--L-----LAGSPPFWHRRQILMLRMIMEGQY-----QFS 325

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
               S  + ++S    DL+ ++L  DP  R+T ++AL HP
Sbjct: 326 ----SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  172 bits (439), Expect = 2e-52
 Identities = 72/279 (25%), Positives = 116/279 (41%), Gaps = 45/279 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
              + +  K++        + +  + E+ LLR + H NI+   D I      T   +YIV
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRI---IDRTNTTLYIV 85

Query: 64  YELMDT-DLHQIIRSHQD----LTDDHCRYFLYQLLRGLKYVHSAN-----VLHRDLKPS 113
            E  +  DL  +I         L ++     + QL   LK  H  +     VLHRDLKP+
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145

Query: 114 NLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE +   S Y    DIWS+GC
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGC 204

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +L E+    P F           I E                   ++ R+  ++      
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIRE------------------GKFRRIPYRY------ 240

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                 S    +++ +ML      R +V+E L +P +  
Sbjct: 241 ------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  177 bits (451), Expect = 4e-52
 Identities = 76/284 (26%), Positives = 126/284 (44%), Gaps = 39/284 (13%)

Query: 4   ETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
            T +E A+K I       + D +  LRE++LL+ +DH NI+ + +       E     Y+
Sbjct: 49  ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKGYFYL 103

Query: 63  VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---N 118
           V E+    +L   I S +  ++      + Q+L G+ Y+H   ++HRDLKP NLLL   +
Sbjct: 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 163

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            + +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  ++
Sbjct: 164 KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL 221

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           +  P F G +    L+ +    G                        F       ++   
Sbjct: 222 SGCPPFNGANEYDILKKV--EKGKYT---------------------FE----LPQWKKV 254

Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP 282
           S  A DL+ KML + P+ RI+  +AL H ++            P
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  174 bits (443), Expect = 4e-52
 Identities = 75/271 (27%), Positives = 125/271 (46%), Gaps = 43/271 (15%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T  E A K I     +  D ++  RE ++ R + H NI+ + D I     +  +  Y+V
Sbjct: 52  TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLV 106

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           ++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL +   
Sbjct: 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 166

Query: 123 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              +K+ DFGLA   ++++    +  T  Y +PE +L    Y+  +DIW+ G IL     
Sbjct: 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVIL----- 220

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    Y+  L     L+G P   DE          A  Y      +P    S  + 
Sbjct: 221 ---------YI--L-----LVGYPPFWDEDQHRLYAQIKAGAY-----DYP----SPEWD 255

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
             +P A  L++ ML  +P +RIT D+AL  P
Sbjct: 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVP 286

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  174 bits (442), Expect = 5e-52
 Identities = 64/316 (20%), Positives = 124/316 (39%), Gaps = 64/316 (20%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-----DHENIIAIKDIIRPPQRETF- 57
           + ++  A+K + N       AK    E  +L+ +     ++ NI+             F 
Sbjct: 58  DNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNIVKYHG--------KFM 106

Query: 58  --NDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
             + + +++E +   L++II  +       +  + +  ++L+ L Y+   ++ H DLKP 
Sbjct: 107 YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166

Query: 114 NLLLN-------------------------ANCDLKIGDFGLARTTSETDFMTEYVVTRW 148
           N+LL+                          +  +K+ DFG A  T ++D+    + TR 
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQ 224

Query: 149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE--- 205
           YRAPE++LN   +  + D+WS GC+L E+ T   LF   +++  L ++  +I    +   
Sbjct: 225 YRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNML 283

Query: 206 -----TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS-------PGAVDLLEKMLVFD 253
                T+     + +  +           +                    D L  +L  D
Sbjct: 284 YEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343

Query: 254 PNRRITVDEALCHPYL 269
           P  R +  E L H +L
Sbjct: 344 PTLRPSPAELLKHKFL 359

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  171 bits (436), Expect = 7e-52
 Identities = 84/271 (30%), Positives = 126/271 (46%), Gaps = 44/271 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T++E A+K I  A     D    LRE++LL+ +DH NI+ + +I+     E  +  YIV
Sbjct: 45  ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIV 99

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
            EL    +L   I   +  ++      + Q+  G+ Y+H  N++HRDLKP N+LL     
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL     
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVIL----- 212

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    Y+    L   L G+P    +     L+     +Y      F       ++ 
Sbjct: 213 ---------YI----L---LSGTPPFYGKNEYDILKRVETGKY-----AFD----LPQWR 247

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
             S  A DL+ KML F P+ RIT  + L HP
Sbjct: 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  171 bits (436), Expect = 9e-52
 Identities = 60/306 (19%), Positives = 110/306 (35%), Gaps = 58/306 (18%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD-------IIRPPQR 54
           N       AIK+I    +  +  ++ +RE+K L  ++H  I+   +         +    
Sbjct: 26  NKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLT---DDHCRYFLYQLLRGLKYVHSANVLHRDL 110
                +YI  +L    +L   +     +       C +   Q+   ++++HS  ++HRDL
Sbjct: 85  SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDL 144

Query: 111 KPSNLLLNANCDLKIGDFGLARTTSETDFM-------------TEYVVTRWYRAPELLLN 157
           KPSN+    +  +K+GDFGL     + +               T  V T+ Y +PE +  
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204

Query: 158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
            + Y+  +DI+S+G IL E++   P     + V  L  +                     
Sbjct: 205 -NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVR-------------------- 241

Query: 218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 277
                        F   F  K P    +++ ML   P  R      + +     L    +
Sbjct: 242 ----------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291

Query: 278 EPVCPR 283
             +  R
Sbjct: 292 TVLRQR 297

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  179 bits (455), Expect = 1e-51
 Identities = 69/319 (21%), Positives = 129/319 (40%), Gaps = 23/319 (7%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND-V 60
           + +T E+VAIK+       + + +R   EI++++ ++H N+++ +++    Q+   ND  
Sbjct: 35  HQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93

Query: 61  YIVYELMDT-DLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            +  E  +  DL + +   ++   L +   R  L  +   L+Y+H   ++HRDLKP N++
Sbjct: 94  LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 153

Query: 117 LNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           L         KI D G A+   + +  TE+V T  Y APELL     YT  +D WS G +
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTL 212

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
             E +T    F       Q           +E  + +     A ++  +LP         
Sbjct: 213 AFECITGFRPFLPNWQPVQWHGKVR--EKSNEHIVVYDDLTGAVKFSSVLPTPNH----- 265

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV------CPRPFSF 287
                +      L+ ML++   +R T  +         L  I    +             
Sbjct: 266 LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHT 325

Query: 288 DFEHPSFTEENIKELIYRE 306
                +   +N+K  + ++
Sbjct: 326 YPVTENENLQNLKSWLQQD 344

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  176 bits (447), Expect = 2e-51
 Identities = 82/270 (30%), Positives = 120/270 (44%), Gaps = 38/270 (14%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T  E AIK I     +     + L E+ +L+ +DH NI+ + D       E   + Y+V
Sbjct: 60  VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLV 114

Query: 64  YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
            E     +L   I       +      + Q+L G+ Y+H  N++HRDLKP NLLL     
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  +KI DFGL+        M E + T +Y APE+L     Y    D+WS+G IL  ++ 
Sbjct: 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLA 232

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F G+     LR +    G                        F     S  + N S
Sbjct: 233 GYPPFGGQTDQEILRKV--EKGKYT---------------------FD----SPEWKNVS 265

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            GA DL+++ML FD  RRI+  +AL HP++
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  172 bits (437), Expect = 6e-51
 Identities = 63/330 (19%), Positives = 122/330 (36%), Gaps = 40/330 (12%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + +T +  AIK   N    R      +RE ++L+ ++H+NI+ +  I    +  T     
Sbjct: 30  HKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIE---EETTTRHKV 85

Query: 62  IVYELMDT-DLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           ++ E      L+ ++        L +      L  ++ G+ ++    ++HR++KP N++ 
Sbjct: 86  LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145

Query: 118 NANCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL-------LNCSEYTAAID 166
               D     K+ DFG AR   + +       T  Y  P++         +  +Y A +D
Sbjct: 146 VIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI--GSPDETSLGFLRSDNAR-RYVRML 223
           +WS+G       T    F   +   + + +   I  G P     G  +++N    +   +
Sbjct: 206 LWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265

Query: 224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPR 283
           P     +              +L  +L  D  +    D+     + A   DI    V   
Sbjct: 266 PVSCSLSRGL-----QVLLTPVLANILEADQEKCWGFDQ-----FFAETSDILHRMVI-H 314

Query: 284 PFSFD-------FEHPSFTEENIKELIYRE 306
            FS         + H   T     EL+Y++
Sbjct: 315 VFSLQQMTAHKIYIHSYNTATIFHELVYKQ 344

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  168 bits (429), Expect = 6e-51
 Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 48/288 (16%)

Query: 4   ETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
            T +E A K I     ++    +  +   RE+ +LR + H NII + DI      E   D
Sbjct: 28  GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----ENKTD 82

Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL- 117
           V ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+HS  + H DLKP N++L 
Sbjct: 83  VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142

Query: 118 ---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
                N  +K+ DFG+A      +       T  + APE ++N        D+WS+G I 
Sbjct: 143 DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVIT 201

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNF 231
                         Y+  L     L G+     ET    L + +A  Y      F     
Sbjct: 202 --------------YI--L-----LSGASPFLGETKQETLTNISAVNY-----DFD---- 231

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
              F N S  A D + ++LV DP RR+T+ ++L H ++  +   N   
Sbjct: 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  174 bits (442), Expect = 8e-51
 Identities = 83/270 (30%), Positives = 128/270 (47%), Gaps = 38/270 (14%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T++E A+K I  A     D    LRE++LL+ +DH NI+ + +I+     E  +  YIV
Sbjct: 45  ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIV 99

Query: 64  YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
            EL    +L   I   +  ++      + Q+  G+ Y+H  N++HRDLKP N+LL     
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL  +++
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS 217

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F GK+    L+ +    G                        F       ++   S
Sbjct: 218 GTPPFYGKNEYDILKRV--ETGKYA---------------------FD----LPQWRTIS 250

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             A DL+ KML F P+ RIT  + L HP++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  165 bits (421), Expect = 8e-50
 Identities = 75/271 (27%), Positives = 110/271 (40%), Gaps = 46/271 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            TR   A KKI        D  R  +EI++++ +DH NII + +       E   D+Y+V
Sbjct: 32  GTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIYLV 84

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
            EL    +L + +   +   +      +  +L  + Y H  NV HRDLKP N L    + 
Sbjct: 85  MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  LK+ DFGLA        M   V T +Y +P++L     Y    D WS G ++     
Sbjct: 145 DSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMM----- 197

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    YV    L   L G P     T    +       +      FP       + 
Sbjct: 198 ---------YV----L---LCGYPPFSAPTDSEVMLKIREGTF-----TFP----EKDWL 232

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
           N SP A  L+ ++L   P +RIT  +AL H 
Sbjct: 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHE 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  167 bits (426), Expect = 8e-50
 Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 44/307 (14%)

Query: 2   NSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++T+E  A K +  +        ++   EI + R + H++++           E  + V
Sbjct: 62  DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDFV 116

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V EL     L ++ +  + LT+   RY+L Q++ G +Y+H   V+HRDLK  NL LN 
Sbjct: 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 176

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           + ++KIGDFGLA T  E D   + V+  T  Y APE+L     ++  +D+WS+GCI+  +
Sbjct: 177 DLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTL 234

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +  +P F           I +                    Y       P         +
Sbjct: 235 LVGKPPFETSCLKETYLRIKK------------------NEY-----SIP--------KH 263

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL--APLHDINEEPVCPRPFSFDFEHPSFT 295
            +P A  L++KML  DP  R T++E L   +     +           P  F     S  
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 323

Query: 296 EENIKEL 302
             N K L
Sbjct: 324 PSNRKPL 330

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  166 bits (422), Expect = 1e-49
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 42/270 (15%)

Query: 2   NSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++T+E  A K +  +        ++   EI + R + H++++           E  + V
Sbjct: 36  DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDFV 90

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V EL     L ++ +  + LT+   RY+L Q++ G +Y+H   V+HRDLK  NL LN 
Sbjct: 91  FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 150

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           + ++KIGDFGLA T  E D   + V+  T  Y APE+L     ++  +D+WS+GCI+  +
Sbjct: 151 DLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTL 208

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +  +P F           I +                    Y       P         +
Sbjct: 209 LVGKPPFETSCLKETYLRIKK------------------NEY-----SIP--------KH 237

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
            +P A  L++KML  DP  R T++E L   
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDE 267

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  166 bits (423), Expect = 1e-49
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 48/283 (16%)

Query: 4   ETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
            T  E A K I      A    +  +   RE+ +LR + H N+I + D+      E   D
Sbjct: 35  STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----ENRTD 89

Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL- 117
           V ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+  + H DLKP N++L 
Sbjct: 90  VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149

Query: 118 ---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
                   +K+ DFGLA    +         T  + APE ++N        D+WS+G I 
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVIT 208

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNF 231
                         Y+  L     L G+     +T    L +  +  Y      F     
Sbjct: 209 --------------YI--L-----LSGASPFLGDTKQETLANITSVSY-----DFD---- 238

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
              F + S  A D + K+LV +  +R+T+ EAL HP++ P+ +
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  165 bits (420), Expect = 2e-49
 Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 50/275 (18%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            +  E  IK I N   +++  ++   EI++L+ +DH NII I ++      E ++++YIV
Sbjct: 45  SSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIV 98

Query: 64  YELMD-----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL- 117
            E  +       +       + L++ +    + Q++  L Y HS +V+H+DLKP N+L  
Sbjct: 99  METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQ 158

Query: 118 --NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
             + +  +KI DFGLA      +  T    T  Y APE+     + T   DIWS G ++ 
Sbjct: 159 DTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVM- 215

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFS 232
                        Y   L     L G       +     +    +            N++
Sbjct: 216 -------------YF--L-----LTGCLPFTGTSLEEVQQKATYKEP----------NYA 245

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                 +P AVDLL++ML  DP RR +  + L H 
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  165 bits (421), Expect = 2e-49
 Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 42/277 (15%)

Query: 1   MNSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
                   VA+KK+   +  D +      ++EI LL+ ++H N+I              N
Sbjct: 52  ACLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKYYASF-----IEDN 105

Query: 59  DVYIVYELMDT-DLHQIIRSHQD----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           ++ IV EL D  DL ++I+  +     + +     +  QL   L+++HS  V+HRD+KP+
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA 165

Query: 114 NLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+ + A   +K+GD GL R  +S+T      V T +Y +PE +   + Y    DIWS+GC
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGC 224

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           +L E+   Q  F G D ++   L  ++                        P  P  ++ 
Sbjct: 225 LLYEMAALQSPFYG-DKMNLYSLCKKIEQCD-------------------YPPLPSDHY- 263

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 S     L+   +  DP +R  V         
Sbjct: 264 ------SEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  166 bits (422), Expect = 2e-49
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 48/280 (17%)

Query: 4   ETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
            T  + A K I      +    +  +   RE+ +L+ + H N+I + ++      E   D
Sbjct: 34  STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----ENKTD 88

Query: 60  VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL- 117
           V ++ EL+   +L   +   + LT++    FL Q+L G+ Y+HS  + H DLKP N++L 
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148

Query: 118 ---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
                   +KI DFGLA      +       T  + APE ++N        D+WS+G I 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVIT 207

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNF 231
                         Y+  L     L G+     +T    L + +A  Y     +F     
Sbjct: 208 --------------YI--L-----LSGASPFLGDTKQETLANVSAVNY-----EFE---- 237

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
              F N S  A D + ++LV DP +R+T+ ++L HP++ P
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  166 bits (423), Expect = 3e-49
 Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 48/288 (16%)

Query: 4   ETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
            T  E A K I      A    +  +   RE+ +LR + H NII + D+      E   D
Sbjct: 35  STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----ENRTD 89

Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL- 117
           V ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+  + H DLKP N++L 
Sbjct: 90  VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149

Query: 118 ---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
                   +K+ DFGLA    +         T  + APE ++N        D+WS+G I 
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVIT 208

Query: 175 GEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNF 231
                         Y+  L     L G+     +T    L +  A  Y      F     
Sbjct: 209 --------------YI--L-----LSGASPFLGDTKQETLANITAVSY-----DFD---- 238

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
              F   S  A D + K+LV +  +R+T+ EAL HP++ P+       
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMV 286

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  164 bits (418), Expect = 8e-49
 Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 46/278 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYI 62
            T +E A K +      +      L EI +L        +I + ++      E  +++ +
Sbjct: 52  STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTSEIIL 106

Query: 63  VYELMDT-DL-HQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-- 117
           + E     ++    +    + ++++     + Q+L G+ Y+H  N++H DLKP N+LL  
Sbjct: 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166

Query: 118 -NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                D+KI DFG++R       + E + T  Y APE +LN    T A D+W++G I   
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIA-- 223

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
                       Y+  L     L  +     E +     + +          +       
Sbjct: 224 ------------YM--L-----LTHTSPFVGEDNQETYLNISQVNV-----DYS----EE 255

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
            F + S  A D ++ +LV +P +R T +  L H +L  
Sbjct: 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  168 bits (428), Expect = 1e-48
 Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 49/291 (16%)

Query: 4   ETREEVAIKKI-----------GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 52
               E AIK I            +  +     +    EI LL+ +DH NII + D+    
Sbjct: 59  NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF--- 115

Query: 53  QRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
             E     Y+V E  +  +L + I +     +      + Q+L G+ Y+H  N++HRD+K
Sbjct: 116 --EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIK 173

Query: 112 PSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 168
           P N+LL   N+  ++KI DFGL+   S+   + + + T +Y APE+L    +Y    D+W
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVW 231

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           S G I+  ++   P F G++    ++ +                        +    F  
Sbjct: 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVE-----------------------KGKYYFD- 267

Query: 229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
                 + N S  A +L++ ML +D N+R T +EAL   ++    +   + 
Sbjct: 268 ---FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  164 bits (417), Expect = 2e-48
 Identities = 81/274 (29%), Positives = 122/274 (44%), Gaps = 46/274 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T++  A+K +       +D K    EI +L  + H NII +K+I      ET  ++ +V
Sbjct: 76  GTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEISLV 126

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
            EL+   +L   I      ++      + Q+L  + Y+H   ++HRDLKP NLL      
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  LKI DFGL++       M     T  Y APE+L  C+ Y   +D+WSVG I      
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIIT----- 240

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    Y+  L     L G     DE    F+     RR +     F     S  + 
Sbjct: 241 ---------YI--L-----LCGFEPFYDERGDQFM----FRRILNCEYYFI----SPWWD 276

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
             S  A DL+ K++V DP +R+T  +AL HP++ 
Sbjct: 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  166 bits (421), Expect = 3e-48
 Identities = 73/300 (24%), Positives = 114/300 (38%), Gaps = 67/300 (22%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDV 60
            S     VA+K++   F +         EIKLL   D H N+I            T   +
Sbjct: 35  GSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTESDDHPNVIRYYCSE-----TTDRFL 84

Query: 61  YIVYELMDTDLHQIIRSHQD-------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           YI  EL + +L  ++ S            + +    L Q+  G+ ++HS  ++HRDLKP 
Sbjct: 85  YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144

Query: 114 NLLL-------------NANCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELL 155
           N+L+               N  + I DFGL +      +S    +     T  +RAPELL
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204

Query: 156 LNCSE------YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 209
              +        T +IDI+S+GC+   I+++     G  Y                    
Sbjct: 205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY-------------------- 244

Query: 210 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             R  N  R +  L +           +    A DL+ +M+  DP +R T  + L HP  
Sbjct: 245 -SRESNIIRGIFSLDEMK----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  162 bits (411), Expect = 9e-48
 Identities = 63/287 (21%), Positives = 119/287 (41%), Gaps = 46/287 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            +++    K +     +++  K+   EI +L    H NI+ + +       E+  ++ ++
Sbjct: 28  SSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLHESF-----ESMEELVMI 79

Query: 64  YELMD-TDLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-- 119
           +E +   D+  +I  S  +L +     +++Q+   L+++HS N+ H D++P N++     
Sbjct: 80  FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  +KI +FG AR     D          Y APE +      + A D+WS+G ++     
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQHDVVSTATDMWSLGTLV----- 193

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    YV  L     L G      ET+   + +     Y      F        F 
Sbjct: 194 ---------YV--L-----LSGINPFLAETNQQIIENIMNAEY-----TFD----EEAFK 228

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPR 283
             S  A+D ++++LV +   R+T  EAL HP+L    +     V   
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  164 bits (417), Expect = 2e-47
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 44/284 (15%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
              +E A   I     +  D ++  RE ++ R + H NI+ + D I           Y++
Sbjct: 34  LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGHHYLI 88

Query: 64  YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
           ++L+   +L + I + +  ++    + + Q+L  + + H   V+HR+LKP NLLL     
Sbjct: 89  FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK 148

Query: 120 NCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLA     E      +  T  Y +PE+L     Y   +D+W+ G IL    
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVIL---- 203

Query: 179 TRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
                     Y+    L   L+G P   DE      +   A  Y      FP    S  +
Sbjct: 204 ----------YI----L---LVGYPPFWDEDQHRLYQQIKAGAY-----DFP----SPEW 237

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
              +P A DL+ KML  +P++RIT  EAL HP+++    +    
Sbjct: 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  162 bits (411), Expect = 2e-47
 Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 50/290 (17%)

Query: 4   ETREEVAIKKIG-NAFDNR--IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           ET ++ A+K +    F +   +  +   RE  +   + H +I+ + +        +   +
Sbjct: 47  ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SSDGML 101

Query: 61  YIVYELMD-TDL-HQIIR---SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           Y+V+E MD  DL  +I++   +    ++    +++ Q+L  L+Y H  N++HRD+KP  +
Sbjct: 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCV 161

Query: 116 LL---NANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           LL     +  +K+G FG+A    E+       V T  + APE ++    Y   +D+W  G
Sbjct: 162 LLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCG 220

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSP--DETSLGFLRSDNARRYVRMLPQFPKQ 229
            IL              ++  L     L G      T           +Y     +    
Sbjct: 221 VIL--------------FI--L-----LSGCLPFYGTKERLFEGIIKGKY-----KMN-- 252

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
               ++ + S  A DL+ +ML+ DP  RITV EAL HP+L        + 
Sbjct: 253 --PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  160 bits (406), Expect = 3e-47
 Identities = 77/274 (28%), Positives = 118/274 (43%), Gaps = 46/274 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T +  A+K I  +            EI +L+ + HENI+ ++DI      E+    Y+V
Sbjct: 32  LTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYYLV 84

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NA 119
            +L+   +L   I      T+      + Q+L  +KY+H   ++HRDLKP NLL      
Sbjct: 85  MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEE 144

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           N  + I DFGL++   +   M+    T  Y APE +L    Y+ A+D WS+G I      
Sbjct: 145 NSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIT----- 197

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    Y+  L     L G P   +ET            Y     +F     S  + 
Sbjct: 198 ---------YI--L-----LCGYPPFYEETESKLFEKIKEGYY-----EFE----SPFWD 232

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
           + S  A D +  +L  DPN R T ++AL HP++ 
Sbjct: 233 DISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  160 bits (407), Expect = 4e-47
 Identities = 67/323 (20%), Positives = 112/323 (34%), Gaps = 84/323 (26%)

Query: 4   ETREEVAIKKI---GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +TR   AIK +        N  D +R   E++L++ + H NI  + ++      E    +
Sbjct: 49  QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYI 103

Query: 61  YIVYELM-----------------------------------------DTDLHQIIRSHQ 79
            +V EL                                           +          
Sbjct: 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDF 163

Query: 80  DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--NANCDLKIGDFGLAR----- 132
              +      + Q+   L Y+H+  + HRD+KP N L   N + ++K+ DFGL++     
Sbjct: 164 VQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKL 223

Query: 133 TTSETDFMTEYVVTRWYRAPELLLNCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVH 191
              E   MT    T ++ APE+L   +E Y    D WS G +L  ++     FPG +   
Sbjct: 224 NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD 283

Query: 192 QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLV 251
            +  +  L                          F     +  +   SP A DLL  +L 
Sbjct: 284 TISQV--LNKKLC---------------------FE----NPNYNVLSPLARDLLSNLLN 316

Query: 252 FDPNRRITVDEALCHPYLAPLHD 274
            + + R     AL HP+++   D
Sbjct: 317 RNVDERFDAMRALQHPWISQFSD 339

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  158 bits (402), Expect = 6e-47
 Identities = 69/274 (25%), Positives = 116/274 (42%), Gaps = 49/274 (17%)

Query: 2   NSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T  EVAIK I   A       +R   E+K+   + H +I+ + +       E  N V
Sbjct: 32  SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSNYV 86

Query: 61  YIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           Y+V       E+       +    +  +++  R+F++Q++ G+ Y+HS  +LHRDL  SN
Sbjct: 87  YLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSN 142

Query: 115 LLLNANCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           LLL  N ++KI DFGLA +     +       T  Y +PE+    S +    D+WS+GC+
Sbjct: 143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCM 201

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
              ++  +P F      + L  +                      Y     + P      
Sbjct: 202 FYTLLIGRPPFDTDTVKNTLNKVV------------------LADY-----EMP------ 232

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                S  A DL+ ++L  +P  R+++   L HP
Sbjct: 233 --SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  160 bits (406), Expect = 2e-46
 Identities = 62/284 (21%), Positives = 114/284 (40%), Gaps = 45/284 (15%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T      K I       +D      EI ++  + H  +I + D       E   ++ ++
Sbjct: 74  ATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVLI 126

Query: 64  YELMD-TDLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--NA 119
            E +   +L  +I      +++     ++ Q   GLK++H  +++H D+KP N++     
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 186

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              +KI DFGLA   +  + +     T  + APE +++        D+W++G +      
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLG----- 240

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    YV  L     L G      E  L  L++     +     +F        F 
Sbjct: 241 ---------YV--L-----LSGLSPFAGEDDLETLQNVKRCDW-----EFD----EDAFS 275

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 280
           + SP A D ++ +L  +P +R+TV +AL HP+L   H      +
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  158 bits (402), Expect = 3e-46
 Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 43/287 (14%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYI 62
            T  E A+K I     ++ D      EI++L     H NII +KD+      +    VY+
Sbjct: 45  ATNMEFAVKIID---KSKRDPTE---EIEILLRYGQHPNIITLKDVY-----DDGKYVYV 93

Query: 63  VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           V ELM   +L   I   +  ++      L+ + + ++Y+H+  V+HRDLKPSN+L     
Sbjct: 94  VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES 153

Query: 122 D----LKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                ++I DFG A+   +E   +     T  + APE +L    Y AA DIWS+G +L  
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYT 212

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++T    F                  PD+T    L    + ++               + 
Sbjct: 213 MLTGYTPF---------------ANGPDDTPEEILARIGSGKF-----SLS----GGYWN 248

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPR 283
           + S  A DL+ KML  DP++R+T    L HP++     + +  +  +
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQ 295

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  156 bits (396), Expect = 5e-46
 Identities = 57/296 (19%), Positives = 98/296 (33%), Gaps = 66/296 (22%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
           +        AIK+        +D +  LRE+     +  H +++              + 
Sbjct: 31  VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDDH 85

Query: 60  VYIVYELMDT-DLHQIIRSHQD----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           + I  E  +   L   I  +        +   +  L Q+ RGL+Y+HS +++H D+KPSN
Sbjct: 86  MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145

Query: 115 LLLNAN-------------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 155
           + ++                        KIGD G     S             + A E+L
Sbjct: 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE---EGDSRFLANEVL 202

Query: 156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 215
                +    DI+++   +      +PL    D  H++R      G              
Sbjct: 203 QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR-----QGRL------------ 245

Query: 216 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
                   P+ P Q  S  F        +LL+ M+  DP RR +    + H  L  
Sbjct: 246 --------PRIP-QVLSQEF-------TELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  162 bits (412), Expect = 6e-46
 Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 45/275 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T    A K +     +  D +   +EI+ +  + H  ++ + D       E  N++ ++
Sbjct: 180 ATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMI 232

Query: 64  YELMD-TDL-HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--NA 119
           YE M   +L  ++   H  +++D    ++ Q+ +GL ++H  N +H DLKP N++     
Sbjct: 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR 292

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           + +LK+ DFGL         +     T  + APE +          D+WSVG +      
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLS----- 346

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    Y+  L     L G      E     LR+  +  +             + F 
Sbjct: 347 ---------YI--L-----LSGLSPFGGENDDETLRNVKSCDW-----NMD----DSAFS 381

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 271
             S    D + K+L+ DPN R+T+ +AL HP+L P
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  154 bits (392), Expect = 2e-45
 Identities = 59/276 (21%), Positives = 113/276 (40%), Gaps = 56/276 (20%)

Query: 2   NSETREEVAIKKIGNAFDNRIDA----KRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
             +++  +A+K +   F  +++      +  RE+++  H+ H NI+ +            
Sbjct: 30  EKQSKFILALKVL---FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA 81

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
             VY++ E      +++ ++      +     ++ +L   L Y HS  V+HRD+KP NLL
Sbjct: 82  TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141

Query: 117 LNANCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           L +  +LKI DFG +     +         +Y+       PE++     +   +D+WS+G
Sbjct: 142 LGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEMIEG-RMHDEKVDLWSLG 194

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            +  E +  +P F    Y    + I                        R+   FP    
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRI-----------------------SRVEFTFP---- 227

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
                  + GA DL+ ++L  +P++R  + E L HP
Sbjct: 228 ----DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  154 bits (392), Expect = 3e-45
 Identities = 67/301 (22%), Positives = 126/301 (41%), Gaps = 75/301 (24%)

Query: 2   NSETREEVAIKKI------------------------GNAFDNRIDAKRTLREIKLLRHM 37
           N       A+K +                        G     R   ++  +EI +L+ +
Sbjct: 34  NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93

Query: 38  DHENIIAIKDIIRPPQRETFNDVYIVYE------LMDTDLHQIIRSHQDLTDDHCRYFLY 91
           DH N++ + +++  P     + +Y+V+E      +M+      + + + L++D  R++  
Sbjct: 94  DHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVME------VPTLKPLSEDQARFYFQ 144

Query: 92  QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-TRWYR 150
            L++G++Y+H   ++HRD+KPSNLL+  +  +KI DFG++     +D +    V T  + 
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFM 204

Query: 151 APELLLNCS-EYT-AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS-P-DET 206
           APE L      ++  A+D+W++G  L              Y      +    G  P  + 
Sbjct: 205 APESLSETRKIFSGKALDVWAMGVTL--------------YC----FVF---GQCPFMDE 243

Query: 207 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
            +  L      +      +FP        P+ +    DL+ +ML  +P  RI V E   H
Sbjct: 244 RIMCLH----SKIKSQALEFP------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293

Query: 267 P 267
           P
Sbjct: 294 P 294

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  156 bits (396), Expect = 4e-45
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 45/274 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
            T  ++A K I        D +    EI ++  +DH N+I + D       E+ ND+ +V
Sbjct: 112 ATGLKLAAKII--KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLV 164

Query: 64  YELMDT-DLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--NA 119
            E +D  +L  +II    +LT+     F+ Q+  G++++H   +LH DLKP N+L     
Sbjct: 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              +KI DFGLAR     + +     T  + APE ++N    +   D+WSVG I      
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIA----- 278

Query: 180 RQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
                    Y+  L     L G      +     L +  A R+               F 
Sbjct: 279 ---------YM--L-----LSGLSPFLGDNDAETLNNILACRW-----DLE----DEEFQ 313

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
           + S  A + + K+L+ + + RI+  EAL HP+L+
Sbjct: 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  154 bits (392), Expect = 4e-45
 Identities = 60/281 (21%), Positives = 100/281 (35%), Gaps = 48/281 (17%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
                 A+K+I      + D +   RE  + R  +H NI+ +       +R   ++ +++
Sbjct: 52  HDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR-ERGAKHEAWLL 108

Query: 64  YELMDT-DLHQIIRSHQD----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
                   L   I   +D    LT+D   + L  + RGL+ +H+    HRDLKP+N+LL 
Sbjct: 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168

Query: 119 ANCDLKIGDFGLART------TSETDFMTEYVVTR----WYRAPELLLN--CSEYTAAID 166
                 + D G           S      +    +     YRAPEL             D
Sbjct: 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS+GC+L  +M  +  +                         F + D+    V+     
Sbjct: 229 VWSLGCVLYAMMFGEGPYDMV----------------------FQKGDSVALAVQNQLSI 266

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
           P+       P  S     LL  M+  DP++R  +   L   
Sbjct: 267 PQ------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  155 bits (393), Expect = 5e-45
 Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 40/283 (14%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH-MDHENIIAIKDIIRPPQRETFNDVYI 62
            T ++ A+K +        D+ +  +E+          +I+ I D+           + I
Sbjct: 52  RTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLI 103

Query: 63  VYELMDTD--LHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-- 117
           + E M+      +I  R  Q  T+      +  +   ++++HS N+ HRD+KP NLL   
Sbjct: 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTS 163

Query: 118 -NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +  LK+ DFG A+ T++    T    T +Y APE+L     Y  + D+WS+G I+  
Sbjct: 164 KEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYI 221

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++   P F                 +    S G  R     +Y      FP    +  + 
Sbjct: 222 LLCGFPPFYSN--------------TGQAISPGMKRRIRLGQY-----GFP----NPEWS 258

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
             S  A  L+  +L  DP  R+T+ + + HP++     + + P
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  154 bits (392), Expect = 8e-45
 Identities = 83/316 (26%), Positives = 140/316 (44%), Gaps = 47/316 (14%)

Query: 2   NSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           + +T+++VA+K I            R  REI  L+ + H +II + D+I      T  D+
Sbjct: 30  HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPTDI 84

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            +V E    +L   I   + +T+D  R F  Q++  ++Y H   ++HRDLKP NLLL+ N
Sbjct: 85  VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGCILGEIMT 179
            ++KI DFGL+   ++ +F+     +  Y APE++     Y    +D+WS G +L  ++ 
Sbjct: 145 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-KLYAGPEVDVWSCGIVLYVMLV 203

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +  F  +   +  + +                          +P F            S
Sbjct: 204 GRLPFDDEFIPNLFKKVNS----------CVYV----------MPDFL-----------S 232

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHP--------YLAPLHDINEEPVCPRPFSFDFEH 291
           PGA  L+ +M+V DP +RIT+ E    P        YL P+ ++       R  S   E 
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEA 292

Query: 292 PSFTEENIKELIYRES 307
             F+E+ I E +  + 
Sbjct: 293 MGFSEDYIVEALRSDE 308

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  153 bits (390), Expect = 1e-44
 Identities = 69/282 (24%), Positives = 125/282 (44%), Gaps = 37/282 (13%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYI 62
           ++ +  A+K I     ++     T +EI  L+  + H NI+ + ++            ++
Sbjct: 34  KSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFL 83

Query: 63  VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---N 118
           V EL++  +L + I+  +  ++    Y + +L+  + ++H   V+HRDLKP NLL    N
Sbjct: 84  VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN 143

Query: 119 ANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
            N ++KI DFG AR    +   +     T  Y APE LLN + Y  + D+WS+G IL  +
Sbjct: 144 DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTM 202

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           ++ Q  F   D         E+                 ++  +    F        + N
Sbjct: 203 LSGQVPFQSHDRSLTCTSAVEI----------------MKKIKKGDFSFE----GEAWKN 242

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
            S  A DL++ +L  DPN+R+ +     + +L     ++  P
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  155 bits (394), Expect = 1e-44
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 43/285 (15%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYI 62
            T+E+ A+K +        D  +  RE++L        +I+ I D+           + I
Sbjct: 85  RTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLI 136

Query: 63  VYELMD--TDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-- 117
           V E +D      +I  R  Q  T+      +  +   ++Y+HS N+ HRD+KP NLL   
Sbjct: 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196

Query: 118 -NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              N  LK+ DFG A+ T+  + +T    T +Y APE+L     Y  + D+WS+G I+  
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYI 255

Query: 177 IMTRQPLFPGKDYVHQLRLITELI--GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
           ++   P F     +     +   I  G  +                     FP    +  
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYE---------------------FP----NPE 290

Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
           +   S     L+  +L  +P +R+T+ E + HP++     + + P
Sbjct: 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  152 bits (387), Expect = 3e-44
 Identities = 65/303 (21%), Positives = 130/303 (42%), Gaps = 45/303 (14%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +  T  EVAIK I     N    ++  RE+++++ ++H NI+ + ++I     ET   +Y
Sbjct: 36  HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLY 90

Query: 62  IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++ E     ++   + +H  + +   R    Q++  ++Y H   ++HRDLK  NLLL+A+
Sbjct: 91  LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD 150

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGCILGEIMT 179
            ++KI DFG +   +    +  +     Y APEL     +Y    +D+WS+G IL  +++
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVS 209

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
               F G++       +            G  R          +P +            S
Sbjct: 210 GSLPFDGQNLKELRERVLR----------GKYR----------IPFYM-----------S 238

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
               +LL++ LV +P +R T+++ +   ++      N          F       +++  
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWI------NAGHEEDELKPFVEPELDISDQKR 292

Query: 300 KEL 302
            ++
Sbjct: 293 IDI 295

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  152 bits (386), Expect = 6e-44
 Identities = 64/313 (20%), Positives = 120/313 (38%), Gaps = 62/313 (19%)

Query: 4   ETREEVAIKKI---------------GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 48
           +  +  A+KK                 +    +        E++++  + +E  +  + I
Sbjct: 52  KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111

Query: 49  IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL--------TDDHCRYFLYQLLRGLKY 99
           I       +++VYI+YE M+   + +       L             +  +  +L    Y
Sbjct: 112 I-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166

Query: 100 VHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPE 153
           +H+  N+ HRD+KPSN+L++ N  +K+ DFG +    +          E++       PE
Sbjct: 167 IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM------PPE 220

Query: 154 LLLNCSEY-TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL--RLITELIGSPDETSLGF 210
              N S Y  A +DIWS+G  L  +      F  K  + +L   + T+ I  P + +   
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRN--- 277

Query: 211 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP--- 267
                       L     +  +      S   +D L+  L  +P  RIT ++AL H    
Sbjct: 278 ----------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

Query: 268 --YLAPLHDINEE 278
              +  L + ++E
Sbjct: 328 DTNIEDLREFSKE 340

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  151 bits (384), Expect = 1e-43
 Identities = 63/295 (21%), Positives = 107/295 (36%), Gaps = 55/295 (18%)

Query: 2   NSETREEVAIKKI------GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 55
           + E  +EV +K I       + +       +   EI +L  ++H NII + DI      E
Sbjct: 45  DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-----E 99

Query: 56  TFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
                 +V E   +  DL   I  H  L +    Y   QL+  + Y+   +++HRD+K  
Sbjct: 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDE 159

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGC 172
           N+++  +  +K+ DFG A           +  T  Y APE+L+  + Y    +++WS+G 
Sbjct: 160 NIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-NPYRGPELEMWSLGV 218

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
            L              Y     L+                       V      P     
Sbjct: 219 TL--------------YT----LVF-----------EENPFCELEETVEAAIHPP----- 244

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL---APLHDINEEPVCPRP 284
                 S   + L+  +L   P RR T+++ +  P++     L D   E V    
Sbjct: 245 ---YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVN 296

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  150 bits (380), Expect = 1e-43
 Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 56/276 (20%)

Query: 2   NSETREEVAIKKIGNAFDNRIDA----KRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
             + +  +A+K +   F ++++      +  REI++  H+ H NI+ + +          
Sbjct: 35  EKQNKFIMALKVL---FKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDR 86

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
             +Y++ E     +L++ ++ H    +     F+ +L   L Y H   V+HRD+KP NLL
Sbjct: 87  KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146

Query: 117 LNANCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           +    +LKI DFG +         T     +Y+       PE++     +   +D+W  G
Sbjct: 147 MGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEMIEG-KTHDEKVDLWCAG 199

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            +  E +   P F    +    R I                       V +  +FP    
Sbjct: 200 VLCYEFLVGMPPFDSPSHTETHRRI-----------------------VNVDLKFP---- 232

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
               P  S G+ DL+ K+L + P +R+ +   + HP
Sbjct: 233 ----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (379), Expect = 2e-43
 Identities = 55/274 (20%), Positives = 114/274 (41%), Gaps = 36/274 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++ET  EVA  ++ +    + + +R   E ++L+ + H NI+   D      +     +
Sbjct: 46  LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCI 104

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLL 117
            +V ELM +  L   ++  + +     R +  Q+L+GL+++H+    ++HRDLK  N+ +
Sbjct: 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164

Query: 118 NA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +KIGD GLA     + F    + T  + APE+     +Y  ++D+++ G  + E
Sbjct: 165 TGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLE 221

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           + T +  +       Q+         P                      F K        
Sbjct: 222 MATSEYPYSECQNAAQIYRRVTSGVKP--------------------ASFDK-------- 253

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
              P   +++E  +  + + R ++ + L H +  
Sbjct: 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  150 bits (380), Expect = 7e-43
 Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 46/307 (14%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +  T+E VA+K I          +   REI   R + H NI+  K++I      T   + 
Sbjct: 41  DKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHLA 92

Query: 62  IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--N 118
           I+ E     +L++ I +    ++D  R+F  QLL G+ Y HS  + HRDLK  N LL  +
Sbjct: 93  IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGCILGEI 177
               LKI DFG ++++         V T  Y APE+LL   EY     D+WS G  L   
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTL--- 208

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
                      YV        L+G     +  F   +  R Y + + +     +    P+
Sbjct: 209 -----------YVM-------LVG-----AYPFEDPEEPRDYRKTIQRILSVKY--SIPD 243

Query: 238 K---SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 294
               SP    L+ ++ V DP  RI++ E   H +   L ++  + +        F+ P  
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWF--LKNLPADLMNESNTGSQFQEPEQ 301

Query: 295 TEENIKE 301
             +++  
Sbjct: 302 PMQSLDT 308

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  148 bits (375), Expect = 2e-42
 Identities = 62/299 (20%), Positives = 110/299 (36%), Gaps = 60/299 (20%)

Query: 2   NSETREEVAIKKIG----NAFDNRIDAKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRE 55
                  VAIK +     + +    +  R   E+ LL+ +      +I + D       E
Sbjct: 64  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-----E 118

Query: 56  TFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
             +   ++ E  +   DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K  
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178

Query: 114 NLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA-IDIWSVG 171
           N+L++ N  +LK+ DFG      +T +   +  TR Y  PE +     Y      +WS+G
Sbjct: 179 NILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRY-HRYHGRSAAVWSLG 236

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            +L              Y     ++            G +  ++    +R    F     
Sbjct: 237 ILL--------------YD----MVC-----------GDIPFEHDEEIIRGQVFFR---- 263

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL------APLHDINEEPVCPRP 284
                  S     L+   L   P+ R T +E   HP++          +I+   + P P
Sbjct: 264 ----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  146 bits (371), Expect = 5e-42
 Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 46/289 (15%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH-MDHENIIAIKDIIRPPQRETFNDVYI 62
            T +E A+K I           R  RE+++L     H N++ + +       E  +  Y+
Sbjct: 36  ITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDRFYL 88

Query: 63  VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---N 118
           V+E M    +   I   +   +      +  +   L ++H+  + HRDLKP N+L    N
Sbjct: 89  VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN 148

Query: 119 ANCDLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELLLNCSE----YTAAID 166
               +KI DF L          +   T  +     +  Y APE++   SE    Y    D
Sbjct: 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208

Query: 167 IWSVGCIL-----GEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 221
           +WS+G IL     G      P F G+          +   +          S    +Y  
Sbjct: 209 LWSLGVILYILLSG-----YPPFVGR---CGSDCGWDRGEACPACQNMLFESIQEGKY-- 258

Query: 222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
              +FP       + + S  A DL+ K+LV D  +R++  + L HP++ 
Sbjct: 259 ---EFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  145 bits (368), Expect = 6e-42
 Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 62/282 (21%)

Query: 2   NSETREEVAIK-----KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 56
           N  T E VA+K     +  +        +   +EI + + ++HEN++             
Sbjct: 28  NRVTEEAVAVKIVDMKRAVD------CPENIKKEICINKMLNHENVVKFYGHR-----RE 76

Query: 57  FNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
            N  Y+   Y    EL D      I     + +   + F +QL+ G+ Y+H   + HRD+
Sbjct: 77  GNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 111 KPSNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA-ID 166
           KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL    E+ A  +D
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVD 190

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS G +L                    ++            G L  D      +    +
Sbjct: 191 VWSCGIVL--------------TA----MLA-----------GELPWDQPSDSCQEYSDW 221

Query: 227 PKQNFSA-RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
            ++      +       + LL K+LV +P+ RIT+ +     
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  145 bits (369), Expect = 7e-42
 Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 45/300 (15%)

Query: 2   NSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +SET    A+K +                +EI+LLR + H+N+I + D++     E    
Sbjct: 26  DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEKQK 82

Query: 60  VYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           +Y+V E       ++   +   +         +  QL+ GL+Y+HS  ++H+D+KP NLL
Sbjct: 83  MYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL 141

Query: 117 LNANCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGC 172
           L     LKI   G+A      +  D       +  ++ PE+      ++   +DIWS G 
Sbjct: 142 LTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
            L  I T    F G +       I                      Y       P     
Sbjct: 202 TLYNITTGLYPFEGDNIYKLFENIG------------------KGSY-----AIP----- 233

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP 292
               +  P   DLL+ ML ++P +R ++ +   H +    H   E PV P P S D +  
Sbjct: 234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV-PIPPSPDTKDR 289

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  145 bits (367), Expect = 9e-42
 Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 46/272 (16%)

Query: 2   NSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T  +VA+K +      +     +  REI+ L+   H +II +  +I      T  D 
Sbjct: 32  HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPTDF 86

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V E +   +L   I  H  + +   R    Q+L  + Y H   V+HRDLKP N+LL+A
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA 146

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGCILGEIM 178
           + + KI DFGL+   S+ +F+     +  Y APE++     Y    +DIWS G IL    
Sbjct: 147 HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSCGVIL---- 201

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF--- 235
                     Y     L+            G L  D+       +P   K+     F   
Sbjct: 202 ----------YA----LLC-----------GTLPFDDEH-----VPTLFKKIRGGVFYIP 231

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
              +     LL  ML  DP +R T+ +   H 
Sbjct: 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  144 bits (366), Expect = 3e-41
 Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 59/302 (19%)

Query: 2   NSETREEVAIKKIG----NAFDNRIDAKRTLREIKLLRHMD----HENIIAIKDIIRPPQ 53
               R +VAIK I       +    D+     E+ LL  +     H  +I + D      
Sbjct: 52  RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF---- 107

Query: 54  RETFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
            ET     +V E      DL   I     L +   R F  Q++  +++ HS  V+HRD+K
Sbjct: 108 -ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIK 166

Query: 112 PSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA-IDIWS 169
             N+L++      K+ DFG      +  +   +  TR Y  PE +    +Y A    +WS
Sbjct: 167 DENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISR-HQYHALPATVWS 224

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G +L              Y     ++            G +  +  +  +     FP  
Sbjct: 225 LGILL--------------YD----MVC-----------GDIPFERDQEILEAELHFP-- 253

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL---APLHDINEEPVCPRPFS 286
                  + SP    L+ + L   P+ R +++E L  P++   A    +N     P P +
Sbjct: 254 ------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLA 307

Query: 287 FD 288
           + 
Sbjct: 308 WS 309

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  144 bits (365), Expect = 5e-41
 Identities = 72/329 (21%), Positives = 120/329 (36%), Gaps = 62/329 (18%)

Query: 2   NSETREEVAIK-----KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 56
           N  T E VA+K     +  +        +   +EI + + ++HEN++             
Sbjct: 28  NRVTEEAVAVKIVDMKRAVD------CPENIKKEICINKMLNHENVVKFYGHR-----RE 76

Query: 57  FNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
            N  Y+   Y    EL D      I     + +   + F +QL+ G+ Y+H   + HRD+
Sbjct: 77  GNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 111 KPSNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA-ID 166
           KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL    E+ A  +D
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVD 190

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ- 225
           +WS G +L                    ++            G L  D      +     
Sbjct: 191 VWSCGIVL--------------TA----MLA-----------GELPWDQPSDSCQEYSDW 221

Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF 285
             K+ +   +       + LL K+LV +P+ RIT+ +     +         +       
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

Query: 286 SFDFEHPSFTEENIKELIYRESVKFNPDP 314
                   F++     L +      +  P
Sbjct: 282 GVSESPSGFSKHIQSNLDFSPVNSASRTP 310

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  143 bits (363), Expect = 5e-41
 Identities = 66/276 (23%), Positives = 111/276 (40%), Gaps = 42/276 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            +   +  +AIK+I               EI L +H+ H+NI+                +
Sbjct: 42  RDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGSFS-----ENGFI 94

Query: 61  YIVYELMDTD-LHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            I  E +    L  ++RS        +    ++  Q+L GLKY+H   ++HRD+K  N+L
Sbjct: 95  KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154

Query: 117 LNA-NCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCSE-YTAAIDIWSVGCI 173
           +N  +  LKI DFG ++  +  +  TE    T  Y APE++      Y  A DIWS+GC 
Sbjct: 155 INTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           + E+ T +P  P  +       +   +G                      P+ P+     
Sbjct: 215 IIEMATGKP--PFYELGEPQAAMF-KVGMFKVH-----------------PEIPE----- 249

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              + S  A   + K    DP++R   ++ L   +L
Sbjct: 250 ---SMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  144 bits (365), Expect = 7e-41
 Identities = 60/278 (21%), Positives = 113/278 (40%), Gaps = 49/278 (17%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            + +T  + A+KK+      R++  R + E+     +    I+ +   +R         V
Sbjct: 78  KDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGAVR-----EGPWV 125

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL++
Sbjct: 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185

Query: 120 N-CDLKIGDFGLAR-----TTSETDFMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGC 172
           +     + DFG A         ++    +Y+  T  + APE+++      A +DIWS  C
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCC 244

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           ++  ++      P   Y  +  L  ++   P                     + P     
Sbjct: 245 MMLHMLNGCH--PWTQY-FRGPLCLKIASEPPPI-----------------REIP----- 279

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
              P+ +P     +++ L  +P  R +  E       A
Sbjct: 280 ---PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  145 bits (366), Expect = 9e-41
 Identities = 43/282 (15%), Positives = 83/282 (29%), Gaps = 55/282 (19%)

Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
            + +EEV   ++     N+  AK  LR I     +       +  +    +       + 
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177

Query: 63  VYELMDTD-------LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +Y  M ++       L     +H+ L          Q++R L  +H   ++H  L+P ++
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC----------SEYTAAI 165
           +L+    + +  F                V+R +  PEL              +  T + 
Sbjct: 238 VLDQRGGVFLTGFEHLVRDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294

Query: 166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           D W++G ++  I            +     I                        R    
Sbjct: 295 DAWALGLVIYWIWCADLPITKDAALGGSEWI-----------------------FRSCKN 331

Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
            P                 LLE  L +    R+   +A+  P
Sbjct: 332 IP------------QPVRALLEGFLRYPKEDRLLPLQAMETP 361

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  143 bits (362), Expect = 1e-40
 Identities = 51/260 (19%), Positives = 95/260 (36%), Gaps = 55/260 (21%)

Query: 30  EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTD---DH 85
           +I+ +     +N +      +         +YI  +L    +L   +     L D     
Sbjct: 111 KIRRMDPFSTKNTV-----GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165

Query: 86  CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF------ 139
           C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+GDFGL     + +       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225

Query: 140 -------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 192
                   T  V T+ Y +PE +   + Y+  +DI+S+G IL E++         + V  
Sbjct: 226 PMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRI 282

Query: 193 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF 252
           +  +                            +FP       F  K P    +++ ML  
Sbjct: 283 ITDVRN-------------------------LKFPLL-----FTQKYPQEHMMVQDMLSP 312

Query: 253 DPNRRITVDEALCHPYLAPL 272
            P  R    + + +     L
Sbjct: 313 SPTERPEATDIIENAIFENL 332

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  142 bits (361), Expect = 2e-40
 Identities = 63/317 (19%), Positives = 116/317 (36%), Gaps = 60/317 (18%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDV 60
           +  +  E A+K++    +     +  ++E+  ++ +  H NI+         + E+    
Sbjct: 49  DVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106

Query: 61  YIVYELMD----TDLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKP 112
                L +      +  +    S   L+ D      YQ  R ++++H     ++HRDLK 
Sbjct: 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166

Query: 113 SNLLLNANCDLKIGDFGLART---------TSETDFMTEYVVTR----WYRAPEL--LLN 157
            NLLL+    +K+ DFG A T         +++   + E  +TR     YR PE+  L +
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226

Query: 158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 217
                   DIW++GCIL  +  RQ  F                          LR  N  
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQHPFEDG---------------------AKLRIVNG- 264

Query: 218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY-LAPLHDIN 276
           +Y       P          +      L+  ML  +P  R+++ E +     +A   ++N
Sbjct: 265 KY-----SIPP------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313

Query: 277 EEPVCPRPFSFDFEHPS 293
            +         +  + S
Sbjct: 314 PKSPITELLEQNGGYGS 330

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  141 bits (357), Expect = 1e-38
 Identities = 74/272 (27%), Positives = 118/272 (43%), Gaps = 46/272 (16%)

Query: 2   NSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  T  +VA+K +      +     +  REI+ L+   H +II +  +I      T +D+
Sbjct: 37  HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPSDI 91

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V E +   +L   I  +  L +   R    Q+L G+ Y H   V+HRDLKP N+LL+A
Sbjct: 92  FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA 151

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGCILGEIM 178
           + + KI DFGL+   S+ +F+     +  Y APE++     Y    +DIWS G IL    
Sbjct: 152 HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVIL---- 206

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF--- 235
                     Y     L+            G L  D+       +P   K+     F   
Sbjct: 207 ----------YA----LLC-----------GTLPFDDDH-----VPTLFKKICDGIFYTP 236

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
              +P  + LL+ ML  DP +R T+ +   H 
Sbjct: 237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  137 bits (346), Expect = 2e-38
 Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 64/285 (22%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYI 62
            T+E+ A+K +        D  +  RE++L        +I+ I D+           + I
Sbjct: 41  RTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC-LLI 92

Query: 63  VYELMDTD--LHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-- 117
           V E +D      +I  R  Q  T+      +  +   ++Y+HS N+ HRD+KP NLL   
Sbjct: 93  VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 152

Query: 118 -NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              N  LK+ DFG                     A E      +Y  + D+WS+G I+  
Sbjct: 153 KRPNAILKLTDFGF--------------------AKETTG--EKYDKSCDMWSLGVIMYI 190

Query: 177 IMTRQPLFPGKDYVHQLRLITELI--GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
           ++   P F     +     +   I  G  +                     FP    +  
Sbjct: 191 LLCGYPPFYSNHGLAISPGMKTRIRMGQYE---------------------FP----NPE 225

Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
           +   S     L+  +L  +P +R+T+ E + HP++     + + P
Sbjct: 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  139 bits (350), Expect = 4e-38
 Identities = 42/283 (14%), Positives = 80/283 (28%), Gaps = 48/283 (16%)

Query: 3   SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
            + +EEV   ++     N+  AK  LR I     +       +  +    +       + 
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182

Query: 63  VYELMDTDLHQIIRS-------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +Y  M ++L             H+ L          Q++R L  +H   ++H  L+P ++
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242

Query: 116 LLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLL----NCSEYTAAIDIWS 169
           +L+    + +  F        +               A  +L     + +  T A D W+
Sbjct: 243 VLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G  +  I            +     I                        R     P  
Sbjct: 303 LGLAIYWIWCADLPNTDDAALGGSEWI-----------------------FRSCKNIP-- 337

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 272
                          LLE  L +    R+   +A+  P    L
Sbjct: 338 ----------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  127 bits (321), Expect = 6e-35
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 13/194 (6%)

Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
             +VA+K +          +    E+ +LR   H NI+        PQ      + IV +
Sbjct: 46  HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ------LAIVTQ 99

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
             +   L+  + + +             Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +
Sbjct: 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159

Query: 124 KIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIM 178
           KIGDFGLA      S +    +   +  + APE++       Y+   D+++ G +L E+M
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219

Query: 179 TRQPLFPGKDYVHQ 192
           T Q  +   +   Q
Sbjct: 220 TGQLPYSNINNRDQ 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 1e-34
 Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 53/283 (18%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIA-----IKDIIRPPQR 54
            +  + + +A+K+I  A  N  + KR L ++   +R +D    +       ++       
Sbjct: 27  RHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE------- 78

Query: 55  ETFNDVYIVYELMDT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRD 109
               DV+I  ELMDT       Q+I   Q + +D        +++ L+++HS  +V+HRD
Sbjct: 79  ---GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD 135

Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE---LLLNCSEYTAAID 166
           +KPSN+L+NA   +K+ DFG++    +          + Y APE     LN   Y+   D
Sbjct: 136 VKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           IWS+G  + E+   +  FP   +    + + +++  P                    PQ 
Sbjct: 196 IWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQL 234

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           P   FSA F       VD   + L  +   R T  E + HP+ 
Sbjct: 235 PADKFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF 270

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  124 bits (314), Expect = 9e-34
 Identities = 48/192 (25%), Positives = 91/192 (47%), Gaps = 15/192 (7%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVYE 65
            +VA+K +     +       LRE+ +++ + H NI+  +  + +PP       + IV E
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN------LSIVTE 114

Query: 66  LMD-TDLHQIIR---SHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNA 119
            +    L++++    + + L +       Y + +G+ Y+H+ N  ++HR+LK  NLL++ 
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174

Query: 120 NCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGL+R  + T         T  + APE +L         D++S G IL E+ 
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELA 233

Query: 179 TRQPLFPGKDYV 190
           T Q  +   +  
Sbjct: 234 TLQQPWGNLNPA 245

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  123 bits (312), Expect = 9e-34
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 24/199 (12%)

Query: 7   EEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIV 63
           +EVA+K        D     +   +E KL   + H NIIA++ + ++ P      ++ +V
Sbjct: 31  DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP------NLCLV 84

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLN- 118
            E      L++++   + +  D    +  Q+ RG+ Y+H      ++HRDLK SN+L+  
Sbjct: 85  MEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143

Query: 119 -------ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
                  +N  LKI DFGLAR    T  M+      W  APE++   S ++   D+WS G
Sbjct: 144 KVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPEVI-RASMFSKGSDVWSYG 201

Query: 172 CILGEIMTRQPLFPGKDYV 190
            +L E++T +  F G D +
Sbjct: 202 VLLWELLTGEVPFRGIDGL 220

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  124 bits (314), Expect = 1e-33
 Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 24/200 (12%)

Query: 6   REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVY 64
             EVAI+ I    DN    K   RE+   R   HEN++  +   + PP       + I+ 
Sbjct: 55  HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH------LAIIT 108

Query: 65  ELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            L     L+ ++R  +  L  +  R    ++++G+ Y+H+  +LH+DLK  N+  + N  
Sbjct: 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK 167

Query: 123 LKIGDFGLARTTSETDFMTEY----VVTRWYR--APELLLNCSE--------YTAAIDIW 168
           + I DFGL   +             +   W    APE++   S         ++   D++
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227

Query: 169 SVGCILGEIMTRQPLFPGKD 188
           ++G I  E+  R+  F  + 
Sbjct: 228 ALGTIWYELHAREWPFKTQP 247

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  122 bits (309), Expect = 5e-33
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 22/194 (11%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           ++VAIK+I    ++  + K  + E++ L  ++H NI+ +            N V +V E 
Sbjct: 32  KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA-------CLNPVCLVMEY 80

Query: 67  MDT-DLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLNA 119
            +   L+ ++   +     T  H   +  Q  +G+ Y+HS     ++HRDLKP NLLL A
Sbjct: 81  AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140

Query: 120 NCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
               LKI DFG A        MT    +  + APE +   S Y+   D++S G IL E++
Sbjct: 141 GGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVI 197

Query: 179 TRQPLFPGKDYVHQ 192
           TR+  F        
Sbjct: 198 TRRKPFDEIGGPAF 211

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (311), Expect = 5e-33
 Identities = 59/293 (20%), Positives = 115/293 (39%), Gaps = 47/293 (16%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-----IKDIIRPPQRETFN 58
            +   +A K I +         + +RE+++L   +   I+        D           
Sbjct: 56  PSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----------G 104

Query: 59  DVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLL 116
           ++ I  E MD   L Q+++    + +         +++GL Y+     ++HRD+KPSN+L
Sbjct: 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164

Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           +N+  ++K+ DFG++    ++   + +V TR Y +PE L   + Y+   DIWS+G  L E
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVE 222

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML------------- 223
           +   +   P  D      +    +      +    R+         +             
Sbjct: 223 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282

Query: 224 -------PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                  P+ P   FS  F        D + K L+ +P  R  + + + H ++
Sbjct: 283 YIVNEPPPKLPSGVFSLEF-------QDFVNKCLIKNPAERADLKQLMVHAFI 328

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (311), Expect = 1e-32
 Identities = 57/306 (18%), Positives = 104/306 (33%), Gaps = 52/306 (16%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF--- 57
               T E V +++I     +         E+ + +  +H NI+  +         TF   
Sbjct: 47  RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA--------TFIAD 98

Query: 58  NDVYIVYELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           N++++V   M       +I +H    + +    Y L  +L+ L Y+H    +HR +K S+
Sbjct: 99  NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH 158

Query: 115 LLLNANCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPELLL-NCSEYTAAI 165
           +L++ +  + +              R     DF    V    + +PE+L  N   Y A  
Sbjct: 159 ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 218

Query: 166 DIWSVGC-------------------ILGEIMTRQP--LFPGKDYVHQLRLITELIGSPD 204
           DI+SVG                    +L E +      L        +   ++      +
Sbjct: 219 DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 278

Query: 205 ETSLGFLRSDNARRYVRMLPQFPKQ-NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 263
                 L +   R      P  P    FS  F          +E+ L  +P+ R +    
Sbjct: 279 SGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF-------HHFVEQCLQRNPDARPSASTL 331

Query: 264 LCHPYL 269
           L H + 
Sbjct: 332 LNHSFF 337

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  120 bits (304), Expect = 2e-32
 Identities = 45/201 (22%), Positives = 85/201 (42%), Gaps = 26/201 (12%)

Query: 7   EEVAIKKI-GNAFDNRIDAKRTL----REIKLLRHMDHENIIAIKDI-IRPPQRETFNDV 60
             VAIK +     +   +         RE+ ++ +++H NI+ +  +   PP        
Sbjct: 45  SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-------- 96

Query: 61  YIVYELMDT-DLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLL 116
            +V E +   DL+  +      +        +  +  G++Y+ + N  ++HRDL+  N+ 
Sbjct: 97  RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156

Query: 117 L-----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE-YTAAIDIWSV 170
           L     NA    K+ DFGL++ +  +  ++  +    + APE +    E YT   D +S 
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214

Query: 171 GCILGEIMTRQPLFPGKDYVH 191
             IL  I+T +  F    Y  
Sbjct: 215 AMILYTILTGEGPFDEYSYGK 235

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  118 bits (298), Expect = 1e-31
 Identities = 31/188 (16%), Positives = 69/188 (36%), Gaps = 16/188 (8%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIVYE 65
            ++ +K +     +   ++    E   LR   H N++ +      PP         ++  
Sbjct: 34  NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA----PHPTLITH 89

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRY--FLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNAN 120
            M    L+ ++    +   D  +   F   + RG+ ++H+    +    L   +++++ +
Sbjct: 90  WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED 149

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIM 178
              +I    +  +      M       W  APE L          + D+WS   +L E++
Sbjct: 150 MTARISMADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTNRRSADMWSFAVLLWELV 205

Query: 179 TRQPLFPG 186
           TR+  F  
Sbjct: 206 TREVPFAD 213

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  119 bits (299), Expect = 4e-31
 Identities = 31/207 (14%), Positives = 70/207 (33%), Gaps = 28/207 (13%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +++ +++  +K    A  N  +     + ++ L+       +              N   
Sbjct: 91  DAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAH-----LFQNGSV 143

Query: 62  IVYELMD-TDLHQIIRSH-----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +V EL     L   I  +     + +       F  ++L  ++ VH   ++H D+KP N 
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203

Query: 116 LLN-----------ANCDLKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCSEY 161
           +L             +  L + D G +       +    T    T  ++  E+L N   +
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-W 262

Query: 162 TAAIDIWSVGCILGEIMTRQPLFPGKD 188
              ID + V   +  ++    +    +
Sbjct: 263 NYQIDYFGVAATVYCMLFGTYMKVKNE 289

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  119 bits (299), Expect = 5e-31
 Identities = 75/342 (21%), Positives = 125/342 (36%), Gaps = 92/342 (26%)

Query: 9   VAIKKIGNAFDNRIDAKRTLREIKLLRHM-----DHENIIAIKDIIRPPQRETFND---- 59
           VA+K +  + ++  +    L EI+LL+ +     +  N    ++++     + F      
Sbjct: 65  VAMK-VVKSAEHYTET--ALDEIRLLKSVRNSDPNDPN----REMVVQL-LDDFKISGVN 116

Query: 60  ---VYIVYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPS 113
              + +V+E++   L + I    +Q L     +  + Q+L+GL Y+H+   ++H D+KP 
Sbjct: 117 GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176

Query: 114 NLLLNAN-------------------------------------------------CDLK 124
           N+LL+ N                                                   +K
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236

Query: 125 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 184
           I D G A    +    TE + TR YR+ E+L+    Y    DIWS  C+  E+ T   LF
Sbjct: 237 IADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLF 293

Query: 185 PGKD------YVHQLRLITELIGSPD-------ETSLGFLRSDNARRYVRMLPQFPKQNF 231
                         + LI EL+G          + S  F       +++  L  +     
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353

Query: 232 SARFPNKSP----GAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                  S     G  D L  ML   P +R T  E L HP+L
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (296), Expect = 7e-31
 Identities = 64/274 (23%), Positives = 102/274 (37%), Gaps = 37/274 (13%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVYE 65
           E+VA+K     F     +     EI     M HENI+  I   I+     T   +Y++ +
Sbjct: 61  EKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT--QLYLITD 115

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--------VLHRDLKPSNLL 116
             +   L+  ++S   L         Y  + GL ++H+          + HRDLK  N+L
Sbjct: 116 YHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174

Query: 117 LNANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELL-----LNCSEYTAAID 166
           +  N    I D GLA      T          V T+ Y  PE+L      N  +     D
Sbjct: 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234

Query: 167 IWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           ++S G IL E+  R       ++Y      +      P + S   +R     + +R  P 
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLV-----PSDPSYEDMREIVCIKKLR--PS 287

Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 259
           FP +  S            L+ +    +P  R+T
Sbjct: 288 FPNRWSSDECL---RQMGKLMTECWAHNPASRLT 318

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (293), Expect = 1e-30
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 29/202 (14%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRT-LREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVY 61
           ET E + +K++    +   + +RT L+E+K++R ++H N++  I  + +  +      + 
Sbjct: 33  ETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR------LN 83

Query: 62  IVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            + E +    L  II+S            F   +  G+ Y+HS N++HRDL   N L+  
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 143

Query: 120 NCDLKIGDFGLARTTSETDF---------------MTEYVVTRWYRAPELLLNCSEYTAA 164
           N ++ + DFGLAR   +                      V   ++ APE++     Y   
Sbjct: 144 NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEK 202

Query: 165 IDIWSVGCILGEIMTRQPLFPG 186
           +D++S G +L EI+ R    P 
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPD 224

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  116 bits (293), Expect = 2e-30
 Identities = 56/284 (19%), Positives = 117/284 (41%), Gaps = 51/284 (17%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIA-----IKDIIRPPQR 54
           ++  + + +A+K+I  +  +  + K+ L ++  ++R  D   I+       ++       
Sbjct: 42  VHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE------- 93

Query: 55  ETFNDVYIVYELMDTDLHQIIRS-----HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHR 108
               D +I  ELM T   +  +         + ++         ++ L ++     ++HR
Sbjct: 94  ---GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHR 150

Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCSEYTAAI 165
           D+KPSN+LL+ + ++K+ DFG++    ++   T     R Y APE +    +   Y    
Sbjct: 151 DIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210

Query: 166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           D+WS+G  L E+ T +  FP   +      +T+++                      L  
Sbjct: 211 DVWSLGITLYELATGR--FPYPKWNSVFDQLTQVVKGDPPQ----------------LSN 252

Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             ++ FS  F       ++ +   L  D ++R    E L HP++
Sbjct: 253 SEEREFSPSF-------INFVNLCLTKDESKRPKYKELLKHPFI 289

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  116 bits (292), Expect = 2e-30
 Identities = 61/283 (21%), Positives = 106/283 (37%), Gaps = 54/283 (19%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIA-----IKDIIRPPQR 54
              +T   +A+K++     N+ + KR L ++  +L+  D   I+      I +       
Sbjct: 45  RFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN------- 96

Query: 55  ETFNDVYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKP 112
               DV+I  ELM T   ++  R    + +         +++ L Y+     V+HRD+KP
Sbjct: 97  ---TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153

Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE----LLLNCSEYTAAIDIW 168
           SN+LL+    +K+ DFG++    +            Y APE          +Y    D+W
Sbjct: 154 SNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213

Query: 169 SVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           S+G  L E+ T + P    K     L  + +    P                    P  P
Sbjct: 214 SLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP--------------------PLLP 251

Query: 228 -KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               FS  F          ++  L  D  +R   ++ L H ++
Sbjct: 252 GHMGFSGDF-------QSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (290), Expect = 2e-30
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 53/278 (19%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF--- 57
           M+  T +EVAI+++      + +    + EI ++R   + NI+   D        ++   
Sbjct: 40  MDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLD--------SYLVG 89

Query: 58  NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
           +++++V E +     TD    + +   + +        + L+ L+++HS  V+HRD+K  
Sbjct: 90  DELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145

Query: 114 NLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LL  +  +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGI 204

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNF 231
           +  E++  +P  P  +  + LR +             +L + N        P+    +  
Sbjct: 205 MAIEMIEGEP--PYLN-ENPLRAL-------------YLIATNGT------PELQNPEKL 242

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           SA F        D L + L  D  +R +  E L H +L
Sbjct: 243 SAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFL 273

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  116 bits (292), Expect = 2e-30
 Identities = 60/276 (21%), Positives = 117/276 (42%), Gaps = 47/276 (17%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETF-- 57
            +    E VAIKK+  +     +  + + +E++ L+ + H N I  +          +  
Sbjct: 74  RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG--------CYLR 125

Query: 58  -NDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
            +  ++V E        ++  H+  L +       +  L+GL Y+HS N++HRD+K  N+
Sbjct: 126 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCI 173
           LL+    +K+GDFG A   +  +     V T ++ APE++L     +Y   +D+WS+G  
Sbjct: 186 LLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
             E+  R+P  P  + ++ +  +             +  + N        P     ++S 
Sbjct: 243 CIELAERKP--PLFN-MNAMSAL-------------YHIAQNES------PALQSGHWSE 280

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            F        + ++  L   P  R T +  L H ++
Sbjct: 281 YF-------RNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  114 bits (286), Expect = 1e-29
 Identities = 63/278 (22%), Positives = 116/278 (41%), Gaps = 53/278 (19%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF--- 57
               +  +VA+K +      R +      E+ ++R   H N++ +          ++   
Sbjct: 65  REKHSGRQVAVKMMDLRKQQRRE--LLFNEVVIMRDYQHFNVVEMYK--------SYLVG 114

Query: 58  NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
            +++++ E +     TD    I S   L ++        +L+ L Y+H+  V+HRD+K  
Sbjct: 115 EELWVLMEFLQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170

Query: 114 NLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           ++LL  +  +K+ DFG  A+ + +       V T ++ APE++   S Y   +DIWS+G 
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGI 229

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNF 231
           ++ E++  +P  P       ++ +                 D+        P+       
Sbjct: 230 MVIEMVDGEP--PYFS-DSPVQAM-------------KRLRDSPP------PKLKNSHKV 267

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           S           D LE+MLV DP  R T  E L HP+L
Sbjct: 268 SPVL-------RDFLERMLVRDPQERATAQELLDHPFL 298

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  112 bits (281), Expect = 5e-29
 Identities = 69/278 (24%), Positives = 123/278 (44%), Gaps = 53/278 (19%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF--- 57
           ++ ET + VAIK++        D +  ++EI +++  D  +++            ++   
Sbjct: 49  IHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVVKYYG--------SYFKN 96

Query: 58  NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
            D++IV E       +D+ ++   ++ LT+D     L   L+GL+Y+H    +HRD+K  
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154

Query: 114 NLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           N+LLN     K+ DFG+  + T         + T ++ APE++     Y    DIWS+G 
Sbjct: 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGI 213

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNF 231
              E+   +P  P  D +H +R I             F+   N        P F   + +
Sbjct: 214 TAIEMAEGKP--PYAD-IHPMRAI-------------FMIPTNPP------PTFRKPELW 251

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
           S  F        D +++ LV  P +R T  + L HP++
Sbjct: 252 SDNF-------TDFVKQCLVKSPEQRATATQLLQHPFV 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  111 bits (280), Expect = 6e-29
 Identities = 48/196 (24%), Positives = 81/196 (41%), Gaps = 30/196 (15%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLRE--IKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIV 63
           E VA+K       +  D K   RE  +     + HENI+  I   +      T   ++++
Sbjct: 32  ENVAVKIF-----SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST--QLWLI 84

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSN 114
               +   L+  ++    L    C   +  +  GL ++H           + HRDLK  N
Sbjct: 85  THYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELL-----LNCSEYTAA 164
           +L+  N    I D GLA   S++    +        T+ Y APE+L     ++C +    
Sbjct: 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203

Query: 165 IDIWSVGCILGEIMTR 180
           +DIW+ G +L E+  R
Sbjct: 204 VDIWAFGLVLWEVARR 219

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 1e-28
 Identities = 66/280 (23%), Positives = 122/280 (43%), Gaps = 44/280 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI-IRPPQRETFN 58
            + +T +  AIK +    D   + K+   EI +L+    H NI       I+       +
Sbjct: 44  RHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100

Query: 59  DVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
            +++V E       TDL +  + +  L ++   Y   ++LRGL ++H   V+HRD+K  N
Sbjct: 101 QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 159

Query: 115 LLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNC----SEYTAAIDIWS 169
           +LL  N ++K+ DFG++     T      ++ T ++ APE++       + Y    D+WS
Sbjct: 160 VLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 219

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G    E+    P  P  D +H +R +             FL   N        P+   +
Sbjct: 220 LGITAIEMAEGAP--PLCD-MHPMRAL-------------FLIPRNPA------PRLKSK 257

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            +S +F          +E  LV + ++R   ++ + HP++
Sbjct: 258 KWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPFI 290

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (276), Expect = 2e-28
 Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 54/290 (18%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-----IKDIIRPPQRE 55
             +  +E+VAIK+I N    +      L+EI+ +    H NI++     +          
Sbjct: 35  YCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-------- 85

Query: 56  TFNDVYIVYELMD----TDLHQIIRSHQD-----LTDDHCRYFLYQLLRGLKYVHSANVL 106
             +++++V +L+      D+ + I +  +     L +      L ++L GL+Y+H    +
Sbjct: 86  --DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI 143

Query: 107 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE------YVVTRWYRAPELLLNCSE 160
           HRD+K  N+LL  +  ++I DFG++   +    +T       +V T  + APE++     
Sbjct: 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG 203

Query: 161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 220
           Y    DIWS G    E+ T     P   Y   ++++              L   N     
Sbjct: 204 YDFKADIWSFGITAIELATGAA--PYHKY-PPMKVL-------------MLTLQNDP--- 244

Query: 221 RMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              P             K       ++   L  DP +R T  E L H + 
Sbjct: 245 ---PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  113 bits (284), Expect = 4e-28
 Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 14/216 (6%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
            V +K + ++ D        + E + L  + H +I+ I + +    R      YIV E +
Sbjct: 108 PVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166

Query: 68  D-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 126
               L +       L       +L ++L  L Y+HS  +++ DLKP N++L     LK+ 
Sbjct: 167 GGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI 223

Query: 127 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 186
           D G     +   ++     T  ++APE++   +  T A DI++VG  L  +    P   G
Sbjct: 224 DLGAVSRINSFGYL---YGTPGFQAPEIVR--TGPTVATDIYTVGRTLAALTLDLPTRNG 278

Query: 187 KDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 219
             YV  L     ++ +           +  D  +R+
Sbjct: 279 -RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (273), Expect = 6e-28
 Identities = 59/282 (20%), Positives = 113/282 (40%), Gaps = 54/282 (19%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF--- 57
            N ET    A K I    +  ++    + EI++L   DH  I+ +           +   
Sbjct: 39  KNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLLG--------AYYHD 88

Query: 58  NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
             ++I+ E         +   +     LT+   +    Q+L  L ++HS  ++HRDLK  
Sbjct: 89  GKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG 146

Query: 114 NLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC----SEYTAAIDIW 168
           N+L+    D+++ DFG+ A+          ++ T ++ APE+++      + Y    DIW
Sbjct: 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP- 227
           S+G  L E+   +P  P  + ++ +R++                + +        P    
Sbjct: 207 SLGITLIEMAQIEP--PHHE-LNPMRVL-------------LKIAKSDP------PTLLT 244

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              +S  F        D L+  L  +P  R +  + L HP++
Sbjct: 245 PSKWSVEF-------RDFLKIALDKNPETRPSAAQLLEHPFV 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  108 bits (271), Expect = 2e-27
 Identities = 54/273 (19%), Positives = 94/273 (34%), Gaps = 35/273 (12%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVYE 65
           EEVA+K           +     EI     + HENI+  I    +     T   +++V +
Sbjct: 66  EEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT--QLWLVSD 120

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNLL 116
             +   L   +  +  +T +           GL ++H           + HRDLK  N+L
Sbjct: 121 YHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179

Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELL-----LNCSEYTAAID 166
           +  N    I D GLA          +        T+ Y APE+L     +   E     D
Sbjct: 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           I+++G +  EI  R  +    +  +QL     +   P    +  +  +   R     P  
Sbjct: 240 IYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVPSDPSVEEMRKVVCEQKLR-----PNI 293

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 259
           P +  S            ++ +    +   R+T
Sbjct: 294 PNRWQSCEAL---RVMAKIMRECWYANGAARLT 323

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (268), Expect = 5e-27
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 22/216 (10%)

Query: 1   MNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +   T   VA+K++  +  D + D     REI++L+ +  + I+  + +   P R++   
Sbjct: 47  LGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALHSDFIVKYRGVSYGPGRQS--- 100

Query: 60  VYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           + +V E + +  L   ++ H+  L       +  Q+ +G++Y+ S   +HRDL   N+L+
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSV 170
            +   +KI DFGLA+          YVV         WY APE L +   ++   D+WS 
Sbjct: 161 ESEAHVKIADFGLAKLLPLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSF 216

Query: 171 GCILGEIMT--RQPLFPGKDYVHQLRLITELIGSPD 204
           G +L E+ T   +   P  +++  +    ++     
Sbjct: 217 GVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  106 bits (266), Expect = 7e-27
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 1   MNSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
               T E+VA+K  K  +  ++  D     +EI++LR++ HENI+  K I          
Sbjct: 45  EGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNG-- 99

Query: 59  DVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            + ++ E + +  L + +  +++ +       +  Q+ +G+ Y+ S   +HRDL   N+L
Sbjct: 100 -IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 158

Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWS 169
           + +   +KIGDFGL +          Y V         WY APE  L  S++  A D+WS
Sbjct: 159 VESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVFWY-APE-CLMQSKFYIASDVWS 214

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
            G  L E++T             + L  ++IG  
Sbjct: 215 FGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  106 bits (267), Expect = 7e-27
 Identities = 57/272 (20%), Positives = 100/272 (36%), Gaps = 33/272 (12%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVYE 65
           E VA+K           + +   E+  L  M HENI+  I    R    +   D++++  
Sbjct: 48  EYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV--DLWLITA 102

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA----------NVLHRDLKPSN 114
             +   L   ++++  ++ +   +    + RGL Y+H             + HRD+K  N
Sbjct: 103 FHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161

Query: 115 LLLNANCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELL----LNCSEYTAAIDI 167
           +LL  N    I DFGLA               V TR Y APE+L        +    ID+
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221

Query: 168 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 227
           +++G +L E+ +R     G    + L    E+   P    +  +     +R     P   
Sbjct: 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-----PVLR 276

Query: 228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 259
                           + +E+    D   R++
Sbjct: 277 DYWQKHAGM---AMLCETIEECWDHDAEARLS 305

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (264), Expect = 1e-26
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 20/189 (10%)

Query: 1   MNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           +   T E VA+KK+  +  ++  D     REI++L+ + H+NI+  K +     R     
Sbjct: 34  LQDNTGEVVAVKKLQHSTEEHLRD---FEREIEILKSLQHDNIVKYKGVCYSAGRRN--- 87

Query: 60  VYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           + ++ E +    L   ++ H++ +       +  Q+ +G++Y+ +   +HRDL   N+L+
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSV 170
                +KIGDFGL +   +      + V         WY APE  L  S+++ A D+WS 
Sbjct: 148 ENENRVKIGDFGLTKVLPQDK--EFFKVKEPGESPIFWY-APE-SLTESKFSVASDVWSF 203

Query: 171 GCILGEIMT 179
           G +L E+ T
Sbjct: 204 GVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (264), Expect = 2e-26
 Identities = 51/188 (27%), Positives = 93/188 (49%), Gaps = 18/188 (9%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T E VA+KK+ ++ +     +   REI++L+ + H+NI+  K +     R     +
Sbjct: 65  LQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---L 119

Query: 61  YIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            ++ E +    L   ++ H++ +       +  Q+ +G++Y+ +   +HRDL   N+L+ 
Sbjct: 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 179

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVG 171
               +KIGDFGL +   +      Y V         WY APE  L  S+++ A D+WS G
Sbjct: 180 NENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIFWY-APE-SLTESKFSVASDVWSFG 235

Query: 172 CILGEIMT 179
            +L E+ T
Sbjct: 236 VVLYELFT 243

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  104 bits (261), Expect = 4e-26
 Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 26/212 (12%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
           N  T E VA+K  K      +R       +EI +LR + HE+II  K         +   
Sbjct: 56  NDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYHEHIIKYKGCCEDAGAAS--- 109

Query: 60  VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           + +V E +    L   +  H  +       F  Q+  G+ Y+H+ + +HRDL   N+LL+
Sbjct: 110 LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVG 171
            +  +KIGDFGLA+   E      Y V         WY APE L     +  A D+WS G
Sbjct: 169 NDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFWY-APECLKEYK-FYYASDVWSFG 224

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
             L E++T                  ELIG  
Sbjct: 225 VTLYELLTH-----CDSSQSPPTKFLELIGIA 251

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (261), Expect = 4e-26
 Identities = 61/278 (21%), Positives = 118/278 (42%), Gaps = 54/278 (19%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETF-- 57
           +++ T++ VAIK I    +   D    + +EI +L   D   +             ++  
Sbjct: 42  IDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG--------SYLK 91

Query: 58  -NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
              ++I+ E +      DL +       L +      L ++L+GL Y+HS   +HRD+K 
Sbjct: 92  DTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 147

Query: 113 SNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           +N+LL+ + ++K+ DFG+A   ++T      +V T ++ APE++   S Y +  DIWS+G
Sbjct: 148 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLG 206

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
               E+   +P  P  +                          +  + + ++P+      
Sbjct: 207 ITAIELARGEP--PHSEL-------------------------HPMKVLFLIPKNNPPTL 239

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              +   S    + +E  L  +P+ R T  E L H ++
Sbjct: 240 EGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (255), Expect = 2e-25
 Identities = 45/196 (22%), Positives = 93/196 (47%), Gaps = 23/196 (11%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDV 60
             +  + VA+K + N  ++       L E  +++ +D+  I+ +  I             
Sbjct: 40  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-------W 92

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  +N +HRDL   N+LL  
Sbjct: 93  MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 152

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGC 172
               KI DFGL++     +    Y          +WY APE  +N  ++++  D+WS G 
Sbjct: 153 QHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGV 208

Query: 173 ILGEIMT--RQPLFPG 186
           ++ E  +  ++P + G
Sbjct: 209 LMWEAFSYGQKP-YRG 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (258), Expect = 3e-25
 Identities = 51/253 (20%), Positives = 111/253 (43%), Gaps = 43/253 (16%)

Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETF---NDVYIVYELMDT-DLHQIIRSHQDLT 82
             +E+++++ ++H  ++ +          +F    D+++V +L+   DL   ++ +    
Sbjct: 62  VFKELQIMQGLEHPFLVNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113

Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 142
           ++  + F+ +L+  L Y+ +  ++HRD+KP N+LL+ +  + I DF +A        +T 
Sbjct: 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173

Query: 143 YVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 200
              T+ Y APE+  +   + Y+ A+D WS+G    E++  +  +  +             
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----------- 222

Query: 201 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-T 259
            S  E    F  +            +P           S   V LL+K+L  +P++R   
Sbjct: 223 TSSKEIVHTFETTV---------VTYP--------SAWSQEMVSLLKKLLEPNPDQRFSQ 265

Query: 260 VDEALCHPYLAPL 272
           + +    PY+  +
Sbjct: 266 LSDVQNFPYMNDI 278

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (254), Expect = 4e-25
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 10/183 (5%)

Query: 8   EVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
            VA+K +      + +   R  RE +    +   +++ I D       E    +Y+   L
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD-----FGEIDGQLYVDMRL 115

Query: 67  MD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           ++  DL  ++R    L        + Q+   L   H+A   HRD+KP N+L++A+    +
Sbjct: 116 INGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYL 175

Query: 126 GDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
            DFG+A  T++         V T +Y APE     S  T   DI+++ C+L E +T  P 
Sbjct: 176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPP 234

Query: 184 FPG 186
           + G
Sbjct: 235 YQG 237

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  101 bits (253), Expect = 5e-25
 Identities = 62/183 (33%), Positives = 97/183 (53%), Gaps = 10/183 (5%)

Query: 8   EVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           +VAIK I     +     KR  RE+     + H+NI+++ D       E  +  Y+V E 
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID-----VDEEDDCYYLVMEY 92

Query: 67  MD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           ++   L + I SH  L+ D    F  Q+L G+K+ H   ++HRD+KP N+L+++N  LKI
Sbjct: 93  IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKI 152

Query: 126 GDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
            DFG+A+  SET    T +V+ T  Y +PE            DI+S+G +L E++  +P 
Sbjct: 153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPP 211

Query: 184 FPG 186
           F G
Sbjct: 212 FNG 214

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (252), Expect = 8e-25
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 47/241 (19%)

Query: 25  KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQD 80
               RE  ++  +DH   + +          TF D   +Y  +      +L + IR    
Sbjct: 75  PYVTRERDVMSRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGS 126

Query: 81  LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR---TTSET 137
             +   R++  +++  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+     S+ 
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186

Query: 138 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 197
                +V T  Y +PELL        + D+W++GCI+ +++   P F   +      LI 
Sbjct: 187 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIF 241

Query: 198 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 257
           + I          ++ +           FP            P A DL+EK+LV D  +R
Sbjct: 242 QKI----------IKLE---------YDFP--------EKFFPKARDLVEKLLVLDATKR 274

Query: 258 I 258
           +
Sbjct: 275 L 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 31/193 (16%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVY 64
            VAIK  K   +   R      L+E   +R  DH +I+ +  +I   P       V+I+ 
Sbjct: 45  AVAIKTCKNCTSDSVREKF---LQEALTMRQFDHPHIVKLIGVITENP-------VWIIM 94

Query: 65  ELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           EL    +L   ++  +  L       + YQL   L Y+ S   +HRD+   N+L+++N  
Sbjct: 95  ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 154

Query: 123 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           +K+GDFGL+R   ++     Y          +W  APE  +N   +T+A D+W  G  + 
Sbjct: 155 VKLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMW 208

Query: 176 EIMT--RQPLFPG 186
           EI+    +P F G
Sbjct: 209 EILMHGVKP-FQG 220

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 99.2 bits (248), Expect = 2e-24
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 25/192 (13%)

Query: 8   EVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYE 65
            VA+K +  +           +RE+  +  +DH N+I +  ++  PP       + +V E
Sbjct: 48  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTE 100

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           L     L   +R HQ          +  Q+  G+ Y+ S   +HRDL   NLLL     +
Sbjct: 101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV 160

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           KIGDFGL R   + D    YV+         W  APE  L    ++ A D W  G  L E
Sbjct: 161 KIGDFGLMRALPQND--DHYVMQEHRKVPFAWC-APE-SLKTRTFSHASDTWMFGVTLWE 216

Query: 177 IMT--RQPLFPG 186
           + T  ++P + G
Sbjct: 217 MFTYGQEP-WIG 227

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 99.6 bits (249), Expect = 2e-24
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 28/191 (14%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYE 65
           VAIK  +   +     +    L E  ++  +D+ ++  +  I            V ++ +
Sbjct: 47  VAIKELREATSPKANKE---ILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 96

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           LM    L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156

Query: 124 KIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           KI DFGLA+     +   EY         +W  A E  +    YT   D+WS G  + E+
Sbjct: 157 KITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWEL 212

Query: 178 MT--RQPLFPG 186
           MT   +P + G
Sbjct: 213 MTFGSKP-YDG 222

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  100 bits (251), Expect = 3e-24
 Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 25/191 (13%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIV 63
            VA+K  +     D +      L+E ++L+   H NI+ +  +   + P       +YIV
Sbjct: 141 LVAVKSCRETLPPDLKAKF---LQEARILKQYSHPNIVRLIGVCTQKQP-------IYIV 190

Query: 64  YELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
            EL+   D    +R+    L        +     G++Y+ S   +HRDL   N L+    
Sbjct: 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250

Query: 122 DLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
            LKI DFG++R  ++  +     +     +W  APE  LN   Y++  D+WS G +L E 
Sbjct: 251 VLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE-ALNYGRYSSESDVWSFGILLWET 308

Query: 178 MT--RQPLFPG 186
            +    P +P 
Sbjct: 309 FSLGASP-YPN 318

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (254), Expect = 4e-24
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 30/204 (14%)

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 113
            T + +  + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 321

Query: 114 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
           N+LL+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           L +++     F      H+ +   E+                 R  + M  + P      
Sbjct: 381 LFKLLRGHSPF----RQHKTKDKHEID----------------RMTLTMAVELP------ 414

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRR 257
              + SP    LLE +L  D NRR
Sbjct: 415 --DSFSPELRSLLEGLLQRDVNRR 436

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.5 bits (246), Expect = 4e-24
 Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 27/192 (14%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           +VAIK  K G    +  +    +RE +++  +D+  I+ +  +           + +V E
Sbjct: 39  DVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVRLIGVC------QAEALMLVME 89

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           +     LH+ +   ++ +   +    L+Q+  G+KY+   N +HRDL   N+LL      
Sbjct: 90  MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           KI DFGL++     D  + Y          +WY APE  +N  ++++  D+WS G  + E
Sbjct: 150 KISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWE 205

Query: 177 IMT--RQPLFPG 186
            ++  ++P +  
Sbjct: 206 ALSYGQKP-YKK 216

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 96.9 bits (242), Expect = 1e-23
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 31/193 (16%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVY 64
            VA+K  K     DN+      + E  +++++DH +I+ +  II   P        +I+ 
Sbjct: 42  NVAVKTCKKDCTLDNKEK---FMSEAVIMKNLDHPHIVKLIGIIEEEP-------TWIIM 91

Query: 65  ELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           EL    +L   +  +++ L       +  Q+ + + Y+ S N +HRD+   N+L+ +   
Sbjct: 92  ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC 151

Query: 123 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           +K+GDFGL+R   + D    Y          +W  +PE  +N   +T A D+W     + 
Sbjct: 152 VKLGDFGLSRYIEDED----YYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMW 205

Query: 176 EIMT--RQPLFPG 186
           EI++  +QP F  
Sbjct: 206 EILSFGKQP-FFW 217

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 96.1 bits (240), Expect = 2e-23
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 27/189 (14%)

Query: 8   EVAIKKIGNAFDNRIDAKRT--LREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYI 62
           +VA+K I      + DA     L E  ++  + H N++ +  +I   +         +YI
Sbjct: 46  KVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-------LYI 92

Query: 63  VYELMDT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           V E M    L   +RS     L  D    F   +   ++Y+   N +HRDL   N+L++ 
Sbjct: 93  VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 152

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +   K+ DFGL +  S T    +  V +W  APE  L   +++   D+WS G +L EI +
Sbjct: 153 DNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE-ALREKKFSTKSDVWSFGILLWEIYS 209

Query: 180 --RQPLFPG 186
             R P +P 
Sbjct: 210 FGRVP-YPR 217

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 27/192 (14%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           +VAIK  K G    +  +    +RE +++  +D+  I+ +  +           + +V E
Sbjct: 365 DVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVRLIGVC------QAEALMLVME 415

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           +     LH+ +   ++ +   +    L+Q+  G+KY+   N +HR+L   N+LL      
Sbjct: 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA 475

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           KI DFGL++     D  + Y          +WY APE  +N  ++++  D+WS G  + E
Sbjct: 476 KISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWE 531

Query: 177 IMT--RQPLFPG 186
            ++  ++P +  
Sbjct: 532 ALSYGQKP-YKK 542

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 98.7 bits (246), Expect = 3e-23
 Identities = 63/270 (23%), Positives = 107/270 (39%), Gaps = 57/270 (21%)

Query: 55  ETFNDVYIVYELMDT-DL-HQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
           ET + + +V  LM+  DL   I    Q    +    ++  ++  GL+ +H   +++RDLK
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
           P N+LL+ +  ++I D GLA    E   +   V T  Y APE++ N   YT + D W++G
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALG 372

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
           C+L E++  Q  F  +    +   +  L+                            +  
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLV----------------------------KEV 404

Query: 232 SARFPNK-SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLHDIN--------- 276
              +  + SP A  L  ++L  DP  R+     +  E   HP       +N         
Sbjct: 405 PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK---KLNFKRLGAGML 461

Query: 277 EEPVCPRPFS------FDFEHPSFTEENIK 300
           E P  P P +       D E    T + ++
Sbjct: 462 EPPFKPDPQAIYCKDVLDIE-QFSTVKGVE 490

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 95.8 bits (239), Expect = 4e-23
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
             A+K +    D   +  + L E  +++   H N++++  I    +        +V   M
Sbjct: 55  HCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYM 109

Query: 68  DT-DLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
              DL   IR+   + T      F  Q+ +G+KY+ S   +HRDL   N +L+    +K+
Sbjct: 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 169

Query: 126 GDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            DFGLAR   + ++ + +  T      +W  A E  L   ++T   D+WS G +L E+MT
Sbjct: 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMT 227

Query: 180 R--QPLFPGKD 188
           R   P +P  +
Sbjct: 228 RGAPP-YPDVN 237

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 94.9 bits (237), Expect = 4e-23
 Identities = 42/192 (21%), Positives = 85/192 (44%), Gaps = 30/192 (15%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYE 65
           +VA+K I    +  +      +E + +  + H  ++    +     P       +YIV E
Sbjct: 34  DVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-------IYIVTE 83

Query: 66  LMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            +    L   +RSH + L         Y +  G+ ++ S   +HRDL   N L++ +  +
Sbjct: 84  YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           K+ DFG+ R   +     +YV +       +W  APE + +  +Y++  D+W+ G ++ E
Sbjct: 144 KVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APE-VFHYFKYSSKSDVWAFGILMWE 197

Query: 177 IMT--RQPLFPG 186
           + +  + P +  
Sbjct: 198 VFSLGKMP-YDL 208

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 95.8 bits (239), Expect = 5e-23
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 26/203 (12%)

Query: 4   ETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
            T  +VA+K  K+ N+     + +  L E   ++   H N+I +  +      +      
Sbjct: 60  GTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117

Query: 62  IVYELMDT-DLHQIIRSH------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
           ++   M   DLH  +         + +       F+  +  G++Y+ + N LHRDL   N
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177

Query: 115 LLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDI 167
            +L  +  + + DFGL++     D    Y          +W  A E L +   YT+  D+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAKMPVKWI-AIESLAD-RVYTSKSDV 232

Query: 168 WSVGCILGEIMTR--QPLFPGKD 188
           W+ G  + EI TR   P +PG  
Sbjct: 233 WAFGVTMWEIATRGMTP-YPGVQ 254

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 95.0 bits (237), Expect = 6e-23
 Identities = 41/192 (21%), Positives = 86/192 (44%), Gaps = 30/192 (15%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYE 65
           +VAIK I    +  +  +  + E +++  + H  ++ +  +   + P       + +V E
Sbjct: 34  KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-------ICLVTE 83

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            M+   L   +R+ +     +        +  G+ Y+  A V+HRDL   N L+  N  +
Sbjct: 84  FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 143

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           K+ DFG+ R   +     +Y  +       +W  +PE + + S Y++  D+WS G ++ E
Sbjct: 144 KVSDFGMTRFVLD----DQYTSSTGTKFPVKWA-SPE-VFSFSRYSSKSDVWSFGVLMWE 197

Query: 177 IMT--RQPLFPG 186
           + +  + P +  
Sbjct: 198 VFSEGKIP-YEN 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.9 bits (239), Expect = 6e-23
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 28/199 (14%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETF 57
           + +    VAIK  K G     R+D    L E  ++    H NII ++ +I    P     
Sbjct: 69  SGKKEVPVAIKTLKAGYTEKQRVDF---LGEAGIMGQFSHHNIIRLEGVISKYKP----- 120

Query: 58  NDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
             + I+ E M+   L + +R      +       L  +  G+KY+ + N +HRDL   N+
Sbjct: 121 --MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 178

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWS 169
           L+N+N   K+ DFGL+R   E D    Y  +      RW  APE  ++  ++T+A D+WS
Sbjct: 179 LVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT-APE-AISYRKFTSASDVWS 235

Query: 170 VGCILGEIMT--RQPLFPG 186
            G ++ E+MT   +P +  
Sbjct: 236 FGIVMWEVMTYGERP-YWE 253

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 98.0 bits (244), Expect = 7e-23
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 31/192 (16%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYE 65
           VAIK  K   +   R      L+E   +R  DH +I+ +  +I   P       V+I+ E
Sbjct: 421 VAIKTCKNCTSDSVREK---FLQEALTMRQFDHPHIVKLIGVITENP-------VWIIME 470

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           L    +L   ++  +  L       + YQL   L Y+ S   +HRD+   N+L+++N  +
Sbjct: 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           K+GDFGL+R   ++     Y          +W  APE  +N   +T+A D+W  G  + E
Sbjct: 531 KLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWE 584

Query: 177 IMT--RQPLFPG 186
           I+    +P F G
Sbjct: 585 ILMHGVKP-FQG 595

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 96.1 bits (239), Expect = 7e-23
 Identities = 70/314 (22%), Positives = 108/314 (34%), Gaps = 43/314 (13%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVYE 65
             VA+K                + I  +  M+H+NI   I    R           +V E
Sbjct: 37  RPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME-YLLVME 92

Query: 66  LMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA---------NVLHRDLKPSNL 115
                 L + +  H       CR   + + RGL Y+H+           + HRDL   N+
Sbjct: 93  YYPNGSLXKYLSLHTSDWVSSCR-LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151

Query: 116 LLNANCDLKIGDFGLARTTSETDF---------MTEYVVTRWYRAPELL------LNCSE 160
           L+  +    I DFGL+   +                 V T  Y APE+L       +   
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211

Query: 161 YTAAIDIWSVGCILGEIMTR-QPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARR 218
               +D++++G I  EI  R   LFPG+    +Q+   TE+   P    +  L S   +R
Sbjct: 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271

Query: 219 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 278
                P+FP+               + +E     D   R+T   A     +A L  I E 
Sbjct: 272 -----PKFPEAWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAE--ERMAELMMIWER 322

Query: 279 PVCPRPFS-FDFEH 291
                P +     H
Sbjct: 323 NKSVSPTAHHHHHH 336

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 23/202 (11%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYI 62
            +  +VA+K +        D +  LRE   ++  DH ++  +  + +R   +       +
Sbjct: 49  GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108

Query: 63  VYELMDT-DLHQIIRSH------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL 115
           +   M   DLH  + +        +L       F+  +  G++Y+ S N +HRDL   N 
Sbjct: 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNC 168

Query: 116 LLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIW 168
           +L  +  + + DFGL+R     D    Y          +W  A E L + + YT   D+W
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPVKWL-ALESLAD-NLYTVHSDVW 223

Query: 169 SVGCILGEIMTR--QPLFPGKD 188
           + G  + EIMTR   P + G +
Sbjct: 224 AFGVTMWEIMTRGQTP-YAGIE 244

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 55  ETFNDVYIVYELMD-----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
           ET  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  N+++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314

Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIW 168
           LKP N+LL+ + +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           ++G  L E++  +  F  +    + + + + +                   +     +P 
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELKQRV-------------------LEQAVTYP- 413

Query: 229 QNFSARFPNKSPGAVDLLEKMLVFDPNRR 257
                     SP + D  E +L  DP +R
Sbjct: 414 -------DKFSPASKDFCEALLQKDPEKR 435

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 27/189 (14%)

Query: 8   EVAIKKIGNAFDNRIDAKRT--LREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYI 62
           +VA+K I      + DA     L E  ++  + H N++ +  +I   +         +YI
Sbjct: 218 KVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-------LYI 264

Query: 63  VYELMDT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           V E M    L   +RS     L  D    F   +   ++Y+   N +HRDL   N+L++ 
Sbjct: 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 324

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +   K+ DFGL +  S T    +  V +W  APE  L   +++   D+WS G +L EI +
Sbjct: 325 DNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE-ALREKKFSTKSDVWSFGILLWEIYS 381

Query: 180 --RQPLFPG 186
             R P +P 
Sbjct: 382 FGRVP-YPR 389

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 60/193 (31%), Positives = 88/193 (45%), Gaps = 28/193 (14%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIV 63
            VAIK  K+G     R D    L E  ++   DH NII ++ ++    P       V IV
Sbjct: 75  SVAIKTLKVGYTEKQRRD---FLGEASIMGQFDHPNIIRLEGVVTKSKP-------VMIV 124

Query: 64  YELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
            E M+   L   +R H    T       L  +  G+KY+     +HRDL   N+L+N+N 
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL 184

Query: 122 DLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
             K+ DFGL R   E D    Y         RW  +PE  +   ++T+A D+WS G +L 
Sbjct: 185 VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWT-SPE-AIAYRKFTSASDVWSYGIVLW 241

Query: 176 EIMT--RQPLFPG 186
           E+M+   +P +  
Sbjct: 242 EVMSYGERP-YWE 253

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 94.7 bits (236), Expect = 1e-22
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 28/193 (14%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIV 63
            VAIK  K G     R D    L E  ++   DH NII ++ ++              IV
Sbjct: 79  PVAIKALKAGYTERQRRDF---LSEASIMGQFDHPNIIRLEGVVTRGRL-------AMIV 128

Query: 64  YELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
            E M+   L   +R+H    T       L  +  G++Y+     +HRDL   N+L+++N 
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL 188

Query: 122 DLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
             K+ DFGL+R   E D    Y  T      RW  APE  +    +++A D+WS G ++ 
Sbjct: 189 VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWT-APE-AIAFRTFSSASDVWSFGVVMW 245

Query: 176 EIMT--RQPLFPG 186
           E++    +P +  
Sbjct: 246 EVLAYGERP-YWN 257

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 20/187 (10%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
            VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +YIV E M
Sbjct: 210 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYM 260

Query: 68  D-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   ++    + L          Q+  G+ YV   N +HRDL+ +N+L+  N   K
Sbjct: 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 320

Query: 125 IGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-- 179
           + DFGLAR   + ++          +W  APE       +T   D+WS G +L E+ T  
Sbjct: 321 VADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKG 378

Query: 180 RQPLFPG 186
           R P +PG
Sbjct: 379 RVP-YPG 384

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 93.8 bits (234), Expect = 2e-22
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 30/192 (15%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYE 65
           +VAIK I    +  +     + E K++ ++ HE ++ +  +   + P       ++I+ E
Sbjct: 50  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-------IFIITE 99

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            M    L   +R  +              +   ++Y+ S   LHRDL   N L+N    +
Sbjct: 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           K+ DFGL+R   +     EY  +       RW   PE +L  S++++  DIW+ G ++ E
Sbjct: 160 KVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPE-VLMYSKFSSKSDIWAFGVLMWE 213

Query: 177 IMT--RQPLFPG 186
           I +  + P +  
Sbjct: 214 IYSLGKMP-YER 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 28/191 (14%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYE 65
           VAIK  +   +     +    L E  ++  +D+ ++  +  I            V ++ +
Sbjct: 47  VAIKELREATSPKANKE---ILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 96

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           LM    L   +R H+D +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156

Query: 124 KIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           KI DFGLA+     +   EY         +W  A E  +    YT   D+WS G  + E+
Sbjct: 157 KITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWEL 212

Query: 178 MT--RQPLFPG 186
           MT   +P + G
Sbjct: 213 MTFGSKP-YDG 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 93.8 bits (234), Expect = 2e-22
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 31/193 (16%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYE 65
            VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E
Sbjct: 40  TVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITE 89

Query: 66  LMDT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            M   +L   +R    Q+++     Y   Q+   ++Y+   N +HRDL   N L+  N  
Sbjct: 90  FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149

Query: 123 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           +K+ DFGL+R     D    Y          +W  APE  L  ++++   D+W+ G +L 
Sbjct: 150 VKVADFGLSRLM-TGD---TYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWAFGVLLW 203

Query: 176 EIMT--RQPLFPG 186
           EI T    P +PG
Sbjct: 204 EIATYGMSP-YPG 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 41/191 (21%), Positives = 81/191 (42%), Gaps = 26/191 (13%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYEL 66
            V IK I      R   +     +  +  +DH +I+ +  +            + +V + 
Sbjct: 44  PVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-------LQLVTQY 95

Query: 67  MDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +    L   +R H+  L       +  Q+ +G+ Y+    ++HR+L   N+LL +   ++
Sbjct: 96  LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQ 155

Query: 125 IGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           + DFG+A      D   + ++        +W  A E  ++  +YT   D+WS G  + E+
Sbjct: 156 VADFGVADLLPPDD---KQLLYSEAKTPIKWM-ALE-SIHFGKYTHQSDVWSYGVTVWEL 210

Query: 178 MT--RQPLFPG 186
           MT   +P + G
Sbjct: 211 MTFGAEP-YAG 220

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 8/185 (4%)

Query: 8   EVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           +VA+K +      +     R  RE +    ++H  I+A+ D     +       YIV E 
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEY 97

Query: 67  MD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +D   L  I+ +   +T       +    + L + H   ++HRD+KP+N++++A   +K+
Sbjct: 98  VDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 157

Query: 126 GDFGLARTTSETDF---MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
            DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L E++T +
Sbjct: 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGE 216

Query: 182 PLFPG 186
           P F G
Sbjct: 217 PPFTG 221

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VA+K +       +  +  L E  +++ + H+ ++ +  ++      T   +YI+ E M
Sbjct: 214 KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV------TKEPIYIITEFM 264

Query: 68  DT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   ++S             F  Q+  G+ ++   N +HRDL+ +N+L++A+   K
Sbjct: 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK 324

Query: 125 IGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           I DFGLAR   +     EY          +W  APE  +N   +T   D+WS G +L EI
Sbjct: 325 IADFGLARVIED----NEYTAREGAKFPIKWT-APE-AINFGSFTIKSDVWSFGILLMEI 378

Query: 178 MT--RQPLFPG 186
           +T  R P +PG
Sbjct: 379 VTYGRIP-YPG 388

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 52/240 (21%), Positives = 102/240 (42%), Gaps = 54/240 (22%)

Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQDLT 82
           TL E ++L+ ++   ++ ++         +F D   +Y +M+     ++   +R     +
Sbjct: 88  TLNEKRILQAVNFPFLVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139

Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-- 140
           + H R++  Q++   +Y+HS ++++RDLKP NLL++    +++ DFG A+      +   
Sbjct: 140 EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199

Query: 141 --TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
              E +      APE++L+   Y  A+D W++G ++ E+    P F     +     I  
Sbjct: 200 GTPEAL------APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

Query: 199 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 258
                     G +R             FP         + S    DLL  +L  D  +R 
Sbjct: 253 ----------GKVR-------------FP--------SHFSSDLKDLLRNLLQVDLTKRF 281

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 20/187 (10%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
            VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +YIV E M
Sbjct: 293 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYM 343

Query: 68  D-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
               L   ++    + L          Q+  G+ YV   N +HRDL+ +N+L+  N   K
Sbjct: 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 403

Query: 125 IGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-- 179
           + DFGLAR   + ++          +W  APE       +T   D+WS G +L E+ T  
Sbjct: 404 VADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKG 461

Query: 180 RQPLFPG 186
           R P +PG
Sbjct: 462 RVP-YPG 467

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 94.1 bits (234), Expect = 4e-22
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
             A+K +    D   +  + L E  +++   H N++++  I    +        +V   M
Sbjct: 119 HCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYM 173

Query: 68  DT-DLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
              DL   IR+   + T      F  Q+ +G+K++ S   +HRDL   N +L+    +K+
Sbjct: 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKV 233

Query: 126 GDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            DFGLAR   + +F + +  T      +W  A E  L   ++T   D+WS G +L E+MT
Sbjct: 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMT 291

Query: 180 R--QPLFPGKD 188
           R   P +P  +
Sbjct: 292 RGAPP-YPDVN 301

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.4 bits (230), Expect = 6e-22
 Identities = 36/195 (18%), Positives = 72/195 (36%), Gaps = 27/195 (13%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYE 65
           EV +K +  A  N   ++       ++  + H++++    +               +V E
Sbjct: 42  EVLLKVLDKAHRN--YSESFFEAASMMSKLSHKHLVLNYGVCVCGDE-------NILVQE 92

Query: 66  LMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            +    L   ++ +++ +          QL   + ++    ++H ++   N+LL    D 
Sbjct: 93  FVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152

Query: 124 --------KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
                   K+ D G++ T    D + E +   W   PE + N      A D WS G  L 
Sbjct: 153 KTGNPPFIKLSDPGISITVLPKDILQERI--PWV-PPECIENPKNLNLATDKWSFGTTLW 209

Query: 176 EIMT--RQPLFPGKD 188
           EI +   +P     D
Sbjct: 210 EICSGGDKP-LSALD 223

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.5 bits (235), Expect = 8e-22
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 31/195 (15%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYE 65
            VA+K +    ++ ++ +  L+E  +++ + H N++ +  +    PP        YI+ E
Sbjct: 247 TVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITE 296

Query: 66  LMDT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
            M   +L   +R    Q+++     Y   Q+   ++Y+   N +HR+L   N L+  N  
Sbjct: 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 356

Query: 123 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           +K+ DFGL+R  +       Y          +W  APE  L  ++++   D+W+ G +L 
Sbjct: 357 VKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWAFGVLLW 410

Query: 176 EIMT--RQPLFPGKD 188
           EI T    P +PG D
Sbjct: 411 EIATYGMSP-YPGID 424

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 91.9 bits (229), Expect = 9e-22
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 20/187 (10%)

Query: 8   EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 67
           +VA+K +       +     L E  L++ + H+ ++ +  ++      T   +YI+ E M
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYM 89

Query: 68  DT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +   L   +++     LT +       Q+  G+ ++   N +HRDL+ +N+L++     K
Sbjct: 90  ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149

Query: 125 IGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-- 179
           I DFGLAR   + ++          +W  APE  +N   +T   D+WS G +L EI+T  
Sbjct: 150 IADFGLARLIEDNEYTAREGAKFPIKWT-APE-AINYGTFTIKSDVWSFGILLTEIVTHG 207

Query: 180 RQPLFPG 186
           R P +PG
Sbjct: 208 RIP-YPG 213

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 22/193 (11%)

Query: 8   EVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 65
           + AIK                 LRE  L+R ++H N++A+  I+ PP+       +++  
Sbjct: 51  QCAIKSLSRITEMQQVEA---FLREGLLMRGLNHPNVLALIGIMLPPE----GLPHVLLP 103

Query: 66  LMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            M   DL Q IRS  ++ T      F  Q+ RG++Y+     +HRDL   N +L+ +  +
Sbjct: 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTV 163

Query: 124 KIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           K+ DFGLAR   + ++ +           +W  A E L     +T   D+WS G +L E+
Sbjct: 164 KVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQT-YRFTTKSDVWSFGVLLWEL 221

Query: 178 MT--RQPLFPGKD 188
           +T    P +   D
Sbjct: 222 LTRGAPP-YRHID 233

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 90.0 bits (224), Expect = 8e-21
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 42/203 (20%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIV 63
           VAIK      +   RI+    L E  +++  +  +++ +  ++   +P          ++
Sbjct: 58  VAIKTVNEAASMRERIE---FLNEASVMKEFNCHHVVRLLGVVSQGQPT--------LVI 106

Query: 64  YELMDT-DLHQIIRSH----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
            ELM   DL   +RS              +         ++  G+ Y+++   +HRDL  
Sbjct: 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 166

Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAI 165
            N ++  +  +KIGDFG+ R   ETD+   Y          RW  +PE L +   +T   
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKD-GVFTTYS 221

Query: 166 DIWSVGCILGEIMT--RQPLFPG 186
           D+WS G +L EI T   QP + G
Sbjct: 222 DVWSFGVVLWEIATLAEQP-YQG 243

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 57/259 (22%), Positives = 99/259 (38%), Gaps = 49/259 (18%)

Query: 21  RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIR 76
           R D+     E  ++   +   ++ +           F D   +Y +M+     DL  ++ 
Sbjct: 110 RSDSAFFWEERDIMAFANSPWVVQLF--------YAFQDDRYLYMVMEYMPGGDLVNLMS 161

Query: 77  SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTS 135
           ++ D+ +   R++  +++  L  +HS   +HRD+KP N+LL+ +  LK+ DFG   +   
Sbjct: 162 NY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220

Query: 136 ETDFMTEYVV-TRWYRAPELLLNC---SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH 191
           E     +  V T  Y +PE+L +      Y    D WSVG  L E++     F     V 
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

Query: 192 QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLV 251
               I                  N +  +     FP         + S  A +L+   L 
Sbjct: 281 TYSKIM-----------------NHKNSLT----FP------DDNDISKEAKNLICAFLT 313

Query: 252 FDPNRRIT---VDEALCHP 267
            D   R+    V+E   H 
Sbjct: 314 -DREVRLGRNGVEEIKRHL 331

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 52/282 (18%), Positives = 101/282 (35%), Gaps = 52/282 (18%)

Query: 4   ETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 62
           +T +  A+K +       R +      E  +L + D   I  +           F D   
Sbjct: 84  QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH--------FAFQDENY 135

Query: 63  VYELMD----TDL-HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           +Y +M+     DL   + +  + +  +  R++L +++  +  VH    +HRD+KP N+LL
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195

Query: 118 NANCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLLN------CSEYTAAIDIWS 169
           +    +++ DFG   +  ++    +   V T  Y +PE+L           Y    D W+
Sbjct: 196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255

Query: 170 VGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ 229
           +G    E+   Q  F                    ET            Y +++      
Sbjct: 256 LGVFAYEMFYGQTPFYADS--------------TAET------------YGKIVHYKEHL 289

Query: 230 NFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPY 268
           +           A D ++++L   P  R+      +   HP+
Sbjct: 290 SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 52/260 (20%), Positives = 104/260 (40%), Gaps = 47/260 (18%)

Query: 21  RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDL-HQII 75
           R +      E  +L + D + I  +           F D   +Y +MD     DL   + 
Sbjct: 115 RAETACFREERDVLVNGDSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLS 166

Query: 76  RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTT 134
           +    L ++  R++L +++  +  VH  + +HRD+KP N+L++ N  +++ DFG   +  
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226

Query: 135 SETDFMTEYVV-TRWYRAPELLLNCSE----YTAAIDIWSVGCILGEIMTRQPLFPGKDY 189
            +    +   V T  Y +PE+L         Y    D WS+G  + E++  +  F  +  
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES- 285

Query: 190 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKM 249
                          ET            Y +++    +  F  +  + S  A DL+ ++
Sbjct: 286 -------------LVET------------YGKIMNHKERFQFPTQVTDVSENAKDLIRRL 320

Query: 250 LVFDPNR--RITVDEALCHP 267
           +    +R  +  +++   HP
Sbjct: 321 ICSREHRLGQNGIEDFKKHP 340

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 87.6 bits (218), Expect = 5e-20
 Identities = 56/242 (23%), Positives = 103/242 (42%), Gaps = 60/242 (24%)

Query: 27  TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLT 82
           T  E  +L  + H  II +          TF D   ++ +MD     +L  ++R  Q   
Sbjct: 53  TNDERLMLSIVTHPFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFP 104

Query: 83  DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-- 140
           +   +++  ++   L+Y+HS ++++RDLKP N+LL+ N  +KI DFG A+   +  +   
Sbjct: 105 NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 164

Query: 141 --TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 198
              +Y+      APE++     Y  +ID WS G ++ E++     F   +          
Sbjct: 165 GTPDYI------APEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN---------- 207

Query: 199 LIGSPDETSLGFLRSDNARRYVRML---PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 255
                 +T            Y ++L    +FP        P  +    DLL +++  D +
Sbjct: 208 ----TMKT------------YEKILNAELRFP--------PFFNEDVKDLLSRLITRDLS 243

Query: 256 RR 257
           +R
Sbjct: 244 QR 245

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 87.2 bits (217), Expect = 8e-20
 Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 71/272 (26%)

Query: 12  KKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIAIKDI---IRPP---------QRETFN 58
           +K+  A   +I A + L++  ++R+     +  A ++I   ++ P         Q  T  
Sbjct: 37  RKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ--TGG 94

Query: 59  DVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
            +Y++  Y    EL      Q+ R      +D   ++L ++   L ++H   +++RDLKP
Sbjct: 95  KLYLILEYLSGGELF----MQLEREGI-FMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149

Query: 113 SNLLLNANCDLKIGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCSEYTAAI 165
            N++LN    +K+ DFGL + +     +T       EY+      APE+L+  S +  A+
Sbjct: 150 ENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM------APEILMR-SGHNRAV 202

Query: 166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           D WS+G ++ +++T  P F G++                +T    L+             
Sbjct: 203 DWWSLGALMYDMLTGAPPFTGEN--------------RKKTIDKILKCK---------LN 239

Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 257
            P        P  +  A DLL+K+L  +   R
Sbjct: 240 LP--------PYLTQEARDLLKKLLKRNAASR 263

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 87.3 bits (217), Expect = 9e-20
 Identities = 42/201 (20%), Positives = 91/201 (45%), Gaps = 45/201 (22%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           EL       + +  +  T+   + ++ +++  L+++H   +++RD+K  N+LL++N  + 
Sbjct: 145 ELF----THLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199

Query: 125 IGDFGLARTTSETDFMTEYVVTRW-------YRAPELLLNCSE-YTAAIDIWSVGCILGE 176
           + DFGL++     +F+ +     +       Y AP+++      +  A+D WS+G ++ E
Sbjct: 200 LTDFGLSK-----EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++T    F      +    I+  I          L+S+         P +P         
Sbjct: 255 LLTGASPFTVDGEKNSQAEISRRI----------LKSE---------PPYP--------Q 287

Query: 237 NKSPGAVDLLEKMLVFDPNRR 257
             S  A DL++++L+ DP +R
Sbjct: 288 EMSALAKDLIQRLLMKDPKKR 308

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 44/210 (20%)

Query: 70  DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 129
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 130 LARTTSETDFMTEYVVTRW------YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 183
           + +     + M     T        Y APE+LL   +Y  ++D WS G +L E++  Q  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 184 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 243
           F G+D               +E        +         P +P              A 
Sbjct: 218 FHGQD--------------EEELFHSIRMDN---------PFYP--------RWLEKEAK 246

Query: 244 DLLEKMLVFDPNRRITVDEALC-HPYLAPL 272
           DLL K+ V +P +R+ V   +  HP    +
Sbjct: 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 86.4 bits (215), Expect = 1e-19
 Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 50/200 (25%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +L      ++ +     T++  +++L +L   L ++HS  +++RDLKP N+LL+    +K
Sbjct: 112 DLF----TRLSKEVM-FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166

Query: 125 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           + DFGL++ + + +          EY+      APE++     +T + D WS G ++ E+
Sbjct: 167 LTDFGLSKESIDHEKKAYSFCGTVEYM------APEVVNR-RGHTQSADWWSFGVLMFEM 219

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +T    F GKD                ET    L++             P          
Sbjct: 220 LTGTLPFQGKD--------------RKETMTMILKAK---------LGMP--------QF 248

Query: 238 KSPGAVDLLEKMLVFDPNRR 257
            SP A  LL  +   +P  R
Sbjct: 249 LSPEAQSLLRMLFKRNPANR 268

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 48/199 (24%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           EL       + R     T++  R++  +++  L+Y+HS +V++RD+K  NL+L+ +  +K
Sbjct: 91  ELF----FHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145

Query: 125 IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           I DFGL +     + +++    +       Y APE+L + ++Y  A+D W +G ++ E+M
Sbjct: 146 ITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
             +  F  +D               +      L  +          +FP           
Sbjct: 200 CGRLPFYNQD--------------HERLFELILMEE---------IRFP--------RTL 228

Query: 239 SPGAVDLLEKMLVFDPNRR 257
           SP A  LL  +L  DP +R
Sbjct: 229 SPEAKSLLAGLLKKDPKQR 247

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 48/199 (24%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +LM      I +S +   +   R++  +++  L ++H   +++RDLK  N+LL+     K
Sbjct: 110 DLM----FHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164

Query: 125 IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           + DFG+ +     + +   V T        Y APE+L     Y  A+D W++G +L E++
Sbjct: 165 LADFGMCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEML 218

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
                F  ++               D+     L  +           +P           
Sbjct: 219 CGHAPFEAEN--------------EDDLFEAILNDE---------VVYP--------TWL 247

Query: 239 SPGAVDLLEKMLVFDPNRR 257
              A  +L+  +  +P  R
Sbjct: 248 HEDATGILKSFMTKNPTMR 266

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 46/208 (22%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVY 64
           VAIK  K       R +      E  L   + H N++ +  ++    P       + +++
Sbjct: 42  VAIKTLKDKAEGPLREE---FRHEAMLRARLQHPNVVCLLGVVTKDQP-------LSMIF 91

Query: 65  ELMDT-DLHQIIRSHQDLTDDHCR----------------YFLYQLLRGLKYVHSANVLH 107
                 DLH+ +      +D                    + + Q+  G++Y+ S +V+H
Sbjct: 92  SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVH 151

Query: 108 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSE 160
           +DL   N+L+    ++KI D GL R     D    Y +        RW  APE ++   +
Sbjct: 152 KDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAIMY-GK 206

Query: 161 YTAAIDIWSVGCILGEIMT--RQPLFPG 186
           ++   DIWS G +L E+ +   QP + G
Sbjct: 207 FSIDSDIWSYGVVLWEVFSYGLQP-YCG 233

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 44/206 (21%)

Query: 9   VAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYE 65
           VA+K +  A ++ R D     RE +LL  + H++I+    +     P       + +V+E
Sbjct: 74  VAVKALKEASESARQD---FQREAELLTMLQHQHIVRFFGVCTEGRP-------LLMVFE 123

Query: 66  LMDT-DLHQIIRSH---------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 109
            M   DL++ +RSH                 L          Q+  G+ Y+   + +HRD
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183

Query: 110 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYT 162
           L   N L+     +KIGDFG++R    TD+   Y V        RW   PE +L   ++T
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPESILY-RKFT 238

Query: 163 AAIDIWSVGCILGEIMT--RQPLFPG 186
              D+WS G +L EI T  +QP +  
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQP-WYQ 263

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 39/199 (19%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +LM      + R  + L ++H R++  ++   L Y+H   +++RDLK  N+LL++   +K
Sbjct: 96  DLM----FHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 150

Query: 125 IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           + D+G+ +     + +     T        Y APE+L    +Y  ++D W++G ++ E+M
Sbjct: 151 LTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 204

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
             +  F            TE     D      L             + P         + 
Sbjct: 205 AGRSPFDIVGSSDNPDQNTE-----DYLFQVILEKQ---------IRIP--------RSL 242

Query: 239 SPGAVDLLEKMLVFDPNRR 257
           S  A  +L+  L  DP  R
Sbjct: 243 SVKAASVLKSFLNKDPKER 261

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.8 bits (208), Expect = 7e-19
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 47/208 (22%)

Query: 9   VAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENII---AIKDIIRPPQRETFNDVYIVY 64
           VA+K + +     R D     RE +LL ++ HE+I+    +     P        + +V+
Sbjct: 48  VAVKALKDPTLAARKD---FQREAELLTNLQHEHIVKFYGVCGDGDP--------LIMVF 96

Query: 65  ELMDT-DLHQIIRSHQDLTDDHCR----------------YFLYQLLRGLKYVHSANVLH 107
           E M   DL++ +R+H                         +   Q+  G+ Y+ S + +H
Sbjct: 97  EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVH 156

Query: 108 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSE 160
           RDL   N L+ AN  +KIGDFG++R    TD+   Y V        RW   PE ++   +
Sbjct: 157 RDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWM-PPESIMY-RK 211

Query: 161 YTAAIDIWSVGCILGEIMT--RQPLFPG 186
           +T   D+WS G IL EI T  +QP +  
Sbjct: 212 FTTESDVWSFGVILWEIFTYGKQP-WFQ 238

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 85.0 bits (211), Expect = 8e-19
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 50/200 (25%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           EL     + + R      +   R++  ++   L Y+HS N+++RDLKP N+LL++   + 
Sbjct: 125 ELF----YHLQRERC-FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179

Query: 125 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           + DFGL +   E +  T       EY+      APE+L     Y   +D W +G +L E+
Sbjct: 180 LTDFGLCKENIEHNSTTSTFCGTPEYL------APEVLHK-QPYDRTVDWWCLGAVLYEM 232

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +   P F  ++                E     L             Q          PN
Sbjct: 233 LYGLPPFYSRN--------------TAEMYDNILNKP---------LQLK--------PN 261

Query: 238 KSPGAVDLLEKMLVFDPNRR 257
            +  A  LLE +L  D  +R
Sbjct: 262 ITNSARHLLEGLLQKDRTKR 281

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.1 bits (211), Expect = 9e-19
 Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 39/199 (19%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +LM      + R  + L ++H R++  ++   L Y+H   +++RDLK  N+LL++   +K
Sbjct: 139 DLM----FHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193

Query: 125 IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
           + D+G+ +     + +     T        Y APE+L    +Y  ++D W++G ++ E+M
Sbjct: 194 LTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 247

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
             +  F            TE     D      L             + P         + 
Sbjct: 248 AGRSPFDIVGSSDNPDQNTE-----DYLFQVILEKQ---------IRIP--------RSL 285

Query: 239 SPGAVDLLEKMLVFDPNRR 257
           S  A  +L+  L  DP  R
Sbjct: 286 SVKAASVLKSFLNKDPKER 304

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 41/200 (20%), Positives = 82/200 (41%), Gaps = 50/200 (25%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +LM    + I +  +   + H  ++  ++  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 107 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161

Query: 125 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           I DFG+ +        T       +Y+      APE++     Y  ++D W+ G +L E+
Sbjct: 162 IADFGMCKENIWDGVTTKTFCGTPDYI------APEIIAY-QPYGKSVDWWAFGVLLYEM 214

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +  Q  F G+D               DE     +  +           +P         +
Sbjct: 215 LAGQAPFEGED--------------EDELFQSIMEHN---------VAYP--------KS 243

Query: 238 KSPGAVDLLEKMLVFDPNRR 257
            S  AV + + ++   P +R
Sbjct: 244 MSKEAVAICKGLMTKHPGKR 263

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 50/225 (22%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMD-HENII----AIKDIIRPPQR 54
            + T   VA+K  K G            + E+K+L H+  H N++    A      P   
Sbjct: 53  KTATCRTVAVKMLKEGATHSEHRA---LMSELKILIHIGHHLNVVNLLGACTKPGGP--- 106

Query: 55  ETFNDVYIVYELMDT-DLHQIIRSH----------------QDLTDDHCRYFLYQLLRGL 97
                + ++ E     +L   +RS                   LT +H   + +Q+ +G+
Sbjct: 107 -----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 161

Query: 98  KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYR 150
           +++ S   +HRDL   N+LL+    +KI DFGLAR   +     +YV         +W  
Sbjct: 162 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWM- 217

Query: 151 APELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQL 193
           APE + +   YT   D+WS G +L EI +    P +PG     + 
Sbjct: 218 APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 260

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 39/195 (20%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDL 123
           EL       + R     ++D  R++  +++  L Y+HS  NV++RDLK  NL+L+ +  +
Sbjct: 234 ELF----FHLSRERV-FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288

Query: 124 KIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 182
           KI DFGL +    +   M  +  T  Y APE+L + ++Y  A+D W +G ++ E+M  + 
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 183 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGA 242
            F  +D+     LI              L  +          +FP            P A
Sbjct: 348 PFYNQDHEKLFELI--------------LMEE---------IRFP--------RTLGPEA 376

Query: 243 VDLLEKMLVFDPNRR 257
             LL  +L  DP +R
Sbjct: 377 KSLLSGLLKKDPKQR 391

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 41/200 (20%), Positives = 81/200 (40%), Gaps = 50/200 (25%)

Query: 65  ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 124
           +LM    + I +  +   + H  ++  ++  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 428 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482

Query: 125 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           I DFG+ +        T       +Y+      APE++     Y  ++D W+ G +L E+
Sbjct: 483 IADFGMCKENIWDGVTTKTFCGTPDYI------APEIIAY-QPYGKSVDWWAFGVLLYEM 535

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +  Q  F G+D     + I E                           +P         +
Sbjct: 536 LAGQAPFEGEDEDELFQSIME-----HN------------------VAYP--------KS 564

Query: 238 KSPGAVDLLEKMLVFDPNRR 257
            S  AV + + ++   P +R
Sbjct: 565 MSKEAVAICKGLMTKHPGKR 584

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.5 bits (202), Expect = 6e-18
 Identities = 60/225 (26%), Positives = 88/225 (39%), Gaps = 49/225 (21%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI--IRPPQRET 56
            S+    VA+K  K       R      + E+K+L ++ +H NI+ +     I  P    
Sbjct: 49  KSDAAMTVAVKMLKPSAHLTEREA---LMSELKVLSYLGNHMNIVNLLGACTIGGP---- 101

Query: 57  FNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRY------------------FLYQLLRGL 97
                ++ E     DL   +R  +D                          F YQ+ +G+
Sbjct: 102 ---TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158

Query: 98  KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYR 150
            ++ S N +HRDL   N+LL      KI DFGLAR          YVV        +W  
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---NYVVKGNARLPVKWM- 214

Query: 151 APELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQL 193
           APE + NC  YT   D+WS G  L E+ +    P +PG     + 
Sbjct: 215 APESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKF 257

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 45/207 (21%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDI--IRPPQRETFNDVYIV 63
           VA+K  K     D +      + E+K++ H+  HENI+ +        P       V ++
Sbjct: 79  VAVKMLKSTAHADEKEA---LMSELKIMSHLGQHENIVNLLGACTHGGP-------VLVI 128

Query: 64  YELMDT-DLHQIIRSH--------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
            E     DL   +R                   +     +F  Q+ +G+ ++ S N +HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188

Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEY 161
           D+   N+LL      KIGDFGLAR          Y+V        +W  APE + +C  Y
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWM-APESIFDCV-Y 243

Query: 162 TAAIDIWSVGCILGEIMT--RQPLFPG 186
           T   D+WS G +L EI +    P +PG
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNP-YPG 269

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 40/209 (19%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI--IRPPQRETF 57
           N  +  +VA+K      +  + +D    L E  ++   +H+NI+    +     P     
Sbjct: 56  NDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFNHQNIVRCIGVSLQSLP----- 107

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLL-------RGLKYVHSANVLHRD 109
              +I+ ELM   DL   +R  +          +  LL        G +Y+   + +HRD
Sbjct: 108 --RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165

Query: 110 LKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCS 159
           +   N LL         KIGDFG+AR      +   Y          +W   PE  +   
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFME-G 220

Query: 160 EYTAAIDIWSVGCILGEIMT--RQPLFPG 186
            +T+  D WS G +L EI +    P +P 
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMP-YPS 248

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.8 bits (197), Expect = 2e-17
 Identities = 30/252 (11%), Positives = 61/252 (24%), Gaps = 60/252 (23%)

Query: 8   EVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
           +VA+  +           + TL     L  +D   +  + D++      T     +V E 
Sbjct: 58  QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRAGGLVVAEW 112

Query: 67  MD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 125
           +    L ++  +    +       +  L       H A V      PS + ++ + D+ +
Sbjct: 113 IRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL 170

Query: 126 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 185
                                                   DI  +G  L  ++  +   P
Sbjct: 171 AYPATMPDA---------------------------NPQDDIRGIGASLYALLVNRWPLP 203

Query: 186 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDL 245
                  L                      A R     P  P    +    +       +
Sbjct: 204 EAGVRSGLAP--------------------AERDTAGQPIEP----ADIDRDIPFQISAV 239

Query: 246 LEKMLVFDPNRR 257
             + +  D   R
Sbjct: 240 AARSVQGDGGIR 251

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 40/209 (19%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI--IRPPQRETF 57
           N  +  +VA+K      +  + +D    L E  ++   +H+NI+    +     P     
Sbjct: 97  NDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFNHQNIVRCIGVSLQSLP----- 148

Query: 58  NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLL-------RGLKYVHSANVLHRD 109
              +I+ ELM   DL   +R  +          +  LL        G +Y+   + +HRD
Sbjct: 149 --RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206

Query: 110 LKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCS 159
           +   N LL         KIGDFG+AR      +   Y          +W   PE  +   
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWM-PPEAFME-G 261

Query: 160 EYTAAIDIWSVGCILGEIMT--RQPLFPG 186
            +T+  D WS G +L EI +    P +P 
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMP-YPS 289

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 55/227 (24%), Positives = 84/227 (37%), Gaps = 60/227 (26%)

Query: 1   MNSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI-----KDIIRPPQ 53
           +  E    VA+K  K   + D + D     RE  L+   D+ NI+ +         +P  
Sbjct: 72  LPYEPFTMVAVKMLKEEASADMQAD---FQREAALMAEFDNPNIVKLLGVCAVG--KPM- 125

Query: 54  RETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR------------------------Y 88
                   +++E M   DL++ +RS    T                              
Sbjct: 126 -------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178

Query: 89  FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-- 146
              Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D    Y     
Sbjct: 179 IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YYKADGN 235

Query: 147 -----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 186
                RW   PE +   + YT   D+W+ G +L EI +   QP + G
Sbjct: 236 DAIPIRWM-PPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQP-YYG 279

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 54/216 (25%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI--IRPPQRETFNDVYIVY 64
           VA+K  K   +     D    L E  +L+ ++H ++I +        P       + ++ 
Sbjct: 56  VAVKMLKENASPSELRD---LLSEFNVLKQVNHPHVIKLYGACSQDGP-------LLLIV 105

Query: 65  ELMDT-DLHQIIRSH------------------------QDLTDDHCRYFLYQLLRGLKY 99
           E      L   +R                          + LT      F +Q+ +G++Y
Sbjct: 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165

Query: 100 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 152
           +    ++HRDL   N+L+     +KI DFGL+R   E D    YV         +W  A 
Sbjct: 166 LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED---SYVKRSQGRIPVKWM-AI 221

Query: 153 ELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 186
           E L +   YT   D+WS G +L EI+T    P +PG
Sbjct: 222 ESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP-YPG 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 79.2 bits (196), Expect = 6e-17
 Identities = 57/212 (26%), Positives = 82/212 (38%), Gaps = 49/212 (23%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI--IRPPQRET 56
               R + AIK  K   + D+  D      E+++L  +  H NII +      R      
Sbjct: 48  KDGLRMDAAIKRMKEYASKDDHRD---FAGELEVLCKLGHHPNIINLLGACEHRGY---- 100

Query: 57  FNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR----------------YFLYQLLRGLKY 99
              +Y+  E     +L   +R  + L  D                   +F   + RG+ Y
Sbjct: 101 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157

Query: 100 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 152
           +     +HRDL   N+L+  N   KI DFGL+R          YV         RW  A 
Sbjct: 158 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKTMGRLPVRWM-AI 210

Query: 153 ELLLNCSEYTAAIDIWSVGCILGEIMT--RQP 182
           E  LN S YT   D+WS G +L EI++    P
Sbjct: 211 E-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 47/209 (22%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI--IRPPQRETFNDVYIV 63
           VA+K  K      +  D    + E+++++ +  H+NII +        P       +Y++
Sbjct: 70  VAVKMLKDDATEKDLSD---LVSEMEMMKMIGKHKNIINLLGACTQDGP-------LYVI 119

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCR----------------YFLYQLLRGLKYVHSANVL 106
            E     +L + +R+ +    ++                     YQL RG++Y+ S   +
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179

Query: 107 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCS 159
           HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L +  
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEALFDR- 234

Query: 160 EYTAAIDIWSVGCILGEIMT--RQPLFPG 186
            YT   D+WS G ++ EI T    P +PG
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSP-YPG 262

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 47/209 (22%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI--IRPPQRETFNDVYIV 63
           VA+K  K      +  D    + E+++++ +  H+NII +        P       +Y++
Sbjct: 116 VAVKMLKDDATEKDLSD---LVSEMEMMKMIGKHKNIINLLGACTQDGP-------LYVI 165

Query: 64  YELMDT-DLHQIIRSHQDLTDDHCR----------------YFLYQLLRGLKYVHSANVL 106
            E     +L + +R+ +    ++                     YQL RG++Y+ S   +
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225

Query: 107 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCS 159
           HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L +  
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEALFD-R 280

Query: 160 EYTAAIDIWSVGCILGEIMT--RQPLFPG 186
            YT   D+WS G ++ EI T    P +PG
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSP-YPG 308

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 20/139 (14%)

Query: 64  YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
            E    DL++   + + L       + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 178 EEEAPEDLYKDFLTLEHLIC-----YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 124 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           KI DFGLAR   +     +YV         +W  APE + +   YT   D+WS G +L E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDR-VYTIQSDVWSFGVLLWE 287

Query: 177 IMT--RQPLFPGKDYVHQL 193
           I +    P +PG     + 
Sbjct: 288 IFSLGASP-YPGVKIDEEF 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 47/209 (22%)

Query: 9   VAIK--KIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI--IRPPQRETFNDVYIV 63
           VA+K  K      +  D    + E+++++ +  H+NII +        P       +Y++
Sbjct: 104 VAVKMLKSDATEKDLSD---LISEMEMMKMIGKHKNIINLLGACTQDGP-------LYVI 153

Query: 64  YELMDT-DLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVL 106
            E     +L + +++                 + L+        YQ+ RG++Y+ S   +
Sbjct: 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 213

Query: 107 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCS 159
           HRDL   N+L+  +  +KI DFGLAR     D    Y  T       +W  APE L +  
Sbjct: 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWM-APEALFDR- 268

Query: 160 EYTAAIDIWSVGCILGEIMT--RQPLFPG 186
            YT   D+WS G +L EI T    P +PG
Sbjct: 269 IYTHQSDVWSFGVLLWEIFTLGGSP-YPG 296

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 52/229 (22%)

Query: 2   NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHM-DHENII------AIKD---II 49
            +    +VA+K  K       R      + E+K++  +  HENI+       +     +I
Sbjct: 71  KTGVSIQVAVKMLKEKADSSEREA---LMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127

Query: 50  ----------------RPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQL 93
                           R    E   +      L + +   ++ + +DL       F YQ+
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL-TFEDLLC-----FAYQV 181

Query: 94  LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------- 146
            +G++++   + +HRDL   N+L+     +KI DFGLAR          YVV        
Sbjct: 182 AKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPV 238

Query: 147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQL 193
           +W  APE L     YT   D+WS G +L EI +    P +PG       
Sbjct: 239 KWM-APESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANF 284

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.4 bits (176), Expect = 2e-14
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 95  RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 149
            G+ ++H  + +HRD+K +N+LL+     KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 150 RAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            APE L    E T   DI+S G +L EI+T
Sbjct: 202 MAPEALRG--EITPKSDIYSFGVVLLEIIT 229

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 65.3 bits (160), Expect = 3e-12
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 16/95 (16%)

Query: 95  RGLKYVH---SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW--- 148
           RGL Y+H      ++HRD+K +N+LL+   +  +GDFGLA+     D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 149 --YRAPELLLN--CSEYTAAIDIWSVGCILGEIMT 179
             + APE L     SE T   D++  G +L E++T
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELIT 230

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 64.9 bits (159), Expect = 4e-12
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 21/106 (19%)

Query: 95  RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 149
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 150 RAPELLLNCSEY------TAAIDIWSVGCILGEIMT-RQPLFPGKD 188
             P       EY      T   D++S G +L E++  R  +     
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 3e-11
 Identities = 41/313 (13%), Positives = 78/313 (24%), Gaps = 68/313 (21%)

Query: 5   TREEVAIKKI---------------GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 49
               VAIK I                      I   + L  +        E  I +  + 
Sbjct: 42  DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101

Query: 50  -------------------------RPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDD 84
                                      P     + ++IV E     +       +  +  
Sbjct: 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLA 161

Query: 85  HCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 143
             +  L+QL   L    ++    HRDL   N+LL      K+      ++++        
Sbjct: 162 TAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC---- 217

Query: 144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 203
                     L ++  +YT +        +  ++   + LF G         I  L+   
Sbjct: 218 ---------GLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKE 266

Query: 204 DETSL-GFLRSDNA------RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 256
           +      +    N          +     F  +  +           +    ML F    
Sbjct: 267 NNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323

Query: 257 RITVDEALCHPYL 269
             +  + LC   L
Sbjct: 324 --SATDLLCQHSL 334

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 30/145 (20%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           N  T E VAIK      +        L  E +  + +   +   I  +        +N  
Sbjct: 30  NLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG--SGDGIPQVYYFGPCGKYN-- 80

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYF--------LYQLLRGLKYVHSANVLHRDLKP 112
            +V EL+   L       +DL D   R F          QL+  ++YVHS N+++RD+KP
Sbjct: 81  AMVLELLGPSL-------EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKP 133

Query: 113 SNLLL--NANCDLKIG---DFGLAR 132
            N L+    N   ++    DF LA+
Sbjct: 134 ENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 35/138 (25%), Positives = 57/138 (41%), Gaps = 16/138 (11%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRT--LREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
            +    EEVAIK         +  K      E K+ + M  +  + I  I        +N
Sbjct: 29  TDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMM--QGGVGIPTIRWCGAEGDYN 80

Query: 59  DVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
              +V EL+   L  +     +  +         Q++  ++Y+HS N +HRD+KP N L+
Sbjct: 81  --VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138

Query: 118 NANCD---LKIGDFGLAR 132
                   + I DFGLA+
Sbjct: 139 GLGKKGNLVYIIDFGLAK 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.4 bits (126), Expect = 6e-08
 Identities = 21/74 (28%), Positives = 37/74 (50%), Gaps = 2/74 (2%)

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-A 119
           ++V E +  DL +I   +             ++L  L+Y+H    +H D+K +NLLL   
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 120 NCD-LKIGDFGLAR 132
           N D + + D+GL+ 
Sbjct: 188 NPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.1 bits (125), Expect = 9e-08
 Identities = 29/157 (18%), Positives = 55/157 (35%), Gaps = 41/157 (26%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP--------- 52
           +  +     +K          D      E+K  +       I      R           
Sbjct: 61  SVGSDAPCVVKV------EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114

Query: 53  -------QRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYF--------LYQLLRGL 97
                    +++   +++ +   +DL       Q + + + + F          ++L  L
Sbjct: 115 GSGLHDKNGKSYR--FMIMDRFGSDL-------QKIYEANAKRFSRKTVLQLSLRILDIL 165

Query: 98  KYVHSANVLHRDLKPSNLLLN-ANCD-LKIGDFGLAR 132
           +Y+H    +H D+K SNLLLN  N D + + D+GLA 
Sbjct: 166 EYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 30/145 (20%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRT--LREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
            N +T EEVAIK         +  K    L E K+ R +  +    I ++        +N
Sbjct: 27  TNIQTNEEVAIKL------ENVKTKHPQLLYESKIYRIL--QGGTGIPNVRWFGVEGDYN 78

Query: 59  DVYIVYELMDTDLHQIIRSHQDLTDDHCRYF--------LYQLLRGLKYVHSANVLHRDL 110
              +V +L+   L       +DL +   R            Q++  +++VHS + LHRD+
Sbjct: 79  --VLVMDLLGPSL-------EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129

Query: 111 KPSNLLLNANCD---LKIGDFGLAR 132
           KP N L+        + I DFGLA+
Sbjct: 130 KPDNFLMGLGRRANQVYIIDFGLAK 154

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 29/147 (19%), Positives = 54/147 (36%), Gaps = 32/147 (21%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIKDIIRPPQRETFN 58
            N    ++VAIK           +       E +  + +       I ++    Q    N
Sbjct: 30  TNLLNNQQVAIK------FEPRRSDAPQLRDEYRTYKLLA--GCTGIPNVYYFGQEGLHN 81

Query: 59  DVYIVYELMDTDLHQIIRSHQDLTDDHCRYF--------LYQLLRGLKYVHSANVLHRDL 110
              +V +L+   L       +DL D   R F          Q+L  ++ +H  ++++RD+
Sbjct: 82  --VLVIDLLGPSL-------EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 132

Query: 111 KPSNLLLNANCDLK-----IGDFGLAR 132
           KP N L+            + DFG+ +
Sbjct: 133 KPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 19/150 (12%), Positives = 48/150 (32%), Gaps = 30/150 (20%)

Query: 2   NSETREEVAIK--------KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 53
           +   +++ ++K             F  R      + + K L       I           
Sbjct: 71  SGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV--H 128

Query: 54  RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFL---------YQLLRGLKYVHSAN 104
           ++ +   ++V   +   L       Q   D   ++ L          +LL  L+++H   
Sbjct: 129 QDKYR--FLVLPSLGRSL-------QSALDVSPKHVLSERSVLQVACRLLDALEFLHENE 179

Query: 105 VLHRDLKPSNLLLNANCDLKI--GDFGLAR 132
            +H ++   N+ ++     ++    +G A 
Sbjct: 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 27/120 (22%), Positives = 49/120 (40%), Gaps = 18/120 (15%)

Query: 19  DNRIDAKRTLREIKLLRHMDHENIIA--IKDIIRPPQRETFNDVYIVYELMDTDLHQIIR 76
           D  I   RT RE + L  +    I A  I D+      +  N   ++  +       +I 
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDV------DLDNKRIMMSYINGKLAKDVIE 431

Query: 77  SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 136
            + D          Y++   +  +H  +V+H DL  SN + + +  + I DFGL + ++ 
Sbjct: 432 DNLD--------IAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI-I-DFGLGKISNL 481

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 3e-05
 Identities = 62/370 (16%), Positives = 104/370 (28%), Gaps = 115/370 (31%)

Query: 20  NRIDAKRTLREIKLLRHMDHENII---------------AIKDIIRPPQRETFNDVY--- 61
           +R+     LR+  LL     +N++                        Q +    ++   
Sbjct: 132 SRLQPYLKLRQ-ALLELRPAKNVLIDGVLGSGKTWVALDVCLS--YKVQCKMDFKIFWLN 188

Query: 62  --------IVYELMDTDLHQIIRSHQDLTDDHCRY---------FLYQLLRGLKYVHSAN 104
                    V E++   L+QI  +    +D               L +LL+   Y +   
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 105 VLHRDLKPSNLL--LNANCDLKIGDFGLA--RTTSETDFMTEYVVTRWY----------- 149
           VL  +++ +      N +C  KI    L   R    TDF++    T              
Sbjct: 249 VL-LNVQNAKAWNAFNLSC--KI----LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301

Query: 150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-----------FPGK-DYVHQLRL-- 195
               LLL        +D      +  E++T  P                 D    +    
Sbjct: 302 EVKSLLLKY------LDC-RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354

Query: 196 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLE----KMLV 251
           +T +I    E+SL  L     R+    L  FP    SA  P        LL      ++ 
Sbjct: 355 LTTII----ESSLNVLEPAEYRKMFDRLSVFPP---SAHIPTI------LLSLIWFDVIK 401

Query: 252 FDPNRRITVDE------ALCHP--YLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELI 303
            D    + V++          P      +  I  E        +   H S  +       
Sbjct: 402 SDV--MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDH------ 452

Query: 304 YRESVKFNPD 313
           Y     F+ D
Sbjct: 453 YNIPKTFDSD 462

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	316
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.67
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.45
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.92
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.87
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.45
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.95
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.95
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.75
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.52
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.4
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.18
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.89
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.83
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.66
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.57
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.26
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.8
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.58
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.98
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.28
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	91.99
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.31
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.61
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.81

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-62  Score=439.34  Aligned_cols=310  Identities=55%  Similarity=0.951  Sum_probs=273.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC-CCCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++...........+.+|+.+|+.++|||||++++++.... ......+|||||||+|+|.+++...++
T Consensus        75 ~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~  154 (398)
T 4b99_A           75 RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP  154 (398)
T ss_dssp             ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSC
T ss_pred             ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCC
Confidence            6789999999999877666667788999999999999999999999987542 234467999999999999999999999


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-----CccccccccccccCcccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~  155 (316)
                      +++.+++.+++||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....     ......+||+.|+|||++
T Consensus       155 l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~  234 (398)
T 4b99_A          155 LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM  234 (398)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence            999999999999999999999999999999999999999999999999999865332     234567899999999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+...++.++||||+||++|||++|++||.+.+..+++..|....+.++...+..........+....+......+...+
T Consensus       235 ~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (398)
T 4b99_A          235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVY  314 (398)
T ss_dssp             TTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHS
T ss_pred             cCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC
Confidence            87667899999999999999999999999999999999999999999988877766666677777777777777777888


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFN  311 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (316)
                      +.+|+++.+||.+||+.||.+|||++|+|+||||+++++..+++.+..++..+++...++.++++++|..+...|+
T Consensus       315 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~k~~i~~ei~~~~  390 (398)
T 4b99_A          315 PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFH  390 (398)
T ss_dssp             TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSCCCCHHHHSCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCCCCCccchhhcCHHHHHHHHHHHHHHHH
Confidence            8999999999999999999999999999999999999998889999888888888888999999999999988875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.7e-58  Score=393.97  Aligned_cols=234  Identities=28%  Similarity=0.493  Sum_probs=191.6

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++..... ......+.+|+.++++++||||+++++++.+.     ..+|+|||||+|+|.+.+.+.++
T Consensus        34 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~g~L~~~l~~~~~  108 (275)
T 3hyh_A           34 HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMVIEYAGNELFDYIVQRDK  108 (275)
T ss_dssp             CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCEEHHHHHHHSCS
T ss_pred             ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCHHHHHHHcCC
Confidence            6789999999999765332 33456789999999999999999999999654     56999999999999999999999


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+...
T Consensus       109 l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y  188 (275)
T 3hyh_A          109 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY  188 (275)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCC
Confidence            99999999999999999999999999999999999999999999999999988766666667899999999999988444


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|++||.+.+.......+....-..                               ...+|+
T Consensus       189 ~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s~  237 (275)
T 3hyh_A          189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-------------------------------PKFLSP  237 (275)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------------------------------CTTSCH
T ss_pred             CCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCCCCH
Confidence            5789999999999999999999999887766666654421111                               025789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ++++||++||+.||++|||++|+++||||+.
T Consensus       238 ~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          238 GAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-57  Score=394.87  Aligned_cols=235  Identities=26%  Similarity=0.453  Sum_probs=204.8

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.||+.||||++++.. .+......+.+|+.++++++|||||+++++|.+.     ..+|||||||+ |+|.+++++.+
T Consensus        53 ~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~yivmEy~~gG~L~~~i~~~~  127 (311)
T 4aw0_A           53 ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIG  127 (311)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHS
T ss_pred             ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcC
Confidence            67899999999997643 2333457789999999999999999999999654     56999999996 69999999989


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---CccccccccccccCccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~  156 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....   ......+||+.|+|||++.
T Consensus       128 ~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~  207 (311)
T 4aw0_A          128 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT  207 (311)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHc
Confidence            9999999999999999999999999999999999999999999999999999876432   2345678999999999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|||||||++|+|++|.+||.+.+..+....+....-..+                               .
T Consensus       208 ~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p-------------------------------~  255 (311)
T 4aw0_A          208 E-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP-------------------------------E  255 (311)
T ss_dssp             H-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------------------------T
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------c
Confidence            7 7799999999999999999999999999887777777654211110                               2


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDE------ALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~e------ll~~~~f~~~~  273 (316)
                      .+|+++++||++||+.||++|||++|      |++||||++++
T Consensus       256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          256 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            57899999999999999999999988      58999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.2e-57  Score=395.26  Aligned_cols=235  Identities=25%  Similarity=0.466  Sum_probs=202.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++.....  ..+.+.+|+.+++.++|||||+++++|.+.     ..+|||||||+ |+|.+++.. ++
T Consensus        95 ~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~-~~  166 (346)
T 4fih_A           95 VRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TR  166 (346)
T ss_dssp             ETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEECCCTTEEHHHHHHH-SC
T ss_pred             ECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CC
Confidence            5789999999999764322  345578999999999999999999999655     56999999996 699998876 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ......+||+.|+|||++.+ .
T Consensus       167 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~  245 (346)
T 4fih_A          167 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-L  245 (346)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-C
Confidence            999999999999999999999999999999999999999999999999999876544 34567899999999999977 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .|+.++|||||||++|||++|.+||.+.+..+....+........                            .....+|
T Consensus       246 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~s  297 (346)
T 4fih_A          246 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------------------------KNLHKVS  297 (346)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------------------------SCGGGSC
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------------------------CccccCC
Confidence            899999999999999999999999998887777766654211110                            1113578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++++||.+||+.||++|||++|+|+||||++..
T Consensus       298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-56  Score=385.22  Aligned_cols=238  Identities=22%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.+|+.||||++............+.+|+.++++++|||||+++++|.... .+...+|||||||+ |+|.+++.+.+.
T Consensus        47 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lvmEy~~gg~L~~~l~~~~~  125 (290)
T 3fpq_A           47 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKV  125 (290)
T ss_dssp             ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEEEECCCSCBHHHHHHHHSS
T ss_pred             ECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEEEeCCCCCCHHHHHHhcCC
Confidence            6789999999999876666667788999999999999999999999986431 12256899999996 799999999899


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEcc-CCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++..++.|+.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+++.... ......+||+.|+|||++.+
T Consensus       126 l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~  204 (290)
T 3fpq_A          126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE  204 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC
Confidence            999999999999999999999998  999999999999985 78999999999976433 33456789999999999864


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                        .++.++|||||||++|||++|++||.+.+....+....... ..+.                           .....
T Consensus       205 --~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~---------------------------~~~~~  254 (290)
T 3fpq_A          205 --KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA---------------------------SFDKV  254 (290)
T ss_dssp             --CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG---------------------------GGGGC
T ss_pred             --CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCC---------------------------CCCcc
Confidence              58999999999999999999999998765544433322111 0000                           01124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      .++++.+||.+||+.||++|||++|+|+||||++
T Consensus       255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            6889999999999999999999999999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.7e-57  Score=396.73  Aligned_cols=235  Identities=26%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      |+.+|+.||||+++...........+.+|+.++++|+|||||++++++.+.     ..+|||||||+ |+|.++|...  
T Consensus        45 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~~~  119 (350)
T 4b9d_A           45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GSLYIVMDYCEGGDLFKRINAQKG  119 (350)
T ss_dssp             ETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTTT
T ss_pred             ECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHcCC
Confidence            678999999999987666666778899999999999999999999999654     56999999996 7999999654  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... .....+||+.|+|||++.+
T Consensus       120 ~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~  199 (350)
T 4b9d_A          120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN  199 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC
Confidence            357899999999999999999999999999999999999999999999999998765432 2345689999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..|+.++|||||||++|||++|++||.+.+..+.+..+......                              .....
T Consensus       200 -~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------------------------------~~~~~  248 (350)
T 4b9d_A          200 -KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP------------------------------PVSLH  248 (350)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------------------------------CCCTT
T ss_pred             -CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------------------------CCCcc
Confidence             78999999999999999999999999998877777766542111                              11135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +|+++.+||.+||+.||.+|||++|+|+||||++-
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            78999999999999999999999999999999763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.4e-57  Score=390.55  Aligned_cols=235  Identities=26%  Similarity=0.418  Sum_probs=197.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+|+.||||+++...........+.+|+.++++++|||||++++++.+.     ..+|+|||||+ |+|.+++.+.+.
T Consensus        48 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~  122 (304)
T 3ubd_A           48 GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVM  122 (304)
T ss_dssp             STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----TEEEEEECCCTTCEEHHHHHHHCC
T ss_pred             CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhcCC
Confidence            356899999999977544444445678999999999999999999999654     56999999996 799999999899


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... .......+||+.|+|||++.+ .
T Consensus       123 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~-~  201 (304)
T 3ubd_A          123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-R  201 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT-S
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhcc-C
Confidence            99999999999999999999999999999999999999999999999999986543 334456789999999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|++||.+.+..+....+.+..-..                               ...+|
T Consensus       202 ~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s  250 (304)
T 3ubd_A          202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-------------------------------PQFLS  250 (304)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTTSC
T ss_pred             CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-------------------------------CCcCC
Confidence            89999999999999999999999999988877777765421111                               12578


Q ss_pred             hHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      +++.+||++||+.||++|||     ++|+++||||++++
T Consensus       251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            99999999999999999998     47999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-55  Score=396.05  Aligned_cols=235  Identities=25%  Similarity=0.465  Sum_probs=202.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||||++.....  ...+.+.+|+.+++.++|||||+++++|...     ..+|||||||+ |+|.+++.. ++
T Consensus       172 ~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~iVmEy~~gG~L~~~i~~-~~  243 (423)
T 4fie_A          172 VRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TR  243 (423)
T ss_dssp             ETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH-SC
T ss_pred             ECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEEEEeCCCCCcHHHHHhc-cC
Confidence            578999999999976432  2345688999999999999999999999755     56999999996 699998865 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ......+||+.|+|||++.+ .
T Consensus       244 l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~  322 (423)
T 4fie_A          244 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-L  322 (423)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC-C
Confidence            999999999999999999999999999999999999999999999999999876543 34567899999999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .|+.++|||||||++|||++|++||.+.+..+.+..+.......                            ......+|
T Consensus       323 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~s  374 (423)
T 4fie_A          323 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------------------------LKNLHKVS  374 (423)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------------------CSCTTSSC
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------------------------CcccccCC
Confidence            89999999999999999999999999888777776665421110                            01123679


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++++||.+||+.||++|||++|+|+||||++..
T Consensus       375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            9999999999999999999999999999998753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.5e-53  Score=388.89  Aligned_cols=313  Identities=40%  Similarity=0.754  Sum_probs=267.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |+.+|+.||||++............+.+|+.+++.++||||+++++++..........+|+||||++|+|.+++.....+
T Consensus        47 ~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l  126 (432)
T 3n9x_A           47 DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFL  126 (432)
T ss_dssp             ETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCC
T ss_pred             ECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCC
Confidence            57889999999998776677777889999999999999999999999976644445679999999999999999988889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----------------------
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----------------------  138 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----------------------  138 (316)
                      ++..++.+++||+.||.|||++||+||||||+||+++.++.+||+|||++.......                       
T Consensus       127 ~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (432)
T 3n9x_A          127 TEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK  206 (432)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---------------------------
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhc
Confidence            999999999999999999999999999999999999999999999999998754332                       


Q ss_pred             ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-----------CCCCCCCCC-----------------cH
Q 021181          139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-----------RQPLFPGKD-----------------YV  190 (316)
Q Consensus       139 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-----------g~~pf~~~~-----------------~~  190 (316)
                      ......+|++|+|||++.....++.++|||||||++|+|++           |.++|.+.+                 ..
T Consensus       207 ~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~  286 (432)
T 3n9x_A          207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR  286 (432)
T ss_dssp             ----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHH
T ss_pred             cccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchH
Confidence            12456789999999997665789999999999999999997           555565544                 35


Q ss_pred             HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          191 HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       191 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      +.+..+....|.+...............+...........+...++.+++++.+||++||+.||.+|||++|+|+||||+
T Consensus       287 ~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  366 (432)
T 3n9x_A          287 DQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK  366 (432)
T ss_dssp             HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence            67888889999998887777777777777777777777777778889999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCcccCCCC-CCCHHHHHHHHHHHHHhcCCCC
Q 021181          271 PLHDINEEPVCPRPFSFDFEHP-SFTEENIKELIYRESVKFNPDP  314 (316)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  314 (316)
                      +++....++.+..++...+... .+++++++.++.+|...|.|..
T Consensus       367 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  411 (432)
T 3n9x_A          367 DVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPEL  411 (432)
T ss_dssp             TTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred             hccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCccc
Confidence            9998888888877777777664 5899999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-53  Score=391.27  Aligned_cols=313  Identities=41%  Similarity=0.788  Sum_probs=265.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |+.+|+.||||++............+.+|+.+++.++||||+++++++.....+....+|+|||+++|+|.+++.....+
T Consensus        74 ~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l  153 (458)
T 3rp9_A           74 DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYL  153 (458)
T ss_dssp             ECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCC
T ss_pred             ECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCC
Confidence            56799999999998766677777889999999999999999999999976554555779999999999999999998899


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----------------------
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----------------------  138 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----------------------  138 (316)
                      ++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++......                       
T Consensus       154 ~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (458)
T 3rp9_A          154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT  233 (458)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC----------------
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccccc
Confidence            999999999999999999999999999999999999999999999999997754221                       


Q ss_pred             -----ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-----------CCCCCCCCC--------------
Q 021181          139 -----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-----------RQPLFPGKD--------------  188 (316)
Q Consensus       139 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-----------g~~pf~~~~--------------  188 (316)
                           .....++|++|+|||++.....++.++|||||||++|||++           |.++|.+.+              
T Consensus       234 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~  313 (458)
T 3rp9_A          234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDF  313 (458)
T ss_dssp             -----------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-----------------
T ss_pred             ccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccc
Confidence                 22345679999999987655779999999999999999998           778887654              


Q ss_pred             ------cHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHH
Q 021181          189 ------YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE  262 (316)
Q Consensus       189 ------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e  262 (316)
                            ..+.+..+....|.+....+..........+....+......+...++..++++.+||++||..||.+|||++|
T Consensus       314 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e  393 (458)
T 3rp9_A          314 KFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE  393 (458)
T ss_dssp             ---CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHH
Confidence                  25677788888999988877777777777788888777778888889999999999999999999999999999


Q ss_pred             HhcCCCCCCCCCCCCCCCCCCCCcccCCC-CCCCHHHHHHHHHHHHHhcCCCC
Q 021181          263 ALCHPYLAPLHDINEEPVCPRPFSFDFEH-PSFTEENIKELIYRESVKFNPDP  314 (316)
Q Consensus       263 ll~~~~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  314 (316)
                      +|+||||++++....++.+..+....+.. .+++.+++++.+.++..+|.|..
T Consensus       394 ~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  446 (458)
T 3rp9_A          394 CLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEI  446 (458)
T ss_dssp             HHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCTTC
T ss_pred             HhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCccc
Confidence            99999999999877777766666655554 35888999999999999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-54  Score=380.18  Aligned_cols=233  Identities=24%  Similarity=0.325  Sum_probs=195.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++.....       .+|+.+++.++|||||++++++.+.     ..+|||||||+ |+|.++++..+.
T Consensus        79 ~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~  146 (336)
T 4g3f_A           79 DKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREG-----PWVNIFMELLEGGSLGQLIKQMGC  146 (336)
T ss_dssp             ETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSS
T ss_pred             ECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHcCC
Confidence            6789999999999764322       3799999999999999999999654     56999999996 799999998899


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCCc------cccccccccccCcc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDF------MTEYVVTRWYRAPE  153 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~------~~~~~~~~~~~aPE  153 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+++.......      ....+||+.|+|||
T Consensus       147 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE  226 (336)
T 4g3f_A          147 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE  226 (336)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHH
Confidence            99999999999999999999999999999999999999987 599999999987654321      23357999999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      ++.+ ..++.++|||||||++|||++|++||.+.+.......+...  .++                          +..
T Consensus       227 ~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~--------------------------~~~  277 (336)
T 4g3f_A          227 VVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP--------------------------IRE  277 (336)
T ss_dssp             HHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG--------------------------GGG
T ss_pred             HHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC--------------------------chh
Confidence            9987 78999999999999999999999999887765555555431  100                          112


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEA-------------LCHPYLAPLHDI  275 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~el-------------l~~~~f~~~~~~  275 (316)
                      ..+.+|+++.++|.+||+.||.+|||+.||             ++|||+.++.+.
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            234689999999999999999999999998             579999887543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-52  Score=376.11  Aligned_cols=308  Identities=44%  Similarity=0.836  Sum_probs=264.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++............+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+++.. ..
T Consensus        46 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~  124 (367)
T 1cm8_A           46 DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EK  124 (367)
T ss_dssp             ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CC
T ss_pred             ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CC
Confidence            56899999999997766666677889999999999999999999999976431 23356799999998899999876 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  .....+|.+|+|||++.+...
T Consensus       125 l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~  202 (367)
T 1cm8_A          125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMR  202 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCC
Confidence            999999999999999999999999999999999999999999999999999876433  345678999999999887667


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++||||+||++|+|++|++||.+.+..+.+..+....+.++..............+....+......+....+..++
T Consensus       203 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (367)
T 1cm8_A          203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP  282 (367)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH
T ss_pred             CChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence            89999999999999999999999999999999999999999998877777777777788888888888888888889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD  313 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (316)
                      .+.+||.+||+.||.+|||++|+++||||+++++...++.+. ++..+++....+.++++.++.++.+.|.|.
T Consensus       283 ~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (367)
T 1cm8_A          283 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPP  354 (367)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC-
T ss_pred             HHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-CCCCChhhhcCCHHHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999999999888777765 567777777788899999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-52  Score=376.65  Aligned_cols=309  Identities=50%  Similarity=0.910  Sum_probs=260.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC-CCCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++............+.+|+.+++.++||||+++++++.... .+....+|++|++++++|.+++.. ..
T Consensus        50 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~  128 (367)
T 2fst_X           50 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QK  128 (367)
T ss_dssp             ETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------CC
T ss_pred             ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CC
Confidence            5688999999999876666667788899999999999999999999987542 123356899999999999988865 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  .....++.+|+|||++.+...
T Consensus       129 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~  206 (367)
T 2fst_X          129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMH  206 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcC
Confidence            999999999999999999999999999999999999999999999999998765432  345678999999999877667


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|++||.+.+..+.+..+....+.+...............+.......+...+...++..++
T Consensus       207 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (367)
T 2fst_X          207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  286 (367)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCH
Confidence            89999999999999999999999999999999999999999988877777777777778888888777778888889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP  314 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (316)
                      .+.+||++||+.||.+|||++|+|+||||+++....+++.+. ++..++.......+.+++++..+...|.|.+
T Consensus       287 ~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  359 (367)
T 2fst_X          287 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP  359 (367)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CCCGGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred             HHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CCCcchhhccCCHHHHHHHHHHHHHHhccCc
Confidence            999999999999999999999999999999999888877766 7888888888999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.3e-52  Score=375.78  Aligned_cols=307  Identities=41%  Similarity=0.767  Sum_probs=248.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++............+.+|+.+++.+. ||||+++++++...+   ...+|+||||++|+|.+++.. ..
T Consensus        30 ~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~-~~  105 (388)
T 3oz6_A           30 DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRA-NI  105 (388)
T ss_dssp             ETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SSCEEEEEECCSEEHHHHHHH-TC
T ss_pred             ECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CCEEEEEecccCcCHHHHHHc-CC
Confidence            5789999999999877667777888999999999997 999999999997543   256999999999999999876 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC----------------------C
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET----------------------D  138 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----------------------~  138 (316)
                      +++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....                      .
T Consensus       106 ~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (388)
T 3oz6_A          106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP  185 (388)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-----------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999999999999999999999998765321                      1


Q ss_pred             ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHH
Q 021181          139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR  218 (316)
Q Consensus       139 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  218 (316)
                      .....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+...............
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~  265 (388)
T 3oz6_A          186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKT  265 (388)
T ss_dssp             ----CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence            12345789999999999876778999999999999999999999999999999999999988888766554433333322


Q ss_pred             HhhhCCCCC---CCCccccC-------------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 021181          219 YVRMLPQFP---KQNFSARF-------------PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP  282 (316)
Q Consensus       219 ~~~~~~~~~---~~~~~~~~-------------~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~  282 (316)
                      +........   ...+...+             ..+++++.+||.+||+.||.+|||++|+++||||+.++....++.+.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~  345 (388)
T 3oz6_A          266 MIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCD  345 (388)
T ss_dssp             HHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCS
T ss_pred             HHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCC
Confidence            222211110   11111111             26789999999999999999999999999999999999999999988


Q ss_pred             CCCcccCCC-CCCCHHHHHHHHHHHHHhcCC
Q 021181          283 RPFSFDFEH-PSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       283 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      ..+.+.+.. ...+.+++++++..+..+|.|
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (388)
T 3oz6_A          346 HIITIPINDNVKHSIDDYRNLVYSEISRRKR  376 (388)
T ss_dssp             SCCCCC------CCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCccccccCCHHHHHHHHHHHHHHhhh
Confidence            888877764 347788999999999988865

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.4e-51  Score=366.80  Aligned_cols=310  Identities=53%  Similarity=0.927  Sum_probs=263.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |..+|+.||||++... ........+.+|+.++++++||||+++++++.....+.....|+|||+++|+|.+++.. +.+
T Consensus        48 ~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~  125 (364)
T 3qyz_A           48 DNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHL  125 (364)
T ss_dssp             ETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-CCC
T ss_pred             ECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-CCC
Confidence            5678999999999753 34445577899999999999999999999997654444567999999999999999876 569


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+........    .....+++.|+|||++.+
T Consensus       126 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  205 (364)
T 3qyz_A          126 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN  205 (364)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC
Confidence            9999999999999999999999999999999999999999999999999976543321    234578999999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+...............+....+......+....+.
T Consensus       206 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (364)
T 3qyz_A          206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN  285 (364)
T ss_dssp             BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTT
T ss_pred             CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCC
Confidence            56789999999999999999999999999999999999999999888766655555555555555555555566667778


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD  313 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (316)
                      +++++.+||.+||+.||.+|||++|+++||||+++.....++....++.++....++..+++++++.++..+|.|.
T Consensus       286 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~  361 (364)
T 3qyz_A          286 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG  361 (364)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC-----CCHHHHHHHHHHHTGGGCC-
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCcccccccCCHHHHHHHHHHHHHHhhhh
Confidence            9999999999999999999999999999999999988888888888999998888999999999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-51  Score=364.37  Aligned_cols=259  Identities=28%  Similarity=0.462  Sum_probs=196.5

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ..+++.||||++....    ....+.+|+++++.+ +||||++++++|...     .++|+|||||+ |+|.+++.   .
T Consensus        46 ~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-----~~~~lvmE~~~g~~L~~~~~---~  113 (361)
T 4f9c_A           46 VGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-----DHVVIAMPYLEHESFLDILN---S  113 (361)
T ss_dssp             TSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-----TEEEEEEECCCCCCHHHHHT---T
T ss_pred             CCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-----CEEEEEEeCCCcccHHHHHc---C
Confidence            4678999999986432    345678999999998 699999999999654     57999999996 69999983   6


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCC---------------------
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETD---------------------  138 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~---------------------  138 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......                     
T Consensus       114 l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (361)
T 4f9c_A          114 LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC  193 (361)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999877 799999999997543221                     


Q ss_pred             --------ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHhhCCCCcccc-
Q 021181          139 --------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSL-  208 (316)
Q Consensus       139 --------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~-  208 (316)
                              .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||.. .+..+++..|....|.+..... 
T Consensus       194 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~  273 (361)
T 4f9c_A          194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAA  273 (361)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhh
Confidence                    123457999999999998766789999999999999999999999855 4666777788777664322110 


Q ss_pred             ----------ccccccchHHHhhhCC-------CCC-----CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          209 ----------GFLRSDNARRYVRMLP-------QFP-----KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       209 ----------~~~~~~~~~~~~~~~~-------~~~-----~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                ................       ...     ..........+|+++.+||++||+.||++|+|++|+|+|
T Consensus       274 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          274 KTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             hhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                      0000111111111000       000     001122345789999999999999999999999999999


Q ss_pred             CCCCCCC
Q 021181          267 PYLAPLH  273 (316)
Q Consensus       267 ~~f~~~~  273 (316)
                      |||+++.
T Consensus       354 p~f~~i~  360 (361)
T 4f9c_A          354 PFFKDMS  360 (361)
T ss_dssp             GGGTTC-
T ss_pred             cccCCCC
Confidence            9999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.6e-51  Score=375.52  Aligned_cols=307  Identities=43%  Similarity=0.777  Sum_probs=237.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++............+.+|+.+++.++||||+++++++..... +....+|+||||++++|.+.+..  .
T Consensus        83 ~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~  160 (464)
T 3ttj_A           83 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--E  160 (464)
T ss_dssp             ETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--C
T ss_pred             ECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--c
Confidence            57789999999998776677777889999999999999999999999975532 34467899999999999888764  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.............+|+.|+|||++.+ ..
T Consensus       161 l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  239 (464)
T 3ttj_A          161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MG  239 (464)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT-CC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC-CC
Confidence            99999999999999999999999999999999999999999999999999988776655667789999999999988 67


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC--
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK--  238 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (316)
                      ++.++|||||||++|+|++|++||.+.+..+.+..+....|.+......... .....+....+......+...++..  
T Consensus       240 ~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (464)
T 3ttj_A          240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLF  318 (464)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGS
T ss_pred             CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-hhhhhHhhcccccCCCChHHhCccccc
Confidence            9999999999999999999999999999999999999999988766554332 2233344444333333333333221  


Q ss_pred             ----------ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC-CCCCCCCcccCCCCCCCHHHHHHHHHHHH
Q 021181          239 ----------SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE-PVCPRPFSFDFEHPSFTEENIKELIYRES  307 (316)
Q Consensus       239 ----------s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (316)
                                ++++.+||++||+.||++|||++|+|+||||+.+.+..+. ......+..++.....+.+++++++.++.
T Consensus       319 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  398 (464)
T 3ttj_A          319 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV  398 (464)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHH
T ss_pred             ccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHH
Confidence                      5679999999999999999999999999999987754432 23334455566666788889999999998


Q ss_pred             HhcCC
Q 021181          308 VKFNP  312 (316)
Q Consensus       308 ~~~~~  312 (316)
                      ..|..
T Consensus       399 ~~~~~  403 (464)
T 3ttj_A          399 MNSEE  403 (464)
T ss_dssp             HC---
T ss_pred             HHhhh
Confidence            87764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.6e-50  Score=362.02  Aligned_cols=307  Identities=46%  Similarity=0.860  Sum_probs=266.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++............+.+|+.+++.++||||+++++++..... .....+++||||++++|.+.+..  .
T Consensus        63 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~  140 (371)
T 4exu_A           63 DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM--E  140 (371)
T ss_dssp             ETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS--C
T ss_pred             ECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhc--C
Confidence            56789999999998766666677889999999999999999999999976532 12234599999999999988743  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+......  .....+++.|+|||++.+...
T Consensus       141 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~  218 (371)
T 4exu_A          141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMH  218 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCC
Confidence            999999999999999999999999999999999999999999999999998765433  344577999999999877567


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|..||.+.+..+.+..+....+.+...............+.......+...+....+.+++
T Consensus       219 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
T 4exu_A          219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASP  298 (371)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCH
T ss_pred             CCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccCh
Confidence            89999999999999999999999999999999999999999888777766666666777777777777777777888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      .+.+||++||+.||.+|||++|+++||||+++...........++.........+.+++++.+.++.+.|.|
T Consensus       299 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          299 QAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999999998887777888888888888889999999999999999988

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.3e-52  Score=360.67  Aligned_cols=238  Identities=24%  Similarity=0.403  Sum_probs=181.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-------CCCCeEEEEEecCC-CcHHH
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-------ETFNDVYIVYELMD-TDLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-------~~~~~~~iv~e~~~-g~L~~   73 (316)
                      |+.+|+.||||+++... .+...+.+.+|+.++++++|||||+++++|...+.       .....+|+|||||+ |+|.+
T Consensus        26 ~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~  104 (299)
T 4g31_A           26 NKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD  104 (299)
T ss_dssp             ETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHH
T ss_pred             ECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHH
Confidence            57899999999997542 44455778999999999999999999999875431       11235799999996 79999


Q ss_pred             HhhcCCCC---CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----------
Q 021181           74 IIRSHQDL---TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----------  139 (316)
Q Consensus        74 ~l~~~~~~---~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----------  139 (316)
                      ++.....+   ....++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......           
T Consensus       105 ~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~  184 (299)
T 4g31_A          105 WMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY  184 (299)
T ss_dssp             HHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-------------------
T ss_pred             HHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccc
Confidence            99876554   4566889999999999999999999999999999999999999999999987644321           


Q ss_pred             --cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchH
Q 021181          140 --MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR  217 (316)
Q Consensus       140 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (316)
                        ....+||+.|+|||++.+ ..++.++|||||||++|||++   ||.+.  .+....+........             
T Consensus       185 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~-------------  245 (299)
T 4g31_A          185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKF-------------  245 (299)
T ss_dssp             -------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCC-------------
T ss_pred             cccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCC-------------
Confidence              234579999999999987 789999999999999999996   67543  222222222221111             


Q ss_pred             HHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                    +...+..++.+.+||++||+.||.+|||+.|+++||||++++
T Consensus       246 --------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          246 --------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             --------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             --------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence                          011123466788999999999999999999999999999865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.1e-51  Score=354.64  Aligned_cols=229  Identities=26%  Similarity=0.394  Sum_probs=191.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      ..+|+.||||+++..  +....+.+.+|+.++++++|||||++++++.+.     ..+|||||||+ |+|.++|...   
T Consensus        40 ~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~  112 (299)
T 4asz_A           40 EQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPD  112 (299)
T ss_dssp             ---CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHTSHH
T ss_pred             CCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCcc
Confidence            467899999999753  445567899999999999999999999999765     45999999996 7999999764   


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccc
Q 021181           79 ----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVV  145 (316)
Q Consensus        79 ----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~  145 (316)
                                ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......   .....+
T Consensus       113 ~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~g  192 (299)
T 4asz_A          113 AVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML  192 (299)
T ss_dssp             HHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEE
T ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceec
Confidence                      3699999999999999999999999999999999999999999999999999986544322   233568


Q ss_pred             cccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCC
Q 021181          146 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP  224 (316)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (316)
                      |+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+......+                     
T Consensus       193 t~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------  250 (299)
T 4asz_A          193 PIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ---------------------  250 (299)
T ss_dssp             CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC---------------------
T ss_pred             ChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence            999999999987 789999999999999999998 899999988777776665422111                     


Q ss_pred             CCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       225 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                               ....+|+++.+|+.+||+.||++|||+++|+  +|+++
T Consensus       251 ---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          251 ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             ---------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence                     1125789999999999999999999999984  34443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=350.98  Aligned_cols=228  Identities=21%  Similarity=0.290  Sum_probs=185.1

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~   84 (316)
                      ..||||+++....+....+.+.+|+.++++++|||||++++++..+      .+|||||||+ |+|.+++... .++++.
T Consensus        59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~------~~~iVmEy~~gGsL~~~l~~~~~~l~~~  132 (307)
T 3omv_A           59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD------NLAIVTQWCEGSSLYKHLHVQETKFQMF  132 (307)
T ss_dssp             SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEEEEECCSSCBHHHHHHTSCCCCCHH
T ss_pred             CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC------eEEEEEEcCCCCCHHHHHhhcCCCCCHH
Confidence            4699999987666666778899999999999999999999987532      3799999996 7999999754 579999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---CccccccccccccCcccccC--CC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLN--CS  159 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~--~~  159 (316)
                      ++..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....   ......+||+.|+|||++.+  ..
T Consensus       133 ~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~  212 (307)
T 3omv_A          133 QLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN  212 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC
T ss_pred             HHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC
Confidence            99999999999999999999999999999999999999999999999875432   22345689999999999864  24


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|||++|+.||.+.+....+..+.......+                         ........++
T Consensus       213 ~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p-------------------------~~~~~~~~~~  267 (307)
T 3omv_A          213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP-------------------------DLSKLYKNCP  267 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-------------------------CSTTSCTTSC
T ss_pred             CCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-------------------------Ccccccccch
Confidence            689999999999999999999999988776665554433211111                         1112234688


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +++.+|+.+||+.||++|||+.||++
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999997643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=355.82  Aligned_cols=227  Identities=24%  Similarity=0.373  Sum_probs=184.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+|+.||||+++..  +....+.+.+|+.++++++|||||++++++.+.     ..+|||||||+ |+|.+++...  
T Consensus        67 ~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~  139 (329)
T 4aoj_A           67 PEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGP  139 (329)
T ss_dssp             C---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTSSC
T ss_pred             cCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHHhcCc
Confidence            4568999999999753  455667899999999999999999999999755     45999999996 7999998753  


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---cccc
Q 021181           79 -------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE  142 (316)
Q Consensus        79 -------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~  142 (316)
                                   +++++.++..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......   ....
T Consensus       140 ~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~  219 (329)
T 4aoj_A          140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR  219 (329)
T ss_dssp             C-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------
T ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCc
Confidence                         358999999999999999999999999999999999999999999999999998754432   2234


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                      ..+|+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+.+..+.......                  
T Consensus       220 ~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~------------------  280 (329)
T 4aoj_A          220 TMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE------------------  280 (329)
T ss_dssp             CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCC------------------
T ss_pred             ccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence            578999999999987 789999999999999999998 899999988777776665422111                  


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                  ....+++++.+|+.+||+.||++|||++||+++
T Consensus       281 ------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          281 ------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             ------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             ------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                        112578999999999999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.8e-50  Score=356.17  Aligned_cols=307  Identities=46%  Similarity=0.857  Sum_probs=261.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |+.+|+.||||++............+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+.+..  .
T Consensus        45 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~  122 (353)
T 3coi_A           45 DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL--K  122 (353)
T ss_dssp             ETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTS--C
T ss_pred             ECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhcC--C
Confidence            56789999999998766666667888999999999999999999999975432 12234699999999999887754  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.+++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||.+......  .....++..|+|||++.+...
T Consensus       123 ~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~  200 (353)
T 3coi_A          123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMH  200 (353)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCC
Confidence            999999999999999999999999999999999999999999999999998765433  234577999999999877567


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+...............+....+..+...+....+.+++
T Consensus       201 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (353)
T 3coi_A          201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASP  280 (353)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCH
Confidence            89999999999999999999999999998888888888888877766655555555566666666666666677778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      ++.++|.+||+.||.+|||++++++||||+.+......+....++.........+.+++++.|.++.+.|-|
T Consensus       281 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          281 QAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence            999999999999999999999999999999998877777777788888888889999999999999999977

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.9e-51  Score=383.43  Aligned_cols=238  Identities=25%  Similarity=0.369  Sum_probs=194.3

Q ss_pred             CCCCCceEEEEEeccccc----ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFD----NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      ++.||+.||||++++...    ..........++.+++.++|||||+++++|.+.     ..+|+|||||. |+|.++|.
T Consensus       210 ~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-----~~lylVmEy~~GGdL~~~l~  284 (689)
T 3v5w_A          210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLS  284 (689)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHH
T ss_pred             ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHH
Confidence            578999999999975421    111222333456777788999999999999655     56999999996 79999999


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ....+||+.|+|||++.
T Consensus       285 ~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~  363 (689)
T 3v5w_A          285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ  363 (689)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHS
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHh
Confidence            98999999999999999999999999999999999999999999999999999998765543 35678999999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +...|+.++|+|||||++|||++|.+||.+.+................                            ....
T Consensus       364 ~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~----------------------------~~p~  415 (689)
T 3v5w_A          364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----------------------------ELPD  415 (689)
T ss_dssp             TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC----------------------------CCCT
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC----------------------------CCCc
Confidence            646799999999999999999999999976533222221111111110                            0113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      .+|+++++||.+||+.||.+|++     ++||++||||++++
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            57999999999999999999998     79999999999987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-50  Score=380.84  Aligned_cols=240  Identities=26%  Similarity=0.443  Sum_probs=208.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      |+.||+.||||++...  .......+.+|+.+|+.++||||++++++|.+.     ..+|+|||||+ |+|.++|.. .+
T Consensus       178 ~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~  250 (573)
T 3uto_A          178 ERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHN  250 (573)
T ss_dssp             ETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHHTCTTS
T ss_pred             ECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHHHhCC
Confidence            5789999999999654  344567788999999999999999999999654     57999999996 799998864 46


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC--CCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++.+++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+++...........+||+.|+|||++.+
T Consensus       251 ~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~  330 (573)
T 3uto_A          251 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG  330 (573)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC
Confidence            79999999999999999999999999999999999999854  8999999999998877766677889999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+.                           ...+.
T Consensus       331 -~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~  382 (573)
T 3uto_A          331 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------------------------SAFSG  382 (573)
T ss_dssp             -CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS---------------------------GGGTT
T ss_pred             -CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc---------------------------ccccC
Confidence             78999999999999999999999999999888877776553322221                           22246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      +|+++++||++||+.||.+|||++|+|+||||+..+...
T Consensus       383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            899999999999999999999999999999999866433

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-50  Score=351.21  Aligned_cols=228  Identities=21%  Similarity=0.337  Sum_probs=189.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+++.||||+++... .....+.+.+|+.++++++|||||+++|++...     ..+++|||||+ |+|.++|...  
T Consensus        52 ~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~  125 (308)
T 4gt4_A           52 PGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSP  125 (308)
T ss_dssp             ----CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCSSCBHHHHHHTTCS
T ss_pred             cCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-----CEEEEEEEcCCCCcHHHHHHhhCc
Confidence            34678999999997543 334557799999999999999999999999755     45899999996 7999999653  


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccc
Q 021181           79 --------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMT  141 (316)
Q Consensus        79 --------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~  141 (316)
                                    ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......   ...
T Consensus       126 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~  205 (308)
T 4gt4_A          126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG  205 (308)
T ss_dssp             SCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSS
T ss_pred             cccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEec
Confidence                          358999999999999999999999999999999999999999999999999997654322   234


Q ss_pred             cccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHh
Q 021181          142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV  220 (316)
Q Consensus       142 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  220 (316)
                      ...+|+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+......+                 
T Consensus       206 ~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------  267 (308)
T 4gt4_A          206 NSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP-----------------  267 (308)
T ss_dssp             SSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC-----------------
T ss_pred             ccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence            5678999999999987 789999999999999999998 899999988777766654321111                 


Q ss_pred             hhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          221 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                   ....+++++.+++.+||+.||++|||++||+++
T Consensus       268 -------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          268 -------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                         113578999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-48  Score=344.86  Aligned_cols=240  Identities=25%  Similarity=0.434  Sum_probs=208.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++.....+......+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...+.
T Consensus        36 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  110 (328)
T 3fe3_A           36 HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGR  110 (328)
T ss_dssp             ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCC
T ss_pred             ECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEEEECCCCCcHHHHHHHcCC
Confidence            567999999999987766666778899999999999999999999999654     56999999995 799999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++............++++.|+|||++.+...
T Consensus       111 l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  190 (328)
T 3fe3_A          111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY  190 (328)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCc
Confidence            99999999999999999999999999999999999999999999999999987766655667789999999999987444


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      .+.++|||||||++|+|++|..||.+.+.......+.......+                               ..+++
T Consensus       191 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p-------------------------------~~~s~  239 (328)
T 3fe3_A          191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-------------------------------FYMST  239 (328)
T ss_dssp             CSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------------------------TTSCH
T ss_pred             CCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------------------------CCCCH
Confidence            46899999999999999999999998887766665544211111                               24688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      ++.++|++||+.||.+|||++|+++||||+.......
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~  276 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE  276 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCC
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccc
Confidence            9999999999999999999999999999998765443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3e-48  Score=340.46  Aligned_cols=264  Identities=38%  Similarity=0.695  Sum_probs=214.4

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLT   82 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~   82 (316)
                      .+|+.||||++............+.+|+.++++++||||+++++++...     ..+++||||++|+|.+.+... ..++
T Consensus        43 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~  117 (311)
T 3niz_A           43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQ  117 (311)
T ss_dssp             TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----SCEEEEEECCSEEHHHHHHTCTTCCC
T ss_pred             CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----CEEEEEEcCCCCCHHHHHHhccCCCC
Confidence            4689999999977655555567888999999999999999999999654     569999999999998888765 4599


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      +.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .......++..|+|||++.+...+
T Consensus       118 ~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  197 (311)
T 3niz_A          118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY  197 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCC
Confidence            9999999999999999999999999999999999999999999999999876533 223445779999999998775678


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          162 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      +.++|||||||++|+|++|.+||.+....+....+....+.+....+.......... ...........+....+.++++
T Consensus       198 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  276 (311)
T 3niz_A          198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK-QRTFQVFEKKPWSSIIPGFCQE  276 (311)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH-SCCCCCCCCCCHHHHSTTCCHH
T ss_pred             CchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh-hcccccccCCcHHHhCcccCHH
Confidence            999999999999999999999999998888899998888887776555433222111 1111122223344455678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +.+||++||+.||.+|||++|+++||||++++
T Consensus       277 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          277 GIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            99999999999999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.3e-48  Score=343.18  Aligned_cols=305  Identities=52%  Similarity=0.918  Sum_probs=246.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      +..+|+.||||++... ........+.+|+.+++.++||||+++++++...........++||||++|+|.+++.. +.+
T Consensus        32 ~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~  109 (353)
T 2b9h_A           32 HKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QML  109 (353)
T ss_dssp             ETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-CCC
T ss_pred             ECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-cCC
Confidence            4678999999999643 34445677889999999999999999999987654344567999999999999999876 579


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----------ccccccccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----------MTEYVVTRWYR  150 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~  150 (316)
                      ++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........           .....++..|+
T Consensus       110 ~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  189 (353)
T 2b9h_A          110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR  189 (353)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccccccc
Confidence            9999999999999999999999999999999999999999999999999876543211           12346799999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCcccc-ccccccchHHHhhhCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      |||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+.+..... ..........+.......+..
T Consensus       190 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (353)
T 2b9h_A          190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAA  269 (353)
T ss_dssp             CHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCC
T ss_pred             CCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCc
Confidence            9999876577899999999999999999999999999988888888888777653322 222233334455555555555


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC----CCCCCCcccCCCCCCCHHHHHHHHHH
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP----VCPRPFSFDFEHPSFTEENIKELIYR  305 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (316)
                      .+....+.+++++.++|++||+.||++|||++|+++||||+.+......+    ..+..+..+.....++.+++++++.+
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (353)
T 2b9h_A          270 PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWN  349 (353)
T ss_dssp             CHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHH
T ss_pred             chhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHH
Confidence            55666678999999999999999999999999999999999987555433    22233555666677999999999998


Q ss_pred             HHH
Q 021181          306 ESV  308 (316)
Q Consensus       306 ~~~  308 (316)
                      +..
T Consensus       350 ~~~  352 (353)
T 2b9h_A          350 EIF  352 (353)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-48  Score=349.82  Aligned_cols=308  Identities=44%  Similarity=0.751  Sum_probs=229.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++............+.+|+.+++.++||||+++++++..... +....+|+||||++|+|.+.+..  .
T Consensus        46 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~  123 (371)
T 2xrw_A           46 DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--E  123 (371)
T ss_dssp             ETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS--C
T ss_pred             ECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh--c
Confidence            56789999999998765566677888999999999999999999999975431 23357999999999999998864  6


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.............++..|+|||++.+ ..
T Consensus       124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  202 (371)
T 2xrw_A          124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MG  202 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTT-CC
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcC-CC
Confidence            89999999999999999999999999999999999999999999999999987665544556788999999999987 67


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC----
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP----  236 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  236 (316)
                      ++.++|||||||++|+|++|..||.+.+.......+....+.+.......... ....+....+......+...++    
T Consensus       203 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (371)
T 2xrw_A          203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLF  281 (371)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH-HHHHHHHSSCCCCCCCHHHHSCGGGS
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh-HHHHHHhhCccccccchhhhcccccC
Confidence            89999999999999999999999999988888888877777665443322211 1111222222222111111111    


Q ss_pred             --------CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC-CCCCCCcccCCCCCCCHHHHHHHHHHHH
Q 021181          237 --------NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP-VCPRPFSFDFEHPSFTEENIKELIYRES  307 (316)
Q Consensus       237 --------~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (316)
                              ..+.++.+||++||+.||.+|||++|+++||||+.+.+..... ..+.....+......+.+++++++..+.
T Consensus       282 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
T 2xrw_A          282 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEV  361 (371)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHH
T ss_pred             cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHH
Confidence                    1256799999999999999999999999999999876433211 1122223345556678889999999999


Q ss_pred             HhcCCC
Q 021181          308 VKFNPD  313 (316)
Q Consensus       308 ~~~~~~  313 (316)
                      .+||--
T Consensus       362 ~~~~~~  367 (371)
T 2xrw_A          362 MDLEHH  367 (371)
T ss_dssp             HHHCC-
T ss_pred             HHHhhh
Confidence            999853

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-48  Score=346.45  Aligned_cols=227  Identities=25%  Similarity=0.400  Sum_probs=187.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCC-CCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      .+++.||||+++... .....+.+.+|+.+++++.| ||||+++++|...+    ..++||||||+ |+|.++|+..   
T Consensus        92 ~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~  166 (353)
T 4ase_A           92 ATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNE  166 (353)
T ss_dssp             TCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGG
T ss_pred             cCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccc
Confidence            456889999997643 34456779999999999965 99999999986542    45899999996 7999999753   


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccc
Q 021181           79 -------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTE  142 (316)
Q Consensus        79 -------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~  142 (316)
                                   ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......   ...
T Consensus       167 ~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~  246 (353)
T 4ase_A          167 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  246 (353)
T ss_dssp             BCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETT
T ss_pred             cccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeecc
Confidence                         3489999999999999999999999999999999999999999999999999987654332   234


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH-HHHHhhCCCCccccccccccchHHHh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLR-LITELIGSPDETSLGFLRSDNARRYV  220 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~  220 (316)
                      ..+|+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+....+. .+..... +.                
T Consensus       247 ~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~----------------  308 (353)
T 4ase_A          247 ARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MR----------------  308 (353)
T ss_dssp             EEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CC----------------
T ss_pred             ccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-CC----------------
Confidence            678999999999987 789999999999999999998 999998876544433 3322111 10                


Q ss_pred             hhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          221 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                   ....+++++.+++.+||+.||++|||++||++|
T Consensus       309 -------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          309 -------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                         112578999999999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-47  Score=333.32  Aligned_cols=265  Identities=37%  Similarity=0.631  Sum_probs=214.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      ++.+|+.||||+++...........+.+|+.++++++||||+++++++...     ..+++||||++|++.+.+.. .+.
T Consensus        23 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   97 (292)
T 3o0g_A           23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGD   97 (292)
T ss_dssp             ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTC
T ss_pred             ECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEEEEEEecCCCCHHHHHHhCCCC
Confidence            567899999999987666666678889999999999999999999999654     56999999999888776655 578


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+...... .......++..|+|||++.+..
T Consensus        98 l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  177 (292)
T 3o0g_A           98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCC
Confidence            999999999999999999999999999999999999999999999999999876533 2334567899999999998756


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPL-FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|+|++|..| |.+.+.......+....+.+....+.........  ................+.+
T Consensus       178 ~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  255 (292)
T 3o0g_A          178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY--KPYPMYPATTSLVNVVPKL  255 (292)
T ss_dssp             CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC--CCCCCCCTTCCCTTTSTTC
T ss_pred             CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc--cccccccCCcchhhccccc
Confidence            689999999999999999987665 6677777888888888887776655432211100  0000000112233344578


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ++++.+||++||+.||++|||++|+++||||+++.
T Consensus       256 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            99999999999999999999999999999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=334.50  Aligned_cols=267  Identities=34%  Similarity=0.567  Sum_probs=214.3

Q ss_pred             CCCCCceEEEEEecccccC---hhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHh
Q 021181            2 NSETREEVAIKKIGNAFDN---RIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII   75 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l   75 (316)
                      |..+|+.||||++......   ......+.+|+.+++.+   +||||+++++++..........++++||+++|+|.+++
T Consensus        30 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~  109 (308)
T 3g33_A           30 DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL  109 (308)
T ss_dssp             CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHH
T ss_pred             ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHH
Confidence            6789999999999754321   11223456777777666   59999999999976542233468999999999999999


Q ss_pred             hcCCC--CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           76 RSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        76 ~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                      .....  +++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.............+|..|+|||
T Consensus       110 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  189 (308)
T 3g33_A          110 DKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPE  189 (308)
T ss_dssp             HTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHH
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCch
Confidence            87654  9999999999999999999999999999999999999999999999999998776666666778899999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      ++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....+.++...+.........    ............
T Consensus       190 ~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  264 (308)
T 3g33_A          190 VLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG----AFPPRGPRPVQS  264 (308)
T ss_dssp             HHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGG----GSCCCCCCCHHH
T ss_pred             HHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccc----ccCCCCCCcHHH
Confidence            9987 67899999999999999999999999999999999999888887776655432221111    111122223344


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..+.+++.+.++|.+||+.||.+|||++|+|+||||++..
T Consensus       265 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          265 VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            4567899999999999999999999999999999998754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.5e-47  Score=341.34  Aligned_cols=307  Identities=38%  Similarity=0.690  Sum_probs=236.6

Q ss_pred             CCCceEEEEEecccccC---------hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHH
Q 021181            4 ETREEVAIKKIGNAFDN---------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQI   74 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~   74 (316)
                      .+|+.||||++......         ......+.+|+.++++++||||+++++++..........+|+||||++|+|.+.
T Consensus        44 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  123 (362)
T 3pg1_A           44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV  123 (362)
T ss_dssp             TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHH
T ss_pred             CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHH
Confidence            35899999999654322         223477899999999999999999999987554344467999999999999988


Q ss_pred             hhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           75 IRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        75 l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                      +... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.............++..|+|||
T Consensus       124 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE  203 (362)
T 3pg1_A          124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPE  203 (362)
T ss_dssp             HHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHH
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcH
Confidence            8765 369999999999999999999999999999999999999999999999999998766555556677899999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh-hCCCCCCCCcc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR-MLPQFPKQNFS  232 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (316)
                      ++.+...++.++|||||||++|+|++|..||.+.+.......+....+.+...............+.. .....+...+.
T Consensus       204 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (362)
T 3pg1_A          204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT  283 (362)
T ss_dssp             HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH
T ss_pred             HhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH
Confidence            98775678999999999999999999999999999899999998888877665443333333333322 22333344455


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFN  311 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (316)
                      ...+.+++.+.+||.+||+.||.+|||++|+++||||+++....+..... .-..++.......+.+++++..+...|+
T Consensus       284 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~~~  361 (362)
T 3pg1_A          284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESVTDVYDMHKIFTAEVERFN  361 (362)
T ss_dssp             HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTC-CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred             hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccc-ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence            56678899999999999999999999999999999999987554433221 1223445545667789999999988876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=335.63  Aligned_cols=271  Identities=32%  Similarity=0.617  Sum_probs=209.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      +..+|+.||||++............+.+|+.++++++||||+++++++...     ...++||||+++ +|.+++...+.
T Consensus        24 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~   98 (311)
T 4agu_A           24 NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRLHLVFEYCDHTVLHELDRYQRG   98 (311)
T ss_dssp             ETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTSSC
T ss_pred             eCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeEEEEEEeCCCchHHHHHhhhcC
Confidence            567899999999977665666667888999999999999999999999654     569999999985 77788887888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.|++.||+|||+.||+||||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+..
T Consensus        99 ~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (311)
T 4agu_A           99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT  178 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCC
Confidence            999999999999999999999999999999999999999999999999999776533 2334567899999999998767


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|.+||.+.+..+....+....+..................................+.++
T Consensus       179 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 4agu_A          179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNIS  258 (311)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCC
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhccccc
Confidence            78999999999999999999999999998888888887777765543221111110000000000111112233446789


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      .++.++|++||+.||.+|||++|+++||||+++....+
T Consensus       259 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          259 YPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             HHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             HHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            99999999999999999999999999999999875544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-47  Score=331.79  Aligned_cols=262  Identities=37%  Similarity=0.644  Sum_probs=209.5

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLT   82 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~   82 (316)
                      .+|+.||||++............+.+|+.+++.++||||+++++++...     ..+++||||++++|.+++... +.++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~   98 (288)
T 1ob3_A           24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLE   98 (288)
T ss_dssp             TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCC
T ss_pred             CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEEEEEEecCCCHHHHHHhcccCCC
Confidence            5789999999976544444456788999999999999999999999654     469999999999999988764 6799


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      +..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .......++..|+|||++.+...+
T Consensus        99 ~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  178 (288)
T 1ob3_A           99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY  178 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCC
Confidence            9999999999999999999999999999999999999999999999998765432 223345679999999999775678


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          162 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      +.++|||||||++|+|++|.+||.+.+..+....+....+.+....++......  .+...........+......++++
T Consensus       179 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  256 (288)
T 1ob3_A          179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP--KYDPNFTVYEPLPWESFLKGLDES  256 (288)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTTCCCCCCCCGGGTCCSCCHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc--ccccccccccCccHHHHhhhcCHH
Confidence            999999999999999999999999998888888888887776655443221110  000111111122233444578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +.++|++||+.||++|||++|+++||||++.
T Consensus       257 ~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          257 GIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            9999999999999999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.9e-47  Score=339.52  Aligned_cols=239  Identities=29%  Similarity=0.473  Sum_probs=204.9

Q ss_pred             CCCCCceEEEEEecccccCh----hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      ++.+|+.||||+++......    .....+.+|+.+++.++||||+++++++...     ..+++||||++ |+|.+++.
T Consensus        33 ~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~  107 (361)
T 2yab_A           33 EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-----TDVVLILELVSGGELFDFLA  107 (361)
T ss_dssp             ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHT
T ss_pred             ECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-----CEEEEEEEcCCCCcHHHHHH
Confidence            56789999999997653222    2356789999999999999999999999654     56999999995 79999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC----CEEEeeeccccccCCCCccccccccccccCc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      ..+.+++.+++.++.||+.||.|||++||+||||||+||+++.++    .++|+|||++.............||+.|+||
T Consensus       108 ~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aP  187 (361)
T 2yab_A          108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP  187 (361)
T ss_dssp             TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECc
Confidence            888999999999999999999999999999999999999998877    7999999999887665555667899999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......+.                           
T Consensus       188 E~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------  239 (361)
T 2yab_A          188 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE---------------------------  239 (361)
T ss_dssp             HHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH---------------------------
T ss_pred             hHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc---------------------------
Confidence            99977 67899999999999999999999999988877776666543222111                           


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .....+++.+.+||++||..||.+|||++|+++||||+.+.
T Consensus       240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            11236789999999999999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.9e-47  Score=335.02  Aligned_cols=267  Identities=37%  Similarity=0.676  Sum_probs=213.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH---   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---   78 (316)
                      ++.+|+.||||+++... .......+.+|+.++++++||||+++++++...     ..+++||||++|+|.+++...   
T Consensus        26 ~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~   99 (317)
T 2pmi_A           26 NKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRTVG   99 (317)
T ss_dssp             CSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TEEEEEEECCCCBHHHHHHHHHSS
T ss_pred             ECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----CeEEEEEEecCCCHHHHHHhcccc
Confidence            56789999999997643 222345678999999999999999999999654     569999999999999988653   


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCccc
Q 021181           79 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        79 ---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~  154 (316)
                         ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......++..|+|||+
T Consensus       100 ~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~  179 (317)
T 2pmi_A          100 NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV  179 (317)
T ss_dssp             SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHH
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchH
Confidence               35899999999999999999999999999999999999999999999999999876533 22345578999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc---
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF---  231 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (316)
                      +.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+....+.......  .+...........+   
T Consensus       180 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  257 (317)
T 2pmi_A          180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP--KYNPNIQQRPPRDLRQV  257 (317)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT--TCCTTCCCCCCCCSHHH
T ss_pred             hhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh--hcccccccccchhHHHh
Confidence            9775678999999999999999999999999999888888888888877655443321110  00000001011111   


Q ss_pred             --cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          232 --SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       232 --~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                        ......++.++.+||.+||+.||.+|||++|+++||||+++....
T Consensus       258 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          258 LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             HGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             hcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence              111236789999999999999999999999999999999876443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-46  Score=331.57  Aligned_cols=235  Identities=26%  Similarity=0.415  Sum_probs=201.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||+++.... .......+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus        26 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~  100 (337)
T 1o6l_A           26 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRER  100 (337)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHS
T ss_pred             ECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcC
Confidence            467899999999976421 233456788999999999999999999999654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.... ........+||+.|+|||++.+ 
T Consensus       101 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-  179 (337)
T 1o6l_A          101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-  179 (337)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC-
Confidence            99999999999999999999999999999999999999999999999999987643 3334456789999999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||.+.+.......+......                               ....+
T Consensus       180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~~  228 (337)
T 1o6l_A          180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------------------------------FPRTL  228 (337)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------------------------CCTTS
T ss_pred             CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------------------------CCCCC
Confidence            67899999999999999999999999888766666555431100                               01257


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ++++.++|.+||+.||.+||     +++|+++||||++++
T Consensus       229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            89999999999999999999     899999999999876

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-47  Score=337.31  Aligned_cols=265  Identities=36%  Similarity=0.650  Sum_probs=204.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |..+|+.||||+++...........+.+|+.++++++||||+++++++...     ..+++||||++|+|.+++...+.+
T Consensus        55 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~  129 (329)
T 3gbz_A           55 DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDKNPDV  129 (329)
T ss_dssp             ETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHCTTC
T ss_pred             ECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----CEEEEEEecCCCCHHHHHhhcCCC
Confidence            567899999999987655555566778999999999999999999999654     569999999999999999998899


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc-----cCCCEEEeeeccccccCCC-CccccccccccccCcccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-----ANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~-----~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~  155 (316)
                      ++..++.++.||+.||.|||++||+||||||+||+++     .++.++|+|||++...... .......++..|+|||++
T Consensus       130 ~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  209 (329)
T 3gbz_A          130 SMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL  209 (329)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHh
Confidence            9999999999999999999999999999999999994     4455999999999775433 223445679999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc-
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR-  234 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (316)
                      .+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+........  +...........+... 
T Consensus       210 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  287 (329)
T 3gbz_A          210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD--WKQSFPKFRGKTLKRVL  287 (329)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT--CCTTCCCCCCCCHHHHH
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh--hhhhhhhhccccHhhhc
Confidence            8756689999999999999999999999999998888888888888776655433211110  0011111111111111 


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus       288 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            123789999999999999999999999999999999754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=334.47  Aligned_cols=269  Identities=36%  Similarity=0.665  Sum_probs=212.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~   80 (316)
                      +..+|+.||||+++..... .....+.+|+.+++.++||||+++++++...     ...++||||++|+|.+++... ..
T Consensus        23 ~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~   96 (324)
T 3mtl_A           23 SKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNI   96 (324)
T ss_dssp             ETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHHTTTC
T ss_pred             ECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEEEEecccccCHHHHHHhcCCC
Confidence            4678999999999654321 1112345799999999999999999999654     459999999999999988765 45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ......++..|+|||++.+..
T Consensus        97 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  176 (324)
T 3mtl_A           97 INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST  176 (324)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCC
Confidence            9999999999999999999999999999999999999999999999999987654332 234457799999999987767


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|.+||.+.+..+....+....+.+....+.......... ....+...........+.++
T Consensus       177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  255 (324)
T 3mtl_A          177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-TYNYPKYRAEALLSHAPRLD  255 (324)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH-HTCCCCCCCCCHHHHCTTSC
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc-ccccccccchhhhhhcCCCC
Confidence            78999999999999999999999999999999999999999988776665433221111 11122222333344556789


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      +++.+||.+||+.||.+|||++|+++||||.++.....
T Consensus       256 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          256 SDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             HHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence            99999999999999999999999999999998875544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=334.62  Aligned_cols=235  Identities=22%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++... ........+..|..+++.+ +||||+++++++...     ..+|+||||++ |+|.+++...
T Consensus        44 ~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~  118 (353)
T 3txo_A           44 VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-----DRLFFVMEFVNGGDLMFHIQKS  118 (353)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHH
T ss_pred             EcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHc
Confidence            56789999999997642 2333456788999999988 799999999999655     56999999996 6999999988


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+||+.|+|||++.+
T Consensus       119 ~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  198 (353)
T 3txo_A          119 RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE  198 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC
Confidence            8999999999999999999999999999999999999999999999999999876432 333456789999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+..+....+.......+                               ..
T Consensus       199 -~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p-------------------------------~~  246 (353)
T 3txo_A          199 -MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP-------------------------------TW  246 (353)
T ss_dssp             -HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------------------------TT
T ss_pred             -CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CC
Confidence             6789999999999999999999999999887777776654211111                               24


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~------~ell~~~~f~~~~  273 (316)
                      +++++.++|++||+.||.+||++      +++++||||++++
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            78899999999999999999998      8999999999876

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-46  Score=335.50  Aligned_cols=238  Identities=29%  Similarity=0.469  Sum_probs=204.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+|+.||||++............+.+|+.+++.++||||+++++++...     ...|+||||+. |+|.+.+.....
T Consensus        50 ~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~  124 (362)
T 2bdw_A           50 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREF  124 (362)
T ss_dssp             ETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSC
T ss_pred             ECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCC
Confidence            567899999999987655666678899999999999999999999999654     56899999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++.............+++.|+|||++.+
T Consensus       125 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (362)
T 2bdw_A          125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK  204 (362)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc
Confidence            99999999999999999999999999999999999998654   599999999988766555556789999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+.......+.......+..                           ....
T Consensus       205 -~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~  256 (362)
T 2bdw_A          205 -DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------------------------EWDT  256 (362)
T ss_dssp             -CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---------------------------GGGG
T ss_pred             -CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------------------cccC
Confidence             678999999999999999999999998887766666655432221111                           1135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +++++.++|.+||+.||.+|||++++++||||...
T Consensus       257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            78899999999999999999999999999999753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.8e-46  Score=339.80  Aligned_cols=238  Identities=28%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.+|+.||+|++............+.+|+.+++.++||||+++++++...     ...|+||||+. |+|.+.+...+.
T Consensus        32 ~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~  106 (444)
T 3soa_A           32 KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-----GHHYLIFDLVTGGELFEDIVAREY  106 (444)
T ss_dssp             ETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----SEEEEEECCCBCCBHHHHHHHCSC
T ss_pred             ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----CEEEEEEEeCCCCCHHHHHHHcCC
Confidence            567999999999987655566677889999999999999999999999654     56999999995 699999999899


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc---cCCCEEEeeeccccccCCCC-ccccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  156 (316)
                      +++.++..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++....... ......|++.|+|||++.
T Consensus       107 ~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~  186 (444)
T 3soa_A          107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR  186 (444)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhc
Confidence            99999999999999999999999999999999999998   45789999999997765433 234567899999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|||||||++|+|++|.+||.+.+.......+.......+..                           ..+
T Consensus       187 ~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~  238 (444)
T 3soa_A          187 K-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP---------------------------EWD  238 (444)
T ss_dssp             T-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT---------------------------TTT
T ss_pred             C-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc---------------------------ccc
Confidence            7 678999999999999999999999999888777777665533222211                           123


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      .+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            678999999999999999999999999999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=328.38  Aligned_cols=239  Identities=28%  Similarity=0.472  Sum_probs=203.3

Q ss_pred             CCCCCceEEEEEecccccC----hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDN----RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      ++.+|+.||||+++.....    ......+.+|+.+++.++||||+++++++...     ..+++||||++ |+|.+++.
T Consensus        32 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~  106 (326)
T 2y0a_A           32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLA  106 (326)
T ss_dssp             ETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHT
T ss_pred             ECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEEcCCCCCHHHHHH
Confidence            4678999999999764322    12457789999999999999999999999654     56999999995 69999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC----CEEEeeeccccccCCCCccccccccccccCc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      ..+.+++.+++.++.||+.||.|||+.||+||||||+||+++.++    .++|+|||++.............+++.|+||
T Consensus       107 ~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  186 (326)
T 2y0a_A          107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP  186 (326)
T ss_dssp             TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCH
T ss_pred             hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCc
Confidence            888899999999999999999999999999999999999998887    7999999999887655555567789999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+.                           
T Consensus       187 E~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------  238 (326)
T 2y0a_A          187 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED---------------------------  238 (326)
T ss_dssp             HHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH---------------------------
T ss_pred             eeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc---------------------------
Confidence            99976 67899999999999999999999999888776666655443221111                           


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .....++..+.++|++||+.||.+|||++|+++||||++..
T Consensus       239 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            11236788999999999999999999999999999998653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.8e-47  Score=335.18  Aligned_cols=235  Identities=30%  Similarity=0.484  Sum_probs=196.4

Q ss_pred             CCCCCceEEEEEecccccCh-hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNR-IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++....... .....+.+|+.+++.++||||+++++++...     ..+++||||++|+|.+.+...+.
T Consensus        30 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~g~l~~~l~~~~~  104 (336)
T 3h4j_B           30 HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKR  104 (336)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCCEEHHHHHHHHCS
T ss_pred             ECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEECCCCcHHHHHHHcCC
Confidence            46799999999996543222 2235688999999999999999999999654     56999999999999999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.+++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++............++++.|+|||++.+...
T Consensus       105 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  184 (336)
T 3h4j_B          105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY  184 (336)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCC
Confidence            99999999999999999999999999999999999999999999999999988766666667789999999999987444


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      .+.++|||||||++|+|++|..||.+.........                               ...........+|+
T Consensus       185 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------------------------------i~~~~~~~p~~~s~  233 (336)
T 3h4j_B          185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------------------------------VNSCVYVMPDFLSP  233 (336)
T ss_dssp             GCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------------------------------CCSSCCCCCTTSCH
T ss_pred             CCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------------------------------HHcCCCCCcccCCH
Confidence            47899999999999999999999976532111100                               00000111235789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ++.++|++||+.||.+|||++|+++||||+..
T Consensus       234 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            99999999999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=329.04  Aligned_cols=268  Identities=37%  Similarity=0.626  Sum_probs=212.0

Q ss_pred             CCCCCceEEEEEecccccCh---hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNR---IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      +..+|+.||||++.......   .....+.+|+.+++.++||||+++++++...     ...++||||++++|.+.+...
T Consensus        31 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~  105 (346)
T 1ua2_A           31 DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDN  105 (346)
T ss_dssp             CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTC
T ss_pred             ECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-----CceEEEEEcCCCCHHHHHHhc
Confidence            56789999999997543222   1124678999999999999999999999654     458999999999999888765


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCccccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  156 (316)
                       ..+++.+++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...... .......+++.|+|||++.
T Consensus       106 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~  185 (346)
T 1ua2_A          106 SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF  185 (346)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhh
Confidence             46899999999999999999999999999999999999999999999999999876433 2334567899999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+..........   .....+...+.....
T Consensus       186 ~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  262 (346)
T 1ua2_A          186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV---TFKSFPGIPLHHIFS  262 (346)
T ss_dssp             TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC---CCCCCCCCCHHHHCT
T ss_pred             CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc---cccccCCCChHHhhc
Confidence            65668999999999999999999999999999888888888888877665554322111000   000111112223345


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      .++.++.+||++||+.||.+|||++|+++||||++......
T Consensus       263 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          263 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence            78899999999999999999999999999999998764443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4e-46  Score=332.26  Aligned_cols=273  Identities=34%  Similarity=0.569  Sum_probs=213.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---CCCCeEEEEEecCCCcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVYIVYELMDTDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~~   78 (316)
                      +..+|+.||||++............+.+|+.+++.++||||+++++++.....   .....+++||||++|+|.+.+...
T Consensus        38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~  117 (351)
T 3mi9_A           38 HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV  117 (351)
T ss_dssp             ETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCT
T ss_pred             ECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhc
Confidence            46789999999997765555455678899999999999999999999875421   113568999999999988887654


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-----CccccccccccccCc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAP  152 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~aP  152 (316)
                       ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......     .......+++.|+||
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          118 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP  197 (351)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCc
Confidence             57999999999999999999999999999999999999999999999999998765422     223445679999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+...++.++|||||||++|+|++|.+||.+.+.......+....+..+...++................ ......
T Consensus       198 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  276 (351)
T 3mi9_A          198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG-QKRKVK  276 (351)
T ss_dssp             HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSS-CCCCHH
T ss_pred             hhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccc-cccCHH
Confidence            9997756789999999999999999999999999998899999998888877665543322111100000000 000000


Q ss_pred             ccC--CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          233 ARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       233 ~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ...  ...++.+.+||.+||+.||.+|||++|+++||||++....
T Consensus       277 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          277 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             HHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             HHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            000  0137789999999999999999999999999999875543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=331.22  Aligned_cols=239  Identities=21%  Similarity=0.430  Sum_probs=199.7

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||++.... ........+.+|+.+++.++||||+++++++...     ..+|+||||+. |+|..++...+
T Consensus        36 ~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~  110 (384)
T 4fr4_A           36 KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----EDMFMVVDLLLGGDLRYHLQQNV  110 (384)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHTTC
T ss_pred             ECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhcC
Confidence            46789999999996542 2333457788999999999999999999999655     56999999995 69999999988


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  157 (316)
                      .+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++............+||+.|+|||++..  
T Consensus       111 ~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  190 (384)
T 4fr4_A          111 HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK  190 (384)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCC
Confidence            999999999999999999999999999999999999999999999999999988776666677889999999999864  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|..||...+.......+........                            .....
T Consensus       191 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------~~p~~  242 (384)
T 4fr4_A          191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV----------------------------TYPSA  242 (384)
T ss_dssp             SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC----------------------------CCCTT
T ss_pred             CCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc----------------------------CCCCc
Confidence            24588999999999999999999999976543222222211111100                            01125


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-~~ell~~~~f~~~~  273 (316)
                      ++..+.++|.+||+.||.+||+ ++++++||||++++
T Consensus       243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            7889999999999999999998 89999999999876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-45  Score=332.28  Aligned_cols=235  Identities=22%  Similarity=0.406  Sum_probs=193.8

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||++++.... ......+..|..++.++ +||||+++++++...     ..+|+||||++ |+|..++...
T Consensus        73 ~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~  147 (396)
T 4dc2_A           73 LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQ  147 (396)
T ss_dssp             ETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHH
T ss_pred             ECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----CEEEEEEEcCCCCcHHHHHHHc
Confidence            4678999999999865332 33345678899999877 899999999999654     56999999996 6999999988


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccc-cCCCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++. ..........+||+.|+|||++.+
T Consensus       148 ~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~  227 (396)
T 4dc2_A          148 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG  227 (396)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC
Confidence            8999999999999999999999999999999999999999999999999999976 333344566789999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---------HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH---------QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~---------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                       ..++.++|||||||++|+|++|.+||.......         ....+..                       ....   
T Consensus       228 -~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----------------------~~~~---  280 (396)
T 4dc2_A          228 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------------------KQIR---  280 (396)
T ss_dssp             -CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-----------------------CCCC---
T ss_pred             -CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-----------------------cccC---
Confidence             778999999999999999999999996542111         1111111                       0001   


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLH  273 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~------~ell~~~~f~~~~  273 (316)
                           ....+++++.+||++||+.||.+||++      +|+++||||++++
T Consensus       281 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          281 -----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             -----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence                 112578999999999999999999985      7999999999886

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-45  Score=321.08  Aligned_cols=235  Identities=24%  Similarity=0.391  Sum_probs=197.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++.....  .....+.+|+.+++.++||||+++++++...     ..+++||||++ |+|.+++.. ..
T Consensus        41 ~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~  112 (297)
T 3fxz_A           41 DVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TC  112 (297)
T ss_dssp             BTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-SC
T ss_pred             ECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEEEEEECCCCCCHHHHHhh-cC
Confidence            578999999999965432  2346688999999999999999999999654     46999999995 799999876 46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++....... ......+++.|+|||.+.+ .
T Consensus       113 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  191 (297)
T 3fxz_A          113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K  191 (297)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC-S
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC-C
Confidence            9999999999999999999999999999999999999999999999999987765433 3345678999999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|..||.+.+.......+.........                            ....++
T Consensus       192 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  243 (297)
T 3fxz_A          192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ----------------------------NPEKLS  243 (297)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS----------------------------CGGGSC
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----------------------------CccccC
Confidence            7899999999999999999999999888766665554432211110                            012568


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..+.++|.+||+.||.+|||++|+++||||+...
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            8899999999999999999999999999998653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.9e-46  Score=331.07  Aligned_cols=235  Identities=26%  Similarity=0.398  Sum_probs=200.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... .......+..|..++..+ +||||+++++++...     ..+|+||||++ |+|.+++...
T Consensus        38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~  112 (345)
T 1xjd_A           38 FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSC  112 (345)
T ss_dssp             ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHH
T ss_pred             ECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHc
Confidence            467899999999976421 223456678899999876 999999999999654     56999999995 7999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++..... .......+||+.|+|||++.+
T Consensus       113 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  192 (345)
T 1xjd_A          113 HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG  192 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC
Confidence            8999999999999999999999999999999999999999999999999999876432 233456789999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+|||||++|+|++|.+||.+.+.......+.......                               ...
T Consensus       193 -~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~  240 (345)
T 1xjd_A          193 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-------------------------------PRW  240 (345)
T ss_dssp             -CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTT
T ss_pred             -CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC-------------------------------Ccc
Confidence             678999999999999999999999999888776666654321100                               024


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~  273 (316)
                      +++++.++|.+||+.||++||++. ++++||||++++
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            788999999999999999999998 999999999886

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=324.61  Aligned_cols=233  Identities=22%  Similarity=0.395  Sum_probs=200.6

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+.     ..+|+||||++ |+|.+++...+
T Consensus        27 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~  101 (318)
T 1fot_A           27 SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQ  101 (318)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTS
T ss_pred             ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----CEEEEEEeCCCCCCHHHHHHHcC
Confidence            467899999999976422 223456678999999999999999999999654     56999999996 69999999988


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++......  ....++|+.|+|||++.+ .
T Consensus       102 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~  178 (318)
T 1fot_A          102 RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-K  178 (318)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcC-C
Confidence            9999999999999999999999999999999999999999999999999999876543  345678999999999977 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|+|||||++|+|++|..||.+.+.......+.......                               .+.++
T Consensus       179 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~~  227 (318)
T 1fot_A          179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-------------------------------PPFFN  227 (318)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC-------------------------------CTTSC
T ss_pred             CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------------------------CCCCC
Confidence            78999999999999999999999998887766666554421110                               12578


Q ss_pred             hHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +++.++|++||+.||.+||     +++++++||||+++.
T Consensus       228 ~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            8999999999999999999     899999999999876

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.7e-46  Score=330.75  Aligned_cols=265  Identities=32%  Similarity=0.594  Sum_probs=207.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      +..+|+.||||++............+.+|+.+++.++||||+++++++...     ...++||||+++ +|.+++...+.
T Consensus        46 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~  120 (331)
T 4aaa_A           46 NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KRWYLVFEFVDHTILDDLELFPNG  120 (331)
T ss_dssp             ETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHSTTC
T ss_pred             ECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CEEEEEEecCCcchHHHHHhhccC
Confidence            567899999999977655666667788999999999999999999999654     569999999985 66677677788


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||.+||+.||+||||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+..
T Consensus       121 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  200 (331)
T 4aaa_A          121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV  200 (331)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCC
Confidence            999999999999999999999999999999999999999999999999998765433 2234557899999999998755


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|.+||.+.+..+....+....+.........+........................+.++
T Consensus       201 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (331)
T 4aaa_A          201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS  280 (331)
T ss_dssp             TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSC
T ss_pred             CcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchh
Confidence            78999999999999999999999999998888888777776665443221111111000000000011122233456789


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus       281 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          281 EVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             HHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            99999999999999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.2e-45  Score=324.10  Aligned_cols=235  Identities=22%  Similarity=0.398  Sum_probs=195.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... .......+.+|..+++++ +||||+++++++...     ..+|+||||++ |+|.+++...
T Consensus        30 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~  104 (345)
T 3a8x_A           30 LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQ  104 (345)
T ss_dssp             ETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHH
T ss_pred             ECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHc
Confidence            467899999999986543 344557788999999988 899999999999654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.... ........++|+.|+|||++.+
T Consensus       105 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  184 (345)
T 3a8x_A          105 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG  184 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCC
Confidence            899999999999999999999999999999999999999999999999999997643 3334456789999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV---------HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                       ..++.++|||||||++|+|++|.+||......         .....+..                       ....   
T Consensus       185 -~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-----------------------~~~~---  237 (345)
T 3a8x_A          185 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------------------KQIR---  237 (345)
T ss_dssp             -CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-----------------------CCCC---
T ss_pred             -CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-----------------------CCCC---
Confidence             67899999999999999999999999753211         11111111                       0000   


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLH  273 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~------~ell~~~~f~~~~  273 (316)
                           ....++.++.++|.+||+.||.+||++      +|+++||||++++
T Consensus       238 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          238 -----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             -----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence                 112578999999999999999999996      7999999999876

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-45  Score=328.55  Aligned_cols=233  Identities=23%  Similarity=0.391  Sum_probs=200.9

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||+++.... .......+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus        62 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~  136 (350)
T 1rdq_E           62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIG  136 (350)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHC
T ss_pred             ECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcC
Confidence            467899999999965422 223456788999999999999999999999654     56999999995 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++......  ....++|+.|+|||++.+ .
T Consensus       137 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~  213 (350)
T 1rdq_E          137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-K  213 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcC-C
Confidence            9999999999999999999999999999999999999999999999999999876543  345678999999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|.+||.+.+.......+.......                               ...++
T Consensus       214 ~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~~  262 (350)
T 1rdq_E          214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-------------------------------PSHFS  262 (350)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTTCC
T ss_pred             CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCCCC
Confidence            78999999999999999999999999887766666655421110                               12578


Q ss_pred             hHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      +++.++|++||+.||.+||+     ++++++||||++++
T Consensus       263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence            99999999999999999998     99999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-45  Score=316.08  Aligned_cols=243  Identities=28%  Similarity=0.465  Sum_probs=207.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+|+.||+|++............+.+|+.++++++||||+++++++...     ...++||||++ ++|.+.+.....
T Consensus        27 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~  101 (284)
T 3kk8_A           27 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREF  101 (284)
T ss_dssp             ETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSS
T ss_pred             EcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CEEEEEEecCCCCCHHHHHHhcCC
Confidence            567899999999987666666778889999999999999999999999654     56899999996 699999888888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC---EEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++..++.++.||+.||.+||++||+||||+|+||+++.++.   ++|+|||.+.............++..|+|||.+.+
T Consensus       102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (284)
T 3kk8_A          102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK  181 (284)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC
Confidence            999999999999999999999999999999999999987655   99999999987766655566788999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||||+++|+|++|..||.+.+.......+.......+.                           .....
T Consensus       182 -~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~  233 (284)
T 3kk8_A          182 -DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---------------------------PEWDT  233 (284)
T ss_dssp             -CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------------------------TTTTT
T ss_pred             -CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc---------------------------hhhcc
Confidence             67899999999999999999999999888777666665543222111                           11235


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      +++++.++|.+||+.||++|||++|+++||||++......
T Consensus       234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             cCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence            7899999999999999999999999999999988664433

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-46  Score=327.00  Aligned_cols=236  Identities=23%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..+|+.||+|.+...   ......+.+|+.+++.++||||+++++++...     ..+++||||++ |+|.+++... .
T Consensus        26 ~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~   97 (321)
T 1tki_A           26 ETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAF   97 (321)
T ss_dssp             ETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSC
T ss_pred             ECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEEEEEEeCCCCCHHHHHHhcCC
Confidence            5678999999999643   33456688999999999999999999999654     56999999996 6999999765 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc--CCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++.+++.++.||+.||.|||+.||+||||||+||+++.  ++.++|+|||++.............+++.|+|||++.+
T Consensus        98 ~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  177 (321)
T 1tki_A           98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH  177 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC
Confidence            7999999999999999999999999999999999999987  78999999999988766655566778999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+.......+.......+.                           ...+.
T Consensus       178 -~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~  229 (321)
T 1tki_A          178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE---------------------------EAFKE  229 (321)
T ss_dssp             -CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH---------------------------HHHTT
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh---------------------------hhhcc
Confidence             66889999999999999999999999988877766666543222211                           12246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +|.++.++|++||+.||.+|||++|+++||||++..
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            789999999999999999999999999999998643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.5e-45  Score=320.91  Aligned_cols=268  Identities=35%  Similarity=0.585  Sum_probs=212.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC-
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-   79 (316)
                      .+|+.||||+++...........+.+|+.+++.+   +||||+++++++..........+++||||++|+|.+++.... 
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~  114 (326)
T 1blx_A           35 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE  114 (326)
T ss_dssp             TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT
T ss_pred             CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhccc
Confidence            5789999999976543333333456777776665   899999999998632222336799999999999999987653 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                       .+++..++.++.||+.||.+||+.||+|+||+|+||+++.++.++|+|||.+.............++..|+|||++.+ 
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  193 (326)
T 1blx_A          115 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-  193 (326)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhc-
Confidence             499999999999999999999999999999999999999999999999999877655444455678999999999987 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|.+||.+.+.......+....+.+....+.........    ..............+.+
T Consensus       194 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  269 (326)
T 1blx_A          194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ----AFHSKSAQPIEKFVTDI  269 (326)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG----GSCCCCCCCGGGTCCSC
T ss_pred             CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchh----hhcccCcchhhhccccC
Confidence            67899999999999999999999999999888888888887777665544321111110    01111122233445678


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      +..+.++|.+||+.||.+|||++|+++||||+++....
T Consensus       270 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            99999999999999999999999999999999876443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-45  Score=338.91  Aligned_cols=235  Identities=27%  Similarity=0.412  Sum_probs=191.0

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||+++... ........+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus       169 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  243 (446)
T 4ejn_A          169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRER  243 (446)
T ss_dssp             ETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----TEEEEEECCCSSCBHHHHHHHHS
T ss_pred             EcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----CEEEEEEeeCCCCcHHHHHHhcC
Confidence            56789999999997643 2333456678999999999999999999999654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..++.++.||+.||+|||+ .||+||||||+|||++.++.++|+|||++..... ........+|+.|+|||++.+
T Consensus       244 ~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  323 (446)
T 4ejn_A          244 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED  323 (446)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC
Confidence            99999999999999999999998 9999999999999999999999999999876432 333456788999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+.......                               ...
T Consensus       324 -~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~  371 (446)
T 4ejn_A          324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-------------------------------PRT  371 (446)
T ss_dssp             -SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTT
T ss_pred             -CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-------------------------------Ccc
Confidence             779999999999999999999999998888766666554321111                               125


Q ss_pred             CChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +++++.+||.+||+.||.+||     +++|+++||||+++.
T Consensus       372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            788999999999999999999     999999999999885

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-45  Score=329.07  Aligned_cols=238  Identities=29%  Similarity=0.420  Sum_probs=180.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+|+.||||++.....   ....+.+|+.+++.++||||+++++++...     ..+++||||++ |+|.+++...+.
T Consensus        41 ~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  112 (361)
T 3uc3_A           41 DKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGR  112 (361)
T ss_dssp             ETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSS
T ss_pred             ECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHhcCC
Confidence            567899999999965432   234578999999999999999999999654     56999999995 699999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC--EEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||++.............+++.|+|||++.+.
T Consensus       113 ~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  192 (361)
T 3uc3_A          113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ  192 (361)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCC
Confidence            999999999999999999999999999999999999987765  999999998765544445566799999999999874


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL-ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...+.++|||||||++|+|++|..||.+......... +..........                          .....
T Consensus       193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~  246 (361)
T 3uc3_A          193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--------------------------PDDIR  246 (361)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC--------------------------CTTSC
T ss_pred             CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC--------------------------CCcCC
Confidence            4334559999999999999999999987643222222 22111111000                          00125


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++++.+||++||+.||.+|||++|+++||||.+..
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            789999999999999999999999999999997643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.9e-45  Score=330.72  Aligned_cols=264  Identities=35%  Similarity=0.635  Sum_probs=208.1

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhh----cC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIR----SH   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~----~~   78 (316)
                      .+++ ||+|++......      ..+|+.+++.++||||+++++++..... .+...+++||||+++++...+.    ..
T Consensus        63 ~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~  135 (394)
T 4e7w_A           63 ESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK  135 (394)
T ss_dssp             TTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTT
T ss_pred             CCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhc
Confidence            4444 888888543211      2379999999999999999999865432 2334588999999987765543    35


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc-cCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||++.............+++.|+|||++.+
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~  215 (394)
T 4e7w_A          136 QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG  215 (394)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC
Confidence            7899999999999999999999999999999999999999 789999999999987765555566788999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC-C
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF-P  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  236 (316)
                      ...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+.......   .....+......+...+ +
T Consensus       216 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  292 (394)
T 4e7w_A          216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY---MEHKFPQIRPHPFSKVFRP  292 (394)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG---SSSCCCCCCCCCHHHHSCT
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh---hhhccccccCCcHHHhccc
Confidence            5678999999999999999999999999999999999999988887654332111000   00011111122222222 3


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      .+++++.+||.+||+.||.+|||+.|+++||||+++.....
T Consensus       293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          293 RTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             TCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred             cCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence            58999999999999999999999999999999999876544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.1e-45  Score=330.97  Aligned_cols=270  Identities=19%  Similarity=0.240  Sum_probs=196.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+|+.||||++............+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...  
T Consensus        48 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  122 (389)
T 3gni_B           48 YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFM  122 (389)
T ss_dssp             ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTCT
T ss_pred             EcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-----CEEEEEEEccCCCCHHHHHhhhcc
Confidence            467899999999987766666678888999999999999999999999654     56999999996 7999999775  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC--------Ccccccccccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--------DFMTEYVVTRWYR  150 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--------~~~~~~~~~~~~~  150 (316)
                      ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+......        .......++..|+
T Consensus       123 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  202 (389)
T 3gni_B          123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL  202 (389)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccccccccc
Confidence            67999999999999999999999999999999999999999999999999987543221        1122346788899


Q ss_pred             CcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC--------Cccccc----cccccchH
Q 021181          151 APELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP--------DETSLG----FLRSDNAR  217 (316)
Q Consensus       151 aPE~~~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------~~~~~~----~~~~~~~~  217 (316)
                      |||++.+. ..++.++|||||||++|+|++|..||.+.+.......+.......        ......    ........
T Consensus       203 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (389)
T 3gni_B          203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS  282 (389)
T ss_dssp             CHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------------
T ss_pred             CHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccc
Confidence            99998763 468999999999999999999999998876555544332111000        000000    00000000


Q ss_pred             HHhhh---CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          218 RYVRM---LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       218 ~~~~~---~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      .....   .+.............+++++.+||++||+.||.+|||++|+++||||+++....
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          283 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             -----------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred             cccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence            00000   000000011122346789999999999999999999999999999999887443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.6e-45  Score=320.51  Aligned_cols=239  Identities=28%  Similarity=0.474  Sum_probs=203.2

Q ss_pred             CCCCCceEEEEEecccccCh----hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      +..+|+.||||++.......    .....+.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++.
T Consensus        33 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~  107 (321)
T 2a2a_A           33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLA  107 (321)
T ss_dssp             ETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHH
T ss_pred             ECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CEEEEEEEcCCCCcHHHHHH
Confidence            46789999999997643222    2457789999999999999999999999654     56999999995 69999999


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC----CEEEeeeccccccCCCCccccccccccccCc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      ..+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++    .++|+|||++.............+++.|+||
T Consensus       108 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aP  187 (321)
T 2a2a_A          108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP  187 (321)
T ss_dssp             TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCc
Confidence            888899999999999999999999999999999999999999888    7999999999877665555566789999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+                           .
T Consensus       188 E~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~  239 (321)
T 2a2a_A          188 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD---------------------------E  239 (321)
T ss_dssp             HHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------------------------H
T ss_pred             ccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC---------------------------h
Confidence            99977 6789999999999999999999999988876666665543221111                           1


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .....++..+.++|.+||+.||.+|||++|+++||||+++.
T Consensus       240 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            11236788999999999999999999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.7e-45  Score=326.66  Aligned_cols=235  Identities=22%  Similarity=0.355  Sum_probs=200.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... .......+..|..++..+ +||+|+++++++...     ..+|+||||++ |+|.+++...
T Consensus        41 ~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~  115 (353)
T 2i0e_A           41 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQV  115 (353)
T ss_dssp             ETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHH
T ss_pred             ECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhc
Confidence            457899999999976422 233456778999999988 899999999999654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.... ........+||+.|+|||++.+
T Consensus       116 ~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  195 (353)
T 2i0e_A          116 GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY  195 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC
Confidence            899999999999999999999999999999999999999999999999999997643 2333456789999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+.......+.......                               ...
T Consensus       196 -~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~  243 (353)
T 2i0e_A          196 -QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------------------------------PKS  243 (353)
T ss_dssp             -CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTT
T ss_pred             -CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-------------------------------CCC
Confidence             678999999999999999999999999888777666665421110                               125


Q ss_pred             CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      +++++.++|++||+.||.+||+     ++++++||||+.++
T Consensus       244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            7899999999999999999995     69999999999876

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.3e-45  Score=322.69  Aligned_cols=240  Identities=26%  Similarity=0.350  Sum_probs=192.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+|+.||||++..... ......+.+|+.+++.++||||+++++++...     ...|+||||++ |+|.+++.....
T Consensus        28 ~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  101 (323)
T 3tki_A           28 NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIG  101 (323)
T ss_dssp             ETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGSBTTTB
T ss_pred             ECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEEEEcCCCCcHHHHHhhcCC
Confidence            567899999999965422 22335678999999999999999999998654     56899999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---CccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......   .......+++.|+|||++.+
T Consensus       102 ~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  181 (323)
T 3tki_A          102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (323)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc
Confidence            999999999999999999999999999999999999999999999999998765322   22345678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|..||...+...............                            ......
T Consensus       182 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  233 (323)
T 3tki_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------------------LNPWKK  233 (323)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----------------------------STTGGG
T ss_pred             CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----------------------------CCcccc
Confidence            4445789999999999999999999998765432222111110000                            011135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      +++.+.+||.+||+.||.+|||++|+++||||++....
T Consensus       234 ~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence            78899999999999999999999999999999876533

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-45  Score=333.74  Aligned_cols=239  Identities=24%  Similarity=0.331  Sum_probs=198.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+.     ..+|+||||++ |+|.+++.. .
T Consensus        90 ~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~-~  163 (410)
T 3v8s_A           90 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-Y  163 (410)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH-C
T ss_pred             ECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-C
Confidence            467899999999965321 122234577999999999999999999999654     56999999995 799998876 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++........  ....+||+.|+|||++.+
T Consensus       164 ~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~  243 (410)
T 3v8s_A          164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS  243 (410)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhc
Confidence            799999999999999999999999999999999999999999999999999987654432  346789999999999976


Q ss_pred             CCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 CSE---YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ~~~---~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      ...   ++.++|||||||++|+|++|.+||.+.+.......+.........                           ..
T Consensus       244 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------p~  296 (410)
T 3v8s_A          244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF---------------------------PD  296 (410)
T ss_dssp             TTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC---------------------------CT
T ss_pred             cCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC---------------------------CC
Confidence            321   678999999999999999999999988877777766542211100                           00


Q ss_pred             CCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~  273 (316)
                      ...+|+++++||++||+.+|.+  |++++|+++||||+++.
T Consensus       297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            1257899999999999999988  99999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-45  Score=337.15  Aligned_cols=236  Identities=29%  Similarity=0.446  Sum_probs=202.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++..... .......+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus        37 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~  111 (476)
T 2y94_A           37 HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNG  111 (476)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCSSEEHHHHTTSSS
T ss_pred             ECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcC
Confidence            467899999999965422 222356788999999999999999999999654     56999999995 79999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.+++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++............++++.|+|||++.+..
T Consensus       112 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  191 (476)
T 2y94_A          112 RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL  191 (476)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCC
Confidence            99999999999999999999999999999999999999999999999999998876665556678999999999998744


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++|||||||++|+|++|..||.+.+.......+.......                               ...++
T Consensus       192 ~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s  240 (476)
T 2y94_A          192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT-------------------------------PQYLN  240 (476)
T ss_dssp             BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC-------------------------------CTTCC
T ss_pred             CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC-------------------------------CccCC
Confidence            45789999999999999999999999887766666554321111                               12468


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++.++|++||+.||.+|||++|+++||||++..
T Consensus       241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            8999999999999999999999999999998643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=331.74  Aligned_cols=267  Identities=32%  Similarity=0.567  Sum_probs=200.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH---   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---   78 (316)
                      +..+++.||||++.....    ...+.+|+.+++.++||||+++++++....   ...+|+||||++|+|.+.+...   
T Consensus        44 ~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~  116 (405)
T 3rgf_A           44 DGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFDYAEHDLWHIIKFHRAS  116 (405)
T ss_dssp             SSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEEEEEECCSEEHHHHHHHHHHH
T ss_pred             cCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEEEEEeCCCCCHHHHHHHhccc
Confidence            446889999999965432    235779999999999999999999996432   2579999999999998887532   


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE----ccCCCEEEeeeccccccCCC----Ccccccc
Q 021181           79 ------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSET----DFMTEYV  144 (316)
Q Consensus        79 ------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~----~~~~~~~  144 (316)
                            ..+++..++.++.||+.||+|||+.||+||||||+||++    +.++.++|+|||++......    .......
T Consensus       117 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  196 (405)
T 3rgf_A          117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV  196 (405)
T ss_dssp             C-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------
T ss_pred             cccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCce
Confidence                  249999999999999999999999999999999999999    67789999999999775432    2234567


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHhhCCCCccccccccccc
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---------VHQLRLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                      +|..|+|||++.+...++.++|||||||++|+|++|.+||.+...         .+.+..+....+.+....+.......
T Consensus       197 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  276 (405)
T 3rgf_A          197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMP  276 (405)
T ss_dssp             CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGST
T ss_pred             ecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCc
Confidence            899999999998756689999999999999999999999976654         47788888888888776665443221


Q ss_pred             hHH-HhhhCCCCCC--CC----ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          216 ARR-YVRMLPQFPK--QN----FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       216 ~~~-~~~~~~~~~~--~~----~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ... ..........  ..    ........++.+.+||++||+.||.+|||++|+|+||||++....
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          277 EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             THHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred             chhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence            111 1111110000  00    011112347889999999999999999999999999999986543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.7e-45  Score=327.29  Aligned_cols=235  Identities=23%  Similarity=0.407  Sum_probs=191.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHH-HhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++.... .......+..|..+ ++.++||||+++++++...     ..+|+||||++ |+|.+++...
T Consensus        59 ~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~  133 (373)
T 2r5t_A           59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRE  133 (373)
T ss_dssp             ETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHH
T ss_pred             EcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhc
Confidence            467899999999976533 23344556677776 4678999999999999654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++... ........+||+.|+|||++.+
T Consensus       134 ~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  213 (373)
T 2r5t_A          134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK  213 (373)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC
Confidence            899999999999999999999999999999999999999999999999999987633 3334556789999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|+|||||++|+|++|.+||.+.+.......+....-                               ...+.
T Consensus       214 -~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~  261 (373)
T 2r5t_A          214 -QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------------------------------QLKPN  261 (373)
T ss_dssp             -CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-------------------------------CCCSS
T ss_pred             -CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-------------------------------CCCCC
Confidence             7789999999999999999999999988877766666544110                               01135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~  273 (316)
                      ++..+.++|.+||+.||.+||++    +++++||||+.++
T Consensus       262 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            78999999999999999999987    6999999999876

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-45  Score=328.70  Aligned_cols=264  Identities=31%  Similarity=0.619  Sum_probs=209.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---------------------------
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---------------------------   54 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---------------------------   54 (316)
                      |..+|+.||||++......      ..+|+.+++.++||||+++++++.....                           
T Consensus        28 ~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  101 (383)
T 3eb0_A           28 DIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHK  101 (383)
T ss_dssp             ETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------------
T ss_pred             ECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccc
Confidence            5689999999998654221      2379999999999999999999864321                           


Q ss_pred             ------CCCCeEEEEEecCCCcHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc-cCCCE
Q 021181           55 ------ETFNDVYIVYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDL  123 (316)
Q Consensus        55 ------~~~~~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~  123 (316)
                            .....+++||||++|+|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+||+++ .++.+
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~  181 (383)
T 3eb0_A          102 SVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL  181 (383)
T ss_dssp             --------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEE
T ss_pred             cccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcE
Confidence                  2234589999999988776664    457899999999999999999999999999999999999998 67899


Q ss_pred             EEeeeccccccCCCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q 021181          124 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP  203 (316)
Q Consensus       124 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  203 (316)
                      +|+|||.+.............++..|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p  261 (383)
T 3eb0_A          182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP  261 (383)
T ss_dssp             EECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999999877666556667889999999998875668999999999999999999999999999999999999888877


Q ss_pred             CccccccccccchHHHhhhCCCCCCCCccccC-CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          204 DETSLGFLRSDNARRYVRMLPQFPKQNFSARF-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ....+......-.   ....+......+.... ..+++++.+||.+||+.||.+|||+.|+++||||+++..
T Consensus       262 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          262 TKEQMIRMNPHYT---EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             CHHHHHHhCcccc---cccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            6543221110000   0001111112222222 358899999999999999999999999999999987753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=326.30  Aligned_cols=237  Identities=24%  Similarity=0.430  Sum_probs=200.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      ++.+|+.||+|++...  .......+.+|+.+++.++||||+++++++...     ..+++||||++ |+|.+++.... 
T Consensus        72 ~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~  144 (387)
T 1kob_A           72 EKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDY  144 (387)
T ss_dssp             ETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTC
T ss_pred             ECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhhcC
Confidence            5678999999999654  233456788999999999999999999999654     56999999996 69999987654 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc--CCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.  .+.++|+|||++.............+|+.|+|||++.+
T Consensus       145 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  224 (387)
T 1kob_A          145 KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR  224 (387)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC
Confidence            6999999999999999999999999999999999999974  47799999999988766555556678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+........                           ......
T Consensus       225 -~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~  276 (387)
T 1kob_A          225 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------------------------EDAFSS  276 (387)
T ss_dssp             -CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------------------------SSTTTT
T ss_pred             -CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------------------cccccc
Confidence             6789999999999999999999999998877666665543211111                           112246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++++.+||.+||+.||.+|||++|+++||||++..
T Consensus       277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            789999999999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.4e-45  Score=320.37  Aligned_cols=234  Identities=25%  Similarity=0.436  Sum_probs=189.5

Q ss_pred             CCCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            3 SETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ..+|+.||||+++....  .......+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus        42 ~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  116 (327)
T 3a62_A           42 ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMQLEREG  116 (327)
T ss_dssp             TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-----SCEEEEEECCTTEEHHHHHHHHS
T ss_pred             CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-----CEEEEEEeCCCCCcHHHHHHhCC
Confidence            47899999999976532  223446678999999999999999999999654     46999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .......+++.|+|||++.+ 
T Consensus       117 ~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  195 (327)
T 3a62_A          117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-  195 (327)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTT-
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC-
Confidence            8999999999999999999999999999999999999999999999999998764332 23345678999999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||.+.+.......+.......                               .+.+
T Consensus       196 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~  244 (327)
T 3a62_A          196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL-------------------------------PPYL  244 (327)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-------------------------------CTTS
T ss_pred             CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------------------------------CCCC
Confidence            678999999999999999999999999887766666554421111                               1256


Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +.++.++|.+||..||.+||     +++++++||||+++.
T Consensus       245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            88999999999999999999     889999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-44  Score=328.49  Aligned_cols=267  Identities=32%  Similarity=0.600  Sum_probs=208.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhh----
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIR----   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~----   76 (316)
                      +..+|+.||||++.....      ...+|+.+++.++||||+++++++..... .+...+++||||++++|.+.+.    
T Consensus        75 ~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  148 (420)
T 1j1b_A           75 LCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR  148 (420)
T ss_dssp             ETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHH
T ss_pred             ECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhh
Confidence            467899999999965321      12379999999999999999999864321 2224578999999988776654    


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCCccccccccccccCcccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                      ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++............++..|+|||++
T Consensus       149 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~  228 (420)
T 1j1b_A          149 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI  228 (420)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHH
Confidence            35679999999999999999999999999999999999999965 56899999999876655555567789999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+...++.++|||||||++|||++|++||.+.+..+.+..+.+..+.+....+......- ..  ...+......+...+
T Consensus       229 ~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~-~~--~~~p~~~~~~~~~~~  305 (420)
T 1j1b_A          229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-TE--FKFPQIKAHPWTKVF  305 (420)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC-CC--CCCCCCCCCCHHHHS
T ss_pred             cCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh-hh--hccCccCCCCHHHhc
Confidence            775678999999999999999999999999999888888888888876543321110000 00  000111111122222


Q ss_pred             -CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          236 -PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       236 -~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                       +.+++++.+||++||+.||.+||++.|+++||||+++.....
T Consensus       306 ~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             CCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence             367899999999999999999999999999999998765443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-45  Score=339.48  Aligned_cols=238  Identities=34%  Similarity=0.577  Sum_probs=202.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+|+.||||++............+.+|+.++++++||||+++++++...     ..+|+||||+. |+|.+.+...+.
T Consensus        43 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~  117 (486)
T 3mwu_A           43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKR  117 (486)
T ss_dssp             ETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSS
T ss_pred             ECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----CEEEEEEEcCCCCcHHHHHHhcCC
Confidence            567899999999976544444567889999999999999999999999654     56999999996 699999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc---cCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||.|||++||+||||||+||+++   .++.++|+|||++.............+++.|+|||++.+
T Consensus       118 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  197 (486)
T 3mwu_A          118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG  197 (486)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC
Confidence            99999999999999999999999999999999999995   456799999999987766655566789999999999875


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                        .++.++|||||||++|+|++|.+||.+.+..+....+..........                           ....
T Consensus       198 --~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~  248 (486)
T 3mwu_A          198 --TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---------------------------QWRT  248 (486)
T ss_dssp             --CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG---------------------------GGGG
T ss_pred             --CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------ccCC
Confidence              58999999999999999999999999988777777665532222111                           1135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +|+++.++|++||+.||.+|||+.++|+||||++..
T Consensus       249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            789999999999999999999999999999998764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.3e-45  Score=325.88  Aligned_cols=275  Identities=33%  Similarity=0.519  Sum_probs=212.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC--CCCCeEEEEEecCCCcHHHHhh---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR--ETFNDVYIVYELMDTDLHQIIR---   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~~~~~iv~e~~~g~L~~~l~---   76 (316)
                      +..+|+.||||++.....   ......+++..++.++||||+++++++...+.  .....+++||||++++|...+.   
T Consensus        44 ~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~  120 (360)
T 3e3p_A           44 EKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY  120 (360)
T ss_dssp             ETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHH
T ss_pred             ECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHh
Confidence            467899999999855322   22345678888889999999999999865321  1223488999999987765543   


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhh--cCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCCCccccccccccccCc
Q 021181           77 -SHQDLTDDHCRYFLYQLLRGLKYVH--SANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        77 -~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                       ....+++..++.++.||+.||.|||  +.||+||||||+||+++. ++.++|+|||++.............++..|+||
T Consensus       121 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP  200 (360)
T ss_dssp             TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCH
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCH
Confidence             5677999999999999999999999  999999999999999997 899999999999887766655667789999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+...++.++|||||||++|+|++|..||.+.+.......+....+.++...............   ........+.
T Consensus       201 E~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  277 (360)
T 3e3p_A          201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD---LYNSKGIPWS  277 (360)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGG---GGCCCCCCHH
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcc---ccccccCCcc
Confidence            9987756689999999999999999999999999998888888888887766543322111000000   0000001111


Q ss_pred             c----cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 021181          233 A----RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP  282 (316)
Q Consensus       233 ~----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~  282 (316)
                      .    .....++++.+||.+||+.||.+|||+.|+++||||+++..........
T Consensus       278 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~  331 (360)
T 3e3p_A          278 NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNN  331 (360)
T ss_dssp             HHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTS
T ss_pred             cccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCC
Confidence            1    1223678899999999999999999999999999999988666544433

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.9e-45  Score=338.43  Aligned_cols=237  Identities=33%  Similarity=0.537  Sum_probs=201.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+|+.||||++............+.+|+.+++.++||||+++++++...     ..+|+|||||. |+|.+.+.....
T Consensus        58 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~  132 (494)
T 3lij_A           58 DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNYYLVMECYKGGELFDEIIHRMK  132 (494)
T ss_dssp             ETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSS
T ss_pred             ECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCcHHHHHHHcCC
Confidence            567899999999987654444567789999999999999999999999654     56999999996 699999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC---CCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++..++.++.||+.||.|||++||+||||||+||+++..   +.+||+|||++.............+++.|+|||++.+
T Consensus       133 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~  212 (494)
T 3lij_A          133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK  212 (494)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc
Confidence            9999999999999999999999999999999999999764   4599999999988776655667789999999999864


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                        .++.++|||||||++|+|++|.+||.+.+..+....+..........                           ....
T Consensus       213 --~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~  263 (494)
T 3lij_A          213 --KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP---------------------------EWKN  263 (494)
T ss_dssp             --CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG---------------------------GGTT
T ss_pred             --cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch---------------------------hccc
Confidence              68999999999999999999999999988777777665533322211                           1236


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +|+.+.++|++||+.||.+|||++++|+||||++.
T Consensus       264 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            78999999999999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-45  Score=333.80  Aligned_cols=241  Identities=22%  Similarity=0.367  Sum_probs=199.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-C
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-H   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~   78 (316)
                      ++.+|+.||||+++.... .......+.+|..++..++||||+++++++.+.     ..+|+||||+. |+|.+++.. .
T Consensus        95 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~~lV~Ey~~gg~L~~~l~~~~  169 (437)
T 4aw2_A           95 LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-----NNLYLVMDYYVGGDLLTLLSKFE  169 (437)
T ss_dssp             ETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTTT
T ss_pred             EcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CEEEEEEecCCCCcHHHHHHHcc
Confidence            467899999999965321 122233478999999999999999999999654     56999999995 799999987 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  ....+||+.|+|||++.
T Consensus       170 ~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          170 DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHh
Confidence            7899999999999999999999999999999999999999999999999999977654332  23467999999999986


Q ss_pred             ----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          157 ----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       157 ----~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                          +...++.++|||||||++|||++|.+||.+.+..+....+........                          +.
T Consensus       250 ~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~p  303 (437)
T 4aw2_A          250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--------------------------FP  303 (437)
T ss_dssp             HHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------------------------CC
T ss_pred             hcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc--------------------------CC
Confidence                235689999999999999999999999999887777776653211100                          01


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~  273 (316)
                      .....+|+++.+||++||+.+|.+  |++++|+++||||++++
T Consensus       304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            112357999999999999998888  99999999999999876

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-44  Score=318.94  Aligned_cols=236  Identities=28%  Similarity=0.473  Sum_probs=174.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||++...     ....+.+|+.+++.+. ||||+++++++.+.     ...|+||||++ |+|.+++...+
T Consensus        32 ~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  101 (325)
T 3kn6_A           32 HKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVMELLNGGELFERIKKKK  101 (325)
T ss_dssp             ETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHCS
T ss_pred             ECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEEEccCCCcHHHHHHhcC
Confidence            5678999999999543     3456779999999997 99999999999654     56999999996 69999999989


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccccCCC-CccccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~  155 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.++   .++|+|||++...... .......++..|+|||++
T Consensus       102 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  181 (325)
T 3kn6_A          102 HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL  181 (325)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHh
Confidence            999999999999999999999999999999999999998765   7999999999765433 223456779999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-------HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      .+ ..++.++|||||||++|+|++|..||.+.+..       +....+......                          
T Consensus       182 ~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--------------------------  234 (325)
T 3kn6_A          182 NQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--------------------------  234 (325)
T ss_dssp             ---CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--------------------------
T ss_pred             cC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--------------------------
Confidence            77 67899999999999999999999999775431       112221110000                          


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                       ........+++++.+||++||+.||.+|||++++++||||++....
T Consensus       235 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          235 -FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             -CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             -CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence             0011123578999999999999999999999999999999875443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-44  Score=319.02  Aligned_cols=239  Identities=26%  Similarity=0.419  Sum_probs=199.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +..+|+.||||+++...........+.+|+.+++.+ .||||+++++++...     ..+++||||+. |+|.+++... 
T Consensus        50 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~  124 (327)
T 3lm5_A           50 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-----SEIILILEYAAGGEIFSLCLPEL  124 (327)
T ss_dssp             ETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGGSSCC
T ss_pred             ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-----CeEEEEEEecCCCcHHHHHHHhc
Confidence            567899999999987655555677889999999999 569999999999654     56999999996 5999988553 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---CCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                       +.+++.+++.++.||+.||++||++||+||||||+||+++.   ++.++|+|||++.............+++.|+|||+
T Consensus       125 ~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  204 (327)
T 3lm5_A          125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI  204 (327)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCee
Confidence             67999999999999999999999999999999999999988   78999999999988766555556778999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      +.+ ..++.++|||||||++|+|++|..||.+.+.......+.........                           ..
T Consensus       205 ~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~  256 (327)
T 3lm5_A          205 LNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---------------------------ET  256 (327)
T ss_dssp             HTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------------------------TT
T ss_pred             ecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---------------------------hh
Confidence            977 67899999999999999999999999988877776666553322221                           12


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...+++.+.++|.+||+.||.+|||++++++||||+++.
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            246789999999999999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-45  Score=320.24  Aligned_cols=245  Identities=21%  Similarity=0.216  Sum_probs=170.1

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCCH
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTD   83 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~   83 (316)
                      +|+.||||+++...   ........|+..+.+++|||||++++++...+ .....+|||||||+ |+|.++++. .++++
T Consensus        25 ~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~   99 (303)
T 3hmm_A           25 RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-YTVTV   99 (303)
T ss_dssp             TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-CCBCH
T ss_pred             CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEecCCCCCcHHHHHHh-CCCCH
Confidence            68999999996432   12222345666677889999999999997543 22246899999996 799999976 56999


Q ss_pred             HHHHHHHHHHHHHHHHhhcC--------CceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----ccccccccccc
Q 021181           84 DHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYR  150 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~--------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~  150 (316)
                      ..+..++.|++.||+|||++        +|+||||||+|||++.++.+||+|||+++.......     ....+||+.|+
T Consensus       100 ~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym  179 (303)
T 3hmm_A          100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM  179 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccccc
Confidence            99999999999999999977        999999999999999999999999999876543321     23457999999


Q ss_pred             CcccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCC-
Q 021181          151 APELLLNCS-----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP-  224 (316)
Q Consensus       151 aPE~~~~~~-----~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  224 (316)
                      |||++.+..     .++.++|||||||++|||++|.+||........          +......  ............. 
T Consensus       180 APE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~----------p~~~~~~--~~~~~~~~~~~~~~  247 (303)
T 3hmm_A          180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL----------PYYDLVP--SDPSVEEMRKVVCE  247 (303)
T ss_dssp             CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC----------TTTTTSC--SSCCHHHHHHHHTT
T ss_pred             CHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc----------cchhccc--ccchHHHHHHHHhc
Confidence            999987522     356789999999999999999887754321000          0000000  0000000000000 


Q ss_pred             CCCCCCccccC--CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          225 QFPKQNFSARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       225 ~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ...+..++...  ...+..+.+++.+||+.||++|||+.||++.
T Consensus       248 ~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            00000011111  1233568999999999999999999998863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-45  Score=316.61  Aligned_cols=237  Identities=27%  Similarity=0.487  Sum_probs=190.1

Q ss_pred             CCCCCceEEEEEecccccCh------------------------hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNR------------------------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF   57 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   57 (316)
                      |..+|+.||||++.......                        .....+.+|+.++++++||||+++++++....   .
T Consensus        34 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~  110 (298)
T 2zv2_A           34 NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPN---E  110 (298)
T ss_dssp             ETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSS---S
T ss_pred             ECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC---C
Confidence            56789999999996542111                        12356789999999999999999999987532   2


Q ss_pred             CeEEEEEecCC-CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC
Q 021181           58 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE  136 (316)
Q Consensus        58 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  136 (316)
                      ..+++||||++ ++|.+++ ....+++.+++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus       111 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  189 (298)
T 2zv2_A          111 DHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG  189 (298)
T ss_dssp             SEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            67999999996 5777654 446799999999999999999999999999999999999999999999999999877654


Q ss_pred             CC-ccccccccccccCcccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccc
Q 021181          137 TD-FMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS  213 (316)
Q Consensus       137 ~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  213 (316)
                      .. ......+++.|+|||.+.+...  ++.++|||||||++|+|++|..||...+.......+.......          
T Consensus       190 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  259 (298)
T 2zv2_A          190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF----------  259 (298)
T ss_dssp             SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred             ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC----------
Confidence            32 2345678999999999876332  3678999999999999999999998876555444443211110          


Q ss_pred             cchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          214 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                                         ...+.+++++.++|.+||+.||.+|||++|+++||||++
T Consensus       260 -------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          260 -------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             -------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             -------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                               011367899999999999999999999999999999863

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=325.63  Aligned_cols=237  Identities=29%  Similarity=0.422  Sum_probs=201.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..+|+.||||+++..  .......+.+|+.++++++||||+++++++...     ..+++||||++ |+|.+++... .
T Consensus       110 ~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~  182 (373)
T 2x4f_A          110 ETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEYVDGGELFDRIIDESY  182 (373)
T ss_dssp             ETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCEEHHHHHHTGG
T ss_pred             EcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCC
Confidence            4578999999999654  234557789999999999999999999999654     56999999996 6998888654 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE--ccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||++  +.++.++|+|||++.............+++.|+|||++.+
T Consensus       183 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  262 (373)
T 2x4f_A          183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY  262 (373)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC
Confidence            69999999999999999999999999999999999999  5667899999999988766555556678999999999876


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+....+..+.......+                           ......
T Consensus       263 -~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~  314 (373)
T 2x4f_A          263 -DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE---------------------------DEEFQD  314 (373)
T ss_dssp             -CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC---------------------------SGGGTT
T ss_pred             -CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---------------------------hhhhcc
Confidence             6789999999999999999999999998887777666654321111                           112246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++++.+||.+||+.||.+|||++|+++||||++..
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            789999999999999999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-44  Score=310.89  Aligned_cols=234  Identities=30%  Similarity=0.455  Sum_probs=188.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      ++.+|+.||+|++.... .......+.+|+.++++++||||+++++++...     ...++||||++ |+|.+.+..   
T Consensus        43 ~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  116 (285)
T 3is5_A           43 ERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNMYIVMETCEGGELLERIVSAQA  116 (285)
T ss_dssp             ETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCSCCBHHHHHHHHHH
T ss_pred             EccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeEEEEEEeCCCCcHHHHHHhhhh
Confidence            46789999999997653 333467789999999999999999999999654     56999999996 699888753   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE---ccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                       ...+++..++.++.||+.||++||++||+||||+|+||++   +.++.++|+|||++.............++..|+|||
T Consensus       117 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE  196 (285)
T 3is5_A          117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE  196 (285)
T ss_dssp             HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChH
Confidence             3679999999999999999999999999999999999999   456789999999998766655556677899999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      .+.  ..++.++|||||||++|+|++|..||.+.+.......+.......                            ..
T Consensus       197 ~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~  246 (285)
T 3is5_A          197 VFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY----------------------------AV  246 (285)
T ss_dssp             HHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------------------------CC
T ss_pred             Hhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc----------------------------cc
Confidence            985  467899999999999999999999998887665554443211111                            01


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ....+++++.++|.+||+.||++|||++|+++||||++
T Consensus       247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            11246889999999999999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=321.48  Aligned_cols=234  Identities=31%  Similarity=0.463  Sum_probs=179.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||+++...    ..+.+.+|+.++++++||||+++++++...     ...++||||++ |+|.+++...+.
T Consensus        74 ~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  144 (349)
T 2w4o_A           74 QKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGY  144 (349)
T ss_dssp             ETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSS
T ss_pred             ECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeEEEEEEeCCCCCHHHHHHhcCC
Confidence            45689999999996532    345678999999999999999999999654     56999999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---CCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||.|||+.||+||||||+||+++.   ++.++|+|||++.............+++.|+|||++.+
T Consensus       145 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  224 (349)
T 2w4o_A          145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG  224 (349)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC
Confidence            999999999999999999999999999999999999975   88999999999987665544556778999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|+|++|..||....... ....+........                           .....
T Consensus       225 -~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~  276 (349)
T 2w4o_A          225 -CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI---------------------------SPWWD  276 (349)
T ss_dssp             -CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC---------------------------TTTTT
T ss_pred             -CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC---------------------------Cchhh
Confidence             678999999999999999999999998766544 3333322111100                           11224


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      .++.++.++|++||+.||++|||+.|+++||||++.
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            678999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=328.90  Aligned_cols=240  Identities=21%  Similarity=0.303  Sum_probs=197.2

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      ++.+|+.||||++++.. ........+.+|..++..++||||+++++++.+.     ..+|+||||+. |+|.+++... 
T Consensus        82 ~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~~lVmE~~~gg~L~~~l~~~~  156 (412)
T 2vd5_A           82 MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-----NYLYLVMEYYVGGDLLTLLSKFG  156 (412)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHS
T ss_pred             ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEEEEEEcCCCCCcHHHHHHhcC
Confidence            46789999999996532 1222334578999999999999999999999654     56999999995 7999999764 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  ....+||+.|+|||++.
T Consensus       157 ~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          157 ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHh
Confidence            4799999999999999999999999999999999999999999999999999987654432  23468999999999987


Q ss_pred             C------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          157 N------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       157 ~------~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      .      ...++.++|||||||++|||++|.+||.+.+..+....+........                          
T Consensus       237 ~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------  290 (412)
T 2vd5_A          237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS--------------------------  290 (412)
T ss_dssp             HHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------------------------
T ss_pred             hcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------------------------
Confidence            3      25689999999999999999999999998887777666653211000                          


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRR---ITVDEALCHPYLAPLH  273 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~ell~~~~f~~~~  273 (316)
                      +......+|+++++||++||+ +|.+|   |+++|+++||||++++
T Consensus       291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            001113578999999999999 99998   5999999999999876

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3e-44  Score=309.65  Aligned_cols=236  Identities=30%  Similarity=0.453  Sum_probs=201.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||+|++.....  .....+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+.+...+.
T Consensus        30 ~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~  102 (277)
T 3f3z_A           30 QKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHKRV  102 (277)
T ss_dssp             ETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCS
T ss_pred             eCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeEEEEEeccCCCcHHHHHHHcCC
Confidence            567899999999976432  2456788999999999999999999999654     56999999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE---ccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.|++.||++||++||+|+||+|+||++   +.++.++|+|||.+.............+++.|+|||.+.+
T Consensus       103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~  182 (277)
T 3f3z_A          103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG  182 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc
Confidence            9999999999999999999999999999999999999   7889999999999987766655566788999999999865


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                        .++.++||||||+++|+|++|..||...+.......+.......+..                           ....
T Consensus       183 --~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~  233 (277)
T 3f3z_A          183 --LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK---------------------------DWLN  233 (277)
T ss_dssp             --CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---------------------------HHTT
T ss_pred             --cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---------------------------hhhc
Confidence              48999999999999999999999999888776666655432222211                           1135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++.+.++|.+||+.||.+|||+.++++||||++..
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            788999999999999999999999999999998644

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=315.57  Aligned_cols=231  Identities=25%  Similarity=0.316  Sum_probs=185.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~   79 (316)
                      +..+|+.||||++...............|+..+..+ +||||+++++++...     ..+++||||++++|.+.+... .
T Consensus        78 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~  152 (311)
T 3p1a_A           78 SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GILYLQTELCGPSLQQHCEAWGA  152 (311)
T ss_dssp             ETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHHCS
T ss_pred             ECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CEEEEEEeccCCCHHHHHHhcCC
Confidence            467899999999877655555666666676666555 999999999999654     569999999999998887654 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.............+|+.|+|||++.+  
T Consensus       153 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--  230 (311)
T 3p1a_A          153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--  230 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--
Confidence            699999999999999999999999999999999999999999999999999887766555556678999999999875  


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|..|+.+...   ...+..  +..                           .......++
T Consensus       231 ~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~--~~~---------------------------~~~~~~~~~  278 (311)
T 3p1a_A          231 SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ--GYL---------------------------PPEFTAGLS  278 (311)
T ss_dssp             CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT--TCC---------------------------CHHHHTTSC
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc--cCC---------------------------CcccccCCC
Confidence            689999999999999999999766644321   111111  000                           011123578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +++.++|.+||+.||++|||++|+++||||++
T Consensus       279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.1e-45  Score=323.83  Aligned_cols=237  Identities=29%  Similarity=0.472  Sum_probs=192.5

Q ss_pred             CCCCCceEEEEEecccc---cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      ++.+|+.||||++....   ........+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+.+..
T Consensus        45 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~  119 (351)
T 3c0i_A           45 NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-----GMLYMVFEFMDGADLCFEIVK  119 (351)
T ss_dssp             ETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHHHH
T ss_pred             ECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHHHH
Confidence            56789999999996432   1222457789999999999999999999999654     56999999997 699877754


Q ss_pred             C----CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC---EEEeeeccccccCCCCc-cccccccccc
Q 021181           78 H----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDF-MTEYVVTRWY  149 (316)
Q Consensus        78 ~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~-~~~~~~~~~~  149 (316)
                      .    ..+++..++.++.||+.||.|||++||+||||||+||+++.++.   ++|+|||++........ .....+|+.|
T Consensus       120 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y  199 (351)
T 3c0i_A          120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF  199 (351)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGG
T ss_pred             hcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCc
Confidence            2    35899999999999999999999999999999999999987655   99999999987655432 3456789999


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      +|||++.+ ..++.++|||||||++|+|++|..||.+.. ......+........                         
T Consensus       200 ~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~-------------------------  252 (351)
T 3c0i_A          200 MAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN-------------------------  252 (351)
T ss_dssp             CCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC-------------------------
T ss_pred             cCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC-------------------------
Confidence            99999987 678999999999999999999999997753 333333332111111                         


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                        ......+++++.++|++||+.||.+|||+.++++||||++.
T Consensus       253 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          253 --PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             --HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             --ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence              11123678999999999999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=316.80  Aligned_cols=271  Identities=44%  Similarity=0.737  Sum_probs=206.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---------CCCCeEEEEEecCCCcHH
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---------ETFNDVYIVYELMDTDLH   72 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---------~~~~~~~iv~e~~~g~L~   72 (316)
                      +..+|+.||||++...  +......+.+|+.++++++||||+++++++.....         ......++||||++|+|.
T Consensus        32 ~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~  109 (320)
T 2i6l_A           32 DNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA  109 (320)
T ss_dssp             ETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHH
T ss_pred             ECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHH
Confidence            4678999999998643  44556788999999999999999999999854321         233678999999999999


Q ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc-cCCCEEEeeeccccccCCC----Cccccccccc
Q 021181           73 QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSET----DFMTEYVVTR  147 (316)
Q Consensus        73 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~----~~~~~~~~~~  147 (316)
                      +++.. +++++..++.++.||+.||++||++||+||||||+||+++ .++.++|+|||.+......    .......++.
T Consensus       110 ~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  188 (320)
T 2i6l_A          110 NVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK  188 (320)
T ss_dssp             HHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCC
T ss_pred             HHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccc
Confidence            99865 6799999999999999999999999999999999999997 5678999999998765432    1223455688


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      .|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+.................. ...+.......+
T Consensus       189 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  267 (320)
T 2i6l_A          189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEP  267 (320)
T ss_dssp             TTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTT-SCHHHHHHTTSC
T ss_pred             cccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhc-CcccccccccCC
Confidence            9999999876577899999999999999999999999998877777766655443332211110000 000111111122


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      ...+....+.++.++.++|++||+.||.+|||++|+++||||+.+.-..
T Consensus       268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          268 HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            2223344467899999999999999999999999999999999765433

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.8e-45  Score=336.71  Aligned_cols=238  Identities=30%  Similarity=0.519  Sum_probs=204.8

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||++..... .......+.+|+.++++++||||+++++++...     ..+++||||+. |+|.+.+...+
T Consensus        47 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~  121 (484)
T 3nyv_A           47 DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-----GYFYLVGEVYTGGELFDEIISRK  121 (484)
T ss_dssp             ETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCS
T ss_pred             ECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEecCCCCCHHHHHHhcC
Confidence            567899999999976432 344567889999999999999999999999654     56999999996 79999999889


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE---ccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      .+++.+++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.............+++.|+|||++.
T Consensus       122 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  201 (484)
T 3nyv_A          122 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH  201 (484)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec
Confidence            99999999999999999999999999999999999999   567899999999998876665556678999999999986


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      +  .++.++|||||||++|+|++|.+||.+.+..+....+..........                           ...
T Consensus       202 ~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~  252 (484)
T 3nyv_A          202 G--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP---------------------------QWK  252 (484)
T ss_dssp             T--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG---------------------------GGG
T ss_pred             C--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccc
Confidence            5  58999999999999999999999999988777777665532222111                           113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .+|+.+.+||++||+.||.+|||++|+|+||||+...
T Consensus       253 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            5789999999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.4e-44  Score=308.89  Aligned_cols=238  Identities=22%  Similarity=0.365  Sum_probs=197.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..++..||+|++............+.+|+.+++.++||||+++++++.... .+...+++||||++ |+|.+++...+.
T Consensus        47 ~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~  125 (290)
T 1t4h_A           47 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKV  125 (290)
T ss_dssp             ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHHSS
T ss_pred             ecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEEEEEEecCCCCHHHHHHHccC
Confidence            5678999999999877667777788999999999999999999999986432 22356899999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEc-cCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++..++.++.||+.||.|||+.|  ++|+||+|+||+++ .++.++|+|||++...... ......++..|+|||.+.+
T Consensus       126 ~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~  204 (290)
T 1t4h_A          126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE  204 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc
Confidence            999999999999999999999999  99999999999997 7899999999998665433 2344568999999998864


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                        .++.++|||||||++|+|++|..||..................+                            ......
T Consensus       205 --~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  254 (290)
T 1t4h_A          205 --KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------------------------ASFDKV  254 (290)
T ss_dssp             --CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------------------------GGGGGC
T ss_pred             --cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----------------------------cccCCC
Confidence              58999999999999999999999998765444433222111000                            011124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      .++++.++|.+||+.||.+|||++++++||||++
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            6788999999999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.4e-44  Score=320.75  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=202.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-----CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-----HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~   76 (316)
                      +..+|+.||||+++.   ..........|+.+++.+.     ||||+++++++...     ...++||||++++|.+++.
T Consensus        56 ~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~  127 (360)
T 3llt_A           56 HIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----DHMCLIFEPLGPSLYEIIT  127 (360)
T ss_dssp             ETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----TEEEEEECCCCCBHHHHHH
T ss_pred             ECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----CeeEEEEcCCCCCHHHHHH
Confidence            457899999999964   2334566778999999996     99999999999654     5699999999989999998


Q ss_pred             cCC--CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-------------------------CCCEEEeeec
Q 021181           77 SHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------------------------NCDLKIGDFG  129 (316)
Q Consensus        77 ~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-------------------------~~~~~l~df~  129 (316)
                      ...  .+++.+++.++.||+.||+|||++||+||||||+||+++.                         ++.++|+|||
T Consensus       128 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG  207 (360)
T 3llt_A          128 RNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG  207 (360)
T ss_dssp             HTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCT
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEecc
Confidence            754  5999999999999999999999999999999999999975                         7889999999


Q ss_pred             cccccCCCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccc
Q 021181          130 LARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG  209 (316)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  209 (316)
                      ++......  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+....+..+.....
T Consensus       208 ~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~  284 (360)
T 3llt_A          208 CATFKSDY--HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY  284 (360)
T ss_dssp             TCEETTSC--CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHH
T ss_pred             CceecCCC--CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHh
Confidence            99765443  245678999999999987 679999999999999999999999999999888888888887766653321


Q ss_pred             cccccchHHHhhh---CCCCCCC------------CccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          210 FLRSDNARRYVRM---LPQFPKQ------------NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       210 ~~~~~~~~~~~~~---~~~~~~~------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      .........+...   ...++..            .........++.+.+||++||+.||.+|||++|+|+||||+
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             hhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            1111100000000   0000000            00001113457889999999999999999999999999996

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.7e-44  Score=319.10  Aligned_cols=238  Identities=28%  Similarity=0.511  Sum_probs=198.7

Q ss_pred             CCCCCceEEEEEecccccC------hhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHH
Q 021181            2 NSETREEVAIKKIGNAFDN------RIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~   73 (316)
                      +..+|+.||||++......      ......+.+|+.+++.+ +||||+++++++...     ...++||||++ ++|.+
T Consensus       115 ~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~  189 (365)
T 2y7j_A          115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS-----SFMFLVFDLMRKGELFD  189 (365)
T ss_dssp             ETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-----SEEEEEECCCTTCBHHH
T ss_pred             ECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-----CEEEEEEEeCCCCcHHH
Confidence            4568999999998654311      12245678999999999 799999999998654     56999999996 59999


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                      ++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.............+++.|+|||
T Consensus       190 ~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE  269 (365)
T 2y7j_A          190 YLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE  269 (365)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHH
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChh
Confidence            99888889999999999999999999999999999999999999999999999999998776655556678899999999


Q ss_pred             cccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          154 LLLN-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       154 ~~~~-----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      ++.+     ...++.++|||||||++|+|++|..||...+.......+.........                       
T Consensus       270 ~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------------------  326 (365)
T 2y7j_A          270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS-----------------------  326 (365)
T ss_dssp             HHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH-----------------------
T ss_pred             hccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-----------------------
Confidence            9863     235788999999999999999999999887766665555442211111                       


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                          .....++..+.++|++||+.||.+|||++++++||||++
T Consensus       327 ----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 ----PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ----HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                111356888999999999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.7e-44  Score=335.23  Aligned_cols=238  Identities=29%  Similarity=0.468  Sum_probs=202.2

Q ss_pred             CCCCCceEEEEEecccccCh-----------hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-C
Q 021181            2 NSETREEVAIKKIGNAFDNR-----------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-T   69 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g   69 (316)
                      ++.+|+.||||++.......           .....+.+|+.++++++||||+++++++...     ..+|+|||||+ |
T Consensus        57 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg  131 (504)
T 3q5i_A           57 EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK-----KYFYLVTEFYEGG  131 (504)
T ss_dssp             ETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTC
T ss_pred             ECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEecCCCC
Confidence            56789999999997643221           3356788999999999999999999999654     56999999996 6


Q ss_pred             cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccccCCCCcccccccc
Q 021181           70 DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETDFMTEYVVT  146 (316)
Q Consensus        70 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~  146 (316)
                      +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++   .++|+|||++.............++
T Consensus       132 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt  211 (504)
T 3q5i_A          132 ELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT  211 (504)
T ss_dssp             BHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSC
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCC
Confidence            9999998888999999999999999999999999999999999999998776   6999999999887766556677899


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      +.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+.......+.                     
T Consensus       212 ~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------  268 (504)
T 3q5i_A          212 AYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF---------------------  268 (504)
T ss_dssp             TTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH---------------------
T ss_pred             cCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---------------------
Confidence            99999999864  5899999999999999999999999998877777766553221111                     


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                            .....+|+++.+||++||+.||.+|||++|+|+||||++..
T Consensus       269 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          269 ------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             ------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence                  11236789999999999999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=320.13  Aligned_cols=230  Identities=23%  Similarity=0.352  Sum_probs=193.6

Q ss_pred             CCCCCceEEEEEecccccCh------hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-C-cHHH
Q 021181            2 NSETREEVAIKKIGNAFDNR------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-T-DLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g-~L~~   73 (316)
                      |+.+|+.||||+++......      .....+.+|+.++++++||||+++++++...     ..+++||||++ | +|.+
T Consensus        45 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~g~~l~~  119 (335)
T 3dls_A           45 DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFA  119 (335)
T ss_dssp             ETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTSCBHHH
T ss_pred             ECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-----CEEEEEEEeCCCCccHHH
Confidence            56789999999997653211      1334567899999999999999999999654     56999999985 5 9999


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                      ++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.............++..|+|||
T Consensus       120 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  199 (335)
T 3dls_A          120 FIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE  199 (335)
T ss_dssp             HHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHH
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChh
Confidence            99998899999999999999999999999999999999999999999999999999998877666666678899999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      ++.+....+.++|||||||++|+|++|..||......         ..                    .        ...
T Consensus       200 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~--------------------~--------~~~  242 (335)
T 3dls_A          200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VE--------------------A--------AIH  242 (335)
T ss_dssp             HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TT--------------------T--------CCC
T ss_pred             hhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hh--------------------h--------ccC
Confidence            9987444488999999999999999999999653210         00                    0        001


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ....+++++.++|.+||+.||.+|||++++++||||++..
T Consensus       243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            1124789999999999999999999999999999998743

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.6e-44  Score=313.12  Aligned_cols=234  Identities=25%  Similarity=0.441  Sum_probs=195.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++....  ......+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++.. ..
T Consensus        66 ~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-~~  137 (321)
T 2c30_A           66 EKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-VR  137 (321)
T ss_dssp             ETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTT-CC
T ss_pred             ECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHh-cC
Confidence            45689999999996542  33456788999999999999999999999654     46999999996 689888764 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ......++..|+|||++.+ .
T Consensus       138 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  216 (321)
T 2c30_A          138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-S  216 (321)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-C
Confidence            9999999999999999999999999999999999999999999999999987765432 2345678999999999977 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|..||...+.......+........                            .....++
T Consensus       217 ~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  268 (321)
T 2c30_A          217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL----------------------------KNSHKVS  268 (321)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------------------------TTGGGSC
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc----------------------------CccccCC
Confidence            789999999999999999999999988776665555443211100                            0012468


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +.+.++|.+||+.||++|||++++++||||.+.
T Consensus       269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            889999999999999999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.7e-44  Score=325.21  Aligned_cols=259  Identities=31%  Similarity=0.568  Sum_probs=204.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC------CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHh
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM------DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII   75 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l   75 (316)
                      |..+|+.||||+++..   ......+.+|+.+++.+      +|+||+++++++...     ..+++|||+++++|.+++
T Consensus       118 ~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l  189 (429)
T 3kvw_A          118 DHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-----NHICMTFELLSMNLYELI  189 (429)
T ss_dssp             ETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-----TEEEEEECCCCCBHHHHH
T ss_pred             ECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-----CeEEEEEeccCCCHHHHH
Confidence            5678999999999653   33445677788888777      577999999998654     569999999999999998


Q ss_pred             hcCC--CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC--EEEeeeccccccCCCCccccccccccccC
Q 021181           76 RSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--LKIGDFGLARTTSETDFMTEYVVTRWYRA  151 (316)
Q Consensus        76 ~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~a  151 (316)
                      ....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++......  .....+++.|+|
T Consensus       190 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~a  267 (429)
T 3kvw_A          190 KKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRA  267 (429)
T ss_dssp             HHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCC
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc--ccccCCCCCccC
Confidence            7754  4999999999999999999999999999999999999999987  999999998765433  334578999999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC--CC----
Q 021181          152 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML--PQ----  225 (316)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----  225 (316)
                      ||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.........  ...+....  +.    
T Consensus       268 PE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  344 (429)
T 3kvw_A          268 PEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR--AKNFVSSKGYPRYCTV  344 (429)
T ss_dssp             HHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT--HHHHBCTTSCBTTSCE
T ss_pred             hHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh--hhhccCCCCCcccccc
Confidence            999987 6789999999999999999999999999999999999998888877654322111  00110000  00    


Q ss_pred             -----------------------CCCCCcccc-CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          226 -----------------------FPKQNFSAR-FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       226 -----------------------~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                             .....+... ....++.+.+||++||++||++|||++|+|+||||++..
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             ECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             cccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence                                   000011111 124578899999999999999999999999999999754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-44  Score=337.98  Aligned_cols=235  Identities=27%  Similarity=0.432  Sum_probs=196.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||++..... .......+.+|+.+++.++||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus       205 ~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l~lVmEy~~gg~L~~~l~~~~  279 (576)
T 2acx_A          205 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMG  279 (576)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHSSS
T ss_pred             ECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcC
Confidence            467899999999965422 223446678999999999999999999999654     56999999995 79999987754


Q ss_pred             C--CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 D--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .  +++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++............+||+.|+|||++.+
T Consensus       280 ~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~  359 (576)
T 2acx_A          280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN  359 (576)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcC
Confidence            3  99999999999999999999999999999999999999999999999999988766555556789999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV----HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                       ..++.++|||||||++|+|++|.+||.+.+..    .....+...   +.                            .
T Consensus       360 -~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---~~----------------------------~  407 (576)
T 2acx_A          360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---PE----------------------------E  407 (576)
T ss_dssp             -CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---CC----------------------------C
T ss_pred             -CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---cc----------------------------c
Confidence             67899999999999999999999999876421    122222110   00                            0


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ....+|+++.+||++||+.||.+||     +++|+++||||++++
T Consensus       408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence            0135789999999999999999999     789999999999875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.7e-44  Score=316.65  Aligned_cols=234  Identities=24%  Similarity=0.373  Sum_probs=195.8

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh-cCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR-SHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~   79 (316)
                      +..+|+.||||++..... .......+.+|+.++++++||||+++++++...     ...++||||+.|+|.+.+. ...
T Consensus        75 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~g~l~~~l~~~~~  149 (348)
T 1u5q_A           75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKK  149 (348)
T ss_dssp             ETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTS
T ss_pred             EccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CeEEEEEecCCCCHHHHHHHhcC
Confidence            467899999999976432 333457788999999999999999999999654     5699999999999988875 456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  157 (316)
                      .+++.+++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......   ....+++.|+|||++..  
T Consensus       150 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~  226 (348)
T 1u5q_A          150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMD  226 (348)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhcccc
Confidence            7999999999999999999999999999999999999999999999999998765432   34578999999999852  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|.+||.+.+....+..+.......                             .....
T Consensus       227 ~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  277 (348)
T 1u5q_A          227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-----------------------------LQSGH  277 (348)
T ss_dssp             SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------------------------CCCTT
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------------------CCCCC
Confidence            3568899999999999999999999998887666555443311110                             01125


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      +++.+.++|.+||+.||.+|||++++++||||...
T Consensus       278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            68899999999999999999999999999999753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.1e-44  Score=311.34  Aligned_cols=237  Identities=25%  Similarity=0.352  Sum_probs=178.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh----c
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR----S   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~----~   77 (316)
                      +..+|+.||||+++...........+.++...++.++||||+++++++...     ...++||||++|+|.+++.    .
T Consensus        28 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~  102 (290)
T 3fme_A           28 HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GDVWICMELMDTSLDKFYKQVIDK  102 (290)
T ss_dssp             ETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SSEEEEEECCSEEHHHHHHHHHHT
T ss_pred             ecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CCEEEEEehhccchHHHHHHHHhc
Confidence            467899999999977654444455556666678889999999999999754     4599999999998877664    3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccc-
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL-  155 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~-  155 (316)
                      ...+++..++.++.||+.||+|||++ |++||||||+||+++.++.++|+|||.+.............++..|+|||.+ 
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~  182 (290)
T 3fme_A          103 GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN  182 (290)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcC
Confidence            57899999999999999999999997 9999999999999999999999999999877665555556789999999997 


Q ss_pred             --cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          156 --LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       156 --~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                        .....++.++|||||||++|+|++|..||...... ........... +.                            
T Consensus       183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------------------------  233 (290)
T 3fme_A          183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQ----------------------------  233 (290)
T ss_dssp             CCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CC----------------------------
T ss_pred             hhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CC----------------------------
Confidence              23367889999999999999999999999864332 22222222110 00                            


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      .....+++++.++|.+||+.||++|||++|+++||||+..
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            0112578899999999999999999999999999999754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.9e-44  Score=314.57  Aligned_cols=261  Identities=31%  Similarity=0.578  Sum_probs=198.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||+++..     ....+.+|+.++++++ ||||+++++++....   ....++||||++ ++|.+++.   
T Consensus        57 ~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~---  125 (330)
T 3nsz_A           57 NITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPALVFEHVNNTDFKQLYQ---  125 (330)
T ss_dssp             ETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEEEEEECCCCCCHHHHGG---
T ss_pred             ECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceEEEEeccCchhHHHHHH---
Confidence            5678999999998642     3456889999999997 999999999997532   256899999997 68888874   


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||++.............++..|+|||.+.+.
T Consensus       126 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (330)
T 3nsz_A          126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY  205 (330)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred             hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCC
Confidence            489999999999999999999999999999999999999777 8999999999877665555667889999999999776


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCcccc-ccccccchHHHhhhCCCCCCCCccc---
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGK-DYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLPQFPKQNFSA---  233 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---  233 (316)
                      ..++.++|||||||++|+|++|..||... +..+.+..+....+....... ..........+...........+..   
T Consensus       206 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (330)
T 3nsz_A          206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH  285 (330)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC
T ss_pred             CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcc
Confidence            77899999999999999999999998554 444555555444442211000 0000000000111111111111111   


Q ss_pred             --cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          234 --RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       234 --~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                        ....+++++.+||++||+.||.+|||++|+|+||||+++.
T Consensus       286 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          286 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence              1123789999999999999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-43  Score=307.89  Aligned_cols=240  Identities=29%  Similarity=0.489  Sum_probs=200.8

Q ss_pred             CCCCCceEEEEEecccccC-------hhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHH
Q 021181            2 NSETREEVAIKKIGNAFDN-------RIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLH   72 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~   72 (316)
                      ++.+|+.||||+++.....       ......+.+|+.+++++. ||||+++++++...     ...++||||++ ++|.
T Consensus        38 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~  112 (298)
T 1phk_A           38 HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGELF  112 (298)
T ss_dssp             ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHH
T ss_pred             EcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC-----CeEEEEEeccCCCcHH
Confidence            4678999999999654211       223466789999999995 99999999999654     56999999996 6999


Q ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCc
Q 021181           73 QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        73 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      +++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|+||
T Consensus       113 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  192 (298)
T 1phk_A          113 DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP  192 (298)
T ss_dssp             HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCH
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCH
Confidence            99988888999999999999999999999999999999999999999999999999999877665555566789999999


Q ss_pred             cccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          153 ELLL-----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       153 E~~~-----~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      |++.     ....++.++||||||+++|+|++|..||...+.......+.........                      
T Consensus       193 E~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------  250 (298)
T 1phk_A          193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS----------------------  250 (298)
T ss_dssp             HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------------------
T ss_pred             HHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc----------------------
Confidence            9985     2356788999999999999999999999888766665555442211110                      


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                           .....++..+.++|.+||+.||.+|||++++++||||++..
T Consensus       251 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          251 -----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             -----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             -----ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence                 11135788999999999999999999999999999999865

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.7e-44  Score=309.43  Aligned_cols=234  Identities=25%  Similarity=0.428  Sum_probs=195.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++..... .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+.+...+
T Consensus        30 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~  104 (279)
T 3fdn_A           30 EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLS  104 (279)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHS
T ss_pred             EccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----CEEEEEEecCCCCcHHHHHHhcC
Confidence            567899999999965422 222346688999999999999999999999654     56999999997 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+ .
T Consensus       105 ~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~  182 (279)
T 3fdn_A          105 KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG-R  182 (279)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTT-C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhcc-C
Confidence            89999999999999999999999999999999999999999999999999886544332 344578999999999977 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++||||||+++|+|++|..||...+.......+.......+                               ..++
T Consensus       183 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~  231 (279)
T 3fdn_A          183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP-------------------------------DFVT  231 (279)
T ss_dssp             CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-------------------------------TTSC
T ss_pred             CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC-------------------------------CcCC
Confidence            789999999999999999999999998877666665544222111                               2468


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +.+.++|.+||+.||.+|||++|+++||||+...
T Consensus       232 ~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          232 EGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            8899999999999999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-43  Score=306.98  Aligned_cols=240  Identities=28%  Similarity=0.443  Sum_probs=201.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++...+
T Consensus        36 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~  110 (294)
T 2rku_A           36 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRK  110 (294)
T ss_dssp             ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHC
T ss_pred             ECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHhcC
Confidence            467899999999976532 344567788999999999999999999999654     56999999997 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+ 
T Consensus       111 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  189 (294)
T 2rku_A          111 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-  189 (294)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc-
Confidence            8999999999999999999999999999999999999999999999999998776433 22344568899999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++||||||+++|+|++|..||......+....+......                               ....+
T Consensus       190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~  238 (294)
T 2rku_A          190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------------------------------IPKHI  238 (294)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-------------------------------CCTTS
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC-------------------------------Ccccc
Confidence            67899999999999999999999999887765554443321100                               11256


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE  278 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~  278 (316)
                      ++.+.++|.+||+.||++|||++++++||||++.......
T Consensus       239 ~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~  278 (294)
T 2rku_A          239 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  278 (294)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCC
Confidence            8889999999999999999999999999999876644443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.2e-44  Score=323.31  Aligned_cols=236  Identities=28%  Similarity=0.456  Sum_probs=182.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHH-hhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.+|+.||||+++..       ..+.+|+.++ +..+||||+++++++.... .+...+|+||||++ |+|.+++...+
T Consensus        83 ~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~  154 (400)
T 1nxk_A           83 NKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRG  154 (400)
T ss_dssp             ETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHCC-
T ss_pred             ECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEEEEeCCCCcHHHHHHHhC
Confidence            5679999999999532       2466888887 4558999999999985411 12256899999996 69999998754


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---CCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           80 --DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        80 --~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                        .+++.+++.++.||+.||.|||+.||+||||||+||+++.   ++.+||+|||++............++|+.|+|||+
T Consensus       155 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~  234 (400)
T 1nxk_A          155 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV  234 (400)
T ss_dssp             --CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhh
Confidence              5999999999999999999999999999999999999998   78899999999987765555566788999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH----QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      +.+ ..++.++|||||||++|+|++|..||.+.+...    ....+......                       .+   
T Consensus       235 ~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-----------------------~~---  287 (400)
T 1nxk_A          235 LGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-----------------------FP---  287 (400)
T ss_dssp             SCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-----------------------CC---
T ss_pred             cCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-----------------------CC---
Confidence            976 778999999999999999999999997664321    22222211100                       00   


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                       ......++.++.+||++||+.||.+|||++|+++||||.+..
T Consensus       288 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          288 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             -TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             -CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence             111246789999999999999999999999999999998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.3e-44  Score=312.56  Aligned_cols=238  Identities=26%  Similarity=0.424  Sum_probs=185.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||++...  .......+.+|+.++.++ +||||+++++++...     ..+|+||||++ |+|.+++...+
T Consensus        34 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  106 (316)
T 2ac3_A           34 NLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DRFYLVFEKMRGGSILSHIHKRR  106 (316)
T ss_dssp             CSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHS
T ss_pred             EcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHhccC
Confidence            5678999999999654  233456788999999985 799999999999654     56999999996 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC---EEEeeeccccccCCCC--------cccccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETD--------FMTEYVVTRW  148 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~--------~~~~~~~~~~  148 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.++.   ++|+|||++.......        ......++..
T Consensus       107 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~  186 (316)
T 2ac3_A          107 HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE  186 (316)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcC
Confidence            8999999999999999999999999999999999999988776   9999999887643221        1223458999


Q ss_pred             ccCcccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---------------HHHHHHHhhCCCCccccc
Q 021181          149 YRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH---------------QLRLITELIGSPDETSLG  209 (316)
Q Consensus       149 ~~aPE~~~~----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~  209 (316)
                      |+|||++..    ...++.++|||||||++|+|++|..||.+....+               ....+....         
T Consensus       187 y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~---------  257 (316)
T 2ac3_A          187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK---------  257 (316)
T ss_dssp             GCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC---------
T ss_pred             ccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC---------
Confidence            999999864    1347889999999999999999999997764211               111111110         


Q ss_pred             cccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                    ...+    ......+++.+.++|++||+.||.+|||++|+++||||++..
T Consensus       258 --------------~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          258 --------------YEFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             --------------CCCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             --------------cccC----chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence                          0000    111235789999999999999999999999999999998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.7e-44  Score=307.64  Aligned_cols=235  Identities=28%  Similarity=0.406  Sum_probs=189.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++..... .......+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++...+
T Consensus        32 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  106 (276)
T 2h6d_A           32 HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHG  106 (276)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHC
T ss_pred             ECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----CeEEEEEeccCCCcHHHHHhccC
Confidence            456899999999965422 223456788999999999999999999998654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.+++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+..
T Consensus       107 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  186 (276)
T 2h6d_A          107 RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL  186 (276)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCC
Confidence            89999999999999999999999999999999999999999999999999998776555455667899999999998744


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ..+.++||||||+++|+|++|..||...+.......+.......                               ...++
T Consensus       187 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~  235 (276)
T 2h6d_A          187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI-------------------------------PEYLN  235 (276)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTTSC
T ss_pred             CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC-------------------------------chhcC
Confidence            44689999999999999999999998877665555443311100                               12467


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ..+.++|.+||+.||.+|||++++++||||++.
T Consensus       236 ~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          236 RSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            889999999999999999999999999999764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.2e-44  Score=316.78  Aligned_cols=235  Identities=31%  Similarity=0.469  Sum_probs=190.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      ++.+|+.||||+++.....      ..+|++++.++ +||||+++++++.+.     ..+|+||||++ |+|.+.+...+
T Consensus        43 ~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~  111 (342)
T 2qr7_A           43 HKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDG-----KYVYVVTELMKGGELLDKILRQK  111 (342)
T ss_dssp             ETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCT
T ss_pred             ECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcC
Confidence            5678999999999764322      34688888887 799999999999654     56999999996 69999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC----CCEEEeeeccccccCCC-CccccccccccccCccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN----CDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~----~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~  154 (316)
                      .+++.+++.++.||+.||.|||++||+||||||+||++...    +.++|+|||++...... ......++++.|+|||+
T Consensus       112 ~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~  191 (342)
T 2qr7_A          112 FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV  191 (342)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHH
Confidence            99999999999999999999999999999999999998443    34999999999865433 23445678999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      +.+ ..++.++|||||||++|+|++|..||.+..   ..+....+.......+                           
T Consensus       192 ~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---------------------------  243 (342)
T 2qr7_A          192 LER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS---------------------------  243 (342)
T ss_dssp             HHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC---------------------------
T ss_pred             hcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC---------------------------
Confidence            976 568899999999999999999999997642   2233333322111110                           


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      ......+|+++.+||++||+.||++|||++++++||||.++...
T Consensus       244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  287 (342)
T 2qr7_A          244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL  287 (342)
T ss_dssp             STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence            11124679999999999999999999999999999999876543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-43  Score=312.14  Aligned_cols=237  Identities=24%  Similarity=0.393  Sum_probs=186.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---------------------------
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---------------------------   54 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---------------------------   54 (316)
                      ++.+|+.||||+++... .....+.+.+|+.++++++||||+++++++.....                           
T Consensus        27 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  105 (332)
T 3qd2_B           27 NKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPM  105 (332)
T ss_dssp             ETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------
T ss_pred             EcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcc
Confidence            46789999999997543 34456788999999999999999999999864321                           


Q ss_pred             -------------------------CCCCeEEEEEecCC-CcHHHHhhcCCC---CCHHHHHHHHHHHHHHHHHhhcCCc
Q 021181           55 -------------------------ETFNDVYIVYELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANV  105 (316)
Q Consensus        55 -------------------------~~~~~~~iv~e~~~-g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~i  105 (316)
                                               .....+++|||||+ |+|.+++.....   .++..++.++.||+.||+|||++||
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  185 (332)
T 3qd2_B          106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL  185 (332)
T ss_dssp             --------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCe
Confidence                                     11234899999996 699999987644   4566789999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCEEEeeeccccccCCCC-------------ccccccccccccCcccccCCCCCCCcchHHHHHH
Q 021181          106 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC  172 (316)
Q Consensus       106 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  172 (316)
                      +||||||+||+++.++.++|+|||++.......             ......+++.|+|||.+.+ ..++.++|||||||
T Consensus       186 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~  264 (332)
T 3qd2_B          186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGL  264 (332)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHH
T ss_pred             eecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHHHH
Confidence            999999999999999999999999988765432             2234568999999999987 67899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhccc
Q 021181          173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF  252 (316)
Q Consensus       173 ~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~  252 (316)
                      ++|+|++|..|+.     .....+........                           .......++++.++|.+||+.
T Consensus       265 il~el~~~~~~~~-----~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          265 ILFELLYSFSTQM-----ERVRIITDVRNLKF---------------------------PLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             HHHHHHSCCCCHH-----HHHHHHHHHHTTCC---------------------------CHHHHHHCHHHHHHHHHHHCS
T ss_pred             HHHHHHHcCCChh-----HHHHHHHHhhccCC---------------------------CcccccCChhHHHHHHHHccC
Confidence            9999999876652     22222221111110                           011123467789999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 021181          253 DPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       253 dP~~Rps~~ell~~~~f~~~  272 (316)
                      ||.+|||++|+++||||+++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCCC
T ss_pred             CCCcCCCHHHHhhchhhhcC
Confidence            99999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.5e-44  Score=307.63  Aligned_cols=240  Identities=30%  Similarity=0.479  Sum_probs=197.6

Q ss_pred             CCCCCceEEEEEecccccC----hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFDN----RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      +..+|+.||||+++.....    ......+.+|+.++++++||||+++++++...     ...++||||++ ++|.+++.
T Consensus        26 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~  100 (283)
T 3bhy_A           26 QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLA  100 (283)
T ss_dssp             ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHH
T ss_pred             EcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-----CeEEEEEeecCCCcHHHHHH
Confidence            4568999999999764322    22467789999999999999999999999654     56999999996 79999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC----CEEEeeeccccccCCCCccccccccccccCc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      ....+++.+++.++.||+.||.+||++|++|+||+|+||+++.++    .++|+|||.+.............++..|+||
T Consensus       101 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  180 (283)
T 3bhy_A          101 EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP  180 (283)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCc
Confidence            888899999999999999999999999999999999999998877    7999999999876655444556789999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |.+.+ ..++.++||||||+++|+|++|..||.+.+.......+.......+                           .
T Consensus       181 E~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~  232 (283)
T 3bhy_A          181 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD---------------------------E  232 (283)
T ss_dssp             HHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC---------------------------H
T ss_pred             ceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc---------------------------c
Confidence            99976 6789999999999999999999999988876665555443211111                           1


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ...+.++..+.++|.+||+.||.+|||++++++||||+.+..
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            122467889999999999999999999999999999987653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-43  Score=340.66  Aligned_cols=235  Identities=22%  Similarity=0.357  Sum_probs=201.7

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ++.+|+.||||+++... ........+..|..++..+ +||+|+++++++...     ..+|+||||++ |+|.+++...
T Consensus       362 ~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~  436 (674)
T 3pfq_A          362 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQV  436 (674)
T ss_dssp             ESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-----SEEEEEEECCCSCBHHHHHHHH
T ss_pred             ECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-----CEEEEEEeCcCCCcHHHHHHhc
Confidence            46789999999997642 2233456778899999888 799999999999654     56999999996 6999999988


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccC-CCCccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+
T Consensus       437 ~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~  516 (674)
T 3pfq_A          437 GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY  516 (674)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC
Confidence            899999999999999999999999999999999999999999999999999998643 3334556789999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|||++|.+||.+.+..+....+.......                               ...
T Consensus       517 -~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~  564 (674)
T 3pfq_A          517 -QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------------------------------PKS  564 (674)
T ss_dssp             -CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC-------------------------------CTT
T ss_pred             -CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-------------------------------Ccc
Confidence             789999999999999999999999999988777776665421111                               125


Q ss_pred             CChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~  273 (316)
                      +++++.+||++||+.||.+||++     +||++||||++++
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            78999999999999999999998     9999999999886

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.5e-43  Score=311.32  Aligned_cols=239  Identities=28%  Similarity=0.449  Sum_probs=201.9

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++....
T Consensus        62 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~  136 (335)
T 2owb_A           62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRK  136 (335)
T ss_dssp             ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHC
T ss_pred             ECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEEEecCCCCCHHHHHhccC
Confidence            46789999999997653 2344567788999999999999999999999654     56999999997 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... .......++..|+|||++.+ 
T Consensus       137 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  215 (335)
T 2owb_A          137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-  215 (335)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT-
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhcc-
Confidence            8999999999999999999999999999999999999999999999999998776433 22345678999999999987 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||......+....+......                               ....+
T Consensus       216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------------------~~~~~  264 (335)
T 2owb_A          216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------------------------------IPKHI  264 (335)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------------------------------CCTTS
T ss_pred             CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC-------------------------------CCccC
Confidence            67899999999999999999999999887766555544331110                               01256


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      ++.+.++|++||+.||.+|||++|+++||||++......
T Consensus       265 ~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~  303 (335)
T 2owb_A          265 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR  303 (335)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence            888999999999999999999999999999988664443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-43  Score=307.20  Aligned_cols=238  Identities=34%  Similarity=0.578  Sum_probs=201.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++............+.+|+.++++++||||+++++++...     ...++|||++. ++|.+.+...+.
T Consensus        43 ~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  117 (287)
T 2wei_A           43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKR  117 (287)
T ss_dssp             ETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSS
T ss_pred             EcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----CeEEEEEEccCCCCHHHHHHhcCC
Confidence            456899999999977655555677899999999999999999999998654     56999999996 699999888788


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC---CCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||.+||++|++|+||+|+||+++.+   +.++|+|||.+.............++..|+|||.+.+
T Consensus       118 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  197 (287)
T 2wei_A          118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG  197 (287)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC
Confidence            9999999999999999999999999999999999999764   4699999999987766555556678999999999865


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                        .++.++||||||+++|+|++|..||.+.+.......+.......+                           ......
T Consensus       198 --~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  248 (287)
T 2wei_A          198 --TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD---------------------------LPQWRT  248 (287)
T ss_dssp             --CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------------------SGGGTT
T ss_pred             --CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------------------chhhhh
Confidence              488999999999999999999999988876666655544211111                           011235


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++++.++|++||+.||.+|||++++++||||++..
T Consensus       249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            789999999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.2e-43  Score=302.82  Aligned_cols=238  Identities=26%  Similarity=0.372  Sum_probs=194.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++..... ......+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++.....
T Consensus        28 ~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  101 (276)
T 2yex_A           28 NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIG  101 (276)
T ss_dssp             ETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTB
T ss_pred             ECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEEEEEEEecCCCcHHHHHhhccC
Confidence            457899999999965432 33457788999999999999999999998654     56899999997 599999988788


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---CccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......   .......++..|+|||.+.+
T Consensus       102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (276)
T 2yex_A          102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (276)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc
Confidence            999999999999999999999999999999999999999999999999998765322   12344568899999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ-LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ....+.++||||||+++|+|++|..||...+.... ..........                             .....
T Consensus       182 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  232 (276)
T 2yex_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-----------------------------LNPWK  232 (276)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-----------------------------STTGG
T ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-----------------------------cCchh
Confidence            44457889999999999999999999987653322 2111110000                             01113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      .+++.+.++|.+||+.||.+|||++|+++||||++...
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            57889999999999999999999999999999987653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.3e-44  Score=325.24  Aligned_cols=237  Identities=35%  Similarity=0.553  Sum_probs=183.1

Q ss_pred             CCCCCceEEEEEecccccC------hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHH
Q 021181            2 NSETREEVAIKKIGNAFDN------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQI   74 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~   74 (316)
                      ++.+|+.||||++......      ......+.+|+.++++++||||+++++++..      ..+++||||++ |+|.+.
T Consensus       156 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~~lv~e~~~~g~L~~~  229 (419)
T 3i6u_A          156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDK  229 (419)
T ss_dssp             ETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES------SEEEEEEECCTTCBGGGG
T ss_pred             ECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec------CceEEEEEcCCCCcHHHH
Confidence            5678999999999754211      1122347899999999999999999999743      34799999996 699999


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccccCCCCccccccccccccC
Q 021181           75 IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETDFMTEYVVTRWYRA  151 (316)
Q Consensus        75 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~a  151 (316)
                      +...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||++.............+++.|+|
T Consensus       230 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~a  309 (419)
T 3i6u_A          230 VVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA  309 (419)
T ss_dssp             TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCC
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccC
Confidence            98888999999999999999999999999999999999999997654   499999999988776655567789999999


Q ss_pred             cccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          152 PELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL-RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       152 PE~~~~--~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      ||++.+  ...++.++|||||||++|+|++|.+||......... ..+.......                         
T Consensus       310 PE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~-------------------------  364 (419)
T 3i6u_A          310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-------------------------  364 (419)
T ss_dssp             TTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC-------------------------
T ss_pred             ceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC-------------------------
Confidence            999853  356778999999999999999999999765433222 2222111000                         


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                        .......+++.+.++|++||+.||.+|||++|+++||||++
T Consensus       365 --~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          365 --IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             --CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             --CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence              11222467899999999999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-43  Score=307.12  Aligned_cols=236  Identities=30%  Similarity=0.464  Sum_probs=195.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||+++...  ......+.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++...+.
T Consensus        30 ~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  102 (304)
T 2jam_A           30 QRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THYYLVMQLVSGGELFDRILERGV  102 (304)
T ss_dssp             ETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSC
T ss_pred             ECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEEEEEEcCCCccHHHHHHHcCC
Confidence            45789999999997542  22345688999999999999999999998654     56999999996 699999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE---ccCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++..++.++.||+.||.+||+.|++|+||+|+||++   +.++.++|+|||.+...... ......++..|+|||.+.+
T Consensus       103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~  181 (304)
T 2jam_A          103 YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ  181 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc
Confidence            9999999999999999999999999999999999999   78899999999998664432 2344568999999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||...+.......+........                           ......
T Consensus       182 -~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~  233 (304)
T 2jam_A          182 -KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE---------------------------SPFWDD  233 (304)
T ss_dssp             -CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC---------------------------TTTTTT
T ss_pred             -CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---------------------------cccccc
Confidence             6789999999999999999999999988876666665544221111                           011235


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +++.+.++|.+||+.||.+|||++++++||||++..
T Consensus       234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          234 ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            789999999999999999999999999999998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-43  Score=315.82  Aligned_cols=240  Identities=26%  Similarity=0.417  Sum_probs=192.5

Q ss_pred             CCCCCceEEEEEecccc---cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+|+.||||++....   ........+.+|+.++++++||||+++++++...     ...++||||++ |+|.+++..
T Consensus        47 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~  121 (345)
T 3hko_A           47 ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-----QYICLVMELCHGGHLLDKLNV  121 (345)
T ss_dssp             ETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHEEE
T ss_pred             ECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-----CeEEEEEeCCCCCcHHHHHHH
Confidence            56789999999996542   2344567889999999999999999999999654     56999999995 799998852


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE
Q 021181           78 ----------------------------------------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL  117 (316)
Q Consensus        78 ----------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~  117 (316)
                                                              ...+++..++.++.||+.||+|||+.||+||||||+||++
T Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  201 (345)
T 3hko_A          122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF  201 (345)
T ss_dssp             EEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE
Confidence                                                    1124678889999999999999999999999999999999


Q ss_pred             ccCC--CEEEeeeccccccCCCC-----ccccccccccccCcccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 021181          118 NANC--DLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY  189 (316)
Q Consensus       118 ~~~~--~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~  189 (316)
                      +.++  .++|+|||++.......     ......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+.
T Consensus       202 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (345)
T 3hko_A          202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND  281 (345)
T ss_dssp             SCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence            8776  89999999987643221     12456789999999998642 5688999999999999999999999998887


Q ss_pred             HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          190 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       190 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                      .+....+.........                           .....+++.+.++|.+||+.||.+||++.++++||||
T Consensus       282 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~  334 (345)
T 3hko_A          282 ADTISQVLNKKLCFEN---------------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI  334 (345)
T ss_dssp             HHHHHHHHHCCCCTTS---------------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred             HHHHHHHHhcccccCC---------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence            7766665542221111                           1112478899999999999999999999999999999


Q ss_pred             CCCC
Q 021181          270 APLH  273 (316)
Q Consensus       270 ~~~~  273 (316)
                      +++.
T Consensus       335 ~~~~  338 (345)
T 3hko_A          335 SQFS  338 (345)
T ss_dssp             HTTS
T ss_pred             ccCh
Confidence            9865

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.7e-43  Score=306.02  Aligned_cols=235  Identities=24%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++..... .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++...+
T Consensus        35 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  109 (284)
T 2vgo_A           35 EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----KRIYLMLEFAPRGELYKELQKHG  109 (284)
T ss_dssp             ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHS
T ss_pred             EcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----CEEEEEEEeCCCCcHHHHHHhcC
Confidence            456889999999965422 222346788999999999999999999999654     56999999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+ .
T Consensus       110 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~  187 (284)
T 2vgo_A          110 RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEG-K  187 (284)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTT-C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhcc-C
Confidence            89999999999999999999999999999999999999999999999999886654332 344578999999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++||||||+++|+|++|..||...+.......+......                               ..+.++
T Consensus       188 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~  236 (284)
T 2vgo_A          188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-------------------------------FPPFLS  236 (284)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-------------------------------CCTTSC
T ss_pred             CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC-------------------------------CCCcCC
Confidence            7899999999999999999999999887765555444321100                               013578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      .++.++|.+||+.||.+|||++++++||||+....
T Consensus       237 ~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          237 DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            89999999999999999999999999999986543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.2e-43  Score=303.57  Aligned_cols=230  Identities=23%  Similarity=0.295  Sum_probs=187.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +..+|+.||||+++...........+.+|+..+..+ +||||+++++++...     ...++||||++ ++|.+++... 
T Consensus        32 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  106 (289)
T 1x8b_A           32 KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENY  106 (289)
T ss_dssp             ETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHH
T ss_pred             EcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEEEEecCCCcHHHHHHhhc
Confidence            457899999999987666666778889999999999 999999999999654     56999999996 5999998764 


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-------------------CCEEEeeeccccccCC
Q 021181           79 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-------------------CDLKIGDFGLARTTSE  136 (316)
Q Consensus        79 ---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-------------------~~~~l~df~~~~~~~~  136 (316)
                         ..+++.+++.++.||+.||.|||++||+||||||+||+++.+                   ..++|+|||.+.....
T Consensus       107 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  186 (289)
T 1x8b_A          107 RIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS  186 (289)
T ss_dssp             HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence               679999999999999999999999999999999999999844                   4799999999877654


Q ss_pred             CCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccch
Q 021181          137 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA  216 (316)
Q Consensus       137 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  216 (316)
                      ..   ...++..|+|||.+.+...++.++|||||||++|+|++|.+++...+.   ...+..  +.              
T Consensus       187 ~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~--~~--------------  244 (289)
T 1x8b_A          187 PQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQ--GR--------------  244 (289)
T ss_dssp             SC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHT--TC--------------
T ss_pred             cc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHc--CC--------------
Confidence            32   345889999999998755667899999999999999999987754432   111111  00              


Q ss_pred             HHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          217 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                                    .......+++++.++|.+||+.||.+|||++++++||||++.
T Consensus       245 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          245 --------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             --------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             --------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                          011123578999999999999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.3e-43  Score=327.97  Aligned_cols=235  Identities=25%  Similarity=0.387  Sum_probs=194.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      ++.+|+.||||++..... .......+..|+.++++++||||+++++++...     ..+|+||||++ |+|.+++... 
T Consensus       206 ~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l~lVmE~~~gg~L~~~l~~~~  280 (543)
T 3c4z_A          206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVD  280 (543)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTSS
T ss_pred             ECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----CEEEEEEEeccCCCHHHHHHHhh
Confidence            467899999999976432 223346788999999999999999999999654     56999999996 6999998763 


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCccc
Q 021181           79 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPEL  154 (316)
Q Consensus        79 ---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~  154 (316)
                         ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ....+||+.|+|||+
T Consensus       281 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~  360 (543)
T 3c4z_A          281 EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL  360 (543)
T ss_dssp             TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHH
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhh
Confidence               4699999999999999999999999999999999999999999999999999987654433 344589999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      +.+ ..++.++|||||||++|+|++|.+||.+.+.    ......+.....                       .     
T Consensus       361 l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~-----------------------~-----  411 (543)
T 3c4z_A          361 LLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV-----------------------T-----  411 (543)
T ss_dssp             HTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-----------------------C-----
T ss_pred             hcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-----------------------C-----
Confidence            987 7799999999999999999999999987642    222222221100                       0     


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                         ....+++++.++|++||+.||.+||+     ++++++||||+++.
T Consensus       412 ---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          412 ---YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             ---CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence               01357899999999999999999996     58999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=304.55  Aligned_cols=235  Identities=28%  Similarity=0.444  Sum_probs=170.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      +..+|+.||||++..... .......+.+|+.++++++||||+++++++...     ...++||||++ ++|.+++... 
T Consensus        32 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  106 (278)
T 3cok_A           32 SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----NYVYLVLEMCHNGEMNRYLKNRV  106 (278)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHTCS
T ss_pred             EccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----CeEEEEEecCCCCcHHHHHhhcc
Confidence            457899999999965422 222346788999999999999999999999654     56999999996 6999998765 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      ..+++.+++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  186 (278)
T 3cok_A          107 KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR  186 (278)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC
Confidence            679999999999999999999999999999999999999999999999999987754322 2234568899999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||||+++|+|++|..||...+.......+..                              . .......
T Consensus       187 -~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------------------~-~~~~~~~  234 (278)
T 3cok_A          187 -SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------------------------A-DYEMPSF  234 (278)
T ss_dssp             ------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------------------------S-CCCCCTT
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------------------------c-ccCCccc
Confidence             6789999999999999999999999977653322221100                              0 0011135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ++.++.++|.+||+.||.+|||++++++||||.+..
T Consensus       235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            788999999999999999999999999999998643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=305.20  Aligned_cols=242  Identities=26%  Similarity=0.387  Sum_probs=196.2

Q ss_pred             CCCCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc--
Q 021181            2 NSETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS--   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~--   77 (316)
                      |..+|+.||||+++....  .......+.+|+.+++.++||||+++++++....   ....++||||++++|.+.+..  
T Consensus        26 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~  102 (305)
T 2wtk_C           26 DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---KQKMYMVMEYCVCGMQEMLDSVP  102 (305)
T ss_dssp             BTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------CEEEEEECCSEEHHHHHHHST
T ss_pred             ECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CCeEEEEehhccCCHHHHHHhCc
Confidence            567899999999976422  2335577899999999999999999999985432   256899999999888887765  


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---CccccccccccccCccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~  154 (316)
                      ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......   .......++..|+|||+
T Consensus       103 ~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  182 (305)
T 2wtk_C          103 EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI  182 (305)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhh
Confidence            456999999999999999999999999999999999999999999999999998765432   22334568999999999


Q ss_pred             ccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccc
Q 021181          155 LLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA  233 (316)
Q Consensus       155 ~~~~~-~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
                      +.+.. ..+.++||||||+++|+|++|..||.+.+.......+......                               
T Consensus       183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-------------------------------  231 (305)
T 2wtk_C          183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-------------------------------  231 (305)
T ss_dssp             HTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-------------------------------
T ss_pred             ccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC-------------------------------
Confidence            87522 2367999999999999999999999887766555544331100                               


Q ss_pred             cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       234 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      ....+++.+.++|.+||+.||.+|||++++++||||++......
T Consensus       232 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~  275 (305)
T 2wtk_C          232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE  275 (305)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred             CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence            11257889999999999999999999999999999998765443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=310.36  Aligned_cols=234  Identities=26%  Similarity=0.369  Sum_probs=187.1

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCC--CCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      .+|+.||||++............+.+|+.+++.++|  +||+++++++...     ..+++|||+.+++|.+++...+.+
T Consensus        31 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~  105 (343)
T 3dbq_A           31 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSI  105 (343)
T ss_dssp             TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHSCCC
T ss_pred             CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----CEEEEEEeCCCCCHHHHHHhcCCC
Confidence            468999999998766666677889999999999976  9999999998654     569999998788999999998999


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccC-
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLN-  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-  157 (316)
                      ++.+++.++.||+.||.|||+.||+||||||+||+++ ++.++|+|||++........   .....+++.|+|||++.+ 
T Consensus       106 ~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  184 (343)
T 3dbq_A          106 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM  184 (343)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhc
Confidence            9999999999999999999999999999999999997 67899999999977644322   235578999999999853 


Q ss_pred             ---------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          158 ---------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       158 ---------~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                               ...++.++|||||||++|+|++|..||...... .....+   .......                     
T Consensus       185 ~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~---------------------  240 (343)
T 3dbq_A          185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDPNHEI---------------------  240 (343)
T ss_dssp             C-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---HCTTSCC---------------------
T ss_pred             cccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH---hcCCccc---------------------
Confidence                     256788999999999999999999999765322 222211   1111100                     


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                           ......+.++.++|.+||+.||.+|||+.|+++||||+..
T Consensus       241 -----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          241 -----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             -----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             -----CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence                 0112356789999999999999999999999999999753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.6e-43  Score=308.21  Aligned_cols=259  Identities=31%  Similarity=0.533  Sum_probs=202.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCC------CccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhh
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE------NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR   76 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~   76 (316)
                      ..+|+.||||+++..   ......+.+|+.+++.++|+      +++++++++...     ..+++||||++++|.+++.
T Consensus        37 ~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~  108 (339)
T 1z57_A           37 KAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-----GHICIVFELLGLSTYDFIK  108 (339)
T ss_dssp             TTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHH
T ss_pred             CCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-----CcEEEEEcCCCCCHHHHHH
Confidence            457899999999643   33456788999999988655      499999998654     5699999999999999998


Q ss_pred             cCC--CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-------------------CCCEEEeeeccccccC
Q 021181           77 SHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------------------NCDLKIGDFGLARTTS  135 (316)
Q Consensus        77 ~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-------------------~~~~~l~df~~~~~~~  135 (316)
                      ..+  ++++.+++.++.||+.||+|||++||+||||||+||+++.                   ++.++|+|||.+....
T Consensus       109 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~  188 (339)
T 1z57_A          109 ENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD  188 (339)
T ss_dssp             HTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETT
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCc
Confidence            765  6899999999999999999999999999999999999987                   6789999999987654


Q ss_pred             CCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccc--
Q 021181          136 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS--  213 (316)
Q Consensus       136 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  213 (316)
                      ..  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+....+..+.........  
T Consensus       189 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  265 (339)
T 1z57_A          189 EH--HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK  265 (339)
T ss_dssp             SC--CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGG
T ss_pred             cc--cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchh
Confidence            33  245578999999999987 6789999999999999999999999999988888888888777665532211110  


Q ss_pred             ------------cchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          214 ------------DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       214 ------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                  ............ +...........++++.++|.+||+.||.+|||++|+++||||+.+.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          266 YFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             GEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             HHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence                        001111111000 00011111223467799999999999999999999999999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.1e-43  Score=309.13  Aligned_cols=239  Identities=34%  Similarity=0.545  Sum_probs=190.1

Q ss_pred             CCCCCceEEEEEeccccc------ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHH
Q 021181            2 NSETREEVAIKKIGNAFD------NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQI   74 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~   74 (316)
                      +..+|+.||||++.....      .......+.+|+.+++.++||||+++++++...      ..|+||||++ ++|.++
T Consensus        31 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~  104 (322)
T 2ycf_A           31 ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE------DYYIVLELMEGGELFDK  104 (322)
T ss_dssp             ETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEECCTTEETHHH
T ss_pred             EcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC------ceEEEEecCCCCcHHHH
Confidence            567899999999975421      112234578999999999999999999998543      2799999996 699999


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC---EEEeeeccccccCCCCccccccccccccC
Q 021181           75 IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRA  151 (316)
Q Consensus        75 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~a  151 (316)
                      +.....+++..++.++.||+.||.|||++||+||||+|+||+++.++.   ++|+|||++.............++..|+|
T Consensus       105 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~a  184 (322)
T 2ycf_A          105 VVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA  184 (322)
T ss_dssp             HSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCC
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccC
Confidence            988889999999999999999999999999999999999999987665   99999999987765544445678999999


Q ss_pred             ccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          152 PELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ-LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       152 PE~~~--~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      ||++.  +...++.++|||||||++|+|++|..||........ ...+.......                         
T Consensus       185 PE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------  239 (322)
T 2ycf_A          185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-------------------------  239 (322)
T ss_dssp             HHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-------------------------
T ss_pred             chhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-------------------------
Confidence            99974  236688999999999999999999999976543322 22222111000                         


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                        .......++..+.++|.+||+.||.+|||++++++||||++..
T Consensus       240 --~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          240 --IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             --CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             --CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence              0112236789999999999999999999999999999998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-44  Score=325.05  Aligned_cols=234  Identities=18%  Similarity=0.231  Sum_probs=181.1

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHH---HHhhCCCCCcccee-------eeecCCCC---------CCC---C
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIK---LLRHMDHENIIAIK-------DIIRPPQR---------ETF---N   58 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~---~l~~l~h~~i~~~~-------~~~~~~~~---------~~~---~   58 (316)
                      +..+|+.||||++.... ......+.+.+|+.   +++.++||||++++       +++...+.         ...   .
T Consensus        94 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  173 (377)
T 3byv_A           94 DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL  173 (377)
T ss_dssp             C-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEE
T ss_pred             ECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEE
Confidence            56789999999997542 34445678889994   55555899999998       44433210         000   0


Q ss_pred             eEEEEEecCCCcHHHHhhcCCCCCH-------HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181           59 DVYIVYELMDTDLHQIIRSHQDLTD-------DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus        59 ~~~iv~e~~~g~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      ..|++|||++|+|.+++...+.+++       ..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       174 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a  253 (377)
T 3byv_A          174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL  253 (377)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence            3789999999999999987655555       788889999999999999999999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCcccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC
Q 021181          132 RTTSETDFMTEYVVTRWYRAPELLLNC----------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG  201 (316)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  201 (316)
                      .....  ......+ ..|+|||++.+.          ..++.++|||||||++|+|++|+.||.+.+.......      
T Consensus       254 ~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~------  324 (377)
T 3byv_A          254 VRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW------  324 (377)
T ss_dssp             EETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG------
T ss_pred             eecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh------
Confidence            86443  2334566 899999999873          2689999999999999999999999965532111100      


Q ss_pred             CCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          202 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                                   .....+.+++++.++|.+||+.||.+|||+.++++||||+++.
T Consensus       325 -----------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          325 -----------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             -----------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             -----------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence                                         0111246789999999999999999999999999999997653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.6e-43  Score=302.39  Aligned_cols=237  Identities=29%  Similarity=0.411  Sum_probs=195.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+|+.||+|++............+.+|+.++++++||||+++++++....   ...+++||||++ ++|.+++...  
T Consensus        27 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~  103 (279)
T 2w5a_A           27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTLYIVMEYCEGGDLASVITKGTK  103 (279)
T ss_dssp             ETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTEEEEEEECCTTEEHHHHHHHHHH
T ss_pred             ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---CceEEEEEeCCCCCCHHHHHHhhcc
Confidence            4578999999999876556667788999999999999999999999875432   256999999996 5999998653  


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCC-----ceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-ccccccccccc
Q 021181           79 --QDLTDDHCRYFLYQLLRGLKYVHSAN-----VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYR  150 (316)
Q Consensus        79 --~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~  150 (316)
                        ..+++..++.++.||+.||++||+.|     ++|+||+|+||+++.++.++|+|||.+........ .....++..|+
T Consensus       104 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~  183 (279)
T 2w5a_A          104 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM  183 (279)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCcccc
Confidence              34999999999999999999999999     99999999999999999999999999877654322 23456789999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      |||.+.+ ..++.++||||||+++|+|++|..||...+.......+......                            
T Consensus       184 aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------  234 (279)
T 2w5a_A          184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----------------------------  234 (279)
T ss_dssp             CHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------------------------
T ss_pred             ChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc----------------------------
Confidence            9999987 67899999999999999999999999888766555554432110                            


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                        .....++.++.++|.+||+.||.+|||++|+++|+|+..-
T Consensus       235 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          235 --RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence              0112578899999999999999999999999999999763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.1e-43  Score=306.06  Aligned_cols=245  Identities=24%  Similarity=0.372  Sum_probs=176.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      +..+|+.||||++..... ......+.+|+.++++++||||+++++++...     ...++||||++ ++|.+++..   
T Consensus        36 ~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  109 (303)
T 2vwi_A           36 CAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DELWLVMKLLSGGSVLDIIKHIVA  109 (303)
T ss_dssp             C----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----SCEEEEEECCTTCBHHHHHHHHHH
T ss_pred             ECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CCcEEEehhccCCchHHHHHHHhh
Confidence            456899999999965432 33456788999999999999999999999655     45899999995 699998863   


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC------cccccccc
Q 021181           78 -----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD------FMTEYVVT  146 (316)
Q Consensus        78 -----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~  146 (316)
                           .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......      ......++
T Consensus       110 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~  189 (303)
T 2vwi_A          110 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT  189 (303)
T ss_dssp             TTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CC
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCC
Confidence                 4569999999999999999999999999999999999999999999999999987654321      12345688


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      ..|+|||++.+...++.++|||||||++|+|++|..||..............  +.......                  
T Consensus       190 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~------------------  249 (303)
T 2vwi_A          190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPSLET------------------  249 (303)
T ss_dssp             CTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCCTTC------------------
T ss_pred             ccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCcccc------------------
Confidence            9999999987545689999999999999999999999988765554433221  11100000                  


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                       ..........++.++.++|.+||+.||.+|||++++++||||++..
T Consensus       250 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          250 -GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             ------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             -ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence             0001122346789999999999999999999999999999999765

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-42  Score=312.62  Aligned_cols=234  Identities=24%  Similarity=0.356  Sum_probs=188.0

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCC--CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~   82 (316)
                      +|+.||||++............+.+|+.+++.+.  ||||+++++++...     ..+|+|||+.+++|.+++.....++
T Consensus        79 ~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~E~~~~~L~~~l~~~~~~~  153 (390)
T 2zmd_A           79 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSID  153 (390)
T ss_dssp             TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHCSSCC
T ss_pred             CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----CEEEEEEecCCCCHHHHHHhcCCCC
Confidence            4899999999876556667788999999999996  59999999998655     4599999977789999999988999


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcccccC--
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~--  157 (316)
                      +.+++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......   ......+|+.|+|||++.+  
T Consensus       154 ~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  232 (390)
T 2zmd_A          154 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS  232 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcc
Confidence            999999999999999999999999999999999995 5889999999998764432   1235678999999999864  


Q ss_pred             --------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          158 --------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       158 --------~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                              ...++.++|||||||++|+|++|.+||...... ..+..+.   ......                      
T Consensus       233 ~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~---~~~~~~----------------------  287 (390)
T 2zmd_A          233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHEI----------------------  287 (390)
T ss_dssp             -----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---CTTSCC----------------------
T ss_pred             ccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh---CccccC----------------------
Confidence                    136888999999999999999999999765422 2222221   111000                      


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                          ......+.++.+||.+||+.||.+|||++|+++||||+...
T Consensus       288 ----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          288 ----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             ----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ----CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                00113477899999999999999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-43  Score=310.86  Aligned_cols=243  Identities=24%  Similarity=0.347  Sum_probs=193.8

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||+++.... .......+.+|+.++++++||||+++++++..... .....|+||||++ ++|.+++...+
T Consensus        33 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~lv~e~~~g~~L~~~l~~~~  111 (311)
T 3ork_A           33 DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGPLPYIVMEYVDGVTLRDIVHTEG  111 (311)
T ss_dssp             ETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEEEEEEEEECCCEEEHHHHHHHHC
T ss_pred             ECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCcccEEEEecCCCCCHHHHHHhcC
Confidence            567899999999977533 33445778899999999999999999999865431 1134699999996 69999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----ccccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~  155 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......    ......++..|+|||.+
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  191 (311)
T 3ork_A          112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA  191 (311)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHh
Confidence            99999999999999999999999999999999999999999999999999987654332    12345689999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|..||.+.+.......+......++                           ....
T Consensus       192 ~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~  243 (311)
T 3ork_A          192 RG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------------------------SARH  243 (311)
T ss_dssp             HT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---------------------------HHHS
T ss_pred             cC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---------------------------cccc
Confidence            87 6789999999999999999999999988876655544433211111                           1112


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ..+++++.++|.+||+.||.+||++.+++.|+|++...
T Consensus       244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            36789999999999999999999999999999997544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-42  Score=311.99  Aligned_cols=259  Identities=32%  Similarity=0.540  Sum_probs=199.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CC-----CccceeeeecCCCCCCCCeEEEEEecCCCcHHHHh
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HE-----NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII   75 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l   75 (316)
                      |..+|+.||||+++..   ......+..|+.+++.++ |+     +|+++++++...     ..+++||||++|+|.+++
T Consensus        75 ~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l  146 (382)
T 2vx3_A           75 DRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-----NHLCLVFEMLSYNLYDLL  146 (382)
T ss_dssp             ETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-----TEEEEEEECCCCBHHHHH
T ss_pred             EcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-----CceEEEEecCCCCHHHHH
Confidence            5678999999999643   334566778888888874 55     489999988654     569999999999999999


Q ss_pred             hcC--CCCCHHHHHHHHHHHHHHHHHhh--cCCceeccCCCCcEEEc--cCCCEEEeeeccccccCCCCccccccccccc
Q 021181           76 RSH--QDLTDDHCRYFLYQLLRGLKYVH--SANVLHRDLKPSNLLLN--ANCDLKIGDFGLARTTSETDFMTEYVVTRWY  149 (316)
Q Consensus        76 ~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (316)
                      ...  +.+++..++.++.||+.||.|||  +.||+||||||+||+++  .++.+||+|||++......  .....+++.|
T Consensus       147 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y  224 (382)
T 2vx3_A          147 RNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFY  224 (382)
T ss_dssp             HHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGG
T ss_pred             hhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccc
Confidence            775  46999999999999999999999  57999999999999994  5788999999999876543  3456789999


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC--
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP--  227 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  227 (316)
                      +|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.......+.  ...+....+...  
T Consensus       225 ~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  301 (382)
T 2vx3_A          225 RSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK--ARKFFEKLPDGTWN  301 (382)
T ss_dssp             CCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT--HHHHEEECTTSCEE
T ss_pred             cChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH--HHHHHHhccccccc
Confidence            99999987 6789999999999999999999999999998899998888888776543322111  111111111000  


Q ss_pred             ------------C---CCc-----------cccCCC-------CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          228 ------------K---QNF-----------SARFPN-------KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       228 ------------~---~~~-----------~~~~~~-------~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                  .   ..+           ......       .++++.+||++||++||++|||++|+|+||||++..
T Consensus       302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             ECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             cccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence                        0   000           000000       114789999999999999999999999999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=308.41  Aligned_cols=260  Identities=17%  Similarity=0.280  Sum_probs=191.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||+++.... ......+.+|+.++++++||||+++++++.....   ...++||||++ |+|.+++.....
T Consensus        30 ~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  105 (319)
T 4euu_A           30 HKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSN  105 (319)
T ss_dssp             ETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEEEEEECCTTCBHHHHHHSGGG
T ss_pred             ECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC---ceEEEEEeCCCCCCHHHHHHHhcc
Confidence            567899999999975432 2235667899999999999999999999875432   46899999996 799999976433


Q ss_pred             ---CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE----ccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           81 ---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        81 ---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                         +++.+++.++.||+.||+|||++||+||||||+||++    +.++.+||+|||++.............++..|+|||
T Consensus       106 ~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  185 (319)
T 4euu_A          106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD  185 (319)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHH
Confidence               9999999999999999999999999999999999999    777889999999998876666556677899999999


Q ss_pred             cccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCCccccccccccchHHHhhhCCC
Q 021181          154 LLLN-------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ  225 (316)
Q Consensus       154 ~~~~-------~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (316)
                      ++..       ...++.++|||||||++|+|++|..||....... ....+.......+...+.......... ......
T Consensus       186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~  264 (319)
T 4euu_A          186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP-IDWSGD  264 (319)
T ss_dssp             HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCC-EEEESS
T ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCc-cccCcc
Confidence            9862       2678899999999999999999999997654322 222222222222211111110000000 000000


Q ss_pred             CCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021181          226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY  268 (316)
Q Consensus       226 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~  268 (316)
                      .+  ........++..+.++|++||+.||++|||++|+++||-
T Consensus       265 ~~--~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          265 MP--VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CC--TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CC--cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            00  000111234567999999999999999999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-42  Score=301.20  Aligned_cols=237  Identities=24%  Similarity=0.382  Sum_probs=189.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      +..+|+.||+|++...  .......+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++.. ..
T Consensus        40 ~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~  112 (302)
T 2j7t_A           40 NKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLWIMIEFCPGGAVDAIMLELDR  112 (302)
T ss_dssp             ETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEEEEECCTTEEHHHHHHHHTS
T ss_pred             EcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEEEEEEeCCCCcHHHHHHhhcc
Confidence            4578999999999654  333456788999999999999999999999654     45899999996 588888765 56


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCccccc--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLL--  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~--  156 (316)
                      .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.  
T Consensus       113 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  192 (302)
T 2j7t_A          113 GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE  192 (302)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccc
Confidence            7999999999999999999999999999999999999999999999999987542211 1123456789999999984  


Q ss_pred             --CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          157 --NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       157 --~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                        ....++.++|||||||++|+|++|..||...+.......+........                            ..
T Consensus       193 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~  244 (302)
T 2j7t_A          193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL----------------------------LT  244 (302)
T ss_dssp             HTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------------------------SS
T ss_pred             cCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc----------------------------CC
Confidence              336788999999999999999999999988876665554433211100                            01


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...++..+.++|.+||+.||.+|||++++++||||+++.
T Consensus       245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            124688899999999999999999999999999998754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.6e-43  Score=317.03  Aligned_cols=261  Identities=29%  Similarity=0.449  Sum_probs=197.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC--------CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHH
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~   73 (316)
                      |..+|+.||||+++..   ......+.+|+.+++.++        |+||+++++++.... .....+++||||++++|.+
T Consensus        58 ~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~  133 (397)
T 1wak_A           58 DIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-VNGTHICMVFEVLGHHLLK  133 (397)
T ss_dssp             ETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-TTEEEEEEEECCCCCBHHH
T ss_pred             ecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-CCCceEEEEEeccCccHHH
Confidence            5678999999999643   344567889999999985        788999999986321 1225799999999988888


Q ss_pred             HhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCC-----------------------------
Q 021181           74 IIRSH--QDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANC-----------------------------  121 (316)
Q Consensus        74 ~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~-----------------------------  121 (316)
                      .+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++                             
T Consensus       134 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (397)
T 1wak_A          134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA  213 (397)
T ss_dssp             HHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC------------------
T ss_pred             HHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccC
Confidence            77654  4699999999999999999999998 999999999999998775                             


Q ss_pred             --------------------CEEEeeeccccccCCCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 021181          122 --------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       122 --------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~  181 (316)
                                          .++|+|||.+......  .....+|..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~  290 (397)
T 1wak_A          214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGD  290 (397)
T ss_dssp             ---CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCC
Confidence                                7999999999776543  344578999999999987 67899999999999999999999


Q ss_pred             CCCCCCC------cHHHHHHHHHhhCCCCccccccccccchHHHhhh---CCCCCCCCc----------cccCCCCChHH
Q 021181          182 PLFPGKD------YVHQLRLITELIGSPDETSLGFLRSDNARRYVRM---LPQFPKQNF----------SARFPNKSPGA  242 (316)
Q Consensus       182 ~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~----------~~~~~~~s~~l  242 (316)
                      .||...+      ....+..+....+.++...+......  ..+...   .........          .......+..+
T Consensus       291 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
T 1wak_A          291 YLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF  368 (397)
T ss_dssp             CSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHH
T ss_pred             CCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCccccccccccCCcchhHhhhhhcccchhhHHHH
Confidence            9998765      34556667777776654322100000  000000   000000000          00011235678


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          243 VDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       243 ~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      .+||.+||+.||++|||++|+|+||||++
T Consensus       369 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          369 TDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            99999999999999999999999999974

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-42  Score=300.26  Aligned_cols=232  Identities=23%  Similarity=0.351  Sum_probs=186.0

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC---
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD---   80 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~---   80 (316)
                      +|+.||||++............+.+|+.++++++||||+++++++...     ..+++||||++ |+|.+++...+.   
T Consensus        59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~  133 (309)
T 3p86_A           59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQ  133 (309)
T ss_dssp             TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TCCEEEEECCTTCBHHHHHHSTTHHHH
T ss_pred             CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CceEEEEecCCCCcHHHHHhhcCCCCC
Confidence            688999999987666666678899999999999999999999999654     45899999996 699999987654   


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++..++.++.||+.||+|||+.|  |+||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  213 (309)
T 3p86_A          134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD  213 (309)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcC
Confidence            999999999999999999999999  9999999999999999999999999987654332 2345678999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+.......+.......                             .....
T Consensus       214 -~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  263 (309)
T 3p86_A          214 -EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-----------------------------EIPRN  263 (309)
T ss_dssp             -CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-----------------------------CCCTT
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------------------------CCCcc
Confidence             678999999999999999999999998887666555443211111                             11135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~  271 (316)
                      +++++.++|.+||+.||.+|||++++++  .+++++
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            7899999999999999999999999987  555554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=302.14  Aligned_cols=234  Identities=27%  Similarity=0.429  Sum_probs=194.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh-cCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR-SHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~-~~~   79 (316)
                      +..+|+.||||++....    ....+.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++. ...
T Consensus        50 ~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~  120 (314)
T 3com_A           50 HKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIIRLRNK  120 (314)
T ss_dssp             ETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTC
T ss_pred             ECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEeecCCCCCHHHHHHhcCC
Confidence            46789999999996532    345688999999999999999999998654     56899999997 59999986 457


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ 
T Consensus       121 ~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  199 (314)
T 3com_A          121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-  199 (314)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS-
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC-
Confidence            89999999999999999999999999999999999999999999999999987654432 2344568899999999977 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++||||||+++|+|++|..||...+.......+.....  ...                          .....+
T Consensus       200 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~  251 (314)
T 3com_A          200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--PTF--------------------------RKPELW  251 (314)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCC--------------------------SSGGGS
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--ccc--------------------------CCcccC
Confidence            6789999999999999999999999988775554443322111  000                          001246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +..+.++|.+||+.||.+|||++++++||||++..
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            88899999999999999999999999999998765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-42  Score=311.15  Aligned_cols=262  Identities=21%  Similarity=0.327  Sum_probs=196.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++...+.
T Consensus        54 ~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  127 (360)
T 3eqc_A           54 HKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGR  127 (360)
T ss_dssp             ETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSS
T ss_pred             ECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEEEEEEECCCCCCHHHHHHHcCC
Confidence            46789999999997652 445567889999999999999999999999654     56999999996 599999998889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.|++.||.|||+. ||+|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+ .
T Consensus       128 ~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~  205 (360)
T 3eqc_A          128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-T  205 (360)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC-C
Confidence            99999999999999999999986 9999999999999999999999999988654322 2234578999999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC-CCccccc-c-------------ccccchHHHhhhCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS-PDETSLG-F-------------LRSDNARRYVRMLP  224 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~-~-------------~~~~~~~~~~~~~~  224 (316)
                      .++.++|||||||++|+|++|..||...+.......+...... ....... .             ..............
T Consensus       206 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (360)
T 3eqc_A          206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV  285 (360)
T ss_dssp             CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHh
Confidence            7899999999999999999999999887755543332111110 0000000 0             00000000000000


Q ss_pred             CCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       225 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...  ........++.++.+||++||+.||.+|||++|+++||||++..
T Consensus       286 ~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          286 NEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             HSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence            000  00111134788999999999999999999999999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.9e-42  Score=298.67  Aligned_cols=232  Identities=26%  Similarity=0.399  Sum_probs=195.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||++..... ......+.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++.. +.
T Consensus        43 ~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~  115 (303)
T 3a7i_A           43 DNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GP  115 (303)
T ss_dssp             ETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHTT-SC
T ss_pred             ECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEEEeCCCCcHHHHHhc-CC
Confidence            467899999999976532 33467789999999999999999999998654     56999999997 599998865 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ .
T Consensus       116 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  194 (303)
T 3a7i_A          116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-S  194 (303)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc-C
Confidence            9999999999999999999999999999999999999999999999999987765433 2345578899999999977 6


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++||||||+++|+|++|..||...+.......+....  +                            ......++
T Consensus       195 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------------------------~~~~~~~~  244 (303)
T 3a7i_A          195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P----------------------------PTLEGNYS  244 (303)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------------------------CCCCSSCC
T ss_pred             CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------------------------CCCccccC
Confidence            78899999999999999999999998877655544433211  0                            01113578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ..+.++|.+||+.||.+|||++++++||||.+
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            89999999999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.5e-42  Score=305.34  Aligned_cols=259  Identities=29%  Similarity=0.512  Sum_probs=200.5

Q ss_pred             CCCCC-ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC------ccceeeeecCCCCCCCCeEEEEEecCCCcHHHH
Q 021181            2 NSETR-EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN------IIAIKDIIRPPQRETFNDVYIVYELMDTDLHQI   74 (316)
Q Consensus         2 d~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~   74 (316)
                      |..++ +.||||+++..   ......+.+|+.+++.++|++      ++.+++++...     ..+++||||++++|.+.
T Consensus        40 ~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~l~~~  111 (355)
T 2eu9_A           40 DHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-----GHMCIAFELLGKNTFEF  111 (355)
T ss_dssp             ETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-----TEEEEEEECCCCBHHHH
T ss_pred             ecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-----CeEEEEEeccCCChHHH
Confidence            34455 79999999642   334567788999999987655      88888888654     56999999999999888


Q ss_pred             hhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE-------------------ccCCCEEEeeeccccc
Q 021181           75 IRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-------------------NANCDLKIGDFGLART  133 (316)
Q Consensus        75 l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~-------------------~~~~~~~l~df~~~~~  133 (316)
                      +....  .+++.+++.++.||+.||+|||++||+||||||+||++                   +.++.++|+|||++..
T Consensus       112 l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~  191 (355)
T 2eu9_A          112 LKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF  191 (355)
T ss_dssp             HHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEE
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccc
Confidence            87653  69999999999999999999999999999999999999                   6788999999999876


Q ss_pred             cCCCCccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccc
Q 021181          134 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS  213 (316)
Q Consensus       134 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  213 (316)
                      ....  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....+..+.........
T Consensus       192 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  268 (355)
T 2eu9_A          192 DHEH--HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK  268 (355)
T ss_dssp             TTSC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSC
T ss_pred             cccc--ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccc
Confidence            5433  244578999999999987 6789999999999999999999999999988888888888877766532211100


Q ss_pred             c--------------chHHHhhh-CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          214 D--------------NARRYVRM-LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       214 ~--------------~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .              ....+... ....  ..........+.++.+||++||+.||.+|||++|+++||||+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          269 QKYFYKGGLVWDENSSDGRYVKENCKPL--KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             GGGEETTEECCCTTSHHHHHHHHHCCCG--GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             hhhhcccccccccccchhccccccCCcc--cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence            0              00001100 0000  000011122356799999999999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-43  Score=311.85  Aligned_cols=238  Identities=21%  Similarity=0.366  Sum_probs=189.6

Q ss_pred             CCCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            3 SETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +.+|+.||||+++....  .......+.+|+.+++.+ +||||+++++++...     ..+++||||++ |+|.+++...
T Consensus        79 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  153 (355)
T 1vzo_A           79 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQR  153 (355)
T ss_dssp             TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHH
T ss_pred             CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-----ceEEEEeecCCCCCHHHHHHHc
Confidence            46899999999975421  122334567899999999 699999999998654     56999999996 6999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  ......+|..|+|||++.
T Consensus       154 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  233 (355)
T 1vzo_A          154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR  233 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhc
Confidence            889999999999999999999999999999999999999999999999999987654322  223457899999999987


Q ss_pred             CC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-hhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          157 NC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE-LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       157 ~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      +. ..++.++|||||||++|+|++|..||...........+.. .....+                            ..
T Consensus       234 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------~~  285 (355)
T 1vzo_A          234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----------------------------PY  285 (355)
T ss_dssp             TCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC----------------------------CC
T ss_pred             CCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC----------------------------CC
Confidence            52 3578899999999999999999999975432221111111 110000                            01


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      ...++..+.++|.+||..||.+||     +++|+++||||+++.
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            135788899999999999999999     999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.2e-42  Score=307.82  Aligned_cols=269  Identities=27%  Similarity=0.426  Sum_probs=199.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-----------CCCccceeeeecCCCCCCCCeEEEEEecCCCc
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-----------HENIIAIKDIIRPPQRETFNDVYIVYELMDTD   70 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~   70 (316)
                      |..+|+.||||++..   .......+.+|+.+++++.           |+||+++++++...+ .....++++||+++++
T Consensus        40 ~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~  115 (373)
T 1q8y_A           40 DMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG-PNGVHVVMVFEVLGEN  115 (373)
T ss_dssp             ETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE-TTEEEEEEEECCCCEE
T ss_pred             ecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC-CCCceEEEEEecCCCC
Confidence            467899999999964   2334566788999998886           899999999987542 1224689999999889


Q ss_pred             HHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEcc------CCCEEEeeeccccccCCCCccc
Q 021181           71 LHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNA------NCDLKIGDFGLARTTSETDFMT  141 (316)
Q Consensus        71 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~------~~~~~l~df~~~~~~~~~~~~~  141 (316)
                      |.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+||+++.      .+.++|+|||++......  ..
T Consensus       116 L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~  193 (373)
T 1q8y_A          116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YT  193 (373)
T ss_dssp             HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CC
T ss_pred             HHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CC
Confidence            99998763  4599999999999999999999998 9999999999999953      347999999998776543  23


Q ss_pred             cccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHhhCCCCccccccccccc
Q 021181          142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD------YVHQLRLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       142 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                      ...++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+      ....+..+....+..+.......... 
T Consensus       194 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-  271 (373)
T 1q8y_A          194 NSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT-  271 (373)
T ss_dssp             SCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTH-
T ss_pred             CCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchh-
Confidence            4578999999999987 678999999999999999999999998654      44556667777776654322111000 


Q ss_pred             hHHHhhh---CCCCCCCCc----------cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 021181          216 ARRYVRM---LPQFPKQNF----------SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP  279 (316)
Q Consensus       216 ~~~~~~~---~~~~~~~~~----------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~  279 (316)
                       ..+...   .........          ......++.++.+||.+||+.||.+|||++|+++||||++........
T Consensus       272 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~  347 (373)
T 1q8y_A          272 -RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR  347 (373)
T ss_dssp             -HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCC
T ss_pred             -hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCccccc
Confidence             000000   000000000          000123467799999999999999999999999999999987555533

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-42  Score=307.61  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=193.4

Q ss_pred             CCceEEEEEecccccChh---------------HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-
Q 021181            5 TREEVAIKKIGNAFDNRI---------------DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-   68 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-   68 (316)
                      +|+.||||++........               ....+.+|+.++++++||||+++++++...     ...++||||++ 
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~  127 (348)
T 2pml_X           53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMEN  127 (348)
T ss_dssp             TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS-----SEEEEEEECCTT
T ss_pred             CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEEEEEeccCC
Confidence            789999999975432211               117789999999999999999999999654     56999999997 


Q ss_pred             CcHHHH------hhc--CCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc
Q 021181           69 TDLHQI------IRS--HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF  139 (316)
Q Consensus        69 g~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  139 (316)
                      |+|.++      +..  ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus       128 ~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~  206 (348)
T 2pml_X          128 DSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-K  206 (348)
T ss_dssp             CBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-E
T ss_pred             CcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-c
Confidence            599988      665  5779999999999999999999998 99999999999999999999999999998776443 3


Q ss_pred             cccccccccccCcccccCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHhhCCCCccccccccccchH
Q 021181          140 MTEYVVTRWYRAPELLLNCSEYTA-AIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPDETSLGFLRSDNAR  217 (316)
Q Consensus       140 ~~~~~~~~~~~aPE~~~~~~~~~~-~~DiwslG~~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (316)
                      .....++..|+|||.+.+...++. ++|||||||++|+|++|..||...+. ......+.......+......       
T Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~-------  279 (348)
T 2pml_X          207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHF-------  279 (348)
T ss_dssp             ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSS-------
T ss_pred             ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhh-------
Confidence            345678999999999987435555 99999999999999999999988765 444444432211111100000       


Q ss_pred             HHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                        .   ..............++.++.++|.+||+.||.+|||++|+++||||++.
T Consensus       280 --~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          280 --L---YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             --T---TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             --h---ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence              0   0000011112224689999999999999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=295.36  Aligned_cols=237  Identities=26%  Similarity=0.402  Sum_probs=187.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      |..+|+.||||++...  .......+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++...  
T Consensus        43 ~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  115 (295)
T 2clq_A           43 DLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFMEQVPGGSLSALLRSKWG  115 (295)
T ss_dssp             ETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEEHHHHHHHTTC
T ss_pred             ECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEEEeCCCCCHHHHHHhhcc
Confidence            4678999999999654  333456788999999999999999999999654     56999999996 6999998765  


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-CCCEEEeeeccccccCCCC-ccccccccccccCcccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~  155 (316)
                       ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+....... ......++..|+|||++
T Consensus       116 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  195 (295)
T 2clq_A          116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII  195 (295)
T ss_dssp             CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHH
T ss_pred             CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhh
Confidence             24678999999999999999999999999999999999987 8999999999987754432 23455788999999998


Q ss_pred             cCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~-~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .+. ..++.++||||||+++|+|++|..||...................+                            ..
T Consensus       196 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------~~  247 (295)
T 2clq_A          196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP----------------------------EI  247 (295)
T ss_dssp             HHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC----------------------------CC
T ss_pred             cCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc----------------------------cc
Confidence            652 2378899999999999999999999976543332221111111110                            11


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...+++++.++|.+||+.||.+|||++++++||||+...
T Consensus       248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            135788999999999999999999999999999998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.9e-43  Score=314.11  Aligned_cols=248  Identities=16%  Similarity=0.163  Sum_probs=174.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhC--CCCCcccee-------eeecCCCCC------------CCCe
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM--DHENIIAIK-------DIIRPPQRE------------TFND   59 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~~i~~~~-------~~~~~~~~~------------~~~~   59 (316)
                      |..+|+.||||++..... .......+.+|+.+++.+  +||||++++       +++...+..            ....
T Consensus        83 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~  162 (371)
T 3q60_A           83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN  162 (371)
T ss_dssp             ETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEE
T ss_pred             ECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeee
Confidence            467899999999987543 334456677885555444  699988755       333322110            0144


Q ss_pred             EEEEEecCCCcHHHHhhcC-CCCCHHHH------HHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeecccc
Q 021181           60 VYIVYELMDTDLHQIIRSH-QDLTDDHC------RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus        60 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      +|+||||++|+|.+++... ..+....+      ..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       163 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~  242 (371)
T 3q60_A          163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW  242 (371)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEE
T ss_pred             EEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceee
Confidence            8999999999999999763 33455555      6777999999999999999999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCcccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccc
Q 021181          133 TTSETDFMTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL  211 (316)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  211 (316)
                      ..+...  ....++..|+|||++.+ ...++.++|||||||++|+|++|+.||.+.......             ..   
T Consensus       243 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------------~~---  304 (371)
T 3q60_A          243 KVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-------------SW---  304 (371)
T ss_dssp             ETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-------------CC---
T ss_pred             ecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-------------ch---
Confidence            765332  24456699999999864 246899999999999999999999999766321000             00   


Q ss_pred             cccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          212 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...      ...............+.+++.+.+||.+||+.||++|||++++++||||+++.
T Consensus       305 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          305 KRP------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             CBC------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             hhh------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            000      00000000001112247899999999999999999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=298.17  Aligned_cols=239  Identities=21%  Similarity=0.293  Sum_probs=180.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      +..+|+.||||++............+..+..+++.++||||+++++++...     ..+++||||+++.+..+... ...
T Consensus        46 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~~l~~~~~~~  120 (318)
T 2dyl_A           46 FRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKKRMQGP  120 (318)
T ss_dssp             ETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHTSC
T ss_pred             EecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CcEEEEEeccCCcHHHHHHHhccC
Confidence            457899999999976544444445555666678888999999999999654     56999999997666655543 567


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc---
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---  156 (316)
                      +++..++.++.||+.||.|||++ |++|+||+|+||+++.++.++|+|||++.............++..|+|||.+.   
T Consensus       121 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  200 (318)
T 2dyl_A          121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD  200 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC---
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhccccc
Confidence            99999999999999999999985 99999999999999999999999999987765554445567899999999985   


Q ss_pred             -CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          157 -NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       157 -~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                       ....++.++|||||||++|+|++|..||.... .......+....  .+.                          ...
T Consensus       201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~--------------------------~~~  252 (318)
T 2dyl_A          201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PPL--------------------------LPG  252 (318)
T ss_dssp             -----CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CCC--------------------------CCS
T ss_pred             ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CCC--------------------------CCc
Confidence             23567889999999999999999999998753 333333332211  100                          001


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...+++++.++|.+||+.||.+||+++++++||||+++.
T Consensus       253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            125789999999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=300.21  Aligned_cols=239  Identities=23%  Similarity=0.380  Sum_probs=187.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCC-CCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR-ETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      +..+|+.||||++.....   ....+.+|+.+++++ +||||+++++++..... .....+++||||++ |+|.+++...
T Consensus        45 ~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  121 (326)
T 2x7f_A           45 HVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT  121 (326)
T ss_dssp             ETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS
T ss_pred             ECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc
Confidence            456899999999965422   345688999999999 89999999999975421 11357999999997 5999999764


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccc
Q 021181           79 --QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 --~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~  155 (316)
                        ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ......++..|+|||++
T Consensus       122 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  201 (326)
T 2x7f_A          122 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  201 (326)
T ss_dssp             GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhh
Confidence              569999999999999999999999999999999999999999999999999987654332 23345689999999998


Q ss_pred             cC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          156 LN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       156 ~~----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      ..    ...++.++|||||||++|+|++|..||...+.......+.....  +                           
T Consensus       202 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~---------------------------  252 (326)
T 2x7f_A          202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--P---------------------------  252 (326)
T ss_dssp             C--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C---------------------------
T ss_pred             ccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--c---------------------------
Confidence            62    25688999999999999999999999988776555444332110  0                           


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ......++..+.++|.+||..||.+||+++++++||||++.
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            00113578899999999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.6e-41  Score=303.16  Aligned_cols=226  Identities=26%  Similarity=0.429  Sum_probs=187.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      .++..||||+++.. ........+.+|+.+++.+ +||||+++++++...     ..+|+||||++ |+|.+++...+  
T Consensus       111 ~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~  184 (370)
T 2psq_A          111 KEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPP  184 (370)
T ss_dssp             TCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC
T ss_pred             CcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCc
Confidence            56778999999765 3444567889999999999 899999999999654     45899999996 69999997653  


Q ss_pred             --------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccc
Q 021181           80 --------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTE  142 (316)
Q Consensus        80 --------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~  142 (316)
                                    .+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........   ...
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  264 (370)
T 2psq_A          185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN  264 (370)
T ss_dssp             -----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTT
T ss_pred             cccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccC
Confidence                          478999999999999999999999999999999999999999999999999986544322   233


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                      ..++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......                   
T Consensus       265 ~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------------  324 (370)
T 2psq_A          265 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM-------------------  324 (370)
T ss_dssp             TTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------------
T ss_pred             CCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-------------------
Confidence            456788999999987 779999999999999999999 99999888766655544321110                   


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                 .....++.++.++|.+||+.||.+||++.|++++
T Consensus       325 -----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          325 -----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       1113578899999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.7e-42  Score=296.67  Aligned_cols=237  Identities=27%  Similarity=0.347  Sum_probs=188.1

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||++..... .......+.+|+.++++++||||+++++++...     ..+|+||||++ ++|.+++...+
T Consensus        32 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~  106 (294)
T 4eqm_A           32 DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----DCYYLVMEYIEGPTLSEYIESHG  106 (294)
T ss_dssp             ETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHC
T ss_pred             ECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----CeEEEEEeCCCCCCHHHHHHhcC
Confidence            567899999999865433 344557889999999999999999999998654     56999999996 59999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......  ......+++.|+|||.+.+
T Consensus       107 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  186 (294)
T 4eqm_A          107 PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG  186 (294)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC
Confidence            99999999999999999999999999999999999999999999999999997765432  2234568999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|+.||.+.+..........  ...+.                        ......+.
T Consensus       187 -~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~------------------------~~~~~~~~  239 (294)
T 4eqm_A          187 -EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--DSVPN------------------------VTTDVRKD  239 (294)
T ss_dssp             -CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--SCCCC------------------------HHHHSCTT
T ss_pred             -CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--ccCCC------------------------cchhcccC
Confidence             6789999999999999999999999988775544333221  11100                        00112246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      +++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            789999999999999999999666555555543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.4e-42  Score=302.09  Aligned_cols=241  Identities=24%  Similarity=0.388  Sum_probs=169.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHH-HHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~---   77 (316)
                      ++.+|+.||||+++.... ......+..|+. +++.++||||+++++++...     ...++||||++|+|.+++..   
T Consensus        43 ~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~  116 (327)
T 3aln_A           43 HKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GDCWICMELMSTSFDKFYKYVYS  116 (327)
T ss_dssp             ETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHHH
T ss_pred             EcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----CceEEEEeecCCChHHHHHHHHh
Confidence            457899999999976533 333445555555 77788999999999999654     46899999999998888763   


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcC-CceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           78 --HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        78 --~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                        ...+++..+..++.|++.||.+||+. ||+||||+|+||+++.++.++|+|||++.............++..|+|||+
T Consensus       117 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~  196 (327)
T 3aln_A          117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER  196 (327)
T ss_dssp             TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------
T ss_pred             hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCcee
Confidence              57799999999999999999999998 999999999999999999999999999977655544445578999999999


Q ss_pred             cc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          155 LL---NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       155 ~~---~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      +.   ....++.++|||||||++|+|++|..||...+....  .+......                       ......
T Consensus       197 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~-----------------------~~~~~~  251 (327)
T 3aln_A          197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQVVKG-----------------------DPPQLS  251 (327)
T ss_dssp             ---------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCS-----------------------CCCCCC
T ss_pred             eccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHHhcC-----------------------CCCCCC
Confidence            84   225688999999999999999999999976532110  00000000                       000000


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ......+++.+.++|++||+.||.+|||+.++++||||....
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            112236789999999999999999999999999999997654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-41  Score=302.37  Aligned_cols=230  Identities=24%  Similarity=0.398  Sum_probs=188.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||+++.. ........+.+|+.+++++ +||||+++++++...+    ..+++||||++ |+|.+++....
T Consensus        48 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~  122 (359)
T 3vhe_A           48 KTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKR  122 (359)
T ss_dssp             STTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTT
T ss_pred             ccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC----CceEEEEEecCCCcHHHHHHhcc
Confidence            4678899999999754 3444567789999999999 7999999999987543    45899999996 69999997654


Q ss_pred             C------------------------------------------------------------------CCHHHHHHHHHHH
Q 021181           80 D------------------------------------------------------------------LTDDHCRYFLYQL   93 (316)
Q Consensus        80 ~------------------------------------------------------------------~~~~~~~~i~~qi   93 (316)
                      .                                                                  +++..++.++.||
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql  202 (359)
T 3vhe_A          123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV  202 (359)
T ss_dssp             TSBCSCC------------------------------------------------------CTTTTCBCHHHHHHHHHHH
T ss_pred             ccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHH
Confidence            3                                                                  8999999999999


Q ss_pred             HHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcccccCCCCCCCcchHHHH
Q 021181           94 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSV  170 (316)
Q Consensus        94 ~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (316)
                      +.||+|||++||+||||||+||+++.++.++|+|||++.......   ......++..|+|||++.+ ..++.++|||||
T Consensus       203 ~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~sl  281 (359)
T 3vhe_A          203 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF  281 (359)
T ss_dssp             HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHH
T ss_pred             HHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhH
Confidence            999999999999999999999999999999999999998654332   2234567888999999987 778999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHh
Q 021181          171 GCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKM  249 (316)
Q Consensus       171 G~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~  249 (316)
                      ||++|+|++ |..||.+..................                             ....+++++.++|.+|
T Consensus       282 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          282 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-----------------------------APDYTTPEMYQTMLDC  332 (359)
T ss_dssp             HHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHH
Confidence            999999998 9999988765444433322111110                             1124788999999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q 021181          250 LVFDPNRRITVDEALCH  266 (316)
Q Consensus       250 L~~dP~~Rps~~ell~~  266 (316)
                      |+.||.+|||++|+++|
T Consensus       333 l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHH
Confidence            99999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2e-41  Score=298.39  Aligned_cols=235  Identities=23%  Similarity=0.349  Sum_probs=176.7

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCC-CCCeEEEEEecCC-CcHHHHhhcCC-----
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE-TFNDVYIVYELMD-TDLHQIIRSHQ-----   79 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~~~~~~iv~e~~~-g~L~~~l~~~~-----   79 (316)
                      ..||||+++...........+.+|+.++++++||||+++++++...... .....++||||+. |+|.+++....     
T Consensus        52 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~  131 (323)
T 3qup_A           52 VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP  131 (323)
T ss_dssp             CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---C
T ss_pred             eeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccc
Confidence            3899999987655666678899999999999999999999998765321 1123599999996 69999886432     


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccc
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~  155 (316)
                       .+++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........   .....++..|+|||.+
T Consensus       132 ~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  211 (323)
T 3qup_A          132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL  211 (323)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhh
Confidence             599999999999999999999999999999999999999999999999999976544322   1233456789999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .+ ..++.++|||||||++|+|++ |.+||.+.+.......+......                              ..
T Consensus       212 ~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~  260 (323)
T 3qup_A          212 AD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL------------------------------KQ  260 (323)
T ss_dssp             HH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------------------------------CC
T ss_pred             cC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC------------------------------CC
Confidence            77 678999999999999999999 99999988776666554432111                              11


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRIT-------VDEALCHPYLAPL  272 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps-------~~ell~~~~f~~~  272 (316)
                      .+.+++++.++|.+||+.||.+|||       ++++++|+|+.+.
T Consensus       261 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          261 PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            1357889999999999999999999       7888899999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5e-41  Score=292.59  Aligned_cols=238  Identities=26%  Similarity=0.394  Sum_probs=181.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC--------CCCCeEEEEEecCC-CcHH
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR--------ETFNDVYIVYELMD-TDLH   72 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--------~~~~~~~iv~e~~~-g~L~   72 (316)
                      +..+|+.||||++..   .......+.+|+.+++.++||||+++++++.....        ......|+||||++ |+|.
T Consensus        27 ~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (303)
T 1zy4_A           27 NALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY  103 (303)
T ss_dssp             ETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHH
T ss_pred             EcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHH
Confidence            457899999999954   23455778899999999999999999998864310        12357899999996 6999


Q ss_pred             HHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC--------------
Q 021181           73 QIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--------------  137 (316)
Q Consensus        73 ~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--------------  137 (316)
                      +++... ..+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+......              
T Consensus       104 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  183 (303)
T 1zy4_A          104 DLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS  183 (303)
T ss_dssp             HHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---------------
T ss_pred             HhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccc
Confidence            999754 45788999999999999999999999999999999999999999999999998765422              


Q ss_pred             -CccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCccccccccccc
Q 021181          138 -DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-DYVHQLRLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       138 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                       .......++..|+|||++.+...++.++|||||||++|+|++   ||... +.......+.......+           
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~-----------  249 (303)
T 1zy4_A          184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFP-----------  249 (303)
T ss_dssp             ----------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCC-----------
T ss_pred             ccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccC-----------
Confidence             122345678999999999875578999999999999999998   45432 21222222221111000           


Q ss_pred             hHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          216 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                                      .......+..+.++|++||+.||.+|||++++++||||+..
T Consensus       250 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          250 ----------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             ----------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             ----------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence                            11123567789999999999999999999999999999753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5e-41  Score=294.54  Aligned_cols=233  Identities=20%  Similarity=0.283  Sum_probs=181.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh-----
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR-----   76 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~-----   76 (316)
                      ..+++.||||+++...........+.+|+.++++++||||+++++++...........++||||++ |+|.+++.     
T Consensus        59 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~  138 (313)
T 3brb_A           59 DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE  138 (313)
T ss_dssp             TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBT
T ss_pred             CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh
Confidence            457789999999876556666788999999999999999999999997654333345799999996 69999984     


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCc
Q 021181           77 -SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAP  152 (316)
Q Consensus        77 -~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aP  152 (316)
                       ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........   .....++..|+||
T Consensus       139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          139 TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCH
T ss_pred             cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCc
Confidence             335699999999999999999999999999999999999999999999999999876543321   2234567789999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF  231 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (316)
                      |.+.+ ..++.++|||||||++|+|++ |.+||.+.........+......                             
T Consensus       219 E~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------  268 (313)
T 3brb_A          219 ESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-----------------------------  268 (313)
T ss_dssp             HHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------------------------
T ss_pred             hhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC-----------------------------
Confidence            99987 778999999999999999999 99999888766655544332111                             


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                       .....+++.+.++|.+||..||.+|||+++++++
T Consensus       269 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 -KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1113578899999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=303.78  Aligned_cols=232  Identities=22%  Similarity=0.290  Sum_probs=188.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      +..+++.||||+++.. ........+.+|+.++++++||||+++++++...     ...++||||++ |+|.+++...  
T Consensus        97 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~  170 (367)
T 3l9p_A           97 NDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-----LPRFILLELMAGGDLKSFLRETRP  170 (367)
T ss_dssp             ---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHSC
T ss_pred             CCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CCCEEEEEeCCCCCHHHHHHhhcc
Confidence            3567889999999654 2444556788999999999999999999999654     44799999995 6999999764  


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC---CEEEeeeccccccCC---CCccccccccc
Q 021181           79 -----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSE---TDFMTEYVVTR  147 (316)
Q Consensus        79 -----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~---~~~~~~~~~~~  147 (316)
                           ..+++.+++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||++.....   ........++.
T Consensus       171 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~  250 (367)
T 3l9p_A          171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV  250 (367)
T ss_dssp             CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCG
T ss_pred             ccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcc
Confidence                 3489999999999999999999999999999999999999555   499999999875422   12233456788


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      .|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+.......                       
T Consensus       251 ~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------  306 (367)
T 3l9p_A          251 KWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD-----------------------  306 (367)
T ss_dssp             GGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-----------------------
T ss_pred             cEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence            9999999977 678999999999999999998 999999888766666554322111                       


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                             ....++..+.++|.+||+.||.+|||+++++++.++.
T Consensus       307 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          307 -------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   1125788899999999999999999999999987653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.2e-41  Score=296.15  Aligned_cols=225  Identities=22%  Similarity=0.332  Sum_probs=185.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~   81 (316)
                      +.+..||||+++... .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++... +.+
T Consensus        75 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  148 (325)
T 3kul_A           75 QRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-----RLAMIVTEYMENGSLDTFLRTHDGQF  148 (325)
T ss_dssp             SCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----GCCEEEEECCTTCBHHHHHHTTTTCS
T ss_pred             CCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CccEEEeeCCCCCcHHHHHHhcccCC
Confidence            345569999997543 444567789999999999999999999999654     45899999996 6999999654 579


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++.+++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........    .....++..|+|||.+.+
T Consensus       149 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  228 (325)
T 3kul_A          149 TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF  228 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC
Confidence            9999999999999999999999999999999999999999999999999987654321    122344678999999976


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|+|++ |..||.+.........+......+                              ...
T Consensus       229 -~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~  277 (325)
T 3kul_A          229 -RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP------------------------------APM  277 (325)
T ss_dssp             -CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC------------------------------CCT
T ss_pred             -CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC------------------------------CCC
Confidence             678999999999999999999 999998887776666554321111                              112


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+++.+.++|.+||+.||.+|||++++++
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            57889999999999999999999999886

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.7e-41  Score=294.79  Aligned_cols=235  Identities=25%  Similarity=0.354  Sum_probs=185.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCC--CCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      .+|+.||||++............+.+|+.++++++  |+||+++++++...     ...++|||+.+++|.+++...+.+
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~  124 (313)
T 3cek_A           50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSI  124 (313)
T ss_dssp             TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHCSSC
T ss_pred             CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-----CEEEEEEecCCCcHHHHHHhcCCC
Confidence            45899999999776566667788999999999996  59999999998654     469999997788999999998899


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  158 (316)
                      ++.+++.++.||+.||.|||++||+||||+|+||+++. +.++|+|||++........   .....++..|+|||.+.+.
T Consensus       125 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  203 (313)
T 3cek_A          125 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM  203 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhc
Confidence            99999999999999999999999999999999999964 8999999999877544322   2345689999999998641


Q ss_pred             ----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          159 ----------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       159 ----------~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                                ..++.++|||||||++|+|++|..||....... ....+.   .....                      
T Consensus       204 ~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~~----------------------  258 (313)
T 3cek_A          204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE----------------------  258 (313)
T ss_dssp             C----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTSC----------------------
T ss_pred             ccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---hcccc----------------------
Confidence                      367889999999999999999999997654322 222111   11000                      


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                          .......+.++.++|.+||+.||.+|||++|+++||||+...
T Consensus       259 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          259 ----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             ----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ----cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence                001124578899999999999999999999999999998643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=290.28  Aligned_cols=228  Identities=24%  Similarity=0.371  Sum_probs=184.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      +..+|+.||+|++..  .+......+.+|+.++++++||||+++++++...     ...++||||++ |+|.+++.. ..
T Consensus        31 ~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  103 (310)
T 3s95_A           31 HRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKSMDS  103 (310)
T ss_dssp             ETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHCCT
T ss_pred             ECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeEEEEEecCCCcHHHHHHhccC
Confidence            567899999999854  3455667899999999999999999999999654     56999999996 699999987 56


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---------------cccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---------------TEYV  144 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------~~~~  144 (316)
                      .+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+.........               ....
T Consensus       104 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (310)
T 3s95_A          104 QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV  183 (310)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccC
Confidence            7999999999999999999999999999999999999999999999999998765433221               1456


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCC
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP  224 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (316)
                      +|+.|+|||.+.+ ..++.++|||||||++|+|++|..||.........                  ...........  
T Consensus       184 gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------------------~~~~~~~~~~~--  242 (310)
T 3s95_A          184 GNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------------------FGLNVRGFLDR--  242 (310)
T ss_dssp             SCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------------------SSBCHHHHHHH--
T ss_pred             CCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------------------Hhhhhhccccc--
Confidence            8999999999987 77899999999999999999999998654311000                  00000011110  


Q ss_pred             CCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       225 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                              ...+.+++.+.++|.+||+.||++|||++++++
T Consensus       243 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 --------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             --------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    011367888999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=300.04  Aligned_cols=226  Identities=25%  Similarity=0.413  Sum_probs=189.3

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      .++..||||+++.. ........+.+|+++++++ +||||+++++++...     ...++||||++ |+|.+++....  
T Consensus        99 ~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~  172 (382)
T 3tt0_A           99 NRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPP  172 (382)
T ss_dssp             TCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCS
T ss_pred             ccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC-----CceEEEEEecCCCcHHHHHHHhccc
Confidence            45678999999765 3445567889999999999 999999999999654     45899999996 69999997654  


Q ss_pred             --------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---cccc
Q 021181           80 --------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE  142 (316)
Q Consensus        80 --------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~  142 (316)
                                    .+++.+++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......   ....
T Consensus       173 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~  252 (382)
T 3tt0_A          173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN  252 (382)
T ss_dssp             SSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTT
T ss_pred             ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccC
Confidence                          49999999999999999999999999999999999999999999999999998765432   2234


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                      ..++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.......                  
T Consensus       253 ~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------  313 (382)
T 3tt0_A          253 GRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD------------------  313 (382)
T ss_dssp             CCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred             CCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence            456788999999987 778999999999999999999 999998887666655544321110                  


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                  ....+++++.++|++||+.||++|||++|++++
T Consensus       314 ------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          314 ------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                        113578899999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=310.22  Aligned_cols=232  Identities=27%  Similarity=0.348  Sum_probs=176.3

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC-C
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-D   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~   80 (316)
                      ..+|+.||||++......     .+.+|+.+++.+ +||||+++++++...     ...|+|||+|+|+|.+++.... .
T Consensus        45 ~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~E~~~g~L~~~l~~~~~~  114 (432)
T 3p23_A           45 MFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDR-----QFQYIAIELCAATLQEYVEQKDFA  114 (432)
T ss_dssp             ESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHSSSCC
T ss_pred             EeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecC-----CEEEEEEECCCCCHHHHHHhcCCC
Confidence            457899999999654322     245899999999 799999999998654     5689999999999999997654 4


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-----CCCEEEeeeccccccCCCC----ccccccccccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-----NCDLKIGDFGLARTTSETD----FMTEYVVTRWYRA  151 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-----~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~a  151 (316)
                      ..+.+++.++.||+.||.|||++||+||||||+||+++.     ...++|+|||++.......    ......+|+.|+|
T Consensus       115 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~A  194 (432)
T 3p23_A          115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA  194 (432)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCC
T ss_pred             ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccC
Confidence            566677899999999999999999999999999999943     3358899999998765432    2344678999999


Q ss_pred             cccccC--CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          152 PELLLN--CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       152 PE~~~~--~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      ||++.+  ...++.++|||||||++|+|++ |..||.......... +   .+......                     
T Consensus       195 PE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~~~~---------------------  249 (432)
T 3p23_A          195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGACSLDC---------------------  249 (432)
T ss_dssp             GGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCCCTT---------------------
T ss_pred             hhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccCCccc---------------------
Confidence            999874  2566789999999999999999 999996654332211 1   11110000                     


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                         .......+..+.++|.+||+.||.+|||++++++||||.++
T Consensus       250 ---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          250 ---LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             ---SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ---cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence               00001235568999999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-40  Score=289.41  Aligned_cols=227  Identities=20%  Similarity=0.303  Sum_probs=186.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||||+++...........+.+|+.+++.++||||+++++++..      ...++||||++ ++|.+++...+.
T Consensus        40 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~  113 (291)
T 1xbb_A           40 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRH  113 (291)
T ss_dssp             CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTT
T ss_pred             CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC------CCcEEEEEeCCCCCHHHHHHhCcC
Confidence            35678999999998765555567889999999999999999999999832      34899999996 699999999888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc----ccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~  156 (316)
                      +++.+++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.........    ....++..|+|||.+.
T Consensus       114 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  193 (291)
T 1xbb_A          114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  193 (291)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc
Confidence            999999999999999999999999999999999999999999999999998776543221    1233467899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++||||||+++|+|++ |..||.+.+.......+......                              ...
T Consensus       194 ~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~  242 (291)
T 1xbb_A          194 Y-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------------------GCP  242 (291)
T ss_dssp             H-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------------------CCC
T ss_pred             c-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCC
Confidence            6 668899999999999999999 99999888766555444321100                              111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++.+.++|.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            357899999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8e-41  Score=293.11  Aligned_cols=227  Identities=24%  Similarity=0.371  Sum_probs=188.3

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC-
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-   80 (316)
                      +.+|+.||||+++.. ........+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++..... 
T Consensus        50 ~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  123 (314)
T 2ivs_A           50 RAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRGFLRESRKV  123 (314)
T ss_dssp             CSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTTTS
T ss_pred             ccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-----CceEEEEeecCCCCHHHHHHHHhhc
Confidence            356789999999754 3445667889999999999999999999998654     45899999996 799999986543 


Q ss_pred             -----------------------CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC
Q 021181           81 -----------------------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET  137 (316)
Q Consensus        81 -----------------------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  137 (316)
                                             +++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus       124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~  203 (314)
T 2ivs_A          124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE  203 (314)
T ss_dssp             TTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTT
T ss_pred             cCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEcccccccccccc
Confidence                                   899999999999999999999999999999999999999999999999998766443


Q ss_pred             Cc---cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccc
Q 021181          138 DF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS  213 (316)
Q Consensus       138 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  213 (316)
                      ..   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+......           
T Consensus       204 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  271 (314)
T 2ivs_A          204 DSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM-----------  271 (314)
T ss_dssp             SCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------
T ss_pred             ccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC-----------
Confidence            22   223455778999999977 678999999999999999999 99999887766555444321110           


Q ss_pred             cchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          214 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                         .....+++++.++|.+||+.||.+|||+++++++
T Consensus       272 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          272 -------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                               1113578999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-40  Score=285.96  Aligned_cols=223  Identities=19%  Similarity=0.326  Sum_probs=185.5

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      +++.||||++.....   ..+.+.+|+.++++++||||+++++++...     ...++||||++ ++|.+++... +.++
T Consensus        33 ~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~  104 (269)
T 4hcu_A           33 NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFA  104 (269)
T ss_dssp             TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTTTTCCC
T ss_pred             CCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceEEEEEeCCCCcHHHHHHhcCcccC
Confidence            577899999976433   235688999999999999999999999654     45899999996 6999998654 4589


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+ ..
T Consensus       105 ~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  183 (269)
T 4hcu_A          105 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR  183 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC-CC
Confidence            99999999999999999999999999999999999999999999999987654332  1223445778999999976 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++||||||+++|+|++ |..||...+.......+........                              ...++
T Consensus       184 ~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  233 (269)
T 4hcu_A          184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------------------------PRLAS  233 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC------------------------------CTTSC
T ss_pred             CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC------------------------------CCcCC
Confidence            8999999999999999999 9999998877666655543211111                              12468


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +.+.++|.+||+.||.+|||+++++++
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          234 THVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            889999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.4e-40  Score=285.19  Aligned_cols=224  Identities=19%  Similarity=0.299  Sum_probs=185.4

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~   81 (316)
                      .++..||||+++....   ....+.+|+.++++++||||+++++++...     ...++||||++ ++|.+++...+ .+
T Consensus        30 ~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  101 (268)
T 3sxs_A           30 KGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----YPIYIVTEYISNGCLLNYLRSHGKGL  101 (268)
T ss_dssp             TTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHHGGGC
T ss_pred             cCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CceEEEEEccCCCcHHHHHHHcCCCC
Confidence            3567899999975433   335688999999999999999999999654     45899999996 68999987654 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++.+++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+........  .....++..|+|||.+.+ .
T Consensus       102 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  180 (268)
T 3sxs_A          102 EPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-F  180 (268)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-S
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-c
Confidence            9999999999999999999999999999999999999999999999999877654432  223345677999999976 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++||||||+++|+|++ |..||...+.......+........                              ...+
T Consensus       181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~  230 (268)
T 3sxs_A          181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------------------------------PHLA  230 (268)
T ss_dssp             EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------------------------------CTTS
T ss_pred             CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC------------------------------CCcC
Confidence            78999999999999999999 9999988876666555433211111                              1246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++.+.++|.+||+.||.+|||+++++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.1e-41  Score=292.08  Aligned_cols=244  Identities=22%  Similarity=0.346  Sum_probs=181.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      +..+|+.||||++...  .......+.+|+.++++++||||+++++++...+.   ..+++||||++ |+|.+++...+ 
T Consensus        35 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  109 (295)
T 3ugc_A           35 QDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKE  109 (295)
T ss_dssp             CSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH---TSCEEEEECCTTCBHHHHHHHCGG
T ss_pred             cCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---CceEEEEEeCCCCCHHHHHHhccc
Confidence            5679999999999653  44556778999999999999999999999864321   45899999995 69999997754 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~  155 (316)
                      .+++.+++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++........    .....++..|+|||.+
T Consensus       110 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (295)
T 3ugc_A          110 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL  189 (295)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHh
Confidence            499999999999999999999999999999999999999999999999999977644321    2234467779999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|..||...... .    ....+......      .............   ......
T Consensus       190 ~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~----~~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~  254 (295)
T 3ugc_A          190 TE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-F----MRMIGNDKQGQ------MIVFHLIELLKNN---GRLPRP  254 (295)
T ss_dssp             HH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-H----HHHHCTTCCTH------HHHHHHHHHHHTT---CCCCCC
T ss_pred             cC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH-H----HhhhcCccccc------hhHHHHHHHHhcc---CcCCCC
Confidence            87 67899999999999999999999988544211 1    11111110000      0000000000000   001112


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++++.++|.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          255 DGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            367899999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-40  Score=290.44  Aligned_cols=229  Identities=24%  Similarity=0.332  Sum_probs=188.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+++.||||+++... .......+.+|+.+++++ +||||+++++++...     ...++||||++ |+|.+++....
T Consensus        49 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  122 (313)
T 1t46_A           49 KSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKR  122 (313)
T ss_dssp             STTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTT
T ss_pred             ccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcc
Confidence            46788999999997543 344567889999999999 999999999999654     45899999996 69999997654


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--
Q 021181           80 ------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--  139 (316)
Q Consensus        80 ------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  139 (316)
                                        .+++.+++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+........  
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  202 (313)
T 1t46_A          123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV  202 (313)
T ss_dssp             TTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE
T ss_pred             cccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccce
Confidence                              489999999999999999999999999999999999999999999999999987654432  


Q ss_pred             -cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchH
Q 021181          140 -MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR  217 (316)
Q Consensus       140 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (316)
                       .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..................             
T Consensus       203 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  268 (313)
T 1t46_A          203 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-------------  268 (313)
T ss_dssp             ECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-------------
T ss_pred             eccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC-------------
Confidence             223456778999999877 678999999999999999998 9999988765444433322111100             


Q ss_pred             HHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                      ....++..+.++|.+||+.||.+|||+++++++
T Consensus       269 ----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          269 ----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                            013578899999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=295.57  Aligned_cols=226  Identities=23%  Similarity=0.284  Sum_probs=186.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      .+++.||||+++... .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++...    
T Consensus        75 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  148 (343)
T 1luf_A           75 EPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHT  148 (343)
T ss_dssp             SSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC--
T ss_pred             CCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-----CceEEEEecCCCCcHHHHHHHhCccc
Confidence            577999999997543 344567789999999999999999999999654     45899999996 6999999764    


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC
Q 021181           79 --------------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD  138 (316)
Q Consensus        79 --------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  138 (316)
                                          ..+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  228 (343)
T 1luf_A          149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD  228 (343)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             ccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCc
Confidence                                568999999999999999999999999999999999999999999999999987653322


Q ss_pred             ---ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCcccccccccc
Q 021181          139 ---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD  214 (316)
Q Consensus       139 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  214 (316)
                         ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+......            
T Consensus       229 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------  295 (343)
T 1luf_A          229 YYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL------------  295 (343)
T ss_dssp             CBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------------
T ss_pred             cccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC------------
Confidence               1234456888999999887 678999999999999999999 99999888766655544331110            


Q ss_pred             chHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          215 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                        .....+++.+.++|++||+.||.+|||+.+++++
T Consensus       296 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          296 ------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence                              1113578899999999999999999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-40  Score=287.33  Aligned_cols=225  Identities=27%  Similarity=0.421  Sum_probs=176.1

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~   81 (316)
                      .++..||||+++.. ........+.+|+.++++++||||+++++++..      ...++||||++ |+|.+++...+ .+
T Consensus        41 ~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~  113 (281)
T 1mp8_A           41 NPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSL  113 (281)
T ss_dssp             -CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTS
T ss_pred             CCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------CccEEEEecCCCCCHHHHHHhcCCCC
Confidence            35678999998654 344556788999999999999999999999843      34789999997 59999997654 69


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..++.++.|++.||.+||+.|++||||||+||+++.++.++|+|||++........  .....++..|+|||++.+ .
T Consensus       114 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  192 (281)
T 1mp8_A          114 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-R  192 (281)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhccc-C
Confidence            9999999999999999999999999999999999999999999999999877654332  223345678999999976 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|+|++ |..||.+.+..+....+......                              ...+.+
T Consensus       193 ~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~------------------------------~~~~~~  242 (281)
T 1mp8_A          193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------------------------PMPPNC  242 (281)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------------------------------CCCTTC
T ss_pred             CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC------------------------------CCCCCC
Confidence            78999999999999999996 99999888766666555432110                              111367


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8999999999999999999999998863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.4e-42  Score=300.58  Aligned_cols=229  Identities=25%  Similarity=0.405  Sum_probs=188.6

Q ss_pred             CCCCCceEEEEEecccccCh----hHHHHHHHHHHHHhhCC--CCCccceeeeecCCCCCCCCeEEEEEecCC--CcHHH
Q 021181            2 NSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~   73 (316)
                      +..+|+.||||++.......    .....+.+|+.+++++.  |+||+++++++...     ...++|||++.  ++|.+
T Consensus        64 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~L~~  138 (320)
T 3a99_A           64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFD  138 (320)
T ss_dssp             ETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHH
T ss_pred             ECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-----CcEEEEEEcCCCCccHHH
Confidence            46789999999997653222    12244668999999996  59999999999654     56999999996  69999


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc-cCCCEEEeeeccccccCCCCccccccccccccCc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      ++...+.+++..++.++.||+.||+|||++||+||||+|+||+++ .++.++|+|||++....... .....++..|+||
T Consensus       139 ~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aP  217 (320)
T 3a99_A          139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPP  217 (320)
T ss_dssp             HHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCH
T ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc-ccCCCCCccCCCh
Confidence            998888999999999999999999999999999999999999999 77899999999987765432 3445789999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+....+.++|||||||++|+|++|..||...+  .    +..  +..                             
T Consensus       218 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~--~~~-----------------------------  260 (320)
T 3a99_A          218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIR--GQV-----------------------------  260 (320)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH--CCC-----------------------------
T ss_pred             HHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhc--ccc-----------------------------
Confidence            998774445788999999999999999999996532  1    100  000                             


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .....+++++.++|.+||+.||.+|||++++++||||++..
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            01135789999999999999999999999999999998764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.1e-41  Score=307.41  Aligned_cols=233  Identities=31%  Similarity=0.389  Sum_probs=174.2

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      ..+|+.||||++...     ....+.+|+.+++.+ +||||+++++++...     ..+|+|||||+|+|.+++......
T Consensus        36 ~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~lv~E~~~gsL~~~l~~~~~~  105 (434)
T 2rio_A           36 SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTD-----RFLYIALELCNLNLQDLVESKNVS  105 (434)
T ss_dssp             ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHTC---
T ss_pred             EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CeEEEEEecCCCCHHHHHhccCCC
Confidence            457999999998543     234567899999876 899999999998654     569999999999999999875443


Q ss_pred             C-------HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-------------CCEEEeeeccccccCCCCc--
Q 021181           82 T-------DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-------------CDLKIGDFGLARTTSETDF--  139 (316)
Q Consensus        82 ~-------~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-------------~~~~l~df~~~~~~~~~~~--  139 (316)
                      .       +..++.++.||+.||+|||++||+||||||+||+++.+             +.++|+|||++........  
T Consensus       106 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  185 (434)
T 2rio_A          106 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF  185 (434)
T ss_dssp             ---------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----
T ss_pred             chhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccc
Confidence            2       23457799999999999999999999999999999754             4799999999987654321  


Q ss_pred             ---cccccccccccCcccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccc
Q 021181          140 ---MTEYVVTRWYRAPELLLN------CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG  209 (316)
Q Consensus       140 ---~~~~~~~~~~~aPE~~~~------~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  209 (316)
                         .....+|+.|+|||++.+      ...++.++|||||||++|+|++ |..||.......  ..+..........  .
T Consensus       186 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~--~  261 (434)
T 2rio_A          186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM--K  261 (434)
T ss_dssp             ---------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC--T
T ss_pred             eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc--c
Confidence               234578999999999864      2568899999999999999998 999997654332  1121111100000  0


Q ss_pred             cccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                                            ......+++++.++|.+||+.||.+|||+.++++||||.+
T Consensus       262 ----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          262 ----------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             ----------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ----------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence                                  0000134678999999999999999999999999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-40  Score=286.15  Aligned_cols=224  Identities=20%  Similarity=0.314  Sum_probs=186.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~   81 (316)
                      .++..||||+++....   ....+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++.. ...+
T Consensus        46 ~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  117 (283)
T 3gen_A           46 RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRF  117 (283)
T ss_dssp             TTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEECCCTTCBHHHHHHCGGGCC
T ss_pred             cCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecC-----CCeEEEEeccCCCcHHHHHHHhccCC
Confidence            4677899999976433   235688999999999999999999999654     45999999995 799999876 4679


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++.+++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+........  .....++..|+|||.+.+ .
T Consensus       118 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  196 (283)
T 3gen_A          118 QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S  196 (283)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc-C
Confidence            9999999999999999999999999999999999999999999999999876543321  223345678999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++||||||+++|+|++ |..||...+.......+........                              ...+
T Consensus       197 ~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~  246 (283)
T 3gen_A          197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------------------------PHLA  246 (283)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------------------------------CTTC
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC------------------------------CCcC
Confidence            78999999999999999998 9999998887766665544222111                              1246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++.+.++|.+||+.||.+|||+++++++
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            7889999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-41  Score=301.74  Aligned_cols=227  Identities=22%  Similarity=0.344  Sum_probs=186.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      ++.+|+.||||+++.. ........+.+|+.++++++||||+++++++...     ..+++||||++ |+|.+++...+ 
T Consensus       135 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~  208 (377)
T 3cbl_A          135 LRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGA  208 (377)
T ss_dssp             ETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHGG
T ss_pred             EecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CCcEEEEEcCCCCCHHHHHHhcCC
Confidence            3468999999999754 2334456788999999999999999999999654     45899999996 79999987653 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc---ccccccccccCccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~  156 (316)
                      .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........   ....++..|+|||.+.
T Consensus       209 ~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~  288 (377)
T 3cbl_A          209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN  288 (377)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhc
Confidence            5999999999999999999999999999999999999999999999999998765433211   1223567899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      . ..++.++|||||||++|||++ |..||.+.+.......+......+                              ..
T Consensus       289 ~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~  337 (377)
T 3cbl_A          289 Y-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP------------------------------CP  337 (377)
T ss_dssp             H-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC------------------------------CC
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CC
Confidence            6 678999999999999999998 999998887665554443211110                              11


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++.+.++|.+||+.||.+|||++++++
T Consensus       338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            246889999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.4e-40  Score=315.59  Aligned_cols=227  Identities=20%  Similarity=0.299  Sum_probs=190.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      ++.+++.||||+++....+......+.+|+.++++++||||+++++++..      ...++||||++ |+|.+++...+.
T Consensus       392 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~  465 (635)
T 4fl3_A          392 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRH  465 (635)
T ss_dssp             CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTT
T ss_pred             CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEEEccCCCCHHHHHhhCCC
Confidence            35678999999998766666667889999999999999999999999853      23789999996 699999998889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~  156 (316)
                      +++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........    .....++..|+|||++.
T Consensus       466 l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~  545 (635)
T 4fl3_A          466 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  545 (635)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc
Confidence            99999999999999999999999999999999999999999999999999987644321    22334567899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|+|++ |..||.+.+..+....+.......                              ..
T Consensus       546 ~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------------------------~p  594 (635)
T 4fl3_A          546 Y-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------------------CP  594 (635)
T ss_dssp             H-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------------------CC
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CC
Confidence            7 779999999999999999998 999999888776666554422111                              11


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++++.++|.+||+.||++||++++|++
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            257899999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-41  Score=299.11  Aligned_cols=241  Identities=23%  Similarity=0.355  Sum_probs=162.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      ++.+|+.||||++...   .   .........++.+.||||+++++++.... .+...+++||||++ |+|.+++...+ 
T Consensus        50 ~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~  122 (336)
T 3fhr_A           50 HRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLIIMECMEGGELFSRIQERGD  122 (336)
T ss_dssp             ETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCTTEEHHHHHHTC-C
T ss_pred             ECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEEEeccCCCCHHHHHHhcCC
Confidence            5678999999998542   1   11223333466779999999999986422 12245899999996 59999998764 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC---CCEEEeeeccccccCCCCccccccccccccCcccc
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                       .+++.+++.++.||+.||.|||++||+||||||+||+++.+   +.++|+|||++...... ......+++.|+|||++
T Consensus       123 ~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~  201 (336)
T 3fhr_A          123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVL  201 (336)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhh
Confidence             69999999999999999999999999999999999999764   45999999998765533 23445779999999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|..||...................                       .........
T Consensus       202 ~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~  257 (336)
T 3fhr_A          202 GP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG-----------------------QYGFPNPEW  257 (336)
T ss_dssp             ---CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------------------------CCCTTTS
T ss_pred             CC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc-----------------------ccccCchhh
Confidence            66 678899999999999999999999997665333211111100000                       000001122


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ..+++++.++|++||+.||.+|||++|+++||||++...
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            467999999999999999999999999999999987543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=294.13  Aligned_cols=229  Identities=23%  Similarity=0.350  Sum_probs=184.0

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      ..++..||||++.... .......+.+|+.+++++ +||||+++++++...     ...++||||++ |+|.+++.... 
T Consensus        72 ~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~  145 (344)
T 1rjb_A           72 TGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKRE  145 (344)
T ss_dssp             SSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTT
T ss_pred             CCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-----CccEEEEecCCCCcHHHHHhhccc
Confidence            3577899999997542 333457789999999999 899999999999654     45899999996 69999997653 


Q ss_pred             ----------------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC
Q 021181           80 ----------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET  137 (316)
Q Consensus        80 ----------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  137 (316)
                                            .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~  225 (344)
T 1rjb_A          146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD  225 (344)
T ss_dssp             CC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred             cccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccC
Confidence                                  2799999999999999999999999999999999999999999999999999765443


Q ss_pred             Cc---cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccc
Q 021181          138 DF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS  213 (316)
Q Consensus       138 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  213 (316)
                      ..   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.......          
T Consensus       226 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------  294 (344)
T 1rjb_A          226 SNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------  294 (344)
T ss_dssp             TTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC----------
T ss_pred             ccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC----------
Confidence            22   233456778999999877 678999999999999999998 999998876544443332211100          


Q ss_pred             cchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021181          214 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP  267 (316)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~  267 (316)
                                         .....+++++.++|.+||+.||.+|||+.+++++-
T Consensus       295 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          295 -------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence                               01125688999999999999999999999998753

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-40  Score=288.20  Aligned_cols=228  Identities=15%  Similarity=0.141  Sum_probs=184.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-   79 (316)
                      +..+|+.||||++....    ....+.+|+.+++.+ +|++++++++++...     ...++||||++++|.+++...+ 
T Consensus        31 ~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~  101 (298)
T 1csn_A           31 NLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGR  101 (298)
T ss_dssp             ETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTT
T ss_pred             ECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----ceeEEEEEecCCCHHHHHHHhcc
Confidence            45789999999986432    223477899999999 799999999998544     5689999999889999998754 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC-----EEEeeeccccccCCCCc--------ccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-----LKIGDFGLARTTSETDF--------MTEYVVT  146 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~--------~~~~~~~  146 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.++.     ++|+|||++........        .....++
T Consensus       102 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt  181 (298)
T 1csn_A          102 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT  181 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCC
Confidence            5999999999999999999999999999999999999987776     99999999977554322        2445689


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV---HQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      ..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..   .....+.......+                   
T Consensus       182 ~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------  241 (298)
T 1csn_A          182 ARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-------------------  241 (298)
T ss_dssp             TTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-------------------
T ss_pred             cccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-------------------
Confidence            99999999977 67899999999999999999999999885432   22222222111111                   


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                             .....+.+++++.++|.+||+.||.+||++++|++
T Consensus       242 -------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          242 -------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             -------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                   01122367899999999999999999999998875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.1e-40  Score=296.42  Aligned_cols=225  Identities=24%  Similarity=0.381  Sum_probs=176.8

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~   81 (316)
                      .++..||||+++... .......+.+|+.++++++||||+++++++...     ...++||||++ |+|.+++...+ .+
T Consensus        71 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~  144 (373)
T 2qol_A           71 KKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQF  144 (373)
T ss_dssp             SCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCS
T ss_pred             CCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CceEEEEeCCCCCcHHHHHHhCCCCC
Confidence            578899999997643 444567889999999999999999999999654     45899999995 79999997654 69


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........    .....++..|+|||.+.+
T Consensus       145 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  224 (373)
T 2qol_A          145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY  224 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc
Confidence            9999999999999999999999999999999999999999999999999877644321    112234668999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|+|++ |..||...+.......+......+.                              ..
T Consensus       225 -~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~------------------------------~~  273 (373)
T 2qol_A          225 -RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------------------------------PM  273 (373)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC------------------------------CT
T ss_pred             -CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------Cc
Confidence             678999999999999999998 9999988876666555433211110                              12


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .++..+.++|.+||+.||.+||+++++++
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            56788999999999999999999998875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-40  Score=288.31  Aligned_cols=230  Identities=23%  Similarity=0.346  Sum_probs=179.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||++..... .......+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++...+
T Consensus        55 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  129 (309)
T 2h34_A           55 DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----GQLYVDMRLINGVDLAAMLRRQG  129 (309)
T ss_dssp             ETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCCCEEHHHHHHHHC
T ss_pred             EcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----CeEEEEEEecCCCCHHHHHHhcC
Confidence            457899999999976533 333457788999999999999999999998654     56999999997 59999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++.+++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.+
T Consensus       130 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  209 (309)
T 2h34_A          130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE  209 (309)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC
Confidence            89999999999999999999999999999999999999999999999999987654432  2234568899999999977


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++||||||+++|+|++|..||.+.+.......+..   ...                         ......+.
T Consensus       210 -~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~-------------------------~~~~~~~~  260 (309)
T 2h34_A          210 -SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ---AIP-------------------------RPSTVRPG  260 (309)
T ss_dssp             -----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS---CCC-------------------------CGGGTSTT
T ss_pred             -CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc---CCC-------------------------CccccCCC
Confidence             6789999999999999999999999987654432222211   000                         01122346


Q ss_pred             CChHHHHHHHHhcccCCCCCC-CHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRI-TVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rp-s~~ell~  265 (316)
                      +++++.++|.+||+.||++|| +++++++
T Consensus       261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            889999999999999999999 7888775

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.8e-40  Score=293.20  Aligned_cols=227  Identities=19%  Similarity=0.170  Sum_probs=183.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      +..+|+.||||++.....    ...+.+|+.+++.+ +||||+++++++...     ...++||||++++|.+++.. .+
T Consensus        30 ~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~  100 (330)
T 2izr_A           30 NLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYNAMVLELLGPSLEDLFDLCDR  100 (330)
T ss_dssp             ETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTT
T ss_pred             ECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----CccEEEEEeCCCCHHHHHHHcCC
Confidence            467899999999865422    23477999999999 999999999998654     56899999998899999986 46


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC-----EEEeeeccccccCCCCc--------ccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-----LKIGDFGLARTTSETDF--------MTEYVVT  146 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~--------~~~~~~~  146 (316)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++.++.     ++|+|||++........        .....+|
T Consensus       101 ~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt  180 (330)
T 2izr_A          101 TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT  180 (330)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCC
Confidence            7999999999999999999999999999999999999998887     99999999986543322        2356789


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh---hCCCCccccccccccchHHHhhhC
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL---IGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      ..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...   ....+.                  
T Consensus       181 ~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------------------  241 (330)
T 2izr_A          181 ARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI------------------  241 (330)
T ss_dssp             TTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH------------------
T ss_pred             ccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH------------------
Confidence            99999999987 77899999999999999999999999886543332222221   110000                  


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                              ......++ ++.++|..||+.||.+||++++|++
T Consensus       242 --------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          242 --------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             --------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                    00011234 8999999999999999999988776

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.5e-40  Score=282.20  Aligned_cols=224  Identities=16%  Similarity=0.238  Sum_probs=185.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~   81 (316)
                      +|+.||||+++...........+.+|+.++++++||||+++++++.....   ...++||||++ |+|.+++....  .+
T Consensus        32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~  108 (271)
T 3kmu_A           32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA---PHPTLITHWMPYGSLYNVLHEGTNFVV  108 (271)
T ss_dssp             TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS---SSCEEEEECCTTCBHHHHHHSCSSCCC
T ss_pred             CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC---CCeEeeecccCCCcHHHHHhhcccCCC
Confidence            48899999998776666677889999999999999999999999875422   56899999996 69999998765  48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++.+++.++.||+.||+|||+.|  ++|+||+|+||+++.++.++++||++......    ....+++.|+|||.+.+ .
T Consensus       109 ~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~  183 (271)
T 3kmu_A          109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQK-K  183 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHS-C
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhcc-C
Confidence            99999999999999999999999  99999999999999999999999987654332    23467899999999876 3


Q ss_pred             CCC---CcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          160 EYT---AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       160 ~~~---~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      .++   .++|||||||++|+|++|..||.+.+.......+......+                             ....
T Consensus       184 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~  234 (271)
T 3kmu_A          184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-----------------------------TIPP  234 (271)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-----------------------------CCCT
T ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-----------------------------CCCC
Confidence            333   37999999999999999999998887666554443211111                             1113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+++++.++|.+||+.||.+|||++++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            57899999999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.7e-40  Score=289.13  Aligned_cols=230  Identities=24%  Similarity=0.392  Sum_probs=187.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+|+.||||+++... .......+.+|+.+++++ +||||+++++++...+    ..+++||||++ |+|.+++....
T Consensus        53 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~  127 (316)
T 2xir_A           53 KTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKR  127 (316)
T ss_dssp             STTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHTCT
T ss_pred             ccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC----CceEEEEEcCCCCcHHHHHHhcc
Confidence            35688999999997643 344556789999999999 7999999999986542    45899999997 69999998765


Q ss_pred             C----------------CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---c
Q 021181           80 D----------------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---M  140 (316)
Q Consensus        80 ~----------------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~  140 (316)
                      .                +++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........   .
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  207 (316)
T 2xir_A          128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  207 (316)
T ss_dssp             TSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEE
T ss_pred             cccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceec
Confidence            4                89999999999999999999999999999999999999999999999999976544322   2


Q ss_pred             ccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHH
Q 021181          141 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY  219 (316)
Q Consensus       141 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  219 (316)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.................                
T Consensus       208 ~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------  270 (316)
T 2xir_A          208 GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------  270 (316)
T ss_dssp             TTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC----------------
T ss_pred             cCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC----------------
Confidence            33456788999999977 678999999999999999998 999998876444333222211110                


Q ss_pred             hhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          220 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                   .....+++.+.++|.+||+.||.+|||++++++|
T Consensus       271 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          271 -------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         0112468899999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-40  Score=284.80  Aligned_cols=227  Identities=21%  Similarity=0.331  Sum_probs=187.5

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~   80 (316)
                      ..+++.||||+++.. ........+.+|+.+++.++||||+++++++..      ...++||||++ ++|.+++... ..
T Consensus        34 ~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~  106 (287)
T 1u59_A           34 RKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREE  106 (287)
T ss_dssp             --CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTT
T ss_pred             CCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------CCcEEEEEeCCCCCHHHHHHhCCcc
Confidence            457889999999764 344566788999999999999999999999842      34899999997 5999998654 56


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~  156 (316)
                      +++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++........    .....++..|+|||.+.
T Consensus       107 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (287)
T 1u59_A          107 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  186 (287)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc
Confidence            99999999999999999999999999999999999999999999999999987654322    12334578899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|+|++ |..||...+.......+.....                              ....
T Consensus       187 ~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~------------------------------~~~~  235 (287)
T 1u59_A          187 F-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------------------------MECP  235 (287)
T ss_dssp             H-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC------------------------------CCCC
T ss_pred             c-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc------------------------------CCCC
Confidence            6 678999999999999999998 9999988876666555433111                              0111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHP  267 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~  267 (316)
                      +.+++++.++|.+||+.||.+||++.+++++.
T Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            36789999999999999999999999999763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.1e-40  Score=284.36  Aligned_cols=226  Identities=21%  Similarity=0.366  Sum_probs=183.6

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~   80 (316)
                      ..++..||||++.... .......+.+|+.+++.++||||+++++++...      ..++||||++ ++|.+++... ..
T Consensus        37 ~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~  109 (281)
T 3cc6_A           37 KGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE------PTWIIMELYPYGELGHYLERNKNS  109 (281)
T ss_dssp             TCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHTTT
T ss_pred             CCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CCEEEEecCCCCCHHHHHHhcccc
Confidence            3456679999997653 344567889999999999999999999998543      3589999997 6999998764 45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.+ 
T Consensus       110 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  188 (281)
T 3cc6_A          110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-  188 (281)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-
Confidence            99999999999999999999999999999999999999999999999999877654322  223455778999999976 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||||||++|+|++ |..||...+.......+......+                              ....
T Consensus       189 ~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~  238 (281)
T 3cc6_A          189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP------------------------------KPDL  238 (281)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC------------------------------CCTT
T ss_pred             CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC------------------------------CCCC
Confidence            678999999999999999998 999998777666555444321111                              0124


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +++.+.++|.+||+.||.+|||+.+++++
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            68899999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=294.71  Aligned_cols=229  Identities=25%  Similarity=0.360  Sum_probs=182.5

Q ss_pred             CCCCCceEEEEEecccccCh----hHHHHHHHHHHHHhhC----CCCCccceeeeecCCCCCCCCeEEEEEec-CC-CcH
Q 021181            2 NSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHM----DHENIIAIKDIIRPPQRETFNDVYIVYEL-MD-TDL   71 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~~~~~~iv~e~-~~-g~L   71 (316)
                      +..+|+.||||++.......    .....+.+|+.++.++    +||||+++++++...     ...++|||+ +. ++|
T Consensus        52 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~~L  126 (312)
T 2iwi_A           52 RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDL  126 (312)
T ss_dssp             CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----------CEEEEECCSSEEEH
T ss_pred             EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-----CeEEEEEEecCCCCCH
Confidence            56789999999997643222    1233456799999988    899999999998654     458999998 55 699


Q ss_pred             HHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc-cCCCEEEeeeccccccCCCCcccccccccccc
Q 021181           72 HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYR  150 (316)
Q Consensus        72 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (316)
                      .+++...+.+++..++.++.||+.||.|||+.||+||||+|+||+++ .++.++|+|||.+....... .....++..|+
T Consensus       127 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~  205 (312)
T 2iwi_A          127 FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYS  205 (312)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTS
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCccccc
Confidence            99998888899999999999999999999999999999999999999 78999999999987765432 34556899999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      |||++.+....+.++|||||||++|+|++|+.||....  .    +...  .                     .      
T Consensus       206 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~--~---------------------~------  250 (312)
T 2iwi_A          206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEA--E---------------------L------  250 (312)
T ss_dssp             CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHT--C---------------------C------
T ss_pred             CceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhhh--c---------------------c------
Confidence            99998764444568999999999999999999996431  1    1110  0                     0      


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                        .....++..+.++|.+||+.||++|||++|+++||||+...
T Consensus       251 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          251 --HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence              01135788999999999999999999999999999999764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.9e-40  Score=284.23  Aligned_cols=225  Identities=23%  Similarity=0.394  Sum_probs=188.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+|+.||||++...   ......+.+|+.++++++||||+++++++...     ..+++||||++ ++|.+++...  
T Consensus        34 ~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~  105 (288)
T 3kfa_A           34 WKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNR  105 (288)
T ss_dssp             EGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHCCT
T ss_pred             ecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhccc
Confidence            4567999999999653   33557788999999999999999999999654     45899999997 6999999764  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (288)
T 3kfa_A          106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  185 (288)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHH
T ss_pred             CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhc
Confidence            4599999999999999999999999999999999999999999999999999987654432  22345577899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++||||||+++|+|++ |.+||...+.......+......                              ...
T Consensus       186 ~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~  234 (288)
T 3kfa_A          186 Y-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------------------------ERP  234 (288)
T ss_dssp             H-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC------------------------------CCC
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC------------------------------CCC
Confidence            7 678999999999999999999 99999888766655554432111                              111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++.+.++|.+||+.||.+|||++++++
T Consensus       235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            357889999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.4e-40  Score=283.37  Aligned_cols=229  Identities=22%  Similarity=0.313  Sum_probs=177.2

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~   83 (316)
                      +..||||+++...........+.+|+.++++++||||++++++...      ...++||||++ ++|.+++.. ...+++
T Consensus        46 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~  119 (289)
T 3og7_A           46 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHASETKFEM  119 (289)
T ss_dssp             SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHTTC---CCH
T ss_pred             cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------CccEEEEEecCCCcHHHHHhhccCCCCH
Confidence            4469999998776677777889999999999999999999997643      34799999997 699998854 456999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---CccccccccccccCcccccC--C
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLN--C  158 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~--~  158 (316)
                      .+++.++.||+.||.+||+.||+||||||+||+++.++.++|+|||++......   .......++..|+|||.+..  .
T Consensus       120 ~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  199 (289)
T 3og7_A          120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS  199 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCC
Confidence            999999999999999999999999999999999999999999999998765432   22334568999999999862  2


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|..||...................+                         .+......+
T Consensus       200 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~  254 (289)
T 3og7_A          200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-------------------------DLSKVRSNC  254 (289)
T ss_dssp             CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-------------------------CTTSSCTTS
T ss_pred             CCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-------------------------chhhccccC
Confidence            5678899999999999999999999988766555544433211111                         111222467


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++.+.++|.+||+.||.+|||++++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            899999999999999999999999985

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-39  Score=281.74  Aligned_cols=226  Identities=22%  Similarity=0.327  Sum_probs=181.0

Q ss_pred             CCCCCceEEEEEecccccChhHH-----HHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHh
Q 021181            2 NSETREEVAIKKIGNAFDNRIDA-----KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQII   75 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l   75 (316)
                      +..+|+.||||++..........     ..+.+|+.+++.++||||+++++++...       .++||||++ |+|.+.+
T Consensus        40 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-------~~lv~e~~~~~~L~~~l  112 (287)
T 4f0f_A           40 LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRL  112 (287)
T ss_dssp             ETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-------TEEEEECCTTCBHHHHH
T ss_pred             EcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-------CeEEEEecCCCCHHHHH
Confidence            46789999999997643322221     6788999999999999999999998644       269999997 7998887


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccCCC-----EEEeeeccccccCCCCccccccccc
Q 021181           76 RSH-QDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCD-----LKIGDFGLARTTSETDFMTEYVVTR  147 (316)
Q Consensus        76 ~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~  147 (316)
                      ... ..+++..++.++.|++.||+|||+.|  |+|+||||+||+++.++.     ++|+|||++......  .....++.
T Consensus       113 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~  190 (287)
T 4f0f_A          113 LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNF  190 (287)
T ss_dssp             HCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCC
T ss_pred             hcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCc
Confidence            654 47999999999999999999999999  999999999999988776     999999998754432  34467899


Q ss_pred             cccCcccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHhhCCCCccccccccccchHHHhhhCC
Q 021181          148 WYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ--LRLITELIGSPDETSLGFLRSDNARRYVRMLP  224 (316)
Q Consensus       148 ~~~aPE~~~~-~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (316)
                      .|+|||++.. ...++.++|||||||++|+|++|..||...+....  ...+.. .+..+                    
T Consensus       191 ~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~--------------------  249 (287)
T 4f0f_A          191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRP--------------------  249 (287)
T ss_dssp             TTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCCCC--------------------
T ss_pred             cccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCCCC--------------------
Confidence            9999999843 24568899999999999999999999987654333  222111 11100                    


Q ss_pred             CCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       225 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                              .....+++.+.++|.+||+.||.+|||++++++
T Consensus       250 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 --------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                    111357889999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.5e-40  Score=301.87  Aligned_cols=220  Identities=25%  Similarity=0.372  Sum_probs=182.0

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC--C
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--L   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--~   81 (316)
                      +|+.||||+++...    ....+.+|+.++++++||||+++++++....    ..+++||||++ |+|.+++...+.  +
T Consensus       215 ~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~  286 (450)
T 1k9a_A          215 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVL  286 (450)
T ss_dssp             TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHHCTTTC
T ss_pred             cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhcCCCCC
Confidence            47899999997542    4467889999999999999999999986542    35899999996 699999986543  7


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      ++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  ....++..|+|||.+.+ ..+
T Consensus       287 ~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~-~~~  363 (450)
T 1k9a_A          287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKF  363 (450)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHS-SCC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcC-CCC
Confidence            999999999999999999999999999999999999999999999999987654322  22356788999999987 779


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|||||||++|+|++ |..||.+.+..+....+......                              .....+++
T Consensus       364 ~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------------------------~~p~~~~~  413 (450)
T 1k9a_A          364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------------------------DAPDGCPP  413 (450)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC------------------------------CCCTTCCH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCCcCCH
Confidence            999999999999999998 99999887766655544332110                              11135789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.++|.+||+.||.+|||+.++++
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.9e-40  Score=289.29  Aligned_cols=226  Identities=26%  Similarity=0.425  Sum_probs=185.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      .+++.||||+++... .......+.+|+.+++++ +||||+++++++...     ..+++||||++ |+|.+++....  
T Consensus        65 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  138 (334)
T 2pvf_A           65 KEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPP  138 (334)
T ss_dssp             ---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCT
T ss_pred             ccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccc
Confidence            578899999997543 444567789999999999 899999999999654     45899999996 69999997654  


Q ss_pred             --------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccc
Q 021181           80 --------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTE  142 (316)
Q Consensus        80 --------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~  142 (316)
                                    .+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........   ...
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  218 (334)
T 2pvf_A          139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN  218 (334)
T ss_dssp             TCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSC
T ss_pred             cccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence                          389999999999999999999999999999999999999999999999999877654322   223


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                      ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+.......                  
T Consensus       219 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------  279 (334)
T 2pvf_A          219 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD------------------  279 (334)
T ss_dssp             CCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------------------
T ss_pred             CCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC------------------
Confidence            445778999999876 678999999999999999999 999998887666555544321110                  


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                  ....++..+.++|.+||+.||.+|||+++++++
T Consensus       280 ------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          280 ------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        113578899999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.2e-40  Score=288.90  Aligned_cols=243  Identities=24%  Similarity=0.308  Sum_probs=183.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+|+.||||+++.. ........+.+|+.++++++||||+++++++...+.   ..+++||||++ |+|.+++... .
T Consensus        56 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~-~  130 (318)
T 3lxp_A           56 NDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRH-S  130 (318)
T ss_dssp             C--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT---TEEEEEECCCTTCBHHHHGGGS-C
T ss_pred             CCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC---ceEEEEEecccCCcHHHHHhhC-C
Confidence            5678999999999765 344556778999999999999999999999975432   57899999996 6999998764 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~  156 (316)
                      +++.+++.++.||+.||++||+.||+|+||||+||+++.++.++|+|||.+........    .....++..|+|||.+.
T Consensus       131 ~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  210 (318)
T 3lxp_A          131 IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK  210 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence            99999999999999999999999999999999999999999999999999987654422    23345677899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|||||||++|+|++|..||.........     ..+.....    ..............      ......
T Consensus       211 ~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~~~------~~~~~~  274 (318)
T 3lxp_A          211 E-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-----LIGIAQGQ----MTVLRLTELLERGE------RLPRPD  274 (318)
T ss_dssp             H-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HHCSCCHH----HHHHHHHHHHHTTC------CCCCCT
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-----hhcccccc----hhHHHHHHHHhccc------CCCCCc
Confidence            7 66889999999999999999999999654221100     00000000    00000000000000      011123


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+++++.++|++||+.||.+|||++++++
T Consensus       275 ~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          275 KCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67899999999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.4e-40  Score=290.40  Aligned_cols=243  Identities=20%  Similarity=0.293  Sum_probs=185.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      +..+|+.||||++...  .....+.+.+|+.++++++||||+++++++...+   ...+++||||++ ++|.+++.. ..
T Consensus        48 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~  122 (327)
T 3lxl_A           48 GDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG---RQSLRLVMEYLPSGCLRDFLQRHRA  122 (327)
T ss_dssp             SSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---SCEEEEEEECCTTCBHHHHHHHHGG
T ss_pred             CCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC---CceEEEEEeecCCCCHHHHHHhccc
Confidence            5789999999999654  3445577899999999999999999999886432   266999999995 799999876 35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~  155 (316)
                      .+++.+++.++.||+.||++||+.||+|+||||+||+++.++.++|+|||.+........    .....++..|+|||.+
T Consensus       123 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  202 (327)
T 3lxl_A          123 RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL  202 (327)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHh
Confidence            699999999999999999999999999999999999999999999999999987654322    2334567789999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|..||..........     .....       ...............   ......
T Consensus       203 ~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-----~~~~~-------~~~~~~~~~~~~~~~---~~~~~~  266 (327)
T 3lxl_A          203 SD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-----MGCER-------DVPALSRLLELLEEG---QRLPAP  266 (327)
T ss_dssp             HH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-----CC-----------CCHHHHHHHHHHTT---CCCCCC
T ss_pred             cc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-----ccccc-------ccccHHHHHHHhhcc---cCCCCC
Confidence            77 668899999999999999999999986543221110     00000       000000000000000   001122


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +.+++.+.++|.+||+.||.+|||++++++
T Consensus       267 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          267 PACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            468899999999999999999999999964

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.8e-40  Score=289.62  Aligned_cols=232  Identities=22%  Similarity=0.298  Sum_probs=186.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      +..+|+.||||++... ........+.+|+.++++++||||+++++++...     ...|+||||++ |+|.+++.... 
T Consensus        56 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  129 (327)
T 2yfx_A           56 NDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-----LPRFILMELMAGGDLKSFLRETRP  129 (327)
T ss_dssp             ----CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTSC
T ss_pred             CCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHhhcc
Confidence            4568889999999644 3444566788999999999999999999999654     44799999995 79999998653 


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---CCCEEEeeeccccccCCCC---ccccccccc
Q 021181           80 ------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETD---FMTEYVVTR  147 (316)
Q Consensus        80 ------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~---~~~~~~~~~  147 (316)
                            .+++.+++.++.||+.||.|||+.||+||||+|+||+++.   +..++|+|||++.......   ......++.
T Consensus       130 ~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  209 (327)
T 2yfx_A          130 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV  209 (327)
T ss_dssp             CSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCG
T ss_pred             cccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCc
Confidence                  4899999999999999999999999999999999999984   4469999999987543222   223445688


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      .|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+......                        
T Consensus       210 ~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------  264 (327)
T 2yfx_A          210 KWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM------------------------  264 (327)
T ss_dssp             GGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------
T ss_pred             ceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC------------------------
Confidence            9999999877 678999999999999999998 99999887766555544332111                        


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                            .....++..+.++|.+||+.||.+||++++++++.|+.
T Consensus       265 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          265 ------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                  01135788999999999999999999999999988754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.9e-40  Score=281.35  Aligned_cols=225  Identities=27%  Similarity=0.367  Sum_probs=173.5

Q ss_pred             CCceEEEEEecccccC--hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            5 TREEVAIKKIGNAFDN--RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      +|+.||||+++.....  ....+.+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++. .+.+
T Consensus        29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~~~~  102 (271)
T 3dtc_A           29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLS-GKRI  102 (271)
T ss_dssp             TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-------CEEEEECCTTEEHHHHHT-SSCC
T ss_pred             cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CceEEEEEcCCCCCHHHHhh-cCCC
Confidence            5889999999764322  23346788999999999999999999999654     45899999996 68888875 4689


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCC---ceeccCCCCcEEEcc--------CCCEEEeeeccccccCCCCcccccccccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLNA--------NCDLKIGDFGLARTTSETDFMTEYVVTRWYR  150 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (316)
                      ++..++.++.|++.||.+||++|   ++||||||+||+++.        ++.++|+|||.+....... .....++..|+
T Consensus       103 ~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~  181 (271)
T 3dtc_A          103 PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWM  181 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGS
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCcccee
Confidence            99999999999999999999999   899999999999986        6789999999987654433 23457899999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      |||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+.......                           
T Consensus       182 aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------  233 (271)
T 3dtc_A          182 APEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL---------------------------  233 (271)
T ss_dssp             CHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC---------------------------
T ss_pred             CHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC---------------------------
Confidence            9999977 678999999999999999999999998877555544332211100                           


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                        .....+++.+.++|.+||+.||.+|||++|++++
T Consensus       234 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          234 --PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence              1113578899999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.8e-40  Score=292.80  Aligned_cols=227  Identities=24%  Similarity=0.323  Sum_probs=181.3

Q ss_pred             CCCCceE--EEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            3 SETREEV--AIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         3 ~~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      ..+|..+  |||.++.. ........+.+|+.+++++ +||||+++++++...     ..+++||||++ |+|.+++...
T Consensus        47 ~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  120 (327)
T 1fvr_A           47 KKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKS  120 (327)
T ss_dssp             EETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTT
T ss_pred             ccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----CceEEEEecCCCCCHHHHHHhc
Confidence            4566655  99998643 2333556788999999999 899999999999654     56999999996 6999999765


Q ss_pred             C----------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccc
Q 021181           79 Q----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE  142 (316)
Q Consensus        79 ~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  142 (316)
                      +                .+++.+++.++.||+.||.+||++||+||||||+||+++.++.++|+|||++...........
T Consensus       121 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~  200 (327)
T 1fvr_A          121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM  200 (327)
T ss_dssp             CHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC--
T ss_pred             ccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccC
Confidence            4                699999999999999999999999999999999999999999999999999875443333334


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                      ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....                    
T Consensus       201 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--------------------  259 (327)
T 1fvr_A          201 GRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--------------------  259 (327)
T ss_dssp             --CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--------------------
T ss_pred             CCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC--------------------
Confidence            456788999999876 668899999999999999998 9999988876555443322100                    


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                ......+++.+.++|.+||+.||.+|||+++++++
T Consensus       260 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 ----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      01112568899999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.4e-40  Score=290.47  Aligned_cols=221  Identities=23%  Similarity=0.326  Sum_probs=177.5

Q ss_pred             eEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCCCHHH
Q 021181            8 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDH   85 (316)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~   85 (316)
                      .||+|.+.... .......+.+|+.++++++||||+++++++...      ..+++++++. |+|.+++.. ...+++..
T Consensus        46 ~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~  118 (327)
T 3poz_A           46 PVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY  118 (327)
T ss_dssp             EEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHSTTSCCHHH
T ss_pred             EEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC------CeEEEEEecCCCcHHHHHHhcCCCCCHHH
Confidence            35888875432 334557789999999999999999999999754      2688999985 799998876 46799999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCCCCCC
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYT  162 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  162 (316)
                      ++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........   .....++..|+|||.+.+ ..++
T Consensus       119 ~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~  197 (327)
T 3poz_A          119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYT  197 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCC
T ss_pred             HHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCC
Confidence            999999999999999999999999999999999999999999999987544332   223345778999999987 7789


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          163 AAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       163 ~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      .++|||||||++|+|++ |..||.+.+.......+......+                              ..+.++.+
T Consensus       198 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~  247 (327)
T 3poz_A          198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------------------------------QPPICTID  247 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------------------------------CCTTBCHH
T ss_pred             chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC------------------------------CCccCCHH
Confidence            99999999999999999 999998877665554443321111                              11346888


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +.+++.+||+.||.+||++.+++++
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=303.61  Aligned_cols=257  Identities=18%  Similarity=0.282  Sum_probs=187.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+|+.||||+++.... ......+.+|+.++++++||||+++++++....   ....++||||++ |+|.+++.....
T Consensus        30 ~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~  105 (396)
T 4eut_A           30 HKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKVLIMEFCPCGSLYTVLEEPSN  105 (396)
T ss_dssp             ETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEEEEECCCTTEEHHHHTTSGGG
T ss_pred             ECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeEEEEecCCCCCHHHHHHhhhc
Confidence            567899999999975432 223566789999999999999999999987543   246899999996 699999976433


Q ss_pred             ---CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE----ccCCCEEEeeeccccccCCCCccccccccccccCcc
Q 021181           81 ---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        81 ---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                         +++..++.++.||+.||+|||++||+||||||+||++    +.++.+||+|||++.............++..|+|||
T Consensus       106 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE  185 (396)
T 4eut_A          106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD  185 (396)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHH
Confidence               9999999999999999999999999999999999999    777889999999998876655555677899999999


Q ss_pred             cccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCccccccccccchHHHhhhCCC
Q 021181          154 LLLNC-------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ  225 (316)
Q Consensus       154 ~~~~~-------~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (316)
                      ++.+.       ..++.++|||||||++|+|++|..||...... .....+.......+...+..........+ .....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~  264 (396)
T 4eut_A          186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI-DWSGD  264 (396)
T ss_dssp             HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCE-EEESS
T ss_pred             HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCc-ccCcc
Confidence            98641       35678999999999999999999999754321 11222222222222221111110000000 00000


Q ss_pred             CCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       226 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+  ........++..+.++|++||+.||++||+++++++
T Consensus       265 ~~--~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          265 MP--VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CC--TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CC--cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            00  000111234567899999999999999999999855

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-39  Score=278.73  Aligned_cols=223  Identities=19%  Similarity=0.319  Sum_probs=184.6

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      +++.||||++.....   ..+.+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++... ..++
T Consensus        31 ~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~  102 (267)
T 3t9t_A           31 NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFA  102 (267)
T ss_dssp             TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHHTTTCCC
T ss_pred             CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeEEEEeCCCCCcHHHHHhhCcccCC
Confidence            678899999976433   235688999999999999999999999654     45899999996 6999999765 5689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||++.+ ..
T Consensus       103 ~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  181 (267)
T 3t9t_A          103 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR  181 (267)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcC-CC
Confidence            99999999999999999999999999999999999999999999999987654321  1123455778999999976 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++||||||+++|+|++ |..||...+.......+.......                              ....++
T Consensus       182 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~------------------------------~~~~~~  231 (267)
T 3t9t_A          182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------------------------------KPRLAS  231 (267)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------------------------CCTTSC
T ss_pred             ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC------------------------------CCccCc
Confidence            8999999999999999999 899998887666655543321110                              012468


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ..+.++|.+||+.||.+|||+++++++
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            889999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-39  Score=284.38  Aligned_cols=244  Identities=25%  Similarity=0.393  Sum_probs=182.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh-cCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR-SHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~-~~~   79 (316)
                      +..+|+.||||++.... .......+.+|+.+++.++||||+++++++...+.   ..+++||||++ |+|.+++. ...
T Consensus        46 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  121 (302)
T 4e5w_A           46 GDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPKNKN  121 (302)
T ss_dssp             SSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHHTT
T ss_pred             cCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---ceEEEEEEeCCCCcHHHHHHhccc
Confidence            56799999999997543 33345778899999999999999999999975432   55899999996 69999994 446


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~  155 (316)
                      .+++.+++.++.||+.||++||+.||+|+||||+||+++.++.++|+|||++........    .....++..|+|||.+
T Consensus       122 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  201 (302)
T 4e5w_A          122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL  201 (302)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeee
Confidence            799999999999999999999999999999999999999999999999999987654432    2345577889999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|..|+....     .......+.....       .............   ......
T Consensus       202 ~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-------~~~~~~~~~~~~~---~~~~~~  265 (302)
T 4e5w_A          202 MQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ-------MTVTRLVNTLKEG---KRLPCP  265 (302)
T ss_dssp             HH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG-------GHHHHHHHHHHTT---CCCCCC
T ss_pred             cC-CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc-------cCHHHHHHHHhcc---CCCCCC
Confidence            77 668899999999999999999998864321     1111111111100       0000011100000   001122


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +.+++.+.++|.+||+.||.+|||++++++
T Consensus       266 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            467899999999999999999999999885

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=290.76  Aligned_cols=231  Identities=23%  Similarity=0.355  Sum_probs=168.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCC---CCCCeEEEEEecCCCcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQR---ETFNDVYIVYELMDTDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~   77 (316)
                      +..+|+.||||++...  .......+.+|+.+++++. ||||+++++++.....   .....++++|||++|+|.+++..
T Consensus        49 ~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~  126 (337)
T 3ll6_A           49 DVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK  126 (337)
T ss_dssp             ETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHH
T ss_pred             ECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHH
Confidence            4678999999998543  4445677889999999995 9999999999853221   23356899999999999988764


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc------------
Q 021181           78 ---HQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM------------  140 (316)
Q Consensus        78 ---~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------  140 (316)
                         .+.+++.+++.++.||+.||.|||+.|  |+|+||||+||+++.++.++|+|||++.........            
T Consensus       127 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  206 (337)
T 3ll6_A          127 MESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE  206 (337)
T ss_dssp             HHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchh
Confidence               567999999999999999999999999  999999999999999999999999999876543221            


Q ss_pred             -ccccccccccCccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchH
Q 021181          141 -TEYVVTRWYRAPELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR  217 (316)
Q Consensus       141 -~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (316)
                       ....++..|+|||++.  ....++.++|||||||++|+|++|..||............   ..                
T Consensus       207 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~----------------  267 (337)
T 3ll6_A          207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---YS----------------  267 (337)
T ss_dssp             -----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------CC----------------
T ss_pred             hccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc---cc----------------
Confidence             1345788999999983  2356788999999999999999999999665432211100   00                


Q ss_pred             HHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021181          218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP  267 (316)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~  267 (316)
                                    .......+..+.++|++||+.||.+|||++|++++-
T Consensus       268 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          268 --------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             --------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             --------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                          001124567799999999999999999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=285.51  Aligned_cols=224  Identities=23%  Similarity=0.360  Sum_probs=179.4

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~   83 (316)
                      +..||||+++... .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++... +.+++
T Consensus        73 ~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~  146 (333)
T 1mqb_A           73 EVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSV  146 (333)
T ss_dssp             EEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCH
T ss_pred             cccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-----CCcEEEEeCCCCCcHHHHHHhCCCCCCH
Confidence            4579999997543 344556788999999999999999999999654     45999999997 5999998764 67999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.++.||+.||.+||+.||+||||||+||+++.++.++|+|||.+........    .....++..|+|||.+.+ .
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  225 (333)
T 1mqb_A          147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-R  225 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-C
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhccc-C
Confidence            99999999999999999999999999999999999999999999999877544321    122334678999999977 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|+|++ |..||...+.......+......+                              ....+
T Consensus       226 ~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  275 (333)
T 1mqb_A          226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------------------------------TPMDC  275 (333)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------------------------CCTTC
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC------------------------------CcccC
Confidence            78999999999999999998 999998887666555443321111                              11256


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +..+.++|.+||+.||.+||++.+++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8889999999999999999999998863

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.6e-40  Score=310.94  Aligned_cols=265  Identities=23%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC-CCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||+++.. ........+.+|+.++++++||||+++++++.... .......++||||++ |+|.+++....
T Consensus        35 ~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~  113 (676)
T 3qa8_A           35 HQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE  113 (676)
T ss_dssp             CTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS
T ss_pred             ECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc
Confidence            5678999999998764 34555677899999999999999999999976522 122456899999995 79999998754


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC---EEEeeeccccccCCCCccccccccccccCcc
Q 021181           80 ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPE  153 (316)
Q Consensus        80 ---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE  153 (316)
                         .+++..++.++.||+.||+|||+.||+||||+|+||+++.++.   ++|+|||.+.............++..|+|||
T Consensus       114 ~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE  193 (676)
T 3qa8_A          114 NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE  193 (676)
T ss_dssp             CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChH
Confidence               6999999999999999999999999999999999999997765   9999999998877666566678899999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC--CCc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK--QNF  231 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  231 (316)
                      .+.+ ..++.++|||||||++|+|++|..||.+..............+........         ...+...+..  ...
T Consensus       194 ~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~---------~l~g~~~~~~~lp~p  263 (676)
T 3qa8_A          194 LLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD---------DLTGAVKFSSVLPTP  263 (676)
T ss_dssp             SSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC---------CCSSSCCCCSSSCCS
T ss_pred             Hhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh---------hhccccccccccCCc
Confidence            9977 778999999999999999999999997764332211000000000000000         0000000100  001


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE  277 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~  277 (316)
                      ......+++.+.++|.+||.+||++|||++++++||||+.+.+...
T Consensus       264 ~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          264 NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            1122346788999999999999999999999999999998774444

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-39  Score=287.00  Aligned_cols=226  Identities=23%  Similarity=0.382  Sum_probs=186.5

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      .+++.||||++... ........+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++...    
T Consensus        53 ~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  126 (322)
T 1p4o_A           53 EPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAM  126 (322)
T ss_dssp             EEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHH
T ss_pred             CCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC-----CccEEEEEeCCCCcHHHHHHHhchhh
Confidence            56889999999754 2344556788999999999999999999999654     45899999996 6999998652    


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccc
Q 021181           79 ------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWY  149 (316)
Q Consensus        79 ------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~  149 (316)
                            ..+++..++.++.||+.||.+||++||+||||||+||+++.++.++|+|||++........   .....++..|
T Consensus       127 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y  206 (322)
T 1p4o_A          127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  206 (322)
T ss_dssp             HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGG
T ss_pred             ccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCc
Confidence                  4579999999999999999999999999999999999999999999999999876543321   1234557889


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      +|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....                           
T Consensus       207 ~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------------  258 (322)
T 1p4o_A          207 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---------------------------  258 (322)
T ss_dssp             CCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC---------------------------
T ss_pred             cChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc---------------------------
Confidence            99999877 678999999999999999999 8999988876665554432110                           


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                         ......++..+.++|.+||+.||.+|||+.|++++
T Consensus       259 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          259 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               01113578899999999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.3e-40  Score=284.17  Aligned_cols=218  Identities=17%  Similarity=0.263  Sum_probs=178.0

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC-CCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-LTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-~~~~   84 (316)
                      ..||+|++...  .......+.+|+.++++++||||+++++++...     ...++||||++ |+|.+++...+. +++.
T Consensus        41 ~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  113 (289)
T 4fvq_A           41 TEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-----DENILVQEFVKFGSLDTYLKKNKNCINIL  113 (289)
T ss_dssp             EEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHH
T ss_pred             hhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHH
Confidence            57999999654  334557789999999999999999999999754     45799999997 699999987655 9999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC--------EEEeeeccccccCCCCccccccccccccCccccc
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      .++.++.||+.||.|||++||+||||||+||+++.++.        ++|+|||.+......   ....++..|+|||.+.
T Consensus       114 ~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~  190 (289)
T 4fvq_A          114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIE  190 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhC
Confidence            99999999999999999999999999999999998887        999999988655332   3345788899999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      +...++.++|||||||++|+|++| .+||...+.......... ...                               ..
T Consensus       191 ~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-~~~-------------------------------~~  238 (289)
T 4fvq_A          191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-RHQ-------------------------------LP  238 (289)
T ss_dssp             CGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCC-------------------------------CC
T ss_pred             CCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-cCC-------------------------------CC
Confidence            756789999999999999999995 556655554333322211 100                               01


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ...++++.++|.+||+.||.+|||+++++++
T Consensus       239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2456779999999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-39  Score=279.80  Aligned_cols=226  Identities=26%  Similarity=0.378  Sum_probs=183.5

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~   81 (316)
                      .++..||+|++... ........+.+|+.+++.++||||+++++++...+    ...+++|||+. |+|.+++.. ...+
T Consensus        47 ~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~  121 (298)
T 3pls_A           47 QNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNP  121 (298)
T ss_dssp             SCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCCEEEECCCTTCBHHHHHHCTTCCC
T ss_pred             Cceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CCcEEEEecccCCCHHHHHhccccCC
Confidence            44558999999753 34445678899999999999999999999997543    33589999995 799999977 4568


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----ccccccccccccCccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~  156 (316)
                      ++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||++.......     ......++..|+|||.+.
T Consensus       122 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  201 (298)
T 3pls_A          122 TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ  201 (298)
T ss_dssp             BHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhc
Confidence            999999999999999999999999999999999999999999999999987653321     223456688999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|+|++ |.+||...+.......+......+                              ..
T Consensus       202 ~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~  250 (298)
T 3pls_A          202 T-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP------------------------------QP  250 (298)
T ss_dssp             T-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC------------------------------CC
T ss_pred             c-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC------------------------------CC
Confidence            7 678999999999999999999 566666666555554443322111                              11


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++.+.++|.+||+.||.+|||++++++
T Consensus       251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            256889999999999999999999999876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-40  Score=291.93  Aligned_cols=245  Identities=22%  Similarity=0.257  Sum_probs=177.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCCH
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTD   83 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~   83 (316)
                      +|+.||||+++..   .........|+.++++++||||+++++++.... .....+++||||++ |+|.+++.. ..+++
T Consensus        46 ~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~  120 (322)
T 3soc_A           46 LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWLITAFHEKGSLSDFLKA-NVVSW  120 (322)
T ss_dssp             TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-CCBCH
T ss_pred             CCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEEEEecCCCCCHHHHHHh-cCCCH
Confidence            4789999999653   233445567999999999999999999997543 12345899999996 699999976 45999


Q ss_pred             HHHHHHHHHHHHHHHHhhcC----------CceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccccccccccc
Q 021181           84 DHCRYFLYQLLRGLKYVHSA----------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYR  150 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~----------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~  150 (316)
                      ..++.++.||+.||+|||+.          ||+||||||+||+++.++.+||+|||++........   .....++..|+
T Consensus       121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  200 (322)
T 3soc_A          121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM  200 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCcccc
Confidence            99999999999999999999          999999999999999999999999999976544322   23457899999


Q ss_pred             CcccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhC-CC
Q 021181          151 APELLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML-PQ  225 (316)
Q Consensus       151 aPE~~~~~----~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  225 (316)
                      |||++.+.    ..++.++|||||||++|+|++|..||.+................+.           ........ ..
T Consensus       201 aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~  269 (322)
T 3soc_A          201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS-----------LEDMQEVVVHK  269 (322)
T ss_dssp             CHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC-----------HHHHHHHHTTS
T ss_pred             CHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc-----------hhhhhhhhhcc
Confidence            99998763    2345678999999999999999999976542211111100000000           00000000 00


Q ss_pred             CCCCCccccC--CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          226 FPKQNFSARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       226 ~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..........  ...++++.++|.+||+.||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          270 KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0000011111  123456999999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-39  Score=303.36  Aligned_cols=225  Identities=22%  Similarity=0.387  Sum_probs=187.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.++..||||+++...   .....+.+|+.++++++||||+++++++...     ..+++||||+. |+|.+++...  
T Consensus       241 ~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~  312 (495)
T 1opk_A          241 WKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNR  312 (495)
T ss_dssp             EGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCT
T ss_pred             EcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEEEEEEccCCCCHHHHHHhcCc
Confidence            34678999999997542   2356789999999999999999999999654     45899999996 7999999764  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .....++..|+|||++.
T Consensus       313 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  392 (495)
T 1opk_A          313 QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  392 (495)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh
Confidence            4589999999999999999999999999999999999999999999999999987654322  12334567899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      . ..++.++|||||||++|+|++ |..||.+.+.......+......                              ...
T Consensus       393 ~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~  441 (495)
T 1opk_A          393 Y-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------------------------ERP  441 (495)
T ss_dssp             H-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC------------------------------CCC
T ss_pred             c-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCC
Confidence            7 678999999999999999999 99999988766655544331110                              111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++.+.++|.+||+.||.+|||+.+|++
T Consensus       442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            357899999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=292.03  Aligned_cols=239  Identities=13%  Similarity=0.083  Sum_probs=183.7

Q ss_pred             CCCceEEEEEecccccChh---------HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHH
Q 021181            4 ETREEVAIKKIGNAFDNRI---------DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQI   74 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~   74 (316)
                      .++..||||++........         ....+.+|+..++.++||||+++++++.... .+....|+||||++++|.++
T Consensus        63 ~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~  141 (345)
T 2v62_A           63 EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF-KGRSYRFMVMERLGIDLQKI  141 (345)
T ss_dssp             GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES-SSCEEEEEEEECEEEEHHHH
T ss_pred             CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc-CCCcEEEEEEeccCCCHHHH
Confidence            4889999999875422111         1123567888999999999999999987532 22367999999998899999


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC--CEEEeeeccccccCCCC--------cccccc
Q 021181           75 IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC--DLKIGDFGLARTTSETD--------FMTEYV  144 (316)
Q Consensus        75 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~--------~~~~~~  144 (316)
                      +...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++  .++|+|||++.......        ......
T Consensus       142 l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~  221 (345)
T 2v62_A          142 SGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN  221 (345)
T ss_dssp             CBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSC
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccC
Confidence            98878999999999999999999999999999999999999999887  99999999997653221        123457


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHH-HHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-DYVH-QLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~-~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      ++..|+|||++.+ ..++.++|||||||++|+|++|..||.+. .... ............+....            ..
T Consensus       222 gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~  288 (345)
T 2v62_A          222 GTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVL------------KW  288 (345)
T ss_dssp             SCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHH------------HH
T ss_pred             CCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHH------------hh
Confidence            8999999999987 67899999999999999999999999653 2222 22222221111111000            00


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .          ....++.++.++|.+||+.||.+||++++|++.
T Consensus       289 ~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          289 A----------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             S----------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             c----------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            0          001578899999999999999999999998863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4e-39  Score=280.44  Aligned_cols=226  Identities=23%  Similarity=0.336  Sum_probs=182.2

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~   81 (316)
                      .++..||+|.+... ........+.+|+.++++++||||+++++++...+    ...++||||++ |+|.+++... ..+
T Consensus        51 ~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~  125 (298)
T 3f66_A           51 GKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNP  125 (298)
T ss_dssp             --CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCCEEEEECCTTCBHHHHHHCTTCCC
T ss_pred             CceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----CceEEEEeCCCCCCHHHHHHhcccCC
Confidence            34557999998753 34455678899999999999999999999875432    45799999997 5999999764 568


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~  156 (316)
                      ++..++.++.||+.||++||++|++||||||+||+++.++.++|+|||.+........     .....++..|+|||.+.
T Consensus       126 ~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (298)
T 3f66_A          126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ  205 (298)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhc
Confidence            9999999999999999999999999999999999999999999999999976543321     22345677899999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|+|++ |.+||...+.......+........                              .
T Consensus       206 ~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~  254 (298)
T 3f66_A          206 T-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ------------------------------P  254 (298)
T ss_dssp             H-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC------------------------------C
T ss_pred             C-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC------------------------------C
Confidence            7 678999999999999999999 7788877765555544433211111                              1


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..++..+.++|.+||+.||.+|||++++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            246888999999999999999999999886

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-39  Score=281.58  Aligned_cols=229  Identities=20%  Similarity=0.175  Sum_probs=181.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      |..+|+.||||++......    ..+.+|+.+++.++|++++..+..+....    ...++||||++++|.+++.. ...
T Consensus        30 ~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~  101 (296)
T 3uzp_A           30 DIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRK  101 (296)
T ss_dssp             ETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTTC
T ss_pred             EcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCC----CceEEEEEecCCCHHHHHHhhccC
Confidence            4678999999998654322    34789999999999888777766664322    56899999998899999973 467


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE---ccCCCEEEeeeccccccCCCCc--------cccccccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDF--------MTEYVVTRWY  149 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~  149 (316)
                      +++.+++.++.||+.||+|||++||+||||||+||++   +.++.++|+|||.+........        .....++..|
T Consensus       102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 3uzp_A          102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999   5889999999999877554322        2345789999


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      +|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.   ......+.......+                      
T Consensus       182 ~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------------  238 (296)
T 3uzp_A          182 ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----------------------  238 (296)
T ss_dssp             CCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----------------------
T ss_pred             CChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc----------------------
Confidence            99999987 6789999999999999999999999987532   122222221100000                      


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                          .......+++++.++|.+||+.||.+|||++++++
T Consensus       239 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 ----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                01112357899999999999999999999998876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4e-40  Score=290.44  Aligned_cols=226  Identities=21%  Similarity=0.289  Sum_probs=180.4

Q ss_pred             CCCCce----EEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            3 SETREE----VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         3 ~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      ..+|+.    ||+|.+.... .......+.+|+.+++.++||||+++++++..      ...++||||+. |+|.+++..
T Consensus        35 ~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~  107 (325)
T 3kex_A           35 IPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQ  107 (325)
T ss_dssp             CCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------SSEEEEEECCTTCBSHHHHHS
T ss_pred             cCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------CccEEEEEeCCCCCHHHHHHH
Confidence            345555    7888775432 22233456789999999999999999998853      34899999996 799999876


Q ss_pred             C-CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcc
Q 021181           78 H-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPE  153 (316)
Q Consensus        78 ~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE  153 (316)
                      . +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       108 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  187 (325)
T 3kex_A          108 HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE  187 (325)
T ss_dssp             SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChH
Confidence            5 579999999999999999999999999999999999999999999999999998764432   223455677899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      .+.+ ..++.++|||||||++|+|++ |..||.+.........+.......                             
T Consensus       188 ~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------  237 (325)
T 3kex_A          188 SIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA-----------------------------  237 (325)
T ss_dssp             HHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC-----------------------------
T ss_pred             Hhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-----------------------------
Confidence            9987 678999999999999999999 999998877665555443321111                             


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                       ....++.++.++|.+||+.||.+|||+.+++++
T Consensus       238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          238 -QPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             012357779999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-39  Score=298.87  Aligned_cols=221  Identities=23%  Similarity=0.407  Sum_probs=184.5

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~   81 (316)
                      ++..||||+++...   ...+.+.+|+.++++++||||+++++++..      ..+++||||+. |+|.+++...  ..+
T Consensus       211 ~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~  281 (454)
T 1qcf_A          211 KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQ  281 (454)
T ss_dssp             TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHHSHHHHTC
T ss_pred             CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------CccEEEEeecCCCcHHHHHHhccCCCC
Confidence            46789999997542   245678999999999999999999999853      34799999996 7999999754  368


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .....++..|+|||++.. .
T Consensus       282 ~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  360 (454)
T 1qcf_A          282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-G  360 (454)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-C
Confidence            9999999999999999999999999999999999999999999999999987643221  123345678999999976 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|||++ |..||.+.+..+....+......+.                              ...+
T Consensus       361 ~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~------------------------------~~~~  410 (454)
T 1qcf_A          361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------------------------------PENC  410 (454)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC------------------------------CTTS
T ss_pred             CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------CCCC
Confidence            78999999999999999999 9999998887776665544221111                              1257


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++++.++|.+||+.||++|||+++|++
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            889999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-40  Score=291.17  Aligned_cols=237  Identities=22%  Similarity=0.323  Sum_probs=182.3

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      .+|+.||||++...  .......+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++....   
T Consensus        61 ~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  133 (321)
T 2qkw_B           61 RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSDLPT  133 (321)
T ss_dssp             TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----TCCEEEEECCTTCBTGGGSSSSCCCS
T ss_pred             CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEEEEEEcCCCCcHHHHHhccCCCc
Confidence            46899999998654  333567789999999999999999999998654     45899999996 69999886543   


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcccc
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~  155 (316)
                       .+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  213 (321)
T 2qkw_B          134 MSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF  213 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHH
T ss_pred             cccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHh
Confidence             58999999999999999999999999999999999999999999999999987644322   22345689999999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---HhhCCCCccccccccccchHHHhhhCCCCCCCC-c
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT---ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN-F  231 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  231 (316)
                      .+ ..++.++|||||||++|+|++|+.||.............   .......                  ........ .
T Consensus       214 ~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~  274 (321)
T 2qkw_B          214 IK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ------------------LEQIVDPNLA  274 (321)
T ss_dssp             HH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC------------------CCSSSSSSCT
T ss_pred             cC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc------------------HHHhcChhhc
Confidence            77 678999999999999999999999997654322111110   0000000                  00000000 0


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ....+.++..+.+++.+||+.||++|||++|++++
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11112356779999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-39  Score=281.01  Aligned_cols=228  Identities=25%  Similarity=0.333  Sum_probs=184.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-----------CCCCeEEEEEecCC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-----------ETFNDVYIVYELMD-T   69 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----------~~~~~~~iv~e~~~-g   69 (316)
                      +..+|+.||||+++...      ..+.+|+.++++++||||+++++++.....           .....+++||||++ |
T Consensus        32 ~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  105 (284)
T 2a19_B           32 HRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKG  105 (284)
T ss_dssp             ETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSC
T ss_pred             EcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCC
Confidence            45689999999996532      235689999999999999999998753110           11245899999997 5


Q ss_pred             cHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccc
Q 021181           70 DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR  147 (316)
Q Consensus        70 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (316)
                      +|.+++...  ..+++..++.++.||+.||.+||++||+|+||+|+||+++.++.++|+|||.+.............++.
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  185 (284)
T 2a19_B          106 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL  185 (284)
T ss_dssp             BHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCC
T ss_pred             CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcc
Confidence            999999654  579999999999999999999999999999999999999999999999999988776655555667899


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      .|+|||.+.+ ..++.++||||||+++|+|++|..|+....  .....+.   ..                         
T Consensus       186 ~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~---~~-------------------------  234 (284)
T 2a19_B          186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR---DG-------------------------  234 (284)
T ss_dssp             TTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH---TT-------------------------
T ss_pred             cccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh---cc-------------------------
Confidence            9999999987 678999999999999999999998873211  1111110   00                         


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                           .....++..+.++|.+||+.||.+|||+.|++++.+.-.
T Consensus       235 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 -----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                 001246888999999999999999999999999977543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=292.81  Aligned_cols=226  Identities=23%  Similarity=0.339  Sum_probs=175.2

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      ++..||||.++.. ........+.+|+.++++++||||+++++++...+    ...++||||++ |+|.+++... ..++
T Consensus       116 ~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~  190 (373)
T 3c1x_A          116 KKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPT  190 (373)
T ss_dssp             EEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----SCCEEEEECCTTCBHHHHHHCTTCCCB
T ss_pred             cEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----CCeEEEEECCCCCCHHHHHhhcccCCC
Confidence            3457999998653 34446678899999999999999999999875432    45789999996 6999999765 4589


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCcccccC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  157 (316)
                      +.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........     .....++..|+|||.+.+
T Consensus       191 ~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  270 (373)
T 3c1x_A          191 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT  270 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC
Confidence            999999999999999999999999999999999999999999999999876543221     123455778999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|+|++ |.+||...+..+....+......                              ....
T Consensus       271 -~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------------------------------~~p~  319 (373)
T 3c1x_A          271 -QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------------------------------LQPE  319 (373)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC------------------------------CCCT
T ss_pred             -CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCC
Confidence             778999999999999999999 78899877655544443321110                              0112


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .++..+.++|.+||+.||.+|||+++++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            578899999999999999999999998863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.1e-39  Score=280.10  Aligned_cols=229  Identities=28%  Similarity=0.418  Sum_probs=175.0

Q ss_pred             CCCCCceEEEEEeccc-ccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--
Q 021181            2 NSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--   77 (316)
                      +..+|+.||||+++.. .........+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++..  
T Consensus        53 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  127 (310)
T 2wqm_A           53 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFK  127 (310)
T ss_dssp             ETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCCSCBHHHHHHHHH
T ss_pred             EcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CcEEEEEecCCCCCHHHHHHHhc
Confidence            4568999999999763 23445567889999999999999999999999654     46999999997 599988864  


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccc
Q 021181           78 --HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL  154 (316)
Q Consensus        78 --~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~  154 (316)
                        ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.
T Consensus       128 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  207 (310)
T 2wqm_A          128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  207 (310)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHH
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHH
Confidence              4669999999999999999999999999999999999999999999999999987654432 2234567899999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV--HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      +.+ ..++.++||||||+++|+|++|..||.+....  .....+... ..+.                            
T Consensus       208 ~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~----------------------------  257 (310)
T 2wqm_A          208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPP----------------------------  257 (310)
T ss_dssp             HTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSCC----------------------------
T ss_pred             hCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCCC----------------------------
Confidence            977 67899999999999999999999999765321  222222110 0000                            


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .....+++++.++|.+||+.||.+|||++++++
T Consensus       258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            011357889999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-39  Score=280.75  Aligned_cols=220  Identities=24%  Similarity=0.367  Sum_probs=174.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC--C
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--L   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--~   81 (316)
                      +|+.||||+++..    ...+.+.+|+.++++++||||+++++++....    ...++||||++ ++|.+++...+.  +
T Consensus        43 ~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~  114 (278)
T 1byg_A           43 RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVL  114 (278)
T ss_dssp             TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHC
T ss_pred             cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceEEEEecCCCCCHHHHHHhcccccC
Confidence            5889999999643    24567889999999999999999999875432    45899999997 599999976543  8


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      ++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......  ....++..|+|||.+.+ ..+
T Consensus       115 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~  191 (278)
T 1byg_A          115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKF  191 (278)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHH-CCC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--cCCCccccccCHHHhCC-CCC
Confidence            999999999999999999999999999999999999999999999999987654332  23356788999999977 678


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++||||||+++|+|++ |..||...+.......+.....                              ......+++
T Consensus       192 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~  241 (278)
T 1byg_A          192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------------------MDAPDGCPP  241 (278)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC------------------------------CCCCTTCCH
T ss_pred             CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------------------------CCCcccCCH
Confidence            999999999999999998 9999988766555444322100                              011135789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+.++|.+||+.||.+|||+.++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.5e-40  Score=284.88  Aligned_cols=229  Identities=20%  Similarity=0.178  Sum_probs=180.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      |..+|+.||||++......    ..+.+|+.+++.++|++++..+..+....    ...++||||++++|.+++.. ...
T Consensus        30 ~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~  101 (296)
T 4hgt_A           30 DIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRK  101 (296)
T ss_dssp             ETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTSC
T ss_pred             EcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCC----CceEEEEEccCCCHHHHHHHhcCC
Confidence            4678999999987543222    34778999999999888877777664322    56899999998899999874 467


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE---ccCCCEEEeeeccccccCCCCc--------cccccccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDF--------MTEYVVTRWY  149 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~  149 (316)
                      +++.+++.++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++........        .....++..|
T Consensus       102 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 4hgt_A          102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccc
Confidence            9999999999999999999999999999999999999   7899999999999977554322        2345789999


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHhhCCCCccccccccccchHHHhhhCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV---HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF  226 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (316)
                      +|||.+.+ ..++.++|||||||++|+|++|..||.+.+..   .....+.......+                      
T Consensus       182 ~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------------  238 (296)
T 4hgt_A          182 ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----------------------  238 (296)
T ss_dssp             CCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----------------------
T ss_pred             cchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch----------------------
Confidence            99999987 67899999999999999999999999875432   12222111100000                      


Q ss_pred             CCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                          .......+++++.++|.+||+.||++|||++++++
T Consensus       239 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 ----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                01112357889999999999999999999999886

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-39  Score=285.07  Aligned_cols=225  Identities=23%  Similarity=0.348  Sum_probs=182.9

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc------
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS------   77 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~------   77 (316)
                      ++.||+|.+.... .......+.+|+.+++.+ +||||+++++++...     ..+++||||++ |+|.+++..      
T Consensus        76 ~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~  149 (333)
T 2i1m_A           76 VLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLE  149 (333)
T ss_dssp             CCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHS
T ss_pred             hhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-----CceEEEEecCCCCcHHHHHHHhccccc
Confidence            4589999997543 344567789999999999 899999999999654     45899999996 599999864      


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---ccccccc
Q 021181           78 --------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVT  146 (316)
Q Consensus        78 --------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~  146 (316)
                              ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........   .....++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  229 (333)
T 2i1m_A          150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP  229 (333)
T ss_dssp             CC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEEC
T ss_pred             ccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCC
Confidence                    24589999999999999999999999999999999999999999999999999976543322   2234567


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCC
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ  225 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (316)
                      ..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+........                     
T Consensus       230 ~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------  287 (333)
T 2i1m_A          230 VKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---------------------  287 (333)
T ss_dssp             GGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------
T ss_pred             ccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------
Confidence            78999999877 678999999999999999998 9999988765544443332211110                     


Q ss_pred             CCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       226 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                              ....+++.+.++|.+||+.||.+|||+++++++
T Consensus       288 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          288 --------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence                    012467889999999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5e-39  Score=277.23  Aligned_cols=221  Identities=24%  Similarity=0.400  Sum_probs=182.8

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~   81 (316)
                      ++..||||++....   ...+.+.+|+.+++.++||||+++++++...      ..++||||++ ++|.+++....  .+
T Consensus        36 ~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~  106 (279)
T 1qpc_A           36 GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFLKTPSGIKL  106 (279)
T ss_dssp             TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHTTSHHHHTC
T ss_pred             CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC------CcEEEEecCCCCCHHHHHhcCCCCCC
Confidence            56789999996543   2346788999999999999999999998532      3799999995 79999987543  69


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++.++..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.+ .
T Consensus       107 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  185 (279)
T 1qpc_A          107 TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-G  185 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-C
Confidence            9999999999999999999999999999999999999999999999999987654332  223345778999999976 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++||||||+++|+|++ |..||.+.+..+....+......                              .....+
T Consensus       186 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~  235 (279)
T 1qpc_A          186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------------------------------VRPDNC  235 (279)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------------------CCCTTC
T ss_pred             CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC------------------------------CCcccc
Confidence            78899999999999999999 99999888766655544331110                              011257


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      +.++.++|.+||+.||++|||++++++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            889999999999999999999999886

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-39  Score=305.29  Aligned_cols=224  Identities=21%  Similarity=0.332  Sum_probs=183.2

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~   81 (316)
                      .++..||||+++... .......+.+|+.++++++||||+++++++..      ..+++||||++ |+|.+++... ..+
T Consensus       361 ~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l  433 (613)
T 2ozo_A          361 KKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEI  433 (613)
T ss_dssp             SCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHTTCTTTS
T ss_pred             CCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEeCCCCcHHHHHhhccCCC
Confidence            467789999997652 34456789999999999999999999999854      23899999996 6999998654 459


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........    .....++..|+|||++.+
T Consensus       434 ~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~  513 (613)
T 2ozo_A          434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF  513 (613)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC
Confidence            9999999999999999999999999999999999999999999999999987643322    112334578999999976


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|||++ |..||.+.+..+....+......                              ....
T Consensus       514 -~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------------------------~~p~  562 (613)
T 2ozo_A          514 -RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------------------------------ECPP  562 (613)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC------------------------------CCCT
T ss_pred             -CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCC
Confidence             679999999999999999998 99999998877766655432111                              1113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+++++.++|.+||+.||.+||++++|++
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            57899999999999999999999998753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=278.64  Aligned_cols=227  Identities=29%  Similarity=0.401  Sum_probs=175.6

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---C
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---D   80 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---~   80 (316)
                      +++.||||++..    ......+.+|+.++++++||||+++++++.+.       .++||||++ |+|.+++....   .
T Consensus        30 ~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~   98 (307)
T 2eva_A           30 RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPY   98 (307)
T ss_dssp             TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-------TEEEEECCTTCBHHHHHHCSSSEEC
T ss_pred             CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-------cEEEEEcCCCCCHHHHHhccCCCCc
Confidence            478899999853    23556788999999999999999999988532       689999996 69999998765   3


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhc---CCceeccCCCCcEEEccCCC-EEEeeeccccccCCCCccccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHS---ANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      ++...+..++.|++.||+|||+   +||+||||||+||+++.++. +||+|||.+......  .....++..|+|||.+.
T Consensus        99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~  176 (307)
T 2eva_A           99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFE  176 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHT
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhC
Confidence            7899999999999999999999   89999999999999998887 799999998765432  23446899999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|||||||++|+|++|+.||................+..                            .....
T Consensus       177 ~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~  227 (307)
T 2eva_A          177 G-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----------------------------PPLIK  227 (307)
T ss_dssp             C-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----------------------------CCCBT
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----------------------------CCccc
Confidence            7 678999999999999999999999997654322111111111111                            11123


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc-----CCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC-----HPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~-----~~~f~~~~  273 (316)
                      .++..+.++|.+||+.||.+|||++++++     ..++....
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence            57889999999999999999999999987     45555443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=284.61  Aligned_cols=225  Identities=23%  Similarity=0.329  Sum_probs=177.2

Q ss_pred             CCCCce----EEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            3 SETREE----VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         3 ~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      ..+|+.    ||+|.+... ........+.+|+.+++.++||||+++++++...      ..+++++++. |+|.+++..
T Consensus        37 ~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~~v~~~~~~g~L~~~l~~  109 (327)
T 3lzb_A           37 IPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVRE  109 (327)
T ss_dssp             CCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS------SEEEEECCCSSCBHHHHHHH
T ss_pred             cCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC------CceEEEEecCCCcHHHHHHh
Confidence            445555    477776543 2334567789999999999999999999998754      2788999986 799999876


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPE  153 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE  153 (316)
                       ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........   .....++..|+|||
T Consensus       110 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3lzb_A          110 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHH
Confidence             45699999999999999999999999999999999999999999999999999977544322   22334577899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      .+.+ ..++.++|||||||++|+|++ |..||.+.........+......+                             
T Consensus       190 ~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------  239 (327)
T 3lzb_A          190 SILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-----------------------------  239 (327)
T ss_dssp             HHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------------------------
T ss_pred             HHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------
Confidence            9987 778999999999999999999 999998887666555443321111                             


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                       ..+.++.++.++|++||+.||.+||+++|+++
T Consensus       240 -~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          240 -QPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             11356888999999999999999999999886

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.6e-40  Score=292.46  Aligned_cols=238  Identities=13%  Similarity=0.089  Sum_probs=178.8

Q ss_pred             CCceEEEEEecccccChh---------HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHh
Q 021181            5 TREEVAIKKIGNAFDNRI---------DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII   75 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l   75 (316)
                      +++.||||++........         .......|+..++.++||||+++++++.... .+....|+||||++++|.+++
T Consensus        64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~  142 (364)
T 3op5_A           64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK-NGKSYRFMIMDRFGSDLQKIY  142 (364)
T ss_dssp             TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEE-TTEEEEEEEEECEEEEHHHHH
T ss_pred             cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeecc-CCcceEEEEEeCCCCCHHHHH
Confidence            478999999865421111         0122345666777889999999999987542 223568999999988999999


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc--cCCCEEEeeeccccccCCCCc--------ccccc
Q 021181           76 RSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN--ANCDLKIGDFGLARTTSETDF--------MTEYV  144 (316)
Q Consensus        76 ~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~--------~~~~~  144 (316)
                      ... +.+++.+++.++.||+.||+|||++||+||||||+||+++  .++.++|+|||++........        .....
T Consensus       143 ~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~  222 (364)
T 3op5_A          143 EANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD  222 (364)
T ss_dssp             HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence            776 6799999999999999999999999999999999999999  889999999999976543211        13345


Q ss_pred             ccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          145 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      +|..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.. ..............            .........
T Consensus       223 gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~  289 (364)
T 3op5_A          223 GTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRE------------NIASLMDKC  289 (364)
T ss_dssp             CCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH------------CHHHHHHHH
T ss_pred             CCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhh------------hHHHHHHHh
Confidence            8999999999987 678999999999999999999999998643 22222211111000            000111100


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..         ...++.++.+++..||+.||.+||++++|++
T Consensus       290 ~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          290 FP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             SC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            00         1367899999999999999999999998876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=288.72  Aligned_cols=227  Identities=9%  Similarity=0.109  Sum_probs=177.0

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccce---------------eeeecCCCCCCCCeEEEEEecCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI---------------KDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~---------------~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      .|+.||||++...       ..+.+|+.++++++||||+++               ++++...    ....++||||+++
T Consensus        74 ~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~lv~e~~~~  142 (352)
T 2jii_A           74 QKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ----DKYRFLVLPSLGR  142 (352)
T ss_dssp             ---CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET----TTEEEEEEECCCE
T ss_pred             cCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC----CcEEEEEecCCCc
Confidence            5899999998643       247799999999999999984               4444321    2578999999988


Q ss_pred             cHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC--CEEEeeeccccccCCCC-------
Q 021181           70 DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC--DLKIGDFGLARTTSETD-------  138 (316)
Q Consensus        70 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~-------  138 (316)
                      +|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||++.......       
T Consensus       143 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  222 (352)
T 2jii_A          143 SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE  222 (352)
T ss_dssp             EHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCT
T ss_pred             CHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccc
Confidence            999999876  7899999999999999999999999999999999999999998  89999999997654321       


Q ss_pred             -ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHH-HHHHHhhCCCCccccccccccc
Q 021181          139 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQL-RLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       139 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~-~~~~~-~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                       ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ....+ .........+.....       
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------  294 (352)
T 2jii_A          223 GSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG-------  294 (352)
T ss_dssp             TSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC-------
T ss_pred             cccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh-------
Confidence             1234478999999999987 678999999999999999999999998764 23322 222222211111000       


Q ss_pred             hHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          216 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                     .......+++++.++|.+||+.||.+|||++++++
T Consensus       295 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          295 ---------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             ---------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ---------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence                           00011257899999999999999999999999876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=283.69  Aligned_cols=232  Identities=24%  Similarity=0.328  Sum_probs=181.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      +..+|+.||||++...  .......+.+|+.+++.++||||+++++++.... ......++||||+. |+|.+++..   
T Consensus        50 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~  126 (317)
T 2buj_A           50 GLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKD  126 (317)
T ss_dssp             ETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHT
T ss_pred             ecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHh
Confidence            4578999999998543  4456678899999999999999999999986321 12256899999997 599988875   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----------ccccccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----------MTEYVVT  146 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----------~~~~~~~  146 (316)
                       ...+++.+++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+........          .....++
T Consensus       127 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt  206 (317)
T 2buj_A          127 KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT  206 (317)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCC
Confidence             46799999999999999999999999999999999999999999999999998765432111          0123458


Q ss_pred             ccccCcccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          147 RWYRAPELLLNCS--EYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       147 ~~~~aPE~~~~~~--~~~~~~DiwslG~~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      ..|+|||++....  .++.++|||||||++|+|++|..||.....  ......+..   .                    
T Consensus       207 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~--------------------  263 (317)
T 2buj_A          207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---Q--------------------  263 (317)
T ss_dssp             GGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---C--------------------
T ss_pred             cccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---c--------------------
Confidence            8999999986522  368899999999999999999999953210  001111100   0                    


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                       ..      ....+.++..+.++|.+||+.||.+|||+++++++
T Consensus       264 -~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 -LS------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CC------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence             00      00113578899999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5e-39  Score=278.72  Aligned_cols=224  Identities=25%  Similarity=0.332  Sum_probs=179.0

Q ss_pred             CceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            6 REEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      +..||||+++.... .......+.+|+.++++++||||+++++++....      .++||||+. ++|.+++... +.++
T Consensus        46 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~v~e~~~~~~L~~~l~~~~~~~~  119 (291)
T 1u46_A           46 TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFL  119 (291)
T ss_dssp             EEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS------CEEEEECCTTCBHHHHHHHHGGGSC
T ss_pred             eeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC------ceeeEecccCCCHHHHHHhccCCcC
Confidence            34799999976432 3445678899999999999999999999986542      789999996 7999988764 5699


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~  158 (316)
                      +..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++........    .....++..|+|||.+.+ 
T Consensus       120 ~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  198 (291)
T 1u46_A          120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-  198 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcC-
Confidence            999999999999999999999999999999999999999999999999877654322    123456778999999976 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++||||||+++|+|++ |..||.+.+.......+.......                             .....
T Consensus       199 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  249 (291)
T 1u46_A          199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------------------------PRPED  249 (291)
T ss_dssp             CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-----------------------------CCCTT
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC-----------------------------CCCcC
Confidence            668899999999999999999 999998887666655543321111                             01135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++.++.++|.+||+.||.+|||+.++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            7899999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.6e-39  Score=280.66  Aligned_cols=239  Identities=25%  Similarity=0.333  Sum_probs=183.2

Q ss_pred             CCceEEEEEecccc--cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---C
Q 021181            5 TREEVAIKKIGNAF--DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---H   78 (316)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---~   78 (316)
                      +|+.||||++....  ........+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++..   .
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  127 (307)
T 2nru_A           53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGT  127 (307)
T ss_dssp             SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGGC
T ss_pred             CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccCC
Confidence            68899999997543  2344567889999999999999999999999654     45899999995 799998863   3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELL  155 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~  155 (316)
                      ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   .....++..|+|||.+
T Consensus       128 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  207 (307)
T 2nru_A          128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL  207 (307)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHh
Confidence            5699999999999999999999999999999999999999999999999999876544321   2345689999999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+  .++.++||||||+++|+|++|.+||...........+.........         ....+..       .......
T Consensus       208 ~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-------~~~~~~~  269 (307)
T 2nru_A          208 RG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK---------TIEDYID-------KKMNDAD  269 (307)
T ss_dssp             TT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC---------CHHHHSC-------SSCSCCC
T ss_pred             cC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh---------hhhhhcc-------ccccccc
Confidence            65  4789999999999999999999999876543322222211111000         0000000       0001111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ..++..+.+++.+||+.||.+|||+++++++
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2345679999999999999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-39  Score=286.07  Aligned_cols=240  Identities=21%  Similarity=0.290  Sum_probs=179.7

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ---   79 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---   79 (316)
                      .+|+.||||++...... .....+.+|+.+++.++||||+++++++...     ...++||||++ |+|.+++....   
T Consensus        52 ~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  125 (326)
T 3uim_A           52 ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPESQ  125 (326)
T ss_dssp             SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SCCEEEEECCTTCBHHHHHHCCSTTC
T ss_pred             cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC-----CceEEEEEeccCCCHHHHHHhccccC
Confidence            46899999999764322 1223588999999999999999999999654     45799999996 69999997653   


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhcC---CceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcc
Q 021181           80 -DLTDDHCRYFLYQLLRGLKYVHSA---NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPE  153 (316)
Q Consensus        80 -~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE  153 (316)
                       .+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||++........  .....++..|+|||
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE  205 (326)
T 3uim_A          126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE  205 (326)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHH
Confidence             499999999999999999999999   999999999999999999999999999987643322  33455899999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          154 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-----DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       154 ~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      .+.+ ..++.++|||||||++|+|++|..||...     ........+..........                  ....
T Consensus       206 ~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~  266 (326)
T 3uim_A          206 YLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE------------------ALVD  266 (326)
T ss_dssp             HHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST------------------TSSC
T ss_pred             Hhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh------------------hhcC
Confidence            9877 66899999999999999999999999521     1111111111100000000                  0000


Q ss_pred             CCc-cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021181          229 QNF-SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY  268 (316)
Q Consensus       229 ~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~  268 (316)
                      ... .......+..+.+++.+||+.||.+|||++|++++-.
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            000 0111123467999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.1e-39  Score=294.27  Aligned_cols=228  Identities=25%  Similarity=0.403  Sum_probs=182.6

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~   82 (316)
                      +..||||+++....   ..+.+.+|+.++++++||||+++++++..      ...++||||++ |+|.+++...  ..++
T Consensus       208 ~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~~~~~~~  278 (452)
T 1fmk_A          208 TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLR  278 (452)
T ss_dssp             TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCC
T ss_pred             CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhcCCCCCC
Confidence            46799999975432   34578999999999999999999999854      34799999996 6999999743  5699


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  .....++..|+|||.+.. ..
T Consensus       279 ~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  357 (452)
T 1fmk_A          279 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR  357 (452)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc-CC
Confidence            999999999999999999999999999999999999999999999999977643322  223345678999999877 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|||||||++|+|++ |..||.+....+....+......+                              ..+.++
T Consensus       358 ~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------------------------~~~~~~  407 (452)
T 1fmk_A          358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------------------------CPPECP  407 (452)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------------------CCTTSC
T ss_pred             CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CCCCCC
Confidence            8999999999999999999 999999887766665554321111                              113578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC--HPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~~~  273 (316)
                      +.+.++|.+||+.||++|||+++|++  ..++....
T Consensus       408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            89999999999999999999999987  46665543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.4e-39  Score=280.37  Aligned_cols=231  Identities=23%  Similarity=0.324  Sum_probs=172.7

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhh--CCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRH--MDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      +|+.||||++...     .......|.+++..  ++||||+++++++.... .....+++||||++ |+|.++++. ..+
T Consensus        30 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~  102 (301)
T 3q4u_A           30 QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWLITHYHEMGSLYDYLQL-TTL  102 (301)
T ss_dssp             TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEEEECCCTTCBHHHHHTT-CCB
T ss_pred             CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEEehhhccCCCHHHHHhh-ccc
Confidence            6889999998543     33445566676666  79999999999876432 22356899999996 699999854 679


Q ss_pred             CHHHHHHHHHHHHHHHHHhh--------cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----ccccccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVH--------SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRW  148 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH--------~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~  148 (316)
                      ++..++.++.||+.||+|||        +.||+||||||+||+++.++.+||+|||++........     .....+|..
T Consensus       103 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  182 (301)
T 3q4u_A          103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR  182 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccc
Confidence            99999999999999999999        99999999999999999999999999999876543322     223478999


Q ss_pred             ccCcccccCCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCCc----HHHHHHHHHhhCCCCccccc
Q 021181          149 YRAPELLLNCS-----EYTAAIDIWSVGCILGEIMTR----------QPLFPGKDY----VHQLRLITELIGSPDETSLG  209 (316)
Q Consensus       149 ~~aPE~~~~~~-----~~~~~~DiwslG~~l~ell~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  209 (316)
                      |+|||.+.+..     .++.++|||||||++|+|++|          ..||.....    ...........+..+...  
T Consensus       183 y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  260 (301)
T 3q4u_A          183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP--  260 (301)
T ss_dssp             GCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC--
T ss_pred             eeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCC--
Confidence            99999997632     234689999999999999999          788855321    111221111111111000  


Q ss_pred             cccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                           .......+++.+.++|.+||+.||.+|||++++++
T Consensus       261 ---------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          261 ---------------------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             ---------------------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---------------------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                                 00001124577999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=280.72  Aligned_cols=244  Identities=21%  Similarity=0.346  Sum_probs=183.1

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~   79 (316)
                      +..+|+.||||++...  .......+.+|+.++++++||||+++++++...+.   ..+++||||++ ++|.+++... .
T Consensus        66 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  140 (326)
T 2w1i_A           66 QDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKE  140 (326)
T ss_dssp             SSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHSTT
T ss_pred             cCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC---CceEEEEECCCCCCHHHHHHhccc
Confidence            5678999999999753  44456788999999999999999999999865431   45899999996 6999999875 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~  155 (316)
                      .+++.+++.++.||+.||++||+.||+|+||||+||+++.++.++|+|||++........    .....++..|+|||.+
T Consensus       141 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  220 (326)
T 2w1i_A          141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL  220 (326)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhh
Confidence            599999999999999999999999999999999999999999999999999987654422    1234456779999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|..||......     .....+.......   ..............      ....
T Consensus       221 ~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~  285 (326)
T 2w1i_A          221 TE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQM---IVFHLIELLKNNGR------LPRP  285 (326)
T ss_dssp             HH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-----HHHHHCTTCCTHH---HHHHHHHHHHTTCC------CCCC
T ss_pred             cC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-----HHHhhccccchhh---hHHHHHHHhhcCCC------CCCC
Confidence            77 66889999999999999999999988543110     1111111000000   00000000000000      0112


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++++.++|++||+.||.+|||+.++++
T Consensus       286 ~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          286 DGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            367899999999999999999999999885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.5e-39  Score=279.05  Aligned_cols=220  Identities=25%  Similarity=0.417  Sum_probs=168.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHH-hhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||+++..       ....+|+.++ +.++||||+++++++.... .+...+++||||++ |+|.+++....
T Consensus        39 ~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~  110 (299)
T 3m2w_A           39 NKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRG  110 (299)
T ss_dssp             ETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEECCCCSCBHHHHHHHCT
T ss_pred             EcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEEEeecCCCcHHHHHHhcc
Confidence            5678999999999532       2466888887 6669999999999986411 12256899999996 59999998754


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---CCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           80 --DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        80 --~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                        .+++.+++.++.||+.||.|||++||+||||||+||+++.   ++.++|+|||++.....                  
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------  172 (299)
T 3m2w_A          111 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------------  172 (299)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT------------------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc------------------
Confidence              6999999999999999999999999999999999999998   78899999998754321                  


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                          ..++.++|||||||++|+|++|..||.+.+.......+...                       ............
T Consensus       173 ----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~  225 (299)
T 3m2w_A          173 ----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-----------------------IRMGQYEFPNPE  225 (299)
T ss_dssp             ----CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-----------------------SCTTCCSSCHHH
T ss_pred             ----ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-----------------------HhhccccCCchh
Confidence                34678999999999999999999999766432211100000                       000000000111


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      ...+++++.++|.+||+.||.+|||++|+++||||++...
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            2467999999999999999999999999999999987553

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-38  Score=295.93  Aligned_cols=228  Identities=25%  Similarity=0.403  Sum_probs=186.6

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLT   82 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~~~   82 (316)
                      +..||||+++....   ..+.+.+|+.++++++||||+++++++..      ..+++||||+. |+|.+++...  ..++
T Consensus       291 ~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~  361 (535)
T 2h8h_A          291 TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLR  361 (535)
T ss_dssp             TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHHHHTTCC
T ss_pred             CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhcCCCCCC
Confidence            46799999975432   34578999999999999999999999854      34799999996 6999999743  5699


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .....++..|+|||.+.. ..
T Consensus       362 ~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  440 (535)
T 2h8h_A          362 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR  440 (535)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CC
Confidence            999999999999999999999999999999999999999999999999976543211  123345678999999877 67


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|||||||++|+|++ |..||.+....+....+......+                              ....++
T Consensus       441 ~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------------------------~~~~~~  490 (535)
T 2h8h_A          441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------------------------CPPECP  490 (535)
T ss_dssp             CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC------------------------------CCTTCC
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CCCCCC
Confidence            8999999999999999999 999999887766665554321110                              113578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC--CCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCH--PYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~--~~f~~~~  273 (316)
                      ..+.+||.+||+.||++|||+++|++.  .+|....
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            899999999999999999999999873  5665443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.5e-39  Score=280.63  Aligned_cols=224  Identities=23%  Similarity=0.296  Sum_probs=178.7

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~   84 (316)
                      ..||+|+++...........+.+|+.++++++||||+++++++...     ..++++|||++ ++|.+++...+ .+++.
T Consensus        56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~  130 (319)
T 2y4i_B           56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVN  130 (319)
T ss_dssp             SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSH
T ss_pred             CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----CceEEEeecccCCcHHHHHHhcCCCCCHH
Confidence            4599999976544444455677899999999999999999999755     45999999996 69999997754 69999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC------CccccccccccccCcccccC-
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET------DFMTEYVVTRWYRAPELLLN-  157 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~-  157 (316)
                      .++.++.||+.||++||+.|++||||+|+||+++ ++.++|+|||++......      .......++..|+|||.+.. 
T Consensus       131 ~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  209 (319)
T 2y4i_B          131 KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL  209 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCB
T ss_pred             HHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhc
Confidence            9999999999999999999999999999999998 679999999987654321      12233457899999999864 


Q ss_pred             -------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          158 -------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       158 -------~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                             ...++.++|||||||++|+|++|..||...........+.......                           
T Consensus       210 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------  262 (319)
T 2y4i_B          210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN---------------------------  262 (319)
T ss_dssp             SCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---------------------------
T ss_pred             cccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---------------------------
Confidence                   2457889999999999999999999998887665555443221110                           


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                        .....++.++.++|.+||+.||.+|||++++++
T Consensus       263 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 --LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             --CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             --CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              001246788999999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-39  Score=296.54  Aligned_cols=234  Identities=18%  Similarity=0.185  Sum_probs=175.7

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCC-CCcccee---------ee------------ecCCCCCCCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDH-ENIIAIK---------DI------------IRPPQRETFN   58 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~~i~~~~---------~~------------~~~~~~~~~~   58 (316)
                      |..+|+.||||++.... ......+.+.+|+.+++.+.| .+...+.         +.            +.........
T Consensus        99 ~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (413)
T 3dzo_A           99 DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL  178 (413)
T ss_dssp             ETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CC
T ss_pred             ecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCcccccc
Confidence            56789999999997432 233345778899999999976 3221111         11            1111101123


Q ss_pred             eEEEEEecCCCcHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181           59 DVYIVYELMDTDLHQIIRS-------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus        59 ~~~iv~e~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      .++++|+.++++|.+++..       .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       179 ~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a  258 (413)
T 3dzo_A          179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL  258 (413)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred             ceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccce
Confidence            5789999999999988841       234778899999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccCccccc---------CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC
Q 021181          132 RTTSETDFMTEYVVTRWYRAPELLL---------NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS  202 (316)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  202 (316)
                      ......  .....+ ..|+|||++.         ....++.++|||||||++|+|++|+.||...+.......       
T Consensus       259 ~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~-------  328 (413)
T 3dzo_A          259 VRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW-------  328 (413)
T ss_dssp             EETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-------
T ss_pred             eecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-------
Confidence            775543  344566 9999999983         225678899999999999999999999976542111000       


Q ss_pred             CCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          203 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                                                  .......+++++.++|.+||+.||++||++.++++||||+++.
T Consensus       329 ----------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          329 ----------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             ----------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence                                        0011136789999999999999999999999999999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.9e-38  Score=290.16  Aligned_cols=231  Identities=20%  Similarity=0.207  Sum_probs=178.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC-ccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~   79 (316)
                      |..+|+.||||++......    ..+..|+.+++.+.|++ +..+..++...     ...++||||++++|.+++.. ..
T Consensus        28 ~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~-----~~~~lvme~~g~sL~~ll~~~~~   98 (483)
T 3sv0_A           28 NIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSR   98 (483)
T ss_dssp             ETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTT
T ss_pred             ECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC-----CEEEEEEECCCCCHHHHHHhhcC
Confidence            4678999999988654322    23778999999998754 44454444332     56899999999999999975 56


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEE---ccCCCEEEeeeccccccCCCCc--------ccccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDF--------MTEYVVTRW  148 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~  148 (316)
                      .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........        .....++..
T Consensus        99 ~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~  178 (483)
T 3sv0_A           99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR  178 (483)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCcc
Confidence            79999999999999999999999999999999999999   6889999999999987654322        125678999


Q ss_pred             ccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          149 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      |+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.........                       
T Consensus       179 Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----------------------  234 (483)
T 3sv0_A          179 YASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-----------------------  234 (483)
T ss_dssp             TCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-----------------------
T ss_pred             ccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-----------------------
Confidence            999999987 67899999999999999999999999886543322222211100000                       


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .........++.++.++|..||+.||.+||++++|++
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            0001112367889999999999999999999987765

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-37  Score=296.95  Aligned_cols=224  Identities=28%  Similarity=0.433  Sum_probs=184.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~~   81 (316)
                      .++..||||+++.. ........+.+|+.++++++||||+++++++..      ...++||||++ |+|.+++...+ .+
T Consensus       416 ~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l  488 (656)
T 2j0j_A          416 NPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSL  488 (656)
T ss_dssp             SCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHTTTTC
T ss_pred             CccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec------CceEEEEEcCCCCcHHHHHHhccCCC
Confidence            35678999998653 344456788999999999999999999999843      23799999996 79999997654 68


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc--ccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.........  ....++..|+|||++.+ .
T Consensus       489 ~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~  567 (656)
T 2j0j_A          489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-R  567 (656)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-C
Confidence            99999999999999999999999999999999999999999999999999876543322  23445678999999976 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|+|++ |.+||.+.+..+....+......+                              ..+.+
T Consensus       568 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~------------------------------~~~~~  617 (656)
T 2j0j_A          568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------------------------MPPNC  617 (656)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC------------------------------CCTTC
T ss_pred             CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CCccc
Confidence            78999999999999999997 999999888777666554421111                              11357


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ++.+.++|.+||+.||.+|||+.++++
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            889999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=279.45  Aligned_cols=255  Identities=20%  Similarity=0.204  Sum_probs=171.8

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHH--HHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIK--LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~--~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      .+|+.||||++...     .......|.+  .+..++||||+++++.+......+...+++||||++ |+|.+++... .
T Consensus        34 ~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~  107 (336)
T 3g2f_A           34 LDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-T  107 (336)
T ss_dssp             ETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-C
T ss_pred             ECCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-c
Confidence            36889999999643     2223334444  455689999999998654332233456899999995 6999999764 4


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcC---------CceeccCCCCcEEEccCCCEEEeeeccccccCCCC---------cccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSA---------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---------FMTE  142 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~---------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------~~~~  142 (316)
                      .++..++.++.||+.||+|||+.         ||+||||||+||+++.++.+||+|||++.......         ....
T Consensus       108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~  187 (336)
T 3g2f_A          108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS  187 (336)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CC
T ss_pred             cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccccc
Confidence            58999999999999999999999         99999999999999999999999999997654321         1224


Q ss_pred             ccccccccCcccccCC------CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCccccccccccc
Q 021181          143 YVVTRWYRAPELLLNC------SEYTAAIDIWSVGCILGEIMTRQPLFPGK-DYVHQLRLITELIGSPDETSLGFLRSDN  215 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (316)
                      ..+|..|+|||++.+.      ..++.++|||||||++|+|++|..||... .............+..+..       ..
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~  260 (336)
T 3g2f_A          188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF-------ED  260 (336)
T ss_dssp             TTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCH-------HH
T ss_pred             CCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchH-------HH
Confidence            5689999999998752      23457899999999999999997665333 2111100000000000000       00


Q ss_pred             hHHHhhhCCCCCCCCcccc---CCCCChHHHHHHHHhcccCCCCCCCHHHHh------cCCCCCCCC
Q 021181          216 ARRYVRMLPQFPKQNFSAR---FPNKSPGAVDLLEKMLVFDPNRRITVDEAL------CHPYLAPLH  273 (316)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~ell------~~~~f~~~~  273 (316)
                      .......  ......+...   ...+++++.++|.+||+.||++|||++|++      -++|-++-.
T Consensus       261 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~  325 (336)
T 3g2f_A          261 MQVLVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS  325 (336)
T ss_dssp             HHHHHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred             HHhhhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence            0000000  0001111111   112456799999999999999999999994      477776643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-37  Score=272.22  Aligned_cols=231  Identities=23%  Similarity=0.262  Sum_probs=168.6

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhC--CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM--DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      +|+.||||++...     .......|.+++..+  +||||+++++++.... .....+++||||++ |+|.++++. ..+
T Consensus        59 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~  131 (337)
T 3mdy_A           59 RGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLITDYHENGSLYDYLKS-TTL  131 (337)
T ss_dssp             TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEEECCCTTCBHHHHHHH-CCB
T ss_pred             CCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEEEeccCCCcHHHHhhc-cCC
Confidence            4889999998532     223344555555544  8999999999987542 22256899999996 699999976 479


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcC--------CceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc-----cccccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-----TEYVVTRW  148 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~  148 (316)
                      ++..++.++.|++.||+|||+.        ||+||||||+||+++.++.+||+|||++.........     ....++..
T Consensus       132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  211 (337)
T 3mdy_A          132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR  211 (337)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcc
Confidence            9999999999999999999998        9999999999999999999999999998765433221     24578999


Q ss_pred             ccCcccccCCCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCCCc----HHHHHHHHHhhCCCCcccc
Q 021181          149 YRAPELLLNCSEYTAA------IDIWSVGCILGEIMTR----------QPLFPGKDY----VHQLRLITELIGSPDETSL  208 (316)
Q Consensus       149 ~~aPE~~~~~~~~~~~------~DiwslG~~l~ell~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~  208 (316)
                      |+|||++.+ ......      +|||||||++|+|++|          ..||.....    ..............+..  
T Consensus       212 y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  288 (337)
T 3mdy_A          212 YMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF--  288 (337)
T ss_dssp             GCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC--
T ss_pred             eeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccc--
Confidence            999999976 444444      8999999999999999          566644321    11111111111100000  


Q ss_pred             ccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          209 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                           ........+++++.++|.+||+.||.+|||+++++++
T Consensus       289 ---------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          289 ---------------------PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             ---------------------CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ---------------------cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                                 0000012456779999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.3e-38  Score=279.64  Aligned_cols=218  Identities=15%  Similarity=0.165  Sum_probs=171.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC---CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      +..+|+.||||+++..     ....+..|+.+++.++   |+||+++++++...     ...|+||||++ |+|.+++..
T Consensus        91 ~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~  160 (365)
T 3e7e_A           91 DAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAINL  160 (365)
T ss_dssp             ---CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-----SCEEEEECCCCSCBHHHHHHH
T ss_pred             ccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-----CCcEEEEeccCCCcHHHHHHH
Confidence            4678999999999643     2345677888888886   99999999999655     45899999996 799999973


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-----------CCCEEEeeeccccccC---CCC
Q 021181           78 -----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-----------NCDLKIGDFGLARTTS---ETD  138 (316)
Q Consensus        78 -----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-----------~~~~~l~df~~~~~~~---~~~  138 (316)
                           ...+++..++.++.||+.||+|||++||+||||||+|||++.           ++.+||+|||++....   ...
T Consensus       161 ~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~  240 (365)
T 3e7e_A          161 YKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT  240 (365)
T ss_dssp             HHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE
T ss_pred             hhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCc
Confidence                 567999999999999999999999999999999999999998           8999999999996543   233


Q ss_pred             ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHH
Q 021181          139 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR  218 (316)
Q Consensus       139 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  218 (316)
                      ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||........              .           
T Consensus       241 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------------~-----------  294 (365)
T 3e7e_A          241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------------K-----------  294 (365)
T ss_dssp             EECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------------E-----------
T ss_pred             eeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCce--------------e-----------
Confidence            3455678999999999987 6689999999999999999999999854421000              0           


Q ss_pred             HhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          219 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                       .       ... .. ....++.+.+++..||+.+|.+|++..+.+.
T Consensus       295 -~-------~~~-~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          295 -P-------EGL-FR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             -E-------CSC-CT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             -e-------chh-cc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence             0       000 00 0124667999999999999999976544443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.1e-37  Score=271.21  Aligned_cols=230  Identities=22%  Similarity=0.275  Sum_probs=174.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhh--CCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRH--MDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~   81 (316)
                      +|+.||||++...     ....+.+|++++..  ++||||+++++++.... .....+++||||++ |+|.+++.. ..+
T Consensus        64 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~  136 (342)
T 1b6c_B           64 RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-YTV  136 (342)
T ss_dssp             TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEEECCCTTCBHHHHHHH-CCB
T ss_pred             cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEEEeecCCCcHHHHHhc-cCc
Confidence            5899999998542     34557788888887  78999999999987653 22236999999997 599999976 579


Q ss_pred             CHHHHHHHHHHHHHHHHHhh--------cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----cccccccccc
Q 021181           82 TDDHCRYFLYQLLRGLKYVH--------SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRW  148 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH--------~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~  148 (316)
                      ++.+++.++.||+.||.|||        +.||+||||||+||+++.++.++|+|||++.......     ......++..
T Consensus       137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~  216 (342)
T 1b6c_B          137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR  216 (342)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGG
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcc
Confidence            99999999999999999999        8999999999999999999999999999987654433     1234578999


Q ss_pred             ccCcccccCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCCc----HHHHHHHHHhhCCCCccccc
Q 021181          149 YRAPELLLNCSE-----YTAAIDIWSVGCILGEIMTR----------QPLFPGKDY----VHQLRLITELIGSPDETSLG  209 (316)
Q Consensus       149 ~~aPE~~~~~~~-----~~~~~DiwslG~~l~ell~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  209 (316)
                      |+|||.+.+...     ++.++|||||||++|+|++|          ..||.....    ..............+     
T Consensus       217 y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  291 (342)
T 1b6c_B          217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP-----  291 (342)
T ss_dssp             GCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC-----
T ss_pred             cCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCC-----
Confidence            999999876322     22689999999999999999          678765421    111111110000000     


Q ss_pred             cccccchHHHhhhCCCCCCCCcccc--CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          210 FLRSDNARRYVRMLPQFPKQNFSAR--FPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                          .+...  ...++..+.++|.+||+.||.+|||+++++++
T Consensus       292 --------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          292 --------------------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             --------------------CCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                                00000  01234579999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.2e-38  Score=277.26  Aligned_cols=230  Identities=17%  Similarity=0.149  Sum_probs=167.8

Q ss_pred             CCceEEEEEeccccc------ChhHHHHHHHHHHHHhhCC---------C-----------------CCccceeeeecCC
Q 021181            5 TREEVAIKKIGNAFD------NRIDAKRTLREIKLLRHMD---------H-----------------ENIIAIKDIIRPP   52 (316)
Q Consensus         5 ~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h-----------------~~i~~~~~~~~~~   52 (316)
                      +|+.||||+++....      .......+.+|+.+++.++         |                 |||+++++++...
T Consensus        42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~  121 (336)
T 2vuw_A           42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST  121 (336)
T ss_dssp             TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence            689999999976532      2233467889999988886         5                 4455555544421


Q ss_pred             C--------CCCCCeEEEEEecCC-CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCC-
Q 021181           53 Q--------RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANC-  121 (316)
Q Consensus        53 ~--------~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~-  121 (316)
                      .        ......+|+||||+. |++.+.+.. +.+++.+++.++.||+.||+||| ++||+||||||+|||++.++ 
T Consensus       122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~  200 (336)
T 2vuw_A          122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL  200 (336)
T ss_dssp             TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSC
T ss_pred             ccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCC
Confidence            0        011367999999995 666666644 67899999999999999999999 99999999999999999887 


Q ss_pred             -------------------CEEEeeeccccccCCCCccccccccccccCcccccCCCCCCCcchHHHHHHH-HHHHHhCC
Q 021181          122 -------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI-LGEIMTRQ  181 (316)
Q Consensus       122 -------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~-l~ell~g~  181 (316)
                                         .+||+|||+++.....    ...+|+.|+|||++.+ .. +.++||||+|++ .+++++|.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g-~~-~~~~Diwsl~~~~~~~~~~g~  274 (336)
T 2vuw_A          201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG-DG-DYQFDIYRLMKKENNNRWGEY  274 (336)
T ss_dssp             SEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC-CS-SHHHHHHHHHHHHHTTCTTSC
T ss_pred             cceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC-CC-ccceehhhhhCCCCccccccc
Confidence                               8999999999876532    4478999999999986 33 889999998777 77788899


Q ss_pred             CCCCCCCcHH-HHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCH
Q 021181          182 PLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV  260 (316)
Q Consensus       182 ~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~  260 (316)
                      .||....+.. ....+.......                        ........+.+++++.+||++||+.|     |+
T Consensus       275 ~p~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~s~~~~dli~~~L~~d-----sa  325 (336)
T 2vuw_A          275 HPYSNVLWLHYLTDKMLKQMTFK------------------------TKCNTPAMKQIKRKIQEFHRTMLNFS-----SA  325 (336)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCCCS------------------------SCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred             CCCcchhhhhHHHHhhhhhhccC------------------------cccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence            9984422111 111111110000                        00001112246788999999999977     99


Q ss_pred             HHHh-cCCCCC
Q 021181          261 DEAL-CHPYLA  270 (316)
Q Consensus       261 ~ell-~~~~f~  270 (316)
                      +|+| +||||+
T Consensus       326 ~e~l~~Hp~f~  336 (336)
T 2vuw_A          326 TDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHCGGGC
T ss_pred             HHHHhcCCCcC
Confidence            9999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-35  Score=256.83  Aligned_cols=206  Identities=13%  Similarity=0.054  Sum_probs=162.1

Q ss_pred             CCCCCceEEEEEecccccC-hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||++...... ......+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.++++.  
T Consensus        52 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~--  124 (286)
T 3uqc_A           52 DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADT--  124 (286)
T ss_dssp             ETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTT--
T ss_pred             ecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhc--
Confidence            5678999999999875433 44557889999999999999999999999654     56999999997 699999865  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .....++..++.||+.||+|||++||+||||||+||+++.+|.++|++++.                   +        .
T Consensus       125 ~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-------------------~--------~  177 (286)
T 3uqc_A          125 SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-------------------M--------P  177 (286)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------------------C--------T
T ss_pred             CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------------------c--------C
Confidence            346678899999999999999999999999999999999999999985432                   2        2


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|+.||.+.+....+....           ..             ............+.++
T Consensus       178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-----------~~-------------~~~~~~~~~~~~~~~~  233 (286)
T 3uqc_A          178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-----------RD-------------TAGQPIEPADIDRDIP  233 (286)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-----------BC-------------TTSCBCCHHHHCTTSC
T ss_pred             CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-----------HH-------------hccCCCChhhcccCCC
Confidence            46889999999999999999999998764221100000           00             0000011122335789


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +++.++|.+||+.||.+| |++|+++.
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999999 99999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-36  Score=292.48  Aligned_cols=220  Identities=23%  Similarity=0.311  Sum_probs=174.7

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCCH
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTD   83 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~   83 (316)
                      +|+.||||++... ........+.+|+.+++.++||||+++++++...+..+....|+||||++ ++|.+++..  .+++
T Consensus       105 ~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~  181 (681)
T 2pzi_A          105 NGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPV  181 (681)
T ss_dssp             TTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCH
T ss_pred             CCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCH
Confidence            7899999998653 23445567889999999999999999999997654222233799999997 588887655  7999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCCCC
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA  163 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (316)
                      .+++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++......   ....+|+.|+|||++.+ . ++.
T Consensus       182 ~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~-~-~~~  255 (681)
T 2pzi_A          182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT-G-PTV  255 (681)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH-C-SCH
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcC-C-CCC
Confidence            9999999999999999999999999999999999885 8999999999876543   44578999999999876 3 488


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChHHH
Q 021181          164 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV  243 (316)
Q Consensus       164 ~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  243 (316)
                      ++|||||||++|+|++|.+||.+.....           .+                       .   .......++.+.
T Consensus       256 ~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~-----------------------~---~~~~~~~~~~l~  298 (681)
T 2pzi_A          256 ATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP-----------------------E---DDPVLKTYDSYG  298 (681)
T ss_dssp             HHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC-----------------------T---TCHHHHHCHHHH
T ss_pred             ceehhhhHHHHHHHHhCCCCCccccccc-----------cc-----------------------c---cccccccCHHHH
Confidence            9999999999999999999886431000           00                       0   000012357799


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          244 DLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       244 ~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      ++|.+||+.||.+||+..+.+.++|+.
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999998888888764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3e-33  Score=263.20  Aligned_cols=170  Identities=18%  Similarity=0.151  Sum_probs=128.3

Q ss_pred             CCCceEEEEEecccc--------cChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHH
Q 021181            4 ETREEVAIKKIGNAF--------DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQ   73 (316)
Q Consensus         4 ~~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~   73 (316)
                      -+|+.||+|++....        ..+.+.+.+.+|+++|+++ .|+||+++++++.+.     ..+|||||||+ ++|.+
T Consensus       257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~~~yLVMEyv~G~~L~d  331 (569)
T 4azs_A          257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----QSGWLVMEKLPGRLLSD  331 (569)
T ss_dssp             EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----SEEEEEEECCCSEEHHH
T ss_pred             cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----CEEEEEEecCCCCcHHH
Confidence            368999999997542        1233456789999999999 799999999999554     67999999997 59999


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAP  152 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aP  152 (316)
                      +|...+++++.   .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++..... ......+||+.|+||
T Consensus       332 ~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          332 MLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVN  408 (569)
T ss_dssp             HHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHH
T ss_pred             HHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccH
Confidence            99998888875   47899999999999999999999999999999999999999999876543 334567899999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPL  183 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~p  183 (316)
                      |++.+  .+..++|+||+|++++++.++..+
T Consensus       409 E~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          409 ELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHC-------------------CCCCTTHHH
T ss_pred             HHhCC--CCCCcccccccccchhhhccccch
Confidence            99976  467789999999998877665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.88  E-value=1.3e-23  Score=196.58  Aligned_cols=165  Identities=21%  Similarity=0.235  Sum_probs=130.8

Q ss_pred             CCceEEEEEecccccC------hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            5 TREEVAIKKIGNAFDN------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      .++.+|+|+.......      ....+.+.+|+.++++++||||+++..++...     ...|+||||++ ++|.+++..
T Consensus       358 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~lVmE~~~ggsL~~~l~~  432 (540)
T 3en9_A          358 LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----DNKRIMMSYINGKLAKDVIED  432 (540)
T ss_dssp             SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----TTTEEEEECCCSEEHHHHSTT
T ss_pred             CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----CccEEEEECCCCCCHHHHHHH
Confidence            5788999987543221      11235578999999999999999544444332     23599999996 799999876


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--------cccccccccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--------MTEYVVTRWY  149 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~  149 (316)
                              +..++.||+.||.|||++||+||||||+||+++.  .+||+|||+++.......        .....+|+.|
T Consensus       433 --------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y  502 (540)
T 3en9_A          433 --------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHE  502 (540)
T ss_dssp             --------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGG
T ss_pred             --------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCc
Confidence                    6689999999999999999999999999999998  999999999988755322        1356789999


Q ss_pred             cCcccccC-CCCCCCcchHHHHHHHHHHHHhCCCCC
Q 021181          150 RAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLF  184 (316)
Q Consensus       150 ~aPE~~~~-~~~~~~~~DiwslG~~l~ell~g~~pf  184 (316)
                      +|||++.. ...|+..+|+||.+.-..+...++.+|
T Consensus       503 ~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          503 KFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             GHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99999864 134677889999998888888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.79  E-value=7.4e-20  Score=157.47  Aligned_cols=124  Identities=19%  Similarity=0.214  Sum_probs=95.3

Q ss_pred             CCCceEEEEEecccccCh----------------hHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC
Q 021181            4 ETREEVAIKKIGNAFDNR----------------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM   67 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~   67 (316)
                      .+|+.||||+++......                .....+.+|+.++++++  | +++.+++..      +..|+||||+
T Consensus       112 ~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~------~~~~lvmE~~  182 (282)
T 1zar_A          112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW------EGNAVLMELI  182 (282)
T ss_dssp             TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE------ETTEEEEECC
T ss_pred             CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec------cceEEEEEec
Confidence            579999999996532111                23567889999999998  5 666665532      2359999999


Q ss_pred             C-CcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcccccccc
Q 021181           68 D-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT  146 (316)
Q Consensus        68 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  146 (316)
                      + |+|.+ +.      ..+...++.|++.||.+||+.||+||||||+||+++ ++.++|+|||++...            
T Consensus       183 ~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~------------  242 (282)
T 1zar_A          183 DAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV------------  242 (282)
T ss_dssp             CCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEET------------
T ss_pred             CCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC------------
Confidence            6 58887 42      133557999999999999999999999999999999 999999999988543            


Q ss_pred             ccccCccccc
Q 021181          147 RWYRAPELLL  156 (316)
Q Consensus       147 ~~~~aPE~~~  156 (316)
                      ..+.|||.+.
T Consensus       243 ~~~~a~e~l~  252 (282)
T 1zar_A          243 GEEGWREILE  252 (282)
T ss_dssp             TSTTHHHHHH
T ss_pred             CCCCHHHHHH
Confidence            2356777764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.67  E-value=1.1e-16  Score=135.86  Aligned_cols=117  Identities=16%  Similarity=0.155  Sum_probs=89.1

Q ss_pred             CCCce--EEEEEecccccC----------------------hhHHHHHHHHHHHHhhCCCCCc--cceeeeecCCCCCCC
Q 021181            4 ETREE--VAIKKIGNAFDN----------------------RIDAKRTLREIKLLRHMDHENI--IAIKDIIRPPQRETF   57 (316)
Q Consensus         4 ~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~~   57 (316)
                      .+|+.  ||||+++.....                      ......+.+|+..+.++.|+++  +.+++.         
T Consensus        70 ~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~---------  140 (258)
T 1zth_A           70 FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY---------  140 (258)
T ss_dssp             ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE---------
T ss_pred             CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc---------
Confidence            57888  999987543111                      0112467899999999988764  444432         


Q ss_pred             CeEEEEEecCC--C----cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeecc
Q 021181           58 NDVYIVYELMD--T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGL  130 (316)
Q Consensus        58 ~~~~iv~e~~~--g----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~  130 (316)
                      ...++||||++  |    +|.+....   .++..+..++.||+.||.+|| ++||+||||||+|||++.  .++|+|||+
T Consensus       141 ~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~  215 (258)
T 1zth_A          141 MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQ  215 (258)
T ss_dssp             ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTT
T ss_pred             CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcc
Confidence            12589999995  3    67776533   235677899999999999999 999999999999999988  899999999


Q ss_pred             cccc
Q 021181          131 ARTT  134 (316)
Q Consensus       131 ~~~~  134 (316)
                      +...
T Consensus       216 a~~~  219 (258)
T 1zth_A          216 AVTL  219 (258)
T ss_dssp             CEET
T ss_pred             cccC
Confidence            8665

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.45  E-value=1.1e-13  Score=122.69  Aligned_cols=117  Identities=15%  Similarity=0.134  Sum_probs=78.8

Q ss_pred             CCCceEEEEEecccccC------------hhH--------HHHHHHHHHHHhhCCCCCcc--ceeeeecCCCCCCCCeEE
Q 021181            4 ETREEVAIKKIGNAFDN------------RID--------AKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVY   61 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~------------~~~--------~~~~~~E~~~l~~l~h~~i~--~~~~~~~~~~~~~~~~~~   61 (316)
                      .+|+.||||+++....+            ...        .....+|...+.++.+.++.  ..++..         ..+
T Consensus       117 ~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~---------~~~  187 (397)
T 4gyi_A          117 EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS---------RHT  187 (397)
T ss_dssp             TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE---------TTE
T ss_pred             CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc---------Cce
Confidence            47999999987643111            000        11123566666666444432  222211         137


Q ss_pred             EEEecCCC-cHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCC----------EEEeeecc
Q 021181           62 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD----------LKIGDFGL  130 (316)
Q Consensus        62 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~----------~~l~df~~  130 (316)
                      |||||++| +|.++.      .......++.||+.+|.+||++||+||||||.|||++.++.          +.++||+.
T Consensus       188 LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q  261 (397)
T 4gyi_A          188 IVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQ  261 (397)
T ss_dssp             EEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTT
T ss_pred             EEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCC
Confidence            99999986 665432      12345678899999999999999999999999999988773          89999997


Q ss_pred             ccccC
Q 021181          131 ARTTS  135 (316)
Q Consensus       131 ~~~~~  135 (316)
                      +....
T Consensus       262 ~V~~~  266 (397)
T 4gyi_A          262 MVSMD  266 (397)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            75543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.08  E-value=4.4e-10  Score=95.12  Aligned_cols=115  Identities=13%  Similarity=0.129  Sum_probs=86.2

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      .|..+++|........  ....+.+|+.+++.+. +..++++++++...     +..|+|||+++| +|.+.+.     +
T Consensus        36 ~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~i~G~~l~~~~~-----~  103 (263)
T 3tm0_A           36 ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYE-----D  103 (263)
T ss_dssp             SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCSSEEHHHHCC-----T
T ss_pred             CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----CceEEEEEecCCeehhhccC-----C
Confidence            3688999998653211  1234789999999884 66788898887543     568999999987 7766531     2


Q ss_pred             HHHHHHHHHHHHHHHHHhhc-----------------------------------------------------------C
Q 021181           83 DDHCRYFLYQLLRGLKYVHS-----------------------------------------------------------A  103 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~-----------------------------------------------------------~  103 (316)
                      ......++.++..+|+.||+                                                           .
T Consensus       104 ~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~  183 (263)
T 3tm0_A          104 EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEEL  183 (263)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCE
T ss_pred             cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCc
Confidence            23345778899999999998                                                           4


Q ss_pred             CceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      +++|||++|.||+++.++.+.++||+.+
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhc
Confidence            4899999999999987655679999865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.92  E-value=1.9e-09  Score=93.36  Aligned_cols=170  Identities=16%  Similarity=0.192  Sum_probs=104.9

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCC--ccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHEN--IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~--i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      ..+++|+...    ......+.+|+.+++.+ .+..  +++++......  ......|+||++++| ++.....  ..++
T Consensus        41 ~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm~~i~G~~l~~~~~--~~l~  112 (304)
T 3sg8_A           41 RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGFTKIKGVPLTPLLL--NNLP  112 (304)
T ss_dssp             TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEEECCCCEECCHHHH--HTSC
T ss_pred             CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEEcccCCeECCcccc--ccCC
Confidence            4688888642    23456788999999888 3333  34444443221  112345889999987 5543322  3567


Q ss_pred             HHHHHHHHHHHHHHHHHhhc----------------------------------------------------------CC
Q 021181           83 DDHCRYFLYQLLRGLKYVHS----------------------------------------------------------AN  104 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~----------------------------------------------------------~~  104 (316)
                      ..+...++.+++..|+.||+                                                          ..
T Consensus       113 ~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  192 (304)
T 3sg8_A          113 KQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPC  192 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCce
Confidence            77778888888888888885                                                          13


Q ss_pred             ceeccCCCCcEEEcc--CCCEEEeeeccccccCCCCccccccccccccCcccc----cCCC---------CCCCcchHHH
Q 021181          105 VLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL----LNCS---------EYTAAIDIWS  169 (316)
Q Consensus       105 i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~---------~~~~~~Diws  169 (316)
                      ++|+|++|.||+++.  .+.+.++||+.+.................-.+|+..    ....         ....-.+.|+
T Consensus       193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~  272 (304)
T 3sg8_A          193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWS  272 (304)
T ss_dssp             EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHH
T ss_pred             eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHH
Confidence            799999999999998  455789999987553221100000000000122211    0000         0112258999


Q ss_pred             HHHHHHHHHhCCCCC
Q 021181          170 VGCILGEIMTRQPLF  184 (316)
Q Consensus       170 lG~~l~ell~g~~pf  184 (316)
                      +|.++|.+.+|.++|
T Consensus       273 l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          273 FEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHcCCHHH
Confidence            999999999998776

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.89  E-value=1.7e-09  Score=91.15  Aligned_cols=110  Identities=15%  Similarity=0.136  Sum_probs=78.8

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      .+|..|++|.....     ....+..|+.+++.+.+.+  +++++++....     +..++|||+++| +| . ..   .
T Consensus        42 ~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v~e~i~G~~l-~-~~---~  106 (264)
T 1nd4_A           42 QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGEVPGQDL-L-SS---H  106 (264)
T ss_dssp             TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEECCSSEET-T-TS---C
T ss_pred             CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEEEEecCCccc-C-cC---c
Confidence            45778999987543     1234678999998885434  56688876543     348999999986 55 3 21   1


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------------------
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSAN--------------------------------------------------------  104 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------------------  104 (316)
                      .+   ...++.+++..|+.||+..                                                        
T Consensus       107 ~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  183 (264)
T 1nd4_A          107 LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED  183 (264)
T ss_dssp             CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred             CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCC
Confidence            22   2356677888888888643                                                        


Q ss_pred             --ceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          105 --VLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       105 --i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                        ++|+|++|.||+++.++.+.|+||+.+
T Consensus       184 ~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          184 LVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             eEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence              999999999999987665679999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.87  E-value=7.3e-09  Score=91.74  Aligned_cols=123  Identities=12%  Similarity=0.201  Sum_probs=87.8

Q ss_pred             CceEEEEEec--ccccChhHHHHHHHHHHHHhhCC--CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCC
Q 021181            6 REEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD   80 (316)
Q Consensus         6 ~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~   80 (316)
                      +..+++|+..  ... .......+.+|+.+++.+.  +..+++++.++.+..  ..+..|+|||+++| .+.+.  ....
T Consensus        61 ~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~vme~v~G~~l~~~--~~~~  135 (359)
T 3dxp_A           61 GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFYIMEFVSGRVLWDQ--SLPG  135 (359)
T ss_dssp             SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEEEEECCCCBCCCCT--TCTT
T ss_pred             CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEEEEEecCCeecCCC--cccc
Confidence            4678888875  321 1123456788999999996  445788888775431  12457899999987 44321  1235


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhc----------------------------------------------------------
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHS----------------------------------------------------------  102 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~----------------------------------------------------------  102 (316)
                      ++..+...++.+++.+|+.||+                                                          
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            6788888999999999999996                                                          


Q ss_pred             CCceeccCCCCcEEEccCCC--EEEeeeccccc
Q 021181          103 ANVLHRDLKPSNLLLNANCD--LKIGDFGLART  133 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~--~~l~df~~~~~  133 (316)
                      .+++|||+++.||+++.++.  +.++||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            36899999999999997753  68999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=4.6e-06  Score=72.03  Aligned_cols=119  Identities=23%  Similarity=0.208  Sum_probs=77.5

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCC---CccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE---NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL   81 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~   81 (316)
                      |..+++|+..    .......+..|+.+++.+.+.   .+++++.+....    .+..+++|++++| ++.....  ..+
T Consensus        39 g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~v~e~i~G~~l~~~~~--~~l  108 (306)
T 3tdw_A           39 NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFVGYRKVQGQILGEDGM--AVL  108 (306)
T ss_dssp             TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEEEEECCCSEECHHHHH--TTS
T ss_pred             CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEEEEeccCCeECchhhh--hhC
Confidence            4678888752    223456788999999999642   356666655321    2457899999987 5544211  123


Q ss_pred             CHHHHHHHHHHHHHHHHHhhc-----------------------------------------------------------
Q 021181           82 TDDHCRYFLYQLLRGLKYVHS-----------------------------------------------------------  102 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~-----------------------------------------------------------  102 (316)
                      +..+...++.++...|+.||+                                                           
T Consensus       109 ~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~  188 (306)
T 3tdw_A          109 PDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRY  188 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCC
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccC
Confidence            444445555555555555543                                                           


Q ss_pred             -CCceeccCCCCcEEEcc---CCCE-EEeeecccccc
Q 021181          103 -ANVLHRDLKPSNLLLNA---NCDL-KIGDFGLARTT  134 (316)
Q Consensus       103 -~~i~H~dl~p~nil~~~---~~~~-~l~df~~~~~~  134 (316)
                       ..++|+|+++.||+++.   ++.+ .|+||+.+...
T Consensus       189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence             24599999999999987   4554 79999977543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.33  E-value=6.3e-06  Score=69.58  Aligned_cols=114  Identities=21%  Similarity=0.247  Sum_probs=77.1

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~   82 (316)
                      .+..++||+-+.     .....+..|...++.+. +--+.++++++.+.     +..|+||++++| ++.+....    .
T Consensus        49 ~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~----~  114 (272)
T 4gkh_A           49 NAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEE----Y  114 (272)
T ss_dssp             TCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHH----C
T ss_pred             CCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCccccccccC----C
Confidence            456788997642     24566788999998884 33367777777544     458999999987 65554432    1


Q ss_pred             HHHHHHHHHHHHHHHHHhhcC----------------------------------------------------------C
Q 021181           83 DDHCRYFLYQLLRGLKYVHSA----------------------------------------------------------N  104 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~----------------------------------------------------------~  104 (316)
                      ......+..++...|+.||+.                                                          .
T Consensus       115 ~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  194 (272)
T 4gkh_A          115 PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSV  194 (272)
T ss_dssp             GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEE
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcE
Confidence            122234445555555555531                                                          2


Q ss_pred             ceeccCCCCcEEEccCCCEEEeeecccc
Q 021181          105 VLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus       105 i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      ++|||+.+.||+++.++.+-|+||+.+.
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence            6899999999999987767799998663

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.95  E-value=9.6e-05  Score=59.51  Aligned_cols=98  Identities=16%  Similarity=0.130  Sum_probs=65.1

Q ss_pred             cHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhh-cCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccc
Q 021181           70 DLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR  147 (316)
Q Consensus        70 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (316)
                      +|.++|+. +.+++++++|.+++|.+.+|.-+- ++.-...=+.|..|++..+|.+.+.+ ..+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            78888875 468999999999999999988762 22212233457899999999988764 1110           1223


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ  181 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~  181 (316)
                      .+.+||...  ...+.+.=|||||+++|.-+--.
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            466888763  34567888999999999888643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.75  E-value=2.7e-05  Score=68.54  Aligned_cols=62  Identities=8%  Similarity=0.144  Sum_probs=38.0

Q ss_pred             CceEEEEEeccccc-ChhHHHHHHHHHHHHhhCC-C--CCccceeeeecCCCCCCCCeEEEEEecCCC
Q 021181            6 REEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD-H--ENIIAIKDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         6 ~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      |..+++|+...... .......+..|+.+++.+. +  -.+++++.+.....  ..+..|+|||+++|
T Consensus        52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~--~~g~~~~v~e~l~G  117 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD--VLGTPFFLMDYVEG  117 (357)
T ss_dssp             EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--TTSSCEEEEECCCC
T ss_pred             CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--ccCCceEEEEecCC
Confidence            67899998654220 0001234678888888884 2  35677887764331  11346899999976

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.52  E-value=0.00035  Score=60.74  Aligned_cols=30  Identities=30%  Similarity=0.382  Sum_probs=26.8

Q ss_pred             cCCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          102 SANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       102 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      ..+++|||+++.||+++.++.+.++||+.+
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            367999999999999988888999999865

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.40  E-value=0.00066  Score=60.52  Aligned_cols=31  Identities=19%  Similarity=0.326  Sum_probs=25.7

Q ss_pred             cCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          102 SANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       102 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ...++|||+.+.||+++.+ .+.++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            4579999999999999875 489999976643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.18  E-value=0.0025  Score=54.42  Aligned_cols=29  Identities=21%  Similarity=0.188  Sum_probs=24.6

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5667899999987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.89  E-value=0.0032  Score=54.52  Aligned_cols=33  Identities=27%  Similarity=0.367  Sum_probs=27.5

Q ss_pred             cCCceeccCCCCcEEEccC----CCEEEeeecccccc
Q 021181          102 SANVLHRDLKPSNLLLNAN----CDLKIGDFGLARTT  134 (316)
Q Consensus       102 ~~~i~H~dl~p~nil~~~~----~~~~l~df~~~~~~  134 (316)
                      ...++|||+.+.||+++.+    +.+.++||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3579999999999999874    67899999877543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.66  E-value=0.0059  Score=54.00  Aligned_cols=117  Identities=14%  Similarity=0.148  Sum_probs=70.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHH----------
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLH----------   72 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~----------   72 (316)
                      +++.|++|+....   ........+|..+++.+. +.-.+++++.+..         .+||||++| +|.          
T Consensus        81 ~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---------g~v~e~i~G~~l~~~~l~~p~~~  148 (379)
T 3feg_A           81 EPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---------GRLEQYIPSRPLKTQELREPVLS  148 (379)
T ss_dssp             CCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---------EEEEECCSEEECCGGGGGCHHHH
T ss_pred             CCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---------ccEEEEecCccCChhHhCCHHHH
Confidence            4578999986321   113445568999998884 3334667766521         389999976 221          


Q ss_pred             ----HHh---hcC-----CCC--CHHHHHHHHHHHHH-------------------HHHHh----hc----CCceeccCC
Q 021181           73 ----QII---RSH-----QDL--TDDHCRYFLYQLLR-------------------GLKYV----HS----ANVLHRDLK  111 (316)
Q Consensus        73 ----~~l---~~~-----~~~--~~~~~~~i~~qi~~-------------------~l~~L----H~----~~i~H~dl~  111 (316)
                          +.+   ...     +..  -..++..|..++..                   .+..|    ..    ..++|+|+.
T Consensus       149 ~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~  228 (379)
T 3feg_A          149 AAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQ  228 (379)
T ss_dssp             HHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCC
T ss_pred             HHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCC
Confidence                111   111     112  24566666655432                   12222    21    259999999


Q ss_pred             CCcEEEccC----CCEEEeeeccccc
Q 021181          112 PSNLLLNAN----CDLKIGDFGLART  133 (316)
Q Consensus       112 p~nil~~~~----~~~~l~df~~~~~  133 (316)
                      +.||+++.+    +.+.++||..+..
T Consensus       229 ~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          229 EGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             GGGEEEESCC---CCEEECCCTTCEE
T ss_pred             CCeEEEcCCCCccCcEEEEecccCCc
Confidence            999999876    6899999987643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.57  E-value=0.022  Score=48.85  Aligned_cols=55  Identities=13%  Similarity=0.103  Sum_probs=39.9

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCC---CCCccceeeeecCCCCCCCCeEEEEEecCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      ++..++||+....     ....+..|+..++.|.   ...+++++......     +..++|||+++|
T Consensus        58 ~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvme~l~G  115 (312)
T 3jr1_A           58 EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLLEALNK  115 (312)
T ss_dssp             SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEEECCCC
T ss_pred             CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEEEeccC
Confidence            3678889986432     3566788999988883   35678888876433     468999999975

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.26  E-value=0.013  Score=52.76  Aligned_cols=52  Identities=10%  Similarity=0.084  Sum_probs=33.2

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC-ccceeeeecCCCCCCCCeEEEEEecCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      ++..|++|+.... .   ....+..|..+++.+...+ .+++++.+..         .+|++|++|
T Consensus       104 ~~~~~vlRi~~~~-~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---------g~v~e~l~G  156 (429)
T 1nw1_A          104 EPNKVLLRVYFNP-E---TESHLVAESVIFTLLSERHLGPKLYGIFSG---------GRLEEYIPS  156 (429)
T ss_dssp             CCSEEEEEEECSC-C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------EEEECCCCE
T ss_pred             CCceEEEEEeCCC-C---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC---------CEEEEEeCC
Confidence            3678999987331 1   1134557999888884333 3667776521         389999976

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.58  E-value=0.038  Score=46.64  Aligned_cols=54  Identities=9%  Similarity=-0.015  Sum_probs=34.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCC---CccceeeeecCCCCCCCCeEEEEEecCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE---NIIAIKDIIRPPQRETFNDVYIVYELMD   68 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~~~~~~~~~~iv~e~~~   68 (316)
                      .+|+.|++|+.....  ......+..|+..|+.|...   -+++++++.  .       -++|||+++
T Consensus        37 ~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~-------~~lv~e~l~   93 (288)
T 3f7w_A           37 ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D-------RTLAMEWVD   93 (288)
T ss_dssp             TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T-------TEEEEECCC
T ss_pred             CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C-------ceEEEEeec
Confidence            578999999875432  12234567899999888422   345555542  1       378999985

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.98  E-value=0.021  Score=51.11  Aligned_cols=79  Identities=9%  Similarity=0.000  Sum_probs=45.5

Q ss_pred             hcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccc--cccccCcccccCCCC--CCCcchHHHHHHHHHH
Q 021181          101 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSE--YTAAIDIWSVGCILGE  176 (316)
Q Consensus       101 H~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~--~~~~~aPE~~~~~~~--~~~~~DiwslG~~l~e  176 (316)
                      +...++|||+++.||+++.++ +.++||+.+..............  ...|++|+.......  ......+...+..+++
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            467899999999999998876 99999987765432111111111  123455554421110  1112344466666666


Q ss_pred             HHhC
Q 021181          177 IMTR  180 (316)
Q Consensus       177 ll~g  180 (316)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.28  E-value=0.12  Score=44.15  Aligned_cols=30  Identities=27%  Similarity=0.302  Sum_probs=25.1

Q ss_pred             cCCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          102 SANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       102 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ...++|||+++.||+++ + .+.++||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            34689999999999998 4 899999986643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.07  E-value=0.06  Score=46.05  Aligned_cols=30  Identities=30%  Similarity=0.306  Sum_probs=25.1

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeecccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            369999999999999877556799998653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=91.99  E-value=0.12  Score=44.78  Aligned_cols=31  Identities=19%  Similarity=0.254  Sum_probs=27.0

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999986644

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.31  E-value=0.22  Score=45.10  Aligned_cols=52  Identities=25%  Similarity=0.224  Sum_probs=31.9

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCc-cceeeeecCCCCCCCCeEEEEEecCCC
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      +..|++|+.......-.+   -..|..+++.|...++ +++++.+. +        ..||+|++|
T Consensus       133 ~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~-~--------G~v~e~I~G  185 (458)
T 2qg7_A          133 QAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT-N--------GRIEEFMDG  185 (458)
T ss_dssp             TEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET-T--------EEEEECCCS
T ss_pred             CceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC-C--------eEEEEeeCC
Confidence            477889987432111111   1488888888864444 66777662 1        359999975

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.61  E-value=0.26  Score=43.01  Aligned_cols=28  Identities=29%  Similarity=0.574  Sum_probs=23.5

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeecccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLAR  132 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~  132 (316)
                      +++|+|+.+.||+++.++ +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            599999999999997654 8999998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.81  E-value=0.48  Score=41.98  Aligned_cols=30  Identities=27%  Similarity=0.362  Sum_probs=24.8

Q ss_pred             CceeccCCCCcEEE------ccCCCEEEeeeccccc
Q 021181          104 NVLHRDLKPSNLLL------NANCDLKIGDFGLART  133 (316)
Q Consensus       104 ~i~H~dl~p~nil~------~~~~~~~l~df~~~~~  133 (316)
                      .++|+|+.+.||++      +.+..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            37899999999999      3456799999987744

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	316
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-89
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-87
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-85
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-71
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-70
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-66
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-66
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-65
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-62
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-61
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-58
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-58
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-58
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-57
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-57
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-53
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-53
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-51
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-43
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-41
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-40
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-38
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-36
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-18

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  267 bits (684), Expect = 6e-89
 Identities = 163/317 (51%), Positives = 217/317 (68%), Gaps = 6/317 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            ++  +  VAIKKI + F+++   +RTLREIK+L    HENII I DIIR P  E   DV
Sbjct: 28  YDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V  LM  DL++++++   L++DH  YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN  
Sbjct: 87  YLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 145

Query: 121 CDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +++ +P+FPGK Y+ QL  I  ++GSP +  L  + +  AR Y+  LP   K  ++  FP
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTE 296
           N    A+DLL+KML F+P++RI V++AL HPYL   +D ++EP+   PF FD E     +
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPK 325

Query: 297 ENIKELIYRESVKFNPD 313
           E +KELI+ E+ +F P 
Sbjct: 326 EKLKELIFEETARFQPG 342

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  262 bits (671), Expect = 5e-87
 Identities = 157/315 (49%), Positives = 213/315 (67%), Gaps = 5/315 (1%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
            +++T   VA+KK+   F + I AKRT RE++LL+HM HEN+I + D+  P +  E FND
Sbjct: 38  FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           VY+V  LM  DL+ I++  Q LTDDH ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N 
Sbjct: 98  VYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T
Sbjct: 157 DCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            + LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L Q PK NF+  F   +
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 299
           P AVDLLEKMLV D ++RIT  +AL H Y A  HD ++EPV   P+   FE      +  
Sbjct: 275 PLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEW 333

Query: 300 KELIYRESVKFNPDP 314
           K L Y E + F P P
Sbjct: 334 KSLTYDEVISFVPPP 348

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (657), Expect = 5e-85
 Identities = 138/312 (44%), Positives = 204/312 (65%), Gaps = 5/312 (1%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 60
           +  T  +VAIKK+   F + + AKR  RE++LL+HM HEN+I + D+  P +  + F D 
Sbjct: 39  DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           Y+V   M TDL ++++ H+ L +D  ++ +YQ+L+GL+Y+H+A ++HRDLKP NL +N +
Sbjct: 99  YLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157

Query: 121 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           C+LKI DFGLAR       MT YVVTRWYRAPE++LN   YT  +DIWSVGCI+ E++T 
Sbjct: 158 CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           + LF G D++ QL+ I ++ G+P    +  L+SD A+ Y++ LP+  K++F++   N SP
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 300
            AV+LLEKMLV D  +R+T  EAL HPY   LHD  +EP     +   F+    T +  K
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWK 334

Query: 301 ELIYRESVKFNP 312
            + Y+E + F P
Sbjct: 335 RVTYKEVLSFKP 346

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 4e-71
 Identities = 95/313 (30%), Positives = 160/313 (51%), Gaps = 20/313 (6%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP-QRETFNDV 60
             ++ E VAIKK+        D +   RE++++R +DH NI+ ++       +++    +
Sbjct: 41  LCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94

Query: 61  YIVYELMDTDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            +V + +   ++++ R +    Q L   + + ++YQL R L Y+HS  + HRD+KP NLL
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154

Query: 117 LNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           L+ +   LK+ DFG A+     +    Y+ +R+YRAPEL+   ++YT++ID+WS GC+L 
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E++  QP+FPG   V QL  I +++G+P       +R  N        PQ     ++  F
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKAHPWTKVF 271

Query: 236 -PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE----PVCPRPFSFDFE 290
            P   P A+ L  ++L + P  R+T  EA  H +   L D N +       P  F+F  +
Sbjct: 272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 331

Query: 291 HPSFTEENIKELI 303
             S        LI
Sbjct: 332 ELSSNPPLATILI 344

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 7e-71
 Identities = 134/322 (41%), Positives = 195/322 (60%), Gaps = 18/322 (5%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 59
            ++     VAIKK+   F N+  AKR  RE+ L++ ++H+NII++ ++  P +  E F D
Sbjct: 37  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           VY+V ELMD +L Q+I+   D   +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ +
Sbjct: 97  VYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++ 
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVR 213

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN-- 237
            + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P++    F   FP+  
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSL 272

Query: 238 ----------KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC-PRPFS 286
                     K+  A DLL KMLV DP +RI+VD+AL HPY+   +D  E     P+ + 
Sbjct: 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYD 332

Query: 287 FDFEHPSFTEENIKELIYRESV 308
              +    T E  KELIY+E +
Sbjct: 333 KQLDEREHTIEEWKELIYKEVM 354

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 6e-70
 Identities = 102/288 (35%), Positives = 146/288 (50%), Gaps = 13/288 (4%)

Query: 2   NSETREEVAIKKIGNAFDNRID---AKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 58
           +  T + VAIKKI     +       +  LREIKLL+ + H NII + D          +
Sbjct: 19  DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA-----FGHKS 73

Query: 59  DVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           ++ +V++ M+TD    I  +   LT  H + ++   L+GL+Y+H   +LHRDLKP+NLLL
Sbjct: 74  NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 133

Query: 118 NANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + N  LK+ DFGLA++  S     T  VVTRWYRAPELL     Y   +D+W+VGCIL E
Sbjct: 134 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 193

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++ R P  PG   + QL  I E +G+P E     + S            FP       F 
Sbjct: 194 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT---FKSFPGIPLHHIFS 250

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRP 284
                 +DL++ + +F+P  RIT  +AL   Y +           PRP
Sbjct: 251 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-67
 Identities = 91/278 (32%), Positives = 146/278 (52%), Gaps = 10/278 (3%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR---PPQRETFN 58
           + +T ++VA+KK+    +        LREIK+L+ + HEN++ + +I R    P      
Sbjct: 31  HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90

Query: 59  DVYIVYELMDTDLHQI-IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
            +Y+V++  + DL  +        T    +  +  LL GL Y+H   +LHRD+K +N+L+
Sbjct: 91  SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150

Query: 118 NANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
             +  LK+ DFGLAR       S+ +  T  VVT WYR PELLL   +Y   ID+W  GC
Sbjct: 151 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ-NF 231
           I+ E+ TR P+  G    HQL LI++L GS        + +      + ++    ++   
Sbjct: 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 270

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
             +   + P A+DL++K+LV DP +RI  D+AL H + 
Sbjct: 271 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 3e-66
 Identities = 59/283 (20%), Positives = 119/283 (42%), Gaps = 23/283 (8%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +  +   +A K I +         + +RE+++L   +   I+            +  ++ 
Sbjct: 27  HKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEIS 80

Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNA 119
           I  E MD   L Q+++    + +         +++GL Y+   + ++HRD+KPSN+L+N+
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             ++K+ DFG++    ++     +V TR Y +PE L   + Y+   DIWS+G  L E+  
Sbjct: 141 RGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAV 198

Query: 180 RQPLFPGKDY-VHQLRLITELIGSPDETS----------LGFLRSDNARRYVRMLPQFPK 228
            +   P  D    +L    ++ G   ET             +         +  L  +  
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258

Query: 229 QNFSARFPNK--SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                + P+   S    D + K L+ +P  R  + + + H ++
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 3e-66
 Identities = 106/276 (38%), Positives = 153/276 (55%), Gaps = 10/276 (3%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N  T E VA+KKI    +        +REI LL+ ++H NI+ + D+       T N +Y
Sbjct: 23  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV-----IHTENKLY 77

Query: 62  IVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+N 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137

Query: 120 NCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E++
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
           TR+ LFPG   + QL  I   +G+PDE    +    +   Y    P++ +Q+FS   P  
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVV--WPGVTSMPDYKPSFPKWARQDFSKVVPPL 255

Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
                 LL +ML +DPN+RI+   AL HP+   +  
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 9e-65
 Identities = 92/278 (33%), Positives = 139/278 (50%), Gaps = 10/278 (3%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVY 61
               VA+K++            T+RE+ +LRH+   +H N++ + D+    + +    + 
Sbjct: 32  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91

Query: 62  IVYELM--DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V+E +  D   +        +  +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ +
Sbjct: 92  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           +  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  S Y   +D+WSVGCI  E+  
Sbjct: 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFR 210

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
           R+PLF G   V QL  I ++IG P E         +     +       Q       +  
Sbjct: 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFVTDID 266

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 277
               DLL K L F+P +RI+   AL HPY   L    E
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  199 bits (507), Expect = 3e-63
 Identities = 95/268 (35%), Positives = 136/268 (50%), Gaps = 9/268 (3%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
              E  A+KKI    ++      T+REI +L+ + H NI+ + D+I   +R     + +V
Sbjct: 24  NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLV 78

Query: 64  YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           +E +D      +      L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +
Sbjct: 79  FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE 138

Query: 123 LKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 181
           LKI DFGLAR            +VT WYRAP++L+   +Y+  IDIWSVGCI  E++   
Sbjct: 139 LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

Query: 182 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 241
           PLFPG     QL  I  ++G+P+  +  +       +Y      +    + +        
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256

Query: 242 AVDLLEKMLVFDPNRRITVDEALCHPYL 269
            +DLL KML  DPN+RIT  +AL H Y 
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (503), Expect = 3e-62
 Identities = 63/311 (20%), Positives = 123/311 (39%), Gaps = 42/311 (13%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +    E VAIKK+  +   +    +  ++E++ L+ + H N I  +           +  
Sbjct: 36  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTA 90

Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++V E    +    +    + L +       +  L+GL Y+HS N++HRD+K  N+LL+ 
Sbjct: 91  WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEI 177
              +K+GDFG A   +       +V T ++ APE++L   E  Y   +D+WS+G    E+
Sbjct: 151 PGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
             R+P     + +  L  I +                         P     ++      
Sbjct: 208 AERKPPLFNMNAMSALYHIAQ----------------------NESPALQSGHW------ 239

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN-EEPVCPRPFSFDFEHPSFTE 296
            S    + ++  L   P  R T +  L H ++           +  R      E  +   
Sbjct: 240 -SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298

Query: 297 ENIKELIYRES 307
             +K+++++E+
Sbjct: 299 RKMKKILFQEA 309

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 7e-62
 Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 40/270 (14%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
             +++  +A+K +     +      +  RE+++  H+ H NI+ +              V
Sbjct: 27  EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATRV 81

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y++ E      +++ ++      +     ++ +L   L Y HS  V+HRD+KP NLLL +
Sbjct: 82  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS 141

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +LKI DFG +     +   T    T  Y  PE++     +   +D+WS+G +  E + 
Sbjct: 142 AGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLV 199

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +P F    Y    + I                        R+   FP           +
Sbjct: 200 GKPPFEANTYQETYKRI-----------------------SRVEFTFP--------DFVT 228

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
            GA DL+ ++L  +P++R  + E L HP++
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  196 bits (500), Expect = 3e-61
 Identities = 63/296 (21%), Positives = 118/296 (39%), Gaps = 39/296 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
               T    A K +    ++  D +   +EI+ +  + H  ++ + D       E  N++
Sbjct: 46  TERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM 98

Query: 61  YIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            ++YE M       ++   H  +++D    ++ Q+ +GL ++H  N +H DLKP N++  
Sbjct: 99  VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 158

Query: 119 A--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              + +LK+ DFGL         +     T  + APE+           D+WSVG +   
Sbjct: 159 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYI 217

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +++    F G++    LR +     + D++                            F 
Sbjct: 218 LLSGLSPFGGENDDETLRNVKSCDWNMDDS---------------------------AFS 250

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP 292
             S    D + K+L+ DPN R+T+ +AL HP+L P +    +   P          
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (492), Expect = 6e-61
 Identities = 96/276 (34%), Positives = 140/276 (50%), Gaps = 8/276 (2%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            N ET E VA+K++    D+       LREI LL+ + H+NI+ + D++           
Sbjct: 22  KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH----SDKKLT 77

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            +               + DL  +  + FL+QLL+GL + HS NVLHRDLKP NLL+N N
Sbjct: 78  LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137

Query: 121 CDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
            +LK+ +FGLAR         +  VVT WYR P++L     Y+ +ID+WS GCI  E+  
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197

Query: 180 -RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
             +PLFPG D   QL+ I  L+G+P E     +      +   M P     +     P  
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP--ATTSLVNVVPKL 255

Query: 239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
           +    DLL+ +L  +P +RI+ +EAL HPY +    
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-60
 Identities = 62/273 (22%), Positives = 108/273 (39%), Gaps = 38/273 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +N  T E VA+K + +        +   +EI + + ++HEN++      R       N  
Sbjct: 25  VNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 78

Query: 61  YIVYELMDTDLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           Y+  E          I     + +   + F +QL+ G+ Y+H   + HRD+KP NLLL+ 
Sbjct: 79  YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 138

Query: 120 NCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             +LKI DFGLA      +    + +   T  Y APELL     +   +D+WS G +L  
Sbjct: 139 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 198

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++  +  +       Q     +                             K+ +   + 
Sbjct: 199 MLAGELPWDQPSDSCQEYSDWKE----------------------------KKTYLNPWK 230

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                 + LL K+LV +P+ RIT+ +     + 
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 5e-59
 Identities = 73/279 (26%), Positives = 113/279 (40%), Gaps = 45/279 (16%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
                + +  K++        + +  + E+ LLR + H NI+   D I      T   +Y
Sbjct: 25  RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRI---IDRTNTTLY 81

Query: 62  IVYELMD-TDLHQII----RSHQDLTDDHCRYFLYQLLRGLKYVH-----SANVLHRDLK 111
           IV E  +  DL  +I    +  Q L ++     + QL   LK  H        VLHRDLK
Sbjct: 82  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141

Query: 112 PSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSV 170
           P+N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE  +N   Y    DIWS+
Sbjct: 142 PANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSL 200

Query: 171 GCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN 230
           GC+L E+    P F           I E                          + P   
Sbjct: 201 GCLLYELCALMPPFTAFSQKELAGKIRE----------------------GKFRRIP--- 235

Query: 231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                   S    +++ +ML      R +V+E L +P +
Sbjct: 236 -----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-58
 Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 47/290 (16%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            N ET    A K I     +  + +  + EI +L   DH NI+ + D          N++
Sbjct: 32  QNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNL 84

Query: 61  YIVYELMDTDL--HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +I+ E          ++   + LT+   +    Q L  L Y+H   ++HRDLK  N+L  
Sbjct: 85  WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT 144

Query: 119 ANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCS----EYTAAIDIWSVGCI 173
            + D+K+ DFG++   T        ++ T ++ APE+++  +     Y    D+WS+G  
Sbjct: 145 LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 204

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           L E+   +P     + +  L  I +                             +    A
Sbjct: 205 LIEMAEIEPPHHELNPMRVLLKIAK----------------------------SEPPTLA 236

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL-----APLHDINEE 278
           +    S    D L+K L  + + R T  + L HP++      P+ ++  E
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAE 286

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  189 bits (481), Expect = 1e-58
 Identities = 81/288 (28%), Positives = 156/288 (54%), Gaps = 24/288 (8%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
           +N    E+V +K +       +  K+  REIK+L ++    NII + DI++ P   T   
Sbjct: 55  INITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP-- 107

Query: 60  VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
             +V+E ++ TD  Q+ ++   LTD   R+++Y++L+ L Y HS  ++HRD+KP N++++
Sbjct: 108 -ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163

Query: 119 A-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
             +  L++ D+GLA            V +R+++ PELL++   Y  ++D+WS+GC+L  +
Sbjct: 164 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223

Query: 178 MT-RQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           +  ++P F G D   QL  I +++G+      +     +   R+  +L +  ++ +    
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283

Query: 236 PNK-----SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 278
            ++     SP A+D L+K+L +D   R+T  EA+ HPY    + + ++
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY---FYTVVKD 328

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-58
 Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 37/270 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           M+  T +EVAI+++      +   +  + EI ++R   + NI+   D          +++
Sbjct: 40  MDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDEL 92

Query: 61  YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           ++V E +       + +   + +        + L+ L+++HS  V+HRD+K  N+LL  +
Sbjct: 93  WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152

Query: 121 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
             +K+ DFG     T E    +  V T ++ APE++     Y   +DIWS+G +  E++ 
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIE 211

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +P +  ++ +  L LI    G+P+                    Q P           S
Sbjct: 212 GEPPYLNENPLRALYLIAT-NGTPE-------------------LQNP--------EKLS 243

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               D L + L  D  +R +  E L H +L
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  187 bits (477), Expect = 7e-58
 Identities = 59/278 (21%), Positives = 113/278 (40%), Gaps = 39/278 (14%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +   T      K I       +D      EI ++  + H  +I + D       E   ++
Sbjct: 49  VEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM 101

Query: 61  YIVYELMD-TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            ++ E +   +L   I +    +++     ++ Q   GLK++H  +++H D+KP N++  
Sbjct: 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 161

Query: 119 A--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +KI DFGLA   +  + +     T  + APE++          D+W++G +   
Sbjct: 162 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYV 220

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +++    F G+D +  L+ +       DE                             F 
Sbjct: 221 LLSGLSPFAGEDDLETLQNVKRCDWEFDED---------------------------AFS 253

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 274
           + SP A D ++ +L  +P +R+TV +AL HP+L   H 
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  185 bits (470), Expect = 1e-57
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 46/283 (16%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAK-------RTLREIKLLRHM-DHENIIAIKDIIRPP 52
           ++  T +E A+K I         A+        TL+E+ +LR +  H NII +KD     
Sbjct: 23  IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79

Query: 53  QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 111
             ET    ++V++LM   +L   +     L++   R  +  LL  +  +H  N++HRDLK
Sbjct: 80  --ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 137

Query: 112 PSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCSEYTAAID 166
           P N+LL+ + ++K+ DFG +      + + E   T  Y APE++      N   Y   +D
Sbjct: 138 PENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 197

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           +WS G I+  ++   P F  +  +  LR+I                       +    QF
Sbjct: 198 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----------------------MSGNYQF 234

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
                S  + + S    DL+ + LV  P +R T +EAL HP+ 
Sbjct: 235 G----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-57
 Identities = 73/319 (22%), Positives = 130/319 (40%), Gaps = 40/319 (12%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFND 59
            N  T+E+ A+K +        D  +  RE++   R     +I+ I D+           
Sbjct: 32  FNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KC 83

Query: 60  VYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           + IV E +D  +L   I+   D   T+      +  +   ++Y+HS N+ HRD+KP NLL
Sbjct: 84  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 143

Query: 117 LNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 173
             +   N  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+WS+G I
Sbjct: 144 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVI 202

Query: 174 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
           +  ++   P F     +     +   I                        +FP      
Sbjct: 203 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-------------------YEFPNP---- 239

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC-PRPFSFDFEHP 292
            +   S     L+  +L  +P +R+T+ E + HP++     + + P+   R    D E  
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 299

Query: 293 SFTEENIKELIYRESVKFN 311
              +E +   +    V + 
Sbjct: 300 EDVKEEMTSALATMRVDYE 318

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-57
 Identities = 58/301 (19%), Positives = 122/301 (40%), Gaps = 40/301 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           + + +++    K +        D     +EI +L    H NI+ + +       E+  ++
Sbjct: 25  VETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEEL 76

Query: 61  YIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            +++E +   D+ + I +   +L +     +++Q+   L+++HS N+ H D++P N++  
Sbjct: 77  VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136

Query: 119 A--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +  +KI +FG AR     D          Y APE+  +    + A D+WS+G ++  
Sbjct: 137 TRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYV 195

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +++    F  +     +  I     + DE +                           F 
Sbjct: 196 LLSGINPFLAETNQQIIENIMNAEYTFDEEA---------------------------FK 228

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTE 296
             S  A+D ++++LV +   R+T  EAL HP+L    +     V        + H    +
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288

Query: 297 E 297
           +
Sbjct: 289 D 289

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (466), Expect = 9e-57
 Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 38/273 (13%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           +  T++ VAIK I        +      EI +L  + H NI+A+ DI      E+   +Y
Sbjct: 30  DKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY 83

Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--- 117
           ++ +L+   +L   I      T+      ++Q+L  +KY+H   ++HRDLKP NLL    
Sbjct: 84  LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143

Query: 118 NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           + +  + I DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I   +
Sbjct: 144 DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYIL 202

Query: 178 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           +   P F  ++       I +     D                           S  + +
Sbjct: 203 LCGYPPFYDENDAKLFEQILKAEYEFD---------------------------SPYWDD 235

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 270
            S  A D +  ++  DP +R T ++AL HP++A
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-55
 Identities = 55/273 (20%), Positives = 115/273 (42%), Gaps = 36/273 (13%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +++ET  EVA  ++ +    + + +R   E ++L+ + H NI+   D      +     +
Sbjct: 29  LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCI 87

Query: 61  YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLL 117
            +V ELM +  L   ++  + +     R +  Q+L+GL+++H+    ++HRDLK  N+ +
Sbjct: 88  VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147

Query: 118 NA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
                 +KIGD GLA       F    + T  + APE+     +Y  ++D+++ G  + E
Sbjct: 148 TGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLE 204

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           + T +  +       Q+                         Y R+       +F     
Sbjct: 205 MATSEYPYSECQNAAQI-------------------------YRRVTSGVKPASFD---K 236

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
              P   +++E  +  + + R ++ + L H + 
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-53
 Identities = 62/274 (22%), Positives = 109/274 (39%), Gaps = 42/274 (15%)

Query: 1   MNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
               T  E AIK +               RE  ++  +DH   + +         +    
Sbjct: 28  RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82

Query: 60  VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +Y         +L + IR      +   R++  +++  L+Y+H   ++HRDLKP N+LLN
Sbjct: 83  LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142

Query: 119 ANCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
            +  ++I DFG A+     S+      +V T  Y +PELL        + D+W++GCI+ 
Sbjct: 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIY 201

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           +++   P F   +     + I                       +++   FP        
Sbjct: 202 QLVAGLPPFRAGNEYLIFQKI-----------------------IKLEYDFP-------- 230

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 269
               P A DL+EK+LV D  +R+  +E   +  L
Sbjct: 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-53
 Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 49/302 (16%)

Query: 2   NSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
              T  + A K I      +    +  +   RE+ +L+ + H N+I + ++      E  
Sbjct: 31  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----ENK 85

Query: 58  NDVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
            DV ++ EL+    L   +   + LT++    FL Q+L G+ Y+HS  + H DLKP N++
Sbjct: 86  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 145

Query: 117 LN----ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 172
           L         +KI DFGLA      +       T  + APE++ N        D+WS+G 
Sbjct: 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGV 204

Query: 173 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           I   +++    F G      L  ++ +    ++                           
Sbjct: 205 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE-------------------------- 238

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP 292
             F N S  A D + ++LV DP +R+T+ ++L HP++ P    + +      +S    HP
Sbjct: 239 -YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP---KDTQQALSSAWS----HP 290

Query: 293 SF 294
            F
Sbjct: 291 QF 292

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-51
 Identities = 51/270 (18%), Positives = 102/270 (37%), Gaps = 38/270 (14%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
           +   +VA+K +          +    E+ +LR   H NI+            T   + IV
Sbjct: 28  KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY------STAPQLAIV 81

Query: 64  YELMD-TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
            +  + + L+  +   +             Q  +G+ Y+H+ +++HRDLK +N+ L+ + 
Sbjct: 82  TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141

Query: 122 DLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL--NCSEYTAAIDIWSVGCILGE 176
            +KIGDFGLA   S    +    +   +  + APE++   + + Y+   D+++ G +L E
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +MT Q  +   +   Q+  +                             +   + S    
Sbjct: 202 LMTGQLPYSNINNRDQIIFMVGR-------------------------GYLSPDLSKVRS 236

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
           N       L+ + L    + R    + L  
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 9e-48
 Identities = 58/288 (20%), Positives = 109/288 (37%), Gaps = 52/288 (18%)

Query: 1   MNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQR 54
           +       VAIK +     + +    +  R   E+ LL+ +      +I + D    P  
Sbjct: 24  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-- 81

Query: 55  ETFNDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 112
              +   ++ E  +   DL   I     L ++  R F +Q+L  +++ H+  VLHRD+K 
Sbjct: 82  ---DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 138

Query: 113 SNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 171
            N+L++ N  +LK+ DFG      +T   T++  TR Y  PE +     +  +  +WS+G
Sbjct: 139 ENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197

Query: 172 CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF 231
            +L +++     F   + + + ++                              F     
Sbjct: 198 ILLYDMVCGDIPFEHDEEIIRGQVF-----------------------------FR---- 224

Query: 232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 279
                  S     L+   L   P+ R T +E   HP++  +    E  
Sbjct: 225 ----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (409), Expect = 1e-47
 Identities = 71/321 (22%), Positives = 128/321 (39%), Gaps = 54/321 (16%)

Query: 2   NSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 57
            ++T +  A+K +             A      + L+   D   I+ +          T 
Sbjct: 25  KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTP 79

Query: 58  NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 116
           + +  + +LM+  DLH  +  H   ++   R++  +++ GL+++H+  V++RDLKP+N+L
Sbjct: 80  DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 139

Query: 117 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           L+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L +
Sbjct: 140 LDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 198

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++     F       +  +                     R  + M  + P         
Sbjct: 199 LLRGHSPFRQHKTKDKHEID--------------------RMTLTMAVELP--------D 230

Query: 237 NKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH-DINEEPVCPRPF----- 285
           + SP    LLE +L  D NRR+        E    P+   L   +      P P      
Sbjct: 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 290

Query: 286 ----SFDFEHPSFTEENIKEL 302
               +  F+  SF EE+ K +
Sbjct: 291 EVNAADAFDIGSFDEEDTKGI 311

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 8e-47
 Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 42/277 (15%)

Query: 1   MNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRH-MDHENIIAIKDIIRPPQRETFN 58
              +T +  AIK +  +      D + T+ E ++L    +H  +  +         +T  
Sbjct: 22  EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76

Query: 59  DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           +++ V E ++  DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL
Sbjct: 77  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136

Query: 118 NANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
           + +  +KI DFG+ +           +  T  Y APE+LL   +Y  ++D WS G +L E
Sbjct: 137 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYE 195

Query: 177 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           ++  Q  F G+D       I                           P +P+        
Sbjct: 196 MLIGQSPFHGQDEEELFHSI-----------------------RMDNPFYPR-------- 224

Query: 237 NKSPGAVDLLEKMLVFDPNRRITV-DEALCHPYLAPL 272
                A DLL K+ V +P +R+ V  +   HP    +
Sbjct: 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  156 bits (394), Expect = 2e-46
 Identities = 61/272 (22%), Positives = 106/272 (38%), Gaps = 35/272 (12%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +     +VA+K +  +   +     R  RE +    ++H  I+A+ D     +       
Sbjct: 28  DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLP 86

Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           YIV E +D   L  I+ +   +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 87  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146

Query: 120 NCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
              +K+ DFG+AR    + +        + T  Y +PE         A  D++S+GC+L 
Sbjct: 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLY 205

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E++T +P F G   V                             VR  P  P    SAR 
Sbjct: 206 EVLTGEPPFTGDSPVSVAYQH-----------------------VREDPIPP----SARH 238

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
              S     ++ K L  +P  R      +   
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 1e-44
 Identities = 54/266 (20%), Positives = 96/266 (36%), Gaps = 45/266 (16%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
              +VA+K I     N   A+  L E  ++  + H N++ +  +I     E    +YIV 
Sbjct: 29  RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVT 80

Query: 65  ELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 121
           E M    L   +RS     L  D    F   +   ++Y+   N +HRDL   N+L++ + 
Sbjct: 81  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140

Query: 122 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR- 180
             K+ DFGL +  S T       +   + APE L    +++   D+WS G +L EI +  
Sbjct: 141 VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFG 197

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +  +P       +  + +                            P            P
Sbjct: 198 RVPYPRIPLKDVVPRVEK----------------------GYKMDAP--------DGCPP 227

Query: 241 GAVDLLEKMLVFDPNRRITVDEALCH 266
              ++++     D   R +  +    
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 6e-44
 Identities = 57/277 (20%), Positives = 111/277 (40%), Gaps = 43/277 (15%)

Query: 1   MNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
               T    A+K +       + +   T+ E ++L++  H  + A+K   +   R     
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR----- 79

Query: 60  VYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           +  V E  +   L   +   +  T++  R++  +++  L+Y+HS +V++RD+K  NL+L+
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
            +  +KI DFGL +         +            +L  ++Y  A+D W +G ++ E+M
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199

Query: 179 TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK 238
             +  F  +D+     LI                       +    +FP+          
Sbjct: 200 CGRLPFYNQDHERLFELI-----------------------LMEEIRFPR--------TL 228

Query: 239 SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLA 270
           SP A  LL  +L  DP +R+        E + H +  
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (375), Expect = 3e-43
 Identities = 61/326 (18%), Positives = 124/326 (38%), Gaps = 61/326 (18%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +       A+K +           + T  E  +L  + H  II +         +    +
Sbjct: 25  SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQI 79

Query: 61  YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +++ + ++  +L  ++R  Q   +   +++  ++   L+Y+HS ++++RDLKP N+LL+ 
Sbjct: 80  FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 139

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
           N  +KI DFG A+   +         T  Y APE +++   Y  +ID WS G ++ E++ 
Sbjct: 140 NGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLA 196

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
               F   + +     I                       +    +FP        P  +
Sbjct: 197 GYTPFYDSNTMKTYEKI-----------------------LNAELRFP--------PFFN 225

Query: 240 PGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLHDINEE---------PVCPRPF 285
               DLL +++  D ++R+       ++   HP+     ++  E         P  P   
Sbjct: 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW---FKEVVWEKLLSRNIETPYEPPIQ 282

Query: 286 SFDFEH---PSFTEENIKELIYRESV 308
               +      + EE+I   +  E  
Sbjct: 283 QGQGDTSQFDKYPEEDINYGVQGEDP 308

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 4e-43
 Identities = 50/276 (18%), Positives = 103/276 (37%), Gaps = 46/276 (16%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
             +  + VA+K + N  ++       L E  +++ +D+  I+ +  I             
Sbjct: 30  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW------M 83

Query: 62  IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
           +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  +N +HRDL   N+LL   
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143

Query: 121 CDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              KI DFGL++      +     T       + APE +    ++++  D+WS G ++ E
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWE 202

Query: 177 IMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
             +  Q  + G        ++ +                            P        
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEK----------------------GERMGCP-------- 232

Query: 236 PNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPY 268
                   DL+     +D   R     V+  L + Y
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-42
 Identities = 48/283 (16%), Positives = 114/283 (40%), Gaps = 42/283 (14%)

Query: 2   NSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
             +T +  A+K +            + T  E ++L H+     +    +      +T   
Sbjct: 48  GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL----VTLHYAFQTETK 103

Query: 60  VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
           ++++ + ++  +L   +   +  T+   + ++ +++  L+++H   +++RD+K  N+LL+
Sbjct: 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 163

Query: 119 ANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           +N  + + DFGL++                  +     +    S +  A+D WS+G ++ 
Sbjct: 164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 223

Query: 176 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           E++T    F      +    I                   +RR ++  P +P        
Sbjct: 224 ELLTGASPFTVDGEKNSQAEI-------------------SRRILKSEPPYP-------- 256

Query: 236 PNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 273
              S  A DL++++L+ DP +R+       DE   H +   ++
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (365), Expect = 2e-41
 Identities = 64/324 (19%), Positives = 126/324 (38%), Gaps = 54/324 (16%)

Query: 1   MNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 59
            + E+    A+K +           + TL E ++L+ ++   ++ ++       ++  N 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF----SFKDNSNL 116

Query: 60  VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
             ++  +   ++   +R     ++ H R++  Q++   +Y+HS ++++RDLKP NLL++ 
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 176

Query: 120 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 179
              +++ DFG A+             T    APE++L+   Y  A+D W++G ++ E+  
Sbjct: 177 QGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAA 233

Query: 180 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
             P F     +     I                            +FP         + S
Sbjct: 234 GYPPFFADQPIQIYEKIV-----------------------SGKVRFP--------SHFS 262

Query: 240 PGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL--HDINEEPVCPRPFSFDFEHP 292
               DLL  +L  D  +R       V++   H + A      I +  V   PF   F+ P
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEA-PFIPKFKGP 321

Query: 293 -------SFTEENIKELIYRESVK 309
                   + EE I+  I  +  K
Sbjct: 322 GDTSNFDDYEEEEIRVSINEKCGK 345

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (364), Expect = 4e-41
 Identities = 68/331 (20%), Positives = 120/331 (36%), Gaps = 39/331 (11%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP---------- 51
           +      VA+K +     +++  +    EIKLL+ ++  +      +             
Sbjct: 34  DMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90

Query: 52  --PQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHR 108
                     +       +         H+ +   + +    QLL GL Y+H    ++H 
Sbjct: 91  HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT 150

Query: 109 DLKPSNLLLNANC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 164
           D+KP N+L+         ++I    L       +  T  + TR YR+PE+LL  + +   
Sbjct: 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG-APWGCG 209

Query: 165 IDIWSVGCILGEIMTRQPLFPGKDY------VHQLRLITELIGSPDETSL-------GFL 211
            DIWS  C++ E++T   LF   +          +  I EL+G      L        F 
Sbjct: 210 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFF 269

Query: 212 RSDNARRYVRMLPQFPKQNFSAR----FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 267
            S    R +  L  +P ++          +++    D L  ML  DP +R      + HP
Sbjct: 270 NSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329

Query: 268 YLAPLHDINEEPVCPRPFSF-DFEHPSFTEE 297
           +L     + E  V  R       + P + EE
Sbjct: 330 WLKDTLGMEEIRVPDRELYGSGSDIPGWFEE 360

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-40
 Identities = 53/267 (19%), Positives = 95/267 (35%), Gaps = 46/267 (17%)

Query: 4   ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 63
               +VA+K +       +     L E  L++ + H+ ++ +  ++      T   +YI+
Sbjct: 35  NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV------TQEPIYII 85

Query: 64  YELMDTDL---HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 120
            E M+           S   LT +       Q+  G+ ++   N +HRDL+ +N+L++  
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145

Query: 121 CDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 178
              KI DFGLAR   + ++           + APE  +N   +T   D+WS G +L EI+
Sbjct: 146 LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIV 204

Query: 179 TR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 237
           T  +  +PG      ++ +                                        N
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRP------------------------------DN 234

Query: 238 KSPGAVDLLEKMLVFDPNRRITVDEAL 264
                  L+       P  R T D   
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLR 261

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-40
 Identities = 57/272 (20%), Positives = 99/272 (36%), Gaps = 48/272 (17%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 66
             VAIK +       +  +  L+E ++++ + HE ++ +  ++      +   +YIV E 
Sbjct: 42  TRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEY 92

Query: 67  MD---TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 123
           M            + + L          Q+  G+ YV   N +HRDL+ +N+L+  N   
Sbjct: 93  MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 152

Query: 124 KIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR- 180
           K+ DFGLAR   + ++           + APE  L    +T   D+WS G +L E+ T+ 
Sbjct: 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKG 211

Query: 181 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 240
           +  +PG      L  +      P                                P    
Sbjct: 212 RVPYPGMVNREVLDQVERGYRMPCP------------------------------PECPE 241

Query: 241 GAVDLLEKMLVFDPNRRITVDE--ALCHPYLA 270
              DL+ +    +P  R T +   A    Y  
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 5e-40
 Identities = 51/279 (18%), Positives = 106/279 (37%), Gaps = 48/279 (17%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
             + + +VAIK +      + D +  +RE +++  +D+  I+ +  + +         + 
Sbjct: 32  MRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA------LM 84

Query: 62  IVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V E+     LH+ +    +++   +    L+Q+  G+KY+   N +HRDL   N+LL  
Sbjct: 85  LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144

Query: 120 NCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
               KI DFGL++     D      +       + APE  +N  ++++  D+WS G  + 
Sbjct: 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMW 203

Query: 176 EIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
           E ++  Q  +        +  I +                          + P       
Sbjct: 204 EALSYGQKPYKKMKGPEVMAFIEQ----------------------GKRMECP------- 234

Query: 235 FPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLA 270
            P   P    L+    ++    R     V++ +   Y +
Sbjct: 235 -PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 8e-40
 Identities = 54/270 (20%), Positives = 92/270 (34%), Gaps = 42/270 (15%)

Query: 2   NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            S     VA+K +  +           +RE+  +  +DH N+I +  ++          +
Sbjct: 32  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV------LTPPM 85

Query: 61  YIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            +V EL    + L ++ +            +  Q+  G+ Y+ S   +HRDL   NLLL 
Sbjct: 86  KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA 145

Query: 119 ANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
               +KIGDFGL R   + D    M E+    +       L    ++ A D W  G  L 
Sbjct: 146 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205

Query: 176 EIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
           E+ T  Q  + G +    L  I                        +   + P      R
Sbjct: 206 EMFTYGQEPWIGLNGSQILHKI-----------------------DKEGERLP------R 236

Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
             +      +++ +     P  R T     
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 56/279 (20%), Positives = 97/279 (34%), Gaps = 33/279 (11%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
             EEVA+K   +  +     +    EI     + HENI+            T+  +++V 
Sbjct: 25  RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80

Query: 65  ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNL 115
           +  +   L   +  +  +T +           GL ++H           + HRDLK  N+
Sbjct: 81  DYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139

Query: 116 LLNANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCS-----EYTAAI 165
           L+  N    I D GLA      T +        V T+ Y APE+L +       E     
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199

Query: 166 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 225
           DI+++G +  EI  R  +  G    +QL     +   P    +  +  +   R     P 
Sbjct: 200 DIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-----PN 253

Query: 226 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
            P +  S            ++ +    +   R+T     
Sbjct: 254 IPNRWQSCEALRV---MAKIMRECWYANGAARLTALRIK 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-39
 Identities = 55/294 (18%), Positives = 103/294 (35%), Gaps = 65/294 (22%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDV 60
            +    +VA+K +    D+  + +  + E+K++  +  HENI+ +              +
Sbjct: 63  KTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSHENIVNLLGAC-----TLSGPI 116

Query: 61  YIVYELMD-TDLHQIIRSHQD-----------------------LTDDHCRYFLYQLLRG 96
           Y+++E     DL   +RS ++                       LT +    F YQ+ +G
Sbjct: 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176

Query: 97  LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPE 153
           ++++   + +HRDL   N+L+     +KI DFGLAR               +   + APE
Sbjct: 177 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236

Query: 154 LLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLR 212
            L     YT   D+WS G +L EI +     +PG         + +     D+       
Sbjct: 237 SLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP------ 289

Query: 213 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
                                     +     +++    FD  +R +       
Sbjct: 290 -----------------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 6e-39
 Identities = 44/267 (16%), Positives = 92/267 (34%), Gaps = 44/267 (16%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
            + +VAIK I    +  +     + E K++ ++ HE ++ +  +           ++I+ 
Sbjct: 27  GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFIIT 78

Query: 65  ELM--DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           E M     L+ +                  +   ++Y+ S   LHRDL   N L+N    
Sbjct: 79  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV 138

Query: 123 LKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           +K+ DFGL+R   + ++           +  PE+L+  S++++  DIW+ G ++ EI + 
Sbjct: 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSL 197

Query: 181 -QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +  +           I + +                                      S
Sbjct: 198 GKMPYERFTNSETAEHIAQGLRLYRP------------------------------HLAS 227

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCH 266
                ++        + R T    L +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 6e-38
 Identities = 44/267 (16%), Positives = 93/267 (34%), Gaps = 44/267 (16%)

Query: 5   TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 64
            +++VAIK I    +  +  +  + E +++  + H  ++ +  +           + +V+
Sbjct: 28  NKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICLVF 79

Query: 65  ELMDT-DLHQIIRSHQDLTD-DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 122
           E M+   L   +R+ + L   +        +  G+ Y+  A V+HRDL   N L+  N  
Sbjct: 80  EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV 139

Query: 123 LKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 180
           +K+ DFG+ R     +    T       + +PE+    S Y++  D+WS G ++ E+ + 
Sbjct: 140 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSE 198

Query: 181 -QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 239
            +  +  +     +  I+                                         S
Sbjct: 199 GKIPYENRSNSEVVEDISTGFRLYKP------------------------------RLAS 228

Query: 240 PGAVDLLEKMLVFDPNRRITVDEALCH 266
                ++       P  R      L  
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-36
 Identities = 63/270 (23%), Positives = 104/270 (38%), Gaps = 43/270 (15%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
                  VAIK   N   + +  ++ L+E   +R  DH +I+ +  +I      T N V+
Sbjct: 31  PENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLIGVI------TENPVW 83

Query: 62  IVYELM--DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           I+ EL         +      L       + YQL   L Y+ S   +HRD+   N+L+++
Sbjct: 84  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143

Query: 120 NCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 177
           N  +K+GDFGL+R   ++ +   ++  +   + APE  +N   +T+A D+W  G  + EI
Sbjct: 144 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEI 202

Query: 178 MTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 236
           +      F G      +  I                              P        P
Sbjct: 203 LMHGVKPFQGVKNNDVIGRIEN----------------------GERLPMP--------P 232

Query: 237 NKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
           N  P    L+ K   +DP+RR    E    
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 3e-36
 Identities = 50/272 (18%), Positives = 95/272 (34%), Gaps = 44/272 (16%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  +    VAIK + + +  +   +  L E  ++   DH N+I ++ ++          V
Sbjct: 49  LPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPV 102

Query: 61  YIVYELMDTDLHQII--RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 118
            I+ E M+         ++    T       L  +  G+KY+   N +HRDL   N+L+N
Sbjct: 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN 162

Query: 119 ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCSEYTAAIDIWSVGCI 173
           +N   K+ DFGL+R   +      Y      + P            ++T+A D+WS G +
Sbjct: 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIV 222

Query: 174 LGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 232
           + E+M+  +  +        +  I +    P                             
Sbjct: 223 MWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP--------------------------- 255

Query: 233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
               +       L+      D N R    + +
Sbjct: 256 ---MDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-36
 Identities = 60/296 (20%), Positives = 101/296 (34%), Gaps = 61/296 (20%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDV 60
               R + AIK++   + ++ D +    E+++L  +  H NII +              +
Sbjct: 33  KDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYL 86

Query: 61  YIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSA 103
           Y+  E     +L   +R                    L+     +F   + RG+ Y+   
Sbjct: 87  YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 146

Query: 104 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 163
             +HRDL   N+L+  N   KI DFGL+R        T   +   + A E  LN S YT 
Sbjct: 147 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE-SLNYSVYTT 205

Query: 164 AIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 222
             D+WS G +L EI++     + G         + +                        
Sbjct: 206 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----------------------GY 243

Query: 223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 278
             + P         N      DL+ +     P  R +  + L       L+ + EE
Sbjct: 244 RLEKP--------LNCDDEVYDLMRQCWREKPYERPSFAQILVS-----LNRMLEE 286

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 4e-36
 Identities = 48/269 (17%), Positives = 99/269 (36%), Gaps = 43/269 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  +    VA+K +    ++ ++ +  L+E  +++ + H N++ +  +            
Sbjct: 37  VWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 88

Query: 61  YIVYELMD---TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 117
           YI+ E M       +    + Q+++     Y   Q+   ++Y+   N +HRDL   N L+
Sbjct: 89  YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 148

Query: 118 NANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
             N  +K+ DFGL+R  T +T                  L  ++++   D+W+ G +L E
Sbjct: 149 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 208

Query: 177 IMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           I T     +PG D      L+ +                          + P        
Sbjct: 209 IATYGMSPYPGIDLSQVYELLEK----------------------DYRMERP-------- 238

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                   +L+     ++P+ R +  E  
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 5e-36
 Identities = 57/315 (18%), Positives = 113/315 (35%), Gaps = 51/315 (16%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
             + +  VAIK++  A   + + K  L E  ++  +D+ ++  +  I           V 
Sbjct: 34  GEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTS------TVQ 86

Query: 62  IVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           ++ +LM     L  +     ++   +   +  Q+ +G+ Y+    ++HRDL   N+L+  
Sbjct: 87  LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146

Query: 120 NCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 176
              +KI DFGLA+     +         V   + A E +L+   YT   D+WS G  + E
Sbjct: 147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWE 205

Query: 177 IMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 235
           +MT     + G        ++ +                            P        
Sbjct: 206 LMTFGSKPYDGIPASEISSILEK----------------------GERLPQP-------- 235

Query: 236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCH-------PYLAPLHDINEEPVCPRPFSFD 288
           P  +     ++ K  + D + R    E +         P    +   +E    P P   +
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295

Query: 289 FEHPSFTEENIKELI 303
           F      EE++ +++
Sbjct: 296 FYRALMDEEDMDDVV 310

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (322), Expect = 1e-35
 Identities = 51/293 (17%), Positives = 92/293 (31%), Gaps = 66/293 (22%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
           +  E    VA+K +       +      RE  L+   D+ NI+ +  +           +
Sbjct: 38  LPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVG-----KPM 91

Query: 61  YIVYELMD-TDLHQIIRSHQD------------------------LTDDHCRYFLYQLLR 95
            +++E M   DL++ +RS                           L+         Q+  
Sbjct: 92  CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 151

Query: 96  GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAP 152
           G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+        +   +  P
Sbjct: 152 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

Query: 153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQ-PLFPGKDYVHQLRLITELIGSPDETSLGFL 211
           E +     YT   D+W+ G +L EI +     + G  +   +  + +             
Sbjct: 212 ESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD------------- 257

Query: 212 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                      +   P         N      +L+       P  R +     
Sbjct: 258 ---------GNILACP--------ENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 5e-35
 Identities = 61/289 (21%), Positives = 104/289 (35%), Gaps = 62/289 (21%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 59
           + S+    VA+K +     +  + +  + E+K+L ++ +H NI+ +              
Sbjct: 48  IKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-----TIGGP 101

Query: 60  VYIVYELMD-TDLHQIIRSHQD------------------LTDDHCRYFLYQLLRGLKYV 100
             ++ E     DL   +R  +D                  L  +    F YQ+ +G+ ++
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 101 HSANVLHRDLKPSNLLLNANCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLN 157
            S N +HRDL   N+LL      KI DFGLAR     S         +   + APE + N
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221

Query: 158 CSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 216
           C  YT   D+WS G  L E+ +     +PG     +   +                    
Sbjct: 222 C-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI------------------- 261

Query: 217 RRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEAL 264
                      K+ F    P        D+++     DP +R T  + +
Sbjct: 262 -----------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (317), Expect = 6e-35
 Identities = 44/276 (15%), Positives = 78/276 (28%), Gaps = 44/276 (15%)

Query: 1   MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 60
            +    EEVAIK        +    +   E K+ + M     I              +  
Sbjct: 27  TDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 78

Query: 61  YIVYELMDTDLHQI-IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL--- 116
            +V EL+   L  +     +  +         Q++  ++Y+HS N +HRD+KP N L   
Sbjct: 79  VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 138

Query: 117 LNANCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCSEYTAAIDIW 168
                 + I DFGLA+   +                 T  Y +    L   E +   D+ 
Sbjct: 139 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLE 197

Query: 169 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK 228
           S+G +L         + G     +                        ++Y R+  +   
Sbjct: 198 SLGYVLMYFNLGSLPWQGLKAATKR-----------------------QKYERISEKKMS 234

Query: 229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
                            L        + +       
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-34
 Identities = 54/273 (19%), Positives = 99/273 (36%), Gaps = 44/273 (16%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           N   +   A+K + N   +  +  + L E  +++   H N++++  I       +     
Sbjct: 51  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPL 105

Query: 62  IVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           +V   M   DL   IR+   + T      F  Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165

Query: 120 NCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 174
              +K+ DFGLAR   + +F      T   +   + A E L    ++T   D+WS G +L
Sbjct: 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLL 224

Query: 175 GEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 233
            E+MTR  P +P  +       + +                                   
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC------------------------- 259

Query: 234 RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 266
                     +++ K        R +  E +  
Sbjct: 260 -----PDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 1e-33
 Identities = 51/270 (18%), Positives = 98/270 (36%), Gaps = 44/270 (16%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
           + +    VAIK +   +  +      L E  ++    H NII ++ +I       +  + 
Sbjct: 32  SGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KYKPMM 85

Query: 62  IVYELM--DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
           I+ E M        +     + +       L  +  G+KY+ + N +HRDL   N+L+N+
Sbjct: 86  IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 145

Query: 120 NCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 175
           N   K+ DFGL+R        T   +   +   + APE +      +A+ D+WS G ++ 
Sbjct: 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMW 204

Query: 176 EIMTRQPLFPGKDYVHQL-RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 234
           E+MT       +   H++ + I +                            P       
Sbjct: 205 EVMTYGERPYWELSNHEVMKAIND----------------------GFRLPTP------- 235

Query: 235 FPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
             +       L+ +    +  RR    + +
Sbjct: 236 -MDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-33
 Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 52/278 (18%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
             E    VAIK +  A   R +    L E  +++  +  +++ +  ++            
Sbjct: 46  KDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTL 99

Query: 62  IVYELMD-TDLHQIIRSHQD----------LTDDHCRYFLYQLLRGLKYVHSANVLHRDL 110
           ++ ELM   DL   +RS +            +         ++  G+ Y+++   +HRDL
Sbjct: 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 159

Query: 111 KPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDI 167
              N ++  +  +KIGDFG+ R   ETD+     + ++   + +PE L +   +T   D+
Sbjct: 160 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDV 218

Query: 168 WSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           WS G +L EI T  +  + G      LR + E                        L   
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----------------------GGLLDK 256

Query: 227 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
           P         N      +L+     ++P  R +  E +
Sbjct: 257 P--------DNCPDMLFELMRMCWQYNPKMRPSFLEII 286

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  119 bits (298), Expect = 3e-32
 Identities = 40/264 (15%), Positives = 85/264 (32%), Gaps = 27/264 (10%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPPQRETFNDV 60
           N    ++VAIK        R DA +   E +  + +     I  +         +     
Sbjct: 26  NLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76

Query: 61  YIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 119
            +V +L+   L  ++    +  +         Q+L  ++ +H  ++++RD+KP N L+  
Sbjct: 77  VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 136

Query: 120 NC-----DLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAID 166
                   + + DFG+ +                     T  Y +        E +   D
Sbjct: 137 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN-THLGREQSRRDD 195

Query: 167 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 226
           + ++G +    +     + G       +    +      T L  L +     + + +   
Sbjct: 196 LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255

Query: 227 PKQNFSARFPNKSPGAVDLLEKML 250
               F A  P+       L  K+L
Sbjct: 256 RNLAFDAT-PDYD-YLQGLFSKVL 277

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 6e-32
 Identities = 57/280 (20%), Positives = 107/280 (38%), Gaps = 59/280 (21%)

Query: 7   EEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYE 65
            +VA+K + +    + D    + E+++++ +  H+NII +              +Y++ E
Sbjct: 46  TKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGAC-----TQDGPLYVIVE 99

Query: 66  LMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHR 108
                +L + +++                 + L+        YQ+ RG++Y+ S   +HR
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159

Query: 109 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCSEYTAAI 165
           DL   N+L+  +  +KI DFGLAR     D+  +     +   + APE L +   YT   
Sbjct: 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQS 218

Query: 166 DIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 224
           D+WS G +L EI T     +PG       +L+ E                          
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE----------------------GHRM 256

Query: 225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 264
             P         N +     ++       P++R T  + +
Sbjct: 257 DKP--------SNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 57/287 (19%)

Query: 2   NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 61
            + T   VA+K +     +  + +  + E+K+L H+ H   +           +    + 
Sbjct: 39  KTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGA---CTKPGGPLM 94

Query: 62  IVYELMD-TDLHQIIRSHQD----------------LTDDHCRYFLYQLLRGLKYVHSAN 104
           ++ E     +L   +RS ++                LT +H   + +Q+ +G++++ S  
Sbjct: 95  VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154

Query: 105 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEY 161
            +HRDL   N+LL+    +KI DFGLAR   +        +  +   + APE + +   Y
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVY 213

Query: 162 TAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 220
           T   D+WS G +L EI +     +PG     +                            
Sbjct: 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----------------------- 250

Query: 221 RMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCH 266
                  K+    R P+  +P     +      +P++R T  E + H
Sbjct: 251 -------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.7 bits (193), Expect = 4e-18
 Identities = 25/182 (13%), Positives = 51/182 (28%), Gaps = 29/182 (15%)

Query: 3   SETREEVAIKKIGNAFDNRIDAK--------RTLREIKLLRHMDHENIIAIKDIIRPPQR 54
           SE   E  +K       +    K                    +   +  ++ +  P   
Sbjct: 21  SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80

Query: 55  ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 114
             +    ++ EL+D      +R        +    L  +L  +   +   ++H DL   N
Sbjct: 81  A-WEGNAVLMELIDAKELYRVRVE------NPDEVLDMILEEVAKFYHRGIVHGDLSQYN 133

Query: 115 LLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 169
           +L++    + I DF  +    E             +  ++           Y    DI S
Sbjct: 134 VLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINS 184

Query: 170 VG 171
             
Sbjct: 185 AI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	316
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.8
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.99
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.66
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.72
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.93

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=393.10  Aligned_cols=307  Identities=45%  Similarity=0.839  Sum_probs=262.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++....++...+.+.+|+.+++.++||||++++++|...+. .....+|+||||++++|..+++. ++
T Consensus        39 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~  117 (346)
T d1cm8a_          39 DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EK  117 (346)
T ss_dssp             ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CC
T ss_pred             ECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-cc
Confidence            67899999999998776666677889999999999999999999999976532 23456899999998888887755 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......  .....+++.|+|||++.+...
T Consensus       118 l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~  195 (346)
T d1cm8a_         118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMR  195 (346)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc--cccccccccccCHHHHcCCCC
Confidence            999999999999999999999999999999999999999999999999999876543  345678999999999987677


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++||||+||++|+|++|++||.+.+....+..+....+.++...+......................+....+.+++
T Consensus       196 ~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  275 (346)
T d1cm8a_         196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP  275 (346)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH
T ss_pred             CCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCH
Confidence            89999999999999999999999999999999999999999988877776666667777777777777788888889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP  312 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
                      ++.+||++||+.||.+|||++|+|+||||+++....+++... .+..+++..+.+.+++++++.++.+-|+|
T Consensus       276 ~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC-CCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence            999999999999999999999999999999998777766654 45566777778889999999999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=387.86  Aligned_cols=309  Identities=51%  Similarity=0.917  Sum_probs=263.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |+.+|+.||||+++....+......+.+|+.++++++||||+++++++..... ++...+++++++++|+|.+++.. ++
T Consensus        39 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~  117 (348)
T d2gfsa1          39 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QK  117 (348)
T ss_dssp             ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CC
T ss_pred             ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-cc
Confidence            67899999999998776677777889999999999999999999999875432 23344566666657899998855 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+......  .....++..|+|||.+.+...
T Consensus       118 l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~  195 (348)
T d2gfsa1         118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMH  195 (348)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc--cccccccccccCchhhcCCcc
Confidence            999999999999999999999999999999999999999999999999998665432  345678999999999887667


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      ++.++|||||||++|+|++|.+||.+.+.......+....+.+.......................+...+......+++
T Consensus       196 ~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  275 (348)
T d2gfsa1         196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  275 (348)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCH
T ss_pred             CCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCH
Confidence            89999999999999999999999999999999999988888877766666666666666666777777777777889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP  314 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (316)
                      ++.+||++||+.||.+|||++|+|+||||+++.+...++.+ .++..++...+.+.+++++++.++.++|+|.|
T Consensus       276 ~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~k~~~~~e~~~~~p~~  348 (348)
T d2gfsa1         276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP  348 (348)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCC-CCCCCGGGGCCCCHHHHHHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCC-CCCCCcccchhcCHHHHHHHHHHHhhccCCCC
Confidence            99999999999999999999999999999999888877765 47777888889999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=379.83  Aligned_cols=311  Identities=52%  Similarity=0.917  Sum_probs=254.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcCCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDL   81 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~   81 (316)
                      |+.||+.||||+++... .......+++|+.++++++||||+++++++..........+++++++++|+|.+++.. .++
T Consensus        29 ~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l  106 (345)
T d1pmea_          29 DNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHL  106 (345)
T ss_dssp             ETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCC
T ss_pred             ECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCC
Confidence            67899999999997542 4445677899999999999999999999997654444456788888778999999976 579


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC----CccccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......    .......+++.|+|||++..
T Consensus       107 ~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  186 (345)
T d1pmea_         107 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN  186 (345)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhc
Confidence            99999999999999999999999999999999999999999999999998765332    22345678999999999877


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++||||+||++|+|++|++||.+.+..+.........+.+...........................+....+.
T Consensus       187 ~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (345)
T d1pmea_         187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN  266 (345)
T ss_dssp             BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTT
T ss_pred             CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCC
Confidence            67789999999999999999999999999988888888877777776654433333344444444555445555666778


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP  314 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (316)
                      +|+++.+||.+||+.||.+|||++|+|+||||+......+.+....++..+....+...+++++++.++..+|-|+-
T Consensus       267 ~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~e~~~~~~~~  343 (345)
T d1pmea_         267 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY  343 (345)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC--------CCHHHHHHHHHHHSGGGSTTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChhhhhCCHHHHHHHHHHHHHhcCCCC
Confidence            89999999999999999999999999999999999888888877777887777778999999999999999999963

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-55  Score=374.14  Aligned_cols=236  Identities=26%  Similarity=0.365  Sum_probs=193.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++.... ....+.+.+|+.++++++||||+++++++.+.     ..+|+|||||+ |+|.+++...+.
T Consensus        26 ~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~   99 (271)
T d1nvra_          26 NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIG   99 (271)
T ss_dssp             ETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTB
T ss_pred             ECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeEEEEeccCCCcHHHHHhcCCC
Confidence            578999999999976432 22345688999999999999999999999655     56999999996 699999988889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC---CccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....   ......+||+.|+|||++.+
T Consensus       100 l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  179 (271)
T d1nvra_         100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  179 (271)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC
Confidence            999999999999999999999999999999999999999999999999999875433   22345689999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|++||...................                            ......
T Consensus       180 ~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  231 (271)
T d1nvra_         180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------------------LNPWKK  231 (271)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT----------------------------STTGGG
T ss_pred             CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------------------CCcccc
Confidence            4445788999999999999999999997765333222221111100                            111235


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +|+++.+||.+||+.||++|||++|+++||||++
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            7899999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=374.69  Aligned_cols=267  Identities=36%  Similarity=0.602  Sum_probs=215.0

Q ss_pred             CCCCCceEEEEEecccccChh---HHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFDNRI---DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~   77 (316)
                      |+.+|+.||||+++.......   ....+.+|+.++++++||||+++++++...     .++|+||||++| ++..++..
T Consensus        19 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ivmE~~~~~~~~~~~~~   93 (299)
T d1ua2a_          19 DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDN   93 (299)
T ss_dssp             CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTC
T ss_pred             ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----CceeehhhhhcchHHhhhhhc
Confidence            678999999999976432221   235688999999999999999999999655     458999999986 55555555


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCccccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  156 (316)
                      ...+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||.+....... .....++|+.|+|||++.
T Consensus        94 ~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  173 (299)
T d1ua2a_          94 SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF  173 (299)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHc
Confidence            6789999999999999999999999999999999999999999999999999998765433 334567899999999987


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ....++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+..........   .....+...+....+
T Consensus       174 ~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  250 (299)
T d1ua2a_         174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV---TFKSFPGIPLHHIFS  250 (299)
T ss_dssp             TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC---CCCCCCCCCHHHHCT
T ss_pred             cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh---hhccCCCCChHHhcc
Confidence            76778999999999999999999999999999999999999998887766554332211110   111222233344556


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      .+++++.+||.+||+.||++|||++|+|+||||++.....
T Consensus       251 ~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~  290 (299)
T d1ua2a_         251 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  290 (299)
T ss_dssp             TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence            7899999999999999999999999999999999765433

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=371.47  Aligned_cols=232  Identities=25%  Similarity=0.428  Sum_probs=200.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.||+.||||++..... .......+.+|+.+++.++||||+++++++.+.     ..+|+|||||+ |+|.+++...+
T Consensus        27 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~ivmEy~~~g~L~~~l~~~~  101 (263)
T d2j4za1          27 EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLS  101 (263)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHS
T ss_pred             ECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHhhcC
Confidence            578999999999975432 233456788999999999999999999999655     56999999996 79999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....||+.|+|||++.+ .
T Consensus       102 ~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~-~  179 (263)
T d2j4za1         102 KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEG-R  179 (263)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTT-C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcC-C
Confidence            99999999999999999999999999999999999999999999999999997765432 345679999999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|+.||.+.+..+....+.+.....                               ...+|
T Consensus       180 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s  228 (263)
T d2j4za1         180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-------------------------------PDFVT  228 (263)
T ss_dssp             CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-------------------------------CTTSC
T ss_pred             CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CccCC
Confidence            78999999999999999999999998887776666554321111                               12478


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +++.+||.+||+.||++|||++|+++||||++
T Consensus       229 ~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         229 EGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999999999999963

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=365.82  Aligned_cols=237  Identities=22%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||+|++..........+.+.+|++++++++||||+++++++.... .+...+|+|||||+ |+|.+++.+.+.
T Consensus        30 ~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~ivmE~~~~g~L~~~l~~~~~  108 (270)
T d1t4ha_          30 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKV  108 (270)
T ss_dssp             ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHHSS
T ss_pred             ECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEEEeCCCCCcHHHHHhcccc
Confidence            5789999999999876666667788999999999999999999999986432 22356899999996 699999998889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCC--ceeccCCCCcEEEc-cCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+
T Consensus       109 ~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~  187 (270)
T d1t4ha_         109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE  187 (270)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC
Confidence            999999999999999999999998  99999999999996 4789999999999765433 3346689999999999865


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                        .++.++|||||||++|+|++|+.||.+......+...... +..+.                           .....
T Consensus       188 --~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~---------------------------~~~~~  237 (270)
T d1t4ha_         188 --KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA---------------------------SFDKV  237 (270)
T ss_dssp             --CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG---------------------------GGGGC
T ss_pred             --CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc---------------------------ccCcc
Confidence              5899999999999999999999999876544443322111 11100                           11125


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA  270 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~  270 (316)
                      .++++.++|.+||+.||++|||++|+|+||||+
T Consensus       238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            688999999999999999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-54  Score=369.13  Aligned_cols=233  Identities=24%  Similarity=0.391  Sum_probs=198.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++....  ...+.+.+|+.+++.++||||+++++++...     ..+|+|||||+ |+|.+++.. +.
T Consensus        41 ~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~-~~  112 (293)
T d1yhwa1          41 DVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TC  112 (293)
T ss_dssp             BTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-SC
T ss_pred             ECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEEEEEecCCCcHHHHhhc-cC
Confidence            678999999999975432  2356789999999999999999999999655     56999999996 699988765 57


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ .
T Consensus       113 l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~  191 (293)
T d1yhwa1         113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K  191 (293)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-S
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcC-C
Confidence            999999999999999999999999999999999999999999999999999876543 33456679999999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|.+||.+.+....+..+........                            .....+|
T Consensus       192 ~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~s  243 (293)
T d1yhwa1         192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------------------------QNPEKLS  243 (293)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC----------------------------SSGGGSC
T ss_pred             CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----------------------------CCcccCC
Confidence            789999999999999999999999988877666655543211110                            0112578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +++++||.+||+.||.+|||++|+++||||+.
T Consensus       244 ~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-54  Score=371.38  Aligned_cols=236  Identities=29%  Similarity=0.488  Sum_probs=184.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||||++....... ....+.+|+.++++++||||+++++++.+.     ..+|+|||||+ |+|.+++...+.
T Consensus        30 ~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lvmE~~~gg~L~~~l~~~~~  103 (307)
T d1a06a_          30 DKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGF  103 (307)
T ss_dssp             ETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSC
T ss_pred             ECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHhhhcccC
Confidence            57899999999997653322 335678999999999999999999999654     56999999996 799999999899


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc---cCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++.+++.++.||+.||+|||++||+||||||+||++.   .++.+||+|||++............+||+.|+|||++.+
T Consensus       104 l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~  183 (307)
T d1a06a_         104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ  183 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC
Confidence            99999999999999999999999999999999999994   578999999999988766666667789999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+.......+.......+                           ....+.
T Consensus       184 -~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~  235 (307)
T d1a06a_         184 -KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD---------------------------SPYWDD  235 (307)
T ss_dssp             -CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC---------------------------TTTTTT
T ss_pred             -CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC---------------------------CccccC
Confidence             7789999999999999999999999998877776666554221111                           112246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +|+++.+||.+||+.||++|||++|+++||||++
T Consensus       236 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            8999999999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-54  Score=365.60  Aligned_cols=234  Identities=29%  Similarity=0.439  Sum_probs=189.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc---
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS---   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---   77 (316)
                      ++.||+.||||+++....++...+.+.+|++++++++||||+++++++.+..   ...+|+|||||+ |+|.+++..   
T Consensus        25 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~~ivmEy~~~g~L~~~i~~~~~  101 (269)
T d2java1          25 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTLYIVMEYCEGGDLASVITKGTK  101 (269)
T ss_dssp             ETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHH
T ss_pred             ECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEEEEEEecCCCCcHHHHHHhccc
Confidence            5789999999999877666667788999999999999999999999986532   256899999996 699998853   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCC-----ceeccCCCCcEEEccCCCEEEeeeccccccCCCC-cccccccccccc
Q 021181           78 -HQDLTDDHCRYFLYQLLRGLKYVHSAN-----VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYR  150 (316)
Q Consensus        78 -~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~  150 (316)
                       ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+++...... ......+|+.|+
T Consensus       102 ~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~  181 (269)
T d2java1         102 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM  181 (269)
T ss_dssp             HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccC
Confidence             467999999999999999999999876     9999999999999999999999999998765443 334578899999


Q ss_pred             CcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCC
Q 021181          151 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN  230 (316)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (316)
                      |||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+......                            
T Consensus       182 APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~----------------------------  232 (269)
T d2java1         182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----------------------------  232 (269)
T ss_dssp             CHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----------------------------
T ss_pred             CHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----------------------------
Confidence            9999977 77899999999999999999999999988877766665442110                            


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 021181          231 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL  269 (316)
Q Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f  269 (316)
                        .....+|+++.+||++||+.||.+|||++|+++|||+
T Consensus       233 --~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         233 --RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence              1112578999999999999999999999999999995

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=367.28  Aligned_cols=239  Identities=28%  Similarity=0.468  Sum_probs=204.6

Q ss_pred             CCCCCceEEEEEeccccc----ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFD----NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      ++.||+.||||++++...    .....+.+.+|+.++++++||||+++++++.+.     ..+|+|||||+ |+|.+++.
T Consensus        31 ~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~gg~L~~~i~  105 (293)
T d1jksa_          31 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLA  105 (293)
T ss_dssp             ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHH
T ss_pred             ECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCccccchhc
Confidence            568999999999975432    222457789999999999999999999999654     56999999996 69999999


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC----CEEEeeeccccccCCCCccccccccccccCc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      ..+.+++.+++.++.||+.||+|||++||+||||||+||+++.++    .+|++|||++.............+++.|+||
T Consensus       106 ~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~AP  185 (293)
T d1jksa_         106 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP  185 (293)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCH
T ss_pred             cccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCH
Confidence            888999999999999999999999999999999999999998776    4999999999887766666677889999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+ ..++.++||||+||++|+|++|..||.+.+..+....+.......+                           .
T Consensus       186 E~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~  237 (293)
T d1jksa_         186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE---------------------------D  237 (293)
T ss_dssp             HHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---------------------------H
T ss_pred             HHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------c
Confidence            99987 7789999999999999999999999998887777666654322111                           1


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ...+.+|+++.+||++||+.||++|||++|+++||||++.+
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            12246789999999999999999999999999999998754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=368.99  Aligned_cols=235  Identities=26%  Similarity=0.456  Sum_probs=199.2

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.||+.||||+++... ........+.+|+.++++++||||+++++++.+.     ..+|+|||||+ |+|.+++...+
T Consensus        29 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~~~  103 (288)
T d1uu3a_          29 ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIG  103 (288)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHS
T ss_pred             ECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----CEEEEEEEccCCCCHHHhhhccC
Confidence            56899999999997543 2333456789999999999999999999999654     56999999996 69999999889


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~  156 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......   ......||+.|+|||++.
T Consensus       104 ~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~  183 (288)
T d1uu3a_         104 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT  183 (288)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeec
Confidence            99999999999999999999999999999999999999999999999999998765332   234567999999999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      + ..++.++|||||||++|+|++|..||.+.+..+....+.+..-..                               ..
T Consensus       184 ~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~  231 (288)
T d1uu3a_         184 E-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-------------------------------PE  231 (288)
T ss_dssp             T-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-------------------------------CT
T ss_pred             c-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC-------------------------------Cc
Confidence            7 778999999999999999999999999888777666654321100                               02


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDE------ALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~e------ll~~~~f~~~~  273 (316)
                      .+|+++++||++||+.||++|||++|      +++||||++++
T Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            57899999999999999999999988      58899999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.2e-53  Score=373.41  Aligned_cols=239  Identities=26%  Similarity=0.445  Sum_probs=206.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      |+.||+.||||++...  .....+.+.+|+.++++++||||+++++++.+.     +.+|+|||||+ |+|.+.+.. .+
T Consensus        47 ~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~  119 (350)
T d1koaa2          47 ERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHN  119 (350)
T ss_dssp             ETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTCTTS
T ss_pred             ECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhhcC
Confidence            5689999999999654  344567789999999999999999999999654     56999999996 799999854 46


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc--CCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++++.+++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.............||+.|+|||++.+
T Consensus       120 ~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~  199 (350)
T d1koaa2         120 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG  199 (350)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC
Confidence            7999999999999999999999999999999999999964  57899999999988877766667889999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+..+....+.......+.                           ...+.
T Consensus       200 -~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~  251 (350)
T d1koaa2         200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------------------------SAFSG  251 (350)
T ss_dssp             -CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC---------------------------GGGGG
T ss_pred             -CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------------------------ccccC
Confidence             77899999999999999999999999988887777776653322221                           12236


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI  275 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~  275 (316)
                      +|+++++||++||+.||++|||++|+|+||||++....
T Consensus       252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            78999999999999999999999999999999986543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=366.51  Aligned_cols=266  Identities=40%  Similarity=0.717  Sum_probs=217.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc--CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS--HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~--~~   79 (316)
                      |..+|+.||||+++.....+.....+.+|++++++++||||+++++++.+.     ..+|+||||++|++.+.+..  .+
T Consensus        23 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~~iv~e~~~~~~~~~~~~~~~~   97 (298)
T d1gz8a_          23 NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASALT   97 (298)
T ss_dssp             ETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTT
T ss_pred             ECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cceeEEEeecCCchhhhhhhhccc
Confidence            578999999999976654444557788999999999999999999999655     56999999999877666543  46


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+...... .......+++.|+|||++...
T Consensus        98 ~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~  177 (298)
T d1gz8a_          98 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC  177 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccc
Confidence            7999999999999999999999999999999999999999999999999999876543 344556889999999998876


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++||||+||++|+|++|+.||.+.+..+....+....+.+....+.....  ...............+....+.+
T Consensus       178 ~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T d1gz8a_         178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPL  255 (298)
T ss_dssp             SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STTCCTTSCCCCCCCHHHHSTTC
T ss_pred             cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc--ccccccccccccccchhhhccCC
Confidence            6678999999999999999999999999988888888888888776655443211  11222233333444445566788


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD  274 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~  274 (316)
                      |.++.+||++||+.||++|||++|+++||||+++..
T Consensus       256 s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            999999999999999999999999999999998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=367.31  Aligned_cols=235  Identities=26%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.||+.||||++++... .......+.+|+.++++++||||+++++++.+.     ..+|+|||||+ |+|.+++...+
T Consensus        26 ~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~iv~ey~~gg~L~~~~~~~~  100 (337)
T d1o6la_          26 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRER  100 (337)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHS
T ss_pred             ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----cccccceeccCCCchhhhhhccc
Confidence            678999999999976432 333457788999999999999999999999655     56999999996 79999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCC-CCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... .......+||+.|+|||++.+ 
T Consensus       101 ~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-  179 (337)
T d1o6la_         101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-  179 (337)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-
T ss_pred             CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccC-
Confidence            999999999999999999999999999999999999999999999999999987543 344566789999999999988 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|+|++|++||.+.+.......+....-..                               ...+
T Consensus       180 ~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~  228 (337)
T d1o6la_         180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-------------------------------PRTL  228 (337)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTTS
T ss_pred             CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC-------------------------------CccC
Confidence            778999999999999999999999999988777666554421111                               1257


Q ss_pred             ChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      |+++.+||++||+.||.+|++     ++|+++||||++++
T Consensus       229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence            899999999999999999995     89999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.5e-53  Score=371.37  Aligned_cols=237  Identities=24%  Similarity=0.433  Sum_probs=205.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      |+.||+.||||+++..  .......+.+|+.++++++||||++++++|.+.     ..+|+|||||+ |+|.+.+...+ 
T Consensus        50 ~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~~~~~~~  122 (352)
T d1koba_          50 EKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDY  122 (352)
T ss_dssp             ETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTC
T ss_pred             ECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCChHHHHHHhcCC
Confidence            5789999999999754  233456788999999999999999999999654     56999999996 79998876654 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc--cCCCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN--ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      ++++.+++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||++.............+++.|+|||++.+
T Consensus       123 ~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (352)
T d1koba_         123 KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR  202 (352)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC
Confidence            699999999999999999999999999999999999998  568999999999998877766667789999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+.                           ...+.
T Consensus       203 -~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~  254 (352)
T d1koba_         203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE---------------------------DAFSS  254 (352)
T ss_dssp             -CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS---------------------------STTTT
T ss_pred             -CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------------------------ccccC
Confidence             77999999999999999999999999998887777776553322221                           12246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      +|+++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       255 ~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            899999999999999999999999999999998643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=365.04  Aligned_cols=235  Identities=26%  Similarity=0.407  Sum_probs=196.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~   79 (316)
                      |+.||+.||||+++..  .....+.+.+|++++++++||||+++++++.+.     ..+|+|||||+ |+|.+++.. .+
T Consensus        33 ~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lvmEy~~~g~L~~~~~~~~~  105 (288)
T d2jfla1          33 NKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELER  105 (288)
T ss_dssp             ETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTS
T ss_pred             ECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEEEEecCCCCcHHHHHHhcCC
Confidence            5789999999999754  333456788999999999999999999999655     56999999996 699988754 56


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccC-
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN-  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-  157 (316)
                      ++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.. 
T Consensus       106 ~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~  185 (288)
T d2jfla1         106 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE  185 (288)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhc
Confidence            7999999999999999999999999999999999999999999999999998765432 22345678999999999842 


Q ss_pred             ---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          158 ---CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       158 ---~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                         ...++.++|||||||++|+|++|++||.+.+..+....+........                            ..
T Consensus       186 ~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------~~  237 (288)
T d2jfla1         186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL----------------------------AQ  237 (288)
T ss_dssp             STTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC----------------------------SS
T ss_pred             ccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------Cc
Confidence               35678999999999999999999999998887777666554211100                            01


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      ...+|+++.+||++||+.||.+|||++|+++||||+.
T Consensus       238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            1357899999999999999999999999999999974

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=364.81  Aligned_cols=233  Identities=24%  Similarity=0.362  Sum_probs=197.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..||+.||||+++.... .....+.+.+|+.++++++||||+++++++.+.     ..+|+|||||. |+|..++...+
T Consensus        36 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~~~~~~  110 (309)
T d1u5ra_          36 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKK  110 (309)
T ss_dssp             ETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTS
T ss_pred             ECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEEEEEEEecCCCchHHHHHhCC
Confidence            578999999999976543 334457789999999999999999999999654     56999999997 56766777778


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccC--
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  157 (316)
                      ++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   ....||+.|+|||++.+  
T Consensus       111 ~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~  187 (309)
T d1u5ra_         111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMD  187 (309)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccC
Confidence            8999999999999999999999999999999999999999999999999999775443   45679999999999864  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ...++.++|||||||++|+|++|..||.+.+..+.+..+........                             ....
T Consensus       188 ~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------------~~~~  238 (309)
T d1u5ra_         188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-----------------------------QSGH  238 (309)
T ss_dssp             SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----------------------------SCTT
T ss_pred             CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------CCCC
Confidence            24588999999999999999999999988877666655543211110                             1135


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +|+++.+||.+||+.||.+|||++|+|+||||.+
T Consensus       239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            7899999999999999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-52  Score=357.32  Aligned_cols=239  Identities=29%  Similarity=0.486  Sum_probs=203.7

Q ss_pred             CCCCCceEEEEEecccccCh-------hHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHH
Q 021181            2 NSETREEVAIKKIGNAFDNR-------IDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLH   72 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~   72 (316)
                      |..+|+.||||+++......       ...+.+.+|+.++++++ ||||+++++++.++     ..+|+|||||+ |+|.
T Consensus        24 ~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~ivmE~~~~g~L~   98 (277)
T d1phka_          24 HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGELF   98 (277)
T ss_dssp             ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHH
T ss_pred             ECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC-----cceEEEEEcCCCchHH
Confidence            56799999999997653221       12346789999999996 99999999999654     57999999996 6999


Q ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCc
Q 021181           73 QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        73 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      +++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...+.........||..|.||
T Consensus        99 ~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~P  178 (277)
T d1phka_          99 DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP  178 (277)
T ss_dssp             HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCH
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCH
Confidence            99998899999999999999999999999999999999999999999999999999999887766556667899999999


Q ss_pred             ccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCC
Q 021181          153 ELLLN-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP  227 (316)
Q Consensus       153 E~~~~-----~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (316)
                      |.+.+     ...++.++||||+||++|+|++|+.||.+.+.......+....-..+                       
T Consensus       179 E~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------  235 (277)
T d1phka_         179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-----------------------  235 (277)
T ss_dssp             HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----------------------
T ss_pred             HHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------
Confidence            99863     24568899999999999999999999999887776666554221111                       


Q ss_pred             CCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          228 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                          ....+.+|+++++||.+||+.||++|||++|+++||||+++
T Consensus       236 ----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 ----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                11123689999999999999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=361.70  Aligned_cols=270  Identities=34%  Similarity=0.584  Sum_probs=215.2

Q ss_pred             CCCC-CceEEEEEecccccChhHHHHHHHHHHHHhhC---CCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHh--
Q 021181            2 NSET-REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII--   75 (316)
Q Consensus         2 d~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l--   75 (316)
                      |.++ |+.||||+++.....+.....+.+|+.+++.+   +||||++++++|.....+....++++||++++++....  
T Consensus        28 ~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~  107 (305)
T d1blxa_          28 DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK  107 (305)
T ss_dssp             ETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH
T ss_pred             EECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh
Confidence            4444 67799999976544443444566777776655   89999999999865433344679999999986554433  


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccc
Q 021181           76 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        76 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                      .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.............||+.|+|||++
T Consensus       108 ~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~  187 (305)
T d1blxa_         108 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL  187 (305)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchh
Confidence            34467999999999999999999999999999999999999999999999999998877666666778899999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++||||+||++|||++|++||.+.+..+.+..+....+.+....+..........    .............
T Consensus       188 ~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  262 (305)
T d1blxa_         188 LQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA----FHSKSAQPIEKFV  262 (305)
T ss_dssp             TT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG----SCCCCCCCGGGTC
T ss_pred             cC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhh----hccccccchhhcc
Confidence            87 789999999999999999999999999999999999999988887765554322211111    1111222233444


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      ..+++.+.+||++||+.||++|||++|+|+||||+++....
T Consensus       263 ~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         263 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             CSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence            57899999999999999999999999999999999886443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-52  Score=362.23  Aligned_cols=233  Identities=22%  Similarity=0.395  Sum_probs=203.2

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.||+.||||+++.... .....+.+.+|+.++++++||||+++++++.+.     ..+|+|||||. |+|..++....
T Consensus        25 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~l~~~~~~~~   99 (316)
T d1fota_          25 SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQ   99 (316)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTS
T ss_pred             ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----CeeeeEeeecCCccccccccccc
Confidence            578999999999976432 233457788999999999999999999999655     56999999996 69999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....  ....+||+.|+|||++.+ .
T Consensus       100 ~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~-~  176 (316)
T d1fota_         100 RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-K  176 (316)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-C
T ss_pred             cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcC-C
Confidence            9999999999999999999999999999999999999999999999999999886543  345689999999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|+.||.+.+..+....+.......                               .+.+|
T Consensus       177 ~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s  225 (316)
T d1fota_         177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-------------------------------PPFFN  225 (316)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC-------------------------------CTTSC
T ss_pred             CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-------------------------------CCCCC
Confidence            78999999999999999999999999988777776665421111                               12578


Q ss_pred             hHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +++.++|.+||+.||.+|+     |++++++||||+++.
T Consensus       226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            9999999999999999996     899999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=372.96  Aligned_cols=261  Identities=22%  Similarity=0.339  Sum_probs=195.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |+.||+.||+|+++... .......+.+|+.++++++||||++++++|.+.     .++|+||||+. |+|.+++.+.+.
T Consensus        27 ~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~iVmEy~~gg~L~~~l~~~~~  100 (322)
T d1s9ja_          27 HKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGR  100 (322)
T ss_dssp             ETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHHHSS
T ss_pred             ECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHhhcCC
Confidence            56899999999997653 344557789999999999999999999999655     56999999997 699999998889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++...... .....+||+.|+|||++.+ .
T Consensus       101 l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~-~  178 (322)
T d1s9ja_         101 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-T  178 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC-S
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcC-C
Confidence            9999999999999999999997 59999999999999999999999999998765432 2345689999999999988 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHhhCCCCccccc--------------cccccchHHHhhhCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLR-LITELIGSPDETSLG--------------FLRSDNARRYVRMLP  224 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~  224 (316)
                      .++.++||||+||++|||++|+.||.+.+...... ......+........              ...............
T Consensus       179 ~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (322)
T d1s9ja_         179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV  258 (322)
T ss_dssp             CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhh
Confidence            89999999999999999999999998876433221 112212211111000              000000011111111


Q ss_pred             CCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          225 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       225 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ......  .....+|.++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       259 ~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         259 NEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             TSCCCC--CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccCCcc--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence            110000  0112468899999999999999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=363.39  Aligned_cols=303  Identities=44%  Similarity=0.775  Sum_probs=227.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC-CCCCeEEEEEecCCCcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~   80 (316)
                      |+.||+.||||+++....+......+.+|+.++++++||||++++++|...+. +...++|+|||||.|++.+.+.  ..
T Consensus        38 d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~  115 (355)
T d2b1pa1          38 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--ME  115 (355)
T ss_dssp             ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SC
T ss_pred             ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh--cC
Confidence            67899999999998776666677889999999999999999999999975432 3457899999999988877764  47


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+.............+|+.|+|||++.+ ..
T Consensus       116 ~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~  194 (355)
T d2b1pa1         116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MG  194 (355)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTT-CC
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcC-CC
Confidence            89999999999999999999999999999999999999999999999999888777666677789999999999987 78


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc------
Q 021181          161 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR------  234 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  234 (316)
                      ++.++||||+||++|+|++|++||.+.+.......+....+.+....+..... ....+...............      
T Consensus       195 ~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (355)
T d2b1pa1         195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLF  273 (355)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH-HHHHHHHTSCCCCCCCHHHHSCGGGS
T ss_pred             CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh-hHHHHhhcCccccccccccccccccc
Confidence            99999999999999999999999999998888888887777665544433221 11222222222222111111      


Q ss_pred             ------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC-CCCCCCCCcccCCCCCCCHHHHHHHHHHHH
Q 021181          235 ------FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSFTEENIKELIYRES  307 (316)
Q Consensus       235 ------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (316)
                            ....|+++.+||++||+.||++|||++|+|+||||+....... ...++..++.+++.-+.+.++++++|.++.
T Consensus       274 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (355)
T d2b1pa1         274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV  353 (355)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHHHH
T ss_pred             cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHh
Confidence                  1124678999999999999999999999999999998653222 233445556677777888899999999886


Q ss_pred             H
Q 021181          308 V  308 (316)
Q Consensus       308 ~  308 (316)
                      +
T Consensus       354 ~  354 (355)
T d2b1pa1         354 M  354 (355)
T ss_dssp             H
T ss_pred             c
Confidence            4

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-51  Score=364.07  Aligned_cols=233  Identities=23%  Similarity=0.391  Sum_probs=202.6

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.||+.||||+++... ........+.+|+.+++.++||||+++++++...     ..+++||||+. |+|...+...+
T Consensus        62 ~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~l~~~~  136 (350)
T d1rdqe_          62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIG  136 (350)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHC
T ss_pred             ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cccccccccccccchhhhHhhcC
Confidence            67899999999997543 2233456788999999999999999999999655     56999999996 79999998888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      .+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  .....||+.|+|||++.+ .
T Consensus       137 ~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~-~  213 (350)
T d1rdqe_         137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-K  213 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcC-C
Confidence            9999999999999999999999999999999999999999999999999999877543  345689999999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      .++.++|||||||++|+|++|.+||.+.+.......+.......                               ...+|
T Consensus       214 ~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s  262 (350)
T d1rdqe_         214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-------------------------------PSHFS  262 (350)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------------CTTCC
T ss_pred             CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC-------------------------------CccCC
Confidence            78999999999999999999999999888777766665422111                               12578


Q ss_pred             hHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 021181          240 PGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH  273 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~  273 (316)
                      +++.++|++||+.||.+|+     |+++|++||||++++
T Consensus       263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence            9999999999999999995     999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4e-51  Score=362.73  Aligned_cols=238  Identities=25%  Similarity=0.365  Sum_probs=195.2

Q ss_pred             CCCCCceEEEEEeccccc-C---hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhh
Q 021181            2 NSETREEVAIKKIGNAFD-N---RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~   76 (316)
                      ++.||+.||||++..... .   .........|+.+++.++||||+++++++...     ..+|+|||||+ |+|.+++.
T Consensus        25 ~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-----~~~~ivmE~~~gg~L~~~l~   99 (364)
T d1omwa3          25 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLS   99 (364)
T ss_dssp             ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHH
T ss_pred             ECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-----CEEEEEEEecCCCcHHHHHH
Confidence            578999999999965321 1   11222334457778888999999999999655     56999999996 79999999


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCccccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  156 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (316)
                      ....+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .....||+.|+|||++.
T Consensus       100 ~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~  178 (364)
T d1omwa3         100 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ  178 (364)
T ss_dssp             HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHS
T ss_pred             hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhh
Confidence            88999999999999999999999999999999999999999999999999999998765443 34568999999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                      ....++.++|||||||++|+|++|+.||.+.+................                            ....
T Consensus       179 ~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------~~~~  230 (364)
T d1omwa3         179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----------------------------ELPD  230 (364)
T ss_dssp             TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC----------------------------CCCS
T ss_pred             cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----------------------------CCCC
Confidence            656789999999999999999999999987654443332222111111                            1113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      .+|+++.+||.+||+.||.+|||     ++|+++||||++++
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            57999999999999999999999     79999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.7e-51  Score=351.02  Aligned_cols=261  Identities=37%  Similarity=0.639  Sum_probs=212.3

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcH-HHHhhcCCCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDL-HQIIRSHQDLT   82 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L-~~~l~~~~~~~   82 (316)
                      .+|+.||||+++....++.....+.+|+.++++++||||+++++++...     +..+++|+++.+++ ..+....+.++
T Consensus        24 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~i~~e~~~~~~~~~~~~~~~~l~   98 (286)
T d1ob3a_          24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLE   98 (286)
T ss_dssp             TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCC
T ss_pred             CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----CceeEEEEeehhhhHHHHHhhcCCcc
Confidence            4789999999977655555567889999999999999999999999755     55999999998655 55556678899


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-cccccccccccCcccccCCCCC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      +.+++.++.||+.||+|||+.||+||||||+|||++.++.+|++|||.+........ .....+++.|.|||.+.+...+
T Consensus        99 ~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~  178 (286)
T d1ob3a_          99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY  178 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSC
T ss_pred             hhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCC
Confidence            999999999999999999999999999999999999999999999999987654332 3445688999999999876778


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          162 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      +.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+.....  ....................+..++.
T Consensus       179 ~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~  256 (286)
T d1ob3a_         179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE--LPKYDPNFTVYEPLPWESFLKGLDES  256 (286)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STTCCTTCCCCCCCCGGGTCCSCCHH
T ss_pred             CcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh--hhhcccccccccCcchhhhcccCCHH
Confidence            9999999999999999999999999998888899888888877665533211  11111122222233344556678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +.+||++||+.||++|||++|+++||||++
T Consensus       257 ~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         257 GIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            999999999999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=357.67  Aligned_cols=266  Identities=32%  Similarity=0.594  Sum_probs=212.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC-CCCCCeEEEEEecCCCcHHHHh----h
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQII----R   76 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l----~   76 (316)
                      |+.+|+.||||++......      ..+|+.++++++||||++++++|.... ..+..++|+|||||++++...+    .
T Consensus        41 ~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~  114 (350)
T d1q5ka_          41 LCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR  114 (350)
T ss_dssp             ETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHH
T ss_pred             ECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhh
Confidence            5789999999999764321      237999999999999999999986442 1334578999999987655444    3


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCCccccccccccccCcccc
Q 021181           77 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  155 (316)
Q Consensus        77 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (316)
                      ....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.............++..|+|||.+
T Consensus       115 ~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  194 (350)
T d1q5ka_         115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI  194 (350)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHh
Confidence            456799999999999999999999999999999999999999875 8999999999887766666777899999999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc-cc
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS-AR  234 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  234 (316)
                      .+...++.++||||+||++|||++|.+||...+..+.+..+.+..|.+....+.........   ..........+. ..
T Consensus       195 ~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  271 (350)
T d1q5ka_         195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVF  271 (350)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C---CCCCCCCCCCGGGTS
T ss_pred             hcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh---ccccccccCchhhhc
Confidence            77678999999999999999999999999999989999999888888765544322111000   001111111111 22


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN  276 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~  276 (316)
                      .+..++++.+||.+||+.||.+|||++|+|+||||+++....
T Consensus       272 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence            346899999999999999999999999999999999886543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=357.42  Aligned_cols=234  Identities=24%  Similarity=0.401  Sum_probs=201.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-   79 (316)
                      |+.||+.||||+++...   .....+.+|+.+++.++||||+++++++.+.     ..+|+|||||+ |+|.+.+...+ 
T Consensus        26 ~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~lvmE~~~gg~L~~~i~~~~~   97 (321)
T d1tkia_          26 ETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAF   97 (321)
T ss_dssp             ETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSC
T ss_pred             ECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCC
Confidence            67899999999997642   2345678999999999999999999999654     56999999996 69999998765 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC--CCEEEeeeccccccCCCCccccccccccccCcccccC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (316)
                      .+++.+++.++.||+.||.|||++||+||||||+|||++.+  +.++|+|||++.............+++.|+|||.+.+
T Consensus        98 ~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~  177 (321)
T d1tkia_          98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH  177 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccC
Confidence            79999999999999999999999999999999999999854  5799999999988766665666788999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|..||.+.+..+....+.......+.                           ...+.
T Consensus       178 -~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~  229 (321)
T d1tkia_         178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE---------------------------EAFKE  229 (321)
T ss_dssp             -CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH---------------------------HHHTT
T ss_pred             -CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh---------------------------hhccC
Confidence             67899999999999999999999999998877777776653222221                           12246


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP  271 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~  271 (316)
                      +|+++++||++||..||.+|||++|+++||||++
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            7999999999999999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=355.06  Aligned_cols=235  Identities=26%  Similarity=0.413  Sum_probs=199.8

Q ss_pred             CCCCCceEEEEEecccc-cChhHHHHHHHHHHHHh-hCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC
Q 021181            2 NSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLR-HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~   78 (316)
                      |+.||+.||||++++.. ........+..|..++. .++||||+++++++.+.     ..+|+|||||+ |+|.+++...
T Consensus        23 ~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~~~yivmEy~~~g~L~~~i~~~   97 (320)
T d1xjda_          23 FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSC   97 (320)
T ss_dssp             ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHH
T ss_pred             ECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----CceeEEEeecCCCcHHHHhhcc
Confidence            57899999999997542 22334456667777665 68999999999999665     56999999996 6999999998


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC-CccccccccccccCcccccC
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  157 (316)
                      +++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.++..... .......||+.|+|||++.+
T Consensus        98 ~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  177 (320)
T d1xjda_          98 HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG  177 (320)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC
Confidence            99999999999999999999999999999999999999999999999999999865433 33445688999999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                       ..++.++|||||||++|+|++|+.||.+.+.......+...  .+.                             ....
T Consensus       178 -~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~-----------------------------~p~~  225 (320)
T d1xjda_         178 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPF-----------------------------YPRW  225 (320)
T ss_dssp             -CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC-----------------------------CCTT
T ss_pred             -CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC-----------------------------CCcc
Confidence             77999999999999999999999999988877776666431  110                             0125


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH  273 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~  273 (316)
                      +|+++.+||++||+.||.+|||+. ++++||||++++
T Consensus       226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence            789999999999999999999996 899999999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-50  Score=349.54  Aligned_cols=270  Identities=34%  Similarity=0.566  Sum_probs=207.6

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCC---CCCCeEEEEEecCCCcHH-HHhhc
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVYIVYELMDTDLH-QIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~-~~l~~   77 (316)
                      |+.+|+.||||++..+...+.....+.+|+.+++.++||||+++++++.....   ....++|++||++++.+. .....
T Consensus        31 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~  110 (318)
T d3blha1          31 HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV  110 (318)
T ss_dssp             ETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT
T ss_pred             ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc
Confidence            57899999999997765555566778999999999999999999999865321   123568999999986554 44455


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----ccccccccccccCc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAP  152 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aP  152 (316)
                      ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.......     .....++|+.|+||
T Consensus       111 ~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aP  190 (318)
T d3blha1         111 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP  190 (318)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCH
T ss_pred             ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhH
Confidence            6789999999999999999999999999999999999999999999999999997654322     23345789999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+...++.++||||+||++|+|++|++||.+.+.......+....+.+........................ ....
T Consensus       191 E~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  269 (318)
T d3blha1         191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK-RKVK  269 (318)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCC-BCHH
T ss_pred             HHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccccc-ccch
Confidence            999876688999999999999999999999999999889999999988887776554443332222111111110 0011


Q ss_pred             ccC--CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          233 ARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       233 ~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ..+  ...++++.+||.+||++||++|||++|+|+||||+..
T Consensus       270 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            110  1247788999999999999999999999999999863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=344.13  Aligned_cols=231  Identities=20%  Similarity=0.302  Sum_probs=190.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      +..+++.||||+++....+....+.+.+|+.++++++||||+++++++..+      ..++|||||+ |+|.+++.....
T Consensus        30 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvmE~~~~g~L~~~l~~~~~  103 (277)
T d1xbba_          30 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVMEMAELGPLNKYLQQNRH  103 (277)
T ss_dssp             CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHHHCTT
T ss_pred             cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEEEcCCCCcHHHHHhhccC
Confidence            356788999999987655666678899999999999999999999998532      3789999996 699999999899


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~  156 (316)
                      +++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......    .....+|+.|+|||.+.
T Consensus       104 l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~  183 (277)
T d1xbba_         104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  183 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhc
Confidence            99999999999999999999999999999999999999999999999999987544322    22356788999999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|||++ |++||.+.+..+....+.+....                              ...
T Consensus       184 ~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------------------------~~p  232 (277)
T d1xbba_         184 Y-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------------------GCP  232 (277)
T ss_dssp             H-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------------------CCC
T ss_pred             C-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCC
Confidence            7 678999999999999999997 89999988876666555432111                              111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHh---cCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEAL---CHPYL  269 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell---~~~~f  269 (316)
                      ..+|+++.+||.+||+.||++|||+++|+   +++|+
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            35789999999999999999999999984   56554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=355.75  Aligned_cols=239  Identities=27%  Similarity=0.427  Sum_probs=190.5

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhh-CCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH-MDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      |+.||+.||||+++..       ..+.+|+.++.+ .+||||++++++|.+.. .....+|+|||||+ |+|.+++... 
T Consensus        33 ~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ivmEy~~gg~L~~~i~~~~  104 (335)
T d2ozaa1          33 NKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRG  104 (335)
T ss_dssp             ETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHSCS
T ss_pred             ECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEEEECCCCCcHHHHHHhcC
Confidence            6789999999999542       346789988655 58999999999986421 12256999999996 6999999874 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc---CCCEEEeeeccccccCCCCccccccccccccCccc
Q 021181           79 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL  154 (316)
Q Consensus        79 -~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (316)
                       .++++.+++.++.||+.||+|||++||+||||||+||+++.   .+.+||+|||+++............||+.|+|||+
T Consensus       105 ~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~  184 (335)
T d2ozaa1         105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV  184 (335)
T ss_dssp             CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCC
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHH
Confidence             46999999999999999999999999999999999999985   46799999999988777666677889999999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          155 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      +.+ ..++.++|||||||++|+|++|++||.+.+.......+........                       ..-....
T Consensus       185 ~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~-----------------------~~~~~~~  240 (335)
T d2ozaa1         185 LGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----------------------YEFPNPE  240 (335)
T ss_dssp             CCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS-----------------------SSCCTTH
T ss_pred             HcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC-----------------------CCCCCcc
Confidence            987 6799999999999999999999999987764444333222111000                       0000111


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL  272 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~  272 (316)
                      ...+|+++.+||++||+.||++|||++|+++||||++.
T Consensus       241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            23578999999999999999999999999999999754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=337.88  Aligned_cols=265  Identities=36%  Similarity=0.605  Sum_probs=214.8

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~   80 (316)
                      |..+|+.||||+++.....+.....+.+|+.+++.++||||+++++++...     ...+++++++. +++..++...+.
T Consensus        23 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~iv~~~~~~~~l~~~~~~~~~   97 (292)
T d1unla_          23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGD   97 (292)
T ss_dssp             ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHTTTC
T ss_pred             ECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cceeEEeeeccccccccccccccc
Confidence            678999999999987666666778899999999999999999999999665     56899999997 477888888889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-ccccccccccccCcccccCCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      +++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....... ......++..|.|||.+....
T Consensus        98 ~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  177 (292)
T d1unla_          98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred             cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCC
Confidence            9999999999999999999999999999999999999999999999999998765543 334456788899999988756


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|+|++|..|| .+.+..+....+....+.+....+........  .................+.+
T Consensus       178 ~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  255 (292)
T d1unla_         178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--YKPYPMYPATTSLVNVVPKL  255 (292)
T ss_dssp             CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--CCCCCCCCTTCCCTTTSTTC
T ss_pred             CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc--ccccccccccchhhhccccC
Confidence            6899999999999999999998875 55566777778888777766554432211100  00000011112233445578


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus       256 s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            99999999999999999999999999999998764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=336.78  Aligned_cols=230  Identities=22%  Similarity=0.303  Sum_probs=186.9

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCH
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTD   83 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~   83 (316)
                      +..||||+++....+....+.+.+|+.++++++||||+++++++..+      .+++|||||+ |+|.+++... .++++
T Consensus        30 ~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~~~lv~Ey~~~g~L~~~l~~~~~~~~~  103 (276)
T d1uwha_          30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAIVTQWCEGSSLYHHLHIIETKFEM  103 (276)
T ss_dssp             SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEEEEECCCEEEHHHHHHTSCCCCCH
T ss_pred             CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc------EEEEEEecCCCCCHHHHHhhccCCCCH
Confidence            44699999987766666778899999999999999999999987533      3799999997 7999998654 56999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccccccccccccCcccccCC--
Q 021181           84 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNC--  158 (316)
Q Consensus        84 ~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~--  158 (316)
                      .++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   ......+|+.|+|||++.+.  
T Consensus       104 ~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~  183 (276)
T d1uwha_         104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK  183 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccC
Confidence            9999999999999999999999999999999999999999999999997754332   23456789999999998642  


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      ..++.++|||||||++|||++|+.||.+.+....+..........+                         ........+
T Consensus       184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p-------------------------~~~~~~~~~  238 (276)
T d1uwha_         184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP-------------------------DLSKVRSNC  238 (276)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-------------------------CGGGSCTTC
T ss_pred             CCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-------------------------cchhccccc
Confidence            3578899999999999999999999998776655544433221111                         111223467


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++++.++|.+||+.||.+|||++||+++
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=340.90  Aligned_cols=229  Identities=25%  Similarity=0.392  Sum_probs=188.9

Q ss_pred             CCCCCceEEEEEecccccCh----hHHHHHHHHHHHHhhCC--CCCccceeeeecCCCCCCCCeEEEEEecCC--CcHHH
Q 021181            2 NSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQ   73 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~   73 (316)
                      |..||+.||||+++......    .....+.+|+.++++++  ||||+++++++...     ..+++|||++.  +++.+
T Consensus        25 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-----~~~~lv~e~~~~~~~l~~   99 (273)
T d1xwsa_          25 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFD   99 (273)
T ss_dssp             ETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHH
T ss_pred             ECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-----CeEEEEEEeccCcchHHH
Confidence            56899999999997643221    12234668999999996  89999999999654     56999999995  47888


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccC-CCEEEeeeccccccCCCCccccccccccccCc
Q 021181           74 IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP  152 (316)
Q Consensus        74 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP  152 (316)
                      ++.....+++.+++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...... ......||+.|+||
T Consensus       100 ~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aP  178 (273)
T d1xwsa_         100 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPP  178 (273)
T ss_dssp             HHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCH
T ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCH
Confidence            98888899999999999999999999999999999999999999854 78999999999765443 34456899999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcc
Q 021181          153 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS  232 (316)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
                      |++.+...++.++|||||||++|+|++|+.||.+.+      .+...  .                     .        
T Consensus       179 E~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~---------------------~--------  221 (273)
T d1xwsa_         179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q---------------------V--------  221 (273)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C---------------------C--------
T ss_pred             HHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--c---------------------c--------
Confidence            999874556788999999999999999999996532      11110  0                     0        


Q ss_pred             ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          233 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       233 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      .....+|+++.+||++||+.||++|||++|+++||||+++.
T Consensus       222 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         222 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            01135799999999999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=336.27  Aligned_cols=230  Identities=21%  Similarity=0.343  Sum_probs=191.3

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCC
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQD   80 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~   80 (316)
                      ..++..||||+++.. ......+.+.+|+.++++++||||+++++++..+      .+|+|||||+ |+|.+++.. ...
T Consensus        33 ~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~lvmE~~~~g~L~~~l~~~~~~  105 (285)
T d1u59a_          33 RKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKREE  105 (285)
T ss_dssp             --CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHTTCTTT
T ss_pred             CCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------eEEEEEEeCCCCcHHHHhhccccC
Confidence            345668999999754 3455667899999999999999999999998542      3799999997 699998765 467


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~  156 (316)
                      +++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......    .....+|..|+|||++.
T Consensus       106 l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (285)
T d1u59a_         106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  185 (285)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHh
Confidence            99999999999999999999999999999999999999999999999999987654432    22446788999999997


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|||++ |+.||.+.+..+....+......                              ...
T Consensus       186 ~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~------------------------------~~p  234 (285)
T d1u59a_         186 F-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------------------------------ECP  234 (285)
T ss_dssp             H-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC------------------------------CCC
T ss_pred             C-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCC
Confidence            7 678999999999999999998 99999988877766655432111                              111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEA---LCHPYLA  270 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~el---l~~~~f~  270 (316)
                      +.+|+++.+||.+||+.||++|||+.+|   |+++|+.
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            3678999999999999999999999887   6778763

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-48  Score=340.98  Aligned_cols=261  Identities=31%  Similarity=0.572  Sum_probs=199.4

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |+.+|+.||||+++..     ....+.+|+.+++.+. ||||+++++++....   ...+++|||||+ ++|....   +
T Consensus        56 ~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~~v~e~~~~~~L~~~~---~  124 (328)
T d3bqca1          56 NITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPALVFEHVNNTDFKQLY---Q  124 (328)
T ss_dssp             ETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEEEEEECCCSCBGGGTT---T
T ss_pred             ECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCceeEEEeecCCCcHHHHh---c
Confidence            6789999999999643     2456789999999995 999999999986532   256999999997 5776543   5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCC-CEEEeeeccccccCCCCccccccccccccCcccccCC
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (316)
                      .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.............+|..|+|||.+.+.
T Consensus       125 ~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~  204 (328)
T d3bqca1         125 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY  204 (328)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCC
Confidence            799999999999999999999999999999999999998765 5899999999887766666677889999999998876


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCccccc-cccccchHHHhhhCCCCCCCCc-----
Q 021181          159 SEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLG-FLRSDNARRYVRMLPQFPKQNF-----  231 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----  231 (316)
                      ..++.++||||+||++|+|++|..||.... .......+....+.+...... .........+...........+     
T Consensus       205 ~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (328)
T d3bqca1         205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH  284 (328)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCC
T ss_pred             CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccc
Confidence            778999999999999999999999997764 344444555555432211110 0000000111111111111111     


Q ss_pred             cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 021181          232 SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH  273 (316)
Q Consensus       232 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~  273 (316)
                      ......+|+++.+||++||+.||.+|||++|+|+||||+++.
T Consensus       285 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             TTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             ccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            112235789999999999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.5e-48  Score=330.63  Aligned_cols=237  Identities=25%  Similarity=0.360  Sum_probs=188.4

Q ss_pred             CCCCCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      |..+|+.||||+++.... +......+.+|+.+++.++||||+++++++.... .....+|+|||||+ |+|.+.+...+
T Consensus        28 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~~~lvmE~~~g~~L~~~~~~~~  106 (277)
T d1o6ya_          28 DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVHTEG  106 (277)
T ss_dssp             ETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCCEEEHHHHHHHHC
T ss_pred             ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCceEEEEEECCCCCEehhhhcccC
Confidence            578999999999987544 3444577899999999999999999999987543 22245899999997 69999998889


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----ccccccccccccCcccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~  155 (316)
                      .+++.+++.++.||+.||+|||++||+||||||+||+++.++..+++|||.+.......    ......||+.|+|||++
T Consensus       107 ~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~  186 (277)
T d1o6ya_         107 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA  186 (277)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHH
Confidence            99999999999999999999999999999999999999999999999999876543322    23456789999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          156 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      .+ ..++.++|||||||++|+|++|.+||.+.+..+....+......++                           ....
T Consensus       187 ~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~  238 (277)
T d1o6ya_         187 RG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------------------------SARH  238 (277)
T ss_dssp             TT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---------------------------GGTS
T ss_pred             cC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---------------------------chhc
Confidence            77 6789999999999999999999999998877666555443211111                           1223


Q ss_pred             CCCChHHHHHHHHhcccCCCCCC-CHHHHhcCCC
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRI-TVDEALCHPY  268 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rp-s~~ell~~~~  268 (316)
                      +.+|+++.++|.+||+.||.+|| |+++++ |+|
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l  271 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMR-ADL  271 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHH
Confidence            46899999999999999999999 555554 444

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-47  Score=332.03  Aligned_cols=223  Identities=24%  Similarity=0.357  Sum_probs=177.5

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~   84 (316)
                      ..||||++.... .....+.+.+|+.++++++|||||++++++...     ..+++|||||+ |+|.+++... +.+++.
T Consensus        55 ~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~  128 (299)
T d1jpaa_          55 IFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVI  128 (299)
T ss_dssp             EEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHTTTTCSCHH
T ss_pred             EEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----CEEEEEEEecCCCcceeeeccccCCCCHH
Confidence            468999886543 444567799999999999999999999999655     45899999996 6999988764 569999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCcc------ccccccccccCcccccCC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~  158 (316)
                      ++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........      ....+|+.|+|||.+.+ 
T Consensus       129 ~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-  207 (299)
T d1jpaa_         129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-  207 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS-
T ss_pred             HHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-
Confidence            99999999999999999999999999999999999999999999999876543221      12456889999999987 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||||||++|||++ |.+||.+.+..+....+......+.                              ...
T Consensus       208 ~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------~~~  257 (299)
T d1jpaa_         208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP------------------------------PMD  257 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC------------------------------CTT
T ss_pred             CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------Ccc
Confidence            779999999999999999998 8999998887776666544221111                              125


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++.++.++|.+||+.||++|||++||++.
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            78899999999999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=326.68  Aligned_cols=224  Identities=19%  Similarity=0.333  Sum_probs=177.9

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~   81 (316)
                      .+++.||||+++....   ..+.+.+|+.++++++||||+++++++...     ..+++||||+. |+|.+++... ..+
T Consensus        27 ~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~   98 (263)
T d1sm2a_          27 LNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLF   98 (263)
T ss_dssp             TTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC
T ss_pred             CCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEEEEecCCCcHHHHhhccccCC
Confidence            3577899999975432   345689999999999999999999999755     45899999996 7999988654 568


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.......  .....+|..|+|||++.+ .
T Consensus        99 ~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~  177 (263)
T d1sm2a_          99 AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S  177 (263)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT-C
T ss_pred             CHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC-C
Confidence            9999999999999999999999999999999999999999999999999977654332  234567899999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|||++ |.+||...+..+....+........                              ...+
T Consensus       178 ~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------------------------------p~~~  227 (263)
T d1sm2a_         178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------------------------PRLA  227 (263)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC------------------------------CTTS
T ss_pred             CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC------------------------------cccc
Confidence            79999999999999999998 6777777776666665544221111                              1246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++++.++|.+||+.||++|||++||+++
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            8899999999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-47  Score=329.78  Aligned_cols=225  Identities=23%  Similarity=0.378  Sum_probs=184.3

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ++.+|+.||||+++.+..   ..+.+.+|+.++++++||||+++++++...     ..+++|||||+ |+|.+++...  
T Consensus        38 ~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~l~~~~~  109 (287)
T d1opja_          38 WKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNR  109 (287)
T ss_dssp             EGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCT
T ss_pred             ECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEEEeecccCcchHHHhhhccc
Confidence            467899999999975432   356789999999999999999999999655     45899999996 7999998654  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCccccc
Q 021181           79 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLL  156 (316)
Q Consensus        79 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (316)
                      ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  .....++..|+|||++.
T Consensus       110 ~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~  189 (287)
T d1opja_         110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  189 (287)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHc
Confidence            5689999999999999999999999999999999999999999999999999987654432  23345788999999998


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccC
Q 021181          157 NCSEYTAAIDIWSVGCILGEIMTRQPL-FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF  235 (316)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
                      + ..++.++|||||||++|||++|..| |.+.+.......+.....                              ....
T Consensus       190 ~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~------------------------------~~~~  238 (287)
T d1opja_         190 Y-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------------------------MERP  238 (287)
T ss_dssp             H-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------------------------------CCCC
T ss_pred             C-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC------------------------------CCCC
Confidence            7 7799999999999999999996555 444444443333322110                              0111


Q ss_pred             CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          236 PNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       236 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+++++.+||.+||+.||++|||++||++
T Consensus       239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            357899999999999999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=329.96  Aligned_cols=227  Identities=23%  Similarity=0.396  Sum_probs=186.6

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--CC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QD   80 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~   80 (316)
                      ++++.||||+++...   ...+.+.+|+.++++++||||+++++++..+      .+++||||++ |+|.+.+...  .+
T Consensus        35 ~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~iv~Ey~~~g~L~~~~~~~~~~~  105 (272)
T d1qpca_          35 NGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFLKTPSGIK  105 (272)
T ss_dssp             TTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHTTSHHHHT
T ss_pred             CCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeEEEEEeCCCCcHHHHHhhcCCCC
Confidence            367889999997543   2345689999999999999999999987543      3689999996 7999877543  35


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCC
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNC  158 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  158 (316)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  .....++..|+|||++.+ 
T Consensus       106 l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-  184 (272)
T d1qpca_         106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-  184 (272)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC-
Confidence            99999999999999999999999999999999999999999999999999987654432  334567889999999987 


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCC
Q 021181          159 SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN  237 (316)
Q Consensus       159 ~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
                      ..++.++|||||||++|||++ |.+||...+..+....+.......                              ....
T Consensus       185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~------------------------------~p~~  234 (272)
T d1qpca_         185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV------------------------------RPDN  234 (272)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------------------CCTT
T ss_pred             CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------------------------------Cccc
Confidence            678999999999999999999 566666666655555544321111                              1125


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 021181          238 KSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLA  270 (316)
Q Consensus       238 ~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~  270 (316)
                      +++++.+||.+||+.||++|||+++|++  ++||+
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            7889999999999999999999999998  77775

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=322.59  Aligned_cols=224  Identities=20%  Similarity=0.319  Sum_probs=189.7

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~   81 (316)
                      ++++.||||+++....   ..+.+.+|+.++++++||||+++++++...     +.+++||||++ |+|.+++.. ...+
T Consensus        26 ~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv~Ey~~~g~l~~~~~~~~~~~   97 (258)
T d1k2pa_          26 RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRF   97 (258)
T ss_dssp             TTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEEEECCTTEEHHHHHHSGGGCC
T ss_pred             CCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEEEEccCCCcHHHhhhccccCC
Confidence            4678999999976433   345789999999999999999999999654     45999999996 788888654 4668


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++..+.+++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........  .....+|..|+|||.+.. .
T Consensus        98 ~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~  176 (258)
T d1k2pa_          98 QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S  176 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-C
T ss_pred             cHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-C
Confidence            9999999999999999999999999999999999999999999999999977554432  234568899999999987 6


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|||++ |+.||.+.+..+....+......+.+                              ..+
T Consensus       177 ~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p------------------------------~~~  226 (258)
T d1k2pa_         177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP------------------------------HLA  226 (258)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC------------------------------TTC
T ss_pred             CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc------------------------------ccc
Confidence            78999999999999999998 89999999877777666542221110                              246


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++++.+||++||+.||++|||++++++|
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            7889999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=334.44  Aligned_cols=225  Identities=24%  Similarity=0.366  Sum_probs=183.5

Q ss_pred             CceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC----
Q 021181            6 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----   79 (316)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----   79 (316)
                      +..||+|++.... .......+.+|+.+++++ +|||||++++++...     ..+|+|||||+ |+|.++++...    
T Consensus        67 ~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~  140 (325)
T d1rjba_          67 SIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFS  140 (325)
T ss_dssp             EEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC-
T ss_pred             eeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCc
Confidence            3479999986543 333456788999999998 899999999999655     45899999996 79999997642    


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-
Q 021181           80 -------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-  139 (316)
Q Consensus        80 -------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  139 (316)
                                         .+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  220 (325)
T d1rjba_         141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY  220 (325)
T ss_dssp             --------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS
T ss_pred             chhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCce
Confidence                               489999999999999999999999999999999999999999999999999977544332 


Q ss_pred             --cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccch
Q 021181          140 --MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA  216 (316)
Q Consensus       140 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  216 (316)
                        .....+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+....+..+......++            
T Consensus       221 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~------------  287 (325)
T d1rjba_         221 VVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD------------  287 (325)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC------------
T ss_pred             eeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC------------
Confidence              234567999999999987 779999999999999999997 8999988776655554433211110            


Q ss_pred             HHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          217 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                       ....+|+++.+||.+||+.||++|||++||++|
T Consensus       288 -----------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         288 -----------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                             113578999999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=321.03  Aligned_cols=229  Identities=24%  Similarity=0.379  Sum_probs=182.5

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc--CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS--HQDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~~   81 (316)
                      +++.||||+++....   ..+.+.+|+.++++++|||||++++++...      .+++||||+. |+|...+..  .+.+
T Consensus        40 ~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~lv~Ey~~~g~l~~~~~~~~~~~l  110 (285)
T d1fmka3          40 GTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVTEYMSKGSLLDFLKGETGKYL  110 (285)
T ss_dssp             TTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEECCCTTCBHHHHHSHHHHTTC
T ss_pred             CCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEecC------CeEEEEEecCCCchhhhhhhcccccc
Confidence            345799999975433   346789999999999999999999998543      3689999996 788877754  3569


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  ......+++.|+|||.+.. .
T Consensus       111 ~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  189 (285)
T d1fmka3         111 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G  189 (285)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC-C
Confidence            999999999999999999999999999999999999999999999999997764332  2334668999999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|||++| .+|+......+....+.+....                              ...+.+
T Consensus       190 ~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~------------------------------~~~~~~  239 (285)
T d1fmka3         190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------------------------PCPPEC  239 (285)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------------------CCCTTS
T ss_pred             CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------------------------CCCccc
Confidence            789999999999999999995 5556666655555555432111                              112367


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCCC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAPLH  273 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~~~  273 (316)
                      ++++.++|.+||+.||++|||+++|++  ++||++..
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            899999999999999999999999998  89998754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=333.31  Aligned_cols=240  Identities=20%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             CCCCCceEEEEEeccccc--ChhHHHHHHHHHHHHhhCCC-CCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc
Q 021181            2 NSETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS   77 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~   77 (316)
                      ++.+|+.||||+++....  +....+.+.+|+.++++++| |||+++++++.+.     ..++++|||+. |+|.+.+..
T Consensus        48 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~  122 (322)
T d1vzoa_          48 GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQ  122 (322)
T ss_dssp             STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHH
T ss_pred             cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-----CceeeeeecccccHHHHHHHh
Confidence            467899999999976432  22234567899999999966 8999999999655     56999999996 799999999


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC--ccccccccccccCcccc
Q 021181           78 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELL  155 (316)
Q Consensus        78 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~  155 (316)
                      .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++......  ......+++.|+|||.+
T Consensus       123 ~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~  202 (322)
T d1vzoa_         123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV  202 (322)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred             cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHh
Confidence            8999999999999999999999999999999999999999999999999999997654332  23456789999999998


Q ss_pred             cCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCcccc
Q 021181          156 LNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR  234 (316)
Q Consensus       156 ~~~~-~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
                      .+.. .++.++|||||||++|+|++|..||.+.+.......+........                   .        ..
T Consensus       203 ~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------------------~--------~~  255 (322)
T d1vzoa_         203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------------------P--------PY  255 (322)
T ss_dssp             TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------------------C--------CC
T ss_pred             hcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------------------C--------CC
Confidence            7533 468899999999999999999999988765444444332211000                   0        01


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 021181          235 FPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH  273 (316)
Q Consensus       235 ~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~  273 (316)
                      ...+|+++.+||.+||+.||.+|||     ++|+++||||++++
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            1357999999999999999999994     89999999999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=319.69  Aligned_cols=225  Identities=27%  Similarity=0.416  Sum_probs=178.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~   81 (316)
                      +++..||||+++.. ..+.....+.+|+.++++++||||+++++++..      ..+|+||||+. |+|.+++.. ...+
T Consensus        33 ~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~iv~E~~~~g~l~~~~~~~~~~l  105 (273)
T d1mp8a_          33 NPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSL  105 (273)
T ss_dssp             -CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTS
T ss_pred             ceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CeEEEEEEeccCCcHHhhhhccCCCC
Confidence            45677999998654 345556789999999999999999999999853      34799999996 688887654 4579


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--cccccccccccCcccccCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCS  159 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  159 (316)
                      ++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......  .....+|+.|+|||++.+ .
T Consensus       106 ~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~  184 (273)
T d1mp8a_         106 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-R  184 (273)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc-C
Confidence            9999999999999999999999999999999999999999999999999987654322  234567899999999987 7


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCC
Q 021181          160 EYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK  238 (316)
Q Consensus       160 ~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
                      .++.++|||||||++|||++ |.+||.+.+..+....+......                              ...+.+
T Consensus       185 ~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------------------------------~~~~~~  234 (273)
T d1mp8a_         185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------------------------PMPPNC  234 (273)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------------------------------CCCTTC
T ss_pred             CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCCCC
Confidence            79999999999999999998 89999988877777665432111                              112367


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          239 SPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       239 s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      |+++.+||.+||+.||.+|||++||+++
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=316.22  Aligned_cols=222  Identities=23%  Similarity=0.368  Sum_probs=174.9

Q ss_pred             ceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCCHH
Q 021181            7 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDD   84 (316)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~   84 (316)
                      ..||||+++... .......+.+|+.++++++|||||++++++...     ...++||||+. |++.+.+... +.+++.
T Consensus        37 ~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  110 (283)
T d1mqba_          37 VPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVL  110 (283)
T ss_dssp             EEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHH
T ss_pred             EEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----CceEEEEEecccCcchhhhhcccccccHH
Confidence            579999997543 344456789999999999999999999999655     45899999996 5787776654 679999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC----ccccccccccccCcccccCCCC
Q 021181           85 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCSE  160 (316)
Q Consensus        85 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~  160 (316)
                      ++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......    ......+|..|+|||.+.+ ..
T Consensus       111 ~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~  189 (283)
T d1mqba_         111 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RK  189 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CC
T ss_pred             HHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CC
Confidence            999999999999999999999999999999999999999999999998754332    1223467889999999987 78


Q ss_pred             CCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCC
Q 021181          161 YTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS  239 (316)
Q Consensus       161 ~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (316)
                      ++.++|||||||++|||++| .+|+...+..+....+......+                              ....++
T Consensus       190 ~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~------------------------------~~~~~~  239 (283)
T d1mqba_         190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------------------------------TPMDCP  239 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------------------------CCTTCB
T ss_pred             CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC------------------------------CchhhH
Confidence            99999999999999999985 55565555555554443321111                              112578


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          240 PGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       240 ~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      ..+.++|.+||+.||++|||+.||++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            88999999999999999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-46  Score=316.05  Aligned_cols=225  Identities=25%  Similarity=0.322  Sum_probs=180.5

Q ss_pred             CCceEEEEEeccccc-ChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCC
Q 021181            5 TREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~   81 (316)
                      ++..||||+++.... .+...+.+.+|+.++++++||||+++++++.++      .+++||||++ |++.+.+.. .+.+
T Consensus        35 ~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~l  108 (273)
T d1u46a_          35 KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHF  108 (273)
T ss_dssp             CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHGGGS
T ss_pred             cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec------chheeeeeecCcchhhhhhcccCCC
Confidence            345799999976543 334457889999999999999999999999643      3689999996 788876654 4569


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc----cccccccccccCcccccC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  157 (316)
                      ++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......    .....++..|+|||.+.+
T Consensus       109 ~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  188 (273)
T d1u46a_         109 LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT  188 (273)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC
Confidence            9999999999999999999999999999999999999999999999999987654432    223456788999999987


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++|||||||++|||++ |.+||.+.+..+....+......+                             ....
T Consensus       189 -~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------~~~~  238 (273)
T d1u46a_         189 -RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------------------------PRPE  238 (273)
T ss_dssp             -CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-----------------------------CCCT
T ss_pred             -CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-----------------------------CCcc
Confidence             778999999999999999998 899999988877776664421111                             1113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                      .+|+++.++|.+||+.||++|||++||++
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            67899999999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=317.28  Aligned_cols=229  Identities=24%  Similarity=0.382  Sum_probs=176.6

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--   78 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--   78 (316)
                      ..+++.||||+++... .......+.+|...+.++ +|+||+.+++++...+    ..+++|||||+ |+|.+++...  
T Consensus        40 ~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~  114 (299)
T d1ywna1          40 TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRN  114 (299)
T ss_dssp             SSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTGG
T ss_pred             ccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhccc
Confidence            4567899999997543 344556677788877776 7999999999886443    45899999996 7999998653  


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---ccc
Q 021181           79 --------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMT  141 (316)
Q Consensus        79 --------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~  141 (316)
                                    ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ...
T Consensus       115 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~  194 (299)
T d1ywna1         115 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  194 (299)
T ss_dssp             GBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTT
T ss_pred             cccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccC
Confidence                          248899999999999999999999999999999999999999999999999997654332   233


Q ss_pred             cccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHh
Q 021181          142 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV  220 (316)
Q Consensus       142 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  220 (316)
                      ...||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+.+.......+......+                 
T Consensus       195 ~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-----------------  256 (299)
T d1ywna1         195 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------  256 (299)
T ss_dssp             SCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred             ceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Confidence            5678999999999987 7799999999999999999986 57888776554443332211111                 


Q ss_pred             hhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          221 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                  .....+++++.++|.+||+.||++|||++|+++|
T Consensus       257 ------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         257 ------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                        1112578899999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=314.31  Aligned_cols=221  Identities=24%  Similarity=0.361  Sum_probs=177.4

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--CC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DL   81 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~~   81 (316)
                      +|+.||||+++.+.    ..+.+.+|++++++++||||+++++++....    ..+|+||||++ |+|.+++....  .+
T Consensus        29 ~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~l  100 (262)
T d1byga_          29 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVL  100 (262)
T ss_dssp             TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHC
T ss_pred             CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhcCCCCC
Confidence            57899999996532    3466889999999999999999999986432    45799999996 79999986543  48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccccccCcccccCCCCC
Q 021181           82 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY  161 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (316)
                      ++..++.++.||+.||.|||+.+|+||||+|+||+++.++.++++|||.++......  ....++..|+|||.+.+ ..+
T Consensus       101 ~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--~~~~~~~~y~aPE~l~~-~~~  177 (262)
T d1byga_         101 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKF  177 (262)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHH-CCC
T ss_pred             CHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC--ccccccccCCChHHHhC-CCC
Confidence            999999999999999999999999999999999999999999999999998755432  34567889999999987 679


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCCh
Q 021181          162 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP  240 (316)
Q Consensus       162 ~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (316)
                      +.++|||||||++|||++ |.+||...+..+....+......                              +....+++
T Consensus       178 t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~------------------------------~~~~~~~~  227 (262)
T d1byga_         178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------------------------DAPDGCPP  227 (262)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC------------------------------CCCTTCCH
T ss_pred             ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCccCCH
Confidence            999999999999999998 79999888777666655321110                              11235788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          241 GAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       241 ~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      ++.+||++||+.||.+|||+.+|+++
T Consensus       228 ~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=319.53  Aligned_cols=221  Identities=23%  Similarity=0.326  Sum_probs=180.0

Q ss_pred             eEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhc-CCCCCHHH
Q 021181            8 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDH   85 (316)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~   85 (316)
                      .||+|+++... +....+.+.+|+.++++++||||+++++++..+.      .+++++++. |+|.+.+.. ...+++..
T Consensus        40 ~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~v~e~~~~~~l~~~~~~~~~~~~~~~  112 (317)
T d1xkka_          40 PVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQY  112 (317)
T ss_dssp             EEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS------EEEEEECCTTCBHHHHHHHTSSSCCHHH
T ss_pred             EEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC------eeEEEEeccCCcccccccccccCCCHHH
Confidence            68999886543 3334577899999999999999999999997542      577778774 788877765 46799999


Q ss_pred             HHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccccCcccccCCCCCC
Q 021181           86 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYT  162 (316)
Q Consensus        86 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  162 (316)
                      ++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........   .....+|..|+|||.+.+ ..++
T Consensus       113 ~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~  191 (317)
T d1xkka_         113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYT  191 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-CCCC
T ss_pred             HHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhc-CCCC
Confidence            999999999999999999999999999999999999999999999987654332   233467899999999987 6799


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCCCCChH
Q 021181          163 AAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG  241 (316)
Q Consensus       163 ~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (316)
                      .++|||||||++|||++ |.+||.+.+..+....+......+                              ..+.++++
T Consensus       192 ~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~------------------------------~p~~~~~~  241 (317)
T d1xkka_         192 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------------------------------QPPICTID  241 (317)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC------------------------------CCTTBCHH
T ss_pred             hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------CCcccCHH
Confidence            99999999999999998 899998887666665554422111                              11357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          242 AVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       242 l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      +.++|.+||+.||.+|||+.||++|
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-45  Score=315.31  Aligned_cols=226  Identities=23%  Similarity=0.284  Sum_probs=187.0

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC--
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ--   79 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--   79 (316)
                      ..+++.||||+++... .......+.+|+.++++++||||+++++++...     ...+++|||++ |+|.+++....  
T Consensus        40 ~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~  113 (301)
T d1lufa_          40 YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPH  113 (301)
T ss_dssp             TSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC-
T ss_pred             CCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-----CceEEEEEecCCCcHHHHHHhcCcc
Confidence            4678899999997543 344567789999999999999999999999654     45899999996 79999986432  


Q ss_pred             ----------------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCC
Q 021181           80 ----------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET  137 (316)
Q Consensus        80 ----------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  137 (316)
                                            .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~  193 (301)
T d1lufa_         114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA  193 (301)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred             ccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCC
Confidence                                  3889999999999999999999999999999999999999999999999998765332


Q ss_pred             C---ccccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHhhCCCCccccccccc
Q 021181          138 D---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ-PLFPGKDYVHQLRLITELIGSPDETSLGFLRS  213 (316)
Q Consensus       138 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  213 (316)
                      .   ......++..|+|||.+.+ ..++.++|||||||++|||++|. +||.+.+..+....+......           
T Consensus       194 ~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~-----------  261 (301)
T d1lufa_         194 DYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-----------  261 (301)
T ss_dssp             GCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             ccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2   2234567889999999987 78999999999999999999985 788888877776665432111           


Q ss_pred             cchHHHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          214 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                         .....+++++.+||.+||+.||++|||+.||++
T Consensus       262 -------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         262 -------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                               111367889999999999999999999999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=311.12  Aligned_cols=225  Identities=25%  Similarity=0.412  Sum_probs=187.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC---
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH---   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---   78 (316)
                      .++..||||+++... .......+.+|...+.++ +||||+++++++.+.     ..+++|||||+ |+|.++|...   
T Consensus        43 ~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~  116 (299)
T d1fgka_          43 NRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPP  116 (299)
T ss_dssp             CCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC
T ss_pred             cCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-----CeEEEEEEccCCCcHHHHHHhhcCC
Confidence            345689999997653 444567788898888888 899999999999755     45899999996 7999999754   


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCC---cccc
Q 021181           79 -------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE  142 (316)
Q Consensus        79 -------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~  142 (316)
                                   ..+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+.......   ....
T Consensus       117 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~  196 (299)
T d1fgka_         117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN  196 (299)
T ss_dssp             ------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTT
T ss_pred             ccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhcccccccccccccc
Confidence                         348999999999999999999999999999999999999999999999999988764432   2344


Q ss_pred             ccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhh
Q 021181          143 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR  221 (316)
Q Consensus       143 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (316)
                      ..+++.|+|||.+.+ +.++.++|||||||++|||++ |.+||.+.+.......+.......                  
T Consensus       197 ~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~------------------  257 (299)
T d1fgka_         197 GRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD------------------  257 (299)
T ss_dssp             SCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred             CCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence            678889999999987 789999999999999999998 799998887666555443211110                  


Q ss_pred             hCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          222 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                  ....+++++.+||.+||+.||.+|||+.||++
T Consensus       258 ------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         258 ------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             ------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                        11257899999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=316.59  Aligned_cols=226  Identities=24%  Similarity=0.318  Sum_probs=182.8

Q ss_pred             CCCc--eEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-
Q 021181            4 ETRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-   78 (316)
Q Consensus         4 ~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-   78 (316)
                      .+|.  .||||+++... .....+.+.+|+++++++ +||||+++++++...     ..+++||||++ |+|.++++.. 
T Consensus        33 ~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~iV~ey~~~g~L~~~l~~~~  106 (309)
T d1fvra_          33 KDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSR  106 (309)
T ss_dssp             ETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTC
T ss_pred             CCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----CeeEEEEEecCCCcHHHHHhhcc
Confidence            4554  57788875432 333456789999999999 799999999999755     56999999996 7999998654 


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccc
Q 021181           79 ---------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY  143 (316)
Q Consensus        79 ---------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  143 (316)
                                     ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus       107 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~  186 (309)
T d1fvra_         107 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG  186 (309)
T ss_dssp             HHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC---
T ss_pred             ccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccce
Confidence                           56999999999999999999999999999999999999999999999999999876655545566


Q ss_pred             cccccccCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhh
Q 021181          144 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM  222 (316)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (316)
                      .+|..|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+....+......                    
T Consensus       187 ~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~--------------------  245 (309)
T d1fvra_         187 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--------------------  245 (309)
T ss_dssp             -CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC--------------------
T ss_pred             ecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC--------------------
Confidence            78999999999987 6789999999999999999996 5678887766666554331110                    


Q ss_pred             CCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          223 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       223 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                                .....+++++.+||.+||+.||++|||++||+++
T Consensus       246 ----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         246 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                      1113578999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-44  Score=310.33  Aligned_cols=228  Identities=24%  Similarity=0.336  Sum_probs=188.9

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhC-CCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~   79 (316)
                      +..+++.||||+++... .......+.+|+.+++.+ +||||+++++++...     ..+++|||||+ |+|.+++....
T Consensus        49 ~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~  122 (311)
T d1t46a_          49 KSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKR  122 (311)
T ss_dssp             STTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTT
T ss_pred             cCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhcc
Confidence            45788999999997653 445567789999999999 699999999999655     45899999996 69999987543


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc--
Q 021181           80 ------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--  139 (316)
Q Consensus        80 ------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  139 (316)
                                        .+++..+..++.||+.||+|||++|++||||||+||+++.++.++++|||.++.......  
T Consensus       123 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~  202 (311)
T d1t46a_         123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV  202 (311)
T ss_dssp             TTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE
T ss_pred             ccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcce
Confidence                              589999999999999999999999999999999999999999999999999987654322  


Q ss_pred             -cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchH
Q 021181          140 -MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR  217 (316)
Q Consensus       140 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (316)
                       .....+|+.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+....+..+......+.             
T Consensus       203 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~-------------  268 (311)
T d1t46a_         203 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-------------  268 (311)
T ss_dssp             ECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-------------
T ss_pred             EeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Confidence             234678999999999987 778999999999999999998 7777877766555554433211110             


Q ss_pred             HHhhhCCCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          218 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                                      .....++.+.+||.+||+.||++|||+++|++
T Consensus       269 ----------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         269 ----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            11256889999999999999999999999885

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-44  Score=309.32  Aligned_cols=231  Identities=23%  Similarity=0.376  Sum_probs=191.4

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC----
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----   78 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----   78 (316)
                      .+++.||||+++... .......+.+|+.++++++||||+++++++...     ...++||||+. |+|.+++...    
T Consensus        48 ~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~  121 (308)
T d1p4oa_          48 EPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAM  121 (308)
T ss_dssp             EEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHH
T ss_pred             CCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-----CceeEEEeecCCCCHHHHHHhccccc
Confidence            456889999997543 444567789999999999999999999999654     45899999996 7999987532    


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc---cccccccccc
Q 021181           79 ------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWY  149 (316)
Q Consensus        79 ------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~  149 (316)
                            ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.......   .....+++.|
T Consensus       122 ~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y  201 (308)
T d1p4oa_         122 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  201 (308)
T ss_dssp             HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGG
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceeccccc
Confidence                  3478999999999999999999999999999999999999999999999999976544322   2334678999


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPK  228 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (316)
                      +|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+....+......                          
T Consensus       202 ~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~--------------------------  254 (308)
T d1p4oa_         202 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL--------------------------  254 (308)
T ss_dssp             CCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC--------------------------
T ss_pred             CCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC--------------------------
Confidence            99999987 7789999999999999999997 5889888877776665432111                          


Q ss_pred             CCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCC
Q 021181          229 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC------HPYLAP  271 (316)
Q Consensus       229 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~------~~~f~~  271 (316)
                          .....+++.+.++|.+||+.||.+|||+++|++      +|+|++
T Consensus       255 ----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         255 ----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             ----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence                111357889999999999999999999999997      676654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=307.51  Aligned_cols=226  Identities=22%  Similarity=0.305  Sum_probs=179.8

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcC-CCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLT   82 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~   82 (316)
                      ++..||||+++.. .+....+.+.+|++++++++||||+++++++...+    ..+++|||||+ |+|.+++... ..++
T Consensus        54 ~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~~~~~~~  128 (311)
T d1r0pa_          54 KKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPT  128 (311)
T ss_dssp             -CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHCTTCCCB
T ss_pred             EEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEEEEEeecCchhhhhccccccch
Confidence            4457999999753 35556688999999999999999999999976432    46899999997 7999888754 4577


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCc-----cccccccccccCcccccC
Q 021181           83 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLN  157 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  157 (316)
                      +..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.......     .....++..|+|||.+.+
T Consensus       129 ~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  208 (311)
T d1r0pa_         129 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT  208 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc
Confidence            888999999999999999999999999999999999999999999999987543321     223467899999999887


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCCCccccCC
Q 021181          158 CSEYTAAIDIWSVGCILGEIMTRQPLFPGK-DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP  236 (316)
Q Consensus       158 ~~~~~~~~DiwslG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
                       ..++.++||||||+++|||++|..||... +..+....+....  .+                            ....
T Consensus       209 -~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--~~----------------------------~~p~  257 (311)
T d1r0pa_         209 -QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RL----------------------------LQPE  257 (311)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--CC----------------------------CCCT
T ss_pred             -CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--CC----------------------------CCcc
Confidence             77899999999999999999977666543 3222232222211  00                            0113


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          237 NKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       237 ~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      .+++++.+||.+||+.||++|||+.|++++
T Consensus       258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            578899999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-42  Score=295.77  Aligned_cols=238  Identities=18%  Similarity=0.163  Sum_probs=179.2

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhc-CCC
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQD   80 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~   80 (316)
                      |..+|+.||||++......    ..+..|+++++.++|++++..+..+...    ....++||||+++++.+.+.. .+.
T Consensus        28 ~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivme~~~~~l~~~~~~~~~~   99 (299)
T d1ckia_          28 DIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVMELLGPSLEDLFNFCSRK   99 (299)
T ss_dssp             ETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEEECCCCBHHHHHHHTTTC
T ss_pred             ECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEEEEcCCchhhhhhhccCC
Confidence            5688999999998654322    2467899999999877766555444322    256899999999888776654 567


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEc---cCCCEEEeeeccccccCCCC--------ccccccccccc
Q 021181           81 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETD--------FMTEYVVTRWY  149 (316)
Q Consensus        81 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~  149 (316)
                      +++..+..++.|++.||+|||++||+||||||+||+++   .+..++++|||+++......        ......||+.|
T Consensus       100 ~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y  179 (299)
T d1ckia_         100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  179 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSS
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccc
Confidence            99999999999999999999999999999999999985   45579999999998764332        12345789999


Q ss_pred             cCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCCCCCCC
Q 021181          150 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ  229 (316)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (316)
                      +|||.+.+ ..++.++|||||||++|||++|..||...........+........                       ..
T Consensus       180 ~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----------------------~~  235 (299)
T d1ckia_         180 ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-----------------------ST  235 (299)
T ss_dssp             CCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-----------------------HS
T ss_pred             cCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-----------------------CC
Confidence            99999987 6799999999999999999999999987664444333222110000                       00


Q ss_pred             CccccCCCCChHHHHHHHHhcccCCCCCCCHH---HHhcCCCCCC
Q 021181          230 NFSARFPNKSPGAVDLLEKMLVFDPNRRITVD---EALCHPYLAP  271 (316)
Q Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~---ell~~~~f~~  271 (316)
                      ........+|+++.++|..||+.||++||+++   ++|+++|.+.
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            01122346889999999999999999999987   5577877543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-42  Score=295.86  Aligned_cols=246  Identities=20%  Similarity=0.198  Sum_probs=170.4

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecCC-CcHHHHhhcCCCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLT   82 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~   82 (316)
                      .+|+.||||+++...   ........|+..+..++||||+++++++...+ .....+|+||||+. |+|.+++++ .+++
T Consensus        24 ~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~   98 (303)
T d1vjya_          24 WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-YTVT   98 (303)
T ss_dssp             ETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-CCBC
T ss_pred             ECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEEecccCCCHHHHHhc-CCCC
Confidence            368899999996432   12222334555667789999999999997653 23346899999996 799999977 4699


Q ss_pred             HHHHHHHHHHHHHHHHHhhc--------CCceeccCCCCcEEEccCCCEEEeeeccccccCCCC-----ccccccccccc
Q 021181           83 DDHCRYFLYQLLRGLKYVHS--------ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRWY  149 (316)
Q Consensus        83 ~~~~~~i~~qi~~~l~~LH~--------~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~  149 (316)
                      +.++..++.|++.||+|||+        +||+||||||+|||++.++.+||+|||++.......     ......||+.|
T Consensus        99 ~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y  178 (303)
T d1vjya_          99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY  178 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCc
Confidence            99999999999999999996        599999999999999999999999999987754332     22346789999


Q ss_pred             cCcccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCccccccccccchHHHhhhCC
Q 021181          150 RAPELLLNCS-----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP  224 (316)
Q Consensus       150 ~aPE~~~~~~-----~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (316)
                      +|||.+....     .++.++|||||||++|||++|.+||.........           ...... .............
T Consensus       179 ~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-----------~~~~~~-~~~~~~~~~~~~~  246 (303)
T d1vjya_         179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-----------YYDLVP-SDPSVEEMRKVVC  246 (303)
T ss_dssp             CCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-----------TTTTSC-SSCCHHHHHHHHT
T ss_pred             CChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-----------hhhccc-ccchHHHHHHHHh
Confidence            9999986522     2456899999999999999999887543211000           000000 0000000000000


Q ss_pred             C-CCCCCccccC--CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021181          225 Q-FPKQNFSARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCH  266 (316)
Q Consensus       225 ~-~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~  266 (316)
                      . .....+....  ......+.+++.+||+.||++|||+.||+++
T Consensus       247 ~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0 0000111111  1223458999999999999999999999763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-41  Score=290.24  Aligned_cols=228  Identities=15%  Similarity=0.131  Sum_probs=180.7

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCC-CCccceeeeecCCCCCCCCeEEEEEecCCCcHHHHhhcC-C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-Q   79 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~   79 (316)
                      |..+|+.||||+++....    ...+.+|++.++.+.| +|++.+++++...     ...++||||++++|.+++... .
T Consensus        26 ~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~~vme~~~~~l~~~~~~~~~   96 (293)
T d1csna_          26 NLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGR   96 (293)
T ss_dssp             ETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTT
T ss_pred             ECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----CccEEEEEecCCCHHHHHHhhcc
Confidence            567899999999865422    2346789999999965 8999999998654     568999999999999988765 4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEcc-----CCCEEEeeeccccccCCCC--------cccccccc
Q 021181           80 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-----NCDLKIGDFGLARTTSETD--------FMTEYVVT  146 (316)
Q Consensus        80 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~-----~~~~~l~df~~~~~~~~~~--------~~~~~~~~  146 (316)
                      .++..++..++.|++.||++||++||+||||||+||+++.     .+.++|+|||+++......        ......||
T Consensus        97 ~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT  176 (293)
T d1csna_          97 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT  176 (293)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEc
Confidence            6999999999999999999999999999999999999974     5789999999997754321        22346789


Q ss_pred             ccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHhhCCCCccccccccccchHHHhhhC
Q 021181          147 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL---RLITELIGSPDETSLGFLRSDNARRYVRML  223 (316)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (316)
                      +.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.......   ..+.......+                   
T Consensus       177 ~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------------------  236 (293)
T d1csna_         177 ARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-------------------  236 (293)
T ss_dssp             TTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-------------------
T ss_pred             hhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-------------------
Confidence            99999999987 77999999999999999999999999876433222   22221110000                   


Q ss_pred             CCCCCCCccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 021181          224 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC  265 (316)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~  265 (316)
                             ..+..+.+|+++.+++..|+..+|++||+.+.+.+
T Consensus       237 -------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 -------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                   11222467899999999999999999998776544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-40  Score=294.97  Aligned_cols=270  Identities=26%  Similarity=0.383  Sum_probs=190.0

Q ss_pred             CCCCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-----------CCCccceeeeecCCCCCCCCeEEEEEecC--C
Q 021181            2 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-----------HENIIAIKDIIRPPQRETFNDVYIVYELM--D   68 (316)
Q Consensus         2 d~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~~~~~~~~~iv~e~~--~   68 (316)
                      |+.+|+.||||+++..   ....+.+.+|+.+++.++           |+||+++++++....   ....+++|.++  .
T Consensus        34 ~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~---~~~~~~~~~~~~~~  107 (362)
T d1q8ya_          34 DMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG---PNGVHVVMVFEVLG  107 (362)
T ss_dssp             ETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE---TTEEEEEEEECCCC
T ss_pred             ECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc---ccceeeeeeecccc
Confidence            6789999999999753   233456778888888774           578999999886432   13455666655  3


Q ss_pred             CcHHH--HhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCceeccCCCCcEEEccCCC------EEEeeeccccccCCCCc
Q 021181           69 TDLHQ--IIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCD------LKIGDFGLARTTSETDF  139 (316)
Q Consensus        69 g~L~~--~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~nil~~~~~~------~~l~df~~~~~~~~~~~  139 (316)
                      +....  .......+++..++.++.||+.||+|||+ .||+||||||+|||++.++.      ++++|||.+......  
T Consensus       108 ~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--  185 (362)
T d1q8ya_         108 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--  185 (362)
T ss_dssp             EEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--
T ss_pred             cccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--
Confidence            33333  33344679999999999999999999997 89999999999999987654      999999998765433  


Q ss_pred             cccccccccccCcccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHhhCCCCccccccccc
Q 021181          140 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD------YVHQLRLITELIGSPDETSLGFLRS  213 (316)
Q Consensus       140 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~  213 (316)
                      .....+++.|+|||++.. ..++.++|+||+||++++|++|+.||...+      ..+.+.......|..+.........
T Consensus       186 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  264 (362)
T d1q8ya_         186 YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY  264 (362)
T ss_dssp             CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred             cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccc
Confidence            345678999999999987 678999999999999999999999997543      2334555566666654433211110


Q ss_pred             cchHHHhh------hCCCCCCCCc-------cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 021181          214 DNARRYVR------MLPQFPKQNF-------SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV  280 (316)
Q Consensus       214 ~~~~~~~~------~~~~~~~~~~-------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~  280 (316)
                      .  ..+..      ..........       .......++++.+||.+||.+||.+|||++|+|+||||++.....+.+.
T Consensus       265 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~  342 (362)
T d1q8ya_         265 T--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV  342 (362)
T ss_dssp             H--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCC
T ss_pred             c--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCC
Confidence            0  00000      0000000000       0011234677999999999999999999999999999998765555444


Q ss_pred             CC
Q 021181          281 CP  282 (316)
Q Consensus       281 ~~  282 (316)
                      ..
T Consensus       343 p~  344 (362)
T d1q8ya_         343 PD  344 (362)
T ss_dssp             TT
T ss_pred             CC
Confidence            33

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.80  E-value=2.5e-20  Score=149.25  Aligned_cols=152  Identities=15%  Similarity=0.120  Sum_probs=104.5

Q ss_pred             CCCceEEEEEecccccC----------------hhHHHHHHHHHHHHhhCCCCCccceeeeecCCCCCCCCeEEEEEecC
Q 021181            4 ETREEVAIKKIGNAFDN----------------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM   67 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~iv~e~~   67 (316)
                      .+|+.||||+++.....                .........|...+.++.|.+++..+++..         .+++||++
T Consensus        22 ~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~---------~~lvme~~   92 (191)
T d1zara2          22 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG---------NAVLMELI   92 (191)
T ss_dssp             TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET---------TEEEEECC
T ss_pred             CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC---------CEEEEEee
Confidence            47899999987542111                112234457889999999999998887641         27999999


Q ss_pred             CCcHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCceeccCCCCcEEEccCCCEEEeeeccccccCCCCccccccccc
Q 021181           68 DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR  147 (316)
Q Consensus        68 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (316)
                      ++...      ..++...+..++.|++.+|++||++||+||||||+|||++.+ .++|+|||.+.....+....-...+.
T Consensus        93 ~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~  165 (191)
T d1zara2          93 DAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDV  165 (191)
T ss_dssp             CCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHH
T ss_pred             ccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHH
Confidence            86321      234556677899999999999999999999999999999865 48999999987665432211000000


Q ss_pred             cccCcccccCCCCCCCcchHHHHHHHH
Q 021181          148 WYRAPELLLNCSEYTAAIDIWSVGCIL  174 (316)
Q Consensus       148 ~~~aPE~~~~~~~~~~~~DiwslG~~l  174 (316)
                      . .-.+.+.  +.|+..+|+||+.--+
T Consensus       166 ~-~~~~~f~--r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         166 R-NIITYFS--RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             H-HHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred             H-HHHHHHc--CCCCCcccHHHHHHHH
Confidence            0 0012222  4678899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.99  E-value=1.3e-05  Score=65.13  Aligned_cols=116  Identities=13%  Similarity=0.113  Sum_probs=71.0

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC-cHHHHhhcCCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL   81 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~   81 (316)
                      .+++.++||+......  .....+.+|...+..+. +--+++++.+....     +..++||++++| ++.+....    
T Consensus        35 ~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-----~~~~lv~~~l~G~~~~~~~~~----  103 (263)
T d1j7la_          35 GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYED----  103 (263)
T ss_dssp             CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCSSEEHHHHTTT----
T ss_pred             eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecC-----CceEEEEEecccccccccccc----
Confidence            3567788898754321  12334667888887774 33356677766433     458999999987 55443321    


Q ss_pred             CHHHHHHHHHHHHHHHHHhhc-----------------------------------------------------------
Q 021181           82 TDDHCRYFLYQLLRGLKYVHS-----------------------------------------------------------  102 (316)
Q Consensus        82 ~~~~~~~i~~qi~~~l~~LH~-----------------------------------------------------------  102 (316)
                       ......++.++...++.||+                                                           
T Consensus       104 -~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  182 (263)
T d1j7la_         104 -EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEE  182 (263)
T ss_dssp             -CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCC
T ss_pred             -cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCC
Confidence             11111223333333333331                                                           


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      ..++|+|+.|.||+++.++.+.++||+.+
T Consensus       183 ~~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             cEEEEeeccCcceeecCCceEEEeechhc
Confidence            12789999999999997766679999865

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.66  E-value=9e-05  Score=59.69  Aligned_cols=56  Identities=11%  Similarity=0.083  Sum_probs=37.3

Q ss_pred             CCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCC--ccceeeeecCCCCCCCCeEEEEEecCCC
Q 021181            4 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      ..|..+++|.......     ..+..|...++.+...+  +++++.+..+.     +..++||++++|
T Consensus        33 ~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~~~i~G   90 (255)
T d1nd4a_          33 QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGEVPG   90 (255)
T ss_dssp             TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEECCSS
T ss_pred             CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEEEeeec
Confidence            4577789998654322     23667888887774323  56677765443     458999999976

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.44  E-value=0.00025  Score=61.18  Aligned_cols=29  Identities=21%  Similarity=0.271  Sum_probs=24.8

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeeccccc
Q 021181          104 NVLHRDLKPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       104 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      .++|||+++.|||++.++ ++++||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            589999999999998764 89999987644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.0011  Score=55.25  Aligned_cols=126  Identities=16%  Similarity=0.167  Sum_probs=68.8

Q ss_pred             CCCCceEEEEEecccccChhHHHHHHHHHHHHhhCCCCCccceeeeecCCC--CCCCCeEEEEEecCCCc------HHHH
Q 021181            3 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ--RETFNDVYIVYELMDTD------LHQI   74 (316)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~~~~~iv~e~~~g~------L~~~   74 (316)
                      .++|..|++|+.+..   ......+..|...+..|...++.-..-....++  .+.....+.++++++|.      ....
T Consensus        43 ~~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~  119 (325)
T d1zyla1          43 DEDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQM  119 (325)
T ss_dssp             CTTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHH
T ss_pred             cCCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHH
Confidence            367899999987533   234566778998888885333322111111111  12335578899998752      1111


Q ss_pred             --h-----------hcC------------------------CCCCH---HHHHHHHHHHHHHHHHhh----cCCceeccC
Q 021181           75 --I-----------RSH------------------------QDLTD---DHCRYFLYQLLRGLKYVH----SANVLHRDL  110 (316)
Q Consensus        75 --l-----------~~~------------------------~~~~~---~~~~~i~~qi~~~l~~LH----~~~i~H~dl  110 (316)
                        +           ...                        ..++.   ......+.+++..+.-.-    ..+++|+|+
T Consensus       120 ~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDl  199 (325)
T d1zyla1         120 EAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDC  199 (325)
T ss_dssp             HHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSC
T ss_pred             HHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCC
Confidence              0           000                        01111   122233334443333321    236899999


Q ss_pred             CCCcEEEccCCCEEEeeeccccc
Q 021181          111 KPSNLLLNANCDLKIGDFGLART  133 (316)
Q Consensus       111 ~p~nil~~~~~~~~l~df~~~~~  133 (316)
                      .+.||+++.+  ..++||+.+..
T Consensus       200 h~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         200 HAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SGGGEEESSS--EEECCCTTCCE
T ss_pred             CcccEEEeCC--ceEEechhccc
Confidence            9999999743  46899987643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.72  E-value=0.0025  Score=54.63  Aligned_cols=52  Identities=10%  Similarity=0.024  Sum_probs=32.6

Q ss_pred             CCceEEEEEecccccChhHHHHHHHHHHHHhhCC-CCCccceeeeecCCCCCCCCeEEEEEecCCC
Q 021181            5 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT   69 (316)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~iv~e~~~g   69 (316)
                      ..+.|++++....    .......+|..+++.+. +.-.+++++++..         ++|++|++|
T Consensus        73 ~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---------g~I~efi~g  125 (395)
T d1nw1a_          73 EPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG---------GRLEEYIPS  125 (395)
T ss_dssp             CCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------EEEECCCCE
T ss_pred             CCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------ceEEEEecc
Confidence            3456777766421    12233557888888884 4445678887631         679999876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.93  E-value=0.014  Score=47.84  Aligned_cols=29  Identities=31%  Similarity=0.342  Sum_probs=25.8

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeeccc
Q 021181          103 ANVLHRDLKPSNLLLNANCDLKIGDFGLA  131 (316)
Q Consensus       103 ~~i~H~dl~p~nil~~~~~~~~l~df~~~  131 (316)
                      .|++|+|+.+.|++++.+...-++||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            47999999999999998877789999865